PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, J; Xi, Y; Li, W; McCarthy, RL; Stratton, SA; Zou, W; Li, W; Dent, SY; Jain, AK; Barton, MC				Li, J.; Xi, Y.; Li, W.; McCarthy, R. L.; Stratton, S. A.; Zou, W.; Li, W.; Dent, S. Y.; Jain, A. K.; Barton, M. C.			TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation	ONCOGENE			English	Article							EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; IN-VITRO PROPAGATION; EXPRESSION ANALYSIS; COMPLEX PRC2; PROTEIN EED; GENOME; METHYLATION; REPRESSION; BINDING	Histone methyl transferase EZH2 (Enhancer of Zeste Homolog 2) is generally associated with H3K27 methylation and gene silencing, as a member of the polycomb repressor 2 (PRC2) complex. Immunoprecipitation and mass spectrometry of the EZH2-protein interactome in estrogen receptor positive, breast cancer-derived MCF7 cells revealed EZH2 interactions with subunits of chromatin remodeler SWI/SNF complex and TRIM28, which formed a complex with EZH2 distinct from PRC2. Unexpectedly, transcriptome profiling showed that EZH2 primarily activates, rather than represses, transcription in MCF7 cells and with TRIM28 co-regulates a set of genes associated with stem cell maintenance and poor survival of breast cancer patients. TRIM28 depletion repressed EZH2 recruitment to chromatin and expression of this gene set, in parallel with decreased CD44(hi)/CD24(lo) mammosphere formation. Mammosphere formation, inhibited by EZH2 depletion, was rescued by ectopic expression of EZH2 but not by TRIM28 expression or by EZH2 mutated at the region (pre-SET domain) of TRIM28 interaction. These results support PRC2-independent functions of EZH2 and TRIM28 in activation of gene expression that promotes mammary stem cell enrichment and maintenance.	[Li, J.; Barton, M. C.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Genes & Dev Grad Program, Houston, TX 77030 USA; [Li, J.; Li, W.; McCarthy, R. L.; Stratton, S. A.; Dent, S. Y.; Jain, A. K.; Barton, M. C.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Li, J.; Li, W.; McCarthy, R. L.; Stratton, S. A.; Dent, S. Y.; Jain, A. K.; Barton, M. C.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Xi, Y.; Zou, W.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Li, W.] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Baylor College of Medicine	Barton, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mbarton@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Barton, Michelle/0000-0002-4042-1374; Jain, Abhinav/0000-0003-3268-514X	CPRIT [RP110471]; Gigli Family Endowed Scholarship of the UT-Graduate School of Biomedical Sciences at Houston, TX; Laura and John Arnold Foundation; Odyssey Program fellowship; CPRIT Core Facility Support [RP120348]; National Institutes of Health through MD Anderson's Cancer Center Support [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA190176] Funding Source: NIH RePORTER	CPRIT; Gigli Family Endowed Scholarship of the UT-Graduate School of Biomedical Sciences at Houston, TX; Laura and John Arnold Foundation; Odyssey Program fellowship; CPRIT Core Facility Support; National Institutes of Health through MD Anderson's Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by CPRIT RP110471 to MCB, WL and SYD. JL received support by a Gigli Family Endowed Scholarship of the UT-Graduate School of Biomedical Sciences at Houston, TX. AKJ was supported by The Laura and John Arnold Foundation and Odyssey Program fellowship. We thank Dr M-C Hung for the Myc-EZH2 plasmid, Dr J-I Park for Flag-EZH2 plasmids and Dr PR Potts for HA-TRIM28, GST-TRIM28 full-length and RBCC only plasmids. This study used the Science Park NGS Core, supported by CPRIT Core Facility Support Grant RP120348, and the Flow Cytometry and Cellular Imaging Facility, which is supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672.	Addison J, 2014, CANCER RES, V75, P344; Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Cama A, 2013, ACTA NEUROPATHOL, V126, P575, DOI 10.1007/s00401-013-1165-y; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Changchien YC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-216; Cheung RK, 2011, NAT REV RHEUMATOL, V7, P502, DOI 10.1038/nrrheum.2011.110; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Gonzalez ME, 2014, P NATL ACAD SCI USA, V111, P3098, DOI 10.1073/pnas.1308953111; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wu RC, 2014, ELECTRON J QUAL THEO, P1; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	66	34	34	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2991	3001		10.1038/onc.2016.453	http://dx.doi.org/10.1038/onc.2016.453			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	28068325	Green Accepted			2022-12-26	WOS:000402000400007
J	Marques, MD; Pinto, JR; Moraes, AH; Iqbal, A; de Magalha, MTQ; Monteiro, J; Pedrote, MM; Sorenson, MM; Silva, JL; de Oliveira, GAP				Marques, Mayra de A.; Pinto, Jose Renato; Moraes, Adolfo H.; Iqbal, Anwar; de Magalha, Mariana T. Q.; Monteiro, Jamila; Pedrote, Murilo M.; Sorenson, Martha M.; Silva, Jerson L.; de Oliveira, Guilherme A. P.			Allosteric Transmission along a Loosely Structured Backbone Allows a Cardiac Troponin C Mutant to Function with Only One Ca2+ Ion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISPERSION NMR-SPECTROSCOPY; MAGNESIUM BINDING-SITES; HYPERTROPHIC CARDIOMYOPATHY; CALCIUM-BINDING; DILATED CARDIOMYOPATHY; TRYPTOPHAN MUTANTS; HIGH-PRESSURE; DOMAIN; MUTATIONS; PROTEINS	Hypertrophic cardiomyopathy (HCM) is one of the most common cardiomyopathies and a major cause of sudden death in young athletes. The Ca2+ sensor of the sarcomere, cardiac troponin C (cTnC), plays an important role in regulating muscle contraction. Although several cardiomyopathy-causing mutations have been identified in cTnC, the limited information about their structural defects has been mapped to the HCM phenotype. Here, we used high-resolution electron-spray ionization mass spectrometry (ESI-MS), Carr-Purcell-MeiboomGill relaxation dispersion (CPMG-RD), and affinity measurements of cTnC for the thin filament in reconstituted papillary muscles to provide evidence of an allosteric mechanism in mutant cTnC that may play a role to the HCM phenotype. We showed that the D145E mutation leads to altered dynamics on a mu s-ms time scale and deactivates both of the divalent cation-binding sites of the cTnC C-domain. CPMG-RD captured a low populated protein-folding conformation triggered by the Glu-145 replacement of Asp. Paradoxically, although D145E C-domain was unable to bind Ca2+, these changes along its backbone allowed it to attach more firmly to thin filaments than the wildtype isoform, providing evidence for an allosteric response of the Ca2+-binding site II in the N-domain. Our findings explain how the effects of an HCM mutation in the C-domain reflect up into the N-domain to cause an increase of Ca2+ affinity in site II, thus opening up new insights into the HCM phenotype.	[Marques, Mayra de A.; Iqbal, Anwar; Monteiro, Jamila; Pedrote, Murilo M.; Sorenson, Martha M.; Silva, Jerson L.; de Oliveira, Guilherme A. P.] Univ Fed Rio de Janeiro, Programa Biol Estrut, Inst Bioquim Med, Inst Nacl Biol Estrutural & Bioimagem,Ctr Nacl Re, BR-21941902 Rio De Janeiro, Brazil; [Pinto, Jose Renato] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32304 USA; [Moraes, Adolfo H.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, Belo Horizonte, MG, Brazil; [de Magalha, Mariana T. Q.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; State University System of Florida; Florida State University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Silva, JL; de Oliveira, GAP (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrut, Inst Bioquim Med, Inst Nacl Biol Estrutural & Bioimagem,Ctr Nacl Re, BR-21941902 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br; gaugusto@bioqmed.ufrj.br	de Oliveira, Guilherme A. P./O-1192-2013; Pinto, Jose Renato/H-2631-2017; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022; Marques, Mayra/AAN-3130-2021; Moraes, Adolfo/G-3931-2018	de Oliveira, Guilherme A. P./0000-0002-0063-5888; Pinto, Jose Renato/0000-0001-9092-4976; Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; Moraes, Adolfo/0000-0002-3344-4084; Pedrote, Murilo/0000-0001-6744-9572; Torquato Quezado de Magalhaes, Mariana/0000-0003-4912-0233; Marques, Mayra/0000-0002-4131-4634	Brazilian Synchrotron Light Laboratory [SAXS-14200]; Brazilian Biosciences National Laboratory [RMN-15571]; National Council of Technological and Scientific Development (CNPQ); Ministry of Health (MS/Decit); Carlos Chagas Filho Foundation; CNPQ; National Institutes of Health [HL128683]; Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	Brazilian Synchrotron Light Laboratory; Brazilian Biosciences National Laboratory; National Council of Technological and Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (MS/Decit); Carlos Chagas Filho Foundation; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant SAXS-14200 from the Brazilian Synchrotron Light Laboratory and Grant RMN-15571 from the Brazilian Biosciences National Laboratory. This work was also supported by grants from the National Council of Technological and Scientific Development (CNPQ), the Ministry of Health (MS/Decit), and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (to J.L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; 1 Recipient of a doctoral fellowship from CNPQ.; 2 Recipient of National Institutes of Health Grant HL128683.; 3 Recipient of a CNPQ research fellowship.; 4 Recipient of a CNPQ research fellowship. To whom correspondence may be addressed. E-mail address: jerson@bioqmed.ufrj.br.; 5 Supported by the Cancer Foundation and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro. To whom correspondence may be addressed. E-mail address: gaugusto@bioqmed.ufrj.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; de Oliveira GAP, 2013, BIOCHEMISTRY-US, V52, P28, DOI 10.1021/bi301139d; De Simone A, 2015, ELIFE, V4, DOI 10.7554/eLife.02777; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; FROMHERZ S, 1995, P NATL ACAD SCI USA, V92, P7652, DOI 10.1073/pnas.92.17.7652; GRABAREK Z, 1995, BIOCHEMISTRY-US, V34, P11872, DOI 10.1021/bi00037a027; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Korzhnev DM, 2004, J AM CHEM SOC, V126, P7320, DOI 10.1021/ja049968b; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Marques MD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00429; Moncrieffe MC, 1999, BIOCHEMISTRY-US, V38, P11973, DOI 10.1021/bi982048j; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Pan BS, 1996, J BIOL CHEM, V271, P817, DOI 10.1074/jbc.271.2.817; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Robertson IM, 2015, J MOL CELL CARDIOL, V87, P257, DOI 10.1016/j.yjmcc.2015.08.017; She MD, 1998, EUR J BIOCHEM, V252, P600, DOI 10.1046/j.1432-1327.1998.2520600.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suarez MC, 2003, BIOCHEMISTRY-US, V42, P5522, DOI 10.1021/bi027102h; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tugarinov V, 2015, ANGEW CHEM INT EDIT, V54, P11157, DOI 10.1002/anie.201505416; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang X, 2001, J BIOL CHEM, V276, P25456, DOI 10.1074/jbc.M102418200; Williams MR, 2016, P NATL ACAD SCI USA, V113, P3257, DOI 10.1073/pnas.1519541113; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031	45	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2379	2394		10.1074/jbc.M116.765362	http://dx.doi.org/10.1074/jbc.M116.765362			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28049727	Green Published, hybrid			2022-12-26	WOS:000395530300028
J	Ginsberg, HS; Albert, M; Acevedo, L; Dyer, MC; Arsnoe, IM; Tsao, JI; Mather, TN; LeBrun, RA				Ginsberg, Howard S.; Albert, Marisa; Acevedo, Lixis; Dyer, Megan C.; Arsnoe, Isis M.; Tsao, Jean I.; Mather, Thomas N.; LeBrun, Roger A.			Environmental Factors Affecting Survival of Immature lxodes scapularis and Implications for Geographical Distribution of Lyme Disease: The Climate/Behavior Hypothesis	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; BLACKLEGGED TICK ACARI; IXODES-SCAPULARIS; BORRELIA-BURGDORFERI; RELATIVE-HUMIDITY; HABITAT DISTRIBUTION; SAMPLING METHODS; IXODIDAE NYMPHS; PACIFICUS ACARI; RANGE EXPANSION	Recent reports suggest that host-seeking nymphs in southern populations of Ixodes scapularis remain below the leaf litter surface, while northern nymphs seek hosts on leaves and twigs above the litter surface. This behavioral difference potentially results in decreased tick contact with humans in the south, and fewer cases of Lyme disease. We studied whether north-south differences in tick survival patterns might contribute to this phenomenon. Four month old larvae resulting from a cross between Wisconsin males and South Carolina females died faster under southern than under northern conditions in the lab, as has previously been reported for ticks from both northern and southern populations. However, newly emerged larvae from Rhode Island parents did not differ consistently in mortality under northern and southern conditions, possibly because of their younger age. Survival is lower, and so the north-south survival difference might be greater in older ticks. Larval survival was positively related to larval size (as measured by scutal area), while survival was positively related to larval fat content in some, but not all, trials. The difference in larval survival under northern vs. southern conditions might simply result from faster metabolism under warmer southern conditions leading to shorter life spans. However, ticks consistently died faster under southern than under northern conditions in the laboratory when relative humidity was low (75%), but not under moderate (85%) or high (95%) RH. Therefore, mortality due to desiccation stress is greater under southern than under northern conditions. We hypothesize that mortality resulting from the greater desiccation stress under southern conditions acts as a selective pressure resulting in the evolution of host-seeking behavior in which immatures remain below the leaf litter surface in southern I. scapularis populations, so as to avoid the desiccating conditions at the surface. If this hypothesis is correct, it has implications for the effect of climate change on the future distribution of Lyme disease.	[Ginsberg, Howard S.] Univ Rhode Isl, USGS Patuxent Wildlife Res Ctr, Woodward Hall PSE, Kingston, RI 02881 USA; [Albert, Marisa; Acevedo, Lixis; Dyer, Megan C.; Mather, Thomas N.; LeBrun, Roger A.] Univ Rhode Isl, Dept Plant Sci & Entomol, Woodward Hall, Kingston, RI 02881 USA; [Arsnoe, Isis M.; Tsao, Jean I.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI USA	United States Department of the Interior; United States Geological Survey; University of Rhode Island; University of Rhode Island; Michigan State University	Ginsberg, HS (corresponding author), Univ Rhode Isl, USGS Patuxent Wildlife Res Ctr, Woodward Hall PSE, Kingston, RI 02881 USA.	hginsberg@usgs.gov		Ginsberg, Howard/0000-0002-4933-2466	National Science Foundation, Ecology and Evolution of Infectious Disease Program [0914376]; University of Rhode Island; U.S. Geological Survey	National Science Foundation, Ecology and Evolution of Infectious Disease Program(National Science Foundation (NSF)); University of Rhode Island; U.S. Geological Survey(United States Geological Survey)	This work was supported by Award ID 0914376 from the National Science Foundation, Ecology and Evolution of Infectious Disease Program, with additional support from the University of Rhode Island and the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPERSON CS, 1993, EXP APPL ACAROL, V17, P719; Arsnoe IM, 2015, THESIS; Arsnoe IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127450; Bechara G. H., 1995, Revista Brasileira de Parasitologia Veterinaria, V4, P61; Berger KA, 2014, J MED ENTOMOL, V51, P769, DOI 10.1603/ME13186; Berger KA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-181; CHIERA JW, 1985, INSECT SCI APPL, V6, P555, DOI 10.1017/S1742758400004409; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Durden LA, 2002, EXP APPL ACAROL, V26, P257, DOI 10.1023/A:1021199914816; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; Giery ST, 2007, J PARASITOL, V93, P511, DOI 10.1645/GE-1053R1.1; Ginsberg HS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-394; GINSBERG HS, 1989, EXP APPL ACAROL, V7, P313, DOI 10.1007/BF01197925; GINSBERG HS, 1989, J MED ENTOMOL, V26, P183, DOI 10.1093/jmedent/26.3.183; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Ginsberg HS, 2008, TICKS, P303; Ginsberg HS, 2017, J MED ENTOM IN PRESS; Goddard J, 2006, J VECTOR ECOL, V31, P421, DOI 10.3376/1081-1710(2006)31[421:NROIIS]2.0.CO;2; Goddard J, 2015, J MED ENTOMOL, V52, P81, DOI 10.1093/jme/tju005; Goddard Jerome, 2002, J Agromedicine, V8, P25, DOI 10.1300/J096v08n02_06; JAMES AM, 1990, J MED ENTOMOL, V27, P324, DOI 10.1093/jmedent/27.3.324; KNULLE WILLI, 1966, J MED ENTOMOL, V2, P335, DOI 10.1093/jmedent/2.4.335; KOCH HG, 1975, J MED ENTOMOL, V12, P213, DOI 10.1093/jmedent/12.2.213; Lantos PM, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv143; Madden RD, 1996, J PARASITOL, V82, P203, DOI 10.2307/3284146; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; OLIVER JH, 1993, J PARASITOL, V79, P684, DOI 10.2307/3283605; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Piesman J, 1999, J VECTOR ECOL, V24, P91; Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2; Rulison EL, 2014, J PARASITOL, V100, P578, DOI 10.1645/14-503.1; Rulison EL, 2013, J VECTOR ECOL, V38, P163, DOI 10.1111/j.1948-7134.2013.12022.x; Schulze TL, 2002, ENVIRON ENTOMOL, V31, P1085, DOI 10.1603/0046-225X-31.6.1085; Siegal, 1956, NONPARAMETRIC STAT B; STAFFORD KC, 1994, J MED ENTOMOL, V31, P310, DOI 10.1093/jmedent/31.2.310; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Vail SG, 1998, J MED ENTOMOL, V35, P1025, DOI 10.1093/jmedent/35.6.1025; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961	48	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168723	10.1371/journal.pone.0168723	http://dx.doi.org/10.1371/journal.pone.0168723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076359	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100017
J	Dona, O; Noseworthy, MD; DeMatteo, C; Connolly, JF				Dona, Olga; Noseworthy, Michael D.; DeMatteo, Carol; Connolly, John F.			Fractal Analysis of Brain Blood Oxygenation Level Dependent (BOLD) Signals from Children with Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							SPONTANEOUS FLUCTUATIONS; ACTIVATION; COMPLEXITY; DIMENSION; SYMPTOMS; NETWORK; MOTIONS; SYSTEMS; NOISES; FMRI	Background Conventional imaging techniques are unable to detect abnormalities in the brain following mild traumatic brain injury (mTBI). Yet patients with mTBI typically show delayed response on neuropsychological evaluation. Because fractal geometry represents complexity, we explored its utility in measuring temporal fluctuations of brain resting state blood oxygen level dependent (rs-BOLD) signal. We hypothesized that there could be a detectable difference in rs-BOLD signal complexity between healthy subjects and mTBI patients based on previous studies that associated reduction in signal complexity with disease. Methods Fifteen subjects (13.4 +/- 2.3 y/o) and 56 age-matched (13.5 +/- 2.34 y/o) healthy controls were scanned using a GE Discovery MR750 3T MRI and 32-channel RF-coil. Axial FSPGR-3D images were used to prescribe rs-BOLD (TE/TR = 35/2000ms), acquired over 6 minutes. Motion correction was performed and anatomical and functional images were aligned and spatially warped to the N27 standard atlas. Fractal analysis, performed on grey matter, was done by estimating the Hurst exponent using de-trended fluctuation analysis and signal summation conversion methods. Results and Conclusions Voxel-wise fractal dimension (FD) was calculated for every subject in the control group to generate mean and standard deviation maps for regional Z-score analysis. Voxel-wise validation of FD normality across controls was confirmed, and non-Gaussian voxels (3.05% over the brain) were eliminated from subsequent analysis. For each mTBI patient, regions where Z-score values were at least 2 standard deviations away from the mean (i.e. where vertical bar Z vertical bar > 2.0) were identified. In individual patients the frequently affected regions were amygdala (p = 0.02), vermis(p = 0.03), caudate head (p = 0.04), hippocampus(p = 0.03), and hypothalamus(p = 0.04), all previously reported as dysfunctional after mTBI, but based on group analysis. It is well known that the brain is best modeled as a complex system. Therefore a measure of complexity using rs-BOLD signal FD could provide an additional method to grade and monitor mTBI. Furthermore, this approach can be personalized thus providing unique patient specific assessment.	[Dona, Olga; Noseworthy, Michael D.; Connolly, John F.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Dona, Olga; Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Med, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Linguist, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Engn Technol Bldg,ETB-406,1280 Main St, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Noseworthy, MD (corresponding author), McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Radiol, Hamilton, ON, Canada.; Noseworthy, MD (corresponding author), McMaster Univ, Dept Elect & Comp Engn, Engn Technol Bldg,ETB-406,1280 Main St, Hamilton, ON L8S 4K1, Canada.	nosewor@mcmaster.ca	; Noseworthy, Michael/B-2957-2011	Connolly, John/0000-0001-8869-5369; Noseworthy, Michael/0000-0003-1464-159X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR), http://www.cihr-irsc.gc.ca/.	Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bullmore ET, 2009, NEUROIMAGE, V47, P1125, DOI 10.1016/j.neuroimage.2009.05.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Eickhoff, 2005, NEUROIMAGE, V25; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Felger JC, 2016, MOL PSYCHIATR, V21, P1358, DOI 10.1038/mp.2015.168; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Herman P, 2011, NEUROIMAGE, V58, P1060, DOI 10.1016/j.neuroimage.2011.06.082; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kannathal N, 2004, P ANN INT IEEE EMBS, V26, P604; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lu Liyan, 2015, IRON DEPOSITION POSI, V2015; Malenka RC, MOL NEUROPHARMACOLOG, p[147, 367, 376]; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MANDELBROT BB, 1985, PHYS SCRIPTA, V32, P257, DOI 10.1088/0031-8949/32/4/001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Munivenkatappa A, 2015, J NEUROSURG SCI; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Simpson PE, 1993, BRAIN RES, V607, P9, DOI 10.1016/0006-8993(93)91483-9; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smits FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149587; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vallez Garcia D, 2016, J NEUROTRAUMA; Warsi MA, 2013, VISUALIZATION IMAGE, V2; Warsi MA, 2012, MAGN RESON MATER PHY, V25, P335, DOI 10.1007/s10334-012-0312-0; Weber AM, 2014, MAGN RESON MATER PHY, V27, P291, DOI 10.1007/s10334-013-0420-5; Wenzel JM, 2015, ACS CHEM NEUROSCI, V6, P16, DOI 10.1021/cn500255p; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	45	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169647	10.1371/journal.pone.0169647	http://dx.doi.org/10.1371/journal.pone.0169647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072842	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200035
J	Mason, TJ; French, K; Jolley, DF				Mason, Tanya J.; French, Kristine; Jolley, Dianne F.			Functional Richness and Identity Do Not Strongly Affect Invasibility of Constructed Dune Communities	PLOS ONE			English	Article							PLANT-COMMUNITIES; GRASSLAND COMMUNITIES; INVASION-RESISTANCE; SPECIES RICHNESS; BIOTIC RESISTANCE; DIVERSITY; BIODIVERSITY; INVADER; AVAILABILITY; TEMPERATURES	Biotic effects are often used to explain community structure and invasion resistance. We evaluated the contribution of functional richness and identity to invasion resistance and abiotic resource availability using a mesocosm experiment. We predicted that higher functional richness would confer greater invasion resistance through greater resource sequestration. We also predicted that niche pre-emption and invasion resistance would be higher in communities which included functional groups similar to the invader than communities where all functional groups were distinct from the invader. We constructed communities of different functional richness and identity but maintained constant species richness and numbers of individuals in the resident community. The constructed communities represented potential fore dune conditions following invader control activities along the Australian east coast. We then simulated an invasion event by bitou (Chrysanthemoides monilifera ssp. rotundata DC. Norl.), a South African shrub invader. We used the same bitou propagule pressure across all treatments and monitored invasion success and resource availability for 13 months. Contrary to our predictions, we found that functional richness did not mediate the number of bitou individuals or bitou cover and functional identity had little effect on invasion success: there was a trend for the grass single functional group treatment to supress bitou individuals, but this trend was obscured when grasses were in multi functional group treatments. We found that all constructed communities facilitated bitou establishment and suppressed bitou cover relative to unplanted mesocosms. Abiotic resource use was either similar among planted communities, or differences did not relate to invasion success (with the exception of light availability). We attribute invasion resistance to bulk plant biomass across planted treatments rather than their functional group arrangement.	[Mason, Tanya J.; French, Kristine] Univ Wollongong, Sch Biol Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW 2522, Australia; [Jolley, Dianne F.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Mason, Tanya J.] Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW 2052, Australia	University of Wollongong; University of Wollongong; University of New South Wales Sydney	Mason, TJ (corresponding author), Univ Wollongong, Sch Biol Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW 2522, Australia.; Mason, TJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW 2052, Australia.	t.mason@unsw.edu.au	French, Kris/I-8202-2012; Jolley, Dianne/D-1597-2009	French, Kris/0000-0001-6938-2017; Jolley, Dianne/0000-0003-1028-1603	Land and Water Australia [UOW06]; NSW Environmental Trust [2007/RR/0026]	Land and Water Australia; NSW Environmental Trust	The research was funded by Land and Water Australia (UOW06, http://lwa.gov.au/) and NSW Environmental Trust (2007/RR/0026, http://www.environment.nsw.gov.au/grants/envtrust.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED B. W., 1949, JOUR RANGE MANAGEMENT, V2, P17, DOI 10.2307/3893829; [Anonymous], 2001, STAT PSYCHOL INTERME; [Anonymous], 1986, ECOLOGY BIOL INVASIO; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Auld TD, 1996, AUST J ECOL, V21, P106, DOI 10.1111/j.1442-9993.1996.tb00589.x; Baker H. G., 1965, The genetics of colonizing species., P147; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BROTHERS TS, 1992, CONSERV BIOL, V6, P91, DOI 10.1046/j.1523-1739.1992.610091.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Catovsky S, 2000, J ECOL, V88, P100, DOI 10.1046/j.1365-2745.2000.00428.x; Chapman R.N., 1931, ANIMAL ECOLOGY SPECI; Clark CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052821; COONEY P A, 1982, Journal of the Soil Conservation Service of New South Wales, V38, P6; Crawley MJ, 1999, ECOL LETT, V2, P140; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Dukes JS, 2001, OECOLOGIA, V126, P563, DOI 10.1007/s004420000549; Eaton A. D., 2005, STANDARD METHODS EXA; Elton CS, 1958, ECOLOGY INVASIONS AN, Vxiv; Emery SM, 2007, J ECOL, V95, P1027, DOI 10.1111/j.1365-2745.2007.01274.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Frankow-Lindberg BE, 2012, OECOLOGIA, V169, P793, DOI 10.1007/s00442-011-2230-7; French Kris, 2008, Plant Protection Quarterly, V23, P24; Gross N, 2013, FUNCT ECOL, V27, P1262, DOI 10.1111/1365-2435.12120; Harden G., 2002, FLORA NEW S WALES, V2, P31; Harden G. J., 2000, FLORA NEW S WALES, V1; Harden G. J., 1992, FLORA NEW S WALES, V3; Harden GJ., 1993, FLORA NEW S WALES VO, V4; Hector A, 2001, ECOL RES, V16, P819, DOI 10.1046/j.1440-1703.2001.00443.x; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Kakani VG, 2008, FUNCT PLANT BIOL, V35, P1243, DOI 10.1071/FP08033; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Ladd B, 2008, OECOLOGIA, V157, P687, DOI 10.1007/s00442-008-1110-2; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lindsay EA, 2005, J APPL ECOL, V42, P556, DOI 10.1111/j.1365-2664.2005.01036.x; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Mason TJ, 2007, BIOL CONSERV, V134, P428, DOI 10.1016/j.biocon.2006.08.032; Mason TJ, 2013, OECOLOGIA, V173, P557, DOI 10.1007/s00442-013-2628-5; Mason TJ, 2012, J VEG SCI, V23, P657, DOI 10.1111/j.1654-1103.2012.01393.x; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Milbau A, 2005, FUNCT ECOL, V19, P27, DOI 10.1111/j.0269-8463.2005.00939.x; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Oelmann Y, 2009, J ECOLOGY, V97, P32; Ortega YK, 2005, ECOL APPL, V15, P651, DOI 10.1890/04-0119; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Prieur-Richard AH, 2000, ECOL LETT, V3, P412, DOI 10.1046/j.1461-0248.2000.00157.x; Scheiner S, 1993, DESIGN ANAL ECOLOGIC, V94, P112; Scherber C, 2010, J PLANT ECOL, V3, P99, DOI 10.1093/jpe/rtq003; Simpson SL, 2002, ENVIRON SCI TECHNOL, V36, P3772, DOI 10.1021/es025632v; Skalova H, 1999, PLANT ECOL, V143, P129, DOI 10.1023/A:1009899803229; Soares-Cordeiro AS, 2011, J EXP BOT, V62, P687, DOI 10.1093/jxb/erq302; Turnbull LA, 2005, J ECOL, V93, P1062, DOI 10.1111/j.1365-2745.2005.01051.x; Vaz-Pinto F, 2013, BIOL INVASIONS, V15, P1833, DOI 10.1007/s10530-013-0412-4; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Von Holle B, 2005, J ECOL, V93, P16, DOI 10.1111/j.0022-0477.2004.00946.x; Von Holle B, 2004, OIKOS, V105, P551, DOI 10.1111/j.0030-1299.2004.12597.x; Walker J., 1990, AUSTR SOIL LAND SURV, P58; Walker LR, 2010, J ECOL, V98, P625, DOI 10.1111/j.1365-2745.2010.01641.x; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579	62	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169243	10.1371/journal.pone.0169243	http://dx.doi.org/10.1371/journal.pone.0169243			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072854	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200010
J	Mier, P; Perez-Pulido, AJ; Reynaud, EG; Andrade-Navarro, MA				Mier, Pablo; Perez-Pulido, Antonio J.; Reynaud, Emmanuel G.; Andrade-Navarro, Miguel A.			Reading the Evolution of Compartmentalization in the Ribosome Assembly Toolbox: The YRG Protein Family	PLOS ONE			English	Article							CRYPTOSPORIDIUM-PARVUM; RICH DOMAIN; GTPASE; SUBUNIT; EUKARYOTES; BIOGENESIS; ORIGIN; TRANSLATION; PERFORMANCE; PROKARYOTES	Reconstructing the transition from a single compartment bacterium to a highly compartmentalized eukaryotic cell is one of the most studied problems of evolutionary cell biology. However, timing and details of the establishment of compartmentalization are unclear and difficult to assess. Here, we propose the use of molecular markers specific to cellular compartments to set up a framework to advance the understanding of this complex intracellular process. Specifically, we use a protein family related to ribosome biogenesis, YRG (YlqF related GTPases), whose evolution is linked to the establishment of cellular compartments, leveraging the current genomic data. We analyzed orthologous proteins of the YRG family in a set of 171 proteomes for a total of 370 proteins. We identified ten YRG protein subfamilies that can be associated to six subcellular compartments (nuclear bodies, nucleolus, nucleus, cytosol, mitochondria, and chloroplast), and which were found in archaeal, bacterial and eukaryotic proteomes. Our analysis reveals organism streamlining related events in specific taxonomic groups such as Fungi. We conclude that the YRG family could be used as a compartmentalization marker, which could help to trace the evolutionary path relating cellular compartments with ribosome biogenesis.	[Mier, Pablo; Andrade-Navarro, Miguel A.] Johannes Gutenberg Univ Mainz, IMB, Fac Biol, Mainz, Germany; [Perez-Pulido, Antonio J.] Univ Pablo Olavide, CABD, UPO CSIC JA, Fac Ciencias Expt Area Genet, Seville, Spain; [Reynaud, Emmanuel G.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland	Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University College Dublin	Mier, P (corresponding author), Johannes Gutenberg Univ Mainz, IMB, Fac Biol, Mainz, Germany.	munoz@uni-mainz.de	Mier, Pablo/P-8916-2019; Reynaud, Emamnuel/H-2928-2019; Perez-Pulido, Antonio J/K-3384-2012	Mier, Pablo/0000-0003-3663-2352; Reynaud, Emamnuel/0000-0003-1502-661X; Perez-Pulido, Antonio J/0000-0003-3343-2822				Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Barrientos A, 2003, MOL BIOL CELL, V14, P2292, DOI 10.1091/mbc.E02-10-0636; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Boddapati N, 2012, J MOL BIOL, V416, P346, DOI 10.1016/j.jmb.2011.12.066; Cavalier-Smith T, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-7; Daigle DM, 2002, BIOCHEMISTRY-US, V41, P11109, DOI 10.1021/bi020355q; Elias M, 2009, BIOESSAYS, V31, P1273, DOI 10.1002/bies.200900117; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Evguenieva-Hackenberg E, 2011, RNA BIOL, V8, P49, DOI 10.4161/rna.8.1.14066; Forterre P, 2011, RES MICROBIOL, V162, P77, DOI 10.1016/j.resmic.2010.10.005; Gabaldon T, 2015, BIOCHIMIE, V119, P262, DOI 10.1016/j.biochi.2015.03.021; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatcher CP, 2011, PLOS ONE, V6; Henriquez FL, 2005, TRENDS PARASITOL, V21, P68, DOI 10.1016/j.pt.2004.11.010; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim DJ, 2008, PROTEINS, V72, P1363, DOI 10.1002/prot.22112; Koonin E. V., 2010, GENOME BIOL, P11; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Lamaye F, 2011, J STRUCT BIOL, V174, P352, DOI 10.1016/j.jsb.2011.02.003; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Ma HH, 2008, TRENDS CELL BIOL, V18, P575, DOI 10.1016/j.tcb.2008.09.003; Mier P, 2015, PLOS ONE, P10; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Putignani L, 2004, PARASITOLOGY, V129, P1, DOI 10.1017/S003118200400527X; Rao MRKS, 2006, J MOL BIOL, V364, P637, DOI 10.1016/j.jmb.2006.09.007; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Weis BL, 2014, PLANT J, V80, P1043, DOI 10.1111/tpj.12703; Zhao HY, 2015, J EXP BOT, V66, P6863, DOI 10.1093/jxb/erv391	42	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169750	10.1371/journal.pone.0169750	http://dx.doi.org/10.1371/journal.pone.0169750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072865	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200042
J	Rosta, K; Al-Aissa, Z; Hadarits, O; Harreiter, J; Nadasdi, A; Kelemen, F; Bancher-Todesca, D; Komlosi, Z; Nemeth, L; Rigo, J; Sziller, I; Somogyi, A; Kautzky-Willer, A; Firneisz, G				Rosta, Klara; Al-Aissa, Zahra; Hadarits, Orsolya; Harreiter, Juergen; Nadasdi, Akos; Kelemen, Fanni; Bancher-Todesca, Dagmar; Komlosi, Zsolt; Nemeth, Laszlo; Rigo, Janos, Jr.; Sziller, Istvan; Somogyi, Aniko; Kautzky-Willer, Alexandra; Firneisz, Gabor			Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; INTERNATIONAL ASSOCIATION; INSULIN-SECRETION; LOCI; RISK; HYPERGLYCEMIA; PREGNANCY; MELATONIN; CDKAL1	Context Genetic variation in human maternal DNA contributes to the susceptibility for development of gestational diabetes mellitus (GDM). Objective We assessed 77 maternal single nucleotide gene polymorphisms (SNPs) for associations with GDM or plasma glucose levels at OGTT in pregnancy. Methods 960 pregnant women (after dropouts 820: case/control: m99'WHO: 303/517, IADPSG: 287/533) were enrolled in two countries into this case-control study. After genomic DNA isolation the 820 samples were collected in a GDM biobank and assessed using KASP (LGC Genomics) genotyping assay. Logistic regression risk models were used to calculate ORs according to IADPSG/m'99WHO criteria based on standard OGTT values. Results The most important risk alleles associated with GDM were rs10830963/G of MTNR1B (OR = 1.84/1.64 [IADPSG/m'99WHO], p = 0.0007/0.006), rs7754840/C (OR = 1.51/NS, p = 0.016) of CDKAL1 and rs1799884/T(OR = 1.4/1.56, p = 0.04/0.006) of GCK. The rs13266634/T (SLC30A8, OR = 0.74/0.71, p = 0.05/0.02) and rs7578326/G (LOC646736/IRS1, OR = 0.62/0.60, p = 0.001/0.006) variants were associated with lower risk to develop GDM. Carrying a minor allele of rs10830963 (MTNR1B); rs7903146 (TCF7L2; rs1799884 (GCK) SNPs were associated with increased plasma glucose levels at routine OGTT. Conclusions We confirmed the robust association of MTNR1B rs10830963/G variant with GDM binary and glycemic traits in this Caucasian case-control study. As novel associations we report the minor, G allele of the rs7578326 SNP in the LOC646736/IRS1 region as a significant and the rs13266634/TSNP (SLC30A8) as a suggestive protective variant against GDM development. Genetic susceptibility appears to be more preponderant in individuals who meet both the modified 99'WHO and the IADPSG GDM diagnostic criteria.	[Rosta, Klara; Bancher-Todesca, Dagmar] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Rosta, Klara; Hadarits, Orsolya; Rigo, Janos, Jr.] Semmelweis Univ, Dept Obstet & Gynecol 1, Budapest, Hungary; [Al-Aissa, Zahra; Nadasdi, Akos; Somogyi, Aniko; Firneisz, Gabor] Semmelweis Univ, Dept Internal Med 2, Budapest, Hungary; [Harreiter, Juergen; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Gender Med Unit, Vienna, Austria; [Kelemen, Fanni; Rigo, Janos, Jr.] Univ Szeged, Fac Med, Szeged, Hungary; [Komlosi, Zsolt] Semmelweis Univ, Dept Pulmonol, Budapest, Hungary; [Nemeth, Laszlo] Eotvos Lorand Univ, Dept Probabil Theory & Stat, Budapest, Hungary; [Sziller, Istvan] Szent Imre Teaching Hosp, Dept Obstet & Gynecol, Budapest, Hungary; [Firneisz, Gabor] Semmelweis Univ, Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary	Medical University of Vienna; Semmelweis University; Semmelweis University; Medical University of Vienna; Szeged University; Semmelweis University; Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University	Firneisz, G (corresponding author), Semmelweis Univ, Dept Internal Med 2, Budapest, Hungary.; Firneisz, G (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary.	firneisz.gabor@med.semmelweis-univ.hu	Nádasdi, Ákos/F-4350-2017; Firneisz, Gabor/AAC-9654-2021	Nádasdi, Ákos/0000-0002-7016-6474; Firneisz, Gabor/0000-0002-9123-8131; Somogyi, Aniko/0000-0003-0807-260X; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Harreiter, Jurgen/0000-0003-2508-9403; Rosta, Klara/0000-0002-3502-3734; Komlosi, Zsolt Istvan/0000-0002-4149-1497	European Foundation for the Study of Diabetes (EFSD): New Horizons Collaborative Research Initiative	European Foundation for the Study of Diabetes (EFSD): New Horizons Collaborative Research Initiative	This work was supported by the European Foundation for the Study of Diabetes (EFSD): New Horizons Collaborative Research Initiative (http://www.uropeandiabetesfoundation.org/index.php/ct-menu-itein-9/14-sample-data-articles/168-efsd-new-horizons-collaborative-research-initiative). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Chen P, 2014, DIABETES, V63, P2551, DOI 10.2337/db13-1815; Cho YM, 2009, DIABETOLOGIA, V52, P253, DOI 10.1007/s00125-008-1196-4; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Freathy RM, 2010, DIABETES, V59, P2682, DOI 10.2337/db10-0177; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Grotenfelt NE, 2016, DIABETOLOGIA, V59, P1655, DOI 10.1007/s00125-016-3989-1; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Huerta-Chagoya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126408; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; KautzkyWiller A, 1997, DIABETES CARE, V20, P1717, DOI 10.2337/diacare.20.11.1717; Kun A, 2015, DIABETOLOGIA, V58, pS74; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Lauenborg J, 2009, J CLIN ENDOCR METAB, V94, P145, DOI 10.1210/jc.2008-1336; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Liao SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040113; Little J, 2009, J CLIN EPIDEMIOL, V62, P597, DOI 10.1016/j.jclinepi.2008.12.004; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000312; Peschke E, 2013, INT J MOL SCI, V14, P6981, DOI 10.3390/ijms14046981; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Robitaille J, 2008, GENET MED, V10, P240, DOI 10.1097/GIM.0b013e31816b8710; Saisho Y, 2010, ENDOCR J, V57, P973, DOI 10.1507/endocrj.K10E-231; Santos ICR, 2010, CLIN CHIM ACTA, V411, P892, DOI 10.1016/j.cca.2010.03.011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott D A, 2002, Health Technol Assess, V6, P1; Soyal SM, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/405371; Tuerxunyiming M, 2015, INT J CLIN EXP MED, V8, P17392; Vejrazkova D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/508923; Vlassi M, 2012, HORM-INT J ENDOCRINO, V11, P70, DOI 10.1007/BF03401539; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams MA, 2003, J REPROD MED, V48, P955; World Health Organization Definitions, WHONCDNCS992; Wu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep30539; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2013, HUM REPROD UPDATE, V19, P376, DOI 10.1093/humupd/dmt013; Zheng JS, 2013, DIABETES CARE, V36, P2621, DOI 10.2337/dc12-2607	48	44	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169781	10.1371/journal.pone.0169781	http://dx.doi.org/10.1371/journal.pone.0169781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072873	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200045
J	Ando, D; Gopinathan, A				Ando, David; Gopinathan, Ajay			Cooperative Interactions between Different Classes of Disordered Proteins Play a Functional Role in the Nuclear Pore Complex of Baker's Yeast	PLOS ONE			English	Article							POLYMER BRUSHES; REPEAT REGIONS; MESSENGER-RNA; TRANSPORT; NUCLEOPORINS; ARCHITECTURE; BINDING; TRANSLOCATION; DYNAMICS; INSIGHTS	Nucleocytoplasmic transport is highly selective, efficient, and is regulated by a poorly understood mechanism involving hundreds of disordered FG nucleoporin proteins (FG nups) lining the inside wall of the nuclear pore complex (NPC). Previous research has concluded that FG nups in Baker's yeast (S. cerevisiae) are present in a bimodal distribution, with the "Forest Model" classifying FG nups as either di-block polymer like "trees" or single-block polymer like "shrubs". Using a combination of coarse-grained modeling and polymer brush modeling, the function of the di-block FG nups has previously been hypothesized in the Di-block Copolymer Brush Gate (DCBG) model to form a higher-order polymer brush architecture which can open and close to regulate transport across the NPC. In this manuscript we work to extend the original DCBG model by first performing coarse grained simulations of the single-block FG nups which confirm that they have a single block polymer structure rather than the di-block structure of tree nups. Our molecular simulations also demonstrate that these single-block FG nups are likely cohesive, compact, collapsed coil polymers, implying that these FG nups are generally localized to their grafting location within the NPC. We find that adding a layer of single-block FG nups to the DCBG model increases the range of cargo sizes which are able to translocate the pore through a cooperative effect involving single-block and di-block FG nups. This effect can explain the puzzling connection between single-block FG nup deletion mutants in S. cerevisiae and the resulting failure of certain large cargo transport through the NPC. Facilitation of large cargo transport via single-block and di-block FG nup cooperativity in the nuclear pore could provide a model mechanism for designing future biomimetic pores of greater applicability.	[Ando, David] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Ando, David] Joint BioEnergy Inst, Emeryville, CA USA; [Gopinathan, Ajay] Univ Calif, Dept Phys, Merced, CA 95340 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Merced	Gopinathan, A (corresponding author), Univ Calif, Dept Phys, Merced, CA 95340 USA.	agopinathan@ucmerced.edu			National Science Foundation (NSF) through the NSF CREST Center for Cellular and Biomolecular Machines [EF-1038697, NSF-DBI-0960480, NSF-DMS-1616926, NSF-HRD-1547848]; James S. McDonnell Foundation; National Science Foundation NSF grant [EF-1038697]; NSF grant [DMS-1616926]; NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced [NSF-HRD-1547848]; Direct For Mathematical & Physical Scien [1616926] Funding Source: National Science Foundation	National Science Foundation (NSF) through the NSF CREST Center for Cellular and Biomolecular Machines(National Science Foundation (NSF)); James S. McDonnell Foundation; National Science Foundation NSF grant(National Science Foundation (NSF)); NSF grant(National Science Foundation (NSF)); NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the following National Science Foundation (NSF: http://www.nsf.gov/) grants EF-1038697 (to AG), NSF-DBI-0960480 (to AG), NSF-DMS-1616926 (to AG), through the NSF CREST Center for Cellular and Biomolecular Machines (NSF-HRD-1547848 (to AG)) and a James S. McDonnell Foundation Award (to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by National Science Foundation NSF grant EF-1038697 and NSF grant DMS-1616926, a James S. McDonnell Foundation Award and in part by the NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced (NSF-HRD-1547848).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Ando D, 2014, BIOPHYS J, V106, P1997, DOI 10.1016/j.bpj.2014.03.021; Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831; Ayton GS, 2007, MRS BULL, V32, P929, DOI 10.1557/mrs2007.190; Bartsch RA, 1996, ACS SYM SER, V642, P1; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Flory P.J., 1971, STAT MECH CHAIN MOL; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Ghavami A, 2014, BIOPHYS J, V107, P1393, DOI [10.1016/j.bpj.2014.07.060, 10.1016/j.bpj.20014.07.060]; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hills RD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000827; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kapinos LE, 2014, BIOPHYS J, V106, P1751, DOI 10.1016/j.bpj.2014.02.021; Karanicolas J, 2002, PROTEIN SCI, V11, P2351, DOI 10.1110/ps.0205402; Karlsson M, 2004, ANNU REV PHYS CHEM, V55, P613, DOI 10.1146/annurev.physchem.55.091602.094319; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Manghi M, 2001, EUR PHYS J E, V5, P519, DOI 10.1007/s101890170035; Martin Donald K., 2007, V1, P1; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Noid WG, 2007, J PHYS CHEM B, V111, P4116, DOI 10.1021/jp068549t; Osmanovic D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061917; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Photos PJ, 2007, SOFT MATTER, V3, P364, DOI 10.1039/b611412c; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prokop A, 2001, ANN NY ACAD SCI, V944, P472; Raveh B, 2016, P NATL ACAD SCI USA, V113, pE2489, DOI 10.1073/pnas.1522663113; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sakiyama Y, 2016, NAT NANOTECHNOL, V11, P719, DOI [10.1038/nnano.2016.62, 10.1038/NNANO.2016.62]; Sevick EM, 1996, MACROMOLECULES, V29, P6952, DOI 10.1021/ma9604552; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Vovk A, 2016, ELIFE, V5, DOI 10.7554/eLife.10785; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zahn R, 2016, ELIFE, V5, DOI 10.7554/eLife.14119; Zilman A, 2007, PLOCOMPUT BIOL, V3, DOI [10.1371/journal.pcbi.0030125, DOI 10.1371/JOURNAL.PCBI.0030125]; Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804	53	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169455	10.1371/journal.pone.0169455	http://dx.doi.org/10.1371/journal.pone.0169455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068389	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900036
J	Armas, F; Camperio, C; Marianelli, C				Armas, Federica; Camperio, Cristina; Marianelli, Cinzia			In Vitro Assessment of the Probiotic Potential of Lactococcus lactis LMG 7930 against Ruminant Mastitis-Causing Pathogens	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; INTRAMAMMARY INFUSION; STAPHYLOCOCCUS-AUREUS; SURFACE-PROPERTIES; ACID BACTERIA; ESCHERICHIA-COLI; BOVINE MASTITIS; LIVE CULTURE; ADHESION; HYDROPHOBICITY	Mastitis in dairy ruminants is considered to be the most expensive disease to farmers worldwide. Recently, the intramammary infusion of lactic acid bacteria has emerged as a potential new alternative to antibiotics for preventing and treating bovine mastitis. In this study we have investigated in vitro the probiotic potential of Lactococcus lactis LMG 7930, a food-grade and nisin-producing strain, against mastitis-causing pathogens. We have characterized its carbohydrate fermentation and antibiotic susceptibility profiles, cell surface properties and antimicrobial activity, as well as its capabilities to adhere to and inhibit the invasion of pathogens into the bovine mammary epithelial cell line BME-UV1d. We found that L. lactis LMG 7930 was sensitive to tested drugs, according to the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), and showed an improved carbohydrate fermentation capacity compared to starter strains. Moreover, the strain exhibited antagonistic properties towards many of the pathogens tested. It presented medium surface hydrophobicity, a low basic property and no electron acceptor capability. It showed low auto-aggregation and no co-aggregation abilities towards any of the tested pathogens. The strain was one of the most adhesive to bovine mammary epithelial cells among tested bacteria, but its internalisation was low. The strain did not affect significantly pathogen invasion; however, a trend to decrease internalization of some pathogens tested was observed. In conclusion, our results suggest that this strain might be a promising candidate for the development of new strategies of mastitis control in ruminants. Future investigations are needed to evaluate its safety and efficacy under field conditions.	[Armas, Federica; Camperio, Cristina; Marianelli, Cinzia] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Rome, Italy; [Armas, Federica] Univ Rome Tre, Dept Sci, Rome, Italy; [Camperio, Cristina] Univ Turin, Dept Anim Pathol, Fac Vet Med, Turin, Italy	Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University; University of Turin	Marianelli, C (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Rome, Italy.	cinzia.marianelli@iss.it	Marianelli, Cinzia/C-7036-2015	Marianelli, Cinzia/0000-0002-5190-4574; Armas, Federica/0000-0001-8034-2972	Italian Ministry of Health [RF-2010-2313040]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health, grant number RF-2010-2313040. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A. A., 2014, British Microbiology Research Journal, V4, P381; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Assis BS, 2015, BENEF MICROBES, V6, P879, DOI 10.3920/BM2015.0019; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Batt C.A., 2014, ENCY FOOD MICROBIOLO, Vsecond; Bouchard DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144831; Bouchard DS, 2013, APPL ENVIRON MICROB, V79, P877, DOI 10.1128/AEM.03323-12; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Espeche MC, 2012, ANAEROBE, V18, P103, DOI 10.1016/j.anaerobe.2012.01.002; Espeche MC, 2009, VET MICROBIOL, V135, P346, DOI 10.1016/j.vetmic.2008.09.078; Collado MC, 2007, J FOOD SCI, V72, pM89, DOI 10.1111/j.1750-3841.2007.00294.x; Crispie F, 2008, J DAIRY RES, V75, P374, DOI 10.1017/S0022029908003385; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Dias FS, 2013, BIOSCI J, V29, P1678; Enriquez-Valencia CE, 2015, CIENC RURAL, V45, P835, DOI 10.1590/0103-8478cr20140586; Even S, 2014, INTERACTIVE PROBIOTICS, P52; Frola ID, 2013, J DAIRY RES, V80, P28, DOI 10.1017/S0022029912000581; Frola ID, 2012, J DAIRY RES, V79, P84, DOI 10.1017/S0022029911000835; Haguingan JMB, 2010, PHILIPP J VET MED, V47, P21; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hamadi F, 2004, ANN MICROBIOL, V54, P213; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; MAMO W, 1994, MICROBIOL IMMUNOL, V38, P305, DOI 10.1111/j.1348-0421.1994.tb01781.x; Mezaini A, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/678495; Oliveira R, 2011, BIOLINE; Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725, DOI 10.1128/AEM.63.5.1725-1731.1997; Plumed-Ferrer C, 2013, VET MICROBIOL, V167, P592, DOI 10.1016/j.vetmic.2013.09.011; SEARS PM, 1992, J DAIRY SCI, V75, P3185, DOI 10.3168/jds.S0022-0302(92)78083-7; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Wyder AB, 2011, RES VET SCI, V91, P349, DOI 10.1016/j.rvsc.2010.09.006; Xu H, 2009, LETT APPL MICROBIOL, V49, P434, DOI 10.1111/j.1472-765X.2009.02684.x	33	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169543	10.1371/journal.pone.0169543	http://dx.doi.org/10.1371/journal.pone.0169543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068371	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900045
J	Bourdin, P; Barberia, I; Oliva, R; Slater, M				Bourdin, Pierre; Barberia, Itxaso; Oliva, Ramon; Slater, Mel			A Virtual Out-of-Body Experience Reduces Fear of Death	PLOS ONE			English	Article							COLLETT-LESTER FEAR; ILLUSORY OWNERSHIP; CARDIAC-ARREST; FEEL; SKIN	Immersive virtual reality can be used to visually substitute a person's real body by a life-sized virtual body (VB) that is seen from first person perspective. Using real-time motion capture the VB can be programmed to move synchronously with the real body (visuomotor synchrony), and also virtual objects seen to strike the VB can be felt through corresponding vibrotactile stimulation on the actual body (visuotactile synchrony). This setup typically gives rise to a strong perceptual illusion of ownership over the VB. When the viewpoint is lifted up and out of the VB so that it is seen below this may result in an out-of-body experience (OBE). In a two-factor between-groups experiment with 16 female participants per group we tested how fear of death might be influenced by two different methods for producing an OBE. In an initial embodiment phase where both groups experienced the same multisensory stimuli there was a strong feeling of body ownership. Then the viewpoint was lifted up and behind the VB. In the experimental group once the viewpoint was out of the VB there was no further connection with it (no visuomotor or visuotactile synchrony). In a control condition, although the viewpoint was in the identical place as in the experimental group, visuomotor and visuotactile synchrony continued. While both groups reported high scores on a question about their OBE illusion, the experimental group had a greater feeling of disownership towards the VB below compared to the control group, in line with previous findings. Fear of death in the experimental group was found to be lower than in the control group. This is in line with previous reports that naturally occurring OBEs are often associated with enhanced belief in life after death.	[Bourdin, Pierre; Barberia, Itxaso; Oliva, Ramon; Slater, Mel] Univ Barcelona, Dept Clin Psychol & Psychobiol, Event Lab, Barcelona, Spain; [Barberia, Itxaso] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England	University of Barcelona; University of Barcelona; ICREA; University of London; University College London	Slater, M (corresponding author), Univ Barcelona, Dept Clin Psychol & Psychobiol, Event Lab, Barcelona, Spain.; Slater, M (corresponding author), ICREA, Barcelona, Spain.; Slater, M (corresponding author), UCL, Dept Comp Sci, London, England.	melslater@ub.edu	Bourdin, Pierre/Y-4958-2019; Slater, Mel/M-5210-2014; BARBERIA, ITXASO/L-8477-2014	Bourdin, Pierre/0000-0002-8745-3787; Slater, Mel/0000-0002-6223-0050; BARBERIA, ITXASO/0000-0003-3045-2289	Immortality Project at UC Riverside; John Templeton Foundation project; Catalan Government [2014-SGR855]; ICREA Funding Source: Custom	Immortality Project at UC Riverside; John Templeton Foundation project; Catalan Government; ICREA(ICREA)	This work was supported by the Immortality Project at UC Riverside, a John Templeton Foundation project, http://www.sptimmortairtyproject.com/wp-content/uploads/2014/04/Abstracts.pdf and the Catalan Government (2014-SGR855), http://www.revistalatinacs.org/071/paper/1087/proyecto.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Immortality Project at UC Riverside, a John Templeton Foundation project and by the Catalan Government (2014-SGR855). We thank Solene Neyret for help with Figs 1 and 2 and the video.	Agrillo C, 2011, REV GEN PSYCHOL, V15, P1, DOI 10.1037/a0021992; Alvarado CS, 2000, VARIETIES OF ANOMALOUS EXPERIENCE: EXAMINING THE SCIENTIFIC EVIDENCE, P183, DOI 10.1037/10371-006; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Bergouignan L, 2014, P NATL ACAD SCI USA, V111, P4421, DOI 10.1073/pnas.1318801111; Bergstrom I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148060; Blackmore S.J., 1982, BODY INVESTIGATION O; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P303, DOI 10.1016/B978-0-12-374168-4.00023-X; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Gabbard G. O., 1984, EYES MIND EMPIRICAL; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Guterstam A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09831; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Hiromitsu K, 2016, MULTISENS RES, V29, P439, DOI 10.1163/22134808-00002523; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Klemenc-Ketis Z, 2013, INT J BEHAV MED, V20, P7, DOI 10.1007/s12529-011-9209-y; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lester D, 2003, DEATH STUD, V27, P81, DOI 10.1080/07481180302873; Lester D., 1994, COLLETT LESTER FEAR; Maselli A, 2013, FRONT HUM NEUROSCI, P7; Maselli A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00693; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; Metzinger T, 2005, MIND MATTER, V3, P57; Moody R. A, 2001, LIFE LIFE 25 ANNIVER; Pamment J, 2016, EUROPEAN J PAIN; Parnia S, 2007, RESUSCITATION, V74, P215, DOI 10.1016/j.resuscitation.2007.01.020; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Plummer M, 2017, JAGS PROGRAM ANAL BA; Pomes A, 2013, FRONT HUM NEUROSCI, P7; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Spanlang B, 2010, ACM S VIRT REAL SOFT, P47; Taylor RM, 2001, P ACM S VIRT REAL SO, P55, DOI [DOI 10.1145/505008.505019, 10.1145/505008.505019.]; Tomas-Sabado J, 2007, DEATH STUD, V31, P249, DOI 10.1080/07481180601152625; TWEMLOW SW, 1982, AM J PSYCHIAT, V139, P450; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8	46	41	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169343	10.1371/journal.pone.0169343	http://dx.doi.org/10.1371/journal.pone.0169343			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WO	28068368	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900026
J	Mano, O; Clark, DA				Mano, Omer; Clark, Damon A.			Graphics Processing Unit-Accelerated Code for Computing Second-Order Wiener Kernels and Spike-Triggered Covariance	PLOS ONE			English	Article							RESPONSES; NEURONS; IDENTIFICATION; MECHANISMS; SYSTEMS	Sensory neuroscience seeks to understand and predict how sensory neurons respond to stimuli. Nonlinear components of neural responses are frequently characterized by the second -order Wiener kernel and the closely-related spike-triggered covariance (STC). Recent advances in data acquisition have made it increasingly common and computationally intensive to compute second-order Wiener kernels/STC matrices. In order to speed up this sort of analysis, we developed a graphics processing unit (GPU)-accelerated module that computes the second-order Wiener kernel of a system's response to a stimulus. The generated kernel can be easily transformed for use in standard STC analyses. Our code speeds up such analyses by factors of over 100 relative to current methods that utilize central processing units (CPUs). It works on any modern GPU and may be integrated into many data analysis workflows. This module accelerates data analysis so that more time can be spent exploring parameter space and interpreting data.	[Mano, Omer; Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Clark, Damon A.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Clark, Damon A.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Clark, DA (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Clark, DA (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.; Clark, DA (corresponding author), Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA.	damon.clark@yale.edu		Mano, Omer/0000-0003-2606-8567	National Institutes of Health [R01EY026555, T32GM007499]; National Science Foundation [IOS1558103]; Alfred P. Sloan Foundation; Searle Foundation, Searle Scholar Award; Smith Family Foundation; Yale University; NATIONAL EYE INSTITUTE [R01EY026555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER; Direct For Biological Sciences [1558103] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Searle Foundation, Searle Scholar Award; Smith Family Foundation; Yale University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institutes of Health, R01EY026555 to DAC; played no role; salary to DAC and OM, National Science Foundation, IOS1558103 to DAC; played no role; salary to DAC, Alfred P. Sloan Foundation, Fellowship to DAC; played no role; salary to DAC, Searle Foundation, Searle Scholar Award to DAC; played no role; salary to DAC, Smith Family Foundation, Scholar Award to DAC; played no role; salary to DAC, National Institutes of Health, T32GM007499 to OM; played no role; salary to OM, Yale University; played no role other than salary to DAC and OM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljadeff J, 2016, NEURON, V91, P221, DOI 10.1016/j.neuron.2016.05.039; Baker CL, 2001, VISUAL NEUROSCI, V18, P465, DOI 10.1017/S0952523801183136; Bialek W, 2005, QBIO0505003 ARXIV; Cantrell DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000967; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Ciregan D, 2012, COMP VIS PATT REC CV; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Dayan P, 2001, COMPUTATIONAL NEUROS; Fox JL, 2010, P NATL ACAD SCI USA, V107, P3840, DOI 10.1073/pnas.0912548107; FRENCH AS, 1993, BIOPHYS J, V65, P832, DOI 10.1016/S0006-3495(93)81116-0; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jing XJ, 2012, J NEUROSCI METH, V203, P220, DOI 10.1016/j.jneumeth.2011.09.014; Kellman P, 2003, NEUROIMAGE, V19, P190, DOI 10.1016/S1053-8119(03)00056-9; Kim AJ, 2011, J COMPUT NEUROSCI, V30, P143, DOI 10.1007/s10827-010-0265-0; Krizhevsky A., 2012, NEURIPS, P1106; LARKIN RM, 1979, BIOL CYBERN, V35, P145, DOI 10.1007/BF00337060; Liu JK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004425; Lochmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058666; Maccione A, 2014, J PHYSIOL-LONDON, V592, P1545, DOI 10.1113/jphysiol.2013.262840; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; MCCANN GD, 1974, J NEUROPHYSIOL, V37, P869, DOI 10.1152/jn.1974.37.5.869; Muthmann JO, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00028; PECE AEC, 1990, BIOPHYS J, V57, P733, DOI 10.1016/S0006-3495(90)82594-7; Peron S, 2015, CURR OPIN NEUROBIOL, V32, P115, DOI 10.1016/j.conb.2015.03.016; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pillow JW, 2006, J VIS, V6, P9; Rivera DC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004528; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Salazar-Gatzimas E, 2016, NEURON, V92, P227, DOI 10.1016/j.neuron.2016.09.017; Samengo I, 2013, J COMPUT NEUROSCI, V34, P137, DOI 10.1007/s10827-012-0411-y; Sandler RA, 2015, J VISION, V15, DOI 10.1167/15.9.16; Schwartz O, 2002, ADV NEURAL INFORM PR; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Strigl D., 2010, PDP; Sun XR, 2013, NATURE COMMUNICATION, V4; Sutter EE, 2001, VISION RES, V41, P1241, DOI 10.1016/S0042-6989(01)00078-5; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VICTOR JD, 1979, J GEN PHYSIOL, V74, P275, DOI 10.1085/jgp.74.2.275; [No title captured]	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169842	10.1371/journal.pone.0169842	http://dx.doi.org/10.1371/journal.pone.0169842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068420	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900073
J	Song, K; Chang, SS; Roper, M; Kim, H; Lee, SJ				Song, Kahye; Chang, Shyr-Shea; Roper, Marcus; Kim, Hyejeong; Lee, Sang Joon			A Biologically-Inspired Symmetric Bidirectional Switch	PLOS ONE			English	Article							HYDROGELS; POLYMERS; SYSTEMS	Stimuli-sensitive hydrogels have been intensively studied because of their potential applications in drug delivery, cell culture, and actuator design. Although hydrogels with directed unidirectional response, i.e. capable of bending actuated by different chemical components reaction in response to several stimuli including water and electric fields, these hydrogels are capable of being actuated in one direction only by the stimulus. By contrast the challenge of building a device that is capable of responding to the same cue (in this case a temperature gradient) to bend in either direction remains unmet. Here, inspired by the structure of pine cone scales, we design a temperature-sensitive hydrogel with bending directed an imposed fishing line. The layers with same PNIPAAm always shrinks in response to the heat. Even the layers made with different chemical property, bends away from a warm surface, whether the warm surface is applied at its upper or lower boundary. To design the bending hydrogel we exploited the coupled responses of the hydrogel; a fishing line intercalating structure and change its construction. In addition to revealing a new capability of stimulus sensitive hydrogels, our study gives insight into the structural features of pine cone bending.	[Song, Kahye; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Chang, Shyr-Shea; Roper, Marcus] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Roper, Marcus; Lee, Sang Joon] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA; [Kim, Hyejeong] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea.; Lee, SJ (corresponding author), Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019	Roper, Marcus/0000-0001-8756-0112	Creative Research Initiative (Diagnosis of Biofluid Flow Phenomena and Biomimic Research) of the Ministry of Science, ICT and Future Planning (MSIP); National Research Foundation (NRF) of Korea [2008-0061991]; National Institute of General Medical Sciences [T32GM008185]; National Science Foundation [DMS-1312543]	Creative Research Initiative (Diagnosis of Biofluid Flow Phenomena and Biomimic Research) of the Ministry of Science, ICT and Future Planning (MSIP); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	This research was financially supported by the Creative Research Initiative (Diagnosis of Biofluid Flow Phenomena and Biomimic Research) of the Ministry of Science, ICT and Future Planning (MSIP) and the National Research Foundation (NRF) of Korea (Contract grant number: 2008-0061991). Shyr-Shea Chang was supported by Grant Number T32GM008185 from the National Institute of General Medical Sciences. Marcus Roper acknowledges financial support from National Science Foundation grant DMS-1312543. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Fahn A., 1972, ANATOMICAL MECH SEED, P151; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Harmon ME, 2003, POLYMER, V44, P4547, DOI 10.1016/S0032-3861(03)00463-4; HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525; Ionov L, 2014, MATER TODAY, V17, P494, DOI 10.1016/j.mattod.2014.07.002; Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5; Kabiri K, 2003, EUR POLYM J, V39, P1341, DOI 10.1016/S0014-3057(02)00391-9; Kim H, 2015, ADV FUNCT MATER, V25, P4496, DOI 10.1002/adfm.201501445; Lee H, 2010, SOFT MATTER, V6, P4342, DOI 10.1039/c0sm00092b; Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355; O'Grady ML, 2010, ACS APPL MATER INTER, V2, P343, DOI 10.1021/am900755w; Prabaharan M, 2006, MACROMOL BIOSCI, V6, P991, DOI 10.1002/mabi.200600164; Ren HY, 2011, MACROMOLECULES, V44, P8516, DOI 10.1021/ma201272j; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Song K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09963; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233	19	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169856	10.1371/journal.pone.0169856	http://dx.doi.org/10.1371/journal.pone.0169856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068391	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900075
J	Wang, L; Yang, LK; Guo, YJ; Du, WL; Yin, YJ; Zhang, T; Lu, HZ				Wang, Ling; Yang, Likai; Guo, Yijie; Du, Weili; Yin, Yajun; Zhang, Tao; Lu, Hongzhao			Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE RAD52; ZINC-FINGER NUCLEASES; DOUBLE-MUSCLED PHENOTYPE; MYOSTATIN GENE; INDUCED MUTATIONS; ENRICHMENT; PROTEIN; RECOMBINATION; KNOCKOUT; DELETION	The CRISPR/Cas9 system has enabled highly efficient genome targeted editing for various organisms. However, few studies have focused on CRISPR/Cas9 nuclease-mediated chicken genome editing compared with mammalian genomes. The current study combined CRISPR with yeast Rad52 (yRad52) to enhance targeted genomic DNA editing in chicken DF-1 cells. The efficiency of CRISPR/Cas9 nuclease-induced targeted mutations in the chicken genome was increased to 41.9% via the enrichment of the dual-reporter surrogate system. In addition, the combined effect of CRISPR nuclease and yRad52 dramatically increased the efficiency of the targeted substitution in the myostatin gene using 50-mer oligodeoxynucleotides (ssODN) as the donor DNA, resulting in a 36.7% editing efficiency after puromycin selection. Furthermore, based on the effect of yRad52, the frequency of exogenous gene integration in the chicken genome was more than 3-fold higher than that without yRad52. Collectively, these results suggest that ssODN is an ideal donor DNA for targeted substitution and that CRISPR/Cas9 combined with yRad52 significantly enhances chicken genome editing. These findings could be extensively applied in other organisms.	[Wang, Ling; Yang, Likai; Du, Weili; Yin, Yajun; Zhang, Tao; Lu, Hongzhao] Shaanxi SCI TECH Univ, Sch Biol Sci & Engn, Hanzhong, Shaanxi, Peoples R China; [Guo, Yijie] Xian Jitong Univ, Sch Basic Med Sci, Dept Pathogen Microbiol & Immunol, Xian, Shaanxi, Peoples R China		Wang, L (corresponding author), Shaanxi SCI TECH Univ, Sch Biol Sci & Engn, Hanzhong, Shaanxi, Peoples R China.	wl@snut.edu.cn		GUO, YIJIE/0000-0002-4949-2048	National Natural Science Foundation of China [31402071]; Shaanxi Education Department Research Project [15JK1145]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Education Department Research Project	This work was supported by the National Natural Science Foundation of China (31402071), (http://www.nsfc.gov.cn/) and the Shaanxi Education Department Research Project (15JK1145), (http://www.snedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YC, 2016, G3-GENES GENOM GENET, V6, P917, DOI 10.1534/g3.116.027706; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Di Primio C, 2005, NUCLEIC ACIDS RES, V33, P4639, DOI 10.1093/nar/gki778; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fan BL, 2011, ANIM BIOTECHNOL, V22, P211, DOI 10.1080/10495398.2011.626885; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson Simon, 2013, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0902s64; Kagawa W, 2014, NUCLEIC ACIDS RES, V42, P941, DOI 10.1093/nar/gkt986; Kalvala A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq486; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052197; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Sacco MA, 2000, J VIROL, V74, P1296, DOI 10.1128/JVI.74.3.1296-1306.2000; Sacco MA, 2014, J GEN VIROL, V95, P2060, DOI 10.1099/vir.0.066852-0; Sauer NJ, 2016, PLANT PHYSIOL, V170, P1917, DOI 10.1104/pp.15.01696; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Stinckens A, 2011, ANIM GENET, V42, P229, DOI 10.1111/j.1365-2052.2010.02144.x; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wragg D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1954-x; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zhang GX, 2012, ANIM GENET, V43, P458, DOI 10.1111/j.1365-2052.2011.02274.x; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zuo QS, 2016, G3-GENES GENOM GENET, V6, P1787, DOI 10.1534/g3.116.028803	42	14	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169768	10.1371/journal.pone.0169768	http://dx.doi.org/10.1371/journal.pone.0169768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068387	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900066
J	Yang, YY; Lian, SY; Meng, L; Qu, LK; Shou, CC				Yang, Yongyong; Lian, Shenyi; Meng, Lin; Qu, Like; Shou, Chengchao			Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS-ASSOCIATED PHOSPHATASE; LYMPH-NODE METASTASIS; KAPPA-B ACTIVATION; TYROSINE-PHOSPHATASE; REGENERATING LIVER-3; COLORECTAL-CANCER; SIGNALING PATHWAY; MYELOID-LEUKEMIA; CELL-MIGRATION	Phosphatase of regenerating liver 3 (PRL-3) promotes cancer metastasis and progression via increasing cell motility and invasiveness, however the mechanism is still not fully understood. Previous reports showed that PRL-3 increases the phosphorylation of many important proteins and suspected that PRL-3-enhanced protein phosphorylation may be due to its regulation on cytokines. To investigate PRL-3's impact on protein phosphorylation and cytokine secretion, we performed antibody arrays against protein phosphorylation and cytokines separately. The data showed that PRL-3 could enhance tyrosine phosphorylation and serine/threonine phosphorylation of diverse signaling proteins. Meanwhile, PRL-3 could affect the secretion of a subset of cytokines. Furthermore, we discovered the PRL-3-increased IL1 alpha secretion was regulated by NF-kappa B and Jak2-Stat3 pathways and inhibiting IL-1 alpha could reduce PRL-3-enhanced cell migration. Therefore, our result indicated that PRL-3 promotes protein phosphorylation by acting as an 'activator kinase' and consequently regulates cytokine secretion.	[Yang, Yongyong; Lian, Shenyi; Meng, Lin; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Lian, Shenyi] Peking Univ, Canc Hosp & Inst, Dept Pathol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China	Peking University; Peking University	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.	cshou@vip.sina.com	Yang, Yongyong/AAZ-9620-2020	yang, yongyong/0000-0003-2297-5848	National 973 Program of China [2015GB553906]; National Natural Science foundation of China [81230046, 81301747]	National 973 Program of China(National Basic Research Program of China); National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Program of China (grant no. 2015GB553906), National Natural Science foundation of China (81230046, 81301747).	Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Arman A, 2003, ADV EXP MED BIOL, V534, P297; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bessette DC, 2007, CELLS TISSUES ORGANS, V185, P232, DOI 10.1159/000101324; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Dong Q, 2015, J ORAL PATHOLOGY ME; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Harris RBS, 2014, BBA-MOL BASIS DIS, V1842, P414, DOI 10.1016/j.bbadis.2013.05.009; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kong L, 2007, NEUROPATHOLOGY, V27, P516, DOI 10.1111/j.1440-1789.2007.00818.x; Kopantzev Y, 2002, ONCOGENE, V21, P6791, DOI 10.1038/sj.onc.1205815; Krndija D, 2012, J CELL SCI, V125, P3883, DOI 10.1242/jcs.104885; Kwon SJ, 2014, PROSTATE, V74, P121, DOI 10.1002/pros.22734; Lai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0566-z; Lian SY, 2013, BIOCHEM BIOPH RES CO, V430, P196, DOI 10.1016/j.bbrc.2012.11.036; Liang F, 2008, J BIOL CHEM, V283, P10339, DOI 10.1074/jbc.M708285200; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Liu YH, 2009, CANCER BIOL THER, V8, P1352, DOI 10.4161/cbt.8.14.8695; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Min SH, 2010, LIFE SCI, V86, P66, DOI 10.1016/j.lfs.2009.11.010; Ming J, 2013, PATHOBIOLOGY, V81, P1, DOI 10.1159/000350310; Ming J, 2012, TUMORI J, V98, P370, DOI 10.1700/1125.12407; Mizuuchi E, 2009, INT J CANCER, V124, P1802, DOI 10.1002/ijc.24111; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ooki A, 2010, INT J CANCER, V127, P543, DOI 10.1002/ijc.25082; Orsatti L, 2009, ELECTROPHORESIS, V30, P2469, DOI 10.1002/elps.200800780; Park JE, 2013, EMBO MOL MED, V5, P1351, DOI 10.1002/emmm.201202183; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Peng LR, 2006, BIOCHEM BIOPH RES CO, V342, P179, DOI 10.1016/j.bbrc.2006.01.102; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Semba S, 2010, CANCER SCI, V101, P2254, DOI 10.1111/j.1349-7006.2010.01651.x; Walls CD, 2013, MOL CELL PROTEOMICS, V12, P3759, DOI 10.1074/mcp.M113.028886; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Xu Y, 2010, J UNIVERS COMPUT SCI, V16, P3; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17046; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhang C, 2015, J MOL MED; Zhao WB, 2008, INT J MOL MED, V22, P187, DOI 10.3892/ijmm_00000007; Zheng P, 2010, J PROTEOME RES, V9, P4897, DOI 10.1021/pr100712t; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2; Zhou JB, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-72; Zimmerman MW, 2014, J BIOL CHEM, V289, P5904, DOI 10.1074/jbc.M113.480038	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169665	10.1371/journal.pone.0169665	http://dx.doi.org/10.1371/journal.pone.0169665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068414	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900055
J	Abdiche, YN; Yeung, AY; Ni, I; Stone, D; Miles, A; Morishige, W; Rossi, A; Strop, P				Abdiche, Yasmina Noubia; Yeung, Andy Yik; Ni, Irene; Stone, Donna; Miles, Adam; Morishige, Winse; Rossi, Andrea; Strop, Pavel			Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another	PLOS ONE			English	Article							STRUCTURAL BASIS; MATURATION; INHIBITION; BIOSENSOR; RECEPTOR; PROTEON; EGFR	Here we describe how real-time label-free biosensors can be used to identify antibodies that compete for closely adjacent or minimally overlapping epitopes on their specific antigen via a mechanism of antibody displacement. By kinetically perturbing one another's binding towards their antigen via the formation of a transient trimolecular complex, antibodies can displace one another in a fully reversible and dose-dependent manner. Displacements can be readily identified when epitope binning assays are performed in a classical sandwich assay format whereby a solution antibody (analyte) is tested for binding to its antigen that is first captured via an immobilized antibody (ligand) because an inverted sandwiching response is observed when an analyte displaces a ligand, signifying the antigen's unusually rapid dissociation from its ligand. In addition to classifying antibodies within a panel in terms of their ability to block or sandwich pair with one another, displacement provides a hybrid mechanism of competition. Using high-throughput epitope binning studies we demonstrate that displacements can be observed on any target, if the antibody panel contains appropriate epitope diversity. Unidirectional displacements occurring between disparate-affinity antibodies can generate apparent asymmetries in a cross-blocking experiment, confounding their interpretation. However, examining competition across a wide enough concentration range will often reveal that these displacements are reversible. Displacement provides a gentle and efficient way of eluting antigen from an otherwise high affinity binding partner which can be leveraged in designing reagents or therapeutic antibodies with unique properties.	[Abdiche, Yasmina Noubia; Yeung, Andy Yik; Ni, Irene; Stone, Donna] Pfizer Inc, Dept Prot Engn, Rinat Oncol Res & Dev, San Francisco, CA 10017 USA; [Miles, Adam] Wasatch Microfluid, Salt Lake City, UT USA; [Morishige, Winse; Strop, Pavel] Bristol Myers Squibb, Dept Prot Engn, Redwood City, CA USA; [Rossi, Andrea] Compugen USA Inc, San Francisco, CA USA	Pfizer; Bristol-Myers Squibb	Abdiche, YN (corresponding author), Pfizer Inc, Dept Prot Engn, Rinat Oncol Res & Dev, San Francisco, CA 10017 USA.	ynoubia@gmail.com			Pfizer, Inc.; Wasatch Microfluidics	Pfizer, Inc.(Pfizer); Wasatch Microfluidics	This study was funded by Pfizer, Inc. The funder provided support in the form of salaries for authors YNA, AYY, IN, DS, WM, AR and PS. Additionally, Wasatch Microfluidics provided support in the form of salary for author AM. These companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Furthermore, three of these co-authors, WM, AR and PS, were employed by Pfizer during the study but at the submission date were employed at other commercial companies, namely Bristol-Myers Squibb (WM and PS) and Compugen USA Inc. (AR). These companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Abdiche YN, 2016, MABS-AUSTIN, V8, P264, DOI 10.1080/19420862.2015.1118596; Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Bee C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080501; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; CHITARRA V, 1993, P NATL ACAD SCI USA, V90, P7711, DOI 10.1073/pnas.90.16.7711; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; De Genest E, 2005, J BIOL CHEM, V280, P14114, DOI 10.1074/jbc.M413011200; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Sivasubramanian A, 2016, MABS, V17	18	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169535	10.1371/journal.pone.0169535	http://dx.doi.org/10.1371/journal.pone.0169535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060885	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500105
J	Ceulemans, LJ; Verbeke, L; Decuypere, JP; Farre, R; De Hertogh, G; Lenaerts, K; Jochmans, I; Monbaliu, D; Nevens, F; Tack, J; Laleman, W; Pirenne, J				Ceulemans, Laurens J.; Verbeke, Len; Decuypere, Jean-Paul; Farre, Ricard; De Hertogh, Gert; Lenaerts, Kaatje; Jochmans, Ina; Monbaliu, Diethard; Nevens, Frederik; Tack, Jan; Laleman, Wim; Pirenne, Jacques			Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL TIGHT JUNCTIONS; BILE-ACID RECEPTOR; OBETICHOLIC ACID; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; FXR; BARRIER; AUTOPHAGY; AGONIST	Introduction The farnesoid X receptor (FXR) is abundantly expressed in the ileum, where it exerts an enteroprotective role as a key regulator of intestinal innate immunity and homeostasis, as shown in pre-clinical models of inflammatory bowel disease. Since intestinal ischemia reper-fusion injury (IRI) is characterized by hyperpermeability, bacterial translocation and inflammation, we aimed to investigate, for the first time, if the FXR-agonist obeticholic acid (OCA) could attenuate intestinal ischemia reperfusion injury. Material and Methods In a validated rat model of intestinal IRI (laparotomy + temporary mesenteric artery clamping), 3 conditions were tested (n = 16/group): laparotomy only (sham group); ischemia 60min+ reperfusion 60min + vehicle pretreatment (IR group); ischemia 60min + reperfusion 60min + OCA pretreatment (IR+ OCA group). Vehicle or OCA (INT-747, 2*30mg/kg) was administered by gavage 24h and 4h prior to IRI. The following end-points were analyzed: 7-day survival; biomarkers of enterocyte viability (L-lactate, I-FABP); histology (morphologic injury to villi/crypts and villus length); intestinal permeability (Ussing chamber); endotoxin translocation (Lipopolysaccharide assay); cytokines (IL-6, IL-1-beta, TNF alpha, IFN-gamma IL-10, IL-13); apoptosis (cleaved caspase-3); and autophagy (LC3, p62). Results It was found that intestinal IRI was associated with high mortality (90%); loss of intestinal integrity (structurally and functionally); increased endotoxin translocation and pro-inflammatory cytokine production; and inhibition of autophagy. Conversely, OCA-pretreatment improved 7-day survival up to 50% which was associated with prevention of epithelial injury,preserved intestinal architecture and permeability. Additionally, FXR-agonism led to decreased pro-inflammatory cytokine release and alleviated autophagy inhibition. Conclusion Pretreatment with OCA, an FXR-agonist, improves survival in a rodent model of intestinal IRI, preserves the gut barrier function and suppresses inflammation. These results turn FXR into a promising target for various conditions associated with intestinal ischemia.	[Ceulemans, Laurens J.; Decuypere, Jean-Paul; Jochmans, Ina; Monbaliu, Diethard; Pirenne, Jacques] Katholieke Univ Leuven, Univ Hosp Leuven, Abdominal Transplant Surg, Leuven, Belgium; [Ceulemans, Laurens J.; Decuypere, Jean-Paul; Jochmans, Ina; Monbaliu, Diethard; Pirenne, Jacques] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Verbeke, Len; Nevens, Frederik; Laleman, Wim] Katholieke Univ Leuven, Liver & Biliopancreat Disorders, Univ Hosp Leuven, Leuven, Belgium; [Farre, Ricard; Tack, Jan] Katholieke Univ Leuven, Gastroenterol, Univ Hosp Leuven, Leuven, Belgium; [Farre, Ricard; Tack, Jan] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Leuven, Belgium; [De Hertogh, Gert] Katholieke Univ Leuven, Translat Cell & Tissue Res, Univ Hosp Leuven, Leuven, Belgium; [De Hertogh, Gert] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Lenaerts, Kaatje] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Surg, Med Ctr, Maastricht, Netherlands	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC)	Ceulemans, LJ (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Abdominal Transplant Surg, Leuven, Belgium.; Ceulemans, LJ (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	ceulemans.laurens@gmail.com	Monbaliu, Diethard/AAK-8499-2020; Laleman, Wim/H-7272-2019; Farre, Ricard/O-4549-2016; Pirenne, Jacques/I-3728-2018; Jochmans, Ina/R-2471-2017; Lenaerts, Kaatje/B-9614-2008; Farre, Ricard/M-9275-2013; Monbaliu, Diethard/I-3733-2018	Monbaliu, Diethard/0000-0002-0506-1609; Laleman, Wim/0000-0002-0842-7813; Farre, Ricard/0000-0001-7158-171X; Pirenne, Jacques/0000-0002-8147-8801; Jochmans, Ina/0000-0003-4592-2810; Lenaerts, Kaatje/0000-0002-9858-0538; Farre, Ricard/0000-0001-7158-171X; Monbaliu, Diethard/0000-0002-0506-1609; Tack, Jan/0000-0002-3206-6704; Ceulemans, Laurens/0000-0002-4261-7100	Belgian Federation for Gastroenterology (BWGE); Flemish Society for Gastroenterology (VVGE); Royal Belgian Surgical Society (RBSS); Fund for Scientific Research - Flanders (FWO Vlaanderen); Methusalem grant from the University of Leuven, Belgium; Ku Leuven, FWO; Roche; Astellas	Belgian Federation for Gastroenterology (BWGE); Flemish Society for Gastroenterology (VVGE); Royal Belgian Surgical Society (RBSS); Fund for Scientific Research - Flanders (FWO Vlaanderen)(FWO); Methusalem grant from the University of Leuven, Belgium; Ku Leuven, FWO; Roche(Roche Holding); Astellas(Astellas Pharmaceuticals)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. L J Ceulemans was granted a research fee by the Belgian Federation for Gastroenterology (BWGE), the Flemish Society for Gastroenterology (VVGE) and the Royal Belgian Surgical Society (RBSS). L Verbeke is an aspirant researcher and was granted a PhD fellowship by the Fund for Scientific Research - Flanders (FWO Vlaanderen). D Monbaliu and F Nevens are senior clinical investigators for the Fund for Scientific Research Flanders (FWO Vlaanderen). J Tack is supported by a Methusalem grant from the University of Leuven, Belgium. J Pirenne has received grants from Ku Leuven, FWO and unrestricted grants form Roche and Astellas. J Pirenne and D Monbaliu received a CAF chair for Abdominal Transplantation research.	Adorini L, 2012, DRUG DISCOV TODAY, V17, P988, DOI 10.1016/j.drudis.2012.05.012; Bae EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086553; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cariou B, 2006, J HEPATOL, V44, P1213, DOI 10.1016/j.jhep.2006.03.006; Ceulemans LJ, 2016, ACTA CHIR BELG, V10, P1; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fasano A, 2004, ADV DRUG DELIVER REV, V56, P795, DOI 10.1016/j.addr.2003.10.045; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gadaleta RM, 2011, BBA-MOL BASIS DIS, V1812, P851, DOI 10.1016/j.bbadis.2011.04.005; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Ghebremariam YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060653; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; HOLLANDER D, 1993, GASTROENTEROLOGY, V104, P1848, DOI 10.1016/0016-5085(93)90668-3; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kagnoff MF, 2014, J CLIN INVEST, V124, P2841, DOI 10.1172/JCI75225; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Klag T, 2013, DIGEST DIS, V31, P310, DOI 10.1159/000354858; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; PARK PO, 1990, SURGERY, V107, P574; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Stojancevic M, 2012, CAN J GASTROENTEROL, V26, P631, DOI 10.1155/2012/538452; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Verbeke L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33453; Verbeke L, 2015, AM J PATHOL, V185, P409, DOI 10.1016/j.ajpath.2014.10.009; Verbeke L, 2014, HEPATOLOGY, V59, P2286, DOI 10.1002/hep.26939; Vignozzi L, 2016, J STEROID BIOCH MOL; Vignozzi L, 2011, J SEX MED, V8, P57, DOI 10.1111/j.1743-6109.2010.02073.x; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wang XM, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/465915; Williams JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043961; Ye LS, 2015, BIOCHEM BIOPH RES CO, V467, P164, DOI 10.1016/j.bbrc.2015.09.067; Zhang XY, 2014, P NATL ACAD SCI USA, V111, P2277, DOI 10.1073/pnas.1323977111	48	29	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169331	10.1371/journal.pone.0169331	http://dx.doi.org/10.1371/journal.pone.0169331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060943	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500083
J	Lei, H; Li, XY; Jing, B; Xu, HZ; Wu, YL				Lei, Hu; Li, Xiangyun; Jing, Bo; Xu, Hanzhang; Wu, Yingli			Human S100A7 Induces Mature Interleukin 1 alpha Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis	PLOS ONE			English	Article							KERATINOCYTE DIFFERENTIATION; SKIN INFLAMMATION; CYTOKINES; IDENTIFICATION; LOCALIZATION; RECEPTOR; ENHANCE; SWITCH; CELLS; MODEL	Psoriatic keratinocytes express exaggerated levels of inflammatory cytokines, and show aberrant hyperproliferation and terminal differentiation in the pathogenesis of psoriasis. The antimicrobial protein hS100A7 (psoriasin) has been found highly expressed in psoriatic skin, but the mechanism and physiological function remain largely unknown. We observed that hS100A7 induces mature interleukin 1 alpha (17kDa) expression in normal human epidermal keratinocytes, which is dependent on RAGE-p38 MAPK and calpain-1 as the inhibitors or knockdown of them completely decreased the expression of mature interleukin1 alpha. Then, we proved mS100a7a15, mature IL-1 alpha and calpain-1 were highly expressed in imquimod-induced psoriasis model and mouse IL-17a-neutralizing antibody treatment attenuated mS100a7a15 expression. At last, PD 151746 (calpain-1 inhibitor) treatment decreased epidermal thickness in imquimod-induced psoriasis model. Taken together, our results suggest that mature IL-1 alpha induced by hS100A7 is via RAGE-p38 MAPK and calpain-1 pathway in keratinocyte and this mechanism may play an important role during psoriasis.	[Lei, Hu; Li, Xiangyun; Jing, Bo; Xu, Hanzhang; Wu, Yingli] Shanghai Jiao Tong Univ, Shanghai Univ, Shanghai Tongren Hosp,Sch Med,E Inst,Fac Basic Me, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai University	Lei, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Univ, Shanghai Tongren Hosp,Sch Med,E Inst,Fac Basic Me, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai, Peoples R China.	hulei@shsmu.edu.cn	Lei, Hu/AAR-7795-2021	Lei, Hu/0000-0003-3288-5205	National Basic Research Program of China (973 Program) [2015CB910403]; National Natural Science Foundation of China [81570118, 81570112]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Basic Research Program of China (973 Program) (NO. 2015CB910403), and National Natural Science Foundation of China (81570118, 81570112).	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Balato A, 2013, ARCH DERMATOL RES, V305, P255, DOI 10.1007/s00403-013-1327-8; Batycka-Baran A, 2015, J DERMATOL SCI, V79, P214, DOI 10.1016/j.jdermsci.2015.05.007; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chamcheu JC, 2015, SKIN PHARMACOL PHYS, V28, P177, DOI 10.1159/000368445; D'Amico F, 2016, CYTOKINE GROWTH FACT; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Grayson M, 2012, NATURE, V492, P549, DOI 10.1038/492S49a; Guilloteau K, 2010, J IMMUNOL; Hattori F, 2014, BRIT J DERMATOL, V171, P742, DOI 10.1111/bjd.13125; Idan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14756; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lei H, 2016, SCI CHINA LIFE SCI; Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7875; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mavropoulos A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/569751; Mee JB, 2006, CYTOKINE, V33, P72, DOI 10.1016/j.cyto.2005.12.001; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Muromoto R, 2016, INT IMMUNOL, V28, P443, DOI 10.1093/intimm/dxw011; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; O'Shaughnessy RFL, 2010, HUM MOL GENET, V19, P2594, DOI 10.1093/hmg/ddq145; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Pietrzak AT, 2008, CLIN CHIM ACTA, V394, P7, DOI 10.1016/j.cca.2008.04.005; Rabeony H, 2015, EUR J IMMUNOL, V45, P2847, DOI 10.1002/eji.201445215; SAUDER DN, 1990, LYMPHOKINE RES, V9, P465; Segrelles C, 2004, CARCINOGENESIS, V25, P1137, DOI 10.1093/carcin/bgh132; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Nguyen TT, 2012, J DERMATOL SCI, V68, P63, DOI 10.1016/j.jdermsci.2012.07.010; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Viguier M, 2010, ANN INTERN MED, V153, P66, DOI 10.7326/0003-4819-153-1-201007060-00030; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169788	10.1371/journal.pone.0169788	http://dx.doi.org/10.1371/journal.pone.0169788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060905	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500138
J	Rhodes, CM; Chang, YC; Regan, S; Triant, VA				Rhodes, Corinne M.; Chang, Yuchiao; Regan, Susan; Triant, Virginia A.			Non-Communicable Disease Preventive Screening by HIV Care Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; QUALITY-OF-CARE; ANTIRETROVIRAL THERAPY; PHYSICIAN EXPERIENCE; ADMINISTRATIVE DATA; POSITIVE PATIENTS; INFECTED PATIENTS; SHARED CARE	Importance The Human Immunodeficiency Virus (HIV) epidemic has evolved, with an increasing non-communicable disease (NCD) burden emerging and need for long-term management, yet there are limited data to help delineate the optimal care model to screen for NCDs for this patient population. Objective The primary aim was to compare rates of NCD preventive screening in persons living with HIV/AIDS (PLWHA) by type of HIV care model, focusing on metabolic/cardiovascular disease (CVD) and cancer screening. We hypothesized that primary care models that included generalists would have higher preventive screening rates. Design Prospective observational cohort study. Setting Partners HealthCare System (PHS) encompassing Brigham & Women's Hospital, Massachusetts General Hospital, and affiliated community health centers. Participants PLWHA age > 18 engaged in active primary care at PHS. Exposure HIV care model categorized as infectious disease (ID) providers only, generalist providers only, or ID plus generalist providers. Main Outcome(s) and Measures(s) Odds of screening for metabolic/CVD outcomes including hypertension (HTN), obesity, hyperlipidemia (HL), and diabetes (DM) and cancer including colorectal cancer (CRC), cervical cancer, and breast cancer. Results In a cohort of 1565 PLWHA, distribution by HIV care model was 875 ID (56%), 90 generalists (6%), and 600 ID plus generalists (38%). Patients in the generalist group had lower odds of viral suppression but similar CD4 counts and ART exposure as compared with ID and ID plus generalist groups. In analyses adjusting for sociodemographic and clinical covariates and clustering within provider, there were no significant differences in metabolic/CVD or cancer screening rates among the three HIV care models. Conclusions There were no notable differences in metabolic/CVD or cancer screening rates by HIV care model after adjusting for sociodemographic and clinical factors. These findings suggest that HIV patients receive similar preventive health care for NCDs independent of HIV care model.	[Rhodes, Corinne M.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Chang, Yuchiao; Regan, Susan; Triant, Virginia A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Chang, Yuchiao; Regan, Susan; Triant, Virginia A.] Harvard Med Sch, Boston, MA USA; [Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Rhodes, CM (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA.	corinne.rhodes@uphs.upenn.edu		Rhodes, Corinne Marie/0000-0002-8773-8563	Health Resources and Service Administration [T32 HP102]; Tyoichi Sasakawa Fellowship Fund; Harvard Catalyst Disparities Enrichment Grant; National Institute of Allergy and Infectious Diseases [K01AI73109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125029, R21HL122138] Funding Source: NIH RePORTER	Health Resources and Service Administration; Tyoichi Sasakawa Fellowship Fund; Harvard Catalyst Disparities Enrichment Grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Health Resources and Service Administration T32 HP102 (CMR), Tyoichi Sasakawa Fellowship Fund (CMR), Harvard Catalyst Disparities Enrichment Grant (CMR), National Institute of Allergy and Infectious Diseases K01AI73109 (VAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; [Anonymous], 2012, COMM REV DAT SYST MO; [Anonymous], 2013, ANN SOCIAL EC SUPPLE; [Anonymous], 2009, AM FACT FINDER INCOM; [Anonymous], 2015, HIV PEOPLE AGED 50; Atlas SJ, 2014, J AM BOARD FAM MED, V27, P474, DOI 10.3122/jabfm.2014.04.130319; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Berkowitz SA, 2015, HEALTH SERV RES, V50, P398, DOI 10.1111/1475-6773.12229; Boyd CM, 2014, CURR OPIN HIV AIDS, V9, P419, DOI 10.1097/COH.0000000000000073; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V61, P41; Chirch LM, 2014, CURR OPIN HIV AIDS, V9, P405, DOI 10.1097/COH.0000000000000074; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diop ME, 2006, AIDS RES HUM RETROV, V22, P1242, DOI 10.1089/aid.2006.22.1242; Duffus WA, 2003, CLIN INFECT DIS, V36, P1577, DOI 10.1086/375070; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fultz SL, 2005, CLIN INFECT DIS, V41, P738, DOI 10.1086/432621; HealthHIV, 2015, HEALTHHIVS 3 ANN STA; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kabagambe EK, 2015, PROGRAM ELECT MED RE; Keller SC, 2014, AIDS CARE, V26, P716, DOI 10.1080/09540121.2013.855700; Kendall CE, 2015, J CLIN EPIDEMIOL, V68, P1301, DOI 10.1016/j.jclinepi.2015.02.008; Kendall CE, 2015, ANN FAM MED, V13, P436, DOI 10.1370/afm.1822; Kendall CE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007428; Kerr CA, 2012, AM J MED QUAL, V27, P321, DOI 10.1177/1062860611425714; Kim PS, 2009, DIABETES CARE, V32, P1591, DOI 10.2337/dc09-0177; Kitahata MM, 2003, J GEN INTERN MED, V18, P95, DOI 10.1046/j.1525-1497.2003.11049.x; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; Landon BE, 2002, J GEN INTERN MED, V17, P12, DOI 10.1046/j.1525-1497.2002.10401.x; Lichtenstein KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120083; Momplaisir F, 2014, AIDS CARE, V26, P87, DOI 10.1080/09540121.2013.802276; Momplaisir F, 2012, J GEN INTERN MED, V27, P940, DOI 10.1007/s11606-012-2010-z; Murphy Shawn N, 2003, AMIA Annu Symp Proc, P489; O'Neill M, 2015, CLIN INFECT DIS; Page J, 2003, HIV Med, V4, P276, DOI 10.1046/j.1468-1293.2003.00157.x; Pellowski JA, 2013, J ASSOC NURSE AIDS C, V24, P422, DOI 10.1016/j.jana.2012.08.007; Polgreen PM, 2003, CLIN INFECT DIS, V37, pE53, DOI 10.1086/376633; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Reinhold JP, 2005, AM J GASTROENTEROL, V100, P1805, DOI 10.1111/j.1572-0241.2005.50038.x; Reinsch N, 2012, EUR J PREV CARDIOL, V19, P267, DOI 10.1177/1741826711398431; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Smetana GW, 2007, ARCH INTERN MED, V167, P10, DOI 10.1001/archinte.167.1.10; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2014, REV CARDIOVASC MED, V15, pS1, DOI 10.3908.ricm15S1S002; Wilson IB, 2005, MED CARE, V43, P12; Wong WCW, 2012, SEX TRANSM INFECT, V88, P125, DOI 10.1136/sextrans-2011-050170	55	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169246	10.1371/journal.pone.0169246	http://dx.doi.org/10.1371/journal.pone.0169246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060868	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500070
J	Verma, M; Erwin, S; Abedi, V; Hontecillas, R; Hoops, S; Leber, A; Bassaganya-Riera, J; Ciupe, SM				Verma, Meghna; Erwin, Samantha; Abedi, Vida; Hontecillas, Raquel; Hoops, Stefan; Leber, Andrew; Bassaganya-Riera, Josep; Ciupe, Stanca M.			Modeling the Mechanisms by Which HIV Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; T-CELL DEPLETION; NATURAL-HISTORY; FOLLICULAR HELPER; POSITIVE MEN; TAT PROTEIN; IMMUNODEFICIENCY; DYNAMICS; CLEARANCE	Human immunodeficiency virus (HIV)-infected patients are at an increased risk of co-infection with human papilloma virus (HPV), and subsequent malignancies such as oral cancer. To determine the role of HIV-associated immune suppression on HPV persistence and pathogenesis, and to investigate the mechanisms underlying the modulation of HPV infection and oral cancer by HIV, we developed a mathematical model of HIV/HPV co-infection. Our model captures known immunological and molecular features such as impaired HPV-specific effector T helper 1 (Th1) cell responses, and enhanced HPV infection due to HIV. We used the model to determine HPV prognosis in the presence of HIV infection, and identified conditions under which HIV infection alters HPV persistence in the oral mucosa system. The model predicts that conditions leading to HPV persistence during HIV/HPV co-infection are the permissive immune environment created by HIV and molecular interactions between the two viruses. The model also determines when HPV infection continues to persist in the short run in a co-infected patient undergoing antiretroviral therapy. Lastly, the model predicts that, under efficacious antiretroviral treatment, HPV infections will decrease in the long run due to the restoration of CD4+ T cell numbers and protective immune responses.	[Verma, Meghna; Abedi, Vida; Hontecillas, Raquel; Hoops, Stefan; Leber, Andrew; Bassaganya-Riera, Josep] Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA; [Erwin, Samantha; Ciupe, Stanca M.] Virginia Tech, Dept Math, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA.; Ciupe, SM (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA USA.	jbassaga@vt.edu; stanca@math.vt.edu	Erwin, Samantha/AAK-8865-2021	Erwin, Samantha/0000-0002-5162-4193; Abedi, Vida/0000-0001-7689-933X; Verma, Meghna/0000-0002-7776-0433	Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org)	[Anonymous], BR J DERMATOL; Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Beachler DC, 2014, AM J EPIDEMIOL; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; BUONAGURO FM, 1994, ANTIBIOT CHEMOTHER, V46, P102; Cameron JE, 2005, SEX TRANSM DIS, V32, P703, DOI 10.1097/01.olq.0000175398.34610.2e; Carbo A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00031; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Chelliah V, 2014, NUCLEIC ACIDS RES; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Ciupe MS, 2006, MATH BIOSCI, V200, P1, DOI 10.1016/j.mbs.2005.12.006; d'Ettorre G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109791; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; De Flora S., 2015, J PREV MED HYG, V56, P15; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Doorbar J, 2012, VACCINE, P30; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Fontes A, 2016, HIGH SPECIFIC IMMUNE; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Geskus RB, 2016, AIDS, V30, P37, DOI 10.1097/QAD.0000000000000874; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Grierson J, 2011, HIV MED, V12, P562, DOI 10.1111/j.1468-1293.2011.00928.x; Grivel JC, 2000, J VIROL, V74, P5347, DOI 10.1128/JVI.74.11.5347-5351.2000; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gupta R KR, 2016, LANCET INFECT DIS; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kim RH, 2008, INT J ONCOL, V33, P777, DOI 10.3892/ijo_00000064; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Kravchenko J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030736; Leber A, 2016, J THEOR BIOL, V398, P74, DOI 10.1016/j.jtbi.2016.02.036; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Mooij SH, 2016, AIDS, V30, P121, DOI 10.1097/QAD.0000000000000909; Moscicki A-B, 2006, VACCINE, P24; Murall CL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1069; Murall CL, 2014, J THEOR BIOL, V350, P98, DOI 10.1016/j.jtbi.2013.12.028; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Nyagol J, 2006, CANCER BIOL THER, V5, P684, DOI 10.4161/cbt.5.6.2907; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; Pallikkuth S, 2016, J VIROL, V90, P2718, DOI 10.1128/JVI.02883-15; Perelson AS, 2008, STAT MED, V27, P4647, DOI 10.1002/sim.3116; Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Picard A, 2016, HPV PREVALENCE HIV P; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Rositch AF, 2012, CANCER RES, V72, P6183, DOI 10.1158/0008-5472.CAN-12-2635; Ryser MD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004113; Sasagawa T, 2012, J INFECT CHEMOTHER, V18, P807, DOI 10.1007/s10156-012-0485-5; Scott M, 2001, CLIN DIAGN LAB IMMUN, V8, P209, DOI 10.1128/CDLI.8.2.209-220.2001; Shiboski CH, 2016, HUMAN PAPILLOMAVIRUS; Society AC, 2015, CANC FACTS FIG 2015; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Sun H, 2015, J VIROL, V89, P11284, DOI 10.1128/JVI.01595-15; Syrjanen S, 2011, Adv Dent Res, V23, P84, DOI 10.1177/0022034511399914; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140; VERNON SD, 1993, VIRUS RES, V27, P133, DOI 10.1016/0168-1702(93)90077-Z; Weinberg A, 2012, J INFECT DIS, V206, P1309, DOI 10.1093/infdis/jis489	69	20	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168133	10.1371/journal.pone.0168133	http://dx.doi.org/10.1371/journal.pone.0168133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060843	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500022
J	Nakamoto, M; Ishihara, K; Watanabe, T; Hirosue, A; Hino, S; Shinohara, M; Nakayama, H; Nakao, M				Nakamoto, Masafumi; Ishihara, Ko; Watanabe, Takehisa; Hirosue, Akiyuki; Hino, Shinjiro; Shinohara, Masanori; Nakayama, Hideki; Nakao, Mitsuyoshi			The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells	PLOS ONE			English	Article							CCCTC-BINDING FACTOR; MAMMARY-TUMOR VIRUS; TARGET GENE; LOCUS; PROTEIN; METHYLATION; EXPRESSION; PROMOTER; SITES; DNA	Glucocorticoid signaling through the glucocorticoid receptor (GR) plays essential roles in the response to stress and in energy metabolism. This hormonal action is integrated to the transcriptional control of GR-target genes in a cell type-specific and condition-dependent manner. In the present study, we found that the GR regulates the angiopoietin-like 4 gene (ANGPTL4) in a CCCTC-binding factor (CTCF)-mediated chromatin context in the human hepatic HepG2 cells. There are at least four CTCF-enriched sites and two GR-binding sites within the ANGPTL4 locus. Among them, the major CTCF-enriched site is positioned near the ANGPTL4 enhancer that binds GR. We showed that CTCF is required for induction and subsequent silencing of ANGPTL4 expression in response to dexamethasone (Dex) and that transcription is diminished after long-term treatment with Dex. Although the ANGPTL4 locus maintains a stable higher-order chromatin conformation in the presence and absence of Dex, the Dex-bound GR activated transcription of ANGPTL4 but not that of the neighboring three genes through interactions among the ANGPTL4 enhancer, promoter, and CTCF sites. These results reveal that liganded GR spatiotemporally controls ANGPTL4 transcription in a chromosomal context.	[Nakamoto, Masafumi; Watanabe, Takehisa; Hirosue, Akiyuki; Hino, Shinjiro; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Nakamoto, Masafumi; Hirosue, Akiyuki; Shinohara, Masanori; Nakayama, Hideki] Kumamoto Univ, Dept Oral & Maxillofacial Surg, Fac Life Sci, Kumamoto, Japan; [Ishihara, Ko] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Nakao, Mitsuyoshi] Japan Agcy Med Res & Dev, Core Res Evolutionary Sci & Technol, Tokyo, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST)	Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan.; Ishihara, K (corresponding author), Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan.; Nakao, M (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolutionary Sci & Technol, Tokyo, Japan.	kishihar@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [JP15H04707, JP15K15068]; Takeda Science Foundation; Japan Agency for Medical Research and Development (CREST)	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development (CREST)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (JSPS KAKENHI) Grant Numbers JP15H04707 and JP15K15068 (https://www.jsps.go.jp/english/e-grants/), by grants from Takeda Science Foundation (http://www.takeda-sci.or.jp/), and the Japan Agency for Medical Research and Development (CREST) (http://www.amed.go.jp/en/) (MiN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041374; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fu VX, 2004, J BIOL CHEM, V279, P52218, DOI 10.1074/jbc.M405015200; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Hakim O, 2009, J BIOL CHEM, V284, P6048, DOI 10.1074/jbc.C800212200; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hirosue A, 2012, AGING CELL, V11, P553, DOI 10.1111/j.1474-9726.2012.00809.x; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Keeton EK, 2002, J BIOL CHEM, V277, P28247, DOI 10.1074/jbc.M203898200; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koliwad SK, 2012, ADIPOCYTE, V1, P182, DOI 10.4161/adip.20787; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Mattijssen F, 2014, MOL METAB, V3, P135, DOI 10.1016/j.molmet.2013.11.004; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Patel R, 2014, MOL ENDOCRINOL, V28, P999, DOI 10.1210/me.2014-1062; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; Shibli-Rahhal A, 2006, CLIN DERMATOL, V24, P260, DOI 10.1016/j.clindermatol.2006.04.012; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Watanabe T, 2012, MOL CELL BIOL, V32, P1529, DOI 10.1128/MCB.06478-11; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169225	10.1371/journal.pone.0169225	http://dx.doi.org/10.1371/journal.pone.0169225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056052	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100026
J	Sun, XM; Ji, YS; Liu, XY; Xiang, M; He, G; Xie, L; Suo, JX; Suo, X				Sun, Xi-meng; Ji, Yong-sheng; Liu, Xian-yong; Xiang, Mei; He, Guang; Xie, Li; Suo, Jing-xia; Suo, Xun			Improvement and Evaluation of Loop-Mediated Isothermal Amplification for Rapid Detection of Toxoplasma gondii Infection in Human Blood Samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WATER SAMPLES; LAMP METHOD; DIAGNOSIS; DNA; IDENTIFICATION; ANTIBODIES; ANTIGENS; ELISA; SERA	Loop-mediated isothermal amplification (LAMP), an attractive DNA amplification method, was developed as a valuable tool for the rapid detection of Toxoplasma gondii. In this study, species-specific LAMP primers were designed by targeting the AF146527 sequence, which was a conserved sequence of 200- to 300-fold repetitive 529 bp fragment of T.gondii. LAMP reaction system was optimized so that it could detect the minimal DNA sample such as a single tachyzoite or 10 copies of recombinant plasmid. No cross-reactivity was found when using DNA from other parasites as templates. Subsequently, a total of 200 human blood samples were directly investigated by two diagnostic methods, LAMP and conventional PCR. Fourteen of 200 (7%) samples were positive for Toxoplasma by LAMP (the primers developed in this study), whereas only 5 of 200 (2.5%) were proved positive by conventional PCR. The procedure of the LAMP assay was very simple, as the reaction would be carried out in a single tube under isothermal conditions at 64 C and the result would be read out with 1 h (as early as 35 min with loop primers). Thus, this method has the advantages of rapid amplification, simple operation, and easy detection and would be useful for rapid and reliable clinical diagnosis of acute toxoplasmosis, especially in developing countries.	[Sun, Xi-meng; Ji, Yong-sheng; Liu, Xian-yong; He, Guang; Xie, Li; Suo, Jing-xia; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing, Peoples R China; [Sun, Xi-meng; Ji, Yong-sheng; Liu, Xian-yong; He, Guang; Xie, Li; Suo, Jing-xia; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Sun, Xi-meng; Liu, Xian-yong; Suo, Jing-xia; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Xian-yong; Suo, Jing-xia; Suo, Xun] China Agr Univ, Key Lab Zoonosis, Minist Agr, Beijing, Peoples R China; [Xiang, Mei] Jilin Univ, Hsop 2, Changchun, Peoples R China; [Sun, Xi-meng] Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China; [Ji, Yong-sheng] Anhui Med Univ, Dept Pathogen Biol, Prov Labs Pathogen Biol & Zoonoses Anhui, Hefei, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Jilin University; Capital Medical University; Anhui Medical University	Suo, X (corresponding author), China Agr Univ, Natl Anim Protozoa Lab, Beijing, Peoples R China.; Suo, X (corresponding author), China Agr Univ, Coll Vet Med, Beijing, Peoples R China.; Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Suo, X (corresponding author), China Agr Univ, Key Lab Zoonosis, Minist Agr, Beijing, Peoples R China.	suoxun@cau.edu.cn	Sun, Ximeng/AAA-8449-2022; Ji, Yongsheng/AAB-7772-2020	LIU, XIANYONG/0000-0001-9425-6784	Special Fund for Agro-scientific Research in the Public Interest [201303042]; National Natural Science Foundation of China [31172309]; Special Cooperation Funds for Science and Technology of Hainan Province [KJHZ2015-31]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Cooperation Funds for Science and Technology of Hainan Province	This research was financially supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201303042), the National Natural Science Foundation of China (No. 31172309), and the Special Cooperation Funds for Science and Technology of Hainan Province (No. KJHZ2015-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan A, 2007, VET PARASITOL, V143, P155, DOI 10.1016/j.vetpar.2006.08.014; Ashburn D, 1998, J CLIN PATHOL-MOL PA, V51, P105; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Dubey JP, 2004, J PARASITOL, V90, P67, DOI 10.1645/GE-110R; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Fatoohi AF, 2002, CLIN DIAGN LAB IMMUN, V9, P704, DOI 10.1128/CDLI.9.3.704-707.2002; Garcia JL, 2006, EXP PARASITOL, V113, P100, DOI 10.1016/j.exppara.2005.12.011; GROSS U, 1992, EUR J CLIN MICROBIOL, V11, P33, DOI 10.1007/BF01971268; Guy EC, 1996, EUR J CLIN MICROBIOL, V15, P836, DOI 10.1007/BF01701532; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Huang XH, 2004, J CLIN MICROBIOL, V42, P351, DOI 10.1128/JCM.42.1.351-353.2004; Ihira M, 2004, J CLIN MICROBIOL, V42, P140, DOI 10.1128/JCM.42.1.140-145.2004; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Karanis P, 2007, APPL ENVIRON MICROB, V73, P5660, DOI 10.1128/AEM.01152-07; Kuboki N, 2003, J CLIN MICROBIOL, V41, P5517, DOI 10.1128/JCM.41.12.5517-5524.2003; Lau YL, 2010, J CLIN MICROBIOL, V48, P3698, DOI 10.1128/JCM.00462-10; LEPORT C, 1992, PRESSE MED, V21, P1165; Mainar-Jaime RC, 2007, VET PARASITOL, V148, P122, DOI 10.1016/j.vetpar.2007.05.018; Meek B, 2003, DIAGN MICR INFEC DIS, V45, P45, DOI 10.1016/S0732-8893(02)00476-5; Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; Njiru ZK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000147; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Sotiriadou I, 2008, DIAGN MICR INFEC DIS, V62, P357, DOI 10.1016/j.diagmicrobio.2008.07.009; Sun XM, 2012, J PROTEOMICS, V77, P423, DOI 10.1016/j.jprot.2012.09.018; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Zhang HS, 2009, EXP PARASITOL, V122, P47, DOI 10.1016/j.exppara.2009.01.012	28	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169125	10.1371/journal.pone.0169125	http://dx.doi.org/10.1371/journal.pone.0169125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056092	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100022
J	Kawaguchi, Y; Taoka, M; Takekiyo, T; Uekita, T; Shoji, I; Hachiya, N; Ichimura, T				Kawaguchi, Yuki; Taoka, Masato; Takekiyo, Takahiro; Uekita, Takamasa; Shoji, Ikuo; Hachiya, Naomi; Ichimura, Tohru			TRIM32-Cytoplasmic-Body Formation Is an ATP-Consuming Process Stimulated by HSP70 in Cells	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNELS; E3 UBIQUITIN LIGASE; RETROVIRAL RESTRICTION; MISFOLDED PROTEINS; CYTOPLASMIC BODIES; QUALITY-CONTROL; MUSCLE ATROPHY; BINDING SITE; IN-VITRO; TRIM32	The spontaneous and energy-releasing reaction of protein aggregation is typically prevented by cellular quality control machinery (QC). TRIM32 is a member of the TRIM (tripartite motif-containing) ubiquitin E3 ligases, and when overexpressed in cultured cells, readily forms spherical inclusions designated as cytoplasmic bodies (CBs) even without proteasome inhibition. Here, we show that HSP70, a central QC component, is a primary binding factor of overexpressed TRIM32. Contrary to expectation, however, we find that this molecular chaperone facilitates and stabilizes CB assembly depending on intrinsic ATPase activity, rather than preventing CB formation. We also show that the HSP70-TRIM32 complex is biochemically distinct from the previously characterized 14-3-3-TRIM32 phospho-complex. Moreover, the two complexes have opposing roles, with HSP70 stimulating CB formation and 14-3-3 retaining TRIM32 in a diffuse form throughout the cytosol. Our results suggest that CB inclusion formation is actively controlled by cellular QC and requires ATP, similar to protein folding and degradation reactions.	[Kawaguchi, Yuki; Takekiyo, Takahiro; Uekita, Takamasa; Ichimura, Tohru] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa, Japan; [Taoka, Masato] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan; [Shoji, Ikuo] Kobe Univ, Ctr Infect Dis, Grad Sch Med, Div Infect Dis Control, Kobe, Hyogo, Japan; [Hachiya, Naomi] Tokyo Metropolitan Ind Technol Res Inst, R&D Div, Biotechnol Grp, Koto Ku, Tokyo, Japan	National Defence Academy - Japan; Tokyo Metropolitan University; Kobe University	Ichimura, T (corresponding author), Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa, Japan.	ichimura@nda.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379	JSPS KAKENHI [JP15K06850, JP15K14427]; Grants-in-Aid for Scientific Research [26660176] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Numbers JP15K06850, JP15K14427). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2010, ENDOCR J, V57, P455, DOI 10.1507/endocrj.K09E-290; Bateman RH, 2002, J AM SOC MASS SPECTR, V13, P792, DOI 10.1016/S1044-0305(02)00420-8; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Cohen S, 2014, J CELL BIOL, V204, P747, DOI 10.1083/jcb.201304167; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fu BS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004960; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Ichimura T, 2013, J CELL SCI, V126, P2014, DOI 10.1242/jcs.122069; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; OHTSUKA K, 1993, BIOCHEM BIOPH RES CO, V197, P235, DOI 10.1006/bbrc.1993.2466; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pawlica P, 2014, J VIROL, V88, P5661, DOI 10.1128/JVI.03717-13; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rohrer KM, 2014, IMMUNOLOGY, V142, P237, DOI 10.1111/imm.12249; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wu XJ, 2004, BIOCHEM J, V378, P793, DOI 10.1042/BJ20031680; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zhang XQ, 2011, MOL BIOL CELL, V22, P3277, DOI 10.1091/mbc.E11-05-0388	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169436	10.1371/journal.pone.0169436	http://dx.doi.org/10.1371/journal.pone.0169436			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052117	gold, Green Submitted, Green Published			2022-12-26	WOS:000391621500061
J	Pereira, CC; Duraes, C; Coelho, R; Gracio, D; Silva, M; Peixoto, A; Logo, P; Pereira, M; Catarino, T; Pinho, S; Teixeira, JP; Macedon, G; Annese, V; Magro, F				Pereira, Cristiana Costa; Duraes, Cecilia; Coelho, Rosa; Gracio, Daniela; Silva, Marco; Peixoto, Armando; Logo, Paula; Pereira, Marcia; Catarino, Telmo; Pinho, Salome; Teixeira, Joao Paulo; Macedon, Guilherme; Annese, Vito; Magro, Fernando			Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; ERYTHROCYTE GPX ACTIVITY; EVIDENCE-BASED CONSENSUS; CROHNS-DISEASE; ULCERATIVE-COLITIS; OXIDATIVE STRESS; RISK; MECHANISMS; CANCER; SUSCEPTIBILITY	Inflammation is the driving force in inflammatory bowel disease (IBD) and its link to oxidative stress and carcinogenesis has long been accepted. The antioxidant system of the intestinal mucosa in IBD is compromised resulting in increased oxidative injury. This defective antioxidant system may be the result of genetic variants in antioxidant genes, which can represent susceptibility factors for IBD, namely Crohn's disease (CD) and ulcerative colitis (UC). Single nucleotide polymorphisms (SNPs) in the antioxidant genes SOD2 (rs4880) and GPX1 (rs1050450) were genotyped in a Portuguese population comprising 436 Crohn's disease and 367 ulcerative colitis patients, and 434 healthy controls. We found that the AA genotype in GPX1 is associated with ulcerative colitis (OR = 1.93, adjusted P-value = 0.037). Moreover, we found nominal significant associations between SOD2 and Crohn's disease susceptibility and disease subphenotypes but these did not withstand the correction for multiple testing. These findings indicate a possible link between disease phenotypes and antioxidant genes. These results suggest a potential role for antioxidant genes in IBD pathogenesis and should be considered in future association studies.	[Pereira, Cristiana Costa; Teixeira, Joao Paulo] Natl Inst Hlth Dr Ricardo Jorge, Dept Environm Hlth, Oporto, Portugal; [Pereira, Cristiana Costa; Magro, Fernando] Univ Porto, Medln UP Ctr Drug Discovery & Innovat Med, Oporto, Portugal; [Pereira, Cristiana Costa; Teixeira, Joao Paulo] Univ Porto, Inst Publ Hlth, EPIUnit, Oporto, Portugal; [Duraes, Cecilia; Pereira, Marcia; Catarino, Telmo; Pinho, Salome] Univ Porto, Ipatimup Inst Mol Pathol & Immunol, Oporto, Portugal; [Duraes, Cecilia; Pereira, Marcia; Catarino, Telmo; Pinho, Salome] Univ Porto, i3S, Oporto, Portugal; [Coelho, Rosa; Silva, Marco; Peixoto, Armando; Macedon, Guilherme; Magro, Fernando] Ctr Hosp Sao Joao, Dept Gastroenterol, Fac Med, Oporto, Portugal; [Gracio, Daniela; Magro, Fernando] Univ Porto, Dept Pharmacol & Therapeut, Fac Med, Oporto, Portugal; [Logo, Paula] HSA Ctr Hosp Porto, Dept Gastroenterol, Oporto, Portugal; [Pereira, Marcia] Univ Porto, Inst Biomed Sci Abel Salazar, Oporto, Portugal; [Annese, Vito] AOU Careggi, Emergency Dept, Gastroenterol Unit, Florence, Italy	Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Universidade do Porto; University of Florence; Azienda Ospedaliero Universitaria Careggi	Magro, F (corresponding author), Univ Porto, Medln UP Ctr Drug Discovery & Innovat Med, Oporto, Portugal.; Magro, F (corresponding author), Ctr Hosp Sao Joao, Dept Gastroenterol, Fac Med, Oporto, Portugal.; Magro, F (corresponding author), Univ Porto, Dept Pharmacol & Therapeut, Fac Med, Oporto, Portugal.	fm@med.up.pt	Duraes, Cecilia/AAY-8903-2021; Durães, Cecília/I-2117-2013; Teixeira, Joao Paulo/F-5445-2013; Pereira, Cristiana MMC/I-6628-2015; Pereira, Cristiana/G-2199-2017; Annese, Vito/AGW-4200-2022; Pinho, Salome/F-1764-2011	Duraes, Cecilia/0000-0001-9282-0708; Durães, Cecília/0000-0001-9282-0708; Teixeira, Joao Paulo/0000-0001-8693-5250; Pereira, Cristiana MMC/0000-0002-2146-1223; Pereira, Cristiana/0000-0002-2146-1223; Annese, Vito/0000-0002-0082-892X; Magro, Fernando/0000-0003-2634-9668; Pereira, Marcia/0000-0002-8708-8388; Macedo, Guilherme/0000-0002-9387-9872; Pinho, Salome/0000-0002-3484-5162	Portuguese Study Group for Inflammatory Bowel Disease (GEDII)	Portuguese Study Group for Inflammatory Bowel Disease (GEDII)	This work was supported by a grant from the Portuguese Study Group for Inflammatory Bowel Disease (GEDII) [http://www.gedii.pt/bolsas_e_premios_a_decorrer]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Achkar JP, 2009, AM J GASTROENTEROL, V104, P1734, DOI 10.1038/ajg.2009.179; Alonso A, 2015, GASTROENTEROLOGY, V148, P794, DOI 10.1053/j.gastro.2014.12.030; Alzoghaibi MA, 2013, WORLD J GASTROENTERO, V19, P6540, DOI 10.3748/wjg.v19.i39.6540; Annese V, 2015, J CROHNS COLITIS, V9, P945, DOI 10.1093/ecco-jcc/jjv141; Azevedo LF, 2010, PHARMACOEPIDEM DR S, V19, P499, DOI 10.1002/pds.1930; Barbisan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107299; Chu FF, 2004, FREE RADICAL BIO MED, V36, P1481, DOI 10.1016/j.freeradbiomed.2004.04.010; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011; Ascencio-Montiel ID, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-110; Degoul F, 2001, GASTROENTEROLOGY, V120, P1468, DOI 10.1053/gast.2001.24051; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Montano MAE, 2012, CYTOKINE, V60, P30, DOI 10.1016/j.cyto.2012.05.022; Hauser F, 2015, GENES IMMUN, V16, P571, DOI 10.1038/gene.2015.35; Hong ZQ, 2013, MOL BIOL REP, V40, P1801, DOI 10.1007/s11033-012-2234-3; Hyams JS, 1996, PEDIATR CLIN N AM, V43, P255, DOI 10.1016/S0031-3955(05)70405-3; Hyams JS, 1996, J PEDIATR-US, V129, P81, DOI 10.1016/S0022-3476(96)70193-2; Ikumoto T, 2014, APMIS, V122, P512, DOI 10.1111/apm.12192; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurjus A, 2016, BBA CLIN, V5, P16, DOI 10.1016/j.bbacli.2015.11.002; Ladislava B, 2012, INFLAMMATORY BOWEL D; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li C., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/387176; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Meplan C, 2015, NUTRIENTS, V7, P3621, DOI 10.3390/nu7053621; Mlakar SJ, 2010, DIS MARKERS, V29, P71, DOI [10.1155/2010/354189, 10.3233/DMA-2010-0728]; Nielsen OH, 2009, NAT CLIN PRACT GASTR, V6, P92, DOI 10.1038/ncpgasthep1340; Nosti PA, 2013, EUR J OBSTET GYN R B, V171, P166, DOI 10.1016/j.ejogrb.2013.08.011; Pereira C, 2015, INFLAMM BOWEL DIS, V21, P2403, DOI 10.1097/MIB.0000000000000506; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Ramos E, 2004, ANN EPIDEMIOL, V14, P437, DOI 10.1016/j.annepidem.2003.09.013; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; St Clair D, 2004, J NUTR, V134, p3190S, DOI 10.1093/jn/134.11.3190S; Sutton A, 2005, PHARMACOGENET GENOM, V15, P311, DOI 10.1097/01213011-200505000-00006; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Xiong YM, 2010, OSTEOARTHR CARTILAGE, V18, P817, DOI 10.1016/j.joca.2010.02.004; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	45	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169102	10.1371/journal.pone.0169102	http://dx.doi.org/10.1371/journal.pone.0169102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052094	Green Published, gold			2022-12-26	WOS:000391621500033
J	Pfurtscheller, G; Schwerdtfeger, A; Brunner, C; Aigner, C; Fink, D; Briton, J; Carmo, MP; Andrade, A				Pfurtscheller, Gert; Schwerdtfeger, Andreas; Brunner, Clemens; Aigner, Christoph; Fink, David; Briton, Joana; Carmo, Marciano P.; Andrade, Alexandre			Distinction between Neural and Vascular BOLD Oscillations and Intertwined Heart Rate Oscillations at 0.1 Hz in the Resting State and during Movement	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CARDIAC RESPONSE; RATE-VARIABILITY; HUMAN CORTEX; BRAIN; FMRI; HEMODYNAMICS; ANXIETY; DESYNCHRONIZATION; CONNECTIVITY	In the resting state, blood oxygen level-dependent (BOLD) oscillations with a frequency of about 0.1 Hz are conspicuous. Whether their origin is neural or vascular is not yet fully understood. Furthermore, it is not clear whether these BOLD oscillations interact with slow oscillations in heart rate (HR). To address these two questions, we estimated phase-locking (PL) values between precentral gyrus (PCG) and insula in 25 scanner-naive individuals during rest and stimulus-paced finger movements in both hemispheres. PL was quantified in terms of time delay and duration in the frequency band 0.07 to 0.13 Hz. Results revealed both positive and negative time delays. Positive time delays characterize neural BOLD oscillations leading in the PCG, whereas negative time delays represent vascular BOLD oscillations leading in the insula. About 50% of the participants revealed positive time delays distinctive for neural BOLD oscillations, either with short or long unilateral or bilateral phase locking episodes. An expected preponderance of neural BOLD oscillations was found in the left hemisphere during right-handed movement and unexpectedly in the right hemisphere during rest. Only neural BOLD oscillations were significantly associated with heart rate variability (HRV) in the 0.1-Hz range in the first resting state. It is well known that participating in magnetic resonance imaging (MRI) studies may be frightening and cause anxiety. In this respect it is important to note that the most significant hemispheric asymmetry (p<0.002) with a right-sided dominance of neural BOLD and a left-sided dominance of vascular BOLD oscillations was found in the first resting session in the scanner-naive individuals. Whether the enhanced left-sided perfusion (dominance of vascular BOLD) or the right-sided dominance of neural BOLD is related to the increased level of anxiety, attention or stress needs further research.	[Pfurtscheller, Gert] Graz Univ Technol, Inst Neural Engn, Graz, Austria; [Pfurtscheller, Gert; Schwerdtfeger, Andreas; Brunner, Clemens; Aigner, Christoph] BioTechMed Graz, Graz, Austria; [Schwerdtfeger, Andreas; Brunner, Clemens; Fink, David] Graz Univ, Inst Psychol, Graz, Austria; [Schwerdtfeger, Andreas] Univ Wuppertal, Hlth Psychol & Appl Diagnost, Wuppertal, Germany; [Aigner, Christoph] Graz Univ Technol, Inst Med Engn, Graz, Austria; [Briton, Joana; Carmo, Marciano P.; Andrade, Alexandre] Univ Lisbon, Inst Biophys & Biomed Engn, Fac Sci, Lisbon, Portugal	Graz University of Technology; University of Graz; University of Wuppertal; Graz University of Technology; Universidade de Lisboa	Schwerdtfeger, A (corresponding author), BioTechMed Graz, Graz, Austria.; Schwerdtfeger, A (corresponding author), Graz Univ, Inst Psychol, Graz, Austria.; Schwerdtfeger, A (corresponding author), Univ Wuppertal, Hlth Psychol & Appl Diagnost, Wuppertal, Germany.	anschwertfeger@uni-wuppertal.de	Andrade, Alexandre/K-6236-2012; Aigner, Christoph Stefan/AAZ-9055-2020; Schwerdtfeger, Andreas Richard/U-5317-2019	Andrade, Alexandre/0000-0002-8107-7338; Aigner, Christoph Stefan/0000-0003-3618-9610; Schwerdtfeger, Andreas/0000-0002-0371-3730	FWF (Austrian Science Fund) [SFB F3209-18]; Austrian Science Fund (FWF) [F 3209] Funding Source: researchfish	FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by FWF (Austrian Science Fund): SFB F3209-18, https://www.fwf.ac.at/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BARRY RJ, 1983, PHYSIOL PSYCHOL, V11, P135; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bruyns-Haylett M, 2013, EUR J NEUROSCI, V38, P2902, DOI 10.1111/ejn.12295; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chikama M, 1997, J NEUROSCI, V17, P9686; DAMEN EJP, 1987, PSYCHOPHYSIOLOGY, V24, P700, DOI 10.1111/j.1469-8986.1987.tb00353.x; Darwin C, 1999, EXPRESSION EMOTIONS, P71; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Florian G, 1998, INT J PSYCHOPHYSIOL, V28, P273, DOI 10.1016/S0167-8760(97)00075-5; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GOLANOV EV, 1994, AM J PHYSIOL, V266, pR204, DOI 10.1152/ajpregu.1994.266.1.R204; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; KATZ RC, 1994, J BEHAV THER EXP PSY, V25, P131, DOI 10.1016/0005-7916(94)90005-1; Lachaux J, 1999, MEASURING PHASE SYNC, V208, P194; Mayer S, 1876, SITZUNGSBERICHT MATH, V74, P281; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Nikulin VV, 2014, NEUROIMAGE, V97, P71, DOI 10.1016/j.neuroimage.2014.04.008; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2017, CLIN NEUROPHYSIOL, V128, P183, DOI 10.1016/j.clinph.2016.10.097; Pfurtscheller G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00379; Pfurtscheller G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043640; Pfurtscheller G, 2012, NEUROSCI LETT, V508, P89, DOI 10.1016/j.neulet.2011.12.025; Rayshubskiy A, 2014, NEUROIMAGE, V87, P323, DOI 10.1016/j.neuroimage.2013.10.044; Rohr CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068015; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Snyder AZ, 2012, NEUROIMAGE, V62, P902, DOI 10.1016/j.neuroimage.2012.01.044; Stancak A, 1996, COGNITIVE BRAIN RES, V4, P171, DOI 10.1016/S0926-6410(96)00031-6; Tankard CF, 2003, BRAIN COGNITION, V52, P70, DOI 10.1016/S0278-2626(03)00010-1; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Woletz M., 2014, 20 M ORG HUM BRAIN M; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yu C, 2001, NEUROIMAGE, V54, P2571	47	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168097	10.1371/journal.pone.0168097	http://dx.doi.org/10.1371/journal.pone.0168097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052074	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500013
J	Ma, X; Huang, J; Tian, Y; Chen, Y; Yang, Y; Zhang, X; Zhang, F; Xue, L				Ma, X.; Huang, J.; Tian, Y.; Chen, Y.; Yang, Y.; Zhang, X.; Zhang, F.; Xue, L.			Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling	ONCOGENE			English	Article							ONCOGENIC RAS; DNA-BINDING; DROSOPHILA; DEATH; EXPRESSION; APOPTOSIS; METASTASIS; ACTIVATION; GROWTH; MAX	Tumor metastasis, but not primary overgrowth, is the leading cause of mortality for cancer patients. During the past decade, Drosophila melanogaster has been well-accepted as an excellent model to address the intrinsic mechanism of different aspects of cancer progression, ranging from tumor initiation to metastasis. In a genetic screen performed in Drosophila, aiming to find novel modulators of tumor invasion, we identified the oncoprotein Myc as a negative regulator. While expression of Myc dramatically blocks tumor invasion and cell migration, loss of Myc promotes cell migration in vivo. The activity of Myc is further enhanced by the co-expression of its transcription partner Max. Mechanistically, we found Myc/Max directly upregulates the transcription of puc, which encodes an inhibitor of JNK signaling crucial for tumor invasion and cell migration. Furthermore, we demonstrated that human cMyc potently suppresses JNK-dependent cell invasion and migration in both Drosophila and lung adenocarcinoma cell lines. These findings provide novel molecular insights into Myc-mediated cancer progression and raise the noteworthy problem in therapeutic strategies as inhibiting Myc might conversely accelerate tumor metastasis.	[Ma, X.; Huang, J.; Chen, Y.; Zhang, X.; Xue, L.] Tongji Univ, Shanghai Peoples Hosp 10, Inst Intervent Vessel, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, Shanghai, Peoples R China; [Tian, Y.; Yang, Y.; Zhang, F.] Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Clin Translat Res Ctr, Shanghai, Peoples R China; [Ma, X.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 333 Cedar St, New Haven, CT 06519 USA	Tongji University; Tongji University; Howard Hughes Medical Institute; Yale University	Zhang, X; Zhang, F; Xue, L (corresponding author), Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	zxpkxy@126.com; fzhang@tongji.edu.cn; lei.xue@tongji.edu.cn		Ma, Xianjue/0000-0003-4360-3947; Zhang, Fan/0000-0003-4068-3726	National Basic Research Program of China (973 Program) [2011CB943903]; National Natural Sciences Foundation of China [31171413, 31371490]; Ministry of Education of China [20120072110023]; Shanghai Committee of Science and Technology [09DZ2260100, 14JC1406000]; Shanghai Pulmonary Hospital and Tongji University [129212]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Pulmonary Hospital and Tongji University	We thank Dr Peter Gallant, Bloomington, VDRC and NIG stock centers for fly stocks and reagents. This work was supported by the National Basic Research Program of China (973 Program) (2011CB943903), National Natural Sciences Foundation of China (31171413 and 31371490), the PhD Programs Foundation of Ministry of Education of China (20120072110023), and Shanghai Committee of Science and Technology (09DZ2260100 and 14JC1406000) to LX, and the research start-up funds from Shanghai Pulmonary Hospital and Tongji University (No. 129212) to FZ.	ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Benassayag C, 2005, MOL CELL BIOL, V25, P9897, DOI 10.1128/MCB.25.22.9897-9909.2005; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Chen YR, 2001, ONCOGENE, V20, P367, DOI 10.1038/sj.onc.1204105; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Ma X, 2016, ONCOGENE, V35, P846, DOI 10.1038/onc.2015.137; Ma X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.111; Ma X, 2014, CELL DEATH DIFFER, V21, P407, DOI 10.1038/cdd.2013.154; Ma X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.392; Ma XJ, 2013, DEV BIOL, V380, P211, DOI 10.1016/j.ydbio.2013.05.013; Ma XJ, 2012, CELL RES, V22, P425, DOI 10.1038/cr.2011.135; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Miles WO, 2011, DIS MODEL MECH, V4, P753, DOI 10.1242/dmm.006908; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pastor-Pareja JC, 2013, ANNU REV GENET, V47, P51, DOI 10.1146/annurev-genet-110711-155414; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Willoughby LF, 2013, DIS MODEL MECH, V6, P521, DOI 10.1242/dmm.009985; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	46	30	33	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3159	3167		10.1038/onc.2016.463	http://dx.doi.org/10.1038/onc.2016.463			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28068320				2022-12-26	WOS:000402617900008
J	Ikebara, JM; Takada, SH; Cardoso, DS; Dias, NMM; de Campos, BCV; Bretherick, TAS; Higa, GSV; Ferraz, MSA; Kihara, AH				Ikebara, Juliane Midori; Takada, Silvia Honda; Cardoso, Debora Sterzeck; Moralles Dias, Natalia Myuki; Vicente de Campos, Beatriz Crossiol; Sanches Bretherick, Talitha Amanda; Vilar Higa, Guilherme Shigueto; Ayres Ferraz, Mariana Sacrini; Kihara, Alexandre Hiroaki			Functional Role of Intracellular Calcium Receptor Inositol 1,4,5-Trisphosphate Type 1 in Rat Hippocampus after Neonatal Anoxia	PLOS ONE			English	Article							2-AMINOETHOXYDIPHENYL BORATE 2-APB; MODULATES GENE-EXPRESSION; 1,4,5-TRIPHOSPHATE RECEPTOR; CA2+ OSCILLATIONS; NEURONAL DEATH; IP3 RECEPTORS; FLUORO-JADE; CELL-DEATH; PUFFS; RELEASE	Anoxia is one of the most prevalent causes of neonatal morbidity and mortality, especially in preterm neonates, constituting an important public health problem due to permanent neurological sequelae observed in patients. Oxygen deprivation triggers a series of simultaneous cascades, culminating in cell death mainly located in more vulnerable metabolic brain regions, such as the hippocampus. In the process of cell death by oxygen deprivation, cytosolic calcium plays crucial roles. Intracellular inositol 1,4,5-trisphosphate receptors (IP3Rs) are important regulators of cytosolic calcium levels, although the role of these receptors in neonatal anoxia is completely unknown. This study focused on the functional role of inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) in rat hippocampus after neonatal anoxia. Quantitative real-time PCR revealed a decrease of IP3R1 gene expression 24 hours after neonatal anoxia. We detected that IP3R1 accumulates specially in CA1, and this spatial pattern did not change after neonatal anoxia. Interestingly, we observed that anoxia triggers translocation of IP3R1 to nucleus in hippocampal cells. We were able to observe that anoxia changes distribution of IP3R1 immunofluorescence signals, as revealed by cluster size analysis. We next examined the role of IP3R1 in the neuronal cell loss triggered by neonatal anoxia. Intrahippocampal injection of non-specific IP3R1 blocker 2-APB clearly reduced the number of Fluoro-Jade C and Tunel positive cells, revealing that activation of IP3R1 increases cell death after neonatal anoxia. Finally, we aimed to disclose mechanistics of IP3R1 in cell death. We were able to determine that blockade of IP3R1 did not reduced the distribution and pixel density of activated caspase 3-positive cells, indicating that the participation of IP3R1 in neuronal cell loss is not related to classical caspase-mediated apoptosis. In summary, this study may contribute to new perspectives in the investigation of neurode-generative mechanisms triggered by oxygen deprivation.	[Ikebara, Juliane Midori; Takada, Silvia Honda; Cardoso, Debora Sterzeck; Moralles Dias, Natalia Myuki; Vicente de Campos, Beatriz Crossiol; Sanches Bretherick, Talitha Amanda; Ayres Ferraz, Mariana Sacrini; Kihara, Alexandre Hiroaki] Univ Fed ABC, Lab Neurogenet, Sao Bernardo Do Campo, SP, Brazil; [Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, Sao Paulo, SP, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Kihara, AH (corresponding author), Univ Fed ABC, Lab Neurogenet, Sao Bernardo Do Campo, SP, Brazil.; Kihara, AH (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, Sao Paulo, SP, Brazil.	alexandrekihara@gmail.com	Takada, Silvia/AAG-9910-2021; Higa, Guilherme S. V./G-4282-2016; Kihara, Alexandre H/C-2458-2012; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Takada, Silvia H/F-4719-2013; Ikebara, Juliane M/O-3177-2016	Higa, Guilherme S. V./0000-0001-7006-9263; Kihara, Alexandre H/0000-0002-4027-7261; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/16711-6, 2014/15018-5, 2014/17434-6, 2015/19657-5, 2015/19699-0, 2015/17044-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308608/2014-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (URL: http://www.fapesp.br/):- 2014/16711-6 AHK - 2014/15018-5 JMI - 2014/17434-6 DSC - 2015/19657-5 BCVC - 2015/19699-0 TASB - 2015/17044-6 GSVH and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (URL: http://cnpq.br/):- 308608/2014-3 AHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Callamaras N, 2000, EMBO J, V19, P3608, DOI 10.1093/emboj/19.14.3608; Cao PX, 2013, BIOPHYS J, V105, P1133, DOI 10.1016/j.bpj.2013.07.034; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; de Menorval MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32331; Dent MAR, 1996, DEVELOPMENT, V122, P1029; Diaz-Munoz M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-60; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fitting S, 2007, NEUROTOXICOLOGY, V28, P101, DOI 10.1016/j.neuro.2006.07.014; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Fritz N, 2008, PFLUG ARCH EUR J PHY, V456, P277, DOI 10.1007/s00424-007-0379-z; Gu Q, 2012, J NEUROSCI METH, V208, P40, DOI 10.1016/j.jneumeth.2012.04.012; Guisoni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115187; Hernandez-Fonseca K, 2005, J NEUROSCI RES, V82, P196, DOI 10.1002/jnr.20631; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Hummler N, 2012, EXP NEUROL, V236, P112, DOI 10.1016/j.expneurol.2012.04.006; Huh YH, 2005, BIOCHEMISTRY-US, V44, P6122, DOI 10.1021/bi048070w; Huh YH, 2003, FEBS LETT, V555, P411, DOI 10.1016/S0014-5793(03)01273-0; Jurkovicova D, 2007, PFLUG ARCH EUR J PHY, V454, P415, DOI 10.1007/s00424-007-0214-6; Jurkovicova D, 2008, ANN NY ACAD SCI, V1148, P421, DOI 10.1196/annals.1410.034; Kesherwani V, 2012, NEUROL RES, V34, P504, DOI 10.1179/1743132812Y.0000000038; Kim DH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00005; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kukkonen JP, 2001, CELL CALCIUM, V30, P117, DOI 10.1054/ceca.2001.0219; Lencesova L, 2012, GEN PHYSIOL BIOPHYS, V31, P119, DOI 10.4149/gpb_2012_014; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Markus NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148164; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Moghimi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126355; Ondrias K, 2011, J CELL PHYSIOL, V226, P3147, DOI 10.1002/jcp.22665; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Qi H, 2014, BIOPHYS J, V106, P2353, DOI 10.1016/j.bpj.2014.04.027; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Rucki M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003965; Ruiz A, 2009, CELL CALCIUM, V46, P273, DOI 10.1016/j.ceca.2009.08.005; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SHARP AH, 1993, J NEUROSCI, V13, P3051; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Swillens S, 1999, P NATL ACAD SCI USA, V96, P13750, DOI 10.1073/pnas.96.24.13750; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Takada SH, 2015, NEUROSCIENCE, V284, P247, DOI 10.1016/j.neuroscience.2014.08.054; Takada SH, 2011, J NEUROSCI METH, V198, P62, DOI 10.1016/j.jneumeth.2011.03.009; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Vexler Z S, 2001, Semin Neonatol, V6, P99, DOI 10.1053/siny.2001.0041; Wacquier B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19316; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	55	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169861	10.1371/journal.pone.0169861	http://dx.doi.org/10.1371/journal.pone.0169861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072885	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200054
J	Ye, XZ; Liu, HY; Jin, YJ; Guo, MM; Huang, AZ; Chen, QZ; Guo, WS; Zhang, FP; Feng, LZ				Ye, Xiaozhen; Liu, Hongyi; Jin, Yajie; Guo, Mengmeng; Huang, Aizhen; Chen, Quanzhu; Guo, Wenshuo; Zhang, Feiping; Feng, Lizhen			Transcriptomic Analysis of Calonectria pseudoreteaudii during Various Stages of Eucalyptus Infection	PLOS ONE			English	Article							FUSARIUM-GRAMINEARUM; FERULOYL ESTERASE; VIRULENCE; GENE; DISEASES; IRON	Eucalyptus leaf blight caused by Calonectria spp. is a serious disease in Eucalyptus seedling and plantations. However, the molecular mechanisms of the infection process and pathogenesis of Calonectria to Eucalyptus is not well-studied. In this study, we analyzed the transcriptomes of C. pseudoreteaudii at three stages of Eucalyptus leaf infection, and in mycelium grown in potato dextrose broth using Illumina RNA-Seq technology. We identified 161 differentially expressed genes between C. pseudoreteaudii from leaf and mycelium grown in potato dextrose broth. GO and KEGG enrichment analyses of these genes suggested that they were mainly involved in oxidoreductase activity, hydrolase activity, and transmembrane transporter activity. Most of the differentially expressed genes at the early infection stage were upregulated. These upregulated genes were mainly involved in cell wall hydrolysis and toxin synthesis, suggesting a role for toxin and cell wall hydrolases in the establishment of Calonectria leaf blight. Genes related to detoxification of phytoalexins were continually upregulated during infection. The candidate effectors and putative pathogenicity determinants identified in this study will help in the functional analysis of C. pseudoreteaudii virulence and pathogenicity.	[Ye, Xiaozhen; Liu, Hongyi; Jin, Yajie; Guo, Mengmeng; Huang, Aizhen; Guo, Wenshuo; Zhang, Feiping; Feng, Lizhen] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China; [Ye, Xiaozhen; Chen, Quanzhu] Fujian Agr & Forestry Univ, Jinshan Coll, Fuzhou, Peoples R China; [Ye, Xiaozhen; Liu, Hongyi; Jin, Yajie; Guo, Mengmeng; Huang, Aizhen; Chen, Quanzhu; Guo, Wenshuo; Feng, Lizhen] Fujian Agr & Forestry Univ, Inst Forestry Protect, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Feng, LZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China.; Feng, LZ (corresponding author), Fujian Agr & Forestry Univ, Inst Forestry Protect, Fuzhou, Peoples R China.	fjflz@126.com			Project of Financial Department of Fujian Province [K8112004a, K81150002]; Natural Science Foundation of Fujian Province [2013J01074]; Fund of Jinshan College of Fujian Agriculture and Forestry University [Z150702]	Project of Financial Department of Fujian Province; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fund of Jinshan College of Fujian Agriculture and Forestry University	This work was funded by the Project of Financial Department of Fujian Province (No. K8112004a and K81150002), the Natural Science Foundation of Fujian Province (No. 2013J01074), and the Fund of Jinshan College of Fujian Agriculture and Forestry University (Z150702 to Quanzhu Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10939; Balcerzak M, 2012, FUNGAL BIOL-UK, V116, P478, DOI 10.1016/j.funbio.2012.01.007; Chen LH, 2013, MOL PLANT PATHOL, V14, P497, DOI 10.1111/mpp.12021; Chen QZ, 2015, J PROTEOMICS, V115, P117, DOI 10.1016/j.jprot.2014.12.008; [陈全助 Chen Quanzhu], 2014, [福建林学院学报, Journal of Fujian College of Forestry], V34, P328; [陈全助 Chen Quanzhu], 2013, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V42, P257; [陈全助 Chen Quanzhu], 2013, [福建林学院学报, Journal of Fujian College of Forestry], V33, P176; [陈全助 Chen Quanzhu], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P297; Chen SF, 2011, PERSOONIA, V26, P1, DOI 10.3767/003158511X555236; Chen XR, 2015, MOL PLANT PATHOLOGY; Chiou CH, 2004, ARCH MICROBIOL, V182, P67, DOI 10.1007/s00203-004-0700-6; Faulds CB, 2006, APPL MICROBIOL BIOT, V71, P622, DOI 10.1007/s00253-005-0184-6; Feng LZ, 2012, BOTANY, V90, P1277, DOI 10.1139/b2012-099; [冯丽贞 FENG Li-zhen], 2009, [福建林学院学报, Journal of Fujian College of Forestry], V29, P293; Feng LiZhen, 2008, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V16, P1188, DOI 10.3724/SP.J.1011.2008.01188; Feng LiZhen, 2008, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V37, P365; [冯丽贞 Feng Lizhen], 2008, [电子显微学报, Journal of Chinese Electronic Microscopy Society], V27, P229; Feng LiZhen, 2008, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V16, P426, DOI 10.3724/SP.J.1011.2008.00426; Greenshields DL, 2007, MOL PLANT PATHOL, V8, P411, DOI [10.1111/j.1364-3703.2007.00401.x, 10.1111/J.1364-3703.2007.00401.X]; Hashimoto M, 2014, NAT PROD REP, V31, P1306, DOI 10.1039/c4np00096j; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Li DH, 2003, MOL PLANT MICROBE IN, V16, P545, DOI 10.1094/MPMI.2003.16.6.545; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Liu T, 2016, MOL GENET GENOMICS; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lombard L, 2015, STUD MYCOL, P151, DOI 10.1016/j.simyco.2014.11.003; Lombard L, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.66.01; Lombard L, 2010, STUD MYCOL, P31, DOI 10.3114/sim.2010.66.03; Lombard L, 2010, PERSOONIA, V24, P1, DOI 10.3767/003158510X486568; Lyu XL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005435; Mohapatra NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056834; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Okmen B, 2013, NEW PHYTOL, V198, P1203, DOI 10.1111/nph.12208; Ruiz GB, 2015, MOL PLANT PATHOLOGY, V17; Serrano M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00274; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; Tam EWT, 2015, TOXINS, V7, P4421, DOI 10.3390/toxins7114421; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wingfield MJ, 2008, SOUTH FORESTS, V70, P139, DOI 10.2989/SOUTH.FOR.2008.70.2.9.537; [郑美珠 ZHENG Meizhu], 2006, [福建林学院学报, Journal of Fujian College of Forestry], V26, P339; Zhou XD, 2008, FUNGAL DIVERS, V32, P1; Zhu J. H., 2011, J FUJIAN FOR SC TECH, V38, P41; Zhu JH, 2011, FOR PEST DIS, V30, P6; Zhu Pei, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P154	50	11	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169598	10.1371/journal.pone.0169598	http://dx.doi.org/10.1371/journal.pone.0169598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072879	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200030
J	Aschauer, C; Perco, P; Heinzel, A; Sunzenauer, J; Oberbauer, R				Aschauer, Constantin; Perco, Paul; Heinzel, Andreas; Sunzenauer, Judith; Oberbauer, Rainer			Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR-BETA; TNF-ALPHA; ENDOTHELIN ANTAGONISTS; CALCINEURIN INHIBITORS; CYCLOSPORINE-A; INFLAMMATION; PROGRESSION; MARKERS; ACTIVATION	Objective To evaluate tacrolimus as therapeutic option for diabetic nephropathy (DN) based on molecular profile and network-based molecular model comparisons. Materials and Methods We generated molecular models representing pathophysiological mechanisms of DN and tacrolimus mechanism of action (MoA) based on literature derived data and transcriptomics datasets. Shared enriched molecular pathways were identified based on both model datasets. A newly generated transcriptomics dataset studying the effect of tacrolimus on mesangial cells in vitro was added to identify mechanisms in DN pathophysiology. We searched for features in interference between the DN molecular model and the tacrolimus MoA molecular model already holding annotation evidence as diagnostic or prognostic biomarker in the context of DN. Results Thirty nine molecular features were shared between the DN molecular model, holding 252 molecular features and the tacrolimus MoA molecular model, holding 209 molecular features, with six additional molecular features affected by tacrolimus in mesangial cells. Significantly affected molecular pathways by both molecular model sets included cytokine-cytokine receptor interactions, adherens junctions, TGF-beta signaling, MAPK signaling, and calcium signaling. Molecular features involved in inflammation and immune response contributing to DN progression were significantly downregulated by tacrolimus (e.g. the tumor necrosis factor alpha (TNF), interleukin 4, or interleukin 10). On the other hand, profibrotic stimuli being detrimental to renal function were induced by tacrolimus like the transforming growth factor beta 1 (TGFB1), endothelin 1 (EDN1), or type IV collagen alpha 1 (COL4A1). Conclusion Patients with DN and elevated TNF levels might benefit from tacrolimus treatment regarding maintaining GFR and reducing inflammation. TGFB1 and EDN1 are proposed as monitoring markers to assess degree of renal damage. Next to this stratification approach, the use of drug combinations consisting of tacrolimus in addition to ACE inhibitors, angiotensin receptor blockers, TGFB1- or EDN1-receptor antagonists might warrant further studies.	[Aschauer, Constantin; Sunzenauer, Judith; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, Vienna, Austria; [Perco, Paul; Heinzel, Andreas] Emergentec Biodev GmbH, Vienna, Austria; [Perco, Paul] Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria	Medical University of Vienna; Emergentec Biodevelopment GmbH; Medical University of Innsbruck	Oberbauer, R (corresponding author), Med Univ Vienna, Dept Nephrol, Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Perco, Paul/U-2489-2019	Perco, Paul/0000-0003-2087-5691; Aschauer, Constantin/0000-0003-3851-734X	Chiesi; emergentec biodevelopment GmbH	Chiesi(Chiesi Pharmaceuticals Inc); emergentec biodevelopment GmbH	Financial support was provided by an unrestricted grant from Chiesi. The funder did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AH and PP are employees of emergentec biodevelopment GmbH. emergentec biodevelopment GmbH provided support in the form of salaries for authors AH and PP, but did not have any additional role in the study design, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.; Financial support was provided by an unrestricted grant from Chiesi. We thank Markus Jeitler and Martin Bilban from the Core Genomics Facility at the Medical University of Vienna for hybridizing, washing and scanning the Affymetrix Human Gene (HuGene) 2.0 ST arrays.	Akool ES, 2008, J IMMUNOL, V181, P2831, DOI 10.4049/jimmunol.181.4.2831; Akool ES, 2012, BIOCHEM PHARMACOL, V83, P286, DOI 10.1016/j.bcp.2011.11.001; Amdur RL, 2016, CLIN J AM SOC NEPHRO, V11, P1546, DOI 10.2215/CJN.13121215; Aomatsu T, 2012, INT J MOL MED, V30, P1152, DOI 10.3892/ijmm.2012.1094; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Campistol JM, 1999, KIDNEY INT, V56, P714, DOI 10.1046/j.1523-1755.1999.00597.x; Canellada A, 2006, MOL CELL NEUROSCI, V31, P692, DOI 10.1016/j.mcn.2005.12.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiPetrillo K, 2003, AM J PHYSIOL-RENAL, V284, pF113, DOI 10.1152/ajprenal.00026.2002; Donate-Correa J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/948417; Fechete R., 2013, J COMPUT SCI SYST BI, V6, P73; Goicoechea M, 2012, J NEPHROL, V25, P969, DOI 10.5301/jn.5000077; Hannah J, 2016, AUTOIMMUN REV, V15, P93, DOI 10.1016/j.autrev.2015.09.006; Heinzel A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00037; Heinzel A, 2014, METHODS MOL BIOL, V1159, P109, DOI 10.1007/978-1-4939-0709-0_7; Hesselink DA, 2014, CLIN PHARMACOKINET, V53, P123, DOI 10.1007/s40262-013-0120-3; Inigo P, 2001, J AM SOC NEPHROL, V12, P822, DOI 10.1681/ASN.V124822; Jin H, 2016, EUR REV MED PHARMACO, V20, P174; Kanasaki Keizo, 2013, Front Endocrinol (Lausanne), V4, P7, DOI 10.3389/fendo.2013.00007; Kern G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096377; Khan SS, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0685-3; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Kohan DE, 2013, BRIT J CLIN PHARMACO, V76, P573, DOI 10.1111/bcp.12064; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Maluf DG, 2014, AM J TRANSPLANT, V14, P1152, DOI 10.1111/ajt.12696; Malvezzi P, 2015, EXPERT OPIN DRUG SAF, V14, P1531, DOI 10.1517/14740338.2015.1083974; Moriwaki Y, 2007, ACTA DIABETOL, V44, P215, DOI 10.1007/s00592-007-0007-6; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Neirynck N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122073; Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013; Qi R, 2014, RENAL FAILURE, V36, P589, DOI 10.3109/0886022X.2014.882713; Qi XM, 2011, INT IMMUNOPHARMACOL, V11, P1613, DOI 10.1016/j.intimp.2011.05.023; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saulnier PJ, 2014, DIABETES CARE, V37, P1425, DOI 10.2337/dc13-2580; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Shaker OG, 2013, HUM EXP TOXICOL, V32, P1089, DOI 10.1177/0960327112470274; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Utimura R, 2003, KIDNEY INT, V63, P209, DOI 10.1046/j.1523-1755.2003.00736.x; Wu YG, 2014, NEPHRON EXP NEPHROL, V128, P46, DOI 10.1159/000366446; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zhang L, 2014, EUR REV MED PHARMACO, V18, P2575	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169518	10.1371/journal.pone.0169518	http://dx.doi.org/10.1371/journal.pone.0169518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060893	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500103
J	Lu, M; Zessin, AS; Glover, W; Hsu, DS				Lu, Min; Zessin, Amelia S.; Glover, Wayne; Hsu, David S.			Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; B-CELL LYMPHOMA; MAMMALIAN TARGET; PHASE-III; CHEMOTHERAPY; COMBINATION; LEUCOVORIN; EXPRESSION; EVEROLIMUS; INHIBITOR	Background Standard of care treatment for colorectal cancer liver metastasis consists of a cytotoxic chemotherapy in combination with a targeted agent. Clinical trials have guided the use of these combinatory therapies, but it remains unclear what the optimal combinations of cytotoxic chemotherapy with a targeted agent are. Methods Using a genomic based approach, gene expression profiling was obtained from tumor samples of patient with colorectal cancer liver metastasis who received an oxaliplatin based therapy. Early passaged colorectal cancer liver metastasis cell lines and patient derived xenografts of colorectal cancer liver metastasis were then treated with oxaliplatin and a mTOR inhibitor. Results Gene set enrichment analysis revealed that the mTOR pathway was activated in patients receiving oxaliplatin based therapy. Treatment of early passaged colorectal cancer lines and patient derived xenografts with oxaliplatin resulted in activation of the mTOR pathway. Combination therapy with oxaliplatin and a mTOR inhibitor resulted in a synergistic effect both in vitro and in vivo. Conclusion Our findings suggest a genomic based approach can be used to identify optimal combinations of cytotoxic chemotherapy with a targeted agent and that these observations can be validated both in vitro and in vivo using patient derived colorectal cancer cell lines and patient derived xenografts prior to clinical use.	[Lu, Min; Zessin, Amelia S.; Glover, Wayne; Hsu, David S.] Duke Univ, Med Ctr, Dept Med Oncol, Durham, NC 27710 USA; [Lu, Min; Glover, Wayne; Hsu, David S.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27710 USA	Duke University; Duke University	Hsu, DS (corresponding author), Duke Univ, Med Ctr, Dept Med Oncol, Durham, NC 27710 USA.; Hsu, DS (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27710 USA.	shiaowen.hsu@duke.edu			Duke Cancer Institute as part of the P30 Cancer Center Support Grant [NIH CA014236]	Duke Cancer Institute as part of the P30 Cancer Center Support Grant	This work was supported from the developmental funds of the Duke Cancer Institute as part of the P30 Cancer Center Support Grant (Grant ID: NIH CA014236). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MC, 2004, CANC DRUG DISC DEV, P125; Atreya CE, 2012, INVEST NEW DRUG, V30, P2219, DOI 10.1007/s10637-012-9793-y; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Golub TR, 2001, NEW ENGL J MED, V344, P601, DOI 10.1056/NEJM200102223440809; Guenot D, 2006, J PATHOL, V208, P643, DOI 10.1002/path.1936; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kim MK, 2012, MOL CANCER THER, V11, P1500, DOI 10.1158/1535-7163.MCT-11-0937; Kim RY, 2011, PERS MED, V8, P331, DOI 10.2217/PME.11.16; O'Reilly T, 2011, ANTI-CANCER DRUG, V22, P58, DOI 10.1097/CAD.0b013e3283400a20; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Punt CJA, 2003, ANN ONCOL, V14, P931, DOI 10.1093/annonc/mdg248; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sadanandam A, 2013, NATURE MED; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tentler JJ, 2010, MOL CANCER THER, V9, P3351, DOI 10.1158/1535-7163.MCT-10-0376; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422	32	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169439	10.1371/journal.pone.0169439	http://dx.doi.org/10.1371/journal.pone.0169439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060954	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500094
J	Natsag, J; Erlandson, KM; Sellmeyer, DE; Haberlen, SA; Margolick, J; Jacobson, LP; Palella, FJ; Koletar, SL; Lake, JE; Post, WS; Brown, TT				Natsag, Javzandulam; Erlandson, Kristine M.; Sellmeyer, Deborah E.; Haberlen, Sabina A.; Margolick, Joseph; Jacobson, Lisa P.; Palella, Frank J., Jr.; Koletar, Susan L.; Lake, Jordan E.; Post, Wendy S.; Brown, Todd T.			HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; INTRAMUSCULAR FAT; ABDOMINAL FAT; PREDICT; IMPACT; AGE; RESISTANCE; DENSITY; FRAILTY; RISK	Background Lower muscle density on computed tomography (CT) provides a measure of fatty infiltration of muscle, an aspect of muscle quality that has been associated with metabolic abnormalities, weakness, decreased mobility, and increased fracture risk in older adults. We assessed the cross-sectional relationship between HIV serostatus, age, thigh muscle attenuation, and thigh muscle cross-sectional area (CSA). Methods Mean CT-quantified Hounsfield units (HU) of the thigh muscle bundle and CSA were evaluated in 368 HIV-infected and 145 HIV-uninfected men enrolled in the Multicenter AIDS Cohort Study (MACS) Cardiovascular Substudy using multivariable linear regression. Models all were adjusted for HIV serostatus, age, race, and body mass index (BMI); each model was further adjusted for covariates that differed by HIV serostatus, including insulin resistance, hepatitis C, malignancy, smoking, alcohol use, and self-reported limitation in physical activity. Results HIV-infected men had greater thigh muscle CSA (p<0.001) but lower muscle density (p<0.001) compared to HIV-uninfected men. Muscle density remained lower in HIV-infected men (p = 0.001) when abdominal visceral adiposity, and thigh subcutaneous adipose tissue area were substituted for BMI in a multivariable model. Muscle density decreased by 0.16 HU per year (p<0.001) of increasing age among the HIV-infected men, but not in the HIV-uninfected men (HIV x age interaction -0.20 HU; p = 0.002). Conclusion HIV-infected men had lower thigh muscle density compared to HIV-uninfected men, and a more pronounced decline with increasing age, indicative of greater fatty infiltration. These findings suggest that lower muscle quality among HIV-infected persons may be a risk factor for impairments in physical function with aging.	[Natsag, Javzandulam; Sellmeyer, Deborah E.; Post, Wendy S.; Brown, Todd T.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Erlandson, Kristine M.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Margolick, Joseph; Jacobson, Lisa P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Palella, Frank J., Jr.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Koletar, Susan L.] Ohio State Univ, Columbus, OH 43210 USA; [Lake, Jordan E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northwestern University; Feinberg School of Medicine; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brown, TT (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	tbrown27@jhmi.edu		Haberlen, Sabina/0000-0002-9467-3454; Jacobson, Lisa P./0000-0003-1722-6826; Erlandson, Kristine/0000-0003-0808-6729	National Institute of Allergy and Infectious Diseases; National Cancer Institute [U01-AI-35042, UL1-RR025005, UM1-AI-35043, U01-AI-35039, U01-AI-35040, U01-AI-35041]; NIH [5T32EB006351-07]; National Heart, Lung, and Blood Institute [R01 HL095129]; National Center for Advancing Translational Sciences, a component of the National Institutes of Health; National Institutes of Health Roadmap for Medical Research [UL1 TR 001079]; NIH/NIA [K23AG050260]; NIH/NIAID [K23AI110532, K24 AI120834]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, UM1AI035043, U01AI035039, K23AI110532, K24AI120834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054366, K23AG050260] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences, a component of the National Institutes of Health; National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (grants U01-Al-35042, UL1-RR025005, UM1-AI-35043, U01-AI-35039, U01-AI-35040, and U01-AI-35041). JN has received grant support from NIH Training Grant T32 (5T32EB006351-07). This study was funded by the National Heart, Lung, and Blood Institute (grant R01 HL095129 to Dr. Post), with additional support from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research (grant UL1 TR 001079). KME received support from the NIH/NIA K23AG050260. JEL received support from NIH/NIAID K23AI110532. TTB was supported by NIH/NIAID K24 AI120834. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addison O, 2014, J NUTR HEALTH AGING, V18, P532, DOI 10.1007/s12603-014-0019-1; Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Goodpaster BH, 1985, J APPL PHYSL, P90; Guaraldi G, 2013, DRUGS, V73, P1431, DOI 10.1007/s40265-013-0108-1; Huang JS, 2002, AIDS, V16, P1265, DOI 10.1097/00002030-200206140-00009; Idoate F, 2015, EUR RADIOL, V25, P2163, DOI 10.1007/s00330-014-3555-5; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KELLEY DE, 1991, AM J CLIN NUTR, V54, P509, DOI 10.1093/ajcn/54.3.509; Kim JH, 2013, CLIN ENDOCRINOL, V78, P512, DOI 10.1111/cen.12016; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Luzi L, 2003, AM J PHYSIOL-ENDOC M, V284, pE274, DOI 10.1152/ajpendo.00391.2001; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Marcus Robin L, 2012, J Aging Res, V2012, P629637, DOI 10.1155/2012/629637; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Potretzke AM, 2004, OBES RES, V12, P1698, DOI 10.1038/oby.2004.210; Taaffe DR, 2009, GERONTOLOGY, V55, P217, DOI 10.1159/000182084; Therkelsen KE, 2013, ARTERIOSCL THROM VAS, V33, P863, DOI 10.1161/ATVBAHA.112.301009; Torriani M, 1985, J APPL PHYSIOL, V95, P1005; Torriani M, 1985, J APPL PHYSL, P100; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Yarasheski KE, 2011, J GERONTOL A-BIOL, V66, P332, DOI 10.1093/gerona/glq228	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169184	10.1371/journal.pone.0169184	http://dx.doi.org/10.1371/journal.pone.0169184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060856	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500065
J	Costa, MC; Oliveira, PRR; Davanco, PV; de Camargo, C; Laganaro, NM; Azeredo, RA; Simpson, J; Silveira, LF; Francisco, MR				Costa, Mariellen C.; Oliveira, Paulo R. R., Jr.; Davanco, Paulo V.; de Camargo, Crisley; Laganaro, Natasha M.; Azeredo, Roberto A.; Simpson, James; Silveira, Luis F.; Francisco, Mercival R.			Recovering the Genetic Identity of an Extinct in-the-Wild Species: The Puzzling Case of the Alagoas Curassow	PLOS ONE			English	Article							MICROSATELLITE MARKERS; POPULATION-STRUCTURE; CONSERVATION VALUE; DETECTING HYBRIDS; DNA TEST; HYBRIDIZATION; MITOCHONDRIAL; INTROGRESSION; INDIVIDUALS; EFFICIENCY	The conservation of many endangered taxa relies on hybrid identification, and when hybrids become morphologically indistinguishable from the parental species, the use of molecular markers can assign individual admixture levels. Here, we present the puzzling case of the extinct in the wild Alagoas Curassow (Pauxi mitu), whose captive population descends from only three individuals. Hybridization with the Razor-billed Curassow (P. tuberosa) began more than eight generations ago, and admixture uncertainty affects the whole population. We applied an analysis framework that combined morphological diagnostic traits, Bayesian clustering analyses using 14 microsatellite loci, and mtDNA haplotypes to assess the ancestry of all individuals that were alive from 2008 to 2012. Simulated data revealed that our microsatellites could accurately assign an individual a hybrid origin until the second back cross generation, which permitted us to identify a pure group among the older, but still reproductive animals. No wild species has ever survived such a severe bottleneck, followed by hybridization, and studying the recovery capability of the selected pure Alagoas Curassow group might provide valuable insights into biological conservation theory.	[Costa, Mariellen C.] Univ Fed Sao Carlos, Programa Pos Grad Ecol & Recursos Nat, Rod Washington Luis, Sao Carlos, SP, Brazil; [Oliveira, Paulo R. R., Jr.; Davanco, Paulo V.; Laganaro, Natasha M.] Univ Fed Sao Carlos, Programa Pos Grad Diversidade Biol & Conservacao, Campus Sorocaba,Rod Joao Leme dos Santos, Sorocaba, SP, Brazil; [de Camargo, Crisley; Francisco, Mercival R.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Campus Sorocaba,Rod Joao Leme dos Santos, Sorocaba, SP, Brazil; [Azeredo, Roberto A.; Simpson, James] Soc Pesquisa Manejo & Reprod Fauna Silvestre, CRAX, Rua Jarbas Camargo, Contagem, MG, Brazil; [Silveira, Luis F.] Univ Sao Paulo, Museu Zool, Secao Aves, Sao Paulo, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade de Sao Paulo	Francisco, MR (corresponding author), Univ Fed Sao Carlos, Dept Ciencias Ambientais, Campus Sorocaba,Rod Joao Leme dos Santos, Sorocaba, SP, Brazil.	mercival@ufscar.br	Silveira, Luis/V-6161-2019; Francisco, Mercival R/G-2497-2013; Costa, Mariellen C/H-6608-2017	Silveira, Luis/0000-0003-2576-7657; Costa, Mariellen C/0000-0001-7501-7606; Francisco, Mercival/0000-0003-2083-7812	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/51197-0]; Fundacao Grupo Boticario de Protecao a Natureza [1002_20141]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Grupo Boticario de Protecao a Natureza	This project has received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Project #2008/51197-0), and Fundacao Grupo Boticario de Protecao a Natureza (Project #1002_20141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anciaes Marina, 2002, Ornitologia Neotropical, V13, P159; Anderson EC, 2002, GENETICS, V160, P1217; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bohling JH, 2013, MOL ECOL, V22, P74, DOI 10.1111/mec.12109; Bohling JH, 2011, MOL ECOL, V20, P2142, DOI 10.1111/j.1365-294X.2011.05084.x; Certner M, 2015, ECOL EVOL, V5, P4263, DOI 10.1002/ece3.1686; Cizkova D, 2012, BIOL CONSERV, V152, P231, DOI 10.1016/j.biocon.2012.04.008; Collar NJ, 1992, THREATENED BIRDS AM; Costa MC, 2014, GENET MOL RES, V13, P9867, DOI 10.4238/2014.November.27.14; Derr JN, 2012, CONSERV BIOL, V26, P1130, DOI 10.1111/j.1523-1739.2012.01905.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fowler AC, 2009, CONSERV GENET, V10, P1747, DOI 10.1007/s10592-008-9778-8; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gongora J, 2006, MOL PHYLOGENET EVOL, V41, P1, DOI 10.1016/j.ympev.2006.05.015; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grau ET, 2003, BIRD CONSERV INT, V13, P115, DOI 10.1017/S0959270303003101; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hoban SM, 2012, EVOL APPL, V5, P720, DOI 10.1111/j.1752-4571.2012.00250.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hvilsom C, 2013, HEREDITY, V110, P586, DOI 10.1038/hdy.2013.9; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES CG, 1995, IBIS, V137, pS173, DOI 10.1111/j.1474-919X.1995.tb08439.x; Kingswood SC, 1998, ANIM CONSERV, V1, P95, DOI 10.1111/j.1469-1795.1998.tb00016.x; Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053; Marie AD, 2011, CONSERV GENET, V12, P1215, DOI 10.1007/s10592-011-0224-y; McCracken KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023173; Medina I, 2013, ECOL EVOL, V3, P4388, DOI 10.1002/ece3.794; Mukesh, 2013, ZOO BIOL, V32, P476, DOI 10.1002/zoo.21081; Munoz-Fuentes V, 2007, MOL ECOL, V16, P629, DOI 10.1111/j.1365-294X.2006.03170.x; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; Pereira Glauco Alves, 2014, Pap. Avulsos Zool., V54, P177, DOI 10.1590/0031-1049.2014.54.14; Pereira SL, 2004, GENOME, V47, P535, DOI 10.1139/G04-009; Piett S, 2015, BIODIVERS CONSERV, V24, P1931, DOI 10.1007/s10531-015-0919-3; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086409; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Robbins TR, 2014, J HERED, V105, P226, DOI 10.1093/jhered/est093; RYDER OA, 1993, CONSERV BIOL, V7, P13, DOI 10.1046/j.1523-1739.1993.07010013.x; Sousa LMS, 2013, CONSERV GENET RESOUR, V5, P181, DOI 10.1007/s12686-012-9763-x; Sanz N, 2009, CONSERV GENET, V10, P225, DOI 10.1007/s10592-008-9550-0; Schreiber A, 1998, ZOO BIOL, V17, P95, DOI 10.1002/(SICI)1098-2361(1998)17:2<95::AID-ZOO5>3.0.CO;2-4; Silveira LF, 2004, ARARAJUBA, V12, P43; Simovich MA, 2013, J CRUSTACEAN BIOL, V33, P730, DOI 10.1163/1937240X-00002164; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2014, EVOLUTION, V68, P241, DOI 10.1111/evo.12260; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vali U, 2010, J AVIAN BIOL, V41, P34, DOI 10.1111/j.1600-048X.2009.04730.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; ZINK RM, 1995, BIOL CONSERV, V74, P69, DOI 10.1016/0006-3207(95)00010-2	62	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169636	10.1371/journal.pone.0169636	http://dx.doi.org/10.1371/journal.pone.0169636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056082	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100064
J	Liu, SH; Zhao, KT; Su, X; Lu, L; Zhao, H; Zhang, XW; Wang, Y; Wu, CC; Chen, JZ; Zhou, Y; Hu, X; Wang, YY; Lu, MJ; Chen, XW; Pei, RJ				Liu, Shuhui; Zhao, Kaitao; Su, Xi; Lu, Lu; Zhao, He; Zhang, Xianwen; Wang, Yun; Wu, Chunchen; Chen, Jizheng; Zhou, Yuan; Hu, Xue; Wang, Yanyi; Lu, Mengji; Chen, Xinwen; Pei, Rongjuan			MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication	PLOS ONE			English	Article							CYCLIC GMP-AMP; AMINO-ACID SUBSTITUTIONS; INNATE IMMUNE-RESPONSE; VIVO HBSAG CLEARANCE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; INTRACELLULAR DNA; CYTOSOLIC DNA; ADAPTIVE IMMUNITY	An efficient clearance of hepatitis B virus (HBV) requires the coordinated work of both the innate and adaptive immune responses. MITA/STING, an adapter protein of the innate immune signaling pathways, plays a key role in regulating innate and adaptive immune responses to DNA virus infection. Previously, we identified an alternatively spliced isoform of MITA/STING, called MITA-related protein (MRP), and found that MRP could specifically block MITA-mediated interferon (IFN) induction while retaining the ability to activate NF-kappa B. Here, we asked whether MITA/STING and MRP were able to control the HBV replication. Both MITA/STING and MRP significantly inhibited HBV replication in vitro. MITA overexpression stimulated IRF3-IFN pathway; while MRP overexpression activated NF-kappa B pathway, suggesting these two isoforms may inhibit HBV replication through different ways. Using a hydrodynamic injection (HI) mouse model, we found that HBV replication was reduced following MITA/STING and MRP expression vectors in mice and was enhanced by the knockout of MITA/STING (MITA/STING(-/-)). The HBV specific humoral and CD8(+) T cell responses were impaired in MITA/STING deficient mice, suggesting the participation of MITA/STING in the initiation of host adaptive immune responses. In summary, our data suggest that MITA/STING and MRP contribute to HBV control via modulation of the innate and adaptive responses.	[Liu, Shuhui; Zhao, Kaitao; Su, Xi; Zhao, He; Zhang, Xianwen; Wang, Yun; Wu, Chunchen; Chen, Jizheng; Zhou, Yuan; Hu, Xue; Wang, Yanyi; Chen, Xinwen; Pei, Rongjuan] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Liu, Shuhui; Zhao, Kaitao; Su, Xi; Zhang, Xianwen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Lu] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan, Peoples R China; [Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Lu, Lu] Jiangdong Ctr Dis Control & Prevent, Ningbo, Zhejiang, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; University of Duisburg Essen	Chen, XW; Pei, RJ (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	chenxw@wh.iov.cn; rongjuan_pei@wh.iov.cn	Lu, Mengji/ABF-9410-2020; zhang, xian/GYA-0290-2022		National Nature Science Foundation of China [31621061, 81461130019, 81672021]; National Basic Research Priorities Program of China [2013CB911100, 2012CB519001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program of China(National Basic Research Program of China)	This work was supported by grants from the National Nature Science Foundation of China (31621061, 81461130019) and the National Basic Research Priorities Program of China (2013CB911100, 2012CB519001). Rongjuna Pei is supported by the National Nature Science Foundation of China (81672021).	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Anghelina D, 2016, J VIROL, V90, P5915, DOI 10.1128/JVI.00500-16; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Cao L, 2014, J VIROL, V88, P8656, DOI 10.1128/JVI.01123-14; Chen HH, 2014, J IMMUNOL, V192, P1162, DOI 10.4049/jimmunol.1300798; Cui XJ, 2016, J VIROL, V90, P486, DOI 10.1128/JVI.01263-15; Dansako H, 2015, FEBS J; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guo F, 2015, ANTIMICROB AGENTS CH, V59, P1273, DOI 10.1128/AAC.04321-14; Han QJ, 2013, SEMIN IMMUNOPATHOL, V35, P23, DOI 10.1007/s00281-012-0331-y; Hervas-Stubbs S, 2014, J IMMUNOL, V193, P1151, DOI 10.4049/jimmunol.1301440; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26150; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Li SX, 2015, VIRUS RES, V210, P119, DOI 10.1016/j.virusres.2015.08.004; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu YH, 2015, J VIROL, V89, P2287, DOI 10.1128/JVI.02760-14; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Pei R, 2014, IMMUN, V6, P182, DOI DOI 10.1159/000353220; Pei RJ, 2014, WORLD J GASTROENTERO, V20, P11618, DOI 10.3748/wjg.v20.i33.11618; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Qin B, 2013, ANTIVIR RES, V97, P93, DOI 10.1016/j.antiviral.2012.12.007; Quinn KM, 2015, J CLIN INVEST, V125, P1129, DOI 10.1172/JCI78280; Ran Y, 2014, CYTOKINE GROWTH F R, V25, P631, DOI 10.1016/j.cytogfr.2014.05.003; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; ROYCHOUDHURY S, 1991, J VIROL, V65, P3617, DOI 10.1128/JVI.65.7.3617-3624.1991; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Sommer G, 2000, VIROLOGY, V271, P371, DOI 10.1006/viro.2000.0331; Song J., 2014, PLOS ONE, V9; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thomsen MK, 2016, HEPATOLOGY; TOMIDA M, 1984, J BIOL CHEM, V259, P978; Toth K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005084; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Xu S, 2012, J VIROL, V86, P13025, DOI 10.1128/JVI.01785-12; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0; Zhang EJ, 2015, VIROLOGY, V475, P56, DOI 10.1016/j.virol.2014.11.004; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25389; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	59	15	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169701	10.1371/journal.pone.0169701	http://dx.doi.org/10.1371/journal.pone.0169701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056087	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100069
J	Mangan, TP; Atkinson, JD; Neuberg, JW; O'Sullivan, D; Wilson, TW; Whale, TF; Neve, L; Umo, NS; Malkin, TL; Murray, BJ				Mangan, T. P.; Atkinson, J. D.; Neuberg, J. W.; O'Sullivan, D.; Wilson, T. W.; Whale, T. F.; Neve, L.; Umo, N. S.; Malkin, T. L.; Murray, B. J.			Heterogeneous Ice Nucleation by Soufriere Hills Volcanic Ash Immersed in Water Droplets	PLOS ONE			English	Article							PARTICLES; MONTSERRAT; FELDSPAR; SAMPLES; NUCLEI; DUST; TIME; RICH	Fine particles of ash emitted during volcanic eruptions may sporadically influence cloud properties on a regional or global scale as well as influencing the dynamics of volcanic clouds and the subsequent dispersion of volcanic aerosol and gases. It has been shown that volcanic ash can trigger ice nucleation, but ash from relatively few volcanoes has been studied for its ice nucleating ability. In this study we quantify the efficiency with which ash from the Soufriere Hills volcano on Montserrat nucleates ice when immersed in supercooled water droplets. Using an ash sample from the 11th February 2010 eruption, we report ice nucleating efficiencies from 246 to 265 K. This wide range of temperatures was achieved using two separate droplet freezing instruments, one employing nanolitre droplets, the other using microlitre droplets. Soufriere Hills volcanic ash was significantly more efficient than all other ash samples that have been previously examined. At present the reasons for these differences are not understood, but may be related to mineralogy, amorphous content and surface chemistry.	[Mangan, T. P.; Atkinson, J. D.; Neuberg, J. W.; O'Sullivan, D.; Wilson, T. W.; Whale, T. F.; Neve, L.; Umo, N. S.; Malkin, T. L.; Murray, B. J.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Mangan, T. P.; Malkin, T. L.] Univ Leeds, Sch Chem, Leeds, W Yorkshire, England; [Atkinson, J. D.] ETH, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Umo, N. S.] Fed Univ Lafia, Dept Chem, Lafia, Nasarawa State, Nigeria	University of Leeds; University of Leeds; Swiss Federal Institutes of Technology Domain; ETH Zurich	Murray, BJ (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England.	b.j.murray@leeds.ac.uk	Whale, Thomas/C-6205-2015; Umo, Nsikanabasi Silas/AAX-5974-2021; Murray, Benjamin/C-1219-2010; Atkinson, James/D-1668-2011	Whale, Thomas/0000-0002-1062-2685; Umo, Nsikanabasi Silas/0000-0002-2571-163X; Murray, Benjamin/0000-0002-8198-8131; Neuberg, Jurgen/0000-0001-7866-0736; Mangan, Thomas/0000-0001-7053-5594	Natural Environment Research Council (NERC) [NE/K004417/1, NE/I013466/1, NE/I020059/1]; European Research Council [ERC240449 ICE, 648661 Marinelce]; NERC; Asymptote [NE/I019057/1]; Niger Delta Development Commission (NDDC) in Nigeria [NDDC/DEHSS/2010PGFS/AK/011]; Natural Environment Research Council [NE/I013466/1, 1047972, NE/K004417/1, NE/M00340X/1, come30001] Funding Source: researchfish; NERC [NE/M00340X/1, NE/K004417/1, come30001, NE/I013466/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Asymptote; Niger Delta Development Commission (NDDC) in Nigeria; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We gratefully acknowledge the Natural Environment Research Council (http://www.nerc.ac.uk/) (NERC, NE/K004417/1, NE/I013466/1, NE/I020059/1), the European Research Council (https://erc.europa.eu/) (ERC240449 ICE, 648661 Marinelce) for funding. T.P. Mangan thanks NERC for a PhD studentship, T.F. Whale thanks NERC and Asymptote for a CASE PhD studentship (NE/I019057/1) and N.S. Umo acknowledges the Niger Delta Development Commission (NDDC) (http://www.nddc.gov.ng/) in Nigeria for financial assistance during his PhD studies (NDDC/DEHSS/2010PGFS/AK/011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Baxter PJ, 1999, SCIENCE, V283, P1142, DOI 10.1126/science.283.5405.1142; Bingemer H, 2012, ATMOS CHEM PHYS, V12, P857, DOI 10.5194/acp-12-857-2012; Bonadonna C, 2002, TEPHRA FALLOUT ERUPT; Broadley SL, 2012, ATMOS CHEM PHYS, V12, P287, DOI 10.5194/acp-12-287-2012; Cole P, 2010, REPORT SCI ADVISOR 1; Cole PD, 2014, GEOL SOC MEM, V39, P71, DOI 10.1144/M39.4; Connolly PJ, 2009, ATMOS CHEM PHYS, V9, P2805, DOI 10.5194/acp-9-2805-2009; de Boer G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046016; Druitt TH, 2002, GEO SOC MEM, P281, DOI 10.1144/GSL.MEM.2002.021.01.13; Durant AJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009064; Durant AJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024175; Fornea AP, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011958; Francis P, 2002, ERUPTION SOUFRIER HI; Gibbs Amy, 2015, GeoResJ, V7, P66, DOI 10.1016/j.grj.2015.06.002; Harrison AD, 2016, ATMOS CHEM PHYS DISC, V2016, P1, DOI DOI 10.5194/ACP-2016-136; Herbert RJ, 2014, ATMOS CHEM PHYS, V14, P8501, DOI 10.5194/acp-14-8501-2014; Hillier S, 2003, SP PUBL INT, P213; HOBBS PV, 1971, NATURE-PHYS SCI, V230, P90, DOI 10.1038/physci230090a0; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Hoyle CR, 2011, ATMOS CHEM PHYS, V11, P9911, DOI 10.5194/acp-11-9911-2011; Kulkarni G, 2015, GEOPHYS RES LETT, V42, P3048, DOI 10.1002/2015GL063270; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Mason B.J., 1971, PHYS CLOUDS; Mather TA, 2003, GEOPHYS MONOGR SER, V139, P189; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Murray BJ, 2011, ATMOS CHEM PHYS, V11, P4191, DOI 10.5194/acp-11-4191-2011; Murray BJ, 2010, PHYS CHEM CHEM PHYS, V12, P10380, DOI 10.1039/c003297b; Niedermeier D, 2015, J GEOPHYS RES-ATMOS, V120, P5036, DOI 10.1002/2014JD022814; Niemand M, 2012, J ATMOS SCI, V69, P3077, DOI 10.1175/JAS-D-11-0249.1; O'Sullivan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08082; O'Sullivan D, 2014, ATMOS CHEM PHYS, V14, P1853, DOI 10.5194/acp-14-1853-2014; Peckhaus A, 2016, ATMOS CHEM PHYS, V16, P11477, DOI 10.5194/acp-16-11477-2016; Schill GP, 2015, ATMOS CHEM PHYS, V15, P7523, DOI 10.5194/acp-15-7523-2015; Schmidt A, 2011, P NATL ACAD SCI USA, V108, P15710, DOI 10.1073/pnas.1108569108; Steinke I, 2011, ATMOS CHEM PHYS, V11, P12945, DOI 10.5194/acp-11-12945-2011; Umo NS, 2015, ATMOS CHEM PHYS, V15, P5195, DOI 10.5194/acp-15-5195-2015; VALI G, 1985, B AM METEOROL SOC, V66, P1426; Wex H, 2014, ATMOS CHEM PHYS, V14, P5529, DOI 10.5194/acp-14-5529-2014; Whale TF, 2015, ATMOS MEAS TECH, V8, P2437, DOI 10.5194/amt-8-2437-2015; Wright TP, 2013, J GEOPHYS RES-ATMOS, V118, P3731, DOI 10.1002/jgrd.50365	41	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169720	10.1371/journal.pone.0169720	http://dx.doi.org/10.1371/journal.pone.0169720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056077	gold, Green Published			2022-12-26	WOS:000391639100073
J	Nielsen, ML; Isbrandt, T; Rasmussen, KB; Thrane, U; Hoof, JB; Larsen, TO; Mortensen, UH				Nielsen, Maria Lund; Isbrandt, Thomas; Rasmussen, Kasper Bowig; Thrane, Ulf; Hoof, Jakob Blaesbjerg; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro			Genes Linked to Production of Secondary Metabolites in Talaromyces atroroseus Revealed Using CRISPR-Cas9	PLOS ONE			English	Article								The full potential of fungal secondary metabolism has until recently been impeded by the lack of universal genetic tools for most species. However, the emergence of several CRISPR-Cas9-based genome editing systems adapted for several genera of filamentous fungi have now opened the doors for future efforts in discovery of novel natural products and elucidation and engineering of their biosynthetic pathways in fungi where no genetic tools are in place. So far, most studies have focused on demonstrating the performance of CRISPR-Cas9 in various fungal model species, and recently we presented a versatile CRISPR-Cas9 system that can be successfully applied in several diverse Aspergillus species. Here we take it one step further and show that our system can be used also in a phylogenetically distinct and largely unexplored species from the genus of Talaromyces. Specifically, we exploit CRISPR-Cas9-based genome editing to identify a new gene in T. atroroseus responsible for production of polyketide-nonribosomal peptide hybrid products, hence, linking fungal secondary metabolites to their genetic origin in a species where no genetic engineering has previously been performed.	[Nielsen, Maria Lund; Isbrandt, Thomas; Rasmussen, Kasper Bowig; Thrane, Ulf; Hoof, Jakob Blaesbjerg; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Rasmussen, Kasper Bowig] Novo Nordisk AS, Niels Steensens Vej 1, Gentofte, Denmark	Technical University of Denmark; Novo Nordisk	Mortensen, UH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	um@bio.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Hoof, Jakob Blæsbjerg/L-6019-2015	Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Thrane, Ulf/0000-0002-6040-4141; Nielsen, Maria Lund/0000-0002-9068-8210; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC0000796] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by a grant from the Novo Nordisk Foundation (http://novonordiskfonden.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Bowig K, 2015, THESIS; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Eley KL, 2007, CHEMBIOCHEM, V8, P289, DOI 10.1002/cbic.200600398; GEMS D, 1991, GENE, V98, P61, DOI 10.1016/0378-1119(91)90104-J; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Kakule TB, 2014, J AM CHEM SOC, V136, P17882, DOI 10.1021/ja511087p; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nielsen ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161199; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Qiao KJ, 2011, METAB ENG, V13, P723, DOI 10.1016/j.ymben.2011.09.008; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Suzuki S, 2000, J NAT PROD, V63, P768, DOI 10.1021/np990371x; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Tuli HS, 2015, J FOOD SCI TECH MYS, V52, P4669, DOI 10.1007/s13197-014-1601-6; West RR, 1996, J ANTIBIOT, V49, P967, DOI 10.7164/antibiotics.49.967; Xu W, 2010, J AM CHEM SOC, V132, P13604, DOI 10.1021/ja107084d	25	55	57	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169712	10.1371/journal.pone.0169712	http://dx.doi.org/10.1371/journal.pone.0169712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056079	Green Published, gold			2022-12-26	WOS:000391639100072
J	Piskacek, M; Havelka, M; Rezacova, M; Knight, A				Piskacek, Martin; Havelka, Marek; Rezacova, Martina; Knight, Andrea			The 9aaTAD Is Exclusive Activation Domain in Gal4	PLOS ONE			English	Article							P53 TRANSACTIVATION DOMAIN; GALACTOSE PATHWAY ENZYMES; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; KIX DOMAIN; ACIDIC ACTIVATORS; GENE-EXPRESSION; DNA-BINDING; PROTEIN; YEAST	The Gal4 protein is a well-known prototypic acidic activator that has multiple activation domains. We have previously identified a new activation domain called the nine amino acid transactivation domain (9aaTAD) in Gal4 protein. The family of the 9aaTAD activators currently comprises over 40 members including p53, MLL, E2A and other members of the Gal4 family; Oaf1 Pip2, Pdr1 and Pdr3. In this study, we revised function of all reported Gal4 activation domains. Surprisingly, we found that beside of the activation domain 9aaTAD none of the previously reported activation domains had considerable transactivation potential and were not involved in the activation of transcription. Our results demonstrated that the 9aaTAD domain is the only decisive activation domain in the Gal4 protein. We found that the artificial peptides included in the original Gal4 constructs were results of an unintended consequence of cloning that were responsible for the artificial transcriptional activity. Importantly, the activation domain 9aaTAD, which is the exclusive activation domain in Gal4, is also the central part of a conserved sequence recognized by the inhibitory protein Gal80. We propose a revision of the Gal4 regulation, in which the activation domain 9aaTAD is directly linked to both activation function and Gal80 mediated inhibition.	[Piskacek, Martin; Havelka, Marek; Rezacova, Martina] Masaryk Univ, Dept Pathol Physiol, Lab Canc Biol & Genet, Brno, Czech Republic; [Knight, Andrea] Masaryk Univ, Fac Med, Dept Pathol Physiol, Gamma Delta T Cell Lab, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Piskacek, M (corresponding author), Masaryk Univ, Dept Pathol Physiol, Lab Canc Biol & Genet, Brno, Czech Republic.	Piskacek@med.muni.cz	Piskacek, Martin/I-4280-2016	Piskacek, Martin/0000-0002-6283-1542; Knight, Andrea/0000-0001-7291-7975	Ministry of Health of the Czech Republic [15-32935A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by Ministry of Health of the Czech Republic 15-32935A.	Aguilar X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098575; Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; Carrozza MJ, 2002, J BIOL CHEM, V277, P24648, DOI 10.1074/jbc.M201965200; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Chou S, 1997, MOL CELL BIOL, V17, P6794, DOI 10.1128/MCB.17.12.6794; Denis CM, 2012, BLOOD; Ding WV, 1997, MOL CELL BIOL, V17, P2538, DOI 10.1128/MCB.17.5.2538; Dorris DR, 2000, MOL CELL BIOL, V20, P4350, DOI 10.1128/MCB.20.12.4350-4358.2000; DOUGLAS HC, 1963, BIOCHIM BIOPHYS ACTA, V68, P155; DOUGLAS HC, 1954, J BACTERIOL, V68, P662, DOI 10.1128/JB.68.6.662-670.1954; DOUGLAS HC, 1966, GENETICS, V54, P911; DOUGLAS HC, 1964, GENETICS, V49, P837; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Egriboz O, 2011, GENETICS, V189, P825, DOI 10.1534/genetics.111.131839; ENGLESBE.E, 1965, J BACTERIOL, V90, P946, DOI 10.1128/JB.90.4.946-957.1965; Erkina TY, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0092-2; Farris TR, 2016, INFECT IMMUN; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; Han Y, 2000, J BIOL CHEM, V275, P14979, DOI 10.1074/jbc.275.20.14979; HASHIMOTO H, 1983, MOL GEN GENET, V191, P31, DOI 10.1007/BF00330886; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; Hong JY, 2011, PHYTOCHEMISTRY, V72, P27, DOI 10.1016/j.phytochem.2010.10.005; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Jiang FL, 2009, MOL CELL BIOL, V29, P5604, DOI 10.1128/MCB.00632-09; JOHNSTON M, 1988, GENETICS, V120, P63; JOHNSTON SA, 1986, P NATL ACAD SCI USA, V83, P6553, DOI 10.1073/pnas.83.17.6553; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Klein J, 2003, J BIOL CHEM, V278, P6779, DOI 10.1074/jbc.M212514200; Krois AS, 2016, P NATL ACAD SCI USA, V113, pE1853, DOI 10.1073/pnas.1602487113; Kumar PR, 2008, SCIENCE, V319, P1090, DOI 10.1126/science.1151903; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; Larsson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073137; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Lee K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162708; Lin LL, 2012, ELECT J DIFFERENTIAL, V2012, P1, DOI DOI 10.1073/PNAS.1116340109; Lindert U, 2009, MOL CELL BIOL, V29, P6283, DOI 10.1128/MCB.00847-09; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Lu XY, 2000, P NATL ACAD SCI USA, V97, P1988, DOI 10.1073/pnas.040573197; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Majmudar CY, 2009, BIOORG MED CHEM LETT, V19, P3733, DOI 10.1016/j.bmcl.2009.05.045; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; Matsushita A, 2012, PLANT J; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; NOGI Y, 1980, CURR GENET, V2, P115, DOI 10.1007/BF00420623; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Piskacek M., 2009, NATURE PRECEDINGS; Piskacek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162842; Piskacek M, 2015, MOL BIOSYST, V11, P844, DOI 10.1039/c4mb00672k; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Presnell JS, 2015, GENOME BIOL EVOL, V7, P2289, DOI 10.1093/gbe/evv141; Ptashne Mark, 2004, Cell, VS116, pS71, DOI 10.1016/S0092-8674(03)01076-6; Ptashne M, 2014, J BIOL CHEM, V289, P5417, DOI 10.1074/jbc.X114.547323; Qiu Y, 2015, PLANT CELL; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; SAKURAI H, 1993, P NATL ACAD SCI USA, V90, P8382, DOI 10.1073/pnas.90.18.8382; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Suzuki Y, 1992, Mol Cell Biol, V12, P4806; Thoden JB, 2008, J BIOL CHEM, V283, P30266, DOI 10.1074/jbc.M805200200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Wang F, 2009, ACS CHEM BIOL, V4, P1017, DOI 10.1021/cb900190u; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	78	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169261	10.1371/journal.pone.0169261	http://dx.doi.org/10.1371/journal.pone.0169261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056036	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100030
J	Rivera-Torres, N; Banas, K; Bialk, P; Bloh, KM; Kmiec, EB				Rivera-Torres, Natalia; Banas, Kelly; Bialk, Pawel; Bloh, Kevin M.; Kmiec, Eric B.			Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASES; MAMMALIAN-CELLS; BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CAS9 RIBONUCLEOPROTEINS; SEQUENCE CORRECTION; REPLICATION; SPECIFICITY; MECHANISMS; GENERATION	CRISPR/Cas9 and single-stranded DNA oligonucleotides (ssODNs) have been used to direct the repair of a single base mutation in human genes. Here, we examine a method designed to increase the precision of RNA guided genome editing in human cells by utilizing a CRISPR/Cas9 ribonucleoprotein (RNP) complex to initiate DNA cleavage. The RNP is assembled in vitro and induces a double stranded break at a specific site surrounding the mutant base designated for correction by the ssODN. We use an integrated mutant eGFP gene, bearing a single base change rendering the expressed protein nonfunctional, as a single copy target in HCT 116 cells. We observe significant gene correction activity of the mutant base, promoted by the RNP and single-stranded DNA oligonucleotide with validation through genotypic and phenotypic readout. We demonstrate that all individual components must be present to obtain successful gene editing. Importantly, we examine the genotype of individually sorted corrected and uncorrected clonally expanded cell populations for the mutagenic footprint left by the action of these gene editing tools. While the DNA sequence of the corrected population is exact with no adjacent sequence modification, the uncorrected population exhibits heterogeneous mutagenicity with a wide variety of deletions and insertions surrounding the target site. We designate this type of DNA aberration as on-site mutagenicity. Analyses of two clonal populations bearing specific DNA insertions surrounding the target site, indicate that point mutation repair has occurred at the level of the gene. The phenotype, however, is not rescued because a section of the single-stranded oligonucleotide has been inserted altering the reading frame and generating truncated proteins. These data illustrate the importance of analysing mutagenicity in uncorrected cells. Our results also form the basis of a simple model for point mutation repair directed by a short single-stranded DNA oligonucleotides and CRISPR/Cas9 ribonucleoprotein complex.	[Rivera-Torres, Natalia; Banas, Kelly; Bialk, Pawel; Bloh, Kevin M.; Kmiec, Eric B.] Helen F Graham Canc Ctr & Res Inst, Gene Editing Inst, Newark, DE 19713 USA; [Rivera-Torres, Natalia; Banas, Kelly; Kmiec, Eric B.] Univ Delaware, Dept Med Sci, Newark, DE 19716 USA; [Bloh, Kevin M.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE USA	Helen F. Graham Cancer Center & Research Institute; University of Delaware; Nemours Alfred I. duPont Hospital for Children	Kmiec, EB (corresponding author), Helen F Graham Canc Ctr & Res Inst, Gene Editing Inst, Newark, DE 19713 USA.; Kmiec, EB (corresponding author), Univ Delaware, Dept Med Sci, Newark, DE 19716 USA.	eric.b.kmiec@christianacare.org			National Institute of General Medical Sciences of the National Institutes of Health [P20GM109021, P20GM13446]; Leukemia Research Foundation of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109021] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leukemia Research Foundation of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers P20GM109021 and P20GM13446, and by the Leukemia Research Foundation of Delaware (EBK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Andersen MS, 2002, J MOL MED-JMM, V80, P770, DOI 10.1007/s00109-002-0393-8; Bialk P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32681; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826; Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119; Falgowski K, 2011, NUCLEIC ACIDS RES, V39, P4783, DOI 10.1093/nar/gkr061; Ferrara L, 2006, DNA REPAIR, V5, P422, DOI 10.1016/j.dnarep.2005.11.009; Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822; Ferrara L, 2004, EXP CELL RES, V300, P170, DOI 10.1016/j.yexcr.2004.06.021; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YL, 2005, MOL BIOTECHNOL, V29, P197, DOI 10.1385/MB:29:3:197; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kouranova E, 2016, CRISPRS OPTIMAL TARG, V27, P464; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302454; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053; Radecke F, 2004, J GENE MED, V6, P1257, DOI 10.1002/jgm.613; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rivera-Torres N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096483; Saintigny Y, 2001, EMBO J, V20, P2596, DOI 10.1093/emboj/20.10.2596; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679	42	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169350	10.1371/journal.pone.0169350	http://dx.doi.org/10.1371/journal.pone.0169350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052104	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500052
J	Strojan, K; Leonardi, A; Bregar, VB; Krizaj, I; Svete, J; Pavlin, M				Strojan, Klemen; Leonardi, Adrijana; Bregar, Vladimir B.; Krizaj, Igor; Svete, Jurij; Pavlin, Mojca			Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona	PLOS ONE			English	Article							ADSORPTION; SERUM; PROTEOMICS; STABILITY; BINDING; IMPACT; GOLD; SIZE	Protein corona of nanoparticles (NPs), which forms when these particles come in to contact with protein-containing fluids, is considered as an overlooked factor in nanomedicine. Through numerous studies it has been becoming increasingly evident that it importantly dictates the interaction of NPs with their surroundings. Several factors that determine the compositions of NPs protein corona have been identified in recent years, but one has remained largely ignored-the composition of media used for dispersion of NPs. Here, we determined the effect of dispersion media on the composition of protein corona of polyacrylic acid-coated cobalt ferrite NPs (PAA NPs) and silica NPs. Our results confirmed some of the basic premises such as NPs type-dependent specificity of the protein corona. But more importantly, we demonstrated the effect of the dispersion media on the protein corona composition. The differences between constituents of the media used for dispersion of NPs, such as divalent ions and macromolecules were responsible for the differences in protein corona composition formed in the presence of fetal bovine serum (FBS). Our results suggest that the protein corona composition is a complex function of the constituents present in the media used for dispersion of NPs. Regardless of the dispersion media and FBS concentration, majority of proteins from either PAA NPs or silica NPs coronas were involved in the process of transport and hemostasis. Interestingly, corona of silica NPs contained three complement system related proteins: complement factor H, complement C3 and complement C4 while PAA NPs bound only one immune system related protein, alpha-2-glycoprotein. Importantly, relative abundance of complement C3 protein in corona of silica NPs was increased when NPs were dispersed in NaCl, which further implies the relevance of dispersion media used to prepare NPs.	[Strojan, Klemen; Bregar, Vladimir B.; Pavlin, Mojca] Univ Ljubljana, Fac Elect Engn, Grp Nano & Biotechnol Applicat, Ljubljana, Slovenia; [Leonardi, Adrijana; Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Krizaj, Igor] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Ljubljana, Slovenia; [Svete, Jurij] Univ Ljubljana, Fac Chem & Chem Technol, Dept Organ Chem, Ljubljana, Slovenia; [Pavlin, Mojca] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana; University of Ljubljana	Pavlin, M (corresponding author), Univ Ljubljana, Fac Elect Engn, Grp Nano & Biotechnol Applicat, Ljubljana, Slovenia.; Pavlin, M (corresponding author), Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia.	mojca.pavlin@fe.uni-lj.si	Pavlin, Mojca/AAD-4738-2022	Pavlin, Mojca/0000-0001-5477-7833	Slovenian Research Agency (ARRS) [J3-6794, J7-7424, J2-6758, P1-0055, P1-0207]; ARRS young researcher programme	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); ARRS young researcher programme	This study was supported by the Slovenian Research Agency (ARRS; www.arrs.gov.si) research grants #J3-6794, #J7-7424, #J2-6758, #P1-0055 and #P1-0207. K.S. was also supported by the ARRS young researcher programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Bregar VB, 2013, INT J NANOMED, V8, P919, DOI 10.2147/IJN.S38749; Caracciolo G, 2015, LANGMUIR, V31, P10764, DOI 10.1021/acs.langmuir.5b02158; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; CHRISTENSEN P, 1978, J IMMUNOL METHODS, V23, P23, DOI 10.1016/0022-1759(78)90106-0; Cukalevski R, 2015, NANO RES, V8, P2733, DOI 10.1007/s12274-015-0780-4; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Deng ZJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455101; Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139; Dominguez-Medina S, 2016, ACS NANO, V10, P2103, DOI 10.1021/acsnano.5b06439; Fadeel B, 2015, BIOCHEM BIOPH RES CO, V468, P498, DOI 10.1016/j.bbrc.2015.06.178; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Grafe C, INT J BIOCH CELL BIO; Hadjidemetriou M, 2016, NANOSCALE, V8, P6948, DOI 10.1039/c5nr09158f; Hajdu A, 2012, COLLOID SURFACE B, V94, P242, DOI 10.1016/j.colsurfb.2012.01.042; Hajipour MJ, 2014, BIOMATER SCI-UK, V2, P1210, DOI 10.1039/c4bm00131a; Hajipour MJ, 2015, NANOSCALE, V7, P8978, DOI 10.1039/c5nr00520e; Hu ZY, 2014, COLLOID SURFACE B, V121, P354, DOI 10.1016/j.colsurfb.2014.06.016; Leonardi A, 2012, J PROTEOME RES, V11, P5046, DOI 10.1021/pr3006155; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Liu ZY, 2016, NANOSCALE, V8, P7544, DOI 10.1039/c5nr08447d; Lojk J, 2015, INT J NANOMED, V10, P1449, DOI 10.2147/IJN.S76134; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Mahmoudi M, 2013, ACS NANO, V7, P6555, DOI 10.1021/nn305337c; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Marucco A, 2016, NANOTOXICOLOGY, V10, P1, DOI 10.3109/17435390.2014.978405; Mayflyan K. R., 2008, V21, P219; Mirshafiee V, INT J BIOCH CELL BIO; Mirshafiee V, 2016, BIOMATERIALS, V75, P295, DOI 10.1016/j.biomaterials.2015.10.019; Moghimi SM, 2014, NANOMED-NANOTECHNOL, V10, P1661, DOI 10.1016/j.nano.2014.04.011; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Palchetti S, 2016, BBA-BIOMEMBRANES, V1858, P189, DOI 10.1016/j.bbamem.2015.11.012; Pavlin M, 2012, DIG J NANOMATER BIOS, V7, P1389; Schottler S, 2016, NANOSCALE, V8, P5526, DOI 10.1039/c5nr08196c; Schottler S., 2016, NAT NANOTECHNOL; Sopotnik M, 2015, CARBON, V95, P560, DOI 10.1016/j.carbon.2015.08.018; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; TOURINHO FA, 1990, J MATER SCI, V25, P3249, DOI 10.1007/BF00587682; Treuel L, 2015, BEILSTEIN J NANOTECH, V6, P857, DOI 10.3762/bjnano.6.88; Vogt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129008; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; Yi DK, 2005, J AM CHEM SOC, V127, P4990, DOI 10.1021/ja0428863; Zanganeh S, INT J BIOCH CELL BIO; Zhang ZJ, 2012, ADV MATER, V24, P1418, DOI 10.1002/adma.201104714; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o	53	89	92	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169552	10.1371/journal.pone.0169552	http://dx.doi.org/10.1371/journal.pone.0169552			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052135	Green Submitted, gold, Green Published			2022-12-26	WOS:000391621500067
J	Syfert, MM; Serbina, L; Burckhardt, D; Knapp, S; Percy, DM				Syfert, Mindy M.; Serbina, Liliya; Burckhardt, Daniel; Knapp, Sandra; Percy, Diana M.			Emerging New Crop Pests: Ecological Modelling and Analysis of the South American Potato Psyllid Russelliana solanicola (Hemiptera: Psylloidea) and Its Wild Relatives	PLOS ONE			English	Article							JUMPING PLANT-LICE; CANDIDATUS LIBERIBACTER; SELECTING THRESHOLDS; PHENOLOGICAL CHANGE; MUSEUM COLLECTIONS; CLIMATE-CHANGE; SOLANACEAE; PREDICTION; INVASIONS; HISTORY	Food security is threatened by newly emerging pests with increased invasive potential accelerated through globalization. The Neotropical jumping plant louse Russelliana solanicola Tuthill is currently a localized potato pest and probable vector of plant pathogens. It is an unusually polyphagous species and is widely distributed in and along the Andes. To date, introductions have been detected in eastern Argentina, southern Brazil and Uruguay. Species distribution models (SDMs) and trait comparisons based on contemporary and historical collections are used to estimate the potential spread of R. solanicola worldwide. We also extend our analyses to all described species in the genus Russelliana in order to assess the value of looking beyond pest species to predict pest spread. We investigate the extent to which data on geographical range and environmental niche can be effectively extracted from museum collections for comparative analyses of pest and non-pest species in Russelliana. Our results indicate that R. solanicola has potential for invasion in many parts of the world with suitable environmental conditions that currently have or are anticipated to increase potato cultivation. Large geographical ranges are characteristic of a morphological subgeneric taxon group that includes R. solanicola; this same group also has a larger environmental breadth than other groups within the genus. Ecological modelling using museum collections provides a useful tool for identifying emerging pests and developing integrated pest management programs.	[Syfert, Mindy M.; Knapp, Sandra; Percy, Diana M.] Nat Hist Museum, Dept Life Sci, London, England; [Serbina, Liliya; Burckhardt, Daniel] Nat Hist Museum, Basel, Switzerland; [Serbina, Liliya] Univ Basel, Inst Nat Landschafts & Umweltschutz, Basel, Switzerland; [Percy, Diana M.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	Natural History Museum London; University of Basel; University of British Columbia	Syfert, MM; Percy, DM (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Percy, DM (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	mmsyfert@gmail.com; d.percy@nhm.ac.uk	Serbina, Liliia/AAI-1366-2020	Serbina, Liliia/0000-0002-5171-8253; Burckhardt, Daniel/0000-0001-8368-5268	National Science Foundation [DEB-0316614]; Swiss Confederation (Federal Commission); Freiwillige Akademische Gesellschaft (FAG), Basel; Natural History Museum's Natural Resources Initiative	National Science Foundation(National Science Foundation (NSF)); Swiss Confederation (Federal Commission); Freiwillige Akademische Gesellschaft (FAG), Basel; Natural History Museum's Natural Resources Initiative	We thank the curators of collections mentioned in the text for facilitating access to specimens; members of the iCollections digitization team at BMNH for imaging and transcription of BMNH collection labels; Caitlin McLaughlin and Liz Duffell for georeferencing support; Julian Ramirez Villegas (CIAT) kindly provided the data for current potato cultivation potential; data collection and geo-referencing of potato wild relatives was done as part of "PBI Solanum: a worldwide treatment" funded by the National Science Foundation (DEB-0316614 to SK). We thank Nadia Bystriakova for insightful discussions in the early stages of this research, and Gary Taylor and an anonymous reviewer for constructive comments on the manuscript. LS was funded by grants from the Swiss Confederation (Federal Commission) and the Freiwillige Akademische Gesellschaft (FAG), Basel; MMS was funded by the Natural History Museum's Natural Resources Initiative.	Alyokhin A, 2013, INSECT PESTS OF POTATO: GLOBAL PERSPECTIVES ON BIOLOGY AND MANAGEMENT, P543, DOI 10.1016/B978-0-12-386895-4.00019-3; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Artigas J. N., 1994, ENTOMOLOGIA EC INSEC; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Bebber DP, 2015, ANNU REV PHYTOPATHOL, V53, P335, DOI 10.1146/annurev-phyto-080614-120207; Brooks SJ, 2014, INT J BIOMETEOROL, V58, P1749, DOI 10.1007/s00484-013-0780-6; Brown JK, 2010, PLANT DIS, V94, P376, DOI 10.1094/PDIS-94-3-0376B; BURCKHARDT D, 1986, Revista Chilena de Entomologia, V14, P95; Burckhardt D, 1997, J NAT HIST, V31, P99, DOI 10.1080/00222939700770081; BURCKHARDT D, 1987, ZOOL J LINN SOC-LOND, V89, P299, DOI 10.1111/j.1096-3642.1987.tb01568.x; Burckhardt D, 2008, DEUT ENTOMOL Z, V55, P79, DOI 10.1002/mmnd.200800005; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Burckhardt Daniel, 2012, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V85, P71; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Chavez R., 2003, Idesia, V21, P9; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Crosslin J, 2010, APSNET FEATURES; Davis CC, 2015, AM J BOT, V102, P1599, DOI 10.3732/ajb.1500237; de Queiroz DL, 2013, AUST J ENTOMOL, V52, P20, DOI 10.1111/aen.12001; Di Euliis D, 2015, EMERG INFECT DIS, V21; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; EPPO, 2014, PQR EPPO PLANT QUAR; Everill PH, 2014, AM J BOT, V101, P1293, DOI 10.3732/ajb.1400045; Fernandez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119891; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Franklin J, 2009, MAPPING SPECIES DIST; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; HARRISON GD, 1987, PHYSIOL ENTOMOL, V12, P407, DOI 10.1111/j.1365-3032.1987.tb00767.x; Hart R, 2014, P NATL ACAD SCI USA, V111, P10615, DOI 10.1073/pnas.1403376111; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2003, AM J POTATO RES, V80, P271, DOI 10.1007/BF02855363; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; HODKINSON ID, 1981, B ENTOMOL RES, V71, P671, DOI 10.1017/S0007485300010208; Jansky SH, 2009, POTATO RES, V52, P57, DOI 10.1007/s11540-008-9121-2; Jarvis A, 2012, TROP PLANT BIOL, V5, P9, DOI 10.1007/s12042-012-9096-7; Jeffries C., 2006, FAO LPGRI, V19, P1; Kent D, 2010, AUST J ENTOMOL, V49, P73, DOI 10.1111/j.1440-6055.2009.00739.x; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Law W, 2005, P NATL ACAD SCI USA, V102, P10218, DOI 10.1073/pnas.0502931102; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Li CH, 2011, AM J POTATO RES, V88, P190, DOI 10.1007/s12230-010-9174-z; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Malenovsky I, 2014, ACTA ENT MUS NAT PRA, V54, P23; Martini X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129373; McCune B., 2002, ANAL ECOLOGICAL COMM; McNeely JA, 2001, GLOBAL STRATEGY INVA; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Munyaneza JE, 2015, AM J POTATO RES, V92, P230, DOI 10.1007/s12230-015-9448-6; Munyaneza JE, 2013, INSECT PESTS OF POTATO: GLOBAL PERSPECTIVES ON BIOLOGY AND MANAGEMENT, P65, DOI 10.1016/B978-0-12-386895-4.00004-1; Oksanen AJ, 2014, VEGAN PACKAGE COMMUN; Olmstead RG, 2013, BOT J LINN SOC, V171, P80, DOI 10.1111/j.1095-8339.2012.01306.x; Ortiz R, 2015, CROP WILD RELATIVES AND CLIMATE CHANGE, P80; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2021, R LANGUAGE ENV STAT; Redden R, 2015, CROP WILD RELATIVES AND CLIMATE CHANGE, P1, DOI 10.1002/9781118854396; Richardson DM, 2007, DIVERS DISTRIB, V13, P299, DOI 10.1111/j.1472-4642.2007.00337.x; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Salazar L. F., 2006, POTATO RES, V49, P43, DOI DOI 10.1007/S11540-006-9005-2; Schafleitner R, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P287; Serbina L, ZOOTAXA IN PRESS; Serbina L, 2015, ZOOTAXA, V4021, P33, DOI 10.11646/zootaxa.4021.1.2; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Spooner DM, 2014, BOT REV, V80, P283, DOI 10.1007/s12229-014-9146-y; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Taylor GS, 2013, ZOOTAXA, V3613, P257, DOI 10.11646/zootaxa.3613.3.4; Tenorio Jorge, 2003, Fitopatologia, V38, P32; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; TUTHILL L. D., 1959, REV PERUANA ENTOMOL AND AGRIC, V2, P1; TUTHILL LEONARD D., 1964, REV PERUANA ENTOMOL, V7, P25; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Zomer, 2010, GLOBAL SOIL WATER BA	90	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0167764	10.1371/journal.pone.0167764	http://dx.doi.org/10.1371/journal.pone.0167764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052088	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500011
J	Islam, S; Mir, AR; Raghav, A; Khan, F; Alam, K; Ali, A; Uddin, M				Islam, Sidra; Mir, Abdul Rouf; Raghav, Alok; Khan, Farzana; Alam, Khursheed; Ali, Asif; Uddin, Moin			Neo-Epitopes Generated on Hydroxyl Radical Modified GlycatedIgG Have Role in Immunopathology of Diabetes Type 2	PLOS ONE			English	Article							INDUCED STRUCTURAL-CHANGES; MONOCYTIC THP-1 CELLS; HUMAN SERUM-ALBUMIN; GLYOXALASE SYSTEM; OXIDATIVE STRESS; CU,ZN-SUPEROXIDE DISMUTASE; PREFERENTIAL RECOGNITION; ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION; PROTEIN DAMAGE	Glycoxidation plays a crucial role in diabetes and its associated complications. Among the glycoxidation agents, methylglyoxal (MG) is known to have very highglycationpotential witha concomitant generation of reactive oxygen species (ROS) during its synthesis and degradation. The presentstudy probes the MG and ROSinduced structural damage to immunoglobulin G (IgG) and alterations in its immunogenicity in diabetes type 2 patients (T2DM). Human IgG was first glycated with MG followed by hydroxyl radical (OH center dot) modification. Glycoxidation mediated effects on IgG were evaluated by various physicochemical techniques likeultraviolet (UV) and fluorescence spectroscopy, 8-anilinonaphthalene-1-sulfonic acid (ANS) binding studies, carbonyl andfree sulfhydryl groups assay, matrix assisted laser desorption ionization mass spectrometry-time of flight (MALDI-TOF), red blood cell (RBC) haemolysis assay, Congored (CR) staining analysis and scanning electron microscopy (SEM). The results revealed hyperchromicityin UV, advanced glycation end product (AGE) specific and ANS fluorescence, quenching in tyrosine and tryptophan fluorescence intensity, enhanced carbonyl content, reduction in free sulfhydryl groups, pronounced shift in m/z value of IgGand decrease in antioxidant activity in RBC induced haemolysis assayupon glycoxidation. SEM and CRstaining assay showed highly altered surface morphology in glycoxidised sample as compared to the native. Enzyme linked immunosorbent assay (ELISA) and band shift assay were performed to assess the changes in immunogenicity of IgG upon glyoxidation and its role in T2DM. The serum antibodies derived from T2DM patients demonstrated strong affinity towards OH center dot treated MG glycatedIgG (OH center dot-MG-IgG) when compared to native IgG (N-IgG) or IgGs treated with MG alone (MG-IgG) or OH center dot alone (OH center dot IgG). This study shows the cumulating effect of OH center dot on the glycation potential of MG. The results point towards the modification of IgG in diabetes patients under the effect of glycoxidative stress, leading to the generation of neo-epitopes on theIgG molecule and rendering it immunogenic.	[Islam, Sidra; Khan, Farzana; Alam, Khursheed; Ali, Asif; Uddin, Moin] Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India; [Mir, Abdul Rouf] Univ Kashmir, Govt Degree Coll Baramulla, Dept Biotechnol, Jammu, India; [Raghav, Alok] Aligarh Muslim Univ, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; University of Kashmir; Aligarh Muslim University	Uddin, M (corresponding author), Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	MIR, ABDUL ROUF/ABD-7542-2020; Raghav, Alok/AAX-3419-2021	MIR, ABDUL ROUF/0000-0002-2897-4419; Alam, Khursheed/0000-0001-9729-9966				Abordo EA, 1996, IMMUNOL LETT, V53, P7, DOI 10.1016/0165-2478(96)02601-6; Ahmad P, 2015, INT J BIOL MACROMOL, V72, P875, DOI 10.1016/j.ijbiomac.2014.10.001; Ahmad P, 2013, INT J BIOL MACROMOL, V59, P349, DOI 10.1016/j.ijbiomac.2013.04.068; Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2012, IUBMB LIFE, V64, P151, DOI 10.1002/iub.582; Allarakha S, 2015, IUBMB LIFE, V67, P338, DOI 10.1002/iub.1375; Amani S, 2014, BIOCHEM ENG J, V91, P120, DOI 10.1016/j.bej.2014.08.004; Amani S, 2014, J FLUORESC, V24, P1423, DOI 10.1007/s10895-014-1424-x; Amani S, 2014, SPECTROCHIM ACTA A, V120, P151, DOI 10.1016/j.saa.2013.09.141; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Ashraf GM, 2014, CNS NEUROL DISORD-DR, V13, P1280, DOI 10.2174/1871527313666140917095514; Ayyadevara S, 2016, HYPERTENSION, V67, P1006, DOI 10.1161/HYPERTENSIONAHA.115.06849; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; Bowen Kristina, 2012, Case Rep Nephrol, V2012, P593460, DOI 10.1155/2012/593460; Cheema MU, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.64; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Chumsae C, 2013, ANAL CHEM, V85, P11401, DOI 10.1021/ac402384y; Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Elias RJ, 2005, J AGR FOOD CHEM, V53, P10248, DOI 10.1021/jf0521698; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Guedes S, 2011, ANAL BIOANAL CHEM, V399, P3529, DOI 10.1007/s00216-011-4679-y; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Iram A, 2012, INT J BIOL MACROMOL, V50, P932, DOI 10.1016/j.ijbiomac.2012.02.012; Jairajpuri DS, 2007, CLIN CHIM ACTA, V378, P86, DOI 10.1016/j.cca.2006.10.020; Jindal S, 2013, J FLUORESC, V23, P367, DOI 10.1007/s10895-013-1162-5; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; KALAPOS MP, 1993, ARCH TOXICOL, V67, P369, DOI 10.1007/BF01973710; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Kang JH, 2003, MOL CELLS, V15, P194; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Khan F, 2016, INT J BIOL MACROMOL, V86, P145, DOI 10.1016/j.ijbiomac.2016.01.053; Khan MA, 2009, SCAND J IMMUNOL, V69, P99, DOI 10.1111/j.1365-3083.2008.02200.x; Khatoon F, 2012, HUM IMMUNOL, V73, P1132, DOI 10.1016/j.humimm.2012.08.011; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; KRYMKIEWICZ N, 1973, FEBS LETT, V29, P51, DOI 10.1016/0014-5793(73)80013-4; Lapolla A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/412103; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lo TWC, 1993, AMINO ACIDS, V5, P172; Ma XX, 2011, J AM SOC MASS SPECTR, V22, P922, DOI 10.1007/s13361-011-0104-1; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Mir AR, 2016, GLYCOBIOLOGY, V26, P129, DOI 10.1093/glycob/cwv082; Mir AR, 2014, INT J BIOL MACROMOL, V69, P260, DOI 10.1016/j.ijbiomac.2014.05.057; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Naeem A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054061; Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338; Neelofar, 2015, RSC ADV, V5, P63605, DOI 10.1039/c5ra07232h; Nimalaratne C, 2011, FOOD CHEM, V129, P155, DOI 10.1016/j.foodchem.2011.04.058; Park YS, 2003, FREE RADICAL RES, V37, P205, DOI 10.1080/1071576021000041005; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; PRINSZE C, 1990, BIOCHIM BIOPHYS ACTA, V1038, P152, DOI 10.1016/0167-4838(90)90198-O; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; RILEY ML, 1995, BBA-MOL BASIS DIS, V1270, P36, DOI 10.1016/0925-4439(94)00069-3; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Stocker P, 2003, BBA-GEN SUBJECTS, V1621, P1, DOI 10.1016/S0304-4165(03)00008-4; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Traverso N, 1997, BBA-GEN SUBJECTS, V1336, P409, DOI 10.1016/S0304-4165(97)00052-4; TRUEB B, 1984, COLLAGEN REL RES, V4, P239; VanderJagt DL, 1997, BIOCHEM PHARMACOL, V53, P1133, DOI 10.1016/S0006-2952(97)00090-7; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Wang X, 1999, CLIN HEMORHEOL MICRO, V21, P137; WESTWOOD ME, 1994, J BIOL CHEM, V269, P32293; Westwood ME, 1996, IMMUNOL LETT, V50, P17, DOI 10.1016/0165-2478(96)02496-0; Zhuo XH, 2014, DIABETES CARE, V37, P2557, DOI 10.2337/dc13-2484	73	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169099	10.1371/journal.pone.0169099	http://dx.doi.org/10.1371/journal.pone.0169099			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046123	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300113
J	Manickavelu, A; Hattori, T; Yamaoka, S; Yoshimura, K; Kondou, Y; Onogi, A; Matsui, M; Iwata, H; Ban, T				Manickavelu, Alagu; Hattori, Tomohiro; Yamaoka, Shuhei; Yoshimura, Kazusa; Kondou, Youichi; Onogi, Akio; Matsui, Minami; Iwata, Hiroyoshi; Ban, Tomohiro			Genetic Nature of Elemental Contents in Wheat Grains and Its Genomic Prediction: Toward the Effective Use of Wheat Landraces from Afghanistan	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; STAPLE FOOD CROPS; MOLECULAR EVALUATION; IRON CONCENTRATIONS; WIDE ASSOCIATION; HUMAN-NUTRITION; ZINC; SELECTION; DIVERSITY; ENVIRONMENTS	Profiling elemental contents in wheat grains and clarifying the underlying genetic systems are important for the breeding of biofortified crops. Our objective was to evaluate the genetic potential of 269 Afghan wheat landraces for increasing elemental contents in wheat cultivars. The contents of three major (Mg, K, and P) and three minor (Mn, Fe, and Zn) elements in wheat grains were measured by energy dispersive X-ray fluorescence spectrometry. Large variations in elemental contents were observed among landraces. Marker-based heritability estimates were low to moderate, suggesting that the elemental contents are complex quantitative traits. Genetic correlations between two locations (Japan and Afghanistan) and among the six elements were estimated using a multi-response Bayesian linear mixed model. Low-to-moderate genetic correlations were observed among major elements and among minor elements respectively, but not between major and minor elements. A single response genome-wide association study detected only one significant marker, which was associated with Zn, suggesting it will be difficult to increase the elemental contents of wheat by conventional marker-assisted selection. Genomic predictions for major elemental contents were moderately or highly accurate, whereas those for minor elements were mostly low or moderate. Our results indicate genomic selection may be useful for the genetic improvement of elemental contents in wheat.	[Manickavelu, Alagu; Yamaoka, Shuhei; Ban, Tomohiro] Yokohama City Univ, Kihara Inst Biol Res, Plant Genet Resources Div, Yokohama, Kanagawa, Japan; [Manickavelu, Alagu] Cent Univ Kerala, Dept Genom Sci, Transit Campus, Riverside, Kerala, India; [Hattori, Tomohiro; Yoshimura, Kazusa; Onogi, Akio; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Kondou, Youichi] Kanto Gakuin Univ, Coll Sci & Engn, Yokohama, Kanagawa, Japan; [Matsui, Minami] Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan	Yokohama City University; Central University of Kerala; University of Tokyo; Kanto Gakuin University	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	iwata@mail.ecc.u-tokyo.ac.jp	Manickavelu, Alagu/M-8506-2015; Matsui, Minami/A-5235-2016	Manickavelu, Alagu/0000-0003-2875-2290; Matsui, Minami/0000-0001-5162-2668; Ban, Tomohiro/0000-0002-7677-9220	Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Science and Technology Agency (JST) / Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (KAKENHI) [16H04858]; Grants-in-Aid for Scientific Research [16H04858] Funding Source: KAKEN	Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Science and Technology Agency (JST) / Japan International Cooperation Agency (JICA)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS), Japan Science and Technology Agency (JST) / Japan International Cooperation Agency (JICA) for 'Project for the Development of Wheat Breeding Materials for Sustainable Food Production in Afghanistan', and Japan Society for the Promotion of Science (KAKENHI grant number 16H04858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Beaulieu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Bouis HE, 2007, J DEV STUD, V43, P79, DOI 10.1080/00220380601055585; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; FAO Soil bulletin, 1973, FAO SOIL B; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Graham R, 1999, FIELD CROP RES, V60, P57, DOI 10.1016/S0378-4290(98)00133-6; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Iwata H, 2013, BREEDING SCI, V63, P125, DOI 10.1270/jsbbs.63.125; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kondou Y, BREEDING SCI; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Manickavelu A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0320-5; Manickavelu A, 2014, PLANT GENET RESOUR-C, V12, pS31, DOI 10.1017/S1479262114000203; Meuwissen THE, 2001, GENETICS, V157, P1819; Morgounov A, 2007, EUPHYTICA, V155, P193, DOI 10.1007/s10681-006-9321-2; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Onogi A, 2016, THEOR APPL GENET, V129, P805, DOI 10.1007/s00122-016-2667-5; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Ortiz-Monasterio JI, 2007, J CEREAL SCI, V46, P293, DOI 10.1016/j.jcs.2007.06.005; Paltridge NG, 2012, PLANT SOIL, V361, P261, DOI 10.1007/s11104-012-1423-0; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Shakoor N, 2016, PLANT PHYSIOL, V170, P1989, DOI 10.1104/pp.15.01971; Sohail Q, 2015, GENET RESOUR CROP EV, V62, P1147, DOI 10.1007/s10722-015-0219-5; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001; Velu G, 2012, FIELD CROP RES, V137, P261, DOI 10.1016/j.fcr.2012.07.018; Velu G, 2011, CZECH J GENET PLANT, V47, pS174, DOI 10.17221/3275-CJGPB; Velu G, 2016, THEOR APPL GENET, V129, P1595, DOI 10.1007/s00122-016-2726-y; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; World Health Organization, 2013, RES UNIVERSAL HLTH C; Yamamoto E, 2016, SCI REP-UK, V6, DOI 10.1038/srep19454; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao FJ, 2009, J CEREAL SCI, V49, P290, DOI 10.1016/j.jcs.2008.11.007	54	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169416	10.1371/journal.pone.0169416	http://dx.doi.org/10.1371/journal.pone.0169416			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072876	gold, Green Submitted, Green Published			2022-12-26	WOS:000391844200019
J	Papazoglou, A; Soos, J; Lundt, A; Wormuth, C; Ginde, VR; Muller, R; Henseler, C; Broich, K; Xie, K; Haenisch, B; Ehninger, D; Weiergraber, M				Papazoglou, Anna; Soos, Julien; Lundt, Andreas; Wormuth, Carola; Ginde, Varun Raj; Mueller, Ralf; Henseler, Christina; Broich, Karl; Xie, Kan; Haenisch, Britta; Ehninger, Dan; Weiergraeber, Marco			Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice	PLOS ONE			English	Article							AMYLOID DEPOSITION; MOUSE MODELS; GENDER-DIFFERENCES; TRANSGENIC MOUSE; DISEASE; BETA; EEG; MECHANISMS; APP; NEURODEGENERATION	Alzheimer's disease (AD) is a multifactorial disorder leading to progressive memory loss and eventually death. In this study, an APPswePS1dE9 AD mouse model has been analyzed for motor cortex theta, beta and gamma frequency alterations using computerized 3D stereotaxic electrode positioning and implantable video-EEG radiotelemetry to perform long-term M1 recordings from both genders considering age, circadian rhythm and activity status of experimental animals. We previously demonstrated that APPswePS1dE9 mice exibit complex alterations in hippocampal frequency power and another recent investigation reported a global increase of alpha, beta and gamma power in APPswePS1dE9 in females of 16-17 weeks of age. In this cortical study in APPswePS1dE9 mice we did not observe any changes in theta, beta and particularly gamma power in both genders at the age of 14, 15,18 and 19 weeks. Importantly, no activity dependence of theta, beta and gamma activity could be detected. These findings clearly point to the fact that EEG activity, particularly gamma power exhibits developmental changes and spatial distinctiveness in the APPswePS1dE9 mouse model of Alzheimer's disease.	[Papazoglou, Anna; Soos, Julien; Lundt, Andreas; Wormuth, Carola; Ginde, Varun Raj; Henseler, Christina; Broich, Karl; Weiergraeber, Marco] Fed Inst Drugs & Med Devices, BfArM, Dept Neuropsychopharmacol, Bonn, Germany; [Soos, Julien; Ginde, Varun Raj; Xie, Kan; Haenisch, Britta; Ehninger, Dan] German Ctr Neurodegenerat Dis, DZNE, Bonn, Germany; [Mueller, Ralf] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne	Weiergraber, M (corresponding author), Fed Inst Drugs & Med Devices, BfArM, Dept Neuropsychopharmacol, Bonn, Germany.	marco.weiergraeber@bfarm.de			Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte, BfArM) Bonn, Germany; German Center for Neurodegenerative Diseases (Deutsches Zentrum fur Neurodegenerative Erkrankungen, DZNE)	Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte, BfArM) Bonn, Germany; German Center for Neurodegenerative Diseases (Deutsches Zentrum fur Neurodegenerative Erkrankungen, DZNE)	This work was financially supported by the Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte, BfArM) Bonn, Germany, and the German Center for Neurodegenerative Diseases (Deutsches Zentrum fur Neurodegenerative Erkrankungen, DZNE).	Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Bland BH, 1996, EXP NEUROL, V138, P286, DOI 10.1006/exnr.1996.0067; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bracco L, 2009, NEUROLOGY, V72, P928, DOI 10.1212/01.wnl.0000344153.68679.37; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cavanaugh SE, 2014, ALTEX-ALTERN ANIM EX, V31, P279, DOI 10.14573/altex.1310071; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Ferreri F, 2016, HUM BRAIN MAPP, V37, P2083, DOI 10.1002/hbm.23158; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcia-Marin V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.028.2009; Gotz J, 2004, INT J DEV NEUROSCI, V22, P453, DOI 10.1016/j.ijdevneu.2004.07.013; Gurevicius K, 2013, CEREB CORTEX, V23, P1148, DOI 10.1093/cercor/bhs105; Gutierrez-Lerma Armando I, 2013, Int J Pept, V2013, P328140, DOI 10.1155/2013/328140; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; HARDY J, 1992, AM J HUM GENET, V50, P648; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiao SS, 2016, NEUROTOX RES, V29, P256, DOI 10.1007/s12640-015-9589-x; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leroy K, 2012, AM J PATHOL, V181, P1928, DOI 10.1016/j.ajpath.2012.08.012; Malm Tarja, 2011, Int J Alzheimers Dis, V2011, P517160, DOI 10.4061/2011/517160; Mann EO, 2005, PROG BIOPHYS MOL BIO, V87, P67, DOI 10.1016/j.pbiomolbio.2004.06.004; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Ordonez-Gutierrez L, 2016, J ALZHEIMERS DIS; Ordonez-Gutierrez L, 2015, J ALZHEIMERS DIS, V44, P1063, DOI 10.3233/JAD-141158; Paesler K, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/825157; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Papazoglou A, 2016, NEURAL PLAS IN PRESS; Papazoglou A, 2016, J VIS EXPT IN PRESS; Pena-Ortega Fernando, 2012, Int J Pept, V2012, P236289, DOI 10.1155/2012/236289; Price DL, 1998, NAT GENET, V19, P314, DOI 10.1038/1196; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; Siwek ME, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/781731; van Deursen JA, 2008, J NEURAL TRANSM, V115, P1301, DOI 10.1007/s00702-008-0083-y; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Weiergraber M, 2005, BRAIN RES PROTOC, V14, P154, DOI 10.1016/j.brainresprot.2004.12.006; Weiergraber M, 2016, J NEUROSCI METH, V268, P53, DOI 10.1016/j.jneumeth.2016.05.010; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Zhang X, 2011, PHARMACOL REP, V63, P1101, DOI 10.1016/S1734-1140(11)70629-6; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	59	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169654	10.1371/journal.pone.0169654	http://dx.doi.org/10.1371/journal.pone.0169654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072877	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200037
J	Biazzi, E; Nazzicari, N; Pecetti, L; Brummer, EC; Palmonari, A; Tava, A; Annicchiarico, P				Biazzi, Elisa; Nazzicari, Nelson; Pecetti, Luciano; Brummer, E. Charles; Palmonari, Alberto; Tava, Aldo; Annicchiarico, Paolo			Genome-Wide Association Mapping and Genomic Selection for Alfalfa (Medicago sativa) Forage Quality Traits	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; GENETIC CORRELATION; INDIGESTIBLE FIBER; DETERGENT FIBER; BIOMASS YIELD; MATURITY; PROTEIN; LOCI; DEGRADABILITY; CULTIVAR	Genetic progress for forage quality has been poor in alfalfa (Medicago sativa L.), the most-grown forage legume worldwide. This study aimed at exploring opportunities for marker-assisted selection (MAS) and genomic selection of forage quality traits based on breeding values of parent plants. Some 154 genotypes from a broadly-based reference population were genotyped by genotyping-by-sequencing (GBS), and phenotyped for leaf-to-stem ratio, leaf and stem contents of protein, neutral detergent fiber (NDF) and acid detergent lignin (ADL), and leaf and stem NDF digestibility after 24 hours (NDFD), of their dense-planted half-sib progenies in three growing conditions (summer harvest, full irrigation; summer harvest, suspended irrigation; autumn harvest). Trait-marker analyses were performed on progeny values averaged over conditions, owing to modest germplasm x condition interaction. Genomic selection exploited 11,450 polymorphic SNP markers, whereas a subset of 8,494 M. truncatula-aligned markers were used for a genome-wide association study (GWAS). GWAS confirmed the polygenic control of quality traits and, in agreement with phenotypic correlations, indicated substantially different genetic control of a given trait in stems and leaves. It detected several SNPs in different annotated genes that were highly linked to stem protein content. Also, it identified a small genomic region on chromosome 8 with high concentration of annotated genes associated with leaf ADL, including one gene probably involved in the lignin pathway. Three genomic selection models, i.e., Ridge-regression BLUP, Bayes B and Bayesian Lasso, displayed similar prediction accuracy, whereas SVR-lin was less accurate. Accuracy values were moderate (0.3 - 0.4) for stem NDFD and leaf protein content, modest for leaf ADL and NDFD, and low to very low for the other traits. Along with previous results for the same germplasm set, this study indicates that GBS data can be exploited to improve both quality traits (by genomic selection or MAS) and forage yield.	[Biazzi, Elisa; Nazzicari, Nelson; Pecetti, Luciano; Tava, Aldo; Annicchiarico, Paolo] Council Agr Res & Econ, Res Ctr Fodder Crops & Dairy Prod CREA FLC, Lodi, Italy; [Brummer, E. Charles] Univ Calif Davis, Dept Plant Sci, Plant Breeding Ctr, Davis, CA 95616 USA; [Palmonari, Alberto] Univ Bologna, Dept Vet Med, Bologna, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of California System; University of California Davis; University of Bologna	Annicchiarico, P (corresponding author), Council Agr Res & Econ, Res Ctr Fodder Crops & Dairy Prod CREA FLC, Lodi, Italy.	paolo.annicchiarico@crea.gov.it	nazzicari, nelson/ABE-1344-2021; biazzi, elisa/AAA-6023-2022	nazzicari, nelson/0000-0003-2710-9885; Annicchiarico, Paolo/0000-0001-8027-1035; Biazzi, Elisa/0000-0002-1348-8709; Aldo, Tava/0000-0003-4657-4053	FP7-ArimNet Project 'Resilient, water- and energy efficient forage and feed crops for Mediterranean agricultural systems (REFORMA)' - Ministry of Agriculture, Food and Forestry Policy [DM11681/7303/12]; 'High quality alfalfa for the dairy chain (Qual&Medica)' - Fondazione Cassa di Risparmio di Bologna; Italian Ministry of Agriculture, Food and Forestry Policy; Fondazione Cassa di Risparmio di Bologna; Regione Emilia-Romagna	FP7-ArimNet Project 'Resilient, water- and energy efficient forage and feed crops for Mediterranean agricultural systems (REFORMA)' - Ministry of Agriculture, Food and Forestry Policy; 'High quality alfalfa for the dairy chain (Qual&Medica)' - Fondazione Cassa di Risparmio di Bologna; Italian Ministry of Agriculture, Food and Forestry Policy; Fondazione Cassa di Risparmio di Bologna(Fondazione Carisbo); Regione Emilia-Romagna(Regione Emilia Romagna)	This work was supported by the FP7-ArimNet Project 'Resilient, water- and energy efficient forage and feed crops for Mediterranean agricultural systems (REFORMA)', funded by the Ministry of Agriculture, Food and Forestry Policy, GRANT NUMBER DM11681/7303/12, (URL: http//reforma.entecra.it/) founding institution: Council for Agricultural Research and Economics-Research Centre for Fodder Crops and Dairy Productions (CREA-FLC), Lodi, Italy to PA and the Project 'High quality alfalfa for the dairy chain (Qual&Medica)' funded by Fondazione Cassa di Risparmio di Bologna and Regione Emilia-Romagna (URL: 8ttp://qualemedica.it/) founding institution: Council for Agricultural Research and Economics-Research Centre for Fodder Crops and Dairy Productions (CREA-FLC), Lodi, Italy to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is part of the FP7-ArimNet project 'Resilient, water- and energy-efficient forage and feed crops for Mediterranean agricultural systems (REFORMA)' funded by the Italian Ministry of Agriculture, Food and Forestry Policy. Chemical analyses were carried out within the project 'High quality alfalfa for the dairy chain (Qual&Medica)' funded by Fondazione Cassa di Risparmio di Bologna and Regione Emilia-Romagna, whereas the Samuel Roberts Noble Foundation contributed with genomic data. We thank Yanling Wei for her contribution to GBS data generation, and Sandro Proietti and Barbara Pintus for technical assistance.	Annicchiarico P, 2007, GRASS FORAGE SCI, V62, P100, DOI 10.1111/j.1365-2494.2007.00562.x; Annicchiarico P, 2015, EUPHYTICA, V205, P409, DOI 10.1007/s10681-015-1399-y; Annicchiarico P, 2013, ANN APPL BIOL, V162, P27, DOI 10.1111/j.1744-7348.2012.00576.x; Annicchiarico P, 2011, FIELD CROP RES, V120, P283, DOI 10.1016/j.fcr.2010.11.003; Annicchiarico P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2212-y; Annicchiarico P, 2015, CRIT REV PLANT SCI, V34, P327, DOI 10.1080/07352689.2014.898462; [Anonymous], 1981, ANAL DIETARY FIBER F; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BURDON RD, 1977, SILVAE GENET, V26, P168; Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; de los Campos G, 2014, BGLR BAYESIAN GEN LI; Delacy I. H., 1996, P39; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; GRIFFIN TS, 1994, CROP SCI, V34, P1654, DOI 10.2135/cropsci1994.0011183X003400060043x; Guines F, 2002, AUST J AGR RES, V53, P401, DOI 10.1071/AR01104; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; HANSON AA, 1988, AGRON MONOGR, V29; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HILL RR, 1977, CROP SCI, V17, P948, DOI 10.2135/cropsci1977.0011183X001700060033x; Ibrahim H. I. M., 2015, American-Eurasian Journal of Agricultural & Environmental Sciences, V15, P1113; Julier B, 2000, CROP SCI, V40, P365, DOI 10.2135/cropsci2000.402365x; Julier B, 1997, AGRONOMIE, V17, P481, DOI 10.1051/agro:19970905; Kang Y, 2015, PLANT CELL ENVIRON, V38, P1997, DOI 10.1111/pce.12520; Khu DM, 2013, CROP SCI, V53, P148, DOI 10.2135/cropsci2012.03.0181; Espinoza LDL, 2013, THEOR APPL GENET, V126, P497, DOI 10.1007/s00122-012-1996-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei L, 2015, PLANT CELL, V27, P2926, DOI 10.1105/tpc.15.00442; Li X, 2015, AIP CONF PROC, V1648, DOI 10.1063/1.4912874; Li XH, 2015, CROP SCI, V55, P1995, DOI 10.2135/cropsci2014.12.0834; Li XH, 2014, G3-GENES GENOM GENET, V4, P1971, DOI 10.1534/g3.114.012245; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Lorenz AJ, 2011, 2011 ADB AGRONOMY, V110, P77, DOI DOI 10.1016/B978-0-12-385531-2.00002-5; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Marten G. C., 1988, Alfalfa and alfalfa improvement, P463; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyer D, 2015, MISC FUNCTIONS DEP S; Nazzicari N, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0490-y; Oba M, 1999, J DAIRY SCI, V82, P589, DOI 10.3168/jds.S0022-0302(99)75271-9; Palmonari A, 2016, J ANIM SCI, V94, P248, DOI 10.2527/jas.2015-9649; Palmonari A, 2014, J DAIRY SCI, V97, P7729, DOI 10.3168/jds.2014-8123; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pecetti L, GRASS FORAG IN PRESS; PETIT HV, 1992, CAN J PLANT SCI, V72, P147, DOI 10.4141/cjps92-015; Raffrenato E, 2011, J DAIRY SCI, V94, P3613, DOI 10.3168/jds.2010-3701; Ray IM, 2015, CROP SCI, V55, P2012, DOI 10.2135/cropsci2014.12.0840; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Rocher S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131918; Rooney WL, 1997, CROP SCI, V37, P128, DOI 10.2135/cropsci1997.0011183X003700010022x; Sakiroglu M, THEOR APPL IN PRESS; Schnurr JA, 2007, CROP SCI, V47, P1672, DOI 10.2135/cropsci2006.12.0762; Schwender H., 2013, scrime: Analysis of High-Dimensional Categorical Data such as SNP Data; Searle SR., 2009, VARIANCE COMPONENTS; Stanton-Geddes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065688; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Teuber LR, 1998, NAAIC STANDARD TESTS; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yari M, 2012, ANIM FEED SCI TECH, V172, P162, DOI 10.1016/j.anifeedsci.2012.01.004; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00956; Yu P, 2003, CAN J ANIM SCI, V83, P279, DOI 10.4141/A02-053; Zhang TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138931	70	65	65	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169234	10.1371/journal.pone.0169234	http://dx.doi.org/10.1371/journal.pone.0169234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068350	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900022
J	Ning, N; Peng, DL; Liu, XP; Yang, S				Ning, Ning; Peng, Danling; Liu, Xiangping; Yang, Shuang			Speech Timing Deficit of Stuttering: Evidence from Contingent Negative Variations	PLOS ONE			English	Article							INHIBITORY CONTROL; CNV AMPLITUDE; TASK; ERP; INCENTIVES; TOPOGRAPHY; HYPOTHESIS; COMPONENTS; FREQUENCY; CORRELATE	The aim of the present study was to investigate the speech preparation processes of adults who stutter (AWS). Fifteen AWS and fifteen adults with fluent speech (AFS) participated in the experiment. The event-related potentials (ERPs) were recorded in a foreperiod paradigm. The warning signal (S1) was a color square, and the following imperative stimulus (S2) was either a white square (the Go signal that required participants to name the color of S1) or a white dot (the NoGo signal that prevents participants from speaking). Three differences were found between AWS and AFS. First, the mean amplitude of the ERP component parietal positivity elicited by S1 (S1-P3) was smaller in AWS than in AFS, which implies that AWS may have deficits in investing working memory on phonological programming. Second, the topographic shift from the early phase to the late phase of contingent negative variation occurred earlier for AWS than for AFS, thus suggesting that the motor preparation process is promoted in AWS. Third, the NoGo effect in the ERP component parietal positivity elicited by S2 (S2-P3) was larger for AFS than for AWS, indicating that AWS have difficulties in inhibiting a planned speech response. These results provide a full picture of the speech preparation and response inhibition processes of AWS. The relationship among these three findings is discussed. However, as stuttering was not manipulated in this study, it is still unclear whether the effects are the causes or the results of stuttering. Further studies are suggested to explore the relationship between stuttering and the effects found in the present study.	[Ning, Ning; Yang, Shuang] Soochow Univ, Sch Educ, Suzhou, Jiang Su, Peoples R China; [Peng, Danling] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Liu, Xiangping] Beijing Normal Univ, Sch Psychol, Beijing, Peoples R China	Soochow University - China; Beijing Normal University; Beijing Normal University	Yang, S (corresponding author), Soochow Univ, Sch Educ, Suzhou, Jiang Su, Peoples R China.	shuang5870156@163.com			Educational Commission of Jiangsu Province of China [2013SJD190003]; National Social Science Foundation of China [14ZDB157]	Educational Commission of Jiangsu Province of China; National Social Science Foundation of China	This work was supported by the Educational Commission of Jiangsu Province of China (grant number: 2013SJD190003, http://jspopss.jschina.com.cn/) awarded to NN, and the National Social Science Foundation of China (grant number: 14ZDB157, http://www.sinoss.net/) awarded to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim A, 2007, J NEUROTHERAPY, V11, P15; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Bajaj A, 2007, J FLUENCY DISORD, V32, P218, DOI 10.1016/j.jfludis.2007.03.002; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Capa RL, 2013, CORTEX, V49, P1943, DOI 10.1016/j.cortex.2012.05.018; Conture EG, 2006, CURRENT ISSUES IN STUTTERING RESEARCH AND PRACTICE, P17; Cui RQ, 2000, CLIN NEUROPHYSIOL, V111, P1847, DOI 10.1016/S1388-2457(00)00388-6; Eggers K, 2013, J FLUENCY DISORD, V38, P1, DOI 10.1016/j.jfludis.2012.10.001; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; Fletcher RJ, 1980, CITY U COLOUR VISION; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Howell P., 2002, CURRENT ISSUES LINGU, P75; Kononowicz TW, 2015, NEUROPSYCHOLOGIA, V75, P201, DOI 10.1016/j.neuropsychologia.2015.06.001; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; Leynes PA, 1998, INT J PSYCHOPHYSIOL, V31, P33, DOI 10.1016/S0167-8760(98)00032-4; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; Maxfield ND, 2015, CLIN NEUROPHYSIOL, V126, P284, DOI 10.1016/j.clinph.2014.05.009; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; [宁宁 NING Ning], 2009, [心理学报, Acta Psychologica Sinica], V41, P387; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulsen DJ, 2015, DEV COGN NEUROS-NETH, V11, P105, DOI 10.1016/j.dcn.2014.09.003; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Piispala J, 2016, J FLUENCY DISORD, V48, P16, DOI 10.1016/j.jfludis.2016.02.001; PINSKY SD, 1980, BRAIN LANG, V11, P374, DOI 10.1016/0093-934X(80)90134-0; PRESCOTT J, 1984, INT J PSYCHOPHYSIOL, V2, P121, DOI 10.1016/0167-8760(84)90005-9; PRESCOTT J, 1988, BIOL PSYCHOL, V27, P259, DOI 10.1016/0301-0511(88)90035-X; Riley GD, 1994, STUTTERING SEVERITY; Rohrbaugh J.W., 1983, TUTORIALS ERP RES EN, P269, DOI 10.1016/S0166-4115(08)62044-0; Rose M, 2001, PSYCHOPHYSIOLOGY, V38, P440; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Stevens A, 1997, PSYCHIAT RES, V66, P45, DOI 10.1016/S0165-1781(96)02938-1; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Vanhoutte S, 2015, NEUROPSYCHOLOGIA, V75, P1, DOI 10.1016/j.neuropsychologia.2015.05.013; Vanhoutte S, 2014, NEUROPSYCHOLOGIA, V64, P349, DOI 10.1016/j.neuropsychologia.2014.09.036; Verleger R, 2015, BIOL PSYCHOL, V108, P25, DOI 10.1016/j.biopsycho.2015.02.010; Walla P, 2004, NEUROIMAGE, V22, P1321, DOI 10.1016/j.neuroimage.2004.03.029; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; ZAPPOLI R, 1991, Neurophysiologie Clinique, V21, P473, DOI 10.1016/S0987-7053(05)80337-5; Zimmermann GN, 1975, ELECTROENCEPHALOGRAP, V37, P599	43	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168836	10.1371/journal.pone.0168836	http://dx.doi.org/10.1371/journal.pone.0168836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WO	28068353	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900013
J	Pancani, S; Tindale, W; Shaw, PJ; McDermott, CJ; Mazza, C				Pancani, Silvia; Tindale, Wendy; Shaw, Pamela J.; McDermott, Christopher J.; Mazza, Claudia			An Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CERVICAL-SPINE; ARM; COORDINATION; DIAGNOSIS; DISEASE; MOTION; PAIN	Background Neck muscle weakness and head drop are well recognised in patients with Amyotrophic lateral sclerosis (ALS), but an objective characterisation of the consequent head movement impairment is lacking. The aim of this study was to quantitatively characterise head movements in ALS compared to aged matched controls. Methods We evaluated two groups, one of thirteen patients with ALS and one of thirteen age-matched controls, during the execution of a series of controlled head movements, performed while wearing two inertial sensors attached on the forehead and sternum, respectively. We quantified the differences between the two groups from the sensor data using indices of velocity, smoothness and movement coupling (intended as a measure of undesired out of plane movements). Findings Results confirmed a general limitation in the ability of the ALS patients to perform and control head movements. High inter-patient variability was observed due to a wide range of observed functional impairment levels. The ability to extend the head backward and flex it laterally were the most compromised, with significantly lower angular velocity (P < 0.05, Cohen's d > 0.8), reduced smoothness and greater presence of coupled movements with respect to the controls. A significant reduction of angular velocity (P < 0.05, Cohen's d > 0.8) in extension, axial rotation and lateral flexion was observed when patients were asked to perform the movements as fast as possible. Interpretation This pilot study is the first study providing a functional objective quantification of head movements in ALS. Further work involving different body areas and correlation with existing methods of evaluating neuromuscular function, such as dynamometry and EMG, is needed to explore the use of this approach as a marker of disease progression in ALS.	[Pancani, Silvia; Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Pancani, Silvia; Tindale, Wendy; Mazza, Claudia] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Tindale, Wendy; McDermott, Christopher J.] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, NIHR Devices Dign Healthcare Technol Cooperat, Sheffield, S Yorkshire, England; [Tindale, Wendy] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Pancani, S (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.; Pancani, S (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.	spancani1@sheffield.ac.uk	McDermott, Christopher/AAU-4988-2020; pancani, silvia/B-1476-2018; McDermott, Chris/GQZ-3919-2022	McDermott, Christopher/0000-0002-1269-9053; Shaw, Pamela/0000-0002-8925-2567; Mazza, Claudia/0000-0002-5215-1746; pancani, silvia/0000-0003-1595-8492	INSIGNEO Institute for in silico Medicine; NIHR Devices for Dignity Healthcare Technology Co-operative; EPSRC Frontier Engineering Awards [EP/K03877X/1]; Engineering and Physical Sciences Research Council [EP/K03877X/1] Funding Source: researchfish; National Institute for Health Research [II-ES-0511-21003, NF-SI-0512-10082] Funding Source: researchfish; Motor Neurone Disease Association [McDermott/Feb15/928-794] Funding Source: researchfish; EPSRC [EP/K03877X/1] Funding Source: UKRI	INSIGNEO Institute for in silico Medicine; NIHR Devices for Dignity Healthcare Technology Co-operative; EPSRC Frontier Engineering Awards(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Motor Neurone Disease Association; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study has been supported by the INSIGNEO Institute for in silico Medicine and the NIHR Devices for Dignity Healthcare Technology Co-operative. Prof. Pamela J. Shaw is supported as an NIHR Senior Investigator. The sensors used in this study have been provided by the EPSRC Frontier Engineering Awards, Grant Reference No. EP/K03877X/1.; The study has been supported by the INSIGNEO Institute for in silico Medicine and the NIHR Devices for Dignity Healthcare Technology Co-operative. Prof. Pamela J. Shaw is supported as an NIHR Senior Investigator. The sensors used in this study have been provided by the EPSRC Frontier Engineering Awards, Grant Reference No. EP/K03877X/1. The data used in this study are available through Figshare.	Andres PL, 1996, J NEUROL SCI, V139, P64, DOI 10.1016/0022-510X(96)00108-6; Baxter S, 2016, AMYOTROPHIC LATERAL, V8421, P1; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Carpinella I, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-67; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; Dall'Alba PT, 2001, SPINE, V26, P2090, DOI 10.1097/00007632-200110010-00009; De Beyl DZ, 2009, MOVEMENT DISORD, V24, P2267, DOI 10.1002/mds.22830; Duc C, 2014, MED ENG PHYS, V36, P49, DOI 10.1016/j.medengphy.2013.09.002; Feipel V, 1999, CLIN BIOMECH, V14, P462, DOI 10.1016/S0268-0033(98)90098-5; Fleiss JL., 2003, STAT METHODS RATES P; Gourie-Devi M, 2003, J NEUROL NEUROSUR PS, V74, P683, DOI 10.1136/jnnp.74.5.683; Jordan K, 2003, STAT MED, V22, P2365, DOI 10.1002/sim.1407; Kent-Braun JA, 1998, MUSCLE NERVE, V21, P762, DOI 10.1002/(SICI)1097-4598(199806)21:6<762::AID-MUS8>3.0.CO;2-5; Malmstrom EM, 2006, SPINE, V31, pE44, DOI 10.1097/01.brs.0000194841.83419.0b; McDermott CJ, 2008, BMJ-BRIT MED J, V336, P658, DOI 10.1136/bmj.39493.511759.BE; Nakamura R., 2013, J NEUROL NEUROSUR PS, P1; Oskarsson B, 2016, MUSCLE NERVE, V53, P234, DOI 10.1002/mus.24703; Pancani S, 2016, CLIN BIOMECH, V32, P201, DOI 10.1016/j.clinbiomech.2015.11.010; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; Tsang SMH, 2013, CLIN BIOMECH, V28, P610, DOI 10.1016/j.clinbiomech.2013.05.009; Tucker WS, 2016, CLIN J SPORT MED, V26, P53, DOI 10.1097/JSM.0000000000000159; Vikne H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-314; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Yan JH, 2000, J MOTOR BEHAV, V32, P121, DOI 10.1080/00222890009601365	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169019	10.1371/journal.pone.0169019	http://dx.doi.org/10.1371/journal.pone.0169019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068376	Green Accepted, gold, Green Published			2022-12-26	WOS:000391843900018
J	Pau, CT; Mosbruger, T; Saxena, R; Welt, CK				Pau, Cindy T.; Mosbruger, Tim; Saxena, Richa; Welt, Corrine K.			Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GONADOTROPIN-SECRETION; HORMONE SYNTHESIS; WOMEN; VARIANTS; BETA; DENND1A; LOCI	Genome-wide association studies and replication analyses have identified (n = 5) or replicated (n = 10) DNA variants associated with risk for polycystic ovary syndrome (PCOS) in European women. However, the causal gene and underlying mechanism for PCOS risk at these loci have not been determined. We hypothesized that analysis of phenotype, gene expression and metformin response as a function of genotype would identify candidate genes and pathways that could provide insight into the underlying mechanism for risk at these loci. To test the hypothesis, subjects with PCOS (n = 427) diagnosed according to the NIH criteria (< 9 menses per year and clinical or biochemical hyperandrogenism) and controls (n = 407) with extensive phenotyping were studied. A subset of subjects (n = 38) underwent a subcutaneous adipose tissue biopsy for RNA sequencing and were subsequently treated with metformin for 12 weeks with standardized outcomes measured. Data were analyzed according to genotype at PCOS risk loci and adjusted for the false discovery rate. A gene variant in the THADA locus was associated with response to metformin and metformin was a predicted upstream regulator at the same locus. Genotype at the FSHB locus was associated with LH levels. Genes near the PCOS risk loci demonstrated differences in expression as a function of genotype in adipose including BLK and NEIL2 (GATA4 locus), GLIPR1 and PHLDA1 (KRR1 locus). Based on the phenotypes, expression quantitative trait loci (eQTL), and upstream regulatory and pathway analyses we hypothesize that there are PCOS subtypes. FSHB, FHSR and LHR loci may influence PCOS risk based on their relationship to gonadotropin levels. The THADA, GATA4, ERBB4, SUMO1P1, KRR1 and RAB5B loci appear to confer risk through metabolic mechanisms. The IRF1, SUMO1P1 and KRR1 loci may confer PCOS risk in development. The TOX3 and GATA4 loci appear to be involved in inflammation and its consequences. The data suggest potential PCOS subtypes and point to the need for additional studies to replicate these findings and identify personalized diagnosis and treatment options for PCOS.	[Pau, Cindy T.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Mosbruger, Tim] Univ Utah, Huntsman Canc Inst Bioinformat, Salt Lake City, UT USA; [Saxena, Richa] Massachusetts Gen Hosp, Dept Anaesthesiol, Boston, MA 02114 USA; [Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet, Boston, MA 02114 USA; [Welt, Corrine K.] Univ Utah, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA	Harvard University; Massachusetts General Hospital; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah	Welt, CK (corresponding author), Univ Utah, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA.	cwelt@genetics.utah.edu	Saxena, Richa/AAG-7279-2020	Saxena, Richa/0000-0003-2233-1065	Eunice Kennedy Shriver National Institute Of Child Health & Human Development [R01HD065029]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [1 UL1 RR025758]; American Diabetes Association [1-10-CT-57]; Partners Healthcare Center for Personalized Genetics Project Grant	Eunice Kennedy Shriver National Institute Of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Diabetes Association(American Diabetes Association); Partners Healthcare Center for Personalized Genetics Project Grant	The project was supported by Award Number R01HD065029 (CKW) from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development, Award Number 1 UL1 RR025758, Harvard Clinical and Translational Science Center, from the National Center for Research Resources, award 1-10-CT-57 (CKW) from the American Diabetes Association and the Partners Healthcare Center for Personalized Genetics Project Grant (CKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2014, J NEUROENDOCRINOL, V26, P785, DOI 10.1111/jne.12178; Martinez-Garcia MA, 2013, J CLIN ENDOCR METAB, V98, pE388, DOI 10.1210/jc.2012-3414; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhatt S, 2014, J CLIN ENDOCR METAB, V99, pE567, DOI 10.1210/jc.2013-2342; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Carmina E, 2008, FERTIL STERIL, V89, P642, DOI 10.1016/j.fertnstert.2007.03.085; Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9464; EHRMANN DA, 1995, ENDOCR REV, V16, P322, DOI 10.1210/er.16.3.322; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hayes MG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8502; Jones MR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005455; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luftner D, 2003, BREAST CANCER RES TR, V80, P245, DOI 10.1023/A:1024911625339; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Meun CK, 2015, 65 ANN M AM SOC HUM; Pau CT, 2014, J CLIN ENDOCR METAB, V99, P1870, DOI 10.1210/jc.2013-4021; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Ruth KS, 2015, EUR J HUM GENET; Saxena R, 2015, HUM REPROD, V30, P1697, DOI 10.1093/humrep/dev110; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4361, DOI 10.1210/jc.2006-1191; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4842, DOI 10.1210/jc.2006-1327; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478	39	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168870	10.1371/journal.pone.0168870	http://dx.doi.org/10.1371/journal.pone.0168870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068351	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900015
J	Przewodowski, W; Przewodowska, A				Przewodowski, Wlodzimierz; Przewodowska, Agnieszka			Development of a Sensitive and Specific Polyclonal Antibody for Serological Detection of Clavibacter michiganensis subsp sepedonicus	PLOS ONE			English	Article							BACTERIAL RING ROT; POLYMERASE-CHAIN-REACTION; CORYNEBACTERIUM-SEPEDONICUM; POTATO-TUBERS; NONMUCOID STRAINS; IDENTIFICATION; PCR; ANTISERA; ELISA; ASSAY	The quarantine bacterium Clavibacter michiganensis subsp. sepedonicus (Cms) causes bacterial ring rot (BRR) in potato but is difficult to detect, hampering the diagnosis of this disease. ELISA immunoassays have not been widely used to detect Cms because commercially available anti-Cms antibodies detect mainly EPS-producing bacteria and can fail to detect strains that do not produce EPS. In the current study, we developed a new type of polyclonal antibody that specifically detects Clavibacter michiganensis subsp. sepedonicus bacteria irrespective of their EPS level. We first found that the presence of bacterial EPS precluded quantitative measurement of bacteria by currently available immunoenzymatic methods, but that washing Cms cells with acidic and basic buffers to remove EPS before analysis successfully standardized ELISA results. We used a mix of three strains of Cms with diverse EPS levels to generate antigen for production of antibodies recognizing Cms cells with and without an EPS layer (IgG-EPS and IgG-N-EPS, respectively). The resulting IgG-N-EPS recognized almost all Cms strains tested in this work regardless of their mucoidal level. The availability of this new antibody renders immunological diagnostics of Cms more sensitive and reliable, as our newly developed antibodies can be used in many type of immunoassays. This work represents an important step forward in efforts to diagnose and prevent the spread of BRR, and the methods and solutions developed in this work are covered by six Polish, one European and one US patents.	[Przewodowski, Wlodzimierz; Przewodowska, Agnieszka] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Potato Protect & Seed Sci Bonin, Gdansk, Poland	Institute of Plant Breeding & Acclimatization	Przewodowski, W (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Potato Protect & Seed Sci Bonin, Gdansk, Poland.	w.przewodowski@ihar.edu.pl		Przewodowski, Wlodzimierz/0000-0002-4456-4727; Przewodowska, Agnieszka/0000-0002-4645-3772	National Centre for Research and Development, Poland [LIDER 28/199/L-3/11/NCBR/2012]	National Centre for Research and Development, Poland	This work was supported by the National Centre for Research and Development, Poland Project: LIDER 28/199/L-3/11/NCBR/2012 (Title: A new high sensitivity diagnostic tool for detection, identification and quarantine of the bacteria Clavibacter michiganensis ssp. sepedonicus). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arahal DR, 2004, SYST APPL MICROBIOL, V27, P581, DOI 10.1078/0723202041748208; BAER D, 1993, PHYTOPATHOLOGY, V83, P157, DOI 10.1094/Phyto-83-157; Ball E, 1993, SEROLOGICAL METHODS, P42; BISHOP AL, 1988, AM POTATO J, V65, P237, DOI 10.1007/BF02854049; CROWLEY CF, 1982, AM POTATO J, V59, P1, DOI 10.1007/BF02854878; Danks C., 2000, Bulletin OEPP, V30, P421, DOI 10.1111/j.1365-2338.2000.tb00922.x; De Boer S. H., 2005, Revista Mexicana de Fitopatologia, V23, P329; DEBOER SH, 1980, AM POTATO J, V57, P457, DOI 10.1007/BF02854462; DEBOER SH, 1984, PHYTOPATHOLOGY, V74, P1431, DOI 10.1094/Phyto-74-1431; DEBOER SH, 1983, AM POTATO J, V60, P661, DOI 10.1007/BF02852837; DEBOER SH, 1988, PLANT DIS, V72, P874, DOI 10.1094/PD-72-0874; DEBOER SH, 1982, PHYTOPATHOLOGY, V72, P1474, DOI 10.1094/Phyto-77-1474; DEBOER SH, 1994, PLANT DIS, V78, P725, DOI 10.1094/PD-78-0725; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; DRENNAN JL, 1993, PLANT DIS, V77, P1243, DOI 10.1094/PD-77-1243; Dykstra TP, 1942, AM POTATO J, V19, P175; Dykstra TP, 1941, AM POTATO J, V18, P27; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; Elphinstone JG, 2004, BIRDS ART ORNITHOLOG, P24; Erwin DC, 1990, COMPENDIUM ALFALFA D, P5; FIRRAO G, 1994, CAN J MICROBIOL, V40, P148, DOI 10.1139/m94-024; GUDMESTAD NC, 1988, CAN J MICROBIOL, V34, P716, DOI 10.1139/m88-122; Gudmestad NC, 2009, PLANT DIS, V93, P649, DOI 10.1094/PDIS-93-6-0649; HENNINGSON PJ, 1993, CAN J MICROBIOL, V39, P291, DOI 10.1139/m93-041; Hu X, 1995, PHYTOPATHOLOGY, V85, P1468, DOI 10.1094/Phyto-85-1468; Jahr H, 1999, ENVIRON MICROBIOL, V1, P113, DOI 10.1046/j.1462-2920.1999.00011.x; Kawchuk LM, 1998, AM J POTATO RES, V75, P235, DOI 10.1007/BF02853602; Kokoskova A B, 1998, PLANT PROTECT SCI, V32, P121; Kokoskova AB, 2000, PLANT PROTECT SCI, V36, P81; Lee IM, 1997, APPL ENVIRON MICROB, V63, P2625, DOI 10.1128/AEM.63.7.2625-2630.1997; MILLER HJ, 1984, NETH J PLANT PATHOL, V90, P23, DOI 10.1007/BF02014179; Mills D, 2003, AM J POTATO RES, V80, P223, DOI 10.1007/BF02855358; Nadar EB, 2009, CURRENT RES TOPICS A, P545; NAPPO Diagnostic Protocol, 2003, RSPM, V3, P1; Palacio-Bielsa A, 2009, J PLANT PATHOL, V91, P249; Pankova Iveta, 2002, Plant Protection Science, V38, P117; Pastrik KH, 1999, J PHYTOPATHOL, V147, P687, DOI 10.1046/j.1439-0434.1999.00442.x; Pastrik KH, 2000, EUR J PLANT PATHOL, V106, P155, DOI 10.1023/A:1008736017029; Przewodowski W, 2014, US. Patent No, Patent No. [US 8,642,275 B2, 8642275]; Przewodowski W, 2011, Polish Patent No, Patent No. [P 210394, 210394]; RADEMAKER JLW, 1997, MOL MICROBIAL ECOL S, V3, P1; Rivas R, 2002, EUR J PLANT PATHOL, V108, P179, DOI 10.1023/A:1015044911913; Schaad NW, 1999, PLANT DIS, V83, P1095, DOI 10.1094/PDIS.1999.83.12.1095; SLACK SA, 1979, AM POTATO J, V56, P441, DOI 10.1007/BF02854063; Smith DS, 2008, PLANT DIS, V92, P684, DOI 10.1094/PDIS-92-5-0684; Stead DE, 1998, PLANT CELL TISS ORG, V52, P17, DOI 10.1023/A:1005991706343; van Beckhoven JRCM, 2002, J APPL MICROBIOL, V93, P840, DOI 10.1046/j.1365-2672.2002.01765.x; Van Beuningen AR, 1995, ZUCHTUNGSCHUNG BERIC, P266; Waleron M, 2010, POSTEP MIKROBIOL, V49, P269; WESTRA AAG, 1992, PHYTOPATHOLOGY, V82, P1193, DOI 10.1094/Phyto-82-1193	50	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169785	10.1371/journal.pone.0169785	http://dx.doi.org/10.1371/journal.pone.0169785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068400	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900069
J	Nguyen, HT; Kugler, JM; Cohen, SM				Hung Thanh Nguyen; Kugler, Jan-Michael; Cohen, Stephen M.			DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins	PLOS ONE			English	Article							TANDEM REPETITIVE SEQUENCE; DEUBIQUITINATING ENZYME; YAP; ACTIVATION; ANGIOMOTIN; PHOSPHORYLATION; INHIBITION; CONVERGE; CELLS; KRAS	The YAP and TAZ transcriptional coactivators promote oncogenic transformation. Elevated YAP/TAZ activity has been documented in human tumors. YAP and TAZ are negatively regulated by the Hippo tumor suppressor pathway. The activity and stability of several Hippo pathway components, including YAP/TAZ, is regulated by ubiquitin mediated protein turnover and several ubiquitin ligase complexes have been implicated in human cancer. However, little is known about the deubiquitylating enzymes that counteract these ubiquitin ligases in regulation of the Hippo pathway. Here we identify the DUB3 family deubiquitylating enzymes as regulators of Hippo pathway activity. We provide evidence that DUB3 proteins regulate YAP/TAZ activity by controlling the stability of the E3 ligase ITCH, the LATS kinases and the AMOT family proteins. As a novel Hippo pathway regulator, DUB3 has the potential to act a tumor suppressor by limiting YAP activity.	[Hung Thanh Nguyen; Kugler, Jan-Michael; Cohen, Stephen M.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen	Cohen, SM (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	scohen@sund.ku.dk	Cohen, Stephen/G-9930-2011; Nguyen, Thanh Hung/M-8118-2014	Cohen, Stephen/0000-0003-2858-9163; Nguyen, Thanh Hung/0000-0001-8378-555X	Novo Nordisk Foundation [NNF120C0000552]; Neye foundation; Novo Nordisk Fonden [NNF12OC0000552] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Neye foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation (NNF120C0000552) and the Neye foundation to SMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JJ, 2013, J BIOL CHEM, V288, P15181, DOI 10.1074/jbc.M112.446534; Allemandou F, 2003, J BIOMED BIOTECHNOL, P202; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Nguyen HT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.1; Nguyen HT, 2014, CELL REP, V8, P707, DOI 10.1016/j.celrep.2014.06.062; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lignitto L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2791; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Okada T, 2002, HUM GENET, V110, P302, DOI 10.1007/s00439-002-0698-2; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Saitoh Y, 2000, GENOMICS, V67, P291, DOI 10.1006/geno.2000.6261; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	38	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169587	10.1371/journal.pone.0169587	http://dx.doi.org/10.1371/journal.pone.0169587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28061504	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500113
J	Jabbari, K; Bernardi, G				Jabbari, Kamel; Bernardi, Giorgio			An Isochore Framework Underlies Chromatin Architecture	PLOS ONE			English	Article							TOPOLOGICALLY ASSOCIATING DOMAINS; HUMAN GENOME; NUCLEAR-ORGANIZATION; MAMMALIAN GENOMES; EVOLUTION; CHROMOSOMES; PRINCIPLES; LANDSCAPE; REGIONS; CELLS	A recent investigation showed the existence of correlations between the architectural features of mammalian interphase chromosomes and the compositional properties of isochores. This result prompted us to compare maps of the Topologically Associating Domains (TADs) and of the Lamina Associated Domains (LADs) with the corresponding isochore maps of mouse and human chromosomes. This approach revealed that: 1) TADs and LADs correspond to isochores, i.e., isochores are the genomic units that underlie chromatin domains; 2) the conservation of TADs and LADs in mammalian genomes is explained by the evolutionary conservation of isochores; 3) chromatin domains corresponding to GC-poor isochores (e. g., LADs) show not only self-interactions but also intrachromosomal interactions with other domains also corresponding to GC-poor isochores even if located far away; in contrast, chromatin domains corresponding to GC-rich isochores (e.g., TADs) show more localized chromosomal interactions, many of which are inter-chromosomal. In conclusion, this investigation establishes a link between DNA sequences and chromatin architecture, explains the evolutionary conservation of TADs and LADs and provides new information on the spatial distribution of GC-poor/genepoor and GC-rich/gene-rich chromosomal regions in the interphase nucleus.	[Jabbari, Kamel] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, Cologne, Germany; [Bernardi, Giorgio] Roma Tre Univ, Dept Sci, Viale Marconi, Rome, Italy; [Bernardi, Giorgio] Stn Zool Anton Dohrn, Naples, Italy	Max Planck Society; Italfarmaco; Roma Tre University; Stazione Zoologica Anton Dohrn di Napoli	Jabbari, K (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, Cologne, Germany.; Bernardi, G (corresponding author), Roma Tre Univ, Dept Sci, Viale Marconi, Rome, Italy.; Bernardi, G (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	kiabbari@age.mpg.de; gbernardi@uniroma3.it	Bernardi, Giorgio/X-8630-2019					BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; Bernardi G., 2004, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Bernardi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143739; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Flicek P., 2014, NUCLEIC ACIDS RES, V42, P749, DOI [10.1093/nar/gkt1196, DOI 10.1093/NAR/GKT1196]; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gonzalez-Sandoval A, 2016, TRENDS GENET; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Paces J, 2004, GENE, V333, P135, DOI 10.1016/j.gene.2004.02.041; Pavlicek A, 2002, FEBS LETT, V511, P175, DOI 10.1016/S0014-5793(01)03282-3; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Pueschel R, 2016, DEVELOPMENT, V143, P910, DOI 10.1242/dev.129007; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rowley MJ, 2016, CURR OPIN CELL BIOL, V40, P8, DOI 10.1016/j.ceb.2016.01.009; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sati S, CHROMOSOME CONFORMAT; Solovei I, 2016, CURR OPIN CELL BIOL, V40, P47, DOI 10.1016/j.ceb.2016.02.014; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115	36	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168023	10.1371/journal.pone.0168023	http://dx.doi.org/10.1371/journal.pone.0168023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060840	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500020
J	Laget, S; Broncy, L; Hormigos, K; Dhingra, DM; BenMohamed, F; Capiod, T; Osteras, M; Farinelli, L; Jackson, S; Paterlini-Brechot, P				Laget, Sophie; Broncy, Lucile; Hormigos, Katia; Dhingra, Dalia M.; BenMohamed, Fatima; Capiod, Thierry; Osteras, Magne; Farinelli, Laurent; Jackson, Stephen; Paterlini-Brechot, Patrizia			Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion	PLOS ONE			English	Article							PERIPHERAL-BLOOD; BREAST-CANCER; COLLECTION DEVICE; EPITHELIAL-CELLS; PROSTATE-CANCER; CARCINOMA CELLS; MOUSE MODEL; SIZE; METASTASIS; ENRICHMENT	Circulating Tumor Cells (CTC) and Circulating Tumor Microemboli (CTM) are Circulating Rare Cells (CRC) which herald tumor invasion and are expected to provide an opportunity to improve the management of cancer patients. An unsolved technical issue in the CTC field is how to obtain highly sensitive and unbiased collection of these fragile and heterogeneous cells, in both live and fixed form, for their molecular study when they are extremely rare, particularly at the beginning of the invasion process. We report on a new protocol to enrich from blood live CTC using ISET (R) (Isolation by SizE of Tumor/Trophoblastic Cells), an open system originally developed for marker-independent isolation of fixed tumor cells. We have assessed the impact of our new enrichment method on live tumor cells antigen expression, cytoskeleton structure, cell viability and ability to expand in culture. We have also explored the ISET (R) in vitro performance to collect intact fixed and live cancer cells by using spiking analyses with extremely low number of fluorescent cultured cells. We describe results consistently showing the feasibility of isolating fixed and live tumor cells with a Lower Limit of Detection (LLOD) of one cancer cell per 10 mL of blood and a sensitivity at LLOD ranging from 83 to 100%. This very high sensitivity threshold can be maintained when plasma is collected before tumor cells isolation. Finally, we have performed a comparative next generation sequencing (NGS) analysis of tumor cells before and after isolation from blood and culture. We established the feasibility of NGS analysis of single live and fixed tumor cells enriched from blood by our system. This study provides new protocols for detection and characterization of CTC collected from blood at the very early steps of tumor invasion.	[Laget, Sophie; Broncy, Lucile; Hormigos, Katia] Rarecells Diagnost, Paris, France; [Broncy, Lucile; BenMohamed, Fatima; Capiod, Thierry; Paterlini-Brechot, Patrizia] Fac Med Paris Descartes, Unite INSERM Eq 13 U1151, Paris, France; [Dhingra, Dalia M.; Jackson, Stephen] Thermo Fisher Sci, San Francisco, CA USA; [Osteras, Magne; Farinelli, Laurent] Fastens SA, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Thermo Fisher Scientific	Paterlini-Brechot, P (corresponding author), Fac Med Paris Descartes, Unite INSERM Eq 13 U1151, Paris, France.	patriziapaterlini@gmail.com	CAPIOD, Thierry/K-4234-2017	CAPIOD, Thierry/0000-0002-8448-7041; Paterlini- Brechot, Patrizia/0000-0001-7981-6325	Fondation Bettencourt-Schueller; Fondation Lefort-Beaumont de l'Institut de France; INSERM; Universite Paris Descartes; Rarecells Diagnostics; INSERM (Institut National de Sante et Recherche Medicale); University Paris Descartes; Thermo Fisher Scientific; Fasteris SA	Fondation Bettencourt-Schueller; Fondation Lefort-Beaumont de l'Institut de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Rarecells Diagnostics; INSERM (Institut National de Sante et Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; Thermo Fisher Scientific; Fasteris SA	This work was supported by Fondation Bettencourt-Schueller, Fondation Lefort-Beaumont de l'Institut de France, INSERM, Universite Paris Descartes and Rarecells Diagnostics. Rarecells Diagnostics, Thermo Fisher Scientific and Fasteris SA provided support in the form of salaries for authors SL, LB, KH, DMD, SJ, MO and LF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors greatly acknowledge INSERM (Institut National de Sante et Recherche Medicale), University Paris Descartes and Fondation Lefort-Beaumont de l'Institut de France for their support and the INEM (Institut Necker Enfants Malades) Imaging Facility. We thank Emilie Dugon, Astrid Girard, Karine Prevost, Davide Brechot and Igor Stzepourginski for their assistance. We thank Gabriela Petkova Campbell for help in reviewing the text.	Abdallah EA, 2016, INT J CANC; Abdallah EA, 2015, INT J CANCER, V137, P1397, DOI 10.1002/ijc.29495; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Alix-Panabieres C, 2005, CLIN CHEM, V51, P1538, DOI 10.1373/clinchem.2005.049445; Alix-Panabieres C, 2005, J IMMUNOL METHODS, V299, P177, DOI 10.1016/j.jim.2005.02.007; Alix-Panabieres C, 2014, LAB CHIP, V14, P57, DOI 10.1039/c3lc50644d; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Balasubramanian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042048; Balic M, 2005, CYTOM PART B-CLIN CY, V68B, P25, DOI 10.1002/cyto.b.20065; Bobek V, 2014, ANTICANCER RES, V34, P2565; Buim MEC, 2015, CANCER BIOL THER, V16, P1289, DOI 10.1080/15384047.2015.1070991; BUTLER TP, 1975, CANCER RES, V35, P512; Calzado-Martin A, 2016, ACS NANO, V10, P3365, DOI 10.1021/acsnano.5b07162; Cayrefourcq L, 2015, CANCER RES, V75, P892, DOI 10.1158/0008-5472.CAN-14-2613; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Conti M, 2016, BIOMED SPECTROSC IMA, V5, P175, DOI 10.3233/BSI-160133; Coumans FA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Cummings J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-226; Dago AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101777; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; De Luca F., 2016, ONCOTARGET, DOI 10.18632/oncotarget.8431.; Desitter I, 2011, ANTICANCER RES, V31, P427; Dickson MN, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3623748; Chinen LTD, 2014, ONCOTARGETS THER, V7, P1609, DOI 10.2147/OTT.S62349; Chinen LTD, 2013, J THORAC DIS, V5, P593, DOI 10.3978/j.issn.2072-1439.2013.09.18; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; El-Heliebi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-214; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Ferreira MM, 2016, MOL ONCOL, V10, P374, DOI 10.1016/j.molonc.2016.01.007; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gogoi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147400; Gupta V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4731647; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Harouaka RA, 2013, JALA-J LAB AUTOM, V18, P455, DOI 10.1177/2211068213494391; Hillig T, 2014, APMIS, V122, P545, DOI 10.1111/apm.12183; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Hofman V, 2014, CURR MOL MED, V14, P440, DOI 10.2174/1566524014666140414205455; Hofman V, 2011, INT J CANCER, P2011; Hofman V, 2011, CYTOPATHOLOGY; Hofman V, 2013, J INVEST DERMATOL, V133, P1378, DOI 10.1038/jid.2012.485; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669; Hvichia GE, 2016, INT J CANCER, V138, P2894, DOI 10.1002/ijc.30007; Ignatiadis M, 2015, CLIN CANCER RES, V21, P4786, DOI 10.1158/1078-0432.CCR-14-1190; Ilie M, 2012, ANN ONCOL, V23, P2907, DOI 10.1093/annonc/mds137; Ilie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111597; Jeganathan N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0543-1; Jemaa M, 2013, CELL CYCLE, V12, P183, DOI 10.4161/cc.23046; Kallergi G, 2016, CELL PHYSIOL BIOCHEM, V40, P411, DOI 10.1159/000452556; Kamande JW, 2013, ANAL CHEM, V85, P9092, DOI 10.1021/ac401720k; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; Khoja L, 2012, BRIT J CANCER, V106, P508, DOI 10.1038/bjc.2011.545; Khoja L, 2014, MELANOMA RES, V24, P40, DOI 10.1097/CMR.0000000000000025; Kim EH, 2013, ANAL BIOCHEM, V440, P114, DOI 10.1016/j.ab.2013.05.016; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Klinger B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.29; Kojima T, 2009, J CLIN INVEST, V119, P3172, DOI 10.1172/JCI38609; Kolostova K, 2014, J FLUORESC, V24, P1531, DOI 10.1007/s10895-014-1439-3; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Kruger S, 2006, LEUKEMIA, V20, P354, DOI 10.1038/sj.leu.2404038; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; LEE TK, 1992, ANAL QUANT CYTOL, V14, P32; Lelievre L, 2004, INT J GYNECOL CANCER, V14, P229, DOI 10.1111/j.1048-891X.2004.014205.x; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Lim E, 2012, J THORAC ONCOL, V7, pE42, DOI 10.1097/JTO.0b013e3182748d5b; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; LIOTTA LA, 1974, CANCER RES, V34, P997; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Long E, 2016, CANC MED; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malara N, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0652-x; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; Mazzini C, 2014, CANCERS, V6, P323, DOI 10.3390/cancers6010323; Morris KL, 2014, CANCER CHEMOTH PHARM, V74, P323, DOI 10.1007/s00280-014-2508-7; Morrow CJ, 2016, ANN ONCOL; Mouawia H, 2012, REPROD BIOMED ONLINE, V25, P508, DOI 10.1016/j.rbmo.2012.08.002; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naume B, 2004, CYTOTHERAPY, V6, P244, DOI 10.1080/14653240410006086; Naume B, 1997, J HEMATOTHER, V6, P103, DOI 10.1089/scd.1.1997.6.103; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neumann MH, 2016, BIOTECHNOL PROG; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Ntouroupi TG, 2008, BRIT J CANCER, V99, P789, DOI 10.1038/sj.bjc.6604545; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pachmann K, 2001, CLIN CHEM LAB MED, V39, P811, DOI 10.1515/CCLM.2001.134; Pailler E, 2015, ANN ONCOL, V26, P1408, DOI 10.1093/annonc/mdv165; Pailler E, 2013, J CLIN ONCOL, V31, P2273, DOI 10.1200/JCO.2012.44.5932; Paiva B, 2013, BLOOD, V122, P3591, DOI 10.1182/blood-2013-06-510453; Pantel K, 2016, MOL ONCOL, V10, P371, DOI 10.1016/j.molonc.2016.01.009; Pantel K, 2016, CLIN CHEM, V62, P328, DOI 10.1373/clinchem.2015.242537; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Paris PL, 2009, CANCER LETT, V277, P164, DOI 10.1016/j.canlet.2008.12.007; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Paterlini-Brechot P, 2014, CANCER MICROENVIRON, V7, P161, DOI 10.1007/s12307-014-0164-4; Payne RE, 2012, BRIT J CANCER, V106, P1790, DOI 10.1038/bjc.2012.137; Pinzani P, 2006, HUM PATHOL, V37, P711, DOI 10.1016/j.humpath.2006.01.026; Pinzani P, 2010, MELANOMA RES, V20, P303, DOI 10.1097/CMR.0b013e32833906e3; Pluim D, 2012, CYTOM PART A, V81A, P664, DOI 10.1002/cyto.a.22049; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Poruk KE, 2016, ANN SURG; Pretlow TG, 2000, CANCER RES, V60, P4033; Qin JB, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-23; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Raz RS, INVENTORMETHOD SEPAR; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Rostami P, 2019, J SCI-ADV MATER DEV, V4, P1, DOI 10.1016/j.jsamd.2019.01.006; RUDY JL, 1989, CLIN CHEM, V35, P509; Runge J, 2014, ORAL DIS, V20, pe120, DOI 10.1111/odi.12171; Salvianti F, 2016, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00076; Saucedo-Zeni N, 2012, INT J ONCOL, V41, P1241, DOI 10.3892/ijo.2012.1557; Schlutter JM, 2015, FETAL DIAGN THER; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Swennenhuis JF, 2015, LAB CHIP, V15, P3039, DOI 10.1039/c5lc00304k; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Vona G, 2004, HEPATOLOGY, V39, P792, DOI 10.1002/hep.20091; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wang ST, 2011, ANGEW CHEM INT EDIT, V50, P3084, DOI 10.1002/anie.201005853; Wang XJ, 2016, EUR J PHARMACOL, V789, P265, DOI 10.1016/j.ejphar.2016.07.044; Warkiani ME, 2014, LAB CHIP, V14, P128, DOI 10.1039/c3lc50617g; Watanabe N, 2002, AM J PHYSIOL-LUNG C, V283, pL726, DOI 10.1152/ajplung.00025.2002; Winer-Jones JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086717; Wu SY, 2014, CLIN CHEM LAB MED, V52, P243, DOI 10.1515/cclm-2013-0558; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138032; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74; Zhang Y, 2015, ANAL CHEM, V87, P9761, DOI 10.1021/acs.analchem.5b01901; Zheng S, 2007, J CHROMATOGR A, V1162, P154, DOI 10.1016/j.chroma.2007.05.064; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Zieglschmid V, 2005, ANTICANCER RES, V25, P1803	155	39	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169427	10.1371/journal.pone.0169427	http://dx.doi.org/10.1371/journal.pone.0169427			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060956	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500091
J	Lin, CS; Shih, CC; Yeh, CC; Hu, CJ; Chung, CL; Chen, TL; Liao, CC				Lin, Chao-Shun; Shih, Chun-Chuan; Yeh, Chun-Chieh; Hu, Chaur-Jong; Chung, Chi-Li; Chen, Ta-Liang; Liao, Chien-Chang			Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIC-STROKE; MUSCLE WEAKNESS; GLOBAL BURDEN; UNITED-STATES; COPD; FIBRINOGEN; MORTALITY; COMORBIDITIES; EXERCISE	Background The risk and outcomes of stroke in patients with chronic obstructive pulmonary disease exacerbations (COPDe) remain unclear. We examined whether patients with COPDe faced increased risk of stroke or post-stroke outcomes. Methods Using Taiwan's National Health Insurance Research Database, we identified 1918 adults with COPDe and selected comparison cohorts of 3836 adults with COPD no exacerbations and 7672 adults without COPD who were frequency matched by age and sex in 2000-2008 (Study 1). Stroke event was identified during 2000-2013 follow-up period. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of stroke associated with COPDe were calculated. In a nested cohort study (Study 2) of 261686 new-diagnosed stroke patients in 2000-2009, we calculated adjusted odds ratios (ORs) and 95% CIs of adverse events after stroke in patients with COPDe. Results Patients with COPDe had increased stroke incidence, with an adjusted HR of 1.28 (95% CI, 1.03-1.59). In the Study 2, COPDe were associated with post-stroke mortality (OR, 1.34, 95% CI 1.20-1.52), epilepsy (OR, 1.43; 95% CI, (1.22-1.67), and pneumonia (OR, 1.50; 95% CI, 1.39-1.62). Previous intubation for COPD and inpatient admissions due to COPD were factors associated with post-stroke adverse events. Conclusion Patients who have had COPDe face increased risks of stroke and post-stroke adverse events.	[Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Dept Anesthesiol, Sch Med, Coll Med, Taipei, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Coll Med, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chung, Chi-Li] Taipei Med Univ Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; I Shou University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; Taipei Medical University; Shuang Ho Hospital	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Dept Anesthesiol, Sch Med, Coll Med, Taipei, Taiwan.; Liao, CC (corresponding author), China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Shuang Ho Hospital, Taipei Medical University [104TMU-SHH-23]; Taiwan's Ministry of Science and Technology [MOST105-2629-B-038-001, MOST105-2314-B-038-025, MOST105-2221-E-038-014, MOST104-2314-B-038-027-MY2, MOST104-2221-E-038-015, NSC102-2314-6-038-021-MY3]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Shuang Ho Hospital, Taipei Medical University; Taiwan's Ministry of Science and Technology; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This research was supported in part by Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Science and Technology (MOST105-2629-B-038-001; MOST105-2314-B-038-025; M OST105-2221-E-038-014; MOST104-2314-B-038-027-MY2; MOST104-2221-E-038-015; NSC102-2314-6-038-021-MY3), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazargani YT, 2014, THORAX, V69, P1149, DOI 10.1136/thoraxjnl-2014-205249; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Burge S, 2003, EUR RESPIR J, V41, p46s, DOI DOI 10.1183/09031936.03.00078002; Chang CS, 2014, SEIZURE-EUR J EPILEP, V23, P377, DOI 10.1016/j.seizure.2014.02.007; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; De Reuck J, 2007, EUR J NEUROL, V14, P989, DOI 10.1111/j.1468-1331.2007.01829.x; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; ERNST E, 1993, BRIT J SPORT MED, V27, P175, DOI 10.1136/bjsm.27.3.175; Fischer U, 2006, ACTA NEUROL SCAND, V113, P108, DOI 10.1111/j.1600-0404.2005.00551.x; Ford ES, 2015, CHEST, V147, P31, DOI 10.1378/chest.14-0972; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gershon A, 2013, JAMA INTERN MED, V173, P1175, DOI 10.1001/jamainternmed.2013.1016; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Kesarwani M, 2009, J HYPERTENS, V27, P1056, DOI 10.1097/HJH.0b013e32832935ce; Koenig W, 1997, CIRCULATION, V95, P335; Kofoed SC, 2003, EUR HEART J, V24, P569, DOI 10.1016/S0195-668X(02)00467-0; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Li ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26636; Liao CC, 2014, BRIT J SURG, V101, P1616, DOI 10.1002/bjs.9639; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130102; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oliveira AJ, 2000, CLIN NEUROPHYSIOL, V111, pS141, DOI 10.1016/S1388-2457(00)00415-6; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Portegies MLP, 2016, AM J RESP CRIT CARE, V193, P251, DOI 10.1164/rccm.201505-0962OC; RAURAMAA R, 1986, CIRCULATION, V74, P939, DOI 10.1161/01.CIR.74.5.939; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Ryan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075887; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2006, THORAX, V61, P1, DOI 10.1136/thx.2005.044941; Singh S, 2013, THORAX, V68, P114, DOI 10.1136/thoraxjnl-2011-201275; Soderholm M, 2016, EUR J EPIDEMIOL, V31, P159, DOI 10.1007/s10654-015-0113-7; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang MT, 2012, INT J CARDIOL, V158, P279, DOI 10.1016/j.ijcard.2012.02.012; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wheaton AG, 2015, J AGING HEALTH, V27, P480, DOI 10.1177/0898264314552419; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801	48	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169429	10.1371/journal.pone.0169429	http://dx.doi.org/10.1371/journal.pone.0169429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060955	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500092
J	Pecori, B; Lastoria, S; Caraco, C; Celentani, M; Tatangelo, F; Avallone, A; Rega, D; De Palma, G; Mormile, M; Budillon, A; Mutol, P; Bianco, F; Aloj, L; Petrille, A; Delrio, P				Pecori, Biagio; Lastoria, Secondo; Caraco, Corradina; Celentani, Marco; Tatangelo, Fabiana; Avallone, Antonio; Rega, Daniela; De Palma, Giampaolo; Mormile, Maria; Budillon, Alfredo; Mutol, Paolo; Bianco, Francesco; Aloj, Luigi; Petrille, Antonella; Delrio, Paolo			Sequential PET/CT with [F-18]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression Analysis	PLOS ONE			English	Article							FDG-PET; CHEMORADIOTHERAPY; RADIOCHEMOTHERAPY; MANAGEMENT; THERAPY; CT	Previous studies indicate that FDG PET/CT may predict pathological response in patients undergoing neoadjuvant chemo-radiotherapy for locally advanced rectal cancer (LARC). Aim of the current study is evaluate if pathological response can be similarly predicted in LARC patients after short course radiation therapy alone. Methods: Thirty-three patients with cT2-3, N0-2, M0 rectal adenocarcinoma treated with hypo fractionated short course neoadjuvant RT (5x5 Gy) with delayed surgery (SCRTDS) were prospectively studied. All patients underwent 3 PET/CT studies at baseline, 10 days from RT end (early), and 53 days from RT end (delayed). Maximal standardized uptake value (SUVmax), mean standardized uptake value (SUVmean) and total lesion glycolysis (TLG) of the primary tumor were measured and recorded at each PET/CT study. We use logistic regression analysis to aggregate different measures of metabolic response to predict the pathological response in the course of SCRTDS. Results: We provide straightforward formulas to classify response and estimate the probability of being a major responder (TRG1-2) or a complete responder (TRG1) for each individual. The formulas are based on the level of TLG at the early PET and on the overall proportional reduction of TLG between baseline and delayed PET studies. Conclusions: This study demonstrates that in the course of SCRTDS it is possible to estimate the probabilities of pathological tumor responses on the basis of PET/CT with FDG. Our formulas make it possible to assess the risks associated to LARC borne by a patient in the course of SCRTDS. These risk assessments can be balanced against other health risks associated with further treatments and can therefore be used to make informed therapy adjustments during SCRTDS.	[Pecori, Biagio; De Palma, Giampaolo; Mutol, Paolo] Ist Nazl Tumori Fdn G Pascale IRCCS, Radiat Oncol Unit, Naples, Italy; [Lastoria, Secondo; Celentani, Marco; Aloj, Luigi] Ist Nazl Tumori Fdn G Pascale IRCCS, Nucl Med Unit, Naples, Italy; [Celentani, Marco] Univ Carlos III Madrid, Dept Econ, Madrid, Spain; [Tatangelo, Fabiana] Ist Nazl Tumori Fdn G Pascale IRCCS, Pathol Unit, Naples, Italy; [Avallone, Antonio] Ist Nazl Tumori Fdn G Pascale IRCCS, Gastrointestinal Med Oncol Unit, Naples, Italy; [Rega, Daniela; Bianco, Francesco; Delrio, Paolo] Ist Nazl Tumori Fdn G Pascale IRCCS, Gastrointestinal Surg Unit, Naples, Italy; [Mormile, Maria] Ist Nazl Tumori Fdn G Pascale IRCCS, Med Phys Unit, Naples, Italy; [Budillon, Alfredo] Ist Nazl Tumori Fdn G Pascale IRCCS, Expt Pharmacol Unit, Naples, Italy; [Petrille, Antonella] Ist Nazl Tumori Fdn G Pascale IRCCS, Diagnost Radiol Unit, Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; Universidad Carlos III de Madrid; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Pecori, B (corresponding author), Ist Nazl Tumori Fdn G Pascale IRCCS, Radiat Oncol Unit, Naples, Italy.	b.pecori@istitutotumori.na.it	Tatangelo, Fabiana/AAA-8413-2020; Rega, Daniela/K-4876-2018; Budillon, Alfredo/K-4763-2016; Aloj, Luigi/AAK-5104-2020; Lastoria, Secondo/J-9607-2018; Petrillo, Antonella/J-5450-2018; Avallone, Antonio/K-4662-2016	Tatangelo, Fabiana/0000-0002-9943-6079; Budillon, Alfredo/0000-0002-6330-6053; Lastoria, Secondo/0000-0002-6649-9903; Petrillo, Antonella/0000-0003-2465-5370; Rega, Daniela/0000-0001-8326-050X; Aloj, Luigi/0000-0002-7452-4961; CELENTANI, MARCO/0000-0003-1662-6887; bianco, francesco/0000-0003-4139-685X; Avallone, Antonio/0000-0001-6188-5664	Italian Ministry of Health [RF-2011-02346914]	Italian Ministry of Health(Ministry of Health, Italy)	This study was partially supported by a Research Grant to AB from the Italian Ministry of Health (RF-2011-02346914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avallone A, 2012, EUR J NUCL MED MOL I, V39, P1848, DOI 10.1007/s00259-012-2229-2; Beppu N, 2015, SURGERY, V158, P225, DOI 10.1016/j.surg.2015.03.014; Bujko K., 2014, PROGRES RECHERCHES C, V203, P171, DOI [10.1007/978-3-319-08060-4_12, DOI 10.1007/978-3-319-08060-4_12]; Bujko K, 2008, RADIOTHER ONCOL, V87, P311, DOI 10.1016/j.radonc.2007.12.020; Cascini GL, 2006, J NUCL MED, V47, P1241; Chen CC, 2005, DIS COLON RECTUM, V48, P722, DOI 10.1007/s10350-004-0851-1; Denecke T, 2005, EUR RADIOL, V15, P1658, DOI 10.1007/s00330-005-2658-4; Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396; Gunderson LL, 2004, J CLIN ONCOL, V22, P1785, DOI 10.1200/JCO.2004.08.173; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; International Commission on Radiation Units and Measurements, 1993, 50 INT COMM RAD UN M; International Commission on Radiation Units and Measurements, 1999, 62 INT COMM RAD US M; Janssen MHM, 2012, INT J RADIAT ONCOL, V82, P849, DOI 10.1016/j.ijrobp.2010.10.029; Janssen MHM, 2010, INT J RADIAT ONCOL, V77, P392, DOI 10.1016/j.ijrobp.2009.04.030; Janssen MHM, 2010, RADIOTHER ONCOL, V94, P151, DOI 10.1016/j.radonc.2009.12.033; Latkauskas T, 2012, COLORECTAL DIS, V14, P294, DOI 10.1111/j.1463-1318.2011.02815.x; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Marijnen CAM, 2001, J CLIN ONCOL, V19, P1976, DOI 10.1200/JCO.2001.19.7.1976; Pettersson D, 2015, BRIT J SURG, V102, P972, DOI 10.1002/bjs.9811; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025; Rajpal R, 2011, PROTEOMICS, V11, P1391, DOI 10.1002/pmic.201000471; Rupinski M, 2016, EJSO-EUR J SURG ONC, V42, P288, DOI 10.1016/j.ejso.2015.09.022; Siegel R, 2008, ONKOLOGIE, V31, P166, DOI 10.1159/000118037; Smith FM, 2010, BRIT J SURG, V97, P1752, DOI 10.1002/bjs.7251; Song SY, 2005, INT J RADIAT ONCOL, V63, P1053, DOI 10.1016/j.ijrobp.2005.03.033; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Swisher SG, 2004, ANN THORAC SURG, V78, P60; Valentini V, 2014, RADIOTHER ONCOL, V110, P195, DOI 10.1016/j.radonc.2013.10.024; van Stiphout RGPM, 2011, RADIOTHER ONCOL, V98, P126, DOI 10.1016/j.radonc.2010.12.002; Vanagunas A, 2004, AM J GASTROENTEROL, V99, P109, DOI 10.1046/j.1572-0241.2003.04019.x	31	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169462	10.1371/journal.pone.0169462	http://dx.doi.org/10.1371/journal.pone.0169462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060889	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500097
J	Prost, K; Birk, JJ; Lehndorff, E; Gerlach, R; Amelung, W				Prost, Katharina; Birk, Jago Jonathan; Lehndorff, Eva; Gerlach, Renate; Amelung, Wulf			Steroid Biomarkers Revisited - Improved Source Identification of Faecal Remains in Archaeological Soil Material	PLOS ONE			English	Article							GAS-LIQUID-CHROMATOGRAPHY; BILE-ACIDS; SURFACE-WATER; PLANT STEROLS; FATTY-ACIDS; CHOLESTEROL; POLLUTION; SEWAGE; COPROSTANOL; INDICATOR	Steroids are used as faecal markers in environmental and in archaeological studies, because they provide insights into ancient agricultural practices and the former presence of animals. Up to now, steroid analyses could only identify and distinguish between herbivore, pig, and human faecal matter and their residues in soils and sediments. We hypothesized that a finer differentiation between faeces of different livestock animals could be achieved when the analyses of several steroids is combined (Delta(5)-sterols, 5 alpha-stanols, 5 beta-stanols, epi-5 beta-stanols, stanones, and bile acids). We therefore reviewed the existing literature on various faecal steroids from livestock and humans and analysed faeces from old livestock breed (cattle, horse, donkey, sheep, goat, goose, and pig) and humans. Additionally, we performed steroid analyses on soil material of four different archaeological periods (sites located in the Lower Rhine Basin, Western Germany, dating to the Linearbandkeramik, Urn-field Period/Bronze Age, Iron Age, Roman Age) with known or supposed faecal inputs. By means of already established and newly applied steroid ratios of the analysed faeces together with results from the literature, all considered livestock faeces, except sheep and cattle, could be distinguished on the basis of their steroid signatures. Most remarkably was the identification of horse faeces (via the ratio: epi-5 beta-stigmastanol: 5 beta-stigmastanol + epicoprostanol: coprostanol; together with the presence of chenodeoxycholic acid) and a successful differentiation between goat (with chenodeoxycholic acid) and sheep/cattle faeces (without chenodeoxycholic acid). The steroid analysis of archaeological soil material confirmed the supposed faecal inputs, even if these inputs had occurred several thousand years ago.	[Prost, Katharina; Lehndorff, Eva; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Bonn, Germany; [Birk, Jago Jonathan] Johannes Gutenberg Univ Mainz, Inst Geog Soil Sci, Mainz, Germany; [Gerlach, Renate] LVR Amt Bodendenkmalpflege Rheinland, Archaeol Heritage Management Rhineland, Bonn, Germany	University of Bonn; Johannes Gutenberg University of Mainz	Prost, K (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Bonn, Germany.	kprost@uni-bonn.de	Prost, Katharina/AAC-4023-2020; Amelung, Wulf/H-2136-2013	Amelung, Wulf/0000-0002-4920-4667; Prost, Katharina/0000-0003-2225-6069	Stiftung zur Forderung der Archaologie im Rheinischen [PN 216]	Stiftung zur Forderung der Archaologie im Rheinischen	This study was funded by the Stiftung zur Forderung der Archaologie im Rheinischen. http://www.archaeolog-stiftung.de/de/wissenschaft/aktuelle_projekte/aktuelle_projekte1.html Grant number: PN 216 KP received a scholarship and money for material costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRO PW, 1992, LIPIDS, V27, P136, DOI 10.1007/BF02535813; [Anonymous], 1994, 10693 ISO; Atkinson CF, 1996, J IND MICROBIOL, V16, P182, DOI 10.1007/BF01570002; Batta AK, 2002, J CHROMATOGR B, V775, P153, DOI 10.1016/S1570-0232(02)00289-1; Bechert T., 2007, PROVINZ NORDGRENZE R; Behrman EJ, 2005, J CHEM EDUC, V82, P1791, DOI 10.1021/ed082p1791; Benecke N., 1994, MITTELEUROPA SUDSKAN; Bergstrom S, 1959, ACTA CHEM SCAND, P13; BETHELL PH, 1994, J ARCHAEOL SCI, V21, P619, DOI 10.1006/jasc.1994.1061; Birk JJ, 2012, J CHROMATOGR A, V1242, P1, DOI 10.1016/j.chroma.2012.04.027; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; BJORKHEM I, 1971, EUR J BIOCHEM, V21, P428, DOI 10.1111/j.1432-1033.1971.tb01488.x; Boessneck J, 1964, KUHN ARCH, V78, P1; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Bull ID, 2003, ARCHAEOMETRY, V45, P149, DOI 10.1111/1475-4754.00101; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; Bull ID, 2001, GEOARCHAEOLOGY, V16, P223, DOI 10.1002/1520-6548(200102)16:2<223::AID-GEA1002>3.0.CO;2-7; Bull ID, 1999, ANTIQUITY, V73, P86, DOI 10.1017/S0003598X0008786X; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; Derrien M, 2011, J AGR FOOD CHEM, V59, P7294, DOI 10.1021/jf201040v; Elhmmali MM, 1997, ENVIRON SCI TECHNOL, V31, P3663, DOI 10.1021/es9704040; ENEROTH P, 1964, J LIPID RES, V5, P245; FITZSIMONS MF, 1995, MAR POLLUT BULL, V30, P306, DOI 10.1016/0025-326X(94)00177-B; Frank T., 2014, AUTOBAHN 4 FUNDPLATZ, P119; Furtula V, 2012, WATER RES, V46, P1079, DOI 10.1016/j.watres.2011.12.002; GASKELL SJ, 1975, NATURE, V254, P209, DOI 10.1038/254209b0; Gerlach R, 2012, QUATERN INT, V265, P191, DOI 10.1016/j.quaint.2011.10.007; Gerlach R, 2011, ARCHAOLOGIE RHEINLAN, V2010, P65; Gerlach R, 2011, TAG LAND VORG HALL S, P27; Gill FL, 2010, ORG GEOCHEM, V41, P467, DOI 10.1016/j.orggeochem.2010.02.001; Gourmelon M, 2010, WATER RES, V44, P4812, DOI 10.1016/j.watres.2010.07.061; Grandmougin-Ferjani A, 1999, PHYTOCHEMISTRY, V50, P1027, DOI 10.1016/S0031-9422(98)00636-0; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; Hagey LR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-133; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; HASLEWOOD GA, 1967, J LIPID RES, V8, P535; Hjulstrom B, 2009, J ARCHAEOL SCI, V36, P174, DOI 10.1016/j.jas.2008.08.005; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; Husmann H., 2014, AUTOBAHN 4 FUNDPLATZ, P71; HWANG KT, 1993, J AM OIL CHEM SOC, V70, P789, DOI 10.1007/BF02542602; ISO, 1995, 10694 ISO; [ISO] International Organization for Standardization, 2005, 10390 ISO; Jurgens S., 2014, AUTOBAHN 4 FUNDPLATZ, P225; KNIGHTS BA, 1983, J ARCHAEOL SCI, V10, P139, DOI 10.1016/0305-4403(83)90048-1; Lauer F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106244; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Leeming R, 1997, ACS SYM SER, V671, P306; LIN DS, 1978, J LIPID RES, V19, P215; Linseele V, 2013, ENVIRON ARCHAEOL, V18, P5, DOI 10.1179/1461410313Z.00000000019; Lloyd CEM, 2012, ORG GEOCHEM, V43, P56, DOI 10.1016/j.orggeochem.2011.11.001; Luning J., 1997, DTSCH AGRARGESCHICHT, P15; MCCALLEY DV, 1981, WATER RES, V15, P1019, DOI 10.1016/0043-1354(81)90211-6; MEURERS-BALKE Jutta, 1999, PFLANZENSPUREN ARCHA, V10, P11; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Myant NB, 1981, BIOL CHOLESTEROL REL; Nash D, 2005, WATER RES, V39, P2964, DOI 10.1016/j.watres.2005.04.063; NODA M, 1988, LIPIDS, V23, P439, DOI 10.1007/BF02535517; PAYNE S, 1985, J ARCHAEOL SCI, V12, P139, DOI 10.1016/0305-4403(85)90058-5; Peters J, 1998, PASSAUER UNIVERSITAT; Piironen V, 2000, J SCI FOOD AGR, V80, P939, DOI [10.1002/(SICI)1097-0010(20000515)80:7<939::AID-JSFA644>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;939::AID-JSFA644&gt;3.0.CO;2-C]; Reddy S, 1998, BRIT J NUTR, V79, P495, DOI 10.1079/BJN19980087; Rogge WF, 2006, ATMOS ENVIRON, V40, P27, DOI 10.1016/j.atmosenv.2005.07.076; SCHUBERT K, 1965, BIOCHIM BIOPHYS ACTA, V106, P592, DOI 10.1016/0005-2760(65)90074-3; Shah VG, 2007, WATER RES, V41, P3691, DOI 10.1016/j.watres.2007.04.006; Shahack-Gross R, 2011, J ARCHAEOL SCI, V38, P205, DOI 10.1016/j.jas.2010.09.019; Simpson IA, 1998, J ARCHAEOL SCI, V25, P729, DOI 10.1006/jasc.1997.0216; Standley LJ, 2000, ENVIRON SCI TECHNOL, V34, P3124, DOI 10.1021/es991381n; SUBBIAH MTR, 1972, COMP BIOCHEM PHYSIOL, V41, P695, DOI 10.1016/0305-0491(72)90082-X; SULPICE JC, 1978, LIPIDS, V13, P217, DOI 10.1007/BF02533403; Taube PS, 2013, ORG GEOCHEM, V58, P96, DOI 10.1016/j.orggeochem.2013.02.004; TAYLOR CD, 1981, GEOCHIM COSMOCHIM AC, V45, P2161, DOI 10.1016/0016-7037(81)90068-5; THOMPSON LK, 1983, SOIL BIOL BIOCHEM, V15, P125, DOI 10.1016/0038-0717(83)90131-1; Tyagi P, 2007, CHEMOSPHERE, V69, P1617, DOI 10.1016/j.chemosphere.2007.05.039; WALKER RW, 1982, CRIT REV ENV CONTR, V12, P91, DOI 10.1080/10643388209381695; Weete JD, 1989, ADV LIPID RES, P115; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Wiedner K, 2015, CATENA, V132, P114, DOI 10.1016/j.catena.2014.10.024; Wilkinson JM, 2005, SILAGE; Wolf M, 2013, ORG GEOCHEM, V55, P11, DOI 10.1016/j.orggeochem.2012.11.002; Wolff H., 1994, LANDLICHE BESIEDLUNG, VII, P37	82	70	71	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0164882	10.1371/journal.pone.0164882	http://dx.doi.org/10.1371/journal.pone.0164882			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060808	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500006
J	Cui, JG; Zhu, BC; Fang, GZ; Smith, E; Brauth, SE; Tang, YZ				Cui, Jianguo; Zhu, Bicheng; Fang, Guangzhan; Smith, Ed; Brauth, Steven E.; Tang, Yezhong			Effect of the Level of Anesthesia on the Auditory Brainstem Response in the Emei Music Frog (Babina daunchina)	PLOS ONE			English	Article							EVOKED-POTENTIALS; XENOPUS-LAEVIS; HEARING; FREQUENCY; SIGNALS; MS222; CALLS	Anesthesia is known to affect the auditory brainstem response (ABR) in mice, rats, birds and lizards. The present study investigated how the level of anesthesia affects ABR recordings in an amphibian species, Babina daunchina. To do this, we compared ABRs evoked by tone pip stimuli recorded from 35 frogs when Tricaine methane sulphonate (MS-222) anesthetic immersion times varied from 0, 5 and 10 minutes after anesthesia induction at sound frequencies between 0.5 and 6 kHz. ABR thresholds increased significantly with immersion time across the 0.5 kHz to 2.5 kHz frequency range, which is the most sensitive frequency range for hearing and the main frequency range of male calls. There were no significant differences for anesthetic levels across the 3 kHz to 6 kHz range. ABR latency was significantly longer in the 10 min group than in the 0 and 5 min groups at frequencies of 0.5, 1.0, 1.5, 2.5 kHz, while ABR latency did not differ across the 3 kHz to 4 kHz range and at 2.0 kHz. Taken together, these results show that the level of anesthesia affects the amplitude, threshold and latency of ABRs in frogs.	[Cui, Jianguo; Zhu, Bicheng; Fang, Guangzhan; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Smith, Ed; Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University System of Maryland; University of Maryland College Park	Cui, JG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	cuijg@cib.ac.cn	fang, guangzhan/AAH-1098-2020; Zhu, Bicheng/AAU-3425-2020	Fang, Guangzhan/0000-0003-1803-6610	Youth Innovation Promotion Association CAS, CAS "Light of West China" Program, National Natural Science Foundation of China [31270042]; Youth Professor Project of CIB [Y3B3011]	Youth Innovation Promotion Association CAS, CAS "Light of West China" Program, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Professor Project of CIB	This work was supported by Youth Innovation Promotion Association CAS, CAS "Light of West China" Program, National Natural Science Foundation of China (31270042) and Youth Professor Project of CIB (Y3B3011) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORG E, 1983, ACTA OTO-LARYNGOL, V95, P19, DOI 10.3109/00016488309130911; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brittan-Powell EF, 2002, J ACOUST SOC AM, V112, P999, DOI 10.1121/1.1494807; Brittan-Powell EF, 2010, J ACOUST SOC AM, V128, P787, DOI 10.1121/1.3458813; Capranica RR, 1983, ADV VERTEBRATE NEURO, P701, DOI DOI 10.1007/978-1-4684-4412-4_36; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; CHEN J, 2016, PLOS ONE, V11; Chen Q, 2011, J HERPETOL, V45, P406; Christensen-Dalsgaard J, 2011, BIOL LETTERS, V7, P139, DOI 10.1098/rsbl.2010.0636; CHURCH MW, 1987, ELECTROEN CLIN NEURO, V67, P570, DOI 10.1016/0013-4694(87)90060-5; Cordova MS, 2007, BRAIN RES, V1153, P78, DOI 10.1016/j.brainres.2007.03.055; CORWIN JT, 1982, ELECTROEN CLIN NEURO, V54, P629, DOI 10.1016/0013-4694(82)90117-1; Cui JG, 2016, EVOLUTION, V70, P922, DOI 10.1111/evo.12889; Cui JG, 2012, BIOL LETTERS, V8, P337, DOI 10.1098/rsbl.2011.1091; Cui JG, 2011, ASIAN HERPETOL RES, V2, P149, DOI 10.3724/SP.J.1245.2011.00149; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Downes U., 1995, B ASS REPT AMPH VET, V5, P11; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Gerhardt H. Carl, 2001, P73; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Hall III J. W., 2007, NEW HDB AUDITORY EVO, P212; Henry KS, 2008, ANIM BEHAV, V76, P1659, DOI 10.1016/j.anbehav.2008.08.003; Higgs DM, 2004, J EXP BIOL, V207, P155, DOI 10.1242/jeb.00735; Katbamna B, 2006, J COMP PHYSIOL A, V192, P381, DOI 10.1007/s00359-005-0076-3; Lalonde-Robert V, 2012, J AM ASSOC LAB ANIM, V51, P464; Liu WR, 2014, J COMP PHYSIOL A, V200, P311, DOI 10.1007/s00359-014-0885-3; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; Mann DA, 2005, BIOL LETTERS, V1, P158, DOI 10.1098/rsbl.2004.0241; MATTSON NS, 1989, AQUACULTURE, V83, P89, DOI 10.1016/0044-8486(89)90063-X; Narins P., 2006, HEARING SOUND COMMUN, DOI [10.1007/978-0-387-47796-1, DOI 10.1007/978-0-387-47796-1, DOI 10.1007/978-0-387-47796-1_1]; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Schrode KM, 2014, J COMP PHYSIOL A, V200, P221, DOI 10.1007/s00359-014-0880-8; SMITH DI, 1991, HEARING RES, V54, P1, DOI 10.1016/0378-5955(91)90130-2; SMITH DI, 1989, ELECTROEN CLIN NEURO, V72, P422, DOI 10.1016/0013-4694(89)90047-3; Stapells DR, 1997, AUDIOL NEURO-OTOL, V2, P257, DOI 10.1159/000259252; Stronks HC, 2010, HEARING RES, V260, P20, DOI 10.1016/j.heares.2009.10.015; van Looij MAJ, 2004, HEARING RES, V193, P75, DOI 10.1016/j.heares.2004.02.009; Wells KD., 2010, ECOLOGY BEHAV AMPHIB; WENSTRUP JJ, 1984, J COMP PHYSIOL, V155, P75, DOI 10.1007/BF00610933; WILCZYNSKI W, 1984, PROG NEUROBIOL, V22, P1, DOI 10.1016/0301-0082(84)90016-9; Yang P, 2014, J COMP PHYSIOL A, V200, P117, DOI 10.1007/s00359-013-0866-y; Zhang DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039772	43	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169449	10.1371/journal.pone.0169449	http://dx.doi.org/10.1371/journal.pone.0169449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056042	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100043
J	Haugarvoll, K; Johansson, S; Rodriguez, CE; Boman, H; Haukanes, BI; Bruland, O; Roque, F; Jonassen, I; Blomqvist, M; Telstad, W; Mansson, JE; Knappskog, PM; Bindoff, LA				Haugarvoll, Kristoffer; Johansson, Stefan; Rodriguez, Carlos E.; Boman, Helge; Haukanes, Bjorn Ivar; Bruland, Ove; Roque, Francisco; Jonassen, Inge; Blomqvist, Maria; Telstad, Wenche; Mansson, Jan-Eric; Knappskog, Per Morten; Bindoff, Laurence A.			GBA2 Mutations Cause a Marinesco-Sjogren-Like Syndrome: Genetic and Biochemical Studies	PLOS ONE			English	Article							NONLYSOSOMAL GLUCOSYLCERAMIDASE; CEREBELLAR-ATAXIA; GAUCHER-DISEASE; MYOPATHY; SIL1; INHIBITORS; CATARACT; LINKAGE; BRAINS; MICE	Background With the advent new sequencing technologies, we now have the tools to understand the phenotypic diversity and the common occurrence of phenocopies. We used these techniques to investigate two Norwegian families with an autosomal recessive cerebellar ataxia with cataracts and mental retardation. Methods and Results Single nucleotide polymorphism (SNP) chip analysis followed by Exome sequencing identified a 2 bp homozygous deletion in GBA2 in both families, c.1528_1529de1 [p.Met510Valfs*17]. Furthermore, we report the biochemical characterization of GBA2 in these patients. Our studies show that a reduced activity of GBA2 is sufficient to elevate the levels of glucosylceramide to similar levels as seen in Gaucher disease. Furthermore, leucocytes seem to be the proper enzyme source for in vitro analysis of GBA2 activity. Conclusions We report GBA2 mutations causing a Marinesco-Sjogren-like syndrome in two Norwegian families. One of the families was originally diagnosed with Marinesco-Sjogren syndrome based on an autosomal recessive cerebellar ataxia with cataracts and mental retardation. Our findings highlight the phenotypic variability associated with GBA2 mutations, and suggest that patients with Marinesco-Sjogren-like syndromes should be tested for mutations in this gene.	[Haugarvoll, Kristoffer; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Haugarvoll, Kristoffer; Knappskog, Per Morten; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Johansson, Stefan; Boman, Helge; Haukanes, Bjorn Ivar; Bruland, Ove; Roque, Francisco; Knappskog, Per Morten] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Johansson, Stefan; Roque, Francisco] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Rodriguez, Carlos E.; Blomqvist, Maria; Mansson, Jan-Eric] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Jonassen, Inge] Univ Bergen, Dept Informat, Computat Biol Unit, Bergen, Norway; [Telstad, Wenche] Forde Hosp, Dept Neurol, Forde, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Gothenburg; University of Bergen	Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.; Knappskog, PM; Bindoff, LA (corresponding author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.; Knappskog, PM (corresponding author), Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway.	per.morten.knappskog@helse-bergen.no; laurence.bindoff@helse-bergen.no	Jonassen, Inge/AAC-7035-2020; Haugarvoll, Kristoffer/AAB-5860-2019; Rodríguez, Carlos/AAJ-6122-2020; Johansson, Stefan/C-4394-2011	Haugarvoll, Kristoffer/0000-0001-9381-1109; Rodríguez, Carlos/0000-0002-6831-0588; Johansson, Stefan/0000-0002-2298-7008; Haukanes, Bjorn Ivar/0000-0003-1559-3366; Bindoff, Laurence/0000-0003-0988-276X	Forening for muskelsyke; Heise Vest. Projevt [911810]	Forening for muskelsyke; Heise Vest. Projevt	Support was provided by: Forening for muskelsyke [http://ffm.no/], grant to LAB and Heise Vest. Projevt #911810 to PMK.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Boukhris A, 2010, NEUROGENETICS, V11, P441, DOI 10.1007/s10048-010-0249-2; Burke DG, 2013, J INHERIT METAB DIS, V36, P869, DOI 10.1007/s10545-012-9561-3; Citterio A, 2014, J NEUROL, V261, P373, DOI 10.1007/s00415-013-7206-6; Dekker N, 2011, BLOOD CELL MOL DIS, V46, P19, DOI 10.1016/j.bcmd.2010.07.009; Erikson A, 2006, ACTA PAEDIATR, V95, P312, DOI 10.1080/08035250500423804; FORSYTH GW, 1993, CLIN CHIM ACTA, V216, P11, DOI 10.1016/0009-8981(93)90135-Q; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Haugarvoll K, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-1; HERVA R, 1987, NEUROPEDIATRICS, V18, P164, DOI 10.1055/s-2008-1052473; Krieger M, 2013, BRAIN, V136, P3634, DOI 10.1093/brain/awt283; Marinesco G, 1931, ENCEPHALE, V26, P97; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Moravcsik E, 1904, ORVOSI HETILAP, V25; Nietupski JB, 2012, MOL GENET METAB, V105, P621, DOI 10.1016/j.ymgme.2012.01.020; NILSSON O, 1982, CLIN GENET, V22, P274; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Pagon RA., 1993, GENEREVIEWS; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; SEWRY CA, 1988, ANN NEUROL, V24, P576, DOI 10.1002/ana.410240416; Sjogren T, 1947, ACTA PSYCHIAT SCAND, V22, P286; SKRE H, 1977, CLIN GENET, V11, P57; SVENNERHOLM L, 1987, J NEUROCHEM, V49, P1772, DOI 10.1111/j.1471-4159.1987.tb02435.x; SVENNERHOLM L, 1979, CLIN CHIM ACTA, V92, P53, DOI 10.1016/0009-8981(79)90396-6; Votsi C, 2014, ANN HUM GENET, V78, P13, DOI 10.1111/ahg.12045	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169309	10.1371/journal.pone.0169309	http://dx.doi.org/10.1371/journal.pone.0169309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052128	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500046
J	Youns, M; Hegazy, WAH				Youns, Mhmoud; Hegazy, Wael Abdel Halim			The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways	PLOS ONE			English	Article							HUMAN BREAST-CANCER; KAPPA B PATHWAYS; PROSTATE-CANCER; CYCLE ARREST; KEY PLAYERS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; DOWN-REGULATION; BLADDER-CANCER; APOPTOSIS	Digestive cancers are major causes of mortality and morbidity worldwide. Fisetin, a naturally occurring flavonoid, has been previously shown anti-proliferative, anti-cancer, neuroprotective, and antioxidant activities. In our study, the anti-tumor activities in addition to regulatory effects of fisetin on some cancer cell lines were investigated. Data presented here showed that fisetin induces growth inhibition, and apoptosis in hepatic (HepG-2), colorectal (Caco-2) and pancreatic (Suit-2) cancer cell lines. Gene expression results showed that 1307 genes were significantly regulated in their expression in hepatic and pancreatic cell lines. 350 genes were commonly up-regulated and 353 genes were commonly down-regulated. Additionally, 604 genes were oppositely expressed in both tumor cells. CDK5 signaling, NRF2mediated oxidative stress response, glucocorticoid signaling, and ERK/MAPKsignaling were among most prominent signaling pathways modulating the growth inhibitory effects of fisetin on hepatic and pancreatic cancer cells. The present analysis showed, for the first time, that the anti-tumor effect of fisetin was mediated mainly through modulation of multiple signaling pathways and via activation of CDKN1A, SEMA3E, GADD45B and GADD45A and down-regulation of TOP2A, KIF20A, CCNB2 and CCNB1 genes.	[Youns, Mhmoud] German Canc Res Ctr, Dept Funct Genome Anal, Neuenheimer Feld 580, Heidelberg, Germany; [Youns, Mhmoud] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo, Egypt; [Hegazy, Wael Abdel Halim] Zagazig Univ, Dept Microbiol & Immunol, Fac Pharm, Al Sharqia, Egypt	Helmholtz Association; German Cancer Research Center (DKFZ); Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); Zagazig University	Youns, M (corresponding author), German Canc Res Ctr, Dept Funct Genome Anal, Neuenheimer Feld 580, Heidelberg, Germany.; Youns, M (corresponding author), Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo, Egypt.	Dr.mahmoudyouns@yahoo.com	Hegazy, Wael/ABF-3684-2021; Hegazy, Wael/ABC-2263-2021	Hegazy, Wael/0000-0001-5683-4803; Youns, Mahmoud/0000-0001-8754-9634				Ahmed MF, 2013, ARCH PHARM, V346, P610, DOI 10.1002/ardp.201300158; Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Arai Y, 2000, J NUTR, V130, P2243; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cali JJ, 2006, EXPERT OPIN DRUG MET, V2, P629, DOI 10.1517/17425255.2.4.629; Casazza A, 2010, J CLIN INVEST, V120, P2684, DOI 10.1172/JCI42118; Chen CM, 2015, TUMOR BIOL, V36, P3407, DOI 10.1007/s13277-014-2975-9; Chen H, 2015, ONCOTARGET, V6, P20449, DOI 10.18632/oncotarget.3936; Chen YC, 2002, ARCH TOXICOL, V76, P351, DOI 10.1007/s00204-002-0346-6; Chen YS, 2015, ACS APPL MATER INTER, V7, P534, DOI 10.1021/am5066893; Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983; Chung MY, 2013, WORLD J GASTROENTERO, V19, P984, DOI 10.3748/wjg.v19.i7.984; Daire V, 2011, ARCH BIOCHEM BIOPHYS, V510, P83, DOI 10.1016/j.abb.2011.02.012; de Souza Rocha Simonini P, 2010, CANCER RES, V70, P9175, DOI DOI 10.1158/0008-5472.CAN-10-1318; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haddad AQ, 2006, PROSTATE CANCER P D, V9, P68, DOI 10.1038/sj.pcan.4500845; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hoffman B, 2007, BLOOD CELL MOL DIS, V39, P344, DOI 10.1016/j.bcmd.2007.06.011; Hwang SW, 2008, J THORAC ONCOL, V3, P942, DOI 10.1097/JTO.0b013e3181803f1e; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jung H, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/150351; Kang KA, 2015, IN VITRO CELL DEV-AN, V51, P300, DOI 10.1007/s11626-014-9830-6; Kang KA, 2014, IN VITRO CELL DEV-AN, V50, P66, DOI 10.1007/s11626-013-9681-6; Khan MI, 2014, ONCOTARGET, V5, P2462, DOI 10.18632/oncotarget.1790; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kim JA, 2015, CARCINOGENESIS, V36, P696, DOI 10.1093/carcin/bgv045; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Li J, 2014, BASIC CLIN PHARMACOL, V115, P321, DOI 10.1111/bcpt.12229; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Li R, 2014, MOL MED REP, V9, P413, DOI 10.3892/mmr.2013.1836; Liebermann DA, 2007, BLOOD CELL MOL DIS, V39, P329, DOI 10.1016/j.bcmd.2007.06.006; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Mulyaningsih S, 2010, J PHARM PHARMACOL, V62, P1037, DOI 10.1111/j.2042-7158.2010.01119.x; Nasr T, 2014, EUR J MED CHEM, V76, P539, DOI 10.1016/j.ejmech.2014.02.026; Olaharski AJ, 2005, MUTAT RES-GEN TOX EN, V582, P79, DOI 10.1016/j.mrgentox.2005.01.002; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Park W, 2013, CANCER PREV RES, V6, P387, DOI 10.1158/1940-6207.CAPR-12-0410; Piao MJ, 2013, BIOMOL THER, V21, P210, DOI 10.4062/biomolther.2013.017; Qiu WH, 2004, AM J PATHOL, V165, P1689, DOI 10.1016/S0002-9440(10)63425-6; Ramachandran C, 2005, ANTICANCER RES, V25, P3293; Sajadian SO, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0213-6; Salazar AT, 2011, INT J CLIN PHARM TH, V49, P93, DOI 10.5414/CPP49093; Sau A, 2010, ARCH BIOCHEM BIOPHYS, V500, P116, DOI 10.1016/j.abb.2010.05.012; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Seo SH, 2015, INT IMMUNOPHARMACOL, V29, P246, DOI 10.1016/j.intimp.2015.11.014; Shi Q, 2016, ONCOTARGET; Smith ML, 2016, J CELL BIOCHEM, V117, P1913, DOI 10.1002/jcb.25490; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Tamura RE, 2012, CURR MOL MED, V12, P634; Tang SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24466; Taniuchi K, 2005, CANCER RES, V65, P105; Vatandoost N, 2016, J CANCER RES CLIN, V142, P341, DOI 10.1007/s00432-015-1928-z; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Yan GR, 2012, PROTEOMICS, V12, P2391, DOI 10.1002/pmic.201100652; Yang PM, 2012, INT J ONCOL, V40, P469, DOI 10.3892/ijo.2011.1203; Ying TH, 2012, ARCH TOXICOL, V86, P263, DOI 10.1007/s00204-011-0754-6; Youns M, 2013, J CELL BIOCHEM, V114, P2654, DOI 10.1002/jcb.24612; Youns M, 2009, DRUG DISCOV THER, V3, P200; Youns M, 2011, EUR J PHARMACOL, V650, P170, DOI 10.1016/j.ejphar.2010.10.026; Youns M, 2010, PLANTA MED, V76, P2019, DOI 10.1055/s-0030-1250432; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014; Zerbini LF, 2005, CLIN CANCER RES, V11, P6409, DOI 10.1158/1078-0432.CCR-05-1475; Zhuo WL, 2015, AM J TRANSL RES, V7, P2045	69	59	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169335	10.1371/journal.pone.0169335	http://dx.doi.org/10.1371/journal.pone.0169335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052097	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500049
J	Yuan, XX; Wei, G; You, YL; Huang, YY; Lee, HJ; Dong, M; Lin, J; Hu, T; Zhang, HL; Zhang, CH; Zhou, HQ; Ye, RC; Qi, XL; Zhai, BQ; Huang, WD; Liu, SN; Xie, W; Liu, QS; Liu, XM; Cui, CB; Li, DH; Zhan, JC; Cheng, J; Yuan, ZQ; Jin, WZ				Yuan, Xiaoxue; Wei, Gang; You, Yilin; Huang, Yuanyuan; Lee, Hyuek Jong; Dong, Meng; Lin, Jun; Hu, Tao; Zhang, Hanlin; Zhang, Chuanhai; Zhou, Huiqiao; Ye, Rongcai; Qi, Xiaolong; Zhai, Baiqiang; Huang, Weidong; Liu, Shunai; Xie, Wen; Liu, Qingsong; Liu, Xiaomeng; Cui, Chengbi; Li, Donghao; Zhan, Jicheng; Cheng, Jun; Yuan, Zengqiang; Jin, Wanzhu			Rutin ameliorates obesity through brown fat activation	FASEB JOURNAL			English	Article						brown adipose tissue; rutin; obesity; energy expenditure; mitochondria	ADIPOSE-TISSUE THERMOGENESIS; DIET-INDUCED OBESITY; GLUCOSE-HOMEOSTASIS; WHITE FAT; SIRT1; MOUSE; COLD; MITOCHONDRIA; INFLAMMATION; STIMULATION	Increasing energy expenditure through activation of brown adipose tissue (BAT) is a critical approach to treating obesity and diabetes. In this study, rutin, a natural compound extracted from mulberry and a drug used as a capillary stabilizer clinically for many years without any side effects, regulated whole-body energy metabolism by enhancing BAT activity. Rutin treatment significantly reduced adiposity, increased energy expenditure, and improved glucose homeostasis in both genetically obese (Db/Db) and diet-induced obesity (DIO) mice. Rutin also induced brown-like adipocyte (beige) formation in subcutaneous adipose tissue in both obesity mouse models. Mechanistically, we found that rutin directly bound to and stabilized SIRT1, leading to hypoacetylation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha protein, which stimulated Tfam transactivation and eventually augmented the number of mitochondria and UCP1 activity in BAT. These findings reveal that rutin is a novel small molecule that activates BAT and may provide a novel therapeutic approach to the treatment of metabolic disorders.-Yuan, X., Wei, G., You, Y., Huang, Y., Lee, H. J., Dong, M., Lin, J., Hu, T., Zhang, H., Zhang, C., Zhou, H., Ye, R., Qi, X., Zhai, B., Huang, W., Liu, S., Xie, W., Liu, Q., Liu, X., Cui, C., Li, D., Zhan, J., Cheng, J., Yuan, Z., Jin, W. Rutin ameliorates obesity through brown fat activation.	[Yuan, Xiaoxue; Wei, Gang; Huang, Yuanyuan; Lee, Hyuek Jong; Dong, Meng; Lin, Jun; Hu, Tao; Zhang, Hanlin; Zhang, Chuanhai; Zhou, Huiqiao; Ye, Rongcai; Jin, Wanzhu] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Qi, Xiaolong; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Yuan, Xiaoxue; Wei, Gang; Huang, Yuanyuan; Dong, Meng; Lin, Jun; Hu, Tao; Zhou, Huiqiao; Ye, Rongcai; Qi, Xiaolong; Yuan, Zengqiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [You, Yilin; Zhai, Baiqiang; Huang, Weidong; Zhan, Jicheng] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Liu, Shunai; Xie, Wen; Cheng, Jun] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China; [Liu, Qingsong] Chinese Acad Sci, High Magnet Field Lab, Hefei, Peoples R China; [Liu, Xiaomeng] Zhoukou Normal Univ, Coll Life Sci, Zhoukou, Henan, Peoples R China; [Cui, Chengbi; Li, Donghao] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Minist Educ, Yanji, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Capital Medical University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Zhoukou Normal University; Yanbian University	Jin, WZ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China.; Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	zqyuan@ibp.ac.cn; jinw@ioz.ac.cn	Zhang, Chuanhai/O-3137-2018; Lee, Hyuek Jong/AAP-9190-2021; Zhan, Jicheng/ABF-8501-2021; Jin, Wanzhu/B-5699-2012; xiaomeng, liu/GLN-4189-2022; Dong, Meng/AAI-6235-2021; Zhang, Chuanhai/N-6655-2019	Zhang, Chuanhai/0000-0001-7644-2436; Jin, Wanzhu/0000-0002-5860-2958; Zhang, Chuanhai/0000-0001-7644-2436; Yuan, Zengqiang/0000-0001-5739-2867; yuan, xiaoxue/0000-0002-2886-4703	Strategic Priority Research Program [XDB13030000]; Key Research Program [KJZD-EW-L01-3]; CAS, One Hundred Talents Program of the CAS; Ministry of Science and Technology of China [2012CBA01301, 2015CB943102, 2012CB944701]; National Natural Science Foundation of China [31171131, 81370951, 81500659]; National Basic Research Program of China [2012CB910701, 2013DFA31990]; Beijing Municipal Administration of Hospitals [ZYLX201402]; National "Twelfth Five-Year" Plan for Science and Technology Support Grants [2012BAD31B07, 2012BAD31B05]; Special Fund for Agro-scientific Research in the Public Interest Grant [201303073-2]	Strategic Priority Research Program(Chinese Academy of Sciences); Key Research Program; CAS, One Hundred Talents Program of the CAS; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Municipal Administration of Hospitals; National "Twelfth Five-Year" Plan for Science and Technology Support Grants; Special Fund for Agro-scientific Research in the Public Interest Grant	The authors thank Dr. Ruiming Xu [Institute of Biophysics, Chinese Academy of Sciences (CAS)] for generously providing us with the SIRT1 proteins. This work was supported by the Strategic Priority Research Program XDB13030000 (to W.J.); Key Research Program KJZD-EW-L01-3 (to W.J.); CAS, One Hundred Talents Program of the CAS (to W.J.); Ministry of Science and Technology of China Grants 2012CBA01301, 2015CB943102, and 2012CB944701 (to W.J.); National Natural Science Foundation of China Grants 31171131 and 81370951 (to W.J.); National Basic Research Program of China Grants 2012CB910701 and 2013DFA31990 (to Z.Y.); National Natural Science Foundation of China Grant 81500659 (to X.L); Beijing Municipal Administration of Hospitals Grant ZYLX201402 (to J.C.); National "Twelfth Five-Year" Plan for Science and Technology Support Grants 2012BAD31B07 and 2012BAD31B05 (to W.H.); and Special Fund for Agro-scientific Research in the Public Interest Grant 201303073-2 (to J.Z.). The authors declare no conflicts of interest.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boutant M, 2015, MOL METAB, V4, P118, DOI 10.1016/j.molmet.2014.12.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Korkmaz A, 2010, J SURG RES, V164, P309, DOI 10.1016/j.jss.2009.03.022; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 1997, MAMM GENOME, V8, P139, DOI 10.1007/s003359900373; Li R, 2012, REGUL PEPTIDES, V178, P16, DOI 10.1016/j.regpep.2012.06.002; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Liu XM, 2013, CELL RES, V23, P851, DOI 10.1038/cr.2013.64; LONCAR D, 1986, J ULTRA MOL STRUCT R, V97, P119, DOI 10.1016/S0889-1605(86)80012-X; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Andrade JMO, 2014, EUR J NUTR, V53, P1503, DOI 10.1007/s00394-014-0655-6; Ozawa Hikaru, 2003, Yakushigaku Zasshi, V38, P93; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Prince PSM, 2006, J BIOCHEM MOL TOXIC, V20, P96, DOI 10.1002/jbt.20117; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; TRAYHURN P, 1979, PFLUG ARCH EUR J PHY, V380, P227, DOI 10.1007/BF00582901; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V361, P1123; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu C, 2013, AM J TRANSL RES, V5, P412; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	52	103	106	4	81	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					333	+		10.1096/fj.201600459RR	http://dx.doi.org/10.1096/fj.201600459RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	28049156				2022-12-26	WOS:000392177600031
J	Lee, JH; Kang, M; Wang, H; Naik, G; Mobley, JA; Sonpavde, G; Garvey, WT; Darley-Usmar, VM; Ponnazhagan, S				Lee, Joo Hyoung; Kang, Minsung; Wang, Hong; Naik, Gurudatta; Mobley, James A.; Sonpavde, Guru; Garvey, W. Timothy; Darley-Usmar, Victor M.; Ponnazhagan, Selvarangan			Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress	FASEB JOURNAL			English	Article						androgen-deprivation therapy; reactive oxygen species; androgen receptor; glucocorticoid receptor; castration resistance	GLUCOCORTICOID-RECEPTOR; RESISTANCE; THERAPY; CELLS; MODEL; DIFFERENTIATION; ENZALUTAMIDE; CHEMOTHERAPY; DEPRIVATION; ABIRATERONE	Androgen-deprivation therapy has been identified to induce oxidative stress in prostate cancer (PCa), leading to reactivation of androgen receptor (AR) signaling in a hormone-refractory manner. Thus, antioxidant therapies have gained attention as adjuvants for castration-resistant PCa. Here, we report for the first time that human endostatin (ES) prevents androgen-independent growth phenotype in PCa cells through its molecular targeting of AR and glucocorticoid receptor (GR) and downstream pro-oxidant signaling. This reversal after ES treatment significantly decreased PCa cell proliferation through down-regulation of GR and up-regulation of manganese superoxide dismutase and reduced glutathione levels. Proteome and biochemical analyses of ES-treated PCa cells further indicated a significant up-regulation of enzymes in the major reactive oxygen species (ROS) scavenging machinery, including catalase, glutathione synthetase, glutathione reductase, NADPH-cytochrome P450 reductase, biliverdin reductase, and thioredoxin reductase, resulting in a concomitant reduction of intracellular ROS. ES further augmented the antioxidant system through up-regulation of glucose influx, the pentose phosphate pathway, and NAD salvaging pathways. This shift in cancer cell redox homeostasis by ES significantly decreased the effect of protumorigenic oxidative machinery on androgen-independent PCa growth, suggesting that ES can suppress GR-induced resistant phenotype upon AR antagonism and that the dual targeting action of ES on AR and GR can be further translated to PCa therapy.-Lee, J. H., Kang, M., Wang, H., Naik, G., Mobley, J. A., Sonpavde, G., Garvey, W. T., Darley-Usmar, V. M., Ponnazhagan, S. Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.	[Lee, Joo Hyoung; Wang, Hong; Darley-Usmar, Victor M.; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Kang, Minsung; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Naik, Gurudatta; Sonpavde, Guru] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Garvey, W. Timothy] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA.	pons@uab.edu	naik, Gurudatta/O-7284-2015; Sonpavde/L-7107-2019; Lee, Joo Hyoung/A-7713-2017	naik, Gurudatta/0000-0001-7265-6605; Sonpavde/0000-0002-1010-9611; Lee, Joo Hyoung/0000-0003-4450-3067; Darley-Usmar, Victor/0000-0001-8921-7086	U.S. National Institutes of Health, National Cancer Institute [R01CA184770, P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA184770] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01CA184770 (to S.P.) and P30CA013148 (to J.A.M.). The authors thank UAB Mass Spectrometry/Proteomics Shared Facility for proteome analysis. The authors declare no conflicts of interest.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; Cha HR, 2016, PROSTATE, V76, P624, DOI 10.1002/pros.23155; Ciccarese C, 2016, CANCER TREAT REV, V43, P27, DOI 10.1016/j.ctrv.2015.12.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Isayeva T, 2007, CANCER RES, V67, P5789, DOI 10.1158/0008-5472.CAN-06-3637; Isikbay M, 2014, HORM CANCER-US, V5, P72, DOI 10.1007/s12672-014-0173-2; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Kang MS, 2015, AM J PHYSIOL-CELL PH, V309, pC767, DOI 10.1152/ajpcell.00101.2015; Kassi E, 2011, CANCER LETT, V302, P1, DOI 10.1016/j.canlet.2010.10.020; Katsogiannou M, 2015, CANCER TREAT REV, V41, P588, DOI 10.1016/j.ctrv.2015.05.003; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Lee JH, 2015, P NATL ACAD SCI USA, V112, P1392, DOI 10.1073/pnas.1417660112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig MR, 2016, PROTEOMICS, V16, P516, DOI 10.1002/pmic.201500133; Pelekanou V, 2016, J CELL BIOCHEM, V117, P2224, DOI 10.1002/jcb.25572; Raciti M, 2016, NEUROPHARMACOLOGY, V107, P422, DOI 10.1016/j.neuropharm.2016.03.022; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Sharifi N, 2008, CLIN CANCER RES, V14, P6073, DOI 10.1158/1078-0432.CCR-08-0591; Shiota M, 2012, ENDOCR-RELAT CANCER, V19, pR243, DOI 10.1530/ERC-12-0232; Shiota M, 2012, J UROLOGY, V187, P707, DOI 10.1016/j.juro.2011.09.147; Shiota M, 2011, FREE RADICAL BIO MED, V51, P1320, DOI 10.1016/j.freeradbiomed.2011.07.011; Spiers JG, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00456; Taplin ME, 2008, BJU INT, V101, P1084, DOI 10.1111/j.1464-410X.2008.07509.x; Teply BA, 2016, CURR OPIN ENDOCRINOL, V23, P279, DOI 10.1097/MED.0000000000000254; Thomas R, 2012, MOL CANCER THER, V11, P87, DOI 10.1158/1535-7163.MCT-11-0540; Wang S, 2015, MOL CANCER THER, V14, P1192, DOI 10.1158/1535-7163.MCT-14-0836; Wang TT, 2014, NEURON, V83, P616, DOI 10.1016/j.neuron.2014.07.003; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Xie N, 2015, INT J CANCER, V136, pE27, DOI 10.1002/ijc.29147; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/y09-027, 10.1139/Y09-027]	42	7	7	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1608	1619		10.1096/fj.201601178R	http://dx.doi.org/10.1096/fj.201601178R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069826	Green Published			2022-12-26	WOS:000398504300027
J	Lima, S; Milstien, S; Spiegel, S				Lima, Santiago; Milstien, Sheldon; Spiegel, Sarah			Sphingosine and Sphingosine Kinase 1 Involvement in Endocytic Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; endosome; sphingolipid; sphingosine kinase (SphK); sphingosine-1-phosphate (S1P); sphingosine	SPHINGOLIPID METABOLISM; PRESYNAPTIC TERMINALS; PLASMA-MEMBRANE; PROTEIN; INHIBITOR; BIF-1; CHOLESTEROL; RECRUITMENT; ENDOPHILIN; UVRAG	The balance between cholesterol and sphingolipids within the plasma membrane has long been implicated in endocytic membrane trafficking. However, in contrast to cholesterol functions, little is still known about the roles of sphingolipids and their metabolites. Perturbing the cholesterol/sphingomyelin balance was shown to induce narrow tubular plasma membrane invaginations enriched with sphingosine kinase 1 (SphK1), the enzyme that converts the bioactive sphingolipid metabolite sphingosine to sphingosine-1-phosphate, and suggested a role for sphingosine phosphorylation in endocytic membrane trafficking. Here we show that sphingosine and sphingosine-like SphK1 inhibitors induced rapid and massive formation of vesicles in diverse cell types that accumulated as dilated late endosomes. However, much smaller vesicles were formed in SphK1-deficient cells. Moreover, inhibition or deletion of SphK1 prolonged the lifetime of sphingosine-induced vesicles. Perturbing the plasma membrane cholesterol/sphingomyelin balance abrogated vesicle formation. This massive endosomal influx was accompanied by dramatic recruitment of the intracellular SphK1 and Bin/Amphiphysin/Rvs domain-containing proteins endophilin-A2 and endophilin-B1 to enlarged endosomes and formation of highly dynamic filamentous networks containing endophilin-B1 and SphK1. Together, our results highlight the importance of sphingosine and its conversion to sphingosine-1-phosphate by SphK1 in endocytic membrane trafficking.	[Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23298 USA.; Lima, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23892 USA.	santiago.lima@vcuhealth.org; sarah.spiegel@vcuhealth.org			National Institutes of Health [K22 CA187314, R01GM043880]; National Institutes of Health, NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [K22CA187314, P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants (K22 CA187314 (to S. L.) and R01GM043880 (to S. S.). The VCU Lipidomics and Microscopy Cores are supported in part by funding from the National Institutes of Health, NCI Cancer Center Support Grant P30 CA016059. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Boulakirba S, 2014, P NATL ACAD SCI USA, V111, P9473, DOI 10.1073/pnas.1401186111; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chan JP, 2012, J NEUROSCI, V32, P17909, DOI 10.1523/JNEUROSCI.2808-12.2012; Chan JP, 2012, GENE DEV, V26, P1070, DOI 10.1101/gad.188003.112; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Contreras FX, 2006, BIOPHYS J, V90, P4085, DOI 10.1529/biophysj.105.076471; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dutta Dipannita, 2012, Cell Logist, V2, P203; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Georgieva R, 2010, J COLLOID INTERF SCI, V350, P502, DOI 10.1016/j.jcis.2010.07.022; Giraldo AMV, 2014, BIOCHEM SOC T, V42, P1460, DOI 10.1042/BST20140145; Goni FM, 2014, BIOCHEM SOC T, V42, P1401, DOI 10.1042/BST20140159; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hoglinger D, 2015, ELIFE, V4, DOI 10.7554/eLife.10616; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Kusner DJ, 2007, J BIOL CHEM, V282, P23147, DOI 10.1074/jbc.M700193200; Lee H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6514; Li L, 2015, CELL BIOL INT, V39, P531, DOI 10.1002/cbin.10424; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lima S, 2014, J LIPID RES, V55, P1525, DOI 10.1194/jlr.D048132; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Maxfield FR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016931; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Meyer SGE, 2012, ARCH BIOCHEM BIOPHYS, V526, P60, DOI 10.1016/j.abb.2012.07.006; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mora R, 2010, GLIA, V58, P1364, DOI 10.1002/glia.21013; Morgan J, 2009, EUKARYOT CELL, V8, P779, DOI 10.1128/EC.00037-09; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Puchkov D, 2013, TRENDS CELL BIOL, V23, P493, DOI 10.1016/j.tcb.2013.05.002; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rosales KR, 2011, BIOCHEM J, V439, P299, DOI 10.1042/BJ20110853; Runkle KB, 2012, CANCER BIOL THER, V13, P956, DOI 10.4161/cbt.20951; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Shichiri M, 2012, J BIOL CHEM, V287, P2926, DOI 10.1074/jbc.M111.321281; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Torgersen ML, 2001, J CELL SCI, V114, P3737; Yonamine I, 2011, J CELL BIOL, V192, P557, DOI 10.1083/jcb.201004098; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Young MM, 2016, CELL REP, V17, P1532, DOI 10.1016/j.celrep.2016.10.019; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	76	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3074	3088		10.1074/jbc.M116.762377	http://dx.doi.org/10.1074/jbc.M116.762377			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049734	Green Published, hybrid			2022-12-26	WOS:000395538800002
J	Shiba, E; Izawa, K; Kaitani, A; Isobe, M; Maehara, A; Uchida, K; Maeda, K; Nakano, N; Ogawa, H; Okumura, K; Kitamura, T; Shimizu, T; Kitaura, J				Shiba, Emiko; Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Uchida, Koichiro; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Kitamura, Toshio; Shimizu, Toshiaki; Kitaura, Jiro			Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; MAST-CELL ACTIVATION; FC-EPSILON-RI; NEUTROPHIL RECRUITMENT; MYD88; LMIR3; REGULATORS; LIGANDS; SYSTEM	LPS triggers inflammatory responses; however, the negative regulation of LPS responses in vivo remains poorly understood. CD300f is an inhibitory receptor among the CD300 family of paired activating and inhibitory receptors. We have previously identified ceramide as a ligand for CD300f and shown that the binding of ceramide to CD300f inhibits IgE-mediated mast cell activation and allergic responses in mouse models. Here we identify the critical role of CD300f in inhibiting LPS-induced skin inflammation. CD300f deficiency remarkably enhanced LPS-induced skin edema and neutrophil recruitment in mice. Higher levels of factors that increase vascular permeability and of factors that induce neutrophil recruitment were detected in LPS-injected skin pouch exudates of CD300f(-/-) mice as compared with wild-type mice. CD300f was highly expressed in mast cells and recruited neutrophils, but not in macrophages, among skin myeloid cells. CD300f deficiency failed to influence the intrinsic migratory ability of neutrophils. Ceramide-CD300f binding suppressed the release of chemical mediators from mast cells and from neutrophils in response to LPS. Adoptive transfer experiments indicated that mast cells mediated enhanced edema in LPS-stimulated skin of CD300f(-/-) mice, whereas mast cells together with recruited neutrophils mediated robust neutrophil accumulation. Importantly, administering a ceramide antibody or ceramide-containing vesicles enhanced or suppressed LPS-induced skin inflammation of wild-type mice, respectively. Thus, ceramide-CD300f binding inhibits LPS-induced skin inflammation, implicating CD300f as a negative regulator of Toll-like receptor 4 (TLR4) signaling in vivo.	[Shiba, Emiko; Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Uchida, Koichiro; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Shimizu, Toshiaki; Kitaura, Jiro] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Shiba, Emiko; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Div Cellular Therapy, Div Stem Cell Signaling, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	Juntendo University; Juntendo University; University of Tokyo	Kitaura, J (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.; Kitamura, T (corresponding author), Univ Tokyo, Div Cellular Therapy, Div Stem Cell Signaling, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; j-kitaura@juntendo.ac.jp	Kitamura, Toshio/AAA-2071-2021	Nakano, Nobuhiro/0000-0002-5317-5950	Japan Society for the Promotion of Science (JSPS) KAKENHI [23390257, 26293231]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 23390257 and 26293231. The authors declare that they have no conflicts of interest with the contents of this article.	Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Kim EJ, 2012, IMMUNOLOGY, V135, P226, DOI 10.1111/j.1365-2567.2011.03528.x; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lee SM, 2012, CLIN EXP IMMUNOL, V167, P438, DOI 10.1111/j.1365-2249.2011.04528.x; Lee SM, 2011, J IMMUNOL, V186, P6296, DOI 10.4049/jimmunol.1002184; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Matsukawa T, 2016, GUT, V65, P777, DOI 10.1136/gutjnl-2014-308900; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	31	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2924	2932		10.1074/jbc.M116.768366	http://dx.doi.org/10.1074/jbc.M116.768366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073916	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000395535100032
J	Liu, S; Gao, WJ; Wang, Y; He, ZY; Feng, XJ; Liu, BF; Liu, X				Liu, Sheng; Gao, Wenjie; Wang, Yao; He, Zhenyu; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin			Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS	PLOS ONE			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; THERMAL-STABILITY; SIALIC ACIDS; GLYCOSYLATION; DERIVATIZATION; STRATEGY; FC; IGG; METHYLAMIDATION; ANTIBODIES	Monitoring glycosylation of the mAbs have been emphasized and routinely characterized in biopharmaceutical industries because the carbohydrate components are closely related to the safety, efficacy, and consistency of the antibodies. In this study, the comprehensive glycan profiling of a biosimilar candidate of cetuximab was successfully characterized using Normal phase high-performance liquid chromatography (NP-HPLC) in combination with Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS). The presence of minor N-linked glycans containing sialic acid lactone residues (NeuAcLac) was observed in the biosimilar for the first time, which could influence the quantitative analysis of sialylated glycans and interfere with quantification of neutral glycans when it was analyzed by high performance liquid chromatography fluorescence (HPLC-FL). To overcome this issue, mild alkali treatment was used to hydrolyze lactone of the sialic acid to their neutral formation, which had no impact on the analysis of other glycans before and after the treatment. As a result, the mild alkali treatment might be helpful to obtain quantitative glycan profiling of the mAbs drugs with enhanced accuracy and robustness.	[Liu, Sheng; Gao, Wenjie; Feng, Xiaojun; Liu, Bi-Feng; Liu, Xin] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab,Syst Biol, Wuhan Natl Lab Optoelect,Coll Life Sci & Trchnol, Britton Chance Ctr Biomed Photon,Dept Biomed Engn, Wuhan, Peoples R China; [Wang, Yao; He, Zhenyu] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China	Huazhong University of Science & Technology	Liu, X (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab,Syst Biol, Wuhan Natl Lab Optoelect,Coll Life Sci & Trchnol, Britton Chance Ctr Biomed Photon,Dept Biomed Engn, Wuhan, Peoples R China.; He, ZY (corresponding author), Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China.	hosan9174@163.com; xliu@mail.hust.edu.cn			National Natural Science Foundation of China [20905027, 81402198]; Independent Innovation Fund of HUST [2015TS092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Fund of HUST	The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (20905027 and 81402198). W.J.G. also thanks the financial support from the Independent Innovation Fund of HUST (2015TS092).	Anumula KR, 2006, ANAL BIOCHEM, V350, P1, DOI 10.1016/j.ab.2005.09.037; Anumula KR, 1998, GLYCOBIOLOGY, V8, P685, DOI 10.1093/glycob/8.7.685; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Gao WJ, 2015, ANAL CHIM ACTA, V896, P102, DOI 10.1016/j.aca.2015.09.028; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; Hua S, 2013, ANAL CHEM, V85, P4636, DOI 10.1021/ac400195h; Huang LH, 2006, ANAL BIOCHEM, V349, P197, DOI 10.1016/j.ab.2005.11.012; Huhn C, 2009, PROTEOMICS, V9, P882, DOI 10.1002/pmic.200800715; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; Li HH, 2016, ANAL CHIM ACTA, V924, P77, DOI 10.1016/j.aca.2016.04.023; Liu HC, 2006, IMMUNOL LETT, V106, P144, DOI 10.1016/j.imlet.2006.05.011; Liu X, 2010, ANAL CHEM, V82, P8300, DOI 10.1021/ac101831t; Maeda E, 2012, ANAL CHEM, V84, P2373, DOI 10.1021/ac300234a; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Mimura Y, 2007, J IMMUNOL METHODS, V326, P116, DOI 10.1016/j.jim.2007.07.014; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Reichert JM, 2014, MABS-AUSTIN, V6, P309, DOI 10.4161/mabs.27903; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Stadlmann J, 2010, J CLIN IMMUNOL, V30, pS15, DOI 10.1007/s10875-010-9409-2; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wheeler SF, 2009, RAPID COMMUN MASS SP, V23, P303, DOI 10.1002/rcm.3867; Xia BY, 2009, ANAL BIOCHEM, V387, P162, DOI 10.1016/j.ab.2009.01.028; Xu PC, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-10; Zhang QW, 2014, ANAL CHEM, V86, P7913, DOI 10.1021/ac501844b; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Zhou H, 2014, ANAL CHEM, V86, P6277, DOI 10.1021/ac500298a	33	18	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0170013	10.1371/journal.pone.0170013	http://dx.doi.org/10.1371/journal.pone.0170013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072827	Green Submitted, gold, Green Published			2022-12-26	WOS:000391844200060
J	Phi, JH; Suzuki, N; Moon, YJ; Park, AK; Wang, KC; Lee, JY; Choi, SA; Chong, S; Shirane, R; Kim, SK				Phi, Ji Hoon; Suzuki, Naoko; Moon, Youn Joo; Park, Ae Kyung; Wang, Kyu-Chang; Lee, Ji Yeoun; Choi, Seung-Ah; Chong, Sangjoon; Shirane, Reizo; Kim, Seung-Ki			Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease	PLOS ONE			English	Article							POLYMORPHISMS; GENES; LEVEL	The etiology and pathogenesis of moyamoya disease (MMD) are still obscure. Previous studies indicated that angiogenic chemokines may play an important role in the pathogenesis of the disease. Recently, it was discovered that peripheral blood-derived endothelial colony-forming cells (ECFCs) and smooth muscle progenitor cells (SPCs) have defective functions in MMD patients. Therefore, the interaction of ECFCs and SPCs, the precursors of two crucial cellular components of vascular walls, with some paracrine molecules is an intriguing subject. In this study, co-culture of ECFCs and SPCs from MMD patients and healthy normal subjects revealed that MMD ECFCs, not SPCs, are responsible for the defective functions of both ECFCs and SPCs. Enhanced migration of SPCs toward MMD ECFCs supported the role for some chemokines secreted by MMD ECFCs. Expression arrays of MMD and normal ECFCs suggested that several candidate cytokines differentially produced by MMD ECFCs. We selected chemokine (C-X-C motif) ligand 6 (CXCR6), interleukin-8 (IL8), chemokine (C-C motif) ligand 2 (CCL2), and CCL5 for study, based on the relatively higher expression of these ligands in MMD ECFCs and their cognate receptors in MMD SPCs. Migration assays showed that only CCL5 significantly augmented the migration activities of SPCs toward ECFCs. Treatment with siRNA for the CCL5 receptor (CCR5) abrogated the effect, confirming that CCL5 is responsible for the interaction of MMD ECFCs and SPCs. These data indicate that ECFCs, not SPCs, are the major players in MMD pathogenesis and that the chemokine CCL5 mediates the interactions. It can be hypothesized that in MMD patients, defective ECFCs direct aberrant SPC recruitment to critical vascular locations through the action of CCL5.	[Phi, Ji Hoon; Suzuki, Naoko; Moon, Youn Joo; Wang, Kyu-Chang; Lee, Ji Yeoun; Choi, Seung-Ah; Chong, Sangjoon; Kim, Seung-Ki] Seoul Natl Univ, Seoul Natl Univ Childrens Hosp, Coll Med, Div Pediat Neurosurg, Seoul, South Korea; [Park, Ae Kyung] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Lee, Ji Yeoun] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Shirane, Reizo] Miyagi Childrens Hosp, Dept Neurosurg, Sendai, Miyagi, Japan	Seoul National University (SNU); Seoul National University Hospital; Sunchon National University; Seoul National University (SNU)	Kim, SK (corresponding author), Seoul Natl Univ, Seoul Natl Univ Childrens Hosp, Coll Med, Div Pediat Neurosurg, Seoul, South Korea.	nsthomas@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0066]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0066).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Houkin K, 1998, Neurosurg Focus, V5, pe2; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Jung KH, 2008, J CEREBR BLOOD F MET, V28, P1795, DOI 10.1038/jcbfm.2008.67; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kang HS, 2006, NEUROSURGERY, V58, P1074, DOI 10.1227/01.NEU.0000215854.66011.4F; Kang HS, 2014, J NEUROSURG, V120, P415, DOI 10.3171/2013.9.JNS131000; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Kim JH, 2010, J NEUROSCI RES, V88, P510, DOI 10.1002/jnr.22228; Kim SK, 2010, MOYAMOYA DISEASE UPDATE, P63, DOI 10.1007/978-4-431-99703-0_10; Kim SK, 2003, STROKE, V34, P2835, DOI 10.1161/01.STR.0000100159.43123.D7; Kubo H, 1993, Nihon Geka Hokan, V62, P82; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lee JY, 2015, ARTERIOSCL THROM VAS, V35, P1670, DOI 10.1161/ATVBAHA.115.305363; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030873; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Noels H, 2014, ARTERIOSCL THROM VAS, V34, P1209, DOI 10.1161/ATVBAHA.113.302878; Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627; Qin X, 2011, CLIN CHIM ACTA, V412, P1112, DOI 10.1016/j.cca.2011.02.033; Rafat N, 2009, STROKE, V40, P432, DOI 10.1161/STROKEAHA.108.529420; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sugiyama T, 2011, NEUROL MED-CHIR, V51, P767; Takekawa Y, 2004, NEUROPATHOLOGY, V24, P236, DOI 10.1111/j.1440-1789.2004.00550.x; Um JY, 2009, J MOL NEUROSCI, V37, P1, DOI 10.1007/s12031-008-9047-9; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401	29	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169714	10.1371/journal.pone.0169714	http://dx.doi.org/10.1371/journal.pone.0169714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072843	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200040
J	Shuryak, I				Shuryak, Igor			Advantages of Synthetic Noise and Machine Learning for Analyzing Radioecological Data Sets	PLOS ONE			English	Article							VARIABLE SELECTION	The ecological effects of accidental or malicious radioactive contamination are insufficiently understood because of the hazards and difficulties associated with conducting studies in radioactively-polluted areas. Data sets from severely contaminated locations can therefore be small. Moreover, many potentially important factors, such as soil concentrations of toxic chemicals, pH, and temperature, can be correlated with radiation levels and with each other. In such situations, commonly-used statistical techniques like generalized linear models (GLMs) may not be able to provide useful information about how radiation and/or these other variables affect the outcome (e.g. abundance of the studied organisms). Ensemble machine learning methods such as random forests offer powerful alternatives. We propose that analysis of small radioecological data sets by GLMs and/or machine learning can be made more informative by using the following techniques: (1) adding synthetic noise variables to provide benchmarks for distinguishing the performances of valuable predictors from irrelevant ones; (2) adding noise directly to the predictors and/or to the outcome to test the robustness of analysis results against random data fluctuations; (3) adding artificial effects to selected predictors to test the sensitivity of the analysis methods in detecting predictor effects; (4) running a selected machine learning method multiple times (with different random-number seeds) to test the robustness of the detected "signal"; (5) using several machine learning methods to test the "signal's" sensitivity to differences in analysis techniques. Here, we applied these approaches to simulated data, and to two published examples of small radioecological data sets: (I) counts of fungal taxa in samples of soil contaminated by the Chernobyl nuclear power plan accident (Ukraine), and (II) bacterial abundance in soil samples under a ruptured nuclear waste storage tank (USA). We show that the proposed techniques were advantageous compared with the methodology used in the original publications where the data sets were presented. Specifically, our approach identified a negative effect of radioactive contamination in data set I, and suggested that in data set II stable chromium could have been a stronger limiting factor for bacterial abundance than the radionuclides Cs-137 and Tc-99. This new information, which was extracted from these data sets using the proposed techniques, can potentially enhance the design of radioactive waste bioremediation.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu			Defense Threat Reduction Agency (DTRA) [11559558]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Defense Threat Reduction Agency (DTRA) grant 11559558 (http://www.dtra.mil/).	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Holzinger ER, 2015, BIOCOMPUT-PAC SYM, P195; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2015, MACH LEARN, V99, P75, DOI 10.1007/s10994-014-5451-2; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Ruggiero CE, 2005, ENVIRON MICROBIOL, V7, P88, DOI 10.1111/j.1462-2920.2004.00666.x; Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-5; Soykan CU, 2014, ECOL APPL, V24, P71, DOI 10.1890/12-0826.1; Szymczak S, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0087-3; ZHDANOVA NN, 1994, MYCOL RES, V98, P789, DOI 10.1016/S0953-7562(09)81057-5	15	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0170007	10.1371/journal.pone.0170007	http://dx.doi.org/10.1371/journal.pone.0170007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068401	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900083
J	Pace, M; Adamantidis, A; Facchin, L; Bassetti, C				Pace, Marta; Adamantidis, Antoine; Facchin, Laura; Bassetti, Claudio			Role of REM Sleep, Melanin Concentrating Hormone and Orexin/Hypocretin Systems in the Sleep Deprivation Pre-Ischemia	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OREXIN-A; ISOFLURANE ANESTHESIA; STROKE MECHANISMS; BRAIN; NEURONS; RAT; ADENOSINE; INFLAMMATION; NEUROGENESIS	Study Objectives Sleep reduction after stroke is linked to poor recovery in patients. Conversely, a neuroprotective effect is observed in animals subjected to acute sleep deprivation (SD) before ischemia. This neuroprotection is associated with an increase of the sleep, melanin concentrating hormone (MCH) and orexin/hypocretin (OX) systems. This study aims to 1) assess the relationship between sleep and recovery; 2) test the association between MCH and OX systems with the pathological mechanisms of stroke. Methods Sprague-Dawley rats were assigned to four experimental groups: (i) SD_IS: SD performed before ischemia; (ii) IS: ischemia; (iii) SD_Sham: SD performed before sham surgery; (iv) Sham: sham surgery. EEG and EMG were recorded. The time-course of the MCH and OX gene expression was measured at 4, 12, 24 hours and 3, 4, 7 days following ischemic surgery by qRT-PCR. Results A reduction of infarct volume was observed in the SD_IS group, which correlated with an increase of REM sleep observed during the acute phase of stroke. Conversely, the IS group showed a reduction of REM sleep. Furthermore, ischemia induces an increase of MCH and OX systems during the acute phase of stroke, although, both systems were still increased for a long period of time only in the SD_IS group. Conclusions Our data indicates that REM sleep may be involved in the neuroprotective effect of SD pre-ischemia, and that both MCH and OX systems were increased during the acute phase of stroke. Future studies should assess the role of REM sleep as a prognostic marker, and test MCH and OXA agonists as new treatment options in the acute phase of stroke.	[Pace, Marta; Adamantidis, Antoine; Facchin, Laura; Bassetti, Claudio] Univ Hosp Bern, Ctr Expt Neurol ZEN, Dept Neurol, Bern, Switzerland; [Pace, Marta] IIT, Dept Neurosci & Brain Technol, Genoa, Italy; [Bassetti, Claudio] Univ Hosp Bern, Sleep Wake Epilepsy Ctr, Dept Neurol, Bern, Switzerland; [Bassetti, Claudio] Univ Bern, Dept Neurol, Div Cognit & Restorat Neurol, Bern, Switzerland	University of Bern; University Hospital of Bern; Istituto Italiano di Tecnologia - IIT; University of Bern; University Hospital of Bern; University of Bern	Pace, M (corresponding author), Univ Hosp Bern, Ctr Expt Neurol ZEN, Dept Neurol, Bern, Switzerland.; Pace, M (corresponding author), IIT, Dept Neurosci & Brain Technol, Genoa, Italy.	marta.pace@iit.it		Pace, Marta/0000-0003-1637-4544; Bassetti, Claudio/0000-0002-4535-0245; Adamantidis, Antoine/0000-0003-2531-5175				Ahmed S, 2011, EXP NEUROL, V232, P168, DOI 10.1016/j.expneurol.2011.08.020; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Ashwell KWS, 2007, BRAIN STRUCT FUNCT, V212, P209, DOI 10.1007/s00429-007-0139-z; Baracchi F, 2011, AM J PHYSIOL-REG I, V301, pR1467, DOI 10.1152/ajpregu.00354.2011; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Basheer R, 2007, NEUROREPORT, V18, P1895, DOI 10.1097/WNR.0b013e3282f262f6; Bassetti Claudio L, 2011, Handb Clin Neurol, V99, P1051, DOI 10.1016/B978-0-444-52007-4.00021-7; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Butterick TA, 2012, NEUROSCI LETT, V524, P30, DOI 10.1016/j.neulet.2012.07.002; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Cam E, 2013, EXP NEUROL, V247, P673, DOI 10.1016/j.expneurol.2013.03.003; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Clark IA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-51; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Duncan PW, 2002, J REHABIL RES DEV, V39, pix; Elmenhorst D, 2007, J NEUROSCI, V27, P2410, DOI 10.1523/JNEUROSCI.5066-06.2007; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; Gerashchenko D, 2004, BRAIN RES, V1019, P162, DOI 10.1016/j.brainres.2004.06.016; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; GIUBILEI F, 1992, ACTA NEUROL SCAND, V86, P567, DOI 10.1111/j.1600-0404.1992.tb05488.x; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Harada S, 2011, J PHARMACOL SCI, V115, P155, DOI 10.1254/jphs.10264FP; Harada S, 2013, J PHARMACOL EXP THER, V344, P276, DOI 10.1124/jpet.112.199604; Hodor A, 2014, ANN CLIN TRANSL NEUR, V1, P765, DOI 10.1002/acn3.115; Hollis JH, 2010, NEUROPHARMACOLOGY, V58, P730, DOI 10.1016/j.neuropharm.2009.12.016; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Irving EA, 2002, NEUROSCI LETT, V324, P53, DOI 10.1016/S0304-3940(02)00176-3; Jang HS, 2010, KOREAN J PHYSIOL PHA, V14, P291, DOI 10.4196/kjpp.2010.14.5.291; KAMEYAMA M, 1985, STROKE, V16, P489, DOI 10.1161/01.STR.16.3.489; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Kitamura E, 2010, NEUROSCI RES, V68, P154, DOI 10.1016/j.neures.2010.06.010; Kotan D, 2013, J INT MED RES, V41, P404, DOI 10.1177/0300060513477002; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Lee SH, 2007, NEUROSCIENCE, V146, P1020, DOI 10.1016/j.neuroscience.2007.02.058; Mashour GA, 2010, ANESTH ANALG, V110, P1283, DOI 10.1213/ANE.0b013e3181d3e861; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Miller DJ, 2011, NEUROHOSPITALIST, V1, P138, DOI 10.1177/1941875211408731; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muller C, 2002, EUR NEUROL, V48, P164, DOI 10.1159/000065509; Nakamachi T, 2005, REGUL PEPTIDES, V126, P49, DOI 10.1016/j.regpep.2004.08.037; Naylor M, 2005, NEUROCHEM INT, V47, P565, DOI 10.1016/j.neuint.2005.07.003; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111; Pace M, 2015, SLEEP; Peyron C, 1998, J NEUROSCI, V18, P9996; Poryazova R, 2015, J SLEEP RES, V24, P54, DOI 10.1111/jsr.12208; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Presse F, 2014, Int J Obes Suppl, V4, pS31, DOI 10.1038/ijosup.2014.9; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sandig H, 2007, P NATL ACAD SCI USA, V104, P12440, DOI 10.1073/pnas.0705457104; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; Siccoli MM, 2008, EUR J NEUROL, V15, P565, DOI 10.1111/j.1468-1331.2008.02119.x; Siengsukon C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00225; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Song J, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0106-1; Stoyanova II, 2012, CELL MOL NEUROBIOL, V32, P49, DOI 10.1007/s10571-011-9733-y; Takase K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099961; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Teske JA, 2010, ACTA PHYSIOL, V198, P303, DOI 10.1111/j.1748-1716.2010.02075.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; Williams-Karnesky RL, 2009, CURR NEUROPHARMACOL, V7, P217, DOI 10.2174/157015909789152209; Winship IR, 2008, J NEUROSCI, V28, P6592, DOI 10.1523/JNEUROSCI.0622-08.2008; Xiong XX, 2013, STROKE, V44, P764, DOI 10.1161/STROKEAHA.112.681700	80	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168430	10.1371/journal.pone.0168430	http://dx.doi.org/10.1371/journal.pone.0168430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28061506	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500031
J	Richoz, AR; Quinn, PC; de Boisferon, AH; Berger, C; Loevenbruck, H; Lewkowicz, DJ; Lee, K; Dole, M; Caldara, R; Pascalis, O				Richoz, Anne-Raphaelle; Quinn, Paul C.; de Boisferon, Anne Hillairet; Berger, Carole; Loevenbruck, Helene; Lewkowicz, David J.; Lee, Kang; Dole, Marjorie; Caldara, Roberto; Pascalis, Olivier			Audio-Visual Perception of Gender by Infants Emerges Earlier for Adult-Directed Speech	PLOS ONE			English	Article							MOTHERS SPEECH; FEMALE FACES; RECOGNITION; PREFERENCE; DISCRIMINATION; VOICE; INFORMATION; COHERENCE; KNOWLEDGE; ENGLISH	Early multisensory perceptual experiences shape the abilities of infants to perform socially-relevant visual categorization, such as the extraction of gender, age, and emotion from faces. Here, we investigated whether multisensory perception of gender is influenced by infant-directed (IDS) or adult-directed (ADS) speech. Six-, 9-, and 12-month-old infants saw side-by-side silent video-clips of talking faces (a male and a female) and heard either a soundtrack of a female or a male voice telling a story in IDS or ADS. Infants participated in only one condition, either IDS or ADS. Consistent with earlier work, infants displayed advantages in matching female relative to male faces and voices. Moreover, the new finding that emerged in the current study was that extraction of gender from face and voice was stronger at 6 months with ADS than with IDS, whereas at 9 and 12 months, matching did not differ for IDS versus ADS. The results indicate that the ability to perceive gender in audiovisual speech is influenced by speech manner. Our data suggest that infants may extract multisensory gender information developmentally earlier when looking at adults engaged in conversation with other adults (i.e., ADS) than when adults are directly talking to them (i.e., IDS). Overall, our findings imply that the circumstances of social interaction may shape early multisensory abilities to perceive gender.	[Richoz, Anne-Raphaelle; Caldara, Roberto] Univ Fribourg, Dept Psychol, Eye & Brain Mapping Lab BMLab, Fribourg, Switzerland; [Richoz, Anne-Raphaelle; de Boisferon, Anne Hillairet; Berger, Carole; Loevenbruck, Helene; Dole, Marjorie; Pascalis, Olivier] Univ Grenoble Alpes, LPNC, Grenoble, France; [Richoz, Anne-Raphaelle; de Boisferon, Anne Hillairet; Berger, Carole; Loevenbruck, Helene; Dole, Marjorie; Pascalis, Olivier] Univ Grenoble Alpes, CNRS UMR 5105, LPNC, Grenoble, France; [Quinn, Paul C.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Lewkowicz, David J.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Lee, Kang] Univ Toronto, Inst Child Study, Toronto, ON, Canada	University of Fribourg; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Delaware; Northeastern University; University of Toronto	Pascalis, O (corresponding author), Univ Grenoble Alpes, LPNC, Grenoble, France.; Pascalis, O (corresponding author), Univ Grenoble Alpes, CNRS UMR 5105, LPNC, Grenoble, France.	olivier.pascalis@univ-grenoble-alpes.fr	Hillairet de Boisferon, Anne/H-4655-2019	Hillairet de Boisferon, Anne/0000-0002-7304-6291; Caldara, Roberto/0000-0002-8260-9949; Lewkowicz, David/0000-0001-6685-3178	National Institute of Child Health and Human Development [R01 HD-46526]; Rectors' Conference of Swiss Universities (CRUS) [F14/06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Rectors' Conference of Swiss Universities (CRUS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant R01 HD-46526 from the National Institute of Child Health and Human Development (P.Q., O.P., K.L.). This research was also supported by grant F14/06 from the Rectors' Conference of Swiss Universities (CRUS) (A.R.R.).	Andruski J., 1997, BIANN M SOC RES CHIL; ASLIN RN, 2000, INT C INF STUD BRIGH; Barenholtz E, 2014, PSYCHON B REV, V21, P1346, DOI 10.3758/s13423-014-0612-7; Boersma P., 2011, EAR HEARING, V32, P266, DOI [10.4278/0890-1171-5.2.91,2, DOI 10.4278/0890-1171-5.2.91,2]; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; COHEN LB, 1979, CHILD DEV, V50, P419, DOI 10.2307/1129417; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; CORNELL EH, 1974, J EXP CHILD PSYCHOL, V18, P98, DOI 10.1016/0022-0965(74)90092-7; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; Csibra G, 2006, ATTENTION PERFORM, P249; Dang JH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00933; de Boisferon AH, 2015, INFANCY, V20, P661, DOI 10.1111/infa.12088; Dohen M., 2009, VISUAL SPEECH RECOGN, P416; Dunst CJ, 2012, J INTELLECT DEV DIS, V37, P89, DOI 10.3109/13668250.2012.673575; FAGAN JF, 1979, INFANT BEHAV DEV, V2, P39, DOI 10.1016/S0163-6383(79)80006-5; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; Fernald A, 1998, PSYCHOL SCI, V9, P228, DOI 10.1111/1467-9280.00044; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FERNALD A, 1984, DEV PSYCHOL, V20, P104, DOI 10.1037/0012-1649.20.1.104; Fernald A., 1992, ADAPTED MIND EVOLUTI; Guellai B, 2011, VIS COGN, V19, P1212, DOI 10.1080/13506285.2011.620578; HOMA D, 1981, J EXP PSYCHOL-HUM L, V7, P418, DOI 10.1037/0278-7393.7.6.418; Kaplan PS, 2002, PSYCHOL SCI, V13, P268, DOI 10.1111/1467-9280.00449; Kaplan PS, 1999, CHILD DEV, V70, P560, DOI 10.1111/1467-8624.00041; KEATING PA, 1994, J PHONETICS, V22, P407, DOI 10.1016/S0095-4470(19)30293-1; KELSO JAS, 1985, J ACOUST SOC AM, V77, P266, DOI 10.1121/1.392268; Kim HI, 2014, DEVELOPMENTAL SCI, V17, P621, DOI 10.1111/desc.12146; Kim HI, 2013, INT J BEHAV DEV, V37, P125, DOI 10.1177/0165025413475972; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; Knight B, 1997, VIS COGN, V4, P265, DOI 10.1080/713756764; LEINBACH MD, 1993, INFANT BEHAV DEV, V16, P317, DOI 10.1016/0163-6383(93)80038-A; Lewkowicz DJ, 2015, J EXP CHILD PSYCHOL, V130, P147, DOI 10.1016/j.jecp.2014.10.006; Lewkowicz DJ, 1998, DEV PSYCHOBIOL, V32, P261, DOI 10.1002/(SICI)1098-2302(199805)32:4<261::AID-DEV1>3.0.CO;2-L; Liu HM, 2003, DEVELOPMENTAL SCI, V6, pF1, DOI 10.1111/1467-7687.00275; Liu SY, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00593; Loevenbruck H., 1999, P 14 INT C PHON SCI, P667; Loevenbruck H., 2000, P 23 JEP AUSS FRANC, P165; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Nakata T, 2004, INFANT BEHAV DEV, V27, P455, DOI 10.1016/j.infbeh.2004.03.002; Newman RS, 2006, INFANCY, V10, P61, DOI 10.1207/s15327078in1001_4; O'Toole AJ, 1998, MEM COGNITION, V26, P146, DOI 10.3758/BF03211378; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Otsuka Y, 2009, CHILD DEV, V80, P1259, DOI 10.1111/j.1467-8624.2009.01330.x; PAPOUSEK M, 1991, INFANT BEHAV DEV, V14, P415, DOI 10.1016/0163-6383(91)90031-M; PAPOUSEK M, 1987, J PSYCHOLINGUIST RES, V16, P491, DOI 10.1007/BF01073274; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; PEGG JE, 1992, INFANT BEHAV DEV, V15, P325, DOI 10.1016/0163-6383(92)80003-D; Poulin-Dubois D, 1998, MERRILL PALMER QUART, V44, P338; POULINDUBOIS D, 1994, DEV PSYCHOL, V30, P436, DOI 10.1037/0012-1649.30.3.436; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Ramsey JL, 2005, DEV REV, V25, P212, DOI 10.1016/j.dr.2005.01.001; Ramsey-Rennels JL, 2006, CURR DIR PSYCHOL SCI, V15, P59, DOI 10.1111/j.0963-7214.2006.00407.x; Rennels JL, 2008, INFANT BEHAV DEV, V31, P665, DOI 10.1016/j.infbeh.2008.04.009; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rose SA, 2003, DEV PSYCHOL, V39, P563, DOI 10.1037/0012-1649.39.3.563; Rosenblum LD, 2008, CURR DIR PSYCHOL SCI, V17, P405, DOI 10.1111/j.1467-8721.2008.00615.x; Schachner A, 2011, DEV PSYCHOL, V47, P19, DOI 10.1037/a0020740; Sugden NA, 2014, DEV PSYCHOBIOL, V56, P249, DOI 10.1002/dev.21183; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Trainor LJ, 2000, PSYCHOL SCI, V11, P188, DOI 10.1111/1467-9280.00240; Trainor LJ, 1997, INFANT BEHAV DEV, V20, P383, DOI 10.1016/S0163-6383(97)90009-6; Trainor LJ, 2002, PSYCHON B REV, V9, P335, DOI 10.3758/BF03196290; Trehub SE, 2001, MUSIC SCI, V5, P37, DOI 10.1177/10298649020050S103; Trehub SE, 2009, ANN NY ACAD SCI, V1169, P508, DOI 10.1111/j.1749-6632.2009.04851.x; Van Borsel J, 2009, J VOICE, V23, P291, DOI 10.1016/j.jvoice.2007.08.002; WALKER-ANDREWS A S, 1991, Ecological Psychology, V3, P55, DOI 10.1207/s15326969eco0302_1; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006; Xiao NQG, 2015, DEV PSYCHOL, V51, P744, DOI 10.1037/dev0000019; Yonas A., 1988, PERCEPTUAL DEV INFAN, V20, P235; Younger BA, 1999, CHILD DEV, V70, P291, DOI 10.1111/1467-8624.00022; Zangl R, 2007, INFANCY, V11, P31, DOI 10.1207/s15327078in1101_2	74	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169325	10.1371/journal.pone.0169325	http://dx.doi.org/10.1371/journal.pone.0169325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060872	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500081
J	Tseng, CW; Lin, CL; Chen, YT; Jeng, LB				Tseng, Chih-Wei; Lin, Cheng-Li; Chen, Yu-Tso; Jeng, Long-Bin			Ischemic Bowel Syndrome in Patients with Spinal Cord Injury: A Nationwide Study	PLOS ONE			English	Article							RISK-FACTORS; HEMODIALYSIS; INFARCTION; MORTALITY; DISEASE; COHORT	Purpose The aim of this study was to determine whether spinal cord injuries (SCI) is associated with increased risk of ischemic bowel syndrome (IBS) in an Asian population by analyzing data from the National Health Insurance Research Database (NHIRD) in Taiwan. Methods Patients aged >= 20 years in the inpatient database with newly identified SCI from 2000 to 2011 were selected as the SCI cohort. For the non-SCI cohort, patients were selected based on a 1:4 risk-set sampling. Hospitalization with a new diagnosis of IBS during the follow-up was the main outcome measure. We used the standard univariable and multivariable Cox proportional hazard regression models to determine adjusted subhazard ratios (SHR) and 95% confidence interval (CI) in the SCI and non-SCI cohorts. Results Patients with SCI were at significant risk for IBS, with an adjusted SHR (aSHR) of 1.25, 95% CI = 1.04-1.51. Multivariable analysis showed individuals with SCI were associated with a greater risk of IBS than individuals without SCI among males (aSHR = 1.47, 95% CI = 1.161.86), all age groups (<= 49 y: aSHR = 2.15, 95% CI = 1.24-3.74; 50-65 y: aSHR = 1.82, 95% CI = 1.15-2.88; >65 y: aSHR = 1.39, 95% CI = 1.11-1.74) and those without comorbidities (aSHR = 1.41, 95% CI = 1.04-1.93). Comorbidities including diabetes, hypertension, heart failure, coronary artery disease (CAD), Stroke, and end stage renal disease (ESRD) significantly increased the risk of IBS. Conclusion Patients hospitalized for SCI have increased risks of developing IBS. Though the mechanism that predisposes SCI patients to IBS is unclear, we suggest that physicians promptly identify and treat correctable risk factors.	[Tseng, Chih-Wei] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Chen, Yu-Tso] Feng Yuan Hosp, Minist Hlth & Welf, Div Gastroenterol & Hepatol, Dept Internal Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Jeng, Long-Bin] China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Jeng, LB (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Jeng, LB (corresponding author), China Med Univ Hosp, Dept Surg, Organ Transplantat Ctr, Taichung, Taiwan.	otc.Jeng@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chen YK, 2013, INT J CARDIOL, V168, P1681, DOI 10.1016/j.ijcard.2013.03.077; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; DiMarco AF, 2014, J SPINAL CORD MED, V37, P670, DOI 10.1179/2045772314Y.0000000208; Fitzgerald T, 2000, AM SURGEON, V66, P623; Flobert C, 2000, AM J GASTROENTEROL, V95, P195; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Groah SL, 2001, SPINAL CORD, V39, P310, DOI 10.1038/sj.sc.3101162; Hagen Ellen Merete, 2012, Tidsskr Nor Laegeforen, V132, P1115, DOI 10.4045/tidsskr.11.0551; Huerta C, 2011, ALIMENT PHARM THER, V33, P969, DOI 10.1111/j.1365-2036.2011.04614.x; John AS, 2000, J AM COLL SURGEONS, V190, P84, DOI 10.1016/S1072-7515(99)00226-4; Kim HR, 2013, CLIN MOL HEPATOL, V19, P417, DOI 10.3350/cmh.2013.19.4.417; Li SY, 2012, AM J NEPHROL, V35, P491, DOI 10.1159/000338451; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Popa Constantin, 2010, J Med Life, V3, P275; Szlachcic Yaga, 2014, Top Spinal Cord Inj Rehabil, V20, P96, DOI 10.1310/sci2002-96; Yang TY, 2015, SPINE, V40, P147, DOI 10.1097/BRS.0000000000000704	19	4	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169070	10.1371/journal.pone.0169070	http://dx.doi.org/10.1371/journal.pone.0169070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056095	Green Submitted, gold, Green Published			2022-12-26	WOS:000391639100019
J	Chidawanyika, F; Nyamukondiwa, C; Strathie, L; Fischer, K				Chidawanyika, Frank; Nyamukondiwa, Casper; Strathie, Lorraine; Fischer, Klaus			Effects of Thermal Regimes, Starvation and Age on Heat Tolerance of the Parthenium Beetle Zygogramma bicolorata (Coleoptera: Chrysomelidae) following Dynamic and Static Protocols	PLOS ONE			English	Article							RED FLOUR BEETLE; CLIMATE-CHANGE; DROSOPHILA-MELANOGASTER; PHYSIOLOGICAL PERFORMANCE; METHODOLOGICAL CONTEXT; TEMPERATURE-VARIATION; CERATITIS-CAPITATA; PLASTIC RESPONSES; INSECT HERBIVORE; CROSS-TOLERANCE	Temperature and resource availability are key elements known to limit the occurrence and survival of arthropods in the wild. In the current era of climate change, critical thermal limits and the factors affecting these may be of particular importance. We therefore investigated the critical thermal maxima (CTmax) of adult Zygogramma bicolorata beetles, a biological control agent for the invasive plant Parthenium hysterophorus, in relation to thermal acclimation, hardening, age, and food availability using static (constant) and dynamic (ramping) protocols. Increasing temperatures and exposure times reduced heat survival. In general, older age and lack of food reduced heat tolerance, suggesting an important impact of resource availability. Acclimation at constant temperatures did not affect CTmax, while fluctuating thermal conditions resulted in a substantial increase. Hardening at 33 degrees C and 35 degrees C improved heat survival in fed young and mid-aged but only partly in old beetles, while CTmax remained unaffected by hardening throughout. These findings stress the importance of methodology when assessing heat tolerance. Temperature data recorded in the field revealed that upper thermal limits are at least occasionally reached in nature. Our results therefore suggest that the occurrence of heat waves may influence the performance and survival of Z. bicolorata, potentially impacting on its field establishment and effectiveness as a biological control agent.	[Chidawanyika, Frank; Strathie, Lorraine] Agr Res Council, Plant Protect Res Inst, Weeds Div, Hilton, South Africa; [Nyamukondiwa, Casper] Botswana Int Univ Sci & Technol, Coll Sci, Dept Biol & Biotechnol Sci, Palapye, Botswana; [Fischer, Klaus] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany	Agricultural Research Council of South Africa; Ernst Moritz Arndt Universitat Greifswald	Chidawanyika, F (corresponding author), Agr Res Council, Plant Protect Res Inst, Weeds Div, Hilton, South Africa.	chidawanyikaF@arc.agric.za	Chidawanyika, Frank/AAJ-7551-2020	Chidawanyika, Frank/0000-0002-4601-768X	Department of Environmental Affairs, South Africa, Natural Resource Management Program	Department of Environmental Affairs, South Africa, Natural Resource Management Program	We appreciate funding support from Department of Environmental Affairs, South Africa, Natural Resource Management Program (https://www.environment.gov.za/branches/environmental_programmes) provided to FC and LS through the Agricultural Research Council. The funders had no role in the design of the study, data collection and manuscript preparation or decision to publish.	Agresti A, 2007, INTRO CATEGORICAL DA; Andersen JL, 2013, J INSECT PHYSIOL, V59, P1041, DOI 10.1016/j.jinsphys.2013.07.008; Andrew NR, 2013, J INSECT PHYSIOL, V59, P870, DOI 10.1016/j.jinsphys.2013.06.003; [Anonymous], 2010, LOW TEMPERATURE BIOL; Auguie B, 2017, GRIDEXTRA MISCELLANE; Basson CH, 2012, EVOLUTION, V66, P296, DOI 10.1111/j.1558-5646.2011.01419.x; Bauerfeind SS, 2014, POPUL ECOL, V56, P239, DOI 10.1007/s10144-013-0409-y; Blackburn S, 2014, J EXP BIOL, V217, P1918, DOI 10.1242/jeb.099184; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Bubliy OA, 2012, FUNCT ECOL, V26, P245, DOI 10.1111/j.1365-2435.2011.01928.x; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chidawanyika F, 2011, EVOL APPL, V4, P534, DOI 10.1111/j.1752-4571.2010.00168.x; Chown SL, 2004, INSECT PHYSL ECOLOGI; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Colinet H, 2016, J GERONTOL A-BIOL, V71, P1574, DOI 10.1093/gerona/glv193; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; Colinet H, 2013, J EXP BIOL, V216, P253, DOI 10.1242/jeb.076216; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Dhileepan K, 2000, BIOCONTROL, V45, P501, DOI 10.1023/A:1026528304473; Dowd WW, 2015, J EXP BIOL, V218, P1956, DOI 10.1242/jeb.114926; Enserink M, 2007, SCIENCE, V317, P310, DOI 10.1126/science.317.5836.310; Esperk T, 2016, J EVOLUTION BIOL, V29, P900, DOI 10.1111/jeb.12832; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fischer K, 2010, CLIM RES, V43, P17, DOI 10.3354/cr00892; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Gerken AR, 2015, P NATL ACAD SCI USA, V112, P4399, DOI 10.1073/pnas.1503456112; Halle S, 2015, BIOL J LINN SOC, V115, P305, DOI 10.1111/bij.12501; Harrison JF, 2012, ECOL ENVIRON PHYSIOL, P1, DOI 10.1093/acprof:oso/9780199225941.001.0001; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Karl I, 2014, PHYSIOL ENTOMOL, V39, P222, DOI 10.1111/phen.12065; Karl I, 2012, PHYSIOL ENTOMOL, V37, P103, DOI 10.1111/j.1365-3032.2011.00814.x; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; King H., 2008, THESIS; Kingsolver JG, 2015, J EXP BIOL, V218, P2218, DOI 10.1242/jeb.120733; Klepsatel P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33667; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Lagerspetz KYH, 2006, J THERM BIOL, V31, P332, DOI 10.1016/j.jtherbio.2006.01.003; Lalouette L, 2010, BIOL LETTERS, V6, P346, DOI 10.1098/rsbl.2009.0873; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Ma G, 2015, J EXP BIOL, V218, P2289, DOI 10.1242/jeb.122127; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Marais E, 2009, J INSECT PHYSIOL, V55, P336, DOI 10.1016/j.jinsphys.2008.11.016; Marshall KE, 2012, J EXP BIOL, V215, P1607, DOI 10.1242/jeb.059956; McConnachie AJ, 2015, BIOCONTROL SCI TECHN, V25, P975, DOI 10.1080/09583157.2015.1023696; Nedved O, 1998, FUNCT ECOL, V12, P816, DOI 10.1046/j.1365-2435.1998.00250.x; Nyamukondiwa C, 2009, J THERM BIOL, V34, P406, DOI 10.1016/j.jtherbio.2009.09.002; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Pappas C, 2007, COMP BIOCHEM PHYS A, V146, P355, DOI 10.1016/j.cbpa.2006.11.010; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Petavy G, 2004, EVOL ECOL RES, V6, P873; Petavy G, 2001, J THERM BIOL, V26, P29, DOI 10.1016/S0306-4565(00)00022-X; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Rezende EL, 2014, FUNCT ECOL, V28, P799, DOI 10.1111/1365-2435.12268; Santos M, 2011, FUNCT ECOL, V25, P1169, DOI 10.1111/j.1365-2435.2011.01908.x; Scharf I, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1344-5; Scott M, 1997, ENTOMOL EXP APPL, V85, P211, DOI 10.1023/A:1003173612155; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; Sinclair BJ, 2013, INTEGR COMP BIOL, V53, P545, DOI 10.1093/icb/ict004; Sorensen JG, 2012, CROP PROT, V38, P87, DOI 10.1016/j.cropro.2012.03.023; Statsoft Inc, 2015, STAT 13 0 DAT AN SOF; Stotter RL, 2009, J THERM BIOL, V34, P320, DOI 10.1016/j.jtherbio.2009.05.002; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2007, SCIENCE, V317, P1678; Terblanche JS, 2014, CURR OPIN INSECT SCI, V4, P60, DOI 10.1016/j.cois.2014.06.003; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Thomson LJ, 2001, FUNCT ECOL, V15, P217, DOI 10.1046/j.1365-2435.2001.00516.x; van Asch M, 2007, GLOBAL CHANGE BIOL, V13, P1596, DOI 10.1111/j.1365-2486.2007.01400.x; van Asch M, 2013, NAT CLIM CHANGE, V3, P244, DOI [10.1038/nclimate1717, 10.1038/NCLIMATE1717]; van Asch M, 2010, FUNCT ECOL, V24, P1103, DOI 10.1111/j.1365-2435.2010.01734.x; Verberk WCEP, 2016, COMP BIOCHEM PHYS A, V192, P64, DOI 10.1016/j.cbpa.2015.10.020; Weldon CW, 2011, J THERM BIOL, V36, P479, DOI 10.1016/j.jtherbio.2011.08.005; Zhang W, 2015, OECOLOGIA, V179, P947, DOI 10.1007/s00442-015-3409-0	84	57	60	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169371	10.1371/journal.pone.0169371	http://dx.doi.org/10.1371/journal.pone.0169371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052099	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500054
J	Riofrio-Lazo, M; Arreguin-Sanchez, F; Paez-Rosas, D				Riofrio-Lazo, Marjorie; Arreguin-Sanchez, Francisco; Paez-Rosas, Diego			Population Abundance of the Endangered Galapagos Sea Lion Zalophus wollebaeki in the Southeastern Galapagos Archipelago	PLOS ONE			English	Article							FUR SEALS; CALIFORNIANUS-CALIFORNIANUS; FORAGING STRATEGIES; PUP PRODUCTION; SITE FIDELITY; CONSERVATION; ISLANDS; UNCERTAINTY; VARIABILITY; PERSPECTIVE	There is great concern regarding the population status of the endangered Galapagos sea lion (GSL) because it has drastically decreased over the last 30 years. We determined the population size and growth trend of the GSL in the Galapagos southeastern region (SER) at three population levels based on the available census data: 1) SER (2011 - 2015), including 13 rookeries on the four islands San Cristobal (SC), Espanola, Floreana, and Santa Fe, comprising 58% of the archipelago's population; 2) SC (2011 - 2015), including five rookeries, comprising 52% of the SER population; and 3) El Malecon (2005 - 2015), the largest rookery on SC and in the SER (43% of the population on SC and 22% in the SER). We also analyzed the influence of environmental variability on pup abundance in these rookeries. The current GSL population size in the SER, after applying correction factors to the counts, is estimated at approximately 2300 - 4100 individuals and has declined at an average annual rate (lambda) of 8.7% over the last five years. A similar trend was determined for SC but at lambda = 1.4% during the same period. For El Malecon, a count-based population viability analysis using a diffusion approximation approach showed that the population increased from 2005 to 2015 at lambda= 2%. The interannual variability in pup abundance was associated with anomalies in sea surface temperature linked to oceanographic-atmospheric events, which impact the abundance and availability of prey, and ultimately may determine the population's reproductive success. Since rookeries in the SER had different population trends, management actions should be implemented based on their specific conditions, giving priority to rookeries such as El Malecon, which, despite showing a slightly increasing population trend, still faces a high risk of extinction due to anthropogenic disturbances and environmental variability that may affect its growth and survival.	[Riofrio-Lazo, Marjorie; Paez-Rosas, Diego] Univ San Francisco Quito, Galapagos Sci Ctr, Galapagos, Ecuador; [Riofrio-Lazo, Marjorie; Arreguin-Sanchez, Francisco] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz, Baja California, Mexico; [Paez-Rosas, Diego] Direcc Parque Nacl Galapagos, Unidad Tecn Operat San Cristobal, San Cristobal Island, Galapagos, Ecuador	Instituto Politecnico Nacional - Mexico	Riofrio-Lazo, M (corresponding author), Univ San Francisco Quito, Galapagos Sci Ctr, Galapagos, Ecuador.; Riofrio-Lazo, M (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz, Baja California, Mexico.	marjorieriofrio@gmail.com	ARREGUIN-SANCHEZ, FRANCISCO/A-7169-2008; Riofrío-Lazo, Marjorie/AFL-8440-2022; Riofrío-Lazo, Marjorie/AAG-8510-2022; Páez-Rosas, Diego/X-3047-2019	ARREGUIN-SANCHEZ, FRANCISCO/0000-0002-0143-6629; Riofrío-Lazo, Marjorie/0000-0003-4431-3458; Riofrío-Lazo, Marjorie/0000-0003-4431-3458; Páez-Rosas, Diego/0000-0002-2446-9888	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador; Universidad San Francisco de Quito through the Galapagos Science Center; Institute Politecnico Nacional through EDI program; Institute Politecnico Nacional through COFAA program	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador; Universidad San Francisco de Quito through the Galapagos Science Center; Institute Politecnico Nacional through EDI program; Institute Politecnico Nacional through COFAA program	This work was funded and supported by Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador through the scholarship provided to MRL, grants from the Universidad San Francisco de Quito through the Galapagos Science Center awarded to MRL and DPR, and the Institute Politecnico Nacional through the EDI and COFAA programs provided to FAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the financial support from the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador through the scholarship provided to the first author and for grants from the Universidad San Francisco de Quito. FAS thanks the Instituto Politecnico Nacional for financial support through the EDI and COFAA programs. We also thank Claudia Hernandez-Camacho for help in performing the PVA and for constructive comments on an early version of the manuscript. The authors also thank the Direccion Parque Nacional Galapagos for the research permits and logistical support, especially to the rangers Jorge Torres and Jefferson Herrera for the fieldwork assistance and census database access. We also thank the Galapagos Science Center for the administrative and laboratory facilities, and we thank all the volunteers who participated in the censuses.	AINLEY DG, 1982, FISH B-NOAA, V80, P253; Alava JJ, 2006, LOW WAKE FI, P495; Alava JJ, 2011, MAR POLLUT BULL, V62, P660, DOI 10.1016/j.marpolbul.2011.01.032; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Aurioles-Gamboa David, 1994, Ciencias Marinas, V20, P535; BERKSON JM, 1985, CAN J FISH AQUAT SCI, V42, P873, DOI 10.1139/f85-111; BONNELL ML, 1987, J WILDLIFE MANAGE, V51, P13, DOI 10.2307/3801621; Brock PM, 2013, ANIM CONSERV, V16, P19, DOI 10.1111/j.1469-1795.2012.00567.x; Chilvers BL, 2007, NEW ZEAL J MAR FRESH, V41, P205, DOI 10.1080/00288330709509909; Costa DP, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P344; Denkinger J, 2014, SOC ECOL INTERACT GA, P285, DOI 10.1007/978-3-319-02769-2_13; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Drago M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147857; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Edgar GJ, 2008, AQUAT CONSERV, V18, P955, DOI 10.1002/aqc.901; Eibl-Eibesfeldt I., KEY ENV GALAPAGOS, V184, P207; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Gonzalez-Suarez M, 2006, ANIM CONSERV, V9, P219, DOI 10.1111/j.1469-1795.2006.00022.x; GUINET C, 1994, ANTARCT SCI, V6, P473, DOI 10.1017/S0954102094000714; Jackson MH, 1993, GALAPAGOS NATURAL HI; Jeglinski JWE, 2015, OECOLOGIA, V179, P1041, DOI 10.1007/s00442-015-3424-1; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Le Boeuf BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-9; Meise K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1001, DOI 10.1007/s00265-013-1526-5; Montero-Serra I., 2012, THESIS; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Morris W., 1999, PRACTICAL HDB POPULA; Morris W. F., 2002, QUANTITATIVE CONSERV; Mueller B, 2011, MAR MAMMAL SCI, V27, P350, DOI 10.1111/j.1748-7692.2010.00404.x; Paez-Rosas D., 2008, THESIS; Paez-Rosas D, 2012, PLAN MANEJO CONSERVA; Paez-Rosas D., 2011, THESIS; Paez-Rosas D, 2016, J WILDLIFE DIS, V52, P100, DOI 10.7589/2015-04-084; Paez-Rosas D, 2014, SOC ECOL INTERACT GA, P71, DOI 10.1007/978-3-319-02769-2_4; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Rueda-Cediel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132255; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; Szteren D, 2006, LOW WAKE FI, P369; Trillmich F., 1986, P196; Trillmich F, 2015, ZALOPHUS WOLLEBAEKI; TRILLMICH F, 1979, NOTICIAS GALAPAGOS, V29, P8; Trillmich F., 1991, PINNIPEDS NINO, P247; Trillmich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154588; Trillmich F, 2014, SOC ECOL INTERACT GA, P61, DOI 10.1007/978-3-319-02769-2_3; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Villegas-Amtmann S, 2016, DEEP SEA RES 2; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Wolf JBW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-150; Wolf JBW, 2007, OECOLOGIA, V152, P553, DOI 10.1007/s00442-007-0665-7	53	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168829	10.1371/journal.pone.0168829	http://dx.doi.org/10.1371/journal.pone.0168829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052081	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500024
J	Tsuruta-Kishino, T; Koya, J; Kataoka, K; Narukawa, K; Sumitomo, Y; Kobayashi, H; Sato, T; Kurokawa, M				Tsuruta-Kishino, T.; Koya, J.; Kataoka, K.; Narukawa, K.; Sumitomo, Y.; Kobayashi, H.; Sato, T.; Kurokawa, M.			Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE NEOPLASMS; GENOMIC INSTABILITY; ACTIVATING MUTATION; PROGENITOR CELLS; GENETIC-ANALYSIS; MOUSE MODEL; DNA-DAMAGE	As leukemic transformation of myeloproliferative neoplasms (MPNs) worsens the clinical outcome, reducing the inherent risk of the critical event in MPN cases could be beneficial. Among genetic alterations concerning the transformation, the frequent one is TP53 mutation. Here we show that retroviral overexpression of Jak2 V617F mutant into wild-type p53 murine bone marrow cells induced polycythemia vera (PV) in the recipient mice, whereas Jak2 V617F-transduced p53-null mice developed lethal leukemia after the preceding PV phase. The leukemic mice had severe anemia, hepatosplenomegaly, pulmonary hemorrhage and expansion of dysplastic erythroid progenitors. Primitive leukemia cells (c-kit+ Sca1+ Lin-(KSL) and CD34-CD16/32c- kit+ Sca1-Lin-(megakaryocyte-erythroid progenitor; MEP)) and erythroid progenitors (CD71+) from Jak2 V617F-transduced p53-null leukemic mice had leukemia-initiating capacity, however, myeloid differentiated populations (Mac-1+) could not recapitulate the disease. Interestingly, recipients transplanted with CD71+ cells rapidly developed erythroid leukemia, which was in sharp contrast to leukemic KSL cells to cause lethal leukemia after the polycythemic state. The leukemic CD71+ cells were more sensitive to INCB18424, a potent JAK inhibitor, than KSL cells. p53 restoration could ameliorate Jak2 V617F-transduced p53-null erythroleukemia. Taken together, our results show that p53 loss is sufficient for inducing leukemic transformation in Jak2 V617Fpositive MPN.	[Tsuruta-Kishino, T.; Koya, J.; Kataoka, K.; Narukawa, K.; Sumitomo, Y.; Kobayashi, H.; Sato, T.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Sumitomo, Y.] Kyowa Hakko Kirin Co, Oncol Res Labs, Machida, Tokyo, Japan; [Sato, T.] Univ Tokyo Hosp, Dept Transfus Med, Bunkyo Ku, Tokyo, Japan; [Kurokawa, M.] Univ Tokyo Hosp, Dept Cell Therapy & Transplantat, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Kyowa Kirin Ltd; University of Tokyo; University of Tokyo	Kurokawa, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Kataoka, Keisuke/AAS-2546-2020	Kataoka, Keisuke/0000-0002-8263-9902; Koya, Junji/0000-0002-0605-1226; Sato, Tomohiko/0000-0002-8244-075X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T Kitamura for Plat-E packaging cells; H Nakauchi and M Onodera for pGCDNsam-IRES-EGFP and Kusabira Orange retroviral vector; S Aizawa for p53 knockout mice (RIKEN BRC, Acc. no. CDB 0001K); A Berns for p53 conditional knockout mice; J Takeda for Mx1-Cre transgenic mice; F Ueki, R Takizawa-Toyama and Y Oikawa for expert for technical assistance. This study was supported by the Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; [Anonymous], 2015, JAKAVI TABLETS 5 MG; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Santos Leonardo Caires dos, 2011, Rev. Bras. Hematol. Hemoter., V33, P417, DOI 10.5581/1516-8484.20110116; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Harutyunyan A, 2011, NEW ENGL J MED, V364, P488, DOI 10.1056/NEJMc1012718; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kennedy JA, 2013, BLOOD, V121, P2725, DOI 10.1182/blood-2012-10-464248; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar C Chandra, 2011, Genes Cancer, V2, P95, DOI 10.1177/1947601911408076; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee HJ, 2013, CLIN CANCER RES, V19, P327, DOI 10.1158/1078-0432.CCR-12-2087; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Marino S, 2000, GENE DEV, V14, P994; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Mullally A, 2012, BLOOD, V120, P166, DOI 10.1182/blood-2012-01-402396; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Pei SS, 2012, BEST PRACT RES CL HA, V25, P415, DOI 10.1016/j.beha.2012.10.003; Peller S, 2003, HUM MUTAT, V21, P277, DOI 10.1002/humu.10190; Pellicano F, 2014, STEM CELLS, V32, P1373, DOI 10.1002/stem.1678; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rampal R, 2014, P NATL ACAD SCI USA, V111, pE5401, DOI 10.1073/pnas.1407792111; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Shin DM, 2001, CANCER EPIDEM BIOMAR, V10, P603; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; TSUKADA T, 1993, ONCOGENE, V8, P3313; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xu HM, 2012, BLOOD, V120, P3089, DOI 10.1182/blood-2012-01-405332; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	60	20	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3300	3311		10.1038/onc.2016.478	http://dx.doi.org/10.1038/onc.2016.478			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28068330				2022-12-26	WOS:000402869800009
J	Bollinedi, H; Krishnan, SG; Prabhu, KV; Singh, NK; Mishra, S; Khurana, JP; Singh, AK				Bollinedi, Haritha; Krishnan, Gopala S.; Prabhu, Kumble Vinod; Singh, Nagendra Kumar; Mishra, Sushma; Khurana, Jitendra P.; Singh, Ashok Kumar			Molecular and Functional Characterization of GR2-R1 Event Based Backcross Derived Lines of Golden Rice in the Genetic Background of a Mega Rice Variety Swarna	PLOS ONE			English	Article							T-DNA TAGS; AUXIN TRANSPORT; INSERTIONAL MUTAGENESIS; CAROTENOID BIOSYNTHESIS; HORMONE INTERACTIONS; ROOT GRAVITROPISM; SEED DORMANCY; PLANT-GROWTH; PRO-VITAMIN; ARABIDOPSIS	Homozygous Golden Rice lines developed in the background of Swarna through marker assisted backcross breeding (MABB) using transgenic GR2-R1 event as a donor for the provitamin A trait have high levels of provitamin A (up to 20 ppm) but are dwarf with pale green leaves and drastically reduced panicle size, grain number and yield as compared to the recurrent parent, Swarna. In this study, we carried out detailed morphological, biochemical and molecular characterization of these lines in a quest to identify the probable reasons for their abnormal phenotype. Nucleotide blast analysis with the primer sequences used to amplify the transgene revealed that the integration of transgene disrupted the native OsAux1 gene, which codes for an auxin transmembrane transporter protein. Real time expression analysis of the transgenes (ZmPsy and CrtI) driven by endosperm-specific promoter revealed the leaky expression of the transgene in the vegetative tissues. We propose that the disruption of OsAux1 disturbed the fine balance of plant growth regulators viz., auxins, gibberellic acid and abscisic acid, leading to the abnormalities in the growth and development of the lines homozygous for the transgene. The study demonstrates the conserved roles of OsAux1 gene in rice and Arabidopsis.	[Bollinedi, Haritha; Krishnan, Gopala S.; Prabhu, Kumble Vinod; Singh, Ashok Kumar] ICAR Indian Agr Res Inst, Div Genet, Delhi, India; [Singh, Nagendra Kumar] ICAR Natl Res Ctr Plant Biotechnol, Pusa Campus, Delhi, India; [Mishra, Sushma; Khurana, Jitendra P.] Univ Delhi, Dept Plant Mol Biol, South Campus, Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi	Singh, AK (corresponding author), ICAR Indian Agr Res Inst, Div Genet, Delhi, India.	aks_gene@yahoo.com	Bollinedi, Haritha/Q-5881-2017; Singh, Nouratan/N-9377-2017; Singh, Ashok/HGF-2506-2022	Singh, Nouratan/0000-0002-8063-8375; Subbaiyan, Gopala Krishnan/0000-0003-3443-8767	Department of Biotechnology, Government of India, New Delhi; Department of Science and Technology	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology(Department of Science & Technology (India))	The research work was carried out under the project titled "Development of Pro-vitamin A rich indica rice varieties through marker assisted backcross breeding using high carotenoid Golden Rice as donor" funded by the Department of Biotechnology, Government of India, New Delhi. The authors thankfully acknowledge SR Rao, Senior Advisor, DBT for his critical input and coordination of the National Network on Golden Rice. The study is part of the Ph.D. research of the first author. The first author acknowledges the Department of Science and Technology for the grant of a merit fellowship.; The research work was carried out under the project titled "Development of Pro-vitamin A rich indica rice varieties through marker assisted backcross breeding using high carotenoid Golden Rice as donor" funded by the Department of Biotechnology, Government of India, New Delhi. We thankfully acknowledge SR Rao, Senior Advisor, DBT for his critical input and coordination of the National Network on Golden Rice. The study is part of the Ph.D. research of the first author. The first author acknowledges the Department of Science and Technology for the grant of a merit fellowship. The authors would like to acknowledge Dr. Madan Pal, principal scientist, Div. of Plant physiology, and Dr. Viswanathan Chinnusamy, Head, Div. of Plant physiology, for their useful discussions and suggestions. The authors would like to thank Dr. AK Mishra, principal scientist, Water Technology Center, IARI, for extending the facility of the root scanner device.	Al-Babili S, 2005, TRENDS PLANT SCI, V10, P565, DOI 10.1016/j.tplants.2005.10.006; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Beisel KG, 2010, PLANT PHYSIOL, V152, P2188, DOI 10.1104/pp.109.151647; Belin C, 2009, PLANT CELL, V21, P2253, DOI 10.1105/tpc.109.067702; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2009, PLANT MOL BIOL, V69, P383, DOI 10.1007/s11103-008-9393-6; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Bollineni H, 2014, INDIAN J GENET PL BR, V74, P624, DOI 10.5958/0975-6906.2014.00901.8; Burkhardt PK, 1997, PLANT J, V11, P1071, DOI 10.1046/j.1365-313X.1997.11051071.x; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cheminant S, 2011, PLANT CELL, V23, P1849, DOI 10.1105/tpc.111.085233; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Chikkappa GK, 2011, J PLANT BIOCHEM BIOT, V20, P29, DOI 10.1007/s13562-010-0021-6; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Ellur RK, 2013, CLIMATE CHANGE SUSTA, P99; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gillespie S, 2001, ADB NUTR DEV SERIES, V4; Gomez-Cadenas A, 2001, PLANT CELL, V13, P667, DOI 10.1105/tpc.13.3.667; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; O'Neill DP, 2002, PLANT PHYSIOL, V130, P1974, DOI 10.1104/pp.010587; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Puchta H, 2003, J PLANT PHYSIOL, V160, P743, DOI 10.1078/0176-1617-01027; Ross JJ, 1998, J PLANT GROWTH REGUL, V17, P141, DOI 10.1007/PL00007027; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9; SHERRIFF LJ, 1994, PLANT PHYSIOL, V104, P277, DOI 10.1104/pp.104.1.277; SOMMER A, 1989, J NUTR, V119, P96, DOI 10.1093/jn/119.1.96; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Swarup R, 2000, BIOCHEM SOC T, V28, P481, DOI 10.1042/0300-5127:0280481; Szabados L, 2002, PLANT J, V32, P233, DOI 10.1046/j.1365-313X.2002.01417.x; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Wolbang CM, 2001, PLANTA, V214, P153, DOI 10.1007/s004250100663; Yaish MW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001098; Yamamoto M, 1998, PLANT CELL PHYSIOL, V39, P660, DOI 10.1093/oxfordjournals.pcp.a029419; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhang YY, 2008, CELL RES, V18, P412, DOI 10.1038/cr.2008.28; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	66	15	15	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169600	10.1371/journal.pone.0169600	http://dx.doi.org/10.1371/journal.pone.0169600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068433	Green Submitted, gold, Green Published			2022-12-26	WOS:000391843900049
J	Nesper, PL; Scarinci, F; Fawzi, AA				Nesper, Peter L.; Scarinci, Fabio; Fawzi, Amani A.			Adaptive Optics Reveals Photoreceptor Abnormalities in Diabetic Macular Ischemia	PLOS ONE			English	Article							RETINAL-DETACHMENT; VISUAL-ACUITY; CONSUMPTION; MICROCIRCULATION; HYPOXIA; IMAGES; ZONE; CAT	Diabetic macular ischemia (DMI) is a phenotype of diabetic retinopathy (DR) associated with chronic hypoxia of retinal tissue. The goal of this prospective observational study was to report evidence of photoreceptor abnormalities using adaptive optics scanning laser ophthalmoscopy (AOSLO) in eyes with DR in the setting of deep capillary plexus (DCP) non-perfusion. Eleven eyes from 11 patients (6 women, age 31-68), diagnosed with DR without macular edema, underwent optical coherence tomography angiography (OCTA) and AOSLO imaging. One patient without OCTA imaging underwent fluorescein angiography to characterize the enlargement of the foveal avascular zone. The parameters studied included photoreceptor heterogeneity packing index (HPi) on AOSLO, as well as DCP non-perfusion and vessel density on OCTA. Using AOSLO, OCTA and spectral domain (SD)-OCT, we observed that photoreceptor abnormalities on AOSLO and SD-OCT were found in eyes with non-perfusion of the DCP on OCTA. All eight eyes with DCP non-flow on OCTA showed photoreceptor abnormalities on AOSLO. Six of the eight eyes also had outer retinal abnormalities on SD-OCT. Three eyes with DR and robust capillary perfusion of the DCP had normal photoreceptors on SD-OCT and AOSLO. Compared to eyes with DR without DCP non-flow, the eight eyes with DCP non-flow had significantly lower HPi (P = 0.013) and parafoveal DCP vessel density (P = 0.016). We found a significant correlation between cone HPi and parafoveal DCP vessel density (r = 0.681, P = 0.030). Using a novel approach with AOSLO and OCTA, this study shows an association between capillary non-perfusion of the DCP and abnormalities in the photoreceptor layer in eyes with DR. This observation is important in confirming the significant contribution of the DCP to oxygen requirements of photoreceptors in DMI, while highlighting the ability of AOSLO to detect subtle photoreceptor changes not always visible on SD-OCT.	[Nesper, Peter L.; Scarinci, Fabio; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Scarinci, Fabio] IRCCS, GB Bietti Eye Fdn, Rome, Italy	Northwestern University; Feinberg School of Medicine; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	Scarinci, Fabio/AAB-5126-2020; fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Scarinci, Fabio/0000-0001-5444-4377	National Institutes of Health [1DP3DK108248]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AAF has received grant support from National Institutes of Health, 1DP3DK108248 and research instrument support by (Non-remunerative funding in the form of research instruments was received from) Boston Micromachines Corporation and OptoVue, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2000, KIDNEY INT, V58, pS113, DOI 10.1046/j.1523-1755.2000.07718.x; ANDERSON DH, 1983, INVEST OPHTH VIS SCI, V24, P906; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; AREND O, 1991, BRIT J OPHTHALMOL, V75, P514, DOI 10.1136/bjo.75.9.514; AREND O, 1995, ARCH OPHTHALMOL-CHIC, V113, P610, DOI 10.1001/archopht.1995.01100050078034; Birol G, 2007, AM J PHYSIOL-HEART C, V293, pH1696, DOI 10.1152/ajpheart.00221.2007; BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1286; BRESNICK GH, 1975, ARCH OPHTHALMOL-CHIC, V93, P1300; Bruce KS, 2015, INVEST OPHTH VIS SCI, V56, P4431, DOI 10.1167/iovs.15-16547; Chen YM, 2011, INVEST OPHTH VIS SCI, V52, P3281, DOI 10.1167/iovs.10-6538; Coscas F, 2016, INVEST OPHTH VIS SCI, V57, pOCT211, DOI 10.1167/iovs.15-18793; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; GRUNWALD JE, 1984, OPHTHALMOLOGY, V91, P1447; Hansen SO, 2013, RETINA-J RET VIT DIS, V33, P1650, DOI 10.1097/IAE.0b013e31828cd03a; HAUGH LM, 1990, ANN BIOMED ENG, V18, P19, DOI 10.1007/BF02368415; Huang G, 2011, OPT LETT, V36, P3786, DOI 10.1364/OL.36.003786; IWASAKI M, 1986, INVEST OPHTH VIS SCI, V27, P1698; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Lammer J, 2016, INVEST OPHTH VIS SCI, V57, P6624, DOI 10.1167/iovs.16-19537; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Lombardo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151380; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Lombardo M, 2013, OPHTHAL PHYSL OPT, V33, P516, DOI 10.1111/opo.12053; Lombardo M, 2013, SENSORS-BASEL, V13, P334, DOI 10.3390/s130100334; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Miller DT, 1996, VISION RES, V36, P1067, DOI 10.1016/0042-6989(95)00225-1; Mkrtchyan M, 2012, AM J OPHTHALMOL, V153, P757, DOI 10.1016/j.ajo.2011.09.007; Palejwala NV, 2015, RETINA-J RET VIT DIS, V35, P2204, DOI 10.1097/IAE.0000000000000867; Park JJ, 2016, RETINA IN PRESS; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 2002, J VISION, V2, P404, DOI 10.1167/2.5.4; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Scarinci F, 2016, AM J OPHTHA IN PRESS; Scarinci F, 2015, JAMA OPHTHALMOL, V133, P1036, DOI 10.1001/jamaophthalmol.2015.2183; Scoles D, 2016, RETINA-J RET VIT DIS, V36, P91, DOI 10.1097/IAE.0000000000000618; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; Sim DA, 2014, INVEST OPHTH VIS SCI, V55, P417, DOI 10.1167/iovs.13-12677; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2353, DOI 10.1167/iovs.12-11103; Tam J, 2012, OPTOMETRY VISION SCI, V89, pE692, DOI 10.1097/OPX.0b013e3182548b07; Valeshabad AK, 2014, OPTOMETRY VISION SCI, V91, P1238, DOI 10.1097/OPX.0000000000000252; Wang SF, 2007, INVEST OPHTH VIS SCI, V48, P1335, DOI 10.1167/iovs.06-0842; Wellard J, 2005, VISUAL NEUROSCI, V22, P501, DOI 10.1017/S0952523805224112; Yi J, VISIBLE LIGHT OPTICA; Yoon MK, 2009, INVEST OPHTH VIS SCI, V50, P1838, DOI 10.1167/iovs.08-2029	49	58	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169926	10.1371/journal.pone.0169926	http://dx.doi.org/10.1371/journal.pone.0169926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068435	gold, Green Submitted, Green Published			2022-12-26	WOS:000391843900081
J	Enomoto-Okawa, Y; Maeda, Y; Harashima, N; Sugawara, Y; Katagiri, F; Hozumi, K; Hui, KM; Nomizu, M; Ito, Y; Kikkawa, Y				Enomoto-Okawa, Yurie; Maeda, Yuka; Harashima, Nozomi; Sugawara, Yumika; Katagiri, Fumihiko; Hozumi, Kentaro; Hui, Kam Man; Nomizu, Motoyoshi; Ito, Yuji; Kikkawa, Yamato			An Anti-Human Lutheran Glycoprotein Phage Antibody Inhibits Cell Migration on Laminin-511: Epitope Mapping of the Antibody	PLOS ONE			English	Article							BLOOD-GROUP GLYCOPROTEIN; ADHESION MOLECULE; HEPATOCELLULAR-CARCINOMA; IMMUNOGLOBULIN SUPERFAMILY; SURFACE GLYCOPROTEIN; BINDING-SITE; B-CAM; EXPRESSION; INTEGRINS; RECEPTOR	The Lutheran glycoprotein (Lu), also known as basal cell adhesion molecule (B-CAM), is an Ig superfamily (IgSF) transmembrane receptor for laminin alpha 5. Although Lu is not present in normal hepatocytes, its expression is significantly increased in hepatocellular carcinoma (HCC). In this study, we isolated thirteen phage antibodies to Lu from a phage library of peripheral blood from HCC patients, suggesting that these patients produced autoantibodies against endogenous Lu. To characterize the phage antibodies, we determined the Lu domains they recognize. The extracellular domain of Lu contains five IgSF domains, D1-D2-D3-D4-D5. The epitope of one phage antibody (A7) was localized to the D5 domain. The other phage antibodies recognized the D2 domain, which is also recognized by a function blocking mouse monoclonal antibody. One of the antibodies to D2 (C7) inhibited the binding of Lu to ligand, and it also prevented tumor cell migration on laminin-511 (LM-511). However, the C7 scFv purified from the periplasm fraction of bacteria did not exhibit the inhibitory effects, indicating that the scFv form could not sterically inhibit the binding of Lu to LM-511. We also identified the amino acid residues that form the epitope recognized by the C7 phage antibody. Mutagenesis studies showed that Arg (247) is necessary for forming the epitope. The C7 phage antibody and its epitope may be useful for developing drugs to prevent HCC progression and/or metastasis.	[Enomoto-Okawa, Yurie; Maeda, Yuka; Ito, Yuji] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima, Japan; [Harashima, Nozomi; Sugawara, Yumika; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi; Kikkawa, Yamato] Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Tokyo, Japan; [Hui, Kam Man] Natl Canc Ctr, Div Cellular & Mol Res, Singapore, Singapore	Kagoshima University; Tokyo University of Pharmacy & Life Sciences; National Cancer Centre Singapore (NCCS)	Ito, Y (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima, Japan.; Kikkawa, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Clin Biochem, Tokyo, Japan.	k2174603@kadai.jp; kikkawa@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010	Hui, Kam/0000-0003-1820-1399; Hozumi, Kentaro/0000-0002-6671-4386	Japan Society for the Promotion of Science, JSPS KAKENHI [26430123, 25460151]; Ministry of Education, Culture, Sports, Science & Technology in Japan, MEXT KAKENHI [26112718]; Grants-in-Aid for Scientific Research [26430123] Funding Source: KAKEN	Japan Society for the Promotion of Science, JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science & Technology in Japan, MEXT KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Society for the Promotion of Science, JSPS KAKENHI Grant Number 26430123 (YK) and 25460151 (YI) [https://www.jsps.go.jp/english/index.html] and The Ministry of Education, Culture, Sports, Science & Technology in Japan, MEXT KAKENHI Grant Number 26112718 (YK) [http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Burton NM, 2008, BLOOD CELL MOL DIS, V40, P446, DOI 10.1016/j.bcmd.2008.01.004; CAMPBELL IG, 1994, CANCER RES, V54, P5761; ElNemer W, 1997, BLOOD, V89, P4608, DOI 10.1182/blood.V89.12.4608; Eyler CE, 2006, TRANSFUSION, V46, P668, DOI 10.1111/j.1537-2995.2006.00779.x; GARINCHESA P, 1994, INT J ONCOL, V5, P1261; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2014, EXP CELL RES, V328, P197, DOI 10.1016/j.yexcr.2014.07.012; Kikkawa Y, 2013, J BIOL CHEM, V288, P30990, DOI 10.1074/jbc.M113.486456; Kikkawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023329; Laurent C, 2001, WORLD J SURG, V25, P1532, DOI 10.1007/s00268-001-0164-7; Lee SP, 1998, BLOOD, V92, P2951, DOI 10.1182/blood.V92.8.2951.420k30_2951_2958; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Muraoka Junko, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P42, DOI 10.1089/mab.2013.0068; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Pavoni E, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-70; Rahuel C, 1996, BLOOD, V88, P1865; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Wick T M, 1996, Curr Opin Hematol, V3, P118; Yang J, 2011, ADV ENG INFORM, V25, P736, DOI 10.1016/j.aei.2011.04.001; Zen Q, 1999, J BIOL CHEM, V274, P728, DOI 10.1074/jbc.274.2.728	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167860	10.1371/journal.pone.0167860	http://dx.doi.org/10.1371/journal.pone.0167860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060819	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500016
J	Eschbach, RS; Clevert, DA; Hirner-Eppeneder, H; Ingrisch, M; Moser, M; Schuster, J; Tadros, D; Schneider, M; Kazmierczak, PM; Reiser, M; Cyran, CC				Eschbach, Ralf Stefan; Clevert, Dirk-Andre; Hirner-Eppeneder, Heidrun; Ingrisch, Michael; Moser, Matthias; Schuster, Jessica; Tadros, Dina; Schneider, Moritz; Kazmierczak, Philipp Maximilian; Reiser, Maximilian; Cyran, Clemens C.			Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANTI-ANGIOGENIC THERAPY; TUMOR-MODELS; MOLECULAR US; CANCER; AGENT; CARCINOMA; BR55; SORAFENIB; PERFUSION	Objectives To investigate contrast-enhanced ultrasound (CEUS) with VEGFR2-targeted microbubbles for monitoring therapy effects of regorafenib on experimental colon carcinomas in rats with correlation to dynamic contrast-enhanced MRI (DCE-MRI) and immunohistochemistry. Materials and Methods Human colorectal adenocarcinoma xenografts (HT-29) were implanted subcutaneously in n =21 (n = 11 therapy group; n = 10 control group) female athymic nude rats (Hsd: RH-Foxn1 (mu)). Animals were imaged at baseline and after a one-week daily treatment with regorafenib or a placebo (10 mg/kg bodyweight), using CEUS with VEGFR2-targeted microbubbles and DCE-MRI. In CEUS tumor perfusion was assessed during an early vascular phase (wash-in area under the curve = WiAUC) and VEGFR2-specific binding during a late molecular phase (signal intensity after 8 (SI8min) and 10 minutes (SI10min)), using a conventional 15L8 linear transducer (transmit frequency 7 MHz, dynamic range 80 dB, depth 25 mm). In DCE-MRI functional parameters plasma flow (PF) and plasma volume (PV) were quantified. For validation purposes, CEUS parameters were correlated with DCE-MRI parameters and immunohistochemical VEGFR2, CD31, Ki-67 and TUNEL stainings. Results CEUS perfusion parameter WiAUC decreased significantly (116,989 +/- 77,048 a.u. to 30,076 +/- 27,095a.u.; p = 0.005) under therapy with no significant changes (133,932 +/- 65,960 a.u. to 84,316 +/- 74,144 a.u.; p = 0.093) in the control group. In the therapy group, the amount of bound microbubbles in the late phase was significantly lower in the therapy than in the control group on day 7 (SI8min: 283 +/- 191 vs. 802 +/- 460 a.u.; p = 0.006); SI10min: 226 +/- 149 vs. 645 +/- 461 a.u.; p = 0.009). PF and PV decreased significantly (PF: 147 +/- 58 mL/100 mL/min to 71 +/- 15 mL/100 mL/min; p = 0.003; PV: 13 +/- 3% to 9 +/- 4%; p = 0.040) in the therapy group. Immunohistochemistry revealed significantly fewer VEGFR2 (7.2 +/- 1.8 vs. 17.8 +/- 4.6; p < 0.001), CD31 (8.1 +/- 3.0 vs. 20.8 +/- 5.7; p < 0.001) and Ki-67 (318.7 +/- 94.0 vs. 468.0 +/- 133.8; p = 0.004) and significantly more TUNEL (672.7 +/- 194.0 vs. 357.6 +/- 192.0; p = 0.003) positive cells in the therapy group. CEUS parameters showed significant (p < 0.05) correlations to DCE-MRI parameters and immunohistochemistry. Conclusions CEUS with VEGFR2-targeted microbubbles allowed for monitoring regorafenib functional and molecular therapy effects on experimental colorectal adenocarcinomas with a significant decline of CEUS and DCE-MRI perfusion parameters as well as a significant reduction of specifically bound microbubbles under therapy, consistent with a reduced expression of VEGFR2.	[Eschbach, Ralf Stefan; Clevert, Dirk-Andre; Hirner-Eppeneder, Heidrun; Moser, Matthias; Schuster, Jessica; Tadros, Dina; Kazmierczak, Philipp Maximilian; Reiser, Maximilian; Cyran, Clemens C.] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany; [Ingrisch, Michael; Schneider, Moritz] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Josef Lissner Lab Biomed Imaging, Munich, Germany	University of Munich; University of Munich	Eschbach, RS (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany.	Ralf.Eschbach@med.lmu.de	Ingrisch, Michael/T-3408-2017	Ingrisch, Michael/0000-0003-0268-9078; Clevert, Dirk Andre/0000-0003-3889-5447	German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 [01EX1021X]; research grant of Bracco Imaging SA, Geneva, Switzerland; research grant of Bayer Vital GmbH, Leverkusen, Germany	German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4(Federal Ministry of Education & Research (BMBF)); research grant of Bracco Imaging SA, Geneva, Switzerland; research grant of Bayer Vital GmbH, Leverkusen, Germany	This study has received funding by the German Federal Ministry of Education and Research (BMBF) Excellence Cluster M4 (01EX1021X). This study was supported by a research grant of Bracco Imaging SA, Geneva, Switzerland by supplying BR55 free of charge, and by a research grant of Bayer Vital GmbH, Leverkusen, Germany, by supplying regorafenib free of charge. The authors of this manuscript declare no other relationships with these companies, whose products or services may be related to the subject matter of this article.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Baetke SC, 2016, RADIOLOGY, V278, P430, DOI 10.1148/radiol.2015142899; Binefa G, 2014, WORLD J GASTROENTERO, V20, P6786, DOI 10.3748/wjg.v20.i22.6786; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Bzyl J, 2011, EUR RADIOL, V21, P1988, DOI 10.1007/s00330-011-2138-y; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Eisenbrey JR, 2013, ULTRASONICS, V53, P1384, DOI 10.1016/j.ultras.2013.04.007; Eschbach RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115543; Ferrara N, 1997, EXS, V79, P209; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Forsberg F, 2008, ULTRASOUND MED BIOL, V34, P1365, DOI 10.1016/j.ultrasmedbio.2008.02.010; Forsberg F, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2013.00073; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Guibal A, 2010, RADIOLOGY, V254, P420, DOI 10.1148/radiol.09090728; Huellner MW, 2012, CANCER IMAGING, V12, P212, DOI 10.1102/1470-7330.2012.0021; Hyvelin JM, 2013, INVEST RADIOL, V48, P570, DOI 10.1097/RLI.0b013e318289f854; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; Lamuraglia M, 2006, EUR J CANCER, V42, P2472, DOI 10.1016/j.ejca.2006.04.023; Lamuraglia M, 2010, CRIT REV ONCOL HEMAT, V73, P202, DOI 10.1016/j.critrevonc.2009.06.001; Lassau N, 2006, AM J ROENTGENOL, V187, P1267, DOI 10.2214/AJR.05.1192; Lassau N, 2010, TARGET ONCOL, V5, P53, DOI 10.1007/s11523-010-0136-7; Makrilia N, 2009, EUR J INTERN MED, V20, P663, DOI 10.1016/j.ejim.2009.07.009; Nunn A, 2004, MICROBUBBLE CONJUGAT; Padhani Anwar R, 2004, Top Magn Reson Imaging, V15, P41, DOI 10.1097/00002142-200402000-00005; Payen T, 2015, ULTRASOUND MED BIOL, V41, P2202, DOI 10.1016/j.ultrasmedbio.2015.04.010; Pillai R, 2010, BIOCONJUGATE CHEM, V21, P556, DOI 10.1021/bc9005688; Pochon S, 2010, INVEST RADIOL, V45, P89, DOI 10.1097/RLI.0b013e3181c5927c; Preda A, 2005, INVEST RADIOL, V40, P349, DOI 10.1097/01.rli.0000163740.40474.48; Pysz MA, 2010, RADIOLOGY, V256, P519, DOI 10.1148/radiol.10091858; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Roccarina D, 2015, WORLD J HEPATOL, V7, P1866, DOI 10.4254/wjh.v7.i14.1866; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Sirsi SR, 2012, ULTRASOUND MED BIOL, V38, P1019, DOI 10.1016/j.ultrasmedbio.2012.01.014; Sohaib A, 2012, CANCER IMAGING, V12, P345, DOI 10.1102/1470-7330.2012.9011; Song T, 2009, MAGN RESON MED, V61, P1242, DOI 10.1002/mrm.21901; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sridharan A, 2013, INVEST RADIOL, V48, P654, DOI 10.1097/RLI.0b013e3182925160; Tardy I, 2010, INVEST RADIOL, V45, P573, DOI 10.1097/RLI.0b013e3181ee8b83; Toaldo MB, 2015, MOL IMAGING BIOL, V17, P29, DOI 10.1007/s11307-014-0764-x; Wang HJ, 2015, INVEST RADIOL, V50, P322, DOI 10.1097/RLI.0000000000000128; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Zocco MA, 2013, J HEPATOL, V59, P1014, DOI 10.1016/j.jhep.2013.06.011	44	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169323	10.1371/journal.pone.0169323	http://dx.doi.org/10.1371/journal.pone.0169323			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060884	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500080
J	Obata, Y; Mizogami, M; Nyhan, D; Berkowitz, DE; Steppan, J; Barodka, V				Obata, Yurie; Mizogami, Maki; Nyhan, Daniel; Berkowitz, Dan E.; Steppan, Jochen; Barodka, Viachaslau			Pilot Study: Estimation of Stroke Volume and Cardiac Output from Pulse Wave Velocity	PLOS ONE			English	Article							POLAR PLOT METHODOLOGY; IDEAL BODY-WEIGHT; DOPPLER-ECHOCARDIOGRAPHY; PRECISION; SURGERY; ABILITY; EQUATIONS; MONITORS; ESCCO; CARE	Background Transesophageal echocardiography (TEE) is increasingly replacing thermodilution pulmonary artery catheters to assess hemodynamics in patients at high risk for cardiovascular morbidity. However, one of the drawbacks of TEE compared to pulmonary artery catheters is the inability to measure real time stroke volume (SV) and cardiac output (CO) continuously. The aim of the present proof of concept study was to validate a novel method of SV estimation, based on pulse wave velocity (PWV) in patients undergoing cardiac surgery. Methods This is a retrospective observational study. We measured pulse transit time by superimposing the radial arterial waveform onto the continuous wave Doppler waveform of the left ventricular outflow tract, and calculated SV (SVPWV) using the transformed Bramwell-Hill equation. The SV measured by TEE (SVTEE) was used as a reference. Results A total of 190 paired SV were measured from 28 patients. A strong correlation was observed between SVPWV and SVTEE with the coefficient of determination (R-2) of 0.71. A mean difference between the two (bias) was 3.70 ml with the limits of agreement ranging from -20.33 to 27.73 ml and a percentage error of 27.4% based on a Bland-Altman analysis. The concordance rate of two methods was 85.0% based on a four-quadrant plot. The angular concordance rate was 85.9% with radial limits of agreement (the radial sector that contained 95% of the data points) of +/- 41.5 degrees based on a polar plot. Conclusions PWV based SV estimation yields reasonable agreement with SV measured by TEE. Further studies are required to assess its utility in different clinical situations.	[Obata, Yurie; Nyhan, Daniel; Berkowitz, Dan E.; Steppan, Jochen; Barodka, Viachaslau] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Cardiac Anesthesia, Baltimore, MD 21205 USA; [Mizogami, Maki] Univ Fukui, Dept Anesthesiol & Reanimatol, Fukui, Japan	Johns Hopkins University; University of Fukui	Barodka, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Cardiac Anesthesia, Baltimore, MD 21205 USA.	vbarodk1@jhmi.edu						Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bataille B, 2012, BRIT J ANAESTH, V109, P879, DOI 10.1093/bja/aes298; Biais M, 2015, BRIT J ANAESTH, V115, P403, DOI 10.1093/bja/aev219; Bramwell JC, 1922, P ROY SOC LOND B BIO, P93; Cannesson M, 2011, CRIT CARE, V15, DOI 10.1186/cc10364; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129; Chemla D, 1998, AM J PHYSIOL-HEART C, V274, pH500, DOI 10.1152/ajpheart.1998.274.2.H500; Chin JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142125; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; De Castro V, 2006, BRIT J ANAESTH, V97, P605, DOI 10.1093/bja/ael236; Erstad BL, 2004, DOSING MEDICAITONS M, V30, P18, DOI [10.1007/s00134-003-2059-6, DOI 10.1007/S00134-003-2059-6]; Harris SN, 1999, J AM SOC ECHOCARDIOG, V12, P754, DOI 10.1016/S0894-7317(99)70026-X; Hirani V, 2012, J AM GERIATR SOC, V60, P550, DOI 10.1111/j.1532-5415.2011.03832.x; Ishihara H, 2012, J CLIN MONIT COMPUT, V26, P465, DOI 10.1007/s10877-012-9384-7; Kamoi Shun, 2015, IFAC - Papers Online, V48, P285, DOI 10.1016/j.ifacol.2015.10.153; Linton NWF, 2002, BRIT J ANAESTH, V89, pA336, DOI 10.1093/bja/aef530; Liu AB, 2011, J MED SYST, V35, P771, DOI 10.1007/s10916-010-9469-0; Marik PE, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-38; Mehta Y, 2014, WORLD J CARDIOL, V6, P1022, DOI 10.4330/wjc.v6.i9.1022; NADLER SB, 1962, SURGERY, V51, P224; Nichols W., 1998, SHOCK, V9, P456, DOI DOI 10.1097/00024382-199806000-00013; Obata Y, CLIN STUDY EFFECTS H; Pai MP, 2000, ANN PHARMACOTHER, V34, P1066, DOI 10.1345/aph.19381; Perrino AC, 1998, ANESTHESIOLOGY, V89, P350, DOI 10.1097/00000542-199808000-00010; Peyton PJ, 2010, ANESTHESIOLOGY, V113, P1220, DOI 10.1097/ALN.0b013e3181ee3130; ROBSON SC, 1988, BRIT HEART J, V59, P680; Saugel B, 2015, ANESTH ANALG, V121, P514, DOI 10.1213/ANE.0000000000000725; Smetkin AA, 2016, J CLIN MONIT COMPUT, P1; Sugo Y, 2010, IEEE ENG MED BIO, P2853, DOI 10.1109/IEMBS.2010.5626343; Thongprayoon C, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-176; Westenberg JJM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-2; 2006, NEW ENGL J MED, V354, P2213, DOI DOI 10.1056/NEJMOA061895	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169853	10.1371/journal.pone.0169853	http://dx.doi.org/10.1371/journal.pone.0169853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060961	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500142
J	Sato, A; Kajiya, H; Mori, N; Sato, H; Fukushima, T; Kido, H; Ohno, J				Sato, Ayako; Kajiya, Hiroshi; Mori, Nana; Sato, Hironobu; Fukushima, Tadao; Kido, Hirofumi; Ohno, Jun			Salmon DNA Accelerates Bone Regeneration by Inducing Osteoblast Migration	PLOS ONE			English	Article							DNA/PROTAMINE COMPLEX PASTE; ALDEHYDE DEHYDROGENASE 1; MESENCHYMAL STEM-CELLS; CIRCULATING DNA; IN-VITRO; PHOSPHATE; COTRANSPORTERS; OSTEOGENESIS; OSTEOPONTIN; EXPRESSION	The initial step of bone regeneration requires the migration of osteogenic cells to defective sites. Our previous studies suggest that a salmon DNA-based scaffold can promote the bone regeneration of calvarial defects in rats. We speculate that the salmon DNA may possess osteoinductive properties, including the homing of migrating osteogenic cells. In the present study, we investigated the influence of the salmon DNA on osteoblastic differentiation and induction of osteoblast migration using MG63 cells (human preosteoblasts) in vitro. Moreover, we analyzed the bone regeneration of a critical-sized in vivo calvarial bone defect (CSD) model in rats. The salmon DNA enhanced both mRNA and protein expression of the osteogenesis-related factors, runt-related transcription factor 2 (Runx2), alkaline phosphatase, and osterix (OSX) in the MG63 cells, compared with the cultivation using osteogenic induction medium alone. From the histochemical and immunohistochemical assays using frozen sections of the bone defects from animals that were implanted with DNA disks, many cells were found to express aldehyde dehydrogenase 1, one of the markers for mesenchymal stem cells. In addition, OSX was observed in the replaced connective tissue of the bone defects. These findings indicate that the DNA induced the migration and accumulation of osteogenic cells to the regenerative tissue. Furthermore, an in vitro transwell migration assay showed that the addition of DNA enhanced an induction of osteoblast migration, compared with the medium alone. The implantation of the DNA disks promoted bone regeneration in the CSD of rats, compared with that of collagen disks. These results indicate that the salmon DNA enhanced osteoblastic differentiation and induction of migration, resulting in the facilitation of bone regeneration.	[Sato, Ayako; Kido, Hirofumi] Fukuoka Dent Coll, Dept Oral Rehabil, Div Oral Implantol, Sawara Ku, Fukuoka, Japan; [Sato, Ayako; Kajiya, Hiroshi; Fukushima, Tadao; Ohno, Jun] Fukuoka Dent Coll, Res Ctr Regenerat Med, Sawara Ku, Fukuoka, Japan; [Kajiya, Hiroshi] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Div Cellular Physiol, Sawara Ku, Fukuoka, Japan; [Mori, Nana] Fukuoka Dent Coll, Dept Odontol, Div Periodontol, Sawara Ku, Fukuoka, Japan; [Sato, Hironobu] Fukuoka Dent Coll, Dept Oral Rehabil, Div Fixed Prosthodont, Sawara Ku, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Ohno, J (corresponding author), Fukuoka Dent Coll, Res Ctr Regenerat Med, Sawara Ku, Fukuoka, Japan.	johno@college.fdcnet.ac.jp	Ohno, Jun/K-3466-2019	Kajiya, Hiroshi/0000-0003-3275-3632	JSPS KAKENHI [25463064, 15K11062]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number #25463064 (HK) and #15K11062 (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673; Cherepanova AV, 2008, ANN NY ACAD SCI, V1137, P218, DOI 10.1196/annals.1448.016; Fukushima T, 2011, J MATER SCI-MATER M, V22, P2607, DOI 10.1007/s10856-011-4446-9; Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131; Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Katsumata Y, 2015, BIOCHEM BIOPH RES CO, V468, P622, DOI 10.1016/j.bbrc.2015.10.172; Kusuma GD, 2016, STEM CELL REV REP, V12, P285, DOI 10.1007/s12015-016-9649-5; Liu TM, 2013, TISSUE ENG PART B-RE, V19, P254, DOI [10.1089/ten.TEB.2012.0527, 10.1089/ten.teb.2012.0527]; Lundquist P, 2007, CELL PHYSIOL BIOCHEM, V19, P43, DOI 10.1159/000099191; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Mori N, 2013, J BIOMED MATER RES B, V101B, P743, DOI 10.1002/jbm.b.32877; Ota N, 2014, INT J ONCOL, V44, P435, DOI 10.3892/ijo.2013.2188; Ramoshebi Lentsha N, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004969; Rangrez AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047807; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299, DOI DOI 10.1097/00003086-198604000-00036; Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111; Shinozaki Y, 2014, J BIOMED MATER RES B, V102, P1669, DOI 10.1002/jbm.b.33143; Shinozaki Y, 2013, J HARD TISSUE BIOL, V22, P401; Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Toda M, 2014, BONE, V67, P237, DOI 10.1016/j.bone.2014.07.018; Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862; Yamaguchi Y, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/s12896-014-0105-9	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169522	10.1371/journal.pone.0169522	http://dx.doi.org/10.1371/journal.pone.0169522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060874	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500104
J	Terrasse, R; Memmi, M; Palle, S; Heyndrickx, L; Vanham, G; Pozzetto, B; Bourlet, T				Terrasse, Rachel; Memmi, Meriam; Palle, Sabine; Heyndrickx, Leo; Vanham, Guido; Pozzetto, Bruno; Bourlet, Thomas			Visualization of X4-and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPITHELIAL-CELLS; SEXUAL TRANSMISSION; RECOMBINANT VIRUSES; EX-VIVO; SELECTIVE TRANSMISSION; LANGERHANS CELLS; INFECTION; REPLICATION; BLOOD	Worldwide most HIV infections occur through heterosexual transmission, involving complex interactions of cell-free and cell-associated particles with cells of the female genital tract mucosa. The ability of HIV-1 to "infect" epithelial cells remains poorly understood. To address this question, replicative-competent chimeric constructs expressing fluorescent proteins and harboring the envelope of X4-or R5-tropic HIV-1 strains were used to "infect" endometrial HEC1-A cells. The virus-cell interactions were visualized using confocal microscopy (CM) at various times post infection. Combined with quantification of viral RNA and total HIV DNA in infected cells, the CM pictures suggest that epithelial cells do not support a complete viral replication cycle: X4-tropic viruses are imported into the nucleus in a non-productive way, whereas R5-tropic viruses transit through the cytoplasm without replication and are preferentially transmitted to susceptible activated peripheral blood mononuclear cells. Within the limit of experiments conducted in vitro on a continued cell line, these results indicate that the epithelial mucosa may participate to the selection of HIV-1 strains at the mucosal level.	[Terrasse, Rachel; Memmi, Meriam; Pozzetto, Bruno; Bourlet, Thomas] Univ Lyon, Grp Immunite Muqueuses & Agents Pathogenes EA3, Fac Med Jacques Lisfranc St Etienne, St Etienne 02, France; [Palle, Sabine] Univ Jean Monnet, Ctr Microscopie Confocale Multiphoton, Pole Opt & Vis, St Etienne 2, France; [Heyndrickx, Leo; Vanham, Guido] Inst Trop Med, Virol Unit, Dept Biomed Sci, Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Pozzetto, B (corresponding author), Univ Lyon, Grp Immunite Muqueuses & Agents Pathogenes EA3, Fac Med Jacques Lisfranc St Etienne, St Etienne 02, France.	bruno.pozzetto@univ-st-etienne.fr		BOURLET, Thomas/0000-0002-9226-1149; POZZETTO, Bruno/0000-0002-2603-8467	University Jean Monnet of Saint-Etienne; Structure Federative de Recherche (SFR) IFRESIS of the Faculty of Medicine of Saint-Etienne, France; Academic Research Community (ARC) 1 of the Rhone-Alpes Region, France; European Erasmus Mundus - AI Idrisi program - University of Granada, Spain	University Jean Monnet of Saint-Etienne; Structure Federative de Recherche (SFR) IFRESIS of the Faculty of Medicine of Saint-Etienne, France; Academic Research Community (ARC) 1 of the Rhone-Alpes Region, France(Region Auvergne-Rhone-Alpes); European Erasmus Mundus - AI Idrisi program - University of Granada, Spain	This work was made possible thanks to grants from the University Jean Monnet of Saint-Etienne and from the Structure Federative de Recherche (SFR) IFRESIS of the Faculty of Medicine of Saint-Etienne, France. RT was funded by a PhD grant from the Academic Research Community (ARC) 1 of the Rhone-Alpes Region, France. MM was funded by a PhD scholarship from the European Erasmus Mundus - AI Idrisi program supported by the University of Granada, Spain.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arien KK, 2012, CURR HIV RES, V10, P73, DOI 10.2174/157016212799304661; Asin SN, 2004, J INFECT DIS, V190, P236, DOI 10.1086/421910; Berlier W, 2006, HUM REPROD, V21, P1135, DOI 10.1093/humrep/dei496; Berlier W, 2005, J MED VIROL, V77, P465, DOI 10.1002/jmv.20478; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Byrn RA, 1997, LANCET, V350, P1141, DOI 10.1016/S0140-6736(97)24042-0; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Dezzutti CS, 2001, J INFECT DIS, V183, P1204, DOI 10.1086/319676; Eckhardt M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022007; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Friedrich B, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-354; Gallay P, 2004, MICROBES INFECT, V6, P617, DOI 10.1016/j.micinf.2004.02.004; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Gianella S, 2012, VIROLOGY, V434, P2, DOI 10.1016/j.virol.2012.09.010; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; HANDLER JS, 1983, J EXP BIOL, V106, P55; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; Kohli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098077; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; Lawrence P, 2012, AIDS, V26, P785, DOI 10.1097/QAD.0b013e328351426e; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; Lu WX, 2014, VIROLOGY, V464, P406, DOI 10.1016/j.virol.2014.07.010; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Merbah M, 2011, AM J REPROD IMMUNOL, V65, P268, DOI 10.1111/j.1600-0897.2010.00967.x; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moyes DL, 2016, ORAL DIS, V22, P66, DOI 10.1111/odi.12410; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Ping LH, 2000, J VIROL, V74, P8946, DOI 10.1128/JVI.74.19.8946-8952.2000; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shen R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/439476; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Southern PJ, 2011, MUCOSAL IMMUNOL, V4, P383, DOI 10.1038/mi.2011.12; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2; Van den Bergh R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035074; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169453	10.1371/journal.pone.0169453	http://dx.doi.org/10.1371/journal.pone.0169453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060897	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500096
J	Hanif, A; Edin, ML; Zeldin, DC; Morisseau, C; Falck, JR; Nayeem, MA				Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Falck, John R.; Nayeem, Mohammed A.			Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and omega-Hydroxylases	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; PPAR-GAMMA; RECEPTORS; ACTIVATION; VASODILATATION; METABOLITES; INDUCTION; MECHANISM; PROMOTES; CALCIUM	Cytochromes P450 metabolize arachidonic acid (AA) into two vasoactive oxylipins with opposing biologic effects: epoxyeicosatrienoic acids (EETs) and omega-(omega)-terminal hydroxyeicosatetraenoic acids (HETEs). EETs have numerous beneficial physiological effects, including vasodilation and protection against ischemia/reperfusion injury, whereas omega-terminal HETEs induce vasoconstriction and vascular dysfunction. We evaluated the effect of these oxylipins on post-ischemic vasodilation known as coronary reactive hyperemia (CRH). CRH prevents the potential harm associated with transient ischemia. The beneficial effects of EETs are reduced after their hydrolysis to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). omega-terminal HETEs are formed by omega-hydroxylase family members. The relationship among endothelial over-expression of sEH (Tie2-sEH Tr), the changes in oxylipins it may produce, the pharmacologic inhibition of omega-hydroxylases, activation of PPAR gamma, and CRH response to a brief ischemia is not known. We hypothesized that CRH is attenuated in isolated mouse hearts with endothelial sEH over-expression through modulation of oxylipin profiles, whereas both inhibition of omega-hydroxylases and activation of PPAR gamma enhance CRH. Compared to WT mice, Tie2-sEH Tr mice had decreased CRH, including repayment volume, repayment duration, and repayment/debt ratio (P < 0.05), whereas inhibition of omega-hydroxylases increased these same CRH parameters in Tie2-sEH Tr mice. Inhibition of sEH with t-AUCB reversed the decreased CRH in Tie2-sEH Tr mice. Endothelial over expression of sEH significantly changed oxylipin profiles, including decreases in DHETs, mid-chain HETEs, and prostaglandins (P < 0.05). Treatment with rosiglitazone, PPAR gamma-agonist, enhanced CRH (P < 0.05) in both Tie2-sEH Tr and wild type (WT) mice. These data demonstrate that endothelial over-expression of sEH (through changing the oxylipin profiles) attenuates CRH, whereas inhibition of omega-hydroxylases and activation of PPAR gamma enhance it.	[Hanif, Ahmad; Nayeem, Mohammed A.] West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Morisseau, Christophe] Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA; [Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Biochem, Dallas, TX 75390 USA	West Virginia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nayeem, MA (corresponding author), West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA.	mnayeem@hsc.wvu.edu	Zeldin, Darryl C/Y-7091-2018; Nayeem, Mohammed A/A-3949-2017; Edin, Matthew/AAI-1934-2019	Zeldin, Darryl C/0000-0002-2087-7307; Nayeem, Mohammed A/0000-0002-7827-4760; Edin, Matthew/0000-0002-7042-500X	National Institutes of Health [HL-114559)]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01 ES025034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034, Z01ES025034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (HL-114559) to MAN, and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to DCZ).	Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, P29; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Berwick ZC, 2010, MICROCIRCULATION, V17, P600, DOI 10.1111/j.1549-8719.2010.00054.x; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, P29; BURHOP KE, 1988, CIRC RES, V62, P687, DOI 10.1161/01.RES.62.4.687; Cai ZJ, 2013, J LIPID RES, V54, P1448, DOI 10.1194/jlr.M036533; Campbell WB, 2002, AM J PHYSIOL-HEART C, V282, pH1656, DOI 10.1152/ajpheart.00597.2001; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; CATELLA F, 1990, P NATL ACAD SCI USA, V87, P5893, DOI 10.1073/pnas.87.15.5893; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, P21; COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143, DOI 10.1152/ajplegacy.1960.199.6.1143; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Ellinsworth DC, 2014, CARDIOVASC RES, V102, P9, DOI 10.1093/cvr/cvu015; Emerson MR, 2004, BRAIN RES, V1021, P140, DOI 10.1016/j.brainres.2004.06.045; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fang X., 1996, CIRC RES, V79, P784, DOI [10.1161/01.RES.79.4.784, DOI 10.1161/01.RES.79.4.784]; Fang X, 2004, AM J PHYSIOL-HEART C, V287, P29; Fritsche KL, 2008, PROSTAG LEUKOTR ESS, V79, P173, DOI 10.1016/j.plefa.2008.09.019; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; HAMMOCK BD, 1983, TOXICOL APPL PHARM, V71, P254, DOI 10.1016/0041-008X(83)90342-3; Hanif A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162147; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Hellmann M, 2015, FUND CLIN PHARMACOL, V29, P510, DOI 10.1111/fcp.12135; Hoopes SL, 2015, PROSTAG OTH LIPID M, V120, P9, DOI 10.1016/j.prostaglandins.2015.03.002; Hou HH, 2012, CARDIOVASC RES, V93, P120, DOI 10.1093/cvr/cvr267; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Ishizuka Tsuneo, 2004, Nihon Jinzo Gakkai Shi, V46, P685; Jiang JG, 2007, PROSTAG OTH LIPID M, V82, P162, DOI 10.1016/j.prostaglandins.2006.08.005; Kingsbury MP, 2000, J MOL CELL CARDIOL, V32, P527, DOI 10.1006/jmcc.1999.1097; KITAKAZE M, 1992, CIRC RES, V71, P558, DOI 10.1161/01.RES.71.3.558; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kunduri SS, 2013, J CARDIOVASC PHARM, V62, P78, DOI 10.1097/FJC.0b013e3182919591; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, P28; Lee CH, 2010, 2010 15TH OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE (OECC), P24; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Li LM, 2014, PLOS ONE, V9, pe8433; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Lukaszewicz KM, 2016, MICROCIRCULATION, V18, P12304; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Maayah ZH, 2016, ARCH TOXICOL, V90, P119, DOI 10.1007/s00204-015-1620-8; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Nayeem MA, 2011, MOL CELL BIOCHEM, V350, P101, DOI 10.1007/s11010-010-0686-0; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Park S, 2008, YONSEI MED J, V49, P592, DOI 10.3349/ymj.2008.49.4.592; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Ponnoth DS, 2012, AM J PHYSIOL-REG I, V302, P7; Pradhan I, 2015, MOL CELL BIOCHEM, V5, P5; PROCTOR KG, 1987, CIRC RES, V60, P50, DOI 10.1161/01.RES.60.1.50; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Sha WX, 2012, IMMUNOBIOLOGY, V217, P1225, DOI 10.1016/j.imbio.2012.05.001; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; STOLL LL, 1994, AM J PHYSIOL, V266, pC990, DOI 10.1152/ajpcell.1994.266.4.C990; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Waldman M, 2016, PROSTAG OTH LIPID M, V7, P30033; Wen Y, 1996, AM J PHYSL, V271; Yadav VR, 2016, MOL CELL BIOCHEM, V15, P15; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]	72	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169584	10.1371/journal.pone.0169584	http://dx.doi.org/10.1371/journal.pone.0169584			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056085	Green Published, gold			2022-12-26	WOS:000391639100056
J	Lu, TY; Son, ZY; Li, QY; Li, ZG; Wang, M; Liu, L; Tian, KG; Li, N				Lu, Tianyu; Son, Zhiyuan; Li, Qiuyan; Li, Zhiguo; Wang, Meng; Liu, Lin; Tian, Kegong; Li, Ning			Overexpression of Histone Deacetylase 6 Enhances Resistance to Porcine Reproductive and Respiratory Syndrome Virus in Pigs	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; PLASMA-MEMBRANE; GENE-EXPRESSION; HDAC6; INFECTION; MICROTUBULE; REPLICATION; CYTOSKELETON; ACETYLATION; TRAFFICKING	Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most economically relevant viral pathogens in pigs and causes substantial losses in the pig industry worldwide each year. At present, PRRSV vaccines do not effectively prevent and control this disease. Consequently, it is necessary to develop new antiviral strategies to compensate for the inefficacy of the available vaccines. Histone deacetylase 6 (HDAC6) is an important member of the histone deacetylase family that is responsible for regulating many important biological processes. Studies have shown that HDAC6 has anti-viral activities during the viral life cycle. However, whether HDAC6 overexpression enhances resistance to PRRSV in pigs remains unknown. In this study, we used a somatic cell cloning method to produce transgenic (TG) pigs that constitutively overexpress porcine HDAC6. These TG pigs showed germ line transmission with continued overexpression of HDAC6. In vitro, virus challenged porcine alveolar macrophages (PAMs) overexpressed HDAC6, which suppressed viral gene expression and PRRSV production. In vivo, resistance to PRRSV in TG pigs was evaluated by direct or cohabitation mediated infection with a highly pathogenic PRRSV (HP-PRRSV) strain. Compared with non-TG (NTG) siblings, TG pigs showed a significantly lower viral load in the lungs and an extended survival time after infection with HPPRRSV via intramuscular injection. In the cohabitation study, NTG pigs housed with challenged NTG pigs exhibited significantly worse clinical symptoms than the other three in-contact groups. These results collectively suggest that HDAC6 overexpression enhances resistance to PRRSV infection both in vitro and in vivo. Our findings suggest the potential involvement of HDAC6 in the response to PRRSV, which will facilitate the development of novel therapies for PRRSV.	[Lu, Tianyu; Son, Zhiyuan; Li, Qiuyan; Wang, Meng; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China; [Li, Zhiguo; Liu, Lin] Nankai Univ, Dept Genet & Cell Biol, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol,Coll Life Sci, Tianjin, Peoples R China; [Tian, Kegong] Natl Res Ctr Vet Med, Luoyang, Henan Province, Peoples R China; [Tian, Kegong] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China	China Agricultural University; Nankai University; Henan Agricultural University	Li, N (corresponding author), China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China.; Tian, KG (corresponding author), Natl Res Ctr Vet Med, Luoyang, Henan Province, Peoples R China.; Tian, KG (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China.	tiankg@263.net; ninglcau@cau.edu.cn			Genetically modified major projects [2011ZX08006]; National Natural Scientific Foundation of China [3149600031]	Genetically modified major projects; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Genetically modified major projects (Project Grant No. 2011ZX08006) to Professor Ning Li (http://www.most.gov.cn/kjjh/), the National Natural Scientific Foundation of China (Project Grant No. 3149600031) to Professor Kegong Tian (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; BOOKOUT AL, 2006, CURR PROTOC MOL BIOL, V15, P15, DOI DOI 10.1002/0471142727.MB1508S73; Clark J, 2003, NAT REV GENET, V4, P825, DOI 10.1038/nrg1183; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Guo XK, 2013, J VIROL, V87, P1159, DOI 10.1128/JVI.02386-12; Hu SW, 2015, ELIFE, V4, DOI 10.7554/eLife.06951; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Husain M, 2014, J VIROL, V88, P11229, DOI 10.1128/JVI.00727-14; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; Jaqaman K, 2012, TRENDS CELL BIOL, V22, P515, DOI 10.1016/j.tcb.2012.07.006; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Li L, 2014, J BIOTECHNOL, V171, P17, DOI 10.1016/j.jbiotec.2013.11.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Malinowsky K, 2008, VIROLOGY, V376, P69, DOI 10.1016/j.virol.2008.02.034; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mosley AJ, 2006, BLOOD, V108, P3801, DOI 10.1182/blood-2006-03-013235; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scortti M, 2006, VET J, V172, P506, DOI 10.1016/j.tvjl.2005.07.015; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shanmukhappa K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-62; Teifke JP, 2001, J COMP PATHOL, V124, P238, DOI 10.1053/jcpa.2000.0458; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wang DK, 2015, PROTEIN CELL, V6, P152, DOI 10.1007/s13238-014-0120-6; Warren JC, 2006, MOL BIOL CELL, V17, P3557, DOI 10.1091/mbc.E05-09-0850; Zhang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154238; Zhang Q, 2014, VIROLOGY, V450, P182, DOI 10.1016/j.virol.2013.12.020; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang YH, 2006, SCI CHINA SER C, V49, P164, DOI 10.1007/s11427-006-0164-9; Zhong MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099425; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	49	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169317	10.1371/journal.pone.0169317	http://dx.doi.org/10.1371/journal.pone.0169317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052127	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500047
J	Vasdekis, AE; Silverman, AM; Stephanopoulos, G				Vasdekis, Andreas E.; Silverman, Andrew M.; Stephanopoulos, Gregory			Exploiting Bioprocessing Fluctuations to Elicit the Mechanistics of De Novo Lipogenesis in Yarrowia lipolytica	PLOS ONE			English	Article							LIPID DROPLETS; GENE-EXPRESSION; METABOLISM; ACCUMULATION; GROWTH; NOISE; STOCHASTICITY; HETEROGENEITY; VARIABILITY; RELEASE	Despite substantial achievements in elucidating the metabolic pathways of lipogenesis, a mechanistic representation of lipid accumulation and degradation has not been fully attained to-date. Recent evidence suggests that lipid accumulation can occur through increases of either the cytosolic copy-number of lipid droplets (LDs), or the LDs size. However, the prevailing phenotype, or how such mechanisms pertain to lipid degradation remain poorly understood. To address this shortcoming, we employed the-recently discovered-innate bioprocessing fluctuations in Yarrowia lipolytica, and performed single-cell fluctuation analysis using optical microscopy and microfluidics that generate a quasi-time invariant microenvironment. We report that lipid accumulation at early stationary phase in rich medium is substantially more likely to occur through variations in the LDs copy-number, rather than the LDs size. Critically, these mechanistics are also preserved during lipid degradation, as well as upon exposure to a protein translation inhibitor. The latter condition additionally induced a lipid accumulation phase, accompanied by the downregulation of lipid catabolism. Our results enable an in-depth mechanistic understanding of lipid biogenesis, and expand longitudinal single-cell fluctuation analyses from gene regulation to metabolism.	[Vasdekis, Andreas E.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA; [Vasdekis, Andreas E.] Pacific Northwest Natl Lab, Environm & Mol Sci Lab, Richland, WA 99354 USA; [Silverman, Andrew M.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Idaho; University of Idaho; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Massachusetts Institute of Technology (MIT)	Vasdekis, AE (corresponding author), Univ Idaho, Dept Phys, Moscow, ID 83844 USA.; Vasdekis, AE (corresponding author), Pacific Northwest Natl Lab, Environm & Mol Sci Lab, Richland, WA 99354 USA.; Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	andreasv@uidaho.edu; gregstep@mit.edu		Vasdekis, Andreas/0000-0003-4315-1047	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103408]; Pacific Northwest National Laboratory (Linus Pauling Fellowship) [PN12005/2406]; US Department of Energy [SC 0008744]; Department of Energy's Office of Biological and Environmental Research; National Institute of General Medical Sciences of the National Institutes of Health [P20GM104420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, P20GM104420] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Pacific Northwest National Laboratory (Linus Pauling Fellowship); US Department of Energy(United States Department of Energy (DOE)); Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AEV acknowledges support from an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20 GM103408), as well as from the Pacific Northwest National Laboratory (Linus Pauling Fellowship - PN12005/2406); GS acknowledges financial support from the US Department of Energy, Grant no. SC 0008744. Part of the research was performed using EMSL, a national user facility sponsored by the Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory.; AEV acknowledges support by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM104420. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. AEV also acknowledges funding from the Pacific Northwest National Laboratory (Linus Pauling Fellowship-PN12005/2406); GS acknowledges financial support from the US Department of Energy, Grant no. SC 0008744. Part of the research was performed using EMSL, a national user facility sponsored by the Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory.	Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Deris JB, 2013, SCIENCE, V342, P1068, DOI 10.1126/science.1237435; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FRENZEN CL, 1988, J MATH BIOL, V26, P689, DOI 10.1007/BF00276148; Garay LA, 2014, J AGR FOOD CHEM, V62, P2709, DOI 10.1021/jf4042134; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Herms A, 2013, CURR BIOL, V23, P1489, DOI 10.1016/j.cub.2013.06.032; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kerkhoven EJ, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.5; Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; Labhsetwar P, 2013, P NATL ACAD SCI USA, V110, P14006, DOI 10.1073/pnas.1222569110; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Liu L, 2015, METAB ENG, V29, P36, DOI 10.1016/j.ymben.2015.02.003; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Morin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027966; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nielsen J, 2003, J BACTERIOL, V185, P7031, DOI 10.1128/JB.185.24.7031-7035.2003; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009; Osumi M, 2012, J ELECTRON MICROSC, V61, P343, DOI 10.1093/jmicro/dfs082; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Read EL, 2012, P NATL ACAD SCI USA, V109, P19727, DOI 10.1073/pnas.1206940109; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Silverman AM, 2016, APPL MICROBIOL BIOT, V100, P3781, DOI 10.1007/s00253-016-7376-0; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Vasdekis AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep17689; Vasdekis AE, 2013, ANNU REV MATER RES, V43, P283, DOI 10.1146/annurev-matsci-071312-121724; Vasdekis AE, 2015, METAB ENG, V27, P115, DOI 10.1016/j.ymben.2014.09.007; Vasdekis AE, 2013, RSC ADV, V3, P6343, DOI 10.1039/c3ra40369f; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wasylenko TM, 2015, METAB ENG, V30, P27, DOI 10.1016/j.ymben.2015.02.007; Welf ES, 2014, BIOPHYS J, V107, P2492, DOI 10.1016/j.bpj.2014.10.032; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zenobi R, 2013, SCIENCE, V342, P1201, DOI 10.1126/science.1243259; Zhang ZY, 2006, LAB CHIP, V6, P906, DOI 10.1039/b518396k; Zhu ZW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2112	53	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168889	10.1371/journal.pone.0168889	http://dx.doi.org/10.1371/journal.pone.0168889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052085	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500025
J	Peck, BCE; Mah, AT; Pitman, WA; Ding, SL; Lund, PK; Sethupathy, P				Peck, Bailey C. E.; Mah, Amanda T.; Pitman, Wendy A.; Ding, Shengli; Lund, P. Kay; Sethupathy, Praveen			Functional Transcriptomics in Diverse Intestinal Epithelial Cell Types Reveals Robust MicroRNA Sensitivity in Intestinal Stem Cells to Microbial Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT MICROBIOTA; ENTEROENDOCRINE CELLS; EXPRESSION; MIR-375; MUCOSA; DIFFERENTIATION; PROLIFERATION; MICROFLORA; DIET; SOX9	Gut microbiota play an important role in regulating the development of the host immune system, metabolic rate, and at times, disease pathogenesis. The factors and mechanisms that mediate interactions between microbiota and the intestinal epithelium are not fully understood. We provide novel evidence that microbiota may control intestinal epithelial stem cell (IESC) proliferation in part through microRNAs (miRNAs). We demonstrate that miRNA profiles differ dramatically across functionally distinct cell types of the mouse jejunal intestinal epithelium and that miRNAs respond to microbiota in a highly cell type-specific manner. Importantly, we also show that miRNAs in IESCs are more prominently regulated by microbiota compared with miRNAs in any other intestinal epithelial cell subtype. We identify miR-375 as one miRNA that is significantly suppressed by the presence of microbiota in IESCs. Using a novel method to knockdown gene and miRNA expression ex vivo enteroids, we demonstrate that we can knock down gene expression in Lgr5(+) IESCs. Furthermore, when we knock down miR-375 in IESCs, we observe significantly increased proliferative capacity. Understanding the mechanisms by which microbiota regulate miRNA expression in IESCs and other intestinal epithelial cell subtypes will elucidate a critical molecular network that controls intestinal homeostasis and, given the heightened interest in miRNA-based therapies, may offer novel therapeutic strategies in the treatment of gastrointestinal diseases associated with altered IESC function.	[Peck, Bailey C. E.; Lund, P. Kay; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Peck, Bailey C. E.; Pitman, Wendy A.; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Mah, Amanda T.; Lund, P. Kay] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Ding, Shengli; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Peck, BCE (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Sch Med, 5100H Genet Med Bldg CB 7264,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sethupathy, P (corresponding author), Univ N Carolina, Dept Genet, Sch Med, 5091 Genet Med Bldg CB 7264,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	bpeck@email.unc.edu; Praveen_sethupathy@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Ariel, Pablo/AGJ-4118-2022	Peck, Bailey/0000-0002-4316-0966	National Institutes of Health [P39DK034987, P40OD010995.]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, F31DK105747, R01DK105965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055336, T32GM007092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Eric Blue for help in developing the GF Sox9-EGFP resource, Elaine Glenny for critical assistance with the anaerobic chamber and the protocol for conventionalization, Dr. C. Lisa Kurtz, Dr. Emily Moorefield, Dr. Jeanette Baran-Gale, and Dr. Kasia Kedziora for technical assistance and training, Dr. John Rawls, Dr. Scott Magness, Dr. Susan Henning, Dr. Michael Shanahan, and Dr. Ajay Gulati for helpful discussions as well as Felicia Heyward and UNC Flow Cytometry Core Facility, the UNC Gnotobiotic Core Facility, Dr. Zhao Lai and the UTHSCSA Genome Sequencing Facility, and Dr. Bob Bagnell and the UNC Microscopy Services Laboratory for critical services. The UNC Gnotobiotic Core Facility is supported through National Institutes of Health Grants P39DK034987 and P40OD010995.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Archambaud C, 2013, MBIO, V4, DOI 10.1128/mBio.00707-13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baran-Gale J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073240; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Everard A, 2014, REV ENDOCR METAB DIS, V15, P189, DOI 10.1007/s11154-014-9288-6; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; GUENET JL, 1970, CR ACAD SCI D NAT, V270, P3087; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; ISHIKAWA K, 1986, ACTA ANAT, V127, P296; Jaladanki R. N., 2011, REGULATION GASTROINT; Knudsen LA, 2015, ENDOCRINOLOGY, V156, P3971, DOI 10.1210/en.2015-1088; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Nathan G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122108; Nezami BG, 2014, GASTROENTEROLOGY, V146, P473, DOI 10.1053/j.gastro.2013.10.053; Patro R., 2015, 021592 BIORXIV; Peck BCE, 2016, J BIOL CHEM, V291, P15975, DOI 10.1074/jbc.M116.733733; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sasabe J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.125, 10.1038/nmicrobiol.2016.125]; Seiler KM, 2015, CELL TISSUE RES, V361, P427, DOI 10.1007/s00441-015-2111-1; Sharma R, 1996, EXPERIENTIA, V52, P664, DOI 10.1007/BF01925570; Siciliano V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3364; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Velasquez-Manoff M, 2015, NATURE, V518, pS3, DOI 10.1038/518S3a; Walker EM, 2014, DEV BIOL, V392, P283, DOI 10.1016/j.ydbio.2014.05.017; Wang DL, 2012, CIRC RES, V111, P967, DOI [10.1161/circresaha.112.266502, 10.1161/CIRCRESAHA.112.266502]; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Zhang ZW, 2013, CELL PHYSIOL BIOCHEM, V32, P1808, DOI 10.1159/000356614	59	71	73	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2586	2600		10.1074/jbc.M116.770099	http://dx.doi.org/10.1074/jbc.M116.770099			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053090	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000395535100003
J	Scheef, L; Nordmeyer-Massner, JA; Smith-Collins, APR; Muller, N; Stegmann-Woessner, G; Jankowski, J; Gieseke, J; Born, M; Seitz, H; Bartmann, P; Schild, HH; Pruessmann, KP; Heep, A; Boecker, H				Scheef, Lukas; Nordmeyer-Massner, Jurek A.; Smith-Collins, Adam P. R.; Mueller, Nicole; Stegmann-Woessner, Gaby; Jankowski, Jacob; Gieseke, Juergen; Born, Mark; Seitz, Hermann; Bartmann, Peter; Schild, Hans H.; Pruessmann, Klaas P.; Heep, Axel; Boecker, Henning			Functional Laterality of Task-Evoked Activation in Sensorimotor Cortex of Preterm Infants: An Optimized 3 T fMRI Study Employing a Customized Neonatal Head Coil	PLOS ONE			English	Article							CORTICOSPINAL PROJECTIONS; CORTICAL-LESIONS; BRAIN; CHILDREN; MOVEMENTS; BIRTH; MRI; ULTRASOUND; PLASTICITY; DIAGNOSIS	Background Functional magnetic resonance imaging (fMRI) in neonates has been introduced as a non-invasive method for studying sensorimotor processing in the developing brain. However, previous neonatal studies have delivered conflicting results regarding localization, lateralization, and directionality of blood oxygenation level dependent (BOLD) responses in sensorimotor cortex (SMC). Amongst the confounding factors in interpreting neonatal fMRI studies include the use of standard adult MR-coils providing insufficient signal to noise, and liberal statistical thresholds, compromising clinical interpretation at the single subject level. Patients / methods Here, we employed a custom-designed neonatal MR-coil adapted and optimized to the head size of a newborn in order to improve robustness, reliability and validity of neonatal sensorimotor fMRI. Thirteen preterm infants with a median gestational age of 26 weeks were scanned at term-corrected age using a prototype 8-channel neonatal head coil at 3T (Achieve, Philips, Best, NL). Sensorimotor stimulation was elicited by passive extension/flexion of the elbow at 1 Hz in a block design. Analysis of temporal signal to noise ratio (tSNR) was performed on the whole brain and the SMC, and was compared to data acquired with an 'adult' 8 channel head coil published previously. Task-evoked activation was determined by single-subject SPM8 analyses, thresholded at p < 0.05, whole-brain FWE-corrected. Results Using a custom-designed neonatal MR-coil, we found significant positive BOLD responses in contralateral SMC after unilateral passive sensorimotor stimulation in all neonates (analyses restricted to artifact-free data sets = 8/13). Improved imaging characteristics of the neonatal MR-coil were evidenced by additional phantom and in vivo tSNR measurements: phantom studies revealed a 240% global increase in tSNR; in vivo studies revealed a 73% global and a 55% local (SMC) increase in tSNR, as compared to the 'adult' MR-coil. Conclusions Our findings strengthen the importance of using optimized coil settings for neonatal fMRI, yielding robust and reproducible SMC activation at the single subject level. We conclude that functional lateralization of SMC activation, as found in children and adults, is already present in the newborn period.	[Scheef, Lukas; Jankowski, Jacob; Born, Mark; Schild, Hans H.; Boecker, Henning] Univ Bonn, Dept Radiol, Bonn, Germany; [Nordmeyer-Massner, Jurek A.; Pruessmann, Klaas P.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Nordmeyer-Massner, Jurek A.; Pruessmann, Klaas P.] ETH, Zurich, Switzerland; [Smith-Collins, Adam P. R.; Heep, Axel] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Mueller, Nicole; Stegmann-Woessner, Gaby; Bartmann, Peter; Heep, Axel] Univ Bonn, Dept Neonatol, Bonn, Germany; [Gieseke, Juergen] Philips Med Syst, Hamburg, Germany; [Seitz, Hermann] Univ Rostock, Dept Mech Engn & Marine Technol, Rostock, Germany	University of Bonn; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bristol; University of Bonn; Philips; Philips Healthcare; University of Rostock	Heep, A (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.; Heep, A (corresponding author), Univ Bonn, Dept Neonatol, Bonn, Germany.	axel.heep@bristol.ac.uk	Boecker, Henning/N-7172-2019; Pruessmann, Klaas P/H-5385-2018; Seitz, Hermann/G-1657-2015	Pruessmann, Klaas P/0000-0003-0009-8362; Seitz, Hermann/0000-0003-3401-0090; Boecker, Henning/0000-0003-2346-0598	Deutsche Forschungsgmeinschaft [HE 5954/1-1]; Academy of Medical Sciences (AMS) [AMS-SGCL10-Smith-Collins] Funding Source: researchfish; National Institute for Health Research [CL-2012-25-003] Funding Source: researchfish	Deutsche Forschungsgmeinschaft; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the Deutsche Forschungsgmeinschaft; HE 5954/1-1. http://gepris.dfg.de The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Allievi AG, 2013, ANN BIOMED ENG, V41, P1181, DOI 10.1007/s10439-013-0782-x; Allievi AG, 2016, CEREB CORTEX, V26, P402, DOI 10.1093/cercor/bhv203; Allievi AG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00197; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Arichi T, 2010, NEUROIMAGE, V49, P2063, DOI 10.1016/j.neuroimage.2009.10.038; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Baron IS, 2010, NEUROPSYCHOL REV, V20, P430, DOI 10.1007/s11065-010-9132-z; Bayley N., 1993, BAYLEY 2 BAYLEY SCAL; Bos AF, 2013, DEV MED CHILD NEUROL, V55, P1, DOI 10.1111/dmcn.12297; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; Cincotta M, 2003, MOVEMENT DISORD, V18, P1294, DOI 10.1002/mds.10545; Cusack R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120202; de Vries LS, 2013, NEURORADIOLOGY, V55, P13, DOI 10.1007/s00234-013-1233-y; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Erberich SG, 2006, NEUROIMAGE, V29, P155, DOI 10.1016/j.neuroimage.2005.07.024; Erberich SG, 2003, NEUROIMAGE, V20, P683, DOI 10.1016/S1053-8119(03)00370-7; Estep ME, 2014, PEDIATR RES, V76, P86, DOI 10.1038/pr.2014.45; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Eyre J. A., 2003, Neural Plasticity, V10, P93, DOI 10.1155/NP.2003.93; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Eyre JA, 2001, NEUROLOGY, V57, P1543, DOI 10.1212/WNL.57.9.1543; Fawke J, 2007, SEMIN FETAL NEONAT M, V12, P374, DOI 10.1016/j.siny.2007.06.002; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; Guzzetta A, 2007, PEDIATR RES, V61, P485, DOI 10.1203/pdr.0b013e3180332c2e; Heep A, 2009, PEDIATRICS, V123, P294, DOI 10.1542/peds.2007-3475; Hughes E. J., 2016, MAGN RESON MED; Huppi PS, 1998, PEDIATR RES, V44, P584; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KARTJETILLOTSON G, 1985, BRAIN RES, V332, P103, DOI 10.1016/0006-8993(85)90393-2; KARTJETILLOTSON G, 1987, BRAIN RES, V415, P172, DOI 10.1016/0006-8993(87)90283-6; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; Koerte I, 2011, DEV MED CHILD NEUROL, V53, P179, DOI 10.1111/j.1469-8749.2010.03840.x; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Nevalainen P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00158; NWAESEI CG, 1988, J PEDIATR-US, V112, P970, DOI 10.1016/S0022-3476(88)80228-2; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Palmer FB, 2004, J PEDIATR-US, V145, pS8, DOI 10.1016/j.jpeds.2004.05.016; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pierrat V, 2001, ARCH DIS CHILD-FETAL, V84, pF151, DOI 10.1136/fn.84.3.F151; Polzin C, 2013, RAPID PROTOTYPING J, V19, P37, DOI 10.1108/13552541311292718; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Setanen S, 2013, ACTA PAEDIATR, V102, P492, DOI 10.1111/apa.12191; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Staudt M, 2010, J ANAT, V217, P469, DOI 10.1111/j.1469-7580.2010.01262.x; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Valkama AM, 2000, ACTA PAEDIATR, V89, P348; van de Weijer-Bergsma EV, 2008, INFANT BEHAV DEV, V31, P333, DOI 10.1016/j.infbeh.2007.12.003; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028	54	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169392	10.1371/journal.pone.0169392	http://dx.doi.org/10.1371/journal.pone.0169392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076368	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100036
J	Ida-Yonemochi, H; Yamada, Y; Yoshikawa, H; Seo, K				Ida-Yonemochi, Hiroko; Yamada, Yurie; Yoshikawa, Hiroyuki; Seo, Kenji			Locally Produced BDNF Promotes Sclerotic Change in Alveolar Bone after Nerve Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; IN-VITRO; DIFFERENTIATION; EXPRESSION; CELLS; DISORDERS; RECEPTORS; SURVIVAL; SYSTEM	Brain-derived neurotrophic factor (BDNF), which is released due to nerve injury, is known to promote the natural healing of injured nerves. It is often observed that damage of mandibular canal induces local sclerotic changes in alveolar bone. We reported that peripheral nerve injury promotes the local production of BDNF; therefore, it was possible to hypothesize that peripheral nerve injury affects sclerotic changes in the alveolar bone. This study aimed to evaluate the effect of BDNF on osteogenesis using in vitro osteoblast-lineage cell culture and an in vivo rat osteotomy model. MC3T3-E1 cells were cultured with BDNF and were examined for cell proliferative activity, chemotaxis and mRNA expression levels of osteoblast differentiation markers. For in vivo study, inferior alveolar nerve (IAN) injury experiments and mandibular cortical osteotomy were performed using a rat model. In the osteotomy model, exogenous BDNF was applied to bone surfaces after corticotomy of the mandible, and we morphologically analyzed the new bone formation. As a result, mRNA expression of osteoblast differentiation marker, osteocalcin, was significantly increased by BDNF, although cell proliferation and migration were not affected. In the in vivo study, osteopontin-positive new bone formation was significantly accelerated in the BDNF-grafted groups, and active bone remodeling, involving trkB-positive osteoblasts and osteocytes, continued after 28 days. In conclusion, BDNF stimulated the differentiation of MC3T3-E1 cells and it promoted new bone formation and maturation. These results suggested that local BDNF produced by peripheral nerve injury contributes to accelerating sclerotic changes in the alveolar bone.	[Ida-Yonemochi, Hiroko] Niigata Univ, Grad Sch Med & Dent Sci, Div Anat & Cell Biol Hard Tissue, Chuo Ku, Niigata, Japan; [Yamada, Yurie; Yoshikawa, Hiroyuki; Seo, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Anesthesiol, Chuo Ku, Niigata, Japan	Niigata University; Niigata University	Seo, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Anesthesiol, Chuo Ku, Niigata, Japan.	seo@dent.niigata-u.ac.jp			Ministry of education, culture, sports, science and technology, Japan [25670854]; MEXT [25670854]; Grants-in-Aid for Scientific Research [26462777] Funding Source: KAKEN	Ministry of education, culture, sports, science and technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a Grant-in-Aid for Scientific Research (no. 25670854 to Kenji Seo) from Ministry of education, culture, sports, science and technology, Japan, 2012-2015, https://www.jsps.go.jp/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. K. Oda of Niigata University for providing the anti-ALP antibody. This work was supported in part by a Grant-in-Aid for Scientific Research (no. 25670854 to Kenji Seo) from MEXT, 2012-2015.	Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Bongenhielm U, 1996, PAIN, V67, P399, DOI 10.1016/0304-3959(96)03119-3; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Foltan R, 2008, MED HYPOTHESES, V71, P572, DOI 10.1016/j.mehy.2008.05.010; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Goldring SR, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000049; Gregg J M, 2000, Ann R Australas Coll Dent Surg, V15, P176; Gu YX, 2013, J BIOMED MATER RES A, V101, P748, DOI 10.1002/jbm.a.34377; Guevara YMV, 2014, NEUROREPORT, V25, P1069, DOI 10.1097/WNR.0000000000000231; Hasegawa R, 2008, ANAT SCI INT, V83, P186, DOI 10.1111/j.1447-073X.2007.00208.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Jimbo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084845; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kilian O, 2014, ANN ANAT, V196, P286, DOI 10.1016/j.aanat.2014.06.001; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; McGonnell IM, 2012, FRONT ENDOCRINOL, V20, P88; MOSS ML, 1970, ACTA ANAT, V77, P341; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Oda K, 1999, J BIOCHEM, V126, P694, DOI 10.1093/oxfordjournals.jbchem.a022505; Polland KE, 2001, CLIN ANAT, V14, P445, DOI 10.1002/ca.1080; Seo K, 2016, PAIN MED; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566; Terumitsu M, 2011, ORAL SURG ORAL MED O, V111, P95, DOI 10.1016/j.tripleo.2010.09.002; Wadu SG, 1997, CLIN ANAT, V10, P82, DOI 10.1002/(SICI)1098-2353(1997)10:2<82::AID-CA2>3.0.CO;2-V; Wu CM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-277; YADA M, 1994, BIOCHEM BIOPH RES CO, V205, P1187, DOI 10.1006/bbrc.1994.2791; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Yoshikawa H, 2016, J ORAL FACI IN PRESS	33	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e016201	10.1371/journal.pone.0169201	http://dx.doi.org/10.1371/journal.pone.0169201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072837	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200009
J	Kuramochi, M; Doi, M				Kuramochi, Masahiro; Doi, Motomichi			A Computational Model Based on Multi-Regional Calcium Imaging Represents the Spatio-Temporal Dynamics in a Caenorhabditis elegans Sensory Neuron	PLOS ONE			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; CHEMOSENSORY NEURONS; NERVOUS-SYSTEM; CHEMOTAXIS; CIRCUIT; INTERNEURON; MEMBRANE; MEMORY; RECONSTRUCTION	Due to the huge number of neuronal cells in the brain and their complex circuit formation, computer simulation of neuronal activity is indispensable to understanding whole brain dynamics. Recently, various computational models have been developed based on whole-brain calcium imaging data. However, these analyses monitor only the activity of neuronal cell bodies and treat the cells as point unit. This point-neuron model is inexpensive in computational costs, but the model is unrealistically simplistic at representing intact neural activities in the brain. Here, we describe a novel three-unit Ordinary Differential Equation (ODE) model based on the neuronal responses derived from a Caenorhabditis elegans salt-sensing neuron. We recorded calcium responses in three regions of the ASER neuron using a simple downstep of NaCl concentration. Our simple ODE model generated from a single recording can adequately reproduce and predict the temporal responses of each part of the neuron to various types of NaCl concentration changes. Our strategy which combines a simple recording data and an ODE mathematical model may be extended to realistically understand whole brain dynamics by computational simulation.	[Kuramochi, Masahiro; Doi, Motomichi] AIST, Biomed Res Inst, Ibaraki, Japan; [Kuramochi, Masahiro; Doi, Motomichi] AIST, Biomed Res Inst, DAI LAB, Ibaraki, Japan; [Kuramochi, Masahiro; Doi, Motomichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Life Sci & Bioengn, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Doi, M (corresponding author), AIST, Biomed Res Inst, Ibaraki, Japan.; Doi, M (corresponding author), AIST, Biomed Res Inst, DAI LAB, Ibaraki, Japan.; Doi, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Life Sci & Bioengn, Ibaraki, Japan.	doi-m@aist.go.jp	Doi, Motomichi/L-7438-2018	Doi, Motomichi/0000-0002-7837-3056; Kuramochi, Masahiro/0000-0003-1643-3997	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [21115522]; NIH Office of Research Infrastructure Programs [P40OD010440]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21115522]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH Office of Research Infrastructure Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas 21115522 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan to MD.; We thank Y. Iino, H. Kunitomo and H. Sato for providing calcium imaging techniques and for sharing a plasmid DNA, and T. Ishihara and T. Teramoto for sharing G-GECO plasmids. We also thank S. Tsukakoshi and M. Sato for technical assistance and Y. Shinkai and other members in AIST for critical discussion. Some strains were provided by the CGC which is funded by NIH Office of Research Infrastructure Programs (P40OD010440). This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas 21115522 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Bargmann C.I., 2006, CHEMOSENSATION C ELE; Barker AJ, 2015, CURR BIOL, V25, P2804, DOI 10.1016/j.cub.2015.09.055; Boyle JH, 2008, BIOSYSTEMS, V94, P170, DOI 10.1016/j.biosystems.2008.05.025; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cho CE, 2016, ELIFE, V5, DOI [10.7554/elife.14000, 10.7554/eLife.14000]; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; DAVIS RE, 1989, J NEUROSCI, V9, P403; DAVIS RE, 1989, J NEUROSCI, V9, P415; Ferree TC, 1999, J COMPUT NEUROSCI, V6, P263, DOI 10.1023/A:1008857906763; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Holland J. H., 1973, SIAM Journal on Computing, V2, P88, DOI 10.1137/0202009; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kato S, 2014, NEURON, V81, P616, DOI 10.1016/j.neuron.2013.11.020; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Li ZY, 2014, CELL, V159, P751, DOI 10.1016/j.cell.2014.09.056; Lindsay TH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1304; Luo LJ, 2014, NEURON, V82, P1115, DOI 10.1016/j.neuron.2014.05.010; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Press W. H., 1992, ART SCI COMPUTING; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Rakowski F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00128; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; Sakata K, 2004, NETWORK-COMP NEURAL, V15, P199, DOI 10.1088/0954-898X/15/3/003; Satoh Y, 2014, J NEUROSCI, V34, P15631, DOI 10.1523/JNEUROSCI.1757-14.2014; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Tsukada Y, 2016, J NEUROSCI, V36, P2571, DOI 10.1523/JNEUROSCI.2837-15.2016; Venkatachalam V, 2016, P NATL ACAD SCI USA, V113, pE1082, DOI 10.1073/pnas.1507109113; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 1996, J NEUROSCI, V16, P4017; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0168415	10.1371/journal.pone.0168415	http://dx.doi.org/10.1371/journal.pone.0168415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072834	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200003
J	Pogozhykh, D; Pakhomova, Y; Pervushina, O; Hofmann, N; Glasmacher, B; Zhegunov, G				Pogozhykh, Denys; Pakhomova, Yuliya; Pervushina, Olga; Hofmann, Nicola; Glasmacher, Birgit; Zhegunov, Gennadiy			Exploring the Possibility of Cryopreservation of Feline and Canine Erythrocytes by Rapid Freezing with Penetrating and Non Penetrating Cryoprotectants	PLOS ONE			English	Article							RED-BLOOD-CELLS; HYDROXYETHYL STARCH; TRANSFUSION MEDICINE; GLYCEROL; DIMETHYLSULFOXIDE; MECHANISM; HEMOLYSIS; LIQUID; CATS; DOG	Efficient application of veterinary blood transfusion approaches for small companion animals requires readily available supply of the donor material. This can be achieved by developing of effective biobanking technologies allowing long-term storage of donor blood components via cryopreservation. Transfusion of an erythrocyte concentrate allows the successful correction of various hematological pathologies, severe bleeding, and etc. While in the past there were several approaches to cryopreserve red blood cells of dogs, to our knowledge there is virtually no data on cryopreservation of feline erythrocytes. In this paper, we performed a comprehensive parameter optimization for low temperature storage of RBCs of both species. Here, the efficiency of single-component and multicomponent cryoprotective media as well as necessary time of pre-incubation with penetrating and non-penetrating cryoprotectants prior to rapid freezing is analyzed. This study showed that glycerol was not sufficient for cryopreservation of red blood cells of the studied species under the investigated conditions. Application of 10% (v/v) ME2SO allowed for a significant reduction of canine and feline erythrocytes hemolysis after thawing. 17.5% hydroxyethyl starch demonstrated the highest cryoprotective activity for both species. It was found that dog RBCs should be incubated in cryoprotective media for 30 min at 22 degrees C prior to freezing, while for cat RBCs 20 min is sufficient. Combination of CPAs was less effective. Presented data may be considered in further studies in veterinary transfusion and blood banking optimization.	[Pogozhykh, Denys] Hannover Med Sch, Inst Transfus Med, Carl Neuberg Str 1, Hannover, Germany; [Pogozhykh, Denys; Hofmann, Nicola; Glasmacher, Birgit] Leibniz Univ Hannover, Inst Multiphase Proc, Callinstr 36, Hannover, Germany; [Pogozhykh, Denys; Pakhomova, Yuliya] Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Kharkov, Ukraine; [Pervushina, Olga; Zhegunov, Gennadiy] Kharkiv State Zooveterinary Acad, Mala Danylivka, Kharkiv Region, Ukraine	Hannover Medical School; Leibniz University Hannover; National Academy of Sciences Ukraine; Institute for Problems of Cryobiology & Cryomedicine of NASU	Pogozhykh, D (corresponding author), Hannover Med Sch, Inst Transfus Med, Carl Neuberg Str 1, Hannover, Germany.; Pogozhykh, D (corresponding author), Leibniz Univ Hannover, Inst Multiphase Proc, Callinstr 36, Hannover, Germany.; Pogozhykh, D (corresponding author), Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Kharkov, Ukraine.	pogozhykh.denys@mh-hannover.de		Yuliia, Pakhomova/0000-0003-2682-3796; Glasmacher, Birgit/0000-0002-2452-1666; Pogozhykh, Denys/0000-0001-7298-5425	Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany; Institute for Multiphase Processes, Leibniz Universitaet Hannover, Hannover, Germany; Kharkiv State Zooveterinary Academy, Mala Danylivka, Kharkiv Region, Ukraine; Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Cluster of Excellence REBIRTH [EXC 62/1]	Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany; Institute for Multiphase Processes, Leibniz Universitaet Hannover, Hannover, Germany; Kharkiv State Zooveterinary Academy, Mala Danylivka, Kharkiv Region, Ukraine; Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Cluster of Excellence REBIRTH	The research conduction and article preparation were funded by the cooperating institutes: 1. Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany; 2. Institute for Multiphase Processes, Leibniz Universitaet Hannover, Hannover, Germany; 3. Kharkiv State Zooveterinary Academy, Mala Danylivka, Kharkiv Region, Ukraine; 4. Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine. Besides, the research was partially supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, EXC 62/1) through travel funding by the Cluster of Excellence REBIRTH. Decisions in study design; in the collection, analysis and interpretation of data; in the writing of the report; and the decision to submit the article for publication were taken by the senior authors.	Babiychuk LA, 2000, TRANSPLANTOLOHIIA, V1, P296; Barfield D, 2011, J FELINE MED SURG, V13, P11, DOI 10.1016/j.jfms.2010.11.006; BARMAN BN, 1993, ANAL BIOCHEM, V212, P35, DOI 10.1006/abio.1993.1287; Belous A. M., 1990, PROBL CRYOBIOL, V4, P3; Bogdanchikova O. A., 2008, PROBL CRYOBIOL, V18, P109, DOI DOI 10.1016/J.CRYOBIOL.2009.08.001; Bogner P, 2002, EUR BIOPHYS J BIOPHY, V31, P145, DOI 10.1007/s00249-001-0198-7; CHRISTOPHER MM, 1990, VET PATHOL, V27, P299, DOI 10.1177/030098589002700501; CONTRERAS TJ, 1979, TRANSFUSION, V19, P279, DOI 10.1046/j.1537-2995.1979.19379204209.x; DeLuca Lawrence A., 2006, Journal of Applied Animal Welfare Science, V9, P129, DOI 10.1207/s15327604jaws0902_3; Denisova O. N., 2005, PROBL CRYOBIOL, V15, P195; FELDMAN BF, 1995, VET CLIN N AM-SMALL, V25, P1231, DOI 10.1016/S0195-5616(95)50151-2; González Guerrero Celia, 2015, Farm Hosp., V39, P382, DOI 10.7399/fh.2015.39.6.8907; Gordienko O. I., 2003, PHYS ALIVE, V11, P29; Graham JE, 2015, AM J VET RES, V76, P487, DOI 10.2460/ajvr.76.6.487; GRIOTWENK ME, 1995, VET CLIN N AM-SMALL, V25, P1305, DOI 10.1016/S0195-5616(95)50156-1; Guerra-Shinohara EM, 1999, BRAZ J MED BIOL RES, V32, P683, DOI 10.1590/S0100-879X1999000600003; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Heesch S, 2012, CRYOLETTERS, V33, P327; Henrich HA, 1999, ZBL CHIR, V124, P271; JAIN NC, 1973, CORNELL VET, V63, P411; Kaneko JJ, 1997, CLIN BIOCH DOMESTIC; Kaufman P M, 1992, Probl Vet Med, V4, P582; Kim H, 2005, CRYOLETTERS, V26, P1; Kim H, 2004, J VET MED SCI, V66, P1543, DOI 10.1292/jvms.66.1543; LANGER R, 1994, INFUSIONSTHERAPIE, V21, P393; MAUK AG, 1972, ARCH BIOCHEM BIOPHYS, V150, P376, DOI 10.1016/0003-9861(72)90052-5; MERYMAN HT, 1971, CRYOBIOLOGY, V8, P489, DOI 10.1016/0011-2240(71)90040-X; Naaldijk Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-49; Obrador R, 2015, J VET EMERG CRIT CAR, V25, P187, DOI 10.1111/vec.12252; Otte S. M., 1991, ADV VET SCI COMP MED, V36; Pakhomova YS, 2013, PROBLEMS CRYOBIOLOGY, V23, P26; Pegg David E, 2007, Methods Mol Biol, V368, P39; Petrenko YA, 2008, CRYOBIOLOGY, V57, P195, DOI 10.1016/j.cryobiol.2008.08.003; PRIBOR DB, 1971, CRYOBIOLOGY, V8, P14, DOI 10.1016/0011-2240(71)90103-9; Quan GB, 2009, CRYOBIOLOGY, V59, P258, DOI 10.1016/j.cryobiol.2009.08.001; Ramazanov V. V., 2010, PROBL CRYOBIOL, V20, P47; Rozanski E, 2004, CLIN TECH SMALL AN P, V19, P83, DOI 10.1053/j.ctsap.2004.01.005; Singbartl K, 1998, CRYOBIOLOGY, V36, P115, DOI 10.1006/cryo.1997.2072; SPUTTEK A, 1992, BEITR INFUS, V30, P292; TAKAHASHI T, 1988, BIOPHYS J, V54, P509, DOI 10.1016/S0006-3495(88)82983-7; VOSS WAG, 1974, CRYOBIOLOGY, V11, P285, DOI 10.1016/0011-2240(74)90004-2; WESSELS JMC, 1973, BIOCHIM BIOPHYS ACTA, V291, P190, DOI 10.1016/0005-2736(73)90411-2; Zhivotova E. N., 2008, P NATL ACAD SCI UKRA, V5, P89	43	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169689	10.1371/journal.pone.0169689	http://dx.doi.org/10.1371/journal.pone.0169689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072844	Green Published, gold			2022-12-26	WOS:000391844200038
J	Williams, SB; Murdock, LL; Baributsa, D				Williams, Scott B.; Murdock, Larry L.; Baributsa, Dieudonne			Storage of Maize in Purdue Improved Crop Storage (PICS) Bags	PLOS ONE			English	Article							PROSTEPHANUS-TRUNCATUS HORN; HERMETIC STORAGE; COWPEA; TECHNOLOGY; ADOPTION; GRAIN; AFRICA; WEST	Interest in using hermetic technologies as a pest management solution for stored grain has risen in recent years. One hermetic approach, Purdue Improved Crop Storage (PICS) bags, has proven successful in controlling the postharvest pests of cowpea. This success encouraged farmers to use of PICS bags for storing other crops including maize. To assess whether maize can be safely stored in PICS bags without loss of quality, we carried out laboratory studies of maize grain infested with Sitophilus zeamais (Motshulsky) and stored in PICS triple bags or in woven polypropylene bags. Over an eight month observation period, temperatures in the bags correlated with ambient temperature for all treatments. Relative humidity inside PICS bags remained constant over this period despite the large changes that occurred in the surrounding environment. Relative humidity in the woven bags followed ambient humidity closely. PICS bags containing S. zeamais-infested grain saw a significant decline in oxygen compared to the other treatments. Grain moisture content declined in woven bags, but remained high in PICS bags. Seed germination was not significantly affected over the first six months in all treatments, but declined after eight months of storage when infested grain was held in woven bags. Relative damage was low across treatments and not significantly different between treatments. Overall, maize showed no signs of deterioration in PICS bags versus the woven bags and PICS bags were superior to woven bags in terms of specific metrics of grain quality.	[Williams, Scott B.; Murdock, Larry L.; Baributsa, Dieudonne] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Williams, SB (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	willi324@purdue.edu			Gates Foundation [OPP1038622]	Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Gates Foundation: OPP1038622, http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo S, 2002, INT J PEST MANAGE, V48, P315, DOI 10.1080/09670870210151670; Alonso-Amelot ME, 2011, J STORED PROD RES, V47, P82, DOI 10.1016/j.jspr.2011.01.001; Anankware J. P., 2013, Journal of Biology, Agriculture and Healthcare, V3, P67; Baoua IB, 2012, J STORED PROD RES, V51, P81, DOI 10.1016/j.jspr.2012.07.003; Baributsa D, 2014, J STORED PROD RES, V58, P59, DOI 10.1016/j.jspr.2014.02.012; Boxall R. A., 2002, Integrated Pest Management Reviews, V7, P105, DOI 10.1023/A:1026397115946; Devereau A.D., 2002, CROP POSTHARVEST SCI, P62; Ibro G, 2014, J STORED PROD RES, V58, P87, DOI 10.1016/j.jspr.2014.02.007; Jones M., 2011, Working Paper - Department of Agricultural Economics, Purdue University; Keil H., 1988, WORKSH CONT CONTR LA, P28; Martin DT, 2015, J STORED PROD RES, V63, P22, DOI 10.1016/j.jspr.2015.05.001; Meikle WG, 2002, J ECON ENTOMOL, V95, P1079, DOI 10.1603/0022-0493-95.5.1079; Moreno-Martinez E, 2000, J STORED PROD RES, V36, P25, DOI 10.1016/S0022-474X(99)00023-5; Moussa B, 2014, J STORED PROD RES, V58, P77, DOI 10.1016/j.jspr.2014.02.008; Mulungu L.S., 2007, Journal of Entomology, V4, P258; Murdock LL, 2014, J STORED PROD RES, V58, P3, DOI 10.1016/j.jspr.2014.02.006; Murdock LL, 2012, J STORED PROD RES, V49, P166, DOI 10.1016/j.jspr.2012.01.002; Njoroge AW, 2014, J STORED PROD RES, V58, P12, DOI 10.1016/j.jspr.2014.02.005; PANTENIUS CU, 1988, INSECT SCI APPL, V9, P725, DOI 10.1017/S1742758400005610; Quezada MY, 2006, POSTHARVEST BIOL TEC, V39, P321, DOI 10.1016/j.postharvbio.2005.10.004; Vales MI, 2014, J STORED PROD RES, V58, P29, DOI 10.1016/j.jspr.2014.01.004; Williams SB, 2014, J STORED PROD RES, V59, P190, DOI 10.1016/j.jspr.2014.08.003; World Bank, 2011, MISS FOOD CAS POSTH	23	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0168624	10.1371/journal.pone.0168624	http://dx.doi.org/10.1371/journal.pone.0168624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072835	gold, Green Published, Green Submitted			2022-12-26	WOS:000391844200006
J	Adams, J; Howsmon, DP; Kruger, U; Geis, E; Gehn, E; Fimbres, V; Pollard, E; Mitchell, J; Ingram, J; Hellmers, R; Quig, D; Hahn, J				Adams, James; Howsmon, Daniel P.; Kruger, Uwe; Geis, Elizabeth; Gehn, Eva; Fimbres, Valeria; Pollard, Elena; Mitchell, Jessica; Ingram, Julie; Hellmers, Robert; Quig, David; Hahn, Juergen			Significant Association of Urinary Toxic Metals and Autism-Related Symptoms-A Nonlinear Statistical Analysis with Cross Validation	PLOS ONE			English	Article							ENVIRONMENTAL MERCURY RELEASE; SPECTRUM DISORDER; OXIDATIVE STRESS; CHILDREN; HAIR; BIOMARKERS; PORPHYRINS; LEAD; METHYLMERCURY; PREVALENCE	Introduction A number of previous studies examined a possible association of toxic metals and autism, and over half of those studies suggest that toxic metal levels are different in individuals with Autism Spectrum Disorders (ASD). Additionally, several studies found that those levels correlate with the severity of ASD. Methods In order to further investigate these points, this paper performs the most detailed statistical analysis to date of a data set in this field. First morning urine samples were collected from 67 children and adults with ASD and 50 neurotypical controls of similar age and gender. The samples were analyzed to determine the levels of 10 urinary toxic metals (UTM). Autism-related symptoms were assessed with eleven behavioral measures. Statistical analysis was used to distinguish participants on the ASD spectrum and neurotypical participants based upon the UTM data alone. The analysis also included examining the association of autism severity with toxic metal excretion data using linear and nonlinear analysis. "Leave-one-out" cross-validation was used to ensure statistical independence of results. Results and Discussion Average excretion levels of several toxic metals (lead, tin, thallium, antimony) were significantly higher in the ASD group. However, ASD classification using univariate statistics proved difficult due to large variability, but nonlinear multivariate statistical analysis significantly improved ASD classification with Type I/II errors of 15% and 18%, respectively. These results clearly indicate that the urinary toxic metal excretion profiles of participants in the ASD group were significantly different from those of the neurotypical participants. Similarly, nonlinear methods determined a significantly stronger association between the behavioral measures and toxic metal excretion. The association was strongest for the Aberrant Behavior Checklist (including subscales on Irritability, Stereotypy, Hyperactivity, and Inappropriate Speech), but significant associations were found for UTM with all eleven autism-related assessments with cross-validation R-2 values ranging from 0.12-0.48.	[Adams, James; Geis, Elizabeth; Gehn, Eva; Fimbres, Valeria; Pollard, Elena; Ingram, Julie] Arizona State Univ, Tempe, AZ 85281 USA; [Howsmon, Daniel P.; Kruger, Uwe; Hahn, Juergen] Rensselaer Polytech Inst, Troy, NY USA; [Mitchell, Jessica] Southwest Coll Naturopath Med, Tempe, AZ USA; [Hellmers, Robert] Arizona Allergy Associates, Phoenix, AZ USA; [Quig, David] Doctors Data, St Charles, IL USA	Arizona State University; Arizona State University-Tempe; Rensselaer Polytechnic Institute	Adams, J (corresponding author), Arizona State Univ, Tempe, AZ 85281 USA.	Jim.Adams@asu.edu	Hahn, Juergen/H-8025-2019	Hahn, Juergen/0000-0002-1078-4203	Autism Research Institute (ARI); Autism Research Institute	Autism Research Institute (ARI); Autism Research Institute	We thank the Autism Research Institute for providing partial funding for this project.	ACCARDO P, 1988, CLIN PEDIATR, V27, P41, DOI 10.1177/000992288802700108; Adams JB, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/532640; Adams J. B., 2008, Toxicological and Environmental Chemistry, V90, P739, DOI 10.1080/02772240701699294; Adams JB, 2007, J TOXICOL ENV HEAL A, V70, P1046, DOI 10.1080/15287390601172080; Adams JB, 2013, BIOL TRACE ELEM RES, V151, P171, DOI 10.1007/s12011-012-9551-1; Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Adams James B, 2009, BMC Clin Pharmacol, V9, P17, DOI 10.1186/1472-6904-9-17; Adams JB, 2006, BIOL TRACE ELEM RES, V110, P193, DOI 10.1385/BTER:110:3:193; Albizzati A, 2012, MINERVA PEDIATR, V64, P27; AMAN MG, 1985, AM J MENT DEF, V89, P492; Bartell SM, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/202783; Blanchard K. Stephen, 2011, Reviews on Environmental Health, V26, P111, DOI 10.1515/REVEH.2011.015; Blaucok-Busch Eleonor, 2012, Maedica (Bucur), V7, P214; Blaurock-Busch Eleonor, 2012, Maedica (Bucur), V7, P38; Blaurock-Busch Eleonor, 2011, Maedica (Bucur), V6, P247; Burnham AJ, 1996, J CHEMOMETR, V10, P31, DOI 10.1002/(SICI)1099-128X(199601)10:1<31::AID-CEM398>3.0.CO;2-1; Burnham AJ, 1999, CHEMOMETR INTELL LAB, V48, P167, DOI 10.1016/S0169-7439(99)00018-0; CAMPBELL M, 1980, J AM ACAD CHILD PSY, V19, P193, DOI 10.1016/S0002-7138(09)60697-X; Chen Q, 2004, CONTROL ENG PRACT, V12, P267, DOI 10.1016/S0967-0661(03)00083-2; COHEN DJ, 1976, AM J DIS CHILD, V130, P47, DOI 10.1001/archpedi.1976.02120020049007; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; DeSoto MC, 2012, J ENV PROT, V3, P1579, DOI DOI 10.4236/JEP.2012.311174; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Elsheshtawy E., 2011, MIDDLE E CURRENT PSY, V18, P6, DOI 10.1097/01.XME.0000392842.64112.64; Eppright T D, 1996, Mo Med, V93, P136; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Geier DA, 2007, J TOXICOL ENV HEAL A, V70, P1723, DOI 10.1080/15287390701457712; Geier DA, 2006, NEUROENDOCRINOL LETT, V27, P833; Geier DA, 2006, NEUROTOX RES, V10, P57, DOI 10.1007/BF03033334; Geier DA, 2012, INT J ENV RES PUB HE, V9, P4486, DOI 10.3390/ijerph9124486; Geier DA, 2009, J TOXICOL ENV HEAL A, V72, P1585, DOI 10.1080/15287390903232475; Geier DA, 2009, J NEUROL SCI, V280, P101, DOI 10.1016/j.jns.2008.08.021; Goin-Kochel RP, 2009, RES AUTISM SPECT DIS, V3, P528, DOI 10.1016/j.rasd.2008.11.001; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Heyer NJ, 2012, AUTISM RES, V5, P84, DOI 10.1002/aur.236; Heyer NJ, 2006, TOXICOL LETT, V161, P159, DOI 10.1016/j.toxlet.2005.09.005; Holmes AS, 2003, INT J TOXICOL, V22, P277, DOI 10.1080/10915810305120; Jackson JE, 2003, USERS GUIDE PRINCIPA; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kern JK, 2007, J TOXICOL ENV HEAL A, V70, P715, DOI 10.1080/15287390601188060; Kern JK, 2011, PEDIATR INT, V53, P147, DOI 10.1111/j.1442-200X.2010.03196.x; Kidd Parris M, 2002, Altern Med Rev, V7, P472; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KONSTANTAREAS MM, 1987, J AUTISM DEV DISORD, V17, P585, DOI 10.1007/BF01486973; Kruger Uwe, 2012, ADV STAT MONITORING; Lewandowski TA, 2009, J TOXICOL ENV HEAL A, V72, P1592, DOI 10.1080/15287390903232483; Li YM, 2003, IMAGE VISION COMPUT, V21, P1077, DOI 10.1016/j.imavis.2003.08.010; Lonsdale D, 2002, NEUROENDOCRINOL LETT, V23, P303; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Majewska MD, 2010, ACTA NEUROBIOL EXP, V70, P196; Mardia K.V, 1980, MULTIVARIATE ANAL; McIntosh D. N., 1999, SENSORY PROFILE USER, P59; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; Nataf R, 2006, TOXICOL APPL PHARM, V214, P99, DOI 10.1016/j.taap.2006.04.008; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; Palmer RF, 2009, HEALTH PLACE, V15, P18, DOI 10.1016/j.healthplace.2008.02.001; Palmer RF, 2006, HEALTH PLACE, V12, P203, DOI 10.1016/j.healthplace.2004.11.005; Patel K, 2007, J ALTERN COMPLEM MED, V13, P1091, DOI 10.1089/acm.2007.0611; Pingree SD, 2001, TOXICOL SCI, V61, P234, DOI 10.1093/toxsci/61.2.234; Priya MDL, 2011, BIOL TRACE ELEM RES, V142, P148, DOI 10.1007/s12011-010-8766-2; Rimland B, 2000, AUTISM TREATMENT EVA; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; ROWLAND IR, 1984, ARCH ENVIRON HEALTH, V39, P401, DOI 10.1080/00039896.1984.10545872; ROWLAND IR, 1980, ARCH ENVIRON HEALTH, V35, P155, DOI 10.1080/00039896.1980.10667485; RURY J, 2006, LINKS ENV MERCURY SP; Schopler E., 2010, CHILDHOOD AUTISM RAT, Vsecond; Schweikert C, 2009, IEEE INT C BIOINF BI, P400, DOI 10.1109/BIBE.2009.69; Scott DW, 2015, MULTIVARIATE DENSITY; Silverman B. W., 1986, DENSITY ESTIMATION S, DOI [10. 1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Woods J. S., 1995, TOXICOLOGY METALS BI, P19, DOI DOI 10.1007/978-3-642-79162-8_; Woods JS, 2010, ENVIRON HEALTH PERSP, V118, P1450, DOI 10.1289/ehp.0901713; Wright B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041326; Youn SI, 2010, J TOXICOL ENV HEAL A, V73, P701, DOI 10.1080/15287391003614000	80	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169526	10.1371/journal.pone.0169526	http://dx.doi.org/10.1371/journal.pone.0169526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068407	gold, Green Submitted, Green Published			2022-12-26	WOS:000391843900041
J	Carim, KJ; Dysthe, JC; Young, MK; McKelvey, KS; Schwartz, MK				Carim, Kellie J.; Dysthe, J. Caleb; Young, Michael K.; McKelvey, Kevin S.; Schwartz, Michael K.			A Noninvasive Tool to Assess the Distribution of Pacific Lamprey (Entosphenus tridentatus) in the Columbia River Basin	PLOS ONE			English	Article								The Pacific lamprey (Entosphenus tridentatus) is an anadromous fish once abundant throughout coastal basins of western North America that has suffered dramatic declines in the last century due primarily to human activities. Here, we describe the development of an environmental DNA (eDNA) assay to detect Pacific lamprey in the Columbia River basin. The eDNA assay successfully amplified tissue derived DNA of Pacific lamprey collected from 12 locations throughout the Columbia River basin. The assay amplifies DNA from other Entosphenus species found outside of the Columbia River basin, but is species-specific within this basin. As a result, the assay presented here may be useful for detecting Entosphenus spp. in geographic range beyond the Columbia River Basin. The assay did not amplify tissue or synthetically derived DNA of 14 commonly sympatric non-target species, including lampreys of the genus Lampetra, which are morphologically similar to Pacific lamprey in the freshwater larval stage.	[Carim, Kellie J.; Dysthe, J. Caleb; Young, Michael K.; McKelvey, Kevin S.; Schwartz, Michael K.] US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59801 USA	United States Department of Agriculture (USDA); United States Forest Service	Carim, KJ (corresponding author), US Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59801 USA.	kelliejcarim@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841; Carim, Kellie/0000-0002-9622-9146	Idaho Power	Idaho Power	The work presented in this manuscript was funded by Idaho Power. The funders assisted in collecting tissue and eDNA samples necessary for eDNA marker development.	Boguski DA, 2012, J FISH BIOL, V81, P1891, DOI 10.1111/j.1095-8649.2012.03417.x; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Carim KJ, 2016, PROTOCOL COLLECTING, P18; Docker MF, 2016, N AM J FISH MANAGE, V36, P780, DOI 10.1080/02755947.2016.1167146; Nawa RK, 2003, COMMUNICATION; R Core Team, 2021, R LANGUAGE ENV STAT; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; USFWS, FED REG, V69; Wang C, 2015, FISHERIES, V40, P72, DOI 10.1080/03632415.2014.996871; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wright E., DECIPHER DATABASE EN	11	8	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169334	10.1371/journal.pone.0169334	http://dx.doi.org/10.1371/journal.pone.0169334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068358	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900025
J	Chen, RT; Jiao, P; Liu, Z; Lu, Y; Xin, HH; Zhang, DP; Miao, YG				Chen, Rui-ting; Jiao, Peng; Liu, Zhen; Lu, Yan; Xin, Hu-hu; Zhang, Deng-pan; Miao, Yun-gen			Role of BmDredd during Apoptosis of Silk Gland in Silkworm, Bombyx mori	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INSECT STEROID-HORMONE; IN-VIVO TRANSFECTION; GENE-EXPRESSION; CASPASE; METAMORPHOSIS; PROTEIN; 20-HYDROXYECDYSONE; COMMITMENT; MECHANISMS	Silk glands (SGs) undergo massive apoptosis driven degeneration during the larval-pupal transformation. To better understand this event on molecular level, we investigated the expression of apoptosis-related genes across the developmental transition period that spans day 4 in the fifth instar Bombyx mori larvae to day 2 pupae. Increases in the expression of BmDredd (an initiator caspase homolog) closely followed the highest BmEcR expression and resembled the expression trend of BmIcE. Simultaneously, we found that BmDredd expression was significantly higher in SG compared to other tissues at 18 h post-spinning, but reduced following injection of the apoptosis inhibitor (Z-DEVD-fmk). Furthermore, BmDredd expression correlated with changes of caspase3-like activities in SG and RNAi-mediated knockdown of BmDredd delayed SG apoptosis. Moreover, caspase3-like activity was increased in SG by overexpression of BmDredd. Taken together, the results suggest that BmDredd plays a critical role in SG apoptosis.	[Chen, Rui-ting; Jiao, Peng; Liu, Zhen; Lu, Yan; Xin, Hu-hu; Zhang, Deng-pan; Miao, Yun-gen] Zhejiang Univ, Coll Anim Sci, Inst Sericulture & Apiculture, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Miao, YG (corresponding author), Zhejiang Univ, Coll Anim Sci, Inst Sericulture & Apiculture, Hangzhou, Zhejiang, Peoples R China.	miaoyg@zju.edu.cn			National Natural Science Foundation of China [NSFC: 31672491/C1703, 31372374/C1703]; National Basic Research Program of China [2012CB114601]; Science and Technology Innovation Team of Zhejiang Province [2010R50031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Innovation Team of Zhejiang Province	The work was supported by the National Natural Science Foundation of China (No. NSFC: 31672491/C1703 and 31372374/C1703), the National Basic Research Program of China (No. 2012CB114601) and the Science and Technology Innovation Team of Zhejiang Province (No. 2010R50031).; The work was supported by the National Natural Science Foundation of China (No. NSFC: 31672491/C1703 and 31372374/C1703), the National Basic Research Program of China (No. 2012CB114601) and the Science and Technology Innovation Team of Zhejiang Province (No. 2010R50031). We are thankful for Tian Canbao Co. Ltd., Huzhou, China providing us ecdysone for silkworm. We also thank Joe Holl (USDA) for discussion and critical reading of the manuscript.	Bhang HEC, 2011, NAT MED, V17, P123, DOI 10.1038/nm.2269; Chen RT, 2016, ARCH INSECT BIOCH PH; Czerski L, 2004, J MOL CELL CARDIOL, V37, P643, DOI 10.1016/j.yjmcc.2004.04.016; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Huang QH, 2001, BBA-MOL CELL RES, V1499, P191, DOI 10.1016/S0167-4889(00)00105-1; Iga M, 2007, MOL CELL ENDOCRINOL, V263, P18, DOI 10.1016/j.mce.2006.08.005; Ji MM, 2013, INSECT MOL BIOL, V22, P273, DOI 10.1111/imb.12019; Jia SH, 2007, J PROTEOME RES, V6, P3003, DOI 10.1021/pr070043f; Jin KY, 2015, APOPTOSIS, V20, P235, DOI [10.1007/s10495-014-1060-6, DOI 10.1007/S10495-014-1060-6]; Jordan BJ, 2014, J BIOTECHNOL, V173, P86, DOI 10.1016/j.jbiotec.2014.01.016; Kakei M, 2005, J INSECT PHYSIOL, V51, P17, DOI 10.1016/j.jinsphys.2004.10.012; Li QR, 2010, CAN J ZOOL, V88, P1169, DOI 10.1139/Z10-083; Linemann Thomas, 2013, Pharmaceutics, V5, P246, DOI 10.3390/pharmaceutics5020246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui H, 2012, J INSECT PHYSIOL, V58, P1575, DOI 10.1016/j.jinsphys.2012.09.012; McKnight CD, 2008, OTOLARYNG HEAD NECK, V139, P245, DOI 10.1016/j.otohns.2008.04.014; Mohammadi Z, 2011, INT J PHARMACEUT, V421, P183, DOI 10.1016/j.ijpharm.2011.09.029; Nagaraju J, 2001, CURRENT SCI, V83, P415; Pan C, 2014, BIOCHEM BIOPH RES CO, V447, P237, DOI 10.1016/j.bbrc.2014.03.093; Peng R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018030; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Terashima J, 2000, DEV GENES EVOL, V210, P545, DOI 10.1007/s004270000100; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tsuzuki S, 2001, INSECT BIOCHEM MOLEC, V31, P321, DOI 10.1016/S0965-1748(00)00124-7; Wang L, 2016, GENE, V591, P362, DOI 10.1016/j.gene.2016.06.018; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xie K, 2016, AUTOPHAGY, V12, P381, DOI 10.1080/15548627.2015.1134079; Yi HS, 2014, BIOCHEM BIOPH RES CO, V445, P100, DOI 10.1016/j.bbrc.2014.01.139; Yin VP, 2007, J CELL BIOL, V178, P85, DOI 10.1083/jcb.200703206; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zhang CD, 2012, J INSECT PHYSIOL, V58, P974, DOI 10.1016/j.jinsphys.2012.04.017; Zhang JY, 2013, ANN ENTOMOL SOC AM, V106, P265, DOI 10.1603/AN12110; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611	33	8	8	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169404	10.1371/journal.pone.0169404	http://dx.doi.org/10.1371/journal.pone.0169404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068357	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900031
J	Jian, HJ; Yang, B; Zhang, AX; Zhang, L; Xu, XF; Li, JN; Liu, LZ				Jian, Hongju; Yang, Bo; Zhang, Aoxiang; Zhang, Li; Xu, Xinfu; Li, Jiana; Liu, Liezhao			Screening of Candidate Leaf Morphology Genes by Integration of QTL Mapping and RNA Sequencing Technologies in Oilseed Rape (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; ARABIDOPSIS-THALIANA; FLOWERING TIME; COMPOUND LEAF; CELL-PROLIFERATION; NATURAL VARIATION; HOMEOBOX GENE; ARCHITECTURE; EXPRESSION	Leaf size and shape play important roles in agronomic traits, such as yield, quality and stress responses. Wide variations in leaf morphological traits exist in cultivated varieties of many plant species. By now, the genetics of leaf shape and size have not been characterized in Brassica napus. In this study, a population of 172 recombinant inbred lines (RILs) was used for quantitative trait locus (QTL) analysis of leaf morphology traits. Furthermore, fresh young leaves of extreme lines with more leaf lobes (referred to as 'A') and extreme lines with fewer lobes (referred to as 'B') selected from the RIL population and leaves of dissected lines (referred to as 'P') were used for transcriptional analysis. A total of 31 QTLs for the leaf morphological traits tested in this study were identified on 12 chromosomes, explaining 5.32-39.34% of the phenotypic variation. There were 8, 6, 2, 5, 8, and 2 QTLs for PL (petiole length), PN (lobe number), LW (lamina width), LL (Lamina length), LL/LTL (the lamina size ratio) and LTL (leaf total length), respectively. In addition, 74, 1,166 and 1,272 differentially expressed genes (DEGs) were identified in 'A vs B', 'A vs P' and 'B vs P' comparisons, respectively. The Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases were used to predict the functions of these DEGs. Gene regulators of leaf shape and size, such as ASYMMETRIC LEAVES 2, gibberellin 20-oxidase 3, genes encoding gibberellin-regulated family protein, genes encoding growth-regulating factor and KNOTTED1-like homeobox were also detected in DEGs. After integrating the QTL mapping and RNA sequencing data, 33 genes, including a gene encoding auxin-responsive GH3 family protein and a gene encoding sphere organelles protein-related gene, were selected as candidates that may control leaf shape. Our findings should be valuable for studies of the genetic control of leaf morphological trait regulation in B. napus.	[Jian, Hongju; Yang, Bo; Zhang, Aoxiang; Zhang, Li; Xu, Xinfu; Li, Jiana; Liu, Liezhao] Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China	Liu, LZ (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing, Peoples R China.	liezhao2003@126.com			National Natural Science Foundation of China [31171584]; 973 Program [2015CB150201]; Fundamental Research Funds for the Central Universities [XDJ K2016E080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31171584), 973 Program (2015CB150201) and Fundamental Research Funds for the Central Universities (XDJ K2016E080).	[Anonymous], PMCPMC3875807, DOI [10.1104/pp.113.229708, DOI 10.1104/PP.113.229708]; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Bertoni G, 2010, PLANT CELL, V22, P3191, DOI 10.1105/tpc.110.221010; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Frary A, 2004, THEOR APPL GENET, V109, P523, DOI 10.1007/s00122-004-1669-x; Gailing O, 2008, PLANT BIOLOGY, V10, P624, DOI 10.1111/j.1438-8677.2008.00063.x; Gonzalez N, 2010, PLANT PHYSIOL, V153, P1261, DOI 10.1104/pp.110.156018; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Horiguchi G, 2006, J PLANT RES, V119, P37, DOI 10.1007/s10265-005-0232-4; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; Janssen BJ, 1998, PLANT PHYSIOL, V117, P771, DOI 10.1104/pp.117.3.771; Jiang CC, 2014, THEOR APPL GENET, V127, P957, DOI 10.1007/s00122-014-2271-5; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kim GT, 2006, PHYSIOL PLANTARUM, V126, P494, DOI 10.1111/j.1399-3054.2005.00634.x; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; Kubo N, 2010, BREEDING SCI, V60, P164, DOI 10.1270/jsbbs.60.164; Lan TH, 2001, THEOR APPL GENET, V103, P383, DOI 10.1007/s001220100615; Li F., 2013, ADV MECH ENG, V2013, P1, DOI DOI 10.1007/S00122-013-2049-1; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Li YF, 2012, SCI HORTIC-AMSTERDAM, V133, P10, DOI 10.1016/j.scienta.2011.10.023; Liu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Mauriat M, 2011, PLANT J, V67, P805, DOI 10.1111/j.1365-313X.2011.04635.x; McCouch SR, 1997, PLANT MOL BIOL, V35, P89, DOI 10.1023/A:1005711431474; Micol JL, 2009, CURR OPIN PLANT BIOL, V12, P9, DOI 10.1016/j.pbi.2008.11.001; Perez-Perez JM, 2002, GENETICS, V162, P893; PubMed Central PMCID, PMCPMC3013673, DOI [10.1093/nar/gkq1066, DOI 10.1093/NAR/GKQ1066]; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Seo E, 2015, BRIEF FUNCT GENOMICS, V14, P260, DOI 10.1093/bfgp/elv011; Tamaoki M, 1997, PLANT CELL PHYSIOL, V38, P917, DOI 10.1093/oxfordjournals.pcp.a029252; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang XD, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0759-7; Wang YG, 2015, EUPHYTICA, V205, P761, DOI 10.1007/s10681-015-1403-6; Xiao D, 2014, PLANT PHYSIOL, V164, P1309, DOI 10.1104/pp.113.227348; Xu LP, 2016, DNA RES, V23, P43, DOI 10.1093/dnares/dsv035; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077909, 10.1371/journal.pone.0076059]; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	52	10	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169641	10.1371/journal.pone.0169641	http://dx.doi.org/10.1371/journal.pone.0169641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068426	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900052
J	Lin, BL; Chen, CY; Huang, CH; Ko, TP; Chiang, CH; Lin, KF; Chang, YC; Lin, PY; Tsai, HHG; Wang, AHJ				Lin, Bo-Lin; Chen, Chin-Yu; Huang, Chun-Hsiang; Ko, Tzu-Ping; Chiang, Cheng-Hung; Lin, Kuan-Fu; Chang, Yuan-Chih; Lin, Po-Yen; Tsai, Hui-Hsu Gavin; Wang, Andrew H-J.			The Arginine Pairs and C-Termini of the Sso7c4 from Sulfolobus solfataricus Participate in Binding and Bending DNA	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; PRIMARY-KINK SITE; CRYSTAL-STRUCTURE; LAMBDA-REPRESSOR; ARCHAEAL HISTONES; INDIRECT READOUT; CORE PARTICLE; CHROMATIN; COMPLEX; SEQUENCE	The Sso7c4 from Sulfolobus solfataricus forms a dimer, which is believed to function as a chromosomal protein involved in genomic DNA compaction and gene regulation. Here, we present the crystal structure of wild-type Sso7c4 at a high resolution of 1.63 angstrom, showing that the two basic C-termini are disordered. Based on the fluorescence polarization (FP) binding assay, two arginine pairs, R11/R220 and R110/R22, on the top surface participate in binding DNA. As shown in electron microscopy (EM) images, wild-type Sso7c4 compacts DNA through bridging and bending interactions, whereas the binding of C-terminally truncated proteins rigidifies and opens DNA molecules, and no compaction of the DNA occurs. Moreover, the FP, EM and fluorescence resonance energy transfer (FRET) data indicated that the two basic and flexible C-terminal arms of the Sso7c4 dimer play a crucial role in binding and bending DNA. Sso7c4 has been classified as a repressor-like protein because of its similarity to Escherichia coli Ecrep 6.8 and Ecrep 7.3 as well as Agrobacterium tumefaciens ACCR in amino acid sequence. Based on these data, we proposed a model of the Sso7c4-DNA complex using a curved DNA molecule in the catabolite activator protein-DNA complex. The DNA end-to-end distance measured with FRET upon wild-type Sso7c4 binding is almost equal to the distance measured in the model, which supports the fidelity of the proposed model. The FRET data also confirm the EM observation showing that the binding of wild-type Sso7c4 reduces the DNA length while the C-terminal truncation does not. A functional role for Sso7c4 in the organization of chromosomal DNA and/or the regulation of gene expression through bridging and bending interactions is suggested.	[Lin, Bo-Lin; Ko, Tzu-Ping; Wang, Andrew H-J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Bo-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Chin-Yu; Lin, Kuan-Fu] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Huang, Chun-Hsiang; Chiang, Cheng-Hung] Natl Synchrotron Radiat Res Ctr, Expt Facil Div, Prot Diffract Grp, Hsinchu, Taiwan; [Chang, Yuan-Chih; Lin, Po-Yen] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Tsai, Hui-Hsu Gavin] Natl Cent Univ, Dept Chem, Taoyuan, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Central University; National Synchrotron Radiation Research Center; Academia Sinica - Taiwan; National Central University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.; Chen, CY (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.	chinyuchen@cc.ncu.edu.tw; ahjwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016	CHANG, Yuan-Chih/0000-0002-0289-3768; Lin, Kuan-Fu/0000-0002-8280-2802	Institute of Biological Chemistry at Academia Sinica; Ministry of Science and Technology, Taiwan [NSC 101-2113-M-008-001-MY2]; Ministry of Science and Technology, Taiwan, ROC	Institute of Biological Chemistry at Academia Sinica; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Institute of Biological Chemistry at Academia Sinica and Ministry of Science and Technology, Taiwan (to Andrew H.-J. Wang). This work was also supported by a grant from Ministry of Science and Technology, Taiwan (NSC 101-2113-M-008-001-MY2 to Chin-Yu Chen).r We thank the technical services with X-ray diffraction data collection provided by the "Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology" and the "National Synchrotron Radiation Research Center", a national user facility supported by the Ministry of Science and Technology, Taiwan, ROC. We are grateful to Hui-Ju Huang for the assistance in EM imaging and also the use of the Tecnai F20 in the Cryo-EM Core Facility, Department of Academic Affairs and Instrument Service at Academia Sinica. We acknowledge Hui-Ling Shr for robotic crystallization screening at the Core Facility of X-ray crystallography and Dr. Meng-Ru Ho for the use of the Biophysical Instrumentation Laboratory for performing FP experiments at the Institute of Biological Chemistry, Academia Sinica, Taiwan, ROC.	Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Albright RA, 1998, J MOL BIOL, V280, P137, DOI 10.1006/jmbi.1998.1848; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Blair Rebecca H, 2013, Methods Mol Biol, V977, P203, DOI 10.1007/978-1-62703-284-1_16; Bock C-T, 2006, ENCY MOL CELL BIOL M; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Chen SF, 2001, J MOL BIOL, V314, P63, DOI 10.1006/jmbi.2001.5089; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; CLARKE ND, 1991, SCIENCE, V254, P267, DOI 10.1126/science.1833818; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Crane-Robinson C, 2006, TRENDS BIOCHEM SCI, V31, P547, DOI 10.1016/j.tibs.2006.08.006; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, FEBS LETT, P1; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Decanniere K, 2000, J MOL BIOL, V303, P35, DOI 10.1006/jmbi.2000.4104; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Driessen RPC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29422; Driessen RPC, 2013, NUCLEIC ACIDS RES, V41, P196, DOI 10.1093/nar/gks1053; Driessen RPC, 2011, BIOCHEM SOC T, V39, P116, DOI 10.1042/BST0390116; Edmondson SP, 2004, BIOCHEMISTRY-US, V43, P13026, DOI 10.1021/bi0491752; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng YG, 2010, PROTEIN SCI, V19, P1253, DOI 10.1002/pro.385; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Henneman B, 2015, AIMS MICROBIOL, V1, P72, DOI 10.3934/microbiol.2015.1.72; Hieb AR, 2007, J MOL BIOL, V372, P619, DOI 10.1016/j.jmb.2007.06.061; Hsu CH, 2011, NUCLEIC ACIDS RES, V39, P6764, DOI 10.1093/nar/gkr283; HUBBARD AJ, 1990, BIOCHEMISTRY-US, V29, P9241, DOI 10.1021/bi00491a019; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lee CC, 2014, ANGEW CHEM INT EDIT, V53, P13054, DOI 10.1002/anie.201405664; LnenicekAllen M, 1996, NUCLEIC ACIDS RES, V24, P1047, DOI 10.1093/nar/24.6.1047; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Maruyama H, 2013, EMBO REP, V14, P711, DOI 10.1038/embor.2013.94; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P4034, DOI 10.1021/bi952555q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy FV, 1999, EMBO J, V18, P6610, DOI 10.1093/emboj/18.23.6610; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Napoli AA, 2006, J MOL BIOL, V357, P173, DOI 10.1016/j.jmb.2005.12.051; Oppermann UCT, 1998, FEBS LETT, V432, P141, DOI 10.1016/S0014-5793(98)00848-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 2011, ACTA CRYSTALLOGR D, V67, P331, DOI 10.1107/S0907444910052224; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Reeve JN, 2004, BIOCHEM SOC T, V32, P227, DOI 10.1042/BST0320227; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Tapias A, 2000, NUCLEIC ACIDS RES, V28, P552, DOI 10.1093/nar/28.2.552; Vaughn JL, 2000, NAT STRUCT BIOL, V7, P1139; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xuan JS, 2012, CURR PROTEIN PEPT SC, V13, P258, DOI 10.2174/138920312800785067; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	71	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169627	10.1371/journal.pone.0169627	http://dx.doi.org/10.1371/journal.pone.0169627			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068385	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900051
J	Lutfi, MF				Lutfi, Mohamed Faisal			Anxiety Level and Cardiac Autonomic Modulations in Coronary Artery Disease and Cardiac Syndrome X Patients	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RISK-FACTORS; CHEST-PAIN; ANGINA; DEPRESSION; DISORDERS; ISCHEMIA; IMPACT; WOMEN	Background Anxiety and cardiac autonomic modulations (CAM) were thoroughly investigated in coronary artery disease (CAD) and cardiac syndrome X (CSX) patients worldwide, but not among Sudanese with similar pathology. Aims To compare levels of anxiety and CAM between Sudanese patients with CSX and CAD. Materials and Methods Anxiety was evaluated in 51 CAD and 26 CSX patients using Taylor Manifest anxiety score (TMAS) questionnaire while heart rate variability derived indices were used to assess CAM, namely natural logarithm of low frequency (LnLF), high frequency (LnHF) and LF/HF ratio (LnLF/HF). Results Low anxiety levels were achieved by 6 (23.1%) and 9 (17.6%) patients with CSX and CAD respectively. High anxiety level was achieved by only one (3.8%) patient, who was suffering from CSX. TMAS was significantly higher in CSX (31.27 (21.97)) compared to CAD (21.86 (12.97), P = 0.021). However, abnormally increased anxiety was not associated with higher risk of CSX. LnLF, LnHF and LnLF/HF were comparable in CAD and CSX patients. Conclusion CSX and CAD patients showed comparable CAM. Although anxiety levels were higher in CSX compared to CAD, TMAS >= 35 failed to show significant association with CSX.	[Lutfi, Mohamed Faisal] Al Neelain Univ, Fac Med & Hlth Sci, Dept Physiol, Khartoum, Sudan		Lutfi, MF (corresponding author), Al Neelain Univ, Fac Med & Hlth Sci, Dept Physiol, Khartoum, Sudan.	mohamedfaisallutfi@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; MA, M LUTFI/GQH-0830-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; 				Altintas E, 2014, INT J CLIN EXP MED, V7, P3520; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Blom EH, 2010, ACTA PAEDIATR, V99, P604, DOI 10.1111/j.1651-2227.2009.01657.x; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Camm AJ, 1996, CIRCULATION, V93, P1043; CANNON RO, 1995, JAMA-J AM MED ASSOC, V273, P883, DOI 10.1001/jama.273.11.883; Chu ZG, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-74; Crea F, 2004, HEART, V90, P457, DOI 10.1136/hrt.2003.020594; Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Francis JL, 2009, PSYCHOSOM MED, V71, P821, DOI 10.1097/PSY.0b013e3181b39aa1; FROBERT O, 1995, EUR HEART J, V16, P1356, DOI 10.1093/oxfordjournals.eurheartj.a060742; Gorman Jack M., 2000, American Heart Journal, V140, pS77; Guzik P, 2007, KARDIOL POL, V65, P262; Ho KY, 1998, GUT, V43, P105, DOI 10.1136/gut.43.1.105; Hrnciar J, 2013, Endocr Regul, V47, P33; Ito T, 1999, PSYCHIAT CLIN NEUROS, V53, P667, DOI 10.1046/j.1440-1819.1999.00623.x; Janszky I, 2010, J AM COLL CARDIOL, V56, P31, DOI 10.1016/j.jacc.2010.03.033; Kang EH, 2010, J KOREAN MED SCI, V25, P613, DOI 10.3346/jkms.2010.25.4.613; Kaski Juan Carlos, 2004, Am J Cardiovasc Drugs, V4, P179, DOI 10.2165/00129784-200404030-00005; Kelly KR, 2014, MED SCI SPORT EXER, V46, P920, DOI 10.1249/MSS.0000000000000200; Khayyam-Nekouei Z, 2013, ARYA ATHEROSCLER, V9, P102; Kotecha D, 2012, HEART, V98, P395, DOI 10.1136/heartjnl-2011-300033; Kroenke K, 1994, Arch Fam Med, V3, P774; Lawes Carlene M M, 2002, Semin Vasc Med, V2, P355, DOI 10.1055/s-2002-36765; Lee WL, 1998, INT J CARDIOL, V66, P253; Lutfi MF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00191; Lutfi MF, 2011, SUDAN J MED SCI, V6, P43; Mohareb MM, 2015, ANN INTERN MED, V162, P549, DOI 10.7326/M14-1889; Musa Hassan Hussein, 2013, Indian Heart J, V65, P232, DOI 10.1016/j.ihj.2013.03.007; Nikolaidis Pantelis Theodoros, 2012, Asian J Sports Med, V3, P168; Soler EP, 2010, CURR CARDIOL REV, V6, P138, DOI 10.2174/157340310791658785; Panting JR, 2002, NEW ENGL J MED, V346, P1948, DOI 10.1056/NEJMoa012369; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Ponikowski P, 1996, AM J CARDIOL, V77, P942, DOI 10.1016/S0002-9149(96)00007-0; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Simula S, 2014, CLIN AUTON RES, V24, P31, DOI 10.1007/s10286-013-0220-z; Suliman A, 2011, CARDIOVASC J AFR, V22, P191, DOI 10.5830/CVJA-2010-054; Suliman A., 2011, SUDAN MED J, V47, P86; SULLIVAN AK, 1994, BRIT MED J, V308, P883, DOI 10.1136/bmj.308.6933.883; Tousoulis D, 2009, CURR PHARM DESIGN, V15, P2037, DOI 10.2174/138161209788453185; Vermeltfoort IAC, 2010, CLIN RES CARDIOL, V99, P475, DOI 10.1007/s00392-010-0159-1; Vermeltfoort IAC, 2009, J NUCL CARDIOL, V16, P405, DOI 10.1007/s12350-008-9032-2; Winchester DE, 2015, EUR HEART J SUPPL, V17, pG10, DOI 10.1093/eurheartj/suv054; Won KB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-134	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0170086	10.1371/journal.pone.0170086	http://dx.doi.org/10.1371/journal.pone.0170086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068419	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900085
J	Molsher, R; Newsome, AE; Newsome, TM; Dickman, CR				Molsher, Robyn; Newsome, Alan E.; Newsome, Thomas M.; Dickman, Christopher R.			Mesopredator Management: Effects of Red Fox Control on the Abundance, Diet and Use of Space by Feral Cats	PLOS ONE			English	Article							NEW-SOUTH-WALES; POPULATION-DYNAMICS; MAMMALIAN CARNIVORES; FELIS-CATUS; AUSTRALIA; ECOLOGY; COMPETITION; RELEASE; FAUNA; DINGO	Apex predators are subject to lethal control in many parts of the world to minimize their impacts on human industries and livelihoods. Diverse communities of smaller predators-mesopredators-often remain after apex predator removal. Despite concern that these mesopredators may be 'released' in the absence of the apex predator and exert negative effects on each other and on co-occurring prey, these interactions have been little studied. Here, we investigate the potential effects of competition and intraguild predation between red foxes (Vulpes vulpes) and feral cats (Felis catus) in south-eastern Australia where the apex predator, the dingo (Canis dingo), has been extirpated by humans. We predicted that the larger fox would dominate the cat in encounters, and used a fox-removal experiment to assess whether foxes affect cat abundance, diet, home-range and habitat use. Our results provide little indication that intraguild predation occurred or that cats responded numerically to the fox removal, but suggest that the fox affects some aspects of cat resource use. In particular, where foxes were removed cats increased their consumption of invertebrates and carrion, decreased their home range size and foraged more in open habitats. Fox control takes place over large areas of Australia to protect threatened native species and agricultural interests. Our results suggest that fox control programmes could lead to changes in the way that cats interact with co-occurring prey, and that some prey may become more vulnerable to cat predation in open habitats after foxes have been removed. Moreover, with intensive and more sustained fox control it is possible that cats could respond numerically and alter their behaviour in different ways to those documented herein. Such outcomes need to be considered when estimating the indirect impacts of fox control. We conclude that novel approaches are urgently required to control invasive mesopredators at the same time, especially in areas where apex predators are absent.	[Molsher, Robyn] Dept Environm Water & Nat Resources, Kangaroo Isl, SA, Australia; [Newsome, Alan E.] CSIRO, Canberra, ACT, Australia; [Newsome, Thomas M.; Dickman, Christopher R.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Newsome, Thomas M.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Newsome, Thomas M.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia; [Newsome, Thomas M.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Oregon State University; Deakin University; University of Washington; University of Washington Seattle	Newsome, TM (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; Newsome, TM (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.; Newsome, TM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia.; Newsome, TM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	tnew5216@uni.sydney.edu.au	Newsome, Thomas M/AET-0276-2022; Dickman, Christopher/Q-4662-2019; Newsome, Thomas M/ABE-8451-2021	Newsome, Thomas M/0000-0003-3457-3256; Dickman, Christopher/0000-0002-1067-3730; Newsome, Thomas M/0000-0003-3457-3256	Department of the Environment and Energy	Department of the Environment and Energy	We gratefully acknowledge CSIRO and the Vertebrate Biocontrol CRC (now the Invasive Animals CRC) for access to the Burrendong study region and use of facilities, and Environment Australia (now the Department of the Environment and Energy) for additional funding.	Algar D., 1998, LANDSCOPE, V13, P28; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; CATLING PC, 1995, WILDLIFE RES, V22, P535, DOI 10.1071/WR9950535; Catling PC, 1988, WILDLIFE RES, V15, P307, DOI DOI 10.1071/WR9880307; CHRISTENSEN P, 1995, REINTRODUCTION BIOLOGY OF AUSTRALIAN AND NEW ZEALAND FAUNA, P199; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crowther MS, 2014, J ZOOL, V293, P192, DOI 10.1111/jzo.12134; Davey C, 2006, ECOSYSTEMS, V9, P992, DOI 10.1007/s10021-004-0173-0; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119303; Glen AS, 2011, AUSTRAL ECOL, V36, P290, DOI 10.1111/j.1442-9993.2010.02149.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Kenward RE, 1996, NALYSIS SYSTEM BIOL; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Marlow NJ, 2015, AUST J ZOOL, V63, P18, DOI 10.1071/ZO14024; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; Molsher R.L., 1999, THESIS; Molsher RL, 2000, WILDLIFE RES, V27, P593, DOI 10.1071/WR99015; Molsher RL, 2001, WILDLIFE RES, V28, P631, DOI 10.1071/WR00027; Nams VO, 1992, PACER COMPUTER SOFTW; Newsome TM, 2015, RESTOR ECOL, V23, P201, DOI 10.1111/rec.12186; Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Peterson RO, 1996, WOLVES CHANGING WORL; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Reddiex B, 2006, WILDLIFE RES, V33, P691, DOI 10.1071/WR05102; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Risbey DA, 1999, WILDLIFE RES, V26, P621; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Schroeder T, 2015, WILDLIFE RES, V42, P529, DOI 10.1071/WR15104; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112	40	37	39	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168460	10.1371/journal.pone.0168460	http://dx.doi.org/10.1371/journal.pone.0168460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068378	gold, Green Submitted, Green Published			2022-12-26	WOS:000391843900009
J	Iguchi, K; Hatano, E; Nirasawa, T; Iwasaki, N; Sato, M; Yamamoto, G; Yamanaka, K; Okamoto, T; Kasai, Y; Nakamura, N; Fuji, H; Sakai, T; Kakuda, N; Seto, S; Taura, K; Tashiro, K; Uemoto, S; Ikegawam, M				Iguchi, Kohta; Hatano, Etsuro; Nirasawa, Takashi; Iwasaki, Noriyuki; Sato, Motohiko; Yamamoto, Gen; Yamanaka, Kenya; Okamoto, Tatsuya; Kasai, Yosuke; Nakamura, Naohiko; Fuji, Hiroaki; Sakai, Tomohito; Kakuda, Nobuto; Seto, Satoru; Taura, Kojiro; Tashiro, Kei; Uemoto, Shinji; Ikegawam, Masaya			Chronological Profiling of Plasma Native Peptides after Hepatectomy in Pigs: Toward the Discovery of Human Biomarkers for Liver Regeneration	PLOS ONE			English	Article							RAT-LIVER; PROTEOME; CANCER; HEMOGLOBIN; ALGORITHM; PROTEASES; PROGRESS; ALBUMIN; MODEL; SIZE	Liver regeneration after partial hepatectomy (PHx) is a time-dependent process, which is tightly regulated by multiple signaling cascades. Failure of this complex process leads to posthepatectomy liver failure (PHLF), which is associated with a high rate of mortality. Thus, it is extremely important to establish a useful biomarker of liver regeneration to help prevent PHLF. Here, we hypothesized that alterations in the plasma peptide profile may predict liver regeneration following PHx and hence we set up a diagnostic platform for monitoring posthepatectomy outcome. We chronologically analyzed plasma peptidomic profiles of 5 partially hepatectomized microminipigs using the ClinProt (TM) system, which consists of magnetic beads and MALDI-TOF/TOF MS. We identified endogenous circulating peptides specific to each phase of the postoperative course after PHx in pigs. Notably, peptide fragments of histones were detected immediately after PHx; the presence of these fragments may trigger liver regeneration in the very acute phase after PHx. An N-terminal fragment of hemoglobin subunit a (3627 m/z) was detected as an acute-phase-specific peptide. In the recovery phase, the short N-terminal fragments of albumin (3028, 3042 m/z) were decreased, whereas the long N-terminal fragment of the protein (8926 m/z) was increased. To further validate and extract phase-specific biomarkers using plasma peptidome after PHx, plasma specimens of 4 patients who underwent PHx were analyzed using the same method as we applied to pigs. It revealed that there was also phase-specificity in peptide profiles, one of which was represented by a fragment of complement C4b (2378 m/z). The strategy described herein is highly efficient for the identification and characterization of peptide biomarkers of liver regeneration in a swine PHx model. This strategy is feasible for application to human biomarker studies and will yield clues for understanding liver regeneration in human clinical trials.	[Iguchi, Kohta; Hatano, Etsuro; Sato, Motohiko; Yamamoto, Gen; Yamanaka, Kenya; Okamoto, Tatsuya; Kasai, Yosuke; Nakamura, Naohiko; Fuji, Hiroaki; Seto, Satoru; Taura, Kojiro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Nirasawa, Takashi; Iwasaki, Noriyuki] Bruker Dalton KK, Yokohama, Kanagawa, Japan; [Sakai, Tomohito; Tashiro, Kei; Ikegawam, Masaya] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Grad Sch Med Sci, Kyoto, Japan; [Kakuda, Nobuto; Ikegawam, Masaya] Doshisha Univ, Fac Life & Med Sci, Dept Life & Med Syst, Kyoto, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Doshisha University	Hatano, E (corresponding author), Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan.; Ikegawam, M (corresponding author), Kyoto Prefectural Univ Med, Dept Genom Med Sci, Grad Sch Med Sci, Kyoto, Japan.; Ikegawam, M (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Life & Med Syst, Kyoto, Japan.	etsu@kuhp.kyoto-u.ac.jp; mikegavva@mail.doshisha.ac.jp	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918	Translational Research Grant from Translational Research Center, Kyoto University Hospital	Translational Research Grant from Translational Research Center, Kyoto University Hospital	This study was supported by Translational Research Grant from Translational Research Center, Kyoto University Hospital, http://www.kuhp.kyoto-u.ac.jp/similar to trc/, EH received the funding. The funder had a role in purchase of animals.	Adam BL, 2002, CANCER RES, V62, P3609; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], 2005, BIOTECHNIQUES; Azad GK, 2014, MOL BIOL REP, V41, P2717, DOI 10.1007/s11033-014-3181-y; Baumann S, 2005, CLIN CHEM, V51, P973, DOI 10.1373/clinchem.2004.047308; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; COUINAUD C, 1954, PRESSE MED, V62, P709; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fruitier I, 1999, FEBS LETT, V447, P81, DOI 10.1016/S0014-5793(99)00271-9; Fukuhara Y, 2003, J HEPATOL, V38, P784, DOI 10.1016/S0168-8278(03)00077-1; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Iguchi K, 2014, LIVER TRANSPLANT, V20, P838, DOI 10.1002/lt.23884; Ivosev G, 2008, ANAL CHEM, V80, P4933, DOI 10.1021/ac800110w; Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555; Kasai Y, 2013, EUR SURG RES, V51, P129, DOI 10.1159/000356297; Kawaguchi H, 2014, J ATHEROSCLER THROMB, V21, P186, DOI 10.5551/jat.21246; Kurumiya Y, 2000, J HEPATOL, V32, P636, DOI 10.1016/S0168-8278(00)80226-3; Li JN, 2002, CLIN CHEM, V48, P1296; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Mastellos DC, 2013, SEMIN IMMUNOL, V25, P29, DOI 10.1016/j.smim.2013.04.002; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; PETERS T, 1977, CLIN CHEM, V23, P5; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Piovesan D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat065; Polaskova V, 2010, ELECTROPHORESIS, V31, P471, DOI 10.1002/elps.200900286; Poon TCW, 2003, CLIN CHEM, V49, P752, DOI 10.1373/49.5.752; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Seimiya M, 2013, HEPATOLOGY, V57, P2093, DOI 10.1002/hep.25972; Shimada T, 2010, J PROTEOME RES, V9, P4490, DOI 10.1021/pr1002388; Straatsburg IH, 2000, J HEPATOL, V32, P783, DOI 10.1016/S0168-8278(00)80247-0; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; Verma N, 2011, PROTEOMICS, V11, P776, DOI 10.1002/pmic.201000320	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167647	10.1371/journal.pone.0167647	http://dx.doi.org/10.1371/journal.pone.0167647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060824	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500013
J	Kaye, B; Foster, PJ; Yoo, TY; Needleman, DJ				Kaye, Bryan; Foster, Peter J.; Yoo, Tae Yeon; Needleman, Daniel J.			Developing and Testing a Bayesian Analysis of Fluorescence Lifetime Measurements	PLOS ONE			English	Article							FRET; MICROSCOPY; CELLS	FRET measurements can provide dynamic spatial information on length scales smaller than the diffraction limit of light. Several methods exist to measure FRET between fluorophores, including Fluorescence Lifetime Imaging Microscopy (FLIM), which relies on the reduction of fluorescence lifetime when a fluorophore is undergoing FRET. FLIM measurements take the form of histograms of photon arrival times, containing contributions from a mixed population of fluorophores both undergoing and not undergoing FRET, with the measured distribution being a mixture of exponentials of different lifetimes. Here, we present an analysis method based on Bayesian inference that rigorously takes into account several experimental complications. We test the precision and accuracy of our analysis on controlled experimental data and verify that we can faithfully extract model parameters, both in the low-photon and low-fraction regimes.	[Kaye, Bryan; Foster, Peter J.; Yoo, Tae Yeon; Needleman, Daniel J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kaye, Bryan; Foster, Peter J.; Yoo, Tae Yeon; Needleman, Daniel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Needleman, Daniel J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Kaye, B (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Kaye, B (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	bryankaye@fas.harvard.edu	Yoo, Tae Yeon/J-6921-2019	Yoo, Tae Yeon/0000-0002-8145-1051; Foster, Peter/0000-0003-1818-5886	National Science Foundation GRFP fellowship [DGE1144152]; National Science Foundation [PHY-0847188, PHY-1305254, DMR-0820484]; United States Israel Binational Science Foundation [BSF 2009271]; FAS Division of Science, Research Computing Group at Harvard University; Samsung scholarship	National Science Foundation GRFP fellowship; National Science Foundation(National Science Foundation (NSF)); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); FAS Division of Science, Research Computing Group at Harvard University; Samsung scholarship(Samsung)	BK was supported by National Science Foundation (http://www.nst.gov/) GRFP fellowship DGE1144152. TYY would like to thank the Samsung scholarship (https://www.ssscholarship.com/community/HomeEn.screen). This work was supported by National Science Foundation (http://www.nsf.gov/) Grants PHY-0847188, PHY-1305254, and DMR-0820484, and United States Israel Binational Science Foundation (http://www.bsf.org.il/BSFPublic/Default.aspx) Grant BSF 2009271 to DJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some computations in this paper were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University. TYY would like to acknowledge the Samsung scholarship for funding his graduate study. The authors would like to thank Jess Crossno, Juhyun Oh, and Julia Schwartzman for inspiring us daily.	Becker W., 2010, BH TCSPC HDB; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1; Chen WY, 2015, BIOPHYS J, V108, P999, DOI 10.1016/j.bpj.2015.01.012; Colyer RA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016008; Hinde E, 2013, MILLISECOND SPATIOTE, P135; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P8; Levine Y., 1997, J FLUORESC, V7, P11, DOI DOI 10.1007/BF02764572; Lin HJ, 2003, CYTOM PART A, V52A, P77, DOI 10.1002/cyto.a.10028; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Ripoll C, 2015, CHEM COMMUN, V51, P16964, DOI 10.1039/c5cc06676j; Rowley MI, 2011, PROC SPIE, V7903, DOI 10.1117/12.873890; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sharman KK, 1999, ANAL CHEM, V71, P947, DOI 10.1021/ac981050d; Sivia Devinderjit, 2006, DATA ANAL BAYESIAN T, DOI DOI 10.1007/10201161_90; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stringari C, 2011, PHASOR APPROACH FLUO, P13582; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yoo TY, 2016, METHODS MOL BIOL, V1413, P169, DOI 10.1007/978-1-4939-3542-0_11	21	17	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169337	10.1371/journal.pone.0169337	http://dx.doi.org/10.1371/journal.pone.0169337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060890	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500084
J	Yan, DM; Zhang, ZH; Luo, QM; Yang, XQ				Yan, Dongmei; Zhang, Zhihong; Luo, Qingming; Yang, Xiaoquan			A Novel Mouse Segmentation Method Based on Dynamic Contrast Enhanced Micro-CT Images	PLOS ONE			English	Article							MICROCOMPUTED TOMOGRAPHY; COMBINED FLUORESCENCE; SYSTEM; REGISTRATION; FUSION	With the development of hybrid imaging scanners, micro-CT is widely used in locating abnormalities, studying drug metabolism, and providing structural priors to aid image reconstruction in functional imaging. Due to the low contrast of soft tissues, segmentation of soft tissue organs from mouse micro-CT images is a challenging problem. In this paper, we propose a mouse segmentation scheme based on dynamic contrast enhanced micro-CT images. With a homemade fast scanning micro-CT scanner, dynamic contrast enhanced images were acquired before and after injection of non-ionic iodinated contrast agents (iohexol). Then the feature vector of each voxel was extracted from the signal intensities at different time points. Based on these features, the heart, liver, spleen, lung, and kidney could be classified into different categories and extracted from separate categories by morphological processing. The bone structure was segmented using a thresholding method. Our method was validated on seven BALB/c mice using two different classifiers: a support vector machine classifier with a radial basis function kernel and a random forest classifier. The results were compared to manual segmentation, and the performance was assessed using the Dice similarity coefficient, false positive ratio, and false negative ratio. The results showed high accuracy with the Dice similarity coefficient ranging from 0.709 +/- 0.078 for the spleen to 0.929 +/- 0.006 for the kidney.	[Yan, Dongmei; Zhang, Zhihong; Luo, Qingming; Yang, Xiaoquan] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China; [Yan, Dongmei; Zhang, Zhihong; Luo, Qingming; Yang, Xiaoquan] Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, XQ (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China.; Yang, XQ (corresponding author), Huazhong Univ Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan, Hubei, Peoples R China.	yangxiaoquan@gmail.com		Luo, Qingming/0000-0002-6725-9311	Science Fund for Creative Research Group of China from National Natural Science Foundation of China [61121004]; Major Research Plan of the National Natural Science Foundation of China from National Natural Science Foundation of China, [91442201]; Science Fund of Hubei Province from Science and Technology Department of Hubei Province [2015CFB314]	Science Fund for Creative Research Group of China from National Natural Science Foundation of China; Major Research Plan of the National Natural Science Foundation of China from National Natural Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Science Fund of Hubei Province from Science and Technology Department of Hubei Province	This work was supported in part by Science Fund for Creative Research Group of China (Grant No. 61121004, from the National Natural Science Foundation of China, http.//www.nsfc.gov.cn/, for authors QL, and XY), the Major Research Plan of the National Natural Science Foundation of China (Grant No. 91442201, from the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, for authors ZZ, and XY), and Science Fund of Hubei Province (Grant No. 2015CFB314, from the Science and Technology Department of Hubei Province, http://www.hbstd.gov.cn/, for authors XY, and DY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Agner SC, 2011, J DIGIT IMAGING, V24, P446, DOI 10.1007/s10278-010-9298-1; Ale A, 2010, MED PHYS, V37, P1976, DOI 10.1118/1.3368603; Badea C. T., 2005, MOL IMAGING, V4, P110; Badea CT, 2006, CONTRAST MEDIA MOL I, V1, P153, DOI 10.1002/cmmi.103; Baiker M, 2010, MED IMAGE ANAL, V14, P723, DOI 10.1016/j.media.2010.04.008; Barber WC, 2010, TECHNOL CANCER RES T, V9, P45, DOI 10.1177/153303461000900105; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Das NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150085; Ecabert O, 2008, IEEE T MED IMAGING, V27, P1189, DOI 10.1109/TMI.2008.918330; Ford NL, 2003, MED PHYS, V30, P2869, DOI 10.1118/1.1617353; Franc BL, 2008, J NUCL MED, V49, P1651, DOI 10.2967/jnumed.108.055442; Freyer M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431101; Fu JW, 2012, J X-RAY SCI TECHNOL, V20, P459, DOI 10.3233/XST-2012-00352; Greschus S, 2005, NEOPLASIA, V7, P730, DOI 10.1593/neo.05160; Guo XL, 2010, IEEE T BIO-MED ENG, V57, P2876, DOI 10.1109/TBME.2010.2073468; Hamy V, 2014, MED IMAGE ANAL, V18, P301, DOI 10.1016/j.media.2013.10.016; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Hyde D, 2008, I S BIOMED IMAGING, P1597, DOI 10.1109/ISBI.2008.4541317; Irving B, 2014, LECT NOTES COMPUT SC, V8673, P609; Jan ML, 2006, NUCL INSTRUM METH A, V569, P314, DOI 10.1016/j.nima.2006.08.106; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Li X, 2008, MED PHYS, V35, P1507, DOI 10.1118/1.2889758; Linguraru MG, 2010, MED PHYS, V37, P771, DOI 10.1118/1.3284530; Liu JT, 2010, OPT EXPRESS, V18, P13102, DOI 10.1364/OE.18.013102; Melbourne A, 2007, PHYS MED BIOL, V52, P5147, DOI 10.1088/0031-9155/52/17/003; Meng YZ, 2014, J X-RAY SCI TECHNOL, V22, P285, DOI 10.3233/XST-140425; Quan GT, 2010, J INNOV OPT HEAL SCI, V3, P39, DOI 10.1142/S1793545810000824; Salvesen S, 1980, Acta Radiol Suppl, V362, P73; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Schulz RB, 2010, IEEE T MED IMAGING, V29, P465, DOI 10.1109/TMI.2009.2035310; Seo Y, 2008, PHYS MED BIOL, V53, pN99, DOI 10.1088/0031-9155/53/7/N01; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Wang HK, 2015, MOL IMAGING BIOL, V17, P18, DOI 10.1007/s11307-014-0767-7; Wang HK, 2012, IEEE T MED IMAGING, V31, P88, DOI 10.1109/TMI.2011.2165294; Xiao D, 2011, PROC SPIE, V7965, DOI 10.1117/12.877921; Yang XQ, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3422252; Yu N, 2015, P SPIE, V9414; Zhu ZQ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-014-0142-z	42	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169424	10.1371/journal.pone.0169424	http://dx.doi.org/10.1371/journal.pone.0169424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060917	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500090
J	Torresdal, JD; Farrell, AD; Goldberg, CS				Torresdal, Jack D.; Farrell, Aidan D.; Goldberg, Caren S.			Environmental DNA Detection of the Golden Tree Frog (Phytotriades auratus) in Bromeliads	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CONSERVATION; TRINIDAD; TOBAGO	The analysis of environmental DNA (eDNA) is a powerful, non-destructive technique for detecting rare or hard to find freshwater organisms. In this study, we investigated the effectiveness of environmental DNA analysis as a method for detecting a rare amphibian, the golden tree frog (Phytotriades auratus). These frogs are believed to live exclusively within one species of tank bromeliad, Glomeropitcairnia erectiflora, found on the highest peaks of the island of Trinidad in the West Indies. Previous survey methods for this species involved bromeliad destruction, while here we collected and analyzed water samples from discrete pools within G. erectiflora plants for species-specific DNA. We found 1) that we can identify the presence of P. auratus in the bromeliads using environmental DNA analysis, and 2) that environmental DNA evidence indicates the presence of a previously undiscovered P. auratus population, increasing the species' range from two isolated 'sky islands' to three.	[Farrell, Aidan D.] Univ West Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Goldberg, Caren S.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA	University West Indies Mona Jamaica; University West Indies Saint Augustine; Washington State University	Goldberg, CS (corresponding author), Washington State Univ, Sch Environm, Pullman, WA 99164 USA.	caren.goldberg@wsu.edu	Goldberg, Caren S/B-4075-2015					Alemu JB I, 2008, ECOHEALTH, V5, P34, DOI 10.1007/s10393-008-0154-4; [Anonymous], 2021, LANG ENV STAT COMP; Beard JS, 1946, NATURAL VEGETATION T; Brady SF, 2004, J NAT PROD, V67, P1283, DOI 10.1021/np0499766; Campbell JA, 2011, FROGLOG, V96, P22; Clarke F.M., 1995, British Herpetological Society Bulletin, V54, P3; Cossel John O. Jr., 2009, Herpetological Review, V40, P45; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hailey A, 2011, CONSERVATION OF CARIBBEAN ISLAND HERPETOFAUNAS, VOL 1: CONSERVATION BIOLOGY AND THE WIDER CARIBBEAN, P183; Hardy J, 2004, PHYTOTRIADES AURATUS; Helmer EH, 2012, FOREST ECOL MANAG, V279, P147, DOI 10.1016/j.foreco.2012.05.016; Jowers MJ, 2008, STUD NEOTROP FAUNA E, V43, P181, DOI 10.1080/01650520801965490; Kenny JS, 1969, STUD FAUNA CURACAO, V29, P1, DOI DOI 10.2307/1442340; McCranie JR, 2005, J HERPETOL, V39, P108, DOI 10.1670/0022-1511(2005)039[0108:NSOMSO]2.0.CO;2; METI (The Ministry of Economy  Trade and Industry of Japan and NASA (the United States National Aeronautics and Space Administration), 2011, ASTER GLOB DIG EL MO; Murphy J.C., 1983, Bulletin of the Chicago Herpetological Society, V18, P24; Read VM., 1982, B CHI HERP SOC, V18, P12; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rivas Gilson A., 2015, Herpetological Review, V46, P153; Rovito SM, 2010, J HERPETOL, V44, P516, DOI 10.1670/09-205.1	21	16	18	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168787	10.1371/journal.pone.0168787	http://dx.doi.org/10.1371/journal.pone.0168787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052079	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500022
J	Ma, XX; Han, N; Shao, CG; Meng, YJ				Ma, Xiaoxia; Han, Ning; Shao, Chaogang; Meng, Yijun			Transcriptome-Wide Discovery of PASRs (Promoter-Associated Small RNAs) and TASRs (Terminus-Associated Small RNAs) in Arabidopsis thaliana	PLOS ONE			English	Article							DIVERGENT TRANSCRIPTION; BIOGENESIS; INITIATION; MICRORNAS; DATABASE; ROLES; SIRNA; MAPS	Hints from animals point to the existence of two novel small RNA (sRNA) species surrounding the transcription start sites (TSSs) and the termini of the genes, respectively. In this study, we performed a comprehensive search for the two sRNA species named promoter-associated sRNAs (PASRs) and terminus-associated sRNAs (TASRs) in Arabidopsis. By using sRNA sequencing data from wild type plants and several mutants related to the sRNA biogenesis, Argonaute (AGO) 1- and AGO4-associated sRNA sequencing data, double-stranded RNA sequencing (dsRNA-seq) data, and DNA methylation profiling data, the biogenesis and action pathways of the PASRs and the TASRs were investigated. PASR and TASR peaks were identified on hundreds of the protein-coding genes. Deep analysis uncovered that some of the sRNA peaks were covered by dsRNA-seq reads, and these peaks were significantly repressed in specific mutants. Besides, certain PASRs and TASRs were preferentially recruited by AGO4, and site-specific DNA methylation signals encompassing the genomic loci of these sRNAs were also detected. Accordingly, we proposed a model that certain PASRs and TASRs were generated through a specific Pol IV-, RDR-, DCL-dependent pathway, and they were associated with AGO4 to perform site-specific DNA methylation on their host genes. The above results indicate the existence of PASRs and TASRs in plants. The proposed biogenesis pathway and action mode of the PASRs and TASRs could facilitate us to perform in-depth functional studies on these novel sRNA species.	[Ma, Xiaoxia; Meng, Yijun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Han, Ning] Zhejiang Univ, Inst Genet, Coll Life Sci, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Shao, Chaogang] Huzhou Univ, Coll Life Sci, Huzhou, Peoples R China	Hangzhou Normal University; Zhejiang University; Huzhou University	Meng, YJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	mengyijun@zju.edu.cn			National Natural Science Foundation of China [31571349, 31601062, 31100937, 31271380]; Zhejiang Provincial Natural Science Foundation of China [LY15C060006, LQ16C060003, LY15C060004]; Public Welfare Technology Application Research Project of Zhejiang Province [2016C33193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Public Welfare Technology Application Research Project of Zhejiang Province	This work was funded by the National Natural Science Foundation of China (31571349, 31601062, 31100937 and 31271380), the Zhejiang Provincial Natural Science Foundation of China (LY15C060006, LQ16C060003, and LY15C060004), and the Public Welfare Technology Application Research Project of Zhejiang Province (2016C33193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cserzo M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-56; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Leng XM, 2014, BIOCHEM BIOPH RES CO, V444, P86, DOI 10.1016/j.bbrc.2014.01.018; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-13; Taft RJ, 2009, CELL CYCLE, V8, P2332, DOI 10.4161/cc.8.15.9154; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XF, 2011, GENOMICS, V97, P235, DOI 10.1016/j.ygeno.2011.01.006; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Yan BX, 2012, CELL MOL LIFE SCI, V69, P2833, DOI 10.1007/s00018-012-0953-1; Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16; Zaramela LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107680; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141	34	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169212	10.1371/journal.pone.0169212	http://dx.doi.org/10.1371/journal.pone.0169212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046132	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300144
J	Maes, S; Props, R; Fitts, JP; De Smet, R; Vanhaecke, F; Boon, N; Hennebel, T				Maes, Synthia; Props, Ruben; Fitts, Jeffrey P.; De Smet, Rebecca; Vanhaecke, Frank; Boon, Nico; Hennebel, Tom			Biological Recovery of Platinum Complexes from Diluted Aqueous Streams by Axenic Cultures	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; PRECIOUS METALS; BIOREDUCTIVE DEPOSITION; HALOPHILIC BACTERIA; FLOW-CYTOMETRY; WASTE-WATER; NANOPARTICLES; PALLADIUM; REDUCTION; ENVIRONMENTS	The widespread use of platinum in high-tech and catalytic applications has led to the production of diverse Pt loaded wastewaters. Effective recovery strategies are needed for the treatment of low concentrated waste streams to prevent pollution and to stimulate recovery of this precious resource. The biological recovery of five common environmental Pt-complexes was studied under acidic conditions; the chloro-complexes PtCl42- and PtCl62-, the amine-complex Pt(NH3)(4)Cl-2 and the pharmaceutical complexes cisplatin and carboplatin. Five bacterial species were screened on their platinum recovery potential; the Gram-negative species Shewanella oneidensis MR-1, Cupriavidus metallidurans CH34, Geobacter metallireducens, and Pseudomonas stutzeri, and the Gram-positive species Bacillus toyonensis. Overall, PtCl42- and PtCl62- were completely recovered by all bacterial species while only S. oneidensis and C. metallidurans were able to recover cisplatin quantitatively (99%), all in the presence of H-2 as electron donor at pH 2. Carboplatin was only partly recovered (max. 25% at pH 7), whereas no recovery was observed in the case of the Pt-tetraamine complex. Transmission electron microscopy (TEM) revealed the presence of both intra- and extracellular platinum particles. Flow cytometry based microbial viability assessment demonstrated the decrease in number of intact bacterial cells during platinum reduction and indicated C. metallidurans to be the most resistant species. This study showed the effective and complete biological recovery of three common Pt-complexes, and estimated the fate and transport of the Pt-complexes in wastewater treatment plants and the natural environment.	[Maes, Synthia; Props, Ruben; Boon, Nico; Hennebel, Tom] Univ Ghent, Ctr Microbial Ecol & Technol, Dept Biochem & Microbial Technol, Ghent, Belgium; [Fitts, Jeffrey P.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NY USA; [De Smet, Rebecca] Univ Ghent, Dept Med & Forens Pathol, Ghent, Belgium; [Vanhaecke, Frank] Univ Ghent, Dept Analyt Chem, Ghent, Belgium	Ghent University; Princeton University; Ghent University; Ghent University	Hennebel, T (corresponding author), Univ Ghent, Ctr Microbial Ecol & Technol, Dept Biochem & Microbial Technol, Ghent, Belgium.	Tom.Hennebel@ugent.be	Boon, Nico/B-4083-2011; Vanhaecke, Frank/AAO-4582-2020; Vanhaecke, Frank F/F-5341-2014; Props, Ruben/AAV-4218-2020	Boon, Nico/0000-0002-7734-3103; Vanhaecke, Frank/0000-0002-1884-3853; Vanhaecke, Frank F/0000-0002-1884-3853; Props, Ruben/0000-0003-4996-2596	Agency for Innovation by Science and Technology (IWT Flanders); Research Foundation Flanders (FWO Flanders); Ghent University [BOFDOC2015000601]; Belgian Nuclear Research Centre; Metgrow Plus project [690088, H2020-SC5-2014-2015]	Agency for Innovation by Science and Technology (IWT Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO Flanders)(FWO); Ghent University(Ghent University); Belgian Nuclear Research Centre; Metgrow Plus project	SM is supported by the Agency for Innovation by Science and Technology (IWT Flanders). TH was supported by a postdoctoral fellowship from the Research Foundation Flanders (FWO Flanders) (http://www.fwo.be). RP was supported by Ghent University (BOFDOC2015000601; http://www.ugent.be/en) and the Belgian Nuclear Research Centre (SCK.CEN) (http://sckcen.be). This work was also supported by the Metgrow Plus project (Contract No. 690088; H2020-SC5-2014-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderden RA, 2006, J CHEM EDUC, V83, P728, DOI 10.1021/ed083p728; Azaroual M, 2001, GEOCHIM COSMOCHIM AC, V65, P4453, DOI 10.1016/S0016-7037(01)00752-9; Bard A. J., 2001, ELECTROCHEMICAL METH; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Brugger J, 2013, CHEM GEOL, V343, P99, DOI 10.1016/j.chemgeo.2013.02.010; Colombo C, 2008, GEOCHEM-EXPLOR ENV A, V8, P91, DOI 10.1144/1467-7873/07-151; Cotton S. A., 2012, CHEM PRECIOUS METALS; Curtis L, 2010, ENVIRON SCI TECHNOL, V44, P3345, DOI 10.1021/es903620z; De Corte S, 2011, J CHEM TECHNOL BIOT, V86, P547, DOI 10.1002/jctb.2549; De Windt W, 2005, ENVIRON MICROBIOL, V7, P314, DOI [10.1111/j.1462-2920.2005.00696.x, 10.1111/j.1462-2920.2004.00696.x]; Gaidhani SV, 2014, PROCESS BIOCHEM, V49, P2313, DOI 10.1016/j.procbio.2014.10.002; Gauthier D, 2010, CHEMSUSCHEM, V3, P1036, DOI 10.1002/cssc.201000091; Graedel TE, 2015, P NATL ACAD SCI USA, V112, P4257, DOI 10.1073/pnas.1500415112; Guibal E, 1999, IND ENG CHEM RES, V38, P4011, DOI 10.1021/ie990165k; Hann S, 2005, ANAL BIOANAL CHEM, V381, P405, DOI 10.1007/s00216-004-2839-z; Hennebel T, 2015, NEW BIOTECHNOL, V32, P121, DOI 10.1016/j.nbt.2013.08.004; Hosseinkhani B, 2014, ENVIRON SCI TECHNOL, V48, P550, DOI 10.1021/es403047u; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Konishi Y, 2007, J BIOTECHNOL, V128, P648, DOI 10.1016/j.jbiotec.2006.11.014; Lenz K, 2005, SCI TOTAL ENVIRON, V345, P141, DOI 10.1016/j.scitotenv.2004.11.007; LORTIE L, 1992, APPL ENVIRON MICROB, V58, P4042, DOI 10.1128/AEM.58.12.4042-4044.1992; Maes S, 2016, WATER RES, V105, P436, DOI 10.1016/j.watres.2016.09.023; Maes S, 2016, ENVIRON SCI TECHNOL, V50, P2619, DOI 10.1021/acs.est.5b05355; Michalke B, 2010, J TRACE ELEM MED BIO, V24, P69, DOI 10.1016/j.jtemb.2010.01.006; Ng CK, 2013, RSC ADV, V3, P22498, DOI 10.1039/c3ra44143a; Nies DH, 2000, EXTREMOPHILES, V4, P77, DOI 10.1007/s007920050140; Pat-Espadas AM, 2013, APPL MICROBIOL BIOT, V97, P9553, DOI 10.1007/s00253-012-4640-9; Rashamuse KJ, 2007, APPL MICROBIOL BIOT, V75, P1429, DOI 10.1007/s00253-007-0963-3; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Ravindra K, 2004, SCI TOTAL ENVIRON, V318, P1, DOI 10.1016/S0048-9697(03)00372-3; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Riddin TL, 2009, ENZYME MICROB TECH, V45, P267, DOI 10.1016/j.enzmictec.2009.06.006; Rotaru AE, 2012, BIOTECHNOL BIOENG, V109, P1889, DOI 10.1002/bit.24500; Schuetz B, 2009, APPL ENVIRON MICROB, V75, P7789, DOI 10.1128/AEM.01834-09; SLMB, 2012, 3331 SLMB FED OFF PU; Tanaka K., 2015, PLOS ONE, V10; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; U.S. Geological Survey, 2016, MIN COMM SUMM 2016; Umeda H, 2011, MATER TRANS, V52, P1462, DOI [10.2320/matertrans.M2010432, 10.2320/matertrans.M20104321]; Van Nevel S, 2013, J MICROBIOL METH, V94, P73, DOI 10.1016/j.mimet.2013.05.007; Vyas N, 2014, SCI TOTAL ENVIRON, V493, P324, DOI 10.1016/j.scitotenv.2014.05.127; Westerhoff P, 2015, ENVIRON SCI TECHNOL, V49, P9479, DOI 10.1021/es505329q; Won SW, 2014, BIORESOURCE TECHNOL, V160, P203, DOI 10.1016/j.biortech.2014.01.121; Yates MD, 2013, ACS SUSTAIN CHEM ENG, V1, P1165, DOI 10.1021/sc4000785; Yong P, 2010, BIOTECHNOL LETT, V32, P1821, DOI 10.1007/s10529-010-0378-6; Zawadzka AM, 2006, APPL ENVIRON MICROB, V72, P3119, DOI 10.1128/AEM.72.5.3119-3129.2006; Zhuang WQ, 2015, CURR OPIN BIOTECH, V33, P327, DOI 10.1016/j.copbio.2015.03.019	47	16	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169093	10.1371/journal.pone.0169093	http://dx.doi.org/10.1371/journal.pone.0169093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046131	Green Submitted, Green Published, gold			2022-12-26	WOS:000391612300112
J	Matthews, S; Belcher, JD; Tee, KL; Girvan, HM; McLean, KJ; Rigby, SEJ; Levy, CW; Leys, D; Parker, DA; Blankley, RT; Munro, AW				Matthews, Sarah; Belcher, James D.; Tee, Kang Lan; Girvan, Hazel M.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Parker, David A.; Blankley, Richard T.; Munro, Andrew W.			Catalytic Determinants of Alkene Production by the Cytochrome P450 Peroxygenase OleT(JE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID ALPHA-HYDROXYLASE; SPHINGOMONAS-PAUCIMOBILIS; FLAVOCYTOCHROME P450BM3; FATTY-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; COMPOUND I; HEME IRON; DECARBOXYLATION	The Jeotgalicoccus sp. peroxygenase cytochrome P450 OleT(JE) (CYP152L1) is a hydrogen peroxide-driven oxidase that catalyzes oxidative decarboxylation of fatty acids, producing terminal alkenes with applications as fine chemicals and biofuels. Understanding mechanisms that favor decarboxylation over fatty acid hydroxylation in OleT(JE) could enable protein engineering to improve catalysis or to introduce decarboxylation activity into P450s with different substrate preferences. In this manuscript, we have focused on OleT(JE) active site residues Phe(79), His(85), and Arg(245) to interrogate their roles in substrate binding and catalytic activity. His85 is a potential proton donor to reactive iron-oxo species during substrate decarboxylation. The H85Q mutant substitutes a glutamine found in several peroxygenases that favor fatty acid hydroxylation. H85Q OleT(JE) still favors alkene production, suggesting alternative protonation mechanisms. However, the mutant undergoes only minor substrate binding-induced heme iron spin state shift toward high spin by comparison with WT OleT(JE), indicating the key role of His85 in this process. Phe79 interacts with His85, and Phe79 mutants showed diminished affinity for shorter chain (C10-C16) fatty acids and weak substrate-induced high spin conversion. F79A OleT(JE) is least affected in substrate oxidation, whereas the F79W/Y mutants exhibit lower stability and cysteine thiolate protonation on reduction. Finally, Arg245 is crucial for binding the substrate carboxylate, and R245E/L mutations severely compromise activity and heme content, although alkene products are formed from some substrates, including stearic acid (C18:0). The results identify crucial roles for the active site amino acid trio in determining OleTJE catalytic efficiency in alkene production and in regulating protein stability, heme iron coordination, and spin state.	[Matthews, Sarah; Belcher, James D.; Tee, Kang Lan; Girvan, Hazel M.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England; [Parker, David A.] Westhollow Technol Ctr, Houston, TX 77028 USA; [Blankley, Richard T.] Agilent Technol UK Ltd, Chester SK8 3GR, Cheshire, England	University of Manchester; Agilent Technologies	Munro, AW (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Girvan, Hazel/0000-0003-2299-8644; Tee, Kang Lan/0000-0001-9458-733X	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC/Shell UK Ltd. [BB/N006275/1, BB/K017802/1]; BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship [BB/J012645/1]; Biotechnology and Biological Sciences Research Council [1225743, BB/N006275/1, BB/K017802/1, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/N006275/1, BB/K017802/1, BB/E013007/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Shell UK Ltd.; BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and by BBSRC/Shell UK Ltd. for Research Grants BB/N006275/1 (to A.W.M. and D.L., supporting K.J.M. and H.M.G.) and BB/K017802/1 (to A.W.M. and D.L., supporting K.L.T.). This work was also supported by BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship BB/J012645/1 (to A.W.M. and R.T.B., supporting S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya JA, 2016, J INORG BIOCHEM, V158, P11, DOI 10.1016/j.jinorgbio.2016.02.031; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dennig A, 2015, ANGEW CHEM INT EDIT, V54, P8819, DOI 10.1002/anie.201502925; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Girhard M, 2007, BIOCHEM BIOPH RES CO, V362, P114, DOI 10.1016/j.bbrc.2007.07.155; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Grant JL, 2016, P NATL ACAD SCI USA, V113, P10049, DOI 10.1073/pnas.1606294113; Grant JL, 2015, J AM CHEM SOC, V137, P4940, DOI 10.1021/jacs.5b01965; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Herman NA, 2016, CURR OPIN CHEM BIOL, V35, P22, DOI 10.1016/j.cbpa.2016.08.009; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Imai Y, 2000, J BIOCHEM-TOKYO, V128, P189, DOI 10.1093/oxfordjournals.jbchem.a022740; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lee DJ, 2003, P AMER CONTR CONF, P278; Li QS, 2001, BIOCHEM BIOPH RES CO, V280, P1258, DOI 10.1006/bbrc.2001.4261; Liu Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-28; Matsunaga I, 1999, LIPIDS, V34, P841, DOI 10.1007/s11745-999-0431-3; Matsunaga I, 1997, J BIOL CHEM, V272, P23592, DOI 10.1074/jbc.272.38.23592; Matsunaga I, 1998, J BIOCHEM-TOKYO, V124, P105, DOI 10.1093/oxfordjournals.jbchem.a022068; Matsunaga I, 2002, BIOCHEMISTRY-US, V41, P1886, DOI 10.1021/bi011883p; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Yan JY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0219-x; Zachos L, 2015, CHEM COMMUN, V51, P1918, DOI 10.1039/c4cc07276f; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	39	55	58	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5128	5143		10.1074/jbc.M116.762336	http://dx.doi.org/10.1074/jbc.M116.762336			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28053093	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000397590400034
J	Karmalkar, AV; Bradley, RS				Karmalkar, Ambarish V.; Bradley, Raymond S.			Consequences of Global Warming of 1.5 degrees C and 2 degrees C for Regional Temperature and Precipitation Changes in the Contiguous United States	PLOS ONE			English	Article							NORTH-AMERICAN CLIMATE; CO2 EMISSIONS; CMIP5; PROJECTIONS; VARIABILITY; HOLE	The differential warming of land and ocean leads to many continental regions in the Northern Hemisphere warming at rates higher than the global mean temperature. Adaptation and conservation efforts will, therefore, benefit from understanding regional consequences of limiting the global mean temperature increase to well below 2 degrees C above pre-industrial levels, a limit agreed upon at the United Nations Climate Summit in Paris in December 2015. Here, we analyze climate model simulations from the Coupled Model Intercomparison Project Phase 5 (CMIP5) to determine the timing and magnitude of regional temperature and precipitation changes across the contiguous United States (US) for global warming of 1.5 and 2 degrees C and highlight consensus and uncertainties in model projections and their implications for making decisions. The regional warming rates differ considerably across the contiguous US, but all regions are projected to reach 2 degrees C about 10-20 years before the global mean temperature. Although there is uncertainty in the timing of exactly when the 1.5 and 2 degrees C thresholds will be crossed regionally, over 80% of the models project at least 2 degrees C warming by 2050 for all regions for the high emissions scenario. This threshold-based approach also highlights regional variations in the rate of warming across the US. The fastest warming region in the contiguous US is the Northeast, which is projected to warm by 3 degrees C when global warming reaches 2 degrees C. The signal-to-noise ratio calculations indicate that the regional warming estimates remain outside the envelope of uncertainty throughout the twenty-first century, making them potentially useful to planners. The regional precipitation projections for global warming of 1.5 degrees C and 2 degrees C are uncertain, but the eastern US is projected to experience wetter winters and the Great Plains and the Northwest US are projected to experience drier summers in the future. The impact of different scenarios on regional precipitation projections is negligible throughout the twenty-first century compared to uncertainties associated with internal variability and model diversity.	[Karmalkar, Ambarish V.] Univ Massachusetts, Northeast Climate Sci Ctr, Amherst, MA 01003 USA; Univ Massachusetts, Climate Syst Res Ctr, Dept Geosci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Karmalkar, AV (corresponding author), Univ Massachusetts, Northeast Climate Sci Ctr, Amherst, MA 01003 USA.	akarmalkar@geo.umass.edu	Karmalkar, Ambarish/GQH-0889-2022; Bradley, Raymond S/P-9358-2015	Bradley, Raymond S/0000-0002-4032-9519	U.S. Department of the Interior's Northeast Climate Science Center from the U.S. Geological Survey [G12AC00001]	U.S. Department of the Interior's Northeast Climate Science Center from the U.S. Geological Survey	The research described in this publication was supported by the U.S. Department of the Interior's Northeast Climate Science Center, Grant or Cooperative Agreement No. G12AC00001 from the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2015, NAT GEOSCI, V8, P898, DOI 10.1038/ngeo2559; Bukovsky M, 2012, MASKS BUKOVSKY REGIO, P07; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Diffenbaugh NS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043888; Fischer EM, 2015, NAT CLIM CHANGE, V5, P560, DOI 10.1038/nclimate2617; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Huntingford C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30294; Jordan A, 2013, CLIM POLICY, V13, P751, DOI 10.1080/14693062.2013.835705; Joshi M, 2011, NAT CLIM CHANGE, V1, P407, DOI 10.1038/NCLIMATE1261; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Kumar S, 2013, J CLIMATE, V26, P3511, DOI 10.1175/JCLI-D-12-00535.1; Kunkel K.E., 2013, REGIONAL CLIMATE TRE; Maloney ED, 2014, J CLIMATE, V27, P2230, DOI 10.1175/JCLI-D-13-00273.1; Matsuura K., 2012, TERRESTRIAL PRECIPIT; Meehl GA, 2015, GEOPHYS RES LETT, V42, P5564, DOI 10.1002/2015GL064586; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mitchell D, 2016, NAT CLIM CHANGE, V6, P735, DOI 10.1038/nclimate3055; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; Rawlins MA, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018137; Rogelj J, 2016, NAT GEOSCI, V9, P187, DOI 10.1038/ngeo2668; Schellnhuber HJ, 2016, NAT CLIM CHANGE, V6, P649, DOI 10.1038/nclimate3013; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Seager R, 2013, NAT CLIM CHANGE, V3, P482, DOI [10.1038/nclimate1787, 10.1038/NCLIMATE1787]; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Sheffield J, 2013, J CLIMATE, V26, P9209, DOI 10.1175/JCLI-D-12-00592.1; Smith DM, 2016, NAT CLIM CHANGE, V6, P936, DOI [10.1038/NCLIMATE3058, 10.1038/nclimate3058]; Sutton RT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028164; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049863; UNFCCC, 2015, ADOPTION PARIS AGREE; van Vliet J, 2012, CLIMATIC CHANGE, V113, P551, DOI 10.1007/s10584-012-0458-9; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [10.7930/J0KW5CXT, DOI 10.7930/J0KW5CXT]	43	145	145	6	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168697	10.1371/journal.pone.0168697	http://dx.doi.org/10.1371/journal.pone.0168697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076360	Green Submitted, gold, Green Published			2022-12-26	WOS:000391857100016
J	Aristidou, C; Koufaris, C; Theodosiou, A; Bak, M; Mehrjouy, MM; Behjati, F; Tanteles, G; Christophidou-Anastasiadou, V; Tommerup, N; Sismani, C				Aristidou, Constantia; Koufaris, Costas; Theodosiou, Athina; Bak, Mads; Mehrjouy, Mana M.; Behjati, Farkhondeh; Tanteles, George; Christophidou-Anastasiadou, Violetta; Tommerup, Niels; Sismani, Carolina			Accurate Breakpoint Mapping in Apparently Balanced Translocation Families with Discordant Phenotypes Using Whole Genome Mate-Pair Sequencing	PLOS ONE			English	Article							COMPLEX CHROMOSOMAL REARRANGEMENTS; DE-NOVO; UNIPARENTAL DISOMY; PRENATAL-DIAGNOSIS; RAPID ANALYSIS; ARRAY CGH; MECHANISMS; END; MICRODELETION; DISRUPTION	Familial apparently balanced translocations (ABTs) segregating with discordant phenotypes are extremely challenging for interpretation and counseling due to the scarcity of publications and lack of routine techniques for quick investigation. Recently, next generation sequencing has emerged as an efficacious methodology for precise detection of translocation breakpoints. However, studies so far have mainly focused on de novo translocations. The present study focuses specifically on familial cases in order to shed some light to this diagnostic dilemma. Whole-genome mate-pair sequencing (WG-MPS) was applied to map the breakpoints in nine two-way ABT carriers from four families. Translocation breakpoints and patient-specific structural variants were validated by Sanger sequencing and quantitative Real Time PCR, respectively. Identical sequencing patterns and breakpoints were identified in affected and non-affected members carrying the same translocations. PTCD1, ATP5J2-PTCD1, CADPS2, and STPG1 were disrupted by the translocations in three families, rendering them initially as possible disease candidate genes. However, subsequent mutation screening and structural variant analysis did not reveal any pathogenic mutations or unique variants in the affected individuals that could explain the phenotypic differences between carriers of the same translocations. In conclusion, we suggest that NGS-based methods, such as WG-MPS, can be successfully used for detailed mapping of translocation breakpoints, which can also be used in routine clinical investigation of ABT cases. Unlike de novo translocations, no associations were determined here between familial two-way ABTs and the phenotype of the affected members, in which the presence of cryptic imbalances and complex chromosomal rearrangements has been excluded. Future whole-exome or whole-genome sequencing will potentially reveal unidentified mutations in the patients underlying the discordant phenotypes within each family. In addition, larger studies are needed to determine the exact percentage for phenotypic risk in families with ABTs.	[Aristidou, Constantia; Koufaris, Costas; Theodosiou, Athina; Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus; [Aristidou, Constantia; Sismani, Carolina] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus; [Bak, Mads; Mehrjouy, Mana M.; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Copenhagen N, Denmark; [Behjati, Farkhondeh] Univ Social Welf & Rehabil Sci, Cytogenet Unit, Genet Res Ctr, Tehran, Iran; [Tanteles, George; Christophidou-Anastasiadou, Violetta] Cyprus Inst Neurol & Genet, Dept Clin Genet, Nicosia, Cyprus; [Christophidou-Anastasiadou, Violetta] Archbishop Makarios III Med Ctr, Nicosia, Cyprus	University of Copenhagen	Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus.; Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus.	csismani@cing.ac.cy	Tommerup, Niels/T-8776-2017; Koufaris, Costas/ABW-5036-2022; Behjati, Farkhondeh/D-8497-2017; Tanteles, George/H-6190-2012	Tommerup, Niels/0000-0003-2304-0112; Koufaris, Costas/0000-0002-1222-5130; Behjati, Farkhondeh/0000-0001-6343-0452; Bak, Mads/0000-0003-2762-1002; Theodosiou, Athina/0000-0003-4363-8162; Sismani, Carolina/0000-0002-9296-8347; Tanteles, George/0000-0002-8117-9852	Lundbeck Foundation [2013-14290]; University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns); Danish Council for Independent Research - Medical Sciences [4183-00482B]; Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus; Cyprus Telethon; Lundbeck Foundation [R13-2007-1172, R151-2013-14290] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns); Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus; Cyprus Telethon; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Lundbeck Foundation [2013-14290]; the University of Copenhagen's Programme for Interdisciplinary Research (Global Genes, Local Concerns); The Danish Council for Independent Research - Medical Sciences [4183-00482B]; and Norway Grants through the Directorate General for European Programmes, Coordination and Development of the Republic of Cyprus. C.A. is funded by a research grant scholarship from Cyprus Telethon provided through the Cyprus School of Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Baptista J, 2008, AM J HUM GENET, V82, P927, DOI 10.1016/j.ajhg.2008.02.012; Bardakjian TM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-137; Bonora E, 2014, EMBO MOL MED, V6, P795, DOI 10.1002/emmm.201303235; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; BUHLER EM, 1983, ANN GENET-PARIS, V26, P133; Calounova G, 2006, NEUROENDOCRINOL LETT, V27, P579; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chen W, 2010, EUR J HUM GENET, V18, P539, DOI 10.1038/ejhg.2009.211; Cheng L, 2010, TRANSCRIPTION FACTOR, V307, P43; Cooper DN, 2013, HUM GENET; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dupont JM, 2002, AM J MED GENET, V111, P405, DOI 10.1002/ajmg.10570; Edvardson S, 2013, J MED GENET, V50, P118, DOI 10.1136/jmedgenet-2012-101223; Fiegler H, 2003, J MED GENET, V40, P664, DOI 10.1136/jmg.40.9.664; FRYNS J P, 1991, Genetic Counseling, V2, P185; Fujikane R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044817; Gribble SM, 2007, J MED GENET, V44, P51, DOI 10.1136/jmg.2006.044909; Gribble SM, 2009, NAT PROTOC, V4, P1722, DOI 10.1038/nprot.2009.183; Hannula K, 2002, PEDIATRICS, V109, P441, DOI 10.1542/peds.109.3.441; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khurana DS, 2013, SEMIN PEDIATR NEUROL, V20, P176, DOI 10.1016/j.spen.2013.10.001; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang D, 2016, CLIN GENET; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Nielsen K, 2000, J MED GENET, V37, P858, DOI [10.1136/jmp.37.11.858, DOI 10.1136/JMG.37.11.858]; Patsalis PC, 2004, EUR J HUM GENET, V12, P647, DOI 10.1038/sj.ejhg.5201211; Peng HH, 2006, J REPROD MED, V51, P699; Pippucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082154; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Rackham O, 2012, BBA-GENE REGUL MECH, V1819, P1008, DOI 10.1016/j.bbagrm.2011.10.007; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Rao L, 2010, J PEDIATR NEUROSCI, V5, P64, DOI 10.4103/1817-1745.66686; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011; Shawky R, 2014, EGYPT J MED HUM GENE, V15, P103, DOI 10.1016/j.ejmhg.2014.01.003; Shoukier M, 2012, AM J MED GENET A, V158A, P229, DOI 10.1002/ajmg.a.34387; Sismani C, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-15; Sobreira NLM, 2011, GENOME RES, V21, P1720, DOI 10.1101/gr.122986.111; Suzuki T, 2014, J HUM GENET, V59, P649, DOI 10.1038/jhg.2014.88; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Vergult S, 2014, EUR J HUM GENET, V22, P652, DOI 10.1038/ejhg.2013.220; Villarreal DD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003026; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; WENGER SL, 1995, AM J MED GENET, V55, P47, DOI 10.1002/ajmg.1320550114; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	57	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169935	10.1371/journal.pone.0169935	http://dx.doi.org/10.1371/journal.pone.0169935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072833	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200059
J	Zhao, J; Xu, T; Yin, DQ; Zhang, B; Bai, JF				Zhao, Jing; Xu, Ting; Yin, Daqiang; Zhang, Bo; Bai, Jianfeng			The Regulatory Roles of MicroRNA in Effects of 2,2 ' 4,4 '-Tetrabromodiphenyl Ether (BDE47) on the Transcriptome of Zebrafish Larvae	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; EXPRESSION PROFILES; TERM EXPOSURE; CANCER; IDENTIFICATION; CHOLESTEROL; HOMEOSTASIS; EMBRYOS; CHINA; CELLS	The developmental neurotoxicity caused by environmental pollutants has received great concern; however, there were still barely known about the underlying toxic mechanisms, especially the influence of varieties of regulatory factors such as microRNA (miRNA). A representative flame retardant, 2,2',4,4'-tetrabromodiphenyl ether (BDE47), was found to disrupt zebrafish development in visual perception and bone formation in previous study, thus here we investigated its effects on miRNA expression profiling of 6 days post fertilization (dpf) zebrafish larvae by deep sequencing. To overcome the shortage of zebrafish miRNA annotation, multiple data processing approaches, especially constructed network based on the interactions between miRNAs and enrichment terms, were adopted and helped us acquire several validated zebrafish miRNAs and two novel miRNAs in BDE47-induced effects, and identify corresponding biological processes of the miRNAs. Among them, miR-735 was supposed to play essential roles in larval sensory development according to analysis results. Our study also provided an effective strategy for analyzing biological effects on non-mammalian miRNAs with limited basic information.	[Zhao, Jing; Bai, Jianfeng] Shanghai Polytech Univ, WEEE Res Ctr, Shanghai Collaborat Innovat Ctr WEEE Recycling, Shanghai, Peoples R China; [Xu, Ting; Yin, Daqiang] Tongji Univ, Coll Environm Sci & Technol, Key Lab Yangtze River Water Environm, Minist Educ, Shanghai, Peoples R China; [Zhang, Bo] Novel Bioinformat Co Ltd, Shanghai, Peoples R China	Shanghai Polytechnic University; Tongji University	Xu, T (corresponding author), Tongji Univ, Coll Environm Sci & Technol, Key Lab Yangtze River Water Environm, Minist Educ, Shanghai, Peoples R China.	xuting@tongji.edu.cn	Xu, Ting/ABI-6242-2020	Xu, Ting/0000-0001-7956-7322	National Nature Science Foundation of China [21507080, 21477086, 21577104]; Novel Bioinformatics Co., Ltd	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novel Bioinformatics Co., Ltd	The study was financially supported by the National Nature Science Foundation of China (21507080, 21477086, and 21577104). Novel Bioinformatics Co., Ltd provided support in the form of salaries for author [BZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dingemans MML, 2011, ENVIRON HEALTH PERSP, V119, P900, DOI 10.1289/ehp.1003035; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012; Funamizu N, 2014, INT J ONCOL, V44, P725, DOI 10.3892/ijo.2014.2243; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P945, DOI 10.1021/es035082g; Jenny MJ, 2012, TOXICOL APPL PHARM, V264, P262, DOI 10.1016/j.taap.2012.08.007; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Ma J, 2012, CHEMOSPHERE, V88, P769, DOI 10.1016/j.chemosphere.2012.03.093; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Nadal E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12464; Ni K, 2013, INT J HYG ENVIR HEAL, V216, P607, DOI 10.1016/j.ijheh.2013.02.002; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Soares AR, 2012, TOXICOL SCI, V127, P18, DOI 10.1093/toxsci/kfs068; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Tal TL, 2012, FASEB J, V26, P1452, DOI 10.1096/fj.11-194464; Vaughn MW, 2005, SCIENCE, V309, P1525, DOI 10.1126/science.1117805; Wagschal A, 2015, NAT MED, V21, P1290, DOI 10.1038/nm.3980; Wang FQ, 2012, ENVIRON SCI TECHNOL, V46, P6822, DOI 10.1021/es3008547; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Xu T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1194-5; Yu LQ, 2014, ENVIRON TOXICOL CHEM, V33, P1354, DOI 10.1002/etc.2562; Zhang L, 2011, J APPL TOXICOL, V31, P210, DOI 10.1002/jat.1583; Zhao J, 2014, CHEMOSPHERE, V94, P53, DOI 10.1016/j.chemosphere.2013.09.010	35	6	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169599	10.1371/journal.pone.0169599	http://dx.doi.org/10.1371/journal.pone.0169599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072866	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200031
J	Chen, ZY; Lin, XC; Qu, B; Gao, WY; Zuo, YJ; Peng, WY; Jin, L; Yu, MB; Lamoureux, E				Chen, Ziyan; Lin, Xianchai; Qu, Bo; Gao, Wuyou; Zuo, Yajing; Peng, Wenyan; Jin, Ling; Yu, Minbin; Lamoureux, Ecosse			Preoperative Expectations and Postoperative Outcomes of Visual Functioning among Cataract Patients in Urban Southern China	PLOS ONE			English	Article							SURGERY; VISION; QUESTIONNAIRE; DISABILITY; HEALTH	Purpose To investigate the relationship between preoperative expectations and actual postoperative outcomes of visual function (VF) among patients undergoing first eye cataract surgery. Methods A longitudinal study of 182 patients from hospitals in urban Southern China were surveyed prior to surgery and 3 month after cataract surgery regarding their preoperative, expected postoperative and actual postoperative VF for each of the items on the Catquest-9SF and their satisfaction with cataract surgery. In addition, detailed clinical data were collected preoperatively and postoperatively. Results The majority of cataract patients in urban Southern China had high expectations for VF outcomes after cataract surgery and in most cases postoperative outcomes achieved the expected level of improvement. The mean (standard deviation, SD) preoperative Catquest-9SF score was 15.7 (5.86) and the mean (SD) expected postoperative score was 26.3 (2.93). The discrepancy between actual and expected improvement was simay need a comprehensive counseling to decrease the discrepancy regarding expected and actual outcomes.gnificantly correlated with patients' health literacy, presence of systemic and ocular comorbidity, preoperative visual acuity of the surgery eye, LOCS III nuclear opalescence and cortical cataract grading. Conclusion Cataract patients in urban Southern China had high expectations for surgery outcomes. Patients with low level of health literacy and the presence of systemic and ocular comorbidity may need a comprehensive counseling to decrease the discrepancy regarding expected and actual outcomes.	[Chen, Ziyan; Lin, Xianchai; Qu, Bo; Gao, Wuyou; Zuo, Yajing; Peng, Wenyan; Jin, Ling; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Lamoureux, Ecosse] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Lamoureux, Ecosse] Duke Natl Univ, Singapore Med Sch, Singapore, Singapore; [Lamoureux, Ecosse] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; University of Melbourne	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yuminbin@mail.sysu.edu.cn	Lamoureux, Ecosse/Z-5482-2019		Guangdong Natural Science Foundation [2015A030313171]; Science and Technology Program of Guangdong Province, China [2013B020400003]; Science and Technology Program of Guangzhou, China [15570001]; National Natural Science Foundation of China [81200685]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangdong Province, China; Science and Technology Program of Guangzhou, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by Guangdong Natural Science Foundation (2015A030313171), Science and Technology Program of Guangdong Province, China (2013B020400003), Science and Technology Program of Guangzhou, China (15570001), and National Natural Science Foundation of China (81200685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu Z, 2011, ETHIOP J HEALTH SCI, V21, P47; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Duan XR, 2013, GRAEF ARCH CLIN EXP, V251, P203, DOI 10.1007/s00417-012-2012-x; Elliott DB, 1997, BRIT J OPHTHALMOL, V81, P889, DOI 10.1136/bjo.81.10.889; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; Helbostad JL, 2013, OPTOMETRY VISION SCI, V90, P392, DOI 10.1097/OPX.0b013e3182843f16; Huang WY, 2012, INVEST OPHTH VIS SCI, V53, P7936, DOI 10.1167/iovs.12-10903; KARBASSI M, 1993, OPTOMETRY VISION SCI, V70, P923, DOI 10.1097/00006324-199311000-00009; Kretz FTA, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0089-9; Kugelberg M, 2008, J CATARACT REFR SURG, V34, P1935, DOI 10.1016/j.jcrs.2008.06.036; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Lundstrom M, 2011, ACTA OPHTHALMOL, V89, P718, DOI 10.1111/j.1755-3768.2009.01801.x; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; Mollazadegan K, 2015, ACTA OPHTHALMOL, V93, P293, DOI 10.1111/aos.12490; Pager CK, 2004, ARCH OPHTHALMOL-CHIC, V122, P1788, DOI 10.1001/archopht.122.12.1788; Pan AP, 2015, AM J OPHTHALMOL, V159, P241, DOI 10.1016/j.ajo.2014.10.025; Seo S, 2016, CLIN EXPT OPHTHALMOL; Skiadaresi E, 2012, ARCH OPHTHALMOL-CHIC, V130, P1377, DOI 10.1001/archophthalmol.2012.1603; Stock MV, 2015, INVEST OPHTH VIS SCI, V56, P2536, DOI 10.1167/iovs.14-16069; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1312, DOI 10.1001/archopht.1995.01100100100038; Umfress AC, 2016, SEMIN OPHTHALMOL; Wang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142858; Wang Y, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-302	23	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169844	10.1371/journal.pone.0169844	http://dx.doi.org/10.1371/journal.pone.0169844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068402	Green Published, gold			2022-12-26	WOS:000391843900074
J	Fear, VS; Boyd, JH; Rea, S; Wood, FM; Duke, JM; Fear, MW				Fear, Vanessa S.; Boyd, James H.; Rea, Suzanne; Wood, Fiona M.; Duke, Janine M.; Fear, Mark W.			Burn Injury Leads to Increased Long-Term Susceptibility to Respiratory Infection in both Mouse Models and Population Studies	PLOS ONE			English	Article							WESTERN-AUSTRALIA; RISK-FACTORS; HEALTH; TRAUMA; MORTALITY; ADULTS; LUNG; SKIN; CIRCULATION; INHALATION	Background Burn injury initiates an acute inflammatory response that subsequently drives wound repair. However, acute disruption to the immune response is also common, leading to susceptibility to sepsis and increased morbidity and mortality. Despite increased understanding of the impact of burn injury on the immune system in the acute phase, little is known about long-term consequences of burn injury on immune function. This study was established to determine whether burn injury has long-term clinical impacts on patients' immune responses. Methods Using a population-based retrospective longitudinal study and linked hospital morbidity and death data from Western Australia, comparative rates of hospitalisation for respiratory infections in burn patients and a non-injured comparator cohort were assessed. In addition, a mouse model of non-severe burn injury was also used in which viral respiratory infection was induced at 4 weeks post-injury using a mouse modified version of the Influenza A virus (H3NN; A/mem/71-a). Results and conclusions The burn injured cohort contained 14893 adult patients from 1980-2012 after removal of those patients with evidence of smoke inhalation or injury to the respiratory tract. During the study follow-up study a total of 2,884 and 2,625 respiratory infection hospital admissions for the burn and uninjured cohorts, respectively, were identified. After adjusting for covariates, the burn cohort experienced significantly elevated admission rates for influenza and viral pneumonia (IRR, 95% CI: 1.73, 1.27-2.36), bacterial pneumonia (IRR, 95% CI: 2.05, 1.85-2.27) and for other types of upper and lower respiratory infections (IRR, 95% CI: 2.38, 2.09-2.71). In the mouse study an increased viral titre was observed after burn injury, accompanied by a reduced CD8 response and increased NK and NKT cells in the draining lymph nodes. This data suggests burn patients are at long-term increased risk of infection due to sustained modulation of the immune response.	[Fear, Vanessa S.] Univ Western Australia, Sch Med & Pharmacol, Tumour Immunol Grp, Perth, WA, Australia; [Fear, Vanessa S.; Rea, Suzanne; Wood, Fiona M.; Duke, Janine M.; Fear, Mark W.] Univ Western Australia, Sch Surg, Burn Injury Res Unit, Perth, WA, Australia; [Boyd, James H.] Curtin Univ, Ctr Data Linkage, Perth, WA, Australia; [Rea, Suzanne; Wood, Fiona M.] Fiona Stanley Hosp, Burns Serv Western Australia, Perth, WA, Australia; [Rea, Suzanne; Wood, Fiona M.] Princess Margaret Hosp, Perth, WA, Australia	University of Western Australia; University of Western Australia; Curtin University	Fear, MW (corresponding author), Univ Western Australia, Sch Surg, Burn Injury Res Unit, Perth, WA, Australia.	Mark.fear@uwa.edu.au	Fear, Mark/H-9170-2014; Fear, Vanessa/O-5618-2019; Fear, Vanessa S/AAF-9805-2020; fiona, wood/F-4703-2013	Fear, Vanessa S/0000-0001-8363-6685; Wood, Fiona Melanie/0000-0002-3284-6540; Boyd, James/0000-0002-8925-8811; fiona, wood/0000-0001-5427-6588; fear, mark/0000-0003-3163-4666	Woodside Coorporation; Fiona Wood Foundation; Chevron Australia	Woodside Coorporation; Fiona Wood Foundation; Chevron Australia	The authors received no specific funding for this work. JD is supported by Woodside Coorporation and Fiona Wood Foundation. MF is supported by Chevron Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund E, 2007, BURNS, V33, P31, DOI 10.1016/j.burns.2006.10.002; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Cameron CM, 2006, B WORLD HEALTH ORGAN, V84, P802, DOI 10.2471/BLT.06.030833; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choileain NN, 2006, ARCH SURG-CHICAGO, V141, P1132, DOI 10.1001/archsurg.141.11.1132; Choileain NN, 2006, SURG-J R COLL SURG E, V4, P23, DOI 10.1016/S1479-666X(06)80018-1; Clark A, 2010, AUST HEALTH REV, V34, P210, DOI 10.1071/AH09805; Cox RA, 2015, BURNS, V41, P1435, DOI 10.1016/j.burns.2015.05.003; DONNELLY TJ, 1994, CRIT CARE MED, V22, P768, DOI 10.1097/00003246-199405000-00010; Duke JM, 2016, BURNS, V42, P366, DOI 10.1016/j.burns.2015.08.020; Duke JM, 2015, ACCIDENT ANAL PREV, V85, P118, DOI 10.1016/j.aap.2015.09.011; Duke JM, 2015, B WORLD HEALTH ORGAN, V93, P400, DOI 10.2471/BLT.14.149146; Duke JM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003845; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS3, DOI 10.1016/j.apmr.2007.09.020; Fauerbach JA, 2005, J BURN CARE REHABIL, V26, P21, DOI 10.1097/01.BCR.0000150216.87940.AC; Fauerbach JA, 2007, J BURN CARE RES, V28, P587, DOI 10.1097/BCR.0B013E318093E470; Fear VS, 2016, BURNS, V42, P815, DOI 10.1016/j.burns.2016.01.013; Fear VS, 2011, J IMMUNOL, V187, P4561, DOI 10.4049/jimmunol.1004189; Gordis L., 2000, EPIDEMIOLOGY, V2; Gross MA, 1989, SURGERY, V106, P6; GROSSO MA, 1989, SURGERY, V106, P310; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; HERNDON DN, 1990, J TRAUMA, V30, pS41; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hoover L, 2006, J TRAUMA, V61, P6; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Hosmer DW, 2002, STATA J, V2, P331, DOI 10.1177/1536867X0200200401; Kagan RJ, 2009, J BURN CARE RES, V30, P204, DOI 10.1097/BCR.0b013e3181923e7d; McGwin G, 2002, SHOCK, V18, P311, DOI 10.1097/00024382-200210000-00004; National Centre for Classification in Health, 2015, AUSTR CONS CLASS DEV; O'Halloran E, 2015, BURNS, V41, P558, DOI 10.1016/j.burns.2014.09.004; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Plichta JK, 2014, CRIT CARE MED, V42, pE420, DOI 10.1097/CCM.0000000000000309; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Pulendran B, 2015, CURR TOP MICROBIOL, V386, P23, DOI 10.1007/82_2014_405; Ramsey KA, 2013, ENVIRON HEALTH PERSP, V121, P1187, DOI 10.1289/ehp.1306748; Randall SM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009395; Rea S, 2009, BURNS, V35, P356, DOI 10.1016/j.burns.2008.07.011; Rue LW, 1995, J BURN CARE REHABILI, V16; Sharma BR, 2007, INFECT DIS CLIN N AM, V21, P745, DOI 10.1016/j.idc.2007.06.003; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Taylor AW, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0031-z; Tennant, 2003, REMOTE AREAS STAT GE; Traber DL, 2007, PULM PHARMACOL THER, V20, P163, DOI 10.1016/j.pupt.2005.12.006; Tran NK, 2012, SURGERY, V151, P456, DOI 10.1016/j.surg.2011.07.030; Trewin D, 2003, SOCIO EC INDEXES ARE; Valvis SM, 2015, J INVEST DERMATOL, V135, P2119, DOI 10.1038/jid.2015.123; Verbist RD, 2012, PLOS ONE, V7, DOI [1016/j.burns.2015.05.003, DOI 10.1016/J.BURNS.2015.05.003]; Wasiak J, 2009, BURNS, V35, P1124, DOI 10.1016/j.burns.2009.04.016	50	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169302	10.1371/journal.pone.0169302	http://dx.doi.org/10.1371/journal.pone.0169302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068397	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900023
J	Huang, YR; Zhong, C; Lin, HX; Wang, JY				Huang, Yiran; Zhong, Cheng; Lin, Hai Xiang; Wang, Jianyi			A Method for Finding Metabolic Pathways Using Atomic Group Tracking	PLOS ONE			English	Article							COMPUTER-AIDED-DESIGN; ESCHERICHIA-COLI; ROUTE SEARCH; TOOL; NETWORKS; IDENTIFICATION; PREDICTION; INFORMATION; VALIDATION; ALGORITHM	A fundamental computational problem in metabolic engineering is to find pathways between compounds. Pathfinding methods using atom tracking have been widely used to find biochemically relevant pathways. However, these methods require the user to define the atoms to be tracked. This may lead to failing to predict the pathways that do not conserve the user-defined atoms. In this work, we propose a pathfinding method called AGPathFinder to find biochemically relevant metabolic pathways between two given compounds. In AGPathFinder, we find alternative pathways by tracking the movement of atomic groups through metabolic networks and use combined information of reaction thermodynamics and compound similarity to guide the search towards more feasible pathways and better performance. The experimental results show that atomic group tracking enables our method to find pathways without the need of defining the atoms to be tracked, avoid hub metabolites, and obtain biochemically meaningful pathways. Our results also demonstrate that atomic group tracking, when incorporated with combined information of reaction thermodynamics and compound similarity, improves the quality of the found pathways. In most cases, the average compound inclusion accuracy and reaction inclusion accuracy for the top resulting pathways of our method are around 0.90 and 0.70, respectively, which are better than those of the existing methods. Additionally, AGPathFinder provides the information of thermodynamic feasibility and compound similarity for the resulting pathways.	[Huang, Yiran] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Yiran; Zhong, Cheng] Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China; [Lin, Hai Xiang] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Wang, Jianyi] Guangxi Univ, Sch Chem & Chem Engn, Nanning, Peoples R China	South China University of Technology; Guangxi University; Delft University of Technology; Guangxi University	Huang, YR (corresponding author), South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Huang, YR; Zhong, C (corresponding author), Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China.	hyr@gxu.edu.cn; chzhong@gxu.edu.cn		Lin, Hai Xiang/0000-0002-1653-4854	National Natural Science Foundation of China [61462005]; Natural Science Foundation of Guangxi [2014GXNSFAA118396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work is supported in part by the National Natural Science Foundation of China under Grant No. 61462005, and Natural Science Foundation of Guangxi under Grant No. 2014GXNSFAA118396.	Alcantara R, 2012, NUCLEIC ACIDS RES, V40, pD754, DOI 10.1093/nar/gkr1126; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Arita M, 2003, GENOME RES, V13, P2455, DOI 10.1101/gr.1212003; Blum T, 2008, BIOINFORMATICS, V24, P2108, DOI 10.1093/bioinformatics/btn360; Blum T, 2008, J COMPUT BIOL, V15, P565, DOI 10.1089/cmb.2008.0044; Boudellioua I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158896; Boyer F, 2003, BIOINFORMATICS, V19, pII26, DOI 10.1093/bioinformatics/btg1055; Campodonico MA, 2014, METAB ENG, V25, P140, DOI 10.1016/j.ymben.2014.07.009; Carbonell P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-10; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; Chowdhury A, 2015, SCI REPORTS 1, V5, pC1362; Croes D, 2006, J MOL BIOL, V356, P222, DOI 10.1016/j.jmb.2005.09.079; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; de Figueiredo LF, 2009, BIOINFORMATICS, V25, P3158, DOI 10.1093/bioinformatics/btp564; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Faust K, 2009, J MOL BIOL, V388, P390, DOI 10.1016/j.jmb.2009.03.006; Feher T, 2014, BIOTECHNOL J, V9, P1446, DOI 10.1002/biot.201400055; Fernandez-Castane A, 2014, J BIOTECHNOL, V192, P302, DOI 10.1016/j.jbiotec.2014.03.029; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Gerard MF, 2015, BIOSYSTEMS, V134, P43, DOI 10.1016/j.biosystems.2015.04.006; Gerard MF, 2013, COMPUT BIOL MED, V43, P1704, DOI 10.1016/j.compbiomed.2013.08.017; Gerlee P, 2009, BIOINFORMATICS, V25, P3282, DOI 10.1093/bioinformatics/btp575; Heath AP, 2011, J COMPUT BIOL, V18, P1575, DOI 10.1089/cmb.2011.0165; Heath AP, 2010, BIOINFORMATICS, V26, P1548, DOI 10.1093/bioinformatics/btq223; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Ismail MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126199; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Khosraviani M, 2016, BIOINFORMATICS, V32, P398, DOI 10.1093/bioinformatics/btv578; Kotera M, 2004, GENOME INFORM, V15, pP062; Latendresse M, 2014, BIOINFORMATICS, V30, P2043, DOI 10.1093/bioinformatics/btu150; Lemer C, 2004, NUCLEIC ACIDS RES, V32, pD443, DOI 10.1093/nar/gkh139; Lim K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S17; Liu F, 2015, COMPUT METH PROG BIO, V118, P134, DOI 10.1016/j.cmpb.2014.11.010; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Markatou M, 2005, J MACH LEARN RES, V6, P1127; McClymont K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt234; McShan DC, 2003, BIOINFORMATICS, V19, P1692, DOI 10.1093/bioinformatics/btg217; Mithani A, 2009, BIOINFORMATICS, V25, P1831, DOI 10.1093/bioinformatics/btp269; Pertusi DA, 2015, BIOINFORMATICS, V31, P1016, DOI 10.1093/bioinformatics/btu760; Pey J, 2014, BIOINFORMATICS, V30, P975, DOI 10.1093/bioinformatics/btt653; Pey J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-134; Pey J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r49; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pitkanen E., 2009, BMC SYST BIOL, V3, P1; Planes FJ, 2008, BRIEF BIOINFORM, V9, P422, DOI 10.1093/bib/bbn018; Rahman SA, 2005, BIOINFORMATICS, V21, P1189, DOI 10.1093/bioinformatics/bti116; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Ranganathan S, 2010, BIOTECHNOL J, V5, P716, DOI 10.1002/biot.201000171; Tabei Y, 2016, BIOINFORMATICS, V32, P278, DOI 10.1093/bioinformatics/btw260; Tervo CJ, 2016, BIOTECHNOL J, V11, P648, DOI 10.1002/biot.201500267; Xia DG, 2011, BIOINFORMATICS, V27, P1581, DOI 10.1093/bioinformatics/btr160; Yousofshahi M, 2011, METAB ENG, V13, P435, DOI 10.1016/j.ymben.2011.01.006; Zhou WD, 2012, J CHEM INF MODEL, V52, P2684, DOI 10.1021/ci300259u; Zhou WD, 2011, BIOINFORMATICS, V27, P1957, DOI 10.1093/bioinformatics/btr271	56	42	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168725	10.1371/journal.pone.0168725	http://dx.doi.org/10.1371/journal.pone.0168725			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068354	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900012
J	Ricciardi, L; Visco-Comandini, F; Erro, R; Morgante, F; Bologna, M; Fasano, A; Ricciardi, D; Edwards, MJ; Kilner, J				Ricciardi, Lucia; Visco-Comandini, Federica; Erro, Roberto; Morgante, Francesca; Bologna, Matteo; Fasano, Alfonso; Ricciardi, Diego; Edwards, Mark J.; Kilner, James			Facial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; PREMOTOR CORTEX; METAANALYSIS; BRADYKINESIA; DEPRESSION; MIMICRY; PEOPLE; FACES	Background and aim Parkinson's disease (PD) patients have impairment of facial expressivity (hypomimia) and difficulties in interpreting the emotional facial expressions produced by others, especially for aversive emotions. We aimed to evaluate the ability to produce facial emotional expressions and to recognize facial emotional expressions produced by others in a group of PD patients and a group of healthy participants in order to explore the relationship between these two abilities and any differences between the two groups of participants. Methods Twenty non-demented, non-depressed PD patients and twenty healthy participants (HC) matched for demographic characteristics were studied. The ability of recognizing emotional facial expressions was assessed with the Ekman 60-faces test (Emotion recognition task). Participants were video-recorded while posing facial expressions of 6 primary emotions (happiness, sadness, surprise, disgust, fear and anger). The most expressive pictures for each emotion were derived from the videos. Ten healthy raters were asked to look at the pictures displayed on a computer-screen in pseudo-random fashion and to identify the emotional label in a six-forced-choice response format (Emotion expressivity task). Reaction time (RT) and accuracy of responses were recorded. At the end of each trial the participant was asked to rate his/her confidence in his/her perceived accuracy of response. Results For emotion recognition, PD reported lower score than HC for Ekman total score (p<0.001), and for single emotions sub-scores happiness, fear, anger, sadness (p<0.01) and surprise (p = 0.02). In the facial emotion expressivity task, PD and HC significantly differed in the total score (p = 0.05) and in the sub-scores for happiness, sadness, anger (all p<0.001). RT and the level of confidence showed significant differences between PD and HC for the same emotions. There was a significant positive correlation between the emotion facial recognition and expressivity in both groups; the correlation was even stronger when ranking emotions from the best recognized to the worst (R = 0.75, p = 0.004). Conclusions PD patients showed difficulties in recognizing emotional facial expressions produced by others and in posing facial emotional expressions compared to healthy subjects. The linear correlation between recognition and expression in both experimental groups suggests that the two mechanisms share a common system, which could be deteriorated in patients with PD. These results open new clinical and rehabilitation perspectives.	[Ricciardi, Lucia; Edwards, Mark J.] St Georges Univ London, Neurosci Res Ctr, Cardiovasc & Cell Sci Res Inst, London, England; [Visco-Comandini, Federica; Erro, Roberto; Kilner, James] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Morgante, Francesca] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Bologna, Matteo] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy; [Bologna, Matteo] Neuromed Inst IRCCS, Pozzilli, Isernia, Italy; [Fasano, Alfonso] Univ Toronto, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada; [Fasano, Alfonso] Univ Toronto, Edmond J Safra Program Parkinsons Dis, Toronto Western Hosp, UHN,Div Neurol, Toronto, ON, Canada; [Ricciardi, Diego] Univ Cattolica Sacro Cuore, Dept Geriatry, Rome, Italy	St Georges University London; University of London; King's College London; University of London; University College London; University of Messina; Sapienza University Rome; IRCCS Neuromed; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ricciardi, L (corresponding author), St Georges Univ London, Neurosci Res Ctr, Cardiovasc & Cell Sci Res Inst, London, England.; Kilner, J (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	lucia.ricciardi2@gmail.com; j.kilner@ucl.ac.uk	Visco-Comandini, Federica/AAC-1558-2019; Bologna, Matteo/K-7886-2016; Erro, Roberto/AAC-2574-2019; Edwards, Mark J/F-1052-2012; Erro, Roberto/GRJ-3466-2022; Morgante, Francesca/E-8717-2010; Fasano, Alfonso/K-2558-2018	Bologna, Matteo/0000-0003-0165-0833; Erro, Roberto/0000-0002-7800-7419; Edwards, Mark J/0000-0002-8283-9015; Morgante, Francesca/0000-0002-9834-3639; Visco Comandini, Federica/0000-0002-3487-2320; Kilner, James/0000-0002-6632-6797; Fasano, Alfonso/0000-0001-5346-0180				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Assogna F, 2008, EUR NEUROPSYCHOPHARM, V18, P835, DOI 10.1016/j.euroneuro.2008.07.004; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bogart KR, 2010, SOC NEUROSCI-UK, V5, P241, DOI 10.1080/17470910903395692; Bologna M, 2013, J NEUROL NEUROSUR PS, V84, P681, DOI 10.1136/jnnp-2012-303993; Brewer R, 2015, AUTISM RES; BUCK R, 1980, CORTEX, V16, P351, DOI 10.1016/S0010-9452(80)80037-2; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 1976, PICTURES FACIAL AFFE; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Fleming Stephen M, 2014, Front Hum Neurosci, V8, P443, DOI 10.3389/fnhum.2014.00443; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Heberlein AS, 2009, EMOT REV, V1, P162, DOI 10.1177/1754073908100441; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JACOBS DH, 1995, NEUROLOGY, V45, P1696, DOI 10.1212/WNL.45.9.1696; KATSIKITIS M, 1991, J NERV MENT DIS, V179, P683, DOI 10.1097/00005053-199111000-00006; MADELEY P, 1995, BEHAV NEUROL, V8, P115, DOI 10.3233/BEN-1995-8207; Marsili L, 2014, PARKINSONISM RELAT D, V20, P370, DOI 10.1016/j.parkreldis.2014.01.013; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Ricciardi L, 2015, J NEUROL SCI, V358, P125, DOI 10.1016/j.jns.2015.08.1516; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Simons G, 2004, J INT NEUROPSYCH SOC, V10, P521, DOI 10.1017/S135561770410413X; Smith M C, 1996, J Int Neuropsychol Soc, V2, P383; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trinkler I, 2013, CORTEX, V49, P549, DOI 10.1016/j.cortex.2011.12.003	35	64	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169110	10.1371/journal.pone.0169110	http://dx.doi.org/10.1371/journal.pone.0169110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WO	28068393	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000391843900020
J	Sarabia-Cobo, CM; Paras-Bravo, P; Amo-Setien, FJ; Alconero-Camarero, AR; Saenz-Jalon, M; Torres-Manrique, B; Sarabia-Lavin, R; Fernandez-Rodriguez, A; Silio-Garcia, T; Fernandez-Pena, R; Paz-Zulueta, M; Santibanez-Marguello, M				Sarabia-Cobo, Carmen M.; Paras-Bravo, Paula; Jose Amo-Setien, Francisco; Rosa Alconero-Camarero, Ana; Saenz-Jalon, Maria; Torres-Manrique, Blanca; Sarabia-Lavin, Raquel; Fernandez-Rodriguez, Angela; Silio-Garcia, Tamara; Fernandez-Pena, Rosario; Paz-Zulueta, Maria; Santibanez-Marguello, Miguel			Validation of the Spanish Version of the ICECAP-O for Nursing Home Residents with Dementia	PLOS ONE			English	Article							OLDER-PEOPLE; LIFE; EQ-5D; MANAGEMENT; CAREGIVERS; VALIDITY; ADULTS; RISK	Background Measurement of health-related quality of life (HRQoL) is important for a chronic disease, such as dementia, which impairs the quality of life of affected patients in addition to their length of life. This is important in the context of economic evaluations when interventions do not (only) affect HRQoL and these other factors also affect overall quality of life. Objective To validate the Spanish translation of the ICECAP-O's capability to measure Health-related quality of life in elderly with dementia who live in nursing homes. Method Cross-sectional study. For 217 residents living in 8 Spanish nursing homes, questionnaires were completed by nursing professionals serving as proxy respondents. We analyzed the internal consistency and other psychometric properties. We investigated the convergent validity of the ICECAP-O with other HRQoL instruments, the EQ-5D extended with a cognitive dimension (EQ-5D+C), the Alzheimer's Disease Related Quality of Life (ADRQL) measures, and the Barthel Index measure of activities of daily living (ADL). Results The ICECAP-O presents satisfactory internal consistency (alpha 0.820). The factorial analysis indicated a structure of five principal dimensions that explain 66.57% of the total variance. Convergent validity between the ICECAP-O, EQ-5D+C, ADRQL, and Barthel Index scores was moderate to good (with correlations of 0.62, 0.61, and 0.68, respectively), but differed between dimensions of the instruments. Discriminant validity was confirmed by finding differences in ICECAP-O scores between subgroups based on ADL scores (0.70 low, 0.59 medium, and 0.39 high level care), dementia severity (0.72 mild, 0.63 medium, and 0.50 severe), and ages (0.59 below 75 years and 0.84 above 75 years). Conclusions This study presented the first use of a Spanish version of the ICECAP-O. The results indicate that the ICECAP-O appears to be a reliable Health-related quality of life measurement instrument showing good convergent and discriminant validity for people with dementia.	[Sarabia-Cobo, Carmen M.; Paras-Bravo, Paula; Jose Amo-Setien, Francisco; Rosa Alconero-Camarero, Ana; Saenz-Jalon, Maria; Torres-Manrique, Blanca; Sarabia-Lavin, Raquel; Fernandez-Rodriguez, Angela; Silio-Garcia, Tamara; Fernandez-Pena, Rosario; Paz-Zulueta, Maria; Santibanez-Marguello, Miguel] Univ Cantabria, Dept Nursing, Cantabria, Spain	Universidad de Cantabria	Sarabia-Cobo, CM (corresponding author), Univ Cantabria, Dept Nursing, Cantabria, Spain.	carmen.sarabia@unican.es	Santibanez, Miguel/L-3323-2017; Fernández-Peña, Rosario/AAN-2494-2020; Parás-Bravo, Paula/AAC-7250-2020; Sarabia-Cobo, Carmen M/T-8293-2019	Santibanez, Miguel/0000-0003-2634-615X; Fernández-Peña, Rosario/0000-0002-6830-6001; Parás-Bravo, Paula/0000-0001-7745-3006; Sarabia-Cobo, Carmen M/0000-0002-7929-4042; SAENZ JALON, MARIA/0000-0002-5476-0350; Sarabia-Lavin, Raquel/0000-0003-3679-4327				Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Bleijlevens MHC, 2015, J ADV NURS, V71, P1378, DOI 10.1111/jan.12561; Bosboom PR, 2012, DEMENT GER COGN D EX, V2, P361, DOI 10.1159/000342172; Bowling A, 2015, AGING MENT HEALTH, V19, P13, DOI 10.1080/13607863.2014.915923; Bulamu NB, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0372-8; Coast J, 2008, J HEALTH SERV RES PO, V13, P31, DOI 10.1258/jhsrp.2008.008024; Coast J, 2008, QUAL LIFE RES, V17, P967, DOI 10.1007/s11136-008-9372-z; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Coast J, 2008, HEALTH ECON, V17, P667, DOI 10.1002/hec.1359; Couzner L, 2012, INT J PUBLIC HEALTH, P1; Davis JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153878; Davis JC, 2013, QUAL LIFE RES, V22, P969, DOI 10.1007/s11136-012-0225-4; Davis JC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-65; de Hoyos-Alonso MC, 2016, NEUROLOGIA, V31, P1, DOI 10.1016/j.nrl.2014.08.008; Diaz-Redondo A, 2014, GERIATR GERONTOL INT, V14, P346, DOI 10.1111/ggi.12108; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gitlin LN, 2012, JAMA-J AM MED ASSOC, V308, P2020, DOI 10.1001/jama.2012.36918; HERCE J. A., 2016, CUADERNOS INFORM EC, V251, P39; Herrmann N, 2008, CAN MED ASSOC J, V179, P1279, DOI 10.1503/cmaj.070804; Hoefman R, THESIS; Hounsome N, 2011, VALUE HEALTH, V14, P390, DOI 10.1016/j.jval.2010.08.002; Kasper JD, 2009, ALZ DIS ASSOC DIS, V23, P275, DOI 10.1097/WAD.0b013e31819b02bc; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Leon-Salas B, 2011, ARCH GERONTOL GERIAT, V53, P13, DOI 10.1016/j.archger.2010.05.021; Levy H, 2016, MANAGE SCI, V62, P1415, DOI 10.1287/mnsc.2015.2184; Lopez Mongil Rosa, 2009, Rev Esp Geriatr Gerontol, V44, P5, DOI 10.1016/j.regg.2008.06.001; MAHONEY F I, 1965, Md State Med J, V14, P61; Makai P, 2014, SOC SCI MED, V102, P83, DOI 10.1016/j.socscimed.2013.11.050; Makai P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092016; Makai P, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-57; Makai P, 2012, QUAL LIFE RES, V21, P801, DOI 10.1007/s11136-011-9997-1; Milte CM, 2014, APPL HEALTH ECON HEA, V12, P73, DOI 10.1007/s40258-013-0068-3; Pusswald G, 2015, J ALZHEIMERS DIS, V47, P479, DOI 10.3233/JAD-150284; Rabins PV, 1999, J MENTAL HLTH AGING, V5; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661; Rista PM, 2016, ARCH GERONTOL GERIAT, V65, P140, DOI 10.1016/j.archger.2016.03.016; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Tabali M, 2015, J GERONTOLOGY GERIAT, V4, P239; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; van Leeuwen KM, 2015, VALUE HEALTH, V18, P35, DOI 10.1016/j.jval.2014.09.006; Wimo A, 2010, WORLD ALZHEIMER REPO; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	42	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169354	10.1371/journal.pone.0169354	http://dx.doi.org/10.1371/journal.pone.0169354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WO	28068375	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900027
J	Crooks, L; Guo, Y				Crooks, Lucy; Guo, Yuanmei			Consequences of Epistasis on Growth in an Erhualian x White Duroc Pig Cross	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RESOURCE POPULATION; GENE INTERACTIONS; PORCINE GENOME; OUTBRED LINES; ANCIENT DNA; SUS-SCROFA; QTL; INTERCROSS; FATNESS	Epistasis describes an interaction between the effects of loci. We included epistasis in quantitative trait locus (QTL) mapping of growth at a series of ages in a cross of a Chinese pig breed, Erhualian, with a commercial line, White Duroc. Erhualian pigs have much lower growth rates than White Duroc. We improved a method for genomewide testing of epistasis and present a clear analysis workflow. We also suggest a new approach for interpreting epistasis results where significant additive and dominance effects of a locus in specific backgrounds are determined. In total, seventeen QTL were found and eleven showed epistasis. Loci on chromosomes 2, 3, 4 and 7 were highlighted as affecting growth at more than one age or forming an interaction network. Epistasis resulted in both the QTL on chromosomes 3 and 7 having effects in opposite directions. We believe it is the first time for the chromosome 7 locus that an allele from a Chinese breed has been found to decrease growth. The consequences of epistasis were diverse. Results were impacted by using growth rather than body weight as the phenotype and by correcting for an effect of mother. Epistasis made a considerable contribution to growth in this population and modelling epistasis was important for accurately determining QTL effects.	[Crooks, Lucy; Guo, Yuanmei] Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang, Jiangxi, Peoples R China; [Crooks, Lucy] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Crooks, Lucy] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England	Jiangxi Agricultural University; Swedish University of Agricultural Sciences; Sheffield Children's NHS Foundation Trust	Guo, Y (corresponding author), Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang, Jiangxi, Peoples R China.	gyuanmei@hotmail.com			National Natural Science Foundation of China [31460590]; Swedish Foundation for Strategic Research [DNR F06-0029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	YG was funded by the National Natural Science Foundation of China (31460590, http://www.nsfc.gov.cn/publish/portal1). LC was funded for part of this work by a Future Research Leader grant from the Swedish Foundation for Strategic Research to Orjan Carlborg (DNR F06-0029, http://stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2012, ANIM GENET, V43, P383, DOI 10.1111/j.1365-2052.2011.02282.x; Beeckmann P, 2003, J ANIM BREED GENET, V120, P20, DOI 10.1046/j.0931-2668.2003.00420.x; Bidanel JP, 2001, GENET SEL EVOL, V33, P289, DOI 10.1051/gse:2001120; Carlborg O, 2000, GENETICS, V155, P2003; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Carlborg O, 2002, GENET RES, V79, P175, DOI 10.1017/S001667230200558X; Carlborg R, 2004, GENET RES, V83, P197, DOI 10.1017/S0016672304006779; Cheverud J. M, 2000, EPISTASIS EVOLUTIONA, P58; CHURCHILL GA, 1994, GENETICS, V138, P963; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Crooks L, 2011, G3-GENES GENOM GENET, V1, P57, DOI 10.1534/g3.111.000109; de Koning DJ, 2001, LIVEST PROD SCI, V72, P185, DOI 10.1016/S0301-6226(01)00226-3; GREEN PE, 1994, PRICING STRATEGY PRA, V2, P4; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1994, GENETICS, V136, P1195; HOLM S, 1979, SCAND J STAT, V6, P65; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lopez S, 2000, J ANIM SCI, V78, P1816; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Mohrmann M, 2006, ANIM GENET, V37, P435, DOI 10.1111/j.1365-2052.2006.01492.x; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Rohrer GA, 2000, J ANIM SCI, V78, P2547; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Routman EJ, 1997, EVOLUTION, V51, P1654, DOI 10.1111/j.1558-5646.1997.tb01488.x; USDA, 2015, SWIN 2012 BAS REF 1; Varona L, 2002, GENET RES, V80, P145, DOI 10.1017/S0016672302005803; Wahlberg P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-248; Walling GA, 2000, GENETICS, V155, P1369; Wei WH, 2011, ANIM GENET, V42, P15, DOI 10.1111/j.1365-2052.2010.02082.x; Wei WH, 2011, ANIM GENET, V42, P83, DOI 10.1111/j.1365-2052.2010.02062.x; Wei WH, 2010, HEREDITY, V104, P401, DOI 10.1038/hdy.2009.129; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhang ZY, 2009, J ANIM SCI, V87, P3458, DOI 10.2527/jas.2008-1694	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0162045	10.1371/journal.pone.0162045	http://dx.doi.org/10.1371/journal.pone.0162045			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060815	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000391641500002
J	Gervasio, S; Voigt, M; Kersting, UG; Farina, D; Sinkjaer, T; Mrachacz-Kersting, N				Gervasio, Sabata; Voigt, Michael; Kersting, Uwe G.; Farina, Dario; Sinkjaer, Thomas; Mrachacz-Kersting, Natalie			Sensory Feedback in Interlimb Coordination: Contralateral Afferent Contribution to the Short-Latency Crossed Response during Human Walking	PLOS ONE			English	Article							TRICEPS SURAE MUSCLES; HUMAN SOLEUS MUSCLE; LAMINA-VIII INTERNEURONS; CENTRAL-NERVOUS-SYSTEM; HETEROGENIC REFLEXES; HUMAN LOCOMOTION; GASTROCNEMIUS-MUSCLE; CAT; REVERSAL; GAIT	A constant coordination between the left and right leg is required to maintain stability during human locomotion, especially in a variable environment. The neural mechanisms underlying this interlimb coordination are not yet known. In animals, interneurons located within the spinal cord allow direct communication between the two sides without the need for the involvement of higher centers. These may also exist in humans since sensory feedback elicited by tibial nerve stimulation on one side (ipsilateral) can affect the muscles activation in the opposite side (contralateral), provoking short-latency crossed responses (SLCRs). The current study investigated whether contralateral afferent feedback contributes to the mechanism controlling the SLCR in human gastrocnemius muscle. Surface electromyogram, kinematic and kinetic data were recorded from subjects during normal walking and hybrid walking (with the legs moving in opposite directions). An inverse dynamics model was applied to estimate the gastrocnemius muscle proprioceptors' firing rate. During normal walking, a significant correlation was observed between the magnitude of SLCRs and the estimated muscle spindle secondary afferent activity (P = 0.04). Moreover, estimated spindle secondary afferent and Golgi tendon organ activity were significantly different (P <= 0.01) when opposite responses have been observed, that is during normal (facilitation) and hybrid walking (inhibition) conditions. Contralateral sensory feedback, specifically spindle secondary afferents, likely plays a significant role in generating the SLCR. This observation has important implications for our understanding of what future research should be focusing on to optimize locomotor recovery in patient populations.	[Gervasio, Sabata; Voigt, Michael; Kersting, Uwe G.; Sinkjaer, Thomas; Mrachacz-Kersting, Natalie] Aalborg Univ, Ctr Sensory Motor Interact SMI, Dept Hlth Sci & Technol, Aalborg, Denmark; [Farina, Dario] Imperial Coll London, Dept Bioengn, London, England; [Sinkjaer, Thomas] Villum Fonden, Soborg, Denmark	Aalborg University; Imperial College London; Villum Fonden	Mrachacz-Kersting, N (corresponding author), Aalborg Univ, Ctr Sensory Motor Interact SMI, Dept Hlth Sci & Technol, Aalborg, Denmark.	nm@hst.aau.dk	Kersting, Uwe/AAS-6693-2021; Mrachacz-Kersting, Natalie/AAE-5064-2020; Farina, Dario/AAB-2648-2019	Mrachacz-Kersting, Natalie/0000-0003-2814-5351; Gervasio, Sabata/0000-0001-6649-7150; Kersting, Uwe G/0000-0001-9373-2080	Obel Family Foundation; Spar Nord Fonden; European Union [600698]; Obelske Familiefonden; Det Frie Forskningsrad [10-082524]	Obel Family Foundation; Spar Nord Fonden; European Union(European Commission); Obelske Familiefonden; Det Frie Forskningsrad(Det Frie Forskningsrad (DFF))	This study was supported by the Obel Family Foundation, the Spar Nord Fonden and by the European Union FP7 program under the project H2R (grant agreement no 600698). Obelske Familiefonden (grant number n/a) provided funding for purchase of equipment used during data collection. Det Frie Forskningsrad (grant agreement no 10-082524) provided funding for purchase of equipment used during data collection. The European Union FP7 program under the project H2R (grant agreement no 600698) provided funding for purchase of equipment used during data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A special thank you to Professor TR Nichols for his valuable comments and for sharing his knowledge. This study was supported by the Obel Family Foundation, the Spar Nord Fonden and by the European Union FP7 program under the project H2R (grant agreement no 600698).	Albracht K, 2008, J BIOMECH, V41, P2211, DOI 10.1016/j.jbiomech.2008.04.020; Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; BERGER W, 1984, J PHYSIOL-LONDON, V357, P109, DOI 10.1113/jphysiol.1984.sp015492; BONASERA SJ, 1994, J NEUROPHYSIOL, V71, P1096, DOI 10.1152/jn.1994.71.3.1096; BROOKE JD, 1985, ELECTROEN CLIN NEURO, V60, P39, DOI 10.1016/0013-4694(85)90949-6; Chin NK, 1962, S MUSCL REC, P241; Cram J, 1998, INTRO SURFACE ELECTR; Cronin NJ, 2009, J PHYSIOL-LONDON, V587, P3375, DOI 10.1113/jphysiol.2008.162610; Cronin NJ, 2009, MUSCLE TENDON STRETC; DIENER HC, 1983, EXP BRAIN RES, V52, P423; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; DIETZ V, 1984, NEUROSCI LETT, V50, P181, DOI 10.1016/0304-3940(84)90483-X; DIETZ V, 1985, EXP BRAIN RES, V61, P153; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; DUYSENS J, 1980, BRAIN RES, V197, P538, DOI 10.1016/0006-8993(80)91143-9; Eccles BJC, 1957, J PHYSL, V137, P22; ECCLES J. C., 1964, PROGR BRAIN RES, V12, P65, DOI 10.1016/S0079-6123(08)60618-4; Edgley SA, 2003, J PHYSIOL-LONDON, V552, P961, DOI 10.1113/jphysiol.2003.048009; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gervasio S, 2015, J NEUROPHYSIOL; Gervasio S, 2013, J NEUROPHYSIOL, V109, P2335, DOI 10.1152/jn.01086.2012; Grieve D, 1978, PREDICTION GASTROCNE, P205; GRILLNER S, 1978, BRAIN RES, V144, P411, DOI 10.1016/0006-8993(78)90169-5; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Higham TE, 2008, BIOL LETTERS, V4, P41, DOI 10.1098/rsbl.2007.0472; Honeycutt CF, 2012, J NEUROPHYSIOL, V108, P1253, DOI 10.1152/jn.00929.2011; Huijing PA, 1985, CELLS TISSUES ORGANS, V123, P101; Hultborn H, 2001, J PHYSIOL-LONDON, V533, P5, DOI 10.1111/j.1469-7793.2001.0005b.x; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Kawakami Y, 2000, J APPL BIOMECH, V16, P88, DOI 10.1123/jab.16.1.88; Kersting UK, 2008, CLIN BIOMECH, V23, P701; Kurihara T., 2005, INT J SPORT HLTH SCI, V3, P226, DOI DOI 10.5432/ijshs.3.226; Lichtwark GA, 2007, J BIOMECH, V40, P157, DOI 10.1016/j.jbiomech.2005.10.035; Lundberg A, 1985, EUR J PHYSL S, V403, pR53; Maas H, 2009, J PHYSIOL-LONDON, V587, P13, DOI 10.1113/jphysiol.2008.165555; Magnus R, 1910, PFLUG ARCH GES PHYS, V134, P545, DOI 10.1007/BF01680321; Magnus R, 1909, MITTEILUNG PFLIIGERS, V130, P219; Mazzaro N, 2005, J NEUROPHYSIOL, V93, P167, DOI 10.1152/jn.00283.2004; Mazzaro N, 2006, EXP BRAIN RES, V173, P713, DOI 10.1007/s00221-006-0451-5; MEUNIER S, 1990, J PHYSIOL-LONDON, V423, P661, DOI 10.1113/jphysiol.1990.sp018046; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; Mileusnic MP, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036001; NAFTCHI NE, 1982, SCIENCE, V217, P1042, DOI 10.1126/science.6126002; NICHOLS TR, 1991, J NEUROPHYSIOL, V66, P1139, DOI 10.1152/jn.1991.66.4.1139; Nichols TR, 1999, J NEUROPHYSIOL, V81, P467, DOI 10.1152/jn.1999.81.2.467; Nielsen JB, 2002, ADV EXP MED BIOL, V508, P369; PEARSON KG, 1993, J NEUROPHYSIOL, V70, P1009, DOI 10.1152/jn.1993.70.3.1009; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; POPPELE RE, 1974, BRAIN RES, V75, P316, DOI 10.1016/0006-8993(74)90753-7; Prochazka A, 1998, J PHYSIOL-LONDON, V507, P293, DOI 10.1111/j.1469-7793.1998.293bu.x; ROSSIGNOL S, 1980, BRAIN RES, V182, P31, DOI 10.1016/0006-8993(80)90828-8; Rossignol S, 1977, SOC NEUR ABSTR; Schafer R.C., 1983, CLIN BIOMECHANICS MU; SCHMIDT RF, 1971, ERG PHYSIOL BIOL CH, V63, P20, DOI 10.1007/BFb0047741; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; SPOOR CW, 1991, EUR J MORPHOL, V29, P137; Stein RB, 2000, J PHYSIOL-LONDON, V525, P781, DOI 10.1111/j.1469-7793.2000.00781.x; Stubbs PW, 2011, MUSCLE NERVE, V43, P845, DOI 10.1002/mus.21964; Stubbs PW, 2011, J NEUROPHYSIOL, V105, P503, DOI 10.1152/jn.00786.2010; Stubbs PW, 2009, J NEUROPHYSIOL, V102, P3596, DOI 10.1152/jn.00667.2009; Voigt M, 1998, ACTA PHYSIOL SCAND, V163, P181; VONUEXKULL J, 1904, ERGEBN PHYSL, V3, P1; Voss VH, 1971, ANAT ANZEIGER, V129, P562; Wickiewicz T, 1983, CLIN ORTHOP RELAT RE, V179; Wilmink RJH, 2003, J NEUROPHYSIOL, V90, P2310, DOI 10.1152/jn.00833.2002; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1	72	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168557	10.1371/journal.pone.0168557	http://dx.doi.org/10.1371/journal.pone.0168557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060839	gold, Green Published			2022-12-26	WOS:000391641500035
J	Jauw, YWS; Zijlstra, JM; de Jong, D; Vugts, DJ; Zweegman, S; Hoekstra, OS; van Dongen, GAMS; Huisman, MC				Jauw, Yvonne W. S.; Zijlstra, Josee M.; de Jong, Daphne; Vugts, Danielle J.; Zweegman, Sonja; Hoekstra, Otto S.; van Dongen, Guus A. M. S.; Huisman, Marc C.			Performance of Zr-89-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma	PLOS ONE			English	Article							IMMUNO-PET; MONOCLONAL-ANTIBODIES; BIFUNCTIONAL CHELATE; RADIATION-DOSIMETRY; RESPONSE ASSESSMENT; TRACER; ZIRCONIUM-89; THERAPY	Purpose Treatment of patients with diffuse large B cell lymphoma (DLBCL) includes rituximab, an anti-CD20 monoclonal antibody (mAb). Insufficient tumor targeting might cause therapy failure. Tumor uptake of (89)Zirconium (Zr-89)-mAb is a potential imaging biomarker for tumor targeting, since it depends on target antigen expression and accessibility. The aim of this pilot study was to describe the performance of Zr-89-labeled-rituximab-PET to assess CD20 targeting in patients with relapsed/refractory DLBCL. Methods Six patients with biopsy-proven DLBCL were included. CD20 expression was assessed using immunohistochemistry (IHC). 74 MBq Zr-89-rituximab (10 mg) was administered after the therapeutic dose of rituximab. Immuno-PET scans on day 0, 3 and 6 post injection (D0, D3 and D6 respectively) were visually assessed and quantified for tumor uptake. Results Tumor uptake of Zr-89-rituximab and CD20 expression were concordant in 5 patients: for one patient, both were negative, for the other four patients visible tumor uptake was concordant with CD20-positive biopsies. Intense tumor uptake of Zr-89-rituximab on PET (SUVpeak = 12.8) corresponded with uniformly positive CD20 expression on IHC in one patient. Moderate tumor uptake of Zr-89-rituximab (range SUVpeak = 3.2-5.4) corresponded with positive CD20 expression on IHC in three patients. In one patient tumor uptake of Zr-89-rituximab was observed (SUVpeak = 3.8), while the biopsy was CD20-negative. Conclusions This study suggests a positive correlation between tumor uptake of Zr-89-rituximab and CD20 expression in tumor biopsies, but further studies are needed to confirm this. This result supports the potential of Zr-89-rituximab-PET as an imaging biomarker for CD20 targeting. For clinical application of 89Zr-rituximab-PET to guide individualized treatment, further studies are required to assess whether tumor targeting is related to clinical benefit of rituximab treatment in individual patients.	[Jauw, Yvonne W. S.; Zijlstra, Josee M.; Zweegman, Sonja] Vrije Univ Amsterdam, Dept Hematol, Med Ctr, Amsterdam, Netherlands; [de Jong, Daphne] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Vugts, Danielle J.; Hoekstra, Otto S.; van Dongen, Guus A. M. S.; Huisman, Marc C.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Jauw, YWS (corresponding author), Vrije Univ Amsterdam, Dept Hematol, Med Ctr, Amsterdam, Netherlands.	yws.jauw@vumc.nl		Zweegman, Sonja/0000-0002-5011-1820; Hoekstra, Otto S/0000-0003-0767-2734; van Dongen, Guus/0000-0001-5939-9851	Dutch Cancer Society [VU 2013-5839]	Dutch Cancer Society(KWF Kankerbestrijding)	This research was financially supported by the Dutch Cancer Society (grant VU 2013-5839 to YJ), https://www.kwf.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; de Jong D, 2007, J CLIN ONCOL, V25, P805, DOI 10.1200/JCO.2006.09.4490; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Gaykema SBM, 2013, J NUCL MED, V54, P1014, DOI 10.2967/jnumed.112.117218; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Lamberts LE, 2016, CLIN CANCER RES, V22, P1642, DOI 10.1158/1078-0432.CCR-15-1272; Lamberts LE, 2015, J CLIN ONCOL, V33, P1491, DOI 10.1200/JCO.2014.57.8278; Makris NE, 2014, J NUCL MED, V55, P264, DOI 10.2967/jnumed.113.130112; Muylle K, 2015, EUR J NUCL MED MOL I, V42, P1304, DOI 10.1007/s00259-015-3025-6; NADLER SB, 1962, SURGERY, V51, P224; Natarajan A, 2015, MOL IMAGING BIOL, V17, P539, DOI 10.1007/s11307-014-0810-8; Natarajan A, 2013, MOL IMAGING BIOL, V15, P468, DOI 10.1007/s11307-013-0624-0; Natarajan A, 2012, BIOCONJUGATE CHEM, V23, P1221, DOI 10.1021/bc300039r; Perk LR, 2010, EUR J NUCL MED MOL I, V37, P250, DOI 10.1007/s00259-009-1263-1; Rizvi SNF, 2012, EUR J NUCL MED MOL I, V39, P512, DOI 10.1007/s00259-011-2008-5; Verel I, 2003, J NUCL MED, V44, P1271; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13	19	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169828	10.1371/journal.pone.0169828	http://dx.doi.org/10.1371/journal.pone.0169828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060891	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500140
J	Larsen, FB; Pedersen, MH; Friis, K; Glumer, C; Lasgaard, M				Larsen, Finn Breinholt; Pedersen, Marie Hauge; Friis, Karina; Glumer, Charlotte; Lasgaard, Mathias			A Latent Class Analysis of Multimorbidity and the Relationship to Socio-Demographic Factors and Health-Related Quality of Life. A National Population-Based Study of 162,283 Danish Adults	PLOS ONE			English	Article							EPIDEMIOLOGY; POLYPHARMACY; COMORBIDITY; ASSOCIATION; CLUSTERS; PATTERNS; CARE	Objectives To identify patterns of multimorbidity in the general population and examine how these patterns are related to socio-demographic factors and health-related quality of life. Study design and setting We used latent class analysis to identify subgroups with statistically distinct and clinically meaningful disease patterns in a nationally representative sample of Danish adults (N = 162,283) aged 16+ years. The analysis was based on 15 chronic diseases. Results Seven classes with different disease patterns were identified: a class with no or only a single chronic condition (59% of the population) labeled "1) Relatively Healthy" and six classes with a very high prevalence of multimorbidity labeled; "2) Hypertension" (14%); "3) Musculoskeletal Disorders" (10%); "4) Headache-Mental Disorders" (7%); "5) Asthma-Allergy" (6%); "6) Complex Cardiometabolic Disorders" (3%); and "7) Complex Respiratory Disorders" (2%). Female gender was associated with an increased likelihood of belonging to any of the six multimorbidity classes except for class 2 (Hypertension). Low educational attainment predicted membership of all of the multimorbidity classes except for class 5 (Asthma Allergy). Marked differences in health-related quality of life between the seven latent classes were found. Poor health-related quality of life was highly associated with membership of class 6 (Complex Cardiometabolic Disorders) and class 7 (Complex Respiratory Disorders). Despite different disease patterns, these two classes had nearly identical profiles in relation to health-related quality of life. Conclusion The results clearly support that diseases tend to compound and interact, which suggests that a differentiated public health and treatment approach towards multimorbidity is needed.	[Larsen, Finn Breinholt; Pedersen, Marie Hauge; Friis, Karina; Lasgaard, Mathias] Cent Denmark Reg, DEFACTUM Publ Hlth & Hlth Serv Res, Aarhus, Denmark; [Glumer, Charlotte] Glostrup Univ Hosp, Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Lasgaard, Mathias] Southern Univ Denmark, Dept Psychol, Odense, Denmark	University of Copenhagen; University of Southern Denmark	Larsen, FB (corresponding author), Cent Denmark Reg, DEFACTUM Publ Hlth & Hlth Serv Res, Aarhus, Denmark.	Finn.Breinholt@stab.rm.dk		Lasgaard, Mathias/0000-0001-5808-8883	Capital Region; Region Zealand; South Denmark Region; Central Denmark Region; North Denmark Region; Ministry of Interior and Health; National Institute of Public Health, University of Southern Denmark	Capital Region; Region Zealand; South Denmark Region; Central Denmark Region; North Denmark Region; Ministry of Interior and Health; National Institute of Public Health, University of Southern Denmark	The Danish National Health Survey was funded by The Capital Region, Region Zealand, The South Denmark Region, The Central Denmark Region, The North Denmark Region, The Ministry of Interior and Health and the National Institute of Public Health, University of Southern Denmark. The present study (based on secondary data analysis) was funded by The Central Denmark Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bakk Z, 2013, SOCIOL METHODOL, V43, P272, DOI 10.1177/0081175012470644; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bartholomew D, 2011, WILEY SER PROBAB ST, P1, DOI 10.1002/9781119970583; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Brzostek D, 2014, POSTEP DERM ALERGOL, V31, P372, DOI 10.5114/pdia.2014.47120; Buratta V., 2003, EUROHIS DEV COMMON I, P21; Christensen AI, 2010, SCAND J PUBLIC HEALT, V2012, P391, DOI DOI 10.1177/1403494812451412; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Dayton C. M., 1999, LATENT CLASS SCALING; Duijts L, 2014, EUR J EPIDEMIOL, V29, P871, DOI 10.1007/s10654-014-9981-5; Everitt BS, 2011, CLUSTER ANAL, DOI [10.1002/9780470977811, DOI 10.1002/9780470977811]; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Friis K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150404; Gallacher KI, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0151-0; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Green MJ, 2014, J CLIN EPIDEMIOL, V67, P1157, DOI 10.1016/j.jclinepi.2014.05.005; Hagenaars JA, 2009, APPL LATENT CLASS AN; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; IOM (Institute of Medicine), 2014, CHRON MULT ILLN GULF; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Kuwornu JP, 2014, CHRON DIS INJ CAN, V34, P218; Masyn K. E., 2013, OXFORD HDB QUANTITAT, V2, P551, DOI DOI 10.1093/OXFORDHB/9780199934898.013.0025; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Parchman ML., 2007, APPL MULTIVAR RES, V12, P163, DOI [DOI 10.22329/AMR.V12I3.658, 10.22329/amr.v12i3.658]; Poblador-Plou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100375; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Richardson K, 2011, DRUG AGING, V28, P547, DOI 10.2165/11592000-000000000-00000; Sarndal CE, 2005, WILEY SER SURV METH, P1; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schuz B, 2009, APPL PSYCHOL-HLTH WE, V1, P23, DOI 10.1111/j.1758-0854.2009.01004.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Smith SM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-6; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Strauss VY, 2014, J CLIN EPIDEMIOL, V67, P1163, DOI 10.1016/j.jclinepi.2014.06.003; Swartz JA, 2011, J URBAN HEALTH, V88, P700, DOI 10.1007/s11524-011-9554-9; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Vermunt J.K., 2013, TECHNICAL GUIDE LATE; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Ware J., 2009, SEXUAL ABUSE AUSTR N, V2, P2; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a	50	70	70	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169426	10.1371/journal.pone.0169426	http://dx.doi.org/10.1371/journal.pone.0169426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AE	28056050	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100041
J	Zhang, YL; Xue, QY; Pan, GQ; Meng, QH; Tuo, XY; Cai, XM; Chen, ZH; Li, Y; Huang, T; Duan, XC; Duan, Y				Zhang, Yanliang; Xue, Qiuyue; Pan, Guoqing; Meng, Qing H.; Tuo, Xiaoyu; Cai, Xuemei; Chen, Zhenghui; Li, Ya; Huang, Tao; Duan, Xincen; Duan, Yong			Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China	PLOS ONE			English	Article							MYC; ADENOCARCINOMA; CARCINOMA; TUMORS; MUTATIONS; COMPONENT; PATHWAY; PROTEIN; GROWTH; TP53	Objectives Lung cancer in Xuanwei (LCXW), China, is known throughout the world for its distinctive characteristics, but little is known about its pathogenesis. The purpose of this study was to screen potential novel "driver genes" in LCXW. Methods Genome-wide DNA copy number alterations (CNAs) were detected by array-based comparative genomic hybridization and differentially expressed genes (DEGs) by gene expression microarrays in 8 paired LCXW and non-cancerous lung tissues. Candidate driver genes were screened by integrated analysis of CNAs and DEGs. The candidate genes were further validated by real-time quantitative polymerase chain reaction. Results Large numbers of CNAs and DEGs were detected, respectively. Some of the most frequently occurring CNAs included gains at 5p15.33-p15.32, 5p15.1-p14.3, and 5p14.3-p14.2 and losses at 11q24.3, 21q21.1, 21q22.12-q22.13, and 21q22.2. Integrated analysis of CNAs and DEGs identified 24 candidate genes with frequent copy number gains and concordant upregulation, which were considered potential oncogenes, including CREB3L4, TRIP13, and CCNE2. In addition, the analysis identified 19 candidate genes with a negative association between copy number change and expression change, considered potential tumor suppressor genes, including AHRR, NKD2, and KLF10. One of the most studied oncogenes, MYC, may not play a carcinogenic role in LCXW. Conclusions This integrated analysis of CNAs and DEGs identified several potential novel LCXW-related genes, laying an important foundation for further research on the pathogenesis of LCXW and identification of novel biomarkers or therapeutic targets.	[Zhang, Yanliang; Xue, Qiuyue; Cai, Xuemei; Chen, Zhenghui; Li, Ya; Duan, Yong] Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China; [Zhang, Yanliang; Xue, Qiuyue; Cai, Xuemei; Chen, Zhenghui; Li, Ya; Duan, Yong] Yunnan Inst Lab Diag, Kunming, Yunnan Province, Peoples R China; [Zhang, Yanliang; Xue, Qiuyue; Cai, Xuemei; Chen, Zhenghui; Li, Ya; Duan, Yong] Yunnan Key Lab Lab Med, Kunming, Yunnan Province, Peoples R China; [Pan, Guoqing; Tuo, Xiaoyu] Kunming Med Univ, Dept Pathol, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China; [Meng, Qing H.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA; [Huang, Tao] Kunming Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China; [Duan, Xincen] Univ Wisconsin Parkside, Dept Biol Sci, Somers, WI USA	Kunming Medical University; Kunming Medical University; University of Texas System; UTMD Anderson Cancer Center; Kunming Medical University; University of Wisconsin System; University of Wisconsin Parkside	Duan, Y (corresponding author), Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China.; Duan, Y (corresponding author), Yunnan Inst Lab Diag, Kunming, Yunnan Province, Peoples R China.; Duan, Y (corresponding author), Yunnan Key Lab Lab Med, Kunming, Yunnan Province, Peoples R China.	duanyong7@139.com	Duan, Xincen/GNM-7574-2022; Meng, Q./GSI-6185-2022		National Natural Science Foundation of China [81160292, 81460325, 81660388]; High Level Talents of Health Technology in Yunnan Province [L-201202]; Key Project for Applied Basic Research in Yunnan Province [2014FA014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level Talents of Health Technology in Yunnan Province; Key Project for Applied Basic Research in Yunnan Province	This study was funded by the National Natural Science Foundation of China (Grant numbers: 81160292, 81460325 and 81660388), High Level Talents of Health Technology in Yunnan Province (Grant number: L-201202), and the Key Project for Applied Basic Research in Yunnan Province (Grant number: 2014FA014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5527; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Caldon CE, 2013, CELL CYCLE, V12, P606, DOI 10.4161/cc.23512; Cavaco I, 2013, DRUG METAB PHARMACOK, V28, P519, DOI 10.2133/dmpk.DMPK-13-SC-035; Chang VHS, 2012, AM J PATHOL, V181, P423, DOI 10.1016/j.ajpath.2012.04.025; CHAPMAN RS, 1988, ARCH ENVIRON HEALTH, V43, P180, DOI 10.1080/00039896.1988.9935850; Chen C, 2013, BIOCHEM BIOPH RES CO, V430, P505, DOI 10.1016/j.bbrc.2012.12.006; Chen D, 2015, CANCER LETT, V362, P208, DOI 10.1016/j.canlet.2015.03.041; Chisholm KM, 2015, AM J SURG PATHOL, V39, P294, DOI 10.1097/PAS.0000000000000365; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dong Y, 2015, ONCOTARGET, V6, P22126, DOI 10.18632/oncotarget.4244; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Fasanelli F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10192; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Granville CA, 2003, MUTAT RES-FUND MOL M, V525, P77, DOI 10.1016/S0027-5107(02)00314-7; Hassan NZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092553; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Hung WT, 2013, CHEMOSPHERE, V90, P2358, DOI 10.1016/j.chemosphere.2012.10.026; Inagaki Y, 2008, CANCER GENET CYTOGEN, V180, P30, DOI 10.1016/j.cancergencyto.2007.09.013; Jin W, 2012, MOL CELL BIOL, V32, P50, DOI 10.1128/MCB.06152-11; Keohavong P, 2003, LUNG CANCER-J IASLC, V41, P21, DOI 10.1016/S0169-5002(03)00125-9; Large DJ, 2009, ENVIRON SCI TECHNOL, V43, P9016, DOI 10.1021/es902033j; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043555; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Payton M, 2002, ONCOGENE, V21, P8529, DOI 10.1038/sj.onc.1206035; Qi H, 2002, CANCER RES, V62, P721; Sarholz B, 2008, BIOMETRICAL J, V50, P927, DOI 10.1002/bimj.200810476; Staaf J, 2013, INT J CANCER, V132, P2020, DOI 10.1002/ijc.27879; Sung CO, 2013, CANCER GENET-NY, V206, P145, DOI 10.1016/j.cancergen.2013.04.002; Todorovic-Rakovic N, 2012, CLIN EXP MED, V12, P217, DOI 10.1007/s10238-011-0169-y; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wang Shi-feng, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P822; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Xiao Yize, 2012, Front Med, V6, P388, DOI 10.1007/s11684-012-0233-3; Zhu C, 2008, 3 CHINESE NATL RETRO	37	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169098	10.1371/journal.pone.0169098	http://dx.doi.org/10.1371/journal.pone.0169098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056099	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100020
J	Riverso, M; Montagnani, V; Stecca, B				Riverso, M.; Montagnani, V.; Stecca, B.			KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth	ONCOGENE			English	Article							KRUPPEL-LIKE FACTORS; TUMOR-SUPPRESSOR; SELF-RENEWAL; STEM-CELL; MUTATIONS; CANCER; INDUCTION; GENE; BRAF; PHOSPHORYLATION	Melanoma is the most lethal form of skin cancer and treatment of metastatic melanoma remains challenging. BRAF/MEK inhibitors show only temporary benefit due the occurrence of resistance and immunotherapy is effective only in a subset of patients. To improve patient survival, there is a need to better understand molecular mechanisms that drive melanoma growth and operate downstream of the mitogen activated protein kinase (MAPK) signaling. The Kruppel-like factor 4 (KLF4) is a zinc-finger transcription factor that plays a critical role in embryonic development, stemness and cancer, where it can act either as oncogene or tumor suppressor. KLF4 is highly expressed in post-mitotic epidermal cells, but its role in melanoma remains unknown. Here, we address the function of KLF4 in melanoma and its interaction with the MAPK signaling pathway. We find that KLF4 is highly expressed in a subset of human melanomas. Ectopic expression of KLF4 enhances melanoma cell growth by decreasing apoptosis. Conversely, knock-down of KLF4 reduces melanoma cell proliferation and induces cell death. In addition, depletion of KLF4 reduces melanoma xenograft growth in vivo. We find that the RAS/RAF/MEK/ERK signaling positively modulates KLF4 expression through the transcription factor E2F1, which directly binds to KLF4 promoter. Overall, our data demonstrate the pro-tumorigenic role of KLF4 in melanoma and uncover a novel ERK1/2-E2F1-KLF4 axis. These findings identify KLF4 as a possible new molecular target for designing novel therapeutic treatments to control melanoma growth.	[Riverso, M.; Montagnani, V.; Stecca, B.] Ist Toscano Tumori, Core Res Lab, Viale Pieraccini 6, I-50139 Florence, Italy; [Stecca, B.] Careggi Univ Hosp, Dept Oncol, Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence; Azienda Ospedaliero Universitaria Careggi	Stecca, B (corresponding author), Ist Toscano Tumori, Core Res Lab, Viale Pieraccini 6, I-50139 Florence, Italy.	barbara.stecca@ittumori.it		Stecca, Barbara/0000-0003-1197-1622	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-14184]	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	We thank Lorenzo Borgognoni, Gianni Gerlini (S. Maria Annunziata Hospital, Florence, Italy), Nicola Pimpinelli (Department of Dermatology, University of Florence, Florence, Italy) and Riccardo Gattai (Department of Medical-Surgical Critical Area, General and Oncological Surgery, University of Florence, Florence, Italy) for providing melanoma samples, Laura Poliseno (Istituto Toscano Tumori, Pisa, Italy) for providing SK-Mel-2, SK-Mel-5, SK-Mel-28 melanoma cell lines and pCDNA3.1-BRAF wt and pCDNA3.1-BRAF-V600E plasmids, Rosario Notaro (Istituto Toscano Tumori, Florence, Italy) for providing K562 cells, and Silvia Pietrobono for assistance with FACS analysis. This work was supported by a grant from AIRC (Associazione Italiana per la Ricerca sul Cancro IG-14184) to BS.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brose MS, 2002, CANCER RES, V62, P6997; Camacho-Vanegas O, 2013, FASEB J, V27, P432, DOI 10.1096/fj.12-220319; Cercek A, 2015, INVEST NEW DRUG, V33, P1086, DOI 10.1007/s10637-015-0273-z; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Driscoll B, 1999, J BIOL CHEM, V274, P9463, DOI 10.1074/jbc.274.14.9463; El-Karim EA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-89; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Farrugia MK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.65; FILMUS J, 1994, ONCOGENE, V9, P3627; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Huang Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.433; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Korotayev K, 2008, CELL SIGNAL, V20, P1221, DOI 10.1016/j.cellsig.2008.02.012; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Li H, 2013, CARCINOGENESIS, V34, P2262, DOI 10.1093/carcin/bgt189; Li J, 2012, CARCINOGENESIS, V33, P1239, DOI 10.1093/carcin/bgs143; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Montagnani V, 2016, ONCOTARGET, V7, P30365, DOI 10.18632/oncotarget.8758; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Muthusamy V, 2013, J INVEST DERMATOL, V133, P1827, DOI 10.1038/jid.2013.48; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pandolfi S, 2015, CELL DEATH DIFFER, V22, P2006, DOI 10.1038/cdd.2015.56; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Putzer BM, 2010, EXPERT REV ANTICANC, V10, P1707, DOI 10.1586/ERA.10.153; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2016, CANCER CELL, V29, P324, DOI 10.1016/j.ccell.2016.02.005; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Yang YZ, 2016, CANCER BIOL THER, V17, P422, DOI 10.1080/15384047.2016.1156260; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu T, 2016, CELL DEATH DIFFER, V23, P207, DOI 10.1038/cdd.2015.85; Zhang L, 2016, ONCOTARGET, V7, P30990, DOI 10.18632/oncotarget.8824	60	57	59	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3322	3333		10.1038/onc.2016.481	http://dx.doi.org/10.1038/onc.2016.481			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28068326	Green Published, hybrid			2022-12-26	WOS:000402869800011
J	Wu, HB; Song, C; Zhang, JC; Zhao, JM; Fu, BB; Mao, TC; Zhang, Y				Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong			Melatonin-mediated upregulation of GLUT1 blocks exit from pluripotency by increasing the uptake of oxidized vitamin C in mouse embryonic stem cells	FASEB JOURNAL			English	Article						dehydroascorbic acid; glucose transporter 1; signaling pathway; differentiation	REPROGRAMMING EFFICIENCY; CANCER-CELLS; IMPROVES; EXPRESSION; NANOG	Melatonin and vitamin C are powerful antioxidants that improve the reprogramming efficiency of induced pluripotent stemcells (iPSCs). However, the effects of the combined treatment of vitamin C andmelatonin on the differentiation of embryonic stem cells (ESCs) have not yet been examined. In this study, we showed that melatonin synergizes with vitamin C to derail exit from pluripotency of mouse ESCs. This effect is related to the increased uptake of dehydroascorbate, the oxidized form of vitamin C, through glucose transporter 1 (Glut1) transporter, which in turn, is upregulated by melatonin treatment. Analysis of the cell signaling pathway profiling systems andspecificpathwayinhibitionindicatedthatmelatoninenhancesGlut1 expressionby activating thePI3K/AKT andMAPK/ERK signaling pathways. Our findings provide a theoretical basis for application ofmelatonin in research on ESCs and iPSCs and for further investigation of the effect of combinatorial compounds on cell reprogramming.- Wu, H., Song, C., Zhang, J., Zhao, J., Fu, B., Mao, T., Zhang, Y. Melatonin-mediated upregulation of GLUT1 blocks exit frompluripotency by increasing the uptake of oxidized vitamin C in mouse embryonic stem cells. FASEB J. 31, 1731-1743 (2017). www.fasebj.org	[Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong] Northwest Agr & Forestry A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wu, HB; Zhang, Y (corresponding author), Northwest A&F Univ, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	hbwu029@nwsuaf.edu.cn; zhangy1956@sina.com		Wu, Haibo/0000-0002-5961-2947	Fourth Military Medical University, Xi'an, China; State Key Program of the National Natural Science Foundation of China [31530075]; China Postdoctoral Science Foundation [2016M590978]	Fourth Military Medical University, Xi'an, China; State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Prof. Zhang (Fourth Military Medical University, Xi'an, China) for the support in feeding nude mice and H&E analysis. This work was funded by State Key Program grant 31530075 of the National Natural Science Foundation of China and the China Postdoctoral Science Foundation Grant 2016M590978. The authors declare no conflicts of interest.	Bai CY, 2016, J PINEAL RES, V61, P154, DOI 10.1111/jpi.12334; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calder PC, 2002, BRIT J NUTR, V88, pS165, DOI 10.1079/BJN2002682; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Czesnikiewicz-Guzik M, 2007, J PHYSIOL PHARMACOL, V58, P5; Debolt S, 2007, ANN BOT-LONDON, V99, P3, DOI 10.1093/aob/mcl236; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Esteban MA, 2012, NAT GENET, V44, P366, DOI 10.1038/ng.2222; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gao S, 2013, J PINEAL RES, V55, P31, DOI 10.1111/jpi.12047; Glenister R., 2013, TRANSL GASTROINTEST, V2, P2; Grant SG, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000982; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Kobylecki CJ, 2015, AM J CLIN NUTR, V101, P1135, DOI 10.3945/ajcn.114.104497; Kumar A, 2012, IN VITRO CELL DEV-AN, V48, P625, DOI 10.1007/s11626-012-9556-2; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Matsa E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008921; Nakano M, 2012, ZYGOTE, V20, P199, DOI 10.1017/S0967199411000190; Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tian WH, 2014, J BIOL CHEM, V289, P3339, DOI 10.1074/jbc.M113.538157; Turek FW, 2004, SLEEP MED, V5, P523, DOI 10.1016/j.sleep.2004.07.009; Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wu HB, 2014, STEM CELLS, V32, P166, DOI 10.1002/stem.1523; Yoe YM, 2011, BRAIN RES, V1385, P1, DOI 10.1016/j.brainres.2011.02.047; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang LM, 2013, J PINEAL RES, V54, P24, DOI 10.1111/j.1600-079X.2012.01016.x	41	15	16	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1731	1743		10.1096/fj.201601085R	http://dx.doi.org/10.1096/fj.201601085R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069827				2022-12-26	WOS:000398504300037
J	Audo, R; Hua, C; Hahne, M; Combe, B; Morel, J; Daien, CI				Audo, Rachel; Hua, Charlotte; Hahne, Michael; Combe, Bernard; Morel, Jacques; Daien, Claire I.			Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANNEXIN-V BINDS; APOPTOTIC CELLS; CYTOKINE PRODUCTION; INTERLEUKIN-10; EXPRESSION; MICE; NEUTROPHILS; MODULATION; INDUCTION	B cells can have a regulatory role, mainly mediated by interleukin 10 (IL-10). IL-10 producing B cells (B10 cells) cells remain to be better characterized. Annexin V binds phosphatidylserine (PS), which is externalized during apoptosis. Previous works suggested that B10 cells are apoptotic cells since they bind Annexin V. Others showed that Annexin V binding could also be expressed on viable B cells. We aimed to explore if PS exposure can be a marker of B10 cells and if PS exposure has a functional role on B cell IL-10 production in healthy subjects. We found that B10 cells were significantly more often Annexin V+ than IL-10 non producing B cells. After CpG activation, Annexin V+ B cells differentiated more often into B10 cells than Annexin V-neg B cells. Cell death and early apoptosis were similar between Annexin V+ and Annexin V-neg B cells. PS blockage, using biotinylated AnV and glyburide, decreased B10 cell differentiation. This study showed that B10 cells have an increased PS exposure independently of any apoptotic state. B cells exposing PS differentiate more into B10 cells whereas PS blockage inhibits B10 cells generation. These results strongly suggest a link between PS exposure and B10 cells.	[Audo, Rachel; Hua, Charlotte; Combe, Bernard; Morel, Jacques; Daien, Claire I.] Univ Hosp Ctr Montpellier, Dept Rheumatol, Montpellier, France; [Audo, Rachel; Hua, Charlotte; Hahne, Michael; Combe, Bernard; Morel, Jacques; Daien, Claire I.] IGMM, CNRS, UMR5535, TNF Alpha Family Lab, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Daien, CI (corresponding author), Univ Hosp Ctr Montpellier, Dept Rheumatol, Montpellier, France.	cidaien@gmail.com	Hua, Charlotte/AAD-5344-2019; AUDO, Rachel/AAD-6091-2020	Hua, Charlotte/0000-0002-7437-377X; AUDO, Rachel/0000-0002-0021-5349; Daien, Claire I/0000-0002-7287-9320	UCB Pharma France S.A. (SIRIUS grant); Centre Hospitalier Universitaire Montpellier (France)	UCB Pharma France S.A. (SIRIUS grant); Centre Hospitalier Universitaire Montpellier (France)	This work was funded by UCB Pharma France S.A. (SIRIUS grant) and also supported by the Centre Hospitalier Universitaire Montpellier (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Balkwill F, 2013, TRENDS IMMUNOL, V34, P169, DOI 10.1016/j.it.2012.10.007; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Castejon R, 1999, CYTOMETRY, V38, P224, DOI 10.1002/(SICI)1097-0320(19991015)38:5<224::AID-CYTO4>3.0.CO;2-0; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dillon SR, 2001, J IMMUNOL, V166, P58, DOI 10.4049/jimmunol.166.1.58; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; FERNANDES H, 1995, ONCOL REP, V2, P985; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Hua C., 2016, J AUTOIMMUN; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Lee JH, 2011, YONSEI MED J, V52, P851, DOI 10.3349/ymj.2011.52.5.851; Martin S, 2000, BIOCHEM BIOPH RES CO, V279, P639, DOI 10.1006/bbrc.2000.3980; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Morabito F, 1998, HAEMATOLOGICA, V83, P1046; Noh Joonyong, 2010, Immune Netw, V10, P247, DOI 10.4110/in.2010.10.6.247; Ramachandra S, 1996, J CLIN INVEST, V98, P1788, DOI 10.1172/JCI118978; Ran S, 2005, CLIN CANCER RES, V11, P1551, DOI 10.1158/1078-0432.CCR-04-1645; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; UTSUGI T, 1991, CANCER RES, V51, P3062; Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010; YEN CS, 2001, GENES IMMUN, V2, P239, DOI DOI 10.1038/SJ.GENE.6363773; Yeung MY, 2015, AM J TRANSPLANT, V15, P942, DOI 10.1111/ajt.13087; Yin Y, 2013, CANCER IMMUNOL RES, V1, P256, DOI 10.1158/2326-6066.CIR-13-0073; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169755	10.1371/journal.pone.0169755	http://dx.doi.org/10.1371/journal.pone.0169755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072868	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200043
J	Faltyn, A; Jakubska-Busse, A; Jarzembowski, P; Prockow, J				Faltyn, Anna; Jakubska-Busse, Anna; Jarzembowski, Pawel; Prockow, Jaroslaw			Juncus quartinianus (Juncaceae, sect. Ozophyllum): A Neglected Species from the Horn of Africa and Its Re-Description Based on Morphological SEM Studies	PLOS ONE			English	Article							EGYPT	Juncus quartinianus (Juncaceae sect. Ozophyllum) was described by Richard in 1851 from Ethiopia. Some authors have treated this species as a synonym of J. fontanesii and others as a synonym of J. oxycarpus. Based on morphological analyses of flowers, fruit and seeds, we propose to restore J. quartinianus as a distinct species from both these taxa. Its detailed re-description and an identification key to the morphologically similar species of Juncus sect. Ozophyllum are provided.	[Faltyn, Anna; Prockow, Jaroslaw] Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Inst Biol, Dept Plant Biol, Wroclaw, Poland; [Jakubska-Busse, Anna; Jarzembowski, Pawel] Univ Wroclaw, Fac Biol Sci, Dept Bot, Inst Environm Biol, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Faltyn, A; Prockow, J (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Inst Biol, Dept Plant Biol, Wroclaw, Poland.	anna.faltyn@up.wroc.pl; jaroslaw.prockow@up.wroc.pl	Proćków, Jarosław/B-4832-2017; Jakubska-Busse, Anna/D-6149-2016; Jarzemebowski, Paweł/AAH-1794-2020; Faltyn-Parzymska, Anna/B-7880-2017	Proćków, Jarosław/0000-0003-4100-3438; Jakubska-Busse, Anna/0000-0003-4284-9910; Jarzemebowski, Paweł/0000-0002-7869-7763; Faltyn-Parzymska, Anna/0000-0001-7422-411X	Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology	Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology	The project was supported by the Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology for 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JG, 1902, FLORA TROPICAL AFRIC, V8, P91; Buchenau F., 1880, BOT JB SYST, V1, P104; Buchenau F, 1906, PFLANZENREICH 4, V36, P1; Buchenau F., 1890, BOT JB SYST, V12, P1; CARTER SUSAN, 1965, KEW BULL, V19, P513, DOI 10.2307/4108212; De Laharpe J., 1825, MEM SOC HIST NAT PAR, V3, P89; Dumortier BC, 1827, FLORULA BELGICA OPER; Juffe D., 2015, IUCN RED LIST THREAT; Khalik KNA, 2010, J SYST EVOL, V48, P215, DOI 10.1111/j.1759-6831.2010.00075.x; Kirschner J, 2004, PRESLIA, V76, P371; KIRSCHNER J, 2002, JUNCUS SPECIES PLA 7; Knapp WM, 2008, SYST BOT, V33, P685, DOI 10.1600/036364408786500145; Knapp WM, 2014, PHYTOTAXA, V174, P243, DOI 10.11646/phytotaxa.174.5.1; KUNTH C.S, 1841, ENUMERATION PLANTARU, V3; LinnU CV., 1753, SPECIES PLANTARUM EX, DOI DOI 10.1111/j.1365-294X.2012.05470.x; Richard A., 1851, ENUMERATIO PLANTARUM, V2; ROGL F., 1998, TPSDIG DIGITIZE COOR, V99, P279; StatSoft Inc, 2013, STAT DAT AN SOFTW SY; Weimarck H., 1946, SVENSK BOT TIDSKR, V40, P141	19	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0167838	10.1371/journal.pone.0167838	http://dx.doi.org/10.1371/journal.pone.0167838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068352	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900005
J	Allyn, J; Allou, N; Augustin, P; Philip, I; Martinet, O; Belghiti, M; Provenchere, S; Montravers, P; Ferdynus, C				Allyn, Jerome; Allou, Nicolas; Augustin, Pascal; Philip, Ivan; Martinet, Olivier; Belghiti, Myriem; Provenchere, Sophie; Montravers, Philippe; Ferdynus, Cyril			A Comparison of a Machine Learning Model with EuroSCORE II in Predicting Mortality after Elective Cardiac Surgery: A Decision Curve Analysis	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; REGRESSION	Background The benefits of cardiac surgery are sometimes difficult to predict and the decision to operate on a given individual is complex. Machine Learning and Decision Curve Analysis (DCA) are recent methods developed to create and evaluate prediction models. Methods and finding We conducted a retrospective cohort study using a prospective collected database from December 2005 to December 2012, from a cardiac surgical center at University Hospital. The different models of prediction of mortality in-hospital after elective cardiac surgery, including EuroSCORE II, a logistic regression model and a machine learning model, were compared by ROC and DCA. Of the 6,520 patients having elective cardiac surgery with cardiopulmonary bypass, 6.3% died. Mean age was 63.4 years old (standard deviation 14.4), and mean EuroSCORE II was 3.7 (4.8) %. The area under ROC curve (IC95%) for the machine learning model (0.795 (0.755-0.834)) was significantly higher than EuroSCORE II or the logistic regression model (respectively, 0.737 (0.691-0.783) and 0.742 (0.698-0.785), p < 0.0001). Decision Curve Analysis showed that the machine learning model, in this monocentric study, has a greater benefit whatever the probability threshold. Conclusions According to ROC and DCA, machine learning model is more accurate in predicting mortality after elective cardiac surgery than EuroSCORE II. These results confirm the use of machine learning methods in the field of medical prediction.	[Allyn, Jerome; Allou, Nicolas; Martinet, Olivier; Belghiti, Myriem] Ctr Hosp Univ Felix Guyon, Reanimat Polyvalente, St Denis, France; [Allyn, Jerome; Allou, Nicolas; Augustin, Pascal; Philip, Ivan; Provenchere, Sophie; Montravers, Philippe] CHU Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat, Paris, France; [Philip, Ivan] Inst Mutualiste Montsouris, Dept Anesthesie Reanimat, 42 Blvd Jourdan, Paris, France; [Montravers, Philippe] Univ Paris 07, PRESS Sorbonne Cite, Paris, France; [Ferdynus, Cyril] CHU La Reunion, Unite Soutien Methodol, St Denis, France; [Ferdynus, Cyril] INSERM, CIC 1410, St Pierre, France	CHU Reunion; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm)	Allyn, J (corresponding author), Ctr Hosp Univ Felix Guyon, Reanimat Polyvalente, St Denis, France.; Allyn, J (corresponding author), CHU Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat, Paris, France.	allyn.jer@gmail.com	ferdynus, cyril/AFV-1963-2022	ferdynus, cyril/0000-0003-1502-0672; Allyn, Jerome/0000-0001-8057-0393				Chen T., 2016, XGBOOST EXTREME GRAD; Chhor V, 2010, EUR J ANAESTH, V27, P702, DOI 10.1097/EJA.0b013e32833a45de; Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fitzgerald M, 2015, JAMA-J AM MED ASSOC, V313, P409, DOI 10.1001/jama.2015.37; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hernandez JM, 2014, ANN SURG, V259, P1208, DOI 10.1097/SLA.0000000000000310; Kessler RC, 2016, MOL PSYCHIATR, V21, P1366, DOI 10.1038/mp.2015.198; Kuwaki K, 2015, J CARDIOVASC SURG, V56, P455; Liu NT, 2014, SHOCK, V42, P108, DOI 10.1097/SHK.0000000000000186; MEYER D, 2015, R PACKAGE VERSION, V1, P6; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Rennie J.D., 2003, P 20 INT C MACH LEAR, DOI 10.5555/3041838.3041916; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shahian DM, 2009, ANN THORAC SURG, V88, pS43, DOI 10.1016/j.athoracsur.2009.05.055; Shariat SF, 2011, CANCER-AM CANCER SOC, V117, P2892, DOI 10.1002/cncr.25903; Shigeta K, 2014, WORLD J SURG, V38, P3248, DOI 10.1007/s00268-014-2738-1; Simm J, 2014, EXTRATREES EXTREMELY; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302; Weichenthal S, 2016, ENVIRON RES, V146, P65, DOI 10.1016/j.envres.2015.12.016; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Zastrow S, 2015, WORLD J UROL, V33, P381, DOI 10.1007/s00345-014-1321-6	28	83	87	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169772	10.1371/journal.pone.0169772	http://dx.doi.org/10.1371/journal.pone.0169772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060903	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500136
J	Bermudez, SE; Gottdenker, N; Krishnvajhala, A; Fox, A; Wilder, HK; Gonzalez, K; Smith, D; Lopez, M; Perea, M; Rigg, C; Montilla, S; Calzada, JE; Saldana, A; Caballero, CM; Lopez, JE				Bermudez, Sergio E.; Gottdenker, Nicole; Krishnvajhala, Aparna; Fox, Amy; Wilder, Hannah K.; Gonzalez, Kadir; Smith, Diorene; Lopez, Marielena; Perea, Milixa; Rigg, Chystrie; Montilla, Santiago; Calzada, Jose E.; Saldana, Azael; Caballero, Carlos M.; Lopez, Job E.			Synanthropic Mammals as Potential Hosts of Tick-Borne Pathogens in Panama	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; EXPERIMENTAL-INFECTION; RICKETTSIA-AMBLYOMMII; SAO-PAULO; CANIS; EHRLICHIA; DISEASES; DOGS; TRANSMISSION; PREVALENCE	Synanthropic wild mammals can be important hosts for many vector-borne zoonotic pathogens. The aim of this study was determine the exposure of synanthropic mammals to two types of tick-borne pathogens in Panama, spotted fever group Rickettsia (SFGR) and Borrelia relapsing fever (RF) spirochetes. One hundred and thirty-one wild mammals were evaluated, including two gray foxes, two crab-eating foxes (from zoos), four coyotes, 62 opossum and 63 spiny rats captured close to rural towns. To evaluate exposure to SFGR, serum samples from the animals were tested by indirect immunofluorescence assay (IFA) using Rickettsia rickettsii and Candidatus Rickettsia amblyommii antigen. Immunoblotting was performed using Borrelia turicatae protein lysates and rGIpQ, to assess infection caused by RF spirochetes. One coyote (25%) and 27 (43%) opossums showed seroreactivity to SFGR. Of these opossums, 11 were seroreactive to C. R. amblyommii. Serological reactivity was not detected to B. turicatae in mammal samples. These findings may reflect a potential role of both mammals in the ecology of tick-borne pathogens in Panama.	[Bermudez, Sergio E.] Inst Conmemorat Gorgas Estudios Salud, Dept Invest Entomol Med, Ciudad De Panama, Panama; [Gottdenker, Nicole] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA USA; [Krishnvajhala, Aparna; Fox, Amy; Lopez, Job E.] Baylor Coll Med, Dept Pediat, Sect Trop Med, Houston, TX 77030 USA; [Krishnvajhala, Aparna; Fox, Amy; Lopez, Job E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Gonzalez, Kadir; Perea, Milixa; Rigg, Chystrie; Montilla, Santiago; Calzada, Jose E.; Saldana, Azael] Inst Conmemorat Gorgas Estudios Salud, Dept Invest Parasitol, Ciudad De Panama, Panama; [Smith, Diorene; Lopez, Marielena] Parque Municipal Summit, Ciudad De Panama, Panama; [Caballero, Carlos M.] Nispero, El Valle, Cocle, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; University System of Georgia; University of Georgia; Baylor College of Medicine; Baylor College of Medicine; Instituto Conmemorativo Gorgas de Estudios de la Salud	Bermudez, SE (corresponding author), Inst Conmemorat Gorgas Estudios Salud, Dept Invest Entomol Med, Ciudad De Panama, Panama.	bermudezsec@gmail.com	Gonzalez, Kadir/ABF-9701-2021	Gonzalez, Kadir/0000-0001-7297-1322; Fox, Amy/0000-0002-2321-5499; Gottdenker, Nicole/0000-0002-3499-2410; Lopez, Job/0000-0003-4802-5779; Saldana, Azael/0000-0002-5653-1332; Perea Vasquez, Milixa/0000-0002-9771-9067; Rigg, Chystrie A./0000-0002-2426-6511	Panamanian SENACYT grant [COL11-043]; United States National Institutes of Health grant [AI123652]; Sistema Nacional de Investigacion (SNI-SENACYT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI123652] Funding Source: NIH RePORTER	Panamanian SENACYT grant; United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sistema Nacional de Investigacion (SNI-SENACYT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from Panamanian SENACYT grant, COL11-043 (NG, AS), and the United States National Institutes of Health grant, AI123652 (JEL). AS and JEC received funds of Sistema Nacional de Investigacion (SNI-SENACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GH, 2012, MAMM BIOL, V77, P84, DOI 10.1016/j.mambio.2011.11.008; Apperson CS, 2008, VECTOR-BORNE ZOONOT, V8, P597, DOI 10.1089/vbz.2007.0271; Barrett A, 2014, VECTOR-BORNE ZOONOT, V14, P20, DOI 10.1089/vbz.2013.1325; Bates L. B., 1921, American Journal of Tropical Medicine, V1, P183; Berman S. L., 2016, ENCY ADOLESCENCE, P1; Bermudez CSE, 2011, VET PARASITOL, V177, P134, DOI 10.1016/j.vetpar.2010.11.020; Bermudez-Mongue Y, 2011, SCIENTIA, V21, P7; Bischof R, 2005, J WILDLIFE DIS, V41, P787, DOI 10.7589/0090-3558-41.4.787; BOZEMAN FM, 1967, AM J TROP MED HYG, V16, P48, DOI 10.4269/ajtmh.1967.16.48; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; BREITSCHWERDT EB, 1994, J CLIN MICROBIOL, V32, P352, DOI 10.1128/JCM.32.2.352-357.1994; CALERO C, 1946, AM J TROP MED, V26, P761; CALERO C, 1952, AM J TROP MED HYG, V1, P631, DOI 10.4269/ajtmh.1952.1.631; Calzada JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053289; Cardoso L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0756-y; Castro D Angelica M., 2015, Tropical Medicine and Health, V43, P217, DOI 10.2149/tmh.2015-07; Darling ST, 1909, ARCH INTERN MED, V4, P150; Dasch G, 1993, AM SOC TROP MED H S3, P49; Davis GE, 1941, PUBLIC HEALTH REP, V56, P1799, DOI 10.2307/4583854; De Luca J, 2013, REV MED PANAMA, V34, P40; DERODANICHE EC, 1950, AM J TROP MED, V30, P511; DERODANICHE EC, 1953, AM J TROP MED HYG, V2, P696, DOI 10.4269/ajtmh.1953.2.696; DUNN LAWRENCE H., 1933, AMER JOUR TROP MED, V13, P201; Eremeeva ME, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2008.02638.x; Estripeaut D, 2007, EMERG INFECT DIS, V13, P1763, DOI 10.3201/eid1311.070931; Girard YA, 2012, VECTOR-BORNE ZOONOT, V12, P913, DOI 10.1089/vbz.2011.0858; Gonzalez Kadir, 2015, Tropical Medicine and Health, V43, P75, DOI 10.2149/tmh.2014-30; Horta MC, 2007, MEM I OSWALDO CRUZ, V102, P793, DOI 10.1590/S0074-02762007000700003; Horta MC, 2009, VECTOR-BORNE ZOONOT, V9, P109, DOI 10.1089/vbz.2008.0114; Hurtado LA, 2014, BIOMEDICA, V34, P260, DOI [10.7705/biomedica.v34i2.2133, 10.1590/S0120-41572014000200012]; Jiang J, 2010, VECTOR-BORNE ZOONOT, V10, P329, DOI 10.1089/vbz.2009.0061; Kelly AL, 2014, TICKS TICK-BORNE DIS, V5, P95, DOI 10.1016/j.ttbdis.2013.08.005; Khlyap LA, 2011, RUSSIAN J BIOL INV, V1, P301; Labruna MB, 2007, APPL ENVIRON MICROB, V73, P869, DOI 10.1128/AEM.02249-06; Labruna MB, 2011, REV MVZ CORDOBA, V16, P2435, DOI 10.21897/rmvz.282; Leschnik M, 2012, J ZOO WILDLIFE MED, V43, P645, DOI 10.1638/2011-0224R.1; Levin ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115105; Lopez JE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002454; McFarlane R, 2012, ECOHEALTH, V9, P24, DOI 10.1007/s10393-012-0763-9; Mendez E, 1987, Rev Med Panama, V12, P217; Millan J, 2015, TICKS TICK-BORNE DIS; Morales-Soto F, 2016, ARCH MED VET, V48, P129, DOI 10.4067/S0301-732X2016000100017; Perez A., 2013, Arq. Inst. Biol., V80, P207; Piranda EM, 2008, MEM I OSWALDO CRUZ, V103, P696, DOI 10.1590/S0074-02762008000700012; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; Silveira I, 2015, ZOONOSES PUBLIC HLTH, V62, P525, DOI 10.1111/zph.12180; Starkey LA, 2013, J WILDLIFE DIS, V49, P670, DOI 10.7589/2012-08-215; Tribaldos M, 2011, J INFECT DEV COUNTR, V5, P737, DOI 10.3855/jidc.2189; Wilder HK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003617	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169047	10.1371/journal.pone.0169047	http://dx.doi.org/10.1371/journal.pone.0169047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060928	gold, Green Published			2022-12-26	WOS:000391641500050
J	de Winkel, KN; Katliar, M; Bulthoff, HH				de Winkel, Ksander N.; Katliar, Mikhail; Buelthoff, Heinrich H.			Causal Inference in Multisensory Heading Estimation	PLOS ONE			English	Article							CUE INTEGRATION; INERTIAL CUES; MOTION; PERCEPTION; POSITION; HUMANS; INFORMATION; CONFLICT; MODELS	A large body of research shows that the Central Nervous System (CNS) integrates multisensory information. However, this strategy should only apply to multisensory signals that have a common cause; independent signals should be segregated. Causal Inference (CI) models account for this notion. Surprisingly, previous findings suggested that visual and inertial cues on heading of self-motion are integrated regardless of discrepancy. We hypothesized that CI does occur, but that characteristics of the motion profiles affect multisensory processing. Participants estimated heading of visual-inertial motion stimuli with several different motion profiles and a range of intersensory discrepancies. The results support the hypothesis that judgments of signal causality are included in the heading estimation process. Moreover, the data suggest a decreasing tolerance for discrepancies and an increasing reliance on visual cues for longer duration motions.	[de Winkel, Ksander N.; Katliar, Mikhail; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Baden Wurttembu, Germany	Max Planck Society	de Winkel, KN (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Baden Wurttembu, Germany.	ksander.dewinkel@tuebingen.mpg.de	de Winkel, Ksander/ABE-5608-2020; Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	de Winkel, Ksander/0000-0003-0534-2723; Bülthoff, Heinrich H/0000-0003-2568-0607; 				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; [Anonymous], 1974, HDB SENSORY PHYSL; Atanasiu V., 2011, KERNEL SMOOTHING DEN; Beierholm U, 2007, ADV NEURAL INFORM PR, P81; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Bos JE, 2015, J VESTIBUL RES-EQUIL, V25, P119, DOI 10.3233/VES-150555; BRANDT T, 1974, EXP BRAIN RES, V21, P337; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Butler JS, 2015, EXP BRAIN RES, V233, P587, DOI 10.1007/s00221-014-4136-1; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; DAvossa G, 1996, VISION RES, V36, P2915, DOI 10.1016/0042-6989(96)00010-7; De Graaf B, 1996, OTOLITH CONTRIBUTION; de Winkel KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127104; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Ghahramani Z, 1997, ADV PSYCHOL, V119, P117; GLASAUER S, 1995, ACTA OTO-LARYNGOL, P37; Gracio BJC, 2013, EXP BRAIN RES, V224, P313, DOI 10.1007/s00221-012-3313-3; Gracio BJC, 2013, J AIRCRAFT, V50, P493, DOI 10.2514/1.C031870; Green DM, 1966, SIGNAL DETECTION THE; Groen EL, 2001, J AIRCRAFT, V38, P600, DOI 10.2514/2.2827; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Hummel N, 2016, J VISION, V16, DOI 10.1167/16.3.19; JOHNSTON IR, 1973, AM J PSYCHOL, V86, P311, DOI 10.2307/1421439; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.7.5; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording K. P., 2011, SENSORY CUE INTEGRAT, P30; Landy M.S., 2011, SENSORY CUE INTEGRAT, P5, DOI [10.1093/acprof:oso/9780195387247.003.0001, DOI 10.1093/ACPROF:OSO/9780195387247.003.0001]; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Li L, 2002, OPTOMETRY VISION SCI, V79, P581, DOI 10.1097/00006324-200209000-00009; LLEWELLYN KR, 1971, J EXP PSYCHOL, V91, P245, DOI 10.1037/h0031788; Merfeld DM, 2001, J NEUROPHYSIOL, V85, P1648, DOI 10.1152/jn.2001.85.4.1648; Nieuwenhuizen Frank M., 2013, Journal of Computing Science and Engineering, V7, P122, DOI 10.5626/JCSE.2013.7.2.122; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Pais ARV, 2010, J AIRCRAFT, V47, P2039, DOI 10.2514/1.C000281; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Rohe T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002073; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seidman SH, 1998, EXP BRAIN RES, V119, P307, DOI 10.1007/s002210050346; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L., 2011, SENSORY CUE INTEGRAT, P251, DOI 10.1093/acprof:oso; Valko Y, 2012, J NEUROSCI, V32, P13537, DOI 10.1523/JNEUROSCI.2157-12.2012; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; WALSH EG, 1961, J PHYSIOL-LONDON, V155, P506, DOI 10.1113/jphysiol.1961.sp006643; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	65	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169676	10.1371/journal.pone.0169676	http://dx.doi.org/10.1371/journal.pone.0169676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060957	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500128
J	Hsu, HC; Liu, LC; Wang, HY; Hung, CM; Lin, YC; Ho, CT; Way, TD				Hsu, Hsiang-Chi; Liu, Liang-Chih; Wang, Hao-Yu; Hung, Chao-Ming; Lin, Ying-Chao; Ho, Chi-Tang; Way, Tzong-Der			Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; CELLS IN-VITRO; TUMOR PROGRESSION; STEM-CELLS; TGF-BETA; METASTASIS; INVASION; PROLIFERATION; APOPTOSIS; ADENOCARCINOMA	"Triple negative breast cancer" (TNBC) is associated with a higher rate and earlier time of recurrence and worse prognosis after recurrence. In this study, we aimed to examine the crosstalk between fibroblasts and TNBC cells. The fibroblasts were isolated from TNBC patients' tissue in tumor burden zones, distal normal zones and interface zones. The fibroblasts were indicated as cancer-associated fibroblasts (CAFs), normal zone fibroblasts (NFs) and interface zone fibroblasts (INFs). Our study found that INFs grew significantly faster than NFs and CAFs in vitro. The epithelial BT20 cells cultured with the conditioned medium of INFs (INFs-CM) and CAFs (CAFs-CM) showed more spindle-like shape and cell scattering than cultured with the conditioned medium of NFs (NFs-CM). These results indicated that factors secreted by INFs-CM or CAFs-CM could induce the epithelial-mesenchymal transition (EMT) phenotype in BT20 cells. Using an in vitro co-culture model, INFs or CAFs induced EMT and promoted cancer cell migration in BT20 cells. Interestingly, we found that emodin inhibited INFs-CM or CAFs-CM-induced EMT programming and phenotype in BT20 cells. Previous studies reported that CAFs and INFs-secreted TGF-beta promoted human breast cancer cell proliferation, here; our results indicated that TGF-beta initiated EMT in BT20 cells. Pretreatment with emodin significantly suppressed the TGF-beta-induced EMT and cell migration in BT20 cells. These results suggest that emodin may be used as a novel agent for the treatment of TNBC.	[Hsu, Hsiang-Chi; Wang, Hao-Yu; Way, Tzong-Der] China Med Univ, Dept Biol Sci & Technol, Coll Biopharmaceut & Food Sci, Taichung, Taiwan; [Liu, Liang-Chih] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Liu, Liang-Chih] China Med Univ, Dept Med, Coll Med, Taichung, Taiwan; [Hung, Chao-Ming] I Shou Univ, E Da Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Hung, Chao-Ming] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Ying-Chao] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Div Neurosurg, Taichung, Taiwan; [Lin, Ying-Chao] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Ying-Chao] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ USA; [Way, Tzong-Der] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; E-Da Hospital; I Shou University; I Shou University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Central Taiwan University Science & Technology; Rutgers State University New Brunswick; Asia University Taiwan	Way, TD (corresponding author), China Med Univ, Dept Biol Sci & Technol, Coll Biopharmaceut & Food Sci, Taichung, Taiwan.; Way, TD (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.	tdway@mail.cmu.edu.tw			National Science Council of the Republic of China [NSC 96-2323-B-039-001, NSC 97-2323-B-039-001]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council of the Republic of China grant NSC 96-2323-B-039-001 and NSC 97-2323-B-039-001.	Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Cardiff RD, 2005, CLIN CANCER RES, V11, P8534, DOI 10.1158/1078-0432.CCR-05-2250; Chen TF, 2015, CELL PHYSIOL BIOCHEM, V35, P1425, DOI 10.1159/000373963; Chen YC, 2002, BIOCHEM PHARMACOL, V64, P1713, DOI 10.1016/S0006-2952(02)01386-2; CHUNG LWK, 1992, J CELL BIOCHEM, P99; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Cunha G R, 1992, Epithelial Cell Biol, V1, P18; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Franco OE, 2012, ADV PHARMACOL, V65, P267, DOI 10.1016/B978-0-12-397927-8.00009-9; Gao MQ, 2013, CANCER LETT, V336, P240, DOI 10.1016/j.canlet.2013.05.011; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Johansson AC, 2012, MOL CANCER RES, V10, P1158, DOI 10.1158/1541-7786.MCR-12-0030; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang S, 2010, J PROTEOME RES, V9, P1157, DOI 10.1021/pr900666q; Kim BS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/838040; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Petrulio Christian A, 2006, Expert Opin Biol Ther, V6, P671, DOI 10.1517/14712598.6.7.671; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Shan LH, 2012, J CLIN PATHOL, V65, P888, DOI 10.1136/jclinpath-2012-200909; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Sun Y, 2015, ONCOL REP, V33, P338, DOI 10.3892/or.2014.3585; Thacker PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120045; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Wang SC, 2001, SEMIN ONCOL, V28, P21, DOI 10.1053/sonc.2001.29724; Way TD, 2014, EUR J CANCER, V50, P366, DOI 10.1016/j.ejca.2013.09.025; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	43	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0164661	10.1371/journal.pone.0164661	http://dx.doi.org/10.1371/journal.pone.0164661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060811	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500005
J	Maznah, Z; Halimah, M; Shitan, M; Karmokar, PK; Najwa, S				Maznah, Zainol; Halimah, Muhamad; Shitan, Mahendran; Karmokar, Provash Kumar; Najwa, Sulaiman			Prediction of Hexaconazole Concentration in the Top Most Layer of Oil Palm Plantation Soil Using Exploratory Data Analysis (EDA)	PLOS ONE			English	Article							FIELD EXPERIMENT; SIMULATION; DISSIPATION; CHLORPYRIFOS; DEGRADATION	Ganoderma boninense is a fungus that can affect oil palm trees and cause a serious disease called the basal stem root (BSR). This disease causes the death of more than 80% of oil palm trees midway through their economic life and hexaconazole is one of the particular fungicides that can control this fungus. Hexaconazole can be applied by the soil drenching method and it will be of interest to know the concentration of the residue in the soil after treatment with respect to time. Hence, a field study was conducted in order to determine the actual concentration of hexaconazole in soil. In the present paper, a new approach that can be used to predict the concentration of pesticides in the soil is proposed. The statistical analysis revealed that the Exploratory Data Analysis (EDA) techniques would be appropriate in this study. The EDA techniques were used to fit a robust resistant model and predict the concentration of the residue in the topmost layer of the soil.	[Maznah, Zainol; Halimah, Muhamad; Najwa, Sulaiman] MPOB, Persiaran Inst, Prod Dev & Advisory Serv Div PDAS, Analyt & Qual Dev Unit, Bandar Baru Bangi Kajang, Selangor, Malaysia; [Shitan, Mahendran; Karmokar, Provash Kumar] Univ Putra Malaysia, Inst Math Res, Lab Computat Stat & Operat Res, Upm Serdang, Selangor, Malaysia; [Karmokar, Provash Kumar] Rajshahi Univ, Dept Stat, Rajshahi, Bangladesh	Malaysian Palm Oil Board; Universiti Putra Malaysia; University of Rajshahi	Maznah, Z (corresponding author), MPOB, Persiaran Inst, Prod Dev & Advisory Serv Div PDAS, Analyt & Qual Dev Unit, Bandar Baru Bangi Kajang, Selangor, Malaysia.	maznahz@mpob.gov.my	Danaee, Mahmoud/F-4147-2012	Danaee, Mahmoud/0000-0002-5014-5684; Shitan, Mahendran/0000-0001-6546-2829; Sulaiman, Najwa/0000-0001-8641-1043	Institute of Mathematical Research and Department of Mathematics, Universiti Putra Malaysia	Institute of Mathematical Research and Department of Mathematics, Universiti Putra Malaysia	This is a joint work between MPOB and Universiti Putra Malaysia. We thank the Director General of MPOB for the permission to publish this article. We are extremely grateful to the technical staff of the Pesticides Laboratory, MPOB for their invaluable technical assistance. Our sincere thanks also go to the Institute of Mathematical Research and Department of Mathematics, Universiti Putra Malaysia for their support in completing this project.	Almorza D, 2008, J APPL STAT, V35, P979, DOI 10.1080/02664760802187536; Behrens JT, 1997, PSYCHOL METHODS, V2, P131, DOI 10.1037/1082-989X.2.2.131; Benjamin M, 1995, MAPPS NEWLETTER, V19; Beulke S, 2000, J ENVIRON QUAL, V29, P1371, DOI 10.2134/jeq2000.00472425002900050001x; BOESTEN JJTI, 1991, J ENVIRON QUAL, V20, P425, DOI 10.2134/jeq1991.00472425002000020015x; Bromilow RH, 1999, PESTIC SCI, V55, P1129, DOI 10.1002/(SICI)1096-9063(199912)55:12&lt;1129::AID-; Chai LK, 2013, J ENVIRON MANAGE, V125, P28, DOI 10.1016/j.jenvman.2013.04.005; Cheah U. B., 2001, Cutting-edge technologies for sustained competitiveness: Proceedings of the 2001 PIPOC International Palm Oil Congress, Chemistry and Technology Conference, Kuala Lumpur, Malaysia, 20-22 August 2001, P105; Curtis D.A., 2003, AM ED RES ASS ANN M; Diekmann F, 2012, J AGRIC FOOD INF, V13, P14, DOI 10.1080/10496505.2012.636005; Halimah M, 2013, J OIL PALM RES, V25, P343; Halimah M, 2012, DRUG TEST ANAL S1, V4, P1; Hinterberger H., 2009, ENCY DATABASE SYSTEM, P1080, DOI [10.1007/978-0-387-39940-9_1384, DOI 10.1007/978-0-387-39940-9_1384]; Idris A. S., 2004, Journal of Oil Palm Research, V16, P12; Idris AS, 2010, MPOB INFORM SERIES, V75; Ismail BS, 2005, B ENVIRON CONTAM TOX, V74, P1143, DOI 10.1007/s00128-005-0700-5; Ismail BS, 2005, J ENVIRON SCI HEAL B, V40, P341, DOI 10.1081/PFC-200045560; Khairuddin H, 1990, THESIS; Kosmelj K, 2003, DEV APPL STAT, V19; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Leith RM, 1991, CANADIAN WATER RESOU, V16, P81; Maznah Z, 2015, ENVIRON SCI POLLUT R, V22, P19648, DOI 10.1007/s11356-015-5178-z; NICHOLLS PH, 1994, J ENVIRON SCI HEAL A, V29, P1157, DOI 10.1080/10934529409376100; Nikas C, 2009, SE EUR BLACK SEA STU, V9, P481, DOI 10.1080/14683850903314972; Pilotti CA, 2003, PLANT PATHOL, V52, P455, DOI 10.1046/j.1365-3059.2003.00870.x; Scorza RP, 2005, PEST MANAG SCI, V61, P432, DOI 10.1002/ps.1004; Shitan M., 2011, EXPLORATORY DATA ANA; Singh G., 1991, PLANTER, V67, P421; Tukey JW, 1977, EXPLORATORY DATA ANA; Velleman P. F., 1981, APPL BASICS COMPUTIN; Wagenet R. J., 1990, Pesticides in the soil environment: processes, impacts, and modeling., P351; Walker A, 1989, WEED RES, V29, P143; Walker A, TECHNICAL MONOGRAPH, V59, P221; Zainol M, 2012, J OIL PALM RES, V24, P1397	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0166203	10.1371/journal.pone.0166203	http://dx.doi.org/10.1371/journal.pone.0166203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060816	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000391641500008
J	Pourcel, C; Midoux, C; Hauck, Y; Vergnaud, G; Latino, L				Pourcel, Christine; Midoux, Cedric; Hauck, Yolande; Vergnaud, Gilles; Latino, Libera			Large Preferred Region for Packaging of Bacterial DNA by phiC725A, a Novel Pseudomonas aeruginosa F116-Like Bacteriophage	PLOS ONE			English	Article							GENOME SEQUENCE; F116; RESISTANCE; PROPHAGE; FAMILY; PHAGES; GENES	Bacteriophage vB_PaeP_PAO1_phiC725A (short name phiC725A) was isolated following mitomycin C induction of C7-25, a clinical Pseudomonas aeruginosa strain carrying phiC725A as a prophage. The phiC725A genome sequence shows similarity to F116, a P. aeruginosa podovirus capable of generalized transduction. Likewise, phiC725A is a podovirus with long tail fibers. PhiC725A was able to lysogenize two additional P. aeruginosa strains in which it was maintained both as a prophage and in an episomal state. Investigation by deep sequencing showed that bacterial DNA carried inside phage particles originated predominantly from a 700-800kb region, immediately flanking the attL prophage insertion site, whether the phages were induced from a lysogen or recovered after infection. This indicates that during productive replication, recombination of phage genomes with the bacterial chromosome at the att site occurs occasionally, allowing packaging of adjacent bacterial DNA.	[Pourcel, Christine; Midoux, Cedric; Hauck, Yolande; Vergnaud, Gilles; Latino, Libera] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pourcel, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	christine.pourcel@gmail.com	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Midoux, Cedric/0000-0002-7964-0929	french "direction generale de l'armement" (DGA) through Agence Nationale de la Recherche (ANR, France) "Resisphage" [ANR-13-ASTRID-0011-01]; joint DGA-IDEX Universite Paris-Saclay doctoral fellowship;  [NIH P30DK089507]	french "direction generale de l'armement" (DGA) through Agence Nationale de la Recherche (ANR, France) "Resisphage"(French National Research Agency (ANR)); joint DGA-IDEX Universite Paris-Saclay doctoral fellowship; 	This study was supported by the french "direction generale de l'armement" (DGA) through Agence Nationale de la Recherche (ANR, France) "Resisphage" ANR-13-ASTRID-0011-01 (http://www.agence-nationale-recherche.fr/), and a joint DGA-IDEX Universite Paris-Saclay doctoral fellowship to Dr. Libera Latino. The Transposon Mutant Collection holds grant #NIH P30DK089507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Byrne M, 2005, GENE, V346, P187, DOI 10.1016/j.gene.2004.11.001; CARUSO M, 1982, MOL GEN GENET, V188, P292, DOI 10.1007/BF00332690; CAVENAGH MM, 1986, J BACTERIOL, V165, P448, DOI 10.1128/jb.165.2.448-452.1986; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Chen J, 2015, ISME J, V9, P1260, DOI 10.1038/ismej.2014.187; Chen J, 2015, MOL CELL, V57, P138, DOI 10.1016/j.molcel.2014.11.011; Essoh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130548; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; FALCO SC, 1977, P NATL ACAD SCI USA, V74, P520, DOI 10.1073/pnas.74.2.520; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hardies SC, 2016, VIROLOGY, V489, P116, DOI 10.1016/j.virol.2015.12.005; HOLLOWAY B. W., 1960, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V38, P321, DOI 10.1038/icb.1960.34; Huang HM, 2014, VIROLOGY, V468, P274, DOI 10.1016/j.virol.2014.07.029; Hulo C, 2015, VIROLOGY, V477, P155, DOI 10.1016/j.virol.2014.10.009; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; KRYLOV VN, 1993, ARCH VIROL, V131, P141, DOI 10.1007/BF01379086; Latino L, 2016, MICROBIOL-SGM, V162, P748, DOI 10.1099/mic.0.000263; Latino L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093777; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; MILLER RV, 1977, J VIROL, V22, P844, DOI 10.1128/JVI.22.3.844-847.1977; MILLER RV, 1974, VIROLOGY, V59, P566, DOI 10.1016/0042-6822(74)90466-8; Moon BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151409; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; PEMBERTON JM, 1973, VIROLOGY, V55, P558, DOI 10.1016/0042-6822(73)90203-1; ROTHMANDENES LB, 1974, VIROLOGY, V60, P65, DOI 10.1016/0042-6822(74)90366-3; Sanchez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107754; Schwudke D, 2008, J BACTERIOL, V190, P332, DOI 10.1128/JB.01402-07; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; STERNBERG N, 1975, NATURE, V256, P97, DOI 10.1038/256097a0; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Tavares P, 1996, J MOL BIOL, V264, P954, DOI 10.1006/jmbi.1996.0689; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; Xu ZN, 2011, RES MICROBIOL, V162, P144, DOI 10.1016/j.resmic.2010.08.003; YOUDERIAN P, 1988, GENETICS, V118, P581; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	41	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169684	10.1371/journal.pone.0169684	http://dx.doi.org/10.1371/journal.pone.0169684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060939	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500129
J	Suga, T; Yamaguchi, H; Sato, T; Maekawa, M; Goto, J; Mano, N				Suga, Takahiro; Yamaguchi, Hiroaki; Sato, Toshihiro; Maekawa, Masamitsu; Goto, Junichi; Mano, Nariyasu			Preference of Conjugated Bile Acids over Unconjugated Bile Acids as Substrates for OATP1B1 and OATP1B3	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDE; HEPATIC-UPTAKE; NUCLEAR RECEPTOR; IDENTIFICATION; TAUROCHOLATE; RAT; SUPERFAMILY; LIGANDS; FAMILY; 1B1	Bile acids, the metabolites of cholesterol, are signaling molecules that play critical role in many physiological functions. They undergo enterohepatic circulation through various transporters expressed in intestine and liver. Human organic anion-transporting polypeptides (OA TP) 1B1 and OATP1B3 contribute to hepatic uptake of bile acids such as taurocholic acid. However, the transport properties of individual bile acids are not well understood. Therefore, we selected HEK293 cells overexpressing OATP1B1 and OATP1B3 to evaluate the transport of five major human bile acids (cholic acid, chenodeoxycholic acid, deoxycholic acid, ursodeoxycholic acid, lithocholic acid) together withtheir glycine and taurine conjugates via OATP1B1 and OATP1B3. The bile acids were quantified by liquid chromatography-tandem mass spectrometry. The present study revealed that cholic acid, chenodeoxyxcholic acid, and deoxycholic acid were transported by OATP1B1 and OATP1B3, while ursodeoxycholic acid and lithocholic acid were not significantly transported by OATPs. However, all the conjugated bile acids were taken up rapidly by OATP1B1 and OATP1B3. Kinetic analyses revealed the involvement of saturable OATP1B1- and OATP1B3-mediated transport of bile acids. The apparent Km values for OATP1B1 and OATP1B3 of the conjugated bile acids were similar (0.74-14.7 mu M for OATP1B1 and 0.47-15.3 mu M for OATP1B3). They exhibited higher affinity than cholic acid (47.1 mu M for OATP1B1 and 42.2 mu M for OATP1B3). Our results suggest that conjugated bile acids (glycine and taurine) are preferred to unconjugated bile acids as substrates for OATP1B1 and OATP1B3.	[Suga, Takahiro; Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan; [Yamaguchi, Hiroaki; Sato, Toshihiro; Maekawa, Masamitsu; Goto, Junichi; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yamaguchi, H; Mano, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan.; Yamaguchi, H; Mano, N (corresponding author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan.	yamaguchi@hosp.tohoku.ac.jp; mano@hosp.tohoku.ac.jp	Mano, Nariyasu/AAS-9994-2020; Sato, Toshihiro/D-7221-2012; Yamaguchi, Hiroaki/G-9969-2012; Maekawa, Masamitsu/GQR-2278-2022	Sato, Toshihiro/0000-0002-8807-2417; Yamaguchi, Hiroaki/0000-0003-3021-6120; Mano, Nariyasu/0000-0003-1679-9024; Maekawa, Masamitsu/0000-0001-6723-0298				Abe T, 2001, GASTROENTEROLOGY, V120, P1689, DOI 10.1053/gast.2001.24804; Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; ANANTHANARAYANAN M, 1994, AM J PHYSIOL-GASTR L, V267, pG637, DOI 10.1152/ajpgi.1994.267.4.G637; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dong ZQ, 2015, INT J PHARMACEUT, V478, P88, DOI 10.1016/j.ijpharm.2014.11.022; GOTO J, 1988, J CHROMATOGR, V452, P119, DOI 10.1016/S0021-9673(01)81441-2; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hong WF, 2015, MOL PHARMACEUT, V12, P4270, DOI 10.1021/acs.molpharmaceut.5b00466; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Huang J, 2013, SCI WORLD J, V2013, P1, DOI DOI 10.1155/2013/329187; JONES AL, 1980, AM J PHYSIOL, V238, pG233, DOI 10.1152/ajpgi.1980.238.3.G233; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Konig J, 2012, BASIC CLIN PHARMACOL, V111, P81, DOI 10.1111/j.1742-7843.2012.00865.x; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Kouzuki H, 1998, J PHARMACOL EXP THER, V286, P1043; Kullak-Ublick GA, 2000, SEMIN LIVER DIS, V20, P273, DOI 10.1055/s-2000-9426; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Letschert K, 2004, PHARMACOGENETICS, V14, P441, DOI 10.1097/01.fpc.0000114744.08559.92; Maeda K, 2006, MOL PHARMACEUT, V3, P70, DOI 10.1021/mp050063u; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; RODA A, 1990, J LIPID RES, V31, P1433; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; St-Pierre MV, 2001, J EXP BIOL, V204, P1673; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wenniger LMD, 2010, DIGEST LIVER DIS, V42, P409, DOI 10.1016/j.dld.2010.03.015; Yamaguchi H, 2008, CANCER LETT, V260, P163, DOI 10.1016/j.canlet.2007.10.040; Yamaguchi H, 2006, J LIPID RES, V47, P1196, DOI 10.1194/jlr.M500532-JLR200; Yamaguchi H, 2011, BIOL PHARM BULL, V34, P389, DOI 10.1248/bpb.34.389; YAMAZAKI M, 1993, AM J PHYSIOL, V264, pG693, DOI 10.1152/ajpgi.1993.264.4.G693; Yan ZR, 2015, J OBSTET GYNAECOL RE, V41, P392, DOI 10.1111/jog.12549	48	61	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169719	10.1371/journal.pone.0169719	http://dx.doi.org/10.1371/journal.pone.0169719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060902	gold, Green Published			2022-12-26	WOS:000391641500134
J	Wang, C; Feng, MC; Yang, WD; Ding, GW; Xiao, LJ; Li, GX; Liu, TT				Wang, Chao; Feng, Meichen; Yang, Wude; Ding, Guangwei; Xiao, Lujie; Li, Guangxin; Liu, Tingting			Extraction of Sensitive Bands for Monitoring the Winter Wheat (Triticum aestivum) Growth Status and Yields Based on the Spectral Reflectance	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LEAST-SQUARES REGRESSION; VEGETATION INDEXES; HYPERSPECTRAL MEASUREMENTS; NITROGEN CONCENTRATION; FOLIAR CHLOROPHYLL; CANOPY REFLECTANCE; SOIL PROPERTIES; DEPTH ANALYSIS; GRAIN-YIELD	To extract the sensitive bands for estimating the winter wheat growth status and yields, field experiments were conducted. The crop variables including aboveground biomass (AGB), soil and plant analyzer development (SPAD) value, yield, and canopy spectra were determined. Statistical methods of correlation analysis, partial least squares (PLS), and stepwise multiple linear regression (SMLR) were used to extract sensitive bands and estimate the crop variables with calibration set. The predictive model based on the selected bands was tested with validation set. The results showed that the crop variables were significantly correlated with spectral reflectance. The major spectral regions were selected with the B-coefficient and variable importance on projection (VIP) parameter derived from the PLS analysis. The calibrated SMLR model based on the selected wavelengths demonstrated an excellent performance as the R-2, TC, and RMSE were 0.634, 0.055, and 843.392 for yield; 0.671, 0.017, and 1.798 for SPAD; and 0.760, 0.081, and 1.164 for AGB. These models also performed accurately and robustly by using the field validation data set. It indicated that these wavelengths retained in models were important. The determined wavelengths for yield, SPAD, and AGB were 350, 410, 730, 1015, 1185 and 1245 nm; 355, 400, 515, 705, 935, 1090, and 1365 nm; and 470, 570, 895, 1170, 1285, and 1355 nm, respectively. This study illustrated that it was feasible to predict the crop variables by using the multivariate method. The step-by-step procedure to select the significant bands and optimize the prediction model of crop variables may serve as a valuable approach. The findings of this study may provide a theoretical and practical reference for rapidly and accurately monitoring the crop growth status and predicting the yield of winter wheat.	[Wang, Chao; Feng, Meichen; Yang, Wude; Xiao, Lujie; Liu, Tingting] Shanxi Agr Univ, Dryland Farming Engn Inst, Taigu, Peoples R China; [Ding, Guangwei; Li, Guangxin] Northern State Univ, Dept Chem, Aberdeen, SD USA; [Li, Guangxin] Shanxi Acad Agr Sci, Inst Crop Sci, Taiyuan, Peoples R China	Shanxi Agricultural University; Northern State University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Yang, WD (corresponding author), Shanxi Agr Univ, Dryland Farming Engn Inst, Taigu, Peoples R China.; Ding, GW (corresponding author), Northern State Univ, Dept Chem, Aberdeen, SD USA.	sxauywd@126.com; guangwei.ding@northern.edu		Meichen, Feng/0000-0002-0338-7963	National Natural Science Foundation of China [31371572, 31201168]; Key Technologies R&D Program of Shanxi Province, China [20110311038]; Shanxi Provincial Foundation for Returned Scholars (Key Program), China (Key 4); Natural Science Foundation for Young Scientists of Shanxi Province, China [2012021023-5]; NSF (USA) [1461092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of Shanxi Province, China; Shanxi Provincial Foundation for Returned Scholars (Key Program), China (Key 4); Natural Science Foundation for Young Scientists of Shanxi Province, China(Natural Science Foundation of Shanxi Province); NSF (USA)(National Science Foundation (NSF))	This work was supported by grants from the National Natural Science Foundation of China (31371572, 31201168), the Key Technologies R&D Program of Shanxi Province, China (20110311038), the Shanxi Provincial Foundation for Returned Scholars (Key Program), China (2014-Key 4); and the Natural Science Foundation for Young Scientists of Shanxi Province, China (2012021023-5). It was also partially supported by an NSF grant (No. 1461092, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajgain R, 2015, FIELD CROP RES, V180, P221, DOI 10.1016/j.fcr.2015.06.010; Cao Q, 2011, PRECIS AGRIC, V13, P45; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; CHAPPELLE EW, 1991, REMOTE SENS ENVIRON, V36, P213, DOI 10.1016/0034-4257(91)90058-E; Chen X, 2006, NUTR CYCL AGROECOSYS, V74, P91, DOI 10.1007/s10705-005-1701-9; Clevers J. G. P. W., 2012, IEEE Journal of Selected Topics In Applied Earth Observations And Remote Sensing, V5, P574, DOI 10.1109/JSTARS.2011.2176468; COWE IA, 1985, APPL SPECTROSC, V39, P257, DOI 10.1366/0003702854248944; Darvishzadeh R, 2008, ISPRS J PHOTOGRAMM, V63, P409, DOI 10.1016/j.isprsjprs.2008.01.001; Diacono M, 2013, AGRON SUSTAIN DEV, V33, P219, DOI 10.1007/s13593-012-0111-z; Errecart PM, 2012, FIELD CROP RES, V129, P46, DOI 10.1016/j.fcr.2012.01.008; Everard CD, 2012, BIOMASS BIOENERG, V45, P203, DOI 10.1016/j.biombioe.2012.06.007; Feng MeiChen, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P183; Fu YY, 2013, SPECTROSC SPECT ANAL, V33, P1315, DOI [10.3964/j.issn.1000-0593(2013)05-1315-05, 10.3964/j.issn.1000-0593(2013)05-4315-05]; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Gnyp ML, 2014, FIELD CROP RES, V155, P42, DOI 10.1016/j.fcr.2013.09.023; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Herrmann I, 2011, REMOTE SENS ENVIRON, V115, P2141, DOI 10.1016/j.rse.2011.04.018; Jia FF, 2013, FIELD CROP RES, V150, P108, DOI 10.1016/j.fcr.2013.06.009; Kira O, 2015, INT J APPL EARTH OBS, V38, P251, DOI 10.1016/j.jag.2015.01.003; Kokaly RF, 1999, REMOTE SENS ENVIRON, V67, P267, DOI 10.1016/S0034-4257(98)00084-4; Lee KS, 2009, T ASABE, V52, P683, DOI 10.13031/2013.27385; Li F, 2014, EUR J AGRON, V52, P198, DOI 10.1016/j.eja.2013.09.006; Li F, 2013, AGR FOREST METEOROL, V180, P44, DOI 10.1016/j.agrformet.2013.05.003; Li WeiGuo, 2007, Journal of Triticeae Crops, V27, P523; Mallet Y, 1997, IEEE T PATTERN ANAL, V19, P1058, DOI 10.1109/34.625106; Mirik M, 2007, COMPUT ELECTRON AGR, V57, P123, DOI 10.1016/j.compag.2007.03.002; Nguyen HT, 2006, EUR J AGRON, V24, P349, DOI 10.1016/j.eja.2006.01.001; Peng Y, 2011, AGR FOREST METEOROL, V151, P1267, DOI 10.1016/j.agrformet.2011.05.005; [任红艳 Ren Hongyan], 2005, [土壤通报, Journal of Soil Science], V36, P26; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; ROTH GW, 1989, AGRON J, V81, P502, DOI 10.2134/agronj1989.00021962008100030022x; Samborski SM, 2009, AGRON J, V101, P800, DOI 10.2134/agronj2008.0162Rx; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHREIBER T, 1993, PHYS REV E, V47, P2401, DOI 10.1103/PhysRevE.47.2401; Sharabian V.R., 2014, ENG AGR ENV FOOD, V7, P14, DOI DOI 10.1016/J.EAEF.2013.12.003; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Thomasson JA, 2001, T ASAE, V44, P1445, DOI 10.13031/2013.7002; Vasques GM, 2009, SOIL SCI SOC AM J, V73, P176, DOI 10.2136/sssaj2008.0015; Wang HF, 2016, PLANT PHYSIOL BIOCH, V98, P39, DOI 10.1016/j.plaphy.2015.10.032; Weber VS, 2012, FIELD CROP RES, V128, P82, DOI 10.1016/j.fcr.2011.12.016; Willaby HW, 2015, PERS INDIV DIFFER, V84, P73, DOI 10.1016/j.paid.2014.09.008; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1994, QSAR CHEMOMETRIC MET, P195; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Xu F, 2013, APPL ENERG, V104, P801, DOI 10.1016/j.apenergy.2012.12.019; Xue LH, 2007, PEDOSPHERE, V17, P646, DOI 10.1016/S1002-0160(07)60077-0; Yacobi YZ, 2011, WATER RES, V45, P2428, DOI 10.1016/j.watres.2011.02.002; Yao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096352; Zhu Y, 2008, INT J APPL EARTH OBS, V10, P1, DOI 10.1016/j.jag.2007.02.006	49	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167679	10.1371/journal.pone.0167679	http://dx.doi.org/10.1371/journal.pone.0167679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060827	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500014
J	Tsai, TT; Tai, CL; Ho, NYJ; Lai, PL; Fu, TS; Niu, CC; Chen, LH; Chen, WJ				Tsai, Tsung-Ting; Tai, Ching-Lung; Ho, Natalie Yi-Ju; Lai, Po-Liang; Fu, Tsai-Sheng; Niu, Chi-Chien; Chen, Lih-Huei; Chen, Wen-Jer			Effects of Strontium Ranelate on Spinal Interbody Fusion Surgery in an Osteoporotic Rat Model	PLOS ONE			English	Article							BONE-FORMATION; POSTMENOPAUSAL OSTEOPOROSIS; STENOSIS; FRACTURE; DEGENERATION; RESORPTION; RESISTANCE; FIXATION; RISK	Osteoporosis is a bone disease that afflicts millions of people around the world, and a variety of spinal integrity issues, such as degenerative spinal stenosis and spondylolisthesis, are frequently concomitant with osteoporosis and are sometimes treated with spinal interbody fusion surgery. Previous studies have demonstrated the efficacy of strontium ranelate (SrR) treatment of osteoporosis in improving bone strength, promoting bone remodeling, and reducing the risk of fractures, but its effects on interbody fusion surgery have not been adequately investigated. SrR-treated rats subjected to interbody fusion surgery exhibited significantly higher lumbar vertebral bone mineral density after 12 weeks of treatment than rats subjected to the same surgery but not treated with SrR. Furthermore, histological and radiographic assessments showed that a greater amount of newly formed bone tissue was present and that better fusion union occurred in the SrR-treated rats than in the untreated rats. Taken together, these results show significant differences in bone mineral density, PINP level, histological score, SrR content and mechanical testing, which demonstrate a relatively moderate effect of SrR treatment on bone strength and remodeling in the specific context of recovery after an interbody fusion surgery, and suggest the potential of SrR treatment as an effective adjunct to spinal interbody fusion surgery for human patients.	[Tsai, Tsung-Ting; Ho, Natalie Yi-Ju; Lai, Po-Liang; Fu, Tsai-Sheng; Niu, Chi-Chien; Chen, Lih-Huei; Chen, Wen-Jer] Chang Gung Mem Hosp, Bone & Joint Res Ctr, Dept Orthopaed Surg, Spine Sect, Taoyuan, Taiwan; [Tai, Ching-Lung; Ho, Natalie Yi-Ju; Lai, Po-Liang; Fu, Tsai-Sheng; Niu, Chi-Chien; Chen, Lih-Huei; Chen, Wen-Jer] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tai, Ching-Lung] Chang Gung Univ, Grad Inst Med Mech, Dept Mech Engn, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Tai, CL (corresponding author), Chang Gung Univ, Grad Inst Med Mech, Dept Mech Engn, Taoyuan, Taiwan.	taici@mail.cgu.edu.tw	Niu, Chi-Chien/AAT-4229-2021	Tai, Ching-Lung/0000-0002-9084-4885	Chang Gung Memorial Hospital, Linkou [CMRPG3C0112]	Chang Gung Memorial Hospital, Linkou	This study was supported by Chang Gung Memorial Hospital, Linkou (CMRPG3C0112). http://www.chang-gung.com/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906; [Anonymous], 2000, NIH Consens Statement, V17, P1; Bain SD, 2009, OSTEOPOROSIS INT, V20, P1417, DOI 10.1007/s00198-008-0815-8; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; BRIDWELL KH, 1993, J SPINAL DISORD, V6, P461, DOI 10.1097/00002517-199306060-00001; Bruel A, 2011, CALCIFIED TISSUE INT, V88, P142, DOI 10.1007/s00223-010-9439-z; Cavagna R, 2008, J SPINAL DISORD TECH, V21, P86, DOI 10.1097/BSD.0b013e3180590c23; Cebesoy O, 2007, JOINT BONE SPINE, V74, P590, DOI 10.1016/j.jbspin.2007.01.034; COE JD, 1990, SPINE, V15, P902, DOI 10.1097/00007632-199009000-00012; Farlay D, 2005, J BONE MINER RES, V20, P1569, DOI 10.1359/JBMR.050405; Glassman SD, 2009, J BONE JOINT SURG AM, V91A, P783, DOI 10.2106/JBJS.H.00288; GOLDBERG VM, 1985, J ORTHOPAED RES, V3, P389, DOI 10.1002/jor.1100030401; Gordjestani M, 2006, CELLS TISSUES ORGANS, V184, P148, DOI 10.1159/000099621; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Keorochana G, 2010, SPINE J, V10, P1014, DOI 10.1016/j.spinee.2010.08.013; Lane NE, 2003, ARTHRITIS RES THER, V5, P214, DOI 10.1186/ar797; Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; MARIE PJ, 1993, J BONE MINER RES, V8, P607; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Okuda S, 2006, J NEUROSURG-SPINE, V4, P304, DOI 10.3171/spi.2006.4.4.304; Ozturan KE, 2011, J ORTHOP RES, V29, P138, DOI 10.1002/jor.21204; Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461; Sato J, 2014, GLOBAL SPINE J, V04, P165; Seeman E, 2008, J BONE MINER RES, V23, P433, DOI 10.1359/JBMR.071105; Sherman S, 2001, ANN NY ACAD SCI, V949, P188; SIENKIEWICZ PJ, 1987, CLIN ORTHOP RELAT R, P172; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Yone K, 1996, SPINE, V21, P242, DOI 10.1097/00007632-199601150-00016; Zhang HN, 2009, J NEUROSURG-SPINE, V10, P522, DOI 10.3171/2009.2.SPINE08925	30	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0167296	10.1371/journal.pone.0167296	http://dx.doi.org/10.1371/journal.pone.0167296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052066	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500009
J	Yuan, WJ; Guo, SG; Gao, JQ; Zhong, MM; Yan, GH; Wu, WM; Chao, YP; Jiang, Y				Yuan, Wenjie; Guo, Shuguang; Gao, Jiaoqi; Zhong, Mingming; Yan, Gonghong; Wu, Wangmeng; Chao, Yapeng; Jiang, Yu			General Control Nonderepressible 2 (GCN2) Kinase Inhibits Target of Rapamycin Complex 1 in Response to Amino Acid Starvation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; TRANSLATIONAL CONTROL; CONTROLS TORC1; CELL-GROWTH; PROTEIN; BINDING; PHOSPHORYLATION; ASSOCIATION; ACTIVATION; AUTOPHAGY	In eukaryotic cells, two conserved protein kinases, Gcn2 and TOR complex 1 (TORC1), couple amino acid conditions to protein translation. Gcn2 functions as an amino acid sensor and is activated by uncharged tRNAs that accumulate when intracellular amino acids are limited. Activated Gcn2 phosphorylates and inhibits eukaryotic initiation factor-2 alpha (eIF2 alpha), resulting in repression of general protein synthesis. Like Gcn2, TORC1 is also involved in sensing amino acid conditions. However, the underlying mechanism remains unclear. In the present study, we show that TORC1 is a direct target of Gcn2 kinase in the yeast Saccharomyces cerevisiae. In response to amino acid starvation, Gcn2 binds to TORC1 and phosphorylates Kog1, the unique regulatory subunit of TORC1, resulting in down-regulation of TORC1 kinase activity. In the absence of Gcn2, TORC1 signaling activity increases and becomes unresponsive to amino acid starvation. Our findings demonstrate that TORC1 is an effector of Gcn2 in amino acid signaling, hence defining a novel mechanism by which TORC1 senses amino acid starvation.	[Yuan, Wenjie; Gao, Jiaoqi] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China; [Yuan, Wenjie; Guo, Shuguang; Gao, Jiaoqi; Zhong, Mingming; Yan, Gonghong; Wu, Wangmeng; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Chao, Yapeng] Chinese Acad Sci, Inst Microbiol, State Key Labs Transducer Technol, Beijing 100101, Peoples R China	Dalian University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Sciences; Institute of Microbiology, CAS	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	yuj5@pitt.edu			National Institutes of Health [CA169186]; National Natural Science Foundation of China [81272269]; NATIONAL CANCER INSTITUTE [R21CA169186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA169186 (to Y.J.) and National Natural Science Foundation of China Grant 81272269 (to Y.J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cully M, 2009, BIOCHEM SOC T, V37, P284, DOI 10.1042/BST0370284; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duran RV, 2012, CELL RES, V22, P1207, DOI 10.1038/cr.2012.68; Duvel K, 2003, CURR TOP MICROBIOL, V279, P19; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Proud CG, 2014, AM J CLIN NUTR, V99, p231S, DOI 10.3945/ajcn.113.066753; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wei YH, 2011, METHODS MOL BIOL, V759, P307, DOI 10.1007/978-1-61779-173-4_18; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Yan GH, 2012, MOL CELL, V45, P743, DOI 10.1016/j.molcel.2012.01.028; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	48	34	36	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2660	2669		10.1074/jbc.M116.772194	http://dx.doi.org/10.1074/jbc.M116.772194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057755	hybrid, Green Published			2022-12-26	WOS:000395535100009
J	Erikson, JM; Valente, AJ; Mummidi, S; Kandikattu, HK; DeMarco, VG; Bender, SB; Fay, WP; Siebenlist, U; Chandrasekar, B				Erikson, John M.; Valente, Anthony J.; Mummidi, Srinivas; Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Bender, Shawn B.; Fay, William P.; Siebenlist, Ulrich; Chandrasekar, Bysani			Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion- induced Myocardial Injury and Adverse Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; IMPROVES CARDIAC-FUNCTION; MICROBUBBLE DESTRUCTION; NITRIC-OXIDE; CARDIOMYOCYTE APOPTOSIS; UP-REGULATION; CIKS ACT1; IN-VITRO; ULTRASOUND	Re-establishing blood supply is the primary goal for reducing myocardial injury in subjects with ischemic heart disease. Paradoxically, reperfusion results in nitroxidative stress and a marked inflammatory response in the heart. TRAF3IP2 (TRAF3 Interacting Protein 2; previously known as CIKS or Act1) is an oxidative stress-responsive cytoplasmic adapter molecule that is an upstream regulator of both I kappa B kinase (IKK) and c-Jun N-terminal kinase (JNK), and an important mediator of autoimmune and inflammatory responses. Here we investigated the role of TRAF3IP2 in ischemia/reperfusion (I/R)-induced nitroxidative stress, inflammation, myocardial dysfunction, injury, and adverse remodeling. Our data show that I/R up-regulates TRAF3IP2 expression in the heart, and its gene deletion, in a conditional cardiomyocyte-specific manner, significantly attenuates I/R-induced nitroxidative stress, IKK/NF-kappa B and JNK/AP-1 activation, inflammatory cytokine, chemokine, and adhesion molecule expression, immune cell infiltration, myocardial injury, and contractile dysfunction. Furthermore, Traf3ip2 gene deletion blunts adverse remodeling 12 weeks post-I/R, as evidenced by reduced hypertrophy, fibrosis, and contractile dysfunction. Supporting the genetic approach, an interventional approach using ultrasound-targeted microbubble destruction-mediated delivery of phosphorothioated TRAF3IP2 antisense oligonucleotides into the LV in a clinically relevant time frame significantly inhibits TRAF3IP2 expression and myocardial injury in wild type mice post-I/R. Furthermore, ameliorating myocardial damage by targeting TRAF3IP2 appears to be more effective to inhibiting its downstream signaling intermediates NF-kappa B and JNK. Therefore, TRAF3IP2 could be a potential therapeutic target in ischemic heart disease.	[Erikson, John M.; Valente, Anthony J.; Mummidi, Srinivas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Fay, William P.; Chandrasekar, Bysani] Univ Missouri, Dept Med, Sch Med, Columbia, MO 65211 USA; [Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Fay, William P.; Chandrasekar, Bysani] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA; [DeMarco, Vincent G.; Bender, Shawn B.; Fay, William P.; Chandrasekar, Bysani] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Bender, Shawn B.; Siebenlist, Ulrich] Univ Missouri, Sch Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Bender, Shawn B.; Chandrasekar, Bysani] Dalton Cardiovasc Res Ctr, Columbia, MO 65201 USA; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chandrasekar, B (corresponding author), Univ Missouri, Sch Med, Med Cardiol, 1 Hosp Dr, Columbia, MO 65212 USA.	chandrasekarb@health.missouri.edu	Mummidi, Srinivas/H-3335-2017; Kandikattu, Hemanth Kumar/AAW-7746-2020	Mummidi, Srinivas/0000-0002-4068-6380; Kandikattu, Hemanth Kumar/0000-0001-5114-3341	United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development [I01-BX002255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722, ZIAAI001095] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002255, IK2BX002030] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development (ORD-BLRD) Service Award I01-BX002255. The authors declare that they have no conflicts of interest with the contents of this article. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chandrasekar B, 1997, FEBS LETT, V401, P30, DOI 10.1016/S0014-5793(96)01426-3; Chandrasekar B, 2001, CIRCULATION, V103, P2296; Chen SY, 2017, METHODS MOL BIOL, V1521, P205, DOI 10.1007/978-1-4939-6588-5_14; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; Eklund EA, 1996, J IMMUNOL, V157, P2418; Entman ML, 2000, Z KARDIOL, V89, P82; Erikson JM, 2003, J MOL CELL CARDIOL, V35, P119, DOI 10.1016/S0022-2828(02)00289-4; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Frantz S, 2007, AM J PATHOL, V171, P507, DOI 10.2353/ajpath.2007.061042; Frazziano G, 2014, AM J PHYSIOL-HEART C, V306, pH197, DOI 10.1152/ajpheart.00977.2012; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Ma XL, 2001, J PHARMACOL EXP THER, V298, P879; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Mukherjee D, 2000, J AM COLL CARDIOL, V35, P1678, DOI 10.1016/S0735-1097(00)00575-1; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; Pall ML, 2013, INT J MOL SCI, V14, P22274, DOI 10.3390/ijms141122274; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Porter TR, 1996, J ULTRAS MED, V15, P577; Qian Yi, 2007, Frontiers of Environmental Science and Engineering in China, V1, P1, DOI 10.1007/s11783-007-0001-9; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Schlaak JF, 2001, SCAND J IMMUNOL, V54, P396, DOI 10.1046/j.1365-3083.2001.00986.x; Schlegel P, 2016, HUM GENE THER METHOD, V27, P71, DOI 10.1089/hgtb.2015.120; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Siddesha JM, 2013, J MOL CELL CARDIOL, V65, P9, DOI 10.1016/j.yjmcc.2013.09.015; Squadrito F, 2003, LAB INVEST, V83, P1097, DOI 10.1097/01.LAB.0000082060.39079.A6; SRINIVASAN SK, 1995, ANTISENSE RES DEV, V5, P131, DOI 10.1089/ard.1995.5.131; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Valente AJ, 2013, FREE RADICAL BIO MED, V60, P125, DOI 10.1016/j.freeradbiomed.2013.02.012; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Venkatesan B, 2013, CELL SIGNAL, V25, P359, DOI 10.1016/j.cellsig.2012.10.009; Wang JF, 2015, INT J CANCER, V137, P2478, DOI 10.1002/ijc.29597; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Wei K, 1997, J AM COLL CARDIOL, V29, P1081, DOI 10.1016/S0735-1097(97)00029-6; Williams CR, 2012, AM J PHYSIOL-CELL PH, V303, pC213, DOI 10.1152/ajpcell.00227.2011; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yariswamy M, 2016, J BIOL CHEM, V291, P19425, DOI 10.1074/jbc.M116.724138; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Zen K, 2006, J MOL CELL CARDIOL, V40, P799, DOI 10.1016/j.yjmcc.2006.03.012; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	61	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2345	2358		10.1074/jbc.M116.764522	http://dx.doi.org/10.1074/jbc.M116.764522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28053087	Green Published, hybrid			2022-12-26	WOS:000395530300025
J	Bozaquel-Morais, BL; Madeira, JB; Venancio, TM; Pacheco-Rosa, T; Masuda, CA; Montero-Lomeli, M				Bozaquel-Morais, Bruno L.; Madeira, Juliana B.; Venancio, Thiago M.; Pacheco-Rosa, Thiago; Masuda, Claudio A.; Montero-Lomeli, Monica			A Chemogenomic Screen Reveals Novel Snf1p/AMPK Independent Regulators of Acetyl-CoA Carboxylase	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID ELONGATION; SACCHAROMYCES-CEREVISIAE; DRUG DISCOVERY; YEAST; IDENTIFICATION; METABOLISM; GENE; EXPRESSION; SORAPHEN	Acetyl-CoA carboxylase (Acc1p) is a key enzyme in fatty acid biosynthesis and is essential for cell viability. To discover new regulators of its activity, we screened a Saccharomyces cerevisiae deletion library for increased sensitivity to soraphen A, a potent Acc1p inhibitor. The hits identified in the screen (118 hits) were filtered using a chemical-phenotype map to exclude those associated with pleiotropic drug resistance. This enabled the identification of 82 ORFs that are genetic interactors of Acc1p. The main functional clusters represented by these hits were "transcriptional regulation", "protein post-translational modifications" and "lipid metabolism" . Further investigation of the "transcriptional regulation" cluster revealed that soraphen A sensitivity is poorly correlated with ACC1 transcript levels. We also studied the three top unknown ORFs that affected soraphen A sensitivity: SOR1 (YDL129W), SOR2 (YIL092W) and SOR3 (YJR039W). Since the C18/C16 ratio of lipid acyl lengths reflects Acc1p activity levels, we evaluated this ratio in the three mutants. Deletion of SOR2 and SOR3 led to reduced acyl lengths, suggesting that Acc1p is indeed down-regulated in these strains. Also, these mutants showed no differences in Snf1p/AMPK activation status and deletion of SNF1 in these backgrounds did not revert soraphen A sensitivity completely. Furthermore, plasmid maintenance was reduced in sor2 Delta strain and this trait was shared with 18 other soraphen A sensitive hits. In summary, our screen uncovered novel Acc1p Snf1p/AMPK-independent regulators.	[Bozaquel-Morais, Bruno L.; Madeira, Juliana B.; Pacheco-Rosa, Thiago; Masuda, Claudio A.; Montero-Lomeli, Monica] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil; [Venancio, Thiago M.] Univ Estadual Norte Fluminense, Campos Goytacazes, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense	Montero-Lomeli, M (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.	montero@bioqmed.ufrj.br	Masuda, Claudio A/F-7214-2014; Venancio, Thiago M/B-5003-2011	Masuda, Claudio A/0000-0002-0310-7108; Venancio, Thiago M/0000-0002-2215-8082; Bozaquel Morais, Bruno Leonardo/0000-0001-5477-4851	Conselho Nacional de Ciencia e Tecnologia (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Cientistas do Nosso Estado) [E - 26 /103.353/2011, E-26/203.203/2015, E-26/110.748/2011, E-26/110.236/2011, E-26/102.259/2013]; Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- APQ1/Sediadas); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Apoio Tecnico); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Auxilio Instalacao); PNPD-CAPES- fellowship (Programa Nacional de Pos Doutorado da CAPES); CNPq fellowship	Conselho Nacional de Ciencia e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Cientistas do Nosso Estado); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- APQ1/Sediadas); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Apoio Tecnico); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Auxilio Instalacao); PNPD-CAPES- fellowship (Programa Nacional de Pos Doutorado da CAPES); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Ciencia e Tecnologia (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ- Cientistas do Nosso Estado: E - 26 /103.353/2011 and E-26/203.203/2015 to MML; E-26/110.748/2011, E-26/110.236/2011 and E-26/102.259/2013 to TMV; APQ1/Sediadas to CAM, Apoio Tecnico to TPR, and Auxilio Instalacao to BLBM). BLBM is recipient of a PNPD-CAPES- fellowship (Programa Nacional de Pos Doutorado da CAPES). JBM is recipient of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourque SD, 2009, JOVE-J VIS EXP, V30, pe1513, DOI [10.3791/1513, DOI 10.3791/1513]; Bozaquel-Morais BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013692; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choy JS, 2011, GENETICS, V189, P11, DOI 10.1534/genetics.111.130781; De-Souza EA, 2014, DIS MODEL MECH, V7, P55, DOI 10.1242/dmm.012641; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; GAUSSIN V, 1996, BIOCH J, V316; GERTH K, 1994, J ANTIBIOT, V47, P23, DOI 10.7164/antibiotics.47.23; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; HARDIE DG, 1992, BIOCHIM BIOPHYS ACTA, V1123, P231, DOI 10.1016/0005-2760(92)90001-C; Harwood H James Jr, 2004, Curr Opin Investig Drugs, V5, P283; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jump DB, 2011, BIOCHEM PHARMACOL, V81, P649, DOI 10.1016/j.bcp.2010.12.014; Kamisaka Y, 2006, BIOSCI BIOTECH BIOCH, V70, P646, DOI 10.1271/bbb.70.646; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Luo DX, 2012, RECENT PAT ANTI-CANC, V7, P168, DOI 10.2174/157489212799972918; Madeira JB, 2015, MOL CELL BIOL, V35, P737, DOI 10.1128/MCB.01314-14; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Suomi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114738; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; Venancio TM, 2010, MOL BIOSYST, V6, P1475, DOI 10.1039/c002567b; Venancio TM, 2010, MOL BIOSYST, V6, P175, DOI 10.1039/b911821g; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; Venancio Thiago Motta, 2012, Frontiers in Genetics, V3, P47, DOI 10.3389/fgene.2012.00047; Wei J, 2015, NATURE, V526, P723, DOI 10.1038/nature15375; WOODS A, 1994, J BIOL CHEM, V269, P19509; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yucel EB, 2013, MOL BIOSYST, V9, P2914, DOI 10.1039/c3mb70248k; Zheng X. F. Steven, 2002, Current Issues in Molecular Biology, V4, P33	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169682	10.1371/journal.pone.0169682	http://dx.doi.org/10.1371/journal.pone.0169682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076367	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100048
J	Na, HK; Cho, CJ; Bae, SE; Lee, JH; Park, YS; Ahn, JY; Kim, DH; Choi, KD; Song, HJ; Lee, GH; Jang, SJ; Jung, HY				Na, Hee Kyong; Cho, Charles J.; Bae, Suh Eun; Lee, Jeong Hoon; Park, Young Soo; Ahn, Ji Yong; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jang, Se Jin; Jung, Hwoon-Yong			Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ENDOSCOPIC FORCEPS BIOPSY; EPITHELIAL NEOPLASIA; PEPSINOGEN TEST; CANCER; DYSPLASIA; DIAGNOSIS; RISK; OLGA; POPULATION	Background In patients with adenoma, assessing premalignant changes in the surrounding mucosa is important for surveillance. This study evaluated atrophic and metaplastic progression in the background mucosa of adenoma or early gastric cancer (EGC) cases. Methods Among 146 consecutive patients who underwent endoscopic resection for intestinal-type gastric neoplasia, the adenoma group included 56 patients with low-grade dysplasia and the ECG group included 90 patients with high-grade dysplasia or invasive carcinoma. For histology, 3 paired biopsies were obtained from the antrum, corpus lesser curvature (CLC), and corpus greater curvature (CGC). Serological atrophy was determined based on pepsinogen A (PGA), progastricsin (PGC), gastrin-17, and total ghrelin levels. Topographic progression of atrophy and/or metaplasia was staged using the operative link on gastritis assessment (OLGA) and operative link on gastric intestinal metaplasia assessment (OLGIM) systems. Results Rates of moderate-to-marked histological atrophy/metaplasia in patients with adenoma were 52.7%/78.2% at the antrum (vs. 58.8%/76.4% in EGC group), 63.5%/75.0% at the CLC (vs. 60.2%/69.7% in EGC group), and 10.9%/17.9% at the CGC (vs. 5.6%/7.8% in EGC group). Serological atrophy indicated by PGA and PGC occurred in 23.2% and 15.6% of cases in the adenoma and ECG groups, respectively (p = 0.25). Mean serum gastrin-17 concentrations of the adenoma group and EGC group were 10.4 and 9.0 pmol/L, respectively (p = 0.54). Mean serum total ghrelin levels were 216.6 and 209.5 pg/mL, respectively (p = 0.71). Additionally, between group rates of stage III-IV OLGA and OLGIM were similar (25.9% vs. 25.0%, p = 0.90; 41.8% vs. 44.9%, p = 0.71, respectively). Conclusions Atrophic and metaplastic progression is extensive and severe in gastric adenoma patients. A surveillance strategy for metachronous tumors should be applied similarly for patients with adenoma or EGC.	[Na, Hee Kyong; Lee, Jeong Hoon; Ahn, Ji Yong; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jung, Hwoon-Yong] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Cho, Charles J.] Univ Ulsan, Dept Biomed Sci, Asan Med Ctr, Coll Med, Seoul, South Korea; [Bae, Suh Eun] Univ Ulsan, Hlth Screening & Promot Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea; [Park, Young Soo; Jang, Se Jin] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, HJ (corresponding author), Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	hjsong@amc.seoul.kr	Ahn, Ji Yong/AGO-1695-2022		Asan Institute for Life Sciences, Seoul, South Korea [2007-423]	Asan Institute for Life Sciences, Seoul, South Korea	This study was supported by a grant (No. 2007-423) from the Asan Institute for Life Sciences, Seoul, South Korea.	Bae SE, 2016, SCAND J GASTROENTERO, V51, P137, DOI 10.3109/00365521.2015.1083049; BEARZI I, 1994, PATHOL RES PRACT, V190, P61, DOI 10.1016/S0344-0338(11)80497-8; Capelle LG, 2010, GASTROINTEST ENDOSC, V71, P1150, DOI 10.1016/j.gie.2009.12.029; Checchi S, 2007, J CLIN ENDOCR METAB, V92, P4346, DOI 10.1210/jc.2007-0988; Cho SJ, 2013, ALIMENT PHARM THER, V38, P1292, DOI 10.1111/apt.12515; Cho SJ, 2011, ENDOSCOPY, V43, P465, DOI 10.1055/s-0030-1256236; Choi CW, 2014, DIGEST DIS SCI, V59, P421, DOI 10.1007/s10620-013-2874-8; CORREA P, 1975, LANCET, V2, P58; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; DIGREGORIO C, 1993, AM J GASTROENTEROL, V88, P1714; Dinis-Ribeiro M, 2004, J MED SCREEN, V11, P141, DOI 10.1258/0969141041732184; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Goddard AF, 2010, GUT, V59, P1270, DOI 10.1136/gut.2009.182089; Isomoto H, 2004, AM J MED, V117, P429, DOI 10.1016/j.amjmed.2004.01.030; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Joo YE, 2013, GUT LIVER, V7, P303, DOI 10.5009/gnl.2013.7.3.303; Kapadia CR, 2003, J CLIN GASTROENTEROL, V36, pS29, DOI 10.1097/00004836-200305001-00006; Kawashima J, 2009, J GASTROENTEROL, V44, P1046, DOI 10.1007/s00535-009-0120-0; Lee CK, 2010, J GASTROEN HEPATOL, V25, P1507, DOI 10.1111/j.1440-1746.2010.006367.x; Lee JH, 2016, SURG ENDOSC, V30, P3987, DOI 10.1007/s00464-015-4710-z; Leja M, 2011, ADV MED SCI-POLAND, V56, P145, DOI 10.2478/v10039-011-0040-0; Lim H, 2014, SURG ENDOSC, V28, P1256, DOI 10.1007/s00464-013-3316-6; McNicholl AG, 2014, EUR J GASTROEN HEPAT, V26, P941, DOI 10.1097/MEG.0000000000000132; Meining A, 2002, J CLIN PATHOL, V55, P770, DOI 10.1136/jcp.55.10.770; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Miki K, 2009, DIGEST ENDOSC, V21, P78, DOI 10.1111/j.1443-1661.2009.00839.x; Nam JH, 2014, HELICOBACTER, V19, P81, DOI 10.1111/hel.12112; Nam SY, 2010, AM J GASTROENTEROL, V105, P2153, DOI 10.1038/ajg.2010.251; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Park DI, 2001, ENDOSCOPY, V33, P501, DOI 10.1055/s-2001-15089; Pizzi M, 2014, DIGEST DIS, V32, P265, DOI 10.1159/000357857; Rugge M, 2005, GASTROENTEROLOGY, V129, P1807, DOI 10.1053/j.gastro.2005.09.056; Rugge M, 2010, ALIMENT PHARM THER, V31, P1104, DOI 10.1111/j.1365-2036.2010.04277.x; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; SARAGA EP, 1987, AM J SURG PATHOL, V11, P788, DOI 10.1097/00000478-198710000-00006; Shiotani A, 2006, VIRCHOWS ARCH, V449, P652, DOI 10.1007/s00428-006-0300-8; Sipponen P, 2007, SCAND J GASTROENTERO, V42, P2, DOI 10.1080/00365520600863720; Storskrubb T, 2008, SCAND J GASTROENTERO, V43, P1448, DOI 10.1080/00365520802273025; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaananen H, 2003, EUR J GASTROEN HEPAT, V15, P885, DOI 10.1097/01.meg.0000059169.46867.01; Varis K, 2000, SCAND J GASTROENTERO, V35, P950; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Yoon SB, 2016, GASTROINTEST ENDOSC, V83, P1176, DOI 10.1016/j.gie.2015.10.024	43	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169456	10.1371/journal.pone.0169456	http://dx.doi.org/10.1371/journal.pone.0169456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072871	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200022
J	Bermudez, JY; Webber, HC; Brown, B; Braun, TA; Clark, AF; Mao, WM				Bermudez, Jaclyn Y.; Webber, Hannah C.; Brown, Bartley; Braun, Terry A.; Clark, Abbot F.; Mao, Weiming			A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing	PLOS ONE			English	Article							INDUCED OCULAR HYPERTENSION; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE RESPONSE; CARTILAGE-HAIR HYPOPLASIA; LINKED ACTIN NETWORKS; LONG PENTRAXIN PTX3; EX-VIVO MODEL; TOPICAL CORTICOSTEROIDS; MICROARRAY ANALYSIS; OUTFLOW RESISTANCE	The most common ocular side effect of glucocorticoid (GC) therapy is GC-induced ocular hypertension (OHT) and GC-induced glaucoma (GIG). GC-induced OHT occurs in about 40% of the general population, while the other 60% are resistant. This study aims to determine the genes and pathways involved in differential GC responsiveness in the trabecular meshwork (TM). Using paired bovine eyes, one eye was perfusion-cultured with 100nM dexamethasone (DEX), while the fellow eye was used to establish a bovine TM (BTM) cell strain. Based on maximum IOP change in the perfused eye, the BTM cell strain was identified as a DEX-responder or non-responder strain. Three responder and three non-responder BTM cell strains were cultured, treated with 0.1% ethanol or 100nM DEX for 7 days. RNA and proteins were extracted for RNA sequencing (RNAseq), qPCR, and Western immunoblotting (WB), respectively. Data were analyzed using the human and bovine genome databases as well as Tophat2 software. Genes were grouped and compared using Student's t-test. We found that DEX induced fibronectin expression in responder BTM cells but not in non-responder cells using WB. RNAseq showed between 93 and 606 differentially expressed genes in different expression groups between responder and non-responder BTM cells. The data generated by RNAseq were validated using qPCR. Pathway analyses showed 35 pathways associated with differentially expressed genes. These genes and pathways may play important roles in GC-induced OHT and will help us to better understand differential ocular responsiveness to GCs.	[Bermudez, Jaclyn Y.; Webber, Hannah C.; Braun, Terry A.; Clark, Abbot F.; Mao, Weiming] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, 3500 Camp Bowie Blvd, Ft Worth, TX 76203 USA; [Brown, Bartley; Braun, Terry A.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Brown, Bartley; Braun, Terry A.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Brown, Bartley; Braun, Terry A.] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; University of Iowa; University of Iowa; University of Iowa	Mao, WM (corresponding author), Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, 3500 Camp Bowie Blvd, Ft Worth, TX 76203 USA.	Weiming.mao@unthsc.edu			National Eye Institute [R21EY023048]; National Institutes of Health training grant in the Neurobiology of Aging [T32 AG20494]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health training grant in the Neurobiology of Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Eye Institute R21EY023048 (W.M.), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also funded by a National Institutes of Health training grant in the Neurobiology of Aging T32 AG20494 (J.Y.B & H.C.W.), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga M, 2014, INVEST OPHTH VIS SCI, V55, P5497, DOI 10.1167/iovs.14-14519; ARMALY MF, 1965, FED PROC, V24, P1274; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Babizhayev MA, 2011, CURR MOL MED, V11, P528, DOI 10.2174/156652411800615126; BECKER B, 1964, AM J OPHTHALMOL, V57, P543, DOI 10.1016/0002-9394(64)92500-0; BECKER BERNARD, 1965, INVEST OPHTHALMOL, V4, P198; Bhattacherjee P, 1999, ARCH OPHTHALMOL-CHIC, V117, P361, DOI 10.1001/archopht.117.3.361; Birke MT, 2011, INVEST OPHTH VIS SCI, V52, P468, DOI 10.1167/iovs.10-5990; Briggs ELA, 2015, MOL VIS, V21, P1162; Buie LK, 2013, INVEST OPHTH VIS SCI, V54, P5441, DOI 10.1167/iovs.13-11651; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chatterjee A, 2014, J OCUL PHARMACOL TH, V30, P447, DOI 10.1089/jop.2014.0013; Chen WL, 2016, CANCER CELL, V30, P779, DOI 10.1016/j.ccell.2016.09.006; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Danias J, 2011, INVEST OPHTH VIS SCI, V52, P8636, DOI 10.1167/iovs.11-7563; Fan BJ, 2008, INVEST OPHTH VIS SCI, V49, P1886, DOI 10.1167/iovs.07-0414; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Fingert JH, 2001, INVEST OPHTH VIS SCI, V42, P145; Flottmann R, 2016, EUR J HUM GENET, V24, P1132, DOI 10.1038/ejhg.2015.266; Gagen D, 2014, J OCUL PHARMACOL TH, V30, P110, DOI 10.1089/jop.2013.0176; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gerometta R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1492, DOI 10.1001/archopht.122.10.1492; Gerometta R, 2009, INVEST OPHTH VIS SCI, V50, P669, DOI 10.1167/iovs.08-2410; Gerometta R, 2010, INVEST OPHTH VIS SCI, V51, P3042, DOI 10.1167/iovs.09-4920; Hayashi H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00012; Ishibashi T, 2002, INVEST OPHTH VIS SCI, V43, P3691; Jain A, 2014, J OCUL PHARMACOL TH, V30, P121, DOI 10.1089/jop.2013.0239; JOHNSON DH, 1987, INVEST OPHTH VIS SCI, V28, P945; JONAS JB, 1990, GRAEF ARCH CLIN EXP, V228, P407, DOI 10.1007/BF00927251; Kelley MJ, 2007, INVEST OPHTH VIS SCI, V48, P2634, DOI 10.1167/iovs.06-1445; KITAZAWA Y, 1981, ARCH OPHTHALMOL-CHIC, V99, P813; Lerzo F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/730828; Leung YF, 2003, MOL VIS, V9, P425; LEWIS JM, 1988, AM J OPHTHALMOL, V106, P607, DOI 10.1016/0002-9394(88)90595-8; Ling XB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091483; Liton PB, 2009, MOL VIS, V15, P326; Liton PB, 2005, BIOCHEM BIOPH RES CO, V337, P1229, DOI 10.1016/j.bbrc.2005.09.182; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Luna C, 2009, MOL VIS, V15, P534; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mao WM, 2013, INVEST OPHTH VIS SCI, V54, P3600, DOI 10.1167/iovs.13-12033; Mao WM, 2012, EXP EYE RES, V105, P53, DOI 10.1016/j.exer.2012.10.007; Mao WM, 2012, INVEST OPHTH VIS SCI, V53, P7043, DOI 10.1167/iovs.12-9664; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Miyara N, 2008, JPN J OPHTHALMOL, V52, P84, DOI 10.1007/s10384-007-0507-5; Morgan JT, 2015, ONCOTARGET, V6, P15362, DOI 10.18632/oncotarget.3798; Naschberger E, 2016, J CLIN INVEST, V126, P4187, DOI 10.1172/JCI78260; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; O'Reilly S, 2011, INVEST OPHTH VIS SCI, V52, P7316, DOI 10.1167/iovs.10-6692; Ohnaka K, 2005, BIOCHEM BIOPH RES CO, V329, P177, DOI 10.1016/j.bbrc.2005.01.117; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Overby DR, 2015, EXP EYE RES, V141, P15, DOI 10.1016/j.exer.2015.06.002; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Pang IH, 2001, EXP EYE RES, V73, P815, DOI 10.1006/exer.2001.1087; Pang IH, 2000, J GLAUCOMA, V9, P468; Raghunathan VK, 2015, INVEST OPHTH VIS SCI, V56, P4447, DOI 10.1167/iovs.15-16739; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rogler LE, 2014, HUM MOL GENET, V23, P368, DOI 10.1093/hmg/ddt427; Rozsa FW, 2006, MOL VIS, V12, P125; Russell P, 1996, J GLAUCOMA, V5, P317; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; SAMPLES JR, 1993, INVEST OPHTH VIS SCI, V34, P3386; Sato S, 2013, TOXICOL APPL PHARM, V273, P90, DOI 10.1016/j.taap.2013.08.017; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; Soria V, 2010, J PINEAL RES, V49, P35, DOI 10.1111/j.1600-079X.2010.00763.x; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; TICHO U, 1979, BRIT J OPHTHALMOL, V63, P646, DOI 10.1136/bjo.63.9.646; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Villarreal G, 2014, INVEST OPHTH VIS SCI, V55, P7433, DOI 10.1167/iovs.13-12652; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wang WH, 2001, MOL VIS, V7, P89; Whitlock NA, 2010, INVEST OPHTH VIS SCI, V51, P6496, DOI 10.1167/iovs.10-5430; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; ZHAN GL, 1992, EXP EYE RES, V54, P211, DOI 10.1016/S0014-4835(05)80210-6; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou TB, 2013, INT J MOL SCI, V14, P226, DOI 10.3390/ijms14010226; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	83	14	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169671	10.1371/journal.pone.0169671	http://dx.doi.org/10.1371/journal.pone.0169671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068412	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900056
J	Wasilkowski, D; Nowak, A; Plaza, G; Mrozik, A				Wasilkowski, Daniel; Nowak, Anna; Plaza, Grazyna; Mrozik, Agnieszka			Effects of Pulp and Na-Bentonite Amendments on the Mobility of Trace Elements, Soil Enzymes Activity and Microbial Parameters under Ex Situ Aided Phytostabilization	PLOS ONE			English	Article							CONTAMINATED SOILS; FUNCTIONAL DIVERSITY; ORGANIC AMENDMENTS; RISK-ASSESSMENT; LEAD; REMEDIATION; METALS; COPPER; ZN; PB	The objective of this study was to explore the potential use of pulp (by-product) from coffee processing and Na-bentonite (commercial product) for minimizing the environmental risk of Zn, Pb and Cd in soil collected from a former mine and zinc-lead smelter. The effects of soil amendments on the physicochemical properties of soil, the structural and functional diversity of the soil microbiome as well as soil enzymes were investigated. Moreover, biomass of Festuca arundinacea Schreb. (cultivar Asterix) and the uptake of trace elements in plant tissues were studied. The outdoor pot set contained the following soils: control soil (initial), untreated soil (without additives) with grass cultivation and soils treated (with additives) with and without plant development. All of the selected parameters were measured at the beginning of the experiment (t(0)), after 2 months of chemical stabilization (t(2)) and at the end of the aided phytostabilization process (t(14)). The obtained results indicated that both amendments efficiently immobilized the bioavailable fractions of Zn (87-91%) and Cd (70-83%) at t(14); however, they were characterized by a lower ability to bind Pb (33-50%). Pulp and Na-bentonite drastically increased the activity of dehydrogenase (70- and 12-fold, respectively) at t14, while the activities of urease, acid and alkaline phosphatases differed significantly depending on the type of material that was added into the soil. Generally, the activities of these enzymes increased; however, the increase was greater for pulp (3.5-6-fold) than for the Na-bentonite treatment (1.3-2.2-fold) as compared to the control. Soil additives significantly influenced the composition and dynamics of the soil microbial biomass over the experiment. At the end, the contribution of microbial groups could be ordered as follows: gram negative bacteria, fungi, gram positive bacteria, actinomycetes regardless of the type of soil enrichment. Conversely, the shift in the functional diversity of the microorganisms in the treated soils mainly resulted from plant cultivation. Meanwhile, the highest biomass of plants at t(14) was collected from the soil with Na-bentonite (6.7 g dw(-1)), while it was much lower in a case of pulp treatment (1.43-1.57 g dw(-1)). Moreover, the measurements of the heavy metal concentrations in the plant roots and shoots clearly indicated that the plants mainly accumulated metals in the roots but that the accumulation of individual metals depended on the soil additives. The efficiency of the accumulation of Pb, Cd and Zn by the roots was determined to be 124, 100 and 26% higher in the soil that was enriched with Na-bentonite in comparison with the soil that was amended with pulp, respectively. The values of the soil indices (soil fertility, soil quality and soil alteration) confirmed the better improvement of soil functioning after its enrichment with the pulp than in the presence of Na-bentonite.	[Wasilkowski, Daniel; Mrozik, Agnieszka] Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland; [Nowak, Anna] Univ Silesia, August Chelkowski Inst Phys, Katowice, Poland; [Plaza, Grazyna] Inst Ecol Ind Areas, Dept Environm Microbiol, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Institute for Ecology of Industrial Areas	Wasilkowski, D (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Biochem, Katowice, Poland.	daniel.wasilkowski@us.edu.pl	Nowak, Anna/B-2224-2015; Wasilkowski, Daniel/ABD-5246-2020	Nowak, Anna/0000-0002-1489-2025; Wasilkowski, Daniel/0000-0001-5766-2767; Mrozik, Agnieszka/0000-0001-9312-7438; Plaza, Grazyna/0000-0001-5862-0905	National Science Centre, Poland [2015/17/N/NZ9/01109]	National Science Centre, Poland(National Science Centre, Poland)	This project was funded by National Science Centre, Poland No. 2015/17/N/NZ9/01109. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by National Science Centre, Poland No. 2015/17/N/NZ9/01109. We thank Michele Simmons who helped improve the English of the manuscript. We also thank dr. Andrzej Woznica from University of Silesia in Katowice for help of graphical data visualization as well as dr. Marta Pogrzeba and dr. Jacek Krzyak from The Institute for Ecology of Industrial Areas in Katowice for soil and seeds of grass.	Abubaker J, 2012, APPL ENERG, V99, P126, DOI 10.1016/j.apenergy.2012.04.050; Ahemad M., 2014, ARAB J CHEM; Alef K., 1995, METHODS APPL SOIL MI, P350; Alvarenga P, 2012, ENVIRON POLLUT, V161, P50, DOI 10.1016/j.envpol.2011.09.044; Ascher J, 2009, APPL SOIL ECOL, V41, P351, DOI 10.1016/j.apsoil.2009.01.001; Baker LR, 2011, APPL SOIL ECOL, V48, P1, DOI 10.1016/j.apsoil.2011.02.007; Balser TC, 2000, THESIS; Beesley L, 2014, ENVIRON POLLUT, V186, P195, DOI 10.1016/j.envpol.2013.11.026; Bending GD, 2002, SOIL BIOL BIOCHEM, V34, P1073, DOI 10.1016/S0038-0717(02)00040-8; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; Bolan NS, 2011, ADV AGRON, V112, P145, DOI 10.1016/B978-0-12-385538-1.00004-4; Cheng SF, 2002, WATER AIR SOIL POLL, V140, P73, DOI 10.1023/A:1020132106541; Dalvi A.A., 2013, ANN PLANT SCI, V2, P362, DOI [DOI 10.1155/2015/756120, rg/10.1155/2015/756120]; Edenborn SL, 2015, J ENVIRON MANAGE, V150, P226, DOI 10.1016/j.jenvman.2014.11.023; Epelde L, 2014, INT J PHYTOREMEDIAT, V16, P971, DOI 10.1080/15226514.2013.810578; Epelde L, 2009, J ENVIRON QUAL, V38, P2041, DOI 10.2134/jeq2009.0006; Erkossa T, 2007, AUST J SOIL RES, V45, P129, DOI 10.1071/SR06064; Fijalkowski K., 2012, IN YNIERIA EKOL, V15, P81; Frac M, 2012, SENSORS-BASEL, V12, P3253, DOI 10.3390/s120303253; FRIEDEL JK, 1994, BIOL FERT SOILS, V18, P291, DOI 10.1007/BF00570631; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Galende MA, 2014, J GEOCHEM EXPLOR, V145, P181, DOI 10.1016/j.gexplo.2014.06.006; Garcia-Sanchez M, 2015, J ENVIRON MANAGE, V162, P63, DOI 10.1016/j.jenvman.2015.07.042; Gomez-Sagasti MT, 2012, WATER AIR SOIL POLL, V223, P3249, DOI 10.1007/s11270-012-1106-8; Guala SD, 2010, ECOL MODEL, V221, P1148, DOI 10.1016/j.ecolmodel.2010.01.003; Hattab-Hambli N, 2016, CHEMOSPHERE, V145, P543, DOI 10.1016/j.chemosphere.2015.11.051; Jones J.B., 2001, LAB GUIDE CONDUCTING, DOI [DOI 10.1201/9781420025293, 10.1201/9781420025293]; Karami N, 2011, J HAZARD MATER, V191, P41, DOI 10.1016/j.jhazmat.2011.04.025; Kim RY, 2015, ENVIRON GEOCHEM HLTH, V37, P1041, DOI 10.1007/s10653-015-9695-y; Kohler J, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1930-0; Komarek M, 2013, ENVIRON POLLUT, V172, P9, DOI 10.1016/j.envpol.2012.07.045; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; Kumpiene J, 2014, SCI TOTAL ENVIRON, V496, P510, DOI 10.1016/j.scitotenv.2014.06.130; Lee SH, 2011, GEODERMA, V161, P1, DOI 10.1016/j.geoderma.2010.11.008; Li M, 2015, ENV GEOCHEM HLTH; Lindenmayer DB, 2011, TRENDS ECOL EVOL, V26, P641, DOI 10.1016/j.tree.2011.08.002; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lopareva-Pohu A, 2011, SCI TOTAL ENVIRON, V409, P647, DOI 10.1016/j.scitotenv.2010.10.040; McKinley VL, 2005, SOIL BIOL BIOCHEM, V37, P1946, DOI 10.1016/j.soilbio.2005.02.033; Melgar-Ramirez R, 2012, WATER AIR SOIL POLL, V223, P6123, DOI 10.1007/s11270-012-1345-8; Mingorance MD, 2014, J SOIL SEDIMENT, V14, P703, DOI 10.1007/s11368-013-0743-x; Nwachukwu OI, 2009, SOIL USE MANAGE, V25, P159, DOI 10.1111/j.1475-2743.2009.00212.x; Panagos P, 2013, ECOL INDIC, V24, P439, DOI 10.1016/j.ecolind.2012.07.020; Park JH, 2011, J HAZARD MATER, V185, P549, DOI 10.1016/j.jhazmat.2010.09.082; Parra A, 2016, CATENA, V136, P59, DOI 10.1016/j.catena.2015.07.018; Pavel PB, 2014, SCI TOTAL ENVIRON, P479; Paz-Ferreiro J, 2012, BIOL FERT SOILS, V48, P511, DOI 10.1007/s00374-011-0644-3; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Puglisi E, 2006, SOIL BIOL BIOCHEM, V38, P1673, DOI 10.1016/j.soilbio.2005.11.021; Puglisi E, 2005, CHEMOSPHERE, V61, P1548, DOI 10.1016/j.chemosphere.2005.04.106; Rizzi L, 2004, CHEMOSPHERE, V57, P1039, DOI 10.1016/j.chemosphere.2004.08.048; Stefanowicz A, 2006, POL J ENVIRON STUD, V15, P669; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Takac P, 2009, PLANT SOIL ENVIRON, V55, P167, DOI 10.17221/21/2009-PSE; Treonis AM, 2010, APPL SOIL ECOL, V46, P103, DOI 10.1016/j.apsoil.2010.06.017; Vandecasteele B, 2010, ENVIRON POLLUT, V158, P2181, DOI 10.1016/j.envpol.2010.02.017; Wasilkowski D, 2014, CLEAN-SOIL AIR WATER, V42, P1618, DOI 10.1002/clen.201300631; Watzinger A, 2014, EUR J SOIL SCI, V65, P40, DOI 10.1111/ejss.12100; Wilke BM, 2005, SOIL BIOL, V5, P47; Wyszkowska J, 2003, POL J ENVIRON STUD, V12, P473; Xiong J, 2015, PEDOSPHERE, V25, P250, DOI 10.1016/S1002-0160(15)60010-8; Zornoza R, 2015, GEODERMA, V245, P1, DOI 10.1016/j.geoderma.2015.01.007	62	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169688	10.1371/journal.pone.0169688	http://dx.doi.org/10.1371/journal.pone.0169688			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068396	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900058
J	Arrazola, MS; Ramos-Fernandez, E; Cisternas, P; Ordenes, D; Inestrosa, NC				Arrazola, Macarena S.; Ramos-Fernandez, Eva; Cisternas, Pedro; Ordenes, Daniela; Inestrosa, Nibaldo C.			Wnt Signaling Prevents the A beta Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SYNUCLEIN TRANSGENIC MICE; CYTOCHROME-C RELEASE; F-ATP SYNTHASE; ALZHEIMERS-DISEASE; CYCLOPHILIN-D; SYNAPTIC MITOCHONDRIA; HEXOKINASE-II; IN-VIVO; ISCHEMIA/REPERFUSION INJURY	Alzheimer's disease (AD) is a neurodegenerative disorder mainly known for synaptic impairment and neuronal cell loss, affecting memory processes. Beside these damages, mitochondria have been implicated in the pathogenesis of AD through the induction of the mitochondrial permeability transition pore (mPTP). The mPTP is a non-selective pore that is formed under apoptotic conditions, disturbing mitochondrial structure and thus, neuronal viability. In AD, A beta oligomers (A beta os) favor the opening of the pore, activating mitochondria-dependent neuronal cell death cascades. The Wnt signaling activated through the ligand Wnt3a has been described as a neuroprotective signaling pathway against amyloid-beta (A beta) peptide toxicity in AD. However, the mechanisms by which Wnt signaling prevents A beta os-induced neuronal cell death are unclear. We proposed here to study whether Wnt signaling protects neurons earlier than the late damages in the progression of the disease, through the preservation of the mitochondrial structure by the mPTP inhibition. To study specific events related to mitochondrial permeabilization we performed live-cell imaging from primary rat hippocampal neurons, and electron microscopy to analyze the mitochondrial morphology and structure. We report here that Wnt3a prevents an A beta os-induced cascade of mitochondrial events that leads to neuronal cell death. This cascade involves (a) mPTP opening, (b) mitochondrial swelling, (c) mitochondrial membrane potential loss and (d) cytochrome c release, thus leading to neuronal cell death. Furthermore, our results suggest that the activation of the Wnt signaling prevents mPTP opening by two possible mechanisms, which involve the inhibition of mitochondrial GSK-3 beta and/or the modulation of mitochondrial hexokinase II levels and activity. This study suggests a possible new approach for the treatment of AD from a mitochondrial perspective, and will also open new lines of study in the field of Wnt signaling in neuroprotection.	[Arrazola, Macarena S.; Ramos-Fernandez, Eva; Ordenes, Daniela; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol, Santiago, Chile; [Cisternas, Pedro] Univ Atacama, Fac Ciencias Natur, Dept Quim & Biol, Copiapo, Chile; [Inestrosa, Nibaldo C.] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile	Pontificia Universidad Catolica de Chile; Universidad de Atacama; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol, Santiago, Chile.; Inestrosa, NC (corresponding author), Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia.; Inestrosa, NC (corresponding author), Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas, Chile.	ninestrosa@bio.puc.cl		Arrazola, Macarena S./0000-0002-0840-8997	CONICYT-PFB from the Basal Center for Excellence in Science and Technology [12/2007]; Fondecyt [1120156, 3140355, 3150475]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)	CONICYT-PFB from the Basal Center for Excellence in Science and Technology; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grant CONICYT-PFB no. 12/2007 from the Basal Center for Excellence in Science and Technology to NCI (http://www.conicyt.cl/pia/sobre-pia/lineas-accion/centros-cientificos-y-tecnologicos-de-excelencia-programa-de-financiamiento-basal/) and by Fondecyt no. 1120156 to NCI (http://www.conicyt.cl/fondecyt/), as well as by a predoctoral fellowship from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) to MSA, Fondecyt Postdoctorado no. 3140355 to ER and by FONDECYT Postdoctorado no. 3150475 to PC (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Gail VW Johnson (Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY) for the kind gift of the mito-Cherry plasmid. We also thank Illustrative Science (www.illustrative-science.com) for the design of the mechanistic model presented in Fig 8, and Gloria Mendez for preparing the primary rat culture of hippocampal neurons. This work was supported by grant CONICYT-PFB no. 12/2007 from the Basal Center for Excellence in Science and Technology and by Fondecyt no. 1120156 to NCI, as well as by a predoctoral fellowship from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) to MSA, Fondecyt Post-doctorado no 3140355 to ERF and by FONDECYT Postdoctorado no. 3150475 to PC.	Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Arrazola MS, 2015, NEURONAL CELL DEATH, p[1254, 87 ~97]; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Balietti M, 2013, J ALZHEIMERS DIS, V34, P887, DOI 10.3233/JAD-121711; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; BERTONI JM, 1981, J NEUROCHEM, V37, P1523, DOI 10.1111/j.1471-4159.1981.tb06322.x; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Chiara F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00016; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; De Ferrari GV, 2014, CNS NEUROL DISORD-DR, V13, P745; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Fu HL, 2014, J HEPATOL, V61, P816, DOI 10.1016/j.jhep.2014.05.017; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gillessen T, 2002, BIOMED PHARMACOTHER, V56, P186, DOI 10.1016/S0753-3322(02)00184-1; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Godoy JA, 2013, J ALZHEIMERS DIS PAR, V3; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hernandez-Resendiz S, 2014, LIFE SCI, V108, P13, DOI 10.1016/j.lfs.2014.04.037; 김미정, 2012, [Applied Microscopy, 한국현미경학회지], V42, P179; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kawamoto EM, 2012, BRAZ J MED BIOL RES, V45, P58, DOI 10.1590/S0100-879X2011007500157; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Korkotian E, 1997, J NEUROSCI, V17, P1670; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li T, 2008, BBA-BIOENERGETICS, V1777, P1409, DOI 10.1016/j.bbabio.2008.08.002; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Linkermann A, 2016, CELL DEATH DIFFER, V23, P1, DOI 10.1038/cdd.2015.151; Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048; Marchionni I, 2009, NEUROSCIENCE, V164, P552, DOI 10.1016/j.neuroscience.2009.07.063; Orellana AMM, 2015, AGING-US, V7, P1094, DOI 10.18632/aging.100853; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Miura T, 2009, J PHARMACOL SCI, V109, P162, DOI 10.1254/jphs.08R27FM; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Moreira PI, 2001, BIOSCIENCE REP, V21, P789, DOI 10.1023/A:1015536808304; Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Nusse R, 2012, COLD SPRING HARB PER, V4, P1; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Paradis E, 1996, J NEUROSCI, V16, P7533; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Rana A, 2015, CLIN EXP PHARM PHYSL, V40, p445?452; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P1913, DOI 10.1016/j.bbadis.2013.06.012; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Shevtzova EF, 2001, B EXP BIOL MED+, V132, P1173, DOI 10.1023/A:1014559331402; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tanno M, 2014, J BIOL CHEM, V289, P29285, DOI 10.1074/jbc.M114.563924; Tapia-Rojas C, 2015, BIOCHEM J, V466, P415, DOI 10.1042/BJ20140207; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Tsai CS, 1998, BIOCHEM CELL BIOL, V76, P107, DOI 10.1139/bcb-76-1-107; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Warne J., 2015, J BIOL CHEM, DOI [10.1074/jbc.M115.700385, DOI 10. 1074/ JBC. M115. 700385]; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	93	33	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168840	10.1371/journal.pone.0168840	http://dx.doi.org/10.1371/journal.pone.0168840			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060833	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500040
J	Hamo, CE; Klem, I; Rao, SV; Songco, V; Najjar, S; Lakatta, EG; Raman, SV; Harrington, RA; Heitner, JF				Hamo, Carine E.; Klem, Igor; Rao, Sunil V.; Songco, Vincent; Najjar, Samer; Lakatta, Edward G.; Raman, Subha V.; Harrington, Robert A.; Heitner, John F.			The Systematic Evaluation of Identifying the Infarct Related Artery Utilizing Cardiac Magnetic Resonance in Patients Presenting with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; REVASCULARIZATION; CONTRAST; ERYTHROPOIETIN; VISUALIZATION; ANGIOPLASTY; PLAQUES; REVEAL	Background Identification of the infarct-related artery (IRA) in patients with STEMI using coronary angiography (CA) is often based on the ECG and can be challenging in patients with severe multi-vessel disease. The current study aimed to determine how often percutaneous intervention (PCI) is performed in a coronary artery different from the artery supplying the territory of acute infarction on cardiac magnetic resonance imaging (CMR). Methods We evaluated 113 patients from the Reduction of infarct Expansion and Ventricular remodeling with Erythropoetin After Large myocardial infarction (REVEAL) trial, who underwent CMR within 4+2 days of revascularization. Blinded reviewers interpreted CA to determine the IRA and CMR to determine the location of infarction on a 17-segment model. In patients with multiple infarcts on CMR, acuity was determined with T2-weighted imaging and/or evidence of microvascular obstruction. Results A total of 5 (4%) patients were found to have a mismatch between the IRA identified on CMR and CA. In 4/5 cases, there were multiple infarcts noted on CMR. Thirteen patients (11.5%) had multiple infarcts in separate territories on CMR with 4 patients (3.5%) having multiple acute infarcts and 9 patients (8%) having both acute and chronic infarcts. Conclusions In this select population of patients, the identification of the IRA by CA was incorrect in 4% of patients presenting with STEMI. Four patients with a mismatch had an acute infarction in more than one coronary artery territory on CMR. The role of CMR in patients presenting with STEMI with multi-vessel disease on CA deserves further investigation.	[Hamo, Carine E.] Stony Brook Univ Hosp, Dept Med, Stony Brook, NY USA; [Klem, Igor; Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Songco, Vincent; Heitner, John F.] New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA; [Najjar, Samer] MedStar Hlth Res Inst, Washington, DC USA; [Najjar, Samer; Lakatta, Edward G.] NIA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Raman, Subha V.] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Duke University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; MedStar Health Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Ohio; Ohio State University; Stanford University	Heitner, JF (corresponding author), New York Methodist Hosp, Div Cardiol, Brooklyn, NY 11215 USA.	jfh9003@nyp.org	Lakatta, Edward G/AAL-1447-2020	Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institute on Aging, the National Institutes of Health, Bethesda, MD, USA	Intramural Research Program of the National Institute on Aging, the National Institutes of Health, Bethesda, MD, USA	This work was supported by the Intramural Research Program of the National Institute on Aging, the National Institutes of Health, Bethesda, MD, USA. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00378352.	Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Bagai A, 2013, AM HEART J, V166, P684, DOI 10.1016/j.ahj.2013.07.027; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Galea N, 2014, RADIOL MED, V119, P309, DOI 10.1007/s11547-013-0341-4; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Grothoff M, 2012, CIRC-CARDIOVASC IMAG, V5, P60, DOI 10.1161/CIRCIMAGING.111.967810; Guazzi MD, 1997, CIRCULATION, V96, P1145, DOI 10.1161/01.CIR.96.4.1145; Hamon M, 2008, CRIT CARE MED, V36, P2023, DOI 10.1097/CCM.0b013e31817d213d; Kim RJ, 2008, CIRCULATION, V117, P629, DOI 10.1161/CIRCULATIONAHA.107.723262; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kumar A, 2006, J AM COLL CARDIOL, V48, P1969, DOI 10.1016/j.jacc.2006.05.078; Kwong Raymond Y, 2004, Crit Pathw Cardiol, V3, P25, DOI 10.1097/01.hpc.0000116584.57152.06; Levine GN, 2016, CATHETER CARDIO INTE, V87, P1001, DOI 10.1002/ccd.26325; Lockie T, 2009, CIRCULATION, V119, P1671, DOI 10.1161/CIRCULATIONAHA.108.816512; Masci PG, 2010, CIRCULATION, V122, P1405, DOI 10.1161/CIRCULATIONAHA.110.940254; Melloni C, 2010, AM HEART J, V160, P795, DOI 10.1016/j.ahj.2010.09.007; MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Spagnoli LG, 2002, J AM COLL CARDIOL, V40, P1579, DOI 10.1016/S0735-1097(02)02376-8; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0619108	10.1371/journal.pone.0169108	http://dx.doi.org/10.1371/journal.pone.0169108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060863	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500054
J	Lee, S; Barron, MG				Lee, Sehan; Barron, Mace G.			Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor alpha Agonists and Antagonists	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING; DOMAIN; IDENTIFICATION; PREDICTION; INSIGHTS; WILDLIFE; DOCKING; HUMANS; QSAR	The flexible hydrophobic ligand binding pocket (LBP) of estrogen receptor alpha (ER alpha) allows the binding of a wide variety of endocrine disruptors. Upon ligand binding, the LBP reshapes around the contours of the ligand and stabilizes the complex by complementary hydrophobic interactions and specific hydrogen bonds with the ligand. Here we present a framework for quantitative analysis of the steric and electronic features of the human ER alpha-ligand complex using three dimensional (3D) protein-ligand interaction description combined with 3D-QSAR approach. An empirical hydrophobicity density field is applied to account for hydrophobic contacts of ligand within the LBP. The obtained 3D-QSAR model revealed that hydrophobic contacts primarily determine binding affinity and govern binding mode with hydrogen bonds. Several residues of the LBP appear to be quite flexible and adopt a spectrum of conformations in various ER alpha-ligand complexes, in particular His524. The 3D-QSAR was combined with molecular docking based on three receptor conformations to accommodate receptor flexibility. The model indicates that the dynamic character of the LBP allows accommodation and stable binding of structurally diverse ligands, and proper representation of the protein flexibility is critical for reasonable description of binding of the ligands. Our results provide a quantitative and mechanistic understanding of binding affinity and mode of ER alpha agonists and antagonists that may be applicable to other nuclear receptors.	[Lee, Sehan; Barron, Mace G.] US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA	United States Environmental Protection Agency	Lee, S (corresponding author), US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA.	lee.sehan@epa.gov			U.S. EPA; U.S. Department of Energy	U.S. EPA(United States Environmental Protection Agency); U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported in part by an appointment to the Oak Ridge Institute for Science and Education participant research program supported by an interagency agreement between the U.S. EPA and the U.S. Department of Energy.; This research was supported in part by an appointment to the ORISE participant research program supported by an interagency agreement between the U.S. EPA and the U.S. Department of Energy. We thank Jeremy Leonard and Kamel Mansouri for review of a draft of this manuscript. The conclusions may not necessarily reflect the views of EPA and no official endorsement should be inferred.	Akahori Y, 2008, TOXICOL IN VITRO, V22, P225, DOI 10.1016/j.tiv.2007.08.004; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blizzard TA, 2005, BIOORG MED CHEM LETT, V15, P107, DOI 10.1016/j.bmcl.2004.10.036; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bovet C, 2007, PROTEIN SCI, V16, P938, DOI 10.1110/ps.062664107; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Delfosse V, 2014, ENVIRON HEALTH PERSP, V122, P1306, DOI 10.1289/ehp.1408453; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Ding D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S5; FANCHENKO ND, 1979, ACTA ENDOCRINOL-COP, V90, P167, DOI 10.1530/acta.0.0900167; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hanson RN, 2003, STEROIDS, V68, P143, DOI 10.1016/S0039-128X(02)00165-4; Harrison PTC, 1997, SCI TOTAL ENVIRON, V205, P97, DOI 10.1016/S0048-9697(97)00212-X; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Lee S, 2016, J COMPUT AID MOL DES, V30, P347, DOI 10.1007/s10822-016-9910-7; Lee S, 2015, TOXICOL SCI, V148, P60, DOI 10.1093/toxsci/kfv160; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; Liu H, 2002, J BIOL CHEM, V277, P9189, DOI 10.1074/jbc.M108335200; Mansouri K, 2016, ENVIRON HEALTH PERSP, V124, P1023, DOI 10.1289/ehp.1510267; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; NO KT, 1993, J AM CHEM SOC, V115, P2005, DOI 10.1021/ja00058a056; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; Rastinejad F, 2013, J MOL ENDOCRINOL, V51, pT1, DOI 10.1530/JME-13-0173; Robinson CV, 1996, J AM CHEM SOC, V118, P8646, DOI 10.1021/ja960211x; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/NCHEMBIO.1214, 10.1038/nchembio.1214]; Tong WD, 1997, ENDOCRINOLOGY, V138, P4022, DOI 10.1210/en.138.9.4022; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vajdos FF, 2007, PROTEIN SCI, V16, P897, DOI 10.1110/ps.062729207; van Lipzig MMH, 2004, J MED CHEM, V47, P1018, DOI 10.1021/jm0309607; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387; Zhang LY, 2013, TOXICOL APPL PHARM, V272, P67, DOI 10.1016/j.taap.2013.04.032	41	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169607	10.1371/journal.pone.0169607	http://dx.doi.org/10.1371/journal.pone.0169607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28061508	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500114
J	Min, CY; Moore, N; Shearstone, JR; Quayle, SN; Huang, PY; van Duzer, JH; Jarpe, MB; Jones, SS; Yang, M				Min, Chengyin; Moore, Nathan; Shearstone, Jeffrey R.; Quayle, Steven N.; Huang, Pengyu; van Duzer, John H.; Jarpe, Matthew B.; Jones, Simon S.; Yang, Min			Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; PHASE-I TRIAL; MYELODYSPLASTIC SYNDROME; EPIGENETIC THERAPY; VALPROIC ACID; DNA METHYLTRANSFERASE; PRECLINICAL MODELS; GENETIC DISSECTION; CELL LYMPHOMA; LUNG-CANCER	Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic stem cell disorders characterized by defects in myeloid differentiation and increased proliferation of neoplastic hematopoietic precursor cells. Outcomes for patients with AML remain poor, highlighting the need for novel treatment options. Aberrant epigenetic regulation plays an important role in the pathogenesis of AML, and inhibitors of DNA methyltransferase or histone deacetylase (HDAC) enzymes have exhibited activity in preclinical AML models. Combination studies with HDAC inhibitors plus DNA methyltransferase inhibitors have potential beneficial clinical activity in AML, however the toxicity profiles of non-selective HDAC inhibitors in the combination setting limit their clinical utility. In this work, we describe the preclinical development of selective inhibitors of HDAC1 and HDAC2, which are hypothesized to have improved safety profiles, for combination therapy in AML. We demonstrate that selective inhibition of HDAC1 and HDAC2 is sufficient to achieve efficacy both as a single agent and in combination with azacitidine in preclinical models of AML, including established AML cell lines, primary leukemia cells from AML patient bone marrow samples and in vivo xenograft models of human AML. Gene expression profiling of AML cells treated with either an HDAC1/2 inhibitor, azacitidine, or the combination of both have identified a list of genes involved in transcription and cell cycle regulation as potential mediators of the combinatorial effects of HDAC1/2 inhibition with azacitidine. Together, these findings support the clinical evaluation of selective HDAC1/2 inhibitors in combination with azacitidine in AML patients.	[Min, Chengyin; Moore, Nathan; Shearstone, Jeffrey R.; Quayle, Steven N.; Huang, Pengyu; van Duzer, John H.; Jarpe, Matthew B.; Jones, Simon S.; Yang, Min] Acetylon Pharmaceut Inc, Boston, MA 02210 USA		Jones, SS (corresponding author), Acetylon Pharmaceut Inc, Boston, MA 02210 USA.	sjones@acetylon.com		Shearstone, Jeffrey/0000-0002-6875-1826	Acetylon Pharmaceuticals	Acetylon Pharmaceuticals	Funding was provided by Acetylon Pharmaceuticals (http://www.acetylon.com). The funder provided support in the form of research materials and salaries for authors CM, NM, JRS, SNQ, PH, JHD, MBJ, SSJ and MY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Bennett TA, 2014, CL LYMPH MYELOM LEUK, V14, P305, DOI 10.1016/j.clml.2013.11.006; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bose P, 2014, LEUKEMIA RES, V38, P862, DOI 10.1016/j.leukres.2014.06.007; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Ceccacci E, 2016, BRIT J CANCER, V114, P605, DOI 10.1038/bjc.2016.36; Celton M, 2014, LEUKEMIA, V28, P1617, DOI 10.1038/leu.2014.67; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; CHRISTMAN JK, 1983, CANCER RES, V43, P763; Dasari A, 2013, INVEST NEW DRUG, V31, P115, DOI 10.1007/s10637-012-9812-z; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Fiskus W, 2014, MOL CANCER THER, V13, P1142, DOI 10.1158/1535-7163.MCT-13-0770; Fiskus W, 2009, CANCER BIOL THER, V8, P939, DOI 10.4161/cbt.8.10.8213; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Fong CY, 2014, HAEMATOLOGICA, V99, P1772, DOI 10.3324/haematol.2013.092007; Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Gojo I, 2013, CLIN CANCER RES, V19, P1838, DOI 10.1158/1078-0432.CCR-12-3165; Greenblatt SM, 2014, LEUKEMIA, V28, P1396, DOI 10.1038/leu.2014.94; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Guha M, 2015, NAT REV DRUG DISCOV, V14, P226, DOI 10.1038/nrd4583; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Issa JP, 2015, CANCER-AM CANCER SOC, V121, P556, DOI 10.1002/cncr.29085; Johnson DP, 2015, ONCOTARGET, V6, P4863, DOI 10.18632/oncotarget.3120; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones Suzanne F, 2011, Clin Adv Hematol Oncol, V9, P225; Kato T, 2015, LEUKEMIA, V29, P576, DOI 10.1038/leu.2014.281; Kirschbaum M, 2014, BRIT J HAEMATOL, V167, P185, DOI 10.1111/bjh.13016; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lainey E, 2013, ONCOGENE, V32, P4331, DOI 10.1038/onc.2012.469; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Lubbert M, 2015, CANCER-AM CANCER SOC, V121, P498, DOI 10.1002/cncr.29083; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Matthews GM, 2015, BLOOD, V126, P2392, DOI 10.1182/blood-2015-03-632984; Matulonis U, 2015, CANCER CHEMOTH PHARM, V76, P417, DOI 10.1007/s00280-015-2813-9; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; MURAKAMI T, 1995, CANCER RES, V55, P3093; Nishioka C, 2011, LEUKEMIA RES, V35, P932, DOI 10.1016/j.leukres.2011.04.004; Novotny-Diermayr V, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.14; Ononye SN, 2012, PHARM PAT ANAL, V1, P207, DOI 10.4155/PPA.12.21; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pleyer L, 2015, DRUG METAB REV, V47, P252, DOI 10.3109/03602532.2014.995379; Pleyer L, 2014, ANN HEMATOL, V93, P1825, DOI 10.1007/s00277-014-2126-9; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rudolph D, 2015, J PHARMACOL EXP THER, V352, P579, DOI 10.1124/jpet.114.221150; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Schneider BJ, 2012, INVEST NEW DRUG, V30, P249, DOI 10.1007/s10637-010-9503-6; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shearstone JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153767; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Shin DY, 2016, CANCER CHEMOTH PHARM, V77, P865, DOI 10.1007/s00280-016-3005-y; Shiozawa K, 2009, CLIN CANCER RES, V15, P1698, DOI 10.1158/1078-0432.CCR-08-1587; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Simon R, 2007, CANCER INFORM, V3, P11; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Stubbs MC, 2015, CLIN CANCER RES, V21, P2348, DOI 10.1158/1078-0432.CCR-14-1290; Su YC, 2012, HEMATOLOGY, V17, P41, DOI 10.1179/102453312X13221316477624; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Sutherland MK, 2010, MABS, V2, P2; Tan P, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.68; Tarhini AA, 2013, ANTICANCER RES, V33, P4475; Tian C, 2015, ANN HEMATOL, V94, P1477, DOI 10.1007/s00277-015-2413-0; Tian C, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S83511; Voso MT, 2015, CURR OPIN ONCOL, V27, P532, DOI 10.1097/CCO.0000000000000231; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047; Wouters BJ, 2016, BLOOD, V127, P42, DOI 10.1182/blood-2015-07-604512; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhou L, 2013, LEUKEMIA, V27, P1358, DOI 10.1038/leu.2012.366	92	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169128	10.1371/journal.pone.0169128	http://dx.doi.org/10.1371/journal.pone.0169128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060870	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500055
J	Sabbaghizadeh, R; Shamsudin, R; Deyhimihaghighi, N; Sedghi, A				Sabbaghizadeh, Rahim; Shamsudin, Roslinda; Deyhimihaghighi, Najmeh; Sedghi, Arman			Enhancement of Dose Response and Nuclear Magnetic Resonance Image of PAGAT Polymer Gel Dosimeter by Adding Silver Nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; RADIATION	In the present study, the normoxic polyacrylamide gelatin and tetrakis hydroxy methyl phosphoniun chloride (PAGAT) polymer gel dosimeters were synthesized with and without the presence of silver (Ag) nanoparticles. The amount of Ag nanoparticles varied from 1 to 3 ml with concentration 3.14 g/l, thus forming two types of PAGAT polymer gel dosimeters before irradiating them with 6 to 25 Gy produced by 1.25-MeV 60 Co gamma rays. In this range, the predominant gamma ray interaction with matter is by Compton scattering effect, as the photoelectric absorption effect diminishes. MRI was employed when evaluating the polymerization of the dosimeters and the gray scale of the MRI film was determined via an optical densitometer. Subsequent analyses of optical densities revealed that the extent of polymerization increased with the increase in the absorbed dose, while the increase of penetration depth within the dosimeters has a reverse effect. Moreover, a significant increase in the optical density-dose response (11.82%) was noted for dosimeters containing 2 ml Ag nanoparticles.	[Sabbaghizadeh, Rahim; Shamsudin, Roslinda] Natl Univ Malaysia, Fac Sci & Technol, Dept Phys, Bangi, Selangor, Malaysia; [Deyhimihaghighi, Najmeh] Univ Putra Malaysia, Dept Phys, Upm Serdang, Selangor, Malaysia; [Sedghi, Arman] Imam Khomeini Int Univ, Dept Mat Engn, Qazvin, Iran	Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Putra Malaysia; Imam Khomeini International University	Sabbaghizadeh, R (corresponding author), Natl Univ Malaysia, Fac Sci & Technol, Dept Phys, Bangi, Selangor, Malaysia.	sabba@ukm.edu.my		Sedghi, Arman/0000-0003-0158-8590	National University of Malayisa (UKM) [DIP-2015-017]	National University of Malayisa (UKM)	This work has been supported by the National University of Malayisa (UKM) Grant Research Fellowship, under grant No. DIP-2015-017.; This work has been supported by the National University of Malayisa (UKM) Grant Research Fellowship, under grant No. DIP-2015-017. The authors would like to thank Ms. Fatemeh Deldarabdolmaleki for valuable assistance in this research work.	ADAMS FH, 1977, RADIOLOGY, V124, P823, DOI 10.1148/124.3.823; Azadbakht B, 2009, J PHYS C SER, V164; Azadbakht B, 2012, RES J APPL SCI, V4, P232; Cai WB, 2007, SMALL, V3, P1840, DOI 10.1002/smll.200700351; Caro C, 2010, SILVER NANOPARTICLES, P201; Evans RD, 1972, AM I PHYS HDB; Funaro M, 2011, MICRO NANO LETT, V6, P759, DOI 10.1049/mnl.2011.0201; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hainfeld JF, 2014, BRIT J RADIOLOGY; Herold DM, 2000, INT J RADIAT BIOL, V76, P1357, DOI 10.1080/09553000050151637; Jones BL, 2010, MED PHYS, V37, P3809, DOI 10.1118/1.3455703; Khan F. M., 2003, PHYS RAD THERAPY, V3; Lee KS, 2006, J PHYS CHEM B, V110, P19220, DOI 10.1021/jp062536y; Mafune F, 2000, J PHYS CHEM B, V104, P8333, DOI 10.1021/jp001803b; Mafune F, 2003, J PHYS CHEM B, V107, P4218, DOI 10.1021/jp021580k; Marques T, J PHYS C SERIES, V250; Maryanski M., 1992, P INT SOC MAGN RES M; Radaideh K, 2010, BIOHEALTH SC B, V2, P38; Sabbaghizadeh R, 2013, J NANOELECTRON OPTOE, V8, P302, DOI 10.1166/jno.2013.1470; Venning AJ, 2005, PHYS MED BIOL, V50, P3875, DOI 10.1088/0031-9155/50/16/015; Venning AJ, 2005, INVESTIGATION RAD SE; Zehtabian M, 2012, RADIAT MEAS, V47, P139, DOI 10.1016/j.radmeas.2011.11.002; Zhang SX, 2009, BIOMED MICRODEVICES, V11, P925, DOI 10.1007/s10544-009-9309-5	23	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168737	10.1371/journal.pone.0168737	http://dx.doi.org/10.1371/journal.pone.0168737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060829	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500037
J	Tanthaisong, P; Imsoonthornruksa, S; Ngernsoungnern, A; Ngernsoungnern, P; Ketudat-Cairns, M; Parnpai, R				Tanthaisong, Prapot; Imsoonthornruksa, Sumeth; Ngernsoungnern, Apichart; Ngernsoungnern, Piyada; Ketudat-Cairns, Mariena; Parnpai, Rangsun			Enhanced Chondrogenic Differentiation of Human Umbilical Cord Wharton's Jelly Derived Mesenchymal Stem Cells by GSK-3 Inhibitors	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CHONDROCYTE DIFFERENTIATION; BETA-CATENIN; CARTILAGE TISSUE; IN-VITRO; PROLIFERATION; ACTIVATION; PATHWAY; LITHIUM; TRANSCRIPTION	Articular cartilage is an avascular, alymphatic, and aneural system with very low regeneration potential because of its limited capacity for self-repair. Mesenchymal stem cells (MSCs) are the preferred choice for cell-based therapies. Glycogen synthase kinase 3 (GSK-3) inhibitors are compounds that can induce the Wnt signaling pathway, which is involved in chondrogenesis and cartilage development. Here, we investigated the influence of lithium chloride (LiCI) and SB216763 synergistically with TGF-beta 3 on chondrogenic differentiation in human mesenchymal stem cells derived from Wharton's jelly tissue (hWJ-MSCs). hWJ-MSCs were cultured and chondrogenic differentiation was induced in monolayer and pellet experiments using chondrogenic medium, chondrogenic medium supplemented with LiCI, or SB216763 for 4 weeks. After in vitro differentiation, cultured cells were examined for the expression of Sox9, ACAN, Col2a1, and beta-catenin markers. Glycosaminoglycan (GAG) accumulation was also examined by Alcian blue staining. The results indicated that SB216763 was more effective than LiCI as evidenced by a higher up-regulation of the expression of cartilage-specific markers, including Sox9, ACAN, Col2a1 as well as GAG accumulation. Moreover, collagen type II expression was strongly observed in cells cultured in the chondrogenic medium + SB216763 as evidenced by western blot analysis. Both treatments appeared to mediate the Wnt signaling pathway by up-regulating p-catenin gene expression. Further analyses showed that all treatments suppressed the progression of chondrocyte hypertrophy, determined by decreased expression of Co110a1 and Runx2. These results indicate that LiCI and SB216763 are potential candidates for further in vivo therapeutic trials and would be of great importance for cartilage regeneration.	[Tanthaisong, Prapot; Imsoonthornruksa, Sumeth; Ketudat-Cairns, Mariena; Parnpai, Rangsun] Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima, Thailand; [Tanthaisong, Prapot; Imsoonthornruksa, Sumeth; Ketudat-Cairns, Mariena; Parnpai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand; [Ngernsoungnern, Apichart; Ngernsoungnern, Piyada] Suranaree Univ Technol, Sch Anat, Inst Sci, Nakhon Ratchasima, Thailand	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology	Parnpai, R (corresponding author), Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima, Thailand.; Parnpai, R (corresponding author), Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand.	rangsun@g.sut.ac.th		Ketudat-Cairns, Mariena/0000-0003-2662-6573	Bangkok Stem Cell Co., Ltd. Nakhon Pathom, Thailand; Suranaree University of Technology (SUT), the Office of the Higher Education Commission under NRU project of Thailand, Thailand Research Fund; SUT postgraduate research fellowships	Bangkok Stem Cell Co., Ltd. Nakhon Pathom, Thailand; Suranaree University of Technology (SUT), the Office of the Higher Education Commission under NRU project of Thailand, Thailand Research Fund; SUT postgraduate research fellowships	This work received financial support from the Bangkok Stem Cell Co., Ltd. Nakhon Pathom, Thailand and Suranaree University of Technology (SUT), the Office of the Higher Education Commission under NRU project of Thailand, Thailand Research Fund. Dr. Imsoonthornruksa was supported by SUT postgraduate research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2011, MOL BIOL CELL, V22, P1300, DOI 10.1091/mbc.E10-07-0566; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Dubovsky SL, 2005, PSYCHIAT CLIN N AM, V28, P349, DOI 10.1016/j.psc.2005.02.003; Eslaminejad MB, 2013, HISTOCHEM CELL BIOL, V140, P623, DOI 10.1007/s00418-013-1121-x; Fischer L, 2002, J BIOL CHEM, V277, P30870, DOI 10.1074/jbc.M109330200; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hasuike S, 2005, J GASTROEN HEPATOL, V20, P1753, DOI 10.1111/j.1440-1746.2005.03922.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Karl A, 2014, TISSUE ENG PT A, V20, P178, DOI [10.1089/ten.TEA.2013.0023, 10.1089/ten.tea.2013.0023]; Kawata K, 2010, J CELL PHYSIOL, V222, P138, DOI 10.1002/jcp.21930; Kirton JP, 2007, CIRC RES, V101, P581, DOI 10.1161/CIRCRESAHA.107.156372; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Krase A, 2014, OSTEOARTHR CARTILAGE, V22, P284, DOI 10.1016/j.joca.2013.11.011; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Narcisi R, 2015, STEM CELL REP, V4, P459, DOI 10.1016/j.stemcr.2015.01.017; Peran M, 2013, STEM CELL RES, V10, P464, DOI 10.1016/j.scr.2013.02.002; Petsa A, 2009, IN VITRO CELL DEV-AN, V45, P573, DOI 10.1007/s11626-009-9227-0; Pham VP, 2011, IN VITRO CELL DEV-AN, V47, P54, DOI 10.1007/s11626-010-9356-5; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Yang Z, 2012, STEM CELLS DEV, V21, P1966, DOI 10.1089/scd.2011.0376; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Zhu ZZ, 2014, FEBS J, V281, P5371, DOI 10.1111/febs.13081; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	19	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168059	10.1371/journal.pone.0168059	http://dx.doi.org/10.1371/journal.pone.0168059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060847	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500021
J	Elhag, O; Zhou, DZ; Song, Q; Soomro, AA; Cai, MM; Zheng, LY; Yu, ZN; Zhang, JB				Elhag, Osama; Zhou, Dingzhong; Song, Qi; Soomro, Abdul Aziz; Cai, Minmin; Zheng, Longyu; Yu, Ziniu; Zhang, Jibin			Screening, Expression, Purification and Functional Characterization of Novel Antimicrobial Peptide Genes from Hermetia illucens (L.)	PLOS ONE			English	Article							BLACK SOLDIER FLY; DIPTERA STRATIOMYIDAE LARVAE; ESCHERICHIA-COLI; ANTIBACTERIAL PEPTIDE; CHEMICAL-SYNTHESIS; INSECT DEFENSIN; SALIVARY-GLANDS; INNATE IMMUNITY; CECROPIN GENE; SARCOTOXIN IA	Antimicrobial peptides from a wide spectrum of insects possess potent microbicidal properties against microbial-related diseases. In this study, seven new gene fragments of three types of antimicrobial peptides were obtained from Hermetia illucens (L), and were named cecropinZl, sarcotoxinl, sarcotoxin (2a), sarcotoxin (2b), sarcotoxin3, stomoxpZH1, and stomoxynZH1(a). Among these genes, a 189-basepair gene (stomoxynZH1) was cloned into the pET32a expression vector and expressed in the Escherichia coli as a fusion protein with thioredoxin. Results show that Trx-stomoxynZH1 exhibits diverse inhibitory activity on various pathogens, including Gram-positive bacterium Staphylococcus aureus, Gramnegative bacterium Escherichia coli, fungus Rhizoctonia solani Khiin (rice)-10, and fungus Sclerotinia sclerotiorum (Lib.) de Bary-14. The minimum inhibitory concentration of Trx-stomoxynZH1 is higher against Gram-positive bacteria than against Gram-negative bacteria but similar between the fungal strains. These results indicate that H. illucens (L.) could provide a rich source for the discovery of novel antimicrobial peptides. Importantly, stomoxynZH1 displays a potential benefit in controlling antibiotic-resistant pathogens.	[Elhag, Osama; Zhou, Dingzhong; Song, Qi; Soomro, Abdul Aziz; Cai, Minmin; Zheng, Longyu; Yu, Ziniu; Zhang, Jibin] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Elhag, Osama] Omdurman Islamic Univ, Fac Sci & Technol, Khartoum, Sudan	Huazhong Agricultural University	Zhang, JB (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	zhangjb@mail.hzau.edu.cn			Special Fund for Agro-scientific Research in the Public Interest, China [201303094]; Natural Science Foundation of Hubei Province, China [2010CBB02002]	Special Fund for Agro-scientific Research in the Public Interest, China; Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This research was funded by the Special Fund for Agro-scientific Research in the Public Interest, China (201303094) and Natural Science Foundation of Hubei Province, China (2010CBB02002).	Alem D., 2014, Journal of Microbial and Biochemical Technology, V6, P268; Aly R, 1999, PROTEIN EXPRES PURIF, V16, P120, DOI 10.1006/prep.1999.1059; Bachanova K, 2002, APIDOLOGIE, V33, P259, DOI 10.1051/apido:2002015; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Boulanger N, 2002, J BIOL CHEM, V277, P49921, DOI 10.1074/jbc.M206296200; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; Butu M, 2011, ROM BIOTECH LETT, V16, P6135; Chernysh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130788; Choi WH, 2012, ENTOMOL RES, V42, P219, DOI 10.1111/j.1748-5967.2012.00465.x; Dang XL, 2010, J MED ENTOMOL, V47, P1141, DOI 10.1603/ME10016; Diener S, 2011, WASTE BIOMASS VALORI, V2, P357, DOI 10.1007/s12649-011-9079-1; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Holaskova E, 2015, BIOTECHNOL ADV, V33, P1005, DOI 10.1016/j.biotechadv.2015.03.007; Hu H, 2013, MOL CELLS, V35, P106, DOI 10.1007/s10059-013-2132-0; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Jin FL, 2006, PROTEIN EXPRES PURIF, V49, P39, DOI 10.1016/j.pep.2006.03.008; KANAI A, 1990, MOL CELL BIOL, V10, P6114, DOI 10.1128/MCB.10.12.6114; Khaledi N, 2015, J APPL MICROBIOL, V118, P704, DOI 10.1111/jam.12730; Kim W, 2011, J ASIA-PAC ENTOMOL, V14, P11, DOI 10.1016/j.aspen.2010.11.003; Kulkarni MM, 2011, CELL MICROBIOL, V13, P913, DOI 10.1111/j.1462-5822.2011.01589.x; Landon C, 2006, BIOPOLYMERS, V81, P92, DOI 10.1002/bip.20370; Lauth X, 1998, INSECT BIOCHEM MOLEC, V28, P1059, DOI 10.1016/S0965-1748(98)00101-5; Lee J, 2016, MOL BIOL REP, V43, P371, DOI 10.1007/s11033-016-3967-1; Liu QL, 2008, ENVIRON ENTOMOL, V37, P1525, DOI 10.1603/0046-225X-37.6.1525; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; MATSUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P128, DOI 10.1093/oxfordjournals.jbchem.a123151; Meiyalaghan Sathiyamoorthy, 2014, BMC Res Notes, V7, P777, DOI 10.1186/1756-0500-7-777; Memarpoor-Yazdi M, 2013, INT J PEPT RES THER, V19, P99, DOI 10.1007/s10989-012-9320-1; Oard S, 2004, J APPL MICROBIOL, V97, P169, DOI 10.1111/j.1365-2672.2004.02291.x; OKADA M, 1985, J BIOL CHEM, V260, P7174; Park SI, 2015, DEV COMP IMMUNOL, V52, P98, DOI 10.1016/j.dci.2015.04.018; Park SI, 2014, ENTOMOL RES, V44, P58, DOI 10.1111/1748-5967.12050; Poppel AK, 2015, ANTIMICROB AGENTS CH, V59, P2508, DOI 10.1128/AAC.05180-14; Rahnamaeian M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0293; Skosyrev VS, 2003, PROTEIN EXPRES PURIF, V28, P350, DOI 10.1016/S1046-5928(02)00697-6; TRYSELIUS Y, 1992, EUR J BIOCHEM, V204, P395, DOI 10.1111/j.1432-1033.1992.tb16648.x; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Wang H., 2012, J AGRON, V1, P1, DOI DOI 10.1007/S00253-011-3863-5; Wang KR, 2013, PEPTIDES, V39, P80, DOI 10.1016/j.peptides.2012.11.002; Wang ZZ, 2013, INSECT MOL BIOL, V22, P297, DOI 10.1111/imb.12021; Wang ZZ, 2013, J INSECT PHYSIOL, V59, P1095, DOI 10.1016/j.jinsphys.2013.08.011; Wei HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156321; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0669-9; Yang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018109; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yu D, 2006, PEPTIDES, V27, P31, DOI 10.1016/j.peptides.2005.06.020; Zhang JX, 2015, PEPTIDES, V68, P197, DOI 10.1016/j.peptides.2014.09.011; Zhang JB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20201	50	83	93	7	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169582	10.1371/journal.pone.0169582	http://dx.doi.org/10.1371/journal.pone.0169582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056070	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100055
J	Gao, JF; Pan, KL; Li, HY; Fan, XY; Sun, LX; Zhang, SJ; Gao, YQ				Gao, Jingfeng; Pan, Kailing; Li, Hongyu; Fan, Xiaoyan; Sun, Lixin; Zhang, Shujun; Gao, Yongqing			Application of GelGreen (TM) in Cesium Chloride Density Gradients for DNA -Stable Isotope Probing Experiments	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; RIBOSOMAL-RNA; BACTERIA; POPULATIONS; COMMUNITY; REVEALS; LINKING	In this study, GelGreen (TM) was investigated as a replacement for SYBR (R) Safe to stain DNA in cesium chloride (CsCI) density gradients for DNA-stable isotope probing (SIP) experiments. Using environmental DNA, the usage of GelGreen (TM) was optimized for sensitivity compared to SYBR (R) Safe, its optimal concentration, detection limit for environmental DNA and its application in environmental DNA-SIP assay. Results showed that GelGreen (TM) was more sensitive than SYBR (R) Safe, while the optimal dosage (15X concentration) needed was approximately one-third of SYBR (R) Safe, suggesting that its sensitivity was three times more superior than SYBR (R) Safe. At these optimal parameters, the detection limit of Gel-Green (TM)-stained environmental DNA was as low as 0.2 mu g, but the usage of 0.5 mu g environmental DNA was recommended to produce a more consistent DNA band. In addition, a modified needle extraction procedure was developed to withdraw DNA effectively by fractionating CsCI density gradients into four or five fractions. The successful application of Gel-Green (TM) staining with C-13-labeled DNA from enriched activated sludge suggests that this stain was an excellent alternative of SYBR (R) Safe in CsCI density gradients for DNA-SIP assays.	[Gao, Jingfeng; Pan, Kailing; Li, Hongyu; Fan, Xiaoyan; Sun, Lixin] Beijing Univ Technol, Coll Environm & Energy Engn, Natl Engn Lab Adv Municipal Wastewater Treatment, Beijing, Peoples R China; [Zhang, Shujun; Gao, Yongqing] Beijing Drainage Grp Co Ltd, Ctr Res & Dev, Beijing, Peoples R China	Beijing University of Technology	Gao, JF (corresponding author), Beijing Univ Technol, Coll Environm & Energy Engn, Natl Engn Lab Adv Municipal Wastewater Treatment, Beijing, Peoples R China.	gao.jingfeng@bjut.edu.cn	gao, jingfeng/AAD-6778-2020; Fan, Xiaoyan/Y-6695-2018	gao, jingfeng/0000-0002-5430-7812; Fan, Xiaoyan/0000-0002-2219-2029	National Natural Science Foundation of China [51078007, 51378027, 51578015]; Beijing Natural Science Foundation [8162010]; Beijing Talent Foundation of BJUT [2013-JH-L06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Talent Foundation of BJUT	This study is funded by National Natural Science Foundation of China (51078007, 51378027 and 51578015)(http://www.nsfc.gov.cn/), Beijing Natural Science Foundation (8162010 (http://www.bjnsf.org/) and Beijing Talent Foundation of BJUT (2013-JH-L06). All the fundings are received by JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Cua LS, 2011, FEMS MICROBIOL LETT, V319, P169, DOI 10.1111/j.1574-6968.2011.02277.x; Fan FL, 2014, SOIL BIOL BIOCHEM, V70, P12, DOI 10.1016/j.soilbio.2013.12.002; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Gao J. F., 2015, DESALIN WATER TREAT, P1; Grob C, 2015, ENVIRON MICROBIOL, V17, P4007, DOI 10.1111/1462-2920.12935; Haines AM, 2015, ELECTROPHORESIS, V36, P941, DOI 10.1002/elps.201400496; Jones MD, 2011, APPL ENVIRON MICROB, V77, P2984, DOI 10.1128/AEM.01942-10; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mao F, 2015, United States patent US, Patent No. [9,102,835, 9102835]; Martineau C, 2008, J MICROBIOL METH, V73, P199, DOI 10.1016/j.mimet.2008.01.016; Martineau C, 2010, APPL ENVIRON MICROB, V76, P5773, DOI 10.1128/AEM.03094-09; Meinhardt KA, 2015, ENV MICROBIOL REP, V7, P354, DOI 10.1111/1758-2229.12259; Neufeld JD, 2008, ENVIRON MICROBIOL, V10, P1526, DOI 10.1111/j.1462-2920.2008.01568.x; Neufeld JD, 2007, MICROB ECOL, V53, P435, DOI 10.1007/s00248-006-9125-x; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Serracca L, 2016, AQUACULT INT, V24, P199, DOI 10.1007/s10499-015-9919-2; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Zhang LM, 2012, ISME J, V6, P1032, DOI 10.1038/ismej.2011.168	24	1	1	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169554	10.1371/journal.pone.0169554	http://dx.doi.org/10.1371/journal.pone.0169554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056074	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100053
J	Kitazawa, M; Hida, S; Fujii, C; Taniguchi, S; Ito, K; Matsumura, T; Okada, N; Sakaizawa, T; Kobayashi, A; Takeoka, M; Miyagawa, S				Kitazawa, Masato; Hida, Shigeaki; Fujii, Chifumi; Taniguchi, Shun'ichiro; Ito, Kensuke; Matsumura, Tomio; Okada, Nagisa; Sakaizawa, Takashi; Kobayashi, Akira; Takeoka, Michiko; Miyagawa, Shin-ichi			ASC Induces Apoptosis via Activation of Caspase-9 by Enhancing Gap Junction - Mediated Intercellular Communication	PLOS ONE			English	Article							RECRUITMENT DOMAIN PROTEIN; BREAST-CANCER CELLS; DNA-DAMAGE; MOLECULAR PLATFORM; CONTACT INHIBITION; HUMAN-MELANOMA; KAPPA-B; INFLAMMASOME; METHYLATION; PATHWAY	ASC (apoptosis-associated speck-like protein containing a CARD) is a key adaptor molecule of inflammasomes that mediates inflammatory and apoptotic signals. Aberrant methylation-induced silencing of ASC has been observed in a variety of cancer cells, thus implicating ASC in tumor suppression, although this role remains incompletely defined especially in the context of closely neighboring cell proliferation. As ASC has been confirmed to be silenced by abnormal methylation in HT1080 fibrosarcoma cells as well, this cell line was investigated to characterize the precise role and mechanism of ASC in tumor progression. The effects of ASC were examined using in vitro cell cultures based on comparisons between low and high cell density conditions as well as in a xenograft murine model. ASC overexpression was established by insertion of the ASC gene into pcDNA3 and pMX-IRES-GFP vectors, the latter being packed into a retrovirus and subjected to reproducible competitive assays using parental cells as an internal control, for evaluation of cell viability. p21 and p53 were silenced using shRNA. Cell viability was suppressed in ASC-expressing transfectants as compared with control cells at high cell density conditions in in vitro culture and colony formation assays and in in vivo ectopic tumor formation trials. This suppression was not detected in low cell density conditions. Furthermore, remarkable progression of apoptosis was observed in ASC-introduced cells at a high cell density, but not at a low one. ASC-dependent apoptosis was mediated not by p21, p53, or caspase-1, but rather by cleavage of caspase-9 as well as by suppression of the NF-kappa B-related X-linked inhibitor-of-apoptosis protein. Caspase-9 cleavage was observed to be dependent on gap junction formation. The remarkable effect of ASC on the induction of apoptosis through caspase-9 and gap junctions revealed in this study may lead to promising new approaches in anticancer therapy.	[Kitazawa, Masato; Sakaizawa, Takashi; Kobayashi, Akira; Takeoka, Michiko; Miyagawa, Shin-ichi] Shinshu Univ, Dept Surg, Sch Med, Matsumoto, Nagano, Japan; [Kitazawa, Masato; Fujii, Chifumi; Taniguchi, Shun'ichiro; Ito, Kensuke; Matsumura, Tomio; Okada, Nagisa] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano, Japan; [Hida, Shigeaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Mizuho Ku, Nagoya, Aichi, Japan	Shinshu University; Shinshu University; Nagoya City University	Kitazawa, M (corresponding author), Shinshu Univ, Dept Surg, Sch Med, Matsumoto, Nagano, Japan.; Kitazawa, M (corresponding author), Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano, Japan.	kita118@shinshu-u.ac.jp		Fujii, Chifumi/0000-0001-8735-5274; Kitazawa, Masato/0000-0001-7737-7592	Ministry of Education, Culture, Sport, Science and Technology, Japan [20012020]	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a grant No 20012020 from the Ministry of Education, Culture, Sport, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bar J, 2004, ONCOGENE, V23, P2128, DOI 10.1038/sj.onc.1207325; Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Chung H, 2016, CELL DEATH DIFFER; Conway KE, 2000, CANCER RES, V60, P6236; Datta R, 2000, J BIOL CHEM, V275, P31733, DOI 10.1074/jbc.M910231199; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Ghebeh H, 2014, BRIT J CANCER, V111, P1552, DOI 10.1038/bjc.2014.453; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Kato H, 2016, ONCOTARGET, V7, P2009, DOI 10.18632/oncotarget.6511; Kavuri SM, 2011, J BIOL CHEM, V286, P16631, DOI 10.1074/jbc.M110.148585; Kelsey L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106437; Krutovskikh VA, 2002, ONCOGENE, V21, P4471, DOI 10.1038/sj.onc.1205567; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj.onc.1205187; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111; Levine JJ, 2003, ONCOGENE, V22, P3475, DOI 10.1038/sj.onc.1206430; Liu QL, 2015, ONCOTARGET, V6, P22706, DOI 10.18632/oncotarget.4256; Liu WM, 2013, J INVEST DERMATOL, V133, P518, DOI 10.1038/jid.2012.317; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McConnell BB, 2000, CANCER RES, V60, P6243; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Ritt MG, 2000, CANCER LETT, V158, P73, DOI 10.1016/S0304-3835(00)00507-3; Salat-Canela C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-31; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Wurstle ML, 2014, J BIOL CHEM, V289, P26277, DOI 10.1074/jbc.M114.590034; Yokoyama T, 2003, CANCER LETT, V202, P101, DOI 10.1016/j.canlet.2003.08.027; Zhang Y, 2012, HEMATOL ONCOL, V30, P62, DOI 10.1002/hon.1010	42	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169340	10.1371/journal.pone.0169340	http://dx.doi.org/10.1371/journal.pone.0169340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056049	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100033
J	Wan, DL; Wan, YQ; Yang, Q; Zou, B; Ren, WB; Ding, Y; Wang, Z; Wang, RG; Wang, K; Hou, XY				Wan, Dongli; Wan, Yongqing; Yang, Qi; Zou, Bo; Ren, Weibo; Ding, Yong; Wang, Zhen; Wang, Ruigang; Wang, Kai; Hou, Xiangyang			Selection of Reference Genes for qRT-PCR Analysis of Gene Expression in Stipa grandis during Environmental Stresses	PLOS ONE			English	Article							REAL-TIME PCR; PRECIPITATION CHANGE; SMIRN POPULATIONS; OXIDATIVE STRESS; QUANTITATIVE PCR; SALICYLIC-ACID; PLANT-GROWTH; P. SMIRN; NORMALIZATION; TOLERANCE	Stipa grandis P. Smirn. is a dominant plant species in the typical steppe of the Xilingole Plateau of Inner Mongolia. Selection of suitable reference genes for the quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) is important for gene expression analysis and research into the molecular mechanisms underlying the stress responses of S. grandis. In the present study, 15 candidate reference genes (EF1 beta, ACT, GAPDH, SamDC, CUL4, CAP, SNF2, SKIP1, SKIP5, SKIP11, UBC2, UBC15, UBC17, UCH, and HERC2) were evaluated for their stability as potential reference genes for qRT-PCR under different stresses. Four algorithms were used: GeNorm, NormFinder, BestKeeper, and RefFinder. The results showed that the most stable reference genes were different under different stress conditions: EF1beta and UBC15during drought and salt stresses; ACT and GAPDH under heat stress; SKIP5 and UBC17 under cold stress; UBC15 and HERC2 under high pH stress; UBC2 and UBC15 under wounding stress; EF1beta and UBC17 under jasmonic acid treatment; UBC15 and CUL4 under abscisic acid treatment; and HERC2 and UBC17 under salicylic acid treatment. EF1beta and HERC2 were the most suitable genes for the global analysis of all samples. Furthermore, six target genes, SgPOD, SgPAL, SgLEA, SgLOX, SgHSP90 and SgPR1, were selected to validate the most and least stable reference genes under different treatments. Our results provide guidelines for reference gene selection for more accurate qRT-PCR quantification and will promote studies of gene expression in S. grandis subjected to environmental stress.	[Wan, Dongli; Ren, Weibo; Ding, Yong; Wang, Zhen; Wang, Kai; Hou, Xiangyang] Chinese Acad Agr Sci, Inst Grassland Res, Key Lab Grassland Resources & Utilizat, Minist Agr, Hohhot, Peoples R China; [Wan, Yongqing; Yang, Qi; Zou, Bo; Wang, Ruigang] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Ministry of Agriculture & Rural Affairs; Inner Mongolia Agricultural University	Hou, XY (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Key Lab Grassland Resources & Utilizat, Minist Agr, Hohhot, Peoples R China.	Houxy16@126.com			National Basic Research Program of China (973 program) [2014CB138804]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2014BS0330]; Central Non-profit Research Institutes Fundamental Research Funds of China [1610332015004]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of Inner Mongolia Autonomous Region of China; Central Non-profit Research Institutes Fundamental Research Funds of China	This work was supported by the National Basic Research Program of China (973 program, 2014CB138804), the Natural Science Foundation of Inner Mongolia Autonomous Region of China (2014BS0330), and the Central Non-profit Research Institutes Fundamental Research Funds of China (1610332015004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Babu RC, 2004, PLANT SCI, V166, P855, DOI 10.1016/j.plantsci.2003.11.023; Bansal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134890; Bennett J, 2015, PLANT CELL REP, V34, P1, DOI 10.1007/s00299-014-1692-6; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen Y, 2015, PLANT CELL REP, V34, P1825, DOI 10.1007/s00299-015-1830-9; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Han XM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0591-5; Han XJ, 2012, PLOS ONE, V7, DOI [10.1016/j.cell.2016.03.003, DOI 10.1016/J.CELL.2016.03.003]; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jha AB., 2012, J BOT, V2012; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Lacerda ALM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136820; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li Y, 2016, MOL PLANT; Lin LY, 2013, MOL GENET GENOMICS, V288, P727, DOI 10.1007/s00438-013-0785-1; LING H, 2014, PLOS ONE, V9; Liu Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01011; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Milioni D, 1997, PLANT MOL BIOL, V35, P955, DOI 10.1023/A:1005874521528; Mishra P, 2013, PROTOPLASMA, V250, P3, DOI 10.1007/s00709-011-0365-3; Mohiuddin, 2016, DNA REPAIR, V40, P67, DOI 10.1016/j.dnarep.2016.02.002; Morreale FE, 2016, CELL, V165, P248, DOI 10.1016/j.cell.2016.03.003; Muller OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136499; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Ren HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052180; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Sharma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150609; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Song XL, 2016, ECOL EVOL, V6, P1871, DOI 10.1002/ece3.1982; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wan DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122641; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wu JB, 2010, BIOCHEM SYST ECOL, V38, P471, DOI 10.1016/j.bse.2010.04.008; Wu JB, 2010, RANGELAND J, V32, P427, DOI 10.1071/RJ09038; Xie F., 2012, PLANT MOL BIOL; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9; Xu ZZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-21; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Yoshida K, 2003, APPL MICROBIOL BIOT, V60, P665, DOI 10.1007/s00253-002-1157-7; Zhang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136355; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zhao NX, 2008, BIOCHEM SYST ECOL, V36, P1, DOI 10.1016/j.bse.2007.08.004	60	12	16	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169465	10.1371/journal.pone.0169465	http://dx.doi.org/10.1371/journal.pone.0169465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056110	Green Submitted, gold, Green Published			2022-12-26	WOS:000391639100045
J	Gasper, R; Schwach, J; Hartmann, J; Holtkamp, A; Wiethaus, J; Riedel, N; Hofmann, E; Frankenberg-Dinkel, N				Gasper, Raphael; Schwach, Julia; Hartmann, Jana; Holtkamp, Andrea; Wiethaus, Jessica; Riedel, Natascha; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Distinct Features of Cyanophage-encoded T-type Phycobiliprotein Lyase Phi CpeT THE ROLE OF AUXILIARY METABOLIC GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; microbiology; photosynthetic pigment; protein crystallization; viral protein	BILE-PIGMENTS; PHYCOERYTHRIN; PROCHLOROCOCCUS; BIOSYNTHESIS; PHYCOCYANOBILIN; IDENTIFICATION; REDUCTION; PROTEINS; INSIGHT; VIRUSES	Auxiliary metabolic genes (AMG) are commonly found in the genomes of phages that infect cyanobacteria and increase the fitness of the cyanophage. AMGs are often homologs of host genes, and also typically related to photosynthesis. For example, the phi cpeT gene in the cyanophage P-HM1 encodes a putative phycobiliprotein lyase related to cyanobacterial T-type lyases, which facilitate attachment of linear tetrapyrrole chromophores to Cys-155 of phycobiliprotein -subunits, suggesting that phi CpeT may also help assemble light-harvesting phycobiliproteins during infection. To investigate this possibility, we structurally and biochemically characterized recombinant phi CpeT. The solved crystal structure of phi CpeT at 1.8- resolution revealed that the protein adopts a similar fold as the cyanobacterial T-type lyase CpcT from Nostoc sp. PCC7120 but overall is more compact and smaller. phi CpeT specifically binds phycoerythrobilin (PEB) in vitro leading to a tight complex that can also be formed in Escherichia coli when it is co-expressed with genes encoding PEB biosynthesis (i.e. ho1 and pebS). The formed phi CpeT<bold>PEB complex was very stable as the chromophore was not lost during chromatography and displayed a strong red fluorescence with a fluorescence quantum yield of </bold>phi(F) = 0.3. This complex was not directly able to transfer PEB to the host phycobiliprotein -subunit. However, it could assist the host lyase CpeS in its function by providing a pool of readily available PEB, a feature that might be important for fast phycobiliprotein assembly during phage infection.	[Gasper, Raphael; Hofmann, Eckhard] Ruhr Univ Bochum, Prot Crystallog Grp, D-44780 Bochum, Germany; [Schwach, Julia; Holtkamp, Andrea; Wiethaus, Jessica; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, Physiol Microorganisms Grp, D-44780 Bochum, Germany; [Hartmann, Jana; Riedel, Natascha; Frankenberg-Dinkel, Nicole] Tech Univ Kaiserslautern, Div Microbiol, Dept Biol, D-67663 Kaiserslautern, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Kaiserslautern	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Physiol Microorganisms Grp, D-44780 Bochum, Germany.	nfranken@bio.uni-kl.de	Frankenberg-Dinkel, Nicole/C-1058-2011; Hofmann, Eckhard/GPF-5024-2022	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X	Deutsche Forschungsgemeinschaft; European Union [Ziel2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Union within the Ziel2.NRW Science-to-Business program (to N. F. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Doron S, 2016, ISME J, V10, P1437, DOI 10.1038/ismej.2015.210; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KROIS D, 1993, J CHEM SOC PERK T 2, P1351, DOI 10.1039/p29930001351; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; Overkamp KE, 2014, HANDB PORPHYR SCI, V28, P187; Puxty RJ, 2015, PHOTOSYNTH RES, V126, P71, DOI 10.1007/s11120-014-0057-x; Rodriguez EA, 2016, NAT METHODS, V13, P763, DOI [10.1038/NMETH.3935, 10.1038/nmeth.3935]; Shan J, 2008, FEMS MICROBIOL LETT, V283, P154, DOI 10.1111/j.1574-6968.2008.01148.x; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; Zhang J, 2012, GENE, V511, P88, DOI 10.1016/j.gene.2012.09.004; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	35	16	17	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3089	3098		10.1074/jbc.M116.769703	http://dx.doi.org/10.1074/jbc.M116.769703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073912	Green Published, hybrid			2022-12-26	WOS:000395538800003
J	Xiao, XW; Chen, CD; Guo, P; Zhang, T; Fischbach, S; Fusco, J; Shiota, C; Prasadan, K; Dong, H; Gittes, GK				Xiao, Xiangwei; Chen, Congde; Guo, Ping; Zhang, Ting; Fischbach, Shane; Fusco, Joseph; Shiota, Chiyo; Prasadan, Krishna; Dong, Henry; Gittes, George K.			Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated Cell Aging in Pancreas-specific SMAD7 Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; cell; cell proliferation; diabetes; type 2 diabetes; TGF; FoxO1; SMAD7	BETA-CELL; ISLET TRANSPLANTATION; TRANSCRIPTION FACTORS; DIABETES-MELLITUS; PRIMARY MECHANISM; ADULT PANCREAS; PROLIFERATION; MASS; DEDIFFERENTIATION; REPLICATION	The mechanisms underlying the effects of exocrine dysfunction on the development of diabetes remain largely unknown. Here we show that pancreatic depletion of SMAD7 resulted in age-dependent increases in cell dysfunction with accelerated glucose intolerance, followed by overt diabetes. The accelerated cell dysfunction and loss of proliferation capacity, two features of cell aging, appeared to be non-cell-autonomous, secondary to the adjacent exocrine failure as a bystander effect. Increased Forkhead box protein 1 (FoxO1) acetylation and nuclear retention was followed by progressive FoxO1 loss in cells that marked the onset of diabetes. Moreover, forced FoxO1 expression in cells prevented cell dysfunction and loss in this model. Thus, we present a model of accelerated cell aging that may be useful for studying the mechanisms underlying cell failure in diabetes. Moreover, we provide evidence highlighting a critical role of FoxO1 in maintaining cell identity in the context of SMAD7 failure.	[Xiao, Xiangwei; Chen, Congde; Guo, Ping; Fischbach, Shane; Fusco, Joseph; Shiota, Chiyo; Prasadan, Krishna; Gittes, George K.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Div Pediat Surg, Pittsburgh, PA 15224 USA; [Zhang, Ting; Dong, Henry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Div Immunogenet, Pittsburgh, PA 15224 USA; [Chen, Congde] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat Surg, Wenzhou 325000, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Peoples R China; [Guo, Ping] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, Houston, TX 77054 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wenzhou Medical University; Wenzhou Medical University; University of Texas System; University of Texas Health Science Center Houston	Xiao, XW; Gittes, GK (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Surg,Div Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	xiangwei.xiao@chp.edu; gittesgk@upmc.edu		Dong, H. Henry/0000-0003-0279-5241; Xiao, Xiangwei/0000-0003-0890-9203	Cochrane-Weber Endowed Fund in Diabetes Research [NO19831]; National Institutes of Health [R01 DK098196]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098196, R01DK098437] Funding Source: NIH RePORTER	Cochrane-Weber Endowed Fund in Diabetes Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Cochrane-Weber Endowed Fund in Diabetes Research Grant NO19831 (to X. X.), National Institutes of Health Grant R01 DK098196 (to G. K. G.), and the Children's Hospital of Pittsburgh. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; DiMagno MJ, 2012, CURR OPIN GASTROEN, V28, P523, DOI 10.1097/MOG.0b013e3283567dea; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; Furuta H, 1998, DIABETES, V47, P1356, DOI 10.2337/diabetes.47.8.1356; Gaglia JL, 2005, ARCH MED RES, V36, P273, DOI 10.1016/j.arcmed.2005.03.014; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Maeda H, 2011, PANCREATOLOGY, V11, P268, DOI 10.1159/000328785; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Pipeleers D, 2008, DIABETES OBES METAB, V10, P54, DOI 10.1111/j.1463-1326.2008.00941.x; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160; Sander M, 2000, DEVELOPMENT, V127, P5533; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Xiao XW, 2016, ENDOCRINOLOGY, V157, P1348, DOI 10.1210/en.2015-1986; Xiao XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21127; Xiao XW, 2015, STEM CELL TRANSL MED, V4, P655, DOI 10.5966/sctm.2014-0248; Xiao XW, 2014, NAT PROTOC, V9, P2719, DOI 10.1038/nprot.2014.183; Xiao XW, 2014, DIABETOLOGIA, V57, P991, DOI 10.1007/s00125-014-3179-y; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428	44	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3456	3465		10.1074/jbc.M116.770032	http://dx.doi.org/10.1074/jbc.M116.770032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28057752	Green Published, hybrid			2022-12-26	WOS:000395538800034
J	Bernard, K; Logsdon, NJ; Miguel, V; Benavides, GA; Zhang, JH; Carter, AB; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Miguel, Veronica; Benavides, Gloria A.; Zhang, Jianhua; Carter, A. Brent; Darley-Usmar, Victor M.; Thannickal, Victor J.			NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-FACTOR-A; ANTIOXIDANT RESPONSE; CONTRACTILE ACTIVITY; SKELETAL-MUSCLE; THYROID-HORMONE; SMOOTH-MUSCLE; COMPLEX I; NRF2; EXPRESSION; ACTIVATION	Mitochondrial bioenergetics are critical for cellular homeostasis and stress responses. The reactive oxygen species-generating enzyme, NADPH oxidase 4 (Nox4), regulates a number of physiological and pathological processes, including cellular differentiation, host defense, and tissue fibrosis. In this study we explored the role of constitutive Nox4 activity in regulating mitochondrial function. An increase in mitochondrial oxygen consumption and reserve capacity was observed in murine and human lung fibroblasts with genetic deficiency (or silencing) of Nox4. Inhibition of Nox4 expression/activity by genetic or pharmacological approaches resulted in stimulation of mitochondrial biogenesis, as evidenced by elevated mitochondrial-to-nuclear DNA ratio and increased expression of the mitochondrial markers transcription factor A (TFAM), citrate synthase, voltage-dependent anion channel (VDAC), and cytochrome c oxidase subunit 4 (COX IV). Induction of mitochondrial biogenesis was dependent on TFAM up-regulation but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha). The enhancement of mitochondrial bioenergetics as well as the increase in mitochondrial proteins in Nox4-deficient lung fibroblasts is inhibited by silencing of nuclear factor erythroid-derived 2-like 2 (Nrf2), supporting a key role for Nrf2 in control of mitochondrial biogenesis. Together, these results indicate a critical role for both Nox4 and Nrf2 in counter-regulation of mitochondrial biogenesis and metabolism.	[Bernard, Karen; Logsdon, Naomi J.; Carter, A. Brent; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL 35294 USA; [Miguel, Veronica] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII 464, Birmingham, AL 35294 USA.	kbernard@uab.edu	Miguel, Veronica/AAA-3645-2021	Darley-Usmar, Victor/0000-0001-8921-7086; Miguel, Veronica/0000-0001-9863-0710	National Institutes of Health [P30AG050886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050886, R01AG046210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to UAB Nathan Shock Center (funded by National Institutes of Health Grant P30AG050886) for technical support.	Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; Bartz RR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00291; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Collu-Marchese M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150073; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gregg JL, 2014, CANCER RES, V74, P3501, DOI 10.1158/0008-5472.CAN-13-2979; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hirschhauser C, 2015, ANTIOXID REDOX SIGN, V23, P1106, DOI 10.1089/ars.2014.6238; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koziel R, 2013, BIOCHEM J, V452, P231, DOI 10.1042/BJ20121778; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957; Mistry RK, 2016, J BIOL CHEM, V291, P1774, DOI 10.1074/jbc.M115.685578; Morrish F, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014225; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Tornatore TF, 2011, AM J PHYSIOL-HEART C, V300, pH902, DOI 10.1152/ajpheart.00319.2010; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wu KLH, 2016, FREE RADICAL BIO MED, V97, P58, DOI 10.1016/j.freeradbiomed.2016.05.012; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302; Zambrano A, 2014, J CELL BIOL, V204, P129, DOI 10.1083/jcb.201305084	61	68	69	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3029	3038		10.1074/jbc.M116.752261	http://dx.doi.org/10.1074/jbc.M116.752261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049732	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000395535100041
J	Sonderegger, C; Fizil, A; Burtscher, L; Hajdu, D; Munoz, A; Gaspari, Z; Read, ND; Batta, G; Marx, F				Sonderegger, Christoph; Fizil, Adam; Burtscher, Laura; Hajdu, Dorottya; Munoz, Alberto; Gaspari, Zoltan; Read, Nick D.; Batta, Gyula; Marx, Florentine			D19S Mutation of the Cationic, Cysteine-Rich Protein PAF: Novel Insights into Its Structural Dynamics, Thermal Unfolding and Antifungal Function	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; CHRYSOGENUM; PLANT; TRANSFORMATION; FUSION	The cysteine-rich, cationic, antifungal protein PAF is abundantly secreted into the culture supernatant of the filamentous Ascomycete Penicillium chrysogenum. The five beta-strands of PAF form a compact beta-barrel that is stabilized by three disulphide bonds. The folding of PAF allows the formation of four surface-exposed loops and distinct charged motifs on the protein surface that might regulate the interaction of PAF with the sensitive target fungus. The growth inhibitory activity of this highly stable protein against opportunistic fungal pathogens provides great potential in antifungal drug research. To understand its mode of action, we started to investigate the surface-exposed loops of PAF and replaced one aspartic acid at position 19 in loop 2 that is potentially involved in PAF active or binding site, with a serine (Asp19 to Ser19). We analysed the overall effects, such as unfolding, electrostatic changes, sporadic conformers and antifungal activity when substituting this specific amino acid to the fairly indifferent amino acid serine. Structural analyses revealed that the overall 3D solution structure is virtually identical with that of PAF. However, PAF(D19S) showed slightly increased dynamics and significant differences in the surface charge distribution. Thermal unfolding identified PAF(D19S) to be rather a two-state folder in contrast to the three-state folder PAF. Functional comparison of PAF(D19S) and PAF revealed that the exchange at residue 19 caused a dramatic loss of antifungal activity: the binding and internalization of PAF(D19S) by target cells was reduced and the protein failed to trigger an intracellular Ca2+ response, all of which are closely linked to the antifungal toxicity of PAF. We conclude that the negatively charged residue Asp19 in loop 2 is essential for full function of the cationic protein PAF.	[Sonderegger, Christoph; Burtscher, Laura; Marx, Florentine] Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria; [Fizil, Adam; Hajdu, Dorottya; Batta, Gyula] Univ Debrecen, Fac Sci & Technol, Dept Organ Chem, Debrecen, Hungary; [Munoz, Alberto; Read, Nick D.] Univ Manchester, Div Infect Immun & Resp Med, Manchester Fungal Infect Grp, Manchester, Lancs, England; [Gaspari, Zoltan] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary	Medical University of Innsbruck; University of Debrecen; University of Manchester	Marx, F (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, Innsbruck, Austria.; Batta, G (corresponding author), Univ Debrecen, Fac Sci & Technol, Dept Organ Chem, Debrecen, Hungary.	batta@unideb.hu; florentine.marx@i-med.ac.at	Gáspári, Zoltán/D-9594-2011	Gáspári, Zoltán/0000-0002-8692-740X; Marx, Florentine/0000-0002-8408-1842; Munoz, Alberto/0000-0002-1622-5074	Austrian Science Fund [FWF P25894-B20, FWF I1644-B20]; Hungarian Science Fund [OTKA ANN 110821, NF 104198]; European Regional Development Fund [GINOP-2.3.2-15-2016-00008]; MedinProt project	Austrian Science Fund(Austrian Science Fund (FWF)); Hungarian Science Fund; European Regional Development Fund(European Commission); MedinProt project	This study was financially supported by the Austrian Science Fund (FWF P25894-B20 to F. M., FWF I1644-B20 to F.M.), the Hungarian Science Fund (OTKA ANN 110821 to G.B. and NF 104198 to Z.G.), and the European Regional Development Fund (GINOP-2.3.2-15-2016-00008). MedinProt project is thanked for financial support of 700 MHz NOESY experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Binder U, 2015, FEBS LETT, V589, P1266, DOI 10.1016/j.febslet.2015.03.037; Binder U, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-209; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Binder U, 2010, MOL MICROBIOL, V75, P294, DOI 10.1111/j.1365-2958.2009.06936.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; CANTORAL JM, 1987, BIO-TECHNOL, V5, P494, DOI 10.1038/nbt0587-494; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Di Pasquale E, 2010, CHEM PHYS LIPIDS, V163, P131, DOI 10.1016/j.chemphyslip.2009.10.006; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fizil A, 2015, CHEM-EUR J, V21, P5136, DOI 10.1002/chem.201404879; Hegedus N, 2011, J BASIC MICROB, V51, P253, DOI 10.1002/jobm.201000321; HENSON OE, 1981, APPL ENVIRON MICROB, V42, P656, DOI 10.1128/AEM.42.4.656-660.1981; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jonson PH, 2001, PROTEIN ENG, V14, P397, DOI 10.1093/protein/14.6.397; Kaiserer L, 2003, ARCH MICROBIOL, V180, P204, DOI 10.1007/s00203-003-0578-8; Keller R., 2004, COMPUTER AIDED RESON, V1; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; Munoz A, 2006, ANTIMICROB AGENTS CH, V50, P3847, DOI 10.1128/AAC.00650-06; Munoz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138008; Munoz A, 2014, MOL MICROBIOL, V92, P1357, DOI 10.1111/mmi.12634; Nelson G, 2004, MOL MICROBIOL, V52, P1437, DOI 10.1111/j.1365-2958.2004.04066.x; Oberparleiter C, 2003, ANTIMICROB AGENTS CH, V47, P3598, DOI 10.1128/AAC.47.11.3598-3601.2003; Palicz Z, 2013, TOXICOL APPL PHARM, V269, P8, DOI 10.1016/j.taap.2013.02.014; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Shen Y, 2010, J BIOMOL NMR, V44, P213; Szappanos H, 2005, N-S ARCH PHARMACOL, V371, P122, DOI 10.1007/s00210-004-1013-7; Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Varadi G, 2013, CHEM-EUR J, V19, P12684, DOI 10.1002/chem.201301098; Vogel HJ, 1956, MICROB GENET B, V13, P42; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zhang J., 2012, PROTEIN PROTEIN INTE	40	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169920	10.1371/journal.pone.0169920	http://dx.doi.org/10.1371/journal.pone.0169920			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072824	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200058
J	Wang, ZW; Wang, Q; Wu, XD; Zhao, L; Yue, GY; Nan, ZT; Wang, PC; Yi, SH; Zou, DF; Qin, Y; Wu, TH; Shi, JZ				Wang, Zhiwei; Wang, Qian; Wu, Xiaodong; Zhao, Lin; Yue, Guangyang; Nan, Zhuotong; Wang, Puchang; Yi, Shuhua; Zou, Defu; Qin, Yu; Wu, Tonghua; Shi, Jianzong			Vegetation Changes in the Permafrost Regions of the Qinghai-Tibetan Plateau from 1982-2012: Different Responses Related to Geographical Locations and Vegetation Types in High-Altitude Areas	PLOS ONE			English	Article							CLIMATE-CHANGE; TRENDS; GIMMS; VARIABILITY; NDVI3G; MODIS	The Qinghai-Tibetan Plateau (QTP) contains the largest permafrost area in a high-altitude region in the world, and the unique hydrothermal environments of the active layers in this region have an important impact on vegetation growth. Geographical locations present different climatic conditions, and in combination with the permafrost environments, these conditions comprehensively affect the local vegetation activity. Therefore, the responses of vegetation to climate change in the permafrost region of the QTP may be varied differently by geographical location and vegetation condition. In this study, using the latest Global Inventory Modeling and Mapping Studies (GIMMS) Normalized Difference Vegetation Index (NDVI) product based on turning points (TPs), which were calculated using a piecewise linear model, 9 areas within the permafrost region of the QTP were selected to investigate the effect of geographical location and vegetation type on vegetation growth from 1982 to 2012. The following 4 vegetation types were observed in the 9 selected study areas: alpine swamp meadow, alpine meadow, alpine steppe and alpine desert. The research results show that, in these study areas, TPs mainly appeared in 2000 and 2001, and almost 55.1% and 35.0% of the TPs were located in 2000 and 2001. The global standardized precipitation evapotranspiration index (SPEI) and 7 meteorological variables were selected to analyze their correlations with NDVI. We found that the main correlative variables to vegetation productivity in study areas from 1982 to 2012 were precipitation, surface downward long-wave radiation and temperature. Furthermore, NDVI changes exhibited by different vegetation types within the same study area followed similar trends. The results show that regional effects rather than vegetation type had a larger impact on changes in vegetation growth in the permafrost regions of the QTP, indicating that climatic factors had a larger impact in the permafrost regions than the environmental factors (including permafrost) related to the underlying surface conditions.	[Wang, Zhiwei; Wang, Qian; Wu, Xiaodong; Zhao, Lin; Yue, Guangyang; Nan, Zhuotong; Yi, Shuhua; Zou, Defu; Qin, Yu; Wu, Tonghua; Shi, Jianzong] Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Peoples R China; [Wang, Zhiwei; Wang, Qian; Wang, Puchang] Chinese Acad Sci, State Key Lab Cryosphere Sci, Cryosphere Res Stn Qinghai Xizang Plateau, Northwest Inst Ecoenvironm & Resources, Lanzhou, Peoples R China; [Wang, Zhiwei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Nan, Zhuotong] Nanjing Normal Univ, Nanjing, Jiangsu, Peoples R China	Guizhou Academy of Agricultural Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Normal University	Wu, XD; Zhao, L (corresponding author), Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Peoples R China.	wxd565@163.com; linzhao@lzb.ac.cn	Zhao, Lin/M-9536-2018; NAN, ZHUOTONG/D-7518-2018; Wu, Tonghua/AAE-4563-2019	Zhao, Lin/0000-0003-0245-8413; NAN, ZHUOTONG/0000-0002-7930-3850; 	Natural Science foundation of China [41421061, 91547119]; State Key Laboratory of Cryosphere Sciences [SKLCS-ZZ-2016]; Guizhou Academy of the Agricultural Sciences Foundation [[2016]0032]; Guizhou Science and technology innovation talents team Foundation of China [[2016]5617]	Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cryosphere Sciences; Guizhou Academy of the Agricultural Sciences Foundation; Guizhou Science and technology innovation talents team Foundation of China	This work was supported by the Natural Science foundation of China (41421061) and the State Key Laboratory of Cryosphere Sciences (SKLCS-ZZ-2016). This work was also supported in part by the Natural Science Foundation of China (91547119) and the Guizhou Academy of the Agricultural Sciences Foundation ([2016]0032). ZW, QW, and PW were affiliated with Guizhou Science and technology innovation talents team Foundation of China (Qiankehepingtairencai [2016]5617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CHINA METEOROLOGICAL; Beck HE, 2011, REMOTE SENS ENVIRON, V115, P2547, DOI 10.1016/j.rse.2011.05.012; Beck PSA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/029501; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Bhatt US, 2013, REMOTE SENS-BASEL, V5, P4229, DOI 10.3390/rs5094229; Chen BZ, 2014, REMOTE SENS ENVIRON, V144, P28, DOI 10.1016/j.rse.2013.12.018; Chen H, 2013, GLOBAL CHANGE BIOL, V19, P2940, DOI 10.1111/gcb.12277; Chen ML, 2014, AGR FOREST METEOROL, V189-190, P81; Chen SY, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045406; Chen YY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015921; de Jong R, 2011, REMOTE SENS ENVIRON, V115, P692, DOI 10.1016/j.rse.2010.10.011; Fensholt R, 2012, REMOTE SENS ENVIRON, V119, P131, DOI 10.1016/j.rse.2011.12.015; Jiang N, 2013, REMOTE SENS-BASEL, V5, P4031, DOI 10.3390/rs5084031; Jin H., 2000, ACTA GEOGRAPHICA SIN, V55, P161, DOI DOI 10.3321/J.ISSN:0375-5444.2000.05.004.(IN; Liu XF, 2014, J GEOGR SCI, V24, P288, DOI 10.1007/s11442-014-1088-0; Peng J, 2012, ECOL INDIC, V14, P28, DOI 10.1016/j.ecolind.2011.08.011; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Pinzon JE, 2014, REMOTE SENS-BASEL, V6, P6929, DOI 10.3390/rs6086929; Sobrino JA, 2011, INT J REMOTE SENS, V32, P4267, DOI 10.1080/01431161.2010.486414; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Vrieling A, 2013, REMOTE SENS-BASEL, V5, P982, DOI 10.3390/rs5020982; Wang ZW, 2016, J MT SCI-ENGL, V13, P1035, DOI 10.1007/s11629-015-3485-y; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yi SH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045403; Zeng FW, 2013, REMOTE SENS-BASEL, V5, P3918, DOI 10.3390/rs5083918; Zhang G.L, 2013, PNAS, V110, P4309; Zhang YL, 2013, GLOBAL PLANET CHANGE, V108, P139, DOI 10.1016/j.gloplacha.2013.06.012	30	11	15	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169732	10.1371/journal.pone.0169732	http://dx.doi.org/10.1371/journal.pone.0169732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068392	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900061
J	Biardeau, X; Przydacz, M; Aharony, S; Loutochin, G; Campeau, L; Kyheng, M; Corcos, J				Biardeau, Xavier; Przydacz, Mikolaj; Aharony, Shachar; Loutochin, George; Campeau, Lysanne; Kyheng, Maeva; Corcos, Jacques			Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model	PLOS ONE			English	Article							BLADDER; INJURY; SPASTICITY; CHILDREN	Background In spinal cord injury, onset of detrusor overactivity (DO) is detrimental for quality of life (incontinence) and renal risk. Prevention has only been achieved with complex sophisticated electrical neuromodulation techniques. Purpose To assess the efficacy of early fesoterodine fumarate (FF) administration in preventing bladder overactivity in a spinal cord transected (SCT) rat model. Methods 33 Sprague-Dawley rats were allocated to 6 groups Group 1: 3 normal controls; Group 2: 6 SCT controls; Group 3: 6 SCT rats + FF 0.18 mg/kg/d; Group 4: 6 SCT rats + FF 0.12 mg/kg/d; Group 5: 6 SCT rats + FF 0.18 mg/kg/d + 72-h wash-out period; Group 6: 6 SCT rats + FF 0.12 mg/kg/d + 72-h wash-out period. SCT was performed at T10. FF was continuously administered. Cystometry was undertaken 6 weeks after SCT in awake rats recording inter-micturition pressure (IMP), baseline pressure, threshold pressure (Pthres) and maximum pressure (Pmax). Normal controls and SCT controls were initially compared using the Mann-Whitney U tests in order to confirm the SCT effect on cystometric parameters. The comparisons in cystometric and metabolic cage parameters between SCT controls and treated rats were done using post-hoc Dunn's tests for Kruskal-Wallis analysis. Statistical testing was conducted at the two-tailed alpha-level of 0.05. Results Pressure parameters were significantly higher in SCT control group compared to normal controls. Six weeks after SCT, IMP was significantly lower in low dose treated group than in SCT controls. Pmax was significantly lower in 3 treated groups compared to SCT controls. Pthres was significantly lower in full time treated groups than in SCT controls. Conclusion Early administration of FF modulates bladder overactivity in a SCT rat model. Whereas short-term prevention has been demonstrated, the long-term should be further analyzed. Clinical application of these results should confirm this finding through randomized research protocols.	[Biardeau, Xavier; Przydacz, Mikolaj; Aharony, Shachar; Loutochin, George; Campeau, Lysanne; Corcos, Jacques] McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ, Canada; [Kyheng, Maeva] Univ Lille, CHRU Lille, EA2694, Dept Biostat, Lille, France	McGill University; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Corcos, J (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ, Canada.	jcorcos@uro.jgh.mcgill.ca			Pfizer Canada	Pfizer Canada(Pfizer)	This study was supported by an unrestricted grant from Pfizer Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x; Aharony S, 2016, TXB NEUROGENIC BLADD, P473; Amend B, 2008, EUR UROL, V53, P1021, DOI 10.1016/j.eururo.2008.01.007; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; Braverman A, 1999, LIFE SCI, V64, P429, DOI 10.1016/S0024-3205(98)00582-7; Elliott AC, 2010, COMPUTER METHODS PRO, V1, P75; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Li P, 2013, SPINAL CORD, V51, P668, DOI 10.1038/sc.2013.60; Nadeau G, 2014, CUAJ-CAN UROL ASSOC, V8, P175, DOI 10.5489/cuaj.1362; Nambiar A, 2014, NEUROUROL URODYNAM, V33, pS21, DOI 10.1002/nau.22631; Sahai Arun, 2011, Curr Urol Rep, V12, P404, DOI 10.1007/s11934-011-0221-1; Salinas FA, 2012, AM J PHYS MED REHAB, V91, P1020, DOI 10.1097/PHM.0b013e3182643c85; Sievert KD, 2010, ANN NEUROL, V67, P74, DOI 10.1002/ana.21814; Somogyi GT, 2003, NEUROCHEM INT, V43, P73, DOI 10.1016/S0197-0186(02)00193-6; Uvin P, 2013, EUR UROL, V64, P502, DOI 10.1016/j.eururo.2013.05.031; Zonta MB, 2013, ARQ NEURO-PSIQUIAT, V71, P453, DOI 10.1590/0004-282X20130061	16	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169694	10.1371/journal.pone.0169694	http://dx.doi.org/10.1371/journal.pone.0169694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060912	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500131
J	Khare, G; Nangpal, P; Tyagi, AK				Khare, Garima; Nangpal, Prachi; Tyagi, Anil K.			Differential Roles of Iron Storage Proteins in Maintaining the Iron Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							OXIDATIVE STRESS; PSEUDOMONAS-AERUGINOSA; HYPOXIC RESPONSE; FERRITIN; BACTERIOFERRITIN; GENE; MUTANT; METABOLISM; PROTECTION; TRANSPORT	Ferritins and bacterioferritins are iron storage proteins that represent key players in iron homeostasis. Several organisms possess both forms of ferritins, however, their relative physiological roles are less understood. Mycobacterium tuberculosis possesses both ferritin (BfrB) and bacterioferritin (BfrA), playing an essential role in its pathogenesis as reported by us earlier. This study provides insights into the role of these two proteins in iron homeostasis by employing M. tuberculosis bfr mutants. Our data suggests that BfrA is required for efficient utilization of stored iron under low iron conditions while BfrB plays a crucial role as the major defense protein under excessive iron conditions. We show that these two proteins provide protection against oxidative stress and hypoxia. Iron incorporation study showed that BfrB has higher capacity for storing iron than BfrA, which augurs well for efficient iron quenching under iron excess conditions. Moreover, iron release assay demonstrated that BfrA has 3 times superior ability to release stored iron emphasizing its requirement for efficient iron release under low iron conditions, facilitated by the presence of heme. Thus, for the first time, our observations suggest that the importance of BfrA or BfrB separately might vary depending upon the iron situation faced by the cell.	[Khare, Garima; Nangpal, Prachi; Tyagi, Anil K.] Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi, India; [Tyagi, Anil K.] Guru Gobind Singh Indraprastha Univ, Sect 16-C, New Delhi, India	University of Delhi; GGS Indraprastha University	Tyagi, AK (corresponding author), Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi, India.; Tyagi, AK (corresponding author), Guru Gobind Singh Indraprastha Univ, Sect 16-C, New Delhi, India.	aniltyagi@south.du.ac.in			Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/COE/05/06-II]; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by financial grant from Department of Biotechnology, Ministry of Science and Technology, Government of India (Grant Number - BT/01/COE/05/06-II). PN is grateful to Council of Scientific and Industrial Research, New Delhi for a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bereswill S, 1998, MICROBIOL-SGM, V144, P2505, DOI 10.1099/00221287-144-9-2505; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Gupta V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008028; Hwang LH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000044; Jones CM, 2010, J BACTERIOL, V192, P6411, DOI 10.1128/JB.00986-10; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; LEVI S, 1988, J BIOL CHEM, V263, P18086; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; McMath LM, 2013, J PORPHYR PHTHALOCYA, V17, P229, DOI 10.1142/S1088424613500211; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Qi Y, 1995, NEUROCHEM, V64, P2458; Ratnayake DB, 2000, MICROBIOL-UK, V146, P1119, DOI 10.1099/00221287-146-5-1119; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smith JJ, 2003, J LAB CLIN MED, V141, P309, DOI 10.1016/S0022-2143(03)00008-8; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Wai SN, 1996, MOL MICROBIOL, V20, P1127, DOI 10.1111/j.1365-2958.1996.tb02633.x; WANG CC, 1969, J BACTERIOL, V98, P1142, DOI 10.1128/JB.98.3.1142-1150.1969; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Yao HL, 2012, J AM CHEM SOC, V134, P13470, DOI 10.1021/ja305180n; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	35	27	29	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169545	10.1371/journal.pone.0169545	http://dx.doi.org/10.1371/journal.pone.0169545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060867	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500108
J	Saito, T; Yokota, K; Kobayakawa, K; Hara, M; Kubota, K; Harimaya, K; Kawaguchi, K; Hayashida, M; Matsumoto, Y; Doi, T; Shiba, K; Nakashima, Y; Okada, S				Saito, Takeyuki; Yokota, Kazuya; Kobayakawa, Kazu; Hara, Masamitsu; Kubota, Kensuke; Harimaya, Katsumi; Kawaguchi, Kenichi; Hayashida, Mitsumasa; Matsumoto, Yoshihiro; Doi, Toshio; Shiba, Keiichiro; Nakashima, Yasuharu; Okada, Seiji			Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATIC STELLATE CELLS; SPINAL-CANAL STENOSIS; MECHANICAL-STRESS; PULMONARY-FIBROSIS; EXPRESSION; PATHOMECHANISM; ANGIOGENESIS; RESPONSES; DISEASE	Lumbar spinal canal stenosis (LSCS) is one of the most common spinal disorders in elderly people, with the number of LSCS patients increasing due to the aging of the population. The ligamentum flavum (LF) is a spinal ligament located in the interior of the vertebral canal, and hypertrophy of the LF, which causes the direct compression of the nerve roots and/or cauda equine, is a major cause of LSCS. Although there have been previous studies on LF hypertrophy, its pathomechanism remains unclear. The purpose of this study is to establish a relevant mouse model of LF hypertrophy and to examine disease-related factors. First, we focused on mechanical stress and developed a loading device for applying consecutive mechanical flexion-extension stress to the mouse LF. After 12 weeks of mechanical stress loading, we found that the LF thickness in the stress group was significantly increased in comparison to the control group. In addition, there were significant increases in the area of collagen fibers, the number of LF cells, and the gene expression of several fibrosis-related factors. However, in this mecnanical stress model, there was no macrophage infiltration, angiogenesis, or increase in the expression of transforming growth factor-beta 1 (TGF-beta 1), which are characteristic features of LF hypertrophy in LSCS patients. We therefore examined the influence of infiltrating macrophages on LF hypertrophy. After inducing macrophage infiltration by micro-injury to the mouse LF, we found excessive collagen synthesis in the injured site with the increased TGF-beta 1 expression at 2 weeks after injury, and further confirmed LF hypertrophy at 6 weeks after injury. Our findings demonstrate that mechanical stress is a causative factor for LF hypertrophy and strongly suggest the importance of macrophage infiltration in the progression of LF hypertrophy via the stimulation of collagen production.	[Saito, Takeyuki; Hara, Masamitsu; Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka, Japan; [Saito, Takeyuki; Kobayakawa, Kazu; Hara, Masamitsu; Harimaya, Katsumi; Kawaguchi, Kenichi; Hayashida, Mitsumasa; Matsumoto, Yoshihiro; Nakashima, Yasuharu; Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Yokota, Kazuya; Kubota, Kensuke; Shiba, Keiichiro] Spinal Injuries Ctr, Dept Orthopaed Surg, Fukuoka, Japan; [Doi, Toshio] Kyushu Univ, Dept Orthopaed Surg, Beppu Hosp, Oita, Japan; [Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka, Japan; [Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Kyushu University	Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka, Japan.; Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan.; Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka, Japan.; Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka, Japan.	seokada@ortho.med.kyushu-u.ac.jp		Kobayakawa, Kazu/0000-0002-7444-0661; Okada, Seiji/0000-0002-5107-8209	Ministry of Education, Science, Sports and Culture of Japan [16H05450]; Research foundations from the general insurance association of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research foundations from the general insurance association of Japan	Grant funds were received in support of this work from a Grant-in-Aid for Scientific Research (16H05450) from the Ministry of Education, Science, Sports and Culture of Japan, and Research foundations from the general insurance association of Japan.	Altinkaya N, 2011, SPINE, V36, pE1093, DOI 10.1097/BRS.0b013e318203e2b5; ANTONIADES HN, 1990, J CLIN INVEST, V86, P1055, DOI 10.1172/JCI114808; Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Chu PS, 2013, HEPATOLOGY, V58, P337, DOI 10.1002/hep.26351; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Hur JW, 2015, NEUROSURGERY, V77, P274, DOI 10.1227/NEU.0000000000000755; Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; Kim HN, 2011, BMB REP, V44, P446, DOI 10.5483/BMBRep.2011.44.7.446; Kirihara Y, 2013, EXP ANIM TOKYO, V62, P173, DOI 10.1538/expanim.62.173; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Kumamaru H, 2012, J CELL PHYSIOL, V227, P1335, DOI 10.1002/jcp.22845; Lakemeier S, 2013, J SPINAL DISORD TECH, V26, P400, DOI 10.1097/BSD.0b013e3182495b88; Lewindon PJ, 2002, AM J PATHOL, V160, P1705, DOI 10.1016/S0002-9440(10)61117-0; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lohr M, 2011, ACTA NEUROCHIR, V153, P134, DOI 10.1007/s00701-010-0839-7; Nagai T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3142; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Okuda T, 2004, SPINE, V29, P1689, DOI 10.1097/01.BRS.0000132510.25378.8C; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Shafaq N, 2012, J SPINAL DISORD TECH, V25, P107, DOI 10.1097/BSD.0b013e31820bb76e; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Towne EB, 1931, ANN SURG, V94, P327, DOI 10.1097/00000658-193109000-00002; YOSHIDA M, 1992, SPINE, V17, P1353, DOI 10.1097/00007632-199211000-00015; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Zhang Y, 2010, SPINE, V35, pE1479, DOI 10.1097/BRS.0b013e3181f3d2df; Zhong ZM, 2011, J ORTHOP RES, V29, P1592, DOI 10.1002/jor.21431	32	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169717	10.1371/journal.pone.0169717	http://dx.doi.org/10.1371/journal.pone.0169717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060908	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500132
J	Helmchen, C; Kirchhoff, JB; Gottlich, M; Sprenger, A				Helmchen, Christoph; Kirchhoff, Jan-Birger; Goettlich, Martin; Sprenger, Andreas			Postural Ataxia in Cerebellar Downbeat Nystagmus: Its Relation to Visual, Proprioceptive and Vestibular Signals and Cerebellar Atrophy	PLOS ONE			English	Article							GRAVITY DEPENDENCE; BALANCE CONTROL; EYE-MOVEMENTS; OCULAR DRIFT; 3,4-DIAMINOPYRIDINE; 4-AMINOPYRIDINE; STABILIZATION; PERFORMANCE; INSTABILITY; SINGLE	Background The cerebellum integrates proprioceptive, vestibular and visual signals for postural control. Cerebellar patients with downbeat nystagmus (DBN) complain of unsteadiness of stance and gait as well as blurred vision and oscillopsia. Objectives The aim of this study was to elucidate the differential role of visual input, gaze eccentricity, vestibular and proprioceptive input on the postural stability in a large cohort of cerebellar patients with DBN, in comparison to healthy age-matched control subjects. Methods Oculomotor (nystagmus, smooth pursuit eye movements) and postural (postural sway speed) parameters were recorded and related to each other and volumetric changes of the cerebellum (voxel-based morphometry, SPM). Results Twenty-seven patients showed larger postural instability in all experimental conditions. Postural sway increased with nystagmus in the eyes closed condition but not with the eyes open. Romberg's ratio remained stable and was not different from healthy controls. Postural sway did not change with gaze position or graviceptive input. It increased with attenuated proprioceptive input and on tandem stance in both groups but Romberg's ratio also did not differ. Cerebellar atrophy (vermal lobule VI, VIII) correlated with the severity of impaired smooth pursuit eye movements of DBN patients. Conclusions Postural ataxia of cerebellar patients with DBN cannot be explained by impaired visual feedback. Despite oscillopsia visual feedback control on cerebellar postural control seems to be preserved as postural sway was strongest on visual deprivation. The increase in postural ataxia is neither related to modulations of single components characterizing nystagmus nor to deprivation of single sensory (visual, proprioceptive) inputs usually stabilizing stance. Re weighting of multisensory signals and/or inappropriate cerebellar motor commands might account for this postural ataxia.	[Helmchen, Christoph; Kirchhoff, Jan-Birger; Goettlich, Martin; Sprenger, Andreas] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Sprenger, Andreas] Univ Lubeck, Inst Psychol 2, Lubeck, Germany	University of Lubeck; University of Lubeck	Helmchen, C (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.	christoph.helmchen@neuro.uni-luebeck.de	Sprenger, Andreas/C-7612-2009	Sprenger, Andreas/0000-0001-9255-7911; Gottlich, Martin/0000-0002-7668-0730				Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Buchele W, 1983, Adv Otorhinolaryngol, V30, P291; Claassen J, 2013, J NEUROL NEUROSUR PS, V84, P1392, DOI 10.1136/jnnp-2012-304736; Crowdy KA, 2000, EXP BRAIN RES, V135, P437, DOI 10.1007/s002210000539; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FUJIMOTO C, 2013, OT D HEAD NECK SURG, V149, P759, DOI DOI 10.1177/0194599813501625; Fujimoto C, 2013, ACTA OTO-LARYNGOL, V133, P454, DOI 10.3109/00016489.2012.742565; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Gottlich M, 2016, HUM BRAIN MAPP, V37, P1998, DOI 10.1002/hbm.23152; Helmchen C, 2004, NEUROLOGY, V63, P752, DOI 10.1212/01.WNL.0000136226.52639.35; Helmchen C, 2012, MOVEMENT DISORD, V27, P1012, DOI 10.1002/mds.25042; Honeine JL, 2015, J NEUROPHYSIOL, V114, P3097, DOI 10.1152/jn.00618.2015; Hufner K, 2007, NEUROLOGY, V69, P1128, DOI 10.1212/01.wnl.0000276953.00969.48; Ivanenko YP, 1999, J PHYSIOL-LONDON, V519, P301, DOI 10.1111/j.1469-7793.1999.0301o.x; Jacobi Heike, 2015, Cerebellum Ataxias, V2, P6, DOI 10.1186/s40673-015-0025-z; Jahn K, 2002, BRAIN, V125, P2005, DOI 10.1093/brain/awf204; Jahn K, 2006, EXP BRAIN RES, V174, P152, DOI 10.1007/s00221-006-0431-9; Kalla R, 2007, BRAIN, V130, P2441, DOI 10.1093/brain/awm172; Krafczyk S, 2006, CLIN NEUROPHYSIOL, V117, P1692, DOI 10.1016/j.clinph.2006.04.022; Krampe RT, 2003, NERVENARZT, V74, P211, DOI 10.1007/s00115-002-1325-0; Kunkel M, 1998, EXP BRAIN RES, V121, P471, DOI 10.1007/s002210050483; Marti S, 2002, ANN NEUROL, V52, P712, DOI 10.1002/ana.10370; Marti S, 2008, EXP BRAIN RES, V188, P613, DOI 10.1007/s00221-008-1396-7; Nardone A, 2006, GAIT POSTURE, V23, P364, DOI 10.1016/j.gaitpost.2005.04.002; Paloski WH, 2006, GAIT POSTURE, V23, P315, DOI 10.1016/j.gaitpost.2005.04.009; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Pierrot-Deseilligny C, 2005, BRAIN, V128, P1237, DOI 10.1093/brain/awh532; Polastri PF, 2012, EXP BRAIN RES, V223, P99, DOI 10.1007/s00221-012-3244-z; Raiche M, 2000, LANCET, V356, P1001, DOI 10.1016/S0140-6736(00)02695-7; Robinson FR, 1997, J NEUROPHYSIOL, V78, P848, DOI 10.1152/jn.1997.78.2.848; Sander T, 2011, J NEUROL, V258, P618, DOI 10.1007/s00415-010-5806-y; Schniepp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105463; Sprenger A, 2005, ANN NY ACAD SCI, V1039, P395, DOI 10.1196/annals.1325.037; Sprenger A, 2015, CEREB CORTEX, V25, P4610, DOI 10.1093/cercor/bhv115; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tjernstrom F, 2015, GAIT POSTURE, V42, P27, DOI 10.1016/j.gaitpost.2014.12.007; Tschan R, 2008, J NEUROL, V255, P1168, DOI 10.1007/s00415-008-0863-1; Tschan Regine, 2010, Psychother Psychosom Med Psychol, V60, pe1, DOI 10.1055/s-0029-1243206; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner JN, 2008, J NEUROL NEUROSUR PS, V79, P672, DOI 10.1136/jnnp.2007.126284	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168808	10.1371/journal.pone.0168808	http://dx.doi.org/10.1371/journal.pone.0168808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056109	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100012
J	Hamed, M; Trumm, J; Spaniol, C; Sethi, R; Irhimeh, MR; Fuellen, G; Paulsen, M; Helms, V				Hamed, Mohamed; Trumm, Johannes; Spaniol, Christian; Sethi, Riccha; Irhimeh, Mohammad R.; Fuellen, Georg; Paulsen, Martina; Helms, Volkhard			Linking Hematopoietic Differentiation to Co-Expressed Sets of Pluripotency-Associated and Imprinted Genes and to Regulatory microRNA-Transcription Factor Motifs	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; NETWORK; INDUCTION; FEATURES; REVEALS; PROTEIN; MEMORY; FETAL; REL	Maintenance of cell pluripotency, differentiation, and reprogramming are regulated by complex gene regulatory networks (GRNs) including monoallelically-expressed imprinted genes. Besides transcriptional control, epigenetic modifications and microRNAs contribute to cellular differentiation. As a model system for studying the capacity of cells to preserve their pluripotency state and the onset of differentiation and subsequent specialization, murine hematopoiesis was used and compared to embryonic stem cells (ESCs) as a control. Using published microarray data, the expression profiles of two sets of genes, pluripotent and imprinted, were compared to a third set of known hematopoietic genes. We found that more than half of the pluripotent and imprinted genes are clearly upregulated in ESCs but subsequently repressed during hematopoiesis. The remaining genes were either upregulated in hematopoietic progenitors or in differentiated blood cells. The three gene sets each consist of three similarly behaving gene groups with similar expression profiles in various lineages of the hematopoietic system as well as in ESCs. To explain this co-regulation behavior, we explored the transcriptional and post-transcriptional mechanisms of pluripotent and imprinted genes and their regulator/target miRNAs in six different hematopoietic lineages. Therewith, lineage-specific transcription factor (TF)-miRNA regulatory networks were generated and their topologies and functional impacts during hematopoiesis were analyzed. This led to the identification of TF-miRNA co-regulatory motifs, for which we validated the contribution to the cellular development of the corresponding lineage in terms of statistical significance and relevance to biological evidence. This analysis also identified key miRNAs and TFs/genes that might play important roles in the derived lineage networks. These molecular associations suggest new aspects of the cellular regulation of the onset of cellular differentiation and during hematopoiesis involving, on one hand, pluripotent genes that were previously not discussed in the context of hematopoiesis and, on the other hand, involve genes that are related to genomic imprinting. These are new links between hematopoiesis and cellular differentiation and the important field of epigenetic modifications.	[Hamed, Mohamed; Spaniol, Christian; Sethi, Riccha; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, Saarbrucken, Germany; [Trumm, Johannes; Fuellen, Georg] Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Irhimeh, Mohammad R.] Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, St Leonards, NSW, Australia; [Paulsen, Martina] Univ Saarland, Dept Genet, Saarbrucken, Germany; [Irhimeh, Mohammad R.] Royal Perth Hosp, CTTWA, Perth, WA, Australia; [Irhimeh, Mohammad R.] Univ Western Australia, Perth, WA, Australia	Saarland University; University of Rostock; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Saarland University; Royal Perth Hospital; University of Western Australia	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, Saarbrucken, Germany.	volkhard.helms@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154	Deutsche Forschungsgemeinschaft [SFB 1027]; DAAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Support was provided by Deutsche Forschungsgemeinschaft (SFB 1027), DAAD (graduate fellowship to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Bult C, 2007, J BIOMOLECULAR TECHN, V18, P2; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; GRUMONT RJ, 1990, ONCOGENE RES, V5, P245; Hamed M, 2015, NUCLEIC ACIDS RES; Hamed M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S2; Hamed M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050285; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutter B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-649; Hutter B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-116; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ingham RJ, 1998, J BIOL CHEM, V273, P30630, DOI 10.1074/jbc.273.46.30630; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kitamura K, 2000, BLOOD, V95, P3371, DOI 10.1182/blood.V95.11.3371.011k37_3371_3379; Klimmeck D, 2014, STEM CELL REP, V3, P858, DOI 10.1016/j.stemcr.2014.08.012; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee EO, 2005, J BIOL CHEM, V280, P7845, DOI 10.1074/jbc.M409101200; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Mougeot JLC, 2011, ORAL SURG ORAL MED O, V112, P446, DOI 10.1016/j.tripleo.2011.05.009; Park SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093853; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venkatraman A, 2013, NATURE; Watowich SS, 2000, J INTERF CYTOK RES, V20, P1065, DOI 10.1089/107999000750053726; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0166852	10.1371/journal.pone.0166852	http://dx.doi.org/10.1371/journal.pone.0166852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052084	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500006
J	Hennika, T; Hu, G; Olaciregui, NG; Barton, KL; Ehteda, A; Chitranjan, A; Chang, C; Gifford, AJ; Tsoli, M; Ziegler, DS; Carcaboso, AM; Becher, OJ				Hennika, Tammy; Hu, Guo; Olaciregui, Nagore G.; Barton, Kelly L.; Ehteda, Anahid; Chitranjan, Arjanna; Chang, Cecilia; Gifford, Andrew J.; Tsoli, Maria; Ziegler, David S.; Carcaboso, Angel M.; Becher, Oren J.			Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models	PLOS ONE			English	Article							ACTIVATING ACVR1 MUTATIONS; HIGH-GRADE GLIOMA; PEDIATRIC GLIOBLASTOMA; DRIVER MUTATIONS; GENE-EXPRESSION; HISTONE H3.3; SUBGROUPS; CHILDREN; H3F3A	Background Diffuse intrinsic pontine glioma (DIPG), or high-grade brainstem glioma (BSG), is one of the major causes of brain tumor-related deaths in children. Its prognosis has remained poor despite numerous efforts to improve survival. Panobinostat, a histone deacetylase inhibitor, is a targeted agent that has recently shown pre-clinical efficacy and entered a phase I clinical trial for the treatment of children with recurrent or progressive DIPG. Methods A collaborative pre-clinical study was conducted using both a genetic BSG mouse model driven by PDGF-B signaling, p53 loss, and ectopic H3.3-K27M or H3.3-WT expression and an H3.3-K27M orthotopic DIPG xenograft model to confirm and extend previously published findings regarding the efficacy of panobinostat in vitro and in vivo. Results In vitro, panobinostat potently inhibited cell proliferation, viability, and clonogenicity and induced apoptosis of human and murine DIPG cells. In vivo analyses of tissue after short-term systemic administration of panobinostat to genetically engineered tumor-bearing mice indicated that the drug reached brainstem tumor tissue to a greater extent than normal brain tissue, reduced proliferation of tumor cells and increased levels of H3 acetylation, demonstrating target inhibition. Extended consecutive daily treatment of both genetic and orthotopic xenograft models with 10 or 20 mg/kg panobinostat consistently led to significant toxicity. Reduced, well-tolerated doses of panobinostat, however, did not prolong overall survival compared to vehicle-treated mice. Conclusion Our collaborative pre-clinical study confirms that panobinostat is an effective targeted agent against DIPG human and murine tumor cells in vitro and in short-term in vivo efficacy studies in mice but does not significantly impact survival of mice bearing H3.3-K27M-mutant tumors. We suggest this may be due to toxicity associated with systemic administration of panobinostat that necessitated dose de-escalation.	[Hennika, Tammy; Hu, Guo; Barton, Kelly L.; Becher, Oren J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hennika, Tammy; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27708 USA; [Olaciregui, Nagore G.; Carcaboso, Angel M.] Fundacio St Joan Deu, Preclin Therapeut & Drug Delivery Res Program, Barcelona, Spain; [Olaciregui, Nagore G.; Carcaboso, Angel M.] Hosp St Joan Deu, Dept Pediat Hematol & Oncol, Barcelona, Spain; [Ehteda, Anahid; Chitranjan, Arjanna; Chang, Cecilia; Gifford, Andrew J.; Tsoli, Maria; Ziegler, David S.] Univ New South Wales, Childrens Canc Inst, Randwick, NSW, Australia; [Gifford, Andrew J.] Prince Wales Hosp, Dept Anat Pathol, Randwick, NSW, Australia; [Ziegler, David S.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Becher, Oren J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; University of Barcelona; Children's Cancer Institute; University of New South Wales Sydney; Duke University	Becher, OJ (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.; Becher, OJ (corresponding author), Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27708 USA.; Becher, OJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	oren.becher@duke.edu	Tsoli, Maria/P-3941-2018; Becher, Oren/AAI-7495-2020	Tsoli, Maria/0000-0003-1155-0510; Gifford, Andrew/0000-0002-4092-2347; Carcaboso, Angel/0000-0002-8485-426X; Becher, Oren/0000-0003-4016-8492; Hu, Guo/0000-0003-0597-208X; Ziegler, David/0000-0001-7451-7916	Duke Cancer Institute seed grant; Rory David Deutsch Foundation; Abbie's Army [K02 NS086917]; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32); National Health and Medical Research Council [APP1085411]; Cancer Institute NSW's Kids Cancer Alliance; Cure Starts Now; Benny Wills Brain Tumour Research Program; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; Fondo Alicia Pueyo; AECC Scientific Foundation; Fundacion Joan Ribas Araquistain; European Union Seventh Framework Programme (FP7) under Marie Curie International Reintegration Grant [PIRG-08-GA-2010-276998]; ISCIII-FEDER [CP13/00189]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS066274, K02NS086917] Funding Source: NIH RePORTER	Duke Cancer Institute seed grant; Rory David Deutsch Foundation; Abbie's Army; Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW's Kids Cancer Alliance; Cure Starts Now; Benny Wills Brain Tumour Research Program; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; Fondo Alicia Pueyo; AECC Scientific Foundation; Fundacion Joan Ribas Araquistain; European Union Seventh Framework Programme (FP7) under Marie Curie International Reintegration Grant; ISCIII-FEDER(Spanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by a Duke Cancer Institute seed grant (OJB), the Rory David Deutsch Foundation, http://www.roryd.org/ (OJB), Abbie's Army, http://www.abbiesarmy.co.uk (OJB), K02 NS086917 (OJB), and a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32) (TH). DSZ received funding from National Health and Medical Research Council (APP1085411), Cancer Institute NSW's Kids Cancer Alliance, The Cure Starts Now, http://www.thecurestartsnow.org, and Benny Wills Brain Tumour Research Program, www.bennywills.org. AMC acknowledges support from the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d'Oncologia de Catalunya, and funding from the Fondo Alicia Pueyo, AECC Scientific Foundation, Fundacion Joan Ribas Araquistain, European Union Seventh Framework Programme (FP7/2007-2013) under Marie Curie International Reintegration Grant (PIRG-08-GA-2010-276998) and ISCIII-FEDER (CP13/00189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne M, 2013, ONCOTARGETS THER, V6, P1613, DOI 10.2147/OTT.S30773; Barton KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077639; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Debinski W, 2009, EXPERT REV NEUROTHER, V9, P1519, DOI 10.1586/ERN.09.99; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Freeman CR, 1998, INT J RADIAT ONCOL, V40, P265, DOI 10.1016/S0360-3016(97)00572-5; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Halvorson KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118926; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mittapalli RK, 2016, MOL CANC THERAPEUTIC; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Nikbakht H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11185; Robison NJ, 2014, J NEURO-ONCOL, V119, P7, DOI 10.1007/s11060-014-1448-8; Schroeder KM, 2014, PEDIATR RES, V75, P205, DOI 10.1038/pr.2013.194; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subashi E, 2016, J NEURO-ONCOL, V126, P243, DOI 10.1007/s11060-015-1969-9; Taylor KR, 2014, CANCER RES, V74, P4565, DOI 10.1158/0008-5472.CAN-14-1298; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	27	95	97	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169485	10.1371/journal.pone.0169485	http://dx.doi.org/10.1371/journal.pone.0169485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052119	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500062
J	Urrutla, I; Martinez, R; Lopez-Euba, T; Velayos, T; de LaPiscina, IM; Bilbao, JR; Rica, I; Castano, L				Urrutla, Ines; Martinez, Rosa; Lopez-Euba, Tamara; Velayos, Teresa; Martinez de LaPiscina, Idoia; Ramon Bilbao, Jose; Rica, Itxaso; Castano, Luis		Spanish Grp Study MODY Type 1 Diab	Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY	PLOS ONE			English	Article							CLINICAL-DIAGNOSIS; GENETIC DIAGNOSIS; CHILDREN; ONSET; MELLITUS; INSULIN; SPAIN; YOUNG; MUTATIONS; HNF1A	Objective The aim of this study was to determine the frequency of susceptible HLA-DRB1 alleles for type 1 diabetes in a cohort of pediatric patients with a confirmed genetic diagnosis of MODY. Materials and Methods 160 families with a proband diagnosed with type 1 diabetes and 74 families with a molecular diagnosis of MODY (61 GCK-MODY and 13 HNF1A-MODY) were categorized at high definition for HLA-DRB1 locus. According to the presence or absence of the susceptible HLA-DRB1 alleles for type 1 diabetes, we considered three different HLA-DRB1 genotypes: 0 risk alleles (no DR3 no DR4); 1 risk allele (DR3 or DR4); 2 risk alleles (DR3 and/or DR4). Results Compared with type 1 diabetes, patients with MODY carried higher frequency of 0 risk alleles, OR 22.7 (95% CI: 10.7-48.6) and lower frequency of 1 or 2 risk alleles, OR 0.53 (95% CI: 0.29-0.96) and OR 0.06 (95% CI: 0.02-0.18), respectively. Conclusions The frequency of HLA-DRB1 risk alleles for type 1 diabetes is significantly lower in patients with MODY. In children and adolescents with diabetes, the presence of 2 risk alleles (DR3 and/or DR4) reduces the probability of MODY diagnosis, whereas the lack of risk alleles increases it. Therefore, we might consider that HLA-DRB1 provides additional information for the selection of patients with high probability of monogenic diabetes.	[Urrutla, Ines; Martinez, Rosa; Lopez-Euba, Tamara; Velayos, Teresa; Martinez de LaPiscina, Idoia; Ramon Bilbao, Jose; Rica, Itxaso; Castano, Luis; Spanish Grp Study MODY Type 1 Diab] Univ Basque Country, Cruces Univ Hosp, CIBERDEM, BioCruces Hlth Res Inst,CIBERER, Baracaldo, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBERER; Hospital Universitario Cruces; University of Basque Country	Castano, L (corresponding author), Univ Basque Country, Cruces Univ Hosp, CIBERDEM, BioCruces Hlth Res Inst,CIBERER, Baracaldo, Spain.	lcastano@osakidetza.eus	Blanco, Leire/O-5114-2017; Bilbao, Jose Ramon/A-9177-2008; URRUTIA, INES/AAB-5641-2019; Martinez, Rosa/AAA-5181-2019; de LaPiscina, Idoia Martinez/AAB-6067-2019; MARTORELL, ARIADNA CAMPOS/AAB-6944-2019	Bilbao, Jose Ramon/0000-0002-3176-501X; URRUTIA, INES/0000-0001-5386-8776; Martinez, Rosa/0000-0003-3800-531X; de LaPiscina, Idoia Martinez/0000-0001-8943-1429; Castano, Luis/0000-0003-0437-9401	University of the Basque Country, UPV/EHU [IT795-13]; Department of Health of the Basque Government [GV2010111185]; ISCIII [PI14/01104]; FEDER (European Funds for Regional Development)	University of the Basque Country, UPV/EHU; Department of Health of the Basque Government; ISCIII(Instituto de Salud Carlos III); FEDER (European Funds for Regional Development)(European Commission)	This work was partially supported by grants from the University of the Basque Country, UPV/EHU (IT795-13), from the Department of Health of the Basque Government (GV2010111185) and from ISCIII (PI14/01104) integrated into the National R&D&I Plan 2013-2016 and co-financed by FEDER (European Funds for Regional Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2013, J PEDIATR ENDOCR MET, V26, P25, DOI 10.1515/jpem-2012-0200; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bahillo-Curieses MP, 2012, ENDOCRINE, V41, P289, DOI 10.1007/s12020-011-9540-8; Barker JM, 2008, DIABETES, V57, P3152, DOI 10.2337/db08-0605; Besser REJ, 2011, DIABETES CARE, V34, P286, DOI 10.2337/dc10-1293; Bilbao JR, 2000, HORM RES, V54, P181, DOI 10.1159/000053256; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Escribano-de-Diego J, 1999, HUM IMMUNOL, V60, P990, DOI 10.1016/S0198-8859(99)00077-4; Estalella I, 2007, CLIN ENDOCRINOL, V67, P538, DOI 10.1111/j.1365-2265.2007.02921.x; Giannopoulou EZ, 2015, DIABETOLOGIA, V58, P2317, DOI 10.1007/s00125-015-3672-y; Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; McDonald TJ, 2011, DIABETIC MED, V28, P1028, DOI 10.1111/j.1464-5491.2011.03287.x; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; Naylor RN, 2014, DIABETES CARE, V37, P202, DOI 10.2337/dc13-0410; Pihoker C, 2013, J CLIN ENDOCR METAB, V98, P4055, DOI 10.1210/jc.2013-1279; Savola K, 1998, DIABETOLOGIA, V41, P1293, DOI 10.1007/s001250051067; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Soria J, 2008, DIABETES RES CLIN PR, V79, P112, DOI 10.1016/j.diabres.2007.06.013; Stanik J, 2014, DIABETOLOGIA, V57, P480, DOI 10.1007/s00125-013-3119-2; Steele AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065326; Stone MA, 2010, DIABETIC MED, V27, P491, DOI 10.1111/j.1464-5491.2009.02920.x; Thanabalasingham G, 2011, DIABETOLOGIA, V54, P2801, DOI 10.1007/s00125-011-2261-y; Urbanova J, 2014, DIABETIC MED, V31, P466, DOI 10.1111/dme.12314; Urbanova J, 2013, INT ARCH ALLERGY IMM, V161, P279, DOI 10.1159/000346906	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169389	10.1371/journal.pone.0169389	http://dx.doi.org/10.1371/journal.pone.0169389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052112	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500056
J	Marshall, SA; Fisher, K; Cheallaigh, AN; White, MD; Payne, KAP; Parker, DA; Rigby, SEJ; Leys, D				Marshall, Stephen A.; Fisher, Karl; Cheallaigh, Aisling N. I.; White, Mark D.; Payne, Karl A. P.; Parker, D. A.; Rigby, Stephen E. J.; Leys, David			Oxidative Maturation and Structural Characterization of Prenylated FMN Binding by UbiD, a Decarboxylase Involved in Bacterial Ubiquinone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; VANILLIC ACID; COENZYME-Q; CHORISMATE; COFACTOR; 4-HYDROXYBENZOATE; ACCUMULATION; DERIVATIVES; MECHANISM; MEMBRANE	The activity of the reversible decarboxylase enzyme Fdc1 is dependent on prenylated FMN (prFMN), a recently discovered cofactor. The oxidized prFMN supports a 1,3-dipolar cycloaddition mechanism that underpins reversible decarboxylation. Fdc1 is a distinct member of the UbiD family of enzymes, with the canonical UbiD catalyzing the (de) carboxylation of para-hydroxybenzoic acid-type substrates. Here we show that the Escherichia coli UbiD enzyme, which is implicated in ubiquinone biosynthesis, cannot be isolated in an active holoenzyme form despite the fact active holoFdc1 is readily obtained. Formation of holoUbiD requires reconstitution in vitro of the apoUbiD with reduced prFMN. Furthermore, although the Fdc1 apoenzyme can be readily reconstituted and activated, in vitro oxidation to the mature prFMN cofactor stalls at formation of a radical prFMN species in holoUbiD. Further oxidative maturation in vitro occurs only at alkaline pH, suggesting a proton-coupled electron transfer precedes formation of the fully oxidized prFMN. Crystal structures of holoUbiD reveal a relatively open active site potentially occluded from solvent through domain motion. The presence of a prFMN sulfite-adduct in one of the UbiD crystal structures confirms oxidative maturation does occur at ambient pH on a slow time scale. Activity could not be detected for a range of putative para-hydroxybenzoic acid substrates tested. However, the lack of an obvious hydrophobic binding pocket for the octaprenyl tail of the proposed ubiquinone precursor substrate does suggest UbiD might act on a non-prenylated precursor. Our data reveals an unexpected variation occurs in domain mobility, prFMN binding, and maturation by the UbiD enzyme family.	[Marshall, Stephen A.; Fisher, Karl; Cheallaigh, Aisling N. I.; White, Mark D.; Payne, Karl A. P.; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Parker, D. A.] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA; [Cheallaigh, Aisling N. I.] AstraZeneca, Silk Rd, Macclesfield SK10 2NA, Cheshire, England; [White, Mark D.] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Manchester; AstraZeneca; University of Oxford	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Fisher, Karl/A-5956-2013	Fisher, Karl/0000-0003-3539-8939; White, Mark/0000-0002-1431-0339; payne, karl/0000-0002-6331-6374	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K017802/1]; BBSRC iCASE studentship; BBSRC [BB/K017802/1, BB/E013007/1, BB/P000622/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, 1352655, BB/P000622/1, BB/K017802/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC iCASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/ K017802/ 1 and a BBSRC iCASE studentship to S. A. M. The authors declare that they have no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez-Rodriguez ML, 2003, FEMS MICROBIOL LETT, V220, P49, DOI 10.1016/S0378-1097(03)00053-3; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Baunach M, 2015, ANGEW CHEM INT EDIT, V54, P12550, DOI 10.1002/anie.201507120; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Chow KT, 1999, MICROBIOL-SGM, V145, P2393, DOI 10.1099/00221287-145-9-2393; Cornforth R. H., 1969, METHODS ENZYMOL, V15, P359; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; HAMILTON JA, 1971, BIOCHEM J, V123, P435, DOI 10.1042/bj1230435; Hasson MS, 1998, BIOCHEMISTRY-US, V37, P9918, DOI 10.1021/bi973047e; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; HOFFMAN BM, 1984, J MAGN RESON, V59, P110, DOI 10.1016/0022-2364(84)90287-7; Jacewicz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063161; Jordan F, 2013, ACS CATAL, V3, P1601, DOI 10.1021/cs400272x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE J, 1974, J BACTERIOL, V118, P41, DOI 10.1128/JB.118.1.41-45.1974; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; MAGER HIX, 1990, PHOTOCHEM PHOTOBIOL, V51, P223, DOI 10.1111/j.1751-1097.1990.tb01707.x; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; METZLER DE, 1954, J AM CHEM SOC, V76, P648, DOI 10.1021/ja01632a004; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NICHOLS BP, 1992, J BACTERIOL, V174, P5309, DOI 10.1128/JB.174.16.5309-5316.1992; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Thulasiram HV, 2006, J ORG CHEM, V71, P1739, DOI 10.1021/jo052384n; UCHIDA K, 1991, AGR BIOL CHEM TOKYO, V55, P2299, DOI 10.1080/00021369.1991.10870950; Wessjohann L, 1996, ANGEW CHEM INT EDIT, V35, P1697, DOI 10.1002/anie.199616971; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; YOUNG IG, 1972, J BACTERIOL, V110, P18, DOI 10.1128/JB.110.1.18-25.1972	43	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4623	4637		10.1074/jbc.M116.762732	http://dx.doi.org/10.1074/jbc.M116.762732			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28057757	Green Published, hybrid			2022-12-26	WOS:000397585100020
J	Yadav, H; Devalaraja, S; Chung, ST; Rane, SG				Yadav, Hariom; Devalaraja, Samir; Chung, Stephanie T.; Rane, Sushil G.			TGF-1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; FOXO; gluconeogenesis; liver; obesity; phosphoprotein phosphatase; SMAD transcription factor; transforming growth factor (TGF-)	ACTIVATED PROTEIN-KINASE; TGF-BETA; GENE-EXPRESSION; C-ELEGANS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; INSULIN SENSITIVITY; DIETARY RESTRICTION; TRANSGENIC MICE; DB/DB MICE; GROWTH	Maintenance of glucose homeostasis is essential for normal physiology. Deviation from normal glucose levels, in either direction, increases susceptibility to serious medical complications such as hypoglycemia and diabetes. Maintenance of glucose homeostasis is achieved via functional interactions among various organs: liver, skeletal muscle, adipose tissue, brain, and the endocrine pancreas. The liver is the primary site of endogenous glucose production, especially during states of prolonged fasting. However, enhanced gluconeogenesis is also a signature feature of type 2 diabetes (T2D). Thus, elucidating the signaling pathways that regulate hepatic gluconeogenesis would allow better insight into the process of normal endogenous glucose production as well as how this process is impaired in T2D. Here we demonstrate that the TGF-1/Smad3 signaling pathway promotes hepatic gluconeogenesis, both upon prolonged fasting and during T2D. In contrast, genetic and pharmacological inhibition of TGF-1/Smad3 signals suppressed endogenous glucose production. TGF-1 and Smad3 signals achieved this effect via the targeting of key regulators of hepatic gluconeogenesis, protein phosphatase 2A (PP2A), AMP-activated protein kinase (AMPK), and FoxO1 proteins. Specifically, TGF-1 signaling suppressed the LKB1-AMPK axis, thereby facilitating the nuclear translocation of FoxO1 and activation of key gluconeogenic genes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. These findings underscore an important role of TGF-1/Smad3 signaling in hepatic gluconeogenesis, both in normal physiology and in the pathophysiology of metabolic diseases such as diabetes, and are thus of significant medical relevance.	[Yadav, Hariom; Devalaraja, Samir; Chung, Stephanie T.; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rane, SG (corresponding author), NIDDK, Clin Res Ctr, Diabet Endocrinol & Obes Branch, NIH, Bldg 10,9000 Rockville Pike, Bethesda, MD 20814 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Aoyama H, 2006, INT J MOL MED, V18, P433; Awad H, 2014, PEDIATR PULM, V49, P885, DOI 10.1002/ppul.22919; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; Chung ST, 2013, DIABETES, V62, pA56; Datto MB, 1999, MOL CELL BIOL, V19, P2495; della Vecchia NF, 2014, BIOMACROMOLECULES, V15, P3811, DOI 10.1021/bm501139h; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Osorio Joana, 2012, Nat Rev Endocrinol, V8, P257, DOI 10.1038/nrendo.2012.34; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; PILKIS SJ, 1988, ANNU REV BIOCHEM, V57, P755, DOI 10.1146/annurev.bi.57.070188.003543; Ramakrishnan SK, 2016, CELL METAB, V23, P505, DOI 10.1016/j.cmet.2016.01.004; Rosmond R, 2003, HORM RES, V59, P191, DOI 10.1159/000069323; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Tiano JP, 2015, J BIOL CHEM, V290, P11431, DOI 10.1074/jbc.A114.617399; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; VENEZIALE CM, 1983, J BIOL CHEM, V258, P4257; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	43	56	66	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3420	3432		10.1074/jbc.M116.764910	http://dx.doi.org/10.1074/jbc.M116.764910			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069811	hybrid, Green Published			2022-12-26	WOS:000395538800031
J	Yang, HS; Embry, RE; Main, RP				Yang, Haisheng; Embry, Rachel E.; Main, Russell P.			Effects of Loading Duration and Short Rest Insertion on Cancellous and Cortical Bone Adaptation in the Mouse Tibia	PLOS ONE			English	Article							IN-VIVO; ADAPTIVE RESPONSE; FEMALE MICE; RAT TIBIAE; COMPRESSION; MODEL; INCREASES; SKELETON; C57BL/6; CELLS	The skeleton's osteogenic response to mechanical loading can be affected by loading duration and rest insertion during a series of loading events. Prior animal loading studies have shown that the cortical bone response saturates quickly and short rest insertions between load cycles can enhance cortical bone formation. However, it remains unknown how loading duration and short rest insertion affect load-induced osteogenesis in the mouse tibial compressive loading model, and particularly in cancellous bone. To address this issue, we applied cyclic loading (-9 N peak load; 4 Hz) to the tibiae of three groups of 16 week-old female C57BL/6 mice for two weeks, with a different number of continuous load cycles applied daily to each group (36, 216 and 1200). A fourth group was loaded under 216 daily load cycles with a 10 s rest insertion after every fourth cycle. We found that as few as 36 load cycles per day were able to induce osteogenic responses in both cancellous and cortical bone. Furthermore, while cortical bone area and thickness continued to increase through 1200 cycles, the incremental increase in the osteogenic response decreased as load number increased, indicating a reduced benefit of the increasing number of load cycles. In the proximal metaphyseal cancellous bone, trabecular thickness increased with load up to 216 cycles. We also found that insertion of a 10 s rest between load cycles did not improve the osteogenic response of the cortical or cancellous tissues compared to continuous loading in this model given the age and sex of the mice and the loading parameters used here. These results suggest that relatively few load cycles (e.g. 36) are sufficient to induce osteogenic responses in both cortical and cancellous bone in the mouse tibial loading model. Mechanistic studies using the mouse tibial loading model to examine bone formation and skeletal mechanobiology could be accomplished with relatively few load cycles.	[Yang, Haisheng; Embry, Rachel E.; Main, Russell P.] Purdue Univ, Musculoskeletal Biol & Mech Lab, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Main, Russell P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Yang, Haisheng] McGill Univ, Dept Pediat Surg, Shriners Hosp Children Canada, Montreal, PQ, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; McGill University	Main, RP (corresponding author), Purdue Univ, Musculoskeletal Biol & Mech Lab, Dept Basic Med Sci, W Lafayette, IN 47907 USA.; Main, RP (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	rmain@purdue.edu			Howard Hughes Medical Institute Science Education Program; National Science Foundation [CMMI-1463523, NSF CMMI-1463523]	Howard Hughes Medical Institute Science Education Program; National Science Foundation(National Science Foundation (NSF))	REE received funding from the Howard Hughes Medical Institute Science Education Program (http://www.hhmi.org). RPM received funding the National Science Foundation (www.nsf.org; CMMI-1463523). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from the Howard Hughes Medical Institute Science Education Program (REE) and the National Science Foundation (NSF CMMI-1463523).	Baumann AP, 2015, BONE, V75, P55, DOI 10.1016/j.bone.2015.01.022; Berman AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130504; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dodge T, 2012, BONE, V51, P810, DOI 10.1016/j.bone.2012.07.021; FORWOOD MR, 1994, BONE, V15, P603, DOI 10.1016/8756-3282(94)90307-7; Forwood MR, 1996, AM J PHYSIOL-ENDOC M, V270, pE419, DOI 10.1152/ajpendo.1996.270.3.E419; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Holguin N, 2014, BONE, V65, P83, DOI 10.1016/j.bone.2014.05.006; Holguin N, 2013, CALCIFIED TISSUE INT, V93, P211, DOI 10.1007/s00223-013-9744-4; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906; LaMothe JM, 2004, J APPL PHYSIOL, V96, P1788, DOI 10.1152/japplphysiol.01145.2003; LANYON LE, 1992, BONE, V13, pS17, DOI 10.1016/8756-3282(92)90191-X; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lynch ME, 2011, BONE, V49, P439, DOI 10.1016/j.bone.2011.05.017; Lynch ME, 2010, J APPL PHYSIOL, V109, P685, DOI 10.1152/japplphysiol.00210.2010; Main RP, 2014, J EXP BIOL, V217, P1775, DOI 10.1242/jeb.085522; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Meakin LB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00154; Melville KM, 2015, J BONE MINER RES, V30, P1468, DOI 10.1002/jbmr.2488; Metzger TA, 2015, J BIOMECH, V48, P3035, DOI 10.1016/j.jbiomech.2015.07.028; Pereira AF, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0590; Robling AG, 2001, J EXP BIOL, V204, P3389; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Silva MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034980; Sinnesael M, 2012, J BONE MINER RES, V27, P2535, DOI 10.1002/jbmr.1713; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Srinivasan S, 2015, MED SCI SPORT EXER, V47, P1095, DOI 10.1249/MSS.0000000000000509; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; TURNER CH, 1994, FASEB J, V8, P875, DOI 10.1096/fasebj.8.11.8070637; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Turner CH, 2003, EXERC SPORT SCI REV, V31, P45, DOI 10.1097/00003677-200301000-00009; Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480; Wallace IJ, 2015, J EXP BIOL, V218, P3002, DOI 10.1242/jeb.118729; Wang B, 2014, J BONE MINER RES, V29, P878, DOI 10.1002/jbmr.2105; Weatherholt AM, 2013, BONE, V52, P372, DOI 10.1016/j.bone.2012.10.026; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Yang HS, 2014, BONE, V66, P131, DOI 10.1016/j.bone.2014.05.019	45	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169519	10.1371/journal.pone.0169519	http://dx.doi.org/10.1371/journal.pone.0169519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076363	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100041
J	Bukoski, JJ; Broadhead, JS; Donato, DC; Murdiyarso, D; Gregoire, TG				Bukoski, Jacob J.; Broadhead, Jeremy S.; Donato, Daniel C.; Murdiyarso, Daniel; Gregoire, Timothy G.			The Use of Mixed Effects Models for Obtaining Low-Cost Ecosystem Carbon Stock Estimates in Mangroves of the Asia-Pacific	PLOS ONE			English	Article							CLIMATE-CHANGE; SOUTHEAST-ASIA; FOREST; PATTERNS; RESTORATION; BIOMASS; STORAGE	Mangroves provide extensive ecosystem services that support local livelihoods and international environmental goals, including coastal protection, biodiversity conservation and the sequestration of carbon (C). While voluntary C market projects seeking to preserve and enhance forest C stocks offer a potential means of generating finance for mangrove conservation, their implementation faces barriers due to the high costs of quantifying C stocks through field inventories. To streamline C quantification in mangrove conservation projects, we develop predictive models for (i) biomass-based C stocks, and (ii) soil-based C stocks for the mangroves of the Asia-Pacific. We compile datasets of mangrove biomass C (197 observations from 48 sites) and soil organic C (99 observations from 27 sites) to parameterize the predictive models, and use linear mixed effect models to model the expected C as a function of stand attributes. The most parsimonious biomass model predicts total biomass C stocks as a function of both basal area and the interaction between latitude and basal area, whereas the most parsimonious soil C model predicts soil C stocks as a function of the logarithmic transformations of both latitude and basal area. Random effects are specified by site for both models, which are found to explain a substantial proportion of variance within the estimation datasets and indicate significant heterogeneity across-sites within the region. The root mean square error (RMSE) of the biomass C model is approximated at 24.6 Mg/ha (18.4% of mean biomass C in the dataset), whereas the RMSE of the soil C model is estimated at 4.9 mg C/cm(3) (14.1% of mean soil C). The results point to a need for standardization of forest metrics to facilitate meta-analyses, as well as provide important considerations for refining ecosystem C stock models in mangroves.	[Bukoski, Jacob J.; Gregoire, Timothy G.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Broadhead, Jeremy S.] UN, Food & Agr Org, Bangkok, Thailand; [Broadhead, Jeremy S.] Spatial Informat Grp, Pleasanton, CA USA; [Donato, Daniel C.] Dept Nat Resources, Olympia, WA USA; [Murdiyarso, Daniel] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Murdiyarso, Daniel] Bogor Agr Univ, Dept Geophys & Meteorol, Bogor, Indonesia	Yale University; Food & Agriculture Organization of the United Nations (FAO); CGIAR; Center for International Forestry Research (CIFOR); Bogor Agricultural University	Bukoski, JJ (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	jbukoski@berkeley.edu	Murdiyarso, Daniel/M-4245-2019	Bukoski, Jacob/0000-0002-2334-5023	Tropical Resources Institute, Yale University; Career and Development Office, School of Forestry and Environmental Studies, Yale University; Carpenter Sperry Fund, Yale University; USAID Lowering Emissions in Asia's Forests; Danida through Mangroves for the Future; Norad through Mangroves for the Future; Sida through Mangroves for the Future; Royal Norwegian Embassy through Mangroves for the Future; Spatial Informatics Group; Royal Norwegian Embassy in Thailand; USAID-LEAF; Tropical Resources Institute at Yale University; USAID Sustainable Wetlands Adaptation and Mitigation Program; Yale School of Forestry Career and Development Organization; Carpenter Sperry Fund	Tropical Resources Institute, Yale University; Career and Development Office, School of Forestry and Environmental Studies, Yale University; Carpenter Sperry Fund, Yale University; USAID Lowering Emissions in Asia's Forests(United States Agency for International Development (USAID)); Danida through Mangroves for the Future; Norad through Mangroves for the Future; Sida through Mangroves for the Future; Royal Norwegian Embassy through Mangroves for the Future; Spatial Informatics Group; Royal Norwegian Embassy in Thailand; USAID-LEAF(United States Agency for International Development (USAID)); Tropical Resources Institute at Yale University; USAID Sustainable Wetlands Adaptation and Mitigation Program(United States Agency for International Development (USAID)); Yale School of Forestry Career and Development Organization; Carpenter Sperry Fund	This work was supported by Tropical Resources Institute, Yale University (JJB); Career and Development Office, School of Forestry and Environmental Studies, Yale University (JJB); Carpenter Sperry Fund, Yale University (JJB); USAID Lowering Emissions in Asia's Forests (JSB); Danida, Norad and Sida through Mangroves for the Future (JSB); and Royal Norwegian Embassy through Mangroves for the Future (JSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Spatial Informatics Group provided support in the form of salaries for author JSB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.r This study comprises one component of the "Income for coastal communities for protecting mangroves" project, implemented as part of the Mangroves for the Future regional programme (MFF), co-chaired by IUCN and UNDP, and financially supported by Danida, Norad, Sida, and the Royal Norwegian Embassy in Thailand. The projectly is jointly implemented by MFF, UN FAO, and the USAID Lowering Emissions in Asia's Forests program. The authors gratefully thank USAID-LEAF, the Tropical Resources Institute at Yale University, the USAID Sustainable Wetlands Adaptation and Mitigation Program, the Yale School of Forestry Career and Development Organization, and the Carpenter Sperry Fund for their financial support of this research. The authors gratefully thank Dr. J. Boone Kauffman for his contribution of key data. For their extensive assistance in field sampling and logistics, the authors thank Geoffrey Blate, Jaruwan Enright, Jim Enright, Richard Mackenzie, Vinh Loi Nguyen, Thuy Phung, Amornwan Resanond, Pham Hong Tinh, Natcha Tulyasuwan, Nguyen Xuan Tung, and Radtasiri Wachirapunyanont as well as our many field team members. Additionally, we gratefully thank the Ashton Lab at Yale FES, particularly Dr. Marlyse Duguid and Dr. Mark Ashton, for their extensive assistance in the development of this study.	Alexander S, 2011, RESTOR ECOL, V19, P683, DOI 10.1111/j.1526-100X.2011.00822.x; Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/CMT.12.20, 10.4155/cmt.12.20]; Angelsen Arild, 2008, MOVING AHEAD REDD IS; [Anonymous], 2022, NLME LINEAR NONLINEA; Balke T, 2016, EARTH SURF PROC LAND, V41, P231, DOI 10.1002/esp.3841; Barton K., 2011, MUMIN MULTIMODEL INF; Bastin JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13156; Berenguer E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133139; Brander LM, 2012, ECOSYST SERV, V1, P62, DOI 10.1016/j.ecoser.2012.06.003; Broadhead J., 2011, GCPRAS237SPA REG FIS, P37; Bunnefeld N, 2012, ECOGRAPHY, V35, P15, DOI 10.1111/j.1600-0587.2011.07078.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; CINTRON G, 1978, BIOTROPICA, V10, P110, DOI 10.2307/2388013; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Forbes K., 2007, ROLE COASTAL FORESTS; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; HA TTT, 2012, OCEAN COAST MANAGE, V69, P185, DOI DOI 10.1016/j.ocecoaman.2012.07.034; Holdaway RJ, 2014, ECOSYSTEMS, V17, P627, DOI 10.1007/s10021-014-9749-5; Hutchison J, 2014, CONSERV LETT, V7, P233, DOI 10.1111/conl.12060; Jardine SL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104013; Kauffman J. B., 2012, CIFOR Working Paper; Kreft I.G.G., 1998, INTRO MULTILEVEL MOD, DOI [10.4135/9781849209366, DOI 10.4135/9781849209366]; Leopold A, 2013, GEODERMA, V202, P62, DOI 10.1016/j.geoderma.2013.03.008; Liu HX, 2014, J ENVIRON MANAGE, V133, P86, DOI 10.1016/j.jenvman.2013.11.037; Locatelli B., 2011, SYNERGIES ADAPTATION; Locatelli T, 2014, AMBIO, V43, P981, DOI 10.1007/s13280-014-0530-y; Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Murdiyarso D, 2011, ADDRESSING CLIMATE C, V41; Murdiyarso D, 2015, NAT CLIM CHANGE, V5, P1089, DOI [10.1038/nclimate2734, 10.1038/NCLIMATE2734]; Murdiyarso D, 2013, CARBON MANAG, V4, P491, DOI [10.4155/CMT.13.46, 10.4155/cmt.13.46]; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Tue NT, 2014, CATENA, V121, P119, DOI 10.1016/j.catena.2014.05.008; Patino J, 2013, ECOGRAPHY, V36, P904, DOI 10.1111/j.1600-0587.2012.00020.x; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Phillips DL, 2000, GLOBAL ECOL BIOGEOGR, V9, P305, DOI 10.1046/j.1365-2699.2000.00197.x; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman MM, 2015, WETL ECOL MANAG, V23, P269, DOI 10.1007/s11273-014-9379-x; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Rodrigues DP, 2015, AQUAT BOT, V120, P346, DOI 10.1016/j.aquabot.2014.10.004; Saenger P., 2002, MANGROVE ECOLOGY SIL, DOI DOI 10.1007/978-94-015-9962-7; Salk CF, 2013, CAN J FOREST RES, V43, P799, DOI 10.1139/cjfr-2013-0048; Sasmito SD, 2016, WETL ECOL MANAG, V24, P263, DOI 10.1007/s11273-015-9466-7; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Spalding M.D., 2010, WORLD ATLAS MANGROVE, DOI 10.4324/9781849776608; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Torres AB, 2012, USING BASAL AREA EST; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Wang G, 2014, EUR J FOREST RES, V133, P993, DOI 10.1007/s10342-014-0817-3; Yanai RD, 2010, ECOSYSTEMS, V13, P239, DOI 10.1007/s10021-010-9315-8; Zaballa Romero ME, 2013, TRANSLATING LESSONS	57	22	22	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169096	10.1371/journal.pone.0169096	http://dx.doi.org/10.1371/journal.pone.0169096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068361	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900019
J	Choquette, A; Troncy, E; Guillot, M; Varin, F; del Castillo, JRE				Choquette, Amelie; Troncy, Eric; Guillot, Martin; Varin, France; del Castillo, Jerome R. E.			Pharmacokinetics of Lidocaine Hydrochloride Administered with or without Adrenaline for the Paravertebral Brachial Plexus Block in Dogs	PLOS ONE			English	Article							NERVE BLOCK; INTRAMUSCULAR INJECTION; SYSTEMIC ABSORPTION; PART II; ROPIVACAINE; BUPIVACAINE; EPINEPHRINE; PROFILES; PLASMA; LEVOBUPIVACAINE	Adrenaline is known to prolong the duration of local anesthesia but its effects on the pharmacokinetic processes of local anesthetic drugs are not fully understood. Our objective was to develop a compartmental model for quantification of adrenaline's impact on the pharmacokinetics of perineurally-injected lidocaine in the dog. Dogs were subjected to paravertebral brachial plexus block using lidocaine alone or adrenalinated lidocaine. Data was collected through a prospective, randomised, blinded crossover protocol performed over three periods. Blood samples were collected during 180 minutes following block execution. Compartmental pharmacokinetic models were developed and their goodness-of-fit were compared. The lowering effects of adrenaline on the absorption of lidocaine were statistically determined with one-sided tests. A one-compartment disposition model with two successive zero-order absorption processes best fitted our experimental data. Adrenaline decreased the peak plasma lidocaine concentration by approximately 60% (P <0.001), decreased this local anesthetic's fast and slow zero-order absorption rates respectively by 50% and 90% (P= 0.046, and P <0.001), which respective durations were prolonged by 90% and 1300% (P <0.020 and P <0.001). Lidocaine demonstrated a previously unreported atypical absorption profile following its paravertebral injection in dogs. Adrenaline decreased the absorption rate of lidocaine and prolonged the duration of its absorption.	[Choquette, Amelie; Troncy, Eric; Guillot, Martin; del Castillo, Jerome R. E.] Univ Montreal, Dept Vet Biomed Sci, Quebecs Anim Pharmacol Res Grp GREPAQ, St Hyacinthe, PQ, Canada; [Varin, France] Univ Montreal, Fac Pharm, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	del Castillo, JRE (corresponding author), Univ Montreal, Dept Vet Biomed Sci, Quebecs Anim Pharmacol Res Grp GREPAQ, St Hyacinthe, PQ, Canada.	jerome.del.castillo@umontreal.ca	del Castillo, Jérôme RE/J-6976-2013; Troncy, Eric/J-6650-2013; del Castillo, Jerome/AAM-9409-2020	del Castillo, Jérôme RE/0000-0001-5046-7926; Troncy, Eric/0000-0003-0209-5261; del Castillo, Jerome/0000-0001-5046-7926	Bourse de recherche clinique of the Association des medecins veterinaires du Quebec (AMVQ); Fonds de recherche clinique Zoetis of Fonds en Sante des Animaux de Compagnie (FSAC), Faculte de Medecine Veterinaire of Universite de Montreal; Natural Sciences and Engineering Research Council of Canada [327158-2008, 441651-2013]; Canada Foundation for Innovation [9483, 24601]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Bourse de recherche clinique of the Association des medecins veterinaires du Quebec (AMVQ); Fonds de recherche clinique Zoetis of Fonds en Sante des Animaux de Compagnie (FSAC), Faculte de Medecine Veterinaire of Universite de Montreal; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by the Bourse de recherche clinique of the Association des medecins veterinaires du Quebec (AMVQ), and the Fonds de recherche clinique Zoetis of Fonds en Sante des Animaux de Compagnie (FSAC), Faculte de Medecine Veterinaire of Universite de Montreal. This study was funded (Pr. Eric Troncy) in part by a Discovery grant (#327158-2008, #441651-2013, supporting salaries) from the Natural Sciences and Engineering Research Council of Canada, as well as by an ongoing New Opportunities Fund grant (#9483) and a Leader Opportunity Fund grant (#24601), supporting pain/function equipment, from the Canada Foundation for Innovation. M. Guillot was the recipient of a Scholarship for postdoctoral research from Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara C, 2010, BRIT J PHARMACOL, V161, P1857, DOI 10.1111/j.1476-5381.2010.01007.x; Bagshaw HS, 2009, VET RADIOL ULTRASOUN, V50, P649, DOI 10.1111/j.1740-8261.2009.01599.x; BAILEY CS, 1987, J VET INTERN MED, V1, P128, DOI 10.1111/j.1939-1676.1987.tb02000.x; BALLARD BE, 1975, J PHARM SCI, V64, P781, DOI 10.1002/jps.2600640510; BENNETT PN, 1982, J PHARMACOKINET BIOP, V10, P265, DOI 10.1007/BF01059261; BURM AGL, 1986, ANESTH ANALG, V65, P1281; BURM AGL, 1987, CLIN PHARMACOKINET, V13, P191, DOI 10.2165/00003088-198713030-00004; Chalkiadis GA, 2013, PEDIATR ANESTH, V23, P58, DOI 10.1111/pan.12074; Choquette A, 2016, VET ANESTH ANA UNPUB; Cox S, 2012, J VET PHARMACOL THER, V35, P305, DOI 10.1111/j.1365-2885.2011.01328.x; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Duke T, 2000, CAN VET J, V41, P949; Feary DJ, 2005, AM J VET RES, V66, P574, DOI 10.2460/ajvr.2005.66.574; Gaudreault F, 2012, J PHARMACOKINET PHAR, V39, P635, DOI 10.1007/s10928-012-9275-z; Gaudreault F, 2009, THER DRUG MONIT, V31, P753, DOI 10.1097/FTD.0b013e3181bc8014; Gerner P, 2010, ANESTH ANALG, V111, P221, DOI 10.1213/ANE.0b013e3181dd2690; Karmakar MK, 2005, ANESTHESIOLOGY, V103, P704, DOI 10.1097/00000542-200510000-00008; le Cotonnec JY, 1998, FERTIL STERIL, V69, P195, DOI 10.1016/S0015-0282(97)00502-5; Lemay E, 2003, CAN J ANAESTH, V50, P562, DOI 10.1007/BF03018641; Lemke KA, 2008, VET CLIN N AM-SMALL, V38, P1231, DOI 10.1016/j.cvsm.2008.06.003; Mahmood AH, 2015, INT J PHARMACEUT, V481, P71, DOI 10.1016/j.ijpharm.2015.01.046; McLennan Danielle N, 2005, Drug Discov Today Technol, V2, P89, DOI 10.1016/j.ddtec.2005.05.006; Mosing M, 2010, VET ANAESTH ANALG, V37, P154, DOI 10.1111/j.1467-2995.2009.00509.x; Ngo LY, 1997, J PHARM SCI-US, V86, P944, DOI 10.1021/js960399i; O'Donnell BD, 2009, ANESTHESIOLOGY, V111, P25, DOI 10.1097/ALN.0b013e3181a915c7; Simon MJG, 2004, BRIT J ANAESTH, V93, P512, DOI 10.1093/bja/aeh241; Sinnott CJ, 2003, ANESTHESIOLOGY, V98, P181, DOI 10.1097/00000542-200301000-00028; Skarda TR, 2007, LUMB JONES VET ANEST, P395; Skarda TR, 2007, LUMB JONES VET ANEST, P561; Thomasy SM, 2005, AM J VET RES, V66, P1162, DOI 10.2460/ajvr.2005.66.1162; Trumpatori BJ, 2010, VET SURG, V39, P785, DOI 10.1111/j.1532-950X.2010.00712.x; TUCKER GT, 1979, CLIN PHARMACOKINET, V4, P241, DOI 10.2165/00003088-197904040-00001; WILCKE JR, 1983, J VET PHARMACOL THER, V6, P49, DOI 10.1111/j.1365-2885.1983.tb00454.x; Wilson DV, 2004, J VET PHARMACOL THER, V27, P105, DOI 10.1111/j.1365-2885.2004.00552.x; Wu ZM, 2013, J PHARM PHARMACOL, V65, P1429, DOI 10.1111/jphp.12114; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; Zhou HH, 2003, J CLIN PHARMACOL, V43, P211, DOI 10.1177/0091270002250613	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169745	10.1371/journal.pone.0169745	http://dx.doi.org/10.1371/journal.pone.0169745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068408	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900062
J	Guarino, MPL; Altomare, A; Barera, S; Locato, V; Cocca, S; Franchin, C; Arrigoni, G; Vannini, C; Grossi, S; Campomenosi, P; Pasqualetti, V; Bracale, M; Alloni, R; De Gara, L; Cicala, M				Guarino, Michele Pier Luca; Altomare, Annamaria; Barera, Simone; Locato, Vittoria; Cocca, Silvia; Franchin, Cinzia; Arrigoni, Giorgio; Vannini, Candida; Grossi, Sarah; Campomenosi, Paola; Pasqualetti, Valentina; Bracale, Marcella; Alloni, Rossana; De Gara, Laura; Cicala, Michele			Effect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human Colon	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; INTESTINAL INFLAMMATION; OXIDATIVE STRESS; HUMAN LIVER; METALLOTHIONEIN; GLUCURONIDATION; PREBIOTICS; EXPRESSION; SUPPLEMENTATION; DETOXIFICATION	In the present study, the protective role of inulin against lipopolysaccharide (LPS)-induced oxidative stress was evaluated on human colonic mucosa using a proteomic approach. Human colonic mucosa and submucosa were sealed between two chambers, with the luminal side facing upwards and overlaid with Krebs (control), LPS or LPS+ inulin IQ solution. The solutions on the submucosal side (undernatants) were collected following 30 min of mucosal exposure. iTRAQ based analysis was used to analyze the total soluble proteomes from human colonic mucosa and submucosa treated with different undernatants. Human colonic muscle strips were exposed to the undernatants to evaluate the response to acetylcholine. Inulin exposure was able to counteract, in human colonic mucosa, the LPS-dependent alteration of some proteins involved in the intestinal contraction (myosin light chain kinase (MLCK), myosin regulatory subunit (MYL)), to reduce the up-regulation of two proteins involved in the radical-mediated oxidative stress (the DNA-apurinic or apyrimidinic site) lyase) APEX1 and the T-complex protein 1 subunit eta (CCT7) and to entail a higher level of some detoxification enzymes (the metallothionein-2 MT2A, the glutathione-S-transferase K GSTk, and two UDP-glucuronosyltransferases UGT2B4, UGT2B17). Inulin exposure was also able to prevent the LPS-dependent intestinal muscle strips contraction impairment and the mucosa glutathione level alterations. Exposure of colonic mucosa to inulin seems to prevent LPS-induced alteration in expression of some key proteins, which promote intestinal motility and inflammation, reducing the radical-mediated oxidative stress.	[Guarino, Michele Pier Luca; Altomare, Annamaria; Cocca, Silvia; Cicala, Michele] Univ Campus Biomed Roma, Gastroenterol Unit, Rome, Italy; [Barera, Simone; Vannini, Candida; Grossi, Sarah; Campomenosi, Paola; Bracale, Marcella] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Locato, Vittoria; Pasqualetti, Valentina; De Gara, Laura] Univ Campus Biomed Roma, Food Sci & Human Nutr Unit, Rome, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Univ Padua, Prote Ctr, Padua, Italy; [Franchin, Cinzia; Arrigoni, Giorgio] Azienda Osped Padova, Padua, Italy; [Alloni, Rossana] Univ Campus Biomed Roma, Surg Unit, Rome, Italy	University Campus Bio-Medico - Rome Italy; University of Insubria; University Campus Bio-Medico - Rome Italy; University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University Campus Bio-Medico - Rome Italy	Altomare, A (corresponding author), Univ Campus Biomed Roma, Gastroenterol Unit, Rome, Italy.	a.altomare@unicampus.it	Franchin, Cinzia/AAM-1196-2021; Arrigoni, Giorgio/A-3535-2014; Cicala, Michele/AAC-1681-2019; vannini, candida/B-3705-2010; Franchin, Cinzia/AHE-4689-2022; De Gara, Laura/Y-8420-2019	Franchin, Cinzia/0000-0001-9223-117X; Arrigoni, Giorgio/0000-0002-4103-2733; Cicala, Michele/0000-0002-5370-2642; vannini, candida/0000-0002-5196-6142; Franchin, Cinzia/0000-0001-9223-117X; Guarino, Michele Pier Luca/0000-0003-3325-9425; Cocca, Silvia/0000-0002-0642-8054; Pasqualetti, Valentina/0000-0002-8558-0731; Barera, Simone/0000-0001-6009-1205	University Campus Bio-Medico of Rome	University Campus Bio-Medico of Rome	The University Campus Bio-Medico of Rome provided internal funding.	Adeoye OO, 2016, FASEB J, V30; Adyshev DM, 2013, AM J RESP CELL MOL, V49, P58, DOI 10.1165/rcmb.2012-0397OC; Altomare A, 2014, AM J PHYSIOL-GASTR L, V307, pG77, DOI 10.1152/ajpgi.00385.2013; Arnould T, 2015, INT J MOL SCI, V16, P18224, DOI 10.3390/ijms160818224; Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022; Bellemare J, 2010, PHARMACOGENOMICS J, V10, P431, DOI 10.1038/tpj.2009.64; Chen M, 2013, J BIOL CHEM, V288, P34647, DOI 10.1074/jbc.M113.510362; Cullen JJ, 1999, SURGERY, V125, P339, DOI 10.1016/S0039-6060(99)70246-1; de Pinto MC, 1999, PROTOPLASMA, V209, P90, DOI 10.1007/BF01415704; Donovan SM, 2012, ADV NUTR, V3, p450S, DOI 10.3945/an.112.001859; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Fernandes R., 2016, CLIN NUTR; Foye OT, 2012, FEMS IMMUNOL MED MIC, V65, P467, DOI 10.1111/j.1574-695X.2012.00978.x; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Goerres M, 2006, ALIMENT PHARM THER, V23, P243, DOI 10.1111/j.1365-2036.2006.02754.x; Guarino MPL, 2013, DIGEST LIVER DIS, V45, P1011, DOI 10.1016/j.dld.2013.06.001; Guslandi M, 2011, J CLIN GASTROENTEROL, V45, P475, DOI 10.1097/MCG.0b013e318207f584; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Holscher HD, 2015, J NUTR, V145, P2025, DOI 10.3945/jn.115.217331; Hur SJ, 2012, NUTR RES, V32, P801, DOI 10.1016/j.nutres.2012.09.013; Inoue KI, 2005, EXP BIOL MED, V230, P75; Jedinak A, 2011, ANTICANCER RES, V31, P379; Kim HS, 2005, INFECT IMMUN, V73, P3714, DOI 10.1128/IAI.73.6.3714-3724.2005; Leenen CHM, 2007, J NUTR, V137, p2572S, DOI 10.1093/jn/137.11.2572S; Lomax AR, 2009, BRIT J NUTR, V101, P633, DOI 10.1017/S0007114508055608; Macfarlane S, 2006, ALIMENT PHARM THER, V24, P701, DOI 10.1111/j.1365-2036.2006.03042.x; Malfatti MA, 2001, CARCINOGENESIS, V22, P1087, DOI 10.1093/carcin/22.7.1087; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P1715, DOI 10.1073/pnas.87.5.1715; Menegazzo L, 2013, FASEB J, V27, P4355, DOI 10.1096/fj.12-223719; MULDER TPJ, 1994, J GASTROEN HEPATOL, V9, P472, DOI 10.1111/j.1440-1746.1994.tb01277.x; Pan YM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-173; Pasqualetti V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098031; Radulovic M, 2016, J PROTEOME RES, V15, P1907, DOI 10.1021/acs.jproteome.6b00101; Rebollar E, 2002, NEUROGASTROENT MOTIL, V14, P633, DOI 10.1046/j.1365-2982.2002.00364.x; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Martinez RCR, 2015, BRIT J NUTR, V114, P1993, DOI 10.1017/S0007114515003864; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Scirocco A, 2010, J CELL PHYSIOL, V223, P442, DOI 10.1002/jcp.22053; Stofilova J, 2015, INT IMMUNOPHARMACOL, V24, P361, DOI 10.1016/j.intimp.2014.12.022; Strassburg CP, 1997, CANCER RES, V57, P2979; Tattoli I, 2012, J CLIN GASTROENTEROL, V46, pS6, DOI 10.1097/MCG.0b013e318265ea7d; Tolin S, 2013, PROTEOMICS, V13, P2031, DOI 10.1002/pmic.201200479; Videla S, 2001, AM J GASTROENTEROL, V96, P1486, DOI 10.1111/j.1572-0241.2001.03802.x; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Welters CFM, 2002, DIS COLON RECTUM, V45, P621, DOI 10.1007/s10350-004-6257-2; Whelan K, 2013, P NUTR SOC, V72, P288, DOI 10.1017/S0029665113001262; Wiener D, 2004, CANCER RES, V64, P1190, DOI 10.1158/0008-5472.CAN-03-3219; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358	53	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169481	10.1371/journal.pone.0169481	http://dx.doi.org/10.1371/journal.pone.0169481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068390	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900038
J	Huang, WS; Kuo, YH; Kuo, HC; Hsieh, MC; Huang, CY; Lee, KC; Lee, KF; Shen, CH; Tung, SY; Teng, CC				Huang, Wen-Shih; Kuo, Yi-Hung; Kuo, Hsing-Chun; Hsieh, Meng-Chiao; Huang, Cheng-Yi; Lee, Ko-Chao; Lee, Kam-Fai; Shen, Chien-Heng; Tung, Shui-Yi; Teng, Chih-Chuan			CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; CYTOTOXIC EVALUATION; PROTEOMIC ANALYSIS; INHIBITION; CIL-102; BAICALEIN; PROTEIN; GROWTH; ACTIVATION; EXPRESSION	CIL-102 (1-[4-(furo[2,3-b]quinolin-4-ylamino)phenyl]ethanone) is a well-known, major active agent of the alkaloid derivative of Camptotheca acuminata with valuable biological properties, including anti-tumorigenic activity. In this study, we investigated the molecular mechanisms by which CIL-102 mediated the induction of cell death, and we performed cell cycle G2/M arrest to clarify molecular changes in colorectal cancer cells (CRC). Treatment of DLD-1 cells with CIL-102 resulted in triggering the extrinsic apoptosis pathway through the activation of Fas-L, caspase-8 and the induction of Bid cleavage and cytochrome c release in a time-dependent manner. In addition, CIL-102 mediated apoptosis and G2/M arrest by phosphorylation of the Jun N-terminus kinase (JNK1/2) signaling pathway. This resulted in the expression of NF kappa B p50, p300 and CREB-binding protein (CBP) levels, and in the induction of p21 and GADD45 as well as the decreased association of cdc2/cyclin B. Furthermore, treatment with the JNK1/2 (SP600125), NF kappa B (PDTI) or the p300/CBP (C646) inhibitors abolished CIL-102-induced cell cycle G2/M arrest and reversed the association of cdc2 with cyclin B. Therefore, we demonstrated that there was an increase in the cellular levels of p21 and GADD45 by CIL-102 reduction in cell viability and cell cycle arrest via the activation of the JNK1/2, NF kappa B p50, p300 and CBP signaling modules. Collectively, our results demonstrated that CIL-102 induced cell cycle arrest and apoptosis of colon cancer cells by upregulating p21 and GADD45 expression and by activating JNK1/2, NF kappa B p50 and p300 to provide a new mechanism for CIL-102 treatment.	[Huang, Wen-Shih; Kuo, Yi-Hung; Hsieh, Meng-Chiao; Huang, Cheng-Yi] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi, Taiwan; [Huang, Wen-Shih; Tung, Shui-Yi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Kuo, Yi-Hung; Hsieh, Meng-Chiao; Shen, Chien-Heng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Chiayi, Taiwan; [Kuo, Hsing-Chun; Teng, Chih-Chuan] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; [Kuo, Hsing-Chun; Teng, Chih-Chuan] CGUST, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Lee, Ko-Chao] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Div Colorectal Surg,Dept Surg,Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Shen, Chien-Heng; Tung, Shui-Yi] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Teng, CC (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan.; Teng, CC (corresponding author), CGUST, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan.	ccteng@gw.cgust.edu.tw	Lee, Ko-Chao/AHC-2415-2022		Chang Gung Memorial Hospital, Linkou [CMRPF6D0071, CMRPF6D0072, CMRPF6D0073, CMRPG6E0192, CMRPG6F0251, CMRPG690171, CMRPG690172]	Chang Gung Memorial Hospital, Linkou	This work was supported by Chang Gung Memorial Hospital, Linkou CMRPF6D0071, CMRPF6D0072, CMRPF6D0073 (Dr Chih-Chuan Teng); Chang Gung Memorial Hospital, Linkou, CMRPG6E0192 (Dr Cheng-Yi Huang); Chang Gung Memorial Hospital, Linkou, CMRPG6F0251 (Dr Wen-Shih Huang); and Chang Gung Memorial Hospital, Linkou, CMRPG690171, CMRPG690172 (Dr Yi-Hung Kuo). There is no financial/commercial conflict of interest.	[Anonymous], 2011, TOXICOL APPL PHARM; Cazzalini O, 2008, NUCLEIC ACIDS RES, V36, P1713, DOI 10.1093/nar/gkn014; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen I-Li, 2003, Chinese Pharmaceutical Journal (Taipei), V55, P49; Chen IL, 2002, HELV CHIM ACTA, V85, P2214, DOI 10.1002/1522-2675(200207)85:7<2214::AID-HLCA2214>3.0.CO;2-W; Chen YL, 2005, EUR J MED CHEM, V40, P928, DOI 10.1016/j.ejmech.2005.04.003; Chiu YW, 2011, TOXICOL APPL PHARM, V255, P316, DOI 10.1016/j.taap.2011.07.008; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang WS, 2012, PROTEOMICS, V12, P810, DOI 10.1002/pmic.201100270; Huang WS, 2012, J CELL PHYSIOL, V227, P1114, DOI 10.1002/jcp.22831; Huang YT, 2005, J BIOL CHEM, V280, P2771, DOI 10.1074/jbc.M408850200; Hun Lee Jong, 2013, J Tradit Complement Med, V3, P69, DOI 10.4103/2225-4110.107700; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Kuo HC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0831-y; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu WH, 2012, INT J BIOCHEM CELL B, V44, P2212, DOI 10.1016/j.biocel.2012.08.021; Lu CC, 2016, J FUNCT FOODS, V21, P474, DOI 10.1016/j.jff.2015.12.031; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Teng CC, 2013, TOXICOL APPL PHARM, V272, P579, DOI 10.1016/j.taap.2013.07.009; Teng CC, 2012, TOXICOL APPL PHARM, V263, P73, DOI 10.1016/j.taap.2012.05.025; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wei MC, 2000, GENE DEV, V14, P2060; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhao YL, 2005, CHEM BIODIVERS, V2, P205, DOI 10.1002/cbdv.200590003	37	20	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168989	10.1371/journal.pone.0168989	http://dx.doi.org/10.1371/journal.pone.0168989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068431	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900017
J	Barnes, AK; Smith, SB; Datta, S				Barnes, Abigail K.; Smith, Summer B.; Datta, Subimal			Beyond Emotional and Spatial Processes: Cognitive Dysfunction in a Depressive Phenotype Produced by Long Photoperiod Exposure	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CHRONIC MILD STRESS; SLEEP-DEPRIVATION DISRUPTS; OBJECT RECOGNITION MEMORY; FORCED SWIM TEST; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT DRUGS; DJUNGARIAN HAMSTER; GENE-EXPRESSION; IMPAIRS MEMORY	Cognitive dysfunction in depression has recently been given more attention and legitimacy as a core symptom of the disorder. However, animal investigations of depression-related cognitive deficits have generally focused on emotional or spatial memory processing. Additionally, the relationship between the cognitive and affective disturbances that are present in depression remains obscure. Interestingly, sleep disruption is one aspect of depression that can be related both to cognition and affect, and may serve as a link between the two. Previous studies have correlated sleep disruption with negative mood and impaired cognition. The present study investigated whether a long photoperiod-induced depressive phenotype showed cognitive deficits, as measured by novel object recognition, and displayed a cognitive vulnerability to an acute period of total sleep deprivation. Adult male Wistar rats were subjected to a long photoperiod (21L:3D) or a normal photoperiod (12L:12D) condition. Our results indicate that our long photoperiod exposed animals showed behaviors in the forced swim test consistent with a depressive phenotype, and showed significant deficits in novel object recognition. Three hours of total sleep deprivation, however, did not significantly change novel object recognition in either group, but the trends suggest that the long photoperiod and normal photoperiod groups had different cognitive responses to total sleep deprivation. Collectively, these results underline the extent of cognitive dysfunction present in depression, and suggest that altered sleep plays a role in generating both the affective and cognitive symptoms of depression.	[Barnes, Abigail K.; Datta, Subimal] Univ Tennessee, Dept Anesthesiol, Grad Sch Med, Knoxville, TN 37996 USA; [Barnes, Abigail K.; Smith, Summer B.; Datta, Subimal] Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA; [Datta, Subimal] Univ Tennessee, Coll Vet Med, Program Comparat & Expt Med, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center	Datta, S (corresponding author), Univ Tennessee, Dept Anesthesiol, Grad Sch Med, Knoxville, TN 37996 USA.; Datta, S (corresponding author), Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA.; Datta, S (corresponding author), Univ Tennessee, Coll Vet Med, Program Comparat & Expt Med, Knoxville, TN 37996 USA.	sdatta1@utk.edu		/0000-0003-1786-238X	National Institutes of Health Research Grant [MH59839]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059839] Funding Source: NIH RePORTER	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by the National Institutes of Health Research Grant MH59839. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by National Institutes of Health Research Grant (MH59839). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Dr. Ralph Lydic, Dr. Helen Baghdoyan, and Dr. Robert Craft for critical discussions for this research. We thank Logan A. Chesney, Michael Totty, and Jennifer Garner for their technical assistance. AKB designed and performed research, analyzed data, and wrote the paper; SBS performed research and analyzed data; SD designed research, analyzed and co-wrote the paper.	Abdallah CG, 2015, EUR NEUROPSYCHOPHARM, V25, P1082, DOI 10.1016/j.euroneuro.2015.04.025; Acosta-Pena E, 2015, SYNAPSE, V69, P15, DOI 10.1002/syn.21779; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Ashley NT, 2013, J EXP BIOL, V216, P2581, DOI 10.1242/jeb.083832; Austin MP, 2001, BRIT J PSYCHIAT, P178; Azogu I, 2015, BEHAV BRAIN RES, V279, P177, DOI 10.1016/j.bbr.2014.11.015; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bastos CP, 2015, PSYCHONEUROENDOCRINO, V57, P14, DOI 10.1016/j.psyneuen.2015.03.020; Becker A, 2010, EUR NEUROPSYCHOPHARM, V20, P802, DOI 10.1016/j.euroneuro.2010.07.009; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Cambras T, 2004, J BIOL RHYTHM, V19, P216, DOI 10.1177/0748730404264201; Carlezon WA, 2005, BIOL PSYCHIAT, V57, P571, DOI 10.1016/j.biopsych.2004.12.011; Castagne V., 2011, CURR PROTOC NEUROSCI; Chan JWY, 2014, SLEEP, V37, P911, DOI 10.5665/sleep.3658; Chen L, 2014, NEUROSCI LETT, V563, P12, DOI 10.1016/j.neulet.2014.01.024; Cheng P, 2013, J SLEEP RES, V22, P459, DOI 10.1111/jsr.12029; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Conradi HJ, 2011, PSYCHOL MED, P41; Dallaspezia S, 2016, J AFFECT DISORDERS, V192, P64, DOI 10.1016/j.jad.2015.11.039; Datta S, 2015, BEHAV BRAIN RES, V292, P381, DOI 10.1016/j.bbr.2015.06.038; Datta S, 2013, J NEUROSCI, V33, P4561, DOI 10.1523/JNEUROSCI.5525-12.2013; Deboer T, 2000, J BIOL RHYTHM, V15, P429, DOI 10.1177/074873000129001512; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2009, BEHAV BRAIN RES, V197, P417, DOI 10.1016/j.bbr.2008.10.007; Morici JF, 2015, BEHAV BRAIN RES, V292, P241, DOI 10.1016/j.bbr.2015.06.030; Feltmann K, 2015, BEHAV NEUROSCI, V129, P701, DOI 10.1037/bne0000100; Femenia T, 2015, INT J NEUROPSYCHOPH, P18; Finan PH, 2015, SLEEP, V38, P1735, DOI 10.5665/sleep.5154; FRANKEN P, 1995, AM J PHYSIOL-REG I, V269, pR691, DOI 10.1152/ajpregu.1995.269.3.R691; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Goeldner C, 2013, NEUROPHARMACOLOGY, V64, P337, DOI 10.1016/j.neuropharm.2012.08.001; Gonda X, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0068-9; Guo J, 2016, METAB BRAIN DIS; Guzman-Marin R, 2006, J PHYSIOL-LONDON, V575, P807, DOI 10.1113/jphysiol.2006.115287; Hammar A, 2009, FRONT HUM NEUROSCI, P3; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; Havekes R, 2015, CURR TOP BEHAV NEURO, V25, P183, DOI 10.1007/7854_2015_369; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hipolide DC, 2005, PROG NEURO-PSYCHOPH, V29, P297, DOI 10.1016/j.pnpbp.2004.11.015; Kaidah S, 2016, BRATISL MED J, V117, P94, DOI 10.4149/BLL_2016_019; Kim YK, 2016, PROG NEURO-PSYCHOPH, V64, P277, DOI 10.1016/j.pnpbp.2015.06.008; Kim Y, 2013, BRAIN RES, V1531, P9, DOI 10.1016/j.brainres.2013.07.048; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Kurlansik SL, 2012, AM FAM PHYSICIAN, V86, P1037; Lee CH, 2016, HIPPOCAMPUS, V26, P1061, DOI 10.1002/hipo.22587; Li S, 2008, LIFE SCI, V82, P934, DOI 10.1016/j.lfs.2008.02.010; Lima ILB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113075; Lopez-Rubalcava C, 2000, NEUROPSYCHOPHARMACOL, V22, P191, DOI 10.1016/S0893-133X(99)00100-1; Luik AI, 2015, SLEEP MED, V16, P850, DOI 10.1016/j.sleep.2015.03.012; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Marazziti D, 2010, EUR J PHARMACOL, P626; Marszalek-Grabska M, 2016, BRAIN RES, V1642, P389, DOI 10.1016/j.brainres.2016.04.026; McDonald RJ, 2013, PHYSIOL BEHAV, V118, P14, DOI 10.1016/j.physbeh.2013.04.010; Mokoena ML, 2015, PSYCHOPHARMACOLOGY, V232, P2921, DOI 10.1007/s00213-015-3928-8; Moodley K, 2015, HIPPOCAMPUS, V25, P939, DOI 10.1002/hipo.22417; Mouton M, 2016, METAB BRAIN DIS, V31, P63, DOI 10.1007/s11011-015-9765-y; Nam H, 2016, PHYSIOL BEHAV, V165, P339, DOI 10.1016/j.physbeh.2016.08.020; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Onaolapo OJ, 2015, ANN NEUROSCI, V22, P139, DOI 10.5214/ans.0972.7531.220304; Orsetti M, 2007, INT J NEUROPSYCHOPH, V10, P345, DOI 10.1017/S1461145706006705; Palchykova S, 2006, PHYSIOL BEHAV, V87, P144, DOI 10.1016/j.physbeh.2005.09.005; Palchykova S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-9; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Palmer CE, 2016, J CLIN CHILD ADOLESC, P1; Robinson OJ, 2012, AM J PSYCHIAT, V169, P152, DOI 10.1176/appi.ajp.2011.11010137; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Rossato JI, 2015, NEUROBIOL LEARN MEM, V125, P146, DOI 10.1016/j.nlm.2015.09.001; Siopi E, 2016, J NEUROSCI, V36, P518, DOI 10.1523/JNEUROSCI.2817-15.2016; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; Stephenson R, 2012, J BIOL RHYTHM, V27, P490, DOI 10.1177/0748730412461247; Takatsu-Coleman AL, 2013, PSYCHONEUROENDOCRINO, V38, P1967, DOI 10.1016/j.psyneuen.2013.02.016; Tang Q, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0674-8; Tronel S, 2015, HIPPOCAMPUS, V25, P1472, DOI 10.1002/hipo.22468; Tudor JC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4949; Van Someren EJW, 2015, J NEUROSCI, V35, P13889, DOI 10.1523/JNEUROSCI.2592-15.2015; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang HY, 2016, NEUROPSYCH DIS TREAT, V12, P1993, DOI 10.2147/NDT.S110162; Warner A, 2010, AM J PHYSIOL-REG I, V298, pR1409, DOI 10.1152/ajpregu.00279.2009; Wolf E, 2016, SLEEP MED REV, V30, P53, DOI 10.1016/j.smrv.2015.11.003; Wu RY, 2016, BEHAV PHARMACOL, V27, P596, DOI 10.1097/FBP.0000000000000252; Xie ML, 2016, BEHAV BRAIN RES, V300, P70, DOI 10.1016/j.bbr.2015.10.002; Yasenkov R, 2012, PROG BRAIN RES, V199, P203, DOI 10.1016/B978-0-444-59427-3.00012-5; Yu T, 2011, INT J NEUROPSYCHOPH, V14, P303, DOI 10.1017/S1461145710000945; Zelinski EL, 2013, EXP BRAIN RES, V224, P125, DOI 10.1007/s00221-012-3293-3; Zhu SH, 2014, NEUROREPORT, V25, P1151, DOI 10.1097/WNR.0000000000000243	93	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0170032	10.1371/journal.pone.0170032	http://dx.doi.org/10.1371/journal.pone.0170032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060930	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500145
J	Duester, L; Wahrendorf, DS; Brinkmann, C; Fabricius, AL; Meermann, B; Pelzer, J; Ecker, D; Renner, M; Schmid, H; Ternes, TA; Heininger, P				Duester, Lars; Wahrendorf, Dierk-Steffen; Brinkmann, Corinna; Fabricius, Anne-Lena; Meermann, Bjoern; Pelzer, Juergen; Ecker, Dennis; Renner, Monika; Schmid, Harald; Ternes, Thomas A.; Heininger, Peter			A Framework to Evaluate the Impact of Armourstones on the Chemical Quality of Surface Water	PLOS ONE			English	Article								Today, basic requirements for construction works include the protection of human health and of the environment. In the tension area between economic demands, circular flow economy and environmental safety, a link between the results from standardized leaching tests and the respective environmental quality standards must be created. To derive maximum release limits of metals and metalloids for armourstones in hydraulic engineering, this link is accomplished via a simple model approach. By treating natural materials and industrial by-products the same way, the article delivers an overview on the recent regulative situation in Europe as well as describes and discusses an innovative approach to derive maximum release limits for monolithic construction products in hydraulic engineering on a conceptual level. On a practical level, a list of test parameters is derived by connecting an extensive dataset (seven armourstone materials with five repetitions and 31 elements tested with the worldwide applied dynamic surface leaching test) with surface water quality standards and predicted no effect concentrations. Finally, the leaching tests results are compared with the envisaged maximum release limits, offering a direct comparison between natural materials and industrial by-products.	[Duester, Lars; Wahrendorf, Dierk-Steffen; Brinkmann, Corinna; Fabricius, Anne-Lena; Meermann, Bjoern; Pelzer, Juergen; Ecker, Dennis; Renner, Monika; Schmid, Harald; Ternes, Thomas A.; Heininger, Peter] Fed Inst Hydrol, Div Qualitat Hydrol G, Mainzer Tor 1, Koblenz, Germany		Duester, L (corresponding author), Fed Inst Hydrol, Div Qualitat Hydrol G, Mainzer Tor 1, Koblenz, Germany.	duester@bafg.de	Duester, Lars/I-3478-2014	Duester, Lars/0000-0001-7025-3810	German Federal Ministry of Transport and Digital Infrastructure (BMVI)	German Federal Ministry of Transport and Digital Infrastructure (BMVI)	The study was financed by The German Federal Ministry of Transport and Digital Infrastructure (BMVI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, 133831 DIN EN; [Anonymous], 2002, 133832 DIN EN; [Anonymous], 2005, 21508 EUR EN EUR CHE; [Anonymous], 2002, 1744 3 DIN EN; [Anonymous], 2021, 166372 CENTS; Biesinger K E, 1972, J FISHERIES RES BOAR, V29; BMVBS, 2015, TECHN REG WASS TR W; BMVBS, 2003, TECHN LIEF WASS TLW; Duester L, 2016, CRITICAL REV ENV SCI, V46; EC, 2010, 24587 EC EUR EN JOIN; EU COMMISSION, 1998, M 125 MAND CEN CENEL; European Copper Institute, 2008, EUR UN RISK ASS REP; Federal Waterways Engineering and Research Institute, 2008, ANW REG BOSCH SOHL B; Garrabrants A., 2012, INTERLABORATORY VALI; Kallquist T, 2007, PNEC METALS MARINE E; Kimball G, 1978, FISHERIES; LUNG-MV (Landesamt fur Umwelt Naturschutz und Geologie Mecklenburg-Vorpommern), 2012, SCHADST OB MECKL VOR; Maycock D., 2012, PROPOSED EQS WATER F; Maycock D, 2007, PRECONSULTATION REPO; Nendza M, 2003, ENTWICKLUNG UMWELTQU; Nendza M, 2014, UFOPLAN UMWELTBUNDES; Nendza M, 2014, EQS DATASHEET ENV QU; OGewV, 2011, VER ZUM SCHUTZ OB OB; PIANC, 2008, G27 PIANC; Potysz A, 2015, CRITICAL REV ENV SCI, V45; Ruedel H, 2015, ENV SCI POLLUTION RE, V22; Salminen R, 2005, GEOCHEMICAL ATLAS 1; SCHER, 2012, OP DRAFT ENV QUAL ST; Schmukat A, 2012, J HAZARDOUS MAT; Schmukat A, 2013, J HAZARDOUS MAT, V260; Schmukat A, 2016, J HAZARDOUS MAT, V304; Song C, 2008, NATURE, V453, P629, DOI 10.1038/nature06981; Thorneloe S A, 2007, WASTE MANAGEMENT, V27; van der Sloot H A, 2003, P WASCON 2003 C SAN; van der Sloot H A, 1990, WASTE MANAGEMENT RES, P8; Wenzel A, 2015, REVISION UMWELTQUALI	36	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168926	10.1371/journal.pone.0168926	http://dx.doi.org/10.1371/journal.pone.0168926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060850	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500045
J	Lee, SY; Shim, CY; Hong, GR; Cho, IJ; Chang, HJ; Ha, JW; Chung, N				Lee, Soo Youn; Shim, Chi Young; Hong, Geu-Ru; Cho, In Jeong; Chang, Hyuk-Jae; Ha, Jong-Won; Chung, Namsik			Determinants and Prognostic Significance of Symptomatic Status in Patients with Moderately Dysfunctional Bicuspid Aortic Valves	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; STENOSIS EAE/ASE RECOMMENDATIONS; NATIVE VALVULAR REGURGITATION; PRESERVED EJECTION FRACTION; ECHOCARDIOGRAPHIC-ASSESSMENT; EUROPEAN-ASSOCIATION; HEART-FAILURE; CHAMBER QUANTIFICATION; CLINICAL-PRACTICE; AMERICAN-SOCIETY	Background We aimed to identify the clinical and echocardiographic determinants of symptoms and their prognostic implications in patients with moderately dysfunctional bicuspid aortic valves (BAVs). Methods Among 1,019 subjects in the BAV registry treated in a single tertiary care center, the records of 127 patients (85 men, age 58 +/- 13 years) with moderately dysfunctional BAVs were comprehensively reviewed. The patients were divided into two groups based on symptom status: asymptomatic (n = 80) vs. symptomatic (n = 47). The primary end-point was defined as a composite of aortic valve surgery, hospitalization for heart failure, and any cause of death. Results The symptomatic group had a higher proportion of females, hypertension, aortic stenosis, and aortopathy than did the asymptomatic group. The symptomatic group showed lower e' (5.5 +/- 1.7 vs. 6.5 +/- 2.2 cm/s, p = 0.003), higher E/e' (13.3 +/- 4.9 vs. 10.9 +/- 3.7, p = 0.002), and larger left atrial volume index (29.9 +/- 11.4 vs. 24.6 +/- 9.1 ml/m(2), p = 0.006) than did the asymptomatic group. In multivariate logistic regression analysis, female gender (odds ratio [OR] 2.84, 95% confidence interval [CI] 1.10-7.36, p = 0.031), hypertension (OR 3.07, 95% CI 1.20-7.82, p = 0.019), moderate aortic stenosis (OR 5.33 5.78, 95% CI 1.99-16.83, p = 0.001), E/e' > 15 (OR 3.82, 95% CI 1.03-11.19, p = 0.015), and aortopathy (OR 2.76, 95% CI 1.07-7.10, p = 0.035) were independently correlated with symptom status. The symptomatic group showed a significantly lower rate of event-free survival during the 8-year follow-up period (54 +/- 9% vs. 68 +/- 10%, p = 0.001). Conclusions In patients with moderately dysfunctional BAVs, the presence of moderate aortic stenosis, aortopathy, and diastolic dysfunction determines symptom status, along with female gender and hypertension. Symptom status was associated with clinical outcomes.	[Lee, Soo Youn; Shim, Chi Young; Hong, Geu-Ru; Cho, In Jeong; Chang, Hyuk-Jae; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Cardiol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Shim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Cardiol, Seoul, South Korea.	cysprs@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304; Chang, Hyuk-Jae/0000-0002-6139-7545; Ha, Jong-Won/0000-0002-8260-2958				Ahn JH, 2016, J AM COLL CARDIOL, V67, P1412, DOI 10.1016/j.jacc.2016.01.013; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Biner S, 2010, JACC-CARDIOVASC IMAG, V3, P899, DOI 10.1016/j.jcmg.2010.07.005; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Chen CH, 2001, J AM COLL CARDIOL, V38, P2028, DOI 10.1016/S0735-1097(01)01651-5; Dahl JS, 2014, CIRC-CARDIOVASC IMAG, V7, P142, DOI 10.1161/CIRCIMAGING.113.000636; Egbe AC, 2016, EUR HEART J; Fuchs C, 2010, HEART, V96, P539, DOI 10.1136/hrt.2009.186650; Galiuto L, 2006, HEART, V92, P208, DOI 10.1136/hrt.2005.062422; Gould KL, 2003, CIRCULATION, V107, P3121, DOI 10.1161/01.CIR.0000074243.02378.80; JOHNSON LL, 1978, CIRCULATION, V57, P582, DOI 10.1161/01.CIR.57.3.582; Kang JW, 2013, JACC-CARDIOVASC IMAG, V6, P150, DOI 10.1016/j.jcmg.2012.11.007; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Lancellotti P, 2010, HEART, V96, P1364, DOI 10.1136/hrt.2009.190942; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee SY, 2015, AM J CARDIOL, V116, P1547, DOI 10.1016/j.amjcard.2015.08.017; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Park SJ, 2013, JACC-CARDIOVASC IMAG, V6, P137, DOI 10.1016/j.jcmg.2012.10.013; Pibarot P, 2009, JACC-CARDIOVASC IMAG, V2, P400, DOI 10.1016/j.jcmg.2009.01.004; Santarpia G, 2012, INT J CARDIOL, V158, P347, DOI 10.1016/j.ijcard.2011.01.046; Shim Chi Young, 2011, J Cardiovasc Ultrasound, V19, P62, DOI 10.4250/jcu.2011.19.2.62; Shim CY, 2013, J AM SOC HYPERTENS, V7, P198, DOI 10.1016/j.jash.2013.01.005; Shim CY, 2011, J AM SOC ECHOCARDIOG, V24, P847, DOI 10.1016/j.echo.2011.04.017; Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; VILLARI B, 1992, AM J CARDIOL, V69, P927, DOI 10.1016/0002-9149(92)90795-Z; Wassmuth R, 2014, EUR HEART J-CARD IMG, V15, P673, DOI 10.1093/ehjci/jet275; Weismann CG, 2016, EUR HEART J-CARD IMG, V17, P225, DOI 10.1093/ehjci/jev151; Weisz SH, 2014, J AM SOC ECHOCARDIOG, V27, P385, DOI 10.1016/j.echo.2013.12.014; Zaid RR, 2013, J AM COLL CARDIOL, V62, P1922, DOI 10.1016/j.jacc.2013.08.1619; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169285	10.1371/journal.pone.0169285	http://dx.doi.org/10.1371/journal.pone.0169285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060855	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500075
J	Rishi, P; Arora, S; Kaur, UJ; Chopra, K; Kaur, IP				Rishi, Praveen; Arora, Sumeha; Kaur, Ujjwal Jit; Chopra, Kanwaljit; Kaur, Indu Pal			Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; PROBIOTICS; METABOLISM; ACTIVATION; MICROBIOTA; HUMANS; INJURY; MODEL; BEADS	Synergistic combination of probiotics with carbohydrate based prebiotics is widely employed for the treatment of various gut related disorders. However, such carbohydrate based prebiotics encourage the growth of pathogens and probiotics, equally. Aim of the study was (i) to explore the possibility of using epigallocatechin gallate (EGCG) a phenolic compound, as a prebiotic for L. plantarum; (ii) to develop and evaluate a microstructured synbox (microen-capsulating both probiotic and EGCG together) in rat model of alcohol liver disease (ALD); and, (iii) to confirm whether the combination can address issues of EGCG bioavailability and probiotic survivability in adverse gut conditions. Growth enhancing effect of EGCG on L. plantarum (12.8 +/- 0.5 log 10 units) was significantly (p <= 0.05) better than inulin (11.4 +/- 0.38 log 10 units), a natural storage carbohydrate. The formulated synbox significantly modulated the levels of alcohol, endotoxin, hepatic enzymes and restored the hepatoarchitecture in comparison to simultaneous administration of free agents. Additionally, using a battery of techniques, levels of various cellular and molecular markers viz. NF-kB/p50, TNF-alpha, IL12/p40, and signalling molecules TLR4, CD14, MD2, MyD88 and COX-2 were observed to be suppressed. Developed microbead synbox, as a single delivery system for both the agents showed synergism and hence, holds promise as a therapeutic option for ALD management.	[Rishi, Praveen; Arora, Sumeha; Kaur, Ujjwal Jit] Panjab Univ, Dept Microbiol, Basic Med Sci Block,South Campus, Chandigarh, India; [Chopra, Kanwaljit; Kaur, Indu Pal] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh, India	Panjab University; Panjab University	Kaur, IP (corresponding author), Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh, India.	indupalkaur@yahoo.com		Rishi, Praveen/0000-0001-5425-8064	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The Indian Council of Medical Research provided funding to carry out experimental studies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora Sumeha, 2014, Mediators Inflamm, V2014, P715130, DOI 10.1155/2014/715130; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Barone R, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.66; Barrie MA, 2005, CLIN APPL IMMUNOL, V5, P225; Barthelmebs L, 2001, LAIT, V81, P161, DOI 10.1051/lait:2001120; BAUCHINGER M, 1975, MUTAT RES, V27, P103, DOI 10.1016/0027-5107(75)90277-8; Bharrhan S, 2012, INNATE IMMUN-LONDON, V18, P70, DOI 10.1177/1753425910393369; Bharrhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020635; Castelli E, 1999, HEPATO-GASTROENTEROL, V46, P1664; Chang B, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-151; Chavarri M, 2010, INT J FOOD MICROBIOL, V142, P185, DOI 10.1016/j.ijfoodmicro.2010.06.022; Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679; Finamore A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094891; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Govind Babu, 2011, Agricultural Journal, V6, P231, DOI 10.3923/aj.2011.231.236; Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950; Hegazy SK, 2010, WORLD J GASTROENTERO, V16, P4145, DOI 10.3748/wjg.v16.i33.4145; Huttner E, 1999, MUTAT RES-GEN TOX EN, V445, P251, DOI 10.1016/S1383-5718(99)00130-8; Iyer C, 2005, J FOOD SCI, V70, pM18, DOI 10.1111/j.1365-2621.2005.tb09041.x; Kaviarasan S, 2008, TOXICOL MECH METHOD, V18, P645, DOI 10.1080/15376510701884985; Kim MS, 2016, WORLD J GASTROENTERO, V22, P8, DOI 10.3748/wjg.v22.i1.8; Kolida S, 2002, BRIT J NUTR, V87, pS193, DOI 10.1079/BJN/2002537; Krasaekoopt W, 2004, INT DAIRY J, V14, P737, DOI 10.1016/j.idairyj.2004.01.004; Krasaekoopt W, 2003, INT DAIRY J, V13, P3, DOI 10.1016/S0958-6946(02)00155-3; Li FY, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/5491465; Li P, 2007, J NUTR, V137, P2763, DOI 10.1093/jn/137.12.2763; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Noth R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-109; Osawa R, 2000, APPL ENVIRON MICROB, V66, P3093, DOI 10.1128/AEM.66.7.3093-3097.2000; Park JH, 2012, BIOSCI BIOTECH BIOCH, V76, P2294, DOI 10.1271/bbb.120598; Ramirez Andrea, 2002, Genetics and Molecular Research, V1, P246; Rishi P, 2009, FEMS MICROBIOL ECOL, V69, P222, DOI 10.1111/j.1574-6941.2009.00703.x; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Si WD, 2006, J CHROMATOGR A, V1125, P204, DOI 10.1016/j.chroma.2006.05.061; Singh PK, 2012, J PHARM PHARMACOL, V64, P207, DOI 10.1111/j.2042-7158.2011.01397.x; Vaquero I, 2004, INT J FOOD MICROBIOL, V96, P199, DOI 10.1016/j.ijfoodmicro.2004.04.004; Vodnar Dan C, 2012, Chem Cent J, V6, P61, DOI 10.1186/1752-153X-6-61; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yuan GJ, 2006, INT J MOL SCI, V7, P204, DOI 10.3390/i7070204	41	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168459	10.1371/journal.pone.0168459	http://dx.doi.org/10.1371/journal.pone.0168459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060832	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500033
J	Sohn, J; Takahashi, M; Okamoto, S; Ishida, Y; Furuta, T; Hioki, H				Sohn, Jaerin; Takahashi, Megumu; Okamoto, Shinichiro; Ishida, Yoko; Furuta, Takahiro; Hioki, Hiroyuki			A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VASOACTIVE INTESTINAL POLYPEPTIDE; VESICULAR GLUTAMATE TRANSPORTERS; PRIMARY SOMATOSENSORY CORTEX; RETROGRADE AXONAL-TRANSPORT; GREEN FLUORESCENT PROTEIN; GABAERGIC CELL SUBTYPES; BASAL GANGLIA CIRCUITS; RAT FRONTAL-CORTEX; VIRAL VECTORS	Visualization of neurons is indispensable for the investigation of neuronal circuits in the central nervous system. Virus vectors have been widely used for labeling particular subsets of neurons, and the adeno-associated virus (AAV) vector has gained popularity as a tool for gene transfer. Here, we developed a single AAV vector Tet-Off platform, AAV-SynTetOff, to improve the gene-transduction efficiency, specifically in neurons. The platform is composed of regulator and response elements in a single AAV genome. After infection of Neuro-2a cells with the AAV-SynTetOff vector, the transduction efficiency of green fluorescent protein (GFP) was increased by approximately 2- and 15-fold relative to the conventional AAV vector with the human cytomegalovirus (CMV) or human synapsin I (SYN) promoter, respectively. We then injected the AAV vectors into the mouse neostriatum. GFP expression in the neostriatal neurons infected with the AAV-SynTetOff vector was approximately 40-times higher than that with the CMV or SYN promoter. By adding a membrane-targeting signal to GFP, the axon fibers of neostriatal neurons were clearly visualized. In contrast, by attaching somatodendritic membrane-targeting signals to GFP, axon fiber labeling was mostly suppressed. Furthermore, we prepared the AAV-SynTetOff vector, which simultaneously expressed somatodendritic membrane-targeted GFP and membrane-targeted red fluorescent protein (RFP). After injection of the vector into the neostriatum, the cell bodies and dendrites of neostriatal neurons were labeled with both GFP and RFP, whereas the axons in the projection sites were labeled only with RFP. Finally, we applied this vector to vasoactive intestinal polypeptide-positive (VIP+) neocortical neurons, one of the subclasses of inhibitory neurons in the neocortex, in layer 2/3 of the mouse primary somatosensory cortex. The results revealed the differential distribution of the somatodendritic and axonal structures at the population level. The AAV-SynTetOff vector developed in the present study exhibits strong fluorescence labeling and has promising applications in neuronal imaging.	[Sohn, Jaerin; Takahashi, Megumu; Okamoto, Shinichiro; Ishida, Yoko; Furuta, Takahiro; Hioki, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Sohn, Jaerin] Natl Inst Physiol Sci, Div Cerebral Circuitry, Higashiyama Ku, Myodaiji Cho, Okazaki, Aichi, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Hioki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	hioki@mbs.med.kyoto-u.ac.jp	Hioki, Hiroyuki/J-9412-2017	Hioki, Hiroyuki/0000-0002-0152-7854; Okamoto, Shinichiro/0000-0002-4589-0006; Sohn, Jaerin/0000-0001-8358-327X; Takahashi, Megumu/0000-0001-5993-8245; Ishida, Yoko/0000-0003-4436-6787	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [13J01992, 16H07425, 15H04266, 16H04663, 15K14333, 25123709, 15H01430, 16H01426]; Grants-in-Aid for Scientific Research [15H01430, 16H07425] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from The Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and Japan Society for the Promotion of Science (JSPS); for JSPS Fellows (13J01992 to J.S.); for Research Activity Start-up (16H07425 to J.S.); for Scientific Research (15H04266 to T.F., 16H04663 to H.H.); for Exploratory Research (15K14333 to H.H.); and for Scientific Research on Innovative Areas, "Neuronal Diversity and Neocortical Organization" (25123709 to H.H.), "Adaptive Circuit Shift" (15H01430 to H.H.), and "Resonance Bio" (16H01426 to H.H.).	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bayraktar T, 2000, J COMP NEUROL, V420, P291; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Budd JML, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00042; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHAPIN JK, 1986, EXP BRAIN RES, V62, P549; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; CONNOR JR, 1984, NEUROSCIENCE, V12, P1027, DOI 10.1016/0306-4522(84)90002-2; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; de Backer MWA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-81; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Furuta T, 2001, J HISTOCHEM CYTOCHEM, V49, P1497, DOI 10.1177/002215540104901203; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Gholizadeh S, 2013, HUM GENE THER METHOD, V24, P205, DOI 10.1089/hgtb.2013.076; Golgi C, 1873, GAZZ MED ITAL LOMBAR, V33, P244; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Hajos F, 1998, NEUROSCIENCE, V85, P45, DOI 10.1016/S0306-4522(97)00590-3; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamamoto M, 2016, J COMP NEUROL; Hermening S, 2006, J VIROL METHODS, V136, P30, DOI 10.1016/j.jviromet.2006.03.031; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Hioki H, 2015, ANAT SCI INT, V90, P7, DOI 10.1007/s12565-014-0264-8; Hioki H, 2013, J NEUROSCI, V33, P544, DOI 10.1523/JNEUROSCI.2255-12.2013; Hioki H, 2010, J COMP NEUROL, V518, P668, DOI 10.1002/cne.22237; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; IZZO PN, 1991, J NEUROSCI METH, V36, P155, DOI 10.1016/0165-0270(91)90041-W; Jones EG, 2007, BRAIN RES REV, V55, P248, DOI 10.1016/j.brainresrev.2007.06.001; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Kameda H, 2012, EUR J NEUROSCI, V35, P838, DOI 10.1111/j.1460-9568.2012.08027.x; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kaneko T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00075; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Ke MT, 2016, CELL REP, V14, P2718, DOI 10.1016/j.celrep.2016.02.057; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; KRISTENSSON K, 1971, BRAIN RES, V29, P363, DOI 10.1016/0006-8993(71)90044-8; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Liguz-Lecznar M, 2007, INT J DEV NEUROSCI, V25, P107, DOI 10.1016/j.ijdevneu.2006.12.005; Lipshutz GS, 2001, MOL THER, V3, P284, DOI 10.1006/mthe.2001.0267; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lukashchuk V, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2015.55; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Mizuno H, 2014, NEURON, V82, P365, DOI 10.1016/j.neuron.2014.02.026; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Muzyczka N, 1992, VIRAL EXPRESSION VEC, V158, P97; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Nishino E, 2008, J NEUROSCI, V28, P7153, DOI 10.1523/JNEUROSCI.4398-07.2008; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Pan C., 2016, NAT METHODS; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Peel AL, 2000, J NEUROSCI METH, V98, P95, DOI 10.1016/S0165-0270(00)00183-7; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pronneke A, 2015, CEREB CORTEX, V25, P4854, DOI 10.1093/cercor/bhv202; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rockland KS, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00061; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shoji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030302; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; STOECKEL K, 1977, BRAIN RES, V132, P273, DOI 10.1016/0006-8993(77)90421-8; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Suzuki Y, 2015, J COMP NEUROL, V523, P262, DOI 10.1002/cne.23680; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Watakabe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046157; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER E, 1993, EUR J NEUROSCI, V5, P691, DOI 10.1111/j.1460-9568.1993.tb00534.x; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; ZILLES K, 1993, BRAIN RES, V618, P149, DOI 10.1016/0006-8993(93)90438-S	109	23	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169611	10.1371/journal.pone.0169611	http://dx.doi.org/10.1371/journal.pone.0169611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060929	Green Published, gold			2022-12-26	WOS:000391641500116
J	Nakai, T; Nakatani, H; Hosoda, C; Nonaka, Y; Okanoya, K				Nakai, Tomoya; Nakatani, Hironori; Hosoda, Chihiro; Nonaka, Yulri; Okanoya, Kazuo			Sense of Accomplishment Is Modulated by a Proper Level of Instruction and Represented in the Brain Reward System	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FMRI; DISCOVERY; ACTIVATION	Problem-solving can be facilitated with instructions or hints, which provide information about given problems. The proper amount of instruction that should be provided for learners is controversial. Research shows that tasks with intermediate difficulty induce the largest sense of accomplishment (SA), leading to an intrinsic motivation for learning. To investigate the effect of instructions, we prepared three instruction levels (No hint, Indirect hint, and Direct hint) for the same insight-problem types. We hypothesized that indirect instructions impose intermediate difficulty for each individual, thereby inducing the greatest SA per person. Based on previous neuroimaging studies that showed involvement of the bilateral caudate in learning and motivation, we expected SA to be processed in this reward system. We recruited twenty-one participants, and investigated neural activations during problem solving by functional magnetic resonance imaging (fMRI). We confirmed that the Indirect hint, which imposed intermediate difficulty, induced the largest SA among the three instruction types. Using fMRI, we showed that activations in the bilateral caudate and anterior cingulate cortex (ACC) were significantly modulated by SA. In the bilateral caudate, the indirect hint induced the largest activation, while the ACC seemed to reflect the difference between correct and incorrect trials. Importantly, such activation pattern was independent of notations (number or letter). Our results indicate that SA is represented in the reward system, and that the Indirect instruction effectively induces such sensation.	[Nakai, Tomoya; Nakatani, Hironori; Hosoda, Chihiro; Nonaka, Yulri; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Nakai, Tomoya] Japan Soc Promot Sci, Tokyo, Japan; [Nakatani, Hironori; Okanoya, Kazuo] Univ Tokyo, Ctr Evolutionary Cognit Sci, Tokyo, Japan; [Hosoda, Chihiro] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Okanoya, Kazuo] Riken Brain Sci Inst, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Okanoya, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.; Okanoya, K (corresponding author), Univ Tokyo, Ctr Evolutionary Cognit Sci, Tokyo, Japan.; Okanoya, K (corresponding author), Riken Brain Sci Inst, Saitama, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp			Impulsing Paradigm Change through Disruptive Technologies (ImPACT) program; Japan Society for the Promotion of Science [26-9945]	Impulsing Paradigm Change through Disruptive Technologies (ImPACT) program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by the Impulsing Paradigm Change through Disruptive Technologies (ImPACT) program (for KO), and by a Grant-in-Aid for JSPS Fellows (No. 26-9945) from the Japan Society for the Promotion of Science (for TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2012, NEUROETHICS-NETH, V5, P105, DOI 10.1007/s12152-011-9119-3; Atkinson J.W., 1964, INTRO MOTIVATION, DOI DOI 10.1007/s00431-012-1719-3; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; BRUNER JS, 1961, HARVARD EDUC REV, V31, P21; Carew TJ, 2010, NEURON, V67, P685, DOI 10.1016/j.neuron.2010.08.028; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; CRAIG RC, 1956, J EDUC PSYCHOL, V47, P223, DOI 10.1037/h0046768; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HARTER S, 1978, CHILD DEV, V49, P788, DOI 10.2307/1128249; HARTER S, 1978, HUM DEV, V21, P34, DOI 10.1159/000271574; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Keller J. M., 1987, PERFORM INSTR, V26, P1, DOI DOI 10.1002/PFI.4160260802; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Lee HS, 2013, ANNU REV PSYCHOL, V64, P445, DOI 10.1146/annurev-psych-113011-143833; Lepper M., 1989, RES MOTIVATION ED, V3, P73; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Mayer RE, 2004, AM PSYCHOL, V59, P14, DOI 10.1037/0003-066X.59.1.14; Murayama K, 2010, P NATL ACAD SCI USA, V107, P20911, DOI 10.1073/pnas.1013305107; Nakai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111439; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Reiser BJ, 1994, TECH REP; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]	38	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168661	10.1371/journal.pone.0168661	http://dx.doi.org/10.1371/journal.pone.0168661			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2TP	28052091	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500021
J	Pixberg, CF; Raba, K; Muller, F; Behrens, B; Honisch, E; Niederacher, D; Neubauer, H; Fehm, T; Goering, W; Schulz, WA; Flohr, P; Boysen, G; Lambros, M; De Bono, JS; Knoefel, WT; Sproll, C; Stoecklein, NH; Neves, RPL				Pixberg, C. F.; Raba, K.; Muller, F.; Behrens, B.; Honisch, E.; Niederacher, D.; Neubauer, H.; Fehm, T.; Goering, W.; Schulz, W. A.; Flohr, P.; Boysen, G.; Lambros, M.; De Bono, J. S.; Knoefel, W. T.; Sproll, C.; Stoecklein, N. H.; Neves, R. P. L.			Analysis of DNA methylation in single circulating tumor cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; BREAST-CANCER; MIR-200 FAMILY; PROMOTER METHYLATION; ADHESION MOLECULE; REPRESSORS ZEB1; CPG ISLAND; GENE; BISULFITE	Direct analysis of circulating tumor cells (CTCs) can inform on molecular mechanisms underlying systemic spread. Here we investigated promoter methylation of three genes regulating epithelial-to-mesenchymal transition (EMT), a key mechanism enabling epithelial tumor cells to disseminate and metastasize. For this, we developed a single-cell protocol based on agaroseembedded bisulfite treatment, which allows investigating DNA methylation of multiple loci via a multiplex PCR (multiplexedscAEBS). We established our assay for the simultaneous analysis of three EMT-associated genes miR-200c/141, miR-200b/a/429 and CDH1 in single cells. The assay was validated in solitary cells of GM14667, MDA-MB-231 and MCF-7 cell lines, achieving a DNA amplification efficiency of 70% with methylation patterns identical to the respective bulk DNA. Then we applied multiplexedscAEBS to 159 single CTCs from 11 patients with metastatic breast and six with metastatic castration-resistant prostate cancer, isolated via CellSearch (EpCAM(pos)/CKpos/CD45(neg)/DAPI(pos)) and subsequent FACS sorting. In contrast to CD45(pos) white blood cells isolated and processed by the identical approach, we observed in the isolated CTCs methylation patterns resembling more those of epithelial-like cells. Methylation at the promoter of microRNA-200 family was significantly higher in prostate CTCs. Data from our single-cell analysis revealed an epigenetic heterogeneity among CTCs and indicates tumor-specific active epigenetic regulation of EMT-associated genes during blood-borne dissemination.	[Pixberg, C. F.; Muller, F.; Behrens, B.; Knoefel, W. T.; Stoecklein, N. H.; Neves, R. P. L.] Univ Hosp, Dept Gen Visceral & Paediat Surg, Dusseldorf, Germany; [Pixberg, C. F.; Raba, K.; Muller, F.; Behrens, B.; Honisch, E.; Niederacher, D.; Neubauer, H.; Fehm, T.; Goering, W.; Schulz, W. A.; Knoefel, W. T.; Sproll, C.; Stoecklein, N. H.; Neves, R. P. L.] Heinrich Heine Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Raba, K.] Univ Hosp, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Honisch, E.; Niederacher, D.; Neubauer, H.; Fehm, T.] Univ Hosp, Dept Obstet & Gynecol, Dusseldorf, Germany; [Goering, W.; Schulz, W. A.] Univ Hosp, Dept Urol, Dusseldorf, Germany; [Flohr, P.; Boysen, G.; Lambros, M.; De Bono, J. S.] Inst Canc Res, Div Canc Therapeut, London, England; [Flohr, P.; Boysen, G.; Lambros, M.; De Bono, J. S.] Inst Canc Res, Div Clin Studies, London, England; [Flohr, P.; Boysen, G.; Lambros, M.; De Bono, J. S.] Royal Marsden NHS Fdn Trust, Drug Dev Unit, London, England; [Sproll, C.] Univ Hosp, Dept Oral Maxillo & Plast Facial Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Stoecklein, NH (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Paediat Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	nikolas.stoecklein@uni-duesseldorf.de	Schulz, Wolfgang/N-3402-2019; Neves, Rui/AAF-9626-2021; Raba, Katharina/B-8697-2017; Neubauer, Hans/C-4467-2016; Boysen, Gunnar/U-3272-2019	Schulz, Wolfgang/0000-0002-2196-463X; Neves, Rui/0000-0002-4515-739X; Raba, Katharina/0000-0001-8818-4219; Neubauer, Hans/0000-0002-3467-4105; Boysen, Gunnar/0000-0001-8364-9881; de Bono, Johann S/0000-0002-2034-595X; Muller, Fabienne/0000-0002-5845-6305; Fehm, Tanja/0000-0002-4926-0108	Dusseldorf School of Oncology (Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe); EU grant reference EU FP7 project CTCTrap [305341]; Deutsche Krebshilfe [109600]; Innovative Medicines Initiative Joint Undertaking (IMI JU); CANCER-ID [115749]; Dusseldorf School of Oncology (Medical Faculty HHU Dusseldorf); Deutsche Krebshilfe (NHS); Medical Research Council [G0601308] Funding Source: researchfish; MRC [G0601308] Funding Source: UKRI	Dusseldorf School of Oncology (Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe); EU grant reference EU FP7 project CTCTrap; Deutsche Krebshilfe(Deutsche Krebshilfe); Innovative Medicines Initiative Joint Undertaking (IMI JU); CANCER-ID; Dusseldorf School of Oncology (Medical Faculty HHU Dusseldorf); Deutsche Krebshilfe (NHS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KR, BB, EH, DN, HN, TF, WTK, CS, NHS and RPLN are members of the Disseminated Cancer Cell Network (DCC Net) Dusseldorf. This work was supported by the Dusseldorf School of Oncology (funded by the Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe and the Medical Faculty HHU Dusseldorf) (to CFP), by an EU grant reference EU FP7 project CTCTrap (Grant #305341 to JSDB), the Deutsche Krebshilfe (Grant #109600 to CS and NHS) and the Innovative Medicines Initiative Joint Undertaking (IMI JU) in conjunction with CANCER-ID (Grant Agreement #115749 to NHS).	Alberter B, 2016, EXPERT REV MOL DIAGN, V16, P25, DOI 10.1586/14737159.2016.1121099; Allard WJ, 2015, CLIN CANCER RES, V21, P2883, DOI 10.1158/1078-0432.CCR-14-2559; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brambert PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117310; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carmona FJ, 2014, CANCER RES, V74, P5608, DOI 10.1158/0008-5472.CAN-13-3659; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chimonidou M, 2013, MOL CANCER RES, V11, P1248, DOI 10.1158/1541-7786.MCR-13-0096; Chimonidou M, 2013, CLIN CHEM, V59, P270, DOI 10.1373/clinchem.2012.191551; Chimonidou M, 2011, CLIN CHEM, V57, P1169, DOI 10.1373/clinchem.2011.165902; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Farias EF, 2010, P NATL ACAD SCI USA, V107, P11811, DOI 10.1073/pnas.1006737107; Friedlander TW, 2014, INT J CANCER, V134, P2284, DOI 10.1002/ijc.28561; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Geuns E, 2003, HUM MOL GENET, V12, P2873, DOI 10.1093/hmg/ddg315; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Geuns E, 2007, J MED GENET, V44, P144, DOI 10.1136/jmg.2006.044149; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Graff JR, 2000, J BIOL CHEM, V275, P2727, DOI 10.1074/jbc.275.4.2727; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; HAYATSU H, 1970, BIOCHEMISTRY-US, V9, P2858, DOI 10.1021/bi00816a016; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Lianidou ES, 2016, MOL ONCOL, V10, P431, DOI 10.1016/j.molonc.2016.01.011; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Magbanua MJM, 2014, CANCER METAST REV, V33, P757, DOI 10.1007/s10555-014-9503-7; MANSOURI A, 1988, DIFFERENTIATION, V38, P67, DOI 10.1111/j.1432-0436.1988.tb00593.x; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Neves RPL, 2014, CLIN CHEM, V60, P1290, DOI 10.1373/clinchem.2014.222331; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pal SK, 2015, CLIN GENITOURIN CANC, V13, P130, DOI 10.1016/j.clgc.2014.08.014; Pantel K, 2016, ONCOGENE, V35, P1216, DOI 10.1038/onc.2015.192; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pixberg CF, 2015, GENES-BASEL, V6, P1053, DOI 10.3390/genes6041053; Polioudaki H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1386-7; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Rao CG, 2005, INT J ONCOL, V27, P49; Rossi E, 2010, CLIN CANCER RES, V16, P5233, DOI 10.1158/1078-0432.CCR-10-1449; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; SHAPIRO R, 1973, J BIOL CHEM, V248, P4060; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Spiliotaki M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0485-8; Steinert G, 2014, CANCER RES, V74, P1694, DOI 10.1158/0008-5472.CAN-13-1885; Stoecklein NH, 2016, EXPERT REV MOL DIAGN, V16, P147, DOI 10.1586/14737159.2016.1123095; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TIERLING S, BISULFITE SEQUENCING; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123976; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	76	50	51	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3223	3231		10.1038/onc.2016.480	http://dx.doi.org/10.1038/onc.2016.480			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28068321				2022-12-26	WOS:000402869800002
J	Liu, YD; Liu, HO; Yang, L; Wu, Q; Liu, WS; Fu, Q; Zhang, WJ; Zhang, HJ; Xu, JJ; Gu, J				Liu, Yidong; Liu, Haiou; Yang, Liu; Wu, Qian; Liu, Weisi; Fu, Qiang; Zhang, Weijuan; Zhang, Haijian; Xu, Jiejie; Gu, Jianxin			Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anoikis; glycobiology; glycosyltransferase; hepatocellular carcinoma; microRNA (miRNA); migration; post-transcriptional regulation; GALNT4; Prognostic biomarker; microRNA-9	POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; VIRUS X PROTEIN; O-GLYCOSYLATION; PANCREATIC-CANCER; POOR-PROGNOSIS; EXPRESSION; CELLS; TRANSFERASES; INVASION; GROWTH	Deregulated expression of N-acetylgalactosaminyltransferases (GALNTs), which is responsible for the initial step of mucin-type O-glycosylation, could produce abnormal truncated O-glycans and thereby exert pivotal functions during malignant transformation. GALNT4 is one of the few isoforms preferring to catalyze partial GalNAc-glycosylated substrates and modify the sites not utilized by other known GALNTs. This study aims to evaluate the impact of GALNT4 expression on malignant transformation of hepatocellular carcinoma (HCC). Immunohistochemistry and in situ hybridization analysis were performed to assess GALNT4 and miR-9 level in clinical specimens, respectively. GALNT4 expression is markedly repressed in primary HCC tissues, and reduced expression of GALNT4 is significantly associated with adverse survival of patients with HCC. Functional investigations demonstrate that repressed GALNT4 could promote migration, invasion, anoikis resistance, and stemness of HCC cells in vitro as well as tumor growth in vivo. The wild-type GALNT4 could modify O-linked glycosylation on EGFR and thus modulate the activity of EGFR. A luciferase activity assay further identified microRNA-9 (miR-9) as the crucial specific arbitrator for GALNT4 expression in HCC cells. Furthermore, restoring GALNT4 expression attenuates miR-9-mediated oncogenic functions. Kaplan-Meier survival analysis indicates that the miR-9/GALNT4 expression signature yields promising prognostic significance to refine the risk stratification of patients with HCC. In conclusion, this study establishes the miR-9/GALNT4 axis as a potential adverse prognostic factor and therapeutic target for HCC patients.	[Liu, Yidong; Yang, Liu; Wu, Qian; Liu, Weisi; Fu, Qiang; Zhang, Haijian; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Zhang, Weijuan] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Liu, Haiou] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JJ; Gu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China.	jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114; Zhang, Haijian/0000-0003-2516-4215; liu, weisi/0000-0002-4730-5448	National Key Projects for Infectious Diseases of China [2012ZX10002012-007, 2016ZX10002018-008]; National Natural Science Foundation of China [31100629, 31270863, 81401988, 81471621, 81472227, 31570803, 81572352]; Program for New Century Excellent Talents in University [NCET-13-0146]	National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Key Projects for Infectious Diseases of China Grants 2012ZX10002012-007 and 2016ZX10002018-008; National Natural Science Foundation of China Grants 31100629, 31270863, 81401988, 81471621, 81472227, 31570803, and 81572352; and Program for New Century Excellent Talents in University Grant NCET-13-0146. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Drakaki A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1562-9; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Gwak JM, 2014, BREAST CANCER RES TR, V147, P39, DOI 10.1007/s10549-014-3069-5; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Huang MJ, 2015, ONCOTARGET, V6, P5650, DOI 10.18632/oncotarget.3117; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Li Z, 2011, BRIT J CANCER, V104, P1882, DOI 10.1038/bjc.2011.166; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wu Q, 2015, J BIOL CHEM, V290, P1170, DOI 10.1074/jbc.M114.601203; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang NN, 2015, ADV DRUG DELIVER REV, V81, P62, DOI 10.1016/j.addr.2014.10.029	32	22	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3186	3200		10.1074/jbc.M116.751685	http://dx.doi.org/10.1074/jbc.M116.751685			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28062574	Green Published, hybrid			2022-12-26	WOS:000395538800012
J	Boros, E; Szabo, A; Zboray, K; Heja, D; Pal, G; Sahin-Toth, M				Boros, Eszter; Szabo, Andras; Zboray, Katalin; Heja, David; Pal, Gabor; Sahin-Toth, Miklos			Overlapping Specificity of Duplicated Human Pancreatic Elastase 3 Isoforms and Archetypal Porcine Elastase 1 Provides Clues to Evolution of Digestive Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; CLONED MESSENGER-RNA; PROTEASE-E; ACTIVE-SITE; SEQUENCE-ANALYSIS; PHAGE-DISPLAY; PROCARBOXYPEPTIDASE-A; MOLECULAR-CLONING; ACID-SEQUENCES; CATHEPSIN-G	Chymotrypsin-like elastases (CELAs) are pancreatic serine proteinases that digest dietary proteins. CELAs are typically expressed in multiple isoforms that can vary among different species. The human pancreas does not express CELA1 but secretes two CELA3 isoforms, CELA3A and CELA3B. The reasons for the CELA3 duplication and the substrate preferences of the duplicated isoforms are unclear. Here, we tested whether CELA3A and CELA3B evolved unique substrate specificities to compensate for the loss of CELA1. We constructed a phage library displaying variants of the substrate-like Schistocerca gregaria proteinase inhibitor 2 (SGPI-2) to select reversible high affinity inhibitors of human CELA3A, CELA3B, and porcine CELA1. Based on the reactive loop sequences of the phage display selected inhibitors, we recombinantly expressed and purified 12 SGPI-2 variants and determined their binding affinities. Wefound that the primary specificity of CELA3A, CELA3B, and CELA1 was similar; all preferred aliphatic side chains at the socalled P1 position, the amino acid residue located directly N-terminal to the scissile peptide bond. P1 Met was an interesting exception that was preferred by CELA1 but weakly recognized by the CELA3 isoforms. The extended substrate specificity of CELA3A and CELA3B was comparable, whereas CELA1 exhibited unique interactions at several subsites. These observations indicated that the CELA1 and CELA3 paralogs have some different but also overlapping specificities and that the duplicated CELA3A and CELA3B isoforms did not evolve distinct substrate preferences. Thus, increased gene dosage rather than specificity divergence of the CELA3 isoforms may compensate for the loss of CELA1 digestive activity in the human pancreas.	[Boros, Eszter; Zboray, Katalin; Heja, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Ctr Exocrine Disorders, Boston, MA 02118 USA; [Boros, Eszter; Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Eotvos Lorand University; Boston University; Boston University	Pal, G (corresponding author), Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	gabor.pal@ttk.elte.hu; miklos@bu.edu	Pal, Gabor/A-6244-2009	Pal, Gabor/0000-0001-7868-7971; Boros, Eszter/0000-0002-0639-4739; Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK095753, R01DK082412, R01DK058088]; National Research, Development and Innovation Office (NKFIH) [NK100769, K119386]; National Development Agency [KMOP-4.2.1/B-102011]; MedInProt Program of the Hungarian Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088, R01DK095753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office (NKFIH); National Development Agency; MedInProt Program of the Hungarian Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK095753, R01DK082412, and R01DK058088 (to M.S.T.), National Research, Development and Innovation Office (NKFIH) Grants NK100769 and K119386, National Development Agency Grant KMOP-4.2.1/B-102011, and the MedInProt Program of the Hungarian Academy of Sciences (to G.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARDELT W, 1974, BIOCHIM BIOPHYS ACTA, V341, P318, DOI 10.1016/0005-2744(74)90224-1; ARDELT W, 1979, ACTA BIOCHIM POL, V26, P267; ATLAS D, 1970, FEBS LETT, V11, P281, DOI 10.1016/0014-5793(70)80548-8; ATLAS D, 1975, J MOL BIOL, V93, P39, DOI 10.1016/0022-2836(75)90358-7; BALO J, 1950, BIOCHEM J, V46, P384, DOI 10.1042/bj0460384; BALO J, 1949, NATURE, V164, P491, DOI 10.1038/164491a0; BIETH J, 1973, BIOCHEM BIOPH RES CO, V53, P383, DOI 10.1016/0006-291X(73)90673-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; FIGARELLA C, 1992, INT J PANCREATOL, V11, P213; FLETCHER TS, 1987, BIOCHEMISTRY-US, V26, P7256, DOI 10.1021/bi00397a010; GERTLER A, 1971, EUR J BIOCHEM, V20, P541, DOI 10.1111/j.1432-1033.1971.tb01425.x; GERTLER A, 1977, BIOCHEMISTRY-US, V16, P2709, DOI 10.1021/bi00631a019; Gestin M, 1997, COMP BIOCHEM PHYS B, V118, P181, DOI 10.1016/S0305-0491(97)00031-X; Gomis-Ruth FX, 1998, EUR J BIOCHEM, V251, P839, DOI 10.1046/j.1432-1327.1998.2510839.x; HARPER JW, 1984, BIOCHEMISTRY-US, V23, P2995, DOI 10.1021/bi00308a023; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; KASAFIREK E, 1976, EUR J BIOCHEM, V69, P1, DOI 10.1111/j.1432-1033.1976.tb10852.x; KAWASHIMA I, 1987, DNA-J MOLEC CELL BIO, V6, P163, DOI 10.1089/dna.1987.6.163; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; KOBAYASHI R, 1981, J BIOL CHEM, V256, P2460; KOBAYASHI R, 1978, J BIOL CHEM, V253, P5526; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; LAMY F, 1961, J BIOL CHEM, V236, P86; LARGMAN C, 1976, BIOCHEMISTRY-US, V15, P2491, DOI 10.1021/bi00656a036; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LEDOUX M, 1975, CAN J BIOCHEM CELL B, V53, P421, DOI 10.1139/o75-058; MACDONALD RJ, 1982, BIOCHEMISTRY-US, V21, P1453, DOI 10.1021/bi00535a053; MALLORY PA, 1975, BIOCHEMISTRY-US, V14, P722, DOI 10.1021/bi00675a012; NARAYANAN AS, 1969, BIOCHEM J, V114, P11, DOI 10.1042/bj1140011; NAUGHTON MA, 1961, BIOCHEM J, V78, P156, DOI 10.1042/bj0780156; Nozach H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-37; OHLSSON K, 1976, H-S Z PHYSIOL CHEM, V357, P1153, DOI 10.1515/bchm2.1976.357.2.1153; POWERS JC, 1977, BIOCHIM BIOPHYS ACTA, V485, P156, DOI 10.1016/0005-2744(77)90203-0; RENAUD A, 1983, J BIOL CHEM, V258, P8312; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHELLENBERGER V, 1989, EUR J BIOCHEM, V179, P161, DOI 10.1111/j.1432-1033.1989.tb14534.x; SHEN W, 1987, BIOCHEMISTRY-US, V26, P3447, DOI 10.1021/bi00386a030; SHIRASU Y, 1987, J BIOCHEM-TOKYO, V102, P1555, DOI 10.1093/oxfordjournals.jbchem.a122204; SHIRASU Y, 1988, J BIOCHEM-TOKYO, V104, P259, DOI 10.1093/oxfordjournals.jbchem.a122454; SHOTTON D M, 1970, Nature (London), V225, P811, DOI 10.1038/225811a0; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Szabo A, 2016, J BIOL CHEM, V291, P17706, DOI 10.1074/jbc.M116.743237; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; SZIEGOLEIT A, 1984, BIOCHEM J, V219, P735, DOI 10.1042/bj2190735; SZIEGOLEIT A, 1982, BIOCHEM J, V207, P573, DOI 10.1042/bj2070573; SZIEGOLEIT A, 1985, EUR J BIOCHEM, V151, P595, DOI 10.1111/j.1432-1033.1985.tb09145.x; TANI T, 1987, J BIOCHEM-TOKYO, V101, P591, DOI 10.1093/jb/101.3.591; TANI T, 1988, J BIOL CHEM, V263, P1231; URAM M, 1969, BIOCHIM BIOPHYS ACTA, V194, P102, DOI 10.1016/0005-2795(69)90185-8; VERED M, 1985, INT J PEPT PROT RES, V25, P76	56	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2690	2702		10.1074/jbc.M116.770560	http://dx.doi.org/10.1074/jbc.M116.770560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062577	Green Published, hybrid			2022-12-26	WOS:000395535100012
J	Calvez, P; Breukink, E; Roper, DI; Dib, M; Contreras-Martel, C; Zapun, A				Calvez, Philippe; Breukink, Eefjan; Roper, David I.; Dib, Melanie; Contreras-Martel, Carlos; Zapun, Andre			Substitutions in PBP2b from beta-Lactam-resistant Streptococcus pneumoniae Have Different Effects on Enzymatic Activity and Drug Reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; THERMAL SHIFT ASSAYS; PEPTIDOGLYCAN SYNTHESIS; CRYSTAL-STRUCTURE; MECHANISM; MANAGEMENT; DIAGNOSIS; REVEALS; PBP1A; 2X	Pneumococcus resists beta-lactams by expressing variants of its target enzymes, the penicillin-binding proteins (PBPs), with many amino acid substitutions. Up to 10% of the sequence can be modified. These altered PBPs have a much reduced reactivity with the drugs but retain their physiological activity of crosslinking the peptidoglycan, the major constituent of the bacterial cell wall. However, because beta-lactams are chemical and structural mimics of the natural substrate, resistance mediated by altered PBPs raises the following paradox: how PBPs that react poorly with the drugs maintain a sufficient level of activity with the physiological substrate. This question is addressed for the first time in this study, which compares the peptidoglycan crosslinking activity of PBP2b from susceptible and resistant strains with their inhibition by different beta-lactams. Unexpectedly, the enzymatic activity of the variants did not correlate with their antibiotic reactivity. This finding indicates that some of the numerous amino acid substitutions were selected to restore a viable level of enzymatic activity by a compensatory molecular mechanism.	[Calvez, Philippe; Dib, Melanie; Contreras-Martel, Carlos; Zapun, Andre] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS, F-38044 Grenoble, France; [Breukink, Eefjan] Univ Utrecht, Bijvoet Ctr Biomol Res, Inst Biomembranes, Dept Chem Biol & Organ Chem, NL-3584 CH Utrecht, Netherlands; [Roper, David I.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Utrecht University; University of Warwick	Zapun, A (corresponding author), Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France.	andre.zapun@ibs.fr	Roper, David I/A-2323-2011; Breukink, Eefjan/I-3039-2016; Contreras-Martel, Carlos/AAA-1212-2021	Roper, David I/0000-0003-0009-621X; Breukink, Eefjan/0000-0002-7311-0660; Zapun, Andre/0000-0001-8953-4399	Agence Nationale de la Recherche [ORBiMP ANR-14-CE14-0003-01]; FRISBI [ANR-10-INSB-05-02]; GRAL Grant within the Grenoble Partnership for Structural Biology [ANR-10-LABX-49-01]; Biotechnology and Biological Sciences Research Council [BB/N003241/1] Funding Source: researchfish; Medical Research Council [G0500643] Funding Source: researchfish; BBSRC [BB/N003241/1] Funding Source: UKRI; MRC [G0500643] Funding Source: UKRI	Agence Nationale de la Recherche(French National Research Agency (ANR)); FRISBI; GRAL Grant within the Grenoble Partnership for Structural Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant ORBiMP ANR-14-CE14-0003-01 from the Agence Nationale de la Recherche and used the platforms of the Grenoble Instruct Center (UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI Grant ANR-10-INSB-05-02 and GRAL Grant ANR-10-LABX-49-01 within the Grenoble Partnership for Structural Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams K. A., 2011, THESIS; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Control for Disease Control and Prevention, 2015, ANT RES THREATS US; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel H, 2014, ANTIMICROB AGENTS CH, V58, P3934, DOI 10.1128/AAC.02547-14; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; GHUYSEN JM, 1986, BIOCHEM J, V235, P159, DOI 10.1042/bj2350159; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; HAKENBECK R, 1987, J GEN MICROBIOL, V133, P755; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Helassa N, 2012, FEBS J, V279, P2071, DOI 10.1111/j.1742-4658.2012.08592.x; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Kardos N, 2011, APPL MICROBIOL BIOT, V92, P677, DOI 10.1007/s00253-011-3587-6; Kocaoglu O, 2015, ANTIMICROB AGENTS CH, V59, P3548, DOI 10.1128/AAC.05142-14; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noirclerc-Savoye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075522; Pagliero E, 2004, ANTIMICROB AGENTS CH, V48, P1848, DOI 10.1128/AAC.48.5.1848-1855.2004; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Philippe J, 2015, ANTIMICROB AGENTS CH, V59, P609, DOI 10.1128/AAC.04283-14; Sauerbier J, 2012, MOL MICROBIOL, V86, P692, DOI 10.1111/mmi.12009; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shapiro AB, 2013, ANAL BIOCHEM, V439, P37, DOI 10.1016/j.ab.2013.04.009; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Tsui HCT, 2014, MOL MICROBIOL, V94, P21, DOI 10.1111/mmi.12745; Tsui HCT, 2016, MOL MICROBIOL, V100, P1039, DOI 10.1111/mmi.13366; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zapun A., 2016, ANTIBIOTICS, V5, pE35; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zapun A, 2013, ACS CHEM BIOL, V8, P2688, DOI 10.1021/cb400575t	47	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2854	2865		10.1074/jbc.M116.764696	http://dx.doi.org/10.1074/jbc.M116.764696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062575	Green Published, hybrid			2022-12-26	WOS:000395535100025
J	Li, R; Yuan, FJ; Fu, W; Zhang, LY; Zhang, N; Wang, YA; Ma, K; Li, X; Wang, LN; Zhu, WG; Zhao, Y				Li, Ran; Yuan, Fengjie; Fu, Wan; Zhang, Luyao; Zhang, Nan; Wang, Yanan; Ma, Ke; Li, Xue; Wang, Lina; Zhu, Wei-Guo; Zhao, Ying			Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT AUTOPHAGY; ATG PROTEINS; COMPLEX; HSP90; GROWTH; DEGRADATION; ACTIVATION; BECLIN-1; AMPK; AKT	The serine/threonine kinase Unc-51-like kinase-1 (Ulk1) is thought to be essential for induction of autophagy, an intracellular bulk degradation process that is activated by various stresses. Although several proteins have been suggested as Ulk1 substrates during autophagic process, it still remains largely unknown about Ulk1's physiological substrates. Here, by performing in vitro and in vivo phosphorylation assay, we report that the co-chaperone cell division cycle protein 37 (Cdc37) is a Ulk1 substrate. Ulk1-mediated phosphorylation of Ser-339 in Cdc37 compromised the recruitment of client kinases to a complex comprising Cdc37 and heat shock protein 90 (Hsp90) but only modestly affected Cdc37 binding to Hsp90. Because the recruitment of protein kinase clients to the Hsp90 complex is essential for their stability and functions, Ser-339 phosphorylation of Cdc37 disrupts its ability as a co-chaperone to coordinate Hsp90. Hsp90 inhibitors are cancer chemotherapeutic agents by inducing depletion of clients, many of which are oncogenes. Upon treatment with an Hsp90 inhibitor in cancer cells, Ulk1 promoted the degradation of Hsp90-Cdc37 client kinases, resulting in increased cellular sensitivity to Hsp90 inhibitors. Thus, our study provides evidence for an anti-proliferative role of Ulk1 in response to Hsp90 inhibition in cancer cells.	[Li, Ran; Yuan, Fengjie; Fu, Wan; Zhang, Luyao; Zhang, Nan; Wang, Yanan; Ma, Ke; Li, Xue; Wang, Lina; Zhu, Wei-Guo; Zhao, Ying] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Peking Tsinghua Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China	Peking University; Tsinghua University; Shenzhen University	Zhao, Y (corresponding author), Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China.	zhaoying0812@bjmu.edu.cn		Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Yanan/0000-0002-8050-3155	National Natural Science Foundation of China [81222028, 81621063, 81472581, 81672712, 91319302, 31261140372]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81222028, 81621063, 81472581, 81672712, 91319302, and 31261140372). The authors declare that they have no conflicts of interest with the contents of this article.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Fremont S, 2013, EMBO REP, V14, P364, DOI 10.1038/embor.2013.23; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He W, 2016, INT J ONCOL, V48, P1710, DOI 10.3892/ijo.2016.3382; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Joshi A, 2016, CELL DEATH DIFFER, V23, P216, DOI 10.1038/cdd.2015.88; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Li TY, 2016, MOL CELL, V62, P359, DOI 10.1016/j.molcel.2016.04.009; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Navone F, 2015, CELLS-BASEL, V4, P354, DOI 10.3390/cells4030354; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yan J, 1999, ONCOGENE, V18, P5850, DOI 10.1038/sj.onc.1202988; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009	49	11	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2830	2841		10.1074/jbc.M116.762443	http://dx.doi.org/10.1074/jbc.M116.762443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073914	Green Published, hybrid			2022-12-26	WOS:000395535100023
J	Rucinque, DS; Souza, APO; Molento, CFM				Rucinque, Daniel Santiago; Oliveira Souza, Ana Paula; Maiolino Molento, Carla Forte			Perception of Fish Sentience, Welfare and Humane Slaughter by Highly Educated Citizens of Bogota A, Colombia and Curitiba, Brazil	PLOS ONE			English	Article							ANIMAL-WELFARE; COGNITIVE-ABILITY; AQUATIC ANIMALS; PUBLIC CONCERN; CURRENT ISSUES; ATTITUDES; PERSPECTIVES; MEAT; PAIN; CHALLENGES	Discussions on farm animal welfare have become frequent, especially in developed countries. The aim of this research was to study the perception of fish sentience, welfare and slaughter by highly educated citizens from Bogota A, Colombia, and Curitiba, Brazil. An online survey with 12 questions presented as open-ended, multiple choice and 5-point Likert-type scale formats was available to respondents. Answers from 395 participants in Bogota A and 387 in Curitiba were analyzed, and results are presented in the order Bogota A followed by Curitiba. The percentage of participants who perceived fish as sentient animals was 79.7% and 71.8%. The classification of sentience perception among taxonomic groups seems in accordance with the phylogenetic proximity to humans, suggesting participants were more likely to perceive sentience in mammals than in other animals. The descending order related to the highest perception of fish suffering in different scenarios was fishing with hook and line (75.6%, 70.6%); municipal live fish fair (68.7%-only in Curitiba); fish-and-pay ponds (59.7%, 54.4%); fish kept as laboratory animals (58.0, 48.1%); fish farming (35.7, 36.8%); fish in pet stores (35.5%, 26.1%); production of ornamental fish (19.3%, 21.8%); fish in aquarium exhibits (18.8%, 16.9%); and fish kept as pets (12.4%, 12.3%). Lack of knowledge about the conditions of capture, handling, transport and sale of ornamental fish may justify the perception of low level of suffering in the last scenarios. Regarding humane slaughter, 57.0% and 55.0% of respondents were unaware of the issue. After reflection induced by the questionnaire, 76.0% and 72% of participants believed that fish should be included in humane slaughter regulations. This study presents original data suggesting that respondents from Bogota A and Curitiba consider fish as sentient beings. The perception of suffering in specific scenarios challenges common activities. Recognition of suffering also endorses humane slaughter regulations to reduce pain in a large number of individuals of fish slaughtered annually for human consumption in Colombia and Brazil.	[Rucinque, Daniel Santiago; Oliveira Souza, Ana Paula; Maiolino Molento, Carla Forte] Univ Fed Parana, Anim Welf Lab, Curitiba, Parana, Brazil	Universidade Federal do Parana	Molento, CFM (corresponding author), Univ Fed Parana, Anim Welf Lab, Curitiba, Parana, Brazil.	carlamolento@ufpr.br	Souza, Ana Paula/AAD-6343-2019; Rucinque, Daniel Santiago/HGD-3834-2022	Rucinque, Daniel Santiago/0000-0003-0522-5746	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00137; [Anonymous], 2009, EFSA J, V954, P1, DOI DOI 10.2903/J.EFSA.2009.954; Arlinghaus R, 2007, FISH FISH, V8, P57, DOI 10.1111/j.1467-2979.2007.00233.x; Arlinghaus R, 2012, FISHERIES, V37, P153, DOI 10.1080/03632415.2012.666472; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Bekoff M, 2007, DIS AQUAT ORGAN, V75, P87, DOI 10.3354/dao075087; Bibost AL, 2014, ANIM COGN, V17, P1045, DOI 10.1007/s10071-014-0734-3; Bonamigo A, 2012, REV BRAS ZOOTECN, V41, P1044, DOI 10.1590/S1516-35982012000400029; Borski RJ, 2003, ILAR J, V44, P286, DOI 10.1093/ilar.44.4.286; BOUTON ME, 1989, ANIM LEARN BEHAV, V17, P188, DOI 10.3758/BF03207634; Braithwaite V., 2010, DO FISH FEEL PAIN; Braithwaite VA, 2014, REV SCI TECH OIE, V33, P245, DOI 10.20506/rst.33.1.2285; Braithwaite VA, 2013, J AGR ENVIRON ETHIC, V26, P7, DOI 10.1007/s10806-011-9355-x; Broom DM, 2007, DIS AQUAT ORGAN, V75, P99, DOI 10.3354/dao075099; Broom DM, 2014, SENTIENCE AND ANIMAL WELFARE, P1, DOI 10.1079/9781780644035.0000; Broom DM, 2010, APPL ANIM BEHAV SCI, V126, P1, DOI 10.1016/j.applanim.2010.05.001; Brown C, 2015, ANIM COGN, V18, P1, DOI 10.1007/s10071-014-0761-0; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Caporale V, 2005, REV SCI TECH OIE, V24, P567, DOI 10.20506/rst.24.2.1594; Cardoso E. S., 2009, CIENCIA NATURA, V31, P131; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Cooke SJ, 2004, BIOL CONSERV, V118, P599, DOI 10.1016/j.biocon.2003.10.009; Cooke SJ, 2007, APPL ANIM BEHAV SCI, V104, P176, DOI 10.1016/j.applanim.2006.09.002; Culum B, 2011, FISH COGNITION BEHAV; DANE (Departamento Administrativo Nacional de Estadisticas), 2010, AN REG PRINC IND SOC; de Araucaria Prefeitura, 2015, AGRICULURA; FAO, 2013, WORLD FISH PROD CAPT; FAO, 2015, ORN FISH; FERGUSON RA, 1992, CAN J FISH AQUAT SCI, V49, P1157, DOI 10.1139/f92-129; Font-I-Furnols M, 2014, MEAT SCI, V98, P361, DOI 10.1016/j.meatsci.2014.06.025; Hammerschmidt J, 2012, THESIS; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Home Office, 2011, STAT SCI PROC LIV AN; Hoogland CT, 2005, APPETITE, V45, P15, DOI 10.1016/j.appet.2005.01.010; Huntingford FA, 2014, REV SCI TECH OIE, V33, P233, DOI 10.20506/rst.33.1.2286; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; IBAMA, 2008, DIAGN GER PRAT CONTR, P217; IBGE, 2010, I BRAS GEOGR EST; Kendall HA, 2006, RURAL SOCIOL, V71, P399, DOI 10.1526/003601106778070617; Knight S, 2009, J SOC ISSUES, V65, P463, DOI 10.1111/j.1540-4560.2009.01609.x; Kupsala S, 2013, J AGR ENVIRON ETHIC, V26, P119, DOI 10.1007/s10806-011-9369-4; Lambooij E, 2008, AQUACULTURE, V275, P88, DOI 10.1016/j.aquaculture.2008.01.026; Livengood E., 2007, U FLORIDA IFAS EX FA, V16, P1; Loughnan S, 2010, APPETITE, V55, P156, DOI 10.1016/j.appet.2010.05.043; Martins CIM, 2014, APPL ANIM BEHAV SCI, V164, P104; Mendes Filho Onivaldo da Rocha, 2010, Interações (Campo Grande), V11, P93, DOI 10.1590/S1518-70122010000100009; Metzger Mitchell M, 2014, J Undergrad Neurosci Educ, V12, pA154; Muir R, 2013, ANIM WELFARE, V22, P323, DOI 10.7120/09627286.22.3.323; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; OIE, 2015, AQ AN HLTH COD; PANKHURST NW, 1994, J FISH BIOL, V45, P1013, DOI 10.1111/j.1095-8649.1994.tb01069.x; Pedrazzani Ana Silvia, 2008, Ciencia Animal Brasileira, V9, P976; Perussatto A, 2012, DIALOGO, P207; Phillips CJC, 2005, J BIOL EDUC, V40, P17, DOI 10.1080/00219266.2005.9656004; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Renctas, 2001, RED NAC COMB AO TRAF, P40; Robb DHF, 2002, ANIM WELFARE, V11, P269; Rocklinsberg H, 2015, J AGR ENVIRON ETHIC, V28, P533, DOI 10.1007/s10806-014-9506-y; Rose JD, 2014, FISH FISH, V15, P97, DOI 10.1111/faf.12010; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Schaeffer R.L., 1990, ELEMENTARY SURVEY SA, V4th; Shrestha RK, 2002, ECOL ECON, V42, P289, DOI 10.1016/S0921-8009(02)00106-4; Signal T, 2006, SOC ANIM, V2, P146; SMAG, 2010, SECR MUN AGR AR; Smith JA., 1991, LIVES BALANCE ETHICS; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2014, ANIM BEHAV, V97, P201, DOI 10.1016/j.anbehav.2014.09.007; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Spooner JM, 2014, LIVEST SCI, V163, P150, DOI 10.1016/j.livsci.2014.02.011; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Toivonen A-L, GLOBAL CHALLENGES RE; Vanhonacker F, 2014, J AGR ENVIRON ETHIC, V27, P153, DOI 10.1007/s10806-013-9479-2; Volpato GL, 2009, ILAR J, V50, P329, DOI 10.1093/ilar.50.4.329; Webster J, 2006, APPL ANIM BEHAV SCI, V100, P1, DOI 10.1016/j.applanim.2006.05.012	76	18	18	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168197	10.1371/journal.pone.0168197	http://dx.doi.org/10.1371/journal.pone.0168197			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WO	28068372	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900007
J	Sun, YR; Zhang, WB; Ma, JC; Pang, HS; Wang, HH				Sun, Yirong; Zhang, Wenbin; Ma, Jincheng; Pang, Hongshen; Wang, Haihong			Overproduction of alpha-Lipoic Acid by Gene Manipulated Escherichia coli	PLOS ONE			English	Article							LIPOATE-PROTEIN LIGASE; CRYSTAL-STRUCTURE; DEHYDROGENASE COMPLEX; SYNTHASE; DOMAINS; PLASMA; LIPB; INTERMEDIATE; METABOLISM; MECHANISMS	Alpha-lipoic acid (LA) is an important enzyme cofactor widely used by organisms and is also a natural antioxidant for the treatment of pathologies driven by low levels of endogenous antioxidants. In order to establish a safer and more efficient process for LA production, we developed a new biological method for LA synthesis based on the emerging knowledge of lipoic acid biosynthesis. We first cloned the lipD gene, which encodes the lipoyl domain of the E2 subunit of pyruvate dehydrogenase, allowing high levels of LipD production. Plasmids containing genes for the biosynthesis of LA were subsequently constructed utilizing various vectors and promotors to produce high levels of LA. These plasmids were transformed into the Escherichia coli strain BL21. Octanoic acid (OA) was used as the substrate for LA synthesis. One transformant, YS61, which carried lipD, lplA, and lipA, produced LA at levels over 200-fold greater than the wild-type strain, showing that LA could be produced efficiently in E. coli using genetic engineering methods.	[Sun, Yirong; Zhang, Wenbin] Chinese Acad Sci, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Sun, Yirong; Zhang, Wenbin] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenbin; Ma, Jincheng; Pang, Hongshen; Wang, Haihong] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China; [Pang, Hongshen] Shenzhen Univ, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; South China Agricultural University; Shenzhen University	Sun, YR (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China.; Sun, YR (corresponding author), Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China.; Wang, HH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China.	sun_yirong@gibh.ac.cn; wanghh36@scau.edu.cn			Guangdong Provincial Public interest research and capacity building projects [2014A010107024]; National Natural Science Foundation of China [31301019, 30870036, 31200028]	Guangdong Provincial Public interest research and capacity building projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Guangdong Provincial Public interest research and capacity building projects (2014A010107024), National Natural Science Foundation of China (31301019, 30870036 and 31200028).	AEvarsson A, 1999, NAT STRUCT BIOL, V6, P785; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; [Anonymous], 2012, COMMUNICATIONS MOBIL; Berg A, 1996, J MOL BIOL, V261, P432, DOI 10.1006/jmbi.1996.0474; Carlson DA, 2007, ALTERN MED REV, V12, P343; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; DEGUCHI Y, 1964, Yakugaku Zasshi, V84, P562; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Goc Z, 2015, ACTA BIOL HUNG, V66, P258, DOI 10.1556/018.66.2015.3.2; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GREGUS Z, 1992, TOXICOL APPL PHARM, V114, P88, DOI 10.1016/0041-008X(92)90100-7; HERBERT AA, 1975, ARCH MICROBIOL, V106, P259, DOI 10.1007/BF00446532; HORNBERGER CS, 1953, J AM CHEM SOC, V75, P1273, DOI 10.1021/ja01102a003; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kruger N J, 1994, Methods Mol Biol, V32, P9; Li BJ, 2015, GENET MOL RES, V14, P17934, DOI 10.4238/2015.December.22.18; Moon HJ, 2009, APPL MICROBIOL BIOT, V83, P329, DOI 10.1007/s00253-009-1899-6; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Moura FA, 2015, CURR TOP MED CHEM, V15, P458, DOI 10.2174/1568026615666150114161358; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Ollagnier-de Choudens S, 2000, BIOCHEMISTRY-US, V39, P4165, DOI 10.1021/bi992090u; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PRATT KJ, 1989, BIOCHEM J, V258, P749, DOI 10.1042/bj2580749; Rahman RNZRA, 2005, PROTEIN EXPRES PURIF, V40, P411, DOI 10.1016/j.pep.2005.01.006; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Ricaud PM, 1996, J MOL BIOL, V264, P179, DOI 10.1006/jmbi.1996.0632; Rochette L, 2015, CAN J PHYSIOL PHARM, V93, P1021, DOI 10.1139/cjpp-2014-0353; Shen W, 2008, J CELL BIOCHEM, V104, P1232, DOI 10.1002/jcb.21701; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun Y., 2011, J AGR SCI, V4, P12; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Teichert J, 2003, J CLIN PHARMACOL, V43, P1257, DOI 10.1177/0091270003258654; Trivedi RK, 2004, BIOMED CHROMATOGR, V18, P681, DOI 10.1002/bmc.375; WHITE RH, 1980, J AM CHEM SOC, V102, P6605, DOI 10.1021/ja00541a059; Witt W, 1998, J CHROMATOGR B, V705, P127, DOI 10.1016/S0378-4347(97)00488-X; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y	42	4	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169369	10.1371/journal.pone.0169369	http://dx.doi.org/10.1371/journal.pone.0169369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068366	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900029
J	Zhou, SF; Abdouh, M; Arena, V; Arena, M; Arena, GO				Zhou, Shufeng; Abdouh, Mohamed; Arena, Vincenzo; Arena, Manuel; Arena, Goffredo Orazio			Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment	PLOS ONE			English	Article							MELANOMA-CELLS; EXTRACELLULAR VESICLES; TERATOCARCINOMA CELLS; TUMOR-FORMATION; ES CELLS; MICROVESICLES; EXOSOMES; GROWTH; DIFFERENTIATION; COMMUNICATION	The embryonic microenvironment is well known to be non-permissive for tumor development because early developmental signals naturally suppress the expression of proto-oncogenes. In an analogous manner, mimicking an early embryonic environment during embryonic stem cell culture has been shown to suppress oncogenic phenotypes of cancer cells. Exosomes derived from human embryonic stem cells harbor substances that mirror the content of the cells of origin and have been reported to reprogram hematopoietic stem/progenitor cells via horizontal transfer of mRNA and proteins. However, the possibility that these embryonic stem cells-derived exosomes might be the main effectors of the anti-tumor effect mediated by the embryonic stem cells has not been explored yet. The present study aims to investigate whether exosomes derived from human embryonic stem cells can reprogram malignant cancer cells to a benign stage and reduce their tumorigenicity. We show that the embryonic stem cell-conditioned medium contains factors that inhibit cancer cell growth and tumorigenicity in vitro and in vivo. Moreover, we demonstrate that exosomes derived from human embryonic stem cells display anti-proliferation and pro-apoptotic effects, and decrease tumor size in a xenograft model. These exosomes are also able to transfer their cargo into target cancer cells, inducing a dose-dependent increase in SOX2, OCT4 and Nanog proteins, leading to a dose-dependent decrease of cancer cell growth and tumorigenicity. This study shows for the first time that human embryonic stem cell-derived exosomes play an important role in the tumor suppressive activity displayed by human embryonic stem cells.	[Zhou, Shufeng; Abdouh, Mohamed; Arena, Goffredo Orazio] McGill Univ, Ctr Hlth, Res Inst, Canc Res Program, Montreal, PQ, Canada; [Zhou, Shufeng] McGill Univ, Montreal Gen Hosp, Dept Expt Surg, Montreal, PQ, Canada; [Arena, Vincenzo] Santo Bambino Hosp, Dept Obstet & Gynecol, Catania, Italy; [Arena, Manuel] Univ Catania, Dept Surg Sci Organ Transplantat & Adv Technol, Catania, Italy; [Arena, Goffredo Orazio] McGill Univ, St Mary Hosp, Dept Surg, Montreal, PQ, Canada	McGill University; McGill University; University of Catania; McGill University	Arena, GO (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Canc Res Program, Montreal, PQ, Canada.; Arena, GO (corresponding author), McGill Univ, St Mary Hosp, Dept Surg, Montreal, PQ, Canada.	goffredo.arena@mcgill.ca	arena, goffredo/AAR-5283-2020	Arena, Goffredo/0000-0002-5293-2972; Abdouh, Mohamed/0000-0003-0702-9335; Zhou, Shufeng/0000-0003-2715-9823	FRSQ scholarship	FRSQ scholarship	This work was financially supported by Giuseppe Monticciolo (Private contribution). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shufeng Zhou is the recipient of a FRSQ scholarship.	Abbott DE, 2008, CANCER MICROENVIRON, V1, P13, DOI 10.1007/s12307-008-0004-5; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bailey CM, 2014, MOL CANCER RES, V12, P1303, DOI 10.1158/1541-7786.MCR-13-0673; Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Desrochers LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11958; Diez-Torre A, 2009, INT J DEV BIOL, V53, P1563, DOI 10.1387/ijdb.093021ad; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Giuffrida D, 2009, CELL PROLIFERAT, V42, P788, DOI 10.1111/j.1365-2184.2009.00640.x; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Joel M, 2013, DEV DYNAM, V242, P1078, DOI 10.1002/dvdy.24001; Kastelowitz N, 2014, CHEMBIOCHEM, V15, P923, DOI 10.1002/cbic.201400043; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Khalkhali-Ellis Z., 2016, STEM CELLS DEV; Khan M, 2015, CIRC RES, V117, P52, DOI 10.1161/CIRCRESAHA.117.305990; Kim J, 2015, EMBO J, V34, P739, DOI 10.15252/embj.201490736; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lai RC, 2016, METHODS MOL BIOL, V1416, P477, DOI 10.1007/978-1-4939-3584-0_29; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Li XS, 2014, LECT NOTES COMPUT SC, V8881, P764, DOI 10.1007/978-3-319-12691-3_56; Lin YL, 2011, MOL CELL BIOCHEM, V351, P109, DOI 10.1007/s11010-011-0717-5; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ohlsson LB, 2003, EXP MOL PATHOL, V75, P248, DOI 10.1016/j.yexmp.2003.06.001; Pera MF, 2000, J CELL SCI, V113, P5; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Schatten G, 2005, NAT METHODS, V2, P455, DOI 10.1038/nmeth0605-455; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Hooser A, 1998, J CELL SCI, V111, P3497; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Zhang S, 2016, OSTEOARTHRITIS CARTI	51	39	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169899	10.1371/journal.pone.0169899	http://dx.doi.org/10.1371/journal.pone.0169899			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068409	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900077
J	Chen, LH; Tsai, HC; Yu, PL; Chung, KR				Chen, Li-Hung; Tsai, Hsieh-Chin; Yu, Pei-Ling; Chung, Kuang-Ren			A Major Facilitator Superfamily Transporter-Mediated Resistance to Oxidative Stress and Fungicides Requires Yap1, Skn7, and MAP Kinases in the Citrus Fungal Pathogen Alternaria alternata	PLOS ONE			English	Article							NATURAL TOXIC COMPOUNDS; MULTIDRUG-RESISTANCE; COLLETOTRICHUM-ACUTATUM; TANGERINE PATHOTYPE; CANDIDA-ALBICANS; GENE-EXPRESSION; YEAST; HOMEOSTASIS; TRANSFORMATION; GRAMINICOLA	Major Facilitator Superfamily (MFS) transporters play an important role in multidrug resistance in fungi. We report an AaMFS19 gene encoding a MFS transporter required for cellular resistance to oxidative stress and fungicides in the phytopathogenic fungus Alternaria alternata. AaMFS19, containing 12 transmembrane domains, displays activity toward a broad range of substrates. Fungal mutants lacking AaMFS19 display profound hypersensitivities to cumyl hydroperoxide, potassium superoxide, many singlet oxygen-generating compounds (eosin Y, rose Bengal, hematoporphyrin, methylene blue, and cercosporin), and the cell wall biosynthesis inhibitor, Congo red. AaMFS19 mutants also increase sensitivity to copper ions, clotrimazole, fludioxonil, and kocide fungicides, 2-chloro-5-hydroxypyridine (CHP), and 2,3,5-triiodobenzoic acid (TIBA). AaMFS19 mutants induce smaller necrotic lesions on leaves of a susceptible citrus cultivar. All observed phenotypes in the mutant are restored by introducing and expressing a wild-type copy of AaMFS19. The wild-type strain of A. alternata treated with either CHP or TIBA reduces radial growth and formation and germination of conidia, increases hyphal branching, and results in decreased expression of the AaMFS19 gene. The expression of AaMFS19 is regulated by the Yap1 transcription activator, the Hog1 and Fus3 mitogen-activated protein (MAP) kinases, the 'two component' histidine kinase, and the Skn7 response regulator. Our results demonstrate that A. alternata confers resistance to different chemicals via a membrane-bound MFS transporter.	[Chen, Li-Hung; Tsai, Hsieh-Chin; Yu, Pei-Ling; Chung, Kuang-Ren] Natl Chung Hsing Univ, Dept Plant Pathol, Coll Agr & Nat Resources, Taichung, Taiwan; [Chung, Kuang-Ren] NCHU, Ctr Biotechnol, Taichung, Taiwan; [Chung, Kuang-Ren] NCHU, NCHU UCD Plant & Food Biotechnol Ctr, Taichung, Taiwan; [Chen, Li-Hung] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; University of California System; University of California Davis	Chung, KR (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Coll Agr & Nat Resources, Taichung, Taiwan.; Chung, KR (corresponding author), NCHU, Ctr Biotechnol, Taichung, Taiwan.; Chung, KR (corresponding author), NCHU, NCHU UCD Plant & Food Biotechnol Ctr, Taichung, Taiwan.	krchung@nchu.edu.tw.edu	Tsai, Hsieh-Chin/AAT-4190-2020; YU, PEI-LING/M-1348-2019; Chung, Kuang-Ren/Q-1157-2019	Chung, Kuang-Ren/0000-0002-2640-2951; Chen, Li-Hung/0000-0002-9636-9501	Ministry of Science and Technology of Taiwan [MOST103-2313-B-005-044-MY2, MOST105-2313-B-005-010-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology of Taiwan (MOST103-2313-B-005-044-MY2 and MOST105-2313-B-005-010-MY3) to KRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimitsu KA, 2003, MOL PLANT PATHOL, V4, P435, DOI 10.1046/j.1364-3703.2003.00189.X; Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; Callahan TM, 1999, MOL PLANT MICROBE IN, V12, P901, DOI 10.1094/MPMI.1999.12.10.901; Chen LH, 2014, MICROBIOL-SGM, V160, P970, DOI 10.1099/mic.0.076182-0; Chen LH, 2012, FUNGAL GENET BIOL, V49, P802, DOI 10.1016/j.fgb.2012.07.006; Chung KR, 2002, FEMS MICROBIOL LETT, V213, P33, DOI 10.1111/j.1574-6968.2002.tb11282.x; Chung KR, 2015, FUNG BIOL-US, P175, DOI 10.1007/978-3-319-10503-1_15; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; Coleman ST, 1997, J BIOL CHEM, V272, P23224, DOI 10.1074/jbc.272.37.23224; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Dhaoui M, 2011, MOL BIOL CELL, V22, P2054, DOI 10.1091/mbc.E10-11-0906; dos Santos SC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00180; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hayashi K, 2002, APPL ENVIRON MICROB, V68, P4996, DOI 10.1128/AEM.68.10.4996-5004.2002; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; Kruger A, 2013, EMBO REP, V14, P1113, DOI 10.1038/embor.2013.165; Lahey KA, 2004, MOL PLANT MICROBE IN, V17, P1394, DOI 10.1094/MPMI.2004.17.12.1394; Lin CH, 2011, CURR MICROBIOL, V62, P807, DOI 10.1007/s00284-010-9795-y; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Lin CH, 2010, FUNGAL GENET BIOL, V47, P381, DOI 10.1016/j.fgb.2009.12.009; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Nerud F, 2001, CHEMOSPHERE, V44, P957, DOI 10.1016/S0045-6535(00)00482-3; Panwar SL, 2008, BIOSCIENCE REP, V28, P217, DOI 10.1042/BSR20080071; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; POTTIER R, 1975, PHOTOCHEM PHOTOBIOL, V22, P59, DOI 10.1111/j.1751-1097.1975.tb06722.x; Rios G, 2013, FEMS YEAST RES, V13, P97, DOI 10.1111/1567-1364.12013; Rognon B, 2006, MICROBIOL-SGM, V152, P3701, DOI 10.1099/mic.0.29277-0; Roohparvar R, 2008, PEST MANAG SCI, V64, P685, DOI 10.1002/ps.1569; Roohparvar R, 2007, FUNGAL GENET BIOL, V44, P378, DOI 10.1016/j.fgb.2006.09.007; Sa-Correia I, 2009, TRENDS MICROBIOL, V17, P22, DOI 10.1016/j.tim.2008.09.007; Shahi P, 2009, BBA-PROTEINS PROTEOM, V1794, P852, DOI 10.1016/j.bbapap.2008.12.012; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Wang MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32437; Watanabe T, 1998, J BIOTECHNOL, V62, P221, DOI 10.1016/S0168-1656(98)00063-7; Yago JI, 2011, MOL PLANT PATHOL, V12, P653, DOI [10.1111/j.1364-3703.2010.00701.x, 10.1111/J.1364-3703.2010.00701.X]; Yang SL, 2016, ENVIRON MICROBIOL, V18, P923, DOI 10.1111/1462-2920.13125; Yang SL, 2013, MOL PLANT PATHOL, V14, P543, DOI 10.1111/mpp.12026; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; Yang SL, 2009, PHYSIOL MOL PLANT P, V74, P100, DOI 10.1016/j.pmpp.2009.09.007; Yu PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149153	43	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169103	10.1371/journal.pone.0169103	http://dx.doi.org/10.1371/journal.pone.0169103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060864	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500053
J	Fitzpatrick, EA; You, DH; Shrestha, B; Siefker, D; Patel, VS; Yadav, N; Jaligama, S; Cormier, SA				Fitzpatrick, Elizabeth A.; You, Dahui; Shrestha, Bishwas; Siefker, David; Patel, Vivek S.; Yadav, Nikki; Jaligama, Sridhar; Cormier, Stephania A.			A Neonatal Murine Model of MRSA Pneumonia	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; IMPAIRED INNATE IMMUNITY; ALVEOLAR MACROPHAGES; NEUTROPHILS; RESPONSES; PATHOGENESIS; COINFECTION; ACTIVATION; INDUCTION	Pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of morbidity and mortality in infants particularly following lower respiratory tract viral infections such as Respiratory Syncytial Virus (RSV). However, the mechanisms by which co-infection of infants by MRSA and RSV cause increased lung pathology are unknown. Because the infant immune system is qualitatively and quantitatively different from adults we developed a model of infant MRSA pneumonia which will allow us to investigate the effects of RSV co-infection on disease severity. We infected neonatal and adult mice with increasing doses of MRSA and demonstrate that neonatal mice have delayed kinetics in clearing the bacteria in comparison to adult mice. There were differences in recruitment of immune cells into the lung following infection. Adult mice exhibited an increase in neutrophil recruitment that coincided with reduced bacterial titers followed by an increase in macrophages. Neonatal mice, however, exhibited an early increase in neutrophils that did not persist despite continued presence of the bacteria. Unlike the adult mice, neonatal mice failed to exhibit an increase in macrophages. Neonates exhibited a decrease in phagocytosis of MRSA suggesting that the decrease in clearance was partially due to deficient phagocytosis of the bacteria. Both neonates and adults responded with an increase in pro-inflammatory cytokines following infection. However, in contrast to the adult mice, neonates did not express constitutive levels of the anti-microbial peptide Reg3 gamma in the lung. Infection of neonates did not stimulate expression of the co-stimulatory molecule CD86 by dendritic cells and neonates exhibited a diminished T cell response compared to adult mice. Overall, we have developed a neonatal model of MRSA pneumonia that displays a similar delay in bacterial clearance as is observed in the neonatal intensive care unit and will be useful for performing co-infection studies.	[Fitzpatrick, Elizabeth A.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [You, Dahui; Shrestha, Bishwas; Siefker, David; Patel, Vivek S.; Yadav, Nikki; Jaligama, Sridhar; Cormier, Stephania A.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cormier, SA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA.	scormier@uthsc.edu	Patel, Vivek/I-2939-2019; Cormier, Stephania A/I-7382-2017; Jaligama, Sridhar/D-5533-2015	Patel, Vivek/0000-0001-8583-1548; Cormier, Stephania A/0000-0002-6050-6172; Jaligama, Sridhar/0000-0001-6374-3336; Shrestha, Bishwas/0000-0002-6159-7686	National Institutes of Health [P42ES013648, R01AI090059, RO1ES015050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013648, R01ES015050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants to SAC from the National Institutes of Health including P42ES013648, R01AI090059, and RO1ES015050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 2000, Int Rev Immunol, V19, P157, DOI 10.3109/08830180009088503; Andrade EB, 2013, J IMMUNOL, V191, P4759, DOI 10.4049/jimmunol.1301752; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Black A, 2012, EUR J IMMUNOL, V42, P311, DOI 10.1002/eji.201141847; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; CHRISTENSEN RD, 1989, PEDIATR RES, V26, P531, DOI 10.1203/00006450-198912000-00001; Coker RK, 1996, EUR RESPIR J, V9, P2501, DOI 10.1183/09031936.96.09122501; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Drossou V, 1997, BIOL NEONATE, V72, P201; Fernandez S, 2004, J IMMUNOL, V172, P2613, DOI 10.4049/jimmunol.172.4.2613; Filias A, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-29; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Garnier F, 2006, EMERG INFECT DIS, V12, P498, DOI 10.3201/eid1203.051040; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Hendricks DW, 2011, BLOOD, V117, P1239, DOI 10.1182/blood-2010-07-299263; Kellen AJ, 2010, EPIDEMIOL INFECT, V138, P666, DOI 10.1017/S095026880999135X; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kurkjian C, 2012, INFECT IMMUN, V80, P2835, DOI 10.1128/IAI.05707-11; Lee JC, 1996, TRENDS MICROBIOL, V4, P162, DOI 10.1016/0966-842X(96)10021-4; Levy O, 2002, PEDIATR RES, V51, P667, DOI 10.1023/01.PDR.0000015551.58081.BB; Levy O, 1999, PEDIATRICS, V104, P1327, DOI 10.1542/peds.104.6.1327; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Marodi L, 2002, CLIN EXP IMMUNOL, V128, P1, DOI 10.1046/j.1365-2249.2002.01873.x; MARRACK P, 1990, SCIENCE, V248, P1066; McGreal EP, 2012, IMMUNOBIOLOGY, V217, P176, DOI 10.1016/j.imbio.2011.07.027; MILLER ME, 1979, PEDIATRICS, V64, P709; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; MOLLICK JA, 1993, J EXP MED, V177, P283, DOI 10.1084/jem.177.2.283; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406; Rana D, 2012, AM J PERINAT, V29, P401, DOI DOI 10.1055/S-0032-1304819; Risson DC, 2007, MED J AUSTRALIA, V186, P479, DOI 10.5694/j.1326-5377.2007.tb01002.x; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Schito GC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01343.x; Stockman LJ, 2010, PEDIATR INFECT DIS J, V29, P1048, DOI 10.1097/INF.0b013e3181eb7315; Nguyen T, 2012, CRIT CARE MED, V40, P3246, DOI 10.1097/CCM.0b013e318260c7f8	44	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169273	10.1371/journal.pone.0169273	http://dx.doi.org/10.1371/journal.pone.0169273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060871	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500074
J	Garcia-Neto, W; Cabrera-Orefice, A; Uribe-Carvajal, S; Kowaltowski, AJ; Luevano-Martinez, LA				Garcia-Neto, Wilson; Cabrera-Orefice, Alfredo; Uribe-Carvajal, Salvador; Kowaltowski, Alicia J.; Luevano-Martinez, Luis Alberto			High Osmolarity Environments Activate the Mitochondrial Alternative Oxidase in Debaryomyces Hansenii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; METABOLISM; STRESS; SALTS; RESPIRATION; PH	The oleaginous yeast Debaryomyces hansenii is a good model to understand molecular mechanisms involved in halotolerance because of its impressive ability to survive under a wide range of salt concentrations. Several cellular adaptations are implicated in this response, including the presence of a cyanide-insensitive ubiquinol oxidase (Aox). This protein, which is present in several taxonomical orders, has been related to different stress responses. However, little is known about its role in mitochondria during transitions from low to high saline environments. In this report, we analyze the effects of Aox in shifts from low to high salt concentrations in the culture media. At early stages of a salt insult, we observed that this protein prevents the overflow of electrons on the mitochondrial respiratory chain, thus, decreasing the production of reactive oxygen species. Interestingly, in the presence of high osmolite concentrations, Aox activity is able to sustain a stable membrane potential when coupled to complex I, despite a compromised cytochrome pathway. Taken together, our results suggest that under high osmolarity conditions Aox plays a critical role regulating mitochondrial physiology.	[Garcia-Neto, Wilson; Kowaltowski, Alicia J.; Luevano-Martinez, Luis Alberto] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Cabrera-Orefice, Alfredo; Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City, DF, Mexico	Universidade de Sao Paulo; Universidad Nacional Autonoma de Mexico	Luevano-Martinez, LA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.	aluevano@iq.usp.br	Luévano-Martínez, Luis Alberto/E-3717-2012; Kowaltowski, Alicia J/H-8698-2012; Cabrera-Orefice, Alfredo/H-3464-2016	Cabrera-Orefice, Alfredo/0000-0002-2042-3794; Uribe-Carvajal, Salvador/0000-0002-7028-8121	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/04919-9]; Institute Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma); John Simon Guggenheim Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Institute Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma); John Simon Guggenheim Memorial Foundation	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Institute Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) and the John Simon Guggenheim Memorial Foundation WGN is supported by an undergraduate fellowship from FAPESP. LALM is supported by postdoctoral fellowships from FAPESP (process number 2013/04919-9).; This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) and the John Simon Guggenheim Memorial Foundation. We would like to gratefully acknowledge Camille Caldeira da Silva, Edson Alves Gomes and Doris Araujo for their technical support. WGN is supported by an undergraduate fellowship from FAPESP. LALM is supported by postdoctoral fellowships from FAPESP (process number 2013/04919-9).	ADLER L, 1985, J BACTERIOL, V162, P300, DOI 10.1128/JB.162.1.300-306.1985; Almagro A, 2000, INT J FOOD MICROBIOL, V56, P191, DOI 10.1016/S0168-1605(00)00220-8; Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Breuer U, 2006, YEAST, V23, P415, DOI 10.1002/yea.1374; Cabrera-Orefice A, 2014, BBA-BIOENERGETICS, V1837, P73, DOI 10.1016/j.bbabio.2013.07.011; Cabrera-Orefice A, 2010, J BIOENERG BIOMEMBR, V42, P11, DOI 10.1007/s10863-009-9264-0; Calahorra M, 1998, YEAST, V14, P501, DOI 10.1002/(SICI)1097-0061(19980430)14:6<501::AID-YEA249>3.0.CO;2-6; Calahorra M, 2009, FEMS YEAST RES, V9, P1293, DOI 10.1111/j.1567-1364.2009.00556.x; Gonzalez-Hernandez JC, 2005, EXTREMOPHILES, V9, P7, DOI 10.1007/s00792-004-0415-2; Gonzalez-Hernandez JC, 2004, YEAST, V21, P403, DOI 10.1002/yea.1108; Grant WD, 2004, SOIL SCI SOC AM J, V359, P1249; Graziano G, 2014, BBA-PROTEINS PROTEOM, V1844, P850, DOI 10.1016/j.bbapap.2014.02.018; Montiel V, 2007, FEMS YEAST RES, V7, P102, DOI 10.1111/j.1567-1364.2006.00115.x; ONISHI HIROSHI, 1963, ADVAN FOOD RES, V12, P53; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Pena A, 2010, J BIOENERG BIOMEMBR, V42, P419, DOI 10.1007/s10863-010-9311-x; Petelenz-Kurdziel E, 2011, INTEGR BIOL-UK, V3, P1120, DOI 10.1039/c1ib00027f; Qiu QS, 2012, J GENET GENOMICS, V39, P167, DOI 10.1016/j.jgg.2012.02.001; Rogov AG, 2015, BIOCHEMISTRY-MOSCOW+, V80, P400, DOI 10.1134/S0006297915040021; Rogov AG, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1615, DOI 10.1134/S0006297914130112; Sanchez NS, 2008, FEMS YEAST RES, V8, P1303, DOI 10.1111/j.1567-1364.2008.00426.x; Sanchez NS, 2006, YEAST, V23, P361, DOI 10.1002/yea.1360; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Turk M, 2007, MICROBIOL-SGM, V153, P3586, DOI 10.1099/mic.0.2007/009563-0; Veiga A, 2003, FEMS YEAST RES, V3, P141, DOI 10.1016/S1567-1356(02)00189-7	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169621	10.1371/journal.pone.0169621	http://dx.doi.org/10.1371/journal.pone.0169621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060946	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500117
J	Liao, W; Atkinson, CT; LaPointe, DA; Samuel, MD				Liao, Wei; Atkinson, Carter T.; LaPointe, Dennis A.; Samuel, Michael D.			Mitigating Future Avian Malaria Threats to Hawaiian Forest Birds from Climate Change	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS DIPTERA; AEDES-JAPONICUS-JAPONICUS; ELEVATIONAL GRADIENT; PLASMODIUM-RELICTUM; FIELD PERFORMANCE; GENETIC-STRUCTURE; POPULATION; MOSQUITO; CULICIDAE; CONSERVATION	Avian malaria, transmitted by Culex quinquefasciatus mosquitoes in the Hawaiian Islands, has been a primary contributor to population range limitations, declines, and extinctions for many endemic Hawaiian honeycreepers. Avian malaria is strongly influenced by climate; therefore, predicted future changes are expected to expand transmission into higher elevations and intensify and lengthen existing transmission periods at lower elevations, leading to further population declines and potential extinction of highly susceptible honeycreepers in mid-and high-elevation forests. Based on future climate changes and resulting malaria risk, we evaluated the viability of alternative conservation strategies to preserve endemic Hawaiian birds at mid and high elevations through the 21st century. We linked an epidemiological model with three alternative climatic projections from the Coupled Model Intercomparison Project to predict future malaria risk and bird population dynamics for the coming century. Based on climate change predictions, proposed strategies included mosquito population suppression using modified males, release of genetically modified refractory mosquitoes, competition from other introduced mosquitoes that are not competent vectors, evolved malaria-tolerance in native honeycreepers, feral pig control to reduce mosquito larval habitats, and predator control to improve bird demographics. Transmission rates of malaria are predicted to be higher than currently observed and are likely to have larger impacts in high elevation forests where current low rates of transmission create a refuge for highly-susceptible birds. As a result, several current and proposed conservation strategies will be insufficient to maintain existing forest bird populations. We concluded that mitigating malaria transmission at high elevations should be a primary conservation goal. Conservation strategies that maintain highly susceptible species like liwi (Drepanis coccinea) will likely benefit other threatened and endangered Hawai'i species, especially in high-elevation forests. Our results showed that mosquito control strategies offer potential long-term benefits to high elevation Hawaiian honeycreepers. However, combined strategies will likely be needed to preserve endemic birds at mid elevations. Given the delay required to research, develop, evaluate, and improve several of these currently untested conservation strategies we suggest that planning should begin expeditiously.	[Liao, Wei] Univ Wisconsin, Dept Forestry & Wildlife Ecol, Madison, WI USA; [Atkinson, Carter T.; LaPointe, Dennis A.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, Volcano, HI USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Samuel, MD (corresponding author), Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI 53706 USA.	mdsamuel@wisc.edu			U. S. Geological Survey - Pacific Island Ecosystems Research Center; National Science Foundation [DEB 0083944]; Department of Forest and Wildlife Ecology at the University of Wisconsin - Madison	U. S. Geological Survey - Pacific Island Ecosystems Research Center; National Science Foundation(National Science Foundation (NSF)); Department of Forest and Wildlife Ecology at the University of Wisconsin - Madison	The U. S. Geological Survey - Pacific Island Ecosystems Research Center funded this project. The National Science Foundation provided financial support for development of the forest bird-malaria simulation model (DEB 0083944). The Department of Forest and Wildlife Ecology at the University of Wisconsin - Madison provided funds for publication costs.	Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; [Anonymous], CONSERVATION BIOL HA; Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Atkinson CT, 2013, ECOHEALTH, V10, P366, DOI 10.1007/s10393-013-0899-2; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Bellini R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-323; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2009, PHILOS T R SOC B, V364, P27, DOI 10.1098/rstb.2008.0160; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Chen, 2013, J NANOMATER, V2013, P1, DOI DOI 10.1016/J.BI0RTECH.2013.01.071); DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Eggert LS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-315; Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140389; Foster JT, 2007, MOL ECOL, V16, P4738, DOI 10.1111/j.1365-294X.2007.03550.x; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Freed LA, 2013, PARASITOL RES, V112, P3887, DOI 10.1007/s00436-013-3578-x; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Giambelluca TW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034377; Gorresen P. Marcos, 2009, P108; Hardstone MC, 2012, J MED ENTOMOL, V49, P277, DOI 10.1603/ME11050; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hobbelen PHF, 2013, THEOR ECOL-NETH, V6, P31, DOI 10.1007/s12080-011-0154-9; Hobbelen PHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049594; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Kaufman MG, 2012, J MED ENTOMOL, V49, P1307, DOI 10.1603/ME12061; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LaPointe DA, 2000, THESIS; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lapointe Dennis A., 2009, P405; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Ledford H, 2015, GENE DRIVE MOSQUITOE; Liao W, 2015, GLOBAL CHANGE BIOL, V21, P4342, DOI 10.1111/gcb.13005; Lindsey Gerald D., 2009, P274; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Lorenz A, 2012, THESIS; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Moreira LA, 2002, INT J PARASITOL, V32, P1599, DOI 10.1016/S0020-7519(02)00188-1; Murrell EG, 2013, OECOLOGIA, V173, P1033, DOI 10.1007/s00442-013-2674-z; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Reiter ME, 2007, J MED ENTOMOL, V44, P861, DOI 10.1603/0022-2585(2007)44[861:LFITSD]2.0.CO;2; Reiter ME, 2009, J VECTOR ECOL, V34, P208, DOI [10.3376/038.034.0206, 10.1111/j.1948-7134.2009.00028.x]; Samuel MD, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00393.1; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Spiegel CS, 2006, BIRD CONSERV INT, V16, P175, DOI 10.1017/S0959270906000244; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; Vanderwerf EA, 2009, J WILDLIFE MANAGE, V73, P737, DOI 10.2193/2008-284; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Wai KT, 2012, PATHOG GLOB HEALTH, V106, P436, DOI 10.1179/2047773212Y.0000000063; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Woodworth Bethany L., 2009, P194; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	70	23	24	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168880	10.1371/journal.pone.0168880	http://dx.doi.org/10.1371/journal.pone.0168880			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060848	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500042
J	Rombouts, M; Cools, N; Grootaert, MOJ; de Bakker, F; Van Brussel, I; Wouters, A; De Meyer, GRY; De Winter, BY; Schrijvers, DM				Rombouts, Miche; Cools, Nathalie; Grootaert, Mandy O. J.; de Bakker, Flore; Van Brussel, Ilse; Wouters, An; De Meyer, Guido R. Y.; De Winter, Benedicte Y.; Schrijvers, Dorien M.			Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ZDC; IN-VIVO DEPLETION; MICE; IMMUNE; INTIMA; HOMEOSTASIS; LIMITATIONS; ACTIVATION; EXPRESSION; ABLATION	Background and aims Increased evidence suggests a pro-atherogenic role for conventional dendritic cells (cDC). However, due to the lack of an exclusive marker for cDC, their exact contribution to atherosclerosis remains elusive. Recently, a unique transcription factor was described for cDC, namely Zbtb46, enabling us to selectively target this cell type in mice. Methods Low-density lipoprotein receptor-deficient (Ldlr (-/-)) mice were transplanted with bone marrow from Zbtb46-diphtheria toxin receptor (DTR) transgenic mice following total body irradiation. Zbtb46-DTR -> Ldlr(-/-)chimeras were fed a Western-type diet for 18 weeks while cDC were depleted by administering diphtheria toxin (DT). Results Although we confirmed efficient direct induction of cDC death in vitro and in vivo upon DT treatment of Zbtb46-DTR mice, advanced atherosclerotic plaque size and composition was not altered. Surprisingly, however, analysis of Zbtb46-DTR -> Ldlr(-/-) chimeras showed that depletion of cDC was not sustained following 18 weeks of DT treatment. In contrast, high levels of anti-DT antibodies were detected. Conclusions Because of the observed generation of anti-DT antibodies and consequently the partial depletion of cDC, no clear decision can be taken on the role of cDC in atherosclerosis. Our results underline the unsuitability of Zbtb46-DTR -> Ldlr(-/-) mice for studying the involvement of cDC in maintaining the disease process of atherosclerosis, as well as of other chronic inflammatory diseases.	[Rombouts, Miche; Grootaert, Mandy O. J.; de Bakker, Flore; Van Brussel, Ilse; De Meyer, Guido R. Y.; Schrijvers, Dorien M.] Univ Antwerp, Lab Physiopharmacol, Fac Pharmaceut Biomed & Vet Sci, Antwerp, Belgium; [Cools, Nathalie] Univ Antwerp, Fac Med & Hlth Sci, Lab Expt Hematol, Vaccine & Infect Dis Inst Vaxinfectio, Antwerp, Belgium; [Wouters, An] Univ Antwerp, Oncol Res Ctr, Fac Med & Hlth Sci, Antwerp, Belgium; [De Winter, Benedicte Y.] Univ Antwerp, Lab Expt Med & Pediat, Fac Med & Hlth Sci, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Rombouts, M (corresponding author), Univ Antwerp, Lab Physiopharmacol, Fac Pharmaceut Biomed & Vet Sci, Antwerp, Belgium.	miche.rombouts@uantwerpen.be	Grootaert, Mandy/ABG-4300-2021; De Meyer, Guido/R-8129-2016; Wouters, An/B-5384-2017; De Winter, Benedicte Y/G-2616-2011	De Meyer, Guido/0000-0003-3848-8702; Wouters, An/0000-0001-7771-1239; De Winter, Benedicte Y/0000-0003-0327-6304	University of Antwerp (BOF-GOA); University of Antwerp (BOF-DOCPRO); University of Antwerp (BOF-KP); Belgian Hercules foundation; Vocatio foundation	University of Antwerp (BOF-GOA); University of Antwerp (BOF-DOCPRO); University of Antwerp (BOF-KP); Belgian Hercules foundation; Vocatio foundation	This work was supported by grants from the University of Antwerp (BOF-GOA, BOF-DOCPRO, BOF-KP), the Belgian Hercules foundation, and from the Vocatio foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Bobryshev YV, 2001, HISTOL HISTOPATHOL, V16, P801, DOI 10.14670/HH-16.801; BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Christiaansen AF, 2014, J IMMUNOL METHODS, V406, P58, DOI 10.1016/j.jim.2014.03.005; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Koltsova EK, 2011, TRENDS IMMUNOL, V32, P540, DOI 10.1016/j.it.2011.07.001; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; LLEWELLYNSMITH IJ, 1985, J HISTOCHEM CYTOCHEM, V33, P857, DOI 10.1177/33.9.3926868; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Mandl M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134176; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Millonig G, 2001, ARTERIOSCL THROM VAS, V21, P503, DOI 10.1161/01.ATV.21.4.503; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Rombouts M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6467375; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Subramanian M, 2013, SEMIN IMMUNOPATHOL; van Blijswijk J, 2013, EUR J IMMUNOL, V43, P22, DOI 10.1002/eji.201243022; Wang JH, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1450398; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atherosclerosis.2004.04.027; Zernecke A, 2015, ARTERIOSCL THROM VAS, V35, P763, DOI 10.1161/ATVBAHA.114.303566	34	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169608	10.1371/journal.pone.0169608	http://dx.doi.org/10.1371/journal.pone.0169608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060909	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000391641500115
J	Shinohara, Y; Kashima, T; Akiyama, H; Shimoda, Y; Li, DJ; Kishi, S				Shinohara, Yoichiro; Kashima, Tomoyuki; Akiyama, Hideo; Shimoda, Yukitoshi; Li, Danjie; Kishi, Shoji			Evaluation of Fundus Blood Flow in Normal Individuals and Patients with Internal Carotid Artery Obstruction Using Laser Speckle Flowgraphy	PLOS ONE			English	Article							OCULAR ISCHEMIC SYNDROME; OPTIC-NERVE HEAD; 2-DIMENSIONAL MEASUREMENT; OPHTHALMIC ARTERY; CIRCULATION; MICROCIRCULATION; ANGIOGRAPHY; NONCONTACT; PRESSURE; VELOCITY	Purpose We investigated whether laser speckle flowgraphy (LSFG) results are comparable in both eyes and whether it is useful in the diagnosis of disparity in ocular ischemic syndrome (OIS) patients. Methods We compared the mean blur rate (MBR) value for various fundus regions in both eyes of 41 healthy subjects and 15 internal carotid artery occlusion (ICAO) cases. We calculated the standard value of the Laterality Index (LI), which was the MBR comparison of both eyes in each of the regions, in the control subjects. We then investigated the correlation between both eyes for the Lls in the entire fundus, the degree of ICAO and visual function. Results The disparity of the Lls in both eyes was least in the entire area of the fundus in control subjects and there was a significant correlation between both eyes of the 41 healthy individuals (P = 0.019). Significant correlations were found for the LI, visual acuity and degree of ICAO. The specificity and sensitivity of LI in the entire area was 93.8% and 100%, respectively. Conclusions LSFG revealed normal individuals have symmetrical fundus blood flow. LSFG could detect OIS and might be a useful tool for detecting disparities in fundus blood flow.	[Shinohara, Yoichiro; Kashima, Tomoyuki; Akiyama, Hideo; Shimoda, Yukitoshi; Li, Danjie; Kishi, Shoji] Gunma Univ, Sch Med, Dept Ophthalmol, Maebashi, Gunma, Japan	Gunma University	Shinohara, Y (corresponding author), Gunma Univ, Sch Med, Dept Ophthalmol, Maebashi, Gunma, Japan.	m14702001@gunma-u.ac.jp						Aizawa N, 2015, ACTA OPHTHALMOL, V93, pE397, DOI 10.1111/aos.12586; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; BROWN GC, 1988, INT OPHTHALMOL, V11, P239, DOI 10.1007/BF00131023; BROWN GC, 1982, OPHTHALMOLOGY, V89, P139; COUNTEE RW, 1978, STROKE, V9, P42, DOI 10.1161/01.STR.9.1.42; Current management of amaurosis fugax, 1990, STROKE J CEREBRAL CI, V21, P201; Hashimoto Y, 2015, JPN J OPHTHALMOL, V59, P252, DOI 10.1007/s10384-015-0380-6; HUCKMAN MS, 1972, AM J OPHTHALMOL, V74, P1094, DOI 10.1016/0002-9394(72)90726-X; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Maeda K, 2009, CLIN OPHTHALMOL, V3, P489; Mendrinos E, 2010, SURV OPHTHALMOL, V55, P2, DOI 10.1016/j.survophthal.2009.02.024; Mizener JB, 1997, OPHTHALMOLOGY, V104, P859, DOI 10.1016/S0161-6420(97)30221-8; OBANA A, 1994, AM J OPHTHALMOL, V118, P749, DOI 10.1016/S0002-9394(14)72554-1; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P2338; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P1752; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P4273; STURROCK GD, 1984, BRIT J OPHTHALMOL, V68, P716, DOI 10.1136/bjo.68.10.716; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Utsugi N, 2004, RETINA-J RET VIT DIS, V24, P915, DOI 10.1097/00006982-200412000-00012; VISONA A, 1987, Heart and Vessels, V3, P91, DOI 10.1007/BF02058525; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7; WEINBERGER J, 1980, STROKE, V11, P290, DOI 10.1161/01.STR.11.3.290; WINTERKORN JMS, 1991, ANN NEUROL, V30, P423, DOI 10.1002/ana.410300317; YANNUZZI LA, 1986, OPHTHALMOLOGY, V93, P611	27	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169596	10.1371/journal.pone.0169596	http://dx.doi.org/10.1371/journal.pone.0169596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056061	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100059
J	Suresh, M; Korolowicz, KE; Balarezo, M; Iyer, RP; Padmanabhan, S; Cleary, D; Gimi, R; Sheri, A; Yon, C; Kallakury, BV; Tucker, RD; Afdhal, N; Menne, S				Suresh, Manasa; Korolowicz, Kyle E.; Balarezo, Maria; Iyer, Radhakrishnan P.; Padmanabhan, Seetharamaiyer; Cleary, Dillon; Gimi, Rayomand; Sheri, Anjaneyulu; Yon, Changsuek; Kallakury, Bhaskar V.; Tucker, Robin D.; Afdhal, Nezam; Menne, Stephan			Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks	PLOS ONE			English	Article							CHRONIC HEPATITIS; RIG-I; VIRUS; MODEL; THERAPY; INFECTION; RECEPTORS; SIGNATURE	SB 9200, an orally bioavailable dinucleotide, activates the viral sensor proteins, retinoic acid-inducible gene 1 (RIG-I) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) causing the induction of the interferon (IFN) signaling cascade for antiviral defense. The present study evaluated the overall antiviral response in woodchucks upon induction of immune response, first with SB 9200 followed by Entecavir (ETV) versus reduction of viral burden with ETV followed by SB 9200 immunomodulation. Woodchucks chronically infected with woodchuck hepatitis virus (WHV) were treated orally with SB 9200 (30 mg/kg/day) and ETV (0.5 mg/kg/day). Group 1 received ETV for 4 weeks followed by SB 9200 for 12 weeks. Group 2 received SB 9200 for 12 weeks followed by ETV for 4 weeks. At the end of treatment in Group 2, average reductions of 6.4 log(10) in serum WHV DNA and 3.3 log(10) in WHV surface antigen were observed whereas in Group 1, average reductions of 4.2 log(10) and 1.1 log(10) in viremia and antigenemia were noted. Both groups demonstrated marked reductions in hepatic WHV nucleic acid levels which were more pronounced in Group 2. Following treatment cessation and the 8-week follow-up, recrudescence of viral replication was observed in Group 1 while viral relapse in Group 2 was significantly delayed. The antiviral effects observed in both groups were associated with temporally different induction of IFN-alpha, IFN-8, and IFN-stimulated genes in blood and liver. These results suggest that the induction of host immune responses by pretreatment with SB 9200 followed by ETV resulted in antiviral efficacy that was superior to that obtained using the strategy of viral reduction with ETV followed by immunomodulation.	[Suresh, Manasa; Korolowicz, Kyle E.; Balarezo, Maria; Yon, Changsuek; Menne, Stephan] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA; [Iyer, Radhakrishnan P.; Padmanabhan, Seetharamaiyer; Cleary, Dillon; Gimi, Rayomand; Sheri, Anjaneyulu; Afdhal, Nezam] Spring Bank Pharmaceut Inc, Milford, MA USA; [Kallakury, Bhaskar V.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Tucker, Robin D.] Georgetown Univ, Med Ctr, Dept Comparat Med, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Menne, S (corresponding author), Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20007 USA.	sm923@georgetown.edu		Afdhal, Nezam/0000-0002-7342-6593	Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201000011I, HHSN27200002 (D06)]; R01 grant from NIAID [AI094469]	Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID); R01 grant from NIAID	This study was supported by Contract HHSN272201000011I, task order HHSN27200002 (D06) to the Department of Microbiology & Immunology, Georgetown University Medical Center (SM) from the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). Support by R01 grant AI094469 to Spring Bank Pharmaceuticals, Inc. (RPI) from NIAID is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berraondo P, 2015, J HEPATOL, V63, P329, DOI 10.1016/j.jhep.2015.02.048; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Colonno RJ, 2001, J INFECT DIS, V184, P1236, DOI 10.1086/324003; Cote Paul J., 1993, Viral Immunology, V6, P161, DOI 10.1089/vim.1993.6.161; Coughlin JE, 2012, DRUG METAB DISPOS, V40, P970, DOI 10.1124/dmd.111.044446; Cunningham ME, 2013, HEPATOLOGY, V58, p928A; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Fletcher SP, 2015, PLOS PATHOG IN PRESS; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Genovesi EV, 1998, ANTIMICROB AGENTS CH, V42, P3209, DOI 10.1128/AAC.42.12.3209; HORNBUCKLE WE, 1985, LAB ANIM SCI, V35, P376; Iyer RP, 2005, CURR OPIN PHARMACOL, V5, P520, DOI 10.1016/j.coph.2005.04.019; Iyer RP, 2004, ANTIMICROB AGENTS CH, V48, P2318, DOI 10.1128/AAC.48.6.2318-2320.2004; Iyer RP, 2014, 27 INT C ANT RES MAY; Korba BE, 2004, ANTIVIR THER, V9, P937; Korolowicz KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161313; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee Jia-Yee, 2004, Clin Liver Dis, V8, P301, DOI 10.1016/j.cld.2004.02.009; Liu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003856; Liu YH, 2015, J VIROL, V89, P2287, DOI 10.1128/JVI.02760-14; Ma ZY, 2015, CELL MOL IMMUNOL, V12, P273, DOI 10.1038/cmi.2014.112; Menne S, 2015, J HEPATOL; Menne S, 2008, ANTIMICROB AGENTS CH, V52, P3617, DOI 10.1128/AAC.00654-08; Menne S, 2007, WORLD J GASTROENTERO, V13, P104, DOI 10.3748/wjg.v13.i1.104; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	36	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169631	10.1371/journal.pone.0169631	http://dx.doi.org/10.1371/journal.pone.0169631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056062	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100063
J	Marcussen, M; Bodker, JS; Christensen, HS; Johansen, P; Nielsen, S; Christiansen, I; Bergmann, OJ; Bogsted, M; Dybkaer, K; Vyberg, M; Johnsen, HE				Marcussen, Mette; Bodker, Julie Stove; Christensen, Heidi Sogaard; Johansen, Preben; Nielsen, Soren; Christiansen, Ilse; Bergmann, Olav Jonas; Bogsted, Martin; Dybkaer, Karen; Vyberg, Mogens; Johnsen, Hans Erik			Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa	PLOS ONE			English	Article							CYCLOOXYGENASE-2 COX-2 EXPRESSION; BEAM-CONDITIONING CHEMOTHERAPY; NF-KAPPA-B; INDUCTION THERAPY; SMALL-INTESTINE; RECEPTOR; PATHWAYS; CELLS; POLYMORPHISMS; PATHOBIOLOGY	Background Toxicity of the oral and gastrointestinal mucosa induced by high-dose melphalan is a clinical challenge with no documented prophylactic interventions or predictive tests. The aim of this study was to describe molecular changes in human oral mucosa and to identify biomarkers correlated with the grade of clinical mucositis. Methods and Findings Ten patients with multiple myeloma (MM) were included. For each patient, we acquired three buccal biopsies, one before, one at 2 days, and one at 20 days after high-dose melphalan administration. We also acquired buccal biopsies from 10 healthy individuals that served as controls. We analyzed the biopsies for global gene expression and performed an immunohistochemical analysis to determine HLA-DRB5 expression. We evaluated associations between clinical mucositis and gene expression profiles. Compared to gene expression levels before and 20 days after therapy, at two days after melphalan treatment, we found gene regulation in the p53 and TNF pathways (MDM2, INPPD5, TIGAR), which favored anti-apoptotic defense, and upregulation of immunoregulatory genes (TREM2, LAMP3) in mucosal dendritic cells. This upregulation was independent of clinical mucositis. HLA-DRB1 and HLA-DRB5 (surface receptors on dendritic cells) were expressed at low levels in all patients with MM, in the subgroup of patients with ulcerative mucositis (UM), and in controls; in contrast, the subgroup with low-grade mucositis (NM) displayed 5-6 fold increases in HLA-DRB1 and HLA-DRB5 expression in the first two biopsies, independent of melphalan treatment. Moreover, different splice variants of HLA-DRB1 were expressed in the UM and NM subgroups. Conclusions Our results revealed that, among patients with MM, immunoregulatory genes and genes involved in defense against apoptosis were affected immediately after melphalan administration, independent of the presence of clinical mucositis. Furthermore, our results suggested that the expression levels of HLA-DRB1 and HLA-DRB5 may serve as potential predictive biomarkers for mucositis severity.	[Marcussen, Mette; Bogsted, Martin; Dybkaer, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Sdr Skovvej 15, Aalborg, Denmark; [Marcussen, Mette; Bodker, Julie Stove; Christensen, Heidi Sogaard; Bogsted, Martin; Dybkaer, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Sdr Skovvej 15, Aalborg, Denmark; [Marcussen, Mette; Bodker, Julie Stove; Christensen, Heidi Sogaard; Christiansen, Ilse; Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Hobrovej 18-22, Aalborg, Denmark; [Johansen, Preben; Nielsen, Soren; Vyberg, Mogens] Aalborg Univ Hosp, Dept Pathol, Ladegaardsgade 3, Aalborg, Denmark; [Bergmann, Olav Jonas] Aarhus Univ, Sch Dent, Fac Hlth Sci, Vennelyst Blvd 9, Aarhus, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University	Marcussen, M (corresponding author), Aalborg Univ, Dept Clin Med, Sdr Skovvej 15, Aalborg, Denmark.; Marcussen, M (corresponding author), Aalborg Univ Hosp, Clin Canc Res Ctr, Sdr Skovvej 15, Aalborg, Denmark.; Marcussen, M (corresponding author), Aalborg Univ Hosp, Dept Haematol, Hobrovej 18-22, Aalborg, Denmark.	mette.marcussen@rn.dk		Bogsted, Martin/0000-0001-9192-1814; marcussen, mette/0000-0003-0795-2293; Dybkaer, Karen/0000-0003-2488-435X; Johnsen, Hans Erik/0000-0001-8253-2913; Christensen, Heidi Sogaard/0000-0002-2692-168X	Det Obelske Familiefond; Health Scientific Research Foundation of The North Denmark Region; Herta Christensen Foundation; Doctor Henrik Kopps Grant	Det Obelske Familiefond; Health Scientific Research Foundation of The North Denmark Region; Herta Christensen Foundation; Doctor Henrik Kopps Grant	Support was provided by: Det Obelske Familiefond [http://www.obel.com/]; The Health Scientific Research Foundation of The North Denmark Region [http://www.aalborguh.rn.dk/Forskning/Forskning-Nyhedsliste-Aalborg/Nyhed?id=c0b95ee0-4e0b-4fdd-bd92-5da0cb92a63e]; Herta Christensen Foundation [http://cvrapi.dk/virksomhed/dk/herta-christensens-fond/11681409]; Doctor Henrik Kopps Grant [http://www.laeger.dk/portal/page/portal/LAEGERDK/Laegerdk/Om%20L%C3%A6geforeningen/L%C3%A6geforeningen%20Nordjylland/Kontakt%20os/Speciall%C3%A6ge%20Heinrich%20Kopps%20Legat]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Akiyama M, 2014, BBA-MOL CELL BIOL L, V1841, P435, DOI 10.1016/j.bbalip.2013.08.009; Al-Dasooqi N, 2009, CANCER CHEMOTH PHARM, V64, P1, DOI 10.1007/s00280-009-0984-y; Aref S, 2017, HEMATOL ONCOL, V35, P51, DOI 10.1002/hon.2206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMANN OJ, 1991, SCAND J INFECT DIS, V23, P355, DOI 10.3109/00365549109024323; Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028; Bowen JM, 2005, PATHOLOGY, V37, P56, DOI 10.1080/00313020400023461; Bowen JM, 2007, INT J CANCER, V121, P1847, DOI 10.1002/ijc.22895; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Chen E., 2003, THESIS; Chen YK, 2011, EUR J CLIN MICROBIOL, V30, P753, DOI 10.1007/s10096-010-1148-z; Coleman EA, 2015, SUPPORT CARE CANCER, V23, P841, DOI 10.1007/s00520-014-2406-x; Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Dorner T, 2012, INT REV IMMUNOL, V31, P363, DOI 10.3109/08830185.2012.709890; Douds JJ, 2014, J CLIN PATHOL, V67, P792, DOI 10.1136/jclinpath-2014-202421; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Fall-Dickson JM, 2007, CLIN THER, V29, P2547, DOI 10.1016/j.clinthera.2007.12.004; Fijlstra M, 2015, SUPPORT CARE CANCER, V23, P1513, DOI 10.1007/s00520-014-2487-6; Fleming S, 2014, CL LYMPH MYELOM LEUK, V14, P291, DOI 10.1016/j.clml.2014.02.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson RJ, 2013, SUPPORT CARE CANCER, V21, P313, DOI 10.1007/s00520-012-1644-z; Gkotzamanidou M, 2014, BRIT J CANCER, V23, P1293; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Lalla R V, 2014, SUPPORT CARE CANCER, V18, P95; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lalla RV, 2010, SUPPORT CARE CANCER, V18, P95, DOI 10.1007/s00520-009-0635-1; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Logan RM, 2008, CANCER CHEMOTH PHARM, V62, P33, DOI 10.1007/s00280-007-0570-0; Logan RM, 2007, ORAL ONCOL, V43, P395, DOI 10.1016/j.oraloncology.2006.04.011; Low SK, 2014, CLIN CANCER RES, V20, P2541, DOI 10.1158/1078-0432.CCR-13-2755; McCann S, 2009, BONE MARROW TRANSPL, V43, P141, DOI 10.1038/bmt.2008.299; Moreau P, 2015, BLOOD, V125, P3076, DOI 10.1182/blood-2014-09-568915; Mougeot JLC, 2011, ORAL SURG ORAL MED O, V112, P446, DOI 10.1016/j.tripleo.2011.05.009; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nath CE, 2010, BRIT J CLIN PHARMACO, V69, P484, DOI 10.1111/j.1365-2125.2010.03638.x; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Podar K, 2007, CANCER RES, V67, P1680, DOI 10.1158/0008-5472.CAN-06-1863; Quinn B, 2007, EUR J ONCOL NURS, V11, pS10, DOI 10.1016/S1462-3889(07)70003-0; R Core Team, 2012, LANG ENV STAT COMP; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Schlecker E, 2014, CANCER RES, V74, P3429, DOI 10.1158/0008-5472.CAN-13-3017; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonis ST, 2013, ORAL DIS, V19, P721, DOI 10.1111/odi.12146; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Srivastava N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00288; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stockmann P, 2013, J CRANIO MAXILL SURG, V41, P71, DOI 10.1016/j.jcms.2012.10.018; Stringer AM, 2013, SUPPORT CARE CANCER, V21, P1843, DOI 10.1007/s00520-013-1741-7; Vasku A, 2013, INT J DERMATOL, V52, P960, DOI 10.1111/ijd.12213; Yeoh ASJ, 2005, INT J RADIAT ONCOL, V63, P1295, DOI 10.1016/j.ijrobp.2005.04.041	59	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169286	10.1371/journal.pone.0169286	http://dx.doi.org/10.1371/journal.pone.0169286			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052121	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500042
J	Narendrula-Kotha, R; Nkongolo, KK				Narendrula-Kotha, Ramya; Nkongolo, Kabwe K.			Microbial Response to Soil Liming of Damaged Ecosystems Revealed by Pyrosequencing and Phospholipid Fatty Acid Analyses	PLOS ONE			English	Article							FUNGAL COMMUNITIES; BACTERIAL COMMUNITY; BETA-DIVERSITY; HEAVY-METALS; PH; BIOMASS; MICROORGANISMS; RECLAMATION; ABSENCE; REGION	Aims To assess the effects of dolomitic limestone applications on soil microbial communities' dynamics and bacterial and fungal biomass, relative abundance, and diversity in metal reclaimed regions. Methods and Results The study was conducted in reclaimed mining sites and metal uncontaminated areas. The limestone applications were performed over 35 years ago. Total microbial biomass was determined by Phospholipid fatty acids. Bacterial and fungal relative abundance and diversity were assessed using 454 pyrosequencing. There was a significant increase of total microbial biomass in limed sites (342 ng/g) compared to unlimed areas (149 ng/g). Chao1 estimates followed the same trend. But the total number of OTUs (Operational Taxonomic Units) in limed (463 OTUs) and unlimed (473 OTUs) soil samples for bacteria were similar. For fungi, OTUs were 96 and 81 for limed and unlimed soil samples, respectively. Likewise, Simpson and Shannon diversity indices revealed no significant differences between limed and unlimed sites. Bacterial and fungal groups specific to either limed or unlimed sites were identified. Five major bacterial phyla including Actinobacteria, Acidobacteria, Chloroflexi, Firmicutes, and Proteobacteria were found. The latter was the most prevalent phylum in all the samples with a relative abundance of 50%. Bradyrhizobiaceae family with 12 genera including the nitrogen fixing Bradirhizobium genus was more abundant in limed sites compared to unlimed areas. For fungi, Ascomycota was the most predominant phylum in unlimed soils (46%) while Basidiomycota phylum represented 86% of all fungi in the limed areas. Conclusion Detailed analysis of the data revealed that although soil liming increases significantly the amount of microbial biomass, the level of species diversity remain statistically unchanged even though the microbial compositions of the damaged and restored sites are different. Significance and Impact of the study Soil liming still have a significant beneficial effects on soil microbial abundance and composition > 35 years after dolomitic limestone applications.	[Narendrula-Kotha, Ramya; Nkongolo, Kabwe K.] Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada; [Nkongolo, Kabwe K.] Laurentian Univ, Dept Biol, Sudbury, ON, Canada	Laurentian University; Laurentian University	Nkongolo, KK (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON, Canada.; Nkongolo, KK (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.	knkongolo@laurentian.ca			Natural Sciences and Engineering Council of Canada; Vale; Sudbury Integrated Nickel Opertions	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vale; Sudbury Integrated Nickel Opertions	This work was supported by Natural Sciences and Engineering Council of Canada (www.NSERC.CA), Vale (www.Vale.com/Canada), and Sudbury Integrated Nickel Opertions (www.Sudburyino.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyan O. N., 2011, Journal of Soil Science and Environmental Management, V2, P9; Anand M, 2003, SCI TOTAL ENVIRON, V311, P247, DOI 10.1016/S0048-9697(03)00058-5; Bakina LG, 2014, EURASIAN SOIL SCI+, V47, P110, DOI 10.1134/S1064229314020021; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Blasiak LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085097; Brown K., 2006, HYDROLOGICAL RESPONS; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; CHAO A, 1984, SCAND J STAT, V11, P265; Curtin D, 1998, SOIL BIOL BIOCHEM, V30, P57, DOI 10.1016/S0038-0717(97)00094-1; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Fernandez-Calvino D, 2010, FEMS MICROBIOL ECOL, V73, P149, DOI 10.1111/j.1574-6941.2010.00873.x; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Fuentes JP, 2006, SOIL TILL RES, V88, P123, DOI 10.1016/j.still.2005.05.001; Goupil Kassandre, 2015, American Journal of Biochemistry and Biotechnology, V11, P45, DOI 10.3844/ajbbsp.2015.45.56; Goupil K., 2014, American Journal of Environmental Sciences, V10, P403, DOI 10.3844/ajessp.2014.403.411; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kamal S, 2010, SOIL BIOL, V19, P31, DOI 10.1007/978-3-642-02436-8_3; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Koranda M, 2014, FEMS MICROBIOL ECOL, V87, P142, DOI 10.1111/1574-6941.12214; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lautenbach William E., 1995, P109; Lavkulich LM, 1981, METHODS MANUAL PEDOL; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Li YY, 2014, J MICROBIOL BIOTECHN, V24, P313, DOI 10.4014/jmb.1309.09001; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Moreira A, 2009, COMMUN SOIL SCI PLAN, V40, P2912, DOI 10.1080/00103620903175371; Muhlbachova G, 2006, PLANT SOIL ENVIRON, V52, P345, DOI 10.17221/3451-PSE; Narendrula R., 2015, Journal of Bioremediation and Biodegradation, V6, P274; Narendrula R, 2012, B ENVIRON CONTAM TOX, V88, P187, DOI 10.1007/s00128-011-0485-7; Nkongolo KK, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2803-5; Nkongolo KK, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1618-x; Pawlett M, 2009, BIOL FERT SOILS, V45, P361, DOI 10.1007/s00374-008-0339-6; Pennanen T, 1998, APPL ENVIRON MICROB, V64, P2173; Pennanen T, 2001, GEODERMA, V100, P91, DOI 10.1016/S0016-7061(00)00082-3; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schmidt SK, 2008, MICROB ECOL, V56, P681, DOI 10.1007/s00248-008-9387-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith J.L., 1996, SSSA SPEC PUBL, V49, P169, DOI DOI 10.2136/SSSASPECPUB49.C10; Tate RL., 2000, SOIL MICROBIOLOGY; Theriault G, 2013, CHEM ECOL, V29, P573, DOI 10.1080/02757540.2013.820715; TOMASIC M, 2013, J CENT EUR AGRIC, V14, P937, DOI DOI 10.5513/JCEA01/14.3.1286; Wang FY, 2011, WORLD J MICROB BIOT, V27, P67, DOI 10.1007/s11274-010-0427-2; Wang YP, 2007, ECOTOX ENVIRON SAFE, V67, P75, DOI 10.1016/j.ecoenv.2006.03.007; WINTERHALDER K, 1983, ENVIRON TECHNOL LETT, V4, P209, DOI 10.1080/09593338309384197; Winterhalder Keith, 1996, Environmental Reviews, V4, P185, DOI 10.1139/a96-011	50	39	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168497	10.1371/journal.pone.0168497	http://dx.doi.org/10.1371/journal.pone.0168497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052072	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500017
J	Palmieri, O; Bossa, F; Valvano, MR; Corritore, G; Latiano, T; Martino, G; D'Inca, R; Cucchiara, S; Pastore, M; D'Altilia, M; Scimeca, D; Biscaglia, G; Andriulli, A; Latiano, A				Palmieri, Orazio; Bossa, Fabrizio; Valvano, Maria Rosa; Corritore, Giuseppe; Latiano, Tiziana; Martino, Giuseppina; D'Inca, Renata; Cucchiara, Salvatore; Pastore, Maria; D'Altilia, Mario; Scimeca, Daniela; Biscaglia, Giuseppe; Andriulli, Angelo; Latiano, Anna			Crohn's Disease Localization Displays Different Predisposing Genetic Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; WORKING PARTY; CLASSIFICATION; RISK; PREDICTION; EPIDEMIOLOGY; BEHAVIOR	Background Crohn's disease (CD) is a pathologic condition with different clinical expressions that may reflect an interplay between genetics and environmental factors. Recently, it has been highlighted that three genetic markers, NOD2, MHC and MST1, were associated to distinct CD sites, supporting the concept that genetic variations may contribute to localize CD. Genetic markers, previously shown to be associated with inflammatory bowel disease (IBD), were tested in CD patients with the aim to better dissect the genetic relationship between ileal, ileocolonic and colonic CD and ascertain whether a different genetic background would support the three disease sites as independent entities. Methods A panel of 29 SNPs of 19 IBD loci were analyzed by TaqMan SNP allelic discrimination method both evaluating their distinct contribute and analyzing all markers jointly. Results Seven hundred and eight CD patients and 537 healthy controls were included in the study. Of the overall population of patients, 237 patients had an ileal involvement (L1), 171 a colonic localization (L2), and the 300 remaining an ileocolon location (L3). We confirmed the association for 23 of 29 variations (P < 0.05). Compared to healthy controls, 16 variations emerged as associated to an ileum disease, 7 with a colonic disease and 14 with an ileocolonic site (P < 0.05). Comparing ileum to colonic CD, 5 SNPs (17%) were differentially associated (P < 0.05). A genetic model score that aggregated the risks of 23 SNPs and their odds ratios (ORs), yielded an Area Under the Curve (AUC) of 0.70 for the overall CD patients. By analyzing each CD location, the AUC remained at the same level for the ileal and ileocolonic sites (0.73 and 0.72, respectively), but dropped to a 0,66 value in patients with colon localization. Conclusions Our findings reaffirm the existence of at least three different subgroups of CD patients, with a genetic signature distinctive for the three main CD sites.	[Palmieri, Orazio; Bossa, Fabrizio; Valvano, Maria Rosa; Corritore, Giuseppe; Latiano, Tiziana; Martino, Giuseppina; Scimeca, Daniela; Biscaglia, Giuseppe; Andriulli, Angelo; Latiano, Anna] Casa Sollievo Sofferenza Hosp, IRCCS, Div Gastroenterol, San Giovanni Rotondo, FG, Italy; [D'Inca, Renata] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Cucchiara, Salvatore] Sapienza Univ Rome, Dept Pediat, Pediat Gastroenterol & Liver Unit, Rome, Italy; [Pastore, Maria; D'Altilia, Mario] Casa Sollievo Sofferenza Hosp, IRCCS, Div Pediat, San Giovanni Rotondo, FG, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Padua; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza	Palmieri, O (corresponding author), Casa Sollievo Sofferenza Hosp, IRCCS, Div Gastroenterol, San Giovanni Rotondo, FG, Italy.	o.palmieri@operapadrepio.it	Palmieri, Orazio/J-7697-2012; Scimeca, Daniela/AAC-7625-2022; Latiano, Anna/R-1965-2016; Biscaglia, Giuseppe/K-2153-2016; Andriulli, Angelo/B-5027-2017; Valvano, Maria Rosa/B-5118-2017; Bossa, Fabrizio/B-3078-2017	Palmieri, Orazio/0000-0002-0019-7929; Latiano, Anna/0000-0003-3719-2061; Biscaglia, Giuseppe/0000-0002-3799-2547; Andriulli, Angelo/0000-0001-8862-7083; Scimeca, Daniela/0000-0003-4633-7912; Valvano, Maria Rosa/0000-0003-4704-8354; Bossa, Fabrizio/0000-0002-4518-9949				Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Bernstein CN, 2012, GUT, V61, P622, DOI 10.1136/gutjnl-2011-301397; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GREENSTEIN AJ, 1988, GUT, V29, P588, DOI 10.1136/gut.29.5.588; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Latiano A, 2010, INFLAMM BOWEL DIS, V16, P1108, DOI 10.1002/ibd.21176; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Mcgovern DPB, 2006, GASTROENTEROLOGY, V131, P1190, DOI 10.1053/j.gastro.2006.08.008; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Musci JOD, 2016, J GASTROENTEROL, V51, P531, DOI 10.1007/s00535-016-1191-3; Palmieri O, 2003, CLIN CHEM, V49, P1675, DOI 10.1373/49.10.1675; Perri F, 1996, INFLAMM BOWEL DIS, V2, P1, DOI 10.1002/ibd.3780020102; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Zupancic K, 2016, WORLD J GASTROENTERO, V22, P3777, DOI 10.3748/wjg.v22.i14.3777	33	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168821	10.1371/journal.pone.0168821	http://dx.doi.org/10.1371/journal.pone.0168821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052082	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500023
J	Pemov, A; Li, H; Patidar, R; Hansen, NF; Sindiri, S; Hartley, SW; Wei, JS; Elkahloun, A; Chandrasekharappa, SC; Boland, JF; Bass, S; Mullikin, JC; Khan, J; Widemann, BC; Wallace, MR; Stewart, DR				Pemov, A.; Li, H.; Patidar, R.; Hansen, N. F.; Sindiri, S.; Hartley, S. W.; Wei, J. S.; Elkahloun, A.; Chandrasekharappa, S. C.; Boland, J. F.; Bass, S.; Mullikin, J. C.; Khan, J.; Widemann, B. C.; Wallace, M. R.; Stewart, D. R.		NISC Comparative Sequencing; NCI DCEG Canc Genomics Res Lab	The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas	ONCOGENE			English	Article							NERVE SHEATH TUMORS; SCHWANN-CELLS; EXPRESSION; CANCER; GENES; MUTATIONS; CHILDREN; BENIGN; PIRFENIDONE; FRAMEWORK	Neurofibromatosis type 1 (NF1) is a common tumor-predisposition disorder due to germline mutations in the tumor suppressor gene NF1. A virtually pathognomonic finding of NF1 is the plexiform neurofibroma (PN), a benign, likely congenital tumor that arises from bi-allelic inactivation of NF1. PN can undergo transformation to a malignant peripheral nerve sheath tumor, an aggressive soft-tissue sarcoma. To better understand the non-NF1 genetic contributions to PN pathogenesis, we performed whole-exome sequencing, RNASeq profiling and genome-wide copy-number determination for 23 low-passage Schwann cell cultures established from surgical PN material with matching germline DNA. All resected tumors were derived from routine debulking surgeries. None of the tumors were considered at risk for malignant transformation at the time; for example, there was no pain or rapid growth. Deep (similar to 500X) NF1 exon sequencing was also conducted on tumor DNA. Non-NF1 somatic mutation verification was performed using the Ampliseq/IonTorrent platform. We identified 100% of the germline NF1 mutations and found somatic NF1 inactivation in 74% of the PN. One individual with three PNs had different NF1 somatic mutations in each tumor. The median number of somatic mutations per sample, including NF1, was one (range 0-8). NF1 was the only gene that was recurrently somatically inactivated in multiple tumors. Gene Set Enrichment Analysis of transcriptome-wide tumor RNA sequencing identified five significant (FDR < 0.01) and seven trending (0.01 <= FDR < 0.02) gene sets related to DNA replication, telomere maintenance and elongation, cell cycle progression, signal transduction and cell proliferation. We found no recurrent non-NF1 locus copy-number variation in PN. This is the first multi-sample whole-exome and whole-transcriptome sequencing study of NF1-associated PN. Taken together with concurrent copy-number data, our comprehensive genetic analysis reveals the primacy of NF1 loss as the driver of PN tumorigenesis.	[Pemov, A.; Stewart, D. R.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Li, H.; Wallace, M. R.] Univ Florida, UF Hlth Canc Ctr, UF Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Patidar, R.; Sindiri, S.; Wei, J. S.; Khan, J.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Hansen, N. F.; Elkahloun, A.; Chandrasekharappa, S. C.; Mullikin, J. C.] NHGRI, Canc Genet & Comparat Genom Branch, Rockville, MD USA; [Hartley, S. W.] NCI, Human Genet Program, Div Canc Epidemiol & Genet, Rockville, MD USA; [Mullikin, J. C.; NISC Comparative Sequencing] NHGRI, NIH, Intramural Sequencing Ctr, Rockville, MD USA; [Boland, J. F.; Bass, S.; NCI DCEG Canc Genomics Res Lab] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, Rockville, MD USA; [Widemann, B. C.] NCI, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, DR (corresponding author), NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Rm 6E450, Bethesda, MD 20892 USA.	drstewart@mail.nih.gov	Khan, Javed/P-9157-2014; Patidar, Rajesh/G-9389-2019; Patidar, Rajesh/M-5520-2019	Patidar, Rajesh/0000-0003-3578-8208; Patidar, Rajesh/0000-0003-3578-8208; sindiri, sivasish/0000-0003-2516-969X	National Human Genome Research Institute; Center for Cancer Research of the National Cancer Institute; Division of Cancer Epidemiology and Genetics of the National Cancer Institute; Department of Defense [DAMD17-98-1-8609, DAMD17-00-1-0549]; National Institutes of Health [R29 NS31550]; Children's Tumor Foundation; NATIONAL CANCER INSTITUTE [ZIABC010801, ZIACP010144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZICHG200365, ZIAHG200330, ZIAHG000029, ZIBHG000196] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for Cancer Research of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding provided by the Intramural Research Programs of the National Human Genome Research Institute, the Center for Cancer Research of the National Cancer Institute and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute. We thank the members of the NISC Comparative Sequencing Program: Betty Barnabas, PhD, Robert Blakesley, PhD, Gerry Bouffard, PhD, Shelise Brooks, BS, Holly Coleman, MSc, Mila Dekhtyar, MSc, Michael Gregory, MSc, Xiaobin Guan, PhD, Jyoti Gupta, MSc, Joel Han, BS, Shi-ling Ho, BS, Richelle Legaspi, MSc, Quino Maduro, BS, Cathy Masiello, MSc, Baishali Maskeri, PhD, Jenny McDowell, PhD, Casandra Montemayor, MSc, Morgan Park, PhD, Nancy Riebow, BS, Karen Schandler, MSc, Brian Schmidt, BS, Christina Sison, BS, Mal Stantripop, BS, James Thomas, PhD, Pam Thomas, PhD, Meg Vemulapalli, MSc, Alice Young, BA. We also thank the members of the NCI DCEG Cancer Genomics Research Laboratory: Michael Beerman, Aaron J Bouk, Seth Brodie, Laurie Burdett, Salma Chowdhury, Charles Chung, Nathan Cole, Michael Cullen, Casey Dagnall, Danielle Debacker, Sadie Frary, Chris Hautman, Belynda Hicks, Herb Higson, Keisha Hines-Harris, Amy Hutchinson, Kristie Jones, Eric Karlins, Sally Larson, Kerrie Lashley, Hyo Jung Lee, Shengchao Li, Tong Li, Wen Luo, Mike Malasky, Michelle Manning, Charles McCoy, Jason Mitchell, Adri O'Neil, Padma Ramya Packirisamy, Timothy Pelc, David Roberson, Aaron Rodriguez, Marianne Siler, Shalabh Suman, Kedest Teshome, Julio Tun, Sue Turner, Bill Utermahlen, Aurelie Vogt, Sarah Wagner, Mingyi Wang, Zhaoming Wang, Kathleen Wyatt, Qi Yang, Meredith Yeager, Sherry Yu, Xijun Zhang, Weiyin Zhou, Bin Zhu. MRW acknowledges funding from the Department of Defense (DAMD17-98-1-8609, DAMD17-00-1-0549), the National Institutes of Health (R29 NS31550), and the Children's Tumor Foundation supporting the development of the PN cultures over a 17-year span. Finally, we thank the patients who enlisted the help of their physicians to contribute tissues to research.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Babovic-Vuksanovic D, 2007, PEDIATR NEUROL, V36, P293, DOI 10.1016/j.pediatrneurol.2007.01.009; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Buchstaller J, 2012, NEUROFIBROMATOSIS TY; Castle B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewan R, 2014, NEURO-ONCOLOGY, V17, P566; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Emi M, 1998, JPN J CANCER RES, V89, P12, DOI 10.1111/j.1349-7006.1998.tb00472.x; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hirbe AC, 2015, CLIN CANCER RES, V21, P4201, DOI 10.1158/1078-0432.CCR-14-3049; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; Jett K, 2010, GENET MED, V12, P1, DOI 10.1097/GIM.0b013e3181bf15e3; Kannan K, 2012, ONCOTARGET, V3, P1194; Kim A, 2009, NEUROLOGY, V73, P1273, DOI 10.1212/WNL.0b013e3181bd1326; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Le LQ, 2011, CANCER RES, V71, P4686, DOI 10.1158/0008-5472.CAN-10-4577; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Levy P, 2007, CLIN CANCER RES, V13, P398, DOI 10.1158/1078-0432.CCR-06-0182; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luscan A, 2014, CLIN CANCER RES, V20, P358, DOI 10.1158/1078-0432.CCR-13-0780; Maertens O, 2006, HUM MUTAT, V27, P1030, DOI 10.1002/humu.20389; Mautner VF, 2008, NEURO-ONCOLOGY, V10, P593, DOI 10.1215/15228517-2008-011; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Muir D, 2001, AM J PATHOL, V158, P501, DOI 10.1016/S0002-9440(10)63992-2; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasmant E, 2011, J NATL CANCER I, V103, P1713, DOI 10.1093/jnci/djr416; Pasmant E, 2010, J NEUROPATH EXP NEUR, V69, P60, DOI 10.1097/NEN.0b013e3181c79bff; PELTONEN J, 1988, LAB INVEST, V59, P760; Pemov A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004575; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sabbagh A, 2009, HUM MOL GENET, V18, P2768, DOI 10.1093/hmg/ddp212; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Smithson LJ, 2016, SEMIN CELL DEV BIOL, V58, P118, DOI 10.1016/j.semcdb.2016.06.002; StemmerRachamimov A, 2012, NEUROFIBROMATOSIS TY, P429; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Upadhyaya M, 2008, HUM MUTAT, V29, P74, DOI [10.1002/humu.20601, 10.1002/humu.20793]; Upadhyaya M, 2012, HUM MUTAT, V33, P763, DOI 10.1002/humu.22044; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Van Loo P, 2012, METHODS MOL BIOL, V802, P57, DOI 10.1007/978-1-61779-400-1_4; Wallace MR, 2000, GENE CHROMOSOME CANC, V27, P117, DOI 10.1002/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weiss B, 2014, PEDIATR BLOOD CANCER, V61, P982, DOI 10.1002/pbc.24873; Widemann BC, 2014, PEDIATR BLOOD CANCER, V61, P1598, DOI 10.1002/pbc.25041; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116	57	53	54	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3168	3177		10.1038/onc.2016.464	http://dx.doi.org/10.1038/onc.2016.464			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28068329	Green Accepted			2022-12-26	WOS:000402617900009
J	Ugale, A; Sawen, P; Dudenhoffer-Pfeifer, M; Wahlestedt, M; Norddahl, GL; Bryder, D				Ugale, A.; Sawen, P.; Dudenhoffer-Pfeifer, M.; Wahlestedt, M.; Norddahl, G. L.; Bryder, D.			MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment	ONCOGENE			English	Article							STEM-CELLS; B-CELL; RAS; PROGENITORS; MUTATIONS; TRANSDIFFERENTIATION; TRANSLOCATIONS; TRANSFORMATION; HEMATOPOIESIS; SPECIFICATION	Translocations involving the mixed lineage leukemia-1 are recurrent events in acute leukemia and associate with lymphoid (ALL), myeloid (AML) or mixed lineage (MLL) subtypes. Despite an association with ALL in humans, murine MLL fusion models are persistently restricted to AML. We here explored this issue using an inducible mixed lineage leukemia-eleven nineteen leukemia (MLL-ENL) mouse model. Although multiple progenitor cell types with myeloid potential are potent AML leukemia-initiating cells, also the earliest lymphoid progenitors were capable of initiating AML. This ability to evoke a latent myeloid potential in the earliest lymphoid progenitors was lost upon further lymphoid commitment. At the same time, more downstream/committed lymphoid precursors also failed to initiate lymphoid leukemia. Co-expression of MLL-ENL with a constitutively active RAS allele, the most common co-mutation in MLL fusion leukemias, could influence on both disease latency and lineage assignment of developing leukemia in what appears to be a mutation-order-dependent manner. Finally, CEBPB-mediated transdifferentation of committed and otherwise leukemia-incompetent B-cell progenitors imbued these cells with leukemic competence for AML. Therefore, apart from providing detailed insight into the differential responsiveness of candidate target cells to a first-hit MLL fusion event, our data warrants caution to therapeutic approaches based on the concept of transdifferentiation.	[Ugale, A.; Sawen, P.; Dudenhoffer-Pfeifer, M.; Wahlestedt, M.; Norddahl, G. L.; Bryder, D.] Lund Univ, Inst Lab Med, Mol Hematol, Klinikgatan 26, S-22184 Lund, Sweden	Lund University	Bryder, D (corresponding author), Lund Univ, Inst Lab Med, Mol Hematol, Klinikgatan 26, S-22184 Lund, Sweden.	David.Bryder@med.lu.se	Bryder, David/Q-6292-2019	Bryder, David/0000-0002-8761-4237	Knut and Alice Wallenberg Foundation; Gunnar Nilsson Cancer Foundation; Swedish Research Council; Swedish Cancer Society; Swedish Pediatric Leukemia Foundation; ERC Consolidator [615068]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Gunnar Nilsson Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Leukemia Foundation; ERC Consolidator	We thank Gerd Sten and Eva Erlandsson for expert technical support. This work was supported by a joint project grant from Knut and Alice Wallenberg Foundation and grants from the Gunnar Nilsson Cancer Foundation, the Swedish Research Council, the Swedish Cancer Society, the Swedish Pediatric Leukemia Foundation and an ERC Consolidator grant 615068 to D.B.	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Cano F, 2008, ONCOGENE, V27, P1945, DOI 10.1038/sj.onc.1210818; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Driessen EMC, 2013, HAEMATOLOGICA, V98, P937, DOI 10.3324/haematol.2012.067983; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Grossmann V, 2013, LEUKEMIA, V27, P1933, DOI 10.1038/leu.2013.90; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sawen P, 2016, CELL REP, V14, P2809, DOI 10.1016/j.celrep.2016.02.073; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Ugale A, 2014, CELL REP, V9, P1246, DOI 10.1016/j.celrep.2014.10.036; van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007; Velasco-Hernandez T, 2016, STEM CELL REP, V7, P21, DOI 10.1016/j.stemcr.2016.06.002; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	27	9	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3207	3212		10.1038/onc.2016.470	http://dx.doi.org/10.1038/onc.2016.470			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28068328				2022-12-26	WOS:000402617900012
J	Kognole, AA; Payne, CM				Kognole, Abhishek A.; Payne, Christina M.			Inhibition of Mammalian Glycoprotein YKL-40 IDENTIFICATION OF THE PHYSIOLOGICAL LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FREE-ENERGY; CRYSTAL-STRUCTURE; ARTICULAR CHONDROCYTES; MOLECULAR-STRUCTURE; EPITHELIAL-CELLS; STRUCTURAL BASIS; SYNOVIAL-FLUID; SERUM YKL-40; FORCE-FIELD; I COLLAGEN	YKL-40 is a mammalian glycoprotein associated with progression, severity, and prognosis of chronic inflammatory diseases and a multitude of cancers. Despite this well documented association, identification of the lectin's physiological ligand and, accordingly, biological function has proven experimentally difficult. YKL-40 has been shown to bind chito-oligosaccharides; however, the production of chitin by the human body has not yet been documented. Possible alternative ligands include proteoglycans, polysaccharides, and fibers like collagen, all of which makeup the extracellular matrix. It is likely that YKL-40 is interacting with these alternative polysaccharides or proteins within the body, extending its function to cell biological roles such as mediating cellular receptors and cell adhesion and migration. Here, we consider the feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan sulfate, heparin, and chondroitin sulfate, and collagen-like peptides as physiological ligands for YKL-40. We use molecular dynamics simulations to resolve the molecular level recognition mechanisms and calculate the free energy of binding the hypothesized ligands to YKL-40, addressing thermodynamic preference relative to chito-oligosaccharides. Our results suggest that chitohexaose and hyaluronan preferentially bind to YKL-40 over collagen, and hyaluronan is likely the preferred physiological ligand, because the negatively charged hyaluronan shows enhanced affinity for YKL-40 over neutral chitohexaose. Collagen binds in two locations at the YKL-40 surface, potentially related to a role in fibrillar formation. Finally, heparin non-specifically binds at the YKL-40 surface, as predicted from structural studies. Overall, YKL-40 likely binds many natural ligands in vivo, but its concurrence with physical maladies may be related to associated increases in hyaluronan.	[Kognole, Abhishek A.; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA	University of Kentucky	Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA.	christy.payne@uky.edu	Payne, Christina/ABE-8330-2020; Kognole, Abhishek A./AAB-5491-2019	Payne, Christina/0000-0001-5264-0964; Kognole, Abhishek A./0000-0002-6033-2344	Kentucky Science and Engineering Foundation [KSEF-148-502-13-307]; National Science Foundation [ACI-1053575, MCB090159]	Kentucky Science and Engineering Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by Kentucky Science and Engineering Foundation Grant KSEF-148-502-13-307). Computational time for this research was provided by the Extreme Science and Engineering Discovery Environment (83), which is supported by National Science Foundation Grant ACI-1053575 under Allocation MCB090159. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANGYAL SJ, 1969, ANGEW CHEM INT EDIT, V8, P157, DOI 10.1002/anie.196901571; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Bleau G, 1999, EXS, V87, P211; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Bronowska AK, 2011, THERMODYNAMICS - INTERACTION STUDIES - SOLIDS, LIQUIDS AND GASES, P1; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Connor JR, 2000, OSTEOARTHR CARTILAGE, V8, P87, DOI 10.1053/joca.1999.0276; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; De Ceuninck F, 1998, J CELL BIOCHEM, V69, P414, DOI 10.1002/(SICI)1097-4644(19980615)69:4<414::AID-JCB3>3.0.CO;2-Q; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hamre AG, 2015, BIOCHEMISTRY-US, V54, P7292, DOI 10.1021/acs.biochem.5b00830; Hamre AG, 2015, J PHYS CHEM B, V119, P9601, DOI 10.1021/acs.jpcb.5b03817; Harvey S, 1998, CLIN CHEM, V44, P509; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Iwata T, 2009, BIOCHEM BIOPH RES CO, V388, P511, DOI 10.1016/j.bbrc.2009.08.024; Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768; Jiang W, 2009, J CHEM THEORY COMPUT, V5, P2583, DOI 10.1021/ct900223z; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Johansen JS, 2006, DAN MED BULL, V53, P172; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lal A, 1999, CANCER RES, V59, P5403; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu LK, 2014, ACTA CRYSTALLOGR F, V70, P1155, DOI 10.1107/S2053230X14015532; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2012, BIOPOLYMERS, V97, P607, DOI 10.1002/bip.22048; Park JA, 2010, J BIOL CHEM, V285, P29817, DOI 10.1074/jbc.M110.103416; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548; Sheinerman FB, 1998, J MOL BIOL, V278, P439, DOI 10.1006/jmbi.1998.1688; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siaens R, 2004, J NUCL MED, V45, P1209; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; ul-Haq Z, 2007, BIOCHEM BIOPH RES CO, V359, P221, DOI 10.1016/j.bbrc.2007.05.074; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	81	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2624	2636		10.1074/jbc.M116.764985	http://dx.doi.org/10.1074/jbc.M116.764985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053085	hybrid, Green Published			2022-12-26	WOS:000395535100006
J	Corna, S; Aspesi, V; Cau, N; Scarpina, F; Valdes, NG; Brugliera, L; Cimolin, V; Capodaglio, P				Corna, Stefano; Aspesi, Valentina; Cau, Nicola; Scarpina, Federica; Valdes, Natalia Gattini; Brugliera, Luigia; Cimolin, Veronica; Capodaglio, Paolo			Dizziness and Falls in Obese Inpatients Undergoing Metabolic Rehabilitation	PLOS ONE			English	Article							TO-STAND MOVEMENT; HANDICAP INVENTORY; COMMUNITY; DISORDERS; SYMPTOMS; VERTIGO; PAIN	Aim The relationship between dizziness and falls in the obese population is a relatively unexplored issue. The aims of the present study were to define the 1-year prevalence of dizziness in an obese inpatient population undergoing metabolic rehabilitation and to investigate possible correlations with fall events. Materials and Methods We recruited 329 obese subjects: 203 female (BMI 43,74 kg/m(2) +/- 0.5 SE; age 17-83 years, 58.33 +/- 0.9 SE) and 126 male (BMI 44,27kg/m2 +/- 0.7 DE age 27-79 years, 58.84 +/- 1 SE). To assess dizziness we used the validated Italian version (38) of the Dizziness Handicap Inventory (DHI). Results Out of the experimental sample, 100 subjects did not complain of dizziness and felt confident about their balance control, while 69.6% reported some degree of dizziness. Their mean DHI score was 22.3, which corresponds to mild dizziness. Twenty-one percent reported more severe dizziness (DHI score > 40). The majority of our sample reported minor dizziness and its perception appears to be independent from BMI: DHI scores were consistent across classes of obesity. Discussion The rate of dizziness and falls (30.1%) in an this obese population was higher than that previously reported in a general matched population. However, obese subjects, in our sample, seem to underestimate their risk of fall and DHI score does not appear a reliable predictor of falls. Since complications associated with falls in obese persons generally require longer treatments than in lean individuals, our findings should be taken into account in order to identify other predictors, including cognitive and perceptual, of risk of fall and to implement fall prevention programs.	[Corna, Stefano; Aspesi, Valentina; Brugliera, Luigia; Capodaglio, Paolo] Osped San Giuseppe, Ist Auxol Italiano, IRCCS, Rehabil Unit, Oggebbio, Verbania, Italy; [Corna, Stefano; Aspesi, Valentina; Brugliera, Luigia; Capodaglio, Paolo] Osped San Giuseppe, Ist Auxol Italiano, IRCCS, Clin Lab Gait Anal & Posture, Oggebbio, Verbania, Italy; [Cau, Nicola; Cimolin, Veronica] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [Scarpina, Federica] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Scarpina, Federica] Osped San Giuseppe, IRCCS, Ist Auxol Italiano, Psychol Res Lab, Oggebbio, Vco, Italy; [Valdes, Natalia Gattini] Univ Chile, Pontificia Univ Catolica Chile, Phys Med & Rehabil Resident, Santiago, Chile	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Polytechnic University of Milan; University of Turin; IRCCS Istituto Auxologico Italiano; Pontificia Universidad Catolica de Chile; Universidad de Chile	Cau, N (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy.	nicola.cau@gmail.com	Cimolin, Veronica/AAF-6414-2019; Cimolin, Veronica/AFY-3578-2022; Corna, Stefano/AAB-9455-2020; Aspesi, Valentina/AAB-6805-2022; Scarpina, Federica/AAB-6335-2019; Paolo, Capodaglio/AAB-7795-2019; Cimolin, Veronica/AAA-3326-2021; Luigia, Brugliera/AAN-3430-2020; Cau, Nicola/AAA-9673-2020	Cimolin, Veronica/0000-0001-6299-7254; Corna, Stefano/0000-0002-7484-0171; Aspesi, Valentina/0000-0003-1783-4290; Scarpina, Federica/0000-0003-4326-1596; Paolo, Capodaglio/0000-0003-3719-8789; Cimolin, Veronica/0000-0001-6299-7254; Luigia, Brugliera/0000-0001-6355-7437; Cau, Nicola/0000-0002-2256-4531				Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Bisdorff A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00029; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Cafri G., 2004, PSYCHOL MEN MASCULIN, V5, P18, DOI [DOI 10.1037/1524-9220.5.1.18, 10.1037/1524-9220.5.1.18]; Cattaneo D, 2007, DISABIL REHABIL, V29, P1920, DOI 10.1080/09638280701191859; de Souza SAF, 2005, OBES SURG, V15, P1238, DOI 10.1381/096089205774512627; Docteur A, 2010, OBESITY, V18, P1464, DOI 10.1038/oby.2009.418; Finkelstein EA, 2007, AM J HEALTH PROMOT, V21, P460, DOI 10.4278/0890-1171-21.5.460; Galli M, 2000, INT J OBESITY, V24, P1488, DOI 10.1038/sj.ijo.0801409; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Mitchell RJ, 2015, ARCH GERONTOL GERIAT, V60, P52, DOI 10.1016/j.archger.2014.09.006; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Mutlu B, 2013, J VESTIBUL RES-EQUIL, V23, P271, DOI 10.3233/VES-130488; Nola G, 2010, ACTA OTORHINOLARYNGO, V30, P190; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Premaor MO, 2014, ARQ BRAS ENDOCRINOL, V58, P470, DOI 10.1590/0004-2730000003274; Scarpina F, 2014, PSYCHIAT RES, V220, P960, DOI 10.1016/j.psychres.2014.08.020; Sibella F, 2003, CLIN BIOMECH, V18, P745, DOI 10.1016/S0268-0033(03)00144-X; Siracuse JJ, 2012, AM J SURG, V203, P335, DOI 10.1016/j.amjsurg.2011.09.018; Skoien AK, 2008, BRIT J GEN PRACT, V58, P619, DOI 10.3399/bjgp08X330744; Vismara L, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-14; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x; Whitney SL, 1999, J VESTIBUL RES-EQUIL, V9, P253; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Young LR, 2012, J VESTIBUL RES-EQUIL, V22, P129, DOI 10.3233/VES-2012-0449	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169322	10.1371/journal.pone.0169322	http://dx.doi.org/10.1371/journal.pone.0169322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076370	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100033
J	Liu, ZZ; Zhang, LF; Shi, SS; Xia, WK				Liu, Zhunzhun; Zhang, Lanfeng; Shi, Songsong; Xia, Wenkai			Objectively Assessed Exercise Behavior in Chinese Patients with Early-Stage Cancer: A Predictor of Perceived Benefits, Communication with Doctors, Medical Coping Modes, Depression and Quality of Life	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; BREAST-CANCER; OPTIMISM; RISK	This study sought to identify factors associated with objectively assessed exercise behavior in Chinese patients with early-stage cancer. Three hundred and fifty one cancer patients were recruited from the Affiliated Jiangyin Hospital of Southeast University Medical College and the Nantong Tumor Hospital. One-way ANOVA, Pearson Chi-square tests and regression analysis were employed to identify the correlations between physical exercise and the measured factors. The results showed that occupation type (chi(2) = 14.065; p = 0.029), monthly individual monthly income level (chi(2) = 24.795; p = 0.003), BMI (chi(2) = 15.709; p = 0.015) and diagnosis (chi(2) = 42.442; p < 0.000) were significantly correlated with the subjects self-reported exercise with different frequency per week. Differences in the frequency of exercise were associated with different degrees of reported Benefit Finding (BF) (F = 24.651; p < 0.000), communication with doctors (F = 15.285; p < 0.000), medical coping modes (F = 45.912; p < 0.000), social support (F = 2.938; p = 0.030), depression (F = 6.017; p < 0.000), and quality of life (F = 12.288; p < 0.000). Multiple regression analysis showed that 1.6%-6.4% of the variance in five variables, excluding social support and optimism could be explained by exercise. Our results indicated that benefit finding, medical coping modes, communication with doctors, social support, depression and quality of life were significantly correlated with exercise. The variance in several psychosocial factors (benefit finding, medical coping modes, the communication with doctors, depression and quality of life) could be explained by exercise. Psychosocial factors should be addressed and examined over time when evaluating the effect of physical exercise that is prescribed as a clinically relevant treatment.	[Liu, Zhunzhun] Jiangsu Jiangyin Peoples Hosp, Dept Nursing, Jiangyin, Jiangsu, Peoples R China; [Zhang, Lanfeng] Nantong Tumor Hosp, Dept Nursing, Nantong, Jiangsu, Peoples R China; [Shi, Songsong] Univ NanTong, Fac Nursing, Nantong, Jiangsu, Peoples R China; [Xia, Wenkai] Jiangsu Jiangyin Peoples Hosp, Dept Nephrol, Jiangyin, Jiangsu, Peoples R China		Xia, WK (corresponding author), Jiangsu Jiangyin Peoples Hosp, Dept Nephrol, Jiangyin, Jiangsu, Peoples R China.	xiawenkai23@163.com		Liu, Zhunzhun/0000-0001-6513-362X	Jiangsu Province health and family planning committee cadre health project [BJI4030]	Jiangsu Province health and family planning committee cadre health project	This study was supported by the Jiangsu Province health and family planning committee cadre health project (BJI4030), Zhang.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; American Cancer Society, 2015, GLOB CANC FACTS FIG, P3; Biddle S., 1993, REV PSICOL DEPORTE, V4, P99; Blanchard CM, 2010, MED SCI SPORT EXER, V42, P665, DOI 10.1249/MSS.0b013e3181bdc685; Brunet J, 2014, SUPPORT CARE CANCER, V22, P689, DOI 10.1007/s00520-013-2023-0; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Crawford JJ, 2015, SUPPORT CARE CANCER, V23, P705, DOI 10.1007/s00520-014-2410-1; FEIFEL H, 1987, J PSYCHOSOM RES, V31, P91, DOI 10.1016/0022-3999(87)90103-6; Furmaniak AC, 2016, J PSYCHOSOM RES, V85, P65, DOI 10.1016/j.jpsychores.2016.03.160; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harper FWK, 2007, PSYCHO-ONCOLOGY, V16, P79, DOI 10.1002/pon.1068; Idorn M, 2016, TRENDS MOL MED, V22, P565, DOI 10.1016/j.molmed.2016.05.007; KAVUSSANU M, 1995, J SPORT EXERCISE PSY, V17, P246, DOI 10.1123/jsep.17.3.246; Kwan ML, 2012, BREAST CANCER RES TR, V131, P679, DOI 10.1007/s10549-011-1788-4; Lai JCL, 2000, PERS INDIV DIFFER, V28, P781, DOI 10.1016/S0191-8869(99)00138-5; Liu ZZ, 2016, EUR J ONCOL NURS, V23, P87, DOI 10.1016/j.ejon.2016.04.005; Lorig K, 1996, OUTCOME MEASURES HLT, P24; McCullough LE, 2016, JAMA INTERN MED, V176, P826, DOI 10.1001/jamainternmed.2016.1521; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008465.pub2; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI DOI 10.1136/BMJ.292.6516.344; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tian J, 2009, SUPPORT CARE CANCER, V17, P1263, DOI 10.1007/s00520-009-0579-5; Weaver KE, 2008, QUAL LIFE RES, V17, P771, DOI 10.1007/s11136-008-9348-z; Xie RH, 2008, ANN EPIDEMIOL, V18, P737	27	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169375	10.1371/journal.pone.0169375	http://dx.doi.org/10.1371/journal.pone.0169375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WR	28072832	gold, Green Published, Green Submitted			2022-12-26	WOS:000391844200017
J	Mukherjee, S; Chattopadhyay, M; Bhattacharya, S; Dasgupta, S; Hussain, S; Bharadwaj, SK; Talukdar, D; Usmani, A; Pradhan, BS; Majumdar, SS; Chattopadhyay, P; Mukhopadhyay, S; Maity, TK; Chaudhuri, MK; Bhattacharya, S				Mukherjee, Sandip; Chattopadhyay, Mrittika; Bhattacharya, Sushmita; Dasgupta, Suman; Hussain, Sahid; Bharadwaj, Saitanya K.; Talukdar, Dhrubajyoti; Usmani, Abul; Pradhan, Bhola S.; Majumdar, Subeer S.; Chattopadhyay, Pronobesh; Mukhopadhyay, Satinath; Maity, Tushar K.; Chaudhuri, Mihir K.; Bhattacharya, Samir			A Small Insulinomimetic Molecule Also Improves Insulin Sensitivity in Diabetic Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; VANADYL SULFATE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; GLYCOGEN-SYNTHASE; GENE-EXPRESSION; IDENTIFICATION; METAL; OBESITY; PHOSPHORYLATION	Dramatic increase of diabetes over the globe is in tandem with the increase in insulin requirement. This is because destruction and dysfunction of pancreatic beta-cells are of common occurrence in both Type1 diabetes and Type2 diabetes, and insulin injection becomes a compulsion. Because of several problems associated with insulin injection, orally active insulin mimetic compounds would be ideal substitute. Here we report a small molecule, a peroxyvanadate compound i.e. DmpzH[VO(O-2)(2)(dmpz)], henceforth referred as dmp, which specifically binds to insulin receptor with considerable affinity (KD-1.17 mu M) thus activating insulin receptor tyrosine kinase and its downstream signaling molecules resulting increased uptake of [C-14] 2 Deoxy-glucose. Oral administration of dmp to streptozotocin treated BALB/c mice lowers blood glucose level and markedly stimulates glucose and fatty acid uptake by skeletal muscle and adipose tissue respectively. In db/db mice, it greatly improves insulin sensitivity through excess expression of PPAR gamma and its target genes i.e. adiponectin, CD36 and aP2. Study on the underlying mechanism demonstrated that excess expression of Wnt3a decreased PPAR gamma whereas dmp suppression of Wnt3a gene increased PPAR gamma expression which subsequently augmented adiponectin. Increased production of adiponectin in db/db mice due to dmp effected lowering of circulatory TG and FFA levels, activates AMPK in skeletal muscle and this stimulates mitochondrial biogenesis and bioenergetics. Decrease of lipid load along with increased mitochondrial activity greatly improves energy homeostasis which has been found to be correlated with the increased insulin sensitivity. The results obtained with dmp, therefore, strongly indicate that dmp could be a potential candidate for insulin replacement therapy.	[Mukherjee, Sandip; Chattopadhyay, Mrittika; Bhattacharya, Samir] Visva Bharati A Cent Univ, Ctr Adv Studies Zool, Sch Life Sci, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India; [Bhattacharya, Sushmita; Maity, Tushar K.] Reg Ctr Biotechnol, Ncr Delhi, India; [Dasgupta, Suman] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur, Assam, India; [Hussain, Sahid; Bharadwaj, Saitanya K.; Talukdar, Dhrubajyoti; Chaudhuri, Mihir K.] Tezpur Univ, Dept Chem Sci, Tezpur, Assam, India; [Usmani, Abul; Pradhan, Bhola S.; Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi, India; [Chattopadhyay, Pronobesh] Def Res Lab, Tezpur, Assam, India; [Mukhopadhyay, Satinath] IPGME&R SSKM Hosp, Dept Endocrinol & Metab, Kolkata, W Bengal, India	Visva Bharati University; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Tezpur University; Tezpur University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Bhattacharya, S (corresponding author), Visva Bharati A Cent Univ, Ctr Adv Studies Zool, Sch Life Sci, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India.; Chaudhuri, MK (corresponding author), Tezpur Univ, Dept Chem Sci, Tezpur, Assam, India.	mkc@tezu.ernet.in; bhattacharyasa@gmail.com	Dasgupta, Suman/B-8808-2013; Usmani, Abul/J-3756-2019; Hussain, Sahid/B-3015-2017	Dasgupta, Suman/0000-0003-2599-2299; Usmani, Abul/0000-0001-5485-7323; Mukhopadhyay, Satinath/0000-0001-8033-5748; Hussain, Sahid/0000-0001-7311-7697; PRADHAN, BHOLA/0000-0002-6346-2523; Majumdar, Subeer/0000-0003-1724-7483	Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi [BT/367/NE/TBP/2012]; DBT; UGC, New Delhi; Indian National Science Academy (INSA); National Science Academy, India (NASI)	Department of Biotechnology (DBT), Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); UGC, New Delhi(University Grants Commission, India); Indian National Science Academy (INSA); National Science Academy, India (NASI)	This research was financially supported by a grant from the Department of Biotechnology (DBT), Ministry of Science and Technology (File No. BT/367/NE/TBP/2012), New Delhi. SanM thanks the DBT for Research Associate (RA) fellowship. MC thanks the UGC, New Delhi, for the award of a UGC-Dr. D.S. Kothari postdoctoral fellowship. DT is thankful to DBT for Senior Research Fellowship (SRF). SaB is grateful to Indian National Science Academy (INSA) for the award of Golden Jubilee Research Professorship and the National Science Academy, India (NASI) for supporting his research activities.	Barma B, 2009, BIOCHIM BIOPHYS ACTA, V1972, P190; BECKER DJ, 1994, EUR J PHARMACOL, V260, P169, DOI 10.1016/0014-2999(94)90334-4; Benedict F., 1930, J NUTR, V3, P172; BHATTACHARJEE CR, 1990, POLYHEDRON, V9, P1653, DOI 10.1016/S0277-5387(00)83967-4; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BRICHARD SM, 1992, ENDOCRINOLOGY, V131, P311, DOI 10.1210/en.131.1.311; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Chattopadhyay M, 2011, METABOLISM, V60, P1702, DOI 10.1016/j.metabol.2011.04.015; CHAUDHURI MK, 1986, INORG CHEM, V25, P168, DOI 10.1021/ic00222a015; Crans DC, 1997, J AM CHEM SOC, V119, P5447, DOI 10.1021/ja9701671; Crans DC, 2013, INORG CHEM, V52, P12262, DOI 10.1021/ic4007873; Cusi K, 2001, J CLIN ENDOCR METAB, V86, P1410, DOI 10.1210/jc.86.3.1410; DOMINGO JL, 1991, TOXICOLOGY, V66, P279, DOI 10.1016/0300-483X(91)90199-B; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Fantus IG, 1998, MOL CELL BIOCHEM, V182, P109, DOI 10.1023/A:1006853426679; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Garcia-Vicente S, 2007, DIABETES, V56, P486, DOI 10.2337/db06-0269; GREEN A, 1986, BIOCHEM J, V238, P663, DOI 10.1042/bj2380663; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Hajri T, 2011, AM J PHYSIOL-ENDOC M, V300, pE350, DOI 10.1152/ajpendo.00307.2010; He KY, 2011, J BIOL CHEM, V286, P37379, DOI 10.1074/jbc.M111.247387; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Levina A, 2011, DALTON T, V40, P11675, DOI 10.1039/c1dt10380f; Lin B, 2007, J PHARMACOL EXP THER, V323, P579, DOI 10.1124/jpet.107.126102; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Lyonnet B., 1899, PRESSE MED, V1, P191; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Marzban L, 2003, J TRACE ELEM EXP MED, V16, P253, DOI 10.1002/jtra.10034; MEYEROVITCH J, 1991, J CLIN INVEST, V87, P1286, DOI 10.1172/JCI115131; Mordes JP, 1992, ANIMAL MODELS DIABET, P1; Mukherjee J, 1996, INDIAN J CHEM A, V35, P471; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pandey SK, 1998, BIOCHEMISTRY-US, V37, P7006, DOI 10.1021/bi9726786; Park KS, 1997, DIABETES, V46, P1230, DOI 10.2337/diabetes.46.7.1230; Paschen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21448; Pitkin RB, 2005, ABLE 2005 P, V27, P374; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Qiang GF, 2014, DIABETES, V63, P1394, DOI 10.2337/db13-0334; Richardson T, 2003, AM J CLIN DERMATOL, V4, P661, DOI 10.2165/00128071-200304100-00001; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; SHECHTER Y, 1980, NATURE, V284, P556, DOI 10.1038/284556a0; SHISHEVA A, 1994, ENDOCRINOLOGY, V134, P507, DOI 10.1210/en.134.1.507; SINGH CB, 1973, J INORG NUCL CHEM, V35, P3947, DOI 10.1016/0022-1902(73)80097-1; Stouffer MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9543; STROUT HV, 1989, ENDOCRINOLOGY, V124, P1918, DOI 10.1210/endo-124-4-1918; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; TAMURA S, 1984, J BIOL CHEM, V259, P6650; TURNER HW, 1979, INORG CHEM, V18, P1221, DOI 10.1021/ic50195a008; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; WALKER PS, 1990, J BIOL CHEM, V265, P1516; Willsky GR, 2013, METALLOMICS, V5, P1491, DOI 10.1039/c3mt00162h; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	61	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169809	10.1371/journal.pone.0169809	http://dx.doi.org/10.1371/journal.pone.0169809			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072841	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200049
J	Yang, QJ; Yang, GJ; Wan, LL; Han, YL; Huo, Y; Li, J; Huang, JL; Lu, J; Gan, R; Guo, C				Yang QuanJun; Yang GenJin; Wan LiLi; Han YongLong; Huo Yan; Li Jie; Huang JinLu; Lu Jin; Gan Run; Guo Cheng			Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study	PLOS ONE			English	Article							MYOCARDIAL TOXICITY; NITRIC-OXIDE; IRON; RATS; MICE; GLUTATHIONE; HEART; CARDIOMYOCYTES; MITOCHONDRIA; PREVENTION	Cardioprotection of dexrazoxane (DZR) against doxorubicin (DOX)-induced cardiotoxicity is contentious and the indicator is controversial. A pairwise comparative metabolomics approach was used to delineate the potential metabolic processes in the present study. Ninety-six BALB/c mice were randomly divided into two supergroups: tumor and control groups. Each supergroup was divided into control, DOX, DZR, and DOX plus DZR treatment groups. DOX treatment resulted in a steady increase in 5-hydroxylysine, 2-hydroxybutyrate, 2-oxoglutarate, 3-hydroxybutyrate, and decrease in glucose, glutamate, cysteine, acetone, methionine, asparate, isoleucine, and glycylproline. DZR treatment led to increase in lactate, 3-hydroxybutyrate, glutamate, alanine, and decrease in glucose, trimethylamine N-oxide and carnosine levels. These metabolites represent potential biomarkers for early prediction of cardiotoxicity of DOX and the cardioprotective evaluation of DZR.	[Yang QuanJun; Wan LiLi; Han YongLong; Huo Yan; Li Jie; Huang JinLu; Lu Jin; Gan Run; Guo Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pharm, Shanghai, Peoples R China; [Yang GenJin] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Guo, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pharm, Shanghai, Peoples R China.	guopharm@126.com	Yang, Quanjun/D-4657-2013; Yang, Quanjun/CAF-0590-2022; Yang, Quanjun/K-9760-2019; wan, li/GRY-7634-2022	Yang, Quanjun/0000-0003-0279-8784; Yang, Quanjun/0000-0003-0279-8784; 	National Natural Science Foundation of China [81503155]; School of Pharmacy, Fudan University; Open Project Program of Key Lab of Smart Drug Delivery [SDD2015-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Pharmacy, Fudan University; Open Project Program of Key Lab of Smart Drug Delivery	This study was supported by National Natural Science Foundation of China 81503155 and School of Pharmacy, Fudan University & The Open Project Program of Key Lab of Smart Drug Delivery SDD2015-03.	Al-Abd AM, 2013, EUR J PHARMACOL, V718, P361, DOI 10.1016/j.ejphar.2013.08.009; Alsaad AMS, 2012, DRUG METAB DISPOS, V40, P2126, DOI 10.1124/dmd.112.046631; Altena R, 2009, LANCET ONCOL, V10, P391, DOI 10.1016/S1470-2045(09)70042-7; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P; Carvalho RA, 2010, TOXICOLOGY, V270, P92, DOI 10.1016/j.tox.2010.01.019; Corna G, 2004, J BIOL CHEM, V279, P13738, DOI 10.1074/jbc.M310106200; Deng J, 2015, THE JOURNAL OF PHARM; Guenancia C, 2015, TOXICOL APPL PHARM, V284, P152, DOI 10.1016/j.taap.2015.02.015; Guerra J, 2005, HEMATOL J, V5, P584, DOI 10.1038/sj.thj.6200573; Guler E, 2011, PEDIATR HEMAT ONCOL, V28, P395, DOI 10.3109/08880018.2011.563373; Hasinoff Brian B, 2003, Cardiovasc Toxicol, V3, P89, DOI 10.1385/CT:3:2:89; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Herman EH, 2001, CANCER CHEMOTH PHARM, V48, P297, DOI 10.1007/s002800100348; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jensen BV, 2002, ANN ONCOL, V13, P699, DOI 10.1093/annonc/mdf132; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Lebrecht D, 2007, BRIT J PHARMACOL, V151, P771, DOI 10.1038/sj.bjp.0707294; Lipshultz SE, 2010, LANCET ONCOL, V11, P950, DOI 10.1016/S1470-2045(10)70204-7; Liu ZM, 2014, FEBS J, V281, P2410, DOI 10.1111/febs.12794; Loncar-Turukalo T, 2015, PHYSIOL MEAS, V36, P727, DOI 10.1088/0967-3334/36/4/727; MALISZA KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P680, DOI 10.1006/abbi.1995.1091; Mansour MA, 2003, J BIOCHEM MOL BIOL, V36, P593; Minotti G, 2004, METHOD ENZYMOL, V378, P340; Mohamed HE, 2000, PHARMACOL RES, V42, P115, DOI 10.1006/phrs.1999.0630; PELIKAN PCD, 1986, J CARDIOVASC PHARM, V8, P1058, DOI 10.1097/00005344-198609000-00026; Reagan WJ, 2013, TOXICOL PATHOL, V41, P1146, DOI 10.1177/0192623313482056; Ruggiero A, 2013, INT J CLIN ONCOL, V18, P927, DOI 10.1007/s10147-012-0458-9; Schaupp CM, 2015, CHEM-BIOL INTERACT, V234, P154, DOI 10.1016/j.cbi.2014.11.010; SCHMITTGRAFF A, 1986, PATHOL RES PRACT, V181, P168, DOI 10.1016/S0344-0338(86)80006-1; Schutz PW, 2011, MOL GENET METAB, V103, P179, DOI 10.1016/j.ymgme.2011.02.015; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Trachtenberg BH, 2011, PEDIATR CARDIOL, V32, P342, DOI 10.1007/s00246-010-9878-3; Vijay V, 2016, TOXICOL APPL PHARM, V295, P68, DOI 10.1016/j.taap.2016.02.003; Wang JS, 2009, METABOLOMICS, V5, P407, DOI 10.1007/s11306-009-0165-3; Yang QJ, 2015, RSC ADV, V5, P11766, DOI 10.1039/c4ra14128h; Yang QJ, 2013, MOL BIOSYST, V9, P3015, DOI 10.1039/c3mb70134d; YODA Y, 1986, CANCER RES, V46, P2551	39	28	32	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169567	10.1371/journal.pone.0169567	http://dx.doi.org/10.1371/journal.pone.0169567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072830	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200027
J	Yan, TT; Zhang, JH; Tang, D; Zhang, XY; Jiang, XP; Zhao, LP; Zhang, Q; Zhang, DX; Huang, YS				Yan, Tiantian; Zhang, Junhui; Tang, Di; Zhang, Xingyue; Jiang, Xupin; Zhao, Liping; Zhang, Qiong; Zhang, Dongxia; Huang, Yuesheng			Hypoxia Regulates mTORC1-Mediated Keratinocyte Motility and Migration via the AMPK Pathway	PLOS ONE			English	Article							MAMMALIAN TARGET; INDUCIBLE FACTOR; CELL-MIGRATION; TGF-BETA; MTOR; CANCER; OXYGEN; PROLIFERATION; ACTIVATION; WOUNDS	Keratinocyte migration, the initial event and rate-limiting step in wound healing, plays a vital role in restoration of the intact skin barrier, also known as re-epithelialization. After acute tissue injury, hypoxic microenvironment gradually develops and acts as an early stimulus to initiate the healing process. Although we have previously found that hypoxia induces keratinocyte migration, the underlying mechanism remains unknown. Here, we first observed that hypoxia increased mTORC1 activity. Recombinant lentivirus vector and Rapamycin were used for silencing mTORC1 in HaCaT cells and primary mouse keratinocytes (MKs). Using cell migration assay and a Zeiss chamber equipped with imaging system, we also demonstrated that mTORC1 downregulation reversed hypoxia-induced keratinocyte motility and lateral migration. Importantly, hypoxia-activated mTORC1 was accompanied by the AMPK downregulation, and we found that the AMPK pathway activators Metformin (Met) and 5-Aminoimidazole- 4-carboxamide 1-beta-D-ribofuranoside (AICAR) decreased the mTORC1 activity, cell motility and lateral migration. Thus, our results suggest that hypoxia regulates mTORC1-mediated keratinocyte motility and migration via the AMPK pathway.	[Yan, Tiantian; Zhang, Junhui; Tang, Di; Zhang, Xingyue; Jiang, Xupin; Zhao, Liping; Zhang, Qiong; Zhang, Dongxia; Huang, Yuesheng] Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China	Army Medical University	Huang, YS (corresponding author), Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China.	yshuangtmmu@163.com			Research fund of the State Key laboratory of Trauma, Burns and combined injury [SKLZZ201203]; State Key Development Program for Basic Research of China [2012CB518101]	Research fund of the State Key laboratory of Trauma, Burns and combined injury; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	State Key Development Program for Basic Research of China (No. 2012CB518101) and Research fund of the State Key laboratory of Trauma, Burns and combined injury (No. SKLZZ201203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2003, CURR TOP MICROBIOL, V279, P299; Ahn YJ, 2012, BMB REP, V45, P489, DOI 10.5483/BMBRep.2012.45.9.169; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Castilho RM, 2013, ORAL DIS, V19, P551, DOI 10.1111/odi.12070; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; HELFMAN T, 1994, CLIN DERMATOL, V12, P121, DOI 10.1016/0738-081X(94)90262-3; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; HUNT TK, 1972, ACTA CHIR SCAND, V138, P109; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; JONES DP, 1986, AM J PHYSIOL, V250, pC663, DOI 10.1152/ajpcell.1986.250.5.C663; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Lin H, 2015, MOL PHARMACOL, V88, P1062, DOI 10.1124/mol.115.099549; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; NIINIKOSKI J, 1972, AM J SURG, V123, P247, DOI 10.1016/0002-9610(72)90277-2; Ochoa-Gonzalez F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150900; Ruthenborg RJ, 2014, MOL CELLS, V37, P637, DOI 10.14348/molcells.2014.0150; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schumacker PT, 2002, AM J PHYSIOL-LUNG C, V283, pL918, DOI 10.1152/ajplung.00205.2002; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Sorokin DV, 2016, B EXP BIOL MED+, V160, P555, DOI 10.1007/s10517-016-3217-5; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; WILSON DF, 1988, J BIOL CHEM, V263, P2712; WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; Xing DM, 2011, WOUND REPAIR REGEN, V19, P205, DOI 10.1111/j.1524-475X.2010.00656.x; Xu J, 2012, CRIT REV FOOD SCI, V52, P373, DOI 10.1080/10408398.2010.500245; Yan Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7137; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhan RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121551; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169155	10.1371/journal.pone.0169155	http://dx.doi.org/10.1371/journal.pone.0169155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068384	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900021
J	Andre, E; Bahati, YL; Musafiri, EM; Rusumba, OB; Van der Linden, D; Zech, F				Andre, Emmanuel; Bahati, Yvette Lufungulo; Musafiri, Eric Mulume; Rusumba, Olivier Bahati; Van der Linden, Dimitri; Zech, Francis			Prediction of Under-Detection of Paediatric Tuberculosis in the Democratic Republic of Congo: Experience of Six Years in the South-Kivu Province	PLOS ONE			English	Article							CHILDREN; POVERTY	Introduction In the field of tuberculosis (TB), and particularly in regard to paediatric TB (PedTB), clinical skills of health professionals play an important role in determining quality of care. In an era where novel diagnostic technologies and efficient treatment regimens are being made available for the poorest, we must not divert our attention from the importance of clinical skills, as this deliverable remains the cornerstone of individualized patient care and ultimately the best assurance for optimal use of resources. The aim of our work was to study the epidemiology of PedTB and the determinants of PedTB under-detection in the South-Kivu Province of the Democratic Republic of Congo (DRC), a setting with nearly no technical resources allowing to support the clinical diagnosis of PedTB, i.e. chest X-rays, rapid molecular tests or culture laboratories. Methods We collected TB notification data from 2010 to 2015 and analysed the space-time variations in notification for the different forms of TB among the 113 health facilities (HF) the South-Kivu Province, a region with a low HIV incidence. The different forms of TB notified were: smear positive pulmonary TB (SS+PTB), smear negative pulmonary TB (SS-PTB) and extra-pulmonary TB (EPTB). We further analysed the distribution of these different forms of the disease per age group and explored the possibility to predict the detection of PedTB. Results Significant differences were observed between HF in regard to the proportion of paediatric TB and the proportion of SS-TB among adults. We found a strong correlation between the proportion of PedTB and three major factors: the proportion of TB cases with no bacteriological confirmation (SS-TB) among adults, the number of TB cases notified by the HF and the fact that the HF was supported or not by Medecins Sans Frontieres (MSF). The proportion of SS-TB among adults was found to be a valid indicator for predicting the level of detection of PedTB at the same HF. Conclusion Our observations strongly suggest that under-detection of PedTB is associated with insufficient clinical skills and technical resources at the HF level which similarly affects other forms of the disease, in particular SS-TB. We demonstrated that, in the specific context of South-Kivu, under-detection of PedTB can be predicted by a low SS-TB/SS+PTB ratio in the adult population. In the context of severely under-resourced settings, this ratio could be used to rapidly identify HF that should benefit in priority from deeper evaluation, and eventually targeted interventions.	[Andre, Emmanuel; Zech, Francis] Catholic Univ Louvain, Inst Rech Expt & Clin, Brussels, Belgium; [Andre, Emmanuel; Van der Linden, Dimitri] Clin Univ St Luc, Brussels, Belgium; [Bahati, Yvette Lufungulo] Hop Prov Gen Reference Bukavu, Bukavu, DEM REP CONGO; [Musafiri, Eric Mulume] Coordinat Prov Lepre & TB, Bukavu, DEM REP CONGO; [Rusumba, Olivier Bahati] Ambassadeurs Lutte TB, Bukavu, DEM REP CONGO	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Andre, E (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Brussels, Belgium.; Andre, E (corresponding author), Clin Univ St Luc, Brussels, Belgium.	emmanuel.andre@uclouvain.be	André, Emmanuel/AAI-4372-2021	André, Emmanuel/0000-0001-8321-3770; Zech, Francis/0000-0002-5224-3712; Van der Linden, Dimitri/0000-0002-2696-4559	TB REACH grant	TB REACH grant	This work was supported by TB REACH grant (Stop TB Partnership) (http://www.stoptb.org/global/awards/tbreach/wave2.asp).	Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Chaulet P, 1989, Bull Int Union Tuberc Lung Dis, V64, P33; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Farmer P, 1991, Semin Respir Infect, V6, P254; Grange J, 1999, J ROY SOC MED, V92, P105, DOI 10.1177/014107689909200301; Hansen C, 2016, PEDIATR CLIN N AM, V63, P37, DOI 10.1016/j.pcl.2015.08.002; Kumar Mani Kant, 2015, J Nat Sci Biol Med, V6, P314, DOI 10.4103/0976-9668.159988; Marais B, 2015, PUBLIC HEALTH ACTION, V5, P90, DOI 10.5588/pha.15.0028; Morel JG, 2003, BIOMETRICAL J, V45, P395, DOI 10.1002/bimj.200390021; PNLT, 2012, RAPP EP TUB; Tuberculosis, 2014, PRACT GUID CLIN NURS; United Nations Department of Economic and Social Affairs Population Division, 2015, REV WORLD POP PROSP; World Health Organization, 2015, GLOB TUB REP 2015	14	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169014	10.1371/journal.pone.0169014	http://dx.doi.org/10.1371/journal.pone.0169014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060846	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500049
J	Fujita, Y; Tsuno, H; Nakayama, J				Fujita, Yuhzo; Tsuno, Haruo; Nakayama, Jiro			Fermented Papaya Preparation Restores Age-Related Reductions in Peripheral Blood Mononuclear Cell Cytolytic Activity in Tube-Fed Patients	PLOS ONE			English	Article							LARGE GRANULAR LYMPHOCYTES; IN-VITRO; MEDITERRANEAN DIET; DENDRITIC CELLS; PHENOLIC-ACIDS; FOOD SOURCES; NK ACTIVITY; POLYPHENOLS; METABOLISM; MICROBIOTA	Tube-fed elderly patients are generally supplied with the same type of nutrition over long periods, resulting in an increased risk for micronutrient deficiencies. Dietary polyphenols promote immunity and have anti-inflammatory, anti-carcinogenic, and anti-oxidative properties. Carica papaya Linn. is rich in several polyphenols; however, these polyphenols are poorly absorbed from the digestive tract in their original polymerized form. Therefore, we determined the molecular components of a fermented Carica papaya Linn. preparation, as well as its effects on immunity and the composition of gut microbiota in tube-fed patients. Different doses of the fermented C. papaya L. preparation were administered to three groups of tube-fed patients for 30 days. Its effects on fecal microbiota composition and immunity were assessed by 16S rRNA gene sequencing and immune-marker analysis, respectively. The chemical composition of the fermented C. papaya L. preparation was analyzed by capillary electrophoresisand liquid chromatography-time of flight mass spectrometry. The fermented C. papaya L. preparation restored peripheral blood mononuclear cell (PBMC) cytolytic activity; however, no other biomarkers of immunity were observed. Treatment with the preparation (9 g/day) significantly reduced the abundance of Firmicutes in the fecal microbiota. In particular, treatment reduced Clostridium scindens and Eggerthella lenta in most patients receiving 9 g/day. Chemical analysis identified low-molecular-weight phenolic acids as polyphenol metabolites; however, no polymerized, large-molecular-weight molecules were detected. Our study indicates that elderly patients who are tube-fed over the long-term have decreased PBMC cytolytic activity. In addition, low-molecular-weight polyphenol metabolites fermented from polymerized polyphenols restore PBMC cytolytic activity and modulate the composition of gut microbiota in tube-fed patients.	[Fujita, Yuhzo; Tsuno, Haruo] Yuno Onsen Hosp, Yuno, Syunan Shi, Yamaguchi, Japan; [Nakayama, Jiro] Kyushu Univ, Fac Agr,Grad Sch, Dept Biosci & Biotechnol,Div Syst Bioeng,Lab Micr, Higashi Ku, Hakozaki, Fukuoka, Japan	Kyushu University	Nakayama, J (corresponding author), Kyushu Univ, Fac Agr,Grad Sch, Dept Biosci & Biotechnol,Div Syst Bioeng,Lab Micr, Higashi Ku, Hakozaki, Fukuoka, Japan.	nakayama@agr.kyushu-u.ac.jp			SAIDO Co., Ltd.	SAIDO Co., Ltd.	The authors received financial support from SAIDO Co., Ltd. for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1988, GERONTOLOGY, V34, P277, DOI 10.1159/000212966; Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P1084, DOI 10.1021/jf803059z; BAETEN C, 1992, SCAND J GASTROENTERO, V27, P95, DOI 10.3109/00365529209096035; Banerjee N, 2012, BREAST CANCER RES TR, V136, P21, DOI 10.1007/s10549-012-2224-0; BHAT CS, 1979, J NEUROCHEM, V32, P1531, DOI 10.1111/j.1471-4159.1979.tb11095.x; Biasi F, 2014, REDOX BIOL, V2, P795, DOI 10.1016/j.redox.2014.06.008; Cai EP, 2009, J AGR FOOD CHEM, V57, P9817, DOI 10.1021/jf902618v; Camous X, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/195956; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Cases J, 2015, INT J FOOD SCI NUTR, V66, P120, DOI 10.3109/09637486.2014.971229; Chavez-Quintal P, 2011, INDIAN J MICROBIOL, V51, P54, DOI 10.1007/s12088-011-0086-5; Clifford MN, 2013, AM J CLIN NUTR, V98, p1619S, DOI 10.3945/ajcn.113.058958; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Collard E, 2010, ANTIOXID REDOX SIGN, V13, P599, DOI 10.1089/ars.2009.3039; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; Deprez S, 2000, J NUTR, V130, P2733, DOI 10.1093/jn/130.11.2733; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Juarez-Rojop IE, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-236; FACCHINI A, 1987, CLIN EXP IMMUNOL, V68, P340; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Georgetti SR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340626; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gonzalez-Gallego J, 2007, NUTR HOSP, V22, P287; Gonzalez-Gallego J, 2010, BRIT J NUTR, V104, pS15, DOI 10.1017/S0007114510003910; GOODWIN JS, 1982, CLIN EXP IMMUNOL, V48, P403; Hara Y, 1997, J CELL BIOCHEM, P52; Hiramoto K, 2008, J SCI FOOD AGR, V88, P1151, DOI 10.1002/jsfa.3190; HIROKAWA K, 1988, ARCH PATHOL LAB MED, V112, P13; Huang AC, 2013, IN VIVO, V27, P627; Imao Katsuki, 1999, Journal of Brain Science, V25, P71; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; ITOH K, 1982, J IMMUNOL, V129, P395; Jacobs DM, 2009, CURR DRUG METAB, V10, P41, DOI 10.2174/138920009787048383; Jensen GS, 2008, J AGR FOOD CHEM, V56, P8326, DOI 10.1021/jf8016157; Killian PH, 2012, CARCINOGENESIS, V33, P2507, DOI 10.1093/carcin/bgs312; Kroon PA, 2004, AM J CLIN NUTR, V80, P15; KRUMHOLZ LR, 1988, J BACTERIOL, V170, P2472, DOI 10.1128/jb.170.6.2472-2479.1988; KUMAGAI K, 1982, J IMMUNOL, V129, P388; Lans CA, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-45; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee HS, 2012, J MED FOOD, V15, P1015, DOI 10.1089/jmf.2012.2187; Lee JS, 2001, CLIN CHIM ACTA, V314, P221, DOI 10.1016/S0009-8981(01)00700-8; Lin S, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-108; Magrone T, 2014, ENDOCR METAB IMMUNE, V14, P272, DOI 10.2174/1871530314666141010105540; MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manach C, 2004, FREE RADICAL RES, V38, P771, DOI 10.1080/10715760410001727858; Mariani E, 1998, INT IMMUNOL, V10, P981, DOI 10.1093/intimm/10.7.981; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; MEYDANI SN, 1995, AM J CLIN NUTR, V62, P1462; Micucci F, 2008, BLOOD, V111, P4165, DOI 10.1182/blood-2007-08-108886; MILLER RA, 1994, EXP GERONTOL, V29, P21, DOI 10.1016/0531-5565(94)90060-4; Mulholland PJ, 2001, ANN ONCOL, V12, P245, DOI 10.1023/A:1008372017097; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60; Nakayama J., 2010, Bioscience and Microflora, V29, P83; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Noda Y, 2008, J CLIN BIOCHEM NUTR, V43, P185, DOI 10.3164/jcbn.2008062; Nurmi T, 2009, J AGR FOOD CHEM, V57, P2274, DOI 10.1021/jf8035116; Olagunju J. A., 2009, Biology and Medicine, V1, P11; Onaku LO, 2011, J VECTOR DIS, V48, P96; Ozdemir O, 2005, CLIN IMMUNOL, V115, P240, DOI 10.1016/j.clim.2005.01.008; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; PARK RHR, 1992, BRIT MED J, V304, P1406, DOI 10.1136/bmj.304.6839.1406; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; PATEL HR, 1992, EUR J IMMUNOL, V22, P253, DOI 10.1002/eji.1830220137; PEPPERCO.MA, 1972, P NATL ACAD SCI USA, V69, P1413, DOI 10.1073/pnas.69.6.1413; Perche O, 2014, CLIN NUTR, V33, P130, DOI 10.1016/j.clnu.2013.03.012; Porrata LF, 2001, BONE MARROW TRANSPL, V28, P673, DOI 10.1038/sj.bmt.1703203; PROSS HF, 1975, CLIN EXP IMMUNOL, V21, P226; Qureshi A. A., 2012, J CLIN EXP CARDIOL, VS5; Rivera-Pastrana DM, 2010, J SCI FOOD AGR, V90, P2358, DOI 10.1002/jsfa.4092; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Ryu JS, 2013, J GINSENG RES, V37, P108, DOI 10.5142/jgr.2013.37.108; Scholz S, 2007, INT J VITAM NUTR RES, V77, P224, DOI 10.1024/0300-9831.77.3.224; Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; STEPHEN AM, 1980, J MED MICROBIOL, V13, P45, DOI 10.1099/00222615-13-1-45; Stoupi S, 2010, MOL NUTR FOOD RES, V54, P747, DOI 10.1002/mnfr.200900123; Tamura A, 2004, J NUTR SCI VITAMINOL, V50, P13, DOI 10.3177/jnsv.50.13; Tapsell LC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-100; Urpi-Sarda M, 2009, J AGR FOOD CHEM, V57, P10134, DOI 10.1021/jf901450z; Wahlberg BJ, 2001, J IMMUNOL METHODS, V253, P69, DOI 10.1016/S0022-1759(01)00361-1; Warner EF, 2016, J NUTR, V146, P465, DOI 10.3945/jn.115.217943; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Zhang J, 2006, NEUROSCIENCE, V143, P63, DOI 10.1016/j.neuroscience.2006.07.023	97	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169240	10.1371/journal.pone.0169240	http://dx.doi.org/10.1371/journal.pone.0169240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060858	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500069
J	Matsuzaki, M; Kulkarni, B; Kuper, H; Wells, JC; Ploubidis, GB; Prabhakaran, P; Gupta, V; Walia, GK; Aggarwal, A; Prabhakaran, D; Smith, GD; Radhakrishna, KV; Ben-Shlomo, Y; Kinra, S				Matsuzaki, Mika; Kulkarni, Bharati; Kuper, Hannah; Wells, Jonathan C.; Ploubidis, George B.; Prabhakaran, Poornima; Gupta, Vipin; Walia, Gagandeep Kaur; Aggarwal, Aastha; Prabhakaran, Dorairaj; Smith, George Davey; Radhakrishna, Kankipati Vijaya; Ben-Shlomo, Yoav; Kinra, Sanjay			Association of Hip Bone Mineral Density and Body Composition in a Rural Indian Population: The Andhra Pradesh Children and Parents Study (APCAPS)	PLOS ONE			English	Article							FAT MASS; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; LEAN MASS; MEN; INDEX; OSTEOPOROSIS; FRACTURES; LEPTIN; DETERMINANTS	Background Fat mass is variably associated with bone mass, possibly due to differential mechanical and biological effects of fat mass. We examined the association of fat mass with bone mass in a lean population. Objective To investigate association between hip bone mineral density and fat and lean mass in a cross-sectional study from southern India. Design The Andhra Pradesh Children and Parents Study is a prospective cohort study in Hyderabad, India. In 2009-2012, the study collected data on anthropometric measures, bone mineral density (BMD), fat mass, and lean mass measured by dual-energy x-ray absorptiometry, and socioeconomic data of the adult participants (n = 1760; mean age = 34.9 years old for women; 2130 and 32.3 for men). Results The median BMI (kg/m(2)) was 20.1 kg/m(2). Women had relatively higher fat mass as compared to men. In models adjusted for lean mass, there was an association between hip bone mineral density and fat mass in women (beta (95% confidence interval): premenopausal 0.025 (0.006 to 0.045); postmenopausal 0.045 (0.014 to 0.076)) but not in men (0.001 (-0.012 to 0.0014)). The association between hip BMD and fat mass was stronger in postmenopausal than premenopausal women. Hip BMD was consistently associated with lean mass, in both men and women. Conclusions In this relatively lean population, lean mass was more consistently associated with hip BMD than fat mass. Weight gain through lean mass improvement may be a more reliable public health strategy for strengthening bone health in transitional settings.	[Matsuzaki, Mika; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Kulkarni, Bharati; Radhakrishna, Kankipati Vijaya] Indian Council Med Res Tarnaka, Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Wells, Jonathan C.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Ploubidis, George B.] Univ London, Inst Educ, Ctr Longitudinal Studies, Dept Populat Hlth & Stat, London, England; [Prabhakaran, Poornima; Walia, Gagandeep Kaur; Aggarwal, Aastha] Publ Hlth Fdn India, Gurgaon, Haryana, India; [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, Gurgaon, Haryana, India; [Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; UCL Institute of Education; Public Health Foundation of India; University of Delhi; University of Bristol	Matsuzaki, M (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.	mika.matsuzaki@lshtm.ac.uk	Aggarwal, Aastha/AAT-1347-2020; Prabhakaran, Dorairaj/B-4147-2011; Davey Smith, George/A-7407-2013; Kulkarni, Bharati/ABB-3188-2020; Ploubidis, George B/G-9531-2011; Ben-Shlomo, Yoav/ABD-2004-2021; Wells, Jonathan/A-4604-2009; Gupta, Vipin/D-1704-2014	Aggarwal, Aastha/0000-0002-8180-8743; Prabhakaran, Dorairaj/0000-0002-3172-834X; Davey Smith, George/0000-0002-1407-8314; Kulkarni, Bharati/0000-0003-0636-318X; Ploubidis, George B/0000-0002-8198-5790; Ben-Shlomo, Yoav/0000-0001-6648-3007; Wells, Jonathan/0000-0003-0411-8025; Gupta, Vipin/0000-0002-0607-5543; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Wellcome Trust [083707, 084774]; European Commission Strategic Award (FP-7); Economic & Social Research Council UK Award; Queensland University of Technology, Australia; Wellcome Trust Capacity Strengthening Strategic Award [084754]; Joint Japan/World Bank Graduate Scholarship Program; Medical Research Council; University of Bristol [MC_UU_12013/1-9]; Economic and Social Research Council [ES/M001660/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; ESRC [ES/M001660/1] Funding Source: UKRI; MRC [MC_UU_12013/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Commission Strategic Award (FP-7); Economic & Social Research Council UK Award(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Queensland University of Technology, Australia; Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); Joint Japan/World Bank Graduate Scholarship Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	APCAPS 2nd and 3rd waves of data collection was funded by the following organizations: Wellcome Trust (www.wellcome.ac.uk/) Grant 083707, Wellcome Trust Strategic Award 084774, European Commission (http://ec.europa.eu/index_en.htm) Strategic Award (FP-7). PhD studentships were provided by Wellcome Trust Award, Economic & Social Research Council UK Award, Queensland University of Technology, Australia ((https://www.qut.edu.au/), Wellcome Trust Capacity Strengthening Strategic Award grant 084754, and Joint Japan/World Bank Graduate Scholarship Program (http://web.worldbank.org). GDS' work is supported by the Medical Research Council and the University of Bristol MC_UU_12013/1-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; ALOIA JF, 1995, AM J CLIN NUTR, V61, P1110, DOI 10.1093/ajcn/61.5.1110; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Blum M, 2003, CALCIFIED TISSUE INT, V73, P27, DOI 10.1007/s00223-002-1019-4; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Douchi T, 1997, MATURITAS, V27, P55, DOI 10.1016/S0378-5122(97)01112-2; Douchi T, 2003, J BONE MINER METAB, V21, P17, DOI 10.1007/s007740300003; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Frost HM, 2000, J BONE MINER METAB, V18, P305, DOI 10.1007/s007740070001; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Hughes JM, 2010, J MUSCULOSKEL NEURON, V10, P128; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kinra S, 2013, INT J EPIDEMIOL; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Lanyon L.E., 2009, IBMS BONEKEY, V6, P218, DOI [10.1138/20090382, DOI 10.1138/20090382]; Liu Jian-Min, 2004, Osteoporos Int, V15, P238, DOI 10.1007/s00198-003-1536-7; Lu H, 2011, OSTEOPOROSIS INT, V22, P3029, DOI 10.1007/s00198-010-1522-9; Matsuzaki M, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0232-5; Matsuzaki M, 2014, AM J CLIN NUTR, V99, P1450, DOI 10.3945/ajcn.113.068791; Meakin LB, 2014, FRONT ENDOCRINOL, V5; Mukherjee A, 2011, ICMR B; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Nguyen TV, 1998, AM J EPIDEMIOL, V147, P3; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; REID IR, 1994, J CLIN ENDOCR METAB, V79, P950, DOI 10.1210/jc.79.4.950; REID IR, 1992, J CLIN ENDOCR METAB, V75, P779, DOI 10.1210/jc.75.3.779; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; TAAFFE DR, 1995, J BONE MINER RES, V10, P586; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; The International Institute for Population Sciences, IND NAT FAM HLTH SUR; Thomas T, 2001, BONE, V29, P114, DOI 10.1016/S8756-3282(01)00487-2; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; Zhu K, 2015, BONE, V74, P146, DOI 10.1016/j.bone.2015.01.015	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167114	10.1371/journal.pone.0167114	http://dx.doi.org/10.1371/journal.pone.0167114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060826	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500011
J	Wee, JLQ; Monteiro, A				Wee, Jocelyn Liang Qi; Monteiro, Antonia			Yellow and the Novel Aposematic Signal, Red, Protect Delias Butterflies from Predators	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; PLANT ASSOCIATIONS; SEXUAL SELECTION; COLOR PATTERN; EVOLUTION; PREY; AVOIDANCE; DIVERSIFICATION; DISCRIMINATION; COMMUNICATION	Butterflies of the South Asian and Australian genus Delias possess striking colours on the ventral wings that are presumed to serve as warning signals to predators. However, this has not been shown empirically. Here we experimentally tested whether the colours of one member of this diverse genus, Delias hyparete, function as aposematic signals. We constructed artificial paper models with either a faithful colour representation of D. hyparete, or with all of its colours converted to grey scale. We also produced models where single colours were left intact, while others were converted to grey-scale or removed entirely. We placed all model types simultaneously in the field, attached to a live mealworm, and measured relative attack rates at three separate field sites. Faithful models of D. hyparete, suffered the least amount of attacks, followed by grey-scale models with unaltered red patches, and by grey-scale models with unaltered yellow patches. We conclude that red and yellow colours function as warning signals. By mapping dorsal and ventral colouration onto a phylogeny of Delias, we observed that yellow and red colours appear almost exclusively on the ventral wing surfaces, and that basal lineages have mostly yellow, white, and black wings, whereas derived lineages contain red colour in addition to the other colours. Red appears to be, thus, a novel adaptive trait in this lineage of butterflies.	[Wee, Jocelyn Liang Qi; Monteiro, Antonia] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore	National University of Singapore; Yale NUS College	Monteiro, A (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.; Monteiro, A (corresponding author), Yale NUS Coll, Singapore, Singapore.	antonia.monteiro@nus.edu.sg	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Wee, Jocelyn/0000-0002-2364-9975	Singapore Ministry of Education [MOE2014-T2-1-146]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by a Singapore Ministry of Education grant MOE2014-T2-1-146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas Lina Maria, 2014, Frontiers in Ecology and Evolution, V2, P25; Aronsson M, 2008, ANIM BEHAV, V75, P417, DOI 10.1016/j.anbehav.2007.05.006; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Braby MF, 2006, ENTOMOL SCI, V9, P383, DOI 10.1111/j.1479-8298.2006.00185.x; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Canfield Michael R., 2010, Tropical Lepidoptera Research, V20, P1; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; Dell'Aglio DD, 2016, ECOL ENTOMOL, V41, P627, DOI 10.1111/een.12335; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Exnerova A, 2006, BIOL J LINN SOC, V88, P143, DOI 10.1111/j.1095-8312.2006.00611.x; Finkbeiner SD, 2014, EVOLUTION, V68, P3410, DOI 10.1111/evo.12524; Finkbeiner SD, 2012, P ROY SOC B-BIOL SCI, V279, P2769, DOI 10.1098/rspb.2012.0203; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Forsman A, 1999, EVOL ECOL, V13, P131, DOI 10.1023/A:1006630911975; Gamberale-Stille G, 2001, BEHAV ECOL, V12, P768, DOI 10.1093/beheco/12.6.768; Hagman M, 2003, EVOLUTION, V57, P2904; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hegna RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2812; Ho S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150614; Hristov N, 2005, CHEMOECOLOGY, V15, P105, DOI 10.1007/s00049-005-0301-0; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kaiser P.K, 1996, HUMAN COLOR VISION; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kauppinen J, 2003, ANIM BEHAV, V66, P505, DOI 10.1006/anbe.2003.2225; KODRICBROWN A, 1985, BEHAV ECOL SOCIOBIOL, V17, P199, DOI 10.1007/BF00300137; Langham GM, 2004, EVOLUTION, V58, P2783; LEIMAR O, 1986, AM NAT, V128, P469, DOI 10.1086/284581; Lindstrom L, 1999, BEHAV ECOL, V10, P317, DOI 10.1093/beheco/10.3.317; Lyytinen A, 1999, EVOL ECOL, V13, P709, DOI 10.1023/A:1011081800202; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Marshall Justin, 2014, Curr Biol, V24, pR1150, DOI 10.1016/j.cub.2014.10.025; Merrill RM, 2015, J EVOLUTION BIOL, V28, P1417, DOI 10.1111/jeb.12672; Merrill RM, 2012, P ROY SOC B-BIOL SCI, V279, P4907, DOI 10.1098/rspb.2012.1968; MOORE BP, 1981, INSECT BIOCHEM, V11, P493, DOI 10.1016/0020-1790(81)90016-0; Morehouse NI, 2010, AM NAT, V176, P768, DOI 10.1086/657043; Muller CJ, 2013, J BIOGEOGR, V40, P881, DOI 10.1111/jbi.12040; Naisbit RE, 2001, P ROY SOC B-BIOL SCI, V268, P1849, DOI 10.1098/rspb.2001.1753; Oliver JC, 2009, P ROYAL SOC LONDON B; Olofsson M, 2013, BIOL J LINN SOC, V109, P290, DOI 10.1111/bij.12063; Olsson P, 2015, J EXP BIOL, V218, P184, DOI 10.1242/jeb.111187; Orr A.G., 1999, Australian Entomologist, V26, P45; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; Prudic KL, 2014, P ROYAL SOC LONDON B, V282; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; ROPER TJ, 1986, Q J EXP PSYCHOL-B, V38, P141; ROPER TJ, 1994, OIKOS, V69, P115, DOI 10.2307/3545290; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Santos JC, 2003, P NATL ACAD SCI USA, V100, P12792, DOI 10.1073/pnas.2133521100; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Stevens M, 2012, P ROY SOC B-BIOL SCI, V279, P417, DOI 10.1098/rspb.2011.1932; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Tan H., 2012, CATERPILLARS SINGAPO; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wang IJ, 2008, EVOLUTION, V62, P2742, DOI 10.1111/j.1558-5646.2008.00507.x; Westerman EL, 2012, P NATL ACAD SCI USA, V109, P10948, DOI 10.1073/pnas.1118378109; Zaccardi G, 2006, J EXP BIOL, V209, P1944, DOI 10.1242/jeb.02207	63	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168243	10.1371/journal.pone.0168243	http://dx.doi.org/10.1371/journal.pone.0168243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060944	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500026
J	Evers, EG; Pielaat, A; Smid, JH; van Duijkeren, E; Vennemann, FBC; Wijnands, LM; Chardon, JE				Evers, Eric G.; Pielaat, Annemarie; Smid, Joost H.; van Duijkeren, Engeline; Vennemann, Francy B. C.; Wijnands, Lucas M.; Chardon, Jurgen E.			Comparative Exposure Assessment of ESBL-Producing Escherichia coli through Meat Consumption	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; BACTERIAL CROSS-CONTAMINATION; LIVING AND/OR WORKING; EXTENDED-SPECTRUM; LISTERIA-MONOCYTOGENES; RISK-ASSESSMENT; SALMONELLA-TYPHIMURIUM; CAMPYLOBACTER-JEJUNI; CUTTING BOARDS; CHICKEN MEAT	The presence of extended-spectrum beta-lactamase (ESBL) and plasmidic AmpC (pAmpC) producing Escherichia coli (EEC) in food animals, especially broilers, has become a major public health concern. The aim of the present study was to quantify the EEC exposure of humans in The Netherlands through the consumption of meat from different food animals. Calculations were done with a simplified Quantitative Microbiological Risk Assessment (QMRA) model. The model took the effect of pre-retail processing, storage at the consumers home and preparation in the kitchen (cross-contamination and heating) on EEC numbers on/in the raw meat products into account. The contribution of beef products (78%) to the total EEC exposure of the Dutch population through the consumption of meat was much higher than for chicken (18%), pork (4.5%), veal (0.1%) and lamb (0%). After slaughter, chicken meat accounted for 97% of total EEC load on meat, but chicken meat experienced a relatively large effect of heating during food preparation. Exposure via consumption of filet americain (a minced beef product consumed raw) was predicted to be highest (61% of total EEC exposure), followed by chicken fillet (13%). It was estimated that only 18% of EEC exposure occurred via cross-contamination during preparation in the kitchen, which was the only route by which EEC survived for surface-contaminated products. Sensitivity analysis showed that model output is not sensitive for most parameters. However, EEC concentration on meat other than chicken meat was an important data gap. In conclusion, the model assessed that consumption of beef products led to a higher exposure to EEC than chicken products, although the prevalence of EEC on raw chicken meat was much higher than on beef. The (relative) risk of this exposure for public health is yet unknown given the lack of a modelling framework and of exposure studies for other potential transmission routes.	[Evers, Eric G.; Pielaat, Annemarie; van Duijkeren, Engeline; Wijnands, Lucas M.; Chardon, Jurgen E.] RIVM, Natl Inst Publ Hlth & Environm, Clb, Ctr Infect Dis Control, Bilthoven, Netherlands; [Smid, Joost H.] niv Utrecht, Inst Risk Assessment Sci IRAS, Utrecht, Netherlands; [Vennemann, Francy B. C.] RIVM, Natl Inst Publ Hlth & Environm, Publ Hlth & Hlth Serv Div, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Netherlands National Institute for Public Health & the Environment	Evers, EG (corresponding author), RIVM, Natl Inst Publ Hlth & Environm, Clb, Ctr Infect Dis Control, Bilthoven, Netherlands.	eric.evers@rivm.nl		Evers, Eric/0000-0003-4689-3169	Ministry of Health, Welfare and Sports [V/050241/15/AB]	Ministry of Health, Welfare and Sports	This work was financially supported by the Ministry of Health, Welfare and Sports (www.government.nl/ministries/ministry-of-health-welfare-and-sport), grant number V/050241/15/AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on the Microbiological Safety of Food (ACMSF), 2007, REP SAF COOK BURG; Bollaerts KE, 2009, RISK ANAL, V29, P820, DOI 10.1111/j.1539-6924.2009.01223.x; CARSON MO, 1987, J FOOD PROTECT, V50, P327, DOI 10.4315/0362-028X-50.4.327; Chardon J, 2016, J FOOD PROTECT, V79, P1221, DOI 10.4315/0362-028X.JFP-15-448; Chen YH, 2001, J FOOD PROTECT, V64, P72, DOI 10.4315/0362-028X-64.1.72; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; Depoorter P, 2012, INT J FOOD MICROBIOL, V159, P30, DOI 10.1016/j.ijfoodmicro.2012.07.026; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Ducic M, 2016, FOOD CONTROL, V59, P400, DOI 10.1016/j.foodcont.2015.06.014; Evers EG, 2016, RISK ANAL, V36, P215, DOI 10.1111/risa.12433; Evers EG, 2010, FOOD CONTROL, V21, P319, DOI 10.1016/j.foodcont.2009.06.013; Gellynck X, 2008, J FOOD PROTECT, V71, P479, DOI 10.4315/0362-028X-71.3.479; Ghafir Y, 2008, J FOOD PROTECT, V71, P35, DOI 10.4315/0362-028X-71.1.35; Gilbert SE, 2007, INT J FOOD MICROBIOL, V117, P306, DOI 10.1016/j.ijfoodmicro.2007.05.004; Gkogka E, 2013, INT J FOOD MICROBIOL, V167, P8, DOI 10.1016/j.ijfoodmicro.2013.04.013; GLASS KA, 1992, APPL ENVIRON MICROB, V58, P2513, DOI 10.1128/AEM.58.8.2513-2516.1992; Goh SG, 2014, FOOD CONTROL, V37, P51, DOI 10.1016/j.foodcont.2013.08.030; Greenland K., 2009, EURO SURVEILLANCE, V14; Heir E, 2010, INT J FOOD MICROBIOL, V141, P195, DOI 10.1016/j.ijfoodmicro.2010.05.017; Henderson HHF, 2008, HET NIEUWE KOOKBOEK; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Huijbers PMC, 2015, ENVIRON SCI TECHNOL, V49, P11993, DOI 10.1021/acs.est.5b02566; Huijbers PMC, 2015, VET MICROBIOL, V176, P120, DOI 10.1016/j.vetmic.2014.12.010; Hwang CA, 2009, INT J FOOD MICROBIOL, V129, P244, DOI 10.1016/j.ijfoodmicro.2008.12.003; ICMSF, 1996, MICR FOODS 5 CHAR MI; ILSI, 2012, RISK ASS APPR SETT T; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kusumaningrum HD, 2004, J FOOD PROTECT, V67, P1892, DOI 10.4315/0362-028X-67.9.1892; Lahou E, 2015, INT J FOOD MICROBIOL, V206, P118, DOI 10.1016/j.ijfoodmicro.2015.04.014; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Luber P, 2006, APPL ENVIRON MICROB, V72, P66, DOI 10.1128/AEM.72.1.66-70.2006; MARAN, MON ANT RES ANT US A; Moller COD, 2015, INT J FOOD MICROBIOL, V196, P109, DOI 10.1016/j.ijfoodmicro.2014.10.010; Montville R, 2003, APPL ENVIRON MICROB, V69, P7188, DOI 10.1128/AEM.69.12.7188-7193.2003; Montville R, 2001, J FOOD PROTECT, V64, P845, DOI 10.4315/0362-028X-64.6.845; Mylius SD, 2007, RISK ANAL, V27, P803, DOI 10.1111/j.1539-6924.2006.00872.x; Nauta MJ, 2003, INT J FOOD MICROBIOL, V83, P205, DOI 10.1016/S0168-1605(02)00374-4; Nauta MJ, 2005, 250911006 RIVM; Nesbitt A., 2006, FOOD CONSUMPTION PAT; Ocke A MC, 2013, 050413001 RIVM; Ocke MC, 2008, 350070001 RIVM; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paltansing S, 2013, EMERG INFECT DIS, V19, P1206, DOI [10.3201/eid1908.130257, 10.3201/eid.1908.130257]; Phang HS, 2011, J FOOD PROTECT, V74, P1708, DOI 10.4315/0362-028X.JFP-10-417; Ravishankar S, 2010, FOOD MICROBIOL, V27, P791, DOI 10.1016/j.fm.2010.04.011; Researchcommissie van het Bedrijfschap Slagersbedrijf, 1994, REC INF SLAG BEDR SL; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Rodriguez A, 2007, J FOOD PROTECT, V70, P1423, DOI 10.4315/0362-028X-70.6.1423; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Ryu JH, 1999, FOOD MICROBIOL, V16, P309, DOI 10.1006/fmic.1998.0233; Schaffner DW, 2007, J FOOD PROTECT, V70, P109, DOI 10.4315/0362-028X-70.1.109; Schijyen JF, 2015, ENVIRON SCI TECHNOL, V49, P11825, DOI 10.1021/acs.est.5b01888; Signorini ML, 2013, PREV VET MED, V109, P37, DOI 10.1016/j.prevetmed.2012.09.011; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Smadi H, 2013, RISK ANAL, V33, P232, DOI 10.1111/j.1539-6924.2012.01841.x; SMC, 2004, NAT CONS FOOD SAF SU; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Tamplin ML, 2005, INT J FOOD MICROBIOL, V100, P335, DOI 10.1016/j.ijfoodmicro.2004.10.029; Tamplin ML, 2002, J FOOD PROTECT, V65, P1535, DOI 10.4315/0362-028X-65.10.1535; Tang JYH, 2011, LETT APPL MICROBIOL, V52, P581, DOI 10.1111/j.1472-765X.2011.03039.x; van Asselt ED, 2008, J APPL MICROBIOL, V105, P1392, DOI 10.1111/j.1365-2672.2008.03875.x; van Asselt E.D., 2012, INT J MICROBIOL; van Asselt ED, 2006, INT J FOOD MICROBIOL, V107, P73, DOI 10.1016/j.ijfoodmicro.2005.08.014; van Gerwen SJC, 1998, J FOOD PROTECT, V61, P1541, DOI 10.4315/0362-028X-61.11.1541; van Hoek AHAM, 2015, INT J FOOD MICROBIOL, V204, P1, DOI 10.1016/j.ijfoodmicro.2015.03.014; van Rossum CTM, 2011, 350050006 RIVM; Verhoeff-Bakkenes L, 2008, J FOOD PROTECT, V71, P1018, DOI 10.4315/0362-028X-71.5.1018; Voedingscentrum, 1999, HYG PRIV HUISH; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Vriese S. de, 2005, Archives of Public Health, V63, P1; Wachtel MR, 2003, J FOOD PROTECT, V66, P1176, DOI 10.4315/0362-028X-66.7.1176; Wareing P, 2010, WORKING COMPANION FO; Wyne M., 2001, CONSUMER KNOWLEDGE P; Zhao P, 1998, J FOOD PROTECT, V61, P960, DOI 10.4315/0362-028X-61.8.960	77	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169589	10.1371/journal.pone.0169589	http://dx.doi.org/10.1371/journal.pone.0169589			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AE	28056081	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100057
J	Kim, HJ; Lee, J; Park, M; Kim, Y; Lee, H; Kim, DK; Joo, KW; Kim, YS; Cho, EJ; Ahn, C; Oh, KH				Kim, Hyo Jin; Lee, Joongyub; Park, Miseon; Kim, Yuri; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Cho, Eun Jin; Ahn, Curie; Oh, Kook-Hwan			Lower Education Level Is a Risk Factor for Peritonitis and Technique Failure but Not a Risk for Overall Mortality in Peritoneal Dialysis under Comprehensive Training System	PLOS ONE			English	Article							CORD INJURY PATIENTS; RETROSPECTIVE COHORT; SKIN FLORA; PREDICTORS; SURVIVAL; CARE; COLONIZATION; DETERMINANTS; COMORBIDITY; CREATININE	Background Lower education level could be a risk factor for higher peritoneal dialysis (PD)-associated peritonitis, potentially resulting in technique failure. This study evaluated the influence of lower education level on the development of peritonitis, technique failure, and overall mortality. Methods Patients over 18 years of age who started PD at Seoul National University Hospital between 2000 and 2012 with information on the academic background were enrolled. Patients were divided into three groups: middle school or lower (academic year <= 9, n = 102), high school (9<academic year <= 12, n = 229), and higher than high school (academic year>12, n = 324). Outcomes were analyzed using Cox proportional hazards models and competing risk regression. Results A total of 655 incident PD patients (60.9% male, age 48.4+/-14.1 years) were analyzed. During follow-up for 41 (interquartile range, 20-65) months, 255 patients (38.9%) experienced more than one episode of peritonitis, 138 patients (21.1%) underwent technique failure, and 78 patients (11.9%) died. After adjustment, middle school or lower education group was an independent risk factor for peritonitis (adjusted hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.10-2.36; P=0.015) and technique failure (adjusted HR, 1.87; 95% CI, 1.103.18; P= 0.038), compared with higher than high school education group. However, lower education was not associated with increased mortality either by as-treated (adjusted HR, 1.11; 95% CI, 0.53-2.33; P= 0.788) or intent-to-treat analysis (P=0.726). Conclusions Although lower education was a significant risk factor for peritonitis and technique failure, it was not associated with increased mortality in PD patients. Comprehensive training and multidisciplinary education may overcome the lower education level in PD.	[Kim, Hyo Jin] Dongguk Univ, Gyeongju Hosp, Dept Internal Med, Gyeongju Si, Gyeongsangbuk D, South Korea; [Lee, Joongyub] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Park, Miseon; Kim, Yuri; Lee, Hajeong; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Ahn, Curie; Oh, Kook-Hwan] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Cho, Eun Jin] Hongseong Med Ctr, Dept Internal Med, Hongseong, South Korea	Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Oh, KH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	khoh@snu.ac.kr	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852				Brown MC, 2011, PERITON DIALYSIS INT, V31, P639, DOI 10.3747/pdi.2010.00185; Chern YB, 2013, PERITON DIALYSIS INT, V33, P552, DOI 10.3747/pdi.2012.00065; Chidambaram M, 2011, PERITON DIALYSIS INT, V31, P565, DOI 10.3747/pdi.2010.00096; CHIN P, 1976, J HYG-CAMBRIDGE, V77, P93, DOI 10.1017/S0022172400055558; Cho EJ, 2012, NEPHROLOGY, V17, P472, DOI 10.1111/j.1440-1797.2012.01598.x; Davenport A, 2009, PERITON DIALYSIS INT, V29, P297; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; de Moraes TP, 2014, PERITON DIALYSIS INT, V34, P714, DOI 10.3747/pdi.2013.00282; Fan XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107485; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gould D, 1994, J Clin Nurs, V3, P339, DOI 10.1111/j.1365-2702.1994.tb00410.x; Kumar VA, 2014, PERITON DIALYSIS INT, V34, P171, DOI 10.3747/pdi.2012.00165; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Martin LC, 2011, CLIN J AM SOC NEPHRO, V6, P1944, DOI 10.2215/CJN.11431210; MONTGOMERIE JZ, 1980, AM J EPIDEMIOL, V112, P508, DOI 10.1093/oxfordjournals.aje.a113020; MONTGOMERIE JZ, 1989, J CLIN MICROBIOL, V27, P1613, DOI 10.1128/JCM.27.7.1613-1616.1989; NOBLE WC, 1974, BRIT J DERMATOL, V91, P201, DOI 10.1111/j.1365-2133.1974.tb15866.x; O'Shea S, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-19; Oliver MJ, 2007, KIDNEY INT, V71, P673, DOI 10.1038/sj.ki.5002107; Oliver MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2737, DOI 10.1093/ndt/gfq085; Shen JI, 2013, PERITON DIALYSIS INT, V33, P155, DOI 10.3747/pdi.2011.00233; SIEKMANN L, 1985, J CLIN CHEM CLIN BIO, V23, P137; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Yang ZK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095894	27	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169063	10.1371/journal.pone.0169063	http://dx.doi.org/10.1371/journal.pone.0169063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056058	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100018
J	Park, HY; Park, JW; Song, HJ; Sohn, HS; Kwon, JW				Park, Hae-Young; Park, Ji-Won; Song, Hong Ji; Sohn, Hyun Soon; Kwon, Jin-Won			The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATIONS; DWELLING OLDER-ADULTS; BODY-MASS INDEX; ELDERLY-PATIENTS; PEOPLE; RISK; OUTCOMES; MULTIMORBIDITY; PREVALENCE; FAILURE	Dementia is a major concern among growing chronic diseases in the aging society and its association with polypharmacy has not been adequately assessed. The objective of this study was to determine the association between polypharmacy and dementia through multiple statistical approaches. We conducted a nested case-control study for newly diagnosed dementia cases using the South Korean National Health Insurance Service sample cohort database (2002-2013, n = 1,025,340). Interactions between polypharmacy (an average use of >= 5 prescription drugs daily) and comorbidities or potentially inappropriate medications (PIMs) were tested. The odds ratios (ORs) for dementia were analyzed according to the presence of comorbidities, PIM uses, the average number of prescribed daily drugs, and significant interactions with polypharmacy using univariate and multiple logistic regression analyses. A higher prevalence of comorbidities, history of PIM use, higher PIM exposure, and higher proportion of polypharmacy were noted among cases than in controls. In the univariate analysis, the OR for dementia increased significantly with the increase in the number of prescribed drugs [1-<5 drugs: 1.72, 95% confidence interval (CI): 1.56-1.88; 5-<10 drugs: 2.64, 95% CI: 2.32-3.05; >= 10 drugs: 3.35, 95% CI: 2.38-4.71; <1 drug used as reference]. Polypharmacy was correlated with comorbidities and PIM use, and significant interactions were observed between polypharmacy and anticholinergics; H2-receptor antagonists; and comorbidities such as hypertension, peripheral or cerebrovascular disease, congestive heart failure, hemiplegia, diabetes, depression, all other mental disorders, chronic obstructive pulmonary disease, peptic ulcer disease, and chronic liver disease (p<0.001). In the multiple regression analysis, most cases exhibited increasing ORs for dementia with increasing polypharmacy levels. Moreover, the increase in OR was more evident in the absence of drugs or comorbidities that showed significant interactions with poly pharmacy than in their presence. Polypharmacy increases the risk of PIM administration, and as some PIMs may have cognition-impairing effects, prolonged polypharmacy may result in dementia. Therefore, efforts are needed to limit or decrease the prescription of medications that have been associated with risk of dementia in the elderly.	[Park, Hae-Young; Kwon, Jin-Won] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Park, Hae-Young; Kwon, Jin-Won] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Daegu, South Korea; [Park, Ji-Won] Kyungpook Natl Univ, Coll Nat Sci, Daegu, South Korea; [Song, Hong Ji] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Gyeonggi Do, South Korea; [Sohn, Hyun Soon] CHA Univ, Grad Sch Clin Pharm, Gyeonggi Do, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Hallym University; Pochon Cha University	Kwon, JW (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Kwon, JW (corresponding author), Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Daegu, South Korea.	jwkwon@knu.ac.kr		Park, Hae-Young/0000-0001-8348-0887	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2015R1C1A2A01052768]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (no. 2015R1C1A2A01052768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhmoud E, 2015, INT J CLIN PHARM-NET, V37, P815, DOI 10.1007/s11096-015-0125-0; Andersen F, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-58; [Anonymous], 2011, WORKSH HLTH PROM PRO; Boustani M, 2007, J AM GERIATR SOC, V55, P1248, DOI 10.1111/j.1532-5415.2007.01270.x; Brown J, 2015, J NEUROL NEUROSUR PS, V86, P680, DOI 10.1136/jnnp-2014-309086; Dohoo IR, 1997, PREV VET MED, V29, P221, DOI 10.1016/S0167-5877(96)01074-4; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Dublin S, 2015, J AM GERIATR SOC, V63, P1519, DOI 10.1111/jgs.13562; Evans MD, 2011, SEIZURE-EUR J EPILEP, V20, P509, DOI 10.1016/j.seizure.2011.02.009; Fields J, 2015, CURR THER RES CLIN E, V77, P79, DOI 10.1016/j.curtheres.2015.08.002; Franchi C, 2016, PHARMACOEPIDEM DR S, V25, P204, DOI 10.1002/pds.3938; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Gallacher KI, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0151-0; Garcia-Ptacek S, 2014, EUR J CLIN NUTR, V68, P1204, DOI 10.1038/ejcn.2014.199; Garfinkel D, 2015, THER ADV DRUG SAF, V6, P212, DOI 10.1177/2042098615613984; Gillette C, 2015, RES SOC ADMIN PHARM, V11, P468, DOI 10.1016/j.sapharm.2014.08.010; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Grandner MA, 2015, OBESITY, V23, P2491, DOI 10.1002/oby.21247; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Gupta M, 2013, BMJ CASE REPORTS, P2013; Haenisch B, 2015, EUR ARCH PSY CLIN N, V265, P419, DOI 10.1007/s00406-014-0554-0; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hwang Hee-Jin, 2015, Drugs Real World Outcomes, V2, P355, DOI 10.1007/s40801-015-0046-1; Jung YH, 2013, 20133119 KOR I HLTH; Jyrkka J, 2011, PHARMACOEPIDEM DR S, V20, P514, DOI 10.1002/pds.2116; Kim KW, 2011, J ALZHEIMERS DIS, V23, P279, DOI 10.3233/JAD-2010-101221; Kim KW, 2011, STUDY DEMENTED ELDER; Kim Kyoungnam, 2015, [Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology, 예술인문사회 융합 멀티미디어 논문지], V5, P197, DOI 10.14257/AJMAHS.2015.06.22; Korean Statisticcal Information Service, EST FUT POP; Lai SW, 2012, GERIATR GERONTOL INT, V12, P491, DOI 10.1111/j.1447-0594.2011.00800.x; Lau DT, 2011, AM J ALZHEIMERS DIS, V26, P606, DOI 10.1177/1533317511432734; Lau DT, 2010, ALZ DIS ASSOC DIS, V24, P56, DOI 10.1097/WAD.0b013e31819d6ec9; Lebedev AV, 2014, AM J GERIATRIC PSYCH, V22; Lee Juneyoung, 2016, INT J EPIDEMIOLOGY; LoGiudice D, 2014, INTERN MED J, V44, P1066, DOI 10.1111/imj.12572; Marengoni A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1059; Martin Prince EA, 2014, WORLD ALZHEIMER REPO; Montastruc F, 2013, EUR J CLIN PHARMACOL, V69, P1589, DOI 10.1007/s00228-013-1506-8; National Institute on Aging National Institutes of Health, 2011, NIH PUBLICATION, V11-7737; Onder G, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.03.014; Park HY, 2016, INT J CLIN PHARM TH, V54, P369, DOI 10.5414/CP202484; Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2; Pedditizi E, 2016, AGE AGEING, V45, P14, DOI 10.1093/ageing/afv151; Peng D., 2011, GLOBAL BURDEN DEMENT; PERROTTA M, 2016, INT J MOL SCI, V17; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Sakakibara M, 2015, J PHARM PHARM SCI, V18, P705, DOI 10.18433/J37P5X; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Turner JP, 2015, SUPPORTIVE CARE CANC; Viswanathan H, 2005, CLIN THER, V27, P88, DOI 10.1016/j.clinthera.2005.01.009; Wang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142123; Wolkowitz OM, 2004, ANN NY ACAD SCI, V1032, P191, DOI 10.1196/annals.1314.018; Wolkowitz OM, 2007, NEUROCASE, V13, P189, DOI 10.1080/13554790701475468; World Health Organization, AG HLTH TECHN REP GL, V5; Zhong GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127836	58	48	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169463	10.1371/journal.pone.0169463	http://dx.doi.org/10.1371/journal.pone.0169463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AE	28056068	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100044
J	Salinas, D; Minor, CA; Carlson, RP; McCutchen, CN; Mumey, BM; June, RK				Salinas, Daniel; Minor, Cody A.; Carlson, Ross P.; McCutchen, Carley N.; Mumey, Brendan M.; June, Ronald K.			Combining Targeted Metabolomic Data with a Model of Glucose Metabolism: Toward Progress in Chondrocyte Mechanotransduction	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; PERICELLULAR MATRIX; OSTEOARTHRITIS; EPIDEMIOLOGY; COMPRESSION; PATTERNS	Osteoarthritis is a debilitating disease likely involving altered metabolism of the chondrocytes in articular cartilage. Chondrocytes can respond metabolically to mechanical loads via cellular mechanotransduction, and metabolic changes are significant because they produce the precursors to the tissue matrix necessary for cartilage health. However, a comprehensive understanding of how energy metabolism changes with loading remains elusive. To improve our understanding of chondrocyte mechanotransduction, we developed a computational model to calculate the rate of reactions (i.e. flux) across multiple components of central energy metabolism based on experimental data. We calculated average reaction flux profiles of central metabolism for SW1353 human chondrocytes subjected to dynamic compression for 30 minutes. The profiles were obtained solving a bounded variable linear least squares problem, representing the stoichiometry of human central energy metabolism. Compression synchronized chondrocyte energy metabolism. These data are consistent with dynamic compression inducing early time changes in central energy metabolism geared towards more active protein synthesis. Furthermore, this analysis demonstrates the utility of combining targeted metabolomic data with a computational model to enable rapid analysis of cellular energy utilization.	[Salinas, Daniel; Mumey, Brendan M.] Montana State Univ, Comp Sci, Bozeman, MT 59717 USA; [Minor, Cody A.] Montana State Univ, Math, Bozeman, MT 59717 USA; [Carlson, Ross P.] Montana State Univ, Chem & Biol Engn, Bozeman, MT 59717 USA; [McCutchen, Carley N.; June, Ronald K.] Montana State Univ, Mech & Ind Engn, Bozeman, MT 59717 USA; [June, Ronald K.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [June, Ronald K.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Washington; University of Washington Seattle	June, RK (corresponding author), Montana State Univ, Mech & Ind Engn, Bozeman, MT 59717 USA.; June, RK (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.; June, RK (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	rjune@montana.edu		Mumey, Brendan/0000-0001-7151-2124; June, Ronald/0000-0003-0752-4109	NIH [P20GM10339405S1]; NSF [1342420, 1554708]; Montana State University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Montana State University	Funding was provided by NIH P20GM10339405S1 (www.nih.gov) to RKJ, NSF 1342420 and 1554708 (www.nsf.gov) to RKJ, and Montana State University (www.montana.edu) to RKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton H., 2010, ELEMENTARY LINEAR AL; Brouillette MJ, 2014, BIOMECH MODEL MECHAN, V13, P565, DOI 10.1007/s10237-013-0518-8; Buckwalter JA, 2013, CARTILAGE, V4, P286, DOI 10.1177/1947603513495889; Carter TE, 2015, J BIOMECH, V48, P1461, DOI 10.1016/j.jbiomech.2015.02.030; Cheng NT, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0995-x; Coleman MC, 2016, ARTHRITIS RHEUMATOL, V68, P662, DOI 10.1002/art.39460; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Guilak F, 2005, ANN BIOMED ENG, V33, P1312, DOI 10.1007/s10439-005-4479-7; HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Jutila AA, 2015, ANN BIOMED ENG, V43, P1132, DOI 10.1007/s10439-014-1183-5; Jutila AA, 2014, ARCH BIOCHEM BIOPHYS, V545, P116, DOI 10.1016/j.abb.2014.01.011; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Lane RS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0566-9; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liu X, 2015, BIOCHEM BIOPH RES CO, V459, P636, DOI 10.1016/j.bbrc.2015.02.162; Martin JA, 2012, OSTEOARTHR CARTILAGE, V20, P323, DOI 10.1016/j.joca.2012.01.003; McDermott BT, 2016, OSTEOARTHRITIS CARTI; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Parker SJ, 2015, PHARMACOL THERAPEUT, V152, P54, DOI 10.1016/j.pharmthera.2015.05.003; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Ruiz-Romero C, 2006, OSTEOARTHR CARTILAGE, V14, P507, DOI 10.1016/j.joca.2005.12.004; Ruiz-Romero C, 2008, PROTEOMICS, V8, P495, DOI 10.1002/pmic.200700249; Seol D, 2012, ARTHRITIS RHEUM-US, V64, P3626, DOI 10.1002/art.34613; Snelling SJB, 2016, OSTEOARTHR CARTILAGE, V24, P883, DOI 10.1016/j.joca.2015.11.021; Stephanopoulos G., 1998, METAB ENG; Taffs R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-114; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Vincent TL, 2007, OSTEOARTHR CARTILAGE, V15, P752, DOI 10.1016/j.joca.2007.01.021; Walpole R, 1974, INTRO STATISTICS, P340; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Willick SE, 2010, CLIN SPORT MED, V29, P417, DOI 10.1016/j.csm.2010.03.006; Zelenski NA, 2015, ARTHRITIS RHEUMATOL, V67, P1286, DOI 10.1002/art.39034; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	41	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168326	10.1371/journal.pone.0168326	http://dx.doi.org/10.1371/journal.pone.0168326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056047	gold, Green Submitted, Green Published			2022-12-26	WOS:000391639100004
J	Faysal, KMR; Park, JS; Nguyen, J; Garcia, L; Subramaniam, AB				Faysal, K. M. Rifat; Park, June S.; Nguyen, Jonny; Garcia, Luis; Subramaniam, Anand Bala			Lipid Bilayers Are Long-Lived on Solvent Cleaned Plasma-Oxidized poly(dimethyl) siloxane (ox-PDMS)	PLOS ONE			English	Article							HYDROPHOBIC RECOVERY; SURFACE MODIFICATION; OXYGEN PLASMA; MEMBRANES; POLYDIMETHYLSILOXANE; PROTEINS; ULTRAVIOLET; SUPPORTS; PHASES; ARRAYS	Although it is well known that phospholipids self-assemble on hydrophilic plasma-oxidized PMDS surfaces (ox-PDMS) to form cell membrane mimetic bilayers, the temporal stability of phospholipid membranes on these surfaces is unknown. Here we report that phospholipid bilayers remain stable on solvent-cleaned ox-PDMS for at least 132 hours after preparation. Absent solvent cleaning, the bilayers were stable for only 36 hours. We characterized the phospholipid bilayers, i) through quantitative comparative analysis of the fluorescence intensity of phospholipid bilayers on ox-PDMS and phospholipid monolayers on native PDMS and, ii) through measurements of the diffusive mobility of the lipids through fluorescence recovery after photobleaching (FRAP). The fluorescence intensity of the phospholipid layer remained consistent with that of a bilayer for 132 hours. The evolution of the diffusive mobility of the phospholipids in the bilayer on ox-PDMS over time was similar to lipids in control bilayers prepared on glass surfaces. Solvent cleaning was essential for the long-term stability of the bilayers on ox-PDMS. Without cleaning in acetone and isopropanol, phospholipid bilayers prepared on ox-PDMS surfaces peeled off in large patches within 36 hours. Importantly, we find that phospholipid bilayers supported on solvent-cleaned ox-PDMS were indistinguishable from phospholipid bilayers supported on glass for at least 36 hours after preparation. Our results provide a link between the two common surfaces used to prepare in vitro biomimetic phospholipid membranes-i) glass surfaces used predominantly in fundamental biophysical experiments, for which there is abundant physicochemical information, with ii) ox-PDMS, the dominant material used in practical, applications-oriented systems to build micro-devices, topographically-patterned surfaces, and biosensors where there is a dearth of information.	[Faysal, K. M. Rifat] Univ Calif Merced, Sch Nat Sci, Dept Phys, Merced, CA USA; [Park, June S.; Nguyen, Jonny; Garcia, Luis; Subramaniam, Anand Bala] Univ Calif Merced, Sch Engn, Dept Bioengn, Merced, CA 95340 USA	University of California System; University of California Merced; University of California System; University of California Merced	Subramaniam, AB (corresponding author), Univ Calif Merced, Sch Engn, Dept Bioengn, Merced, CA 95340 USA.	asubramaniam@ucmerced.edu		Subramaniam, Anand/0000-0002-1998-9299	National Science Foundation [CBET-1512686]; National Science Foundation REU Award [DMR-1359406]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation REU Award(National Science Foundation (NSF))	This work was supported by the National Science Foundation CBET-1512686. ABS, KMRF, JN and the National Science Foundation REU Award Number DMR-1359406. JSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644; Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037; Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195; Bourgaux C, 2014, J CONTROL RELEASE, V190, P127, DOI 10.1016/j.jconrel.2014.05.012; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Eddington DT, 2006, SENSOR ACTUAT B-CHEM, V114, P170, DOI 10.1016/j.snb.2005.04.037; Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.2002.8594; Feriani L, 2014, CHEM PHYS LIPIDS, V185, P1; Hillborg H, 2000, POLYMER, V41, P6851, DOI 10.1016/S0032-3861(00)00039-2; Hovis JS, 2001, LANGMUIR, V17, P3400, DOI 10.1021/la0017577; Hsieh WT, 2012, LANGMUIR, V28, P12838, DOI 10.1021/la302205b; Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w; Kaigala GV, 2012, ANGEW CHEM INT EDIT, V51, P11224, DOI 10.1002/anie.201201798; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kitazoe K, 2011, LAB CHIP, V11, P3256, DOI 10.1039/c1lc20392d; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lenz P, 2004, LANGMUIR, V20, P11092, DOI 10.1021/la048450i; Medina-Plaza C, 2014, BIOSENS BIOELECTRON, V57, P276, DOI 10.1016/j.bios.2014.02.023; Mylonas C, 1999, IN VIVO, V13, P295; Nafday OA, 2012, SMALL, V8, P1021, DOI 10.1002/smll.201102096; Ogunyankin MO, 2013, ANALYST, V138, P3719, DOI 10.1039/c3an00020f; Ogunyankin MO, 2013, LANGMUIR, V29, P6109, DOI 10.1021/la401011d; Phillips KS, 2005, ANAL CHEM, V77, P327, DOI 10.1021/ac049356+; Reimhult E, 2008, TRENDS BIOTECHNOL, V26, P82, DOI 10.1016/j.tibtech.2007.11.004; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Sanii B, 2008, NANO LETT, V8, P866, DOI 10.1021/nl073085b; Scomparin C, 2009, EUR PHYS J E, V28, P211, DOI 10.1140/epje/i2008-10407-3; Staykova M, 2011, P NATL ACAD SCI USA, V108, P9084, DOI 10.1073/pnas.1102358108; Subramaniam AB, 2013, NAT MATER, V12, P128, DOI [10.1038/NMAT3492, 10.1038/nmat3492]; Subramaniam AB, 2010, ADV MATER, V22, P2142, DOI 10.1002/adma.200903625; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; Zhao LH, 2012, SENSOR ACTUAT A-PHYS, V181, P33, DOI 10.1016/j.sna.2012.04.038; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	35	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169487	10.1371/journal.pone.0169487	http://dx.doi.org/10.1371/journal.pone.0169487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052115	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500063
J	Dancs, PT; Ruisanchez, E; Balogh, A; Panta, CR; Miklos, Z; Nusing, RM; Aoki, J; Chun, J; Offermanns, S; Tigyi, G; Benyo, Z				Dancs, Peter Tibor; Ruisanchez, Eva; Balogh, Andrea; Panta, Cecilia Rita; Miklos, Zsuzsanna; Nuesing, Rolf M.; Aoki, Junken; Chun, Jerold; Offermanns, Stefan; Tigyi, Gabor; Benyo, Zoltan			LPA(1) receptor-mediated thromboxane A(2) release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction	FASEB JOURNAL			English	Article						LPA; vasoconstriction; endothelial dysfunction; platelet activation; TP receptor	SPONTANEOUSLY HYPERTENSIVE-RATS; AORTIC ENDOTHELIAL-CELLS; BLOOD-PRESSURE; CEREBRAL VASOSPASM; CA2+ INFLUX; IN-SITU; MOUSE; ANTAGONIST; ACTIVATION; DISCOVERY	Lysophosphatidic acid (LPA) has been recognized recently as an endothelium-dependent vasodilator, but several lines of evidence indicate that it may also stimulate vascular smooth muscle cells (VSMCs), thereby contributing to vasoregulation and remodeling. In the present study, mRNA expression of all 6 LPA receptor genes was detected in murine aortic VSMCs, with the highest levels of LPA(1), LPA(2), LPA(4), and LPA(6). In endothelium-denuded thoracic aorta (TA) and abdominal aorta (AA) segments, 1-oleoyl-LPA and the LPA(1-3) agonist VPC31143 induced dose-dependent vasoconstriction. VPC31143-induced AA contraction was sensitive to pertussis toxin (PTX), the LPA(1&3) antagonist Ki16425, and genetic deletion of LPA(1) but not that of LPA(2) or inhibition of LPA(3), by diacylglycerol pyrophosphate. Surprisingly, vasoconstriction was also diminished in vessels lacking cyclooxygenase-1 [COX1 knockout (KO)] or the thromboxane prostanoid (TP) receptor (TPKO). VPC31143 increased thromboxane A(2)(TXA(2)) release from TA of wild-type, TP-KO, and LPA(2)-KO mice but not from LPA(1)-KO or COX1-KO mice, and PTX blocked this effect. Our findings indicate that LPA causes vasoconstriction in VSMCs, mediated by LPA(1)-, G(i)-, and COX1-dependent autocrine/paracrine TXA(2) release and consequent TP activation. We propose that this new-found interaction between the LPA/LPA(1) and TXA(2)/TP pathways plays significant roles in vasoregulation, hemostasis, thrombosis, and vascular remodeling.-Dancs, P. T., Ruisanchez, E., Balogh, A., Panta, C. R., Miklos, Z., N " using, R. M., Aoki, J., Chun, J., Offermanns, S., Tigyi, G., Beny ' o, Z. LPA(1) receptor-mediated thromboxane A(2) release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.	[Dancs, Peter Tibor; Ruisanchez, Eva; Panta, Cecilia Rita; Miklos, Zsuzsanna; Benyo, Zoltan] Semmelweis Univ, Inst Expt Clin Res, Budapest, Hungary; [Balogh, Andrea; Tigyi, Gabor] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 894 Union Ave, Memphis, TN 38163 USA; [Nuesing, Rolf M.] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Semmelweis University; University of Tennessee System; University of Tennessee Health Science Center; Goethe University Frankfurt; Tohoku University; Sanford Burnham Prebys Medical Discovery Institute; Max Planck Society	Tigyi, G (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 894 Union Ave, Memphis, TN 38163 USA.; Benyo, Z (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, POB 2, H-1428 Budapest, Hungary.	gtigyi@uthsc.edu; benyo.zoltan@med.semmelweis-univ.hu	Chun, Jerold/Y-4670-2019; MiklÃs, Zsuzsanna/AAZ-2597-2021; Offermanns, Stefan/L-3313-2017	MiklÃs, Zsuzsanna/0000-0001-8577-4475; Panta, Cecilia Rita/0000-0003-4162-0882; Offermanns, Stefan/0000-0001-8676-6805	Hungarian Scientific Research Fund [K-101775, K-112964]; Fulbright Specialist Program [6458]; U.S. National Institutes of Health (NIH) National Cancer Institute [CA092160]; NIH National Institute of Neurological Disorders and Stroke [NS084398]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084398] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Fulbright Specialist Program; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Hungarian Scientific Research Fund (K-101775 and K-112964; to Z.B.), the Fulbright Specialist Program (Project ID 6458; to G.T.), the U.S. National Institutes of Health (NIH) National Cancer Institute (Grant CA092160; to G.T.), and the NIH National Institute of Neurological Disorders and Stroke (Grant NS084398; to J.C.). The authors thank Margit Kerek, Laszlo Hricisak, Ildiko Muranyi, and Agnes Fulop (Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary) for expert technical assistance and for managing the transgenic mouse colonies and Andras Kucsa (Semmelweis University) for graphic artwork of Figure 7.	Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Bot M, 2010, AM J PATHOL, V176, P3073, DOI 10.2353/ajpath.2010.090009; CHAN RC, 1984, J NEUROSURG, V61, P1120, DOI 10.3171/jns.1984.61.6.1120; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Fischer DJ, 2001, MOL PHARMACOL, V60, P776; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Horvath B, 2005, J CARDIOVASC PHARM, V45, P225, DOI 10.1097/01.fjc.0000154377.90069.b9; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; LaBelle EF, 1998, AM J PHYSIOL-CELL PH, V274, pC1129, DOI 10.1152/ajpcell.1998.274.4.C1129; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Mallem Y, 2005, AUTON NEUROSCI-BASIC, V118, P61, DOI 10.1016/j.autneu.2005.01.003; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MONG S, 1986, J PHARMACOL EXP THER, V239, P63; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; NEBIGIL C, 1993, J PHARMACOL EXP THER, V266, P1113; Niioka T, 2013, J CARDIOVASC PHARM, V62, P530, DOI 10.1097/FJC.0000000000000013; Ohata H, 2001, CIRC RES, V88, P925, DOI 10.1161/hh0901.090300; OHATA H, 1995, BIOCHEM BIOPH RES CO, V208, P19, DOI 10.1006/bbrc.1995.1299; Ohata H, 1996, LIFE SCI, V58, P2217, DOI 10.1016/0024-3205(96)00216-0; Ohata H, 2011, EXP PHYSIOL, V96, P468, DOI 10.1113/expphysiol.2011.056416; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Petitcolin MA, 2001, BIOCHEM PHARMACOL, V61, P485, DOI 10.1016/S0006-2952(00)00547-5; Ruisanchez E, 2014, FASEB J, V28, P880, DOI 10.1096/fj.13-234997; SASAKI T, 1982, J NEUROSURG, V57, P74, DOI 10.3171/jns.1982.57.1.0074; Schober A, 2012, BRIT J PHARMACOL, V167, P465, DOI 10.1111/j.1476-5381.2012.02021.x; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; SEN S, 1968, AM J PHYSIOL, V214, P337, DOI 10.1152/ajplegacy.1968.214.2.337; Sheng XY, 2015, DEVELOPMENT, V142, P1390, DOI 10.1242/dev.121723; Shibata K, 2011, J CARDIOVASC PHARM, V57, P604, DOI 10.1097/FJC.0b013e3182144174; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Smyth SS, 2014, ARTERIOSCL THROM VAS, V34, P479, DOI 10.1161/ATVBAHA.113.302737; Tamaruya Y, 2004, ANGEW CHEM INT EDIT, V43, P2834, DOI 10.1002/anie.200454065; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048, DOI 10.1152/ajpheart.1995.268.5.H2048; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; TOKUMURA A, 1991, J PHARM PHARMACOL, V43, P774, DOI 10.1111/j.2042-7158.1991.tb03480.x; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; TOKUMURA A, 1982, J PHARM PHARMACOL, V34, P514, DOI 10.1111/j.2042-7158.1982.tb04776.x; van Meijeren CE, 2004, EUR J PHARMACOL, V488, P127, DOI 10.1016/j.ejphar.2004.02.003; Yakubu M. A., 1997, AM J PHYS COMP INTEG, V42, pR703; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	53	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1547	1555		10.1096/fj.201600735R	http://dx.doi.org/10.1096/fj.201600735R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069828	Green Published			2022-12-26	WOS:000398504300022
J	Lesage, J; Suarez-Carmona, M; Neyrinck-Leglantier, D; Grelet, S; Blacher, S; Hunziker, W; Birembaut, P; Noel, A; Nawrocki-Raby, B; Gilles, C; Polette, M				Lesage, Julien; Suarez-Carmona, Meggy; Neyrinck-Leglantier, Deborah; Grelet, Simon; Blacher, Silvia; Hunziker, Walter; Birembaut, Philippe; Noel, Agnes; Nawrocki-Raby, Beatrice; Gilles, Christine; Polette, Myriam			Zonula occludens-1/NF-kappa B/CXCL8: a new regulatory axis for tumor angiogenesis	FASEB JOURNAL			English	Article						EMT; tumor progression; ZO-1; IL-8	EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX-METALLOPROTEINASE EXPRESSION; NF-KAPPA-B; LUNG-CANCER; VIMENTIN EXPRESSION; TIGHT JUNCTIONS; BETA-CATENIN; CELL-LINE; IN-VIVO; INTERLEUKIN-8	Zonula occludens-1 (ZO-1) is a submembrane scaffolding protein thatmay display proinvasive functions when it relocates from tight junctions into the cytonuclear compartment. This article examines the functional involvement of ZO-1 in CXCL8/ IL-8 chemokine expression in lung and breast tumor cells. ZO-1 small interfering RNA and cDNA transfection experiments emphasized regulation of CXCL8/ IL-8 expression via a cytonuclear pool of ZO-1. Luciferase reporter assays highlighted a 173-bp region of CXCL8/ IL-8 promoter that responded to ZO-1. Moreover, by using mutated promoter constructs, we identified a NF-kappa B site as critical in this activation. Furthermore, NF-kappa Bpathwaysignaling analysis revealedboth IkBaandp65phosphorylationinZO-1-overexpressingcells, and subsequent p65 silencing validated its requirement for CXCL8/ IL-8 induction. Investigation of the functional implication of this regulatory axis next showed the proangiogenic activity of ZO-1 in both ex vivo and in vivo angiogenesis assays. Finally, we found that non-small-cell lung carcinoma that presented a cytonuclear ZO-1 pattern was significantly more angiogenic that that without detectable cytonuclear ZO-1 expression. Taken together, our results demonstrate that ZO-1 regulatesCXCL8/IL-8 expression via theNF-kappa B signaling pathway and its p65 subunit, which subsequently modulates the transcription of IL-8. We also provide evidence of a newly identified regulatory pathway that could promote angiogenesis. Thus, our results support the concept that the ZO-1 shuttle from the cell junction to the cytonuclear compartment may affect both the intrinsic invasive properties of tumor cells and the establishment of the protumoral microenvironment.-Lesage, J., Suarez-Carmona, M., Neyrinck-Leglantier, D., Grelet, S., Blacher, S., Hunziker, W., Birembaut, P., No " el, A., Nawrocki-Raby, B., Gilles, C., Polette, M. Zonula occludens-1/ NF-kappa B/ CXCL8: a new regulatory axis for tumor angiogenesis. FASEB J. 31, 1678-1688 (2017). www.fasebj.org	[Lesage, Julien; Neyrinck-Leglantier, Deborah; Birembaut, Philippe; Nawrocki-Raby, Beatrice; Polette, Myriam] Univ Reims, Struct Federat Rech Champagne Ardennes Picardie S, INSERM, UMR S 903, Reims, France; [Suarez-Carmona, Meggy; Blacher, Silvia; Noel, Agnes; Gilles, Christine] Univ Liege, Lab Tumor & Dev Biol, Grappe Interdisciplinaire Genoproteom Appl GIGA C, Liege, Belgium; [Grelet, Simon] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC USA; [Hunziker, Walter] Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore; [Birembaut, Philippe; Polette, Myriam] Ctr Hosp Univ, Lab Biopathol, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; University of Liege; Medical University of South Carolina; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); CHU de Reims; Universite de Reims Champagne-Ardenne	Polette, M (corresponding author), INSERM, UMR S 903, 45 Rue Cognacq Jay, F-51100 Reims, France.	myriam.polette@univ-reims.fr	Raby, Beatrice/P-5666-2016; Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Raby, Beatrice/0000-0002-3163-8619; Hunziker, Walter/0000-0002-5265-4933; Noel, Agnes/0000-0002-7670-6179; Deborah, Neyrinck-Leglantier/0000-0001-9139-8680	Region Champagne-Ardenne, La Ligue Contre le Cancer; Lions Club of Soissons; Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI INCa (Canceropole Grand-Est Project); Fonds National de la Recherche Scientifique (FRS-FNRS); Partenariat Hubert Curien-Tournesol	Region Champagne-Ardenne, La Ligue Contre le Cancer; Lions Club of Soissons; Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI INCa (Canceropole Grand-Est Project); Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Partenariat Hubert Curien-Tournesol	This work was supported by Region Champagne-Ardenne, La Ligue Contre le Cancer (Comites de la Marne, HauteMarne, Meurthe-et-Moselle et Yonne), Lions Club of Soissons, Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI 2004-2010 INCa (Canceropole Grand-Est Project), Fonds National de la Recherche Scientifique (FRS-FNRS), and Partenariat Hubert Curien-Tournesol. The authors thank Marie Dehuy, Erika Konradowski, and Isabelle Dasoul (Laboratory of Tumor and Development Biology, University of Liege) for technical assistance. The authors also thank Christine Terryn (Plateforme en Imagerie Cellulaire et Tissulaire, University of Reims Champagne-Ardenne).	Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brysse A, 2012, MOL CANCER RES, V10, P121, DOI 10.1158/1541-7786.MCR-11-0180; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1111/j.1365-2249.2003.02305.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Gilles C, 2003, CANCER RES, V63, P2658; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Lenoir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092715; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Luczka E, 2013, CLIN EXP METASTAS, V30, P833, DOI 10.1007/s10585-013-9583-8; Maekawa K, 1999, BIOCHEM J, V337, P179, DOI 10.1042/0264-6021:3370179; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Murayama T, 1997, J VIROL, V71, P5692, DOI 10.1128/JVI.71.7.5692-5695.1997; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Resnick MB, 2005, HUM PATHOL, V36, P886, DOI 10.1016/j.humpath.2005.05.019; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; SOMMERS CL, 1992, CANCER RES, V52, P5190; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Suarez-Carmona M, 2015, J PATHOL, V236, P491, DOI 10.1002/path.4546; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419; Wu S, 2012, CANCER MED-US, V1, P306, DOI 10.1002/cam4.28; Wu SH, 2013, MOL CELL BIOCHEM, V375, P69, DOI 10.1007/s11010-012-1529-y; Youmba SB, 2012, J PEDIATR GASTR NUTR, V54, P463, DOI 10.1097/MPG.0b013e318247240d	54	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1678	1688		10.1096/fj.201600890R	http://dx.doi.org/10.1096/fj.201600890R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28057697				2022-12-26	WOS:000398504300032
J	Malara, A; Fresia, C; Di Buduo, CA; Soprano, PM; Moccia, F; Balduini, C; Zocchi, E; De Flora, A; Balduini, A				Malara, Alessandro; Fresia, Chiara; Di Buduo, Christian Andrea; Soprano, Paolo Maria; Moccia, Francesco; Balduini, Cesare; Zocchi, Elena; De Flora, Antonio; Balduini, Alessandra			The Plant Hormone Abscisic Acid Is a Prosurvival Factor in Human and Murine Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); B cell lymphoma 2 (Bcl-2) family; calcium; cyclic ADP Ribose (cADPR); ERK; PKA; megakaryocyte; thrombopoiesis	CYCLIC ADP-RIBOSE; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MESENCHYMAL STEM-CELLS; PLATELET PRODUCTION; SIGNALING PATHWAY; EX-VIVO; THROMBOPOIETIN; APOPTOSIS; CALCIUM	Abscisic acid (ABA) is a phytohormone involved in pivotal physiological functions in higher plants. Recently, ABA has been proven to be also secreted and active in mammals, where it stimulates the activity of innate immune cells, mesenchymal and hematopoietic stem cells, and insulin-releasing pancreatic cells through a signaling pathway involving the second messenger cyclic ADP-ribose (cADPR). In addition to behaving like an animal hormone, ABA also holds promise as a nutraceutical plant-derived compound in humans. Many biological functions of ABA in mammals are mediated by its binding to the LANCL-2 receptor protein. A putative binding of ABA to GRP78, a key regulator of endoplasmic reticulum stress, has also been proposed. Here we investigated the role of exogenous ABA in modulating thrombopoiesis, the process of platelet generation. Our results demonstrate that expression of both LANCL-2 and GRP78 is up-regulated during hematopoietic stem cell differentiation into mature megakaryocytes (Mks). Functional ABA receptors exist in mature Mks because ABA induces an intracellular Ca2+ increase ([Ca2+](i)) through PKA activation and subsequent cADPR generation. In vitro exposure of human or murine hematopoietic progenitor cells to 10 m ABA does not increase recombinant thrombopoietin (rTpo)-dependent Mk differentiation or platelet release. However, under conditions of cell stress induced by rTpo and serum deprivation, ABA stimulates, in a PKA- and cADPR-dependent fashion, the mitogen-activated kinase ERK 1/2, resulting in the modulation of lymphoma 2 (Bcl-2) family members, increased Mk survival, and higher rates of platelet production. In conclusion, we demonstrate that ABA is a prosurvival factor for Mks in a Tpo-independent manner.	[Malara, Alessandro; Di Buduo, Christian Andrea; Soprano, Paolo Maria; Balduini, Alessandra] Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Labs Biotechnol, Via Forlanini 6, I-27100 Pavia, Italy; [Moccia, Francesco; Balduini, Cesare] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Fresia, Chiara; Zocchi, Elena; De Flora, Antonio] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Genoa; Tufts University	Balduini, A (corresponding author), Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Labs Biotechnol, Via Forlanini 6, I-27100 Pavia, Italy.	alessandra.balduini@unipv.it	Moccia, Francesco/AAX-6447-2020; BALDUINI, ALESSANDRA/AAC-3363-2022; Di Buduo, Christian A/G-4771-2018; malara, alessandro/K-4027-2016	Moccia, Francesco/0000-0003-0010-0098; BALDUINI, ALESSANDRA/0000-0003-3145-1245; Di Buduo, Christian A/0000-0002-6472-2008; malara, alessandro/0000-0002-3396-3693; Soprano, Paolo Maria/0000-0001-6637-3852; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Italian Ministry of University and Research FIRB [RBFR1299KO]	Italian Ministry of University and Research FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by Italian Ministry of University and Research FIRB Grant RBFR1299KO (to A. M. and C. F). The authors declare that they have no conflicts of interest with the contents of this article.	Ameri P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115992; Balduini A, 2016, THROMB HAEMOSTASIS, V115, P250, DOI 10.1160/TH15-07-0570; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; CHOI ES, 1995, BLOOD, V85, P402; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; De Flora A., 2014, MESSENGER, V3, P86, DOI DOI 10.1166/MSR.2014.1029; Debrincat MA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.97; Debrincat MA, 2012, BLOOD, V119, P5850, DOI 10.1182/blood-2011-12-398834; den Dekker E, 2001, THROMB HAEMOSTASIS, V86, P1106; Di Buduo CA, 2016, HAEMATOLOGICA, V101, P1479, DOI 10.3324/haematol.2016.146746; Di Buduo CA, 2015, BLOOD, V125, P2254, DOI 10.1182/blood-2014-08-595561; Di Buduo CA, 2014, HAEMATOLOGICA, V99, P769, DOI 10.3324/haematol.2013.096859; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Fresia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26658; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2015, BBA-PROTEINS PROTEOM, V1854, P1132, DOI 10.1016/j.bbapap.2014.12.015; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; Ishikawa T, 1998, J GASTROEN HEPATOL, V13, P907, DOI 10.1111/j.1440-1746.1998.tb00760.x; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Ito T, 1996, BRIT J HAEMATOL, V94, P387, DOI 10.1046/j.1365-2141.1996.d01-1813.x; Josefsson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4455; Kaushansky K, 2005, ANN NY ACAD SCI, V1044, P139, DOI 10.1196/annals.1349.018; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 1997, STEM CELLS, V15, P97, DOI 10.1002/stem.5530150813; Kharenko OA, 2013, J BIOCHEM, V154, P383, DOI 10.1093/jb/mvt067; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lopez JJ, 2013, ARTERIOSCL THROM VAS, V33, P2750, DOI 10.1161/ATVBAHA.113.302184; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Magnone M, 2015, FASEB J, V29, P4783, DOI 10.1096/fj.15-277731; Malara A, 2015, CELL MOL LIFE SCI, V72, P1517, DOI 10.1007/s00018-014-1813-y; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Osada M, 1999, EXP HEMATOL, V27, P131, DOI 10.1016/S0301-472X(98)00007-1; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Tao R, 2011, J CELL MOL MED, V15, P2684, DOI 10.1111/j.1582-4934.2011.01263.x; Trakala M, 2015, DEV CELL, V32, P155, DOI 10.1016/j.devcel.2014.12.015; UNEYAMA H, 1993, J BIOL CHEM, V268, P168; Vigliarolo T, 2016, INT J BIOCHEM CELL B, V75, P99, DOI 10.1016/j.biocel.2016.03.006; Vigliarolo T, 2015, J BIOL CHEM, V290, P13042, DOI 10.1074/jbc.M114.629501; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zauli G, 1996, BRIT J HAEMATOL, V92, P711, DOI 10.1046/j.1365-2141.1996.367904.x; Zhou N, 2016, INT J CANCER, V138, P1947, DOI 10.1002/ijc.29935	70	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3239	3251		10.1074/jbc.M116.751693	http://dx.doi.org/10.1074/jbc.M116.751693			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049729	hybrid, Green Published			2022-12-26	WOS:000395538800016
J	Vincent, MS; Canestrari, MJ; Leone, P; Stathopulos, J; Ize, B; Zoued, A; Cambillau, C; Kellenberger, C; Roussel, A; Cascales, E				Vincent, Maxence S.; Canestrari, Mickael J.; Leone, Philippe; Stathopulos, Julien; Ize, Berengere; Zoued, Abdelrahim; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain; Cascales, Eric			Characterization of the Porphyromonas gingivalis Type IX Secretion Trans-envelope PorKLMNP Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; membrane protein; microbiology; protein assembly; protein complex; protein purification; protein secretion; secretion	ENTEROAGGREGATIVE ESCHERICHIA-COLI; TRANSMEMBRANE PROTEIN TOPOLOGY; BACTERIAL GLIDING MOTILITY; GRAM-NEGATIVE BACTERIA; C-TERMINAL DOMAIN; VI SECRETION; TANNERELLA-FORSYTHIA; 2-COMPONENT SYSTEM; SIGNAL PEPTIDES; IV SECRETION	The transport of proteins at the cell surface of Bacteroidetes depends on a secretory apparatus known as type IX secretion system (T9SS). This machine is responsible for the cell surface exposition of various proteins, such as adhesins, required for gliding motility in Flavobacterium, S-layer components in Tannerella forsythia, and tooth tissue-degrading enzymes in the oral pathogen Porphyromonas gingivalis. Although a number of subunits of the T9SS have been identified, we lack details on the architecture of this secretion apparatus. Here we provide evidence that five of the genes encoding the core complex of the T9SS are co-transcribed and that the gene products are distributed in the cell envelope. Protein-protein interaction studies then revealed that these proteins oligomerize and interact through a dense network of contacts.	[Vincent, Maxence S.; Canestrari, Mickael J.; Ize, Berengere; Zoued, Abdelrahim; Cascales, Eric] Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France; [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France; [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR 7257, Campus Luminy,Case 932, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	cascales@imm.cnrs.fr	IZE, Bérengère/GLQ-7207-2022; kellenberger, christine/AAV-9304-2020; CASCALES, ERIC/G-7420-2011	IZE, Bérengère/0000-0001-9106-9254; CASCALES, ERIC/0000-0003-0611-9179; Zoued, Abdelrahim/0000-0002-6973-1755; Vincent, Maxence S./0000-0001-8431-7504; Canestrari, Mickael/0000-0003-3501-7139	CNRS; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-15-CE11-0019-01]; French Ministere de la Recherche; Fondation pour la Recherche Medicale [FDT20140931060]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministere de la Recherche(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS, the Aix-Marseille Universite, and a grant from the Agence Nationale de la Recherche (ANR-15-CE11-0019-01). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from the French Ministere de la Recherche.; Supported by an end-of-thesis fellowship from the Fondation pour la Recherche Medicale (FDT20140931060).	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Boisvert H, 2014, P NATL ACAD SCI USA, V111, P5355, DOI 10.1073/pnas.1402740111; Boisvert H, 2010, INFECT IMMUN, V78, P3616, DOI 10.1128/IAI.00187-10; Braun TF, 2005, J BACTERIOL, V187, P2628, DOI 10.1128/JB.187.8.2628-2637.2005; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Flaugnatti N, 2016, MOL MICROBIOL, V99, P1099, DOI 10.1111/mmi.13292; Glew MD, 2014, J PROTEOMICS, V110, P72, DOI 10.1016/j.jprot.2014.07.033; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Gorasia DG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005820; Goulas T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11969; Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Nakane D, 2013, P NATL ACAD SCI USA, V110, P11145, DOI 10.1073/pnas.1219753110; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Narita Y, 2014, MICROBIOL-SGM, V160, P2295, DOI 10.1099/mic.0.080192-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rhodes RG, 2011, J BACTERIOL, V193, P599, DOI 10.1128/JB.01203-10; Rocas IN, 2001, ORAL SURG ORAL MED O, V91, P468, DOI 10.1067/moe.2001.114379; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Sakamoto M, 2005, J PERIODONTAL RES, V40, P277, DOI 10.1111/j.1600-0765.2005.00793.x; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Shrivastava A, 2015, CURR OPIN MICROBIOL, V28, P93, DOI 10.1016/j.mib.2015.07.018; Shrivastava A, 2015, CURR BIOL, V25, P338, DOI 10.1016/j.cub.2014.11.045; Shrivastava A, 2013, J BACTERIOL, V195, P3201, DOI 10.1128/JB.00333-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Taguchi Y, 2016, INFECT IMMUN, V84, P230, DOI 10.1128/IAI.01308-15; Tomek MB, 2014, MOL ORAL MICROBIOL, V29, P307, DOI 10.1111/omi.12062; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182	60	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3252	3261		10.1074/jbc.M116.765081	http://dx.doi.org/10.1074/jbc.M116.765081			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28057754	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000395538800017
J	Zhao, WK; Tong, H; Huang, YK; Yan, Y; Teng, HJ; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Tong, Huan; Huang, Yikai; Yan, Yun; Teng, Huajian; Xia, Yin; Jiang, Qing; Qin, Jinzhong			Essential Role for Polycomb Group Protein Pcgf6 in Embryonic Stem Cell Maintenance and a Noncanonical Polycomb Repressive Complex 1 (PRC1) Integrity.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SELF-RENEWAL; CHROMATIN-STRUCTURE; MOUSE DEVELOPMENT; NANOS PROTEINS; MICE; DIFFERENTIATION; RING1B; E2F6; ESCS	The Polycomb group (PcG) proteins have an important role in controlling the expression of key genes implicated in embryonic development, differentiation, and decision of cell fates. Emerging evidence suggests that Polycomb repressive complexes 1 (PRC1) is defined by the six Polycomb group RING finger protein (Pcgf) paralogs, and Pcgf proteins can assemble into noncanonical PRC1 complexes. However, little is known about the precise mechanisms of differently composed noncanonical PRC1 in the maintenance of the pluripotent cell state. Here we disrupt the Pcgf genes in mouse embryonic stem cells by CRISPR-Cas9 and find Pcgf6 null embryonic stem cells display severe defects in self-renewal and differentiation. Furthermore, Pcgf6 regulates genes mostly involved in differentiation and spermatogenesis by assembling a noncanonical PRC1 complex PRC1.6. Notably, Pcgf6 deletion causes a dramatic decrease in PRC1.6 binding to target genes and no loss of H2AK119ub1. Thus, Pcgf6 is essential for recruitment of PRC1.6 to chromatin. Our results reveal a previously uncharacterized, H2AK119ub1 independent chromatin assembly associated with PRC1.6 complex.	[Zhao, Wukui; Tong, Huan; Huang, Yikai; Yan, Yun; Teng, Huajian; Qin, Jinzhong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Chinese University of Hong Kong; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31471387, 31671532]; Shuangchuang Program of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shuangchuang Program of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (31471387 and 31671532) and by the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.) The authors declare that they have no conflicts of interest with the contents of this article	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Washkowitz AJ, 2015, DEVELOPMENT, V142, P31, DOI 10.1242/dev.111104; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yang CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26899; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zdzieblo D, 2014, STEM CELLS, V32, P3112, DOI 10.1002/stem.1826	52	37	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2773	2784		10.1074/jbc.M116.763961	http://dx.doi.org/10.1074/jbc.M116.763961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049731	Green Published, hybrid			2022-12-26	WOS:000395535100018
J	Braukmann, TWA; Kuzmina, ML; Sills, J; Zakharov, EV; Hebert, PDN				Braukmann, Thomas W. A.; Kuzmina, Maria L.; Sills, Jesse; Zakharov, Evgeny V.; Hebert, Paul D. N.			Testing the Efficacy of DNA Barcodes for Identifying the Vascular Plants of Canada	PLOS ONE			English	Article							LAND PLANTS; MATK GENE; IDENTIFICATION; DIVERSITY; PHYLOGENY; RATES; MITOCHONDRIAL; CHLOROPLAST; DISPERSION; RESOLUTION	Their relatively slow rates of molecular evolution, as well as frequent exposure to hybridization and introgression, often make it difficult to discriminate species of vascular plants with the standard barcode markers (rbcL, matK, ITS2). Previous studies have examined these constraints in narrow geographic or taxonomic contexts, but the present investigation expands analysis to consider the performance of these gene regions in discriminating the species in local floras at sites across Canada. To test identification success, we employed a DNA barcode reference library with sequence records for 96% of the 5108 vascular plant species known from Canada, but coverage varied from 94% for rbcL to 60% for ITS2 and 39% for matK. Using plant lists from 27 national parks and one scientific reserve, we tested the efficacy of DNA barcodes in identifying the plants in simulated species assemblages from six biogeographic regions of Canada using BLAST and mothur. Mean pairwise distance (MPD) and mean nearest taxon distance (MNTD) were strong predictors of barcode performance for different plant families and genera, and both metrics supported ITS2 as possessing the highest genetic diversity. All three genes performed strongly in assigning the taxa present in local floras to the correct genus with values ranging from 91% for rbcL to 97% for ITS2 and 98% for matK. However, matK delivered the highest species discrimination (-81%) followed by ITS2 (-72%) and rbcL (-44%). Despite the low number of plant taxa in the Canadian Arctic, DNA barcodes had the least success in discriminating species from this biogeographic region with resolution ranging from 36% with rbcL to 69% with matK. Species resolution was higher in the other settings, peaking in the Woodland region at 52% for rbcL and 87% for matK. Our results indicate that DNA barcoding is very effective in identifying Canadian plants to a genus, and that it performs well in discriminating species in regions where floristic diversity is highest.	[Braukmann, Thomas W. A.; Kuzmina, Maria L.; Sills, Jesse; Zakharov, Evgeny V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada	University of Guelph	Braukmann, TWA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada.	tbraukma@uoguelph.ca	Braukmann, Thomas/N-7333-2019	Braukmann, Thomas/0000-0002-2452-3776; Kuzmina, Maria/0000-0003-2725-9146	International Barcode of Life project - Genome Canada through Ontario Genomics; Canada Foundation for Innovation; Ontario Ministry for Research and Innovation; Canada First Research Excellence Fund	International Barcode of Life project - Genome Canada through Ontario Genomics; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Canada First Research Excellence Fund	This research was funded through the International Barcode of Life project supported by the Genome Canada through Ontario Genomics, Canada Foundation for Innovation, and by the Ontario Ministry for Research and Innovation. It is also a contribution to the Food From Thought research program supported by the Canada First Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank two reviewers for helpful comments on an earlier version of this paper. We extend special gratitude to David Erikson and Ina Anreiter for friendly suggestions and comments during the preparation of our manuscript. We also thank Bruce Bennet and Sergei Pono-marenko for providing updated species lists for several national parks. This research was funded through the International Barcode of Life project supported by the Genome Canada through Ontario Genomics, Canada Foundation for Innovation, and by the Ontario Ministry for Research and Innovation. It is also a contribution to the Food From Thought research program supported by the Canada First Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanesyan A, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300082; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bello A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv124; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Brochmann C, 2008, PLANT ECOL DIVERS, V1, P181, DOI 10.1080/17550870802331904; Brouillet L, 2010, VASCAN DATABASE VASC; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fogelqvist J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0461-7; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Grundt HH, 2006, P NATL ACAD SCI USA, V103, P972, DOI 10.1073/pnas.0510270103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2011, FOOD CHEM, V127, P1335, DOI 10.1016/j.foodchem.2011.01.094; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Kuzmina ML, 2016, DNA BARCODE LI UNPUB; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lauron-Moreau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121965; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Lebrija-Trejos E, 2014, ECOLOGY, V95, P940, DOI 10.1890/13-0623.1; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu XJ, 2013, FUNCT ECOL, V27, P264, DOI 10.1111/1365-2435.12018; Mandel JR, 2015, J SYST EVOL, V53, P391, DOI 10.1111/jse.12167; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; Miller Michael J., 2011, 2011 IEEE Hot Chips 23 Symposium (HCS), P1, DOI 10.1109/HOTCHIPS.2011.7477493; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Naciri Y, 2012, MOL ECOL RESOUR, V12, P575, DOI 10.1111/j.1755-0998.2012.03130.x; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Puente-Lelievre C, 2013, MOL PHYLOGENET EVOL, V66, P203, DOI 10.1016/j.ympev.2012.09.027; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Santamaria M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S15; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Skrede I, 2009, HEREDITY, V102, P293, DOI 10.1038/hdy.2008.120; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Swenson Nathan G, 2012, Methods Mol Biol, V858, P409, DOI 10.1007/978-1-61779-591-6_20; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Tekpinar AD, 2016, TURK J BIOL, V40, P250, DOI 10.3906/biy-1502-5; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyler SC, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0678-0	81	44	49	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169515	10.1371/journal.pone.0169515	http://dx.doi.org/10.1371/journal.pone.0169515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072819	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200025
J	Rolland-Debord, C; Fry, S; Giovannelli, J; Langlois, C; Bricout, N; Aguilaniu, B; Bellocq, A; Le Rouzic, O; Dominique, S; Delobbe, A; Francois, G; Tazi, A; Wallaert, B; Chenivesse, C				Rolland-Debord, Camille; Fry, Stephanie; Giovannelli, Jonathan; Langlois, Carole; Bricout, Nicolas; Aguilaniu, Bernard; Bellocq, Agnes; Le Rouzic, Olivier; Dominique, Stephane; Delobbe, Alain; Francois, Geraldine; Tazi, Abdellatif; Wallaert, Benoit; Chenivesse, Cecile			Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; COMPUTED-TOMOGRAPHY; HYPERTENSION; DYSPNEA; OXYGEN; CONSTRAINTS; EVOLUTION; VOLUME; IMPACT	Background Reduced exercise capacity severely impacts quality of life in pulmonary Langerhans cell histiocytosis. Ascertaining mechanisms that impair exercise capacity is necessary to identify targets for symptomatic treatments. Methods Dyspnea, pulmonary function tests and cardiopulmonary exercise test were analysed in 62 study participants. Data were compared between subjects with impaired and normal aerobic capacity (V'O-2 peak less than 84% versus 84% predicted or more). Data were reduced using a principal component analysis. Multivariate analysis included V'O-2 peak as the dependent variable and principal components as covariates. Results V'O-2 peak was reduced in 44 subjects (71%). Subjects with impaired aerobic capacity presented: (i) decreased FEV1, FVC, FEV1/FVC, DLCO and DLCO/VA and increased AaDO(2), (ii) increased ventilatory equivalents at ventilatory threshold, VD/VT peak, AaDO(2) peak and PaCO2 peak and decreased ventilatory reserve and PaO2 peak. There was no difference between groups in dyspnea scores. Principal component analysis extracted 4 principal components interpreted as follows: PC1: gas exchange; PC2: "pseudorestriction"; PC3: exercise-induced hyperpnea; PC4: air trapping. Multivariate analysis explained 65% of V'O-2 peak. The 4 principal components were independently associated with V'O-2 peak (beta coefficients: PC1: 9.3 [4.6; 14], PC2: 7.5 [3; 11.9], PC3:-5.3 [-9.6;-1.], PC4:-9.8 [-14,9;-4.7]). Conclusion Impaired exercise capacity is frequent in pulmonary Langerhans cell histiocytosis. It is mainly caused by pulmonary changes but is not associated with increased dyspnea intensity. Therefore, treating the lung represents a relevant approach for improving exercise capacity, even in patients experiencing mild dyspnea.	[Rolland-Debord, Camille; Fry, Stephanie; Wallaert, Benoit; Chenivesse, Cecile] Univ Lille, Ctr Competence Malad Pulmonaires Rares, Serv Pneumol & ImmunoAllergol, CHU Lille, Lille, France; [Rolland-Debord, Camille] Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Paris, France; [Rolland-Debord, Camille] UPMC Univ Paris 06, Sorbonne Univ, UMRS Neurophysiol Resp Expt 1158, INSERM, Paris, France; [Giovannelli, Jonathan] Univ Lille, Pole Sante Publ, Pharmacie & Pharmacol, CHU Lille, Lille, France; [Langlois, Carole] Univ Lille, Serv Biostat, CHU Lille, Lille, France; [Bricout, Nicolas] Univ Lille, Serv Radiol, CHU Lille, Lille, France; [Aguilaniu, Bernard] Univ Joseph Fourrier, Fac Med, La Tronche, France; [Bellocq, Agnes] Grp Hosp Pitie Salpetriere Charles, AP HP, Serv Explorat Fonct Respirat Exercice & Dyspnee, Paris, France; [Dominique, Stephane] Univ Rouen, Ctr Hosp U, Clin Pneumol, Hop Charles Nicolle,Univ Rouen, Rouen, France; [Delobbe, Alain] Ctr Hosp Reg Citadelle, Serv Pneumol, Liege, Belgium; [Dominique, Stephane] Univ Picardie Jules Verne, Ctr Hosp, Serv Pneumol & Reanimat, Univ Amiens, Amiens, France; [Tazi, Abdellatif] Univ Paris Diderot, Hop St Louis, AP HP,Equipe Rech Biostat & Epiderniol Clin, Serv Pneumol,Ctr Reference Histiocytose Langerha, Paris, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; Universite de Rouen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Rolland-Debord, C (corresponding author), Univ Lille, Ctr Competence Malad Pulmonaires Rares, Serv Pneumol & ImmunoAllergol, CHU Lille, Lille, France.; Rolland-Debord, C (corresponding author), Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Paris, France.; Rolland-Debord, C (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMRS Neurophysiol Resp Expt 1158, INSERM, Paris, France.	camille.rolland-debord@aphp.fr	giovannelli, jonathan/I-5307-2018	giovannelli, jonathan/0000-0002-7516-4670; Bricout, Nicolas/0000-0003-1469-3613; Le Rouzic, Olivier/0000-0003-4439-2950; BELLOCQ, Agnes/0000-0002-9297-7534				ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Brauner MW, 1997, RADIOLOGY, V204, P497, DOI 10.1148/radiology.204.2.9240543; Canuet M, 2007, RESPIRATION, V74, P640, DOI 10.1159/000106843; Chenivesse C, 2006, REV MAL RESPIR, V23, P141, DOI 10.1016/S0761-8425(06)71477-2; Crausman RS, 1996, AM J RESP CRIT CARE, V153, P426, DOI 10.1164/ajrccm.153.1.8542154; Delobbe K, 1996, EUR RESPIR J, V9, P2002; Elbehairy AF, 2013, DRUGS, V73, P1991, DOI 10.1007/s40265-013-0145-9; Elia D, 2015, EUR J INTERN MED, V26, P351, DOI 10.1016/j.ejim.2015.04.001; Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C; Fukuda Y, 2014, EUR J PREV CARDIOL, V21, P1481, DOI 10.1177/2047487313497603; Hannink J, 2010, RESP MED, V104, P1700, DOI 10.1016/j.rmed.2010.04.007; HARRISEZE AO, 1994, AM J RESP CRIT CARE, V150, P1616, DOI 10.1164/ajrccm.150.6.7952624; Laveneziana P, 2007, APPL PHYSIOL NUTR ME, V32, P1225, DOI 10.1139/H07-119; Laveneziana P, 2011, AM J RESP CRIT CARE, V184, P1367, DOI 10.1164/rccm.201106-1128OC; Le Pavec J, 2012, CHEST, V142, P1150, DOI 10.1378/chest.11-2490; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Obert J, 2015, REV MAL RESPIR, V32, P850, DOI 10.1016/j.rmr.2015.01.005; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Pastre J, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-74; Raoof S, CYSTIC LUNG DIS ALGO; Roden AC, 2014, AM J SURG PATHOL, V38, P548, DOI 10.1097/PAS.0000000000000129; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Tazi A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0249-2; Tazi A, 2012, EUR RESPIR J, V40, P905, DOI 10.1183/09031936.00210711; Vassallo R, 2002, NEW ENGL J MED, V346, P484, DOI 10.1056/NEJMoa012087; Visca D, 2011, EUR RESPIR J, V38, P987, DOI 10.1183/09031936.00190710; Wallaert B, 2011, RESPIRATION, V82, P501, DOI 10.1159/000330050	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0170035	10.1371/journal.pone.0170035	http://dx.doi.org/10.1371/journal.pone.0170035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072848	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200061
J	Zhang, L; Zhou, YX; Li, XF; Cheng, TT				Zhang, Lian; Zhou, Yanxia; Li, Xufang; Cheng, Tingting			Hyperbilirubinemia Influences Sleep-Wake Cycles of Term Newborns in a Non-Linear Manner	PLOS ONE			English	Article							BILIRUBIN-INDUCED NEUROTOXICITY; INDUCED NEUROLOGIC DYSFUNCTION; PRETERM INFANTS; PREMATURE-INFANTS; ELECTROENCEPHALOGRAPHY; KERNICTERUS; PATTERN	Hyperbilirubinemia is a common cause for irreversible neuronal influence in the brain of term newborns, while the feature of neurological symptoms associated with hyperbilirubinemia has not been well characterized yet. In the present study, we examined a total of 203 neonates suffering from hyperbilirubinemia with a bedside amplitude-integrated Electroencephalography (aEEG) device, in order to determine whether there is any special change in sleep-wake cycles (SWCs). Among these patients, 14 cases showed no recognizable SWCs with the total serum bilirubin (TSB) level at 483.9-996.2 pmol/L; 75 cases exhibited reduced SWCs with the TSB level at 311.2-688.5 pmol/L; and the rest cases had the normal SWCs. The number of the normal SWCs occurrence had a significant negative correlation with the increased TSB level in a non-linear manner (r=-0.689, p <0.001). In addition, the increased TSB reshaped the structure of SWC by narrowing down the broadband and broadening the narrowband. Spearman's correlation analysis indicated a significant negative correlation between the TSB level and the ratio of broadband (r=-0.618, p < 0.001), a significant positive correlation between the TSB level and the narrowband ratio (r=0.618, p < 0.001), respectively. Furthermore, the change of SWC seemed like a continuous phenomenon, and the hyperbilirubinemia caused SWC changes was fit into a loess model in this paper. In summary, the hyperbilirubinemia influenced SWC of term newborns significantly at a non-linear manner, and these results revealed the feature of the neurological sequela that is associated with TSB.	[Zhang, Lian; Li, Xufang; Cheng, Tingting] Guangzhou Women & Childrens Med Ctr, Dept Neonatol, Guangzhou, Guangdong, Peoples R China; [Zhou, Yanxia] Guangzhou Women & Childrens Med Ctr, Dept Neurol, Guangzhou, Guangdong, Peoples R China		Zhang, L (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Neonatol, Guangzhou, Guangdong, Peoples R China.	zhliande@qq.com			Guangzhou Science Technology and Innovation Commission [1563000668]	Guangzhou Science Technology and Innovation Commission	This work was supported by the Guangzhou Science Technology and Innovation Commission 1563000668 (Lian Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlOtaibi SF, 2005, CAN J NEUROL SCI, V32, P311, DOI 10.1017/S0317167100004182; Amin SB, 2015, J PEDIATR-US, V166, P571, DOI 10.1016/j.jpeds.2014.12.003; Amin SB, 2004, SEMIN PERINATOL, V28, P340, DOI 10.1053/j.semperi.2004.09.005; Ardakani SB, 2011, IRAN J PEDIATR, V21, P28; Axelin A, 2013, J PERINAT NEONAT NUR, V27, P263, DOI 10.1097/JPN.0b013e31829dc2d3; Bekke K, 1967, WHO TECH REP SER, V366, P1; Bhutani VK, 2015, SEMIN FETAL NEONAT M, V20, P6, DOI 10.1016/j.siny.2014.12.008; Bourgoin-Heck M, 2015, NEONATOLOGY, V108, P42, DOI 10.1159/000381205; Gurses D, 2002, PEDIATR RES, V52, P125, DOI 10.1203/01.PDR.0000016662.84289.BA; HELLSTROMWESTAS L, 1992, ACTA PAEDIATR, V81, P812, DOI 10.1111/j.1651-2227.1992.tb12109.x; Kidokoro H, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0030-1270479; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Kuniaki T., 1993, JPN J CLIN CHEM, V22, P116, DOI [DOI 10.14921/JSCC1971B.22.2_116, 10.14921/jscc1971b.22.2_116]; Magill PJ, 2000, J NEUROSCI, V20, P820, DOI 10.1523/JNEUROSCI.20-02-00820.2000; Maisels MJ, 2004, PEDIATRICS, V114, P297; Newman TB, 2006, NEW ENGL J MED, V354, P1889, DOI 10.1056/NEJMoa054244; Olischar M, 2004, CHILD NERV SYST, V20, P41, DOI 10.1007/s00381-003-0809-y; Oren DA, 2002, BIOL PSYCHIAT, V51, P422, DOI 10.1016/S0006-3223(01)01254-9; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Ostrow JD, 2004, TRENDS MOL MED, V10, P65, DOI 10.1016/j.molmed.2003.12.003; Peng Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120683; SCHEIDT PC, 1991, PEDIATRICS, V87, P797; Scher MS, 1996, PEDIATR NEUROL, V14, P137, DOI 10.1016/0887-8994(96)00013-6; Sgro M, 2006, CAN MED ASSOC J, V175, P587, DOI 10.1503/cmaj.060328; Shellhaas RA, 2011, J CLIN NEUROPHYSIOL, V28, P611, DOI 10.1097/WNP.0b013e31823e96d7; Soorani-Lunsing I, 2001, PEDIATR RES, V50, P701, DOI 10.1203/00006450-200112000-00012; ter HHJ, 2004, PEDIATR RES, V55, P1026, DOI [10.1203/01.pdr.0000127019.52562.8c, DOI 10.1203/01.PDR.0000127019.52562.8C]; Ter HHJ, 2012, NEONATOLOGY, V102, P120, DOI [10.1159/000338580, DOI 10.1159/000338580]; THORNBERG E, 1990, ACTA PAEDIATR SCAND, V79, P20, DOI 10.1111/j.1651-2227.1990.tb11324.x; YOKOCHI K, 1995, ACTA PAEDIATR, V84, P937, DOI 10.1111/j.1651-2227.1995.tb13796.x; Zhang L, 2003, PEDIATR RES, V53, P939, DOI 10.1203/01.PDR.0000061563.63230.86; Zhang L, 2011, NEUROSCI BULL, V27, P251, DOI 10.1007/s12264-011-1413-x	32	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169783	10.1371/journal.pone.0169783	http://dx.doi.org/10.1371/journal.pone.0169783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072860	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200046
J	Bourgeon, L; Burke, A; Higham, T				Bourgeon, Lauriane; Burke, Ariane; Higham, Thomas			Earliest Human Presence in North America Dated to the Last Glacial Maximum: New Radiocarbon Dates from Bluefish Caves, Canada	PLOS ONE			English	Article							CUT MARKS; MAMMOTH GRAVEYARD; PLEISTOCENE; DISPERSAL; SITE; COLONIZATION; BONE; PERCUSSION; MODELS; ORIGIN	The timing of the first entry of humans into North America is still hotly debated within the scientific community. Excavations conducted at Bluefish Caves (Yukon Territory) from 1977 to 1987 yielded a series of radiocarbon dates that led archaeologists to propose that the initial dispersal of human groups into Eastern Beringia (Alaska and the Yukon Territory) occurred during the Last Glacial Maximum (LGM). This hypothesis proved highly controversial in the absence of other sites of similar age and concerns about the stratigraphy and anthropogenic signature of the bone assemblages that yielded the dates. The weight of the available archaeological evidence suggests that the first peopling of North America occurred ca. 14,000 cal BP (calibrated years Before Present), i.e., well after the LGM. Here, we report new AMS radiocarbon dates obtained on cut-marked bone samples identified during a comprehensive taphonomic analysis of the Bluefish Caves fauna. Our results demonstrate that humans occupied the site as early as 24,000 cal BP (19,650 +/- 130 C-14 BP). In addition to proving that Bluefish Caves is the oldest known archaeological site in North America, the results offer archaeological support for the "Beringian standstill hypothesis", which proposes that a genetically isolated human population persisted in Beringia during the LGM and dispersed from there to North and South America during the post-LGM period.	[Bourgeon, Lauriane; Burke, Ariane] Univ Montreal, Dept Anthropol, Montreal, PQ, Canada; [Higham, Thomas] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford Radiocarbon Accelerator Unit, Oxford, England	Universite de Montreal; University of Oxford	Bourgeon, L (corresponding author), Univ Montreal, Dept Anthropol, Montreal, PQ, Canada.	lauriane.bourgeon@umontreal.ca	Burke, Ariane/GRJ-1125-2022; Higham, Tom/Y-2707-2019	Higham, Tom/0000-0002-5949-598X; Burke, Ariane/0000-0002-7033-7798	Fonds de Recherche Quebecois Societe et Culture [2015-SE-179537]; NERC [NRCF010002] Funding Source: UKRI; Natural Environment Research Council [NRCF010002] Funding Source: researchfish	Fonds de Recherche Quebecois Societe et Culture; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by Fonds de Recherche Quebecois Societe et Culture (2015-SE-179537), grant received by AB.	Abe Y., 2005, THESIS; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Binford LRB., 1981, ANCIENT MEN MODERN M; Boschin F, 2012, INT J OSTEOARCHAEOL, V22, P549, DOI 10.1002/oa.1272; Bourgeon L., 2015, PALEOAMERICA, V1, P105; Braun DR, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2016.0006; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Burke A, 1998, ARCTIC, V51, P105; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Cinq-Mars J., 1979, CAN J ARCHAEOL, V3, P1; Cinq-Mars J., 1999, ICE AGE PEOPLE N AM, P200; Cinq-Mars Jacques, 1990, REV ARQUELOGIA AM, V1, P9; Comez-Coutouly YA, 2011, THESIS; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; Costamagno S, 2009, ARCHAEOFAUNA, V18, P9; Dixon EJ, 1999, BONES BOATS BISON AR; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Duches R, 2016, J ARCHAEOL SCI, V66, P88, DOI 10.1016/j.jas.2016.01.005; Easton N.A., 2011, YENISEI YUKON INTERP, P289; Endacott N. A., 2008, THESIS; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Goebel T, 2010, J ARCHAEOL SCI, V37, P2640, DOI 10.1016/j.jas.2010.05.024; Guadelli JL, 2008, ANN PALEONTOL, V94, P121, DOI 10.1016/j.annpal.2008.05.002; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; Harington CR, 2011, QUATERNARY SCI REV, V30, P2341, DOI 10.1016/j.quascirev.2011.05.020; Harington CR, 2008, BLUEFISH CAVES FAUNA, V19; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Heintzman PD, 2016, P NATL ACAD SCI USA, V113, P8057, DOI 10.1073/pnas.1601077113; Hockett B, 2013, AM ANTIQUITY, V78, P762, DOI 10.7183/0002-7316.78.4.762; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Hoffecker JF, 2016, EVOL ANTHROPOL, V25, P64, DOI 10.1002/evan.21478; Holmes C. E., 2011, YENISEI YUKON INTERP; Hopkins DM, 1982, PALEOECOLOGY BERINGI; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; Lyman RL, 1987, ADV ARCHAEOLOGICAL M, V10, P249, DOI DOI 10.1016/B978-0-12-003110-8.50008-6; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; McCuaig-Balkwill D, 1998, 8 INT C INT COUNC AR, P9; Merritt SR, 2012, J ARCHAEOL SCI, V39, P2984, DOI 10.1016/j.jas.2012.04.036; Monnier GF, 2014, J ARCHAEOL SCI, V50, P305, DOI 10.1016/j.jas.2014.06.025; Morlan R.E, 1980, NATL MUSEUM MAN MERC; Morlan RE, 2003, QUATERNARY RES, V60, P123, DOI 10.1016/S0033-5894(03)00070-X; Morlan RE., 1982, PALEOECOLOGY BERINGI, P353; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Nikolskiy P, 2013, J ARCHAEOL SCI, V40, P4189, DOI 10.1016/j.jas.2013.05.020; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Perdersen MW, 2016, NATURE, V537; Pitulko VV, 2016, SCIENCE, V351, P260, DOI 10.1126/science.aad0554; Pitulko VV, 2014, GEOARCHAEOLOGY, V29, P277, DOI 10.1002/gea.21483; Pitulko VV, 2011, GEOARCHAEOLOGY, V26, P5, DOI 10.1002/gea.20342; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Potter BA, 2013, PALEOAMERICAN ODYSSE, P81; Potter BA, 2007, ENVIRON ARCHAEOL, V12, P3, DOI 10.1179/174963107x172714; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2001, RADIOCARBON, V43, P355; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Ritchie J.C., 1982, CANADA GEOGRAPHIE PH, V36, P241; Sattler R. A., 1997, GEOARCHAEOLOGY, V12, P657; Scott GR, 2016, QUATERNARY INT; Shipman P., 1988, SCANNING ELECT MICRO, ppp. 303; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tackney JC, 2015, P NATL ACAD SCI USA, V112, P13833, DOI 10.1073/pnas.1511903112; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Todisco D, 2008, ARCTIC, V61, P87; Vinson DM, 1993, THESIS; WALKER PL, 1977, AM ANTIQUITY, V42, P605, DOI 10.2307/278934; West F.H., 1996, AM BEGINNINGS PREHIS; WHEAT J B, 1979, Plains Anthropologist, V24, P1; Yesner DR, 2001, QUATERNARY SCI REV, V20, P315, DOI 10.1016/S0277-3791(00)00114-1; Zazula GD, 2006, QUATERN INT, V142, P2, DOI 10.1016/j.quaint.2005.03.010	79	96	96	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169486	10.1371/journal.pone.0169486	http://dx.doi.org/10.1371/journal.pone.0169486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EH3AX	28060931	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500101
J	Goji, A; Ito, H; Mori, K; Harada, M; Hisaoka, S; Toda, Y; Mori, T; Abe, Y; Miyazaki, M; Kagami, S				Goji, Aya; Ito, Hiromichi; Mori, Kenji; Harada, Masafumi; Hisaoka, Sonoka; Toda, Yoshihiro; Mori, Tatsuo; Abe, Yoko; Miyazaki, Masahito; Kagami, Shoji			Assessment of Anterior Cingulate Cortex (ACC) and Left Cerebellar Metabolism in Asperger's Syndrome with Proton Magnetic Resonance Spectroscopy (MRS)	PLOS ONE			English	Article							AUTISM; ABNORMALITIES	Purpose Proton magnetic resonance spectroscopy (H-1 MRS) is a noninvasive neuroimaging method to quantify biochemical metabolites in vivo and it can serve as a powerful tool to monitor neurobiochemical profiles in the brain. Asperger's syndrome (AS) is a type of autism spectrum disorder, which is characterized by impaired social skills and restrictive, repetitive patterns of interest and activities, while intellectual levels and language skills are relatively preserved. Despite clinical aspects have been well-characterized, neurometabolic profiling in the brain of AS remains to be clear. The present study used proton magnetic resonance spectroscopy (H-1 MRS) to investigate whether pediatric AS is associated with measurable neurometabolic abnormalities that can contribute new information on the neurobiological underpinnings of the disorder. Methods Study participants consisted of 34 children with AS (2-12 years old; mean age 5.2 (+/- 2.0); 28 boys) and 19 typically developed children (2-11 years old; mean age 5.6 (+/- 2.6); 12 boys) who served as the normal control group. The H-1 MRS data were obtained from two regions of interest: the anterior cingulate cortex (ACC) and left cerebellum. Results In the ACC, levels of N-acetylaspartate (NAA), total creatine (tCr), total choline-containing compounds (tCho) and myo-Inositol (mI) were significantly decreased in children with AS compared to controls. On the other hand, no significant group differences in any of the metabolites were found in the left cerebellum. Neither age nor sex accounted for the metabolic findings in the regions. Conclusion The finding of decreased levels of NAA, tCr, tCho, and mI in the ACC but not in left cerebellar voxels in the AS, suggests a lower ACC neuronal density in the present AS cohort compared to controls.	[Goji, Aya; Ito, Hiromichi; Toda, Yoshihiro; Mori, Tatsuo; Abe, Yoko; Miyazaki, Masahito; Kagami, Shoji] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Pediat, Tokushima, Japan; [Mori, Kenji] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Child Hlth & Nursing, Tokushima, Japan; [Harada, Masafumi; Hisaoka, Sonoka] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Radiol, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Goji, A (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Pediat, Tokushima, Japan.	gojiasko@yahoo.co.jp						Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.65; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Casamassimo P, 2006, PEDIATRICS, V118, P2587, DOI 10.1542/peds.2006-2780; Geramita M, 2011, NMR BIOMED, V24, P1089, DOI 10.1002/nbm.1662; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Harada M, 1999, J MAGN RESON IMAGING, V10, P124, DOI 10.1002/(SICI)1522-2586(199908)10:2<124::AID-JMRI3>3.3.CO;2-K; Ipser JC, 2012, METAB BRAIN DIS, V27, P275, DOI 10.1007/s11011-012-9293-y; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; O'Brien FM, 2010, PSYCHIAT RES-NEUROIM, V184, P77, DOI 10.1016/j.pscychresns.2010.08.007; Oner O, 2007, AM J NEURORADIOL, V28, P1494, DOI 10.3174/ajnr.A0625; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; Polsek D, 2011, TRANSL NEUROSCI, V2, P256, DOI 10.2478/s13380-011-0024-3; Rorthman DL, 1993, NEUROLOGY, V90, P5662; Shungu DC, 2016, NMR BIOMED, V29, P932, DOI 10.1002/nbm.3539; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138	22	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169288	10.1371/journal.pone.0169288	http://dx.doi.org/10.1371/journal.pone.0169288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060873	Green Published, gold			2022-12-26	WOS:000391641500077
J	Jing, HR; Wang, SX; Wang, M; Fu, WL; Zhang, C; Xu, DG				Jing, Haoran; Wang, Shaoxia; Wang, Min; Fu, Wenliang; Zhang, Chao; Xu, Donggang			Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-kappa B Pathway	PLOS ONE			English	Article							NEUROINFLAMMATION	Parkinson's disease (PD) is a complex multi-system and age-related neurodegenerative disorder. The intervention targeting neuroinflammation in PD patients is one effective strategy to slow down or inhibit disease progression. Microglia-mediated inflammatory response plays an important role in Parkinson's, Alzheimer's and other cerebral diseases. Isobavachalcone is a main component of Chinese herb medicine Psoralea corylifolia, which function includes immunoregulation, anti-oxidation and the regulation of beta-amyloid (A beta 42) deposited in hippocampus in Alzheimer's patients. Whether it has the therapeutic effect on Parkinson's disease, however, is unclear. In this study, we found that isobavachalcone could effectively remit Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), prolong the residence time of mice on Rota-rod and alleviate the neuronal necrosis. It also inhibited the over-activation of microglia, and decreased the expression of IL-6 and IL-1 beta in the brain of PD mice. In vitro, isobavachalcone could inhibit nuclear factor-kappaB (NF-kappa B) pathway through inhibiting the LPS-induced transfer of NF-kappa B subunit from cytoplasm to nucleus in BV-2 cells. Isobavachalcone decreased the LPS-induced oxidative stress and the expression of inflammatory cytokines, and provided a neuroprotective effect by antagonizing microglia-mediated inflammation. Our results indicated that isobavachalcone may be a candidated drug against Parkinson's disease with great clinical potential.	[Jing, Haoran; Wang, Min; Fu, Wenliang; Zhang, Chao; Xu, Donggang] Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China; [Jing, Haoran; Wang, Shaoxia] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Chinese Med Pharmacol, Tianjin, Peoples R China	Academy of Military Medical Sciences - China; Tianjin University of Traditional Chinese Medicine	Xu, DG (corresponding author), Beijing Inst Basic Med Sci, Lab Genome Engn, Beijing, Peoples R China.	xudg@bmi.ac.cn			Applied Basic Research Program of Science and Technology Commission Foundation of Beijing [Z141100000514007]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09102301-017]	Applied Basic Research Program of Science and Technology Commission Foundation of Beijing; National Science and Technology Major Project of the Ministry of Science and Technology of China	The Applied Basic Research Program of Science and Technology Commission Foundation of Beijing (Z141100000514007) National Science and Technology Major Project of the Ministry of Science and Technology of China (2012ZX09102301-017).	Akihisa T, 2006, J NAT PROD, V69, P38, DOI 10.1021/np058080d; Bruck D., 2015, NEUROBIOL DIS; Chang CY, 2015, BIOCHEM BIOPH RES CO, V463, P421, DOI 10.1016/j.bbrc.2015.05.088; Chen XM, 2013, FEBS LETT, V587, P2930, DOI 10.1016/j.febslet.2013.07.037; Dzoyem JP, 2013, DRUG DISCOV THER, V7, P66, DOI 10.5582/ddt.2013.v7.2.66; Li YG, 2015, FITOTERAPIA, V101, P99, DOI 10.1016/j.fitote.2015.01.004; Murugan M, 2011, GLIA, V59, P521, DOI 10.1002/glia.21121; Papa S, 2016, BIOMATERIALS, V75, P13, DOI 10.1016/j.biomaterials.2015.10.015; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Rizzo F, 2014, CELL MOL LIFE SCI, V71, P999, DOI 10.1007/s00018-013-1480-4; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Tsai RY, 2015, J FORMOS MED ASSOC, V114, P446, DOI 10.1016/j.jfma.2014.12.004; Tsai WJ, 1996, J NAT PROD, V59, P671, DOI 10.1021/np960157y; Wang HM, 2015, EUR J MED CHEM, V92, P439, DOI 10.1016/j.ejmech.2015.01.007; Xiao GD, 2010, J CHROMATOGR A, V1217, P5470, DOI 10.1016/j.chroma.2010.06.041; Xin D, 2010, PHYTOMEDICINE, V17, P126, DOI 10.1016/j.phymed.2009.05.015	17	56	61	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169560	10.1371/journal.pone.0169560	http://dx.doi.org/10.1371/journal.pone.0169560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060896	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500109
J	Kim, SY; Bang, W; Kim, MS; Park, B; Kim, JH; Chol, HG				Kim, So Young; Bang, Woojin; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Chol, Hyo Geun			Nocturia Is Associated with Slipping and Falling	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; RISK; POPULATION; SLEEP; OBESITY; HEALTH; ADULTS; MEN; PREVALENCE	Several reports have demonstrated associations between falls and nocturia in the elderly. However, little information is available regarding other age groups. This study evaluated the relationship between the frequency of nocturia and falls in men using a large, population-based survey in Korea, and the results were adjusted for various confounding factors. Data from a 2011 Korean community health survey (KCHS) were retrieved for 92,660 men aged 19 to 103 years. Information regarding the history of slips or falls in the past year was collected. The frequency of nocturia was classified as 0, 1, 2, 3, 4, and >= 5 instances a night. Walking during the day, education, income, body mass index (BMI), smoking, alcohol consumption, sleep time, stress level and medical histories of hypertension, diabetes mellitus, hyperlipidemia, cerebral stroke, angina or myocardial infarction, arthritis, and osteoporosis were adjusted using multiple logistic regression analysis with complex sampling. A subgroup analysis was conducted for young (19-30 years), middle-aged (31-60 years), and elderly individuals (61+ years). Approximately 14.6% of the men had a history of falls. Their mean age was 42.9 years, which was significantly higher than that of the non-faller group (P < 0.001). An increased frequency of nocturia was associated with increased adjusted odds ratio (AOR) for falls (AOR for 1 instance of nocturia/night = 1.41 [95% confidence interval, 1.33-1.50]; AOR for 2 instances = 1.41 [1.33-1.50]; AOR for 3 instances = 2.00 [1.75-2.28]; AOR for 4 instances = 2.12 [1.73-2.61]; AOR for-5 instances = 2.02 [1.74-2.36], P < 0.001). In the subgroup analysis, the AORs for falls significantly increased in all age groups as the frequency of nocturia increased.	[Kim, So Young] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, So Young] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Bang, Woojin] Hallym Univ, Sacred Heart Hosp, Dept Urol, Anyang, South Korea; [Kim, Min-Su] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Park, Bumjung; Chol, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hallym University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Hallym University	Chol, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2015-55]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) 17 from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2015-55).	Abdelmoteleb H, 2016, INT J SURG, V25, P164, DOI 10.1016/j.ijsu.2015.11.043; [Anonymous], 2009, WHAT AR EQ SCAL; Appell RA, 2008, NEUROUROL URODYNAM, V27, P34, DOI 10.1002/nau.20484; Asplund R, 2005, BJU INT, V95, P816, DOI 10.1111/j.1464-410X.2005.05407.x; Asplund R, 2004, BJU INT, V93, P1253, DOI 10.1111/j.1464-410X.2004.04835.x; Baker DI, 2005, J AM GERIATR SOC, V53, P675, DOI 10.1111/j.1532-5415.2005.53218.x; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bliwise DL, 2009, SLEEP MED, V10, P540, DOI 10.1016/j.sleep.2008.04.002; Bosch JLHR, 2013, J UROLOGY, V189, pS86, DOI 10.1016/j.juro.2012.11.033; Boye NDA, 2015, GERIATR GERONTOL INT, V15, P350, DOI 10.1111/ggi.12287; Breyer BN, 2013, J UROLOGY, V190, P953, DOI 10.1016/j.juro.2013.03.126; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Cote KA, 2003, SLEEP, V26, P687, DOI 10.1093/sleep/26.6.687; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; Finan PH, 2015, SLEEP, V38, P1735, DOI 10.5665/sleep.5154; Gonzalez N, 2014, INT J CLIN PRACT, V68, P919, DOI 10.1111/ijcp.12410; Gulur DM, 2011, BJU INT, V107, P702, DOI 10.1111/j.1464-410X.2010.09763.x; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Hita-Contreras F, 2015, MATURITAS, V80, P126, DOI 10.1016/j.maturitas.2014.11.009; International Obesity Taskforce, 2000, AS PAC PERSP RED OB; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Kim SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003130; Kim SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002397; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135753; Lin HW, 2014, LARYNGOSCOPE, V124, P2797, DOI 10.1002/lary.24806; Lin SI, 2015, GERIATR GERONTOL INT, V15, P579, DOI 10.1111/ggi.12320; Madhu C, 2015, INT J CLIN PRACT, V69, P1508, DOI 10.1111/ijcp.12727; Marshall LM, 2016, J UROLOGY, V196, P166, DOI 10.1016/j.juro.2016.02.081; Morris V, 2007, INT J CLIN PRACT, V61, P320, DOI 10.1111/j.1742-1241.2006.01174.x; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Ohayon MM, 2008, J PSYCHIATR RES, V43, P48, DOI 10.1016/j.jpsychires.2008.02.001; Ren J, 2014, SOUTH MED J, V107, P294, DOI 10.1097/SMJ.0000000000000097; Rim H, 2011, J KOREAN MED SCI, V26, P1409, DOI 10.3346/jkms.2011.26.11.1409; Rustom JS, 2011, ACTAS UROL ESP, V35, P4, DOI [10.1016/j.acuro.2010.05.017, 10.1016/S2173-5786(11)70002-6]; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; Stubbs B, 2016, PAIN PRACT, V16, P80, DOI 10.1111/papr.12264; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; van Kerrebroevk P, 2007, EUR UROL, V52, P221, DOI 10.1016/j.eururo.2007.01.027; Vaughan CP, 2010, INT J CLIN PRACT, V64, P577, DOI 10.1111/j.1742-1241.2009.02326.x; Yu HJ, 2006, UROLOGY, V67, P713, DOI 10.1016/j.urology.2005.10.054	42	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169690	10.1371/journal.pone.0169690	http://dx.doi.org/10.1371/journal.pone.0169690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060916	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500130
J	Ricci, F; Catozzi, C; Murgia, X; Rosa, B; Amidani, D; Lorenzini, L; Bianco, F; Rivetti, C; Catinella, S; Villetti, G; Civelli, M; Pioselli, B; Dani, C; Salomone, F				Ricci, Francesca; Catozzi, Chiara; Murgia, Xabier; Rosa, Brenda; Amidani, Davide; Lorenzini, Luca; Bianco, Federico; Rivetti, Claudio; Catinella, Silvia; Villetti, Gino; Civelli, Maurizio; Pioselli, Barbara; Dani, Carlo; Salomone, Fabrizio			Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; SURFACTANT THERAPY; PREMATURE LAMBS; GAS-EXCHANGE; CONTROLLED-TRIAL; PORACTANT-ALPHA; ANIMAL-MODEL; BLOOD-FLOW; OPEN-LABEL; VENTILATION	Nasal continuous positive airway pressure (nCPAP) is a widely accepted technique of non-invasive respiratory support in spontaneously-breathing premature infants with respiratory distress syndrome (RDS). Surfactant administration techniques compatible with nCPAP ventilation strategy are actively investigated. Our aim is to set up and validate a respiratory distress animal model that can be managed on nCPAP suitable for surfactant administration techniques studies. Surfactant depletion was induced by bronchoalveolar lavages (BALs) on 18 adult rabbits. Full depletion was assessed by surfactant component analysis on the BALs samples. Animals were randomized into two groups: Control group (nCPAP only) and InSurE group, consisting of a bolus of surfactant (Poractant alfa, 200 mg/kg) followed by nCPAP. Arterial blood gases were monitored until animal sacrifice, 3 hours post treatment. Lung mechanics were evaluated just before and after BALs, at the time of treatment, and at the end of the procedure. Surfactant phospholipids and protein analysis as well as surface tension measurements on sequential BALs confirmed the efficacy of the surfactant depletion procedure. The InSurE group showed a significant improvement of blood oxygenation and lung mechanics. On the contrary, no signs of recovery were appreciated in animals treated with just nCPAP. The surfactant-depleted adult rabbit RDS model proved to be a valuable and efficient preclinical tool for mimicking the clinical scenario of preterm infants affected by mild/moderate RDS who spontaneously breathe and do not require mechanical ventilation. This population is of particular interest as potential target for the non-invasive administration of surfactant.	[Ricci, Francesca; Catozzi, Chiara; Rosa, Brenda; Lorenzini, Luca; Bianco, Federico; Catinella, Silvia; Villetti, Gino; Civelli, Maurizio; Pioselli, Barbara; Salomone, Fabrizio] Chiesi Farmaceut, R&D Dept, Parma, Italy; [Murgia, Xabier] Helmholtz Inst Pharmaceut Res Saarland, Dept Drug Delivery, Saarbrucken, Germany; [Amidani, Davide; Rivetti, Claudio] Univ Parma, Dept Life Sci, Parma, Italy; [Dani, Carlo] Careggi Univ Hosp Florence, Drug Res & Child Hlth, Dept Neurosci Psychol, Florence, Italy	Chiesi Pharmaceuticals Inc; Helmholtz Association; Helmholtz-Center for Infection Research; University of Parma; University of Florence; Azienda Ospedaliero Universitaria Careggi	Salomone, F (corresponding author), Chiesi Farmaceut, R&D Dept, Parma, Italy.	f.salomone@chiesi.com	Pioselli, Barbara/ABH-3439-2020	Rosa, Brenda/0000-0002-7203-0490; salomone, fabrizio/0000-0002-9083-3932; Lorenzini, Luca/0000-0002-5257-0131	Chiesi Farmaceutici S.p.A.	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc)	The present study was supported by Chiesi Farmaceutici S.p.A. The funder provided support in the form of salaries for authors [FR, CC, BR, LL, FB, SC, GV, BP, FS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADAMS FH, 1978, PEDIATR RES, V12, P841, DOI 10.1203/00006450-197808000-00008; ALVAREZ FJ, 1995, ACTA ANAESTH SCAND, V39, P970, DOI 10.1111/j.1399-6576.1995.tb04207.x; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Bahlmann H, 2000, ACTA ANAESTH SCAND, V44, P612, DOI 10.1034/j.1399-6576.2000.00521.x; Berggren E, 2000, ACTA PAEDIATR, V89, P460, DOI 10.1080/080352500750028195; Blennow M, 2015, NEONATOLOGY, V107, P330, DOI 10.1159/000381122; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bringezu F, 2001, LANGMUIR, V17, P4641, DOI 10.1021/la0103158; Dargaville PA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3985; Dargaville PA, 2013, NEONATOLOGY, V104, P8, DOI 10.1159/000346460; Dargaville PA, 2011, ARCH DIS CHILD-FETAL, V96, pF243, DOI 10.1136/adc.2010.192518; Dijk PH, 1997, INTENS CARE MED, V23, P1070, DOI 10.1007/s001340050458; Dijk PH, 1997, INTENS CARE MED, V23, P1077, DOI 10.1007/s001340050459; Finer NN, 2010, J AEROSOL MED PULM D, V23, P303, DOI 10.1089/jamp.2009.0758; Gastiasoro-Cuesta E, 2006, PEDIATRICS, V117, P295, DOI 10.1542/peds.2005-0378; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; Goikoetxea E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106835; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hutten MC, 2015, PEDIATR RES, V78, P664, DOI 10.1038/pr.2015.165; JOBE A, 1983, PEDIATR RES, V17, P444, DOI 10.1203/00006450-198306000-00002; Jorch G, 1997, PEDIATR PULM, V24, P222, DOI 10.1002/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O; Kandler MA, 2001, AM J RESP CRIT CARE, V164, P31, DOI 10.1164/ajrccm.164.1.2010049; Kanmaz HG, 2013, PEDIATRICS, V131, pE502, DOI 10.1542/peds.2012-0603; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; Lampland AL, 2014, PEDIATR PULM, V49, P482, DOI 10.1002/ppul.22844; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mazela J, 2007, CURR OPIN PEDIATR, V19, P155, DOI 10.1097/MOP.0b013e32807fb013; MOORE BG, 1990, J PHYS CHEM-US, V94, P4588, DOI 10.1021/j100374a042; Nowotarska SW, 2014, MOLECULES, V19, P7497, DOI 10.3390/molecules19067497; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Rahmel DK, 2012, REPROD TOXICOL, V34, P204, DOI 10.1016/j.reprotox.2012.05.089; Rey-Santano C, 2013, PEDIATR RES, V73, P639, DOI 10.1038/pr.2013.24; Roberts KD, 2010, PEDIATR RES, V68, P414, DOI 10.1203/PDR.0b013e3181ef7619; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Schmolzer GM, 2011, INTENS CARE MED, V37, P1833, DOI 10.1007/s00134-011-2366-2; SEIDNER SR, 1995, AM J RESP CRIT CARE, V152, P113, DOI 10.1164/ajrccm.152.1.7599809; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Wada K, 1985, J APPL PHYSIOL, V83, P1054; Walsh BK, 2013, RESP CARE, V58, P367, DOI 10.4187/respcare.02189; Walther FJ, 2014, PEERJ, V2, DOI 10.7717/peerj.403; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; Zhang H, 2012, PEDIATR RES, V71, P316, DOI 10.1038/pr.2011.78; Zhang H, 2011, LANGMUIR, V27, P8351, DOI 10.1021/la201482n	44	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169190	10.1371/journal.pone.0169190	http://dx.doi.org/10.1371/journal.pone.0169190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060859	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500066
J	Senevirathne, G; Kerney, R; Meegaskumbura, M				Senevirathne, Gayani; Kerney, Ryan; Meegaskumbura, Madhava			Comparative Postembryonic Skeletal Ontogeny in Two Sister Lineages of Old World Tree Frogs (Rhacophoridae: Taruga, Polypedates)	PLOS ONE			English	Article							WESTERN-GHATS; CRANIAL ONTOGENY; ANURA; EVOLUTION; PHYLOGENY; AMPHIBIA; GENERA; EMPHASIS; RANIDAE; INDIA	Rhacophoridae, a family of morphologically cryptic frogs, with many genetically distinct evolutionary lineages, is understudied with respect to skeletal morphology, life history traits and skeletal ontogeny. Here we analyze two species each from two sister lineages, Taruga and Polypedates, and compare their postembryonic skeletal ontogeny, larval chondrocrania and adult osteology in the context of a well-resolved phylogeny. We further compare these ontogenetic traits with the direct-developing Pseudophilautus silus. For each species, we differentially stained a nearly complete developmental series of tadpoles from early postembryonic stages through metamorphosis to determine the intraspecific and interspecific differences of cranial and postcranial bones. Chondrocrania of the four species differ in 1) size; 2) presence/absence of anterolateral and posterior process; and 3) shape of the suprarostral cartilages. Interspecific variation of ossification sequences is limited during early stages, but conspicuous during later development. Early cranial ossification is typical of other anuran larvae, where the frontoparietal, exoccipital and parasphenoid ossify first. The ossification sequences of the cranial bones vary considerably within the four species. Both species of Taruga show a faster cranial ossification rate than Polypedates. Seven cranial bones form when larvae near metamorphic climax. Ossification of all 18 cranial bones is initiated by larval Gosner stage 46 in T. eques. However, some cranial bone formation is not initiated until after metamorphosis in the other three species. Postcranial sequence does not vary significantly. The comparison of adult osteology highlights two characters, which have not been previously recorded: presence/absence of the parieto-squamosal plates and bifurcated base of the omosternum. This study will provide a starting point for comparative analyses of rhacophorid skeletal ontogeny and facilitate the study of the evolution of ontogenetic repatterning associated with the life history variation in the family.	[Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Postgrad Inst Sci, Peradeniya, Sri Lanka; [Kerney, Ryan] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	University of Peradeniya; University of Peradeniya; Gettysburg College	Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Postgrad Inst Sci, Peradeniya, Sri Lanka.	madhava88m@gmail.com	Senevirathne, Gayani/ABD-5713-2021; Meegaskumbura, Madhava/F-8782-2013	Meegaskumbura, Madhava/0000-0002-4599-6724; Senevirathne, Gayani/0000-0001-6704-9691; Kerney, Ryan/0000-0002-4740-7735	Rufford Foundation [192721]	Rufford Foundation	Rufford Foundation Small Grant (#192721) to GS supported the tadpole DNA barcoding work.	Abraham RK, 2013, ZOOTAXA, V3640, P177, DOI 10.11646/zootaxa.3640.2.3; Ahl E, 1931, TIERREICH; AmphibiaWeb, 2016, AMPHIBIAWEB INF AMPH; Biju SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145727; Biju SD, 2010, CURR SCI INDIA, V98, P1119; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Cannatella D, 1999, TADPOLES, P52; Duellman W. E., 1986, BIOL AMPHIBIANS; Gosner K. L., 1960, Herpetologica, V16, P183; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas A, 1998, J MORPHOL, V238, P109, DOI 10.1002/(SICI)1097-4687(199811)238:2<109::AID-JMOR1>3.0.CO;2-#; HANKEN J, 1992, J MORPHOL, V211, P95, DOI 10.1002/jmor.1052110111; HANKEN J, 1988, J MORPHOL, V195, P247, DOI 10.1002/jmor.1051950303; Hoffman A. C., 1932, South African Journal of Science, V29, P562; Kerney R, 2007, J MORPHOL, V268, P715, DOI 10.1002/jmor.10545; Laurent P., 1951, Revue de Zoologie et de Botanique Africaines, V45, P116; Li JT, 2008, MOL PHYLOGENET EVOL, V48, P302, DOI 10.1016/j.ympev.2008.03.023; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; LIEM S S, 1970, Fieldiana Zoology, V57, P1; Maglia AM, 2007, J MORPHOL, V268, P194, DOI 10.1002/jmor.10508; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Meegaskumbura M, 2015, ZOOL SCR, V44, P509, DOI 10.1111/zsc.12121; Meegaskumbura Madhava, 2010, Ceylon Journal of Science Biological Sciences, V39, P75; Okutomi K., 1937, Zeitschrift fuer Anatomie Entw Mech, V107, P28, DOI 10.1007/BF02119771; ORTON GL, 1953, SYST ZOOL, V2, P63, DOI 10.2307/2411661; ORTON GL, 1957, SYST ZOOL, V6, P79, DOI 10.2307/2411805; Palumbi Stephen R., 1996, P205; Pugener LA, 2009, J MORPHOL, V270, P52, DOI 10.1002/jmor.10665; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Pugener LA, 1997, J MORPHOL, V233, P267, DOI 10.1002/(SICI)1097-4687(199709)233:3<267::AID-JMOR6>3.0.CO;2-0; Ramaswami L. S., 1956, Current Science, V25, P19; Ramaswami LS, 1938, NATURE, V142, P577, DOI 10.1038/142577a0; Ridewood W. G., 1898, Journal of the Linnean Society, Vxxvi, P474; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott E, 2005, CLADISTICS, V21, P507, DOI 10.1111/j.1096-0031.2005.00079.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR W R, 1985, Cybium, V9, P107; Trueb L., 1973, P65; Wilkinson JA, 2002, MOL PHYLOGENET EVOL, V24, P265, DOI 10.1016/S1055-7903(02)00212-9; Wilkinson Jeffery A., 2000, Contemporary Herpetology, V2000, pUnpaginated; Yeh J, 2002, EVOLUTION, V56, P2484; Yu GH, 2008, ZOOL J LINN SOC-LOND, V153, P733, DOI 10.1111/j.1096-3642.2008.00404.x; Yu GH, 2009, MOL PHYLOGENET EVOL, V50, P571, DOI 10.1016/j.ympev.2008.11.023	45	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167939	10.1371/journal.pone.0167939	http://dx.doi.org/10.1371/journal.pone.0167939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060923	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500018
J	Vejrik, L; Vejrikova, I; Kocvara, L; Sajdlova, Z; The, SCH; Smejkal, M; Peterka, J; Cech, M				Vejrik, Lukas; Vejrikova, Ivana; Kocvara, Lubos; Sajdlova, Zuzana; Son Chung Hoang The; Smejkal, Marek; Peterka, Jiri; Cech, Martin			Thirty-Year-Old Paradigm about Unpalatable Perch Egg Strands Disclaimed by the Freshwater Top-Predator, the European Catfish (Silurus glanis)	PLOS ONE			English	Article							CORMORANT PHALACROCORAX-CARBO; FLUVIATILIS L.; SITE SELECTION; FISH; SIZE; LAKE; INTRODUCTIONS; DEPOSITION; MORTALITY; ROLES	So far, perch egg strands have been considered unpalatable biological material. However, we repeatedly found egg strands of European perch (Perca fluviatilis) in the diet of European catfish (Silurus glanis) caught by longlines in Milada and Most Lakes, Czech Republic. The finding proves that perch egg strands compose a standard food source for this large freshwater predatory fish. It extends the present knowledge on catfish foraging plasticity, showing it as an even more opportunistic feeder. Utilization of perch egg strands broadens the catfish diet niche width and represents an advantage against other fish predators. Comparison of datasets from extensive gillnet and SCUBA diver sampling campaigns gave the evidence that at least in localities where food sources are limited, multilevel predation by catfish may have an important impact on the perch population.	[Vejrik, Lukas; Vejrikova, Ivana; Kocvara, Lubos; Sajdlova, Zuzana; Son Chung Hoang The; Smejkal, Marek; Peterka, Jiri; Cech, Martin] Czech Acad Sci, Inst Hydrobiol, Ctr Biol, Sadkach 7, Ceske Budejovice, Czech Republic; [Vejrik, Lukas] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Vejrik, L (corresponding author), Czech Acad Sci, Inst Hydrobiol, Ctr Biol, Sadkach 7, Ceske Budejovice, Czech Republic.; Vejrik, L (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice, Czech Republic.	vejrik.lukas@seznam.cz	Peterka, Jiří/C-7218-2014; Vejřík, Lukáš/E-1607-2017; Čech, Martin/C-5797-2014; Sajdlova, Zuzana/R-1383-2018; Vejříková, Ivana/E-1624-2017; Kocvara, Lubos/AAD-4568-2021; Šmejkal, Marek/E-1269-2017	Vejřík, Lukáš/0000-0001-8911-9128; Čech, Martin/0000-0003-1350-4286; Vejříková, Ivana/0000-0001-9113-2815; Šmejkal, Marek/0000-0002-7887-6411	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0204]; Norwegian Financial Mechanism [7F14316, MSMT-28477/2014]; Czech Science Foundation [206/09/P266]; European Union's Horizon 2020 research and innovation programme [677039]; Grant Agency of University of South Bohemia [04-151/2016/P]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Norwegian Financial Mechanism; Czech Science Foundation(Grant Agency of the Czech Republic); European Union's Horizon 2020 research and innovation programme; Grant Agency of University of South Bohemia	The study was supported by projects No. CZ.1.07/2.3.00/20.0204 (CEKOPOT) of the Ministry of Education, Youth and Sports, No. 7F14316 of the Norwegian Financial Mechanism 2009-2014 under contract number MSMT-28477/2014, No. 206/09/P266 of the Czech Science Foundation, No. 677039 (CLIMEFISH) of the European Union's Horizon 2020 research and innovation programme, and No. 04-151/2016/P of the Grant Agency of University of South Bohemia.	AALTO SK, 1990, CAN J FISH AQUAT SCI, V47, P1959, DOI 10.1139/f90-220; ADAMEK Z, 1999, RIBARSTVO, V57, P47; Alp A, 2004, TURK J VET ANIM SCI, V28, P613; Auguie B, 2017, GRIDEXTRA MISCELLANE; Carol J, 2007, ECOL FRESHW FISH, V16, P450, DOI 10.1111/j.1600-0633.2007.00225.x; Cech M, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012026; Cech M, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011070; Cech M, 2008, WATERBIRDS, V31, P438; Cech M, 2012, J LIMNOL, V71, P170, DOI 10.4081/jlimnol.2012.e18; Cech M, 2011, FOLIA ZOOL, V60, P129; Cech M, 2010, HYDROBIOLOGIA, V649, P375, DOI 10.1007/s10750-010-0251-6; Cech M, 2009, HYDROBIOLOGIA, V630, P105, DOI 10.1007/s10750-009-9783-z; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; Cunico AM, 2014, BIOINVASIONS REC, V3, P117, DOI 10.3391/bir.2014.3.2.10; DIAMOND M, 1986, FRESHWATER BIOL, V16, P373, DOI 10.1111/j.1365-2427.1986.tb00977.x; Dubois JP, 1996, ANN ZOOL FENN, V33, P417; Elvira B, 2001, J FISH BIOL, V59, P323, DOI 10.1006/jfbi.2001.1753; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gillet C, 2007, J FISH BIOL, V70, P1001, DOI 10.1111/j.1095-8649.2007.01359.x; GILLET C, 1995, HYDROBIOLOGIA, V300, P409, DOI 10.1007/BF00024482; GUMAA SA, 1978, FRESHWATER BIOL, V8, P221, DOI 10.1111/j.1365-2427.1978.tb01443.x; GUNTHORPE L, 1990, TOXICON, V28, P1199, DOI 10.1016/0041-0101(90)90120-V; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; KRUEGER CC, 1991, CAN J FISH AQUAT SCI, V48, P66, DOI 10.1139/f91-305; NEWSOME GE, 1987, CAN J FISH AQUAT SCI, V44, P1221; NEWSOME GE, 1985, CAN J ZOOL, V63, P2882, DOI 10.1139/z85-430; Nunn AD, 2007, FRESHWATER BIOL, V52, P1576, DOI 10.1111/j.1365-2427.2007.01789.x; Peterka J., 2015, COMPLEX FISH STOCK A; Seaburg KG, 1957, PROGR FISH CULT, V19, P137, DOI [DOI 10.1577/1548-8659(1957)19[137:ASSFLF]2.0.CO;2, 10.1577/1548-8659(1957)19[137:ASSFLF]2.0.CO;2]; Smith C, 2001, J FISH BIOL, V58, P880, DOI 10.1111/j.1095-8649.2001.tb00538.x; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Van Neer W, 1993, HERLEVEND VERLEDEN; Vasek M, 2013, ECOL ENG, V52, P104, DOI 10.1016/j.ecoleng.2012.12.100; ZEH M, 1989, AQUAT SCI, V51, P100, DOI 10.1007/BF00879297	35	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169000	10.1371/journal.pone.0169000	http://dx.doi.org/10.1371/journal.pone.0169000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060862	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500048
J	Wang, J; Butler, RR; Wu, F; Pombert, JF; Kilbane, JJ; Stark, BC				Wang, Jia; Butler, Robert R., III; Wu, Fan; Pombert, Jean-Francois; Kilbane, John J., II; Stark, Benjamin C.			Enhancement of Microbial Biodesulfurization via Genetic Engineering and Adaptive Evolution	PLOS ONE			English	Article							SP STRAIN IGTS8; RHODOCOCCUS-ERYTHROPOLIS; DESULFURIZATION ACTIVITY; FOSSIL-FUELS; DIBENZOTHIOPHENE DESULFURIZATION; OXIDATIVE DESULFURIZATION; DSZ OPERON; SULFUR; ENZYMES; HYDRODESULFURIZATION	In previous work from our laboratories a synthetic gene encoding a peptide ("Sulpeptide 1" or "S1") with a high proportion of methionine and cysteine residues had been designed to act as a sulfur sink and was inserted into the dsz (desulfurization) operon of Rhodococcus erythropolis IGTS8. In the work described here this construct (dszAS1BC) and the intact dsz operon (dszABC) cloned into vector pRESX under control of the (Rhodococcus) kstD promoter were transformed into the desulfurization-negative strain CW25 of Rhodococcus qingshengii. The resulting strains (CW25[pRESX-dszABC] and CW25[pRESX-dszAS1BC]) were subjected to adaptive selection by repeated passages at log phase (up to 100 times) in minimal medium with dibenzothiophene (DBT) as sole sulfur source. For both strains DBT metabolism peaked early in the selection process and then decreased, eventually averaging four times that of the initial transformed cells; the maximum specific activity achieved by CW25[pRESX-dszAS1BC] exceeded that of CW25[pRESX-dszABC]. Growth rates increased by 7-fold (CW25[pRESX-dszABC]) and 13-fold (CW25[pRESX-dszAS1BC]) and these increases were stable. The adaptations of CW25[pRESX-dszAS1BC] were correlated with a 3-5X increase in plasmid copy numbers from those of the initial transformed cells; whole genome sequencing indicated that during its selection processes no mutations occurred to any of the dsz, S1, or other genes and promoters involved in sulfur metabolism, stress response, or DNA methylation, and that the effect of the sulfur sink produced by S1 is likely very small compared to the cells' overall cysteine and methionine requirements. Nevertheless, a combination of genetic engineering using sulfur sinks and increasing Dsz capability with adaptive selection may be a viable strategy to increase biodesulfurization ability.	[Wang, Jia; Butler, Robert R., III; Wu, Fan; Pombert, Jean-Francois; Kilbane, John J., II; Stark, Benjamin C.] IIT, Dept Biol, Chicago, IL 60616 USA	Illinois Institute of Technology	Stark, BC (corresponding author), IIT, Dept Biol, Chicago, IL 60616 USA.	starkb@iit.edu		Butler, Robert/0000-0003-0200-8682; Pombert, Jean-Francois/0000-0002-3449-8375	Saudi Arabian Oil Company (Saudi Aramco) [6600019855]	Saudi Arabian Oil Company (Saudi Aramco)	This work was supported by grant No. 6600019855 from the Saudi Arabian Oil Company (Saudi Aramco) (http://www.saudiaramco.com/en/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant No. 6600019855 from the Saudi Arabian Oil Company (Saudi Aramco).	Abin-Fuentes A, 2013, APPL ENVIRON MICROB, V79, P7807, DOI 10.1128/AEM.02696-13; Aggarwal S, 2012, MOL BIOSYST, V8, P2724, DOI 10.1039/c2mb25127b; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Brunet S, 2005, APPL CATAL A-GEN, V278, P143, DOI 10.1016/j.apcata.2004.10.012; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Corro G, 2002, REACT KINET CATAL L, V75, P89, DOI 10.1023/A:1014853602908; DENOME SA, 1994, J BACTERIOL, V176, P6707, DOI 10.1128/JB.176.21.6707-6716.1994; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Furuya T, 2001, FEMS MICROBIOL LETT, V204, P129, DOI 10.1111/j.1574-6968.2001.tb10875.x; Gray KA, 2003, CURR OPIN MICROBIOL, V6, P229, DOI 10.1016/S1369-5274(03)00065-1; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hirasawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P239, DOI 10.1271/bbb.65.239; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Ishii Y, 2000, BIOCHEM BIOPH RES CO, V270, P81, DOI 10.1006/bbrc.2000.2370; Kayser KJ, 2002, APPL MICROBIOL BIOT, V59, P737, DOI 10.1007/s00253-002-1030-8; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KILBANE JJ, 1992, BIOTECHNOL BIOENG, V40, P1107, DOI 10.1002/bit.260400915; Kilbane JJ, 2004, STUD SURF SCI CATAL, V151, P29; KILBANE JJ, 1989, TRENDS BIOTECHNOL, V7, P97, DOI 10.1016/0167-7799(89)90007-3; Kilbane JJ, 2006, CURR OPIN BIOTECH, V17, P305, DOI 10.1016/j.copbio.2006.04.005; Kirimura K, 2001, J BIOSCI BIOENG, V91, P262, DOI 10.1263/jbb.91.262; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Konishi J, 1997, APPL ENVIRON MICROB, V63, P3164, DOI 10.1128/AEM.63.8.3164-3169.1997; Larisch C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-4; Lei BF, 1996, J BACTERIOL, V178, P5699, DOI 10.1128/jb.178.19.5699-5705.1996; Leiser OP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142997; Li FL, 2003, FEMS MICROBIOL LETT, V223, P301, DOI 10.1016/S0378-1097(03)00397-5; Li GQ, 2007, BIOSCI BIOTECH BIOCH, V71, P849, DOI 10.1271/bbb.60189; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McFarland BL, 1998, CRIT REV MICROBIOL, V24, P99, DOI 10.1080/10408419891294208; Pan J, 2013, FUEL, V112, P385, DOI 10.1016/j.fuel.2013.04.065; PEARLMAN RS, 1984, J PHYS CHEM REF DATA, V13, P555, DOI 10.1063/1.555712; Qiu L, 2016, RSC ADV, V6, P17036, DOI 10.1039/c5ra23077b; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Subramanian S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt551; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; van der Geize R, 2008, APPL ENVIRON MICROB, V74, P7197, DOI 10.1128/AEM.00888-08; Wang J, 2015, BIOTECHNOL LETT, V37, P2201, DOI 10.1007/s10529-015-1918-x; Yang CP, 2016, SEP PURIF TECHNOL, V163, P153, DOI 10.1016/j.seppur.2016.02.050; Zhao K, 2015, RSC ADV, V5, P66013, DOI 10.1039/c5ra12305d	49	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168833	10.1371/journal.pone.0168833	http://dx.doi.org/10.1371/journal.pone.0168833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060828	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500039
J	Risso, K; Guillouet-De-Salvador, F; Valerio, L; Pugliese, P; Naqvi, A; Durant, J; Demonchy, E; Perbost, I; Cue, E; Marquette, CH; Roger, PM				Risso, Karine; Guillouet-de-Salvador, Francine; Valerio, Laure; Pugliese, Pascal; Naqvi, Alissa; Durant, Jacques; Demonchy, Elisa; Perbost, Isabelle; Cue, Eric; Marquette, Charles-Hugo; Roger, Pierre-Marie			COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY SYMPTOMS; TOBACCO SMOKING; LUNG-DISEASE; PREVALENCE; COHORT; ABNORMALITIES; COLONIZATION; INDIVIDUALS; POPULATION	Background COPD is a frequent and significant cause of respiratory morbidity in HIV-infected patients despite the control of HIV. We aimed to analyze the factors correlated with COPD in this population to evaluate the existence of specific indicators of vulnerability in this population. Methods and Findings 623 HIV-infected outpatients were enrolled during one year. This population was characterised by a dedicated questionnaire and electronic patient records. COPD screening was performed according to recommended spirometric criteria. The prevalence of COPD was 9.0%. Age and smoking were independently correlated with COPD (OR, 1.61 per 10 years increase, P=0.007; OR, 1.28 per 10 pack-year increase, P=0.003, respectively). Body mass index (BMI) and CD4 cell-count were independently and negatively correlated with COPD (OR, 0.78, P<0.001; OR, 0.77 per 100 cell/mm(3) increase, P < 0.001, respectively). Among COPD patients, 77% did not know their diagnosis. Five COPD-patients never smoked and 44.2% did not have any respiratory symptoms and so were not eligible to perform a spirometry according to the guidelines. Conclusions In addition to known risk factors, immune defect through CD4 cell count was independently and strongly correlated with COPD. COPD is largely underdiagnosed and thus unmanaged. However, early management and urgent smoking cessation are essential to improve prognosis. Clinicians' awareness on the particular vulnerability for COPD in HIV-infected patients is crucial. Moreover, indications to perform conventional spirometry to diagnose COPD may include more parameters than tobacco-smoking and respiratory complaints with a particular concern toward patients with a profound CD4 cell count defect.	[Risso, Karine; Guillouet-de-Salvador, Francine; Pugliese, Pascal; Naqvi, Alissa; Durant, Jacques; Demonchy, Elisa; Perbost, Isabelle; Cue, Eric; Roger, Pierre-Marie] CHU Nice, Serv Infectiol, Nice, France; [Risso, Karine; Demonchy, Elisa; Marquette, Charles-Hugo; Roger, Pierre-Marie] Univ Nice Sophia Antipolis, Nice, France; [Valerio, Laure] Ctr Hosp Dracenie, Dept Informat Med, Draguignan, France; [Marquette, Charles-Hugo] CHU Nice, Serv Pneumol, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Risso, K (corresponding author), CHU Nice, Serv Infectiol, Nice, France.; Risso, K (corresponding author), Univ Nice Sophia Antipolis, Nice, France.	risso.k@chu-nice.fr	Marquette, Charles Hugo/O-4084-2016	Marquette, Charles Hugo/0000-0002-0846-9941; Risso, Karine/0000-0001-9715-197X	Association pour la Recherche et l'Enseignement en Pathologie Respiratoire et en Oncologie Thoracique; Association Hospitalo-Universitaire de Lutte Contre le Sida; University Hospital Center of Nice	Association pour la Recherche et l'Enseignement en Pathologie Respiratoire et en Oncologie Thoracique; Association Hospitalo-Universitaire de Lutte Contre le Sida; University Hospital Center of Nice	This work was supported by the "Association pour la Recherche et l'Enseignement en Pathologie Respiratoire et en Oncologie Thoracique", and "Association Hospitalo-Universitaire de Lutte Contre le Sida". This study was sponsored by University Hospital Center of Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Aberg Judith A, 2012, Top Antivir Med, V20, P101; Akanbi MO, 2015, J AIDS CLIN RES, V6; Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; Beck F, PREMIERS RESULTATS 2; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Burgel PR, 2012, EUR RESPIR J, V40, P4, DOI 10.1183/09031936.00022412; CDC, 2011, HIV SURV REP; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Diaz PT, 2003, CHEST, V123, P1977, DOI 10.1378/chest.123.6.1977; Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; Duffau P, 2015, AIDS, V29, P2099, DOI 10.1097/QAD.0000000000000807; Duval X, 2008, ANTIVIR THER, V13, P389; Fischer WA, 2014, COPD, V11, P10, DOI 10.3109/15412555.2013.800854; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058812; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Global strategy for the diagnosis management and prevention of COPD, GLOB IN CHRON OBSTR, P1; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hirani A, 2011, RESP MED, V105, P1655, DOI 10.1016/j.rmed.2011.05.009; Hogg JC, 2008, INT J TUBERC LUNG D, V12, P467; Lanadula G, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Makinson A, 2016, J THORAC ONCOL, V11, P1644, DOI 10.1016/j.jtho.2016.06.026; Makinson A, 2015, EUR RESPIR J, V45, P828, DOI 10.1183/09031936.00154914; Marin JM, 2013, EUR RESPIR J, V42, P323, DOI 10.1183/09031936.00121012; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morlat P., PRISE CHARGE ME A DI; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Popescu L, 2014, AM J RESP CRIT CARE, V190, P744, DOI 10.1164/rccm.201407-1226OC; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Roche N, 2008, EUR RESPIR J, V31, P1227, DOI 10.1183/09031936.00089607; Saberi P, 2013, HIV MED, V14, P519, DOI 10.1111/hiv.12039; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Segal Leopoldo N, 2011, Proc Am Thorac Soc, V8, P282, DOI 10.1513/pats.201006-044WR; Shipley TW, 2010, J INFECT DIS, V202, P302, DOI 10.1086/653485; Shirley DK, 2015, AIDS PATIENT CARE ST, V29, P232, DOI 10.1089/apc.2014.0265; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; US Preventive Services Task Force Recommendation Statement, 2016, JAMA-J AM MED ASSOC, V315, P1372; Valiathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097698; Zielinski J, 2006, EUR RESPIR J, V27, P833, DOI 10.1183/09031936.06.00025905	46	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169359	10.1371/journal.pone.0169359	http://dx.doi.org/10.1371/journal.pone.0169359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056048	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100035
J	Cazzola, D; Holsgrove, TP; Preatoni, E; Gill, HS; Trewartha, G				Cazzola, Dario; Holsgrove, Timothy P.; Preatoni, Ezio; Gill, Harinderjit S.; Trewartha, Grant			Cervical Spine Injuries: A Whole-Body Musculoskeletal Model for the Analysis of Spinal Loading	PLOS ONE			English	Article							RUGBY-UNION; DYNAMIC SIMULATIONS; MUSCLE CONTRIBUTIONS; UPPER EXTREMITY; CORD-INJURY; JOINT; SHOULDER; PARAMETERS; MOTION; MECHANISMS	Cervical spine trauma from sport or traffic collisions can have devastating consequences for individuals and a high societal cost. The precise mechanisms of such injuries are still unknown as investigation is hampered by the difficulty in experimentally replicating the conditions under which these injuries occur. We harness the benefits of computer simulation to report on the creation and validation of i) a generic musculoskeletal model (MASI) for the analyses of cervical spine loading in healthy subjects, and ii) a population-specific version of the model (Rugby Model), for investigating cervical spine injury mechanisms during rugby activities. The musculoskeletal models were created in OpenSim, and validated against in vivo data of a healthy subject and a rugby player performing neck and upper limb movements. The novel aspects of the Rugby Model comprise i) population-specific inertial properties and muscle parameters representing rugby forward players, and ii) a custom scapula clavicular joint that allows the application of multiple external loads. We confirm the utility of the developed generic and population-specific models via verification steps and validation of kinematics, joint moments and neuromuscular activations during rugby scrummaging and neck functional movements, which achieve results comparable with in vivo and in vitro data. The Rugby Model was validated and used for the first time to provide insight into anatomical loading and cervical spine injury mechanisms related to rugby, whilst the MASI introduces a new computational tool to allow investigation of spinal injuries arising from other sporting activities, transport, and ergonomic applications. The models used in this study are freely available at simtk.org and allow to integrate in silico analyses with experimental approaches in injury prevention.	[Cazzola, Dario; Preatoni, Ezio; Trewartha, Grant] Univ Bath, Dept Hlth, Bath, Avon, England; [Holsgrove, Timothy P.; Gill, Harinderjit S.] Univ Bath, Dept Mech Engn, Ctr Orthopaed Biomech, Bath, Avon, England; [Holsgrove, Timothy P.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England	University of Bath; University of Bath; University of Exeter	Cazzola, D (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	d.cazzola@bath.ac.uk	Holsgrove, Timothy P/G-1064-2015; Cazzola, Dario/K-3464-2014; Preatoni, Ezio/N-3554-2019; Gill, Richie H. S./A-9808-2011	Cazzola, Dario/0000-0001-7877-6755; Preatoni, Ezio/0000-0001-5383-7072; Gill, Richie H. S./0000-0002-7740-2062; Holsgrove, Timothy/0000-0003-2832-4958	Rugby Football Union (RFU) Injured Players Foundation; Engineering and Physical Sciences Research Council [EP/M023281/1] Funding Source: researchfish; EPSRC [EP/M023281/1] Funding Source: UKRI	Rugby Football Union (RFU) Injured Players Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project is funded by the Rugby Football Union (RFU) Injured Players Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Ackland DC, 2011, J BIOMECH, V44, P475, DOI 10.1016/j.jbiomech.2010.09.036; [Anonymous], 2012, ANTHROPOMETRIC REFER; Blana D, 2008, J BIOMECH, V41, P1714, DOI 10.1016/j.jbiomech.2008.03.001; Bolsterlee B, 2015, J BIOMECH, V48, P1760, DOI 10.1016/j.jbiomech.2015.05.005; Bolsterlee B, 2014, MED BIOL ENG COMPUT, V52, P283, DOI 10.1007/s11517-013-1065-2; Carbone V, 2015, J BIOMECH, V48, P734, DOI 10.1016/j.jbiomech.2014.12.034; Cazzola D, 2015, SCANDINAVIAN J MED S; Cazzola D, 2015, BRIT J SPORT MED, V49, P541, DOI 10.1136/bjsports-2013-092904; Christophy M, 2012, BIOMECH MODEL MECHAN, V11, P19, DOI 10.1007/s10237-011-0290-6; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Davidson PL, 2008, J BIOMECH, V41, P3506, DOI 10.1016/j.jbiomech.2008.09.021; de Bruijn E, 2016, MULTIBODY SYST DYN, V36, P339, DOI 10.1007/s11044-015-9461-z; de Groot JH, 2001, CLIN BIOMECH, V16, P735, DOI 10.1016/S0268-0033(01)00065-1; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Zee M, 2007, J BIOMECH, V40, P1219, DOI 10.1016/j.jbiomech.2006.05.030; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Dennison CR, 2012, BRIT J SPORT MED, V46, P545, DOI 10.1136/bjsports-2012-091257; DVORAK J, 1992, SPINE, V17, pS393, DOI 10.1097/00007632-199210001-00009; DVORAK J, 1987, SPINE, V12, P726, DOI 10.1097/00007632-198710000-00002; DVORAK J, 1993, SPINE, V18, P120, DOI 10.1097/00007632-199301000-00018; DVORAK J, 1988, SPINE, V13, P748, DOI 10.1097/00007632-198807000-00007; Fice JB, 2014, ANN BIOMED ENG, V42, P1846, DOI 10.1007/s10439-014-1046-0; Fuller CW, 2007, CLIN J SPORT MED, V17, P10, DOI 10.1097/JSM.0b013e31802e9c28; Fuller CW, 2013, J SPORT SCI, V31, P795, DOI 10.1080/02640414.2012.753156; Fung M, 2001, J SHOULDER ELB SURG, V10, P278, DOI 10.1067/mse.2001.114496; Garner B A, 2001, Comput Methods Biomech Biomed Engin, V4, P93; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Ivancic Paul C, 2006, Traffic Inj Prev, V7, P389, DOI 10.1080/15389580600789127; Ivancic PC, 2007, ACCIDENT ANAL PREV, V39, P688, DOI 10.1016/j.aap.2006.10.015; Ivancic PC, 2011, SPINE J, V11, P224, DOI 10.1016/j.spinee.2011.01.025; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; Kuster D, 2012, BRIT J SPORT MED, V46, P550, DOI 10.1136/bjsports-2011-090360; Lark SD, 2010, J SPORT SCI, V28, P649, DOI 10.1080/02640411003631968; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Ludewig PM, 2010, CLIN BIOMECH, V25, P415, DOI 10.1016/j.clinbiomech.2010.01.015; Ludewig PM, 2009, J BONE JOINT SURG AM, V91A, P378, DOI 10.2106/JBJS.G.01483; Martelli S, 2015, COMPUT METHOD BIOMEC, V18, P1555, DOI 10.1080/10255842.2014.930134; Matias R, 2009, J BIOMECH, V42, P331, DOI 10.1016/j.jbiomech.2008.11.027; McLean SG, 2003, J BIOMECH ENG-T ASME, V125, P864, DOI 10.1115/1.1634282; Miura T, 2002, SPINE, V27, P43, DOI 10.1097/00007632-200201010-00011; Nightingale RW, 2000, J BIOMECH, V33, P191, DOI 10.1016/S0021-9290(99)00156-6; Nikooyan AA, 2011, MED BIOL ENG COMPUT, V49, P1425, DOI 10.1007/s11517-011-0839-7; Olivier PE, 2008, J SCI MED SPORT, V11, P96, DOI 10.1016/j.jsams.2007.01.009; Panjabi MM, 2004, CLIN BIOMECH, V19, P1, DOI 10.1016/j.clinbiomech.2003.09.006; PENNING L, 1978, AM J ROENTGENOL, V130, P317, DOI 10.2214/ajr.130.2.317; PENNING L, 1987, SPINE, V12, P732, DOI 10.1097/00007632-198710000-00003; Piazza SJ, 2001, J BIOMECH ENG-T ASME, V123, P599, DOI 10.1115/1.1406950; Pizzolato C, 2015, J BIOMECH, V48, P3929, DOI 10.1016/j.jbiomech.2015.09.021; Preatoni E, 2015, SCANDINAVIAN J MED S; Preatoni E, 2015, BRIT J SPORT MED, V49, P520, DOI 10.1136/bjsports-2013-092938; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; Rasmussen J, 2009, INT J IND ERGONOM, V39, P52, DOI 10.1016/j.ergon.2008.07.008; Reinbolt JA, 2007, IEEE T BIO-MED ENG, V54, P782, DOI 10.1109/TBME.2006.889187; Reinbolt JA, 2011, PROC IUTAM, V2, P186, DOI 10.1016/j.piutam.2011.04.019; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2011, J BIOMECH, V44, P1346, DOI 10.1016/j.jbiomech.2011.01.001; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Seminati E, 2016, SPORT BIOMECH, P1; Senteler M, 2016, COMPUT METHOD BIOMEC, V19, P538, DOI 10.1080/10255842.2015.1043906; Sheets AL, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000155; Sherman MA, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2013, VOL 7B; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Dao TT, 2015, DATA KNOWL ENG, V96-97, P3, DOI 10.1016/j.datak.2015.04.001; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Venter DJL, 2004, S AFR J RES SPORT PH, V26, P33, DOI DOI 10.4314/SAJRS.V26I2.25894; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu JZ, 2009, ANN BIOMED ENG, V37, P1177, DOI 10.1007/s10439-009-9674-5; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; YEADON MR, 1990, J BIOMECH, V23, P67, DOI 10.1016/0021-9290(90)90370-I; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	83	33	33	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169329	10.1371/journal.pone.0169329	http://dx.doi.org/10.1371/journal.pone.0169329			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052130	Green Published, gold			2022-12-26	WOS:000391621500048
J	Vieira, EM; de Camargo, NF; Colas, PF; Ribeiro, JF; Cruz-Neto, AP				Vieira, Emerson M.; de Camargo, Nicholas F.; Colas, Paul F.; Ribeiro, Juliana F.; Cruz-Neto, Ariovaldo P.			Geographic Variation in Daily Temporal Activity Patterns of a Neotropical Marsupial (Gracilinanus agilis)	PLOS ONE			English	Article							SMALL-MAMMAL POPULATIONS; PHYLOGENETIC-RELATIONSHIPS; MICOUREUS-DEMERARAE; BODY-TEMPERATURE; ATLANTIC FOREST; SMALL FRAGMENTS; PREDATION RISK; SPACE USE; CERRADO; MOONLIGHT	The temporal activity of animals is an outcome of both biotic and abiotic factors, which may vary along the geographic range of the species. Therefore, studies conducted with a species in different localities with distinct features could elucidate how animals deal with such factors. In this study, we used live traps equipped with timing devices to investigate the temporal activity patterns of the didelphid Gracilinanus agilis in two dry-woodland areas of the Brazilian savanna (Cerrado). These areas were located about 660 km apart, one in Central Brazil and the other in Southeastern Brazil. We compared such patterns considering both reproductive and non-reproductive periods, and how it varies as a function of temperature on a seasonal basis. In Central Brazil, we found a constant, and temperature-independent activity during the night in both reproductive and non-reproductive periods. On the other hand, in Southeastern Brazil, we detected a constant activity during the reproductive period, but in the non-reproductive period G. agilis presented a peak of activity between two and four hours after sunset. Moreover, in this latter we found a relation between temporal activity and temperature during the autumn and spring. These differences in temporal activity between areas, observed during the non-reproductive period, might be associated with the higher seasonal variability in temperature, and lower mean temperatures in the Southeastern site in comparison to the Central one. In Southeastern Brazil, the decrease in temperature during the non-reproductive season possibly forced G. agilis to be active only at certain hours of the night. However, likely due to the reproductive activities (intensive foraging and searching for mates) this marsupial showed constant, temperature-independent activity during the night in the reproductive period at both sites.	[Vieira, Emerson M.; de Camargo, Nicholas F.; Ribeiro, Juliana F.] Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Lab Ecol Vertebrados, Brasilia, DF, Brazil; [Colas, Paul F.; Cruz-Neto, Ariovaldo P.] Univ Estadual Paulista UNESP, Inst Biociencias Rio Claro, Dept Zool, Sao Paulo, SP, Brazil	Universidade de Brasilia; Universidade Estadual Paulista	Vieira, EM (corresponding author), Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Lab Ecol Vertebrados, Brasilia, DF, Brazil.	emweira@unb.br	Camargo, Nícholas/Q-2039-2019; cruz-neto, ariovaldo/Y-7225-2019; Camargo, Nícholas F/B-3389-2019; Vieira, Emerson Monteiro/F-3562-2010	Camargo, Nícholas/0000-0001-6859-8780; cruz-neto, ariovaldo/0000-0001-5270-7276; Camargo, Nícholas F/0000-0001-6859-8780; Vieira, Emerson Monteiro/0000-0003-3488-621X; Colas-Rosas, Paul Francois/0000-0003-4487-7114; Ribeiro, Juliana Fernandes/0000-0002-7611-1175	Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq) (NFC) [132792/2010-9, 132791/2010-2]; Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [00/09968-8];  [308153/2007-3];  [483117/2009-9]	Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq) (NFC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	We thank the Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; http://www.cnpq.br) for the graduate scholarships (NFC, No 132792/2010-9; and JFR, No 132791/2010-2), the Research Productivity Grant (EMV, No 308153/2007-3), and the research funding (EMV, No 483117/2009-9) granted during this study. We also thank the The Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; http://www.fapesp.br) for the research funding (APC-N, No 00/09968-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKON PU, 1988, J BIOGEOGR, V15, P403, DOI 10.2307/2845271; Ayres M, 2007, BIOESTAT VERSAO 5 0; Bacigalupe LD, 2003, J MAMMAL, V84, P311, DOI 10.1644/1545-1542(2003)084<0311:AASUBD>2.0.CO;2; Baumler W., 1975, Acta Theriologica, V20, P365; Bittencourt Emerson B., 1999, Ciencia e Cultura (Sao Paulo), V51, P126; Bonvicino CR, 2003, STUD NEOTROP FAUNA E, V38, P1, DOI 10.1076/snfe.38.1.1.14030; Castro-Arellano I, 2009, J TROP ECOL, V25, P593, DOI 10.1017/S0266467409990186; Christian N, 2007, NATURWISSENSCHAFTEN, V94, P483, DOI 10.1007/s00114-007-0215-5; Cooper CE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P153, DOI 10.1086/595967; Costa LP, 2003, P BIOL SOC WASH, V116, P275; de Camargo NF, 2014, ACTA THERIOL, V59, P183, DOI 10.1007/s13364-013-0152-y; Delciellos AC, 2009, J MAMMAL, V90, P104, DOI 10.1644/07-MAMM-A-115.1; Duarte L, 2009, INT J BODY COMPOSITI, V7, P57; EISENBERG JF, 1981, AM NAT, V118, P1, DOI 10.1086/283796; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; EMMONS LH, 1990, NEOTROPICAL RAINFORE; Everts LG, 2004, CHRONOBIOL INT, V21, P57, DOI 10.1081/CBI-120027982; Semedo TBF, 2015, ZOOL J LINN SOC-LOND, V173, P190, DOI 10.1111/zoj.12203; Fernandez F., 1998, ENC IINT EC MAT, P59; Ferreira MS, 2014, J TROP ECOL, V30, P169, DOI 10.1017/S0266467413000886; GRAIPEL ME, 2003, MASTOZOOL NEOTROP, V10, P255; Halle S, 2000, ECOL STU AN, V141, P67; Hernandez L, 2005, WILDLIFE BIOL, V11, P215, DOI 10.2981/0909-6396(2005)11[215:FITLOF]2.0.CO;2; Instituto Nacional de Meteorologia-Inmet, 2016, BANC DAD MET ENS PES; JulienLaferriere D, 1997, J MAMMAL, V78, P251, DOI 10.2307/1382659; Koeppen W., 1900, GEOGR Z, V6, P593, DOI DOI 10.2307/27803939; Koprowski JL, 2005, J MAMMAL, V86, P947, DOI 10.1644/1545-1542(2005)86[947:TBAPAB]2.0.CO;2; Kortner G, 2000, OECOLOGIA, V123, P350, DOI 10.1007/s004420051021; KORTNER G, 1995, PHYSIOL BEHAV, V58, P31, DOI 10.1016/0031-9384(94)00384-H; KOSKELA E, 1995, BEHAV ECOL, V6, P311, DOI 10.1093/beheco/6.3.311; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lacher TE, 2001, BIOTROPICA, V33, P171; Ladine TA, 1997, MAMMALIA, V61, P345; Lagos VO, 1995, OIKOS, V74, P259, DOI 10.2307/3545655; Leite MD, 2013, J TROP ECOL, V29, P261, DOI 10.1017/S0266467413000187; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Loss S, 2011, ZOOTAXA, P1; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Maestri R, 2014, ACTA THERIOL, V59, P427, DOI 10.1007/s13364-014-0177-x; Martins EG, 2008, BIOTROPICA, V40, P132, DOI 10.1111/j.1744-7429.2007.00319.x; Martins EG, 2006, J TROP ECOL, V22, P461, DOI 10.1017/S0266467406003269; MCMANUS JJ, 1971, J MAMMAL, V52, P846, DOI 10.2307/1378945; MCNAB BK, 1983, J ZOOL, V199, P1; Mendonca AF, 2015, J MAMMAL, V96, P368, DOI 10.1093/jmammal/gyv038; MIRANDA AC, 1993, J TROP ECOL, V9, P313, DOI 10.1017/S0266467400007367; Moraes Edsel Amorim Jr, 2004, Boletim do Museu de Biologia Mello Leitao Nova Serie, P57; NITIKMAN L Z, 1987, Annals of Carnegie Museum, V56, P75; O'Donnell CFJ, 2000, NEW ZEAL J ZOOL, V27, P207, DOI 10.1080/03014223.2000.9518228; Observatorio Nacional, 2016, AN INT OBS NAC; Paise G, 2006, J MAMMAL, V87, P733, DOI 10.1644/05-MAMM-A-158R5.1; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pinheiro PS, 2002, STUD NEOTROP FAUNA E, V37, P213, DOI 10.1076/snfe.37.3.213.8575; Presley SJ, 2009, J MAMMAL, V90, P210, DOI 10.1644/08-MAMM-A-089.1; Prugh LR, 2014, J ANIM ECOL, V83, P504, DOI 10.1111/1365-2656.12148; Quental TB, 2001, J TROP ECOL, V17, P339, DOI 10.1017/S0266467401001237; Ribeiro JF., 1998, CERRADO AMBIENTE FLO, P89; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHOWALTER TD, 2000, INSECT ECOLOGY ECOSY; SigRH, 2016, SIST INIT GER REC HI; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; STALLINGS JR, 1994, J TROP ECOL, V10, P431, DOI 10.1017/S0266467400008099; Stokes MK, 2001, CAN J ZOOL, V79, P966, DOI 10.1139/cjz-79-6-966; TALLMON D, 1994, J MAMMAL, V75, P97, DOI 10.2307/1382240; Therrien JF, 2014, ECOLOGY, V95, P56, DOI 10.1890/13-0458.1; Thompson Steven D., 1992, P213; VICKERY WL, 1981, J MAMMAL, V62, P140, DOI 10.2307/1380484; Vieira EM, 2010, CAN J ZOOL, V88, P259, DOI 10.1139/Z09-142; VIEIRA EM, 1995, J TROP ECOL, V11, P255, DOI 10.1017/S0266467400008725; Vieira EM, 2011, INTEGR ZOOL, V6, P375, DOI 10.1111/j.1749-4877.2011.00266.x; Voss RS, 2009, B AM MUS NAT HIST, P1; Weinbeer M, 2006, BIOTROPICA, V38, P69, DOI 10.1111/j.1744-7429.2006.00101.x; Witt AA, 2010, PUBLICACION SEMESTRA, V17, P353; Zalewski A, 2001, ACTA THERIOL, V46, P295, DOI 10.1007/BF03192436	76	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168495	10.1371/journal.pone.0168495	http://dx.doi.org/10.1371/journal.pone.0168495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052077	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500016
J	Rai, V; Thomas, DG; Beach, JR; Egelhoff, TT				Rai, Vandana; Thomas, Dustin G.; Beach, Jordan R.; Egelhoff, Thomas T.			Myosin IIA Heavy Chain Phosphorylation Mediates Adhesion Maturation and Protrusion in Three Dimensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cytoskeleton; extracellular matrix; invasion; myosin	PROTEIN-KINASE-C; CELL-MIGRATION; CARCINOMA-CELLS; DYNAMICS; INVASION; MATRIX; MOTILITY; RECRUITMENT; GENERATION; PAXILLIN	Non-muscle myosin II (NMII) is a conserved force-producing cytoskeletal enzyme with important but poorly understood roles in cell migration. To investigate myosin heavy chain (MHC) phosphorylation roles in 3D migration, we expressed GFP-tagged NMIIA wild-type or mutant constructs in cells depleted of endogenous NMIIA protein. We find that individual mutation or double mutation of Ser-1916 or Ser-1943 to alanine potently blocks recruitment of GFP-NM-IIA filaments to leading edge protrusions in 2D, and this in turn blocks maturation of anterior focal adhesions. When placed in 3D collagen gels, cells expressing wild-type GFP MHC-IIA behave like parental cells, displaying robust and active formation and retraction of protrusions. However, cells depleted of NMIIA or cells expressing the mutant GFP MHC-IIA display severe defects in invasion and in stabilizing protrusions in 3D. These studies reveal an NMIIA-specific role in 3D invasion that requires competence for NMIIA phosphorylation at Ser-1916 and Ser-1943. In sum, these results demonstrate a critical and previously unrecognized role for NMIIA phosphorylation in 3D invasion.	[Rai, Vandana; Thomas, Dustin G.; Beach, Jordan R.; Egelhoff, Thomas T.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Egelhoff, TT (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.; Egelhoff, TT (corresponding author), Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44106 USA.	tte@case.edu		Beach, Jordan/0000-0003-0633-4928	National Institutes of Health [GM50009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM50009. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelstein R S, 1989, Adv Exp Med Biol, V255, P289; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Betapudi V, 2011, J MOL BIOL, V407, P673, DOI 10.1016/j.jmb.2011.02.010; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova Natalya G, 2013, Bioarchitecture, V3, P77; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Kolega J, 1998, J CELL SCI, V111, P2085; Kubow KE, 2013, CURR BIOL, V23, P1607, DOI 10.1016/j.cub.2013.06.053; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2015, CURR BIOL, V25, P175, DOI 10.1016/j.cub.2014.11.043; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Thomas DG, 2015, J CELL BIOL, V210, P583, DOI 10.1083/jcb.201502039; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094	47	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3099	3111		10.1074/jbc.M116.733402	http://dx.doi.org/10.1074/jbc.M116.733402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28053086	hybrid, Green Published			2022-12-26	WOS:000395538800004
J	Liu, T; Chen, L; Zhou, Y; Jiang, X; Duan, YW; Yang, Q				Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing			Structure, Catalysis, and Inhibition of OfChi-h, the Lepidoptera-exclusive Insect Chitinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-III CHITINASE; CRYSTAL-STRUCTURES; BOMBYX-MORI; FUNCTIONAL EXPRESSION; AROMATIC RESIDUES; MOLECULAR-CLONING; BMCHI-H; CDNA; GENE; BACTERIAL	Chitinase-h (Chi-h) is of special interest among insect chitinases due to its exclusive distribution in lepidopteran insects and high sequence identity with bacterial and baculovirus homologs. Here OfChi-h, a Chi-h from Ostrinia furnacalis, was investigated. Crystal structures of both OfChi-h and its complex with chitoheptaose ((GlcN) 7) reveal that OfChi-h possesses a long and asymmetric substrate binding cleft, which is a typical characteristics of a processive exo-chitinase. The structural comparison between OfChi-h and its bacterial homolog SmChiA uncovered two phenylalanine-to-tryptophan site variants in OfChi-h at subsites +2 and possibly -7. The F232W/F396W double mutant endowedSmChiA with higher hydrolytic activities toward insoluble substrates, such as insect cuticle, alpha-chitin, and chitin nanowhisker. An enzymatic assay demonstrated that OfChi-h outperformed OfChtI, an insect endochitinase, toward the insoluble substrates, but showed lower activity toward the soluble substrate ethylene glycol chitin. Furthermore, OfChi-h was found to be inhibited by N, N',N"-trimethylglucosamine- N, N',N",N"'-tetraacetylchitotetraose (TMG(GlcNAc)(4)), a substrate analog which can be degraded into TMG-(GlcNAc)(1-2). Injection of TMG-(GlcNAc)(4) into 5th-instar O. furnacalis larvae led to severe defects in pupation. This work provides insights into a molting-indispensable insect chitinase that is phylogenetically closer to bacterial chitinases than insect chitinases.	[Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, 2 Linggong Rd, Dalian 116024, Peoples R China; [Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing] Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, 2 Linggong Rd, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China.	qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Liu, Tian/0000-0001-9768-5496	Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; Program for Liaoning Excellent Talents in University [LJQ2014006]; Fundamental Research Funds for the Central Universities [DUT16QY48, DUT16TD22]	Program for National Natural Science Funds for Distinguished Young Scholar; Program for Liaoning Excellent Talents in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Program for National Natural Science Funds for Distinguished Young Scholar (31425021), the Program for Liaoning Excellent Talents in University (LJQ2014006), and the Fundamental Research Funds for the Central Universities (DUT16QY48, DUT16TD22). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad T, 2003, BIOCHEM BIOPH RES CO, V310, P188, DOI 10.1016/j.bbrc.2003.08.136; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feix M, 2000, ARCH INSECT BIOCHEM, V45, P24, DOI 10.1002/1520-6327(200009)45:1&lt;24::AID-ARCH3&gt;3.0.CO;2-H; Fitches E, 2004, INSECT BIOCHEM MOLEC, V34, P1037, DOI 10.1016/j.ibmb.2004.06.012; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Hsieh YC, 2010, J BIOL CHEM, V285, P31603, DOI 10.1074/jbc.M110.149310; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Kim MG, 1998, INSECT BIOCHEM MOLEC, V28, P163, DOI 10.1016/S0965-1748(97)00112-4; Kitaoku Y, 2015, PLANTA, V242, P895, DOI 10.1007/s00425-015-2330-4; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; KRAMER KJ, 1993, INSECT BIOCHEM MOLEC, V23, P691, DOI 10.1016/0965-1748(93)90043-R; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Madhuprakash J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15657; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Masuda T, 2015, BIOSCI BIOTECH BIOCH, V79, P45, DOI 10.1080/09168451.2014.962475; Matsumoto T, 1999, P JPN ACAD B-PHYS, V75, P269, DOI 10.2183/pjab.75.269; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ohnuma T, 2011, PLANTA, V234, P123, DOI 10.1007/s00425-011-1390-3; Ohnuma T, 2011, PLANT MOL BIOL, V75, P291, DOI 10.1007/s11103-010-9727-z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paek A, 2012, MOL CELLS, V33, P439, DOI 10.1007/s10059-012-2133-4; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Schuttelkopf AW, 2010, BIOORGAN MED CHEM, V18, P8334, DOI 10.1016/j.bmc.2010.09.062; Shinoda T, 2001, INSECT BIOCHEM MOLEC, V31, P521, DOI 10.1016/S0965-1748(00)00133-8; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Tanaka T, 2001, J BIOL CHEM, V276, P35629, DOI 10.1074/jbc.M105919200; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tsuji H, 2010, FEBS J, V277, P2683, DOI [10.1111/j.1742-464X.2010.07685.x, 10.1111/j.1742-4658.2010.07685.x]; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Umemoto N, 2015, PLANT J, V82, P54, DOI 10.1111/tpj.12785; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Wu QY, 2013, INSECT SCI, V20, P147, DOI 10.1111/j.1744-7917.2012.01512.x; Yang JJ, 2010, EURASIP J IMAGE VIDE, DOI 10.1155/2010/461450; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang DW, 2012, ARCH INSECT BIOCHEM, V79, P220, DOI 10.1002/arch.21018; Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899; Zheng Y, 2002, INSECT BIOCHEM MOLEC, V32, P1813, DOI 10.1016/S0965-1748(02)00166-2; Zhu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-248; Zhu KY, 2016, ANNU REV ENTOMOL, V61, P177, DOI 10.1146/annurev-ento-010715-023933; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	64	48	57	9	52	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2080	2088		10.1074/jbc.M116.755330	http://dx.doi.org/10.1074/jbc.M116.755330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28053084	Green Published, hybrid			2022-12-26	WOS:000395530300003
J	El-Sharkawy, I; Sherif, S; Abdulla, M; Jayasankar, S				El-Sharkawy, Islam; Sherif, Sherif; Abdulla, Mahboob; Jayasankar, Subramanian			Plum Fruit Development Occurs via Gibberellin-Sensitive and-Insensitive DELLA Repressors	PLOS ONE			English	Article							GROWTH-REGULATORY MECHANISM; ARABIDOPSIS-THALIANA; MOLECULAR-MECHANISM; GENETIC-ANALYSIS; PLANT-GROWTH; ROOT-GROWTH; FUNCTIONAL-CHARACTERIZATION; PARTHENOCARPIC ABILITY; SIGNAL-TRANSDUCTION; FLORAL DEVELOPMENT	Fruit growth depends on highly coordinated hormonal activities. The phytohormone gibberellin (GA) promotes growth by triggering degradation of the growth-repressing DELLA proteins; however, the extent to which such proteins contribute to GA-mediated fruit development remains to be clarified. Three new plum genes encoding DELLA proteins, PsIGAI, PsIRGL and PsIRGA were isolated and functionally characterized. Analysis of expression profile during fruit development suggested that PsIDELLA are transcriptionally regulated during flower and fruit ontogeny with potential positive regulation by GA and ethylene, depending on organ and developmental stage. PsIGAI and PsIRGL deduced proteins contain all domains present in typical DELLA proteins. However, PsIRGA exhibited a degenerated DELLA domain and subsequently lacks in GID1 DELLA interaction property. Ps/DELLA overexpression in WT Arabidopsis caused dramatic disruption in overall growth including root length, stem elongation, plant architecture, flower structure, fertility, and considerable retardation in development due to dramatic distortion in GA-metabolic pathway. GA treatment enhanced PsIGAI/PsIRGL interaction with PsIGID1 receptors, causing protein destabilization and relief of growth-restraining effect. By contrast, PsIRGA protein was not degraded by GA due to its inability to interact with PsIGID1. Relative to other PsIDELLA mutants, Ps/RGA plants displayed stronger constitutive repressive growth that was irreversible by GA application. The present results describe additional complexities in GA-signalling during plum fruit development, which may be particularly important to optimize successful reproductive growth.	[El-Sharkawy, Islam] Florida A&M Univ, Ctr Viticulture & Small Fruit Res, Tallahassee, FL 32307 USA; [El-Sharkawy, Islam; Sherif, Sherif] Damanhour Univ, Fac Agr, Damanhour, Egypt; [Sherif, Sherif; Jayasankar, Subramanian] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Abdulla, Mahboob] Nazarbayev Univ, Dept Chem, Sch Sci & Technol, Astana, Kazakhstan	State University System of Florida; Florida A&M University; Egyptian Knowledge Bank (EKB); Damanhour University; University of Guelph; Nazarbayev University	Jayasankar, S (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	jsubrama@uoguelph.ca		Mahboob, Abdulla/0000-0002-3521-5664; sherif, sherif/0000-0002-2801-0679; Subramanian, Jayasankar/0000-0002-1236-6240				Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Acheampong AK, 2015, J EXP BOT, V66, P1463, DOI 10.1093/jxb/eru504; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ariizumi T, 2008, PLANT CELL, V20, P2447, DOI 10.1105/tpc.108.058487; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; BUKOVAC MJ, 1979, PLANT PHYSIOL, V63, P129, DOI 10.1104/pp.63.1.129; Busov V, 2006, PLANTA, V224, P288, DOI 10.1007/s00425-005-0213-9; Calvo AP, 2004, PHYSIOL PLANTARUM, V120, P623, DOI 10.1111/j.0031-9317.2004.0270.x; Carbonell-Bejerano P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-84; Serrani JC, 2007, PLANT PHYSIOL, V145, P246, DOI 10.1104/pp.107.098335; Carrera E, 2012, PLANT PHYSIOL, V160, P1581, DOI 10.1104/pp.112.204552; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; CRANE J C, 1969, Hortscience, V4, P108; Davies P.J., 2004, PLANT HORMONES BIOSY; Davies PJ., 2013, PLANT HORMONES PHYSL; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; El-Sharkawy I, 2008, J EXP BOT, V59, P2009, DOI 10.1093/jxb/ern056; El-Sharkawy I, 2007, J EXP BOT, V58, P3631, DOI 10.1093/jxb/erm213; El-Sharkawy I, 2012, J EXP BOT, V63, P1225, DOI 10.1093/jxb/err345; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; El-Sharkawy I, 2014, PLANT MOL BIOL, V84, P399, DOI 10.1007/s11103-013-0139-8; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fleck B, 2002, PLANT J, V44, P88; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fuentes S, 2012, PLANT CELL, V24, P3982, DOI 10.1105/tpc.112.103192; Galvao VC, 2012, DEVELOPMENT, V139, P4072, DOI 10.1242/dev.080879; Gao XH, 2011, MOL PLANT, V4, P601, DOI 10.1093/mp/ssr046; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gomi K, 2003, CURR OPIN PLANT BIOL, V6, P489, DOI 10.1016/S1369-5266(03)00079-7; Goto N, 1999, CAN J BOT, V77, P944, DOI 10.1139/cjb-77-7-944; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Harberd NP, 2003, SCIENCE, V299, P1853, DOI 10.1126/science.1083217; HARBERD NP, 1989, GENETICS, V121, P827; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Hirano K, 2012, PLANT J, V71, P443, DOI 10.1111/j.1365-313X.2012.05000.x; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Hou XL, 2008, PLANT PHYSIOL, V147, P1126, DOI 10.1104/pp.108.121301; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Itoh H, 2005, PLANT J, V44, P669, DOI 10.1111/j.1365-313X.2005.02562.x; Itoh H, 2005, PLANT CELL PHYSIOL, V46, P1392, DOI 10.1093/pcp/pci152; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; JACKSON DI, 1968, AUST J BIOL SCI, V21, P209; King KE, 2001, GENETICS, V159, P767; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kumar R, 2014, J EXP BOT, V65, P4561, DOI 10.1093/jxb/eru277; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Liu T, 2007, BIOCHEM BIOPH RES CO, V358, P983, DOI 10.1016/j.bbrc.2007.04.205; Mariotti L, 2011, J PLANT GROWTH REGUL, V30, P405, DOI 10.1007/s00344-011-9204-1; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Mesejo C, 2013, PHYSIOL PLANTARUM, V148, P87, DOI 10.1111/j.1399-3054.2012.01697.x; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; NIJJAR GS, 1969, J HORTIC SCI BIOTECH, V44, P91, DOI 10.1080/00221589.1969.11514289; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Ozga JA, 2003, J PLANT GROWTH REGUL, V22, P73, DOI 10.1007/s00344-003-0024-9; Ozga JA, 2002, PLANT PHYSIOL, V128, P1379, DOI 10.1104/pp.010800; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; SACHER JA, 1973, ANNU REV PLANT PHYS, V24, P197, DOI 10.1146/annurev.pp.24.060173.001213; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Sheerin DJ, 2011, BIOCHEM J, V435, P629, DOI 10.1042/BJ20101941; Sponsel VM, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P63; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; TALON M, 1992, PLANT PHYSIOL, V99, P1575, DOI 10.1104/pp.99.4.1575; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanimoto E, 2012, ANN BOT-LONDON, V110, P373, DOI 10.1093/aob/mcs049; Thomas SG, 2004, PLANT PHYSIOL, V135, P668, DOI 10.1104/pp.104.040279; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; TUCKER DJ, 1976, NEW PHYTOL, V77, P561, DOI 10.1111/j.1469-8137.1976.tb04647.x; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ubeda-Tomas S, 2008, NAT CELL BIOL, V10, P625, DOI 10.1038/ncb1726; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Vivian-Smith A, 1999, PLANT PHYSIOL, V121, P437, DOI 10.1104/pp.121.2.437; WALSER RH, 1981, J AM SOC HORTIC SCI, V106, P91; Wang SS, 2012, J PLANT PHYSIOL, V169, P303, DOI 10.1016/j.jplph.2011.09.012; Wang T, 2004, BIOPHYS J, V87, P1618, DOI 10.1529/biophysj.104.040964; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Weston DE, 2008, PLANT PHYSIOL, V147, P199, DOI 10.1104/pp.108.115808; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; YAMAGUCHI I, 1976, PLANT CELL PHYSIOL, V17, P611; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037	118	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169440	10.1371/journal.pone.0169440	http://dx.doi.org/10.1371/journal.pone.0169440			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076366	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100037
J	Archambault, AS; Turcotte, C; Martin, C; Lefebvre, JS; Provost, V; Laviolette, M; Flamand, N				Archambault, Anne-Sophie; Turcotte, Caroline; Martin, Cyril; Lefebvre, Julie S.; Provost, Veronique; Laviolette, Michel; Flamand, Nicolas			Leukotriene B-4 Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the omega-Oxidation of Leukotriene B-4 In Vitro and In Cellulo	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN NEUTROPHILS; INSULIN-RESISTANCE; ARACHIDONIC-ACID; BREAST-CANCER; DOWN-REGULATION; CDNA CLONING; OBESE MICE; S6K1; DEATH	LTB4 is an inflammatory lipid mediator mainly biosynthesized by leukocytes. Since its implication in inflammatory diseases is well recognized, many tools to regulate its biosynthesis have been developed and showed promising results in vitro and in vivo, but mixed results in clinical trials. Recently, the mTOR pathway component p70S6 kinase 1 (p70S6K1) has been linked to LTC4 synthase and the biosynthesis of cysteinyl-leukotrienes. In this respect, we investigated if p70S6K1 could also play a role in LTB4 biosynthesis. We thus evaluated the impact of the p70S6K1 inhibitors PF-4708671 and LY2584702 on LTB4 biosynthesis in human neutrophils. At a concentration of 10 mu M, both compounds inhibited S6 phosphorylation, although neither one inhibited the thapsigargin-induced LTB4 biosynthesis, as assessed by the sum of LTB4, 20-OH-LTB4, and 20-COOH-LTB4. However, PF-4708671, but not LY2584702, inhibited the omega-oxidation of LTB4 into 20-OH-LTB4 by intact neutrophils and by recombinant CYP4F3A, leading to increased LTB4 levels. This was true for both endogenously biosynthesized and exogenously added LTB4. In contrast to that of 17-octadecynoic acid, the inhibitory effect of PF-4708671 was easily removed by washing the neutrophils, indicating that PF-4708671 was a reversible CYP4F3A inhibitor. At optimal concentration, PF-4708671 increased the half-life of LTB4 in our neutrophil suspensions by 7.5 fold, compared to 5 fold for 17-octadecynoic acid. Finally, Michaelis-Menten and Line weaver -Burk plots indicate that PF-4708671 is a mixed inhibitor of CYP4F3A. In conclusion, we show that PF-4708671 inhibits CYP4F3A and prevents the omega-oxidation of LTB4 in cellulo, which might result in increased LTB4 levels in vivo.	[Archambault, Anne-Sophie; Turcotte, Caroline; Martin, Cyril; Lefebvre, Julie S.; Provost, Veronique; Laviolette, Michel; Flamand, Nicolas] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Archambault, Anne-Sophie; Turcotte, Caroline; Laviolette, Michel; Flamand, Nicolas] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada	Laval University; Laval University	Flamand, N (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.; Flamand, N (corresponding author), Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada.	Nicolas.Flamand@criucpq.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200; Archambault, Anne-Sophie/0000-0001-7243-7445	Merck Sharpe & Dohme - Faculte de medecine de l'Universite Laval; Natural Sciences and Engineering Research Council of Canada; Fonds sur les maladies respiratoires J.-D. Begin - P.-H. Lavoie; Respiratory Health Network of the Fonds de recherche en Sante-Quebec; Fonds de recherche du Quebec-Sante	Merck Sharpe & Dohme - Faculte de medecine de l'Universite Laval; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds sur les maladies respiratoires J.-D. Begin - P.-H. Lavoie; Respiratory Health Network of the Fonds de recherche en Sante-Quebec; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants to NF from the Merck Sharpe & Dohme - Faculte de medecine de l'Universite Laval, the Natural Sciences and Engineering Research Council of Canada, and the Fonds sur les maladies respiratoires J.-D. Begin - P.-H. Lavoie. ASA was the recipient of a training award from the Respiratory Health Network of the Fonds de recherche en Sante-Quebec and is the recipient of a master degree award from the Fonds de recherche du Quebec-Sante. ML and NF are members of the inflammation group of the Respiratory Health Network of the Fonds de recherche en Sante-Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2016, J BIOL CHEM, V291, P18410, DOI 10.1074/jbc.M116.735647; [Anonymous], DATA SCI J, DOI DOI 10.1080/15384101.2015.1044188; Arnold N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103284; Ben-Hur V, 2013, CELL REP, V3, P103, DOI 10.1016/j.celrep.2012.11.020; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; Choi HN, 2013, BIOCHEM BIOPH RES CO, V432, P123, DOI 10.1016/j.bbrc.2013.01.074; Chouinard F, 2013, J LEUKOCYTE BIOL, V93, P267, DOI 10.1189/jlb.0412200; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Esser J, 2011, FASEB J, V25, P1417, DOI 10.1096/fj.10-175828; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Grasso S, 2014, NEOPLASIA, V16, P845, DOI 10.1016/j.neo.2014.08.011; Hong SE, 2015, J CANCER RES CLIN, V141, P1171, DOI 10.1007/s00432-014-1887-9; Hong SE, 2013, CELL BIOL TOXICOL, V29, P273, DOI 10.1007/s10565-013-9253-2; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Khotskaya YB, 2014, AM J TRANSL RES, V6, P361; KIKUTA Y, 1993, J BIOL CHEM, V268, P9376; Krump E, 1997, ADV EXP MED BIOL, V400, P583; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Mothe-Satney I, 2012, DIABETES, V61, P2311, DOI 10.2337/db11-1455; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; POWELL WS, 1990, J BIOL CHEM, V265, P9131; Qiu ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147185; Rajan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059725; Segatto I, 2013, J MOL CELL BIOL, V5, P428, DOI 10.1093/jmcb/mjt027; SHAK S, 1985, J BIOL CHEM, V260, P3023; Shum M, 2016, DIABETOLOGIA, V59, P592, DOI 10.1007/s00125-015-3839-6; SOBERMAN RJ, 1985, P NATL ACAD SCI USA, V82, P2292, DOI 10.1073/pnas.82.8.2292; Song X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.242; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Tolcher A, 2014, EUR J CANCER, V50, P867, DOI 10.1016/j.ejca.2013.11.039; Vainer GW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107364; WETTERHOLM A, 1995, J PHARMACOL EXP THER, V275, P31; Yokomizo T, 1996, J BIOL CHEM, V271, P2844, DOI 10.1074/jbc.271.5.2844	39	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169804	10.1371/journal.pone.0169804	http://dx.doi.org/10.1371/journal.pone.0169804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068410	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900070
J	Borquez, J; Brante, A				Borquez, Jessica; Brante, Antonio			Paternity Outcomes in the Freshwater Gastropod, Chilina dombeiana in the Biobio River, Chile	PLOS ONE			English	Article							MULTIPLE PATERNITY; INBREEDING DEPRESSION; PAIRWISE RELATEDNESS; SELF-FERTILIZATION; SPERM COMPETITION; MATE AVAILABILITY; GENETIC BENEFITS; SEXUAL SELECTION; SNAIL; POPULATION	Studying the mating system of obligate aquatic organisms that inhabit river ecosystems is important for understanding its evolution as well as the role of biological and environmental factors in modulating population dynamics and species distributional patterns. Here, we studied the reproductive strategy of the Chilean endemic freshwater snail, Chilina dombeiana, in the Biobio River, one of the largest rivers in Chile. This species has a low potential for dispersal given the absence of a free-swimming larval stage (benthic larval development) and given that adults have a low capacity for mobility. We hypothesized that: 1. Females would mate with different males (polyandry) resulting in intrabrood multiple paternity, 2. Individuals from closer sites would be more related than individuals from distant sites, and 3. Male parental contributions would be unevenly distributed within broods. Individuals from three different sites were sampled along the river: upper, mid, and river mouth. In the laboratory, hatching juveniles from a total of 15 broods were collected for paternity analyses. We used microsatellite markers and the programs GERUD and COLONY to determine whether multiple paternity exists and to estimate the contribution of different males to the brood. We found that multiple paternity was very common at all of the sites analyzed with as many as 8 males fertilizing a single female and a mean of 4.2 fathers per brood estimated by COLONY. Sire contribution was skewed to particular males in several broods. In addition, overall relatedness among broods for the three sites ranged from 0.17 to 0.45 with evidence of many half-siblings. Relatedness differed among the three sites. Particularly in upstream sites or in anthropogenically disturbed populations, the high levels of multiple paternity observed in C. dombeiana may be an efficient strategy to avoid inbreeding and prevent the loss of genetic diversity within populations.	[Borquez, Jessica; Brante, Antonio] Univ Catolica Ssma, CIBAS, Fac Ciencias, Dept Ecol, Concepcion, Chile	Universidad Catolica de la Santisima Concepcion	Brante, A (corresponding author), Univ Catolica Ssma, CIBAS, Fac Ciencias, Dept Ecol, Concepcion, Chile.	abrante@ucsc.cl	Bórquez, Jéssica P./ABG-5853-2021; Bórquez, Jéssica/AAO-6839-2020	Bórquez, Jéssica/0000-0002-2376-771X; Brante, Antonio/0000-0002-2699-9700	 [FONDECYT 3140561];  [FONDECYT 1130868]	; 	This work was supported by the postdoctoral grant FONDECYT 3140561 to JB and FONDECYT 1130868 to AB.; This work was supported by the postdoctoral grant FONDECYT 3140561 to JB and FONDECYT 1130868 to AB. Special thanks to Emily Giles for correcting the English writing of this manuscript and two anonymous reviewers.	Aguirre JD, 2012, EVOLUTION, V66, P94, DOI 10.1111/j.1558-5646.2011.01413.x; Ashby B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0048; Bai Z, 2011, J MOLLUS STUD, P1; Belkhir K, 1996, GENETIX 4 05 LOGICIE; Bergeron P, 2011, J EVOLUTION BIOL, V24, P1685, DOI 10.1111/j.1420-9101.2011.02294.x; Borquez J, 2011, MOL ECOL RESOUR, V11, P757; Borquez J, 2015, NAUTILUS, V129, P169; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Burdfield-Steel ER, 2015, BEHAV ECOL, V26, P1423, DOI 10.1093/beheco/arv103; Christian AD, 2007, MOL ECOL NOTES, V7, P570, DOI 10.1111/j.1471-8286.2007.01743.x; CoutellecVreto MA, 1997, HEREDITY, V79, P277, DOI 10.1038/hdy.1997.155; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Dupont L, 2006, MOL ECOL, V15, P3009, DOI 10.1111/j.1365-294X.2006.02988.x; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Escobar JS, 2011, EVOLUTION, V65, P1233, DOI 10.1111/j.1558-5646.2011.01218.x; Ferguson CD, 2013, FRESHW SCI, V32, P267, DOI 10.1899/12-028.1; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Frankham R, INTRO CONSERVATION G, P2; Garefalaki ME, 2010, J EVOLUTION BIOL, V23, P966, DOI 10.1111/j.1420-9101.2010.01964.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hedrick PW, GENETICS POPULATIONS; JARNE P, 1991, EVOLUTION, V45, P1136, DOI 10.1111/j.1558-5646.1991.tb04380.x; JARNE P, 1993, BIOL J LINN SOC, V49, P99, DOI 10.1111/j.1095-8312.1993.tb00893.x; Jarne Philippe, 2010, P173; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnson SL, 2010, ANIM BEHAV, V80, P773, DOI 10.1016/j.anbehav.2010.07.019; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Karaket T, 2012, AQUACULTURE, V324, P307, DOI 10.1016/j.aquaculture.2011.10.045; Kimura K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-264; Klemme I, 2008, P ROY SOC B-BIOL SCI, V275, P1095, DOI 10.1098/rspb.2008.0038; Le Cam S, 2014, J HERED, V105, P397, DOI 10.1093/jhered/esu002; Lombardo RC, 2012, J MOLLUS STUD, V78, P283, DOI 10.1093/mollus/eys010; Lynch M, 1999, GENETICS, V152, P1753; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Mavarez J, 2002, MOL ECOL, V11, P879, DOI 10.1046/j.1365-294X.2002.01486.x; MULVEY M, 1981, J HERED, V72, P308, DOI 10.1093/oxfordjournals.jhered.a109512; Nakadera Y, 2015, BEHAV ECOL, V26, P232, DOI 10.1093/beheco/aru184; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Noel E, 2016, EVOLUTION, V70, P625, DOI 10.1111/evo.12886; Oppliger A, 2003, MOL ECOL, V12, P485, DOI 10.1046/j.1365-294X.2003.01748.x; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; Pizzari Tommaso, 2013, Philos Trans R Soc Lond B Biol Sci, V368, P20120041, DOI 10.1098/rstb.2012.0041; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROLLINSON D, 1989, J ZOOL, V217, P295, DOI 10.1111/j.1469-7998.1989.tb02489.x; RUDOLPH PH, 1985, J MOLLUS STUD, V51, P267; Slatyer RA, 2012, BIOL REV, V87, P1, DOI 10.1111/j.1469-185X.2011.00182.x; Soper DM, 2012, ECOL EVOL, V2, P3179, DOI 10.1002/ece3.408; STADLER T, 1995, P ROY SOC B-BIOL SCI, V262, P119, DOI 10.1098/rspb.1995.0185; Stadler T, 1997, ECOLOGY EVOLUTION FR, P231; Takahasi Y., 2009, FRESH SURFACE WATER, VI, P259; Thrall PH, 1997, AM NAT, V149, P485, DOI 10.1086/286001; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tsitrone A, 2003, AM NAT, V162, P474, DOI 10.1086/376889; Valdovinos C, 2006, CUENCA RIO BIOBIO HI; Valdovinos C, 2006, BIODIVERSIDAD CHILE, P204; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Viard F, 1997, P ROY SOC B-BIOL SCI, V264, P39, DOI 10.1098/rspb.1997.0006; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang JL, 2002, GENETICS, V160, P1203; Wasserman TN, 2012, LANDSCAPE ECOL, V27, P211, DOI 10.1007/s10980-011-9653-8; WETHINGTON AR, 1991, AM MALACOL BULL, V9, P99; Xue DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086508; Yue GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012721; Zahradnik TD, 2008, J MOLLUS STUD, V74, P245, DOI 10.1093/mollus/eyn014; Valdovinos Zarges Claudio, 2006, Gayana (Concepc.), V70, P88; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260	79	5	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169574	10.1371/journal.pone.0169574	http://dx.doi.org/10.1371/journal.pone.0169574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068418	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900047
J	Bau, JG; Chia, T; Wei, SH; Li, YH; Kuo, FC				Bau, Jian-Guo; Chia, Taipau; Wei, Shan-Hua; Li, Yung-Hui; Kuo, Fun-Chie			Correlations of Neck/Shoulder Perfusion Characteristics and Pain Symptoms of the Female Office Workers with Sedentary Lifestyle	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LASER-DOPPLER FLOWMETRY; COMPUTER USERS; BLOOD-FLOW; MUSCULOSKELETAL DISORDERS; MUSCLE-ACTIVITY; RISK-FACTORS; NECK PAIN; SHOULDER; MICROCIRCULATION	Aim Modern office workers are often impacted by chronic neck/shoulder pain. Most of the previous studies which investigated the relationship of the occupational factors and musculoskeletal symptoms had adopted questionnaire survey. In this study the microcirculatory characteristics and perceived symptoms in neck/shoulder region were compared among office workers with sedentary lifestyle. Methods Thirty-seven female office workers were recruited in this study. Microcirculatory flow in neck/shoulder region characterized by the mean blood flow (MMBF value), pulsatile blood flow (PMBF value), and the PMBF/MMBF ratio (perfusion pulsatility, PP) were investigated using Laser Doppler Flowmetry (LDF). A Chinese version of the Standardized Nordic Musculoskeletal Questionnaire (NMQ) were also administered to collect the information of perceived neck/shoulder symptoms. Correlations between the perfusion characteristics and the individual/occupational factors were analyzed using the Spearman test. The difference of the MMBF values between the low-pain group (pain level <= 2) and the high-pain group (pain level>2) were compared using the Mann-Whitney U test. Results There were 81% participants reported neck or shoulder pain symptoms. The duration of shoulder pain was significantly correlated with the workers' age and the duration of employment (p<0.01) (n = 37). While both the MMBF and PMBF values in shoulder region were significantly reduced with the workers' age and the duration of employment (p<0.05) (n = 27). And there was a 54% reduction in the MMBF value of the workers from age of 23 to 47. And the MMBF value of the high-pain group (n = 15) was significantly lower than the value of the low-pain group (n = 15) (p<0.05). The duration of shoulder pain showed a moderately negative correlation with PMBF values (n = 19). Besides, the PP value was moderately correlated with shoulder pain level attributed by the rapid reduction of MMBF values (p = 0.07). Conclusion In this study, the LDF method was used for the first time in the workplace in Taiwan. It was demonstrated that the MMBF in shoulder region were affected by aging effect and towards lower value at higher pain level. Impaired microcirculation caused by age effect, when coupled with sedentary lifestyle, was found to be more likely to evoke ischemia shoulder pain. Further studies are needed to assess current indicator, PP value, and the underlying mechanism of pain caused by sedentary lifestyle.	[Bau, Jian-Guo] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan; [Chia, Taipau; Kuo, Fun-Chie] Hungkuang Univ, Dept Safety Hlth & Environm Engn, Taichung, Taiwan; [Wei, Shan-Hua] Cheng Ching Gen Hosp, Neurol Surg, Taichung, Taiwan; [Li, Yung-Hui] Natl Cent Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Hungkuang University; Hungkuang University; National Central University	Chia, T (corresponding author), Hungkuang Univ, Dept Safety Hlth & Environm Engn, Taichung, Taiwan.	tpchia38@gmail.com	Bau, Jian-Guo/AAF-6251-2021					Abularrage CJ, 2005, J VASC SURG, V42, P574, DOI 10.1016/j.jvs.2005.05.019; Andersen JH, 2003, OCCUP ENVIRON MED, V60, P649, DOI 10.1136/oem.60.9.649; Andersen LL, 2010, EUR J APPL PHYSIOL, V110, P389, DOI 10.1007/s00421-010-1517-4; Bau JG, 2013, SENSORS, V13, P478; Boltz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082351; Brisson C, 1999, SCAND J WORK ENV HEA, V25, P255, DOI 10.5271/sjweh.432; Cagnie B, 2012, EUR J APPL PHYSIOL, V112, P3305, DOI 10.1007/s00421-012-2322-z; Chang JH, 2014, AM J IND MED, V57, P476, DOI 10.1002/ajim.22300; Clough G, 2009, MICROVASC RES, V78, P155, DOI 10.1016/j.mvr.2009.05.003; Crutchfield K, 2004, Patent, Patent No. [US6692443 B2, 6692443]; de Vries HJ, 2013, J OCCUP REHABIL, V23, P1, DOI 10.1007/s10926-012-9373-1; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Figus A, 2006, J PLAST RECONSTR AES, V59, P604, DOI 10.1016/j.bjps.2005.09.047; Gerr F, 2005, OCCUP ENVIRON MED, V62, P478, DOI 10.1136/oem.2004.015792; Haufler AJ, 2000, AM J IND MED, V38, P507, DOI 10.1002/1097-0274(200011)38:5<507::AID-AJIM3>3.3.CO;2-X; Hoyerup P, 2013, REGUL PEPTIDES, V180, P12, DOI 10.1016/j.regpep.2012.10.002; Huysmans MA, 2012, INT ARCH OCC ENV HEA, V85, P651, DOI 10.1007/s00420-011-0717-5; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; JOZSA L, 1990, ARCH ORTHOP TRAUM SU, V110, P15, DOI 10.1007/BF00431359; Juul-Kristensen B, 2006, EUR J APPL PHYSIOL, V96, P136, DOI 10.1007/s00421-004-1220-4; King TK, 2013, ERGONOMICS, V56, P59, DOI 10.1080/00140139.2012.733735; Larsen MK, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-101; Larsson R, 1999, PAIN, V79, P45, DOI 10.1016/S0304-3959(98)00144-4; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma C, 2011, ARCH PHYS MED REHAB, V92, P849, DOI 10.1016/j.apmr.2010.12.037; Nelson NA, 1998, HUM FACTORS, V40, P337, DOI 10.1518/001872098779480398; Pedersen MT, 2009, J OCCUP ENVIRON MED, V51, P759, DOI 10.1097/JOM.0b013e3181a8663a; Petrasek P, 2010, US patent, Patent No. [2010/0241015 A1, 20100241015]; Puissant C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061320; Roe C, 2002, INT J IND ERGONOM, V30, P251, DOI 10.1016/S0169-8141(02)00129-4; Stoyneva Z., 2012, PERSPECT MED, V1, P89, DOI [10.1016/j.permed.2012.03.009, DOI 10.1016/J.PERMED.2012.03.009]; Strom V, 2009, PAIN, V144, P147, DOI 10.1016/j.pain.2009.04.002; Tornqvist EW, 2009, INT ARCH OCC ENV HEA, V82, P689, DOI 10.1007/s00420-009-0396-7; Tsai HH, 2011, IND HEALTH, V49, P311, DOI 10.2486/indhealth.MS1152; VandenBrande P, 1997, MICROVASC RES, V53, P156, DOI 10.1006/mvre.1996.1995; Wahlstrom J, 2005, OCCUP MED-OXFORD, V55, P168, DOI 10.1093/occmed/kqi083; Westgaard RH, 1997, INT J IND ERGONOM, V20, P463, DOI 10.1016/S0169-8141(96)00076-5	38	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169318	10.1371/journal.pone.0169318	http://dx.doi.org/10.1371/journal.pone.0169318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060875	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500079
J	Cortegiani, A; Russotto, V; Montalto, F; Lozzo, P; Meschis, R; Pugliesi, M; Mariano, D; Benenati, V; Raineri, SM; Gregoretti, C; Giarratano, A				Cortegiani, Andrea; Russotto, Vincenzo; Montalto, Francesca; Lozzo, Pasquale; Meschis, Roberta; Pugliesi, Marinella; Mariano, Dario; Benenati, Vincenzo; Raineri, Santi Maurizio; Gregoretti, Cesare; Giarratano, Antonino			Use of a Real-Time Training Software (Laerdal QCPR (R)) Compared to Instructor-Based Feedback for High-Quality Chest Compressions Acquisition in Secondary School Students: A Randomized Trial	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION QUALITY; HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; AUDIOVISUAL FEEDBACK; EUROPEAN RESUSCITATION; COUNCIL GUIDELINES; CPR; IMPROVEMENT; SURVIVAL; DEVICE	High-quality chest compressions are pivotal to improve survival from cardiac arrest. Basic life support training of school students is an international priority. The aim of this trial was to assess the effectiveness of a real-time training software (Laerdal QCPR (R)) compared to a standard instructor-based feedback for chest compressions acquisition in secondary school students. After an interactive frontal lesson about basic life support and high quality chest compressions, 144 students were randomized to two types of chest compressions training: 1) using Laerdal QCPR (R) (QCPR group- 72 students) for real-time feedback during chest compressions with the guide of an instructor who considered software data for students' correction 2) based on standard instructor-based feedback (SF group- 72 students). Both groups had a minimum of a 2-minute chest compressions training session. Students were required to reach a minimum technical skill level before the evaluation. We evaluated all students at 7 days from the training with a 2-minute chest compressions session. The primary outcome was the compression score, which is an overall measure of chest compressions quality calculated by the software expressed as percentage. 125 students were present at the evaluation session (60 from QCPR group and 65 from SF group). Students in QCPR group had a significantly higher compression score (median 90%, IQR 81.9-96.0) compared to SF group (median 67%, IQR 27.7-87.5), p = 0.0003. Students in QCPR group performed significantly higher percentage of fully released chest compressions (71% [IQR 24.5-99.0] vs 24% [IQR 2.5-88.2]; p = 0.005) and better chest compression rate (117.5/min [IQR 106-123.5] vs 125/min [115-135.2]; p = 0.001). In secondary school students, a training for chest compressions based on a real-time feedback software (Laerdal QCPR (R)) guided by an instructor is superior to instructor-based feedback training in terms of chest compression technical skill acquisition.	[Cortegiani, Andrea; Russotto, Vincenzo; Montalto, Francesca; Lozzo, Pasquale; Meschis, Roberta; Pugliesi, Marinella; Mariano, Dario; Benenati, Vincenzo; Raineri, Santi Maurizio; Gregoretti, Cesare; Giarratano, Antonino] Univ Palermo, Policlin P Giaccone, Dept Biopathol & Med Biotechnol,DIBIMED, Sect Anesthesia Analgesia Intens Care & Emergency, Palermo, Italy	University of Palermo	Cortegiani, A (corresponding author), Univ Palermo, Policlin P Giaccone, Dept Biopathol & Med Biotechnol,DIBIMED, Sect Anesthesia Analgesia Intens Care & Emergency, Palermo, Italy.	cortegiania@gmail.com	Russotto, Vincenzo/AAC-2388-2022; Cortegiani, Andrea/H-4902-2016; Russotto, Vincenzo/AAM-3265-2020	Cortegiani, Andrea/0000-0003-1416-9993; Russotto, Vincenzo/0000-0003-1411-9099				Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; Abella BS, 2016, CURR OPIN CRIT CARE, V22, P218, DOI 10.1097/MCC.0000000000000296; Abella BS, 2013, CURR OPIN CRIT CARE, V19, P175, DOI 10.1097/MCC.0b013e328360ac76; [Anonymous], 2015, RESUSCITATION, V94, pA5, DOI 10.1016/j.resuscitation.2015.07.005; Bobrow BJ, 2013, ANN EMERG MED, V62, P47, DOI 10.1016/j.annemergmed.2012.12.020; Bohn A, 2012, RESUSCITATION, V83, P619, DOI 10.1016/j.resuscitation.2012.01.020; Colquhoun M, 2012, RESUSCITATION, V83, P543, DOI 10.1016/j.resuscitation.2012.03.004; Cortegiani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125685; Couper K, 2015, CRIT CARE MED, V43, P2321, DOI 10.1097/CCM.0000000000001202; Edelson DP, 2006, RESUSCITATION, V71, P137, DOI 10.1016/j.resuscitation.2006.04.008; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Gonzalez-Salvado V, 2016, AM J EMERG MED, V34, P993, DOI 10.1016/j.ajem.2016.02.047; Greif R, 2015, RESUSCITATION, V95, P288, DOI 10.1016/j.resuscitation.2015.07.032; Hostler David, 2011, BMJ, V342, pd512, DOI 10.1136/bmj.d512; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Kirkbright S, 2014, RESUSCITATION, V85, P460, DOI 10.1016/j.resuscitation.2013.12.012; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Levine AI, 2013, COMPREHENSIVE TXB HE; Lin S, 2016, CRITICAL CARE, V20, P1; Miro O, 2006, RESUSCITATION, V70, P107, DOI 10.1016/j.resuscitation.2005.11.015; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Nolan JP, 2014, CURR OPIN CRIT CARE, V20, P227, DOI 10.1097/MCC.0000000000000083; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Reder S, 2006, RESUSCITATION, V69, P443, DOI 10.1016/j.resuscitation.2005.08.020; Stiell IG, 2012, CRIT CARE MED, V40, P1192, DOI 10.1097/CCM.0b013e31823bc8bb; Vahedian-Azimi A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1296-3; Wallace SK, 2013, CIRC-CARDIOVASC QUAL, V6, P148, DOI 10.1161/CIRCOUTCOMES.111.000041; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	28	36	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169591	10.1371/journal.pone.0169591	http://dx.doi.org/10.1371/journal.pone.0169591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056076	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100058
J	Das, S; Meher, PK; Rai, A; Bhar, LM; Mandal, BN				Das, Samarendra; Meher, Prabina Kumar; Rai, Anil; Bhar, Lal Mohan; Mandal, Baidya Nath			Statistical Approaches for Gene Selection, Hub Gene Identification and Module Interaction in Gene Co-Expression Network Analysis: An Application to Aluminum Stress in Soybean (Glycine max L.)	PLOS ONE			English	Article							RANDOM FOREST; MICROARRAY; TOLERANCE; BIOLOGY; OXYGEN; CLASSIFICATION; MECHANISMS; EXPRESSION; RESISTANCE	Selection of informative genes is an important problem in gene expression studies. The small sample size and the large number of genes in gene expression data make the selection process complex. Further, the selected informative genes may act as a vital input for gene co-expression network analysis. Moreover, the identification of hub genes and module interactions in gene co-expression networks is yet to be fully explored. This paper presents a statistically sound gene selection technique based on support vector machine algorithm for selecting informative genes from high dimensional gene expression data. Also, an attempt has been made to develop a statistical approach for identification of hub genes in the gene co-expression network. Besides, a differential hub gene analysis approach has also been developed to group the identified hub genes into various groups based on their gene connectivity in a case vs. control study. Based on this proposed approach, an R package, i.e., dhga (https://cran.r-projectorg/web/packagesidhga) has been developed. The comparative performance of the proposed gene selection technique as well as hub gene identification approach was evaluated on three different crop microarray datasets. The proposed gene selection technique outperformed most of the existing techniques for selecting robust set of informative genes. Based on the proposed hub gene identification approach, a few number of hub genes were identified as compared to the existing approach, which is in accordance with the principle of scale free property of real networks. In this study, some key genes along with their Arabidopsis orthologs has been reported, which can be used for Aluminum toxic stress response engineering in soybean. The functional analysis of various selected key genes revealed the underlying molecular mechanisms of Aluminum toxic stress response in soybean.	[Das, Samarendra; Meher, Prabina Kumar; Bhar, Lal Mohan] Indian Agr Res Inst, ICAR, Div Stat Genet, New Delhi, India; [Rai, Anil] Indian Agr Res Inst, ICAR, Ctr Agr Bioinformat, New Delhi, India; [Mandal, Baidya Nath] Indian Agr Res Inst, ICAR, Div Design Expt, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Rai, A (corresponding author), Indian Agr Res Inst, ICAR, Ctr Agr Bioinformat, New Delhi, India.	anilrai@iasri.res.in	Meher, Prabina Kumar/V-9439-2019	Meher, Prabina Kumar/0000-0002-7098-8785; Das, Samarendra/0000-0002-0263-7027	Indian Council of Agriculture Research (ICAR) [Agril.Edn.4-1/2013-AP]	Indian Council of Agriculture Research (ICAR)(Indian Council of Agricultural Research (ICAR))	The grant (Agril.Edn.4-1/2013-A&P dated 11.11.2014) received from Indian Council of Agriculture Research (ICAR) (www.icar.org.in) for Centre for Agricultural Bioinformatics (CABin) scheme of Indian Agricultural Statistics Research Institute (IASRI).	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Ash RB., 2000, PROBABILITY MEASURE; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bi DB, 2015, COMPUT BIOL CHEM, V56, P71, DOI 10.1016/j.compbiolchem.2015.04.001; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T.J., 2017, STAT MODELS S, P249, DOI DOI 10.1201/9780203738535; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kursa MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-8; Lai H, 2011, ACTA BIOPHYS SIN, V26, P833; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LeCun Y, 1990, ADV NEURAL INFORM PR, P598, DOI DOI 10.5555/109230.109298; Liang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021750; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Mao KZ, 2006, IEEE T BIO-MED ENG, V53, P1153, DOI 10.1109/TBME.2006.873538; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Niu XM, 1996, PLANT PHYSIOL, V111, P679, DOI 10.1104/pp.111.3.679; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Panda SK, 2009, PLANT SIGNAL BEHAV, V4, P592, DOI 10.4161/psb.4.7.8903; R_Core_Team, 2015, R LANG ENV STAT COMP; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rohatgi V. K., 2011, INTRO PROBABILITY ST; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064929; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; Yang LT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/173682; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]	56	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169605	10.1371/journal.pone.0169605	http://dx.doi.org/10.1371/journal.pone.0169605			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056073	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100061
J	Monnard, CR; Miles-Chan, JL				Monnard, Cathrfona R.; Miles-Chan, Jennifer L.			Energy Cost of Standing in a Multi-Ethnic Cohort: Are Energy-Savers a Minority or the Majority?	PLOS ONE			English	Article							BODY-MASS INDEX; STANDARD ACTIVITIES; EXPENDITURE; EXERCISE; ADULTS; POPULATION; VALIDATION; OBESITY; FAT	Background The disease risks associated with sedentary behavior are now firmly established, and consequently there is much interest in methods of increasing low-intensity physical activity. In this context, it is a widely held belief that altering posture allocation can modify energy expenditure (EE) to impact upon body weight regulation and health. However, we recently showed the existence of two distinct phenotypes pertaining to the energy cost of standing with the majority of a Caucasian cohort showing no sustained increase in EE during standing relative to sitting. Here we investigated whether this phenomenon is also observed across a multi-ethnic male cohort. Objective To determine the magnitude and time-course of changes in EE and respiratory quotient (RQ) during steady-state standing versus sitting, and to explore inter-individual variability in these responses across 4 ethnic groups (European, Indian, Chinese, African) Design Min-by-min monitoring using posture-adapted ventilated-hood indirect calorimetry was conducted in 35 healthy, men (20-43 years) during 10 min of steady-state standing versus sitting comfortably. Results 69% of subjects showed little or no increase (<5%) in EE during standing compared to sitting (energy savers). Furthermore, the proportion of energy savers did not significantly differ between ethnic groups, despite ethnic differences in anthropometry; with body weight as the primary predictor of the energy cost of standing maintenance (r(2) = 0.30, p = 0.001). Conclusion Our results indicate that the majority of individuals in a multi-ethnic cohort display a postural energy-saver phenotype. The mechanisms by which the large majority of individuals appear to maintain sitting and standing postures at the same energetic cost remains to be elucidated but is of considerable importance to our understanding of the spontaneous physical activity compartment of EE and its potential as a target for weight regulation.	[Monnard, Cathrfona R.; Miles-Chan, Jennifer L.] Univ Fribourg, Dept Med Physiol, Chemin Musee 5, Fribourg, Switzerland	University of Fribourg	Miles-Chan, JL (corresponding author), Univ Fribourg, Dept Med Physiol, Chemin Musee 5, Fribourg, Switzerland.	jenniferlynn.miles@unifr.ch	Miles-Chan, Jennifer/Q-2464-2019; Monnard, Cathriona/V-1189-2018	Miles-Chan, Jennifer/0000-0003-0313-7048; Monnard, Cathriona/0000-0002-6907-9007				Aglago KE, 2013, EUR J CLIN NUTR, V67, P1081, DOI 10.1038/ejcn.2013.125; Allen K, 2010, IMPROVING PATIENT TREATMENT ADHERENCE: A CLINICIAN'S GUIDE, P9, DOI 10.1007/978-1-4419-5866-2_2; Alonso AC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/985312; BJORNTORP P, 1995, INT J OBESITY, V19, pS1; Bosy-Westphal A, 2013, EUR J CLIN NUTR, V67, pS14, DOI 10.1038/ejcn.2012.160; COLE AH, 1987, BRIT J NUTR, V58, P357, DOI 10.1079/BJN19870105; Cruz-Gomez NS, 2011, OBESITY FACTS, V4, P212, DOI 10.1159/000329408; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; GEISSLER CA, 1985, ANN NUTR METAB, V29, P40, DOI 10.1159/000176952; Hatamoto M, 2016, BIORESOURCE TECHNOL, V204, P171, DOI 10.1016/j.biortech.2015.12.052; Hawari NS, 2016, MED SCI SPORTS EXERC; Hills AP, 1998, P NUTR SOC, V57, P93, DOI 10.1079/PNS19980015; Kanade AN, 2001, EUR J CLIN NUTR, V55, P708, DOI 10.1038/sj.ejcn.1601211; Katzmarzyk PT, 1996, AM J PHYS ANTHROPOL, V99, P537, DOI 10.1002/ajpa.1330990402; LAWRENCE M, 1985, AM J CLIN NUTR, V42, P753, DOI 10.1093/ajcn/42.5.753; Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113883; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MAHADEVA K, 1953, J PHYSIOL-LONDON, V121, P225, DOI 10.1113/jphysiol.1953.sp004943; Miles-Chan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065827; MILLER DS, 1982, P NUTR SOC, V41, P193, DOI 10.1079/PNS19820030; Nigam P, 2013, DIABETES METAB SYND, V7, P72, DOI 10.1016/j.dsx.2013.02.031; Nightingale CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076426; NORGAN NG, 1994, EUR J CLIN NUTR, V48, pS10; PASSMORE R, 1955, PHYSIOL REV, V35, P801, DOI 10.1152/physrev.1955.35.4.801; Perri MG, 2002, HEALTH PSYCHOL, V21, P452, DOI 10.1037//0278-6133.21.5.452; PHANG PT, 1990, JPEN-PARENTER ENTER, V14, P259, DOI 10.1177/0148607190014003259; STRICKLAND SS, 1990, ANN HUM BIOL, V17, P133, DOI 10.1080/03014469000000882; Thorp AA, 2016, J PHYS ACT HEALTH, V13, P24, DOI 10.1123/jpah.2014-0420; Vaz M, 2005, PUBLIC HEALTH NUTR, V8, P1153, DOI 10.1079/PHN2005802; VOHRA SB, 1995, CLIN NUTR, V14, P155, DOI 10.1016/S0261-5614(95)80013-1; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169478	10.1371/journal.pone.0169478	http://dx.doi.org/10.1371/journal.pone.0169478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056094	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100046
J	Liang, LH; Sun, MX; Shi, HY; Luan, TT				Liang, Lihua; Sun, Mingxiao; Shi, Hongyu; Luan, Tiantian			Design and Analyze a New Measuring Lift Device for Fin Stabilizers Using Stiffness Matrix of Euler-Bernoulli Beam	PLOS ONE			English	Article								Fin-angle feedback control is usually used in conventional fin stabilizers, and its actual anti-rolling effect is difficult to reach theoretical design requirements. Primarily, lift of control torque is a theoretical value calculated by static hydrodynamic characteristics of fin. However, hydrodynamic characteristics of fin are dynamic while fin is moving in waves. As a result, there is a large deviation between actual value and theoretical value of lift. Firstly, the reasons of deviation are analyzed theoretically, which could avoid a variety of interference factors and complex theoretical derivations. Secondly, a new device is designed for direct measurement of actual lift, which is composed of fin-shaft combined mechanism and sensors. This new device can make fin-shaft not only be the basic function of rotating fin, but also detect actual lift. Through analysis using stiffness matrix of Euler-Bernoulli beam, displacement of shaft-core end is measured instead of lift which is difficult to measure. Then quantitative relationship between lift and displacement is defined. Three main factors are analyzed with quantitative relationship. What is more, two installation modes of sensors and a removable shaft-end cover are proposed according to hydrodynamic characteristics of fin. Thus the new device contributes to maintenance and measurement. Lastly, the effectiveness and accuracy of device are verified by contrasting calculation and simulation on the basis of actual design parameters. And the new measuring lift method can be proved to be effective through experiments. The new device is achieved from conventional fin stabilizers. Accordingly, the reliability of original equipment is inherited. The alteration of fin stabilizers is minor, which is suitable for engineering application. In addition, the flexural properties of fin-shaft are digitized with analysis of stiffness matrix. This method provides theoretical support for engineering application by carrying out finite element analysis with computers.	[Liang, Lihua; Sun, Mingxiao; Shi, Hongyu; Luan, Tiantian] Harbin Engn Univ, Coll Automat, Nangang Dist 145, Harbin, Heilongjiang Pr, Peoples R China	Harbin Engineering University	Sun, MX (corresponding author), Harbin Engn Univ, Coll Automat, Nangang Dist 145, Harbin, Heilongjiang Pr, Peoples R China.	sunmingxiao1986@163.com		Luan, Tiantian/0000-0002-4525-1415; SUN, Mingxiao/0000-0001-6528-919X				Chadwick J., 1960, U.S. Patent, Patent No. [2960959, US: 2960959]; Confield I., 2008, U.S. Patent, Patent No. [0196508, US: 0196508]; Dobashi S., 2007, Fin stabilizer for vessel and control method and control program therefor, Patent No. [US: 263942, 263942]; Elhassanein A, 2015, J COMPUT THEOR NANOS, V12, P1519, DOI 10.1166/jctn.2015.3923; Fish FE, 2004, IEEE J OCEANIC ENG, V29, P605, DOI 10.1109/JOE.2004.833213; Gere J. M., 2009, MECH MAT; Jin Hongzhang, 2013, Journal of Huazhong University of Science and Technology (Natural Science Edition), V41, P115; Juvinall R. C., 2006, FUNDAMENTALS MACHINE; Li JY, 2015, J COMPUT THEOR NANOS, V12, P2084, DOI 10.1166/jctn.2015.3989; Liang L., 2015, INT J SMART HOME, V9, P1, DOI DOI 10.HTTPS://D0I.0RG/10.14257/IJSH.2015.9.6.01; Liang L., 2015, J COMPUTATIONAL INFO, V11, P3217; Liang L. H., Has the patent of the fin mechanism with the dynamic measurement of the fin and the fin, Patent No. [CN201010127056.5, 2010101270565]; Liang LH, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P1412, DOI 10.1109/ICMA.2016.7558770; Liang Y. H., 2008, RES FIN STABILIZERS; Liang YH, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-7, CONFERENCE PROCEEDINGS, P3070, DOI 10.1109/ICMA.2009.5246071; Ma J. E., 2003, EXPT REPORT DYNAMIC; Ni XD, 2015, J COMPUT THEOR NANOS, V12, P2691, DOI 10.1166/jetn.205.4164; Perez T, 2008, CONTROL ENG PRACT, V16, P482, DOI 10.1016/j.conengprac.2006.02.016; Song J., 2011, CONTROL DECISION, V26, P1352; Song Ji-guang, 2015, Control Theory & Applications, V32, P703, DOI 10.7641/CTA.2015.40499; Song Ji-guang, 2011, Control and Decision, V26, P1343; [宋吉广 Song Jiguang], 2013, [中国造船, Shipbuilding of China], V54, P1; Surendran S, 2007, OCEAN ENG, V34, P542, DOI 10.1016/j.oceaneng.2006.01.008; Wang F, 2009, MEASUREMENT, V42, P954, DOI 10.1016/j.measurement.2009.01.018; Wang Fan, 2009, OCEAN ENG, V36, P1425, DOI DOI 10.1016/J.OCEANENG.2009.07.013; Xia GQ, 2016, 2016 INT C NAT COMP, P447; Xia GQ, 2016, INT J HYBRID INFORM, V9, P31; Yang S., 2011, EXPT TECHNOLOGY MANA, V10, P47; Yanhua Liang, 2010, Journal of Control Theory and Applications, V8, P485, DOI 10.1007/s11768-010-9037-7	29	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168972	10.1371/journal.pone.0168972	http://dx.doi.org/10.1371/journal.pone.0168972			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046122	Green Published, gold			2022-12-26	WOS:000391612300081
J	Fu, CW; Lin, TH				Fu, Chien-wei; Lin, Thy-Hou			Predicting the Metabolic Sites by Flavin Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors	PLOS ONE			English	Article							RABBIT LIVER-MICROSOMES; IN-VITRO EVALUATION; N-OXYGENATION; S-OXYGENATION; ACTIVATION-ENERGIES; ISOFORM SPECIFICITY; THIOETHER COMPOUNDS; BASES PRINCIPLE; RS-PREDICTOR; SOFT ACIDS	As an important enzyme in Phase I drug metabolism, the flavin-containing monooxygenase (FMO) also metabolizes some xenobiotics with soft nucleophiles. The site of metabolism (SOM) on a molecule is the site where the metabolic reaction is exerted by an enzyme. Accurate prediction of SOMs on drug molecules will assist the search for drug leads during the optimization process. Here, some quantum mechanics features such as the condensed Fukui function and attributes from circular fingerprints (called Molprint2D) are computed and classified using the support vector machine (SVM) for predicting some potential SOMs on a series of drugs that can be metabolized by FMO enzymes. The condensed Fukui function f(A)(-) representing the nucleophilicity of central atom A and the attributes from circular fingerprints accounting the influence of neighbors on the central atom. The total number of FMO substrates and non-substrates collected in the study is 85 and they are equally divided into the training and test sets with each carrying roughly the same number of potential SOMs. However, only N-oxidation and S-oxidation features were considered in the prediction since the available C-oxidation data was scarce. In the training process, the LibSVM package of WEKA package and the option of 10-fold cross validation are employed. The prediction performance on the test set evaluated by accuracy, Matthews correlation coefficient and area under ROC curve computed are 0.829, 0.659, and 0.877 respectively. This work reveals that the SVM model built can accurately predict the potential SOMs for drug molecules that are metabolizable by the FMO enzymes.	[Lin, Thy-Hou] Natl Taiwan Univ Hosp, Hsin Chu Branch, Inst Mol Med, Dept Pharm, Hsinchu, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University	Lin, TH (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Inst Mol Med, Dept Pharm, Hsinchu, Taiwan.	thlin@life.nthu.edu.tw			Ministry of Science and Technology, Taiwan ROC [MOST 105-2320-B007-001-MY2]	Ministry of Science and Technology, Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work has been supported by a grant MOST 105-2320-B007-001-MY2 from the Ministry of Science and Technology, Taiwan ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Inc. TC, ACCELRYS METABOLITE; [Anonymous], 2018, PHYS ACTIVITY, V55, P273, DOI [10.1016/j, DOI 10.1186/1479]; Attar M, 2003, DRUG METAB DISPOS, V31, P476, DOI 10.1124/dmd.31.4.476; Ayers P.W., 2009, CHEM REACTIVITY THEO; Ayers PW, 2002, J CHEM PHYS, V116, P8731, DOI 10.1063/1.1467338; Ayers PW, 1984, J AM CHEM SOC, V106, P4049; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bender A, 2004, J CHEM INF COMP SCI, V44, P170, DOI 10.1021/ci034207y; Bultinck P, 2003, J CHEM INF COMP SCI, V43, P422, DOI 10.1021/ci0255883; Bultinck P, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2749518; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Campagna-Slater V, 2012, J CHEM INF MODEL, V52, P2471, DOI 10.1021/ci3003073; Capolongo F, 2010, J VET PHARMACOL THER, V33, P341, DOI 10.1111/j.1365-2885.2009.01145.x; Carlsson L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-362; Cashman JR, 2004, DRUG DISCOV TODAY, V9, P574, DOI 10.1016/S1359-6446(04)03136-8; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Cashman JR, 2000, CURR DRUG METAB, V1, P181, DOI 10.2174/1389200003339135; Cashman JR, 1999, J PHARMACOL EXP THER, V288, P1251; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; Cashman JR, 1986, MOL PHARM, V29; Catucci G, 2013, INT J MOL SCI, V14, P2707, DOI 10.3390/ijms14022707; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chung WG, 2000, JPN J PHARMACOL, V84, P213, DOI 10.1254/jjp.84.213; Chung WG, 1997, BIOCHEM BIOPH RES CO, V235, P685, DOI 10.1006/bbrc.1997.6866; Cruciani G, 2014, J MED CHEM, V57, P6183, DOI 10.1021/jm5007098; Deng P, 2013, ANTIMICROB AGENTS CH, V57, P1743, DOI 10.1128/AAC.02282-12; DIXIT A, 1984, ARCH BIOCHEM BIOPHYS, V233, P50, DOI 10.1016/0003-9861(84)90600-3; FREDERICK CB, 1982, CANCER RES, V42, P2671; FUKUI K, 1952, J CHEM PHYS, V20, P722, DOI 10.1063/1.1700523; Fura A, 2006, DRUG DISCOV TODAY, V11, P133, DOI 10.1016/S1359-6446(05)03681-0; Furnes B, 2005, DRUG METAB DISPOS, V33, P214, DOI 10.1124/dmd.104.000984; GAZQUEZ JL, 1994, J PHYS CHEM-US, V98, P4591, DOI 10.1021/j100068a018; Goracci L, 2013, J CHEM INF MODEL, V53, P1436, DOI 10.1021/ci400113t; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamman MA, 2000, BIOCHEM PHARMACOL, V60, P7, DOI 10.1016/S0006-2952(00)00301-4; Hanlon SP, 2012, CHEM COMMUNICATIONS; Hasegawa K, 2010, MOL INFORM, V29, P243, DOI 10.1002/minf.200900086; Henderson MC, 2014, TOXICOL APPL PHARM, V278, P91, DOI 10.1016/j.taap.2014.04.002; Henderson MC, 2004, CHEM RES TOXICOL, V17, P633, DOI 10.1021/tx034253s; Henderson MC, 2004, BIOCHEM PHARMACOL, V68, P959, DOI 10.1016/j.bcp.2004.05.051; Jacobsen W, 2000, DRUG METAB DISPOS, V28, P1343; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kajita J, 2002, DRUG METAB DISPOS, V30, P1504, DOI 10.1124/dmd.30.12.1504; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karanam BV, 2004, DRUG METAB DISPOS, V32, P1061, DOI 10.1124/dmd.104.000224; Kim YM, 2000, DRUG METAB DISPOS, V28, P1003; Kirchmair J, 2013, J CHEM INF MODEL, V53, P2896, DOI 10.1021/ci400503s; Kousba A, 2007, DRUG METAB DISPOS, V35, P2242, DOI 10.1124/dmd.107.017384; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Krueger SK, 2002, DRUG METAB DISPOS, V30, P34, DOI 10.1124/dmd.30.1.34; Lang DH, 2000, BRIT J CLIN PHARMACO, V50, P311, DOI 10.1046/j.1365-2125.2000.00265.x; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee SK, 2009, XENOBIOTICA, V39, P680, DOI 10.1080/00498250902998699; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin J, 1997, J PHARMACOL EXP THER, V282, P1269; Lin J, 1997, CHEM RES TOXICOL, V10, P842, DOI 10.1021/tx970030o; Lin J, 1996, CHEM RES TOXICOL, V9, P1183, DOI 10.1021/tx9600614; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; MENDEZ F, 1994, J AM CHEM SOC, V116, P9298, DOI 10.1021/ja00099a055; Mu FP, 2011, BIOINFORMATICS, V27, P1537, DOI 10.1093/bioinformatics/btr177; Mushiroda T, 2000, DRUG METAB DISPOS, V28, P1231; Ohmi N, 2003, XENOBIOTICA, V33, P1221, DOI 10.1080/00498250310001624627; Olsen L, 2006, J MED CHEM, V49, P6489, DOI 10.1021/jm060551l; PARK SB, 1993, CHEM RES TOXICOL, V6, P880, DOI 10.1021/tx00036a019; PARR RG, 1984, J AM CHEM SOC, V106, P4049, DOI 10.1021/ja00326a036; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; Pichard-Garcia L, 2004, DRUG METAB DISPOS, V32, P80, DOI 10.1124/dmd.32.1.80; Pike MG, 2001, DRUG METAB DISPOS, V29, P127; Ring BJ, 1999, DRUG METAB DISPOS, V27, P1099; Ring BJ, 1996, J PHARMACOL EXP THER, V276, P658; Ripp SL, 1997, MOL PHARMACOL, V51, P507; Ripp SL, 1999, ARCH BIOCHEM BIOPHYS, V367, P322, DOI 10.1006/abbi.1999.1247; RODRIGUES AD, 1995, DRUG METAB DISPOS, V23, P1143; Rodriguez RJ, 2000, DRUG METAB DISPOS, V28, P1083; Rudik AV, 2014, J CHEM INF MODEL, V54, P498, DOI 10.1021/ci400472j; Rydberg P, 2010, ACS MED CHEM LETT, V1, P96, DOI 10.1021/ml100016x; Rydberg P, 2008, J PHYS CHEM A, V112, P13058, DOI 10.1021/jp803854v; Salva M, 2003, DRUG METAB DISPOS, V31, P404, DOI 10.1124/dmd.31.4.404; Scalmani G., 2016, GAUSSIAN 09; Shiraga T, 2012, BIOL PHARM BULL, V35, P413, DOI 10.1248/bpb.35.413; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Tang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30441; Tiznado W, 2005, J PHYS CHEM A, V109, P3220, DOI 10.1021/jp0450787; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Tugnait M, 1997, DRUG METAB DISPOS, V25, P524; Tyzack JD, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-29; Tyzack JD, 2013, J CHEM INF MODEL, V53, P1294, DOI 10.1021/ci400058s; Usmani KA, 2004, DRUG METAB DISPOS, V32, P333, DOI 10.1124/dmd.32.3.333; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vyas PM, 2006, J PHARMACOL EXP THER, V319, P497, DOI 10.1124/jpet.106.105874; Wang LF, 2008, DRUG METAB DISPOS, V36, P1828, DOI 10.1124/dmd.107.020255; Washio T, 2001, BIOL PHARM BULL, V24, P1263, DOI 10.1248/bpb.24.1263; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xing L, 2003, J CHEM INF COMP SCI, V43, P870, DOI 10.1021/ci020386s; Xing L, 2002, J CHEM INF COMP SCI, V42, P796, DOI 10.1021/ci010315d; Yamazaki M, 2014, BIOCHEM PHARMACOL, V90, P159, DOI 10.1016/j.bcp.2014.04.019; YANG W, 1986, J AM CHEM SOC, V108, P5708, DOI 10.1021/ja00279a008; YANG W, 1984, J CHEM PHYS, V81, P2862, DOI 10.1063/1.447964; Yanni SB, 2010, DRUG METAB DISPOS, V38, P25, DOI 10.1124/dmd.109.029769; Yeung CK, 2000, DRUG METAB DISPOS, V28, P1107; Zaretzki J, 2013, J CHEM INF MODEL, V53, P3373, DOI 10.1021/ci400518g; Zaretzki J, 2012, J CHEM INF MODEL, V52, P1637, DOI 10.1021/ci300009z; Zaretzki J, 2011, J CHEM INF MODEL, V51, P1667, DOI 10.1021/ci2000488; Zhou SF, 2002, EUR J DRUG METAB PH, V27, P179, DOI 10.1007/BF03190455; ZIEGLER DM, 1993, ANNU REV PHARMACOL, V33, P179, DOI 10.1146/annurev.pharmtox.33.1.179; ZIEGLER DM, 1988, DRUG METAB REV, V19, P1, DOI 10.3109/03602538809049617	111	6	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169910	10.1371/journal.pone.0169910	http://dx.doi.org/10.1371/journal.pone.0169910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072829	gold, Green Published, Green Submitted			2022-12-26	WOS:000391844200056
J	Ctori, I; Huntjens, B				Ctori, Irene; Huntjens, Byki			The Association between Foveal Morphology and Macular Pigment Spatial Distribution: An Ethnicity Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL THICKNESS; PRIMATE RETINAS; HEALTHY EYES; DENSITY; AGE; PROFILE; POPULATION; DEGENERATION; SEX	Purpose Macular pigment (MP) spatial distribution varies considerably among individuals. We investigated ethnic variations in MP spatial distribution in relation to foveal architecture. Methods We measured MP optical density (MPOD) using heterochromatic flicker photometry (MAP test, City, University of London) in 76 white, 80 South Asian and 70 black volunteers (18 to 39 years). MPOD spatial profiles were classified objectively as exponential, ring-like or central dip, based on deviations away from an exponential fit. Measurements including total retinal thickness (RT), inner retinal layer (IRL), inner and outer plexiform layer (IPL and OPL) thickness, foveal width and foveal pit slope were taken from Spectralis SD-OCT (Heidelberg, Germany) scans. Results Integrated MPOD up to 1.8 degrees (MPODint) was higher in South Asian (0.84 +/- 0.26) and black (0.84 +/- 0.31) than whites (0.63 +/- 0.24, P<0.0005). Ethnicity explained around 10% of the variance while gender played no significant role. MPOD profile phenotypes were associated with ethnicity: 58% with ring profiles were South Asian and 43% with dip profiles were black (chi(2) (4,226) = 13.4, P = 0.009). MPODint was lower in exponential (0.66 +/- 0.21) compared to ring- like (0.96 +/- 0.26) and central dip (1.00 +/- 0.32, P<0.0005) groups. White subjects had thicker IRL at 0 degrees (130 +/- 21 mu m) than South Asian (123 +/- 16 mu m) and blacks (116 +/- 14 mu m; F(2) = 12.4, P<0.0005), with comparable results for IPL (P<0.0005) and OPL (P = 0.03). There was no significant difference in IRL, IPL or OPL (from 0 to 3.8 degrees retinal eccentricity) or foveal width between MP profile groups (P>0.05). Conclusion We report a significant difference in the amount and distribution of MP between ethnicities that is not explained by variations in foveal morphology.	[Ctori, Irene; Huntjens, Byki] Univ London, Appl Vis Res Ctr, Henry Wellcome Labs Vis Sci City, London, England	University of London	Huntjens, B (corresponding author), Univ London, Appl Vis Res Ctr, Henry Wellcome Labs Vis Sci City, London, England.	Byki.Huntjens.1@city.ac.uk		ctori, irene/0000-0003-1523-4996; Huntjens, Byki/0000-0002-4864-0723				Asefzadeh B, 2007, OPTOMETRY VISION SCI, V84, P941; Barbur JL, 2010, OPHTHAL PHYSL OPT, V30, P470, DOI 10.1111/j.1475-1313.2010.00748.x; Beatty S, 2001, INVEST OPHTH VIS SCI, V42, P439; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Berendschot TTJM, 2006, INVEST OPHTH VIS SCI, V47, P709, DOI 10.1167/iovs.05-0663; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; Ciulla TA, 2004, AM J OPHTHALMOL, V138, P582, DOI 10.1016/j.ajo.2004.05.057; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Ctori I, 2015, GRAEF ARCH CLIN EXP, V253, P733, DOI 10.1007/s00417-014-2915-9; Delori FC, 2006, J OPT SOC AM A, V23, P521, DOI 10.1364/JOSAA.23.000521; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; Dietzel M, 2011, INVEST OPHTH VIS SCI, V52, P8016, DOI 10.1167/iovs.11-7610; Ding Y, 2014, J NEURAL TRANSM, V121, P1367, DOI 10.1007/s00702-014-1214-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gass JDM, 1999, ARCH OPHTHALMOL-CHIC, V117, P821; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 1996, VISION RES, V36, P3003, DOI 10.1016/0042-6989(96)00008-9; Hammond BR, 1996, EXP EYE RES, V62, P713; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; Hammond BR, 1997, J OPT SOC AM A, V14, P1187, DOI 10.1364/JOSAA.14.001187; HENDRICKSON A, 1992, EYE, V6, P136, DOI 10.1038/eye.1992.29; Hendrickson A, 2012, AM J OPHTHALMOL, V154, P767, DOI 10.1016/j.ajo.2012.05.007; Howells O, 2013, INVEST OPHTH VIS SCI, V54, P2711, DOI 10.1167/iovs.12-10957; Huntjens B, 2014, ACTA OPHTHALMOL, V92; Huntjens B, 2014, INVEST OPHTH VIS SCI, V55, P1440, DOI 10.1167/iovs.13-13204; Kanis MJ, 2007, EXP EYE RES, V84, P934, DOI 10.1016/j.exer.2007.01.020; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Kirby ML, 2010, INVEST OPHTH VIS SCI, V51, P6722, DOI 10.1167/iovs.10-5344; Kirby ML, 2009, INVEST OPHTH VIS SCI, V50, P1383, DOI 10.1167/iovs.08-2494; Kyle-Little Z, 2014, FRONT NUTR, V1; Liew SHM, 2006, EXP EYE RES, V82, P915, DOI 10.1016/j.exer.2005.10.014; Liew SHM, 2005, INVEST OPHTH VIS SCI, V46, P4430, DOI 10.1167/iovs.05-0519; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; Nolan JM, 2008, INVEST OPHTH VIS SCI, V49, P2134, DOI 10.1167/iovs.07-0933; Nolan JM, 2010, OPHTHALMIC RES, V44, P131, DOI 10.1159/000315531; Office for National Statistics, ETHN NAT ID ENGL WAL; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Paunescu LA, 2004, INVEST OPHTH VIS SCI, V45, P1716, DOI 10.1167/iovs.03-0514; Pilat AV, 2014, BRIT J OPHTHALMOL, V98, P941, DOI 10.1136/bjophthalmol-2013-303119; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Raman R, 2011, INVEST OPHTH VIS SCI, V52, P7910, DOI 10.1167/iovs.11-7636; Sanchez-Cano A, 2008, OPHTHAL PHYSL OPT, V28, P21, DOI 10.1111/j.1475-1313.2007.00527.x; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P660; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Tick S, 2011, INVEST OPHTH VIS SCI, V52, P5105, DOI 10.1167/iovs.10-7005; Trieschmann M, 2008, EYE, V22, P132, DOI 10.1038/sj.eye.6702780; Van Der Veen RLP, 2009, EUR J OPHTHALMOL, V19, P836, DOI 10.1177/112067210901900524; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Westrup VMZ, 2014, INVEST OPHTH VIS SCI, V55, P1169, DOI 10.1167/iovs.13-12903; Wolf-Schnurrbusch UEK, 2007, INVEST OPHTH VIS SCI, V48, P3783, DOI 10.1167/iovs.06-1218	58	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169520	10.1371/journal.pone.0169520	http://dx.doi.org/10.1371/journal.pone.0169520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068388	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000391843900040
J	Gillespie, AV; Ehrlich, JL; Grove-White, DH				Gillespie, Amy V.; Ehrlich, James L.; Grove-White, Dai H.			Effect of Calf Gender on Milk Yield and Fatty Acid Content in Holstein Dairy Cows	PLOS ONE			English	Article							BIRTH-WEIGHT; SEXED SEMEN; LACTATION; GROWTH; VARIABILITY; PERFORMANCE; PREVENTION; PREDICTION; DISORDERS; FERTILITY	The scale of sexed semen use to avoid the birth of unwanted bull calves in the UK dairy industry depends on several economic factors. It has been suggested in other studies that calf gender may affect milk yield in Holsteins-something that would affect the economics of sexed semen use. The present study used a large milk recording data set to evaluate the effect of calf gender (both calf born and calf in utero) on both milk yield and saturated fat content. Linear regression was used to model data for first lactation and second lactation separately. Results showed that giving birth to a heifer calf conferred a 1% milk yield advantage in first lactation heifers, whilst giving birth to a bull calf conferred a 0.5% advantage in second lactation. Heifer calves were also associated with a 0.66kg reduction in saturated fatty acid content of milk in first lactation, but there was no significant difference between the genders in second lactation. No relationship was found between calf gender and milk mono-or polyunsaturated fatty acid content. The observed effects of calf gender on both yield and saturated fatty acid content was considered minor when compared to nutritional and genetic influences.	[Gillespie, Amy V.; Grove-White, Dai H.] Univ Liverpool, Sch Vet Sci, Livestock Hlth & Welf, Leahurst Campus,Chester High Rd, Neston, England; [Ehrlich, James L.] Dairy Vet Grp, Argyle, NY USA	University of Liverpool	Gillespie, AV (corresponding author), Univ Liverpool, Sch Vet Sci, Livestock Hlth & Welf, Leahurst Campus,Chester High Rd, Neston, England.	amyg@liv.ac.uk		Gillespie, Amy/0000-0002-0017-3388				AKERS RM, 1985, J DAIRY SCI, V68, P501, DOI 10.3168/jds.S0022-0302(85)80849-3; [Anonymous], 2014, REPLICATION STUDY FR; Arnould VMR, 2009, J APPL GENET, V50, P29, DOI 10.1007/BF03195649; Beavers L, 2014, IS SEX BIASED MILK P; Boadi D, 2004, CAN J ANIM SCI, V84, P319, DOI 10.4141/A03-109; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Brickell JS, 2009, THERIOGENOLOGY, V72, P408, DOI 10.1016/j.theriogenology.2009.03.015; Butler ST, 2014, ANIMAL, V8, P165, DOI 10.1017/S1751731114000664; Chegini A, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015132-6320; CHEW BP, 1981, J DAIRY SCI, V64, P2401, DOI 10.3168/jds.S0022-0302(81)82863-9; Cole JB, 2012, J DAIRY SCI, V95, P4041, DOI 10.3168/jds.2011-4905; COLEMAN DA, 1985, J DAIRY SCI, V68, P1793, DOI 10.3168/jds.S0022-0302(85)81029-8; CORREA MT, 1993, J DAIRY SCI, V76, P1305, DOI 10.3168/jds.S0022-0302(93)77461-5; De Vries A., 2009, EC SEXED SEMEN DAIRY; DeJarnette JM, 2007, J ANIM SCI, V85, P228; del Rio NS, 2007, J DAIRY SCI, V90, P1255, DOI 10.3168/jds.S0022-0302(07)71614-4; DELUYKER HA, 1991, J DAIRY SCI, V74, P436, DOI 10.3168/jds.S0022-0302(91)78189-7; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Ehrlich JL, 2013, PEERJ, V1, DOI 10.7717/peerj.54; ERB HN, 1985, J DAIRY SCI, V68, P3337, DOI 10.3168/jds.S0022-0302(85)81244-3; Flint APF, 1997, GEN COMP ENDOCR, V106, P374, DOI 10.1006/gcen.1997.6879; FOOTE RH, 1977, THERIOGENOLOGY, V8, P349, DOI 10.1016/0093-691X(77)90186-8; Fourichon C, 1999, PREV VET MED, V41, P1, DOI 10.1016/S0167-5877(99)00035-5; Fujita M, 2012, AM J PHYS ANTHROPOL, V149, P52, DOI 10.1002/ajpa.22092; Graesboll K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124051; Green LE, 2002, J DAIRY SCI, V85, P2250, DOI 10.3168/jds.S0022-0302(02)74304-X; Haug A., 2007, LIPIDS HEALTH DIS, V6, P6; Healy AA, 2013, J DAIRY SCI, V96, P1905, DOI 10.3168/jds.2012-5465; Hess MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151236; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Johanson JM, 2003, J DAIRY SCI, V86, P3745, DOI 10.3168/jds.S0022-0302(03)73981-2; Kertz AF, 1997, J DAIRY SCI, V80, P525, DOI 10.3168/jds.S0022-0302(97)75966-6; Knight CH, 2001, LIVEST PROD SCI, V70, P87, DOI 10.1016/S0301-6226(01)00200-7; Livingstone KM, 2015, J DAIRY SCI, V98, P4000, DOI 10.3168/jds.2014-8987; Norman HD, 2010, J DAIRY SCI, V93, P3880, DOI 10.3168/jds.2009-2781; Pegolo S, 2016, J DAIRY SCI, V99, P1315, DOI 10.3168/jds.2015-9596; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; PTAK E, 1993, LIVEST PROD SCI, V34, P23, DOI 10.1016/0301-6226(93)90033-E; RSPCA (Royal Society for Prevention of Cruelty to Animals), 2012, RSPCA ROYAL SOC PREV; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Soyeurt H, 2007, J DAIRY SCI, V90, P4435, DOI 10.3168/jds.2007-0054; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Swali A, 2006, THERIOGENOLOGY, V66, P1173, DOI 10.1016/j.theriogenology.2006.03.028; THOMPSON JR, 1983, J DAIRY SCI, V66, P1119, DOI 10.3168/jds.S0022-0302(83)81909-2; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; TYRRELL HF, 1965, J DAIRY SCI, V48, P1215, DOI 10.3168/jds.S0022-0302(65)88430-2; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Weigel K. A., 2004, J DAIRY SCI, V87, pE120, DOI DOI 10.3168/JDS.S0022-0302(04)70067-3	49	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169503	10.1371/journal.pone.0169503	http://dx.doi.org/10.1371/journal.pone.0169503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068399	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900039
J	Hatoum, D; Yagoub, D; Ahadi, A; Nassif, NT; McGowan, EM				Hatoum, Diana; Yagoub, Daniel; Ahadi, Alireza; Nassif, Najah T.; McGowan, Eileen M.			Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer	PLOS ONE			English	Article							INCREASES OSTEOCLAST FORMATION; A1 EXPRESSION; P53; ESTROGEN; RECEPTOR; ASSOCIATION; PROLIFERATION; APOPTOSIS; INVASION; ARREST	The annexin family and S100A associated proteins are important regulators of diverse calcium-dependent cellular processes including cell division, growth regulation and apoptosis. Dysfunction of individual annexin and S100A proteins is associated with cancer progression, metastasis and cancer drug resistance. This manuscript describes the novel finding of differential regulation of the annexin and S100A family of proteins by activation of p53 in breast cancer cells. Additionally, the observed differential regulation is found to be beneficial to the survival of breast cancer cells and to influence treatment efficacy. We have used unbiased, quantitative proteomics to determine the proteomic changes occurring post p14ARF-p53 activation in estrogen receptor (ER) breast cancer cells. In this report we identified differential regulation of the annexin/S100A family, through unique peptide recognition at the N-terminal regions, demonstrating p14ARF-p53 is a central orchestrator of the annexin/S100A family of calcium regulators in favor of pro-survival functions in the breast cancer cell. This regulation was found to be cell-type specific. Retrospective human breast cancer studies have demonstrated that tumors with functional wild type p53 (p53wt) respond poorly to some chemotherapy agents compared to tumors with a non-functional p53. Given that modulation of calcium signaling has been demonstrated to change sensitivity of chemotherapeutic agents to apoptotic signals, in principle, we explored the paradigm of how p53 modulation of calcium regulators in ER+ breast cancer patients impacts and influences therapeutic outcomes.	[Hatoum, Diana; Nassif, Najah T.; McGowan, Eileen M.] Univ Technol Sydney, Sch Life Sci, Fac Engn & IT, Fac Sci, Sydney, NSW, Australia; [Yagoub, Daniel] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Ahadi, Alireza] Univ Technol Sydney, Fac Engn & IT, Sydney, NSW, Australia	University of Technology Sydney; University of New South Wales Sydney; University of Technology Sydney	McGowan, EM (corresponding author), Univ Technol Sydney, Sch Life Sci, Fac Engn & IT, Fac Sci, Sydney, NSW, Australia.	Eileen.McGowan@uts.edu.au	Nassif, Najah T/G-6214-2012	Nassif, Najah T/0000-0003-2675-8322; ahadi, alireza/0000-0002-2018-3065; Hatoum, Diana/0000-0003-0512-171X; McGowan, Eileen/0000-0001-6371-3751	Australian Postgraduate Award (APA); Sydney Vital Research Scholarship Award; Translational Cancer Research Network (TCRN) top-up Award	Australian Postgraduate Award (APA)(Australian Government); Sydney Vital Research Scholarship Award; Translational Cancer Research Network (TCRN) top-up Award	This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. DH is supported by an Australian Postgraduate Award (APA), a Sydney Vital Research Scholarship Award and a Translational Cancer Research Network (TCRN) top-up Award.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Ang EZF, 2009, MOL CANCER RES, V7, P266, DOI 10.1158/1541-7786.MCR-08-0147; Arii Y, 2015, BIOSCI BIOTECH BIOCH, V79, P978, DOI 10.1080/09168451.2014.1003131; Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109; Balmer MT, 2014, CANCER BIOL THER, V15, P1000, DOI 10.4161/cbt.29112; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Bertheau P, 2002, LANCET, V360, P852, DOI 10.1016/S0140-6736(02)09969-5; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bhardwaj A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127678; Burgess A, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00007; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Clarke R, 2015, MOL CELL ENDOCRINOL, V418, P220, DOI 10.1016/j.mce.2015.09.035; Cmoch Anna, 2012, Postepy Biochem, V58, P429; Crane EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135101; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Gallagher S, 2005, CELL CYCLE, V4, P465, DOI 10.4161/cc.4.3.1526; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Giorgi C, 2015, CELL CYCLE, V14, P933, DOI 10.1080/15384101.2015.1010973; Gurpinar E, 2015, TRENDS CELL BIOL, V25, P486, DOI 10.1016/j.tcb.2015.04.001; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; Hu H, 2015, TECHNOL CANC RES TRE; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Jaiswal JK, 2015, CELL CYCLE, V14, P502, DOI 10.1080/15384101.2014.995495; Jaiswal JK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4795; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Lehmann-Che J, 2007, M S-MED SCI, V23, P1021, DOI 10.1051/medsci/200723111021; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Liu YD, 2015, BRIT J PHARMACOL, V172, P1664, DOI 10.1111/bph.12978; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McGowan EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042246; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Okano M, 2015, ONCOL REP, V33, P1064, DOI 10.3892/or.2015.3720; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Piljic A, 2006, MOL BIOL CELL, V17, P3318, DOI 10.1091/mbc.E06-01-0041; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Sobral-Leite M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0392-6; Stewart TA, 2014, BIOCH BIOPHYSICA ACT; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang CY, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/308976; Wang T, 2015, ONCOTARGET, V6, P30975, DOI 10.18632/oncotarget.5199; Xia LQ, 2004, CANCER RES, V64, P221, DOI 10.1158/0008-5472.CAN-03-0969; Yagoub D, 2014, MOL ENDOCRINOL, V28, P1899, DOI 10.1210/me.2013-1423; Yom CK, 2011, J BREAST CANCER, V14, P262, DOI 10.4048/jbc.2011.14.4.262; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	57	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169925	10.1371/journal.pone.0169925	http://dx.doi.org/10.1371/journal.pone.0169925			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068434	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900080
J	Kazerouni, A; Wein, LM				Kazerouni, Abbas; Wein, Lawrence M.			Exploring the Efficacy of Pooled Stools in Fecal Microbiota Transplantation for Microbiota-Associated Chronic Diseases	PLOS ONE			English	Article								Fecal microbiota transplantation is being assessed as a treatment for chronic microbiotarelated diseases such as ulcerative colitis. Results from an initial randomized trial suggest that remission rates depend on unobservable features of the fecal donors and observable features of the patients. We use mathematical modeling to assess the efficacy of pooling stools from different donors during multiple rounds of treatment. In the model, there are two types of patients and two types of donors, where the patient type is observable and the donor type (effective or not effective) is not observable. In the model, clinical outcomes from earlier rounds of treatment are used to estimate the current likelihood that each donor is effective, and then each patient in each round is treated by a pool of donors that are currently deemed to be the most effective. Relative to the no-pooling case, pools of size two or three significantly increase the proportion of patients in remission during the first several rounds of treatment. Although based on data from a single randomized trial, our modeling suggests that pooling of stools - via daily cycling of encapsulated stool from several different donors - may be beneficial in fecal microbiota transplantation for chronic microbiota-related diseases.	[Kazerouni, Abbas] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wein, Lawrence M.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University	Wein, LM (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	lwein@stanford.edu						Berger JO, 1980, STAT DECISION THEORY, DOI [10.1007/978-1-4757-4286-2, DOI 10.1007/978-1-4757-4286-2]; Dai B, 2013, BERNOULLI, V19, P1465, DOI 10.3150/12-BEJSP10; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kazerouni A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0140-3; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Smith MB, 2014, NATURE, V506, P290, DOI 10.1038/506290a; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Stollman N, 2015, AM J GASTROENTEROL, V110, P600, DOI 10.1038/ajg.2015.81; Vermeire S., 2015, J CROHNS COLITIS	11	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0163956	10.1371/journal.pone.0163956	http://dx.doi.org/10.1371/journal.pone.0163956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068341	Green Published, gold			2022-12-26	WOS:000391843900001
J	Lu, Y; Wang, AH; Shi, P; Zhang, H				Lu, Yang; Wang, AiHua; Shi, Peng; Zhang, Hui			A Theoretical Study on the Antioxidant Activity of Piceatannol and Isorhapontigenin Scavenging Nitric Oxide and Nitrogen Dioxide Radicals	PLOS ONE			English	Article							ELECTRON-TRANSFER REACTIONS; RESVERATROL; STILBENE; ANALOGS; GRAPES; REACTIVITY; MECHANISM; OXIDATION; ENERGIES; STRESS	The antioxidant activity of naturally occurring stilbene compounds piceatannol (PIC) and isorhapontigenin (ISO) scavenging two free radicals (NO and NO2) were studied using density functional theory (DFT) method. Four reaction mechanisms have been considered: hydrogen atom transfer (HAT), radical adduct formation (RAF), single electron transfer (SET), and sequential proton loss electron transfer (SPLET). The reaction channels in water solution were traced independently, and the respective thermodynamic and kinetic parameters were obtained. We found PIC and ISO scavenge NO mainly through RAF mechanism, and scavenge NO2 through HAT mechanism. The capacity of PIC scavenging NO2 is much higher than ISO, but the reactivity of scavenging NO is lower than ISO.	[Lu, Yang; Wang, AiHua; Shi, Peng] Harbin Univ Sci & Technol, Coll Mat Sci & Engn, Harbin, Peoples R China; [Zhang, Hui] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China	Harbin University of Science & Technology; Harbin University of Science & Technology	Zhang, H (corresponding author), Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China.	hust_zhanghui11@hotmail.com						Bastianetto S, 2009, CNS NEUROSCI THER, V15, P76, DOI 10.1111/j.1755-5949.2008.00074.x; Bavaresco L, 2002, VITIS, V41, P133; Benson S. W., 1982, FDN CHEM KINETICS; Camaioni DM, 2005, J PHYS CHEM A, V109, P10795, DOI 10.1021/jp054088k; Ceron-Carrasco JP, 2010, J PHYS CHEM B, V114, P4366, DOI 10.1021/jp911846h; Cordova-Gomez M, 2013, RSC ADV, V3, P20209, DOI 10.1039/c3ra42923g; Djoko B, 2007, J AGR FOOD CHEM, V55, P2376, DOI 10.1021/jf062741a; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; DOUGLAS WH, 1978, J DENT RES, V57, P800, DOI 10.1177/00220345780570070801; Fang YN, 2002, PHYTOMEDICINE, V9, P734, DOI 10.1078/094471102321621359; FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019; Frisch G. W., 2013, GAUSSIAN 09; Galano A, 2013, J COMPUT CHEM, V34, P2430, DOI 10.1002/jcc.23409; Galano A, 2010, J PHYS CHEM B, V114, P6625, DOI 10.1021/jp912001c; Iliya I, 2003, PHYTOCHEMISTRY, V62, P601, DOI 10.1016/S0031-9422(02)00670-2; Fernandez-Marin MI, 2012, FOOD CHEM, V135, P1353, DOI 10.1016/j.foodchem.2012.05.086; Iuga C, 2011, J PHYS CHEM B, V115, P12234, DOI 10.1021/jp206347u; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; King RE, 2006, COMPR REV FOOD SCI F, V5, P65, DOI 10.1111/j.1541-4337.2006.00001.x; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Ku KL, 2005, J AGR FOOD CHEM, V53, P3877, DOI 10.1021/jf050242o; Li J B, 1991, Yao Xue Xue Bao, V26, P437; Lu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133259; Marcus RA, 1997, PURE APPL CHEM, V69, P13, DOI 10.1351/pac199769010013; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P41, DOI 10.1016/S0968-0896(00)00215-7; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Noguchi N, 1999, CHEM ACTIVE OXYGEN S, P3; Okuno Y, 1997, CHEM-EUR J, V3, P212, DOI 10.1002/chem.19970030208; Ovesna Z, 2006, ONCOLOGY; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Perez-Gonzalez A, 2016, THEOR CHEM ACC, V135, DOI 10.1007/s00214-016-1913-x; Perez-Gonzalez A, 2012, J MEX CHEM SOC, V56, P241; Rhayem Y, 2008, CHEM PHYS LIPIDS, V155, P48, DOI 10.1016/j.chemphyslip.2008.06.001; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rossi M, 2008, J AGR FOOD CHEM, V56, P10557, DOI 10.1021/jf801923j; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Wang QL, 2001, JPN J PHARMACOL, V87, P61, DOI 10.1254/jjp.87.61; Yokozawa T, 2007, BIOL PHARM BULL, V30, P2007, DOI 10.1248/bpb.30.2007; Zavala-Oseguera C, 2009, J PHYS CHEM A, V113, P13913, DOI 10.1021/jp906144d	46	17	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169773	10.1371/journal.pone.0169773	http://dx.doi.org/10.1371/journal.pone.0169773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068377	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900067
J	Oddone, F; Roberti, G; Micera, A; Busanello, A; Bonini, S; Quaranta, L; Agnifili, L; Manni, G				Oddone, Francesco; Roberti, Gloria; Micera, Alessandra; Busanello, Anna; Bonini, Stefano; Quaranta, Luciano; Agnifili, Luca; Manni, Gianluca			Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; ALZHEIMERS-DISEASE; BDNF SERUM; AXONAL-TRANSPORT; MESSENGER-RNA; PLASMA-LEVELS; EXPRESSION; NGF; AGE	Purpose To investigate the serum levels of Brain Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in patients affected by primary open angle glaucoma with a wide spectrum of disease severity compared to healthy controls and to explore their relationship with morphological and functional glaucoma parameters. Materials and Methods 45 patients affected by glaucoma at different stages and 15 age-matched healthy control subjects underwent visual field testing, peripapillary retinal nerve fibre layer thickness measurement using Spectral Domain Optical Coherence Tomography and blood collection for both neurotrophins detection by Enzyme-Linked Immunosorbent Assay. Statistical analysis and association between biostrumental and biochemical data were investigated. Results Serum levels of BDNF in glaucoma patients were significantly lower than those measured in healthy controls (261.2 +/- 75.0 pg/ml vs 313.6 +/- 79.6 pg/ml, p = 0.03). Subgroups analysis showed that serum levels of BDNF were significantly lower in early (253.8 +/- 40.7 pg/ml, p = 0.019) and moderate glaucoma (231.3 +/- 54.3 pg/ml, p = 0.04) but not in advanced glaucoma (296.2 +/- 103.1 pg/ml, p = 0.06) compared to healthy controls. Serum levels of NGF in glaucoma patients were significantly lower than those measured in the healthy controls (4.1 +/- 1 pg/mL vs 5.5 +/- 1.2 pg/mL, p = 0.01). Subgroups analysis showed that serum levels of NGF were significantly lower in early (3.5 +/- 0.9 pg/mL, p = 0.0008) and moderate glaucoma (3.8 +/- 0.7 pg/ml, p< 0.0001) but not in advanced glaucoma (5.0 +/- 0.7 pg/ml, p = 0.32) compared to healthy controls. BDNF serum levels were not related to age, visual field mean deviation or retinal nerve fibre layer thickness either in glaucoma or in controls while NGF levels were significantly related to visual field mean deviation in the glaucoma group (r(2) = 0.26, p = 0.004). Conclusions BDNF and NGF serum levels are reduced in the early and moderate glaucoma stages, suggesting the possibility that both factors could be further investigated as potential circulating biomarkers for the early detection of glaucoma.	[Oddone, Francesco; Roberti, Gloria; Micera, Alessandra; Busanello, Anna] IRCCS Fdn GB Bietti, Rome, Italy; [Bonini, Stefano] Campus Biomed Univ, Dept Ophthalmol, Rome, Italy; [Quaranta, Luciano] Dept Med & Surg Specialties, Sect Ophthalmol, Radiol Sci, Brescia, Italy; [Quaranta, Luciano] Publ Hlth Univ Brescia, Brescia, Italy; [Agnifili, Luca] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Ophthalmol Clin, Chieti, Italy; [Manni, Gianluca] Univ Roma Tor Vergata, DSCMT, Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University Campus Bio-Medico - Rome Italy; G d'Annunzio University of Chieti-Pescara; University of Rome Tor Vergata	Roberti, G (corresponding author), IRCCS Fdn GB Bietti, Rome, Italy.	gloriaroberti82@gmail.com	Micera, Alessandra/J-3373-2013; Agnifili, Luca/AAC-6345-2022; Bonini, Sergio/T-6594-2019; Oddone, Francesco/K-8876-2016; Bonini, Stefano/A-2250-2012	Bonini, Sergio/0000-0003-0079-3031; Oddone, Francesco/0000-0002-2504-0004; quaranta, luciano/0000-0002-5462-1713; manni, gianluca/0000-0002-9006-8556; Bonini, Stefano/0000-0002-7787-2144	Italian Ministry of Health; Fondazione Roma	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	The research for this paper was financially supported by the Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva E, 1993, Rev Neurosci, V4, P41; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; ALOE L, 1986, P NATL ACAD SCI USA, V83, P6184, DOI 10.1073/pnas.83.16.6184; ALOE L, 1994, P NATL ACAD SCI USA, V91, P10440, DOI 10.1073/pnas.91.22.10440; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Chen YW, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S81432; Coassin M, 2008, GRAEF ARCH CLIN EXP, V246, P1743, DOI 10.1007/s00417-008-0913-5; Domenici L, 2014, PLOS ONE, V23, P9; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fanaei H, 2016, NEUROPEPTIDES, V56, P25, DOI 10.1016/j.npep.2015.11.003; Faria MC, 2014, J PSYCHIATR RES, V53, P166, DOI 10.1016/j.jpsychires.2014.01.019; Gao H, 2002, ARCH OPHTHALMOL-CHIC, V120, P797; Ghaffariyeh A, 2011, OPTOMETRY VISION SCI, V88, P80, DOI 10.1097/OPX.0b013e3181fc329f; Ghaffariyeh A, 2009, OPTOMETRY, V80, P635, DOI 10.1016/j.optm.2008.09.014; Gupta V, 2014, BBA-MOL BASIS DIS, V1842, P1567, DOI 10.1016/j.bbadis.2014.05.026; Hellweg R, 1998, INT J DEV NEUROSCI, V16, P787, DOI 10.1016/S0736-5748(98)00088-4; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Micera A, 2006, EXP EYE RES, V83, P747, DOI 10.1016/j.exer.2006.03.010; Micera A, 2016, ADV THER, V33, P252, DOI 10.1007/s12325-016-0285-x; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Piccinni A, 2015, J AFFECT DISORDERS, V171, P167, DOI 10.1016/j.jad.2014.08.058; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Qiu M, OPHTHALMOLOGY, V12, P733; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Roberti G, 2014, J CELL PHYSIOL, V229, P1130, DOI 10.1002/jcp.24573; Scalzo P, 2010, J NEUROL, V257, P540, DOI 10.1007/s00415-009-5357-2; SCHUMER RA, 1994, ARCH OPHTHALMOL-CHIC, V112, P37, DOI 10.1001/archopht.1994.01090130047015; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; Wood JPM, 2001, EXP EYE RES, V72, P79, DOI 10.1006/exer.2000.0929; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	45	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168565	10.1371/journal.pone.0168565	http://dx.doi.org/10.1371/journal.pone.0168565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068360	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900010
J	Chinnapaiyan, S; Padre, T; Dutta, R; Agudelo, M; Morris, A; Nair, M; Unwalla, HJ				Chinnapaiyan, S.; Padre, T.; Dutta, R.; Agudelo, M.; Morris, A.; Nair, M.; Unwalla, H. J.			HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SURFACE LIQUID VOLUME; TAT PROTEIN; RALTEGRAVIR INTENSIFICATION; CIGARETTE-SMOKING; MESSENGER-RNA; CELLS; DNA; EXPRESSION; REPLICATION	Recurrent lung infections and pneumonia are emerging as significant comorbidities in the HIV-infected population in the era of combination antiretroviral therapy (cART). HIV infection has been reported to suppress nasal mucociliary clearance (MCC). Since the primary components driving nasal MCC and bronchial MCC are identical, it is possible that bronchial MCC is affected as well. Effective MCC requires optimal ciliary beating which depends on the maintenance of the airway surface liquid (ASL), a function of cystic fibrosis transmembrane conductance regulator (CFTR) activity and the integrity of the signaling mechanism that regulates ciliary beating and fluid secretion. Impairment of either component of the MCC apparatus can compromise its efficacy and promote microbial colonization. We demonstrate that primary bronchial epithelium expresses HIV receptor CD4 and co-receptors CCR5 and CXCR4 and can be infected by both R5 and X4 tropic strains of HIV. We show that HIV Tat suppresses CFTR biogenesis and function in primary bronchial epithelial cells by a pathway involving TGF-beta signaling. HIV infection also interferes with bronchial epithelial cell differentiation and suppresses ciliogenesis. These findings suggest that HIV infection suppresses tracheobronchial mucociliary clearance and this may predispose HIV-infected patients to recurrent lung infections, pneumonia and chronic bronchitis.	[Chinnapaiyan, S.; Padre, T.; Dutta, R.; Agudelo, M.; Nair, M.; Unwalla, H. J.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Inst Neuroimmune Pharmacol, Miami, FL 33199 USA; [Morris, A.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	State University System of Florida; Florida International University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Unwalla, HJ (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Inst Neuroimmune Pharmacol, Miami, FL 33199 USA.	hunwalla@fiu.edu	CHINNAPAIYAN, SRINIVASAN/ABA-2916-2020; Dutta, Rajib/W-3358-2019	CHINNAPAIYAN, SRINIVASAN/0000-0001-5633-9749; Dutta, Rajib/0000-0001-6570-9238; Unwalla, Hoshang/0000-0001-5704-6876	Florida International University [1R21HL128141-01A1, HL090339, R01 HL120398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL128141] Funding Source: NIH RePORTER	Florida International University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research was funded in part by 1R21HL128141-01A1 and laboratory start-up funds by Florida International University to HU and HL090339 and R01 HL120398 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Brune KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149679; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Brussel A, 2003, AIDS, V17, P645, DOI 10.1097/00002030-200303280-00001; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chavez HH, 2007, JAIDS-J ACQ IMM DEF, V45, P247, DOI 10.1097/QAI.0b013e3180415dc2; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Crothers K, 2005, J GEN INTERN MED, V20, P1142, DOI 10.1111/j.1525-1497.2005.0255.x; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dezzutti CS, 2001, J INFECT DIS, V183, P1204, DOI 10.1086/319676; Dickson SJ, 2007, THORAX, V62, P964, DOI 10.1136/thx.2006.072256; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; GIBELLINI D, 1994, BRIT J HAEMATOL, V88, P261, DOI 10.1111/j.1365-2141.1994.tb05016.x; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; Gundavarapu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077160; Halbert CL, 2007, HUM GENE THER, V18, P344, DOI 10.1089/hum.2006.182; Kalichman SC, 2015, JAIDS-J ACQ IMM DEF, V70, P503, DOI 10.1097/QAI.0000000000000776; Kalichman SC, 2013, J GEN INTERN MED, V28, P399, DOI 10.1007/s11606-012-2231-1; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; LEE TC, 1992, NEW BIOL, V4, P66; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; MILGRIM LM, 1995, LARYNGOSCOPE, V105, P1202, DOI 10.1288/00005537-199511000-00012; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; PAVIA D, 1983, EUR J RESPIR DIS, V64, P41; REID L, 1976, POSTGRAD MED J, V52, P183, DOI 10.1136/pgmj.52.606.183; Rosen EJ, 2005, LARYNGOSCOPE, V115, P27, DOI 10.1097/01.mlg.0000150678.83602.d4; RUTLAND J, 1982, AM REV RESPIR DIS, V125, P100; SCADDEN DT, 1990, BLOOD, V76, P317; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; STEVENSON M, 1990, J VIROL, V64, P2421, DOI 10.1128/JVI.64.5.2421-2425.1990; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; TAYLOR JP, 1993, VIROLOGY, V195, P780, DOI 10.1006/viro.1993.1430; Twigg HL, 1999, AM J RESP CRIT CARE, V159, P1439, DOI 10.1164/ajrccm.159.5.9808031; Unwalla HJ, 2006, J VIROL, V80, P1863, DOI 10.1128/JVI.80.4.1863-1873.2006; Unwalla HJ, 2015, AM J RESP CELL MOL, V52, P65, DOI 10.1165/rcmb.2013-0538OC; Unwalla HJ, 2012, AM J RESP CELL MOL, V46, P551, DOI 10.1165/rcmb.2011-0220OC; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WANNER A, 1986, CLIN CHEST MED, V7, P247; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wilson R, 1996, EUR RESPIR J, V9, P1523, DOI 10.1183/09031936.96.09071523; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Zhang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104090; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; [朱近 ZHU Jin], 2009, [遥感信息, Remote Sensing Information], P3; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007	70	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169161	10.1371/journal.pone.0169161	http://dx.doi.org/10.1371/journal.pone.0169161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060951	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500059
J	Krops, LA; Jaarsma, EA; Dijkstra, PU; Geertzen, JHB; Dekker, R				Krops, Leonie A.; Jaarsma, Eva A.; Dijkstra, Pieter U.; Geertzen, Jan H. B.; Dekker, Rienk			Health Related Quality of Life in a Dutch Rehabilitation Population: Reference Values and the Effect of Physical Activity	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; SF-36; DISABILITY; PAIN; AMPUTATION; DISEASE; PEOPLE; INDIVIDUALS; MULTICENTER	Purpose To establish reference values for Health Related Quality of Life (HRQoL) in a Dutch rehabilitation population, and to study effects of patient characteristics, diagnosis and physical activity on HRQoL in this population. Method Former rehabilitation patients (3169) were asked to fill in a questionnaire including the Dutch version of the RAND-36. Differences between our rehabilitation patients and Dutch reference values were analyzed (t-tests). Effects of patient characteristics, diagnosis and movement intensity on scores on the subscales of the RAND-36 were analyzed using block wise multiple regression analyses. Results In total 1223 patients (39%) returned the questionnaire. HRQoL was significantly poorer in the rehabilitation patients compared to Dutch reference values on all subscales (p<0.001) except for health change (p = 0.197). Longer time between questionnaire and last treatment was associated with a smaller health change (p = 0.035). Higher age negatively affected physical functioning (p<0.001), social functioning (p = 0.004) and health change (p = 0.001). Diagnosis affected outcomes on all subscales except role limitations physical, and mental health (p ranged <0.001 to 0.643). Higher movement intensity was associated with better outcomes on all subscales except for mental health (p ranged <0.001 to 0.190). Conclusions HRQoL is poorer in rehabilitation patients compared to Dutch reference values. Physical components of HRQoL are affected by diagnosis. In rehabilitation patients an association	[Krops, Leonie A.; Jaarsma, Eva A.; Dijkstra, Pieter U.; Geertzen, Jan H. B.; Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Krops, LA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	l.a.krops@umcg.nl	Krops, Leonie/AAD-2972-2020	Krops, Leonie/0000-0003-1721-3953; Jaarsma, Eva Annika/0000-0002-0674-3660	University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine [85100]	University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine	This study was funded by the University of Groningen, University Medical Center Groningen, Department of Rehabilitation Medicine (85100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Adler RH, 2009, J PSYCHOSOM RES, V67, P607, DOI 10.1016/j.jpsychores.2009.08.008; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Andresen EM, 1999, ARCH PHYS MED REHAB, V80, P877, DOI 10.1016/S0003-9993(99)90077-1; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P313, DOI 10.3233/NRE-2010-0614; Aymerich M, 2009, PATIENT PREFER ADHER, V3, P311; Barrera M, 2012, PEDIATR BLOOD CANCER, V58, P265, DOI 10.1002/pbc.23017; Baumstarck K, 2013, EUR J NEUROL, V20, P907, DOI 10.1111/ene.12087; Davidson JH, 2010, DISABIL REHABIL, V32, P1855, DOI 10.3109/09638281003734441; Drulovic J, 2007, ACTA NEUROL SCAND, V115, P147, DOI 10.1111/j.1600-0404.2006.00729.x; Ebrahimzadeh MH, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.16720; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fernandez O, 2011, MULT SCLER J, V17, P1238, DOI 10.1177/1352458511407951; Fernandez-Munoz JJ, 2015, ACTA NEUROL SCAND, V132, P118, DOI 10.1111/ane.12370; Forbes A, 2006, CLIN REHABIL, V20, P67, DOI 10.1191/0269215506cr880oa; Forchheimer M, 2004, AM J PHYS MED REHAB, V83, P390, DOI 10.1097/01.PHM.0000124441.78275.C9; Gavelova M, 2015, DISABIL HEALTH J, V8, P372, DOI 10.1016/j.dhjo.2015.02.006; GELLERT GA, 1993, QUAL LIFE RES, V2, P357, DOI 10.1007/BF00449431; Grytten N, 2012, ACTA NEUROL SCAND, V126, P51, DOI 10.1111/ane.12033; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hazell Michelle L, 2009, Prim Care Respir J, V18, P165, DOI 10.3132/pcrj.2009.00001; Hermann BP, 1996, EPILEPSY RES, V25, P113, DOI 10.1016/0920-1211(96)00024-1; Jaarsma EA, 2016, J REHABIL MED, V48, P72, DOI 10.2340/16501977-2017; Kivisild A, 2014, SPINAL CORD, V52, P570, DOI 10.1038/sc.2014.47; Klevan G, 2014, ACTA NEUROL SCAND, V129, P21, DOI 10.1111/ane.12142; Lauche R, 2013, FORSCH KOMPLEMENTMED, V20, P328, DOI 10.1159/000355634; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; Lidal IB, 2008, SPINAL CORD, V46, P710, DOI 10.1038/sc.2008.17; Lin MR, 2007, AM J PHYS MED REHAB, V86, P104, DOI 10.1097/01.phm.0000247780.64373.0e; McCutcheon Tonna, 2005, Gastroenterol Nurs, V28, P221, DOI 10.1097/00001610-200505000-00005; Miller A, 2006, QUAL LIFE RES, V15, P259, DOI 10.1007/s11136-005-0891-6; Nicassio PM, 2011, J PSYCHOSOM RES, V71, P79, DOI 10.1016/j.jpsychores.2011.01.008; Nordeman L, 2012, CLIN J PAIN, V28, P65, DOI 10.1097/AJP.0b013e318223622c; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Riazi A, 2003, J NEUROL NEUROSUR PS, V74, P710, DOI 10.1136/jnnp.74.6.710; Rognoni C, 2014, STUD HEALTH TECHNOL, V205, P935, DOI 10.3233/978-1-61499-432-9-935; Schoppen T, 2002, ARCH PHYS MED REHAB, V83, P628, DOI 10.1053/apmr.2002.32473; Schrier E, 2016, QUAL LIFE RES, V25, P135, DOI 10.1007/s11136-015-1060-1; Sinha R, 2011, PROSTHET ORTHOT INT, V35, P90, DOI 10.1177/0309364610397087; Szilasiova J, 2011, DISABIL REHABIL, V33, P1587, DOI 10.3109/09638288.2010.540292; Taghipour H, 2009, J ORTHOP TRAUMA, V23, P525, DOI 10.1097/BOT.0b013e3181a10241; Tramonti F, 2014, SPINAL CORD, V52, P231, DOI 10.1038/sc.2013.156; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; van der Zee KI., 2012, MEASURING GEN HLTH S, V2nd; VANDERZEE KI, 1993, TIJDSCHRIFT SOCIALE, V71, P183; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	47	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169169	10.1371/journal.pone.0169169	http://dx.doi.org/10.1371/journal.pone.0169169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060949	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500060
J	Seo, J; Jin, D; Choi, CH; Lee, H				Seo, Jiyoun; Jin, Daeyong; Choi, Chan-Hun; Lee, Hyunju			Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs	PLOS ONE			English	Article							CELL-PROLIFERATION; BAYESIAN NETWORKS; GENE-EXPRESSION; C-MYC; GLIOBLASTOMA; RECEPTORS; ACTIVATION; STEM; SEQUENCES; APOPTOSIS	MicroRNAs (miRNAs) are responsible for the regulation of target genes involved in various biological processes, and may play oncogenic or tumor suppressive roles. Many studies have investigated the relationships between miRNAs and their target genes, using mRNA and miRNA expression data. However, mRNA expression levels do not necessarily represent the exact gene expression profiles, since protein translation may be regulated in several different ways. Despite this, large-scale protein expression data have been integrated rarely when predicting gene-miRNA relationships. This study explores two approaches for the investigation of gene-miRNA relationships by integrating mRNA expression and protein expression data. First, miRNAs were ranked according to their effects on cancer development. We calculated influence scores for each miRNA, based on the number of significant mRNA-miRNA and protein-miRNA correlations. Furthermore, we constructed modules containing mRNAs, proteins, and miRNAs, in which these three molecular types are highly correlated. The regulatory interactions between miRNA and genes in these modules have been validated based on the direct regulations, indirect regulations, and co-regulations through transcription factors. We applied our approaches to glioblastomas (GBMs), ranked miRNAs depending on their effects on GBM, and obtained 52 GBM-related modules. Compared with the miRNA rankings and modules constructed using only mRNA expression data, the rankings and modules constructed using mRNA and protein expression data were shown to have better performance. Additionally, we experimentally verified that miR-504, highly ranked and included in the identified modules, plays a suppressive role in GBM development. We demonstrated that the integration of both expression profiles allows a more precise analysis of gene-miRNA interactions and the identification of a higher number of cancer-related miRNAs and regulatory mechanisms.	[Seo, Jiyoun; Jin, Daeyong; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwanjgu, South Korea; [Choi, Chan-Hun] Dongshin Univ, Coll Korean Med, Naju Si, Jeollanam Do, South Korea	Gwangju Institute of Science & Technology (GIST); Dongshin University	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwanjgu, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	GIST Research Institute (GRI); National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2016R1A2B2013855]	GIST Research Institute (GRI); National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the GIST Research Institute (GRI) in 2016 and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1A2B2013855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aure MR, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0135-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berezowska S, 2011, CURR PHARM DESIGN, V17, P2468, DOI 10.2174/138161211797249233; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen HC, 2016, TUMOR BIOL, V37, P6761, DOI 10.1007/s13277-015-4575-8; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chu TJ, 2015, BIOINFORMATICS, V31, P1780, DOI 10.1093/bioinformatics/btv038; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui R, 2016, CANCER LETT, V374, P1, DOI 10.1016/j.canlet.2016.01.051; D'Urso PI, 2012, INT J ONCOL, V41, P228, DOI 10.3892/ijo.2012.1420; Da Sacco L, 2013, INT J MOL SCI, V14, P480, DOI 10.3390/ijms14010480; de Olano N, 2012, MOL CANCER RES, V10, P1189, DOI 10.1158/1541-7786.MCR-11-0559; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Guan YL, 2015, INT J CLIN EXP PATHO, V8, P727; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu W, 2012, MOL CELL, V10, P1189; Huret JL, 2000, NUCLEIC ACIDS RES, V28, P349, DOI 10.1093/nar/28.1.349; Jin D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004042; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kendrick N, 2014, GENES MRNA LEVEL DOE; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mao H, 2012, CANCER INVEST, V30, P48, DOI 10.3109/07357907.2011.630050; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rusk N, 2008, NAT METHODS, V5, P122, DOI 10.1038/nmeth0208-122a; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tie XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066008; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voth B, 2015, J CLIN NEUROSCI, V22, P1071, DOI 10.1016/j.jocn.2015.02.002; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wu AH, 2010, CELL ONCOL, V32, P313, DOI 10.3233/CLO-2010-0524; Yang CH, 2014, J BIOL CHEM, V289, P25079, DOI 10.1074/jbc.M114.593863; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Zhang SH, 2011, BIOINFORMATICS, V27, pI401, DOI 10.1093/bioinformatics/btr206; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	65	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168412	10.1371/journal.pone.0168412	http://dx.doi.org/10.1371/journal.pone.0168412			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056026	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100005
J	Zhao, YJ; Xiong, YX; Wang, Y				Zhao, Yi-jiao; Xiong, Yu-xue; Wang, Yong			Three-Dimensional Accuracy of Facial Scan for Facial Deformities in Clinics: A New Evaluation Method for Facial Scanner Accuracy	PLOS ONE			English	Article							CLEFT-LIP; ASYMMETRY; SYMMETRY; PALATE; REPRODUCIBILITY; QUANTIFICATION; ADOLESCENTS; IMAGES; SYSTEM; 2D	In this study, the practical accuracy (PA) of optical facial scanners for facial deformity patients in oral clinic was evaluated. Ten patients with a variety of facial deformities from oral clinical were included in the study. For each patient, a three-dimensional (3D) face model was acquired, via a high-accuracy industrial "line-laser" scanner (Faro), as the reference model and two test models were obtained, via a "stereophotography" (3dMD) and a "structured light" facial scanner (FaceScan) separately. Registration based on the iterative closest point (ICP) algorithm was executed to overlap the test models to reference models, and "3D error" as a new measurement indicator calculated by reverse engineering software (Geomagic Studio) was used to evaluate the 3D global and partial (upper, middle, and lower parts of face) PA of each facial scanner. The respective 3D accuracy of stereophotography and structured light facial scanners obtained for facial deformities was 0.58+/-0.11 mm and 0.57+/-0.07 mm. The 3D accuracy of different facial partitions was inconsistent; the middle face had the best performance. Although the PA of two facial scanners was lower than their nominal accuracy (NA), they all met the requirement for oral clinic use.	[Zhao, Yi-jiao; Xiong, Yu-xue; Wang, Yong] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Zhao, Yi-jiao; Xiong, Yu-xue; Wang, Yong] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Zhao, Yi-jiao; Xiong, Yu-xue; Wang, Yong] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Zhao, Yi-jiao; Xiong, Yu-xue; Wang, Yong] Peking Univ, Ctr Digital Dent, Sch & Hosp Stomatol, Beijing, Peoples R China	Peking University	Wang, Y (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Wang, Y (corresponding author), Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China.; Wang, Y (corresponding author), Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.; Wang, Y (corresponding author), Peking Univ, Ctr Digital Dent, Sch & Hosp Stomatol, Beijing, Peoples R China.	kqcadcs@bjmu.edu.cn			National Natural Science Foundation of China [81300921]; Scientific Research Innovation Foundation for Youth Doctors of Peking University School of Stomatology [pkuss20120207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Innovation Foundation for Youth Doctors of Peking University School of Stomatology	This study was supported by the National Natural Science Foundation of China (Grant No. 81300921) and the Scientific Research Innovation Foundation for Youth Doctors of Peking University School of Stomatology (Grant No. pkuss20120207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hiyali A, 2015, J ORAL MAXIL SURG, V73, P2380, DOI 10.1016/j.joms.2015.05.008; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Artopoulos A, 2014, INT J ORAL MAX SURG, V43, P654, DOI 10.1016/j.ijom.2013.10.005; Benz M, 2005, P ICMP 2005 BMT BERL, P64; Berlin NF, 2014, J CRANIO MAXILL SURG, V42, P265, DOI 10.1016/j.jcms.2013.07.033; Berssenbrugge P, 2014, J CRANIO MAXILL SURG, V42, pE327, DOI 10.1016/j.jcms.2014.01.028; Bilwatsch S, 2006, J CRANIO MAXILL SURG, V34, P253, DOI 10.1016/j.jcms.2006.03.001; Damstra J, 2012, CLIN ORAL INVEST, V16, P285, DOI 10.1007/s00784-011-0512-4; Djordjevic J, 2014, EUR J ORTHODONT, V36, P125, DOI 10.1093/ejo/cjr091; Djordjevic J, 2013, EUR J ORTHODONT, V35, P143, DOI 10.1093/ejo/cjr006; Ferrario VF, 2003, J CRANIOFAC SURG, V14, P739, DOI 10.1097/00001665-200309000-00026; Hartmann J, 2007, J OROFAC ORTHOP, V68, P477, DOI 10.1007/s00056-007-0652-Y; Heike CL, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-18; Kim JY, 2014, J CRANIO MAXILL SURG, V42, P313, DOI 10.1016/j.jcms.2013.05.019; Lane C, 2008, AM J ORTHOD DENTOFAC, V133, P612, DOI 10.1016/j.ajodo.2007.03.023; Liu Yi, 2007, Zhonghua Kou Qiang Yi Xue Za Zhi, V42, P37; Liu Yun-song, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P90; Long L. H., 2008, ZHONGGUO MEI RONG YI, V17, P701; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, P168, DOI DOI 10.1016/J.AJ0D0.2008.11.023; Meyer-Marcotty P, 2011, EUR J ORTHODONT, V33, P647, DOI 10.1093/ejo/cjq146; Nkenke E, 2006, CLEFT PALATE-CRAN J, V43, P129, DOI 10.1597/04-138.1; Primozic J, 2012, ORTHOD CRANIOFAC RES, V15, P237, DOI 10.1111/j.1601-6343.2012.01550.x; Shujaat S, 2014, INT J ORAL MAX SURG, V43, P907, DOI 10.1016/j.ijom.2014.01.010; Toma AM, 2009, ORTHOD CRANIOFAC RES, V12, P33, DOI 10.1111/j.1601-6343.2008.01435.x; Weber DW, 2013, AM J ORTHOD DENTOFAC, V143, P738, DOI 10.1016/j.ajodo.2012.11.026; Wei Yan, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P100; [熊耀阳 XIONG Yao-yang], 2010, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V30, P66; Zhao Yi-jiao, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P76; Zhao YJ, 2016, SHI YONG KOU QIANG Y, V32, P104	30	59	61	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169402	10.1371/journal.pone.0169402	http://dx.doi.org/10.1371/journal.pone.0169402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056044	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100039
J	Ginster, S; Bardet, M; Unterreiner, A; Malinverni, C; Renner, F; Lam, S; Freuler, F; Gerrits, B; Voshol, J; Calzascia, T; Regnier, CH; Renatus, M; Nikolay, R; Israel, L; Bornancin, F				Ginster, Stefanie; Bardet, Maureen; Unterreiner, Adeline; Malinverni, Claire; Renner, Florian; Lam, Stephen; Freuler, Felix; Gerrits, Bertran; Voshol, Johannes; Calzascia, Thomas; Regnier, Catherine H.; Renatus, Martin; Nikolay, Rainer; Israel, Laura; Bornancin, Frederic			Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; T-CELL-ACTIVATION; PARACASPASE MALT1; UBIQUITIN LIGASE; PROTEASE ACTIVITY; LYMPHOMA; CARMA1; BCL10; REGULATOR; PHOSPHORYLATION	The paracaspase MALT1 has arginine-directed proteolytic activity triggered by engagement of immune receptors. Recruitment of MALT1 into activation complexes is required for MALT1 proteolytic function. Here, co-expression of MALT1 in HEK293 cells, either with activated CARD11 and BCL10 or with TRAF6, was used to explore the mechanism of MALT1 activation at the molecular level. This work identified a prominent self-cleavage site of MALT1 isoform A (MALT1A) at R781 (R770 in MALT1B) and revealed that TRAF6 can activate MALT1 independently of the CBM. Intramolecular cleavage at R781/R770 removes a C-terminal TRAF6-binding site in both MALT1 isoforms, leaving MALT1B devoid of the two key interaction sites with TRAF6. A previously identified auto-proteolysis site of MALT1 at R149 leads to deletion of the death-domain, thereby abolishing interaction with BCL10. By using MALT1 isoforms and cleaved fragments thereof, as well as TRAF6 WT and mutant forms, this work shows that TRAF6 induces N-terminal auto-proteolytic cleavage of MALT1 at R149 and accelerates MALT1 protein turnover. The MALT1 fragment generated by N-terminal self-cleavage at R149 was labile and displayed enhanced signaling properties that required an intact K644 residue, previously shown to be a site for mono-ubiquitination of MALT1. Conversely, C-terminal self-cleavage at R781/R770 hampered the ability for self-cleavage at R149 and stabilized MALT1 by hindering interaction with TRAF6. C-terminal self-cleavage had limited impact on MALT1A but severely reduced MALT1B proteolytic and signaling functions. It also abrogated NF-kappa B activation by N-terminally cleaved MALT1A. Altogether, this study provides further insights into mechanisms that regulate the scaffolding and activation cycle of MALT1. It also emphasizes the reduced functional capacity of MALT1B as compared to MALT1A.	[Ginster, Stefanie; Bardet, Maureen; Unterreiner, Adeline; Malinverni, Claire; Renner, Florian; Lam, Stephen; Freuler, Felix; Gerrits, Bertran; Voshol, Johannes; Calzascia, Thomas; Regnier, Catherine H.; Renatus, Martin; Nikolay, Rainer; Israel, Laura; Bornancin, Frederic] Novartis Inst BioMed Res, Novartis Campus, Basel, Switzerland; [Ginster, Stefanie] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Renner, Florian] Janssen Res & Dev, Oncol Discovery, Beerse, Belgium; [Gerrits, Bertran] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Nikolay, Rainer] Charite, Inst Med Phys & Biophys, Berlin, Germany	Novartis; University of Lausanne; Johnson & Johnson; Janssen Pharmaceuticals; Swiss Federal Institutes of Technology Domain; ETH Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bornancin, F (corresponding author), Novartis Inst BioMed Res, Novartis Campus, Basel, Switzerland.	frederic.bornancin@novartis.com	Bornancin, Frederic/AAA-2888-2021	Bornancin, Frederic/0000-0002-0152-6720; Nikolay, Rainer/0000-0003-4713-2548; Regnier, Catherine/0000-0002-4386-1324; Renner, Florian/0000-0003-3326-0303; Calzascia, Thomas/0000-0001-8225-6744				Afonina IS, 2015, FEBS J, V282, P3286, DOI 10.1111/febs.13325; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Baens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103774; Bornancin F, 2015, J IMMUNOL, V194, P3723, DOI 10.4049/jimmunol.1402254; Cabalzar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072051; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Douanne T, 2016, J CELL SCI; Elton L, 2016, FEBS J, V283, P403, DOI 10.1111/febs.13597; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Hailfinger S, 2009, RATIO, P1; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hulpiau P, 2016, CELL MOL LIFE SCI, V73, P1103, DOI 10.1007/s00018-015-2041-9; Jaworski M, 2016, CELL MOL LIFE SCI, V73, P459, DOI 10.1007/s00018-015-2059-z; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Langel FD, 2008, J BIOL CHEM, V283, P32419, DOI 10.1074/jbc.M800670200; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li Y, 2013, PROTEIN CELL, V4, P62, DOI 10.1007/s13238-012-2120-8; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Malinverni C, 2010, BIOCHEM BIOPH RES CO, V400, P543, DOI 10.1016/j.bbrc.2010.08.091; Martinez-Forero I, 2009, CLIN CANCER RES, V15, P6751, DOI 10.1158/1078-0432.CCR-09-1225; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Nagel D, 2015, ONCOTARGET, V6, P42232, DOI 10.18632/oncotarget.6273; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Park Y, 2013, P NATL ACAD SCI USA, V110, P9433, DOI 10.1073/pnas.1221925110; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Perez de Diego R., 2015, J ALLERGY CLIN IMMUN, V1, P1; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rosebeck S, 2011, MALT LYMPHOMA CBM SI, P1; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang KZQ, 2010, J CELL BIOCHEM, V110, P763, DOI 10.1002/jcb.22589; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	53	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169026	10.1371/journal.pone.0169026	http://dx.doi.org/10.1371/journal.pone.0169026			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052131	Green Submitted, gold, Green Published			2022-12-26	WOS:000391621500027
J	Jeeyapant, A; Kingston, HW; Plewes, K; Maude, RJ; Hanson, J; Herdman, MT; Leopold, SJ; Ngernseng, T; Charunwatthanal', P; Phu, H; Ghose, A; Hasan, MMU; Fanello, CI; Faiz, MA; Hien, TT; Day, NPJ; White, NJ; Dondorp, AM				Jeeyapant, Atthanee; Kingston, Hugh W.; Plewes, Katherine; Maude, Richard J.; Hanson, Josh; Herdman, M. Trent; Leopold, Stije J.; Ngernseng, Thatsanun; Charunwatthanal', Prakaykaew; Nguyen Hoan Phu; Ghose, Aniruddha; Hasan, M. Mahtab Uddin; Fanello, Caterina I.; Faiz, Md Abul; Tran Tinh Hien; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.			Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; ADJUNCTIVE THERAPY; CEREBRAL MALARIA; LACTIC-ACIDOSIS; CHILDREN; ADULTS; BRAIN; MANIFESTATIONS	Background Clinical trials in severe falciparum malaria require a large sample size to detect clinically meaningful differences in mortality. This means few interventions can be evaluated at any time. Using a validated surrogate endpoint for mortality would provide a useful alternative allowing a smaller sample size. Here we evaluate changes in coma score and plasma lactate as surrogate endpoints for mortality in severe falciparum malaria. Methods Three datasets of clinical studies in severe malaria were re-evaluated: studies from Chittagong, Bangladesh (adults), the African AQUAMAT' trial comparing artesunate and quinine (children), and the Vietnamese `AQ' study (adults) comparing artemether with quinine. The absolute change, relative change, slope of the normalization over time, and time to normalization were derived from sequential measurements of plasma lactate and coma score, and validated for their use as surrogate endpoint, including the proportion of treatment effect on mortality explained (PTE) by these surrogate measures. Results Improvements in lactate concentration or coma scores over the first 24 hours of admission, were strongly prognostic for survival in all datasets. In hyperlactataemic patients in the AQ study (n = 173), lower mortality with artemether compared to quinine closely correlated with faster reduction in plasma lactate concentration, with a high PTE of the relative change in plasma lactate at 8 and 12 hours of 0.81 and 0.75, respectively. In paediatric patients enrolled in the AQUAMAT' study with cerebral malaria (n = 785), mortality was lower with artesunate compared to quinine, but this was not associated with faster coma recovery. Conclusions The relative changes in plasma lactate concentration assessed at 8 or 12 hours after admission are valid surrogate endpoints for severe malaria studies on antimalarial drugs or adjuvant treatments aiming at improving the microcirculation. Measures of coma recovery are not valid surrogate endpoints for mortality.	[Jeeyapant, Atthanee; Kingston, Hugh W.; Plewes, Katherine; Maude, Richard J.; Hanson, Josh; Herdman, M. Trent; Leopold, Stije J.; Ngernseng, Thatsanun; Charunwatthanal', Prakaykaew; Fanello, Caterina I.; Faiz, Md Abul; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Kingston, Hugh W.] Charles Darwin Univ, Darwin, NT, Australia; [Kingston, Hugh W.; Plewes, Katherine; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Hanson, Josh] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Herdman, M. Trent] Univ Coll, Oxford, England; [Charunwatthanal', Prakaykaew] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Nguyen Hoan Phu; Tran Tinh Hien] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Ghose, Aniruddha; Hasan, M. Mahtab Uddin] Chittagong Med Coll Hosp, Dept Med, Chittagong, Bangladesh; [Fanello, Caterina I.] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Faiz, Md Abul] Dev Care Fdn, Malaria Res Grp, Dhaka, Bangladesh	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Charles Darwin University; University of Oxford; Charles Darwin University; Menzies School of Health Research; University of Oxford; Mahidol University; University of Oxford; Chittagong Medical College; Universite de Kinshasa	Dondorp, AM (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Dondorp, AM (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	arjen@tropmedres.ac	Fanello, Caterina/AAT-9679-2021; White, Nick/AAC-6527-2019; Maude, Richard James/AAV-3567-2020; Hanson, Josh/ABD-9328-2020	Fanello, Caterina/0000-0003-1932-9562; White, Nick/0000-0002-1897-1978; Maude, Richard James/0000-0002-5355-0562; Leopold, Stije J./0000-0002-0482-5689; Hanson, Josh/0000-0002-1423-3839	Wellcome Trust of Great Britain (MOP Thailand Core Award) [106698/B14/Z]; National Institute for Health Research [ACF-2014-18-007] Funding Source: researchfish	Wellcome Trust of Great Britain (MOP Thailand Core Award); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Wellcome Trust of Great Britain (MOP Thailand Core Award), grant number: 106698/B14/Z (title: Wellcome Trust of Great Britain, MOP Thailand Core award 2015-2020, Wellcome Trust of Great Britain).	Agbenyega T, 2003, J CLIN PHARMACOL, V43, P386, DOI 10.1177/0091270003251392; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Atta H, 2014, E MEDITERR HEALTH J, V20, P219, DOI 10.26719/2014.20.4.219; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Curley Martha A Q, 2005, Pediatr Crit Care Med, V6, pS150, DOI 10.1097/01.PCC.0000161582.63265.B6; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Hanson J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0365-9; Hanson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087020; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hanson JP, 2013, CRIT CARE MED, V41, P972, DOI 10.1097/CCM.0b013e31827466d2; Hawkes M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-176; Hawkes MT, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0946-2; Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409; Held J, 2015, EXPERT OPIN INV DRUG, V24, P363, DOI 10.1517/13543784.2015.1000483; Hien TT, 2003, LANCET, V362, P295, DOI 10.1016/S0140-6736(03)13974-8; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Huang J, 2010, STAT BIOPHARM RES, V2, P229, DOI 10.1198/sbr.2009.0070; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; Maude RJ, 2014, J INFECT DIS, V209, P120, DOI 10.1093/infdis/jit410; Maude RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027273; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-177; McCall MBB, 2006, T ROY SOC TROP MED H, V100, P1098, DOI 10.1016/j.trstmh.2006.02.017; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Mohanty S, 2006, INDIAN J MED RES, V124, P245; Mohanty S, 2011, CLIN INFECT DIS, V53, P349, DOI 10.1093/cid/cir405; Plewes K, PARACETAMOL EFFECT O; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Smith H.J., COCHRANE DB SYST REV, V2, P2003, DOI [10.1002/14651858.CD001474, DOI 10.1002/14651858.CD001474]; Van Geloven N, 2012, HUM REPROD, V27, P889, DOI 10.1093/humrep/der456; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069587	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169307	10.1371/journal.pone.0169307	http://dx.doi.org/10.1371/journal.pone.0169307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052109	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500045
J	Masuyama, K; Shojo, H; Nakanishi, H; Inokuchi, S; Adachi, N				Masuyama, Kotoka; Shojo, Hideki; Nakanishi, Hiroaki; Inokuchi, Shota; Adachi, Noboru			Sex Determination from Fragmented and Degenerated DNA by Amplified Product-Length Polymorphism Bidirectional SNP Analysis of Amelogenin and SRY Genes	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; ANCIENT DNA; ENZYMATIC AMPLIFICATION; GENDER IDENTIFICATION; DEOXYRIBONUCLEIC-ACID; POPULATION-SAMPLE; PCR AMPLIFICATION	Sex determination is important in archeology and anthropology for the study of past societies, cultures, and human activities. Sex determination is also one of the most important components of individual identification in criminal investigations. We developed a new method of sex determination by detecting a single-nucleotide polymorphism in the amelogenin gene using amplified product-length polymorphisms in combination with sex-determining region Y analysis. We particularly focused on the most common types of postmortem DNA damage in ancient and forensic samples: fragmentation and nucleotide modification resulting from deamination. Amplicon size was designed to be less than 60 bp to make the method more useful for analyzing degraded DNA samples. All DNA samples collected from eight Japanese individuals (four male, four female) were evaluated correctly using our method. The detection limit for accurate sex determination was determined to be 20 pg of DNA. We compared our new method with commercial short tandem repeat analysis kits using DNA samples artificially fragmented by ultraviolet irradiation. Our novel method was the most robust for highly fragmented DNA samples. To deal with allelic dropout resulting from deamination, we adopted "bidirectional analysis," which analyzed samples from both sense and antisense strands. This new method was applied to 14 Jomon individuals (3500-year-old bone samples) whose sex had been identified morphologically. We could correctly identify the sex of 11 out of 14 individuals. These results show that our method is reliable for the sex determination of highly degenerated samples.	[Masuyama, Kotoka; Shojo, Hideki; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Chuo Ku, Yamanashi, Japan; [Nakanishi, Hiroaki; Inokuchi, Shota] Juntendo Univ, Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo, Japan	University of Yamanashi; Juntendo University	Shojo, H; Adachi, N (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Chuo Ku, Yamanashi, Japan.	hshohjoh@yamanashi.ac.jp; nadachi@yamanashi.ac.jp			Japan Society for the Promotion of Science [26440257, 25251043, 16H01954]; JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North"	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North"	The work by Noboru Adachi was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (26440257, 25251043, 16H01954), and JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work by NA was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26440257, 25251043, 16H01954), and JSPS Core to Core Program (Advanced Research Networks) "Advanced Core Research Center for the History of Human Ecology in the North."	Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; AKANE A, 1991, FORENSIC SCI INT, V49, P81, DOI 10.1016/0379-0738(91)90174-H; Aoshima T, 1998, ELECTROPHORESIS, V19, P659, DOI 10.1002/elps.1150190508; Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; BERKOVITZ GD, 1992, HUM GENET, V88, P411, DOI 10.1007/BF00215675; Binladen J, 2007, BIOTECHNIQUES, V42, P172, DOI 10.2144/000112316; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Cadenas AM, 2007, FORENSIC SCI INT, V166, P155, DOI 10.1016/j.forsciint.2006.05.002; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Chang YM, 2007, FORENSIC SCI INT, V166, P115, DOI 10.1016/j.forsciint.2006.04.013; Chen WJ, 2014, FORENSIC SCI INT-GEN, V8, P73, DOI 10.1016/j.fsigen.2013.07.003; Drobni K., 2006, INT CONGR SER, V1288, P268, DOI [10.1016/j.ics.2005.08.020, DOI 10.1016/J.ICS.2005.08.020]; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; HaasRochholz H, 1997, INT J LEGAL MED, V110, P312, DOI 10.1007/s004140050094; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Honda H, 2001, CLIN CHEM, V47, P41; Kakuda T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158463; Kashyap VK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-37; Lamers R, 2009, J MOL EVOL, V68, P40, DOI 10.1007/s00239-008-9184-3; Lattanzi W, 2005, HUM GENET, V116, P395, DOI 10.1007/s00439-004-1238-z; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1973, BIOCHEMISTRY-US, V12, P5151, DOI 10.1021/bi00749a020; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Ma Y, 2012, INT J LEGAL MED, V126, P713, DOI 10.1007/s00414-012-0720-8; Michael A, 2004, J FORENSIC SCI, V49, P258; Mitchell RJ, 2006, ANN HUM BIOL, V33, P227, DOI 10.1080/03014460600594620; Nakanishi H, 2015, INT J LEGAL MED, V129, P23, DOI 10.1007/s00414-014-1065-2; NEESER D, 1995, J FORENSIC SCI, V40, P239; Olivieri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008629; Ou XL, 2012, INT J LEGAL MED, V126, P513, DOI 10.1007/s00414-011-0594-1; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Parkin EJ, 2007, FORENSIC SCI INT, V166, P176, DOI 10.1016/j.forsciint.2006.05.007; Parkin EJ, 2006, FORENSIC SCI INT, V161, P1, DOI 10.1016/j.forsciint.2005.10.008; Pfoser K, EVALUATION POWERPLEX; Reynolds R, 1996, J FORENSIC SCI, V41, P279; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Shojo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136995; Stacks B, 1996, J FORENSIC SCI, V41, P287; Steinlechner M, 2002, INT J LEGAL MED, V116, P117, DOI 10.1007/s00414-001-0264-9; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Sun XJ, 2010, J ORG CHEM, V75, P1848, DOI 10.1021/jo9023683; Takayama T., 2009, LEG MED, V11, P578; Thangaraj K, 2002, INT J LEGAL MED, V116, P121, DOI 10.1007/s00414-001-0262-y; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; Watanabe G, 1997, HUM GENET, V99, P34; Watanabe G, 2001, ELECTROPHORESIS, V22, P418; Watanabe G, 1999, INT J LEGAL MED, V112, P134, DOI 10.1007/s004140050216; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wei T, 2008, J VIROL METHODS, V153, P16, DOI 10.1016/j.jviromet.2008.06.020; WITT M, 1989, HUM GENET, V82, P271, DOI 10.1007/BF00291168; Yamazaki S, 2009, PHYS CHEM CHEM PHYS, V11, P10165, DOI 10.1039/b913131k; Yong RYY, 2007, HUM GENET, V122, P237, DOI 10.1007/s00439-007-0389-0	60	9	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169348	10.1371/journal.pone.0169348	http://dx.doi.org/10.1371/journal.pone.0169348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052096	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500051
J	Rombouts, SJE; Nijkamp, MW; van Dijck, WPM; Brosens, LAA; Konings, M; van Hillegersberg, R; Rinkes, IHMB; Hagendoom, J; Wittkamp, FH; Molenaar, IQ				Rombouts, Steffi J. E.; Nijkamp, Maarten W.; van Dijck, Willemijn P. M.; Brosens, Lodewijk A. A.; Konings, Maurits; van Hillegersberg, R.; Rinkes, Inne H. M. Borel; Hagendoom, Jeroen; Wittkamp, Fred H.; Molenaar, I. Quintus			Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; PHASE-III; GEMCITABINE; OXALIPLATIN; SURVIVAL; MODALITY; CANCER; SAFETY	Background Irreversible electroporation (IRE) with needle electrodes is being explored as treatment option in locally advanced pancreatic cancer. Several studies have shown promising results with IRE needles, positioned around the tumor to achieve tumor ablation. Disadvantages are the technical difficulties for needle placement, the time needed to achieve tumor ablation, the risk of needle track seeding and most important the possible occurrence of postoperative pancreatic fistula via the needle tracks. The aim of this experimental study was to evaluate the feasibility of a new IRE-technique using two parallel plate electrodes, in a porcine model. Methods Twelve healthy pigs underwent laparotomy. The pancreas was mobilized to enable positioning of the paddles. A standard monophasic external cardiac defibrillator was used to perform an ablation in 3 separate parts of the pancreas; either a single application of 50 or 100J or a serial application of 4x50J. After 6 hours, pancreatectomy was performed for histology and pigs were terminated. Results Histology showed necrosis of pancreatic parenchyma with neutrophil influx in 5/12, 11/12 and 12/12 of the ablated areas at 50, 100, and 4x50J respectively. The electric current density threshold to achieve necrosis was 4.3, 5.1 and 3.4 A/cm(2) respectively. The ablation threshold was significantly lower for the serial compared to the single applications (p = 0.003). The content of the ablated areas differed between the applications: areas treated with a single application of 50 J often contained vital areas without obvious necrosis, whereas half of the sections treated with 100 J showed small islands of normal looking cells surrounded by necrosis, while all sections receiving 4x50 J showed a homogeneous necrotic lesion. Conclusion Pancreatic tissue can be successfully ablated using two parallel paddles around the tissue. A serial application of 4x50J was most effective in creating a homogeneous necrotic lesion.	[Rombouts, Steffi J. E.; Nijkamp, Maarten W.; van Dijck, Willemijn P. M.; van Hillegersberg, R.; Rinkes, Inne H. M. Borel; Hagendoom, Jeroen; Molenaar, I. Quintus] Univ Med Ctr Utrecht, Ctr Canc, Dept Surg, Utrecht, Netherlands; [Brosens, Lodewijk A. A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Konings, Maurits] Univ Med Ctr Utrecht, Dept Innovat Res, Utrecht, Netherlands; [Wittkamp, Fred H.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Rombouts, SJE (corresponding author), Univ Med Ctr Utrecht, Ctr Canc, Dept Surg, Utrecht, Netherlands.	s.j.e.rombouts@umcutrecht.nl	Brosens, Lodewijk A.A./E-8792-2018	Brosens, Lodewijk A.A./0000-0003-1341-8994				Bower M, 2011, J SURG ONCOL, V104, P22, DOI 10.1002/jso.21899; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cantore M, 2012, BRIT J SURG, V99, P1083, DOI 10.1002/bjs.8789; Charpentier KP, 2010, HPB, V12, P348, DOI 10.1111/j.1477-2574.2010.00174.x; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; du Pre BC, 2013, EUROPACE, V15, P144, DOI 10.1093/europace/eus171; Fritz S, 2015, PANCREAS, V44, P791, DOI 10.1097/MPA.0000000000000331; Girelli R, 2013, LANGENBECK ARCH SURG, V398, P63, DOI 10.1007/s00423-012-1011-z; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Martin RCG, 2015, ANN SURG, V262, P486, DOI 10.1097/SLA.0000000000001441; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Moss RA, 2010, ONCOTARGETS THER, V3, P111; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; Rombouts SJ, 2016, ANN SURG ONCOL, V4; Rombouts SJE, 2015, BRIT J SURG; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Thomson KR, 2015, TECH VASC INTERV RAD, V18, P128, DOI 10.1053/j.tvir.2015.06.002; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Weaver J C, 1998, J Investig Dermatol Symp Proc, V3, P143; Wiersinga WJ, 2003, BRIT J SURG, V90, P306, DOI 10.1002/bjs.4040; Wu YL, 2006, J SURG ONCOL, V94, P392, DOI 10.1002/jso.20580	25	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169396	10.1371/journal.pone.0169396	http://dx.doi.org/10.1371/journal.pone.0169396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052102	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500057
J	Wang, P; Wang, YN; Tang, WZ; Wang, XX; Pang, YN; Yang, S; Wei, YB; Gao, HC; Wang, DL; Cao, ZZ				Wang, Pei; Wang, Yanen; Tang, Weizhong; Wang, Xingxing; Pang, Yanan; Yang, Su; Wei, Yibo; Gao, Haochen; Wang, Dalin; Cao, Zhizhong			Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway	PLOS ONE			English	Article							GENE-THERAPY; TGF-BETA; ACTIVATION; RECEPTORS; KINASE; P38; SIGNALS; ERK1/2; BMP; PHOSPHORYLATION	Bone morphogenetic protein-9 (BMP9) shows great osteoinductive potential in bone regeneration. Periodontal ligament stem cells (PDLSCs) with multi-differentiation capability and low immunogenicity are increasingly used as seed cells for periodontal regenerative therapies. In the present study, we investigated the potent osteogenic activity of BMP9 on human PDLSCs (hPDLSCs), in which the c-Jun N-terminal kinase (JNK) pathway is possibly involved. Our results showed that JNK inhibition by the specific inhibitor SP600125 or adenovirus expressing small interfering RNA (siRNA) targeting JNK (AdR-si-JNK) significantly decreased BMP9-induced gene and protein expression of early and late osteogenic markers, such as runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN), in hPDLSCs. We also confirmed the in-vivo positive effect of JNKs on ectopic bone formation induced by hPDLSCs injected into the musculature of athymic nude mice and BMP9 ex vivo gene delivery. For the cellular mechanism, we found that BMP9 activated the phosphorylation of JNKs and Smad2/3, and that JNKs may engage in cross-talk with the Smad2/3 pathway in BMP9-mediated osteogenesis.	[Wang, Pei; Wang, Yanen; Tang, Weizhong; Wang, Xingxing; Yang, Su; Wei, Yibo; Gao, Haochen; Wang, Dalin; Cao, Zhizhong] Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai, Peoples R China; [Pang, Yanan] Second Mil Med Univ, Changhai Hosp, Clin Res Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, DL; Cao, ZZ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai, Peoples R China.	13651750632wtt@sina.com; jiuyehui521@sina.cn			Science and Technology Commission of Shanghai Municipality [13411951202, 09ZR1400200]; Natural Science Foundation of China [81170987]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Science and Technology Commission of Shanghai Municipality (No.13411951202 and NO. 09ZR1400200), and the Natural Science Foundation of China (NO. 81170987). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Science and Technology Commission of Shanghai Municipality (No.13411951202 and NO. 09ZR1400200), and the Natural Science Foundation of China (NO. 81170987).	Alvarez R, 2015, INT J ORAL SCI, V7, P213, DOI 10.1038/ijos.2015.42; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1097/00006123-200211000-00020; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Fujioka-Kobayashi M, 2016, J PERIODONTOL, V87, pE101, DOI 10.1902/jop.2016.150561; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hakki SS, 2014, J BIOMED MATER RES B, V102, P119, DOI 10.1002/jbm.b.32988; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li CH, 2012, INT J MED SCI, V9, P862, DOI 10.7150/ijms.5027; Liu H, 2011, J BONE MINER RES, V26, P1122, DOI 10.1002/jbmr.296; Liu L, 2009, J ENDODONT, V35, P1368, DOI 10.1016/j.joen.2009.07.005; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Qin W, 2014, CONNECT TISSUE RES, V55, P217, DOI 10.3109/03008207.2014.882331; Scaduto AA, 1999, ORTHOP CLIN N AM, V30, P625, DOI 10.1016/S0030-5898(05)70115-2; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Wang Y, 2013, J ORTHOP RES, V31, P1796, DOI 10.1002/jor.22427; Wu NN, 2010, ACTA BIOCH BIOPH SIN, V42, P699, DOI 10.1093/abbs/gmq075; Xiang L, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/610952; Xu DJ, 2012, BMB REP, V45, P247, DOI 10.5483/BMBRep.2012.45.4.247; Xu JP, 2009, STEM CELLS DEV, V18, P487, DOI 10.1089/scd.2008.0113; Ye G, 2014, INT J MED SCI, V11, P1065, DOI 10.7150/ijms.8473; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; Zhao YF, 2013, BMB REP, V46, P422, DOI 10.5483/BMBRep.2013.46.8.266	39	17	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169123	10.1371/journal.pone.0169123	http://dx.doi.org/10.1371/journal.pone.0169123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052093	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500034
J	Xin, ZG; Huang, J; Smith, AR; Chen, JP; Burke, J; Sattler, SE; Zhao, DZ				Xin, Zhanguo; Huang, Jian; Smith, Ashley R.; Chen, Junping; Burke, John; Sattler, Scott E.; Zhao, Dazhong			Morphological Characterization of a New and Easily Recognizable Nuclear Male Sterile Mutant of Sorghum (Sorghum bicolor)	PLOS ONE			English	Article							POLLEN FERTILITY RESTORATION; GENOME-WIDE ASSOCIATION; ANTHER DEVELOPMENT; GENE ENCODES; L. MOENCH; TAPETUM; ARABIDOPSIS; POPULATION; PROTEIN; PLANTS	Sorghum (Sorghum bicolor L. Moench) is one of the most important grain crops in the world. The nuclear male sterility (NMS) trait, which is caused by mutations on the nuclear gene, is valuable for hybrid breeding and genetic studies. Several NMS mutants have been reported previously, but none of them were well characterized. Here, we present our detailed morphological characterization of a new and easily recognizable NMS sorghum mutant male sterile 8 (ms8) isolated from an elite inbred BTx623 mutagenized by ethyl methane sulfonate (EMS). Our results show that the ms8 mutant phenotype was caused by a mutation on a single recessive nuclear gene that is different from all available NMS loci reported in sorghum. In fertile sorghum plants, yellow anthers appeared first during anthesis, while in the ms8 mutant, white hairy stigma emerged first and only small white anthers were observed, making ms8 plants easily recognizable when flowering. The ovary development and seed production after manual pollination are normal in the ms8 mutant, indicating it is female fertile and male sterile only. We found that ms8 anthers did not produce pollen grains. Further analysis revealed that ms8 anthers were defective in tapetum development, which led to the arrest of pollen formation. As a stable male sterile mutant across different environments, greenhouses, and fields in different locations, the ms8 mutant could be a useful breeding tool. Moreover, ms8 might be an important for elucidating male gametophyte development in sorghum and other plants.	[Xin, Zhanguo; Chen, Junping; Burke, John] USDA ARS, Plant Stress & Germplasm Dev Unit, Lubbock, TX USA; [Huang, Jian; Smith, Ashley R.; Zhao, Dazhong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Sattler, Scott E.] USDA ARS PA Grain, Forage & Bioenergy Res Unit, 251 Filley Hall Food Ind Complex, Lincoln, NE USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Milwaukee	Zhao, DZ (corresponding author), Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA.	dzhao@uwm.edu	Smith, Ashley/GZB-0298-2022; /CAH-4560-2022	Huang, Jian/0000-0001-9167-1421; Sattler, Scott/0000-0002-6814-4073; Xin, Zhanguo/0000-0003-1471-7785	National Science Foundation [IOS-0721192, IOS-1322796]; Research Growth Initiative (RGI) at the University of Wisconsin-Milwaukee; UW-Madison/UW-Milwaukee Intercampus Research Incentive Grants Program; Shaw Scientist Award from the Greater Milwaukee Foundation; Bradley Catalyst Award from the UWM Research Foundation; Direct For Biological Sciences [1322796] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Research Growth Initiative (RGI) at the University of Wisconsin-Milwaukee; UW-Madison/UW-Milwaukee Intercampus Research Incentive Grants Program; Shaw Scientist Award from the Greater Milwaukee Foundation; Bradley Catalyst Award from the UWM Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partially supported by the National Science Foundation (IOS-0721192 and IOS-1322796), the Research Growth Initiative (RGI) at the University of Wisconsin-Milwaukee, and the UW-Madison/UW-Milwaukee Intercampus Research Incentive Grants Program to DZ. DZ also thankfully acknowledges supports of the Shaw Scientist Award from the Greater Milwaukee Foundation and the Bradley Catalyst Award from the UWM Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DJ, 1971, CROP SCI, V11, P308, DOI 10.2135/cropsci1971.0011183X001100020046x; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Ayyangar GNR, 1942, INDIAN J AGR SCI, V12, P529; BARABAS Z, 1962, NATURE, V195, P257, DOI 10.1038/195257a0; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Clement C, 2001, BOT REV, V67, P54, DOI 10.1007/BF02857849; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Dong NV, 2000, THEOR APPL GENET, V100, P727, DOI 10.1007/s001220051345; Dudley JW, 2004, CROP SCI, V44, P1419, DOI 10.2135/cropsci2004.1419; ELLSTRAND NC, 1983, THEOR APPL GENET, V66, P323, DOI 10.1007/BF00251167; Ferreira SD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-210; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Hsieh K, 2007, PLANT CELL, V19, P582, DOI 10.1105/tpc.106.049049; Huang J, 2016, PLOS GENET IN PRESS; Huang J, 2016, FRONT PLANT SCI, V7; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jia GX, 2008, P NATL ACAD SCI USA, V105, P2220, DOI 10.1073/pnas.0708795105; Jordan DR, 2011, THEOR APPL GENET, V123, P383, DOI 10.1007/s00122-011-1591-y; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; PACINI E, 1985, PLANT SYST EVOL, V149, P155, DOI 10.1007/BF00983304; Packer DJ, 2011, FIELD CROP RES, V123, P47, DOI 10.1016/j.fcr.2011.04.013; Parish RW, 2012, FUNCT PLANT BIOL, V39, P553, DOI 10.1071/FP12090; Parish RW, 2010, PLANT SCI, V178, P73, DOI 10.1016/j.plantsci.2009.11.001; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pedersen JF, 2001, CROP SCI, V41, P607, DOI 10.2135/cropsci2001.412607x; Perez-Vich B, 2005, CROP SCI, V45, P1851, DOI 10.2135/cropsci2004.0684; Praveen M, 2015, PLANT SCI, V238, P73, DOI 10.1016/j.plantsci.2015.05.020; Recker JR, 2013, CROP SCI, V53, P1375, DOI 10.2135/cropsci2012.10.0573; Rhodes DH, 2014, J AGR FOOD CHEM, V62, P10916, DOI 10.1021/jf503651t; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Upadhyaya HD, 2009, CROP SCI, V49, P1769, DOI 10.2135/cropsci2009.01.0014; Walbot V, 2016, ANNU REV PLANT BIOL, V67, P365, DOI 10.1146/annurev-arplant-043015-111804; Xin Z, 2012, PLANT GENETICS GENOM, P169; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Zhang DB, 2014, CURR OPIN PLANT BIOL, V17, P49, DOI 10.1016/j.pbi.2013.11.001; Zhang H, 2013, P NATL ACAD SCI USA, V110, P76, DOI 10.1073/pnas.1213041110; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhao DZ, 2009, SEX PLANT REPROD, V22, P221, DOI 10.1007/s00497-009-0106-3; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902	44	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0165195	10.1371/journal.pone.0165195	http://dx.doi.org/10.1371/journal.pone.0165195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052078	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500004
J	Zhao, B; Hu, W; Kumar, S; Gonyo, P; Rana, U; Liu, Z; Wang, B; Duong, WQ; Yang, Z; Williams, CL; Miao, QR				Zhao, B.; Hu, W.; Kumar, S.; Gonyo, P.; Rana, U.; Liu, Z.; Wang, B.; Duong, W. Q.; Yang, Z.; Williams, C. L.; Miao, Q. R.			The Nogo-B receptor promotes Ras plasma membrane localization and activation	ONCOGENE			English	Article							UNDECAPRENYL PYROPHOSPHATE SYNTHASE; MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; H-RAS; K-RAS; MALIGNANT-TRANSFORMATION; DRUG-RESISTANCE; FAMILY PROTEINS; PDE-DELTA; IN-VITRO	The localization of prenylated Ras at the plasma membrane promotes activation of Ras by receptor tyrosine kinases and stimulates oncogenic signaling by mutant Ras. The Nogo-B receptor (NgBR) is a transmembrane receptor that contains a conserved hydrophobic pocket. Here, we demonstrate that the NgBR promotes the membrane accumulation of Ras by directly binding prenylated Ras at the plasma membrane. We show that NgBR knockdown diminishes the membrane localization of Ras in multiple cell types. NgBR overexpression in NIH-3T3 fibroblasts increases membrane-associated Ras, induces the transformed phenotype in vitro, and promotes the formation of fibrosarcoma in nude mice. NgBR knockdown in human breast cancer cells reduces Ras membrane localization, inhibits epidermal growth factor (EGF)-stimulated Ras signaling and diminishes tumorigenesis of xenografts in nude mice. Our data demonstrate that NgBR is a unique receptor that promotes accumulation of prenylated Ras at the plasma membrane and promotes EGF pathways.	[Zhao, B.; Hu, W.; Rana, U.; Liu, Z.; Wang, B.; Duong, W. Q.; Miao, Q. R.] Med Coll Wisconsin, Dept Surg, Childrens Res Inst, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Zhao, B.; Hu, W.; Kumar, S.; Rana, U.; Liu, Z.; Wang, B.; Duong, W. Q.; Miao, Q. R.] Med Coll Wisconsin, Dept Pathol, Childrens Res Inst, Div Pediat Pathol, Milwaukee, WI 53226 USA; [Zhao, B.] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci, Dalian, Liaoning, Peoples R China; [Gonyo, P.; Williams, C. L.; Miao, Q. R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Wang, B.] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China; [Yang, Z.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Medical College of Wisconsin; Medical College of Wisconsin; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Medical College of Wisconsin; China-Japan Friendship Hospital; Wayne State University	Miao, QR (corresponding author), Med Coll Wisconsin, Dept Surg & Pathol, Childrens Res Inst, Div Pediat Surg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Miao, QR (corresponding author), Med Coll Wisconsin, Dept Surg & Pathol, Childrens Res Inst, Div Pediat Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	qmiao@mcw.edu	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238; Duong, William/0000-0002-2879-8590	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); AHA [SDG 0730079N]; NIH [R01HL108938, R01 CA188871, R01HL128647]; American Cancer Society [86-004-26]; Kathy Duffey Fogarty Award for breast cancer research; Children's Hospital of Wisconsin Research Institute Pilot Innovative Research Grant; AHA postdoctoral fellowship [13POST13940002, 11POST5690035]; China State Key Basic Research Program [2016YFA0501401]; Hundred Talents Program of CAS; Rock River Cancer Research Foundation; Division of Pediatric Pathology, Medical College of Wisconsin; Advancing a Healthier Wisconsin endowment; Wisconsin Breast Cancer Showhouse (WBCS); We Care Fund; NATIONAL CANCER INSTITUTE [R01CA188871] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108938, R01HL128647] Funding Source: NIH RePORTER	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Kathy Duffey Fogarty Award for breast cancer research; Children's Hospital of Wisconsin Research Institute Pilot Innovative Research Grant; AHA postdoctoral fellowship(American Heart Association); China State Key Basic Research Program; Hundred Talents Program of CAS(Chinese Academy of Sciences); Rock River Cancer Research Foundation; Division of Pediatric Pathology, Medical College of Wisconsin; Advancing a Healthier Wisconsin endowment; Wisconsin Breast Cancer Showhouse (WBCS); We Care Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr John Hancock at University of Texas Health Science Center at Houston generously provided pEGFP-C1 vector. This work is supported in part by start-up funds from Division of Pediatric Surgery and Division of Pediatric Pathology, Medical College of Wisconsin (MCW) and Advancing a Healthier Wisconsin endowment to MCW, AHA SDG 0730079N, NIH R01HL108938, Wisconsin Breast Cancer Showhouse (WBCS), Institutional Research Grant # 86-004-26 from the American Cancer Society, We Care Fund, Kathy Duffey Fogarty Award for breast cancer research, State of Wisconsin Tax Check-off program for breast & prostate cancer research and Children's Hospital of Wisconsin Research Institute Pilot Innovative Research Grant to QRM., AHA postdoctoral fellowship 13POST13940002 and 11POST5690035, China State Key Basic Research Program Grant 2016YFA0501401 and the support from the Hundred Talents Program of CAS to BZ. Additional support was provided by NIH R01 CA188871 (CLW), the Rock River Cancer Research Foundation (CLW), and the Nancy Laning Sobczak, PhD., Breast Cancer Research Award (CLW), NIH R01HL128647 (ZY).	Abramovitz A, 2012, BIOCHEMISTRY-US, V51, P715, DOI 10.1021/bi201211v; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bernhard EJ, 1998, CANCER RES, V58, P1754; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chang SY, 2004, PROTEIN SCI, V13, P971, DOI 10.1110/ps.03519904; Chen APC, 2005, BIOCHEM J, V386, P169, DOI 10.1042/BJ20040785; CLARK R, 1988, CANCER RES, V48, P4689; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; DATI C, 1991, INT J CANCER, V47, P833, DOI 10.1002/ijc.2910470607; DEFEO D, 1981, P NATL ACAD SCI-BIOL, V78, P3328, DOI 10.1073/pnas.78.6.3328; Dong CY, 2016, ONCOTARGET, V7, P8850, DOI 10.18632/oncotarget.7091; GUNZBURG WH, 1988, CARCINOGENESIS, V9, P1849, DOI 10.1093/carcin/9.10.1849; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Miyakis S, 1998, BIOCHEM BIOPH RES CO, V251, P609, DOI 10.1006/bbrc.1998.9527; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Omerovic J, 2009, FEBS J, V276, P1817, DOI 10.1111/j.1742-4658.2009.06928.x; Parish CA, 1997, BIOCHEMISTRY-US, V36, P2686, DOI 10.1021/bi961844r; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Rana U, 2016, DEV BIOL, V410, P190, DOI 10.1016/j.ydbio.2015.12.023; REDMOND SMS, 1988, ONCOGENE, V2, P259; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schmick M, 2015, TRENDS CELL BIOL, V25, P190, DOI 10.1016/j.tcb.2015.02.004; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078083; WATSON DMA, 1991, BREAST CANCER RES TR, V17, P161, DOI 10.1007/BF01806365; Weise K, 2013, FARADAY DISCUSS, V161, P549, DOI 10.1039/c2fd20100c; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhao B, BLOOD, V116, P5423; Zhao BF, 2015, J PROTEOMICS, V112, P38, DOI 10.1016/j.jprot.2014.08.007; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	71	21	22	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3406	3416		10.1038/onc.2016.484	http://dx.doi.org/10.1038/onc.2016.484			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28068323	Green Accepted			2022-12-26	WOS:000403340700005
J	Wang, YL; Wang, LM; Xue, JJ; Dong, JB; Cai, J; Hua, XD; Wang, MH; Zhang, CZ; Liu, FQ				Wang, Yulong; Wang, Limin; Xue, Juanjuan; Dong, Jinbo; Cai, Jia; Hua, Xiude; Wang, Minghua; Zhang, Cunzheng; Liu, Fengquan			Signal-Amplified Lateral Flow Test Strip for Visual Detection of Cu2+	PLOS ONE			English	Article							UNMODIFIED GOLD NANOPARTICLES; TEMPLATED CLICK CHEMISTRY; COLORIMETRIC DETECTION; COPPER(II) IONS; FLUORESCENT DETECTION; BIOSENSOR; CADMIUM; DNAZYME; LIGATION; SENSORS	A signal-amplified lateral flow test strip (SA-LFTS) for the detection of Cu2+ in aqueous solution was constructed based on Cutcatalyzed click chemistry and hybridization of single stranded DNA (ssDNA). Alkyne and azide modified ssDNA acted as specific elements for Cu2+ recognition, and a chemical ligation product formed through Cutcatalyzed alkyneazide cycloaddition. Hybridization of ssDNA-labeled gold nanoparticles resulted in high sensitivity, and the output signal could be observed directly by the naked eye. Using the developed SA-LFTS under optimal conditions, Cu2+ could be detected rapidly with limit of detections of 5 nM and 4.2 nM by visual observation and quantitative analysis, respectively. The sensitivity (i.e. the visual limit of detection) of the SA-LFTS was 80-times higher than that of traditional LFTS. The SA-LFTS was applied to the determination of Cu2+ in municipal water and river water samples with the results showing good recovery and accuracy. The developed test strip is promising for point-of-care applications and detection of Cu2+ in the field.	[Wang, Yulong; Liu, Fengquan] Nanjing Agr Univ, Jiangsu Acad Agr Sci, Inst Plant Protect, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Wang, Limin; Xue, Juanjuan; Dong, Jinbo; Cai, Jia; Hua, Xiude; Wang, Minghua; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhang, Cunzheng] Jiangsu Acad Agr Sci, Inst Food Qual Safety & Detect Res, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Jiangsu Acad Agr Sci, Inst Plant Protect, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.; Wang, LM; Liu, FQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	wlm@njau.edu.cn; fqliu20011@sina.com			Natural Science Foundation of Jiangsu Province [BK20140685]; National High Technology Research and Development Program of China [2012AA101401-1, 2013AA065601]; National Natural Science Foundation of China [31401771]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140685), the National High Technology Research and Development Program of China (2012AA101401-1, 2013AA065601), and the National Natural Science Foundation of China (31401771).	Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P217, DOI 10.1081/CLT-100102421; Brewer GJ, 2009, J AM COLL NUTR, V28, P238, DOI 10.1080/07315724.2009.10719777; Brown DR, 2004, DALTON T, P1907, DOI 10.1039/b401985g; Carmi N, 2001, BIOORGAN MED CHEM, V9, P2589, DOI 10.1016/S0968-0896(01)00035-9; Chan MS, 2000, TALANTA, V51, P373, DOI 10.1016/S0039-9140(99)00283-0; Chen JH, 2014, ANAL CHEM, V86, P3108, DOI 10.1021/ac404170j; Chen ZP, 2013, RSC ADV, V3, P13318, DOI 10.1039/c3ra40559a; Ge CC, 2014, ANAL CHEM, V86, P6387, DOI 10.1021/ac501739a; Georgopoulos PG, 2001, J TOXICOL ENV HEAL B, V4, P341, DOI 10.1080/109374001753146207; HAHN SH, 1995, BIOCHEM MOL MED, V54, P142, DOI 10.1006/bmme.1995.1021; Lin ZY, 2012, ANAL METHODS-UK, V4, P612, DOI 10.1039/c2ay05765d; Miao XM, 2012, ANALYST, V137, P3064, DOI 10.1039/c2an35217f; Qiu SY, 2011, ANAL CHIM ACTA, V707, P57, DOI 10.1016/j.aca.2011.09.013; Rao XY, 2013, CHEM RES CHINESE U, V29, P868, DOI 10.1007/s40242-013-3039-1; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Shen QP, 2013, BIOSENS BIOELECTRON, V41, P663, DOI 10.1016/j.bios.2012.09.032; Shen QP, 2012, CHEM COMMUN, V48, P281, DOI 10.1039/c1cc16049d; Song YJ, 2010, CHEM COMMUN, V46, P6572, DOI 10.1039/c0cc01593h; Su J, 2013, BIOSENS BIOELECTRON, V45, P219, DOI 10.1016/j.bios.2013.01.069; Townsend AT, 1998, J ANAL ATOM SPECTROM, V13, P1213, DOI 10.1039/a805021j; Wang D, 2015, RSC ADV, V5, P75722, DOI 10.1039/c5ra11752f; Wang FY, 2015, TALANTA, V132, P72, DOI 10.1016/j.talanta.2014.08.064; Wang WD, 2010, TETRAHEDRON, V66, P3695, DOI 10.1016/j.tet.2010.03.070; Wu JF, 1997, ANAL CHEM, V69, P2464, DOI 10.1021/ac961204u; Zhang Q, 2012, BIOSENS BIOELECTRON, V38, P331, DOI 10.1016/j.bios.2012.06.011; Zhou LF, 2013, METHODS, V64, P299, DOI 10.1016/j.ymeth.2013.09.001; Zhou Y, 2008, ANGEW CHEM INT EDIT, V47, P7454, DOI 10.1002/anie.200802317; Zhu MY, 2014, BIOSENS BIOELECTRON, V61, P14, DOI 10.1016/j.bios.2014.04.049	28	6	6	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169345	10.1371/journal.pone.0169345	http://dx.doi.org/10.1371/journal.pone.0169345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072878	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200015
J	Gelin, P; Fauvelot, C; Mehn, V; Bureau, S; Rouze, H; Magalon, H				Gelin, Pauline; Fauvelot, Cecile; Mehn, Vincent; Bureau, Sophie; Rouze, Heloise; Magalon, Helene			Superclone Expansion, Long-Distance Clonal Dispersal and Local Genetic Structuring in the Coral Pocillopora damicornis Type beta in Reunion Island, South Western Indian Ocean	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; COMPUTER-PROGRAM; SEXUAL REPRODUCTION; NATURAL-POPULATIONS; ASEXUAL PRODUCTION; GENUS POCILLOPORA; REEF; SCLERACTINIA; SOFTWARE; LARVAE	The scleractinian coral Pocillopora damicornis type beta is known to present a mixed reproduction mode: through sexual reproduction, new genotypes are created, while asexual reproduction insures their propagation. In order to investigate the relative proportion of each reproduction mode in P. damicornis type beta populations from Reunion Island, Indian Ocean, clonal propagation along the west coast was assessed through four sampling sites with increasing geographical distance between sites. Coral colonies were sampled either exhaustively, randomly or haphazardly within each site, and genotypic diversity was assessed using 13 microsatellite loci over a total of 510 P. damicornis type beta determined a posteriori from their mtDNA haplotype (a 840 bp sequenced fragment of the Open Reading Frame). Overall, 47% of all the sampled colonies presented the same multi-locus genotype (MLG), a superclone, suggesting that asexual propagation is extremely important in Reunion Island. Within each site, numerous MLGs were shared by several colonies, suggesting local clonal propagation through fragmentation. Moreover, some of these MLGs were found to be shared among several sites located 40 km apart. While asexual reproduction by fragmentation seems unlikely over long distances, our results suggest a production of parthenogenetic larvae. Despite shared MLGs, two differentiated clusters were enclosed among populations of the west coast of Reunion Island, revealing the necessity to set up appropriate managing strategies at a local scale.	[Gelin, Pauline; Mehn, Vincent; Bureau, Sophie; Magalon, Helene] Univ La Reunion, CNRS, Lab Excellence CORAIL, UMR ENTROPIE,IRD, St Denis, Reunion, France; [Fauvelot, Cecile; Rouze, Heloise] Univ La Reunion, CNRS, Lab Excellence CORAIL, UMR ENTROPIE,IRD,Ctr IRD Noumea, New Caledonia, Reunion, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of La Reunion; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of La Reunion	Gelin, P (corresponding author), Univ La Reunion, CNRS, Lab Excellence CORAIL, UMR ENTROPIE,IRD, St Denis, Reunion, France.	pauline.gelin@univ-reunion.fr	Magalon, Helene/ABH-1252-2020	Magalon, Helene/0000-0002-7061-955X; Fauvelot, Cecile/0000-0003-0806-1222	program CONPOCINPA (Laboratoire d'excellence CORAIL fund); Laboratoire d'excellence CORAIL	program CONPOCINPA (Laboratoire d'excellence CORAIL fund); Laboratoire d'excellence CORAIL	This study was supported by program CONPOCINPA (Laboratoire d'excellence CORAIL fund, http://www.labex-coral.fr/). Pauline Gelin was financially supported by a PhD contract from the Laboratoire d'excellence CORAIL (http:/www.labex-fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2014, MAR BIOL, V161, P531, DOI 10.1007/s00227-013-2355-9; Alberto F, 2005, MOL ECOL, V14, P2669, DOI 10.1111/j.1365-294X.2005.02640.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Belkhir K, 2004, 5000 CNRS UMR; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Caron V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097744; Combosch DJ, 2013, ECOL EVOL, V3, P3379, DOI 10.1002/ece3.721; Combosch DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021200; Crow JF, 1999, J EVOLUTION BIOL, V12, P1023; CROW JF, 1994, DEV GENET, V15, P205, DOI 10.1002/dvg.1020150303; Denis V, 2010, CAPACITES MODALITES; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher RA, 1930, GENETICAL THEORY NAT; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Galbraith HS, 2009, HYDROBIOLOGIA, V636, P35, DOI 10.1007/s10750-009-9933-3; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014; Gitzendanner MA, 2012, CONSERV GENET, V13, P223, DOI 10.1007/s10592-011-0287-9; Gorospe KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122127; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hohenlohe PA, 2004, BIOL J LINN SOC, V82, P169, DOI 10.1111/j.1095-8312.2004.00318.x; HOLMAN EW, 1987, SYST ZOOL, V36, P381, DOI 10.2307/2413402; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; HUNTER CL, 1993, EVOLUTION, V47, P1213, DOI 10.1111/j.1558-5646.1993.tb02148.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Japaud A, 2015, MAR FRESHWATER RES, V66, P847, DOI 10.1071/MF14181; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; KOJIS BL, 1982, MAR ECOL PROG SER, V8, P251, DOI 10.3354/meps008251; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; Marti-Puig P, 2014, B MAR SCI, V90, P211, DOI 10.5343/bms.2012.1080; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Neiman M, 2014, J EVOLUTION BIOL, V27, P1346, DOI 10.1111/jeb.12357; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Perrier X., 2006, DARWIN SOFTWARE; Pinzon JH, 2012, CORAL REEFS, V31, P765, DOI 10.1007/s00338-012-0887-y; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Postaire B, 2015, BIOCHEM SYST ECOL, V62, P137, DOI 10.1016/j.bse.2015.08.011; Pous S, 2014, J GEOPHYS RES-OCEANS, V119, P1957, DOI 10.1002/2013JC009704; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosser NL, 2015, MOL ECOL, V24, P5006, DOI 10.1111/mec.13372; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach Sebastian, 2014, Galaxea - Tokyo, V16, P11; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Schmidt-Roach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050847; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Shanks AL, 2009, BIOL BULL-US, V216, P373; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; Souter Petra, 2009, BMC Ecology, V9, P19, DOI 10.1186/1472-6785-9-19; Starger CJ, 2010, CORAL REEFS, V29, P547, DOI 10.1007/s00338-010-0609-2; Starger CJ, 2008, MOL ECOL RESOUR, V8, P619, DOI 10.1111/j.1471-8286.2007.02017.x; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1988, GENETICS, V118, P705; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Torda G, 2013, MOL ECOL, V22, P5805, DOI 10.1111/mec.12540; Torda G, 2013, MOL ECOL, V22, P5821, DOI 10.1111/mec.12539; Torda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058447; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron JEN, 1976, SCI AIOM; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WARD S, 1992, MAR BIOL, V112, P641, DOI 10.1007/BF00346182; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams DE, 2014, CORAL REEFS, V33, P595, DOI 10.1007/s00338-014-1157-y; Yund PO, 2000, TRENDS ECOL EVOL, V15, P10, DOI 10.1016/S0169-5347(99)01744-9	87	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169692	10.1371/journal.pone.0169692	http://dx.doi.org/10.1371/journal.pone.0169692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068406	Green Submitted, gold, Green Published			2022-12-26	WOS:000391843900059
J	Wen, HB; Cao, ZM; Hua, D; Xu, P; Ma, XY; Jin, W; Yuan, XH; Gu, RB				Wen, Hai B.; Cao, Zhe M.; Hua, Dan; Xu, Pao; Ma, Xue Y.; Jin, Wu; Yuan, Xin H.; Gu, Ruo B.			The Complete Maternally and Paternally Inherited Mitochondrial Genomes of a Freshwater Mussel Potamilus alatus (Bivalvia: Unionidae)	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; OXIDASE-II GENE; PHYLOGENETIC UTILITY; EVOLUTION; DNA; UNIONOIDA; EXTENSION; SEQUENCE; ORIGIN; RNAS	Doubly uniparental inheritance (DUI) of mitochondrial DNA, found only in some bivalve families and characterized by the existence of gender-associated mtDNA lineages that are inherited through males (M-type) or females (F-type), is one of the very few exceptions to the general rule of strict maternal mtDNA inheritance in animals. M-type sequences are often undetected and hence still underrepresented in the GenBank, which hinders the progress of the understanding of the DUI phenomenon. We have sequenced and analyzed the complete M and F mitogenomes of a freshwater mussel, Potamilus alatus. The M-type was 493 bp longer (M = 16 560, F = 16 067 bp). Gene contents, order and the distribution of genes between L and H strands were typical for unionid mussels. Candidates for the two ORFan genes (forf and mod) were found in respective mitogenomes. Both mitogenomes had a very similar A+T bias: F = 61% and M = 62.2%. The M mitogenome-specific cox2 extension (144 bp) is much shorter than in other sequenced unionid mitogenomes (531-576 bp), which might be characteristic for the Potamilus genus. The overall topology of the phylogenetic tree is in very good agreement with the currently accepted phylogenetic relationships within the Unionidae: both studied sequences were placed within the Ambleminae subfamily clusters in the corresponding M and F clades.	[Wen, Hai B.; Xu, Pao; Yuan, Xin H.; Gu, Ruo B.] Nanjing Agr Univ, Wuxi Fishery Coll, Nanjing, Jiangsu, Peoples R China; [Wen, Hai B.; Cao, Zhe M.; Xu, Pao; Ma, Xue Y.; Jin, Wu; Yuan, Xin H.; Gu, Ruo B.] Chinese Acad Fishery Sci, Minist Agr, Freshwater Fisheries Res Ctr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Jiangsu, Peoples R China; [Wen, Hai B.; Hua, Dan; Xu, Pao; Ma, Xue Y.; Jin, Wu; Yuan, Xin H.; Gu, Ruo B.] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Sino US Cooperat Lab Germplasm Conservat & Utiliz, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS	Wen, HB; Xu, P; Gu, RB (corresponding author), Nanjing Agr Univ, Wuxi Fishery Coll, Nanjing, Jiangsu, Peoples R China.; Wen, HB; Xu, P; Gu, RB (corresponding author), Chinese Acad Fishery Sci, Minist Agr, Freshwater Fisheries Res Ctr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Jiangsu, Peoples R China.; Wen, HB; Xu, P; Gu, RB (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Sino US Cooperat Lab Germplasm Conservat & Utiliz, Wuxi, Jiangsu, Peoples R China.	wenhb@ffrc.cn; xup@ffrc.cn.ac; gurb@ffrc.cn			Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences [2015JBFM02]; Fisheries Sanxin Engineering Funds of Ocean and Fishery Bureau of Jiangsu Province [Y2014-38]	Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences; Fisheries Sanxin Engineering Funds of Ocean and Fishery Bureau of Jiangsu Province	This study was supported by the Special Scientific Research Funds for Central Non-profit Institutes of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences (Grant number: 2015JBFM02), and Fisheries Sanxin Engineering Funds of Ocean and Fishery Bureau of Jiangsu Province (Grant number: Y2014-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CT, 2016, MITOCHONDRIAL DNA A, V27, P1552, DOI 10.3109/19401736.2014.953133; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Boyle EE, 2013, MAR BIOL, V160, P413, DOI 10.1007/s00227-012-2099-y; Breton S, 2006, GENETICS, V172, P1107, DOI 10.1534/genetics.105.047159; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Doublet V, 2015, RNA BIOL, V12, P1159, DOI 10.1080/15476286.2015.1090078; Doucet-Beaupre H, 2012, MOL PHYLOGENET EVOL, V63, P430, DOI 10.1016/j.ympev.2012.01.017; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Feng L, 2016, CONSERV GENET RESOUR; Hoeh WR, 1997, MOL BIOL EVOL, V14, P959, DOI 10.1093/oxfordjournals.molbev.a025839; Hua D., 2005, THESIS; Hua D, 2007, N AM J AQUACULT, V69, P147, DOI 10.1577/A05-108.1; Huang XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084352; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lee JH, 2016, MITOCHONDRIAL DNA A, V27, P1026, DOI 10.3109/19401736.2014.926537; Lopes-Lima M, 2017, MOL PHYLOGENET EVOL, V106, P174, DOI 10.1016/j.ympev.2016.08.021; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Milani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028194; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Song XL, 2016, MITOCHONDRIAL DNA A, V27, P549, DOI 10.3109/19401736.2014.905852; Soroka M, 2010, J APPL GENET, V51, P469, DOI 10.1007/BF03208876; Soroka M, 2016, MITOCHONDRIAL DNA A, V27, P1679, DOI 10.3109/19401736.2014.958725; Soroka M, 2015, MITOCHONDR DNA, V26, P267, DOI 10.3109/19401736.2013.823176; Soroka Marianna, 2010, Folia Malacologica, V18, P147, DOI 10.2478/v10125-010-0015-y; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stewart DT, 1996, GENETICS, V143, P1349; Stewart DT, 2013, EVOLUTIONARY BIOL EX, P245, DOI DOI 10.1007/978-3-642-38212-3_16; Suyama M, 2006, NUCLEIC ACIDS RES, P34; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Walker JM, 2006, MALACOLOGIA, V48, P265; Wen HB, 2015, J MORPHOL, V276, P1273, DOI 10.1002/jmor.20406; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu R- W, 2015, MITOCHONDRIAL DNA; Zanatta DT, 2006, MOL PHYLOGENET EVOL, V41, P195, DOI 10.1016/j.ympev.2006.05.030; Zbawicka M, 2010, GENE, V456, P45, DOI 10.1016/j.gene.2010.02.009; Zhou C- H, 2015, MITOCHONDRIAL DNA; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	52	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169749	10.1371/journal.pone.0169749	http://dx.doi.org/10.1371/journal.pone.0169749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068380	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900063
J	Zhang, M; Sun, S; Mesurolle, B				Zhang, Michelle; Sun, Simon; Mesurolle, Benoit			The Impact of Pre-Operative Breast MRI on Surgical Waiting Time	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CANCER-SURGERY; DIAGNOSIS; DISTRESS; YOUNG; WOMEN	Purpose To assess the impact of pre-operative breast MRI on surgical waiting time, and to identify factors contributing to the delay. Materials and Methods A retrospective cohort study involving 1274 patients was conducted after obtaining institutional ethics review. Surgical candidates for newly diagnosed breast cancer from 2007 to 2013 at a tertiary center were divided into 2 groups: those who had pre-operative MRI and those who did not. Linear regression using matched populations was used to compare the surgical waiting times, defined as time from the date of the first positive biopsy to the date of surgery. Potential influences on surgical waiting time and subgroup analysis were obtained using median regression analysis and the Kruskal-Wallis test. Results Mean surgical waiting time was 57.9 days (95% CI: 55.6-60.1) for MRI patients, compared to 46.8 days (95% CI: 45.1-48.9) for the control group, after matching for potential confounding factors (p<0.0001). Increased surgical waiting time was associated with more favorable pathology, later year of diagnosis, older patient age, surgeon and summer time. Second-look ultrasound and subsequent biopsies were associated with increased waiting time (p = 0.001). Conclusions Pre-operative breast MRI increased surgical waiting time by 11 days using a conventional average of differences, and by 12 days after using a full matching statistical method (p<0.0001), with the main contributor being additional post-MRI procedures and imaging.	[Zhang, Michelle; Sun, Simon; Mesurolle, Benoit] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cedar Breast Clin, 1001 Blvd Decarie, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital	Mesurolle, B (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cedar Breast Clin, 1001 Blvd Decarie, Montreal, PQ, Canada.	bmesurolle@yahoo.fr		Sun, Simon/0000-0002-0062-197X				Adkisson CD, 2011, ANN SURG ONCOL, V18, P1678, DOI 10.1245/s10434-010-1491-4; Angarita FA, 2010, ANN SURG ONCOL, V17, pS273, DOI 10.1245/s10434-010-1239-1; [Anonymous], 2013, GLOBOCAN 2012 V1 0 C; Baliski C, 2014, AM J SURG, V207, P686, DOI 10.1016/j.amjsurg.2014.01.002; Bardell T, 2006, CLIN ONCOL-UK, V18, P401, DOI 10.1016/j.clon.2006.02.012; Bilimoria KY, 2011, ANN SURG, V253, P779, DOI 10.1097/SLA.0b013e318211cc0f; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P180, DOI 10.1016/j.jamcollsurg.2009.04.010; Brocken P, 2012, PSYCHO-ONCOLOGY, V21, P1, DOI 10.1002/pon.1929; Canadian Institute for Health Information, 2016, WAIT TIM PRIOR PROC; Caplan L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00087; Chandwani S, 2014, ANN SURG ONCOL, V21, P3473, DOI 10.1245/s10434-014-3748-9; Daniels J, 2008, CURR OPIN ONCOL, V20, P367, DOI 10.1097/CCO.0b013e3283021658; De Felice C, 2012, EUR J GYNAECOL ONCOL, V33, P193; Dore C, 2013, HEALTH CARE WOMEN IN, V34, P34, DOI 10.1080/07399332.2012.673656; Flory N, 2011, RADIOLOGY, V260, P166, DOI 10.1148/radiol.11102211; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Hollingsworth AB, 2008, AM J SURG, V196, P389, DOI 10.1016/j.amjsurg.2007.10.009; Hulvat M, 2010, SURGERY, V148, P746, DOI 10.1016/j.surg.2010.07.012; JONES RVH, 1994, BRIT J GEN PRACT, V44, P370; Kaufman CS, 2010, ANN SURG ONCOL, V17, P377, DOI 10.1245/s10434-009-0729-5; Koenker R., 2009, QUANTREG QUANTILE RE; Kothari A, 2003, INT J CLIN PRACT, V57, P200; Krishnan M, 2008, AM J ROENTGENOL, V190, pA31; Lang EV, 2009, RADIOLOGY, V250, P631, DOI 10.1148/radiol.2503081087; Lee SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004874; Love RR, 2004, BREAST CANCER RES TR, V86, P117, DOI 10.1023/B:BREA.0000032980.55245.c3; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Mayo NE, 2001, CAN MED ASSOC J, V164, P1133; Molinie F, 2013, BREAST, V22, P810, DOI 10.1016/j.breast.2013.02.009; Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-330; Nori J, 2014, BREAST J, V20, P243, DOI 10.1111/tbj.12250; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Salem DS, 2013, J THORAC DIS, V5, pS9, DOI 10.3978/j.issn.2072-1439.2013.05.02; Sariego J, 2010, AM SURGEON, V76, P1397; Tendulkar RD, 2009, CANCER-AM CANCER SOC, V115, P1621, DOI 10.1002/cncr.24172; Wilson AR, 1990, EUR J CANCER, V49, P3579	37	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169756	10.1371/journal.pone.0169756	http://dx.doi.org/10.1371/journal.pone.0169756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068382	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900064
J	Fakkert, IE; van der Veer, E; Abma, EM; Lefrandt, JD; Wolffenbuttel, BHR; Oosterwijk, JC; Slart, RHJA; Westrik, IG; de Bock, GH; Mourits, MJE				Fakkert, Ingrid E.; van der Veer, Eveline; Abma, Elske Marije; Lefrandt, Joop D.; Wolffenbuttel, Bruce H. R.; Oosterwijk, Jan C.; Slart, Riemer H. J. A.; Westrik, Iris G.; de Bock, Geertruida H.; Mourits, Marian J. E.			Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer	PLOS ONE			English	Article								Background Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA1/2 mutation carriers. Premenopausal RRSO is hypothesized to increase fracture risk more than natural menopause. Elevated bone turnover markers (BTMs) might predict fracture risk. We investigated BTM levels after RRSO and aimed to identify clinical characteristics associated with elevated BTMs. Methods Osteocalcin (OC), procollagen type I N-terminal peptide (PINP) and serum C-telopeptide of type I collagen (sCTx) were measured in 210 women >= 2 years after RRSO before age 53. BTM Z-scores were calculated using an existing reference cohort of age-matched women. Clinical characteristics were assessed by questionnaire. Results BTMs after RRSO were higher than age-matched reference values: median Z-scores OC 0.11, p = 0.003; PINP 0.84, p < 0.001; sCTx 0.53, p < 0.001 (compared to Z = 0). After excluding women with recent fractures or BTM interfering medication, Z-scores increased to 0.34, 1.14 and 0.88, respectively. Z-scores for OC and PINP were inversely correlated to age at RRSO. No correlation was found with fracture incidence or history of breast cancer. Conclusions Five years after RRSO, BTMs were higher than age-matched reference values. Since elevated BTMs might predict higher fracture risk, prospective studies are required to evaluate the clinical implications of this finding.	[Fakkert, Ingrid E.; de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Abma, Elske Marije] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Geriatr Med, Groningen, Netherlands; [Lefrandt, Joop D.; Westrik, Iris G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Oosterwijk, Jan C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Slart, Riemer H. J. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Slart, Riemer H. J. A.] Univ Twente, Dept Biomed Photon Imaging, Enschede, Netherlands; [Mourits, Marian J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol, Groningen, Netherlands; [Fakkert, Ingrid E.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Twente; University of Groningen; Radboud University Nijmegen	Fakkert, IE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Fakkert, IE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.	i.e.fakkert@umcg.nl	Fakkert, Ingrid E./G-9366-2016; Oosterwijk, Jan C./G-5770-2011; de Bock, Geertruida H./F-6529-2014	Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; de Bock, Geertruida H./0000-0003-3104-4471	Amgen; Menarini; Nycomed; Willpharma	Amgen(Amgen); Menarini(Menarini Group); Nycomed; Willpharma	Unrestricted grants by Amgen, Menarini, Nycomed and Willpharma. Junior Scientific Masterclass MD/PhD funds of the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adami S, 2008, CALCIFIED TISSUE INT, V82, P341, DOI 10.1007/s00223-008-9126-5; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Ardawi MSM, 2010, BONE, V47, P804, DOI 10.1016/j.bone.2010.07.017; Bahar S, 2011, EUR J OBSTET GYN R B, V159, P194, DOI 10.1016/j.ejogrb.2011.06.033; CBO, 2011, RICHTL OST FRACT DER; Challberg J, 2011, BRIT J CANCER, V105, P22, DOI 10.1038/bjc.2011.202; Chapman JS, 2011, GYNECOL ONCOL, V122, P339, DOI 10.1016/j.ygyno.2011.04.004; De Bock GH, 2012, MATURITAS, V71, P3, DOI 10.1016/j.maturitas.2011.10.008; Delmas PD, 2008, OSTEOPOROSIS INT, V19, P1153, DOI 10.1007/s00198-007-0545-3; Doorenbos CRC, 2012, J STEROID BIOCHEM, V128, P56, DOI 10.1016/j.jsbmb.2011.09.002; Eastell R, 2006, J BONE MINER RES, V21, P1215, DOI 10.1359/JBMR.060508; Evans DG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3829; Fakkert IE, 2015, EUR J CANCER, V51, P400, DOI 10.1016/j.ejca.2014.11.022; Garcia-Perez MA, 2004, CALCIFIED TISSUE INT, V74, P143, DOI 10.1007/s00223-003-0054-0; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Hamwi A, 2001, CLIN CHEM LAB MED, V39, P414, DOI 10.1515/CCLM.2001.066; Hashimoto K, 1995, MATURITAS, V22, P185, DOI 10.1016/0378-5122(95)00940-M; Hegeman J H, 2004, Ned Tijdschr Geneeskd, V148, P2180; Kelly TL, 1990, J BONE MINER RES, pS249; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Michelsen TM, 2009, GYNECOL ONCOL, V113, P128, DOI 10.1016/j.ygyno.2008.12.024; Morgante G, 2001, GYNECOL ENDOCRINOL, V15, P466, DOI 10.1080/713602985; NABON, 2012, BREAST CANC DUTCH GU; Ohta H, 2002, MATURITAS, V43, P27, DOI 10.1016/S0378-5122(02)00180-9; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Peris P, 1999, BONE, V25, P349, DOI 10.1016/S8756-3282(99)00175-1; Sornay-Rendu E, 2003, BONE, V33, P159, DOI 10.1016/S8756-3282(03)00171-6; van der Kolk DM, 2010, BREAST CANCER RES TR, V124, P643, DOI 10.1007/s10549-010-0805-3; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vesco KK, 2012, MENOPAUSE, V19, P510, DOI 10.1097/gme.0b013e318239caeb; Yasumizu T, 1999, ENDOCR J, V46, P337, DOI 10.1507/endocrj.46.337	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169673	10.1371/journal.pone.0169673	http://dx.doi.org/10.1371/journal.pone.0169673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060958	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500127
J	Jin, LXZY; Rangan, A; Mehlsen, J; Andersen, LB; Larsen, SC; Heitmann, BL				Jin, Lexie Zhiyan; Rangan, Anna; Mehlsen, Jesper; Andersen, Lars Bo; Larsen, Sofus C.; Heitmann, Berit L.			Association Between Use of Cannabis in Adolescence and Weight Change into Midlife	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; MARIJUANA USE; ORBITOFRONTAL CORTEX; OVERWEIGHT PATIENTS; INSULIN-RESISTANCE; RECEPTOR BLOCKER; SUBSTANCE USE; OBESITY; RIMONABANT	Cannabis use has been found to stimulate appetite and potentially promote weight gain via activation of the endocannabinoid system. Despite the fact that the onset of cannabis use is typically during adolescence, the association between adolescence cannabis use and long-term change in body weight is generally unknown. This study aims to examine the association between adolescence cannabis use and weight change to midlife, while accounting for the use of other substances. The study applied 20 to 22 years of follow-up data on 712 Danish adolescents aged between 15 and 19 years at baseline. Self-reported height and weight, cannabis, cigarette and alcohol use, socioeconomic status (SES) and physical activity levels were assessed in baseline surveys conducted in 1983 and 1985. The follow-up survey was conducted in 2005. In total 19.1% (n = 136) of adolescents reported having used/using cannabis. Weight gain between adolescence and midlife was not related to cannabis exposure during adolescence in either crude or adjusted models, and associations were not modified by baseline alcohol intake or smoking. However, cannabis use was significantly associated with cigarette smoking (p<0.001) and alcohol intake (p<0.001) and inversely associated with physical activity levels (p = 0.04). In conclusion, this study does not provide evidence of an association between adolescence cannabis use and weight change from adolescence to midlife.	[Jin, Lexie Zhiyan; Rangan, Anna] Univ Sydney, Sch Mol Biosci, Camperdown, NSW, Australia; [Mehlsen, Jesper] Frederiksberg Univ Hosp, Coordinating Res Ctr, Frederiksberg, Denmark; [Andersen, Lars Bo] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Exercise Epidemiol Unit, Odense, Denmark; [Larsen, Sofus C.; Heitmann, Berit L.] Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Larsen, Sofus C.; Heitmann, Berit L.] Bispebjerg Hosp, Frederiksberg, Denmark; [Heitmann, Berit L.] Univ Copenhagen, Sect Gen Med, Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark	University of Sydney; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Sydney; University of Southern Denmark	Heitmann, BL (corresponding author), Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Heitmann, BL (corresponding author), Bispebjerg Hosp, Frederiksberg, Denmark.; Heitmann, BL (corresponding author), Univ Copenhagen, Sect Gen Med, Inst Publ Hlth, Copenhagen, Denmark.; Heitmann, BL (corresponding author), Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia.; Heitmann, BL (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark.	Berit.Lilienthal.Heitmann@regionh.dk	Mehlsen, Jesper/AAA-5848-2022; Larsen, Sofus Christian/AAO-5894-2020	Larsen, Sofus Christian/0000-0002-0838-9378; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Medical Research Council [09-060078/FSS]; Danish Ministry of Health [2003-0200-13]; Aase & Einar Danielsens Foundation; Copenhagen Capital Region	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Ministry of Health; Aase & Einar Danielsens Foundation; Copenhagen Capital Region	Supported by the Danish Medical Research Council (grant number 09-060078/FSS), The Danish Ministry of Health (2003-0200-13), Aase & Einar Danielsens Foundation, and The Copenhagen Hospital Corporation (now Copenhagen Capital Region).	[Anonymous], 2015, MAR; [Anonymous], OV 5 SOC GROUPS INT; Bassett DR, 2000, MED SCI SPORT EXER, V32, P1018; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dube E, 2015, PHARMACOL BIOCHEM BE, V135, P121, DOI 10.1016/j.pbb.2015.04.018; Ellen S, 2001, PUBLIC HEALTH NUTR, V4, P781; European Monitoring Centre for Drugs and Drug Addiction, 2011, STAT DRUGS PROBL EUR; Farhat T, 2010, AM J PREV MED, V38, P258, DOI 10.1016/j.amepre.2009.10.038; Francesca MF, 2014, PNAS, V111, P16913, DOI [10.1073/pnas.1415297111, DOI 10.1073/PNAS.1415297111]; Fratta W, 2013, CURR OPIN NEUROBIOL, V23, P487, DOI 10.1016/j.conb.2013.02.002; Hare-Bruun H, 2011, J NUTR, V141, P928, DOI 10.3945/jn.110.133413; HARRISON ER, 1993, AM J DRUG ALCOHOL AB, V19, P423, DOI 10.3109/00952999309001632; Holes-Lewis KA, 2013, AM J MED SCI, V345, P284, DOI 10.1097/MAJ.0b013e31828abcfd; Huang DYC, 2013, ADDICT BEHAV, V38, P2653, DOI 10.1016/j.addbeh.2013.06.024; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Marilyn AH, 2007, CHEM BIODIVERS, V4, P1770; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Ngueta G, 2015, OBESITY, V23, P290, DOI 10.1002/oby.20973; Pava MJ, 2012, ALCOHOL, V46, P185, DOI 10.1016/j.alcohol.2012.01.002; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Riedel G, 2009, BRIT J PHARMACOL, V156, P1154, DOI 10.1111/j.1476-5381.2008.00107.x; Rodondi N, 2006, AM J CARDIOL, V98, P478, DOI 10.1016/j.amjcard.2006.03.024; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Shott ME, 2015, INT J OBESITY, V39, P214, DOI 10.1038/ijo.2014.121; SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369; Thompson CA, 2015, ANN EPIDEMIOL, V25, P486, DOI 10.1016/j.annepidem.2015.01.013; United Nations Office on Drugs and Crime, 2011, CRIMINAL INTELLIGENC; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vidot DC, 2016, MATERN CHILD HLTH J, V20, P870, DOI 10.1007/s10995-015-1875-y; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; Wargent E, NUTR DIABETES; Warren M, 2005, J ADDICT DIS, V24, P95, DOI 10.1300/J069v24n03_08; Yann LS, 2011, AM J EPIDEMIOL, V174, P929, DOI [10.1093/aje/kwr200, DOI 10.1093/AJE/KWR200]; ZWILLICH CW, 1978, AM REV RESPIR DIS, V118, P885	37	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168897	10.1371/journal.pone.0168897	http://dx.doi.org/10.1371/journal.pone.0168897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060830	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500043
J	Rosso, C; Nasr, M; Walley, KC; Harlow, ER; Haghpanah, B; Vaziri, A; Ramappa, AJ; Nazarian, A; DeAngelis, JP				Rosso, Claudio; Nasr, Michael; Walley, Kempland C.; Harlow, Ethan R.; Haghpanah, Babak; Vaziri, Ashkan; Ramappa, Arun J.; Nazarian, Ara; DeAngelis, Joseph P.			Glenohumeral Joint Kinematics following Clavicular Fracture and Repairs	PLOS ONE			English	Article							ROTATOR CUFF TEARS; SHOULDER INSTABILITY; SCAPULAR DYSKINESIS; MOTION; EPIDEMIOLOGY; TRANSLATIONS; MALUNIONS; INJURY	Background The purpose of this biomechanical study was to determine the effect of shortened clavicle malunion on the center of rotation of the glenohumeral (GH) joint, and the capacity of repair to restore baseline kinematics. Methods Six shoulders underwent automated abduction (ABD) and abbreviated throwing motion (ATM) using a 7-DoF automated upper extremity testing system in combination with an infrared motion capture system to measure the center of rotation of the GH joint. ATM was defined as pure lateral abduction and late cocking phase to the end of acceleration. Torsos with intact clavicle underwent testing to establish baseline kinematics. Then, the clavicles were subjected to midshaft fracture followed by kinematics testing. The fractured clavicles underwent repairs first by clavicle length restoration with plate fixation, and then by wiring of fragments with a 2-cm overlap to simulate shortened malunion. Kinematic testing was conducted after each repair technique. Center of rotation of the GH joint was plotted across all axes to outline 3D motion trajectory and area under the curve. Results Throughout ABD, malunion resulted in increased posterior and superior translation compared to baseline. Plate fixation restored posterior and superior translations at lower abduction angles but resulted in excess anterior and inferior translation at overhead angles. Throughout ATM, all conditions were significantly anterior and superior to baseline. Translation with malunion was situated anterior to the fractured and ORIF conditions at lower angles of external rotation. Plate fixation did not restore baseline anteroposterior or superoinferior translation at any angle measured. Conclusions This study illustrates the complex interplay of the clavicle and the GH joint. While abnormal clavicle alignment alters shoulder motion, restoration of clavicle length does not necessarily restore GH kinematics to baseline. Rehabilitation of the injured shoulder must address the osseous injury and the dynamic forces of the shoulder girdle.	[Rosso, Claudio; Nasr, Michael; Walley, Kempland C.; Harlow, Ethan R.; Haghpanah, Babak; Nazarian, Ara] Harvard Med Sch, Carl J Shapiro Dept Orthopaed Surg, Ctr Adv Orthopaed Studies, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Haghpanah, Babak; Vaziri, Ashkan] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Ramappa, Arun J.; Nazarian, Ara; DeAngelis, Joseph P.] Harvard Med Sch, Carl J Shapiro Dept Orthopaed Surg, Beth Israel Deaconess Med Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	DeAngelis, JP (corresponding author), Harvard Med Sch, Carl J Shapiro Dept Orthopaed Surg, Beth Israel Deaconess Med Ctr, Boston, MA USA.	jpdeange@bidmc.harvard.edu		Walley, Kempland/0000-0003-4488-0663	Major League Baseball Medical Advisory Committee; Carl Shapiro Department of Orthopaedic Surgery at Beth Israel Deaconess Medical Center; Qatar National Research Fund; United States National Science Foundation's Civil, Mechanical, and Manufacturing Innovation [1149750]; Carl Shapiro Department of Orthopaedic Surgery at Harvard Medical School	Major League Baseball Medical Advisory Committee; Carl Shapiro Department of Orthopaedic Surgery at Beth Israel Deaconess Medical Center; Qatar National Research Fund(Qatar National Research Fund (QNRF)); United States National Science Foundation's Civil, Mechanical, and Manufacturing Innovation; Carl Shapiro Department of Orthopaedic Surgery at Harvard Medical School	This work was supported by a grant from the Major League Baseball Medical Advisory Committee (AN and AJR), departmental funding from the Carl Shapiro Department of Orthopaedic Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School (AN and AJR), an NPRP award from the Qatar National Research Fund (AV) and a grant from the United States National Science Foundation's Civil, Mechanical, and Manufacturing Innovation (Grant No. 1149750 (AV)). The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This work was supported by a grant from the Major League Baseball Medical Advisory Committee (AN and AJR), Departmental funding from the Carl Shapiro Department of Orthopaedic Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School (AN and AJR), a NPRP award from the Qatar National Research Fund (AV) and a grant from the United States National Science Foundation's Civil, Mechanical, and Manufacturing Innovation (Grant No. 1149750 (AV)).	ALLMAN FL, 1967, J BONE JOINT SURG AM, VA 49, P774, DOI 10.2106/00004623-196749040-00024; Bergin D, 2009, MAGN RESON IMAGING C, V17, P595, DOI 10.1016/j.mric.2009.06.002; Brophy RH, 2005, CLIN SPORT MED, V24, P47, DOI 10.1016/j.csm.2004.08.010; Cereatti A, 2015, J MED BIOL IN PRESS; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Entezari V, 2012, BONE JOINT RES, V1, P78, DOI 10.1302/2046-3758.15.2000051; ESKOLA A, 1986, ARCH ORTHOP TRAUM SU, V105, P337, DOI 10.1007/BF00449938; Grazier K, 1984, AM ACAD ORTHOP SURG, V1, P73; Hill JM, 1997, J BONE JOINT SURG BR, V79B, P537, DOI 10.1302/0301-620X.79B4.7529; Hillen RJ, 2007, STRATEG TRAUMA LIMB, V2, P59, DOI 10.1007/s11751-007-0024-6; Hillen RJ, 2012, CLIN BIOMECH, V27, P777, DOI 10.1016/j.clinbiomech.2012.05.003; Hillen RJ, 2010, ACTA ORTHOP, V81, P273, DOI 10.3109/17453674.2010.480939; Khan LAK, 2009, J BONE JOINT SURG AM, V91A, P447, DOI 10.2106/JBJS.H.00034; Kibler WB, 2010, BRIT J SPORT MED, V44, P300, DOI 10.1136/bjsm.2009.058834; Kibler WB, 2012, J AM ACAD ORTHOP SUR, V20, P364, DOI 10.5435/JAAOS-20-06-364; Kim HM, 2010, J BONE JOINT SURG AM, V92A, P1088, DOI 10.2106/JBJS.I.00686; Lazarides S, 2006, J SHOULDER ELB SURG, V15, P191, DOI 10.1016/j.jse.2005.08.007; Ledger M, 2005, J SHOULDER ELB SURG, V14, P349, DOI 10.1016/j.jse.2004.09.011; Matava MJ, 2005, AM J SPORT MED, V33, P1405, DOI 10.1177/0363546505280213; Matsumura N, 2010, AM J SPORT MED, V38, P1000, DOI 10.1177/0363546509355143; McKee MD, 2006, J BONE JOINT SURG AM, V88A, P35, DOI 10.2106/JBJS.D.02795; McKee MD, 2003, J BONE JOINT SURG AM, V85A, P790, DOI 10.2106/00004623-200305000-00003; Mckee MD, 2007, J BONE JOINT SURG AM, V89A, P1, DOI 10.2106/JBJS.F.00020; Meskers CGM, 1998, J BIOMECH, V31, P93, DOI 10.1016/S0021-9290(97)00101-2; Mueller AM, 2014, AM J SPORT MED, V42, P2455, DOI 10.1177/0363546514547348; Mueller AM, 2013, J SHOULDER ELB SURG, V22, P986, DOI 10.1016/j.jse.2012.09.010; Nowak J, 2004, J SHOULDER ELB SURG, V13, P479, DOI 10.1016/j.jse.2004.01.026; Pecci M, 2008, AM FAM PHYSICIAN, V77, P65; Postacchini F, 2002, J SHOULDER ELB SURG, V11, P452, DOI 10.1067/mse.2002.126613; Postacchini R, 2010, INT ORTHOP, V34, P731, DOI 10.1007/s00264-009-0850-x; Ranalletta M, 2015, AM J SPORT MED, V43, P565, DOI 10.1177/0363546514559913; Robinson CM, 1998, J BONE JOINT SURG BR, V80B, P476, DOI 10.1302/0301-620X.80B3.8079; Rosso C, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-24; Seroyer ST, 2010, SPORTS HEALTH, V2, P135, DOI 10.1177/1941738110362656; Veeger HEJ, 2007, J BIOMECH, V40, P2119, DOI 10.1016/j.jbiomech.2006.10.016; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	36	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0164549	10.1371/journal.pone.0164549	http://dx.doi.org/10.1371/journal.pone.0164549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060814	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500003
J	Lange, A; Sunden-Cullberg, J; Magnuson, A; Hultgren, O				Lange, Anna; Sunden-Cullberg, Jonas; Magnuson, Anders; Hultgren, Olof			Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality	PLOS ONE			English	Article							PROGRAMMED DEATH-1; IMPROVES SURVIVAL; SEPTIC SHOCK; COSTIMULATORY MOLECULES; CELL-ACTIVATION; PD-1; EXPRESSION; CTLA-4; BTLA; FORM	Introduction and aims B- and T-lymphocyte Attenuator (BTLA), Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed Death 1 (PD-1) are co-inhibitory receptors that regulate T cell activation. In the present study of ICU-treated patients we measured plasma concentrations of their soluble isoforms, with the aim to evaluate their potential as sepsis biomarkers and utility as prognostic indicators. Methods 101 patients with sepsis, 28 patients with non-infectious critical illness (ICU controls) and 31 blood donors (healthy controls, HC) were included in the study. Plasma concentrations of soluble BTLA (sBTLA), CTLA-4 (sCTLA-4) and PD-1 (sPD-1) were measured with ELISA in serial blood samples. Comparisons were made with Mann-Whitney Utest and correlations were assessed with Spearman's Rank correlation test. Cox proportional hazard models, with sBTLA and sPD-1 as fixed and sBTLA as time-varying covariates, were used to determine association with 28-day mortality. Results sBTLA levels were significantly higher in the sepsis cohort (median 14 ng/mL, IQR 8-29) compared to ICU controls (9 ng/mL, IQR 5-26, p = 0.048) and HC (2.9 ng/mL, IQR 0.9-9.1, p<0.01), and correlated to SOFA score. sBTLA levels were higher in 28 day sepsis non-survivors than in survivors (baseline median 28 ng/mL, IQR 13-41 vs 13 ng/mL, IQR 8-23, p = 0.04). After adjustment for age and comorbidities, the relative risk of 28 day mortality was nearly 5-fold higher in sepsis patients with a baseline sBTLA > 21 ng/mL, compared to those with a level below this threshold. sBTLA was even more associated with mortality in the time-varying analysis. sPD-1 levels were lower in the sepsis cohort compared to HC but not compared to ICU controls and were not associated with mortality. sCTLA-4 was detectable in only one subject. Conclusion Plasma concentrations of soluble BTLA were increased early in sepsis/septic shock and correlated to severity of disease. A baseline concentration >21 ng/mL was associated with a poor prognosis.	[Lange, Anna] Univ Orebro, Sch Med Sci, Dept Infect Dis, Orebro, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Infect Dis, Stockholm, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ Hosp Huddinge, Ctr Infect Med, Karolinska Inst, Stockholm, Sweden; [Magnuson, Anders] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Hultgren, Olof] Univ Orebro, Sch Med Sci, Dept Microbiol & Immunol, Orebro, Sweden	Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Orebro University; Orebro University	Lange, A (corresponding author), Univ Orebro, Sch Med Sci, Dept Infect Dis, Orebro, Sweden.	anna.lange@regionorebrolan.se	Sundén-Cullberg, Jonas/AAW-5210-2020	Sundén-Cullberg, Jonas/0000-0002-8189-4960	Research Committee Region Orebro County; Nyckelfonden Region Orebro County; Olle Engkvist fund; Signe and Olof Wallenius trust; ALF; Karolinska University Hospital, Huddinge, Research Foundation	Research Committee Region Orebro County; Nyckelfonden Region Orebro County; Olle Engkvist fund; Signe and Olof Wallenius trust; ALF; Karolinska University Hospital, Huddinge, Research Foundation	The study was conducted with the financial support from research grants from the Research Committee Region Orebro County, Nyckelfonden Region Orebro County, the Olle Engkvist fund, the Signe and Olof Wallenius trust, ALF project funding, and the Karolinska University Hospital, Huddinge, Research Foundation.	Atesoglu EB, 2014, CLIN APPL THROMB HEM; Bernard A, 2002, TRANSPLANTATION, V73, pS31, DOI 10.1097/00007890-200201151-00011; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boulougouris G, 1998, J IMMUNOL, V161, P3919; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chen H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085631, 10.1371/journal.pone.0086214, 10.1371/journal.pone.0087753]; Cheng TT, 2016, SHOCK, V45, P40, DOI 10.1097/SHK.0000000000000479; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Greisen SR, 2014, SCAND J RHEUMATOL, V43, P101, DOI 10.3109/03009742.2013.823517; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hamers L, 2015, MINERVA ANESTESIOL, V81, P426; HOLM S, 1979, SCAND J STAT, V6, P65; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liu CP, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0859-z; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Oya Y, 2008, ARTHRITIS RHEUM-US, V58, P2498, DOI 10.1002/art.23674; Roger PM, 2012, J CRIT CARE, V27, P384, DOI 10.1016/j.jcrc.2012.04.010; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Saverino D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112509; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Shao R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1024-4; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Simone R, 2014, SOLUBLE FORM CTLA 4, V2014; Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wang X, APPL MONOCLONAL ANTI, P1557; Wang X., 2012, MATH PROBL ENG, V2012, P12, DOI DOI 10.1016/J.AUTC0N.2012.10.012; Wang XF, 2007, TISSUE ANTIGENS, V69, P145, DOI 10.1111/j.1399-0039.2006.00710.x; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yanaba K, 2016, J DERMATOL; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	48	27	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169176	10.1371/journal.pone.0169176	http://dx.doi.org/10.1371/journal.pone.0169176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056053	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100023
J	Wu, JJ; Wang, XC; Chung, YY; Koh, CH; Liu, ZF; Guo, HC; Yuan, Q; Wang, C; Su, SW; Wei, HM				Wu, Jianjun; Wang, Xiangchong; Chung, Ying Ying; Koh, Cai Hong; Liu, Zhenfeng; Guo, Huicai; Yuan, Qiang; Wang, Chuan; Su, Suwen; Wei, Heming			L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; PLURIPOTENT STEM-CELLS; SUDDEN CARDIAC DEATH; LONG-QT SYNDROME; ACTION-POTENTIALS; INDUCED ARRHYTHMIAS; SODIUM-CHANNELS; SINGLE CELLS; GUINEA-PIGS; IN-VIVO	Aconitine (ACO) is well-known for causing lethal ventricular tachyarrhythmias. While cardiac Na+ channel opening during repolarization has long been documented in animal cardiac myocytes, the cellular effects and mechanism of ACO in human remain unexplored. This study aimed to assess the proarrhythmic effects of ACO in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). ACO concentration-dependently (0.3 similar to 3.0 mu M) shortened the action potentials (AP) durations (APD) in ventricular-like hiPSC-CMs by > 40% and induced delayed after-depolarization. Laser-scanning confocal calcium imaging analysis showed that ACO decreased the duration and amplitude of [Ca2+](i) transients and increased in the beating frequencies by over 60%. Moreover, ACO was found to markedly reduce the L-type calcium channel (LTCC) currents (I-Ca,I-L) in hiPSC-CMs associated with a positive-shift of activation and a negative shift of inactivation. ACO failed to alter the peak and late Na+ currents (I-Na) in hiPSC-CMs while it drastically increased the late I-Na in Guinea-pig ventricular myocytes associated with enhanced activation/delayed inactivation of I-Na at -55 mV similar to-85 mV. Further, the effects of ACO on I-ca,I-L, I-Na and the rapid delayed rectifier potassium current (I-kr) were validated in heterologous expression systems by automated voltage-clamping assays and a moderate suppression of I-kr was observed in addition to concentration-dependent I-ca,I-L inhibition. Lastly, increased beating frequency, decreased Ca2+ wave and shortened field potential duration were recorded from hiPSC-CMs by microelectrode arrays assay. In summary, our data demonstrated that LTCC inhibition could play a main role in the proarrhythmic action of ACO in human cardiomyocytes.	[Wu, Jianjun; Chung, Ying Ying; Koh, Cai Hong; Liu, Zhenfeng; Wei, Heming] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Wang, Xiangchong; Wang, Chuan; Su, Suwen] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Guo, Huicai] Hebei Med Univ, Dept Toxicol, Shijiazhuang, Hebei, Peoples R China; [Yuan, Qiang] Duke NUS Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore; [Wei, Heming] Duke NUS Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore	National Heart Centre Singapore; Hebei Medical University; Hebei Medical University; National University of Singapore; National University of Singapore	Wei, HM (corresponding author), Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore.; Su, SW (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China.; Wei, HM (corresponding author), Duke NUS Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore.	suswmk@hebamu.edu.cn; wei.he.ming@nhcs.com.sg	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; YUAN, Qiang/0000-0003-3077-9548	National Medical Research Council, NMRC [CG12Aug09]; Duke-NUS GOH Cardiovascular Research Award [GCR/2012/0006]; National Natural Science Foundation of China, NSFC [81273600]; Natural Science Foundation of Hebei Province [C2011206145, H2013206147]; National Natural Science Foundation of China [81273600, 31171097]; Natural Science Foundation of Hebei Province, China [C2011206145, C2014206419]	National Medical Research Council, NMRC(National Medical Research Council, Singapore); Duke-NUS GOH Cardiovascular Research Award; National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province, China(Natural Science Foundation of Hebei Province)	This work was supported by: National Medical Research Council, NMRC CG12Aug09, Dr Heming Wei; Duke-NUS GOH Cardiovascular Research Award, GCR/2012/0006, Dr Heming Wei; National Natural Science Foundation of China, NSFC, 81273600, Suwen Su; Natural Science Foundation of Hebei Province, C2011206145, H2013206147, Suwen Su; National Natural Science Foundation of China, No. 81273600, 31171097, Dr Chuan Wang; and the Natural Science Foundation of Hebei Province, China, No. C2011206145, C2014206419, Dr Chuan Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amran MS, 2004, J PHARMACOL EXP THER, V310, P83, DOI 10.1124/jpet.104.066951; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Bartosova L, 2007, EUR J PHARMACOL, V575, P127, DOI 10.1016/j.ejphar.2007.07.044; Belson MG, 2000, AM J EMERG MED, V18, P581, DOI 10.1053/ajem.2000.9264; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Chan TYK, 2009, CLIN TOXICOL, V47, P279, DOI 10.1080/15563650902904407; Chen L, 1995, Yao Xue Xue Bao, V30, P168; Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084; Colussi C, 2010, CARDIOVASC RES, V87, P73, DOI 10.1093/cvr/cvq035; Findlay I, 2004, J PHYSIOL-LONDON, V554, P275, DOI 10.1113/jphysiol.2003.047902; Fu M, 2008, BIOCHEM PHARMACOL, V75, P2147, DOI 10.1016/j.bcp.2008.02.027; Hancox JC, 1996, BRIT J PHARMACOL, V118, P1447, DOI 10.1111/j.1476-5381.1996.tb15559.x; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; HONERJAGER P, 1983, N-S ARCH PHARMACOL, V322, P49, DOI 10.1007/BF00649352; Kim JJ, 2015, J MOL CELL CARDIOL, V81, P81, DOI 10.1016/j.yjmcc.2015.01.013; Kim TK, 2013, J KOREAN SOC EMERGEN, V24, P548; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Linz KW, 2000, PFLUG ARCH EUR J PHY, V439, P588, DOI 10.1007/s004240050982; Liu QH, 2012, J CARDIOVASC PHARM, V59, P37, DOI 10.1097/FJC.0b013e3182350bcc; Lu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115648; Ma DR, 2013, INT J CARDIOL, V168, P5277, DOI 10.1016/j.ijcard.2013.08.015; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Niitsu H, 2013, FORENSIC SCI INT, V227, P111, DOI 10.1016/j.forsciint.2012.10.021; NILIUS B, 1986, GEN PHYSIOL BIOPHYS, V5, P473; O'Hara T, 2012, AM J PHYSIOL-HEART C, V302, pH1023, DOI 10.1152/ajpheart.00785.2011; OHNO Y, 1992, TOHOKU J EXP MED, V167, P155, DOI 10.1620/tjem.167.155; PEPER K, 1967, PFLUG ARCH GES PHYS, V296, P328, DOI 10.1007/BF00362532; Rajamohan D, 2016, STEM CELLS DEV, V25, P439, DOI 10.1089/scd.2015.0253; Rao S, 2000, PFLUG ARCH EUR J PHY, V439, P349, DOI 10.1007/s004240050949; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Sheng XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045963; Spencer CI, 2014, STEM CELL REP, V3, P269, DOI 10.1016/j.stemcr.2014.06.003; TAI YT, 1992, LANCET, V340, P1254, DOI 10.1016/0140-6736(92)92951-B; Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Wang Y, 2008, ICEMS 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ELECTRICAL MACHINES AND SYSTEMS, VOLS 1- 8, P2008; Wright SN, 2002, J PHYSIOL-LONDON, V538, P759, DOI 10.1113/jphysiol.2001.012915; Xie SL, 2015, J ETHNOPHARMACOL, V166, P375, DOI 10.1016/j.jep.2015.03.023; Zhang GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055266; Zhao O, 2007, SHOCK, V28, P717, DOI 10.1097/shk.0b013e318050c914	43	25	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168435	10.1371/journal.pone.0168435	http://dx.doi.org/10.1371/journal.pone.0168435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056022	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100006
J	Zacher, B; Michel, M; Schwalb, B; Cramer, P; Tresch, A; Gagneur, J				Zacher, Benedikt; Michel, Margaux; Schwalb, Bjoern; Cramer, Patrick; Tresch, Achim; Gagneur, Julien			Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; HUMAN GENOME; CHROMATIN-STATE; SYSTEMATIC ANNOTATION; REGULATORY MOTIFS; HOT REGIONS; TRANSCRIPTION; DISCOVERY; ELEMENTS; DISTINCT	Accurate maps of promoters and enhancers are required for understanding transcriptional regulation. Promoters and enhancers are usually mapped by integration of chromatin assays charting histone modifications, DNA accessibility, and transcription factor binding. However, current algorithms are limited by unrealistic data distribution assumptions. Here we propose GenoSTAN (Genomic STate ANnotation), a hidden Markov model overcoming these limitations. We map promoters and enhancers for 127 cell types and tissues from the ENCODE and Roadmap Epigenomics projects, today's largest compendium of chromatin assays. Extensive benchmarks demonstrate that GenoSTAN generally identifies promoters and enhancers with significantly higher accuracy than previous methods. Moreover, GenoSTAN-derived promoters and enhancers showed significantly higher enrichment of complex trait-associated genetic variants than current annotations. Altogether, GenoSTAN provides an easy-to-use tool to define promoters and enhancers in any system, and our annotation of human transcriptional cis-regulatory elements constitutes a rich resource for future research in biology and medicine.	[Zacher, Benedikt; Gagneur, Julien] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci CIPSM, Gene Ctr, Munich, Germany; [Zacher, Benedikt; Gagneur, Julien] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci CIPSM, Dept Biochem, Munich, Germany; [Tresch, Achim] Univ Cologne, Dept Biol, Cologne, Germany; [Tresch, Achim] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Michel, Margaux; Schwalb, Bjoern; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany; [Gagneur, Julien] Tech Univ Munich, Dept Informat, Garching, Germany	University of Munich; University of Munich; University of Cologne; Max Planck Society; Max Planck Society; Technical University of Munich	Zacher, B; Gagneur, J (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci CIPSM, Gene Ctr, Munich, Germany.; Zacher, B; Gagneur, J (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci CIPSM, Dept Biochem, Munich, Germany.; Tresch, A (corresponding author), Univ Cologne, Dept Biol, Cologne, Germany.; Tresch, A (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	benedikt.zacher@gmail.com; tresch@mpipz.mpg.de; gagneur@in.turn.de		Schwalb, Bjorn/0000-0003-2987-2622; Gagneur, Julien/0000-0002-8924-8365	German Academic Exchange Service (DAAD); German Federal Ministry of Education and Research (BMBF e:Bio grant); Deutsche Forschungsgemeinschaft (DFG) [SFB680]; Bavarian Research Center for Molecular Biosystems; Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics" grant [FKZ 01ZX1405A]; Advanced Grant TRANSREGULON of the European Research Council; Deutsche Forschungsgemeinschaft; Volkswagen Foundation; CIMED; SciLifeLab; German Research Foundation (DFG); Technische Universitat Munchen within the Open Access Publishing Funding Programme	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF e:Bio grant)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian Research Center for Molecular Biosystems; Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics" grant(Federal Ministry of Education & Research (BMBF)); Advanced Grant TRANSREGULON of the European Research Council; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); CIMED; SciLifeLab; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the Open Access Publishing Funding Programme	BZ was supported by German Academic Exchange Service (DAAD short term research grant). AT was supported by the German Federal Ministry of Education and Research (BMBF e:Bio grant) and by the Deutsche Forschungsgemeinschaft (DFG SFB680 grant). JG was supported by the Bavarian Research Center for Molecular Biosystems and the Bundesministerium fur Bildung und Forschung, Juniorverbund in der Systemmedizin "mitOmics" grant FKZ 01ZX1405A. PC was funded by Advanced Grant TRANSREGULON of the European Research Council, the Deutsche Forschungsgemeinschaft, the Volkswagen Foundation, CIMED, and SciLifeLab. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the Open Access Publishing Funding Programme.	Andersson R, 2015, BIOESSAYS, V37, P314, DOI 10.1002/bies.201400162; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Benjamini Y, 2001, ANN STAT, V29, P1165; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grotan V, 2008, POILOG POISSON LOGNO; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleftogiannis D, 2016, BRIEF BIOINFORM, V17, P967, DOI 10.1093/bib/bbv101; Kleftogiannis D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1058; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11633; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-199; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mammana A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0708-z; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Org T, 2015, EMBO J, V34, P759, DOI 10.15252/embj.201490542; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Won KJ, 2013, NUCLEIC ACIDS RES, V41, P4423, DOI 10.1093/nar/gkt143; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zacher B, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145654; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5	64	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169249	10.1371/journal.pone.0169249	http://dx.doi.org/10.1371/journal.pone.0169249			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056037	Green Submitted, gold, Green Published			2022-12-26	WOS:000391639100028
J	Gaeta, X; Le, L; Lin, Y; Xie, Y; Lowry, WE				Gaeta, Xavier; Le, Luat; Lin, Ying; Xie, Yuan; Lowry, William E.			Defining Transcriptional Regulatory Mechanisms for Primary let-7 miRNAs	PLOS ONE			English	Article							SMALL TEMPORAL RNAS; CAENORHABDITIS-ELEGANS; STEM-CELLS; C-ELEGANS; MICRORNA; EXPRESSION; LIN28; PROMOTER; GENOME; PROLIFERATION	The let-7 family of miRNAs have been shown to control developmental timing in organisms from C. elegans to humans; their function in several essential cell processes throughout development is also well conserved. Numerous studies have defined several steps of post-transcriptional regulation of let-7 production; from pri-miRNA through pre-miRNA, to the mature miRNA that targets endogenous mRNAs for degradation or translational inhibition. Less-well defined are modes of transcriptional regulation of the pri-miRNAs for let-7. let-7 pri-miRNAs are expressed in polycistronic fashion, in long transcripts newly annotated based on chromatin-associated RNA-sequencing. Upon differentiation, we found that some let-7 pri-miRNAs are regulated at the transcriptional level, while others appear to be constitutively transcribed. Using the Epigenetic Roadmap database, we further annotated regulatory elements of each polycistron identified putative promoters and enhancers. Probing these regulatory elements for transcription factor binding sites identified factors that regulate transcription of let-7 in both promoter and enhancer regions, and identified novel regulatory mechanisms for this important class of miRNAs.	[Gaeta, Xavier; Lowry, William E.] Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA; [Gaeta, Xavier; Lin, Ying; Lowry, William E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Le, Luat; Xie, Yuan; Lowry, William E.] Univ Calif Los Angeles, Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Lowry, William E.] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lowry, WE (corresponding author), Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA.; Lowry, WE (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Lowry, WE (corresponding author), Univ Calif Los Angeles, Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Lowry, WE (corresponding author), Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	blowry@ucla.edu		Gaeta, Xavier/0000-0002-2097-9581	National Institutes of Health (NIH) [P01GM99134]; NRSA-NIH-GMS [GM113641-01]; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, F31GM113641] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA-NIH-GMS; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH, P01GM99134) to WEL and an NRSA-NIH-GMS to XG. This research was also supported by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We highly appreciate the outstanding technical support given to this work by Jessica Cinkornpumin. This work was funded by the National Institutes of Health (NIH, P01GM99134) to WEL and an NRSA-NIH-GMS (GM113641-01) to XG. This research was also supported by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group	Amin V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7370; Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2015, GENOME RES, V25, P1401, DOI 10.1101/gr.193607.115; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guan HY, 2011, MOL BIOL REP, V38, P5327, DOI 10.1007/s11033-011-0683-8; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hosseinpour B, 2013, GENE, V531, P212, DOI 10.1016/j.gene.2013.09.011; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Mullard A, 2015, NAT REV DRUG DISCOV, V14, P223, DOI 10.1038/nrd4582; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Patterson M, 2014, STEM CELL REPORTS; Patterson M, 2012, CELL RES, V22, P178, DOI 10.1038/cr.2011.133; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040; Triboulet R, 2015, CELL REP, V13, P260, DOI 10.1016/j.celrep.2015.08.086; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Xie Y, 2014, STEM CELL REPORTS; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	40	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169237	10.1371/journal.pone.0169237	http://dx.doi.org/10.1371/journal.pone.0169237			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052101	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500038
J	Nagy-Reis, MB; Nichols, JD; Chiarello, AG; Ribeiro, MC; Betz, EZF				Nagy-Reis, Mariana B.; Nichols, James D.; Chiarello, Adriano G.; Ribeiro, Milton Cezar; Betz, Eleonore Z. F.			Landscape Use and Co-Occurrence Patterns of Neotropical Spotted Cats	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; OCELOT LEOPARDUS-PARDALIS; SPECIES OCCURRENCE; CARNIVORA FELIDAE; PUMA-CONCOLOR; FOOD-HABITS; OCCUPANCY; CONSERVATION; MAMMALS; IDENTIFICATION	Small felids influence ecosystem dynamics through prey and plant population changes. Although most of these species are threatened, they are accorded one of the lowest research efforts of all felids, and we lack basic information about them. Many felids occur in sympatry, where intraguild competition is frequent. Therefore, assessing the role of inter specific interactions along with the relative importance of landscape characteristics is necessary to understand how these species co-occur in space. Here, we selected three morphologically similar and closely related species of small Neotropical cats to evaluate the roles of interspecific interactions, geomorphometry, environmental, and anthropogenic landscape characteristics on their habitat use. We collected data with camera trapping and scat sampling in a large protected Atlantic forest remnant (35,000 ha). Throughout occupancy modeling we investigated whether these species occur together more or less frequently than would be expected by chance, while dealing with imperfect detection and incorporating possible habitat preferences into the models. We used occupancy as a measure of their habitat use. Although intraguild competition can be an important determinant of carnivore assemblages, in our system, we did not find evidence that one species affects the habitat use of the other. Evidence suggested that proximity to the nature reserve (a more protected area) was a more important driver of Neotropical spotted cats' occurrence than interspecific interactions or geomorphometry and environmental landscape characteristics even though our entire study area is under some type of protection. This suggests that small felids can be sensitive to the area protection status, emphasizing the importance of maintaining and creating reserves and other areas with elevated protection for the proper management and conservation of the group.	[Nagy-Reis, Mariana B.; Betz, Eleonore Z. F.] Univ Estadual Campinas, Dept Anim Biol, UNICAMP, Campinas, SP, Brazil; [Nichols, James D.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Chiarello, Adriano G.] Univ Sao Paulo, Dept Biol, Ribeirao Preto, SP, Brazil; [Ribeiro, Milton Cezar] Univ Estadual Sao Paulo UNESP, Dept Ecol, Spatial Ecol & Conservat Lab LEEC, Rio Claro, SP, Brazil	Universidade Estadual de Campinas; United States Department of the Interior; United States Geological Survey; Universidade de Sao Paulo; Universidade Estadual Paulista	Nagy-Reis, MB (corresponding author), Univ Estadual Campinas, Dept Anim Biol, UNICAMP, Campinas, SP, Brazil.	mariana.nbreis@gmail.com	Nichols, James/AAG-1500-2019; Chiarello, Adriano Garcia/G-2510-2012; Setz, Eleonore Z F/C-1050-2012; Nichols, James/AAF-7336-2020	Chiarello, Adriano Garcia/0000-0003-1914-5480; Setz, Eleonore Z F/0000-0001-7638-7086; 	Coordination for the Improvement of Higher Education Personnel (CAPES); Idea Wild; Sao Paulo Research Foundation (FAPESP) [2013/07162-6, 2013/50421-2]; Brazilian Science Council (CNPq) [305902/2014-8, 312045/2013-1]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Idea Wild; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Science Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MBNR received funding from the Coordination for the Improvement of Higher Education Personnel (CAPES; www.capes.gov.br) and Idea Wild (www.ideawild.org). EZFS received funding from the Sao Paulo Research Foundation (FAPESP; grant 2013/07162-6; www.fapesp.br). AGC received funding from The Brazilian Science Council (CNPq; process 305902/2014-8; www.cnpq.br). MCR has been continuously supported by grants and scholarships from The Brazilian Science Council (CNPq; process 312045/2013-1) and Sao Paulo Research Foundation (FAPESP; grant 2013/50421-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	alvarez B, 2013, PLATAFORMA QGIS; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andreasen James K., 2001, Ecological Indicators, V1, P21, DOI 10.1016/S1470-160X(01)00007-3; [Anonymous], 1992, HIST NATURAL SERRA J; Bianchi RD, 2011, ZOOLOGIA-CURITIBA, V28, P127, DOI 10.1590/S1984-46702011000100018; Boscolo D, 2009, LANDSCAPE ECOL, V24, P907, DOI 10.1007/s10980-009-9370-8; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CARLEY C J, 1970, Southwestern Naturalist, V15, P209, DOI 10.2307/3670349; Carrillo E, 2000, CONSERV BIOL, V14, P1580, DOI 10.1046/j.1523-1739.2000.99103.x; Carvajal-Villarreal S, 2012, MAMMALIA, V76, P237, DOI 10.1515/mammalia-2011-0100; Catullo G, 2008, BIOL CONSERV, V141, P2730, DOI 10.1016/j.biocon.2008.08.019; Cavalcanti SMC, 2011, BIOL CONSERVATION WI, P383; Chaves PB, 2012, MOL ECOL RESOUR, V12, P18, DOI 10.1111/j.1755-0998.2011.03056.x; Chernova OF., 2001, DOKL AKAD NAUK, V376, P81, DOI DOI 10.1023/A:1018854816328; Ciocheti G, 2014, THESIS; Craft ME, 2011, BIOL CONSERVATION WI, P263; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Bianchi RD, 2007, AM J PRIMATOL, V69, P1173, DOI 10.1002/ajp.20415; De Marinis AM, 2006, WILDLIFE BIOL, V12, P305, DOI 10.2981/0909-6396(2006)12[305:HIKOWA]2.0.CO;2; de Oliveira T, 2008, LEOPARDUS TIGRINUS I; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Dinata Y, 2008, BIRD CONSERV INT, V18, P30, DOI 10.1017/S0959270908000051; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Eckstein RA, 2000, APPL ANIM BEHAV SCI, V68, P131, DOI 10.1016/S0168-1591(00)00094-0; EMMONS LH, 1988, REV ECOL-TERRE VIE, V43, P133; ESRI, 2009, ARCGIS; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Feer F, 1997, NEOTROPICAL RAINFORE; Gompper ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146055; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Haines AM, 2005, J WILDLIFE MANAGE, V69, P255, DOI 10.2193/0022-541X(2005)069<0255:SASOMI>2.0.CO;2; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Hetherington DA, 2007, BIOL CONSERV, V137, P37, DOI 10.1016/j.biocon.2007.01.009; HILTON H, 1978, AM MIDL NAT, V100, P223, DOI 10.2307/2424793; Hines J., 2006, PRESENCE2 SOFTWARE E; INPE (BR), 2014, TOP BANC DAD GEOM BR; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; Jackson P., 1996, BIOL CONSERVATION; Jackson RM, 2011, BIOL CONSERVATION WI, P417; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth KU, 2011, BIOL CONSERVATION WI, P197; Kendall Katherine C., 2008, P141; KENNEDY AJ, 1982, CAN J ZOOL, V60, P536, DOI 10.1139/z82-080; KITCHENER A., 1991, NATURAL HIST WILD CA; Kitchener AC, 2011, BIOL CONSERVATION WI, P83; Konecny M.J., 1989, P243; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Licona M, 2011, ANIM CONSERV, V14, P206, DOI 10.1111/j.1469-1795.2010.00416.x; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Loveridge AJ, 2011, BIOL CONSERVATION WI, P161; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; Macdonald DW, 2011, BIOL CONSERVATION WI, P3; Macdonald DW, 2011, BIOL CONSERVATION WI, P599; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie Darryl I., 2004, P149; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manly B.F.J., 2002, RESOURCE SELECTION A; Meng J, 1997, NATURE, V385, P712, DOI 10.1038/385712a0; Meza AD, 2002, AM MIDL NAT, V148, P146; Michalski F, 2006, ANIM CONSERV, V9, P179, DOI 10.1111/j.1469-1795.2006.00025.x; Miotto RA., 2007, Braz. J. Biol., V67, P963, DOI 10.1590/S1519-69842007000500023; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; MUKHERJEE S, 1994, MAMMALIA, V58, P139, DOI 10.1515/mamm.1994.58.1.139; Munson L, 2011, BIOL CONSERVATION WI, P237; Murphy T, 2011, BIOL CONSERVATION WI, P431; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy-Reis MB, 2015, 52 AN BEH M; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; Oliveira TG., 1994, NEOTROPICAL CATS ECO; Oliveira TG, 2011, BIOL CONSERVATION WI, P559; Oliveira-Santos LGR, 2008, J TROP ECOL, V24, P563, DOI 10.1017/S0266467408005324; Oliveira-Santos LGR, 2012, ZOOLOGIA-CURITIBA, V29, P115, DOI 10.1590/S1984-46702012000200003; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Phillips A., 2004, PARKS, V14, P4; Quadros Juliana, 2010, Arquivos do Museu Nacional Rio de Janeiro, V68, P47; Quadros T, 2006, REV BRAS ZOOL, V23, P274; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; ROSENZWEIG ML, 1966, J MAMMAL, V47, P602, DOI 10.2307/1377891; Samejima H, 2012, FOREST ECOL MANAG, V270, P248, DOI 10.1016/j.foreco.2012.01.013; Sanderson JG, 2011, SMALL WILD CATS ANIM; Sarmento PB, 2011, EUR J WILDLIFE RES, V57, P119, DOI 10.1007/s10344-010-0405-x; SCHOENER TW, 1982, AM SCI, V70, P586; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Silva-Pereira JE, 2011, MAMM BIOL, V76, P308, DOI 10.1016/j.mambio.2010.09.001; SMPMA-Secretaria Municipal de Planejamento e Meio Ambiente, 2008, PLAN MAN RES BIOL MU; Soulu M., 1999, CONTINENTAL CONSERVA; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Taberlet P, 2001, CONSERV BIOL SER, V5, P313; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; TEAM Network, 2011, TERRESTRIAL VERTEBRA; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Vanstreels RET, 2010, BIOTA NEOTROP, V10, P333, DOI 10.1590/S1676-06032010000100029; Torre Ignacio, 2005, Galemys, V17, P41; Trigo TC, 2013, CURR BIOL, V23, P2528, DOI 10.1016/j.cub.2013.10.046; Trigo TC, 2013, STUD NEOTROP FAUNA E, V48, P56, DOI 10.1080/01650521.2013.774789; Wang E, 2002, STUD NEOTROP FAUNA E, V37, P207, DOI 10.1076/snfe.37.3.207.8564; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	116	43	43	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168441	10.1371/journal.pone.0168441	http://dx.doi.org/10.1371/journal.pone.0168441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052073	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500015
J	Tang, WT; Pu, CF; Li, M				Tang, Wenting; Pu, Chuanfen; Li, Man			Interaction between Antibacterial Peptide Apep10 and Escherichia coli Membrane Lipids Evaluated Using Liposome as Pseudo-Stationary Phase	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; CAPILLARY-ELECTROPHORESIS; ELECTROKINETIC CHROMATOGRAPHY; STAPHYLOCOCCUS-AUREUS; BINDING; THERMODYNAMICS; PHOSPHOLIPIDS; PERFORMANCE; PROTEINS; BILAYERS	Liposomes constructed from Escherichia coli membrane lipids were used as a pseudo-stationary phase in capillary electrophoresis and immobilised liposome chromatography to evaluate the interaction between antibacterial peptide (ABP) Apep10 and bacterial membrane lipids. The peptide mobility decreased as the concentration of liposomes increased, providing evidence for the existence of this interaction. The binding constant between Apep10 and the Escherichia coli membranes lipid liposome was higher than that of Apep10 with a mixed phospholipids liposome at the same temperature. The capillary electrophoresis results indicate that the binding ability of Apep10 with a liposome was dependent on the liposome's lipid compositions. Thermodynamic analysis by immobilised liposome chromatography indicated that hydrophobic and electrostatic effects contributed to the partitioning of Apep10 in the membrane lipids. The liposomes constructed from bacterial membrane lipid were more suitable as the model membranes used to study dynamic ABP/membrane interactions than those constructed from specific ratios of particular phospholipids, with its more biomimetic phospholipid composition and contents. This study provides an appropriate model for the evaluation of ABP-membrane interactions.	[Tang, Wenting; Pu, Chuanfen; Li, Man] Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao 266109, Peoples R China	Qingdao Agricultural University	Tang, WT (corresponding author), Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao 266109, Peoples R China.	twtfly@126.com			University Science and Technology Project of Shandong Province of China [J16LE22]; Doctoral Science Foundation of Shandong Province of China [BS2015SW019]; Advanced Talents Foundation of Qingdao Agricultural University [6631115030]	University Science and Technology Project of Shandong Province of China; Doctoral Science Foundation of Shandong Province of China; Advanced Talents Foundation of Qingdao Agricultural University	This study was supported by University Science and Technology Project of Shandong Province of China (no. J16LE22, http://www.sdedu.gov.cn/, WT), Doctoral Science Foundation of Shandong Province of China (no. BS2015SW019, http://www.sdstc.gov.cn/, WT), and Advanced Talents Foundation of Qingdao Agricultural University (no. 6631115030, www.qau.edu.cn, WT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey C, 2008, J MOL BIOL, V375, P376, DOI 10.1016/j.jmb.2007.10.053; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bilek G, 2006, J CHROMATOGR B, V841, P38, DOI 10.1016/j.jchromb.2006.03.031; Boija E, 2006, BBA-BIOMEMBRANES, V1758, P620, DOI 10.1016/j.bbamem.2006.04.007; Bonev BB, 2000, BIOCHEMISTRY-US, V39, P11425, DOI 10.1021/bi0001170; Choi MJ, 2004, PEPTIDES, V25, P675, DOI 10.1016/j.peptides.2004.01.004; Corradini D, 2004, J CHROMATOGR A, V1051, P103, DOI 10.1016/j.chroma.2004.06.116; Dennison SR, 2006, BIOCHEM BIOPH RES CO, V347, P1006, DOI 10.1016/j.bbrc.2006.06.181; El-Hady D, 2010, J PHARMACEUT BIOMED, V52, P232, DOI 10.1016/j.jpba.2009.12.022; Faccone D, 2014, EUR J MED CHEM, V71, P31, DOI 10.1016/j.ejmech.2013.10.065; Franzen U, 2011, ELECTROPHORESIS, V32, P738, DOI 10.1002/elps.201000552; Fu HQ, 2011, ELECTROPHORESIS, V32, P749, DOI 10.1002/elps.201000618; Gallagher ES, 2015, J CHROMATOGR A, V1385, P28, DOI 10.1016/j.chroma.2015.01.052; Liang C, 2015, TRAC-TREND ANAL CHEM, V68, P28, DOI 10.1016/j.trac.2015.02.009; Liu XY, 2001, J CHROMATOGR B, V750, P51, DOI 10.1016/S0378-4347(00)00427-8; Mady MM, 2012, CELL BIOCHEM BIOPHYS, V62, P481, DOI 10.1007/s12013-011-9334-x; Mady MM, 2011, MOL PHYS, V109, P1593, DOI 10.1080/00268976.2011.575408; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Ngo KX, 2009, COLLOID SURFACE B, V73, P399, DOI 10.1016/j.colsurfb.2009.06.015; Penn SG, 2002, J PHYS CHEM, V99, P3875; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SCHMALZING D, 1993, J CHROMATOGR A, V652, P149, DOI 10.1016/0021-9673(93)80655-R; Sevcsik E, 2007, BBA-BIOMEMBRANES, V1768, P2586, DOI 10.1016/j.bbamem.2007.06.015; Tanaka Y, 2002, J CHROMATOGR B, V768, P81, DOI 10.1016/S0378-4347(01)00488-1; Tang WT, 2014, J AGR FOOD CHEM, V62, P1564, DOI 10.1021/jf4052286; van Kan EJM, 2003, BBA-BIOMEMBRANES, V1615, P84, DOI 10.1016/S0005-2736(03)00233-5; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Wang TH, 2010, J MOL STRUCT, V970, P128, DOI 10.1016/j.molstruc.2010.02.061; Wiedmer SK, 2004, TRAC-TREND ANAL CHEM, V23, P562, DOI 10.1016/j.trac.2004.03.001; Xiao JH, 2012, J AGR FOOD CHEM, V60, P4535, DOI 10.1021/jf2052509; Yoshimoto N, 2006, BIOCHEM ENG J, V29, P174, DOI 10.1016/j.bej.2005.08.030; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang HJ, 2014, ANAL METHODS-UK, V6, P725, DOI 10.1039/c3ay41541d; ZHANG YX, 1995, ANAL BIOCHEM, V229, P291, DOI 10.1006/abio.1995.1415	34	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0164594	10.1371/journal.pone.0164594	http://dx.doi.org/10.1371/journal.pone.0164594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052090	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500003
J	Wang, SC; Lai, KR; Li, CY; Chiang, CS; Yu, GY; Sakamoto, N; Tu, WY; Hsieh, MH; Huang, JF; Chuang, WL; Dai, CY; Yu, ML				Wang, Shu-Chi; Lai, Kuan-Ru; Li, Chia-Yang; Chiang, Chi-Shiun; Yu, Guann-Yi; Sakamoto, Naoya; Tu, Wen-Yu; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Chuang, Wan-Long; Dai, Chia-Yen; Yu, Ming-Lung			The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities	PLOS ONE			English	Article							VIRUS CORE PROTEIN; REPLICATION; LIVER; GENE; ATM	Hepatitis C virus (HCV)-induced hepatic stress is associated with increased oxidative DNA damage and has been implicated in hepatic inflammation. However, HCV infection and replication are uneven and vary among individual hepatocytes. To investigate the effect of the viral load on host DNA damage, we used an Enhanced Yellow Fluorescent Protein gene (EYFP)-tagged HCV virus to distinguish between HCV intracellular high viral load (HVL) cells and low viral load (LVL) cells. The cell sorting efficiency was confirmed by the high expression of the HCV polyprotein. We found DNA damage gamma-H2AX foci in the HVL population. Comet assays demonstrated that HVL was related to the extent of the DNA strand breaks. Surprisingly, the DNA qPCR arrays and western blotting showed that the damage-related genes GPX2, MRE11, phospho-ATM, and OGG1 were significantly up-regulated in LVL cells but inversely down-regulated or consistently expressed in HVL cells. The colony survival assay to examine the repair abilities of these cells in response to irradiation showed that the LVL cells were more resistant to irradiation and had an increased ability to repair radiation-induced damage. This study found that intracellular viral loads drove cellular DNA damage levels but suppressed damage-related gene expression. However, the increase in damage-related gene expression in the LVL cells may be affected by ROS from the HVL cells. These findings provide new insights into the distinct DNA damage and repair responses resulting from different viral loads in HCV-infected cells.	[Wang, Shu-Chi; Hsieh, Meng-Hsuan; Dai, Chia-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan; [Lai, Kuan-Ru] Changhua Christian Hosp, Changhua, Taiwan; [Li, Chia-Yang] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Li, Chia-Yang; Chuang, Wan-Long; Dai, Chia-Yen; Yu, Ming-Lung] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Sakamoto, Naoya] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Tu, Wen-Yu; Huang, Jee-Fu; Chuang, Wan-Long; Dai, Chia-Yen; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Hsieh, Meng-Hsuan; Chuang, Wan-Long; Dai, Chia-Yen; Yu, Ming-Lung] Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan; [Huang, Jee-Fu; Chuang, Wan-Long; Dai, Chia-Yen; Yu, Ming-Lung] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan; [Yu, Ming-Lung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Tsing Hua University; National Health Research Institutes - Taiwan; Tokyo Medical & Dental University (TMDU); Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University	Dai, CY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan.; Dai, CY; Yu, ML (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Dai, CY; Yu, ML (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Dai, CY; Yu, ML (corresponding author), Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan.; Dai, CY; Yu, ML (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Yu, ML (corresponding author), Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan.; Yu, ML (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.	daichiayen@gmail.com; fish6069@gmail.com	Huang, Jee-Fu/AAX-4622-2020; Chiang, Chi-Shiun/A-9562-2008; Hsieh, Meng Hsuan/AAY-7973-2021; Dai, Chia-Yen/V-6560-2019; Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Yu, Guann-Yi/O-5139-2019	Huang, Jee-Fu/0000-0002-2752-7051; Chiang, Chi-Shiun/0000-0002-2581-4129; Dai, Chia-Yen/0000-0003-2296-3054; Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Yu, Guann-Yi/0000-0002-0580-8282; LI, CHIA-YANG/0000-0001-5689-9850; Hsieh, Meng-Hsuen/0000-0001-9739-3901	Ministry of Science Technology [MOST-104-2314-B-037-089]; Kaohsiung Medical University Hospital; Kaohsiung Medical University Aim for the Top Universities Grant [KMU-TP104E07, KMU-TP104E08, KMU-TP104E09];  [105-CCH-KMU-001]	Ministry of Science Technology; Kaohsiung Medical University Hospital; Kaohsiung Medical University Aim for the Top Universities Grant; 	This study is supported by the Ministry of Science Technology (MOST-104-2314-B-037-089), and Kaohsiung Medical University Hospital and grants from Kaohsiung Medical University "Aim for the Top Universities Grant (KMU-TP104E07, KMU-TP104E08 and KMU-TP104E09), and grants from 105-CCH-KMU-001. The foundation and institutes did not influence the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Arciello M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/971024; Baek KH, 2006, J MOL BIOL, V359, P22, DOI 10.1016/j.jmb.2006.03.020; Bittar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062581; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; D'Odorico A, 1999, HEPATO-GASTROENTEROL, V46, P1831; DeMaria N, 1996, FREE RADICAL BIO MED, V21, P291, DOI 10.1016/0891-5849(96)00044-5; Farinati F, 2002, MOL CELL ENDOCRINOL, V193, P85, DOI 10.1016/S0303-7207(02)00100-4; Graw F, 2015, J VIROL, V89, P6551, DOI 10.1128/JVI.00016-15; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0; Huang CF, 2014, J HEPATOL, V61, P67, DOI 10.1016/j.jhep.2014.02.022; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Korenaga M, 2005, J CLIN GASTROENTEROL, V39, pS162, DOI 10.1097/01.mcg.0000155517.02468.46; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Saito K, 2006, J VIROL, V80, P4372, DOI 10.1128/JVI.80.9.4372-4379.2006; van Pelt JF, 2004, CANCER LETT, V209, P197, DOI 10.1016/j.canlet.2003.11.035; Wang SC, 2011, INT J RADIAT BIOL, V87, P432, DOI 10.3109/09553002.2011.538128; Yamamoto M, 2011, HEPATOL RES, V41, P258, DOI 10.1111/j.1872-034X.2010.00771.x; Yeh ML, 2015, KAOHSIUNG J MED SCI, V31, P77, DOI 10.1016/j.kjms.2014.11.003; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	24	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0164281	10.1371/journal.pone.0164281	http://dx.doi.org/10.1371/journal.pone.0164281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052067	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500002
J	Wang, S; Xu, YR; Shen, ZY; Wang, LJ; Qiao, F; Zhang, X; Li, MH; Wu, LG				Wang, Shuang; Xu, Yiran; Shen, Zhengyan; Wang, Lijun; Qiao, Feng; Zhang, Xu; Li, Minghua; Wu, Ligeng			The Extent of the Crack on Artificial Simulation Models with CBCT and Periapical Radiography	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ROOT FRACTURES; DIAGNOSIS; TEETH; MANAGEMENT; DENSITY	Background The aim of this study was to investigate the extent of the crack of a cracked tooth on an artificial simulation model with Periapical Radiography (PR) and cone beam computed tomography (CBCT) in vitro, providing the basis for early diagnosis and an appropriate treatment plan. Methods Forty-four teeth with different extents of artificial cracks, created by exposure to liquid nitrogen after hot water at 100 degrees C, were collected. They were subjected to PR and CBCT. Microcomputed tomography (micro-CT) examination, regarded as a relatively more accurate measurement than others, was used to measure and record the crack depth. Three observers, an endodontic graduate student, an experienced endodontist, and an experienced radiologist, examined the PR and CBCT results independently, and the presence or absence of cracks with PR and CBCT were respectively recorded. The external consistency ICC with 95% confidence interval (95% CI) was used to analyze the consistency among the graduate student, endodontist, and radiologist; ROC curves were used for the analysis of diagnostic performance of both radiographic modalities for tooth cracks with crack depth. Results For the interpretation of the PR results, there were statistically significant differences among the three different observers (P < 0.001), and the interpretation of the CBCT results (P < 0.001). In the group of results read by the graduate student, the sensitivity of diagnosis with CBCT and PR was 77.27% and 22.73%, respectively (P < 0.001). In the group of results read by the endodontist, the sensitivity of diagnosis with CBCT and PR was 81.81% and 8.19%, respectively (P < 0.001). In the group of results read by the radiologist, the sensitivity of diagnosis with CBCT and PR was 88.64% and 11.36%, respectively (P < 0.001). As for CBCT diagnosis, the critical value for the graduate, endodontist, and radiologist was 3.20 mm, 2.06 mm, and 1.24 mm, respectively. For the PR diagnosis, the critical value for the graduate, endodontist, and radiologist was 6.12 mm, 6.94 mm, and 6.94 mm, respectively. Conclusions Within the limitations of this study, on an artificial simulation model of cracked teeth for early diagnosis, we recommend that it would be better for a cracked tooth to be diagnosed by a radiologist with CBCT than PR, CBCT with a minimum depth of 1.24 mm.	[Wang, Shuang; Shen, Zhengyan; Zhang, Xu; Wu, Ligeng] Tianjin Med Univ, Sch Stomatol, Dept Endodont, Tianjin, Peoples R China; [Xu, Yiran] Stomatol Hosp Yantai, Dept Endodont, Yantai, Shandong, Peoples R China; [Wang, Lijun] Tianjin Med Univ, Sch Stomatol, Dept Radiol, Tianjin, Peoples R China; [Qiao, Feng] Tianjin Med Univ, Sch Stomatol, Dept Maxillofacial Surg, Tianjin, Peoples R China; [Li, Minghua] BYBO Dent Grp, Beijing, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wu, LG (corresponding author), Tianjin Med Univ, Sch Stomatol, Dept Endodont, Tianjin, Peoples R China.	lwu06@tmu.edu.cn	Qiao, Feng/ABA-3328-2021		National Natural Science Foundation of China [81571016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant no. 81571016).	Andreasen J.OA.LA.F, 2012, TXB COLOR ATLAS DENT; Berman LH, 2010, J ENDODONT, V36, P442, DOI 10.1016/j.joen.2009.12.018; Christensen GJ, 2007, J AM DENT ASSOC, V138, P101, DOI 10.14219/jada.archive.2007.0028; Farman AG, 2005, ORAL SURG ORAL MED O, V100, P395, DOI 10.1016/j.tripleo.2005.05.055; Geurtsen W, 2003, QUINTESSENCE INT, V34, P409; Hassan B, 2010, J ENDODONT, V36, P126, DOI 10.1016/j.joen.2009.09.013; Hassan B, 2009, J ENDODONT, V35, P719, DOI 10.1016/j.joen.2009.01.022; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; Katsumata A, 2009, ORAL SURG ORAL MED O, V107, P420, DOI 10.1016/j.tripleo.2008.05.049; Kim S, 2012, J ENDODONT, V38, P153, DOI 10.1016/j.joen.2011.09.008; Kim SY, 2013, J ENDODONT, V39, P449, DOI 10.1016/j.joen.2012.11.052; Liang X, 2010, EUR J RADIOL, V75, P265, DOI 10.1016/j.ejrad.2009.03.042; LLOYD BA, 1978, J DENT RES, V57, P571, DOI 10.1177/00220345780570040701; Lubisich EB, 2010, J ESTHET RESTOR DENT, V22, P158, DOI 10.1111/j.1708-8240.2010.00330.x; Mathew S, 2012, J PHARM BIOALLIED SC, V4, pS242, DOI 10.4103/0975-7406.100219; May JJ, 2013, PEDIATR DENT, V35, P120; Michaelson PL, 2015, J ENDODONT, V41, P130, DOI 10.1016/j.joen.2014.06.021; Opdam NJM, 2008, J ENDODONT, V34, P808, DOI 10.1016/j.joen.2008.04.011; Ozer SY, 2010, J ENDODONT, V36, P1245, DOI 10.1016/j.joen.2010.03.021; Scarfe WC, 2009, INT J DENT, V2009, DOI 10.1155/2009/634567; Melo SLS, 2010, J ENDODONT, V36, P1879, DOI 10.1016/j.joen.2010.08.025; Todd Randolph, 2014, Dent Clin North Am, V58, P523, DOI 10.1016/j.cden.2014.03.003; Venskutonis T, 2014, J ENDODONT, V40, P1895, DOI 10.1016/j.joen.2014.05.009	23	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169150	10.1371/journal.pone.0169150	http://dx.doi.org/10.1371/journal.pone.0169150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052126	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500036
J	Zhou, H; Liu, Y; Zhu, R; Ding, F; Wan, Y; Li, Y; Liu, Z				Zhou, H.; Liu, Y.; Zhu, R.; Ding, F.; Wan, Y.; Li, Y.; Liu, Z.			FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation	ONCOGENE			English	Article							F-BOX PROTEIN; SCF UBIQUITIN LIGASE; P38-ALPHA MAP KINASE; INDUCED DNA-DAMAGE; TUMOR-SUPPRESSOR; CELL PROLIFERATION; DOWN-REGULATION; MUSCLE ATROPHY; GENE; IDENTIFICATION	Kruppel- like factor 4 (KLF4, GKLF) is a zinc-finger transcription factor involved in a large variety of cellular processes, including apoptosis, cell cycle progression, as well as stem cell renewal. KLF4 is critical for cell fate decision and has an ambivalent role in tumorigenesis. Emerging data keep reminding us that KLF4 dysregulation either facilitates or impedes tumor progression, making it important to clarify the regulating network of KLF4. Like most transcription factors, KLF4 has a rather short half-life within the cell and its turnover must be carefully orchestrated by ubiquitination and ubiquitin-proteasome system. To better understand the mechanism of KLF4 ubiquitination, we performed a genome-wide screen of E3 ligase small interfering RNA library based on western blot and identified SCF-FBXO32 to be a new E3 ligase, which is responsible for KLF4 ubiquitination and degradation. The F-box domain is critical for FBXO32-dependent KLF4 ubiquitination and degradation. Furthermore, we demonstrated that FBXO32 physically interacts with the N-terminus (1-60 aa) of KLF4 via its C-terminus (228-355 aa) and directly targets KLF4 for ubiquitination and degradation. We also found out that p38 mitogen-activated protein kinase pathway may be implicated in FBXO32-mediated ubiquitination of KLF4, as p38 kinase inhibitor coincidently abrogates endogenous KLF4 ubiquitination and degradation, as well as FBXO32-dependent exogenous KLF4 ubiquitination and degradation. Finally, FBXO32 inhibits colony formation in vitro and primary tumor initiation and growth in vivo through targeting KLF4 into degradation. Our findings thus further elucidate the tumor-suppressive function of FBXO32 in breast cancer. These results expand our understanding of the posttranslational modification of KLF4 and of its role in breast cancer development and provide a potential target for diagnosis and therapeutic treatment of breast cancer.	[Zhou, H.; Liu, Y.; Zhu, R.; Ding, F.; Li, Y.; Liu, Z.] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zhou, H.; Liu, Y.; Zhu, R.; Ding, F.; Li, Y.; Liu, Z.] Peking Union Med Coll, Collaborat Innovat Ctr Canc Med, Beijing 100021, Peoples R China; [Wan, Y.] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA USA; [Wan, Y.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, Y; Liu, Z (corresponding author), Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Li, Y; Liu, Z (corresponding author), Peking Union Med Coll, Collaborat Innovat Ctr Canc Med, Beijing 100021, Peoples R China.	liyi@cicams.ac.cn; liuzh@cicams.ac.cn	Liu, Yongshuo/GRX-6416-2022; Liu, Yongshuo/AGZ-8274-2022	Liu, Yongshuo/0000-0001-8190-0139; Liu, Yongshuo/0000-0001-8190-0139	National Natural Science Foundation of China [81130043, 81420108025]; Ministry of Science and Technology [2016YFC1302100, 2013CB911004]; NATIONAL CANCER INSTITUTE [R01CA202963, R01CA154695] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by National Natural Science Foundation of China (81130043 and 81420108025) and grants from the Ministry of Science and Technology (2016YFC1302100 and 2013CB911004).	Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Derbre F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046668; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guo W, 2015, NEOPLASMA, V62, P646, DOI 10.4149/neo_2015_078; Hu D, 2012, J BIOL CHEM, V287, P13584, DOI 10.1074/jbc.M112.343566; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jogo M, 2009, FEBS LETT, V583, P2715, DOI 10.1016/j.febslet.2009.07.033; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li Y, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002392; Luo AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096610; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mei ZC, 2015, J BIOL CHEM, V290, P16202, DOI 10.1074/jbc.M115.645978; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Tian X, 2015, ONCOTARGET, V6, P22767, DOI 10.18632/oncotarget.4082; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2016, CANCER CELL, V29, P324, DOI 10.1016/j.ccell.2016.02.005; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wu Z, 2011, CELL DEATH DIFFER, V18, P1771, DOI 10.1038/cdd.2011.48; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	50	41	43	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3312	3321		10.1038/onc.2016.479	http://dx.doi.org/10.1038/onc.2016.479			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28068319	Green Accepted			2022-12-26	WOS:000402869800010
J	Astapenkova, A; Heneberg, P; Bogusch, P				Astapenkova, Alena; Heneberg, Petr; Bogusch, Petr			Larvae and Nests of Aculeate Hymenoptera ( Hymenoptera: Aculeata) Nesting in Reed Galls Induced by Lipara spp. (Diptera: Chloropidae) with a Review of Species Recorded. Part II.	PLOS ONE			English	Review							SERVE	The ability of aculeate Hymenoptera to utilize wetlands is poorly understood, and descriptions of their nests and developmental stages are largely absent. Here we present results based on our survey of hymenopterans using galls induced by Lipara spp. flies on common reed Phragmites australis in the years 2015-2016. We studied 20,704 galls, of which 9,446 were longitudinally cut and the brood from them reared in the laboratory, while the remaining 11,258 galls reared in rearing bags also in laboratory conditions. We recorded eight species that were previously not known to nest in reed galls: cuckoo wasps Chrysis rutilans and Trichrysis pumilionis, solitary wasps Stenodynerus chevrieranus and Stenodynerus clypeopictus, and bees Pseudoanthidium tenellum, Stelis punctulatissima, Hylaeus communis and Hylaeus confusus. Forty five species of Hymenoptera: Aculeata are known to be associated with reed galls, of which 36 make their nests there, and the other are six parasitoids of the family Chrysididae and three cuckoo bees of the genus Stelis. Of these species, Pemphredon fabricii and in southern Europe also Heriades rubicola are very common in reed galls, followed by Hylaeus pectoralis and two species of the genus Trypoxylon. We also found new host-parasite associations: Chrysis angustula in nests of Pemphredon fabricii, Chrysis rutilans in nests of Stenodynerus clypeopictus, Trichrysis pumilionis in nests of Trypoxylon deceptorium, and Stelis breviuscula in nests of Heriades rubicola. We provide new descriptions of the nests of seven species nesting in reed galls and morphology of mature larvae of eight species nesting in reed galls and two parasitoids and one nest cleptoparasite. The larvae are usually very similar to those of related species but possess characteristics that make them easy to distinguish from related species. Our results show that common reeds are not only expansive and harmful, but very important for many insect species associated with habitats dominated by this plant species.	[Astapenkova, Alena; Bogusch, Petr] Univ Hradec Kralove, Fac Sci, Dept Biol, Rokitanskeho 62, Hradec Kralove, Czech Republic; [Heneberg, Petr] Charles Univ Prague, Fac Med 3, Ruska 87, Prague, Czech Republic	University of Hradec Kralove; Charles University Prague	Bogusch, P (corresponding author), Univ Hradec Kralove, Fac Sci, Dept Biol, Rokitanskeho 62, Hradec Kralove, Czech Republic.	bogusch.petr@gmail.com	Bogusch, Petr/AAN-6667-2020; Bogusch, Petr/Q-6111-2016; Heneberg, Petr/C-1881-2012	Bogusch, Petr/0000-0002-4554-6141; Heneberg, Petr/0000-0002-0703-951X	University Hradec Kralove [2101/2015, 2101/2016]	University Hradec Kralove	The study was funded only by internal grants of University Hradec Kralove-Specificky vyzkum 2101/2015 and 2101/2016, main holder PB.; We would like to thank all of the relevant authorities for allowing us to perform research in protected areas and in areas with restricted access, and for their help with the processing of permits. Our thanks also go to Frantisek Malir (University of Hradec Kralove) for assistance in translating texts originally written in French, and to Reesie Azarbal (Hradec Kralove) for English revision. Our studies were supported by grants Specificky vyzkum of University of Hradec Kralove Nr. 2101/2015 and 2101/2016.	ANTROPOV A V, 1991, Entomologicheskoe Obozrenie, V70, P672; ASIS JD, 1994, J KANSAS ENTOMOL SOC, V67, P199; Banaszak J, 1998, MEGACHILID BEES EURO; Beaumont J., 1945, MITT SCHWEIZ ENTOMOL, V19, P467; Blommers Leo H. M., 2008, Entomologische Berichten (Amsterdam), V68, P170; Blosch M., 2000, GRABWESPEN DEUTSCHLA; Bogusch P., 2007, ACTA ENT MUS NAT PRA, V11, P1; Bogusch P, 2016, BIODIVERS CONSERV, V25, P827, DOI 10.1007/s10531-016-1070-5; Bogusch P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130802; DANKS HV, 1971, T ROY ENT SOC LONDON, V122, P323; Dely-Draskovits A., 1994, Folia Entomologica Hungarica, V55, P65; Else George R., 1995, British Journal of Entomology and Natural History, V8, P43; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Grandi G., 1961, B I ENTOMOL U BOLOGN, V25, P1; Haffliger P, 2007, DAMAGE BASED IDENTIF; Heneberg P, 2014, BIOL CONSERV, V172, P146, DOI 10.1016/j.biocon.2014.02.037; Jacobs HJ, 2007, TIERWELT DEUTSCHLAND; Janvier H, 1962, ANN SCI NAT ZOOL, V4, P489; Janvier H, 1961, ANN SCI NAT ZOOL, V12, P1; JANVIER H, 2012, ENTOMOFAUNA, V2, P1; Janvier H, 1961, ANN SCI NAT ZOOL, V12, P281; Linsenmaier W, 1997, VEROFF NAT MUS LUZER, V9, P5; Macek J, 2010, REPUBLIKY ZAHADLOVI; Nartshuk E. P., 2013, FAUNA ENTOMOL SCAD, V43, p[i, 1]; Niehuis O, 2000, DEUT ENTOMOL Z, V47, P181; Nieto A., 2014, EUROPEAN RED LIST BE; O'Neill K., 2001, CORNELL S ARTHR BIOL, pXIV + 406; SMISSEN J, 2003, NOT FAUN GEMBLOUX, V52, P53; Svacha P., 1987, ACTA U CAROLINAE BIO, V30, P1; Tormos J, 2001, ANN ENTOMOL SOC AM, V94, P809, DOI 10.1603/0013-8746(2001)094[0809:ASSOLO]2.0.CO;2; Tormos J, 1997, J ENTOMOL SCI, V32, P113, DOI 10.18474/0749-8004-32.2.113; Westrich P., 1989, WILDBIENEN BADEN WUR, V1; Westrich P., 2008, EUCERA, V1, P1; Wolf H., 1988, Hessische Faunistische Briefe, V8, P16	34	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169592	10.1371/journal.pone.0169592	http://dx.doi.org/10.1371/journal.pone.0169592			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076373	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100044
J	Bytoft, B; Knorr, S; Vlachova, Z; Jensen, RB; Mathiesen, ER; Beck-Nielsen, H; Gravholt, CH; Jensen, DM; Clausen, TD; Mortensen, EL; Damm, P				Bytoft, Birgitte; Knorr, Sine; Vlachova, Zuzana; Jensen, Rikke B.; Mathiesen, Elisabeth R.; Beck-Nielsen, Henning; Gravholt, Claus H.; Jensen, Dorte M.; Clausen, Tine D.; Mortensen, Erik L.; Damm, Peter			Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; HYPERACTIVITY DISORDER; RISK-FACTORS; CHILDREN; MOTHERS; PREGNANCY; OUTCOMES; ADHD; METAANALYSIS; MELLITUS	Objective The aim of this study was to examine the potential association between intrauterine exposure to maternal diabetes and attention deficits in the offspring. Research design and methods Adolescent offspring of a prospectively followed cohort of women with type 1 diabetes (n = 269) and a control group from the background population (n = 293) participated in a follow-up assessment in 2012-2013. We used scores from Conners Continuous Performance Test II to assess attention and based on a principal component analysis we evaluated scores on five different attention factors: focused attention, vigilance, hyperactivity/impulsivity, sustained attention and response style. Results A higher frequency of the exposed offspring had a parent/self-reported use of Attention Deficit Hyperactivity Disorder (ADHD) medication compared to the control group (2.2% vs. 0.0%, p = 0.01). Clinical significant differences between adolescents exposed to maternal diabetes and unexposed controls were not found in either single scores on Conners Continuous Performance Test or on any of the five attention factors identified. Conclusions Exposure to maternal type 1 diabetes did not seem to increase the risk of attention deficits in the adolescent offspring. However, a higher self-reported use of ADHD medication in the exposed group could suggest a difference in attention not revealed by the applied test.	[Bytoft, Birgitte; Mathiesen, Elisabeth R.; Damm, Peter] Copenhagen Univ Hosp, Ctr Pregnant Women Diabet, Rigshosp, Copenhagen, Denmark; [Bytoft, Birgitte; Damm, Peter] Copenhagen Univ Hosp, Dept Obstet, Rigshosp, Copenhagen, Denmark; [Bytoft, Birgitte; Jensen, Rikke B.; Mathiesen, Elisabeth R.; Damm, Peter] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Knorr, Sine; Gravholt, Claus H.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Knorr, Sine; Gravholt, Claus H.] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [Vlachova, Zuzana; Beck-Nielsen, Henning; Jensen, Dorte M.] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Vlachova, Zuzana; Jensen, Dorte M.] Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, Odense, Denmark; [Jensen, Rikke B.] Copenhagen Univ Hosp, Dept Growth & Reprod, Rigshosp, Copenhagen, Denmark; [Mathiesen, Elisabeth R.] Copenhagen Univ Hosp, Dept Endocrinol, Rigshosp, Copenhagen, Denmark; [Jensen, Dorte M.] Odense Univ Hosp, Dept Gynecol & Obstet, Odense, Denmark; [Clausen, Tine D.] Nordsjaellands Hosp, Dept Gynecol & Obstet, Hillerod, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen	Bytoft, B (corresponding author), Copenhagen Univ Hosp, Ctr Pregnant Women Diabet, Rigshosp, Copenhagen, Denmark.	Birgitte.bytoft@regionh.dk	Jensen, Rikke Beck/AAB-3236-2020; Clausen, Tine Dalsgaard/X-3720-2019; Jensen, Dorte Møller/T-6656-2019; Gravholt, Claus H./Z-1435-2018	Jensen, Dorte Møller/0000-0002-3298-9824; Gravholt, Claus H./0000-0001-5924-1720; Knorr, Sine/0000-0001-6552-5340; Jensen, Rikke Beck/0000-0002-4522-672X; Clausen, Tine Dalsgaard/0000-0001-5585-2153; Damm, Peter/0000-0002-2067-5246; Mathiesen, elisabeth/0000-0003-3279-0863	European Foundation for the Study of Diabetes; Danish Ministry of Science, Innovation and Higher Education; Lundbeck Foundation; Danish Diabetes Academy; Beckett Foundation; Novo Nordisk; Danielsen Foundation; Novo Nordisk Fonden [NNF14OC0009275] Funding Source: researchfish	European Foundation for the Study of Diabetes; Danish Ministry of Science, Innovation and Higher Education; Lundbeck Foundation(Lundbeckfonden); Danish Diabetes Academy; Beckett Foundation; Novo Nordisk(Novo Nordisk); Danielsen Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by the European Foundation for the Study of Diabetes; The Danish Ministry of Science, Innovation and Higher Education; Lundbeck Foundation; Danish Diabetes Academy; Beckett Foundation and Danielsen Foundation. HBN receives research support from Novo Nordisk, a commercial company. The sponsors of the study had no involvement in design, conduction or interpretation of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Blais JC, 2016, JAMA PSYCHIAT; Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Barkley RA, 2004, J CHILD PSYCHOL PSYC, V45, P195, DOI 10.1111/j.1469-7610.2004.00214.x; Brinciotti M, 2009, CLIN NEUROPHYSIOL, V120, P563, DOI 10.1016/j.clinph.2008.12.028; Brinciotti M, 2011, EXP DIABETES RES, DOI 10.1155/2011/640535; Bytoft B, 2016, DIABETES CARE; Chan E, 2016, JAMA-J AM MED ASSOC, V315, P1997, DOI 10.1001/jama.2016.5453; Chandna AR, 2015, NEUROSCIENCE, V303, P241, DOI 10.1016/j.neuroscience.2015.06.063; Connors C., 2004, CONNERS CPT 2 WINDOW; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Craig F, 2016, NEUROPSYCH DIS TREAT, V12, P1191, DOI 10.2147/NDT.S104620; DuPaul GJ, 2016, J ABNORM CHILD PSYCH; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Foulon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125996; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Instanes JT, 2015, BIOL PSYCHIAT; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Kapellen TM, 2016, J PEDIATR ENDOCR MET, V29, P1293, DOI 10.1515/jpem-2016-0171; Knorr S, 2015, DIABETES CARE, V38, P1238, DOI 10.2337/dc15-0223; Lahey BB, 2016, J ABNORM PSYCHOL, V125, P168, DOI 10.1037/abn0000086; Lopez-Vicente M, 2014, NEUROPSYCHOLOGY, V28, P202, DOI 10.1037/neu0000048; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Nomura Y, 2012, ARCH PEDIAT ADOL MED, V166, P337, DOI 10.1001/archpediatrics.2011.784; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Rivera HM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00194; Schmitt J, 2012, ARCH PEDIAT ADOL MED, V166, P1074, DOI 10.1001/archpediatrics.2012.1078; Singh A, 2015, HEALTH PSYCHOL RES, V3, P23, DOI 10.4081/hpr.2015.2115; Sivertsen B, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-83; Sonuga-Barke EJS, 2014, J CHILD PSYCHOL PSYC, V55, pe1, DOI 10.1111/jcpp.12360; Tarver J, 2014, CHILD CARE HLTH DEV, V40, P762, DOI 10.1111/cch.12139; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Van Lieshout RJ, 2008, J PSYCHIATR NEUROSCI, V33, P395; Vlachova Z, 2015, DIABETOLOGIA, V58, P1454, DOI 10.1007/s00125-015-3589-5	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169308	10.1371/journal.pone.0169308	http://dx.doi.org/10.1371/journal.pone.0169308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH5WR	28072839	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200012
J	Haupt, M; Bennett, NC; Oosthuizen, MK				Haupt, Meghan; Bennett, Nigel C.; Oosthuizen, Maria K.			Locomotor Activity and Body Temperature Patterns over a Temperature Gradient in the Highveld Mole-Rat (Cryptomys hottentotus pretoriae)	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; VISUAL-SYSTEM; SUPRACHIASMATIC NUCLEUS; FOSSORIAL; RODENTIA; SOLITARY; BEHAVIOR; FAMILY; WHEEL; THERMOREGULATION	African mole-rats are strictly subterranean mammals that live in extensive burrow systems. High humidity levels in the burrows prevent mole-rats from thermoregulating using evaporative cooling. However, the relatively stable environment of the burrows promotes moderate temperatures and small daily temperature fluctuations. Mole-rats therefore display a relatively wide range of thermoregulation abilities. Some species cannot maintain their body temperatures at a constant level, whereas others employ behavioural thermoregulation. Here we test the effect of ambient temperature on locomotor activity and body temperature, and the relationship between the two parameters, in the highveld mole-rat. We exposed mole-rats to a 12L:12D and a DD light cycle at ambient temperatures of 30 degrees C, 25 degrees C and 20 degrees C while locomotor activity and body temperature were measured simultaneously. In addition, we investigated the endogenous rhythms of locomotor activity and body temperature at different ambient temperatures. Mole-rats displayed nocturnal activity at all three ambient temperatures and were most active at 20 degrees C, but least active at 30 degrees C. Body temperature was highest at 30 degrees C and lowest at 20 degrees C, and the daily cycle was highly correlated with locomotor activity. We show that the mole-rats have endogenous rhythms for both locomotor activity and body temperature. However, the endogenous body temperature rhythm appears to be less robust compared to the locomotor activity rhythm. Female mole-rats appear to be more sensitive to temperature changes than males, increased heterothermy is evident at lower ambient temperatures, whilst males show smaller variation in their body temperatures with changing ambient temperatures. Mole-rats may rely more heavily on behavioural thermoregulation as it is more energy efficient in an already challenging environment.	[Haupt, Meghan; Bennett, Nigel C.; Oosthuizen, Maria K.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa	University of Pretoria	Oosthuizen, MK (corresponding author), Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa.	moosthuizen@zoology.up.ac.za	Oosthuizen, Maria Kathleen/K-7923-2012; Oosthuizen, Maria/U-7276-2019	Oosthuizen, Maria Kathleen/0000-0001-6305-8283; 	Research Development Fund (UP); South African Research Chair of Mammal Behavioural Ecology and Physiology	Research Development Fund (UP); South African Research Chair of Mammal Behavioural Ecology and Physiology	This study was supported by the Research Development Fund (UP), MKO, and the South African Research Chair of Mammal Behavioural Ecology and Physiology, NCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angellitta MJJ, 2010, FRONTIERS BIOSCIEN E, VE2, P861; Animals NRCUCftUotGftCaUoL, 2011, GUIDE CARE USE LAB A; Begall S., 2007, SUBTERRANEAN RODENTS; Begall S, 2015, J THERM BIOL, V53, P15, DOI 10.1016/j.jtherbio.2015.08.003; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1993, J ZOOL, V231, P179, DOI 10.1111/j.1469-7998.1993.tb01910.x; BENNETT NC, 1994, OECOLOGIA, V97, P222, DOI 10.1007/BF00323153; BENNETT NC, 1988, S AFR J ZOOL, V23, P189; Benstaali C, 2001, LIFE SCI, V68, P2645, DOI 10.1016/S0024-3205(01)01081-5; Boyles JG, 2012, J EXP ZOOL PART A, V317A, P73, DOI 10.1002/jez.723; Brett R.A., 1991, P97; Broekman M, 2006, PHYSIOL BEHAV, V89, P750, DOI 10.1016/j.physbeh.2006.08.023; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Buffenstein R, 1996, MAMMALIA, V60, P591, DOI 10.1515/mamm.1996.60.4.591; COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; de Vries JL, 2008, J ZOOL, V276, P343, DOI 10.1111/j.1469-7998.2008.00496.x; Demas GE, 2001, BIOL RHYTHM RES, V32, P1, DOI 10.1076/brhm.32.1.1.7287; Eckardt NA, 2006, PLANT CELL, V18, P1105, DOI 10.1105/tpc.106.043356; Feldhamer GA, 2007, MAMMALOGY ADAPTATION; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; HAIM A, 1986, Cimbebasia Series A, V8, P49; HAIM A, 1988, COMP BIOCHEM PHYS A, V91, P123, DOI 10.1016/0300-9629(88)91603-9; Hart L, 2004, PHYSIOL BEHAV, V82, P563, DOI 10.1016/j.physbeh.2004.05.008; HICKMAN GC, 1979, S AFR J ZOOL, V14, P9; Kott O, 2016, ETHOLOGY, V122, P682, DOI 10.1111/eth.12515; Lovegrove BG, 1996, PHYSIOL BEHAV, V60, P991; LOVEGROVE BG, 1988, J ZOOL, V216, P391, DOI 10.1111/j.1469-7998.1988.tb02437.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; MCNAB BK, 1966, ECOLOGY, V47, P712, DOI 10.2307/1934259; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nemec P, 2004, EUR J NEUROSCI, V20, P757, DOI 10.1111/j.1460-9568.2004.03510.x; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nevo E, 1995, ACTA THERIOL, P9; Oosthuizen MK, 2015, J ZOOL, V297, P1, DOI 10.1111/jzo.12254; Oosthuizen MK, 2010, CHRONOBIOL INT, V27, P1532, DOI 10.3109/07420528.2010.510227; Oosthuizen MK, 2005, NEUROSCIENCE, V133, P555, DOI 10.1016/j.neuroscience.2005.01.017; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Refinetti R, 1999, AM J PHYSIOL-REG I, V277, pR1493, DOI 10.1152/ajpregu.1999.277.5.R1493; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riccio AP, 2000, PHYSIOL BEHAV, V71, P15, DOI 10.1016/S0031-9384(00)00280-8; ROPER TJ, 1976, PHYSIOL BEHAV, V17, P549, DOI 10.1016/0031-9384(76)90121-9; Roper TJ, 2001, J ZOOL, V254, P101, DOI 10.1017/S0952836901000590; Schottner K, 2006, PHYSIOL BEHAV, V89, P205, DOI 10.1016/j.physbeh.2006.06.014; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Streicher S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026346; Tachinardi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085674; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; YAHAV S, 1991, PHYSIOL ZOOL, V64, P871, DOI 10.1086/physzool.64.3.30158212	52	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169644	10.1371/journal.pone.0169644	http://dx.doi.org/10.1371/journal.pone.0169644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072840	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200034
J	Ortiz, ME; Bleckwedel, J; Fadda, S; Picariello, G; Hebert, EM; Raya, RR; Mozzi, F				Eugenia Ortiz, Maria; Bleckwedel, Juliana; Fadda, Silvina; Picariello, Gianluca; Hebert, Elvira M.; Raya, Raul R.; Mozzi, Fernanda			Global Analysis of Mannitol 2-Dehydrogenase in Lactobacillus reuteri CRL 1101 during Mannitol Production through Enzymatic, Genetic and Proteomic Approaches	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; DEHYDROGENASE GENE; METABOLISM; PURIFICATION; FERMENTATION; CLONING; GROWTH; BARLEY; MDH	Several plants, fungi, algae, and certain bacteria produce mannitol, a polyol derived from fructose. Mannitol has multiple industrial applications in the food, pharmaceutical, and medical industries, being mainly used as a non-metabolizable sweetener in foods. Many hetero-fermentative lactic acid bacteria synthesize mannitol when an alternative electron acceptor such as fructose is present in the medium. In previous work, we reported the ability of Lacto-bacillus reuteri CRL 1101 to efficiently produce mannitol from sugarcane molasses as carbon source at constant pH of 5.0; the activity of the enzyme mannitol 2-dehydrogenase (MDH) responsible for the fructose conversion into mannitol being highest during the log cell growth phase. Here, a detailed assessment of the MDH activity and relative expression of the mdh gene during the growth of L. reuteri CRL 1101 in the presence of fructose is presented. It was observed that MDH was markedly induced by the presence of fructose. A direct correlation between the maximum MDH enzyme activity and a high level of mdh transcript expression during the log-phase of cells grown in a fructose-containing chemically defined medium was detected. Furthermore, two proteomic approaches (2DE and shotgun proteomics) applied in this study confirmed the inducible expression of MDH in L. reuteri. A global study of the effect of fructose on activity, mdh gene, and protein expressions of MDH in L. reuteri is thus for the first time presented. This work represents a deep insight into the polyol formation by a Lactobacillus strain with biotechnological potential in the nutraceutics and pharmaceutical areas.	[Eugenia Ortiz, Maria; Bleckwedel, Juliana; Fadda, Silvina; Hebert, Elvira M.; Raya, Raul R.; Mozzi, Fernanda] Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacilos CERELA, Chacabuco 145, San Miguel De Tucuman, Argentina; [Picariello, Gianluca] CNR, Ist Sci Alimentaz, Avellino, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Mozzi, F (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacilos CERELA, Chacabuco 145, San Miguel De Tucuman, Argentina.	fmozzi@cerela.org.ar	Hebert, Elvira Maria/H-6635-2019; Mozzi, Fernanda/AHE-0168-2022	Hebert, Elvira Maria/0000-0001-8288-9701; Mozzi, Fernanda/0000-0002-2661-7661; PICARIELLO, Gianluca/0000-0003-1290-1239	CONICET from Argentina [PIP 2010-0062]; FONCyT from Argentina [Prestamo BID PICT 2008-933]; CONICET (Argentina); CNR (Italy)	CONICET from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT from Argentina; CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNR (Italy)(Consiglio Nazionale delle Ricerche (CNR))	We acknowledge the financial support of CONICET (PIP 2010-0062) and FONCyT (Prestamo BID PICT 2008-933) from Argentina and the bilateral cooperation agreement between CONICET (Argentina) and CNR (Italy) "Analisis de bacterias lacticas productoras de manitol: un enfoque proteomico" (2011-2012).	Aarnikunnas J, 2002, APPL MICROBIOL BIOT, V59, P665, DOI 10.1007/s00253-002-1070-0; Adachi O, 1999, BIOSCI BIOTECH BIOCH, V63, P402, DOI 10.1271/bbb.63.402; Brown T, 1998, QUIMICA CIENCIA CENT, P145; Brunker P, 1997, BBA-GENE STRUCT EXPR, V1351, P157, DOI 10.1016/S0167-4781(96)00189-3; Calmes B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00131; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carvalheiro F, 2011, J IND MICROBIOL BIOT, V38, P221, DOI 10.1007/s10295-010-0823-5; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; DEBORD B, 1987, DRUG DEV IND PHARM, V13, P1533, DOI 10.3109/03639048709068679; Ortiz ME, 2015, APPL MICROBIOL BIOT, V99, P8717, DOI 10.1007/s00253-015-6730-y; Ortiz ME, 2012, APPL MICROBIOL BIOT, V95, P991, DOI 10.1007/s00253-012-3945-z; Ganzle MG, 2007, FOOD MICROBIOL, V24, P128, DOI 10.1016/j.fm.2006.07.006; Ganzle MG, 2003, INT J FOOD MICROBIOL, V80, P31, DOI 10.1016/S0168-1605(02)00146-0; Groisillier A, 2015, APPL ENVIRON MICROB, V81, P1790, DOI 10.1128/AEM.02808-14; Hahn G, 2003, ARCH MICROBIOL, V179, P101, DOI 10.1007/s00203-002-0507-2; Hammes W. P., 2009, BERGEYS MANUAL SYSTE, P465, DOI DOI 10.1007/0-387-28022-7; Hebert EM, 2004, METH BIOTEC, V16, P139; Hole AS, 2012, J AGR FOOD CHEM, V60, P6369, DOI 10.1021/jf300410h; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Karsten U, 1997, PLANTA, V201, P173, DOI 10.1007/BF01007701; Kets EPW, 1996, J BACTERIOL, V178, P6665, DOI 10.1128/jb.178.23.6665-6670.1996; Korakli M, 2003, FEMS MICROBIOL LETT, V220, P281, DOI 10.1016/S0378-1097(03)00129-0; Lawson ME, 2000, ENCY CHEM TECHNOLOGY, P93; Livesey G, 2003, NUTR RES REV, V16, P163, DOI 10.1079/NRR200371; MARTINEZ G, 1963, J BIOL CHEM, V238, P1598; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P475, DOI 10.1128/AEM.69.1.475-482.2003; Nidetzky B, 1996, BIOCATAL BIOTRANSFOR, V14, P47, DOI 10.3109/10242429609106876; NIEHAUS WG, 1982, J BACTERIOL, V151, P243, DOI 10.1128/JB.151.1.243-250.1982; O'Donnell MM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-48; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Pallin A, 2016, FOOD MICROBIOL, V57, P159, DOI 10.1016/j.fm.2016.02.011; Papagiannia M, 2014, J BIOTECHNOL, V181, P20, DOI 10.1016/j.jbiotec.2014.04.007; Saha BC, 2004, BIOTECHNOL PROGR, V20, P537, DOI 10.1021/bp034277p; SAKAI S, 1968, BIOCHIM BIOPHYS ACTA, V151, P684, DOI 10.1016/0005-2744(68)90017-X; SALMINEN S, 1998, LACTIC ACID BACTERIA, P343; Salminen S, 2002, FOOD ADDITIVES, P447; Sasaki Y, 2005, APPL MICROBIOL BIOT, V68, P36, DOI 10.1007/s00253-004-1841-x; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Schiweck H, 2012, ULLMANNS ENCY IND CH, P2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNEIDER KH, 1989, EUR J BIOCHEM, V184, P15, DOI 10.1111/j.1432-1033.1989.tb14984.x; Shao ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097935; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Song SH, 2009, APPL MICROBIOL BIOT, V84, P55, DOI 10.1007/s00253-009-2086-5; Stromeck A, 2011, J AGR FOOD CHEM, V59, P1392, DOI 10.1021/jf103546t; Tyler CA, 2016, J APPL MICROBIOL, V120, P1336, DOI 10.1111/jam.13108; VIIKARI L, 1986, APPL MICROBIOL BIOT, V24, P471; Vrancken G, 2009, FOOD MICROBIOL, V26, P720, DOI 10.1016/j.fm.2009.07.006; Vrancken G., 2010, BIOTECHNOL LACT ACID, P193; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Wennerholm K, 1991, HDB SWEETENERS, P205; Wisselink HW, 2002, INT DAIRY J, V12, P151, DOI 10.1016/S0958-6946(01)00153-4; Bustos AY, 2015, FOOD RES INT, V77, P599, DOI 10.1016/j.foodres.2015.10.001; Zahid N, 2016, APPL MICROBIOL BIOT, V100, P9967, DOI 10.1007/s00253-016-7680-8; Zaunmuller T, 2006, APPL MICROBIOL BIOT, V72, P421, DOI 10.1007/s00253-006-0514-3	58	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169441	10.1371/journal.pone.0169441	http://dx.doi.org/10.1371/journal.pone.0169441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060932	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500095
J	Moar, W; Khajuria, C; Pleau, M; Ilagan, O; Chen, M; Jiang, CJ; Price, P; McNulty, B; Clark, T; Head, G				Moar, William; Khajuria, Chitvan; Pleau, Michael; Ilagan, Oliver; Chen, Mao; Jiang, Changjian; Price, Paula; McNulty, Brian; Clark, Thomas; Head, Graham			Cry3Bb1-Resistant Western Corn Rootworm, Diabrotica virgifera virgifera (LeConte) Does Not Exhibit Cross-Resistance to DvSnf7 dsRNA	PLOS ONE			English	Article							COLEOPTERA; RNA	Background and Methodology There is a continuing need to express new insect control compounds in transgenic maize against western corn rootworm, Diabrotica virgifera virgifera (LeConte) (WCR). In this study three experiments were conducted to determine cross-resistance between the new insecticidal DvSnf7 dsRNA, and Bacillus thuringiensis (Bt) Cry3Bb1; used to control WCR since 2003, with field-evolved resistance being reported. Laboratory susceptible and Cry3Bb1-resistant WCR were evaluated against DvSnf7 dsRNA in larval diet-incorporation bioassays. Additionally, the susceptibility of seven field and one field-derived WCR populations to DvSnf7 (and Cry3Bb1) was assessed in larval diet-overlay bioassays. Finally, beetle emergence of laboratory susceptible and Cry3Bb1-resistant WCR was evaluated with maize plants in the greenhouse expressing Cry3Bb1, Cry34Ab1/Cry35Ab1, or DvSnf7 dsRNA singly, or in combination. Principal Findings and Conclusions The Cry3Bb1-resistant colony had slight but significantly (2.7-fold; P<0.05) decreased susceptibility to DvSnf7 compared to the susceptible colony, but when repeated using a field-derived WCR population selected for reduced Cry3Bb1 susceptibility, there was no significant difference (P<0.05) in DvSnf7 susceptibility compared to that same susceptible population. Additionally, this 2.7-fold difference in susceptibility falls within the range of DvSnf7 susceptibility among the seven field populations tested. Additionally, there was no correlation between susceptibility to DvSnf7 and Cry3Bb1 for all populations evaluated. In greenhouse studies, there were no significant differences (P<0.05) between beetle emergence of susceptible and Cry3Bb1-resistant colonies on DvSnf7 and Cry34Ab1/Cry35Ab1, and between DvSnf7 and MON 87411 (DvSnf7 + Cry3Bb1) for the Cry3Bb1-resistant colony. These results demonstrate no cross-resistance between DvSnf7 and Cry3Bb1 against WCR. Therefore, pyramiding DvSnf7 with Bt proteins such as Cry3Bb1 and Cry34Ab1/Cry35Ab1 will provide a valuable IRM tool against WCR that will increase the durability of these Bt proteins. These results also illustrate the importance of using appropriate bioassay methods when characterizing field-evolved resistant WCR populations.	[Moar, William; Khajuria, Chitvan; Pleau, Michael; Ilagan, Oliver; Chen, Mao; Jiang, Changjian; Price, Paula; McNulty, Brian; Clark, Thomas; Head, Graham] Monsanto Co, 700 Chesterfield 800 N Lindbergh Blvd, St Louis, MO 63166 USA	Monsanto	Moar, W (corresponding author), Monsanto Co, 700 Chesterfield 800 N Lindbergh Blvd, St Louis, MO 63166 USA.	william.moar@monsanto.com		Head, Graham/0000-0003-0521-0616	Monsanto	Monsanto	All authors are Monsanto employees, and Monsanto accepted no outside funding for this research represented in this manuscript. The funder (Monsanto) provided support in the form of salaries for all authors, and also played a role in the design, data analysis and the decision to publish.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; [Anonymous], SAS SOFTW REL 9 4 TS; Auer C, 2009, TRENDS BIOTECHNOL, V27, P644, DOI 10.1016/j.tibtech.2009.08.005; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; BRANSON TF, 1976, ENTOMOL EXP APPL, V19, P148, DOI 10.1007/BF00345776; Cappelle K, 2016, INSECT MOL BIOL, V25, P315, DOI 10.1111/imb.12222; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; Clark TL, 2001, INSECT MOL BIOL, V10, P303, DOI 10.1046/j.0962-1075.2001.00269.x; Crickmore N, 2015, BACILLUS THURINGIENS; Cullen EM, 2013, J INTEGR PEST MANAG, V4, pD1, DOI 10.1603/IPM13012; Dowdy S., 2004, STAT RES, V3rd; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2014, PNAS; Gilissen LJW, 1998, TRANSGENIC RES, V7, P157, DOI 10.1023/A:1008832711805; Jakka SRK, 2016, SCI REPORTS; Levine SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118622; Li XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08700; Moar W, 2008, NAT BIOTECHNOL, V26, P1072, DOI 10.1038/nbt1008-1072; Monsanto, 2014, PET DET NONR STAT CO; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; Ramaseshadri P, 2012, PLOS ONE, V8; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Tinsley NA, 2013, J APPL ENTOMOL, V137, P161, DOI 10.1111/j.1439-0418.2012.01736.x; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Velez AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157520; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; Walters FS, 2010, APPL ENVIRON MICROB, V76, P3082, DOI 10.1128/AEM.00155-10; ZUKOFF SN, J EC ENTOMOL, V109, P1387	35	24	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169175	10.1371/journal.pone.0169175	http://dx.doi.org/10.1371/journal.pone.0169175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060922	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500062
J	Quinto-Sanchez, M; Cintas, C; de Cerqueira, CCS; Ramallo, V; Acuna-Alonzo, V; Adhikari, K; Castillo, L; Gomez-Valdes, J; Everardo, P; De Avila, F; Hunemeier, T; Jaramillo, C; Arias, W; Fuentes, M; Gallo, C; Poletti, G; Schuler-Faccini, L; Bortolini, MC; Canizales-Quinteros, S; Rothhammer, F; Bedoya, G; Rosique, J; Ruiz-Linares, A; Gonzalez-Jose, R				Quinto-Sanchez, Mirsha; Cintas, Celia; Silva de Cerqueira, Caio Cesar; Ramallo, Virginia; Acuna-Alonzo, Victor; Adhikari, Kaustubh; Castillo, Lucia; Gomez-Valdes, Jorge; Everardo, Paola; De Avila, Francisco; Huenemeier, Tabita; Jaramillo, Claudia; Arias, Williams; Fuentes, Macarena; Gallo, Carla; Poletti, Giovani; Schuler-Faccini, Lavinia; Bortolini, Maria Catira; Canizales-Quinteros, Samuel; Rothhammer, Francisco; Bedoya, Gabriel; Rosique, Javier; Ruiz-Linares, Andres; Gonzalez-Jose, Rolando			Socioeconomic Status Is Not Related with Facial Fluctuating Asymmetry: Evidence from Latin-American Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DEVELOPMENTAL INSTABILITY; SEXUAL-DIMORPHISM; GEOMETRIC MORPHOMETRICS; DIRECTIONAL ASYMMETRY; HEALTHY-SUBJECTS; SHAPE-ANALYSIS; HUMAN FACES; SYMMETRY; STABILITY	The expression of facial asymmetries has been recurrently related with poverty and/or disadvantaged socioeconomic status. Departing from the developmental instability theory, previous approaches attempted to test the statistical relationship between the stress experienced by individuals grown in poor conditions and an increase in facial and corporal asymmetry. Here we aim to further evaluate such hypothesis on a large sample of admixed Latin Americans individuals by exploring if low socioeconomic status individuals tend to exhibit greater facial fluctuating asymmetry values. To do so, we implement Procrustes analysis of variance and Hierarchical Linear Modelling (HLM) to estimate potential associations between facial fluctuating asymmetry values and socioeconomic status. We report significant relationships between facial fluctuating asymmetry values and age, sex, and genetic ancestry, while socioeconomic status failed to exhibit any strong statistical relationship with facial asymmetry. These results are persistent after the effect of heterozygosity (a proxy for genetic ancestry) is controlled in the model. Our results indicate that, at least on the studied sample, there is no relationship between socioeconomic stress (as intended as low socioeconomic status) and facial asymmetries.	[Quinto-Sanchez, Mirsha; Cintas, Celia; Silva de Cerqueira, Caio Cesar; Ramallo, Virginia; Castillo, Lucia; Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Ciencias Sociales & Humanas, Grp Invest Biol Evolut Humana, Puerto Madryn, Chubut, Argentina; [Quinto-Sanchez, Mirsha; Silva de Cerqueira, Caio Cesar] Univ Nacl Autonoma Mexico, Fac Med, Ciencia Forense, Mexico City, DF, Mexico; [Silva de Cerqueira, Caio Cesar] Superintendencia Policia Tecn Cient Estado Sao Pa, Equipe Pericias Criminalist Ourinhos, Sao Paulo, Brazil; [Acuna-Alonzo, Victor; Adhikari, Kaustubh; Fuentes, Macarena; Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Acuna-Alonzo, Victor; Adhikari, Kaustubh; Fuentes, Macarena; Ruiz-Linares, Andres] UCL, Genet Inst, London, England; [Acuna-Alonzo, Victor; Everardo, Paola; De Avila, Francisco] Escuela Nacl Antropol & Hist, Inst Nacl Antropol & Hist, Mexico City, DF, Mexico; [Gomez-Valdes, Jorge] Escuela Nacl Antropol & Hist, Posgrad Antropol Fis, Mexico City, Mexico; [Huenemeier, Tabita] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508 Sao Paulo, Brazil; [Jaramillo, Claudia; Arias, Williams; Bedoya, Gabriel] Univ Antioquia, GENMOL, Medellin, Colombia; [Fuentes, Macarena] Univ Tarapaca, Fac Ciencias Salud, Dept Tecnol Med, Arica, Chile; [Gallo, Carla; Poletti, Giovani] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lima, Peru; [Schuler-Faccini, Lavinia; Bortolini, Maria Catira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Porto Alegre, RS, Brazil; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Inst Nacl Med Genom, Unidad Genorn Poblac Aplicada Salud, Mexico City, DF, Mexico; [Rothhammer, Francisco] Univ Tarapace, Inst Alta Invest, Arica, Chile; [Rosique, Javier] Univ Antioquia, Fac Ciencias Sociales & Humanas, Dept Anthropol, Medellin, Colombia; [Ruiz-Linares, Andres] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Ruiz-Linares, Andres] Aix Marseille Univ, CNRS, EFS, ADES, Marseille, France	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional Autonoma de Mexico; University of London; University College London; University of London; University College London; Universidade de Sao Paulo; Universidad de Antioquia; Universidad de Tarapaca; Universidad Peruana Cayetano Heredia; Universidade Federal do Rio Grande do Sul; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad de Antioquia; Fudan University; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Gonzalez-Jose, R (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Ciencias Sociales & Humanas, Grp Invest Biol Evolut Humana, Puerto Madryn, Chubut, Argentina.	rolando@cenpat-conicet.gob.ar	Hünemeier, Tábita/F-4181-2011; Gallo, Carla/Q-4296-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; Everardo, Paola/AAB-3231-2020; Ruiz-Linares, Andres/AAR-1104-2021; Everardo, Paola/AAQ-5332-2021	SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Everardo, Paola/0000-0002-7629-1022; Ruiz-Linares, Andres/0000-0001-8372-1011; Rosique-Gracia, Javier/0000-0003-2686-8820; Gallo, Carla/0000-0001-8348-0473; Cintas, Celia/0000-0002-8064-9189; Hunemeier, Tabita/0000-0002-3156-2079; Gonzalez-Jose, Rolando/0000-0002-8128-9381; Arias, William/0000-0002-2543-4855	CONICET Latin American grand program [41488]; Leverhulme Trust [F/07 134/DF]; BBSRC [BB/I021213/1]; Biotechnology and Biological Sciences Research Council [BB/I021213/1] Funding Source: researchfish	CONICET Latin American grand program; Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the CONICET Latin American grand program (No. 41488 to MQS), Leverhulme Trust (F/07 134/DF to ARL) and BBSRC (BB/I021213/1 to ARL).	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11616; Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10815; Adhikari K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8500; Azevedo J. P., 2013, POLICY RES WORKING P, DOI [10.1596/1813-9450-6715, DOI 10.1596/1813-9450-6715]; Bigoni L, 2013, AM J PHYS ANTHROPOL, V150, P349, DOI 10.1002/ajpa.22210; Bjorklund M, 1997, ANN ZOOL FENN, V34, P133; Bjorksten TA, 2000, TRENDS ECOL EVOL, V15, P163, DOI 10.1016/S0169-5347(99)01788-7; CEPAL, 2012, STAT YB LAT AM CAR; Chen E, 2006, SOC SCI MED, V62, P2161, DOI 10.1016/j.socscimed.2005.08.054; Claes P, 2012, J ANAT, V221, P97, DOI 10.1111/j.1469-7580.2012.01528.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DeLeon VB, 2007, AM J PHYS ANTHROPOL, V132, P520, DOI 10.1002/ajpa.20549; Ercan I, 2008, J ANAT, V213, P663, DOI 10.1111/j.1469-7580.2008.01002.x; Evans GW, 2007, PSYCHOL SCI, V18, P953, DOI 10.1111/j.1467-9280.2007.02008.x; FARKAS LG, 1981, ANGLE ORTHOD, V51, P70; Farrera A, 2015, AM J HUM BIOL, V27, P387, DOI 10.1002/ajhb.22657; Ferrario VF, 2001, J ORAL MAXIL SURG, V59, P382, DOI 10.1053/joms.2001.21872; FERRARIO VF, 1995, J ANAT, V186, P103; Gawlikowska A, 2007, HOMO, V58, P159, DOI 10.1016/j.jchb.2006.10.001; GRAHAM JH, 1993, GENETICA, V89, P121, DOI 10.1007/BF02424509; Hallgrimsson B, 1999, INT J PRIMATOL, V20, P121, DOI 10.1023/A:1020540418554; Houle D, 2000, J EVOLUTION BIOL, V13, P720; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; LIVSHITS G, 1991, HUM BIOL, V63, P441; Lynch M., 1998, GENETICS ANAL QUANTI; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Marmot M., 2005, PUBLIC HEALTH; MCKENZIE JA, 1988, GENETICS, V120, P213; Mezey JG, 2000, GENETICS, V156, P305; Milne BJ, 2003, EVOL HUM BEHAV, V24, P53, DOI 10.1016/S1090-5138(02)00120-4; Moller AP, 1997, J EVOLUTION BIOL, V10, P69, DOI 10.1007/s000360050009; Ozener B, 2011, COLLEGIUM ANTROPOL, V35, P1001; Ozener B, 2010, HOMO, V61, P459, DOI 10.1016/j.jchb.2010.09.004; Ozener B, 2010, EVOL HUM BEHAV, V31, P436, DOI 10.1016/j.evolhumbehav.2010.06.003; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P321, DOI 10.1002/ajpa.21357; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Pellegrino A, 2000, INT SOC SCI J, V52, P395, DOI 10.1111/1468-2451.00268; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pound N, P R SOC LOND B, V281; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinto-Sanchez M, 2015, AM J PHYS ANTHROPOL, V157, P58, DOI 10.1002/ajpa.22688; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; Rhodes G, 2001, EVOL HUM BEHAV, V22, P31, DOI 10.1016/S1090-5138(00)00060-X; Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sigelman C. K., 2009, LIFE SPAN HUMAN DEV; Simmons LW, 2004, BEHAV ECOL, V15, P864, DOI 10.1093/beheco/arh099; Singleton M, 2002, J HUM EVOL, V42, P547, DOI 10.1006/jhev.2001.0539; Smith WM, 2000, LATERALITY, V5, P251, DOI 10.1080/135765000406094; Sokal R.R., 2012, BIOMETRY; Tomas R, 1998, BUILDING NEW BIOCULT, P43; Trotsky Leon, 1932, HIST RUSSIAN REVOLUT, V1; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Weisensee KE, 2013, AM J HUM BIOL, V25, P411, DOI 10.1002/ajhb.22390; Wilson JM, 1996, J HUM EVOL, V30, P529, DOI 10.1006/jhev.1996.0041; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zaidel DW, 2010, SYMMETRY-BASEL, V2, P136, DOI 10.3390/sym2010136	77	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169287	10.1371/journal.pone.0169287	http://dx.doi.org/10.1371/journal.pone.0169287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060876	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000391641500076
J	Seebacher, V; Reinthaller, A; Koelbl, H; Concin, N; Nehoda, R; Polterauer, S				Seebacher, Veronika; Reinthaller, Alexander; Koelbl, Heinz; Concin, Nicole; Nehoda, Regina; Polterauer, Stephan			The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer - A Retrospective Study	PLOS ONE			English	Article							RELATIVE DOSE INTENSITY; CLINICAL-PRACTICE; OPEN-LABEL; CARBOPLATIN; PACLITAXEL; MULTICENTER; TRIALS; WOMEN; DENSE	Objective The aim of the present study was to investigate the prognostic role of the duration of adjuvant chemotherapy in patients with epithelial ovarian, fallopian tube and primary peritoneal cancer (EOC). Materials and Methods Within the present study we retrospectively evaluated the data of 165 consecutive patients with EOC treated with primary surgery followed by six completed cycles of platinum-taxan based intravenous adjuvant chemotherapy. Medians of total duration of chemotherapy were compared with clinical-pathological parameters. Patients were stratified into four risk groups according to the delay in days of total duration of chemotherapy, and univariate and multi-variable survival analyses were performed. Results The median duration of six completed cycles of chemotherapy comprised 113 days (IQR 107-124 days). Uni- and multi-variable survival analyses revealed a delay of total duration of chemotherapy of at least 9 days to be associated with progression-free (PFS), cancer-specific (CSS) and overall survival (OS). Hazard ratios (HR), confidence intervals (95% CI) and p-values for PFS, CSS and OS due to delay of chemo-duration were 2.9 (1.6-5.4; p = 0.001), 2.9 (1.3-6.2; p = 0.008) and 2.6 (1.3-5.4; p = 0.008), respectively. Prolonged total chemo-duration was associated with the amount of postoperative residual disease (p = 0.001) and the patients' age (p = 0.03). Conclusion The present study suggests a prolonged duration of adjuvant chemotherapy after primary surgery to adversely affect PFS, CSS and OS in patients with EOC. Yet larger studies are required to validate our results.	[Seebacher, Veronika; Reinthaller, Alexander; Koelbl, Heinz; Polterauer, Stephan] Med Univ Vienna, Ctr Comprehens Canc, Dept Gynecol & Gynecol Oncol, Gynecol Canc Unit, Vienna, Austria; [Reinthaller, Alexander; Polterauer, Stephan] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria; [Concin, Nicole; Nehoda, Regina] Med Univ Innsbruck, Dept Gynecol & Obstet, Innsbruck, Austria	Medical University of Vienna; Medical University of Innsbruck	Seebacher, V (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Dept Gynecol & Gynecol Oncol, Gynecol Canc Unit, Vienna, Austria.	veronika.seebacher@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021	Polterauer, Stephan/0000-0002-9649-4505; Concin, Nicole/0000-0002-9795-2643				Anuradha S, 2016, ACTA ONCOL, V55, P226, DOI 10.3109/0284186X.2015.1054950; Ben-Josef E, 2010, J CLIN ONCOL, V28, P5061, DOI 10.1200/JCO.2010.29.1351; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Chang J, 2000, EUR J CANCER, V36, pS11; Chen SW, 2003, RADIOTHER ONCOL, V67, P69, DOI 10.1016/S0167-8140(02)00439-5; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Fauci JM, 2011, GYNECOL ONCOL, V122, P532, DOI 10.1016/j.ygyno.2011.05.023; Ferlay J, 2013, GLOBOCAN2012 V1 0 CA; Gibson SJ, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00063; Hanna RK, 2013, GYNECOL ONCOL, V129, P74, DOI 10.1016/j.ygyno.2012.12.017; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Ma BBY, 2010, LANCET ONCOL, V11, P75, DOI 10.1016/S1470-2045(09)70160-3; McGuire WP, 2003, BRIT J CANCER, V89, pS3, DOI 10.1038/sj.bjc.6601494; Nagel CI, 2012, GYNECOL ONCOL, V124, P221, DOI 10.1016/j.ygyno.2011.10.003; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; REPETTO L, 1993, EUR J CANCER, V29A, P181, DOI 10.1016/0959-8049(93)90169-G; Smith TJ, 2015, J CLIN ONCOL, V33, P3199, DOI 10.1200/JCO.2015.62.3488	21	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169272	10.1371/journal.pone.0169272	http://dx.doi.org/10.1371/journal.pone.0169272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060918	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500073
J	Skovereng, K; Ettema, G; van Beekvelt, M				Skovereng, Knut; Ettema, Gertjan; van Beekvelt, Mireille			The Effect of Cadence on Shank Muscle Oxygen Consumption and Deoxygenation in Relation to Joint Specific Power and Cycling Kinematics	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PEDALING CADENCE; COORDINATION; WORK; GASTROCNEMIUS; HETEROGENEITY; DETERMINANTS; SIMULATIONS; METABOLISM; OUTPUT	The purpose of the present study was to investigate the effect of cadence on joint specific power and cycling kinematics in the ankle joint in addition to muscle oxygenation and muscle VO2 in the gastrocnemius and tibialis anterior. Thirteen cyclists cycled at a cadence of 60, 70, 80, 90, 100 and 110 rpm at a constant external work rate of 160.1 +/- 21.3 W. Increasing cadence led to a decrease in ankle power in the dorsal flexion phase and to an increase in ankle joint angular velocity above 80 rpm. In addition, increasing cadence increased deoxygenation and desaturation for both the gastrocnemius and tibialis anterior muscles. Muscle VO2 increased following increased cadence but only in the tibialis anterior and only at cadences above 80 rpm, thus coinciding with the increase in ankle joint angular velocity. There was no effect of cadence in the gastrocnemius. This study demonstrates that high cadences lead to increased mVO(2) in the TA muscles that cannot be explained by power in the dorsal flexion phase.	[Skovereng, Knut; Ettema, Gertjan; van Beekvelt, Mireille] Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Dept Neurosci, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Skovereng, K (corresponding author), Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Dept Neurosci, Trondheim, Norway.	knut.skovereng@ntnu.no	Ettema, Gertjan/C-2104-2018	Skovereng, Knut/0000-0002-4392-9704				Ansley L, 2009, EUR J SPORT SCI, V9, P61, DOI 10.1080/17461390802684325; Baum BS, 2003, J ELECTROMYOGR KINES, V13, P181, DOI 10.1016/S1050-6411(02)00110-4; Bini RR, 2010, J SPORT REHABIL, V19, P301, DOI 10.1123/jsr.19.3.301; Bini RR, 2010, ISOKINET EXERC SCI, V18, P7, DOI 10.3233/IES-2010-0361; Boone J, 2014, EUROPEAN J APPL PHYS; Brizendine JT, 2013, MED SCI SPORT EXER, V45, P869, DOI 10.1249/MSS.0b013e31827e0eb6; Elmer SJ, 2011, MED SCI SPORT EXER, V43, P1940, DOI 10.1249/MSS.0b013e31821b00c5; Ericson M, 1986, Scand J Rehabil Med Suppl, V16, P1; ERICSON MO, 1988, EUR J APPL PHYSIOL O, V57, P382, DOI 10.1007/BF00417980; Ettema G, 2009, J ELECTROMYOGR KINES, V19, pE94, DOI 10.1016/j.jelekin.2007.11.009; Fenn WO, 1924, J PHYSIOL-LONDON, V58, P0373, DOI 10.1113/jphysiol.1924.sp002141; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; HULL ML, 1985, J BIOMECH, V18, P631, DOI 10.1016/0021-9290(85)90019-3; Kounalakis SN, 2012, APPL PHYSIOL NUTR ME, V37, P407, DOI [10.1139/h2012-011, 10.1139/H2012-011]; Lucia A, 2004, MED SCI SPORT EXER, V36, P1048, DOI 10.1249/01.MSS.0000128249.10305.8A; McDaniel J, 2014, J APPL BIOMECH, V30, P423, DOI 10.1123/jab.2013-0246; McGhie D, 2011, J ELECTROMYOGR KINES, V21, P18, DOI 10.1016/j.jelekin.2010.04.007; Mornieux G, 2007, EUR J APPL PHYSIOL, V102, P11, DOI 10.1007/s00421-007-0555-z; Neptune RR, 1997, J BIOMECH, V30, P1051, DOI 10.1016/S0021-9290(97)00071-7; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515, DOI 10.1152/jn.1999.82.2.515; Ryan TE, 2012, J APPL PHYSIOL, V113, P175, DOI 10.1152/japplphysiol.00319.2012; Sanderson DJ, 2006, J ELECTROMYOGR KINES, V16, P642, DOI 10.1016/j.jelekin.2005.11.003; Sargeant AJ, 2007, EXP PHYSIOL, V92, P323, DOI 10.1113/expphysiol.2006.034322; Skovereng K, 2016, EUR J APPL PHYSIOL, V116, P1207, DOI 10.1007/s00421-016-3379-x; Umberger BR, 2006, J BIOMECH, V39, P1472, DOI 10.1016/j.jbiomech.2005.03.025; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; Vogiatzis I, 2015, J APPL PHYSIOL, V118, P783, DOI 10.1152/japplphysiol.00458.2014; Zajac FE, 2002, J BIOMECH, V35, P1011, DOI 10.1016/S0021-9290(02)00046-5; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; Zorgati H, 2013, APPL PHYSIOL NUTR ME, V38, P1206, DOI 10.1139/apnm-2012-0504	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169573	10.1371/journal.pone.0169573	http://dx.doi.org/10.1371/journal.pone.0169573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060894	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500110
J	Pyle, CJ; Akhter, S; Bao, S; Dodd, CE; Schlesinger, LS; Knoell, DL				Pyle, Charlie J.; Akhter, Saife; Bao, ShengYing; Dodd, Claire E.; Schlesinger, Larry S.; Knoell, Daren L.			Zinc Modulates Endotoxin-Induced Human Macrophage Inflammation through ZIP8 Induction and C/EBP beta Inhibition	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TNF-ALPHA; TRANSCRIPTION FACTOR; MEDIATED INHIBITION; CYTOKINE PRODUCTION; IL-10 PRODUCTION; GENE-EXPRESSION; PROTEIN-KINASE; BOVIS BCG; LIPOPOLYSACCHARIDE	Two vital functions of the innate immune system are to initiate inflammation and redistribute micronutrients in favor of the host. Zinc is an essential micronutrient used in host defense. The zinc importer ZIP8 is uniquely induced through stimulation of the NF-kappa B pathway by LPS in monocytes and functions to regulate inflammation in a zinc-dependent manner. Herein we determined the impact of zinc metabolism following LPS-induced inflammation in human macrophages. We observed that ZIP8 is constitutively expressed in resting macrophages and strikingly elevated following LPS exposure, a response that is unique compared to the 13 other known zinc import proteins. During LPS exposure, extracellular zinc concentrations within the physiological range markedly reduced IL-10 mRNA expression and protein release but increased mRNA expression of TNF alpha, IL-8, and IL-6. ZIP8 knockdown inhibited LPS-driven cellular accumulation of zinc and prevented zinc-dependent reduction of IL-10 release. Further, zinc supplementation reduced nuclear localization and activity of C/EBP beta, a transcription factor known to drive IL-10 expression. These studies demonstrate for the first time that zinc regulates LPS-mediated immune activation of human macrophages in a ZIP8-dependent manner, reducing IL-10. Based on these findings we predict that macrophage zinc metabolism is important in host defense against pathogens.	[Pyle, Charlie J.; Dodd, Claire E.; Schlesinger, Larry S.; Knoell, Daren L.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Pyle, Charlie J.; Akhter, Saife; Bao, ShengYing; Schlesinger, Larry S.; Knoell, Daren L.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Bao, ShengYing; Knoell, Daren L.] Univ Nebraska, Coll Pharm, Med Ctr, Omaha, NE 68182 USA; [Dodd, Claire E.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Nebraska System; University of Nebraska Medical Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schlesinger, LS; Knoell, DL (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.; Schlesinger, LS; Knoell, DL (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Knoell, DL (corresponding author), Univ Nebraska, Coll Pharm, Med Ctr, Omaha, NE 68182 USA.; Schlesinger, LS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu; daren.knoell@unmc.edu		Pyle, Charlie/0000-0002-6355-0638	National Institutes of Allergy and Infectious Disease [R01 AI059639]; National Heart Lung and Blood Institute [R01 HL118268]	National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Allergy and Infectious Disease grant #R01 AI059639 and the National Heart Lung and Blood Institute grant #R01 HL118268.	Asakawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119428; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Begum NA, 2002, GENOMICS, V80, P630, DOI 10.1006/geno.2002.7000; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; CHANG CJ, 1995, DNA CELL BIOL, V14, P529, DOI 10.1089/dna.1995.14.529; Cox JN, 2016, AM J PHYSIOL-LUNG C, V311, pL754, DOI 10.1152/ajplung.00022.2016; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DRIESSEN C, 1995, IMMUNOLOGY, V84, P272; Figueroa JAL, 2014, METALLOMICS, V6, P301, DOI 10.1039/c3mt00283g; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Foey AD, 1998, J IMMUNOL, V160, P920; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Gracias DT, 2011, ADV EXP MED BIOL, V780, P15, DOI 10.1007/978-1-4419-5632-3_2; Grider A, 2015, BIOMETALS, V28, P959, DOI 10.1007/s10534-015-9880-6; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hardyman JEJ, 2016, METALLOMICS, V8, P337, DOI 10.1039/c5mt00305a; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; Lai TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073153; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Maret W, 2008, EXP GERONTOL, V43, P363, DOI 10.1016/j.exger.2007.11.005; McDermott JR, 2016, ONCOTARGET; Nagasaki A, 1996, J BIOL CHEM, V271, P2658, DOI 10.1074/jbc.271.5.2658; NATSUKA S, 1992, BLOOD, V79, P460; Nguyen HA, 2012, AM J PHYSIOL-LUNG C, V303, pL608, DOI 10.1152/ajplung.00067.2012; Niehof M, 2001, J MOL BIOL, V309, P855, DOI 10.1006/jmbi.2001.4708; Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200; PILCH SM, 1985, J NUTR, V115, P1393, DOI 10.1093/jn/115.11.1393; Pope R, 2000, CYTOKINE, V12, P1171, DOI 10.1006/cyto.2000.0691; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SCHLESINGER LS, 1991, J IMMUNOL, V147, P1983; Shih CJ, 2013, INFLAMMATION, V36, P616, DOI 10.1007/s10753-012-9583-x; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Song J, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-31; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Stafford S. L., 2013, BIOSCI REP, V33; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thomassen MJ, 1996, CLIN IMMUNOL IMMUNOP, V80, P321, DOI 10.1006/clin.1996.0130; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; von Bulow V, 2005, J IMMUNOL, V175, P4697, DOI 10.4049/jimmunol.175.7.4697; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Weaver BP, 2012, BIOMETALS, V25, P319, DOI 10.1007/s10534-011-9508-4; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Wellinghausen N, 1996, J IMMUNOL, V157, P3139; Winters MS, 2010, J INFECT DIS, V202, P1136, DOI 10.1086/656191; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286; Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155865	75	38	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169531	10.1371/journal.pone.0169531	http://dx.doi.org/10.1371/journal.pone.0169531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056086	Green Submitted, gold, Green Published			2022-12-26	WOS:000391639100050
J	Mayer, C; Windhager, S; Schaefer, K; Mitteroecker, P				Mayer, Christine; Windhager, Sonja; Schaefer, Katrin; Mitteroecker, Philipp			BMI and WHR Are Reflected in Female Facial Shape and Texture: A Geometric Morphometric Image Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; PERCEIVED ATTRACTIVENESS; SKIN-COLOR; ADIPOSITY; HEALTH; WOMEN; FRUIT; RATIO; CUES; FAT	Facial markers of body composition are frequently studied in evolutionary psychology and are important in computational and forensic face recognition. We assessed the association of body mass index (BMI) and waist-to-hip ratio (WHR) with facial shape and texture (color pattern) in a sample of young Middle European women by a combination of geometric morphometrics and image analysis. Faces of women with high BMI had a wider and rounder facial outline relative to the size of the eyes and lips, and relatively lower eyebrows. Furthermore, women with high BMI had a brighter and more reddish skin color than women with lower BMI. The same facial features were associated with WHR, even though BMI and WHR were only moderately correlated. Yet BMI was better predictable than WHR from facial attributes. After leave-one-out cross-validation, we were able to predict 25% of variation in BMI and 10% of variation in WHR by facial shape. Facial texture predicted only about 3-10% of variation in BMI and WHR. This indicates that facial shape primarily reflects total fat proportion, rather than the distribution of fat within the body. The association of reddish facial texture in high-BMI women may be mediated by increased blood pressure and superficial blood flow as well as diet. Our study elucidates how geometric morphometric image analysis serves to quantify the effect of biological factors such as BMI and WHR to facial shape and color, which in turn contributes to social perception.	[Mayer, Christine; Windhager, Sonja; Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Mayer, Christine] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Mayer, Christine] Univ Oslo, EvoGene, Oslo, Norway; [Windhager, Sonja; Schaefer, Katrin] Univ Vienna, Dept Anthropol, Fac Life Sci, Vienna, Austria	University of Vienna; University of Oslo; University of Oslo; University of Vienna	Mitteroecker, P (corresponding author), Univ Vienna, Dept Theoret Biol, Vienna, Austria.	philipp.mitteroecker@univiei.ac.at	Schaefer, Katrin/G-8632-2011; Windhager, Sonja/K-7618-2013	Schaefer, Katrin/0000-0002-0173-3092; Windhager, Sonja/0000-0003-1809-8678; Syrowatka, Christine/0000-0002-0315-5142	Austrian Science Fund FWF [P 29397] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Alaluf S, 2002, J NUTR, V132, P399, DOI 10.1093/jn/132.3.399; ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Brincat MP, 2000, MATURITAS, V35, P107, DOI 10.1016/S0378-5122(00)00097-9; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Droyvold WB, 2005, INT J OBESITY, V29, P650, DOI 10.1038/sj.ijo.0802944; Drummond PD, 1999, PSYCHOPHYSIOLOGY, V36, P325, DOI 10.1017/S0048577299980344; Drummond PD, 2001, PSYCHOPHYSIOLOGY, V38, P190, DOI 10.1111/1469-8986.3820190; Epel ES, 2000, PSYCHOSOM MED, V62, P623, DOI 10.1097/00006842-200009000-00005; Ferrario VF, 2004, ANGLE ORTHOD, V74, P37; Fink B, 2003, ANN HUM BIOL, V30, P728, DOI 10.1080/03014460310001620153; Fisher CI, 2014, PERCEPTION, V43, P499, DOI 10.1068/p7728; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Ghalaeh Reihaneh Seyed, 2012, J Educ Health Promot, V1, P29, DOI 10.4103/2277-9531.99969; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Henderson AJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0380; Jones AL, 2016, BODY IMAGE, V17, P57, DOI 10.1016/j.bodyim.2016.02.001; Lee BJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/818607; Lefevre CE, 2015, Q J EXP PSYCHOL, V68, P284, DOI 10.1080/17470218.2014.944194; Levine JA, 1998, NEW ENGL J MED, V339, P1946, DOI 10.1056/NEJM199812243392619; Loffler H, 2002, SKIN RES TECHNOL, V8, P19; Martens H., 1992, MULTIVARIATE CALIBRA; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Mayer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115076; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Pezdirc K, 2015, NUTRIENTS, V7, P5800, DOI 10.3390/nu7075251; Pierard GE, 1998, J EUR ACAD DERMATOL, V10, P1; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wilkinson C., 2004, FORENSIC FACIAL RECO; Windhager S, 2013, AM J HUM BIOL, V25, P847, DOI 10.1002/ajhb.22444; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Wolffhechel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140347; Zhang D, 2005, LECT NOTES COMPUT SC, V3497	46	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169336	10.1371/journal.pone.0169336	http://dx.doi.org/10.1371/journal.pone.0169336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052103	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500050
J	Silva-Alves, MS; Secolin, R; Carvalho, BS; Yasuda, CL; Bilevicius, E; Alvim, MKM; Santos, RO; -Morelli, CVM; Cendes, F; Lopes-Cendes, I				Silva-Alves, Mariana S.; Secolin, Rodrigo; Carvalho, Benilton S.; Yasuda, Clarissa L.; Bilevicius, Elizabeth; Alvim, Marina K. M.; Santos, Renato O.; -Morelli, Claudia V. Maurer; Cendes, Fernando; Lopes-Cendes, Iscia			A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HIPPOCAMPAL SCLEROSIS; ANTIEPILEPTIC DRUGS; RISK PREDICTION; EXPRESSION; RESISTANCE; POLYMORPHISM; METAANALYSIS	Mesial temporal lobe epilepsy is the most common form of adult epilepsy in surgical series. Currently, the only characteristic used to predict poor response to clinical treatment in this syndrome is the presence of hippocampal sclerosis. Single nucleotide polymorphisms ( SNPs) located in genes encoding drug transporter and metabolism proteins could influence response to therapy. Therefore, we aimed to evaluate whether combining information from clinical variables as well as SNPs in candidate genes could improve the accuracy of predicting response to drug therapy in patients with mesial temporal lobe epilepsy. For this, we divided 237 patients into two groups: 75 responsive and 162 refractory to antiepileptic drug therapy. We genotyped 119 SNPs in ABCB1, ABCC2, CYP1A1, CYP1A2, CYP1B1, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, and CYP3A5 genes. We used 98 additional SNPs to evaluate population stratification. We assessed a first scenario using only clinical variables and a second one including SNP information. The random forests algorithm combined with leave-one-out cross-validation was used to identify the best predictive model in each scenario and compared their accuracies using the area under the curve statistic. Additionally, we built a variable importance plot to present the set of most relevant predictors on the best model. The selected best model included the presence of hippocampal sclerosis and 56 SNPs. Furthermore, including SNPs in the model improved accuracy from 0.4568 to 0.8177. Our findings suggest that adding genetic information provided by SNPs, located on drug transport and metabolism genes, can improve the accuracy for predicting which patients with mesial temporal lobe epilepsy are likely to be refractory to drug treatment, making it possible to identify patients who may benefit from epilepsy surgery sooner.	[Silva-Alves, Mariana S.; Secolin, Rodrigo; Santos, Renato O.; -Morelli, Claudia V. Maurer; Lopes-Cendes, Iscia] Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil; [Silva-Alves, Mariana S.; Secolin, Rodrigo; Carvalho, Benilton S.; Yasuda, Clarissa L.; Bilevicius, Elizabeth; Alvim, Marina K. M.; Santos, Renato O.; -Morelli, Claudia V. Maurer; Cendes, Fernando; Lopes-Cendes, Iscia] Brazilian Inst Neurosci & Neurotechnol BRAINN, Campinas, SP, Brazil; [Carvalho, Benilton S.] Univ Estadual Campinas, UNICAMP, Dept Stat, Inst Math Stat & Sci Comp, Campinas, SP, Brazil; [Yasuda, Clarissa L.; Bilevicius, Elizabeth; Alvim, Marina K. M.; Cendes, Fernando] Univ Estadual Campinas, UNICAMP, Dept Neurol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Lopes-Cendes, I (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil.; Lopes-Cendes, I (corresponding author), Brazilian Inst Neurosci & Neurotechnol BRAINN, Campinas, SP, Brazil.	icendes@unicamp.br	Cendes, Fernando/C-1301-2012; Alvim, Marina/C-1704-2017; yasuda, clarissa l/B-7934-2013; Lopes-Cendes, Iscia/B-9416-2013; yasuda, clarissa lin/D-4599-2018; Carvalho, Benilton/L-9329-2019; Secolin, Rodrigo/G-1738-2010; Secolin, Rodrigo/AAG-2115-2019; Maurer-Morelli, Claudia/G-7434-2012; Santos, Renato O/K-7194-2013	Cendes, Fernando/0000-0001-9336-9568; Alvim, Marina/0000-0002-6780-0761; yasuda, clarissa l/0000-0001-9084-7173; Lopes-Cendes, Iscia/0000-0002-6221-6822; yasuda, clarissa lin/0000-0001-9084-7173; Carvalho, Benilton/0000-0001-5122-5646; Secolin, Rodrigo/0000-0002-2485-9560; Secolin, Rodrigo/0000-0002-2485-9560; Maurer-Morelli, Claudia/0000-0001-7929-2197; Santos, Renato O/0000-0002-9195-1009	FAPESP [2013/07559-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by FAPESP, grant number 2013/07559-3.	Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x; Balan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089253; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye Tesfaye M., 2011, Human Genomics, V5, P220; Baye TM, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-1; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Boussadia B, 2014, NEUROSCIENCE, V281, P124, DOI 10.1016/j.neuroscience.2014.09.055; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cavalleri GL, 2011, PHARMACOGENOMICS, V12, P1429, DOI [10.2217/PGS.11.85, 10.2217/pgs.11.85]; Cendes F, 2014, ACTA NEUROPATHOL, V128, P21, DOI 10.1007/s00401-014-1292-0; Coan AC, 2014, AM J NEURORADIOL, V35, P77, DOI 10.3174/ajnr.A3640; Dauchy S, 2008, J NEUROCHEM, V107, P1518, DOI 10.1111/j.1471-4159.2008.05720.x; de Haan HG, 2012, BLOOD, V120, P656, DOI 10.1182/blood-2011-12-397752; De Moura RR, 2015, AM J HUM BIOL, V27, P674, DOI 10.1002/ajhb.22714; Dite GS, 2013, BREAST CANCER RES TR, V139, P887, DOI 10.1007/s10549-013-2610-2; Djordjevic N, 2016, EUR J CLIN PHARMACOL, V72, P439, DOI 10.1007/s00228-015-2006-9; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Emich-Widera E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/526837; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feldmann M, 2013, LANCET NEUROL, V12, P777, DOI 10.1016/S1474-4422(13)70109-1; Ghosh C, 2011, EPILEPSIA, V52, P562, DOI 10.1111/j.1528-1167.2010.02956.x; Grover S, 2013, EPILEPSIA, V54, P936, DOI 10.1111/epi.12132; Hastie T., 2009, UNSUPERVISED LEARNIN; Kim WJ, 2010, PHARMACOGENET GENOM, V20, P249, DOI 10.1097/FPC.0b013e328338073a; Klotz U, 2007, CLIN PHARMACOKINET, V46, P271, DOI 10.2165/00003088-200746040-00001; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma AM, 2013, DRUG DES DEV THER, V7, P1447, DOI 10.2147/DDDT.S52533; Muller B, 2016, HUM GENET, V135, P259, DOI 10.1007/s00439-016-1636-z; Nurmohamed L, 2010, EPILEPSIA, V51, P1882, DOI 10.1111/j.1528-1167.2010.02588.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056128; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Samer CF, 2013, MOL DIAGN THER, V17, P165, DOI 10.1007/s40291-013-0028-5; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Talwar P., 2016, PHARMACOGENOMICS J; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Turakulov R, 2003, HUM HERED, V55, P37, DOI 10.1159/000071808; van der Weide J, 2001, PHARMACOGENETICS, V11, P287, DOI 10.1097/00008571-200106000-00002; Varoglu AO, 2009, EPILEPSY RES, V85, P206, DOI 10.1016/j.eplepsyres.2009.03.001; Wang G, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0294-9; Yasuda Clarissa Lin, 2012, Expert Opin Med Diagn, V6, P295, DOI 10.1517/17530059.2012.683408	44	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169214	10.1371/journal.pone.0169214	http://dx.doi.org/10.1371/journal.pone.0169214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052106	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500037
J	Xie, XS; Zubarev, RA				Xie, Xueshu; Zubarev, Roman A.			On the Effect of Planetary Stable Isotope Compositions on Growth and Survival of Terrestrial Organisms	PLOS ONE			English	Article							HEAVY-WATER; RESONANCE HYPOTHESIS; BIOLOGICAL PROCESSES; ESCHERICHIA-COLI; DEUTERIUM; SPECIFICITY; REPLACEMENT; BACTERIA; D2O	Isotopic compositions of reactants affect the rates of chemical and biochemical reactions. Usually it is assumed that heavy stable isotope enrichment leads to progressively slower reactions. Yet the effect of stable isotopes may be nonlinear, as exemplified by the "isotopic resonance" phenomenon. Since the isotopic compositions of other planets of Solar system, including Mars and Venus, are markedly different from terrestrial (e.g., deuterium content is and X100 times higher, respectively), it is far from certain that terrestrial life will thrive in these isotopic conditions. Here we found that Martian deuterium content negatively affected survival of shrimp in semi-closed biosphere on a year-long time scale. Moreover, the bacterium Escherichia coli grows slower at Martian isotopic compositions and even slower at Venus's compositions. Thus, the biological impact of varying stable isotope compositions needs to be taken into account when planning interplanetary missions.	[Xie, Xueshu; Zubarev, Roman A.] Karolinska Inst, Div Physiol Chem 1, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Zubarev, RA (corresponding author), Karolinska Inst, Div Physiol Chem 1, Dept Med Biochem & Biophys, Stockholm, Sweden.	Roman.Zubarev@ki.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Xie, Xueshu/0000-0002-5605-1961	Swedish Research Council [2011-3726]; KAW Foundation [2010.022]	Swedish Research Council(Swedish Research CouncilEuropean Commission); KAW Foundation	This work was funded by the Swedish Research Council, grant 2011-3726, and KAW Foundation, grant 2010.022.	Barnes TC, 1934, SCIENCE, V79, P370, DOI 10.1126/science.79.2051.370; Barnes T. C, 1935, PROTOPLASMA, V22, P431; Barnes T. C, 1933, J AM CHEM SOC, V55, P4332; Barnes T. C, 1933, J AM CHEM SOC, V55, P5059; CAMERON AGW, 1973, SPACE SCI REV, V15, P121, DOI 10.1007/BF00172440; Curry J, 1935, SCIENCE, V81, P275, DOI 10.1126/science.81.2098.275; CZAJKA DM, 1961, AM J PHYSIOL, V201, P357, DOI 10.1152/ajplegacy.1961.201.2.357; Fegley B., 2013, GLOB EARTH PHYS, P320; Filiou MD, 2012, PROTEOMICS, V12, P3121, DOI 10.1002/pmic.201200209; Filiou MD, 2011, BIOL PSYCHIAT, V70, P1074, DOI 10.1016/j.biopsych.2011.06.009; GREGG CT, 1973, LIFE SCI, V13, P775, DOI 10.1016/0024-3205(73)90068-4; KATZ JJ, 1966, SCIENCE, V151, P1187, DOI 10.1126/science.151.3715.1187; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; KLEIN PD, 1986, J CLIN PHARMACOL, V26, P378, DOI 10.1002/j.1552-4604.1986.tb03544.x; Krempels K, 2013, J CANC RES THER, V1, P194, DOI DOI 10.14312/2052-4994.2013-29; Krempels K, 2008, INTEGR CANCER THER, V7, P172, DOI 10.1177/1534735408322851; LOBYSHEV VI, 1983, BIOFIZIKA+, V28, P666; LOBYSHEV VI, 1982, BIOFIZIKA+, V27, P595; LOBYSHEV VI, 1978, BIOFIZIKA+, V23, P390; Lockemann G, 1934, BER DTSCH CHEM GES, V67, P1299, DOI 10.1002/cber.19340670733; Macht DI, 1934, J AM CHEM SOC, V56, P246, DOI 10.1021/ja01316a507; MORGAN JW, 1980, P NATL ACAD SCI USA, V77, P6973, DOI 10.1073/pnas.77.12.6973; Nikitin DI, 2003, BIOFIZIKA+, V48, P678; Richards OW, 1934, J BACTERIOL, V28, P289, DOI 10.1128/JB.28.3.289-294.1934; Richards OW., 1933, AM J BOT, V20, P679; Saal AE, 2013, SCIENCE, V340, P1317, DOI 10.1126/science.1235142; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; UPHAUS RA, 1967, BIOCHIM BIOPHYS ACTA, V141, P625, DOI 10.1016/0304-4165(67)90191-2; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Xie XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09215; Xie XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102071; Zubarev Roman A., 2011, Genomics Proteomics & Bioinformatics, V9, P15, DOI 10.1016/S1672-0229(11)60003-X; Zubarev RA, 2010, CENT EUR J BIOL, V5, P190, DOI 10.2478/s11535-009-0069-2	33	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169296	10.1371/journal.pone.0169296	http://dx.doi.org/10.1371/journal.pone.0169296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052100	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500043
J	Sumegi, K; Fekete, K; Antus, C; Debreceni, B; Hocsak, E; Gallyas, F; Sumegi, B; Szabo, A				Sumegi, Katalin; Fekete, Katalin; Antus, Csenge; Debreceni, Balazs; Hocsak, Eniko; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Szabo, Aliz			BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species	PLOS ONE			English	Article							ACUTE LUNG INJURY; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ATYPICAL ANTIPSYCHOTICS; N-ACETYLCYSTEINE; NADPH OXIDASE; CELL; DYSFUNCTION; INHIBITOR; APOPTOSIS	Reactive oxygen species (ROS) play a critical role in the progression of mitochondria related diseases. A novel insulin sensitizer drug candidate, BGP-15, has been shown to have protective effects in several oxidative stress-related diseases in animal and human studies. In this study, we investigated whether the protective effects of BGP-15 are predominantly via preserving mitochondrial integrity and reducing mitochondrial ROS production. BGP-15 was found to accumulate in the mitochondria, protect against ROS-induced mitochondrial depolarization and attenuate ROS-induced mitochondrial ROS production in a cell culture model, and also reduced ROS production predominantly at the complex I-Ill system in isolated mitochondria. At physiologically relevant concentrations, BGP-15 protected against hydrogen peroxide-induced cell death by reducing both apoptosis and necrosis. Additionally, it attenuated bacterial lipopolysaccharide (LPS)-induced collapse of mitochondrial membrane potential and ROS production in LPS-sensitive U-251 glioma cells, suggesting that BGP-15 may have a protective role in inflammatory diseases. However, BGP-15 did not have any antioxidant effects as shown by in vitro chemical and cell culture systems. These data suggest that BGP-15 could be a novel mitochondrial drug candidate for the prevention of ROS-related and inflammatory disease progression.	[Sumegi, Katalin; Fekete, Katalin; Antus, Csenge; Debreceni, Balazs; Hocsak, Eniko; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Szabo, Aliz] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, MTA PTE Nucl Mitochondrial Interact Res Grp, Sch Med, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs	Szabo, A (corresponding author), Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary.	aliz.szabo@aok.pte.hu	Gallyas, Ferenc/C-2272-2012; Gallyas, Ferenc/AAY-5343-2020		Hungarian National Research Foundations [OTKA K-104220, OTKA NN-109841]	Hungarian National Research Foundations(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian National Research Foundations OTKA K-104220 (BS) and OTKA NN-109841 (FG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BR J PHARM; Babot M, 2014, BBA-BIOENERGETICS, V1837, P1083, DOI 10.1016/j.bbabio.2014.02.018; Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199; Bardos G, 2003, TOXICOL APPL PHARM, V190, P9, DOI 10.1016/S0041-008X(03)00155-8; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coyle LC, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.002; Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Fonai F, 2015, BBA-MOL BASIS DIS, V1852, P2563, DOI 10.1016/j.bbadis.2015.09.004; Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gombos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028818; HOGEBOOM GH, 1950, J BIOL CHEM, V186, P417; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Idelman G, 2015, REDOX BIOL, V5, P398, DOI 10.1016/j.redox.2015.06.008; Jaffery Z, 2012, CATHETER CARDIO INTE, V79, P921, DOI 10.1002/ccd.23157; Jegatheeswaran S, 2011, HPB, V13, P71, DOI 10.1111/j.1477-2574.2010.00263.x; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Klegeris A, 2001, NEUROSCI LETT, V313, P41, DOI 10.1016/S0304-3940(01)02251-0; Korbecki J, 2013, J PHYSIOL PHARMACOL, V64, P409; Literati-Nagy B, 2010, BRAIN RES BULL, V83, P340, DOI 10.1016/j.brainresbull.2010.09.005; Literati-Nagy Z, 2012, PATHOL ONCOL RES, V18, P1071, DOI 10.1007/s12253-012-9546-4; Literati-Nagy Z, 2012, CELL STRESS CHAPERON, V17, P517, DOI 10.1007/s12192-012-0327-5; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; Matsuno K, 2012, FREE RADICAL BIO MED, V53, P1718, DOI 10.1016/j.freeradbiomed.2012.08.590; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mazzaccara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034956; Nagy G, 2010, TOXICOL APPL PHARM, V243, P96, DOI 10.1016/j.taap.2009.11.017; Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10; Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013; Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Priber J, 2015, BIOCHEM CELL BIOL, V93, P241, DOI 10.1139/bcb-2014-0120; Racz I, 2002, BIOCHEM PHARMACOL, V63, P1099, DOI 10.1016/S0006-2952(01)00935-2; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; Sarszegi Z, 2012, MOL CELL BIOCHEM, V365, P129, DOI 10.1007/s11010-012-1252-8; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Seeley EJ, 2013, J CLIN INVEST, V123, P1015, DOI 10.1172/JCI68093; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Szczepanowska K, 2015, BBA-BIOENERGETICS, V1847, P1362, DOI 10.1016/j.bbabio.2015.05.016; Tajeddine N, 2016, BBA-GEN SUBJECTS, V1860, P1079, DOI 10.1016/j.bbagen.2016.02.013; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Teshima Y, 2014, CIRC J, V78, P300, DOI 10.1253/circj.CJ-13-1187; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	58	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169372	10.1371/journal.pone.0169372	http://dx.doi.org/10.1371/journal.pone.0169372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046125	gold, Green Published, Green Submitted			2022-12-26	WOS:000391612300177
J	Rahman, A; Haugh, JM				Rahman, Anisur; Haugh, Jason M.			Kinetic Modeling and Analysis of the Akt/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling Axis Reveals Cooperative, Feedforward Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TSC2 GAP ACTIVITY; TUBEROUS SCLEROSIS; CELL-GROWTH; RHEB; PHOSPHORYLATION; ACTIVATION; PROTEIN; KINASE; ERK; BINDING	Mechanistic target of rapamycin complex 1)mTORC1) controls biosynthesis and has been implicated in uncontrolled cell growth in cancer. Although many details of mTORC1 regulation are well understood, a systems- level, predictive framework synthesizing those details is currently lacking. We constructed various mathematical models of mTORC1 activation mediated by Akt and aligned the model outputs to kinetic data acquired for growth factor- stimulated cells. A model based on a putative feedforward loop orchestrated by Akt consistently predicted how the pathway was altered by depletion of key regulatory proteins. Analysis of the successful model also elucidates two dynamical motifs: neutralization of a negative regulator, which characterizes how Akt indirectly activates mTORC1, and seesaw enzyme regulation, which describes how activated and inhibited states of mTORC1 are controlled in concert to produce a nonlinear, ultrasensitive response. Such insights lend quantitative understanding of signaling networks and their precise manipulation in various contexts.	[Rahman, Anisur; Haugh, Jason M.] North Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu		Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [R01-GM088987]; National Science Foundation [1330746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM088987 (to J.M.H.) and National Science Foundation Grant 1330746. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Everett RD, 2010, J VIROL, V84, P3695, DOI 10.1128/JVI.00021-10; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nascimento EBM, 2010, CELL SIGNAL, V22, P961, DOI 10.1016/j.cellsig.2010.02.002; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rahman A, 2014, BIOPHYS J, V107, pL29, DOI 10.1016/j.bpj.2014.10.003; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038	31	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2866	2872		10.1074/jbc.M116.761205	http://dx.doi.org/10.1074/jbc.M116.761205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28069808	Green Published, hybrid			2022-12-26	WOS:000395535100026
J	Toksoy, A; Sennefelder, H; Adam, C; Hofmann, S; Trautmann, A; Goebeler, M; Schmidt, M				Toksoy, Atiye; Sennefelder, Helga; Adam, Christian; Hofmann, Sonja; Trautmann, Axel; Goebeler, Matthias; Schmidt, Marc			Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC CONTACT-DERMATITIS; HYPERSENSITIVITY REACTIONS; NALP3 INFLAMMASOME; GENE-EXPRESSION; PEPTIDE REPERTOIRE; INNATE IMMUNITY; MECHANISMS; SELF; INDUCTION; MONOCYTES	There is experimental and clinical evidence that some exanthematous allergic drug hypersensitivity reactions are mediated by drug- specific T cells. We hypothesized that the capacity of certain drugs to directly stimulate the innate immune system may contribute to generate drug- specific T cells. Here we analyzed whether abacavir, an HIV-1 reverse transcriptase inhibitor often inducing severe delayed- type drug hypersensitivity, can trigger innate immune activation that may contribute to its allergic potential. We show that abacavir fails to generate direct innate immune activation in human monocytes but potently triggers IL- 1 beta release upon pro- inflammatory priming with phorbol ester or Toll- like receptor stimulation. IL- 1 beta processing and secretion were sensitive to Caspase-1 inhibition, NLRP3 knockdown, and K+ efflux inhibition and were not observed with other non-allergenic nucleoside reverse transcriptase inhibitors, identifying abacavir as a specific inflammasome activator. It further correlated with dose-dependent mitochondrial reactive oxygen species production and cytotoxicity, indicating that inflammasome activation resulted from mitochondrial damage. However, both NLRP3 depletion and inhibition of K+ efflux mitigated abacavir-induced mitochondrial reactive oxygen species production and cytotoxicity, suggesting that these processes were secondary to NLRP3 activation. Instead, depletion of cardiolipin synthase 1 abolished abacavir-induced IL-1 beta secretion, suggesting that mitochondrial cardiolipin release may trigger abacavir-induced inflammasome activation. Our data identify abacavir as a novel inflammasome-stimulating drug allergen. They implicate a potential contribution of innate immune activation to medication-induced delayed-type hypersensitivity, which may stimulate new concepts for treatment and prevention of drug allergies.	[Toksoy, Atiye; Sennefelder, Helga; Adam, Christian; Hofmann, Sonja; Trautmann, Axel; Goebeler, Matthias; Schmidt, Marc] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Josef Schneider Str 2, D-97080 Wurzburg, Germany	University of Wurzburg	Schmidt, M (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	schmidt_M11@ukw.de	Schmidt, Marc/E-8821-2010	Schmidt, Marc/0000-0002-8643-1615; Adam, Christian/0000-0001-7721-4144	Department of Dermatology, University Hospital Wurzburg, Germany	Department of Dermatology, University Hospital Wurzburg, Germany	This work was supported by the Department of Dermatology, University Hospital Wurzburg, Germany. The authors declare that they have no conflicts of interest with the contents of this article.	Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Cutrell AG, 2004, ANN PHARMACOTHER, V38, P2171, DOI 10.1345/aph.1E202; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; Hernandez JC, 2014, INTERVIROLOGY, V57, P36, DOI 10.1159/000353902; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2015, ANNU REV MED, V66, P439, DOI 10.1146/annurev-med-050913-022745; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Schmidt M, 2015, J DTSCH DERMATOL GES, V13, P653, DOI 10.1111/ddg.12673; Schrijvers R, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0073-8; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Weston JK, 2014, CHEM RES TOXICOL, V27, P949, DOI 10.1021/tx5001333; White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2805	2814	7	10.1074/jbc.M116.749473	http://dx.doi.org/10.1074/jbc.M116.749473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057759	Green Published, hybrid			2022-12-26	WOS:000395535100021
J	Hichino, A; Okamoto, M; Taga, S; Akizuki, R; Endo, S; Matsunaga, T; Ikari, A				Hichino, Asami; Okamoto, Miki; Taga, Saeko; Akizuki, Risa; Endo, Satoshi; Matsunaga, Toshiyuki; Ikari, Akira			Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CANCER-CELLS; TIGHT JUNCTIONS; GASTRIC CARCINOGENESIS; UP-REGULATION; GROWTH; PROGNOSIS; CARCINOMA; PROMOTES; PATHWAY	Claudin-2 is highly expressed in lung adenocarcinoma tissues and increases proliferation in adenocarcinoma cells. The chemicals that reduce claudin-2 expression may have anti-cancer effects, but such therapeutic medicines have not been developed. We found that azacitidine (AZA), a DNA methylation inhibitor, and trichostatin A (TSA) and sodium butyrate (NaB), histone deacetylase (HDAC) inhibitors, decrease claudin-2 levels. The effect of AZA was mediated by the inhibition of phosphorylated Akt and NF-kappa B. LY-294002, an inhibitor of phosphatidylinositol 3-kinase (PI3K), and BAY 11-7082, an NF-kappa B inhibitor, decreased claudin-2 levels. The reporter activity of claudin-2 was decreased by AZA and LY-294002, which was blocked by the mutation in a putative NF-kappa B-binding site. NF-kappa B bound to the promoter region of claudin-2, which was inhibited by AZA and LY-294002. AZA is suggested to decrease the claudin-2 mRNA level mediated by the inhibition of a PI3K/Akt/NF-kappa B pathway. TSA and NaB did not change phosphorylated Akt and NF-kappa B levels. Furthermore, these inhibitors did not change the reporter activity of claudin-2 but decreased the stability of claudin-2 mRNA mediated by the elevation of miR-497 microRNA. The binding of histone H3 to the promoter region of miR-497 was inhibited by TSA and NaB, whereas that of claudin-2 was not. These results suggest that HDAC inhibitors decrease claudin-2 levels mediated by the elevation of miR-497 expression. Cell proliferation was additively decreased by AZA, TSA, and NaB, which was partially rescued by ectopic expression of claudin-2. We suggest that epigenetic inhibitors suppress the abnormal proliferation of lung adenocarcinoma cells highly expressing claudin-2.	[Hichino, Asami; Okamoto, Miki; Taga, Saeko; Akizuki, Risa; Endo, Satoshi; Matsunaga, Toshiyuki; Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan	Gifu Pharmaceutical University	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Endo, Satoshi/F-8059-2011	Endo, Satoshi/0000-0003-0578-9672				Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Ansari J, 2016, TRANSL LUNG CANCER R, V5, P155, DOI 10.21037/tlcr.2016.02.02; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Di Cello F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068630; Flores AR, 2014, J COMP PATHOL, V150, P169, DOI 10.1016/j.jcpa.2013.09.004; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Halasz J, 2006, HUM PATHOL, V37, P555, DOI 10.1016/j.humpath.2005.12.015; Hamm CA, 2015, PHARMACOL THERAPEUT, V151, P72, DOI 10.1016/j.pharmthera.2015.03.003; Han ZY, 2015, ONCOTARGET, V6, P13149, DOI 10.18632/oncotarget.3693; Ikari A, 2014, BBA-MOL CELL RES, V1843, P2079, DOI 10.1016/j.bbamcr.2014.05.017; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Ikari A, 2011, LIFE SCI, V88, P628, DOI 10.1016/j.lfs.2011.02.002; Kim HS, 2012, PATHOBIOLOGY, V79, P84, DOI 10.1159/000334340; Kinugasa T, 2007, ANTICANCER RES, V27, P3729; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Nguyen TTP, 2011, BREAST CANCER RES TR, V130, P73, DOI 10.1007/s10549-010-1304-2; Park YJ, 2011, PROG DRUG RES, V67, P25, DOI 10.1007/978-3-7643-8989-5_2; Patonai A, 2011, VIRCHOWS ARCH, V458, P679, DOI 10.1007/s00428-011-1077-y; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Schnermann J, 2013, AM J PHYSIOL-RENAL, V305, pF1352, DOI 10.1152/ajprenal.00342.2013; Song X, 2008, HISTOL HISTOPATHOL, V23, P673, DOI 10.14670/HH-23.673; Sonoki H, 2015, NUTRIENTS, V7, P4578, DOI 10.3390/nu7064578; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Valente S, 2014, J MED CHEM, V57, P6259, DOI 10.1021/jm500303u; Valente S, 2013, CHEMMEDCHEM, V8, P800, DOI 10.1002/cmdc.201300005; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Xin S, 2007, ONCOLOGY-BASEL, V73, P357, DOI 10.1159/000135351; Yang G, 2016, ONCOTARGET, V7, P55900, DOI 10.18632/oncotarget.10152; Zhao WY, 2013, BIOCHEM BIOPH RES CO, V435, P466, DOI 10.1016/j.bbrc.2013.05.010; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	48	26	28	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2411	2421		10.1074/jbc.M116.762807	http://dx.doi.org/10.1074/jbc.M116.762807			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28057758	Green Published, hybrid			2022-12-26	WOS:000395530300030
J	Allardet-Servent, J; Lebsir, M; Dubroca, C; Fabrigoule, M; Jordana, S; Signouret, T; Castanier, M; Thomas, G; Soundaravelou, R; Lepidi, A; Delapierre, L; Penaranda, G; Halfon, P; Seghboyan, JM				Allardet-Servent, Jerome; Lebsir, Melissa; Dubroca, Christian; Fabrigoule, Martine; Jordana, Sylvie; Signouret, Thomas; Castanier, Matthias; Thomas, Guillemette; Soundaravelou, Rettinavelou; Lepidi, Anne; Delapierre, Laurence; Penaranda, Guillaume; Halfon, Philippe; Seghboyan, Jean-Marie			Point-of-Care Versus Central Laboratory Measurements of Hemoglobin, Hematocrit, Glucose, Bicarbonate and Electrolytes: A Prospective Observational Study in Critically Ill Patients	PLOS ONE			English	Article							ION-SELECTIVE ELECTRODES; BLOOD-GAS; WHOLE-BLOOD; DXH 800; SODIUM; RECOMMENDATIONS; POTASSIUM; HYPONATREMIA; ANALYZERS; SAPPHIRE	Introduction Rapid detection of abnormal biological values using point-of-care (POC) testing allows clinicians to promptly initiate therapy; however, there are concerns regarding the reliability of POC measurements. We investigated the agreement between the latest generation blood gas analyzer and central laboratory measurements of electrolytes, bicarbonate, hemoglobin, hematocrit, and glucose. Methods 314 paired samples were collected prospectively from 51 critically ill patients. All samples were drawn simultaneously in the morning from an arterial line. BD Vacutainer tubes were analyzed in the central laboratory using Beckman Coulter analyzers (AU 5800 and DxH 800). BD Preset 3 ml heparinized-syringes were analyzed immediately in the ICU using the POC Siemens RAPIDPoint 500 blood gas system. We used CLIA proficiency testing criteria to define acceptable analytical performance and interchangeability. Results Biases, limits of agreement (+/- 1.96 SD) and coefficients of correlation were respectively: 1.3 (-2.2 to 4.8 mmol/L, r = 0.936) for sodium; 0.2 (-0.2 to 0.6 mmol/L, r = 0.944) for potassium; -0.9 (-3.7 to 2 mmol/L, r = 0.967) for chloride; 0.8 (-1.9 to 3.4 mmol/L, r = 0.968) for bicarbonate; -11 (-30 to 9 mg/dL, r = 0.972) for glucose; -0.8 (-1.4 to -0.2 g/dL, r = 0.985) for hemoglobin; and -1.1 (-2.9 to 0.7%, r = 0.981) for hematocrit. All differences were below CLIA cut-off values, except for hemoglobin. Conclusions Compared to central Laboratory analyzers, the POC Siemens RAPIDPoint 500 blood gas system satisfied the CLIA criteria of interchangeability for all tested parameters, except for hemoglobin. These results are warranted for our own procedures and devices. Bearing these restrictions, we recommend clinicians to initiate an appropriate therapy based on POC testing without awaiting a control measurement.	[Allardet-Servent, Jerome; Signouret, Thomas; Castanier, Matthias; Thomas, Guillemette; Soundaravelou, Rettinavelou; Lepidi, Anne; Delapierre, Laurence; Seghboyan, Jean-Marie] Hop Europeen Marseille, Serv Reanimat, Marseille, France; [Lebsir, Melissa; Dubroca, Christian; Fabrigoule, Martine; Jordana, Sylvie; Penaranda, Guillaume; Halfon, Philippe] Lab Biol Specialisee Alphabio, Lab Europeen, Marseille, France		Allardet-Servent, J (corresponding author), Hop Europeen Marseille, Serv Reanimat, Marseille, France.	j.allardetservent@hopital-europeen.fr		ALLARDET-SERVENT, Jerome/0000-0002-6464-2382; PENARANDA, Guillaume/0000-0002-7461-4254	Clinical Research Department of the Hopital Europeen Marseille	Clinical Research Department of the Hopital Europeen Marseille	We thank the nurses of the Intensive Care Unit of the Hopital Europeen Marseille and the laboratory technicians of the Laboratoire Europeen for their commitment. We thank the Clinical Research Department of the Hopital Europeen Marseille for its support.	ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; Arabi YM, 2009, CRIT CARE MED, V37, P2536, DOI 10.1097/CCM.0b013e3181a381ad; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Budak YU, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-17; BURNETT RW, 1995, EUR J CLIN CHEM CLIN, V33, P247; Burnett RW, 2000, CLIN CHEM LAB MED, V38, P1065, DOI 10.1515/CCLM.2000.159; Chacko B, 2011, INDIAN J CRIT CARE M, V15, P24, DOI 10.4103/0972-5229.78219; Chow E, 2008, BRIT J BIOMED SCI, V65, P128, DOI 10.1080/09674845.2008.11732815; CLSI, 2013, CLSI DOCUMENT EP09 A, V3rd; CLSI, 2004, GP43A4 CLSI; CORNBLEET PJ, 1979, CLIN CHEM, V25, P432; Davis BH, 2010, INT J LAB HEMATOL, V32, P139, DOI 10.1111/j.1751-553X.2009.01196.x; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Frasca D, 2011, CRIT CARE MED, V39, P2277, DOI 10.1097/CCM.0b013e3182227e2d; Gumz ML, 2015, NEW ENGL J MED, V373, P60, DOI 10.1056/NEJMra1313341; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; Jain A, 2009, INT J EMERG MED, V2, P117, DOI 10.1007/s12245-009-0091-1; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Kost GJ, 1999, CHEST, V115, P1140, DOI 10.1378/chest.115.4.1140; Kumar V, 2008, CLIN CHEM, V54, P1586, DOI 10.1373/clinchem.2008.107441; Lee JW, 2011, ELECTROLYTE BLOOD PR, V8, P72; Lee-Lewandrowski E, 2009, CLIN LAB MED, V29, P479, DOI 10.1016/j.cll.2009.07.001; Leino A, 2011, CLIN CHEM LAB MED, V49, P1187, DOI 10.1515/CCLM.2011.185; LEVY GB, 1981, CLIN CHEM, V27, P1435; Medicare, 1992, FED REG, V28, P7002; Meintker L, 2013, AM J CLIN PATHOL, V139, P641, DOI 10.1309/AJCP7D8ECZRXGWCG; Mirzazadeh M, 2016, EMERG MED J, V33, P181, DOI 10.1136/emermed-2015-204669; Morimatsu H, 2003, ANESTHESIOLOGY, V98, P1077, DOI 10.1097/00000542-200305000-00009; Moritz ML, 2015, NEW ENGL J MED, V373, P1350, DOI 10.1056/NEJMra1412877; Myers GJ, 2007, PERFUSION-UK, V22, P179, DOI 10.1177/0267659107080826; Nicolas T, 2013, ANN BIOL CLIN-PARIS, V71, P305, DOI 10.1684/abc.2013.0821; Pereira AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129568; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Stove V, 2016, CRIT CARE MED, V44, pE83, DOI 10.1097/CCM.0000000000001304; Tan BT, 2011, AM J CLIN PATHOL, V135, P939, DOI 10.1309/AJCP1V3UXEIQTSLE; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P577; Tsuda I, 1998, LAB HEMATOL, V4, P276; van den Ancker W, 2015, INTENS CARE MED, V41, P553, DOI 10.1007/s00134-014-3623-y	41	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169593	10.1371/journal.pone.0169593	http://dx.doi.org/10.1371/journal.pone.0169593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072822	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200028
J	Huang, HS; Qiu, JW; Liu, TL; Yu, YY; Guo, QW; Luo, DS; Ao, YF				Huang, Hongshi; Qiu, Jianwei; Liu, Tianlin; Yu, Yuanyuan; Guo, Qinwei; Luo, Dingsheng; Ao, Yingfang			Similarity of Center of Pressure Progression during Walking and Jogging of Anterior Cruciate Ligament Deficient Patients	PLOS ONE			English	Article							RECONSTRUCTED KNEES; KINEMATICS; GAIT	Objective To evaluate the center of pressure (COP) progression similarity and its change during walking and jogging in Anterior Cruciate Ligament deficient (ACLD) patients. Methods A study was performed in 64 unilateral ACLD subjects and 32 healthy volunteers who walked and jogged on footscan (R) system at a self-selected speed. COP trajectory during walking and jogging was calculated. The robustness and similarity scores of COP (SSCOP, similarity scores with respect to corresponding COP trajectories) were computed, and then the Analysis of Variance test was employed to compare among different conditions (left or right side, within a subject or between subjects, walking or jogging). Results (1) During the same motion status (walking or jogging), SSCOP were higher than 0.885. However, SSCOP between walking and jogging were lower than 0.25 in both the healthy and ACLD group. SSCOP between the intrasubjects were statistically higher than those between the intersubjects (p<0.01). (2) SSCOP in the ACLD group were statistically significantly reduced to 0.885 +/- 0.074 compared to 0.912 +/- 0.057 in healthy volunteers during walking, and 0.903 +/- 0.066 in the ACLD group compared to 0.919 +/- 0.050 in the healthy group during jogging (p<0.01). Conclusions SSCOP can distinguish walking from jogging, and SSCOP of ACLD patients would be different from that of healthy controls. The study protocol was approved by the Institutional Research Board of Peking University Third Hospital (IRB00006761-2012010).	[Huang, Hongshi; Yu, Yuanyuan; Guo, Qinwei; Ao, Yingfang] Peking Univ, Inst Sports Med, Hosp 3, Beijing, Peoples R China; [Qiu, Jianwei; Liu, Tianlin; Luo, Dingsheng] Peking Univ, Minist Educ, Speech & Hearing Res Ctr, Key Lab Machine Percept, Beijing, Peoples R China; [Qiu, Jianwei; Liu, Tianlin; Luo, Dingsheng] Peking Univ, Sch Elect Engn & Comp Sci, Dept Machine Intelligence, Beijing, Peoples R China	Peking University; Peking University; Peking University	Ao, YF (corresponding author), Peking Univ, Inst Sports Med, Hosp 3, Beijing, Peoples R China.; Luo, DS (corresponding author), Peking Univ, Minist Educ, Speech & Hearing Res Ctr, Key Lab Machine Percept, Beijing, Peoples R China.; Luo, DS (corresponding author), Peking Univ, Sch Elect Engn & Comp Sci, Dept Machine Intelligence, Beijing, Peoples R China.	dsluo@cis.pku.edu.cn; aoyingfang@163.com	Guo, Qinwei/AAK-8402-2021	Yu, Yuanyuan/0000-0002-6179-521X; Ao, Yingfang/0000-0002-8909-2022	Beijing Nova Program [2008A006]; Opening Foundation of Key Laboratory of Cryogenics (TIPC, CAS) [CRYO 201316]; Peking-Tsinghua Center for Life Sciences; Seeding Grant for Medicine and Information Sciences of Peking University [BMU20140424]	Beijing Nova Program(Beijing Municipal Science & Technology Commission); Opening Foundation of Key Laboratory of Cryogenics (TIPC, CAS); Peking-Tsinghua Center for Life Sciences; Seeding Grant for Medicine and Information Sciences of Peking University	The work in this manuscript was supported by Beijing Nova Program (2008A006), Opening Foundation of Key Laboratory of Cryogenics (CRYO 201316, TIPC, CAS), Peking-Tsinghua Center for Life Sciences, and the Seeding Grant for Medicine and Information Sciences of Peking University (BMU20140424).	Andriacchi TP, 2005, J BIOMECH, V38, P293, DOI 10.1016/j.jbiomech.2004.02.010; Besselink A, CLIN ORTHOPEDIC REHA, P393; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Chevalier TL, 2010, GAIT POSTURE, V31, P397, DOI 10.1016/j.gaitpost.2009.11.016; De Cock A, 2006, GAIT POSTURE, V23, P339, DOI 10.1016/j.gaitpost.2005.04.011; Fuller EA, 1999, J AM PODIAT MED ASSN, V89, P278, DOI 10.7547/87507315-89-6-278; Gao B, 2010, CLIN BIOMECH, V25, P222, DOI 10.1016/j.clinbiomech.2009.11.006; Georgoulis AD, 2003, AM J SPORT MED, V31, P75, DOI 10.1177/03635465030310012401; Han TR, 1999, GAIT POSTURE, V10, P248, DOI 10.1016/S0966-6362(99)00040-5; HINTERMANN B, 1994, FOOT ANKLE INT, V15, P386, DOI 10.1177/107110079401500708; HIROKAWA S, 1989, J BIOMED ENG, V11, P449, DOI 10.1016/0141-5425(89)90038-1; Huang H, 2009, P 22 C INT SOC BIOM, P210; Huang Hongshi, 2015, Acta Scientiarum Naturalium Universitatis Pekinensis, V51, P1035, DOI 10.13209/j.0479-8023.2015.128; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; Luo DS, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P837, DOI 10.1109/ICMA.2013.6618024; MATSUSAKA N, 1986, ACTA ORTHOP SCAND, V57, P555, DOI 10.3109/17453678609014793; MCCAW ST, 1995, J BIOMECH, V28, P985, DOI 10.1016/0021-9290(94)00151-S; Mittlmeier T, 1999, CLIN BIOMECH, V14, P576, DOI 10.1016/S0268-0033(99)00035-2; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Sadeghi H, 2003, GAIT POSTURE, V17, P197, DOI 10.1016/S0966-6362(02)00089-9; Sadeghi H, 2001, AM J PHYS MED REHAB, V80, P821, DOI 10.1097/00002060-200111000-00006; Stergiou N, 2007, SPORTS MED, V37, P601, DOI 10.2165/00007256-200737070-00004; Tudor-Locke C, 2004, MED SCI SPORT EXER, V36, P1567, DOI 10.1249/01.MSS.0000139806.53824.2E; Van de Velde SK, 2009, J BONE JOINT SURG AM, V91A, P167, DOI [10.2106/JBJS.H.01382, 10.2106/JBJS.H.00177]; Whittle M., 2002, GAIT ANAL INTRO, P59	25	4	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169421	10.1371/journal.pone.0169421	http://dx.doi.org/10.1371/journal.pone.0169421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072874	gold, Green Published, Green Submitted			2022-12-26	WOS:000391844200020
J	Skuja, S; Zieda, A; Ravina, K; Chapenko, S; Roga, S; Teteris, O; Groma, V; Murovska, M				Skuja, Sandra; Zieda, Anete; Ravina, Kristine; Chapenko, Svetlana; Roga, Silvija; Teteris, Ojars; Groma, Valerija; Murovska, Modra			Structural and Ultrastructural Alterations in Human Olfactory Pathways and Possible Associations with Herpesvirus 6 Infection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MICROGLIA; VIRUS; CHILDREN; BRAIN; DNA; REACTIVATION; STRATEGIES; ENTRY; HHV-6	Structural and ultrastructural alterations in human olfactory pathways and putative associations with human herpesvirus 6 (HHV-6) infection were studied. The olfactory bulb/tract samples from 20 subjects with an unspecified encephalopathy determined by pathomorphological examination of the brain autopsy, 17 healthy age-matched and 16 younger controls were used. HHV-6 DNA was detected in 60, 29, and 19% of cases in these groups, respectively. In the whole encephalopathy group, significantly more HHV-6 positive neurons and oligodendrocytes were found in the gray matter, whereas, significantly more HHV-6 positive astrocytes, oligodendrocytes, microglia/macrophages and endothelial cells were found in the white matter. Additionally, significantly more HHV-6 positive astrocytes and, in particular, oligodendrocytes were found in the white matter when compared to the gray matter. Furthermore, when only HHV-6 PCR+ encephalopathy cases were studied, we observed similar but stronger associations between HHV-6 positive oligodendrocytes and CD68 positive cells in the white matter. Cellular alterations were additionally evidenced by anti-S100 immunostaining, demonstrating a significantly higher number of S100 positive cells in the gray matter of the whole encephalopathy group when compared to the young controls, and in the white matter when compared to both control groups. In spite the decreased S100 expression in the PCR+ encephalopathy group when compared to PCIT cases and controls, groups demonstrated significantly higher number of S100 positive cells in the white compared to the gray matter. Ultrastructural changes confirming the damage of myelin included irregularity of membranes and ballooning of paranodal loops. This study shows that among the cellular targets of the nervous system, HHV-6 most severely affects oligodendrocytes and the myelin made by them.	[Skuja, Sandra; Zieda, Anete; Groma, Valerija] Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia; [Ravina, Kristine] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Chapenko, Svetlana; Murovska, Modra] Riga Stradins Univ, A Kirchenstein Inst Microbiol & Virol, Riga, Latvia; [Roga, Silvija] Riga 1st Hosp, Dept Pathol, Riga, Latvia; [Teteris, Ojars] Latvian State Ctr Forens Med Examinat, Riga, Latvia	Riga Stradins University; Stanford University; Riga Stradins University	Skuja, S (corresponding author), Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia.	sandra.skuja@rsu.lv	Murovska, Modra/O-5089-2019; Murovska, Modra/AAP-9393-2020; Skuja, Sandra/AAG-9437-2019	Murovska, Modra/0000-0003-0971-1784; Skuja, Sandra/0000-0002-3589-9429	Latvian Council of Science [478/2012]; EC 7FP HELTH project BALTINFECT "Unlocking infectious diseases research potential at Riga Stradins University"	Latvian Council of Science(Latvian Ministry of Education and Science); EC 7FP HELTH project BALTINFECT "Unlocking infectious diseases research potential at Riga Stradins University"	This study is supported by the Latvian Council of Science Grant Nr.478/2012 "Elucidation of the involvement of p-herpesviruses HHV 6 and HHV 7 infection in the development of encephalopathy, encephalitis and epilepsy by using multidisciplinary approach" and 2013-2017 EC 7FP HELTH project BALTINFECT "Unlocking infectious diseases research potential at Riga Stradins University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 2010, J MED VIROL, V82, P1903, DOI 10.1002/jmv.21860; ABLASHI DV, 1987, NATURE, V329, P207, DOI 10.1038/329207a0; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Attems J, 2014, ACTA NEUROPATHOL, V127, P459, DOI 10.1007/s00401-014-1261-7; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Blumberg BM, 2000, J CLIN VIROL, V16, P159, DOI 10.1016/S1386-6532(99)00084-0; Braun DK, 1997, CLIN MICROBIOL REV, V10, P521, DOI 10.1128/CMR.10.3.521; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Chapenko S, 2016, J NEUROVIROL, V22, P488, DOI 10.1007/s13365-015-0417-0; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; De Bolle L, 2005, CLIN MICROBIOL REV, V18, P217, DOI 10.1128/CMR.18.1.217-245.2005; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Doorn KJ, 2014, BRAIN PATHOL, V24, P152, DOI 10.1111/bpa.12088; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Isaacson E, 2005, CLIN INFECT DIS, V40, P890, DOI 10.1086/427944; Ito M, 2000, ACTA NEUROPATHOL, V100, P337, DOI 10.1007/s004010000198; Kalinke U, 2011, VIRULENCE, V2, P367, DOI 10.4161/viru.2.4.16138; Kawabe S, 2010, J MED VIROL, V82, P1410, DOI 10.1002/jmv.21808; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Lautenschlager I, 2012, TRANSPL INT, V25, P493, DOI 10.1111/j.1432-2277.2012.01443.x; Lin WR, 2002, J PATHOL, V197, P395, DOI 10.1002/path.1127; Maeki T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/384069; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Moritani T, 2014, RADIOL CLIN N AM, V52, P355, DOI 10.1016/j.rcl.2013.11.001; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Niehusmann P, 2010, EPILEPSIA, V51, P2478, DOI 10.1111/j.1528-1167.2010.02741.x; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pietilainen-Nicklen J, 2014, J CLIN VIROL, V61, P216, DOI 10.1016/j.jcv.2014.07.006; Reynaud JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00174; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Roussarie JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001331; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; SECCHIERO P, 1995, J INFECT DIS, V171, P273, DOI 10.1093/infdis/171.2.273; Simpson S, 2014, ACTA NEUROL SCAND, V130, P328, DOI 10.1111/ane.12268; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Tsukahara H, 2013, PEDIATR INT, V55, P461, DOI 10.1111/ped.12094; van Riel D, 2014, J INFECT DIS, V210, P419, DOI 10.1093/infdis/jiu097; Voumvourakis KI, 2010, MAYO CLIN PROC, V85, P1023, DOI 10.4065/mcp.2010.0350; Yao K, 2010, J MED VIROL, V82, P1669, DOI 10.1002/jmv.21861; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	46	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0170071	10.1371/journal.pone.0170071	http://dx.doi.org/10.1371/journal.pone.0170071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072884	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200062
J	Urakova, N; Strive, T; Frese, M				Urakova, Nadya; Strive, Tanja; Frese, Michael			RNA-Dependent RNA Polymerases of Both Virulent and Benign Rabbit Caliciviruses Induce Striking Rearrangement of Golgi Membranes	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; ENDOPLASMIC-RETICULUM; REPLICATION COMPLEX; PROTEIN; LOCALIZATION; EXPRESSION; INFECTION; IDENTIFICATION; LAGOVIRUS; RCV-A1	The extremely pathogenic Rabbit haemorrhagic disease virus (RHDV) and the completely benign Rabbit calicivirus (RCV) are closely related members of the genus Lagovirus (family Caliciviridae). The molecular mechanisms that determine the dramatic difference in virulence are unknown, but indirect evidence suggests that different properties of their RNA dependent RNA polymerases (RdRps) may at least partially be responsible for the contrasting phenotypes. Here we report that the unusual ability of the RHDV RdRp to induce a striking rearrangement of the Golgi network is not specific to RHDV, but a common feature of virulent and benign rabbit caliciviruses alike. Expression of rabbit calicivirus RdRps induced a redistribution of both cis/medial and medial/trans Golgi membrane markers, but not that of an endoplasmic reticulum membrane marker. Inactivating mutations in the conserved GDD motif did not abolish the ability of RHDV RdRp to rearrange the Golgi network, suggesting that polymerase activity and metal co-factors are not required for this function. Finally, we discuss possible implications of RdRp-induced membrane rearrangements on virus replication and host immune responses.	[Urakova, Nadya; Strive, Tanja; Frese, Michael] CSIRO Hlth & Biosecur, Canberra, ACT, Australia; [Urakova, Nadya; Strive, Tanja; Frese, Michael] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Urakova, Nadya; Frese, Michael] Univ Canberra, Hlth Res Inst, Canberra, ACT 2601, Australia; [Strive, Tanja; Frese, Michael] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Canberra; University of Canberra; University of Canberra	Frese, M (corresponding author), CSIRO Hlth & Biosecur, Canberra, ACT, Australia.; Frese, M (corresponding author), Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia.; Frese, M (corresponding author), Univ Canberra, Hlth Res Inst, Canberra, ACT 2601, Australia.; Frese, M (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	michael.frese@canberra.edu.au	Strive, Tanja/C-1486-2008	Frese, Michael/0000-0002-1059-2375; URAKOVA, NADEZDA (Nadya)/0000-0003-3499-8158	Invasive Animals Cooperative Research Centre (IACRC) [IACRC 3.L.4]; IACRC; University of Canberra International Postgraduate Research Scholarship	Invasive Animals Cooperative Research Centre (IACRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); IACRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of Canberra International Postgraduate Research Scholarship	T.S and M.F. obtained funding from the Invasive Animals Cooperative Research Centre (IACRC; http://www.invasiveanimals.com/), grant #IACRC 3.L.4; N.U. is supported by the IACRC and a University of Canberra (http://www.canberra.edu.au/) International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070; Clarke IN, 1997, J GEN VIROL, V78, P291, DOI 10.1099/0022-1317-78-2-291; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Gant VU, 2014, J VIROL, V88, P5912, DOI 10.1128/JVI.03032-13; Hoehn M, 2013, J VIROL METHODS, V188, P148, DOI 10.1016/j.jviromet.2012.11.043; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Kopek BG, 2010, J VIROL, V84, P12492, DOI 10.1128/JVI.01495-10; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; Machin A, 2001, J BIOL CHEM, V276, P27787, DOI 10.1074/jbc.M100707200; Mahar JE, 2016, J VIROL, V90, P9317, DOI 10.1128/JVI.01212-16; Meyers G, 2000, VIROLOGY, V276, P349, DOI 10.1006/viro.2000.0545; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004; Strive T, 2010, VIROLOGY, V398, P125, DOI 10.1016/j.virol.2009.11.045; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; te Velthuis AJW, 2014, CELL MOL LIFE SCI, V71, P4403, DOI 10.1007/s00018-014-1695-z; Urakova N, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040100; Urakova N, 2015, VIROLOGY, V484, P69, DOI 10.1016/j.virol.2015.05.004; Vazquez AL, 2000, J VIROL, V74, P3888, DOI 10.1128/JVI.74.8.3888-3891.2000; Wirblich C, 1996, J VIROL, V70, P7974, DOI 10.1128/JVI.70.11.7974-7983.1996; Zhou ZG, 2013, J VIROL, V87, P11721, DOI 10.1128/JVI.01355-13	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169913	10.1371/journal.pone.0169913	http://dx.doi.org/10.1371/journal.pone.0169913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072826	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200057
J	Ihare, T; Mitsui, T; Nakamura, Y; Kira, S; Nakagomi, H; Sawada, N; Hirayama, Y; Shibata, K; Shigetomi, E; Shinozaki, Y; Yoshiyama, M; Andersson, KE; Nakao, A; Takeda, M; Koizumi, S				Ihare, Tatsuya; Mitsui, Takahiko; Nakamura, Yuki; Kira, Satoru; Nakagomi, Hiroshi; Sawada, Norifumi; Hirayama, Yuri; Shibata, Keisuke; Shigetomi, Eiji; Shinozaki, Yoichi; Yoshiyama, Mitsuharu; Andersson, Karl-Erik; Nakao, Atsuhito; Takeda, Masayuki; Koizumi, Schuichi			Clock Genes Regulate the Circadian Expression of Piezo1, TRPV4, Connexin26, and VNUT in an Ex Vivo Mouse Bladder Mucosa	PLOS ONE			English	Article							UROTHELIAL CELL-CULTURES; EVOKED CA2+ INFLUX; ATP RELEASE; NOCTURIA; MECHANISMS; TRANSCRIPTION; OSCILLATION; INVOLVEMENT; MICTURITION; PREVALENCE	Objectives Clock(Delta 19/Delta 19) mice is an experimental model mouse for nocturia (NOC). Using the bladder mucosa obtained from Clock(Delta 19/Delta 19) mice, we investigated the gene expression rhythms of mechanosensory cation channels such as transient receptor potential cation channel subfamily V member 4 (TRPV4) and Piezol, and main ATP release pathways including vesicular nucleotide transporter (VNUT) and Connexin26(Cx26), in addition to clock genes. Materials and methods Eight-to twelve-week-old male C57BL/6 mice (WT) and age-and sex-matched C57BL/6 Clock(Delta 19/Delta 19) mice, which were bred under 12-h light/dark conditions for 2 weeks, were used. Gene expression rhythms and transcriptional regulation mechanisms in clock genes, mechanosensor, Cx26 and VNUTwere measured in the mouse bladder mucosa, collected every 4 hours from WT and Clock(Delta 19/Delta 19) mice using quantitative RT-PCR, a Western blot analysis, and ChIP assays. Results WT mice showed circadian rhythms in clock genes as well as mechanosensor, Cx26 and VNUT. Their expression was low during the sleep phase. The results of ChIP assays showed Clock protein binding to the promotor regions and the transcriptional regulation of mechanosensor, Cx26 and VNUT. In contrast, all of these circadian expressions were disrupted in Clock(Delta 19/Delta 19) mice. The gene expression of mechanosensor, Cx26 and VNUT was maintained at a higher level in spite of the sleep phase. Conclusions Mechanosensor, Cx26 and VNUTexpressed with circadian rhythm in the mouse bladder mucosa. The disruption of circadian rhythms in these genes, induced by the abnormalities in clock genes, may be factors contributing to NOC because of hypersensitivity to bladder wall extension.	[Ihare, Tatsuya; Mitsui, Takahiko; Kira, Satoru; Nakagomi, Hiroshi; Sawada, Norifumi; Yoshiyama, Mitsuharu; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Urol, Chuo Ku, Yamanashi, Japan; [Nakamura, Yuki; Nakao, Atsuhito] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Immunol, Chuo Ku, Yamanashi, Japan; [Hirayama, Yuri; Shibata, Keisuke; Shigetomi, Eiji; Shinozaki, Yoichi; Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Neuropharmacol, Chuo Ku, Yamanashi, Japan; [Andersson, Karl-Erik] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC USA	University of Yamanashi; University of Yamanashi; University of Yamanashi; Wake Forest University	Takeda, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Urol, Chuo Ku, Yamanashi, Japan.; Koizumi, S (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Neuropharmacol, Chuo Ku, Yamanashi, Japan.	matakeda@yamanashi.ac.jp; skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/E-8594-2010; SHIGETOMI, EIJI/I-2372-2012; Koizumi, Schuichi/E-8568-2010; , Takahiko/H-6660-2019; Yoshiyama, Mitsuharu/Q-9080-2019; Shinozaki, Youichi/AAC-9431-2019	Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106; Yoshiyama, Mitsuharu/0000-0001-8695-884X; Shinozaki, Youichi/0000-0002-6448-1304	Astellas Pharma Inc	Astellas Pharma Inc(Astellas Pharmaceuticals)	This work was financially supported by grants from Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Asplund R, 2006, ARCH GERONTOL GERIAT, V43, P319, DOI 10.1016/j.archger.2005.12.002; Asplund R, 2005, BJU INT, V95, P816, DOI 10.1111/j.1464-410X.2005.05407.x; Asplund R, 1999, BJU INT, V84, P297; Bing MH, 2006, BJU INT, V98, P599, DOI 10.1111/j.1464-410X.2006.06390.x; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Bjaelde RG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00238; Bosch JLHR, 2013, J UROLOGY, V189, pS86, DOI 10.1016/j.juro.2012.11.033; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; de Groat WC, 2004, UROLOGY, V64, P7, DOI 10.1016/j.urology.2004.08.063; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Haefliger JA, 2002, EXP CELL RES, V274, P216, DOI 10.1006/excr.2001.5465; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Ihara T, 2016, NEUROUROL URODYN; Knight GE, 2002, AM J PHYSIOL-RENAL, V282, pF281, DOI 10.1152/ajprenal.00293.2000; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nakagomi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29761; Nakamura Y, 2014, J ALLERGY CLIN IMMUN, V133, P568, DOI 10.1016/j.jaci.2013.07.040; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Oelke M, 2014, WORLD J UROL, V32, P1109, DOI 10.1007/s00345-014-1396-0; Okamura H, 2010, ADV DRUG DELIVER REV, V62, P876, DOI 10.1016/j.addr.2010.06.004; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2000, J NEUROSCI, V20, P7525; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Wu CH, 2014, FASEB J, V28, P4610, DOI 10.1096/fj.13-243295	40	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168234	10.1371/journal.pone.0168234	http://dx.doi.org/10.1371/journal.pone.0168234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060940	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500025
J	Strom, J; Them, J; Mansson, F; Ahl, J; Savidge, TC; Dann, SM; Resman, F				Strom, Jonathan; Them, Johan; Mansson, Fredrik; Ahl, Jonas; Savidge, Tor C.; Dann, Sara M.; Resman, Fredrik			The Association between GABA-Modulators and Clostridium difficile Infection - A Matched Retrospective Case-Control Study	PLOS ONE			English	Article							RISK; MORTALITY; DIARRHEA; DISEASE; EPIDEMIOLOGY; PATHOGENESIS; ZOLPIDEM; UPDATE	Objective Recently, metabolomics studies have suggested that the neurotransmitter.-amino butyric acid (GABA) may modulate C. difficile infection (CDI) pathogenesis. In the present study, we investigated the association between GABA-modulating pharmaceuticals and CDI development. Methods In July-December 2013, we performed a matched, retrospective case-control study in Skane county, Sweden, to assess the association between the use of GABA-modulators (defined as regular use of at least one of the following: zolpidem, zopiclone, benzodiazepines, gabapentin, pregabalin or baclofen) and CDI. Multivariate regression models, adjusted for known risk factors for CDI, were fitted to assess the associations and a propensity score-adjusted analysis was performed. Results The study included 292 cases and 292 matched controls. In a multivariate regression model only recent antibiotic use (clindamycin, cephalosporins and fluoroquinolones) and nursing home residency was significantly associated with CDI. The regular use of any GABA-modulator was not associated with CDI (OR = 1.07, 95% CI 0.69-1.66, p = 0.76). The association between regular use of the selective GABA-agonist zolpidem and CDI trended towards significance (OR = 2.31, 95% CI 0.91-5.86, p = 0.078). These associations remained when only cases treated with antibiotics were included. Corresponding findings for zolpidem was observed in a propensity-score adjusted analysis (OR = 2.52, 95% CI 0.91-6.97, p = 0.075). Severe initial CDI was significantly associated with CDI recurrence (OR = 3.77, 95% CU 1.20-11.86, p = 0.023). Conclusion This study did not identify a general association between GABA-modulators and CDI. A trend towards a significant association between zolpidem and CDI was observed, an association that should be re-assessed in a study appropriately powered for this particular hypothesis.	[Strom, Jonathan; Them, Johan; Mansson, Fredrik; Ahl, Jonas; Resman, Fredrik] Lund Univ, Dept Translat Med, Infect Dis Unit, Malmo, Sweden; [Savidge, Tor C.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Dann, Sara M.] Texas Childrens Hosp, Texas Childrens Microbiome Ctr, Houston, TX 77030 USA; [Dann, Sara M.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	Lund University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston	Resman, F (corresponding author), Lund Univ, Dept Translat Med, Infect Dis Unit, Malmo, Sweden.	fredrik.resman@med.lu.se		Tham, Johan/0000-0002-6994-1672; Dann, Sara/0000-0002-6893-2838; Resman, Fredrik/0000-0002-3433-512X	National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK) [R21 DK096323-01]; National Institute of Allergy and Infectious Diseases [R01 NIAID AI10094001, U01 AI124290-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124290] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in the publication was supported by National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK) R21 DK096323-01 and the National Institute of Allergy and Infectious Diseases R01 NIAID AI10094001 and U01 AI124290-01 (TS).	Aitken SL, 2013, USE ZOLPIDEM Y AMINO; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Dann S, 2015, GASTROENTEROLOGY, V148, pS727; Das R, 2010, AM J GASTROENTEROL, V105, P2040, DOI 10.1038/ajg.2010.142; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Folkhalsomyndigheten, 2015, CLOSTR DIFF ARSR 201; Guyot A, 2001, J ANTIMICROB CHEMOTH, V48, P747, DOI 10.1093/jac/48.5.747; Huang CY, 2014, J PSYCHIATR RES, V54, P116, DOI 10.1016/j.jpsychires.2014.03.017; Inns T, 2013, J HOSP INFECT, V84, P235, DOI 10.1016/j.jhin.2013.04.008; Krantis A, 2000, NEWS PHYSIOL SCI, V15, P284; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; O'Donoghue C, 2011, CURR OPIN GASTROEN, V27, P38, DOI 10.1097/MOG.0b013e3283411634; Paul AM, 2014, NEUROSCIENCE, V273, P24, DOI 10.1016/j.neuroscience.2014.04.037; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Rogers MAM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-121; Rossokhin AV, 2014, MOL CELL NEUROSCI, V63, P72, DOI 10.1016/j.mcn.2014.10.001; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Tonna I, 2005, POSTGRAD MED J, V81, P367, DOI 10.1136/pgmj.2004.028480; Wilcox MH, 2001, J ANTIMICROB CHEMOTH, V47, P358, DOI 10.1093/jac/47.3.358; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	30	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169386	10.1371/journal.pone.0169386	http://dx.doi.org/10.1371/journal.pone.0169386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060888	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500086
J	Zhong, YM; Guo, XZ; Xiao, H; Luo, JY; Zuo, CG; Huang, XB; Huang, JJ; Mi, L; Zhang, QJ; Liu, X				Zhong, Yimin; Guo, Xinxing; Xiao, Hui; Luo, Jingyi; Zuo, Chengguo; Huang, Xiaobo; Huang, Jingjing; Mi, Lan; Zhang, Qingjiong; Liu, Xing			Flat Anterior Chamber after Trabeculectomy in Secondary Angle-Closure Glaucoma with BEST1 Gene Mutation: Case Series	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE BESTROPHINOPATHY; VITELLIFORM MACULAR DYSTROPHY; CHOROIDAL THICKNESS; MALIGNANT GLAUCOMA; NANOPHTHALMOS; DISEASE	Purpose Trabeculectomy has been regarded as a mainstay of initial treatment in eyes of angle closure glaucoma (ACG) with peripheral anterior synechia > 180 degrees in the Chinese population while its efficacy in secondary ACG with BEST1 gene mutation remains unclear. We set out to investigate the treatment outcome of trabeculectomy for secondary ACG in a group of patients with autosomal recessive bestrophinopathy (ARB). Methods In this retrospective case series study, 8 secondary ACG patients with ARB and their 4 recruited family members underwent a thorough ophthalmic examination including best-corrected visual acuity, Goldmann applanation tonometry, gonioscopy, and fundus examinations. Ultrasound biomicroscopy, optical coherence tomography (OCT), ultrasound A-scan, B-scan, electro-oculography (EOG), Humphrey perimetry, fundus photography, fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were also performed. Blood samples were obtained in the patients and their available family members to analyze the variants of the BEST1 gene. Trabeculectomy was performed in the 8 patients (15 eyes). Results The age of onset varied from 13 to 38 years. The average axial length (AL) of the affected eyes was 21.82+/-0.92 mm and the average anterior chamber depth (ACD) was 2.19+/-0.29 mm. There was marked axial shallowing of the anterior chamber in all 15 eyes after trabeculectomy, and was not improved with potent mydriatics. The IOP was elevated in 3 eyes. Variable degree of yellowish subretinal deposits was observed in the posterior retina. The FFA showed punctuate or patched hyperfluorescence suggesting retinal pigment epithelium impairment. The ICGA demonstrated dilatation of choroidal vessels. The OCT revealed diffused neuroretinal detachment in the posterior and midperipheral retina, with intraretinal fluid collections, and hyperreflective subretinal accumulations. The average subfoveal choroidal thickness of the patients was 382.36+/-80.09 mu m. All the patients and enrolled family members carried mutation in BEST1 gene. Conclusions ARB is a rare condition with fundus manifestations mimicking various diseases. Careful discrimination should be taken to exclude any secondary causes for ACG before treatment. Concerning the high incidence of postoperative shallow anterior chamber, selection of filtering surgery should be very careful in these patients.	[Zhong, Yimin; Guo, Xinxing; Xiao, Hui; Luo, Jingyi; Zuo, Chengguo; Huang, Xiaobo; Huang, Jingjing; Mi, Lan; Zhang, Qingjiong; Liu, Xing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, X (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	liuxing@mail.sysu.edu.cn	Guo, Xinxing/AAT-1652-2020; Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X; Luo, Jingyi/0000-0002-8408-3880	National Natural Science Foundation of China [81200686]; Science and Technology Planning Project of Guangdong Province, China [20126050600032]; Science and Technology Planning Project of Guangzhou City [2013J4500019]; Research Fund for the Doctoral Program of Higher Education of China [20120171120108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Planning Project of Guangzhou City; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) (YZ, project number: 81200686); Science and Technology Planning Project of Guangdong Province, China (international cooperation program) (http://pro.gdstc.gov.cn/egrantweb/) (XL, project number: 20126050600032); Science and Technology Planning Project of Guangzhou City (international cooperation program) (http://apply.gzsi.gov.cn/) (XL, project number: 2013J4500019); Research Fund for the Doctoral Program of Higher Education of China (http://www.cutech.edu.cn/cn/kyjj/A0103index_1.htm) (YZ, project number: 20120171120108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon CJF, 2007, ARCH OPHTHALMOL-CHIC, V125, P1100, DOI 10.1001/archopht.125.8.1100; Boon CJF, 2013, OPHTHALMOLOGY, V120, P809, DOI 10.1016/j.ophtha.2012.09.057; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Boon CJF, 2009, RETINA-J RET VIT DIS, V29, P835, DOI 10.1097/IAE.0b013e31819d4fda; Borman AD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1088, DOI 10.1001/archophthalmol.2011.197; Brown M, 2006, DOC OPHTHALMOL, V113, P205, DOI 10.1007/s10633-006-9030-0; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Crowley C, 2014, DOC OPHTHALMOL, V129, P57, DOI 10.1007/s10633-014-9444-z; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Fung AT, 2015, RETINA-J RET VIT DIS, V35, P773, DOI 10.1097/IAE.0000000000000387; GHOSE S, 1985, BRIT J OPHTHALMOL, V69, P624, DOI 10.1136/bjo.69.8.624; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; He M, 2006, EYE, V20, P3, DOI 10.1038/sj.eye.6701797; Kinnick TR, 2011, RETINA-J RET VIT DIS, V31, P581, DOI 10.1097/IAE.0b013e318203ee60; Liang YB, 2015, J GLAUCOMA, V24, P469, DOI 10.1097/IJG.0000000000000075; Low S, 2011, MOL VIS, V17, P2272; MACKAY CJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P366, DOI 10.1001/archopht.1987.01060030086032; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; Quigley HA, 2000, BRIT J OPHTHALMOL, V84, P860, DOI 10.1136/bjo.84.8.860; Quigley HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P693, DOI 10.1001/archophthalmol.2009.80; Ritch R, 2003, OPHTHALMOLOGY, V110, P1880, DOI 10.1016/S0161-6420(03)00563-3; Wang ZH, 2014, OPHTHALMOLOGY, V121, P862, DOI 10.1016/j.ophtha.2013.10.035; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wittstrom E, 2011, OPHTHALMIC GENET, V32, P217, DOI 10.3109/13816810.2011.567884; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5	27	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169395	10.1371/journal.pone.0169395	http://dx.doi.org/10.1371/journal.pone.0169395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056057	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100038
J	Gotting, M; Schwarzer, M; Gerber, A; Klingelhofer, D; Groneberg, DA				Goetting, Michael; Schwarzer, Mario; Gerber, Alexander; Klingelhoefer, Doris; Groneberg, David A.			Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping	PLOS ONE			English	Article							COLOGNE CONSENSUS CONFERENCE; DISEASE UPDATED RECOMMENDATIONS; ARTERIAL-HYPERTENSION; COMBINATION THERAPY; PREDICTING SURVIVAL; HEART-DISEASE; DIAGNOSIS; PATHOPHYSIOLOGY; GUIDELINES; QUANTITY	Pulmonary hypertension (PH) is characterized by the increase of the mean pulmonary arterial pressure in the lung circulation. Despite the large number of experimental and clinical studies conducted on pulmonary hypertension, there is no comprehensive work that analyzed the global research activity on PH so far. We retrieved the bibliometric data of the publications on pulmonary hypertension for two periods from the Web of science database. Here, we set the first investigation period from 1900 to 2007 (t1) due to the cited half life of articles and the relating difficulties to interpret the citation parameters. The second evaluation period (t2) covers the time interval from 2008 onwards including the year 2015. The data were analyzed and processed to density-equalizing maps using the NewQIS platform. A total number of 18,986 publications were identified in t1 that come from 85 countries. The US published the highest number of publications (n = 7,290), followed by the UK, Germany, Japan and France. In t2 19,676 items could be found worked out by 130 countries. The raking started just the same with the USA as most publishing nation with 7,127 publications on PH, followed by the UK and Germany. Japan fell back on 6th place, whereas China came into view on the 5th position. Analyzing the average citation rate as a parameter for research quality, Mexico reached the highest value in t1 and Ireland in t2. While, the country specific h-index underlined the leading position of the US research in both evaluation periods again. The average number of international collaboration items was expanding from none in 1978 to 530 items in 2015 with the USA as the country with the highest number of collaboration articles. The present study is the first large scale density-equalizing mapping and scientometric analysis of global PH research activity. Our data draw a sketch of the global research architecture in this field, indicating a need for specific research programs in countries with a lower human development index.	[Goetting, Michael] Free Univ Berlin, Div Hlth Econ & Metr, Inst Occupat Med, Charite Univ Med Berlin, Berlin, Germany; [Goetting, Michael] Humboldt Univ, Berlin, Germany; [Schwarzer, Mario; Gerber, Alexander; Klingelhoefer, Doris; Groneberg, David A.] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Goethe University Frankfurt	Klingelhofer, D (corresponding author), Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	klingelhoefer@med.uni-frankfurt.de	Groneberg, David/A-5132-2018; Klingelhoefer, Doris/AFF-8213-2022	Groneberg, David/0000-0001-8551-6556; 				Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; [Anonymous], 2004, J AM COLL CARDIOLOGY, V43, p1S; Bai YY, 2011, CARDIOLOGY, V120, P157, DOI 10.1159/000334431; Baradia D, 2012, PHARM PAT ANAL, V1, P577, DOI [10.4155/ppa.12.66, 10.4155/PPA.12.66]; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Coeytaux RR, 2014, CHEST, V145, P1055, DOI 10.1378/chest.13-1864; Eickelberg O, 2005, INTERNIST, V46, P759, DOI 10.1007/s00108-005-1431-8; Escribano-Subias P, 2012, EUR RESPIR J, V40, P596, DOI 10.1183/09031936.00101211; Fricke R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-454; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gerber A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-2; Gerber A, 2013, RHEUMATOL INT, V33, P2743, DOI 10.1007/s00296-013-2805-1; Ghofrani HA, 2011, INT J CARDIOL, V154, pS20, DOI 10.1016/S0167-5273(11)70490-9; Gorenflo M, 2014, DEUT MED WOCHENSCHR, V139, pS166, DOI 10.1055/s-0034-1387491; Groneberg-Kloft Beatrix, 2009, J Occup Med Toxicol, V4, P16, DOI 10.1186/1745-6673-4-16; Groneberg-Kloft B, 2009, EMBO REP, V10, DOI 10.1038/embor.2009.162; Groneberg-Kloft B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-16; Groneberg-Kloft B, 2009, J ASTHMA, V46, P147, DOI 10.1080/02770900802503115; Grunig E, 2011, INT J CARDIOL, V154, pS3, DOI 10.1016/S0167-5273(11)70488-0; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoeper MM, 2011, INT J CARDIOL, V154, pS45, DOI 10.1016/S0167-5273(11)70492-2; Hoeper MM, 2004, EUR RESPIR J, V24, P339, DOI 10.1183/09031936.04.00072104; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kempny A, 2013, INT J CARDIOL, V168, P5182, DOI 10.1016/j.ijcard.2013.07.198; Klose H, 2014, DEUT MED WOCHENSCHR, V139, pS142, DOI 10.1055/s-0034-1387489; Kusano KF, 2011, GEN THORAC CARDIOVAS, V59, P538, DOI 10.1007/s11748-010-0747-z; Lee WTN, 2012, EUR RESPIR J, V40, P604, DOI 10.1183/09031936.00196611; Levinson Andrew T, 2011, Ther Adv Respir Dis, V5, P419, DOI 10.1177/1753465811411602; Lordan JL, 2011, EXPERT REV RESP MED, V5, P441, DOI [10.1586/ers.11.21, 10.1586/ERS.11.21]; Maron BA, 2013, HANDB EXP PHARMACOL, V218, P31, DOI 10.1007/978-3-642-38664-0_2; Mathew Rajamma, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P165; McLaughlin VV, 2011, EUR RESPIR REV, V20, P262, DOI 10.1183/09059180.00006411; McLaughlin VV, 2013, CLIN CHEST MED, V34, P825, DOI 10.1016/j.ccm.2013.09.003; Mund M, 2014, INT J ENV RES PUB HE, V11, P5792, DOI 10.3390/ijerph110605792; Norfolk SG, 2013, CLIN CHEST MED, V34, P857, DOI 10.1016/j.ccm.2013.09.002; OECD Science, 2014, TECHN IND OUTL 2014; Opitz CF, 2011, INT J CARDIOL, V154, pS13, DOI 10.1016/S0167-5273(11)70489-2; Pugh ME, 2013, CLIN CHEST MED, V34, P841, DOI 10.1016/j.ccm.2013.08.007; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rich S, 2008, CIRCULATION, V118, P2190, DOI 10.1161/CIRCULATIONAHA.107.723007; Rosenkranz S, 2011, INT J CARDIOL, V154, pS34, DOI 10.1016/S0167-5273(11)70491-0; Rosenkranz S, 2011, INT J CARDIOL, V154, pS1, DOI 10.1016/S0167-5273(11)70487-9; Rubin LJ, 2002, AM J RESP CRIT CARE, V166, P1308, DOI 10.1164/rccm.2208008; Schmidt S, 2013, J VIRAL HEPATITIS; Schoffel N, 2009, INT J ENV RES PUB HE, V6, P2919, DOI 10.3390/ijerph6122919; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Van Noorden R., 2014, NATURE NEWS BLOG; Vitzthum K, 2010, J CARDIOTHOR VASC AN, V24, P731, DOI 10.1053/j.jvca.2009.05.010; Vitzthum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011254; Wilkens H, 2011, INT J CARDIOL, V154, pS54, DOI 10.1016/S0167-5273(11)70493-4; Wu Y, 2013, CURR HYPERTENS REP, V15, P614, DOI 10.1007/s11906-013-0394-8; Yamamura K, 2012, INT J CARDIOL, V161, pE1, DOI 10.1016/j.ijcard.2012.03.021	62	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169238	10.1371/journal.pone.0169238	http://dx.doi.org/10.1371/journal.pone.0169238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052133	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500039
J	Sommese, RF; Ritt, M; Swanson, CJ; Sivaramakrishnan, S				Sommese, Ruth F.; Ritt, Michael; Swanson, Carter J.; Sivaramakrishnan, Sivaraj			The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKC alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C BETA-II; PROTEIN-KINASE; ACTIVATION; NUCLEOTIDES; INHIBITION; MECHANISMS; EVOLUTION; ISOFORMS; AFFINITY; POCKET	Resolving the conformational dynamics of large multidomain proteins has proven to be a significant challenge. Here we use a variety of techniques to dissect the roles of individual protein kinase C alpha (PKC alpha) regulatory domains in maintaining catalytic autoinhibition. We find that whereas the pseudosubstrate domain is necessary for autoinhibition it is not sufficient. Instead, each regulatory domain (C1a, C1b, and C2) appears to strengthen the pseudosubstrate- catalytic domain interaction in a nucleotide- dependent manner. The pseudosubstrate and C1a domains, however, are minimally essential for maintaining the inactivated state. Furthermore, disrupting known interactions between the C1a and other regulatory domains releases the autoinhibited interaction and increases basal activity. Modulating this interaction between the catalytic and regulatory domains reveals a direct correlation between autoinhibition and membrane translocation following PKC activation.	[Sommese, Ruth F.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Swanson, Carter J.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Univ Minnesota, 4-124 MCB,420 Washington Ave SE, Twin Cities Minneapolis, MN 55455 USA.	sivaraj@umn.edu			American Heart Association Scientist Development Grant [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Huang SM, 1999, BIOCHEMISTRY-US, V38, P12020, DOI 10.1021/bi990594m; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kirwan AF, 2003, BIOCHEM J, V373, P571, DOI 10.1042/BJ20030011; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107	37	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2873	2880		10.1074/jbc.M116.768457	http://dx.doi.org/10.1074/jbc.M116.768457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049730	hybrid, Green Published			2022-12-26	WOS:000395535100027
J	Singh, A; Sharma, RK; Chagtoo, M; Agarwal, G; George, N; Sinha, N; Godbole, MM				Singh, Aru; Sharma, Raj Kumar; Chagtoo, Megha; Agarwal, Gaurav; George, Nelson; Sinha, Neeraj; Godbole, Madan M.			H-1 NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SQUAMOUS-CELL CARCINOMA; BIOMARKERS; SPECTROSCOPY; CHANNEL; SERUM; TISSUE; ADENOCARCINOMA; INHIBITION; APOPTOSIS	H-1 NMR is used to detect alterations in metabolites and their linkage to metabolic processes in a number of pathological conditions including breast cancer. Inositol 1, 4, 5 trisphosphate (IP3R) receptor is an intracellular calcium channel known to regulate metabolism and cellular bioenergetics. Its expression is up regulated in a number of cancers. However, its linkage to metabolism in disease conditions has not been evaluated. This study was designed to determine the association if any, of these metabolites with altered expression of IP3R in breast cancer. We used H-1 NMR to identify metabolites in the serum of breast cancer patients (n = 27) and performed Real-time Polymerase Chain Reaction analysis for quantifying the expression of IP3R type 3 and type 2 in tissues from breast cancer patients (n = 40). Principal Component Analysis (PCA) and Partial Least Square-Discriminant Analysis (PLS-DA) clearly distinguished patients with high/low IP3R expression from healthy subjects. The present study revealed high expression of IP3R type 2 and type 3 in human breast tumor tissue compared to adjacent non tumorous tissue. Moreover, patients with >= 2-fold increase in IP3R (high IP3R group) had significantly higher concentration of metabolic intermediates compared to those with < 2-fold increase in IP3R (low IP3R group). We observed an increase in lipoprotein content and the levels of metabolites like lactate, lysine and alanine and a decrease in the levels of pyruvate and glucose in serum of high IP3R group patients when compared to those in healthy subjects. Receiver operating characteristic (ROC) curve analysis was performed to show the clinical utility of metabolites. In addition to the human studies, functional relevance of IP(3)Rs in causing metabolic disruption was observed in MCF-7 and MDA MB-231 cells. Results from our studies bring forth the importance of metabolic (or metabolomics) profiling of serum by H-1 NMR in conjunction with tissue expression studies for characterizing breast cancer patients. The results from this study provide new insights into relationship of breast cancer metabolites with IP3R.	[Singh, Aru; Chagtoo, Megha; Godbole, Madan M.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India; [Sharma, Raj Kumar; Sinha, Neeraj] Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Agarwal, Gaurav; George, Nelson] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Godbole, MM (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Raebareli Rd, Lucknow, Uttar Pradesh, India.	madangodbole@yahoo.co.in	Agarwal, Gaurav/K-2998-2013; Sharma, Raj Kumar/AAQ-5288-2021	Agarwal, Gaurav/0000-0003-4194-2670; Sharma, Raj Kumar/0000-0003-0623-3238; CHAGTOO, MEGHA/0000-0003-2168-7860; Sinha, Neeraj/0000-0003-3235-6127	Council for Scientific and Industrial Research-University Grant Commission, New Delhi, Government of India	Council for Scientific and Industrial Research-University Grant Commission, New Delhi, Government of India	Mrs. Aru Singh, "the first author", received her fellowship from Council for Scientific and Industrial Research-University Grant Commission, New Delhi, Government of India. Besides this, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Bal D, 2008, ACTA BIOCHIM POL, V55, P107, DOI 10.18388/abp.2008_3103; Bansal N, 2013, J PROTEOME RES, V12, P5839, DOI 10.1021/pr400859w; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Bharti SK, 2012, METABOLOMICS, V8, P540, DOI 10.1007/s11306-011-0339-7; Bogren LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107493; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Budczies J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-334; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; Chen Y, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P181; Choi DL, 2014, BIOORG MED CHEM LETT, V24, P1565, DOI 10.1016/j.bmcl.2014.01.071; Chung L, 2013, BRIT J CANCER, V108, P351, DOI 10.1038/bjc.2012.552; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; Deja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084637; Frede J, 2013, EUR J CANCER, V49, P2331, DOI 10.1016/j.ejca.2013.03.016; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Gu HW, 2011, ANAL CHIM ACTA, V686, P57, DOI 10.1016/j.aca.2010.11.040; Gunther UL, 2015, PATHOBIOLOGY, V82, P153, DOI 10.1159/000430844; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Jobard E, 2014, CANCER LETT, V343, P33, DOI 10.1016/j.canlet.2013.09.011; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Kumar D, 2015, J PROTEOME RES, V14, P1455, DOI 10.1021/pr5011108; Louis E, 2016, ANN ONCOL, V27, P178, DOI 10.1093/annonc/mdv499; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parys JB, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-17; Perez-Plasencia Carlos, 2007, Infect Agent Cancer, V2, P16, DOI 10.1186/1750-9378-2-16; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Rai RK, 2013, METABOLOMICS, V9, P667, DOI 10.1007/s11306-012-0472-y; Rocha CM, 2015, CARCINOGENESIS, V36, P68, DOI 10.1093/carcin/bgu226; Sakakura C, 2003, ANTICANCER RES, V23, P3691; Sanders ME, 2008, J PROTEOME RES, V7, P1500, DOI 10.1021/pr7008109; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Singh C, 2015, METABOLOMICS, V11, P166, DOI 10.1007/s11306-014-0688-0; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; Sonkar K, 2013, METABOLOMICS, V9, P515, DOI 10.1007/s11306-012-0468-7; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; Tripathi P, 2009, J GASTROINTEST LIVER, V18, P329; Tsunoda T, 2005, ONCOGENE, V24, P1396, DOI 10.1038/sj.onc.1208313; van Winden AWJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-4; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yan SK, 2008, ORAL ONCOL, V44, P477, DOI 10.1016/j.oraloncology.2007.06.007; Zhong F, 2011, BLOOD, V117, P2924, DOI 10.1182/blood-2010-09-307405	51	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169330	10.1371/journal.pone.0169330	http://dx.doi.org/10.1371/journal.pone.0169330			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072864	Green Submitted, gold, Green Published			2022-12-26	WOS:000391844200013
J	Chopan, M; Littenberg, B				Chopan, Mustafa; Littenberg, Benjamin			The Association of Hot Red Chili Pepper Consumption and Mortality: A Large Population-Based Cohort Study	PLOS ONE			English	Article							MOLECULAR TARGETS; GUT MICROBIOME; METABOLISM; INFLAMMATION; QUERCETIN; SPICES; FOODS	The evidence base for the health effects of spice consumption is insufficient, with only one large population-based study and no reports from Europe or North America. Our objective was to analyze the association between consumption of hot red chili peppers and mortality, using a population-based prospective cohort from the National Health and Nutritional Examination Survey (NHANES) Ill, a representative sample of US noninstitutionalized adults, in which participants were surveyed from 1988 to 1994. The frequency of hot red chili pepper consumption was measured in 16,179 participants at least 18 years of age. Total and cause-specific mortality were the main outcome measures. During 273,877 person-years of follow-up (median 18.9 years), a total of 4,946 deaths were observed. Total mortality for participants who consumed hot red chili peppers was 21.6% compared to 33.6% for those who did not (absolute risk reduction of 12%; relative risk of 0.64). Adjusted for demographic, lifestyle, and clinical characteristics, the hazard ratio was 0.87 (P=0.01; 95% Confidence Interval 0.77, 0.97). Consumption of hot red chili peppers was associated with a 13% reduction in the instantaneous hazard of death. Similar, but statistically nonsignificant trends were seen for deaths from vascular disease, but not from other causes. In this large population based prospective study, the consumption of hot red chili pepper was associated with reduced mortality. Hot red chili peppers may be a beneficial component of the diet.	[Chopan, Mustafa; Littenberg, Benjamin] Univ Vermont, Coll Med, Burlington, VT 05405 USA	University of Vermont	Chopan, M (corresponding author), Univ Vermont, Coll Med, Burlington, VT 05405 USA.	mustafa.chopan@med.uvm.edu		Littenberg, Benjamin/0000-0002-7647-1808				Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78; Bergonzelli GE, 2003, ANTIMICROB AGENTS CH, V47, P3240, DOI 10.1128/AAC.47.10.3240-3246.2003; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention, 1996, AN REP GUID 3 NAT HL; Centers for Disease Control and Prevention, 1997, PLAN OP 3 NAT HLTH N; Centers for Disease Control and Prevention, 2015, QUEST DAT REL DOC PR; Chen YC, 2001, J CELL BIOCHEM, V82, P537, DOI 10.1002/jcb.1184; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Drenowatz C, 2015, OBES RES CLIN PRACT, V9, P592, DOI 10.1016/j.orcp.2015.03.007; Guarini G, 2012, AM J PHYSIOL-HEART C, V303, pH216, DOI 10.1152/ajpheart.00011.2012; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Lai PK, 2004, CURR MED CHEM, V11, P1451, DOI 10.2174/0929867043365107; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lee MS, 2011, PHYTOTHER RES, V25, P935, DOI 10.1002/ptr.3339; Li L, 2012, PFLUG ARCH EUR J PHY, V463, P727, DOI 10.1007/s00424-012-1078-y; Liu Zhi-He, 1996, Journal of the Faculty of Applied Biological Science Hiroshima University, V35, P181; Lv J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3942; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; Nam JK, 2014, KOR J MED HIST, V23, P319, DOI 10.13081/kjmh.2014.23.319; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11; Parekh N, 2012, J OBES, V2012, DOI 10.1155/2012/518358; PubMed, 2016, RES BY YEAR 2016; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rhodes DG, 2013, AM J CLIN NUTR, V97, P958, DOI 10.3945/ajcn.112.044982; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5; Zsombok A, 2013, J DIABETES COMPLICAT, V27, P287, DOI 10.1016/j.jdiacomp.2012.11.006	34	47	48	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169876	10.1371/journal.pone.0169876	http://dx.doi.org/10.1371/journal.pone.0169876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068423	gold, Green Submitted, Green Published			2022-12-26	WOS:000391843900076
J	Kim, YH; Jung, JC; Gum, SI; Park, SB; Ma, JY; Kim, YI; Lee, KW; Park, YJ				Kim, Yeoun-Hee; Jung, Jae-Chang; Gum, Sang Il; Park, Su-Bin; Ma, Jin Yeul; Kim, Yong Il; Lee, Kyoo Won; Park, Young Jeung			Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and-13	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOPICAL CYCLOSPORINE; SUBCONJUNCTIVAL BEVACIZUMAB; RECURRENT PTERYGIUM; INTRAVITREAL BEVACIZUMAB; DIFFERENTIAL EXPRESSION; PLASMINOGEN-ACTIVATOR; MACULAR DEGENERATION; ANGIOGENESIS; PATHOGENESIS	We examined the connection between matrix metalloproteinase (MMP) expression/activity and pterygium fibroblast migration, and how these were affected by bevacizumab and/or cyclosporine A (CsA). Fibroblasts were obtained from 20 pterygia and 6 normal conjunctival specimens. Expression levels of MMP-3 and MMP-13 were examined after bevacizumab administration. Immunofluorescence staining was used to examine expression of both MMPs in fibroblasts migrating out from explanted pterygium tissues. Rates of cell migration from explant-cultured pterygia tissues and scratch-wounded confluent pterygium fibroblasts were examined in the presence of MMP-3 or MMP-13 inhibitors, as well as bevacizumab and/or CsA. A scratch wound healing migration assay was performed to determine the effects of bevacizumab and/or CsA. Protein expression of both MMPs in pterygium tissues and in cells migrating from organ-cultured pterygium tissues was greater than that observed in normal cells. Inhibition of the activities of both MMPs decreased their expression levels; these were also significantly reduced in bevacizumab-injected pterygium tissues. Bevacizumab significantly reduced the expression of both MMPs and cell migration. Pretreatment with CsA prior to bevacizumab exposure markedly inhibited cell migration and the expression of both MMPs. CsA enhanced the inhibitory effects of bevacizumab on pterygium fibroblast migration in vitro, possibly by inhibiting expression of both MMPs. These findings suggest that combined CsA and bevacizumab treatment may provide a potential therapeutic strategy for reducing the rate of pterygium recurrence.	[Kim, Yeoun-Hee; Gum, Sang Il; Kim, Yong Il; Lee, Kyoo Won; Park, Young Jeung] Cheil Eye Hosp, Cheil Eye Res Inst, 1 Ayang Ro, Daegu, South Korea; [Kim, Yeoun-Hee; Ma, Jin Yeul] KIOM, KM Applicat Ctr, Daegu, South Korea; [Jung, Jae-Chang; Park, Su-Bin] Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Daegu, South Korea	Korea Institute of Oriental Medicine (KIOM); Kyungpook National University	Park, YJ (corresponding author), Cheil Eye Hosp, Cheil Eye Res Inst, 1 Ayang Ro, Daegu, South Korea.	eyepark9@naver.com		kim, Yeoun-Hee/0000-0002-2815-5886	Cheil-nammyung Foundation Research Fund; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [K16281]; Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01060777]	Cheil-nammyung Foundation Research Fund; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea; Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by the 2012 Cheil-nammyung Foundation Research Fund. This work has been supported by the Grant K16281, awarded to the Korea Institute of Oriental Medicine (KIOM) from the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea. This research was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01060777).; This study was supported by the 2012 Cheil-nammyung Foundation Research Fund. In addition, this work was supported by the Grant K16281, awarded to the Korea Institute of Oriental Medicine (KIOM) from the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea. This research was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01060777).	Acar BT, 2013, INT OPHTHALMOL, V33, P507, DOI 10.1007/s10792-013-9732-8; Al Fayez MF, 2002, OPHTHALMOLOGY, V109, P1752, DOI 10.1016/S0161-6420(02)01160-0; An MX, 2011, INT J OPHTHALMOL-CHI, V4, P353, DOI 10.3980/j.issn.2222-3959.2011.04.05; Aydin A, 2008, J FR OPHTALMOL, V31, P699, DOI 10.1016/S0181-5512(08)74384-5; Bahar I, 2008, CURR EYE RES, V33, P23, DOI 10.1080/02713680701799101; Bai HQ, 2010, HISTOCHEM CELL BIOL, V134, P527, DOI 10.1007/s00418-010-0751-5; Bayar SA, 2014, INT OPHTHALMOL, V34, P541, DOI 10.1007/s10792-013-9852-1; Besharati Mohammad Reza, 2011, Acta Med Iran, V49, P179; Bopp S, 2007, BRIT J OPHTHALMOL, V91, P1259, DOI 10.1136/bjo.2007.120303; Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; CAMERON ME, 1983, BRIT J OPHTHALMOL, V67, P604, DOI 10.1136/bjo.67.9.604; Chao SC, 2011, MOL VIS, V17, P23; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Coroneo M T, 1999, Curr Opin Ophthalmol, V10, P282, DOI 10.1097/00055735-199908000-00011; CORONEO MT, 1993, BRIT J OPHTHALMOL, V77, P734, DOI 10.1136/bjo.77.11.734; DAKE Y, 1989, ACTA HISTOCHEM, V87, P71, DOI 10.1016/S0065-1281(89)80035-2; Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyeres.2004.02.002; Di Girolamo N, 2002, INVEST OPHTH VIS SCI, V43, P3430; Di Girolamo N, 2000, Dev Immunol, V7, P131, DOI 10.1155/2000/82708; Di Girolamo N, 2001, INVEST OPHTH VIS SCI, V42, P1963; Di Girolamo N, 2000, INVEST OPHTH VIS SCI, V41, P4142; Dushku N, 2001, ARCH OPHTHALMOL-CHIC, V119, P695, DOI 10.1001/archopht.119.5.695; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang CL, 2013, INVEST OPHTH VIS SCI, V54, P4563, DOI 10.1167/iovs.13-11604; Gebhardt M, 2005, OPHTHALMOLOGY, V112, P1023, DOI 10.1016/j.ophtha.2005.01.023; Girolamo F, 2004, HISTOCHEM CELL BIOL, V122, P261, DOI 10.1007/s00418-004-0705-x; GOLDFELD AE, 1992, P NATL ACAD SCI USA, V89, P12198, DOI 10.1073/pnas.89.24.12198; Gunduz K, 1997, OPHTHALMIC RES, V29, P405; Viveiros MMH, 2016, INT OPHTHALMOL, V36, P237, DOI 10.1007/s10792-015-0106-2; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hercules Laura Almeida, 2006, Arq. Bras. Oftalmol., V69, P831, DOI 10.1590/S0004-27492006000600010; HILGERS JHC, 1960, AM J OPHTHALMOL, V50, P635, DOI 10.1016/0002-9394(60)90245-2; HOLLAND EJ, 1993, CORNEA, V12, P413, DOI 10.1097/00003226-199309000-00008; Hu QW, 2014, CORNEA, V33, P154, DOI 10.1097/ICO.0000000000000037; Hurwitz Herbert, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS62, DOI 10.3816/CCC.2004.s.010; Hwang Shinyoung, 2015, Korean J Ophthalmol, V29, P375, DOI 10.3341/kjo.2015.29.6.375; Jin J, 2003, CORNEA, V22, P473, DOI 10.1097/00003226-200307000-00015; KARAI I, 1984, BRIT J OPHTHALMOL, V68, P347, DOI 10.1136/bjo.68.5.347; Kasetsuwan N, 2015, CLIN THER, V37, P2347, DOI 10.1016/j.clinthera.2015.08.023; Kim Hyun Ho, 2008, Korean J Ophthalmol, V22, P147, DOI 10.3341/kjo.2008.22.3.147; Kim YH, 2015, CORNEA, V34, P1137, DOI 10.1097/ICO.0000000000000477; Krebs I, 2009, ACTA OPHTHALMOL, V87, P611, DOI 10.1111/j.1755-3768.2008.01312.x; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lee DH, 2001, CORNEA, V20, P738, DOI 10.1097/00003226-200110000-00013; Leippi S, 2009, OPHTHALMOLOGE, V106, P413, DOI 10.1007/s00347-009-1936-y; Lekhanont K, 2012, CORNEA, V31, P155, DOI 10.1097/ICO.0b013e3182151e0e; Li DQ, 2001, ARCH OPHTHALMOL-CHIC, V119, P71; Li DQ, 2000, INVEST OPHTH VIS SCI, V41, P404; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Liu Wei, 2014, Eye Sci, V29, P214; Lushchyk T, 2013, ACTA OPHTHALMOL, V91, pe456, DOI 10.1111/aos.12119; Marcovich AL, 2002, CURR EYE RES, V25, P17, DOI 10.1076/ceyr.25.1.17.9959; Marionnet AV, 1997, EXP DERMATOL, V6, P22, DOI 10.1111/j.1600-0625.1997.tb00141.x; Massova I, 1998, BIOORG MED CHEM LETT, V8, P853, DOI 10.1016/S0960-894X(98)00128-0; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Motarjemizadeh Q, 2016, INT OPHTHALMOL, V36, P63, DOI 10.1007/s10792-015-0076-4; Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793; Nagai H, 2002, J BONE MINER METAB, V20, P142, DOI 10.1007/s007740200020; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1997, BIOL CHEM, V378, P151; Naib-Majani W, 2004, GRAEF ARCH CLIN EXP, V242, P332, DOI 10.1007/s00417-003-0846-y; Nakamura M, 1999, CORNEA, V18, P452, DOI 10.1097/00003226-199907000-00011; Nava-Castaneda A, 2015, J OCUL PHARMACOL TH, V31, P106, DOI 10.1089/jop.2014.0060; Ozgurhan EB, 2013, CORNEA, V32, P835, DOI 10.1097/ICO.0b013e3182772d4e; Ozsutcu M, 2014, INDIAN J OPHTHALMOL, V62, P407, DOI 10.4103/0301-4738.120220; Ozulken K, 2012, EUR J OPHTHALMOL, V22, pS5, DOI 10.5301/ejo.5000004; Park YM, 2015, KOREAN J PHYSIOL PHA, V19, P357, DOI 10.4196/kjpp.2015.19.4.357; Pedersen KB, 2009, ACTA OPHTHALMOL, V87, P714, DOI 10.1111/j.1755-3768.2008.01346.x; Peng ML, 2014, BRIT J OPHTHALMOL, V98, P556, DOI 10.1136/bjophthalmol-2013-303436; Pucci N, 2002, ANN ALLERG ASTHMA IM, V89, P298, DOI 10.1016/S1081-1206(10)61958-8; Reid TW, 2010, EYE CONTACT LENS, V36, P290, DOI 10.1097/ICL.0b013e3181eea8fe; Sacchetti M, 2014, BRIT J OPHTHALMOL, V98, P1016, DOI 10.1136/bjophthalmol-2013-304072; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Sahin H, 2012, J ORTHOP RES, V30, P1952, DOI 10.1002/jor.22147; SECCHI AG, 1990, AM J OPHTHALMOL, V110, P641, DOI 10.1016/S0002-9394(14)77061-8; Seet LF, 2012, INVEST OPHTH VIS SCI, V53, P587, DOI 10.1167/iovs.11-7941; Silva MVD, 1999, GRAEF ARCH CLIN EXP, V237, P840, DOI 10.1007/s004170050321; Singh P, 2015, INDIAN J OPHTHALMOL, V63, P779, DOI 10.4103/0301-4738.171508; Smit DP, 2007, CLIN OPHTHALMOL, V1, P273; Soloman A, 2000, INVEST OPHTH VIS SCI, V41, P2154; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Strong B, 2005, CORNEA, V24, P80, DOI 10.1097/01.ico.0000133994.22392.47; Tatlipinar S, 2005, BRIT J OPHTHALMOL, V89, P1363, DOI 10.1136/bjo.2005.070888; Threlfall TJ, 1999, AM J OPHTHALMOL, V128, P280, DOI 10.1016/S0002-9394(99)00161-0; Tok OY, 2008, OPHTHALMOLOGICA, V222, P391, DOI 10.1159/000151740; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Tsai YY, 2010, INVEST OPHTH VIS SCI, V51, P3462, DOI 10.1167/iovs.09-4921; Turan-Vural E, 2011, CLIN OPHTHALMOL, V5, P881, DOI 10.2147/OPTH.S19469; Utine CA, 2010, OCUL IMMUNOL INFLAMM, V18, P352, DOI 10.3109/09273948.2010.498657; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yang SF, 2009, INVEST OPHTH VIS SCI, V50, P4588, DOI 10.1167/iovs.08-3147; Zehetner C, 2013, BRIT J OPHTHALMOL, V97, P454, DOI 10.1136/bjophthalmol-2012-302451; ZHAO JC, 1993, CORNEA, V12, P481, DOI 10.1097/00003226-199311000-00004; Ziaei M, 2015, CORNEA, V34, P110, DOI 10.1097/ICO.0000000000000291; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	101	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169675	10.1371/journal.pone.0169675	http://dx.doi.org/10.1371/journal.pone.0169675			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068383	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900057
J	McCowan, LME; Thompson, JMD; Taylor, RS; Baker, PN; North, RA; Poston, L; Roberts, CT; Simpson, NAB; Walker, JJ; Myers, J; Kenny, LC				McCowan, Lesley M. E.; Thompson, John M. D.; Taylor, Rennae S.; Baker, Philip N.; North, Robyn A.; Poston, Lucilla; Roberts, Claire T.; Simpson, Nigel A. B.; Walker, James J.; Myers, Jenny; Kenny, Louise C.		SCOPE Consortium	Prediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy Biomarkers	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; PLASMA-PROTEIN-A; INTERNATIONAL PROSPECTIVE COHORT; FETAL-GROWTH; HYPERTENSIVE DISORDERS; DIAGNOSTIC-ACCURACY; NUCHAL TRANSLUCENCY; PREECLAMPSIA; BIRTH; CLASSIFICATION	Objective Most small for gestational age pregnancies are unrecognised before birth, resulting in substantial avoidable perinatal mortality and morbidity. Our objective was to develop multivariable prediction models for small for gestational age combining clinical risk factors and biomarkers at 15 +/- 1 weeks' with ultrasound parameters at 20 +/- 1 weeks' gestation. Methods Data from 5606 participants in the Screening for Pregnancy Endpoints (SCOPE) cohort study were divided into Training (n = 3735) and Validation datasets (n = 1871). The primary outcomes were All-SGA (small for gestational age with birthweight < 10th customised centile), Normotensive-SGA (small for gestational age with a normotensive mother) and Hypertensive-SGA (small for gestational age with an hypertensive mother). The comparison group comprised women without the respective small for gestational age phenotype. Multivariable analysis was performed using stepwise logistic regression beginning with clinical variables, and subsequent additions of biomarker and then ultrasound (biometry and Doppler) variables. Model performance was assessed in Training and Validation datasets by calculating area under the curve. Results 633 (11.2%) infants were All-SGA, 465(8.2%) Normotensive-SGA and 168 (3%) Hypertensive- SGA. Area under the curve (95% Confidence Intervals) for All-SGA using 15 +/- 1 weeks' clinical variables, 15 +/- 1 weeks' clinical+biomarker variables and clinical + biomarkers + biometry /Doppler at 20 +/- 1 weeks' were: 0.63 (0.59-0.67), 0.64 (0.60-0.68) and 0.69 (0.66-0.73) respectively in the Validation dataset; Normotensive-SGA results were similar: 0.61 (0.57-0.66), 0.61 (0.56-0.66) and 0.68 (0.64-0.73) with small increases in performance in the Training datasets. Area under the curve (95% Confidence Intervals) for Hypertensive-SGA were: 0.76 (0.70-0.82), 0.80 (0.75-0.86) and 0.84 (0.78-0.89) with minimal change in the Training datasets. Conclusion Models for prediction of small for gestational age, which combine biomarkers, clinical and ultrasound data from a cohort of low-risk nulliparous women achieved modest performance. Incorporation of biomarkers into the models resulted in no improvement in performance of prediction of All-SGA and Normotensive-SGA but a small improvement in prediction of Hypertensive-SGA. Our models currently have insufficient reliability for application in clinical practice however, they have potential utility in two-staged screening tests which include third trimester biomarkers and or fetal biometry.	[McCowan, Lesley M. E.; Thompson, John M. D.; Taylor, Rennae S.] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand; [McCowan, Lesley M. E.] Univ Auckland, Dept Paediat Child & Youth Hlth, Middlemore Hosp, South Auckland Clin Sch, Auckland, New Zealand; [McCowan, Lesley M. E.] Auckland Dist Hlth Board, Natl Womens, Auckland, New Zealand; [Thompson, John M. D.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Baker, Philip N.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [North, Robyn A.; Poston, Lucilla] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England; [North, Robyn A.; Poston, Lucilla] Kings Hlth Partners, London, England; [Roberts, Claire T.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Roberts, Claire T.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Simpson, Nigel A. B.; Walker, James J.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sect Obstet & Gynaecol, Leeds, W Yorkshire, England; [Myers, Jenny] Univ Manchester, Maternal & Fetal Heath Res Ctr, Manchester, Lancs, England; [Kenny, Louise C.] Univ Coll, Dept Obstet & Gynaecol, INFANT Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [Kenny, Louise C.] Univ Coll Cork, Dept Obstet & Gynaecol, Cork, Ireland	University of Auckland; University of Auckland; Auckland District Health Board; University of Auckland; University of Auckland; University of London; King's College London; University of London; King's College London; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Leeds; University of Manchester; University College Cork; University College Cork	McCowan, LME (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand.; McCowan, LME (corresponding author), Univ Auckland, Dept Paediat Child & Youth Hlth, Middlemore Hosp, South Auckland Clin Sch, Auckland, New Zealand.; McCowan, LME (corresponding author), Auckland Dist Hlth Board, Natl Womens, Auckland, New Zealand.	l.mccowan@auckland.ac.nz	Kenny, Louise C/G-1112-2011; Kenny, Louise/X-6329-2019	Kenny, Louise C/0000-0002-9011-759X; Kenny, Louise/0000-0002-9011-759X; Briley, Annette/0000-0002-4266-920X; Myers, Jenny/0000-0003-0913-2096; Roberts, Claire/0000-0002-9250-2192; Taylor, Rennae/0000-0003-1718-9332; Poston, Lucilla/0000-0003-1100-2821; Black, Michael/0000-0003-1174-6054	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council [04/198]; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Health Research Board of Ireland [CSA/2007/2]; National Health Service NEAT Grant [FSD025]; Biotechnology and Biological Sciences Research council [GT084]; University of Manchester Proof of Concept Funding (University of Manchester); Guy's and St. Thomas' Charity (King's College London); Tommy's charity (King's College London); Cerebra UK; Alere Inc, San Diego, CA; Science Foundation Ireland Program Grant for INFANT [12/RC/2272]; National Health and Medical Research Council (NHMRC) [GNT1020749]; Tommy's charity (University of Manchester)	New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Health Research Board of Ireland; National Health Service NEAT Grant; Biotechnology and Biological Sciences Research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Proof of Concept Funding (University of Manchester); Guy's and St. Thomas' Charity (King's College London); Tommy's charity (King's College London); Cerebra UK; Alere Inc, San Diego, CA; Science Foundation Ireland Program Grant for INFANT(Science Foundation Ireland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Tommy's charity (University of Manchester)	The New Zealand SCOPE study was funded by the New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council (04/198) http://www.hrc.govt.nzl; Evelyn Bond Fund, Auckland District Health Board Charitable Trust (http://www.adhb.govt.nz/researchoffice/A+Grant-Cmtee/ADHB Grants Committee.htm#ABOUT_THE_ADHB_CHARITABLE_TRUST), The Australian SCOPE study was funded by the Premier's Science and Research Fund, South Australian Government (http://www.statedevelopment.sa.gov.au/science/premiers-research-and-industry-fund), The Irish SCOPE study was funded by the Health Research Board of Ireland (CSA/2007/2; http://www.hrb.ie), The UK SCOPE study was funded by National Health Service NEAT Grant (Neat Grant FSD025), Biotechnology and Biological Sciences Research council (www.bbsrc.ac.uk/funding; GT084) and University of Manchester Proof of Concept Funding (University of Manchester); Guy's and St. Thomas' Charity (King's College London) and Tommy's charity (http://www.tommys.org/; King's College London and University of Manchester); and Cerebra UK (www.cerebra.org.uk; University of Leeds). The biomarker study was funded by an unrestricted research grant from Alere Inc, San Diego, CA (www.alere.com), to the universities in the SCOPE consortium. L.C. Kenny is supported by a Science Foundation Ireland Program Grant for INFANT (12/RC/2272). C.T. Roberts is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship GNT1020749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Anderson NH, 2015, AM J OBSTET GYNECOL; Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; [Anonymous], 2012, PERINATAL STAT SERIE; [Anonymous], 2012, PER STAT REP 2010; Australian NZCTR, 2007, ACTRN12607000551493; Barker DJP, 2007, HYPERTENSION, V50, P565, DOI 10.1161/HYPERTENSIONAHA.107.091512; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; BONNO M, 1994, LAB INVEST, V71, P560; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Cali U, 2013, CLIN EXP OBSTET GYN, V40, P45; Chaiworapongsa T, 2016, J MATERN-FETAL NEO M, V29, P1214, DOI 10.3109/14767058.2015.1048431; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Crovetto F, 2016, ULTRASOUND OBSTET GY; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Dugoff L, 2004, AM J OBSTET GYNECOL, V191, P1446, DOI 10.1016/j.ajog.2004.06.052; Endo H, 2005, INT J MOL MED, V16, P79; Foidart JM, 2010, ULTRASOUND OBST GYN, V35, P680, DOI 10.1002/uog.7621; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gardosi J, 2009, BJOG-INT J OBSTET GY, V116, P1356, DOI 10.1111/j.1471-0528.2009.02245.x; Griffin M, 2015, ULTRASOUND OBST GYN, V46, P182, DOI 10.1002/uog.14860; Groom KM, 2007, BJOG-INT J OBSTET GY, V114, P478, DOI 10.1111/j.1471-0528.2007.01277.x; Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897; Infoshore, 2011, TOT CONF DISTR HLTH; Karagiannis G, 2011, FETAL DIAGN THER, V29, P148, DOI 10.1159/000321694; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Krantz D, 2004, AM J OBSTET GYNECOL, V191, P1452, DOI 10.1016/j.ajog.2004.05.068; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; MacLennan AH, 2015, AM J OBSTET GYNECOL, V213, P779, DOI 10.1016/j.ajog.2015.05.034; McCarthy F, 2015, REPROD SCI; McCowan L, 2004, AUST NZ J OBSTET GYN, V44, P428, DOI 10.1111/j.1479-828X.2004.00272.x; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; McCowan LME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070917; McCowan LME, 2005, BJOG-INT J OBSTET GY, V112, P1026, DOI 10.1111/j.1471-0528.2005.00656.x; Montanari L, 2009, FETAL DIAGN THER, V25, P130, DOI 10.1159/000207554; Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195; Myers JE, 2013, HYPERTENSION, V61, P1281, DOI 10.1161/HYPERTENSIONAHA.113.01168; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Office for National Statistics, 2009, SER FM1, V37; Parra-Saavedra M, 2013, PLACENTA, V34, P1136, DOI 10.1016/j.placenta.2013.09.018; PMMRC, 2012, 6 ANN REP PER MAT MO; Poon LC, 2015, ULTRASOUND OBST GYN, V46, P437, DOI 10.1002/uog.14904; Poon LCY, 2013, FETAL DIAGN THER, V33, P16, DOI 10.1159/000341712; Reboul Q, 2016, ULTRASOUND OBST GYN, V6, P6; Roberts CT, 2008, PLACENTA, V29, pS42, DOI 10.1016/j.placenta.2007.12.002; Roex A, 2012, AUST NZ J OBSTET GYN, V52, P78, DOI 10.1111/j.1479-828X.2011.01408.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Triunfo S, 2016, ULTRASOUND OBST GYN, V47, P81, DOI 10.1002/uog.15740; Wright J, 2006, MIDIRS MIDWIFERY DIG, V16, P341; Zhong Y, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0608-y	56	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169311	10.1371/journal.pone.0169311	http://dx.doi.org/10.1371/journal.pone.0169311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068394	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900024
J	Hong, S; Takahashi, H; Nadres, ET; Mortazavian, H; Caputo, GA; Younger, JG; Kuroda, K				Hong, Sungyoup; Takahashi, Haruko; Nadres, Enrico T.; Mortazavian, Hamid; Caputo, Gregory A.; Younger, John G.; Kuroda, Kenichi			A Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							INHIBITORY CONCENTRATION; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL; DESIGN; DAPTOMYCIN; MECHANISM; BEHAVIOR; SURFACE; SYSTEM; IMPACT	In this report, we demonstrate the pH-dependent, in vitro antimicrobial activity of a cationic, amphiphilic random copolymer against clinical isolates of drug-resistant Staphylococcus aureus. The polymer was developed toward a long-term goal of potential utility in the treatment of skin infections. The proposed mechanism of action of the polymer is through selectively binding to bacterial membranes and subsequent disruption of the membrane structure/integrity, ultimately resulting in bacterial cell death. The polymer showed bactericidal activity against clinical isolates of methicillin-resistant or vancomycin-intermediate S. aureus. The polymer was effective in killing S. aureus at neutral pH, but inactive under acidic conditions (pH 5.5). The polymer did not exhibit any significant hemolytic activity against human red blood cells or display cytotoxicity to human dermal fibroblasts over a range of pH values (5.5-7.4). These results indicate that the polymer activity was selective against bacteria over human cells. Using this polymer, we propose a new potential strategy for treatment of skin infections using the pH-sensitive antimicrobial polymer agent that would selectively target infections at pH-neutral wound sites, but not the acidic, healthy skin.	[Hong, Sungyoup] Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul, South Korea; [Takahashi, Haruko; Nadres, Enrico T.; Mortazavian, Hamid; Kuroda, Kenichi] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Caputo, Gregory A.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ USA; [Younger, John G.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA	Catholic University of Korea; University of Michigan System; University of Michigan; Rowan University; University of Michigan System; University of Michigan	Hong, S (corresponding author), Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul, South Korea.; Kuroda, K (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	emhong@catholic.ac.kr; kkuroda@umich.edu		Hong, Sungyoup/0000-0002-3387-6194; Nadres, Enrico/0000-0002-7591-5868; Mortazavian, Hamid/0000-0001-9060-2774; Caputo, Gregory/0000-0002-4510-2815	Catholic Medical Center Research Foundation; Catholic University of Korea Daejeon St. Mary's Hospital, Clinical Research Institute Grant - Catholic University of Korea Daejeon St. Mary's Hospital [CMCDJ-A-2016-006]; National Science Foundation [DMR-0845592]; Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan; JSPS [26-774]	Catholic Medical Center Research Foundation; Catholic University of Korea Daejeon St. Mary's Hospital, Clinical Research Institute Grant - Catholic University of Korea Daejeon St. Mary's Hospital; National Science Foundation(National Science Foundation (NSF)); Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2016 (to SH). This study was also supported by The Catholic University of Korea Daejeon St. Mary's Hospital, Clinical Research Institute Grant (CMCDJ-A-2016-006 to SH) funded by The Catholic University of Korea Daejeon St. Mary's Hospital. We thank the National Science Foundation for NSF CAREER Award (DMR-0845592 to K.K.) and the Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan for financial support. This work was also supported by JSPS Postdoctoral Fellowships for Research Abroad (No. 26-774 to H.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulMajid KB, 1997, FEMS IMMUNOL MED MIC, V17, P79, DOI 10.1016/S0928-8244(96)00108-3; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campbell ML, 2012, ANN PHARMACOTHER, V46, P1587, DOI 10.1345/aph.1R211; Chaili S, 2015, INFECT IMMUNITY; CHANG YH, 1993, MACROMOLECULES, V26, P6121, DOI 10.1021/ma00074a038; Cheung AL, 2014, INFECT IMMUN, V82, P5336, DOI 10.1128/IAI.02480-14; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Clinical Laboratory Standard Institute, 2015, M07A10 CLIN LAB STAN, VTwelfth; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Edelsberg J, 2014, DIAGN MICR INFEC DIS, V78, P255, DOI 10.1016/j.diagmicrobio.2013.11.011; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hirai Y, 2016, MACROMOLECULES, V49, P5084, DOI 10.1021/acs.macromol.6b01085; Jiang YJ, 2013, MACROMOLECULES, V46, P3959, DOI 10.1021/ma400484b; Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q; Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0; Klodzinska E, 2010, ELECTROPHORESIS, V31, P1590, DOI 10.1002/elps.200900559; Kolar SL, 2011, MICROBIOL-SGM, V157, P2206, DOI 10.1099/mic.0.049692-0; Kusonwiriyawong C, 2003, EUR J PHARM BIOPHARM, V56, P237, DOI 10.1016/S0939-6411(03)00093-6; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matousek JL, 2002, VET DERMATOL, V13, P293, DOI 10.1046/j.1365-3164.2002.00312.x; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mensa B, 2014, ANTIMICROB AGENTS CH, V58, P5136, DOI 10.1128/AAC.02955-14; Mercer DK, 2013, FUTURE MED CHEM, V5, P315, DOI [10.4155/FMC.12.213, 10.4155/fmc.12.213]; MORISHIMA Y, 1995, MACROMOLECULES, V28, P2874, DOI 10.1021/ma00112a037; Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005; Nadres ET, 2016, J POLYM SCI A, DOI DOI 10.1016/J.IJANTIMICAG.2013.05.008; Palermo EF, 2012, BIOMACROMOLECULES, V13, P1632, DOI 10.1021/bm300342u; Riley MA, 2013, FUTURE MED CHEM, V5, P1231, DOI 10.4155/fmc.13.79; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; Schreml S, 2010, J EUR ACAD DERMATOL, V24, P373, DOI 10.1111/j.1468-3083.2009.03413.x; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Sovadinova I, 2011, POLYMERS-BASEL, V3, P1512, DOI 10.3390/polym3031512; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Tashiro T, 2001, MACROMOL MATER ENG, V286, P63; Wang YZ, 2011, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2011-11; Yang SJ, 2012, INFECT IMMUN, V80, P74, DOI 10.1128/IAI.05669-11; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	43	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169262	10.1371/journal.pone.0169262	http://dx.doi.org/10.1371/journal.pone.0169262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060853	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500071
J	Jang, MK; Kim, JH; Jung, MH				Jang, Min-Kyung; Kim, Ji-Hyun; Jung, Myeong Ho			Histone H3K9 Demethylase JMJD2B Activates Adipogenesis by Regulating H3K9 Methylation on PPAR gamma and C/EBP alpha during Adipogenesis	PLOS ONE			English	Article							EXPRESSION; LSD1; DIFFERENTIATION; REVERSAL; FAMILY	Previous studies have shown that tri-or di-methylation of histone H3 at lysine 9 (H3K9me3/ me2) on the promoter of the peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer-binding protein alpha (C/EBP alpha) contribute to the repression of PPAR gamma and C/ EBPa and inhibition of adipogenesis in 3T3-L1 preadipocytes. The balance of histone methylation is regulated by histone methyltransferases and demethylases. However, it is poorly understood which demethylases are responsible for removing H3K9me3/me2 on the promoter of PPAR gamma and C/EBP alpha. JMJD2B is a H3K9me3/me2 demethylase that was previously shown to activate adipogenesis by promoting mitotic clonal expansion. Nevertheless, it remains unclear whether JMJD2B plays a role in the regulation of adipogenesis by removing H3K9me3/me2 on the promoter of PPAR gamma and C/EBP alpha and subsequently activating PPAR gamma and C/EBP alpha expression. Here, we showed that JMJD2B decreased H3K9me3/me2 on the promoter of PPAR gamma and C/EBP alpha, which in turn stimulated the expression of PPAR gamma and C/EBP alpha. JMJD2B knockdown using siRNA in 3T3-L1 preadipocytes repressed the expression of PPAR gamma and C/EBP alpha, resulting in inhibition of adipogenesis. This was accompanied by increased enrichment of H3K9me3/me2 on the promoter of PPAR gamma and C/EBP alpha. In contrast, overexpression of JMJD2B increased the expression of PPAR gamma and C/EBP alpha, which was accompanied by decreased enrichment of H3K9me3/me2 on the promoter and activated adipogenesis. Together, these results indicate that JMJD2B regulates PPAR gamma and C/EBP alpha during adipogenesis.	[Jang, Min-Kyung; Kim, Ji-Hyun; Jung, Myeong Ho] Pusan Natl Univ, Sch Korean Med, 49 Busandaehak Ro, Yangsan, Gyeongnam, South Korea	Pusan National University	Jung, MH (corresponding author), Pusan Natl Univ, Sch Korean Med, 49 Busandaehak Ro, Yangsan, Gyeongnam, South Korea.	jung0603@pusan.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2013R1A1A2064655]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	We declare that this research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF-2013R1A1A2064655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Labbe RM, 2014, AM J TRANSL RES, V6, P1; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Matsumura Y, 2015, MOL CELL, V60, P584, DOI 10.1016/j.molcel.2015.10.025; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zhang ZC, 2014, MOL CELL BIOL, V34, P2330, DOI 10.1128/MCB.00070-14	20	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168185	10.1371/journal.pone.0168185	http://dx.doi.org/10.1371/journal.pone.0168185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060835	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500023
J	Maier, AK; Jung, R; Villinger, C; Schubert, A; Walther, P; Sinzger, C; Lieber, D				Maier, Anna Katharina; Jung, Raimund; Villinger, Clarissa; Schubert, Axel; Walther, Paul; Sinzger, Christian; Lieber, Diana			A Luciferase Gene Driven by an Alphaherpesviral Promoter Also Responds to Immediate Early Antigens of the Betaherpesvirus HCMV, Allowing Comparative Analyses of Different Human Herpesviruses in One Reporter Cell Line	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; HUMAN CYTOMEGALOVIRUS-INFECTION; GREEN FLUORESCENT PROTEIN; EXPRESSING HUMAN CYTOMEGALOVIRUS; OPEN READING FRAME; ENDOTHELIAL-CELLS; IN-VITRO; NEUTRALIZING EPITOPE; ANTIVIRAL ACTIVITY; MELANOMA-CELLS	Widely used methods for quantification of human cytomegalovirus (HCMV) infection in cell culture such as immunoblotting or plaque reduction assays are generally restricted to low throughput and require time-consuming evaluation. Up to now, only few HCMV reporter cell lines have been generated to overcome these restrictions and they are afflicted with other limitations because permanently expandable cell lines are normally not fully permissive to HCMV. In this work, a previously existing epithelial cell line hosting a luciferase gene under control of a Varicella-zoster virus promoter was adopted to investigate HCMV infection. The cells were susceptible to different HCMV strains at infection efficiencies that corresponded to their respective degree of epithelial cell tropism. Expression of early and late viral antigens, formation of nuclear inclusions, release of infectious virus progeny, and focal growth indicated productive viral replication. However, viral release and spread occurred at lower levels than in primary cell lines which appears to be due to a malfunction of virion morphogenesis during the nuclear stage. Expression of the luciferase reporter gene was specifically induced in HCMV infected cultures as a function of the virus dose and dependent on viral immediate early gene expression. The level of reporter activity accurately reflected infection efficiencies as determined by viral antigen immunostaining, and hence could discriminate the cell tropism of the tested virus strains. As proof-of-principle, we demonstrate that this cell line is applicable to evaluate drug resistance of clinical HCMV isolates and the neutralization capacity of human sera, and that it allows comparative and simultaneous analysis of HCMV and human herpes simplex virus type 1. In summary, the permanent epithelial reporter cell line allows robust, rapid and objective quantitation of HCMV infection and it will be particularly useful in higher throughput analyses as well as in comparative analyses of different human herpesviruses.	[Maier, Anna Katharina; Jung, Raimund; Villinger, Clarissa; Schubert, Axel; Sinzger, Christian; Lieber, Diana] Univ Ulm, Med Ctr, Inst Virol, Ulm, Germany; [Villinger, Clarissa; Walther, Paul] Univ Ulm, Cent Facil Electron Microscopy, Ulm, Germany; [Maier, Anna Katharina] Boehringer Ingelheim Pharma GmbH &Co KG, Biberach, Germany; [Jung, Raimund] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Ulm University; Ulm University; Boehringer Ingelheim; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lieber, D (corresponding author), Univ Ulm, Med Ctr, Inst Virol, Ulm, Germany.	diana.lieber@uni-ulm.de		Read, Clarissa/0000-0002-4632-2684	Medical Faculty of Ulm University [Baustein/L.SBN.0094]; Ulm University through Hertha-Nathorff program	Medical Faculty of Ulm University; Ulm University through Hertha-Nathorff program	DL received funding from the Medical Faculty of Ulm University through grant Baustein/L.SBN.0094 and from Ulm University through the Hertha-Nathorff program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2006, J GEN VIROL, V87, P2451, DOI 10.1099/vir.0.81921-0; Ariza-Heredia EJ, 2014, CANCER LETT, V342, P1, DOI 10.1016/j.canlet.2013.09.004; BEAN MA, 1975, CANCER RES, V35, P2902; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Cavignac Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131614; Chevillotte M, 2009, ANTIMICROB AGENTS CH, V53, P3752, DOI 10.1128/AAC.00165-09; DISNEY GH, 1990, J GEN VIROL, V71, P2681, DOI 10.1099/0022-1317-71-11-2681; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Drouot E, 2013, J CLIN MICROBIOL, V51, P3216, DOI 10.1128/JCM.01275-13; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Falk JJ, 2016, J VIROL METHODS; FELSER JM, 1988, J VIROL, V62, P2076, DOI 10.1128/JVI.62.6.2076-2082.1988; FELSER JM, 1987, J VIROL, V61, P225, DOI 10.1128/JVI.61.1.225-228.1987; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Fukui Y, 2008, ANTIMICROB AGENTS CH, V52, P2420, DOI 10.1128/AAC.00134-08; Gilbert C, 2005, ANTIMICROB AGENTS CH, V49, P4860, DOI 10.1128/AAC.49.12.4860-4866.2005; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; GROSE C, 1978, INFECT IMMUN, V19, P199, DOI 10.1128/IAI.19.1.199-203.1978; Gwee A, 2014, PEDIATR INFECT DIS J, V33, P115, DOI 10.1097/INF.0000000000000032; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-40; Hippenmeyer PJ, 1996, ANTIVIR RES, V32, P35, DOI 10.1016/0166-3542(95)00976-0; Hochdorfer D, 2016, J VIROL, V90, P6430, DOI 10.1128/JVI.00145-16; Inoue N, 2012, J VIROL, V86, P12198, DOI 10.1128/JVI.01280-12; Lieber D, 2015, BIOTECHNIQUES, V59, P127, DOI 10.2144/000114326; Lieber D, 2013, METHODS MOL BIOL, V1064, P171, DOI 10.1007/978-1-62703-601-6_12; Liu WT, 2001, J VIROL METHODS, V96, P85, DOI 10.1016/S0166-0934(01)00320-2; Luganini A, 2008, J APPL MICROBIOL, V105, P1791, DOI 10.1111/j.1365-2672.2008.03927.x; Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; MASUHO Y, 1987, J GEN VIROL, V68, P1457, DOI 10.1099/0022-1317-68-5-1457; May T, 2010, TISSUE ENG PT A, V16, P441, DOI [10.1089/ten.tea.2009.0184, 10.1089/ten.TEA.2009.0184]; MEYER H, 1990, J GEN VIROL, V71, P2443, DOI 10.1099/0022-1317-71-10-2443; NOWLIN DM, 1991, J VIROL, V65, P3114, DOI 10.1128/JVI.65.6.3114-3121.1991; Pavic I, 1997, ANTIMICROB AGENTS CH, V41, P2686, DOI 10.1128/AAC.41.12.2686; PLOTKIN SA, 1975, INFECT IMMUN, V12, P521, DOI 10.1128/IAI.12.3.521-527.1975; Potzsch S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002172; ROWE WP, 1956, P SOC EXP BIOL MED, V92, P418, DOI 10.3181/00379727-92-22497; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Sassenscheidt J, 2006, J VIROL METHODS, V138, P40, DOI 10.1016/j.jviromet.2006.07.015; Schauflinger M, 2013, CELL MICROBIOL, V15, P305, DOI 10.1111/cmi.12077; Scrivano L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001256; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Sinzger C, 1997, J VIROL METHODS, V63, P103, DOI 10.1016/S0166-0934(97)02082-X; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; SPAETE RR, 1987, P NATL ACAD SCI USA, V84, P7213, DOI 10.1073/pnas.84.20.7213; Spiller OB, 1997, J GEN VIROL, V78, P3349, DOI 10.1099/0022-1317-78-12-3349; STAMMINGER T, 1991, J VIROL, V65, P2273, DOI 10.1128/JVI.65.5.2273-2282.1991; Strang BL, 2012, J VIROL, V86, P2089, DOI 10.1128/JVI.06720-11; Ueno T, 2006, ANTIMICROB AGENTS CH, V50, P2806, DOI 10.1128/AAC.01641-05; Villinger C, 2015, VIRUSES-BASEL, V7, P5686, DOI 10.3390/v7112900; WALDMAN WJ, 1991, ARCH VIROL, V117, P143, DOI 10.1007/BF01310761; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wang GQ, 2006, ANTIMICROB AGENTS CH, V50, P3142, DOI 10.1128/AAC.00342-06; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625; Wiegers AK, 2015, J VIROL, V89, P361, DOI 10.1128/JVI.02393-14	60	0	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169580	10.1371/journal.pone.0169580	http://dx.doi.org/10.1371/journal.pone.0169580			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060895	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500111
J	Yang, YW; Jiang, YZ; Hsu, CM; Chen, LW				Yang, Ying-Wei; Jiang, Yu-Zhen; Hsu, Ching-Mei; Chen, Lee-Wei			Pseudomonas aeruginosa Ventilator-Associated Pneumonia Induces Lung Injury through TNF-alpha/c-Jun NH2-Terminal Kinase Pathways	PLOS ONE			English	Article							MECHANICAL VENTILATION; INFLAMMATION; SUSCEPTIBILITY; MACROPHAGES; FIBROSIS	Ventilator-associated pneumonia (VAP) is a common nosocomial infection among intensive care unit (ICU) patients. Pseudomonas aeruginosa (PA) is the most common multidrug-resistant Gram-negative pathogen and VAP caused by PA carries a high rate of morbidity and mortality. This study examined the molecular mechanism of PA VAP-induced lung injury. C57BL/6 wild-type (WT) mice and JNK1 knockout (JNK1(-/-)) mice received mechanical ventilation (MV) for 3 h at 2 days after receiving nasal instillation of PA. The WT and JNK1(-/-) mice also received MV after the induction of lung injury by instillation of supernatants from PA-stimulated alveolar macrophages (AMs). AMs isolated from WT, I kappa B-kinase (IKK) beta(Delta Mye) (IKK beta was selectively deleted in macrophages), and JNK1(-/-) mice were ex vivo stimulated with live PA and supernatants were collected for cytokine assay. Intranasal instillation of 10(6) PA enhanced MV-induced NF-kappa B DNA binding activity in the lungs and nitrite levels in BALF. MV after PA instillation significantly increased the expression of ICAM and VCAM in the lungs and TNF-alpha, IL-1 beta, and IL-6 levels in bronchoalveolar lavage fluid (BALF) of WT mice, but not in JNK1(-/-) mice. MV after supernatant instillation induced more total protein concentration in BALF and neutrophil sequestration in the lungs in WT mice than JNK1(-/-) mice and cytokine assay of supernatants indicated that TNF-alpha is a critical regulator of PA VAP-induced lung injury. Ex vivo PA stimulation induced TNF-alpha production by AMs from WT as well as JNK1(-/-) mice but not IKK beta(Delta Mye) mice. In summary, PA colonization plays an important role in PA VAP-induced lung injury through the induction of JNK1-mediated inflammation. These results suggest that the pathogenesis mechanism of PA VAP involves production of TNF-alpha through activation of IKK/NF-kappa B pathways in AMs and JNK signaling pathway in the lungs.	[Yang, Ying-Wei; Chen, Lee-Wei] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Yang, Ying-Wei] Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Jiang, Yu-Zhen; Hsu, Ching-Mei] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Chen, Lee-Wei] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Sun Yat Sen University; Kaohsiung Veterans General Hospital	Chen, LW (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Chen, LW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan.	chenlw2001@yahoo.com.tw		Chen, Lee-Wei/0000-0002-3583-1248	National Science Council [NSC1052314B010052]; Kaohsiung Veterans General Hospital [VGHKS102-024, 104-71]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	This work was supported by National Science Council (NSC1052314B010052), Kaohsiung Veterans General Hospital (VGHKS102-024, 104-71) to LWC.	Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Budweiser Stephan, 2008, Int J Chron Obstruct Pulmon Dis, V3, P605; Cetin I, 2004, RESPIRATION, V71, P625, DOI 10.1159/000081764; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; El Solh AA, 2009, J ANTIMICROB CHEMOTH, V64, P229, DOI 10.1093/jac/dkp201; Francois B, 2012, CRIT CARE MED, V40, P2320, DOI 10.1097/CCM.0b013e31825334f6; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jia J, 2003, INFECT IMMUN, V71, P3361, DOI 10.1128/IAI.71.6.3361-3370.2003; Jones W Keith, 2003, Cardiovasc Toxicol, V3, P229, DOI 10.1385/CT:3:3:229; Kollef MH, 2014, CRIT CARE MED, V42, P2178, DOI 10.1097/CCM.0000000000000510; Lin CY, 2003, CRIT CARE MED, V31, P1429, DOI 10.1097/01.CCM.0000063449.58029.81; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Noda E, 2003, PEDIATR PULM, V36, P475, DOI 10.1002/ppul.10370; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Srivastava SK, 2009, EXP EYE RES, V88, P2, DOI 10.1016/j.exer.2008.03.012; Valencia M, 2009, CURR OPIN CRIT CARE, V15, P30, DOI 10.1097/MCC.0b013e3283220e78; Wolters PJ, 2009, J IMMUNOL, V182, P8056, DOI 10.4049/jimmunol.0801323; Zhou HJ, 2008, CRIT CARE MED, V36, P2495, DOI 10.1097/CCM.0b013e318183f3f8	25	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169267	10.1371/journal.pone.0169267	http://dx.doi.org/10.1371/journal.pone.0169267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060857	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500072
J	Yuan, FL; Wang, D; Xu, K; Wang, JX; Zhang, ZJ; Yang, L; Yang, GY; Li, S				Yuan, Falei; Wang, Dong; Xu, Kang; Wang, Jixian; Zhang, Zhijun; Yang, Li; Yang, Guo-Yuan; Li, Song			Contribution of Vascular Cells to Neointimal Formation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROGENITOR CELLS; DEFICIENT MICE; STEM-CELLS; DIFFERENTIATION; INJURY; MIGRATION; ARTERY	The de-differentiation and proliferation of smooth muscle cells (SMCs) are widely accepted as the major contributor to vascular remodeling. However, recent studies indicate that vascular stem cells (VSCs) also play an important role, but their relative contribution remains to be elucidated. In this study, we used genetic lineage tracing approach to further investigate the contribution of SMCs and VSCs to neointimal thickening in response to endothelium denudation injury or artery ligation. In vitro and in vivo analysis of MYH11-cre/Rosa-loxP-RFP mouse artery showed that SMCs proliferated at a much slower rate than non-SMCs. Upon denudation or ligation injury, two distinct types of neointima were identified: Type-I neointimal cells mainly involved SMCs, while Type II mainly involved non-SMCs. Using Sox10-cre/Rosa-IoxP-LacZ mice, we found that Sox10(+) cells were one of the cell sources in neointima. In addition, lineage tracing using Tie2-cre/Rosa-LoxP-RFP showed that endothelial cells also contributed to the neointimal formation, but rarely transdifferentiated into mesenchymal lineages. These results provide a novel insight into the contribution of vascular cells to neointima formation, and have significant impact on the development of more effective therapies that target specific vascular cell types.	[Yuan, Falei; Wang, Jixian; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai, Peoples R China; [Yuan, Falei; Wang, Jixian; Zhang, Zhijun; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China; [Yuan, Falei; Wang, Jixian; Zhang, Zhijun; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Yuan, Falei; Wang, Dong; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Wang, Dong; Li, Song] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Wang, Dong; Li, Song] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Xu, Kang; Yang, Li] Chongqing Univ, Dept Bioengn, Chongqing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chongqing University	Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai, Peoples R China.; Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China.; Yang, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China.; Li, S (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Li, S (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.; Li, S (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	gyyang0626@163.com; songli@ucla.edu	Xu, Kang/AAB-5737-2019; Wang, Dong/AAW-1537-2021	Xu, Kang/0000-0002-8492-2058; Wang, Dong/0000-0003-3489-915X	National Institutes of Health [HL771213, HL121450, EB012240]; National Natural Science Foundation of China [81428014, 81471178, 11532004, 31270990]; National Basic Research Program of China (973 Program) [2011CB504405]; Science and Technology Commission of Shanghai Municipality [13140903500, 13ZR1422600]; Shanghai Jiao Tong University Foundation for technological innovation of major projects [12X190030021]; KC Wong Foundation; National Innovation and Attracting Talents Project [B06023]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Jiao Tong University Foundation for technological innovation of major projects; KC Wong Foundation; National Innovation and Attracting Talents Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by research grants from the National Institutes of Health (HL771213, HL121450 and EB012240 to SL), the National Natural Science Foundation of China (#81428014 to GYY and SL, #81471178 to GYY, #11532004 and #31270990 to LY), National Basic Research Program of China (973 Program 2011CB504405), the Science and Technology Commission of Shanghai Municipality (13140903500 and 13ZR1422600), Shanghai Jiao Tong University Foundation for technological innovation of major projects (12X190030021 GYY) and KC Wong Foundation (GYY), and National Innovation and Attracting Talents Project (B06023 to LY).	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Chappell J., 2016, CIRC RES; Churchman Adrian T., 2009, V467, P127, DOI 10.1007/978-1-59745-241-0_7; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Hass GM, 1954, S ATHEROSCLEROSIS, p24 ~ 32; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Holifield B, 1996, J CLIN INVEST, V97, P814, DOI 10.1172/JCI118481; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Huang NF, 2011, AM J TRANSL RES, V3, P139; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kumar A, 1997, CIRCULATION, V96, P4333; Liao YB, 2007, ARTERIOSCL THROM VAS, V27, P1037, DOI 10.1161/ATVBAHA.106.137182; McKeown SJ, 2005, DEV DYNAM, V233, P430, DOI 10.1002/dvdy.20341; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiao LN, 2014, CIRCULATION, V129, P692, DOI 10.1161/CIRCULATIONAHA.113.003734; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Sainz J, 2006, ARTERIOSCL THROM VAS, V26, P281, DOI 10.1161/01.ATV.0000197793.83391.91; Tang ZY, 2013, CIRC RES, V112, P23, DOI 10.1161/CIRCRESAHA.112.281055; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; WISSLER RW, 1968, J ATHEROSCLER RES, V8, P201, DOI 10.1016/S0368-1319(68)80056-0	23	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168914	10.1371/journal.pone.0168914	http://dx.doi.org/10.1371/journal.pone.0168914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060852	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500044
J	Laporte, AN; Barrott, JJ; Yao, RJ; Poulin, NM; Brodin, BA; Jones, KB; Underhill, TM; Nielsen, TO				Laporte, Aimee N.; Barrott, Jared J.; Yao, Ren Jie; Poulin, Neal M.; Brodin, Bertha A.; Jones, Kevin B.; Underhill, T. Michael; Nielsen, Torsten O.			HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CELL CARCINOMA-CELLS; ENDOPLASMIC-RETICULUM; TUMOR-SUPPRESSOR; GENE-EXPRESSION; BORTEZOMIB; STRESS; FUSION; DISRUPTION; INDUCTION	Conventional cytotoxic therapies for synovial sarcoma provide limited benefit, and no drugs specifically targeting its driving SS18-SSX fusion oncoprotein are currently available. Patients remain at high risk for early and late metastasis. A high-throughput drug screen consisting of over 900 tool compounds and epigenetic modifiers, representing over 100 drug classes, was undertaken in a panel of synovial sarcoma cell lines to uncover novel sensitizing agents and targetable pathways. Top scoring drug categories were found to be HDAC inhibitors and proteasomal targeting agents. We find that the HDAC inhibitor quisinostat disrupts the SS18-SSX driving protein complex, thereby reestablishing expression of EGR1 and CDKN2A tumor suppressors. In combination with proteasome inhibition, HDAC inhibitors synergize to decrease cell viability and elicit apoptosis. Quisinostat inhibits aggre-some formation in response to proteasome inhibition, and combination treatment leads to elevated endoplasmic reticulum stress, activation of pro-apoptotic effector proteins BIM and BIK, phosphorylation of BCL-2, increased levels of reactive oxygen species, and suppression of tumor growth in a murine model of synovial sarcoma. This study identifies and provides mechanistic support for a particular susceptibility of synovial sarcoma to the combination of quisinostat and proteasome inhibition.	[Laporte, Aimee N.; Yao, Ren Jie; Poulin, Neal M.; Nielsen, Torsten O.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Fac Med, Vancouver, BC, Canada; [Barrott, Jared J.; Jones, Kevin B.] Univ Utah, Dept Orthopaed, Huntsman Canc Inst, Salt Lake City, UT USA; [Brodin, Bertha A.] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Underhill, T. Michael] Univ British Columbia, Dept Cellular & Physiol Sci, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Karolinska Institutet; University of British Columbia	Nielsen, TO (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Fac Med, Vancouver, BC, Canada.	torsten@mail.ubc.ca		Barrott, Jared/0000-0001-6059-9009	Canadian Cancer Society Research Institute [701582]; Terry Fox Research Institute [TFF 105265]; Liddy Shriver Sarcoma Initiative; Sarcoma Cancer Foundation of Canada (Beth England's Sarcoma Research Fund)	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Liddy Shriver Sarcoma Initiative; Sarcoma Cancer Foundation of Canada (Beth England's Sarcoma Research Fund)	This work was supported by the Canadian Cancer Society Research Institute (Grant # 701582) (http://www.cancer.ca/research/); Terry Fox Research Institute (TFF 105265 New Frontiers in Cancer) (http://www.tfri.ca/en/research/program-project-grants.aspx); The Liddy Shriver Sarcoma Initiative (http://sarcomahelp.org/) and the Sarcoma Cancer Foundation of Canada (Beth England's Sarcoma Research Fund) (http://sarcomacancer.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Bush KT, 1997, J BIOL CHEM, V272, P9086; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Deleu S, 2009, CANCER RES, V69, P5307, DOI 10.1158/0008-5472.CAN-08-4472; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hirakawa N, 1996, HUM PATHOL, V27, P1060, DOI 10.1016/S0046-8177(96)90284-1; Ihle MA, 2016, J PATHOL CLIN RES, V2, P59, DOI 10.1002/cjp2.35; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones KB, 2016, ONCOGENE; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Khan O, 2010, P NATL ACAD SCI USA, V107, P6532, DOI 10.1073/pnas.0913912107; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; Kovi RC, 2010, CELL DEATH DIFFER, V17, P513, DOI 10.1038/cdd.2009.140; Krieg AH, 2010, ANN ONCOLOGY; Ladanyi M, 2001, ONCOGENE, V20, P5755, DOI 10.1038/sj.onc.1204601; Laporte AN, 2016, ONCOTARGET, V7, P34384, DOI 10.18632/oncotarget.8882; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li CY, 2008, MOL CANCER THER, V7, P1647, DOI 10.1158/1535-7163.MCT-07-2444; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Mancuso T, 2000, LAB INVEST, V80, P805, DOI 10.1038/labinvest.3780085; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Moreau P, 2016, LEUKEMIA LYMPHOMA, P1; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; NOJIMA T, 1990, ACTA PATHOL JAPON, V40, P486; Okcu MF, 2001, MED PEDIATR ONCOL, V37, P90, DOI 10.1002/mpo.1175; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; Sandberg AA, 2002, CANCER GENET CYTOGEN, V133, P1, DOI 10.1016/S0165-4608(01)00626-4; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Shukla N, 2016, CANC RES; Siegel DS, 2016, CLIN LYMPHOMA MYELOM; SONOBE H, 1992, LAB INVEST, V67, P498; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169407	10.1371/journal.pone.0169407	http://dx.doi.org/10.1371/journal.pone.0169407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056055	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100040
J	Leinonen, T; Maki, N; Martikainen, P				Leinonen, Taina; Maki, Netta; Martikainen, Pekka			Trajectories of Antidepressant Medication before and after the Onset of Unemployment by Subsequent Employment Experience	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH; JOB LOSS; PAID EMPLOYMENT; FOLLOW-UP; MORTALITY; SYMPTOMS; SUICIDE; WOMEN; ADAPTATION	Background The unemployed more often suffer from depression than the employed. We examined whether mental health deterioration occurs already before unemployment implicating health selection, or whether it mostly occurs after becoming exposed to the experience rendering causal explanations more likely. Methods We used nationally representative Finnish register data to examine changes in depressive morbidity as measured by antidepressant medication in 1995-2009 over four years before and since a new onset of unemployment (N = 28 000) at the age of 30-60 compared to the employed (N = 124 136). We examined separately those who became continuously long-term unemployed, intermittently unemployed and unemployed with eventual re-employment in the second, third or fourth year since the year of onset. Annual repeated measurements were analysed using generalised estimation equations. Results Among the employed antidepressant medication increased slowly but steadily over the study period and it was mainly at a lower level than among the unemployed. In the four years leading to unemployment there was excess increase in medication that was generally stronger among those with longer duration of the eventual unemployment experience. During unemployment medication decreased in all groups except among the intermittently unemployed. By the first year of re-employment antidepressant medication reached a level similar to that among the employed and afterwards followed no consistent trend. Conclusions The associations of unemployment and re-employment with depressive morbidity appear to be largely driven by health selection. The question of potential causal associations remains unresolved for intermittent unemployment in particular.	[Leinonen, Taina; Martikainen, Pekka] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Maki, Netta] City Helsinki Urban Facts, Helsinki, Finland; [Martikainen, Pekka] Stockholm Univ, CHESS, Ctr Hlth Equ Studies, Stockholm, Sweden; [Martikainen, Pekka] Karolinska Inst, Stockholm, Sweden; [Martikainen, Pekka] Max Planck Inst Demog Res, Rostock, Germany	University of Helsinki; Stockholm University; Karolinska Institutet; Max Planck Society	Leinonen, T (corresponding author), Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland.	taina.leinonen@helsinki.fi		Martikainen, Pekka/0000-0001-9374-1438	Academy of Finland; Joint Committee for Nordic Research Councils for the Humanities and the Social Sciences [219643/F10]	Academy of Finland(Academy of Finland); Joint Committee for Nordic Research Councils for the Humanities and the Social Sciences	This study was supported by the Academy of Finland and the Joint Committee for Nordic Research Councils for the Humanities and the Social Sciences (project no. 219643/F10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2015, EUR J PUBLIC HEALTH, V25, P368, DOI 10.1093/eurpub/cku176; Ahs A, 2012, INT J BEHAV MED, V19, P29, DOI 10.1007/s12529-010-9129-2; Ahs AMH, 2006, HEALTH POLICY, V78, P178, DOI 10.1016/j.healthpol.2005.10.010; Backhans MC, 2012, EUR J PUBLIC HEALTH, V22, P429, DOI 10.1093/eurpub/ckr059; Benach J, 2014, ANNU REV PUBL HEALTH, V35, P229, DOI 10.1146/annurev-publhealth-032013-182500; Booker CL, 2012, J EPIDEMIOL COMMUN H, V66, P832, DOI 10.1136/jech.2010.126755; Burgard SA, 2007, J HEALTH SOC BEHAV, V48, P369, DOI 10.1177/002214650704800403; Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030; Butterworth P, 2012, SOC PSYCH PSYCH EPID, V47, P1013, DOI 10.1007/s00127-011-0409-1; Daly M, 2013, SOC SCI MED, V80, P19, DOI 10.1016/j.socscimed.2012.12.008; Ferrie JE, 2008, SCAND J WORK ENV HEA, P98; Gallo WT, 2006, INT ARCH OCC ENV HEA, V80, P109, DOI 10.1007/s00420-006-0108-5; Garcy AM, 2013, AM J PUBLIC HEALTH, V103, P1031, DOI 10.2105/AJPH.2013.301210; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gathergood J, 2013, HEALTH ECON, V22, P643, DOI 10.1002/hec.2831; Hamalainen J, 2009, DEPRESS ANXIETY, V26, P1049, DOI 10.1002/da.20524; Hanson LLM, 2016, EPIDEMIOLOGY, V27, P257, DOI 10.1097/EDE.0000000000000414; Heponiemi T, 2007, J PSYCHOSOM RES, V63, P425, DOI 10.1016/j.jpsychores.2007.04.005; Jefferis BJ, 2011, SOC SCI MED, V73, P1627, DOI 10.1016/j.socscimed.2011.09.029; Kasl SV, 2000, SOCIAL EPIDEMIOLOGY, P118; Kaspersen SL, 2016, OCCUP ENV MED; Kim TJ, 2016, INT ARCH OCC ENV HEA, V89, P561, DOI 10.1007/s00420-015-1107-1; Leach LS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-621; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Maki N, 2012, J EPIDEMIOL COMMUN H, V66, P302, DOI 10.1136/jech.2009.105908; Martikainen P, 2007, AM J EPIDEMIOL, V165, P1070, DOI 10.1093/aje/kwm057; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Milner A, 2014, PSYCHOL MED, V44, P909, DOI 10.1017/S0033291713001621; Milner A, 2014, OCCUP ENVIRON MED, V71, P167, DOI 10.1136/oemed-2013-101759; Mossakowski KN, 2009, AM J PUBLIC HEALTH, V99, P1826, DOI 10.2105/AJPH.2008.152561; Moustgaard H, 2013, J AFFECT DISORDERS, V148, P278, DOI 10.1016/j.jad.2012.12.008; Olesen SC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-144; Ose SO, 2015, EUR J PUBLIC HLTH; Osthus S, 2012, SOC SCI MED, V75, P946, DOI 10.1016/j.socscimed.2012.04.036; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Richards D, 2011, CLIN PSYCHOL REV, V31, P1117, DOI 10.1016/j.cpr.2011.07.004; Rueda S, 2015, AM J PUBLIC HEALTH, V102, P541; Rugulies R, 2010, J EPIDEMIOL COMMUN H, V64, P75, DOI 10.1136/jech.2008.078493; Schmitz H, 2011, LABOUR ECON, V18, P71, DOI 10.1016/j.labeco.2010.08.005; Schuring M, 2015, SCAND J WORK ENV HEA, V41, P441, DOI 10.5271/sjweh.3514; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; Skarlund M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-893; Steele F, 2013, EPIDEMIOLOGY, V24, P703, DOI 10.1097/EDE.0b013e31829d2479; Strandh M, 2014, EUR J PUBLIC HEALTH, V24, P440, DOI 10.1093/eurpub/cku005; Twisk JWR, 2003, APPL LONGITUDINAL DA; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; van Rijn RM, 2014, OCCUP ENVIRON MED, V71, P295, DOI 10.1136/oemed-2013-101591; Virtanen P, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-123	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169652	10.1371/journal.pone.0169652	http://dx.doi.org/10.1371/journal.pone.0169652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AE	28056083	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100067
J	Zhang, XQ; Xu, ZY; Pei, HS; Chen, Z; Tan, XY; Hu, J; Yang, B; Sung, JS				Zhang, Xiuqing; Xu, Zhangyang; Pei, Haisheng; Chen, Zhou; Tan, Xiaoyan; Hu, Jing; Yang, Bin; Sung, Junshe			Intraspecific Variation and Phylogenetic Relationships Are Revealed by ITS1 Secondary Structure Analysis and Single-Nucleotide Polymorphism in Ganoderma lucidum	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODE; ANTIOXIDANT ACTIVITY; GENETIC DIVERSITY; FRUITING BODIES; OIL PALM; IDENTIFICATION; POLYSACCHARIDES; SEQUENCE; MUSHROOM	Ganoderma lucidum is a typical polypore fungus used for traditional Chinese medical purposes. The taxonomic delimitation of Ganoderma lucidum is still debated. In this study, we sequenced seven internal transcribed spacer (ITS) sequences of Ganoderma lucidum strains and annotated the ITS1 and ITS2 regions. Phylogenetic analysis of ITS1 differentiated the strains into three geographic groups. Groups 1-3 were originated from Europe, tropical Asia, and eastern Asia, respectively. While ITS2 could only differentiate the strains into two groups in which Group 2 originated from tropical Asia gathered with Groups 1 and 3 originated from Europe and eastern Asia. By determining the secondary structures of the ITS1 sequences, these three groups exhibited similar structures with a conserved central core and differed helices. While compared to Group 2, Groups 1 and 3 of ITS2 sequences shared similar structures with the difference in helix 4. Large-scale evaluation of ITS1 and ITS2 both exhibited that the majority of subgroups in the same group shared the similar structures. Further Weblogo analysis of ITS1 sequences revealed two main variable regions located in helix 2 in which C/T or A/G substitutions frequently occurred and ITS1 exhibited more nucleotide variances compared to ITS2. ITS1 multi-alignment of seven spawn strains and culture tests indicated that a single-nucleotide polymorphism (SNP) site at position 180 correlated with strain antagonism. The HZ, TK and 203 fusion strains of Ganoderma lucidum had a Tat position 180, whereas other strains exhibiting antagonism, including DB, RB, JQ, and YS, had a C. Taken together, compared to ITS2 region, ITS1 region could differentiated Ganoderma lucidum into three geographic originations based on phylogenetic analysis and secondary structure prediction. Besides, a SNP in ITS 1 could delineate Ganoderma lucidum strains at the intraspecific level. These findings will be implemented to improve species quality control in the Ganoderma industry.	[Zhang, Xiuqing; Tan, Xiaoyan; Hu, Jing] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Xu, Zhangyang; Pei, Haisheng; Chen, Zhou; Sung, Junshe] Chinese Acad Agr Engn, Beijing, Peoples R China; [Xu, Zhangyang; Yang, Bin] Washington State Univ, Dept Biol Syst Engn, Richland, WA USA	China Agricultural University; Chinese Academy of Agricultural Engineering; Washington State University	Zhang, XQ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Sung, JS (corresponding author), Chinese Acad Agr Engn, Beijing, Peoples R China.	xiuningzhang@cau.edu.cn; Sunjsh61@163.com	yang, bin/AAS-9794-2020	yang, bin/0000-0003-1686-8800	National Natural Science Foundation of China [21576142]; Infinitus (China) Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Infinitus (China) Company	This study was supported by National Natural Science Foundation of China (21576142). Thanks are given to Infinitus (China) Company for the financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASKAVEG JE, 1989, MYCOL RES, V92, P182, DOI 10.1016/S0953-7562(89)80010-3; ADASKAVEG JE, 1987, MYCOLOGIA, V79, P603, DOI 10.2307/3807601; Baby S, 2015, PHYTOCHEMISTRY, V114, P66, DOI 10.1016/j.phytochem.2015.03.010; Bao DP, 2004, J WOOD SCI, V50, P162, DOI 10.1007/s10086-003-0540-z; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Byun Y, 2006, NUCLEIC ACIDS RES, V34, pW416, DOI 10.1093/nar/gkl210; Cao Y, 2013, MYCOL PROG, V12, P121, DOI 10.1007/s11557-012-0819-9; Cao Y, 2012, FUNGAL DIVERS, V56, P49, DOI 10.1007/s13225-012-0178-5; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duffy B, 2003, ANNU REV PHYTOPATHOL, V41, P501, DOI 10.1146/annurev.phyto.41.052002.095606; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferreira ICFR, 2015, PHYTOCHEMISTRY, V114, P38, DOI 10.1016/j.phytochem.2014.10.011; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao YH, 2003, FOOD REV INT, V19, P275, DOI 10.1081/FRI-120023480; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giovannetti M, 2003, APPL ENVIRON MICROB, V69, P616, DOI 10.1128/AEM.69.1.616-624.2003; Gottlieb AM, 2000, MYCOL RES, V104, P1033, DOI 10.1017/S095375620000304X; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Tran HB, 2014, MOLECULES, V19, P13473, DOI 10.3390/molecules190913473; Karsten P.A., 1881, REV MYCOL TOULOUSE, V3, P16; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Kinge TR, 2011, MYCOSPHERE, V2, P179; Kinge TR, 2012, AUST J BOT, V60, P526, DOI 10.1071/BT12011; Koetschan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091928; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Lai CSW, 2008, BRAIN RES, V1190, P215, DOI 10.1016/j.brainres.2007.10.103; Lan J., 1998, CHINESE PHARM J, V33, P714; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li Saifei, 2016, Mycology-An International Journal On Fungal Biology, V7, P74, DOI 10.1080/21501203.2016.1171805; Liao BS, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0056-7; Lin SB, 2003, LIFE SCI, V72, P2381, DOI 10.1016/S0024-3205(03)00124-3; Lin YL, 2005, J LEUKOCYTE BIOL, V78, P533, DOI 10.1189/jlb.0804481; Liu W, 2010, INT J BIOL MACROMOL, V46, P451, DOI 10.1016/j.ijbiomac.2010.02.006; Liu YF, 2014, CARBOHYD POLYM, V101, P968, DOI 10.1016/j.carbpol.2013.10.024; Liu ZG, 2016, CARBOHYD POLYM, V142, P141, DOI 10.1016/j.carbpol.2016.01.021; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Merciere M, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1123-2; Molina MC, 2005, MYCOLOGIA, V97, P454, DOI 10.3852/mycologia.97.2.454; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Moncalvo JM, 1995, MYCOL RES, V99, P1489, DOI 10.1016/S0953-7562(09)80798-3; Park DS, 1996, J AGR SCI BIOTECHNOL, V38, P251; Pilotti CA, 2002, MYCOL RES, V106, P1315, DOI 10.1017/S0953756202006755; Rambaut A., 2009, FIGTREE; Saltarelli R, 2009, FOOD CHEM, V116, P143, DOI 10.1016/j.foodchem.2009.02.023; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith BJ, 2000, MYCOL RES, V104, P943, DOI 10.1017/S0953756200002458; Szedlay Gyongyi, 2002, Acta Microbiologica et Immunologica Hungarica, V49, P235, DOI 10.1556/AMicr.49.2002.2-3.9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YJ, 2002, ENZYME MICROB TECH, V31, P20, DOI 10.1016/S0141-0229(02)00066-2; Utomo C, 2005, MYCOPATHOLOGIA, V159, P159, DOI 10.1007/s11046-004-4439-z; Wang DM, 2005, CAN J MICROBIOL, V51, P113, DOI 10.1139/W04-118; Wang DM, 2009, BOT STUD, V50, P451; Wang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34940; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Xiang L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00467; Xiang XZ, 2016, J NAT MED-TOKYO, V70, P645, DOI 10.1007/s11418-016-0995-z; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Xu ZY, 2014, J NAT MED-TOKYO, V68, P576, DOI 10.1007/s11418-014-0842-z; Yahaya NFM, 2014, TRENDS FOOD SCI TECH, V39, P104, DOI 10.1016/j.tifs.2014.06.002; Yang G, 2014, J RECEPT SIGNAL TRAN, P1; Yang Z. L., 2013, Mycology - An International Journal on Fungal Biology, V4, P1; Zheng LY, 2009, MICROBIOL RES, V164, P312, DOI 10.1016/j.micres.2007.02.002; Zhou XW, 2015, GENET MOL RES, V14, P886, DOI 10.4238/2015.February.2.12; Zhou XW, 2008, PLANTA MED, V74, P197, DOI 10.1055/s-2008-1034289	69	50	57	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169042	10.1371/journal.pone.0169042	http://dx.doi.org/10.1371/journal.pone.0169042			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056060	gold, Green Submitted, Green Published			2022-12-26	WOS:000391639100017
J	Amouzegar, A; Gharibzadeh, S; Kazemian, E; Mehran, L; Tohidi, M; Azizi, F				Amouzegar, Atieh; Gharibzadeh, Safoora; Kazemian, Elham; Mehran, Ladan; Tohidi, Maryam; Azizi, Fereidoun			The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study	PLOS ONE			English	Article							IODINE DEFICIENCY; AUTOIMMUNE-THYROIDITIS; PEROXIDASE ANTIBODIES; WHICKHAM SURVEY; FOLLOW-UP; DISEASE; COMMUNITY; HYPOTHYROIDISM; THYROGLOBULIN; HYPERTHYROIDISM	Objective Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population based study. Material and Methods This prospective study was conducted within the framework of the Tehran Thyroid Study (TTS) on 5783 (2376 men and 3407 women) individuals aged >= 20 years who had thyroid function tests at baseline and were followed up for median 9.1 year with TPOAb measurements at approximately every 3 years. Results The mean age of total population at baseline was 40.04 +/- 14.32. At baseline, of the 5783 participants, 742 (12.8%) were TPOAb positive, with higher prevalence among women than in men (16.0 vs. 8.5%, p = 0.001). The prevalence of TPOAb positivity in the total population was 11.9, 14.9 and 13.6% in the young, middle age and elderly respectively. The total incidence rate (95`)/X1) of TPOAb positivity in the total population (5020) was 7.1 (6.36-7.98) per 1000 person-years of follow-up, with higher incidence of TPOAb positivity among young participants, i.e. 8.5 (7.5-9.7) per 1000 person-years. Sex specific incidence rate demonstrated that TPOAb positivity was higher in women, 9.3 (8.2-10.7) per 1000 person-years. The Cox's proportional hazard model analysis showed that the hazard ratio of developing TPOAb positivity was higher in women than men (P<0.0001) and tended to increase slightly with serum TSH levels (P<0.0001) but declined with increasing age (P<0.0001) in the total population. Our findings demonstrate that individuals, who became TPOAb positive in each phase, had significant elevation of TSH levels at the phase of seroconversion, compared to baseline values. Conclusion Gender, age and elevated serum TSH were found to be risk factors for developing TPOAb positivity. Furthermore, compared to baseline a significant elevation of TSH levels during seroconversion phase was observed in TPOAb positive individuals.	[Amouzegar, Atieh; Gharibzadeh, Safoora; Kazemian, Elham; Mehran, Ladan; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Gharibzadeh, Safoora] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Tohidi, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Azizi, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.	azizi@endocrine.ac.ir	Tohidi, Maryam/V-2261-2019; Azizi, Fereidoun/ABD-4136-2021; Kazemian, Elham/CAG-0678-2022; Gharibzadeh, Safoora/J-9914-2017; Amouzegar, Atieh/K-1551-2017	Azizi, Fereidoun/0000-0002-6470-2517; Gharibzadeh, Safoora/0000-0003-4535-4040; Amouzegar, Atieh/0000-0001-9433-9408; amouzegar, atieh/0000-0003-1046-0003	Shaheed Beheshti University of Medical Science	Shaheed Beheshti University of Medical Science	This study was granted by Shaheed Beheshti University of Medical Science.	Aghini-Lombardi F, 1999, J CLIN ENDOCR METAB, V84, P561, DOI 10.1210/jc.84.2.561; Allahabadia A, 1999, J ENDOCRINOL, V163, P7, DOI 10.1677/joe.0.1630007; Amouzegar A, 2013, J ENDOCRINOL INVEST, V36, P950, DOI 10.3275/9033; Azizi F, 2013, ARCH IRAN MED, V16, P418, DOI 013167/AIM.0011; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; Brix TH, 1998, CLIN ENDOCRINOL, V48, P397; Bryhni B, 1996, J INTERN MED, V239, P517, DOI 10.1046/j.1365-2796.1996.488823000.x; Delshad H, 2012, THYROID, V22, P415, DOI 10.1089/thy.2011.0156; Gey A, 2013, BRIT J DERMATOL, V168, P756, DOI 10.1111/bjd.12166; Ghoraishian Seyed Mohammad, 2006, Iran J Immunol, V3, P146, DOI IJIv3i3A8; Heydarian P, 2002, IRANIAN J ENDOCRINOL, V4, P229; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; HOOPER B, 1972, CLIN EXP IMMUNOL, V12, P79; Kabelitz M, 2003, EUR J ENDOCRINOL, V148, P301, DOI 10.1530/eje.0.1480301; Knudsen N, 1999, CLIN ENDOCRINOL, V51, P361, DOI 10.1046/j.1365-2265.1999.00816.x; LAURBERG P, 1987, J CLIN ENDOCR METAB, V64, P969, DOI 10.1210/jcem-64-5-969; Li YS, 2008, J CLIN ENDOCR METAB, V93, P1751, DOI 10.1210/jc.2007-2368; Pedersen IB, 2003, CLIN ENDOCRINOL, V58, P36, DOI 10.1046/j.1365-2265.2003.01633.x; Saboori AM, 1998, CLIN EXP IMMUNOL, V113, P297; SAFRAN M, 1987, ENDOCRIN METAB CLIN, V16, P327, DOI 10.1016/S0889-8529(18)30482-1; Shin JI, 2009, J RHEUMATOL, V36, P449, DOI 10.3899/jrheum.080725; Strieder TGA, 2008, ARCH INTERN MED, V168, P1657, DOI 10.1001/archinte.168.15.1657; Swain M, 2005, INDIAN J CLIN BIOCHE, V20, P9, DOI 10.1007/BF02893034; TUNBRIDGE WMG, 1981, BRIT MED J, V282, P258, DOI 10.1136/bmj.282.6260.258; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; Zaletel K, 2011, CURR GENOMICS, V12, P576, DOI 10.2174/138920211798120763	30	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169283	10.1371/journal.pone.0169283	http://dx.doi.org/10.1371/journal.pone.0169283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052092	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500041
J	Grange, LJ; Smith, CR; Lindsay, DJ; Bentlage, B; Youngbluth, MJ				Grange, Laura J.; Smith, Craig R.; Lindsay, Dhugal J.; Bentlage, Bastian; Youngbluth, Marsh J.			High Abundance of the Epibenthic Trachymedusa Ptychogastria polaris Allman, 1878 (Hydrozoa, Trachylina) in Subpolar Fjords along the West Antarctic Peninsula	PLOS ONE			English	Article							BENTHIC BOUNDARY-LAYER; GELATINOUS ZOOPLANKTON; NORTHEAST GREENLAND; OXYGEN-CONSUMPTION; SUBMARINE CANYONS; CNIDARIA HYDROZOA; BARENTS SEA; SP NOV.; WATER; HYDROMEDUSAE	Medusae can be conspicuous and abundant members of seafloor communities in deep-sea benthic boundary layers. The epibenthic trachymedusa, Ptychogastria polaris Allman, 1878 (Hydrozoa: Trachylina: Ptychogastriidae) occurs in the cold, high latitude systems of both the northern and southern hemispheres, with a circumpolar distribution in Arctic and sub Arctic areas, and disjunct reports of a few individuals from Antarctica. In January-February 2010, during benthic megafaunal photosurveys in three subpolar fjords along the West Antarctic Peninsula (Andvord, Flandres and Barilari Bays), P. polaris was recorded in Antarctic Peninsula waters. The trachymedusa, identified from megacore-collected specimens, was a common component of the epifauna in the sediment floored basins at 436-725 m depths in Andvord and Flandres Bays, reaching densities up to 13 m(-2), with mean densities in individual basins ranging from 0.06 to 4.19 m(-2). These densities are 2 to 400-fold higher than previously reported for P. polaris in either the Arctic or Antarctic. This trachymedusa had an aggregated distribution, occurring frequently in Andvord Bay, but was often solitary in Flandres Bay, with a distribution not significantly different from random. Epibenthic individuals were similar in size, typically measuring 15-25 mm in bell diameter. A morphologically similar trachymedusa, presumably the same species, was also observed in the water column near the bottom in all three fjords. This benthopelagic form attained abundances of up to 7 m(-2) of seafloor; however, most P. polaris (similar to 80%), were observed on soft sediments. Our findings indicate that fjords provide a prime habitat for the development of dense populations of P. polaris, potentially resulting from high and varied food inputs to the fjord floors. Because P. polaris resides in the water column and at the seafloor, large P. polaris populations may contribute significantly to pelagic-benthic coupling in the WAP fjord ecosystems.	[Grange, Laura J.; Smith, Craig R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Lindsay, Dhugal J.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Natsushima Cho, Yokosuka, Kanagawa, Japan; [Bentlage, Bastian] Natl Museum Nat Hist, Dept Invertebrate Zool, Smithsonian Inst, Washington, DC 20560 USA; [Youngbluth, Marsh J.] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL USA; [Grange, Laura J.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Bentlage, Bastian] Univ Guam Marine Lab, UOG Stn, Mangilao, GU USA	University of Hawaii System; University of Hawaii Manoa; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Smithsonian Institution; Smithsonian National Museum of Natural History; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; NERC National Oceanography Centre; University of Southampton; University of Guam	Grange, LJ (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.; Grange, LJ (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England.	L.J.Grange@noc.soton.ac.uk	Grange, Laura/E-8495-2014	Grange, Laura/0000-0001-9222-6848	Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA [OPP-0732711]; Smithsonian Peter Buck postdoctoral fellowship; Office of Integrative Activities [1457769] Funding Source: National Science Foundation	Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA; Smithsonian Peter Buck postdoctoral fellowship; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This material is based upon work supported by the Office of Polar Programs (OPP), United States National Science Foundation under the LARISSA Project OPP-0732711 to C.R.S. B.B. wishes to acknowledge support through a Smithsonian Peter Buck postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman G. J., 1878, P290; ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; [Anonymous], 2005, SYST BIODIVERS, DOI [DOI 10.1017/S1477200004001513, 10.1017/S1477200004001513]; [Anonymous], 1995, GLACIAL ENV; Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; BOERO F, 1991, ZOOL J LINN SOC-LOND, V101, P189, DOI 10.1111/j.1096-3642.1991.tb00893.x; Boero F, 1996, TRENDS ECOL EVOL, V11, P177, DOI 10.1016/0169-5347(96)20007-2; Boldt KV, 2013, J GEOPHYS RES-EARTH, V118, P2072, DOI 10.1002/jgrf.20145; Bouillon J, 2000, SCI MAR, V64, P87, DOI 10.3989/scimar.2000.64s187; Bouillon J, 2001, POLAR BIOL, V24, P839, DOI 10.1007/s003000100289; Bouillon J, 2006, MEMOIRES NATL HIST N, V194; Breder CM., ZOOL SCI CONTRIB NY, V41, P13; Cantero ALP, 2004, POLAR BIOL, V27, P767, DOI 10.1007/s00300-004-0654-9; Cartes JE, 1998, PROG OCEANOGR, V41, P111, DOI 10.1016/S0079-6611(98)00018-4; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHILDRESS JJ, 1989, LIMNOL OCEANOGR, V34, P913, DOI 10.4319/lo.1989.34.5.0913; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOMACK EW, 1993, GEOL SOC AM BULL, V105, P1175, DOI 10.1130/0016-7606(1993)105<1175:OAPCOM>2.3.CO;2; Elliott J. M., 1983, FRESHWATER BIOL ASS, V25; Fuentes V, 2006, J PLANKTON RES, V28, P959, DOI 10.1093/plankt/fbl025; Galea HR, 2016, EUR J TAXON, V252, P1, DOI 10.5852/ejt.2016.252; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gili JM, 2006, MAR ECOL PROG SER, V322, P43, DOI 10.3354/meps322043; Gili JM, 1998, SCI MAR, V62, P113; Gili JM, 1999, ZOOL J LINN SOC-LOND, V125, P313, DOI 10.1006/zjls.1997.0107; Gili JM, 2000, DEEP-SEA RES PT I, V47, P1513, DOI 10.1016/S0967-0637(99)00119-3; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Grossmann MM, 2013, MAR ECOL-EVOL PERSP, V34, P63, DOI 10.1111/maec.12026; Grossmann MM, 2012, POLAR SCI, V6, P196, DOI 10.1016/j.polar.2011.11.001; Haeckel E., 1881, MONOGRAPHIE MEDUSEN; HAECKEL E, 1879, SYSTEM MEDUSEN 1 THE; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Hosia A, 2007, MAR BIOL, V151, P177, DOI 10.1007/s00227-006-0466-2; HOSIE GW, 1994, MAR ECOL PROG SER, V106, P21, DOI 10.3354/meps106021; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koppes M, 2015, NATURE, V526, P100, DOI 10.1038/nature15385; Kramp P. L., 1947, Danish Ingolf-Expedition, V5, P1; Kramp P. L., 1957, Discovery Reports, V29, P1; Kramp P.L., 1942, GODTHAAB EXPEDITION, V81, P1; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; LARSON R J, 1986, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P191; LARSON RJ, 1992, B MAR SCI, V51, P277; Lindsay Dhugal, 2014, P266; Lindsay D, 2010, ZOOTAXA, P31; Lindsay Dhugal J., 2007, Plankton & Benthos Research, V2, P98, DOI 10.3800/pbr.2.98; Maas O, 1906, FAUNA ARCTICA, V4, P479; MACKIE GO, 1985, J PLANKTON RES, V7, P753, DOI 10.1093/plankt/7.6.753; Maddison W.P., 2016, MESQUITE MODULAR SYS; Matsumoto GI, 1997, INVERTEBR BIOL, V116, P17, DOI 10.2307/3226920; Miyake Hiroshi, 2005, Plankton Biology and Ecology, V52, P58; Miyake Hiroshi, 2004, JAMSTEC Journal of Deep Sea Research, V24, P37; Miyake Hiroshi, 2002, Plankton Biology and Ecology, V49, P44; Munoz YP, 2014, GSA ANN M VANC BRIT; NaumoV D. V., 1960, Opredeliteli Faune SSSR Izdav zool Inst Akad Nauk SSSR, V70, P1; PAGES F, 1994, POLAR BIOL, V14, P243; Pages F, 1997, ANN I OCEANOGR PARIS, V73, P139; Panteleeva NN, 1999, POLAR BIOL, V22, P372, DOI 10.1007/s003000050431; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Piepenburg D, 1996, MAR BIOL, V125, P321, DOI 10.1007/BF00346313; Piepenburg D, 1996, POLAR BIOL, V16, P383, DOI 10.1007/BF02390420; Purcell JE, 2000, MAR ECOL PROG SER, V195, P145, DOI 10.3354/meps195145; Rasband WS., 1997, SOFTWARE SYSTEM; Raskoff KA, 2010, DEEP SEA RES 2, V57, P111; Ronowicz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120204; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schnack-Schiel SB, 2005, SCI MAR, V69, P39, DOI 10.3989/scimar.2005.69s239; Sirenko BI, 1996, POLAR BIOL, V16, P345; SMITH KL, 1982, LIMNOL OCEANOGR, V27, P461, DOI 10.4319/lo.1982.27.3.0461; Sokal R.R., 2012, BIOMETRY; Stepanjants SD, 2006, MAR BIOL RES, V2, P200, DOI 10.1080/17451000600781767; Stepanjants S.D., 1989, P397; Stubing D, 1998, POLAR BIOL, V19, P193, DOI 10.1007/s003000050234; Sweetman AK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2210; Sweetman AK, 2011, DEEP-SEA RES PT I, V58, P1206, DOI 10.1016/j.dsr.2011.08.006; Toyokawa M, 2003, DEEP-SEA RES PT I, V50, P809, DOI 10.1016/S0967-0637(03)00056-6; Vanhoffen E, 1912, DTSCH SUDPOLAR EXPED, V13, P351; Zamponi M., 1985, HIST NAT, V5, P269; Zheng LM, 2014, ACTA OCEANOL SIN, V33, P55, DOI 10.1007/s13131-014-0415-8	84	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168648	10.1371/journal.pone.0168648	http://dx.doi.org/10.1371/journal.pone.0168648			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052087	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000391621500020
J	Hyam, R				Hyam, Roger			Automated Image Sampling and Classification Can Be Used to Explore Perceived Naturalness of Urban Spaces	PLOS ONE			English	Article							GREEN SPACE; ENVIRONMENTS; BENEFITS; STRESS	The psychological restorative effects of exposure to nature are well established and extend to just viewing of images of nature. A previous study has shown that Perceived Naturalness (PN) of images correlates with their restorative value. This study tests whether it is possible to detect degree of PN of images using an image classifier. It takes images that have been scored by humans for PN (including a subset that have been assessed for restorative value) and passes them through the Google Vision API image classification service. The resulting labels are assigned to broad semantic classes to create a Calculated Semantic Naturalness (CSN) metric for each image. It was found that CSN correlates with PN. CSN was then calculated for a geospatial sampling of Google Street View images across the city of Edinburgh. CSN was found to correlate with PN in this sample also indicating the technique may be useful in large scale studies. Because CSN correlates with PN which correlates with restorativeness it is suggested that CSN or a similar measure may be useful in automatically detecting restorative images and locations. In an exploratory aside CSN was not found to correlate with an indicator of socioeconomic deprivation.	[Hyam, Roger] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland		Hyam, R (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	r.hyam@rbge.org.uk			Scottish Government	Scottish Government	This work was supported by grant in aid funding to the Royal Botanic Garden Edinburgh from the Scottish Government as part of our contribution to the Edinburgh Living Landscape and Scotland's Biodiversity Strategy particularly Big Step 3: Quality Greenspace for Health and Education Benefits providing the evidence to deliver Priority Project 5: More People Experiencing and Enjoying Nature and Priority Project 7: Developing Scotland's Natural Health Service.	[Anonymous], 2012, SCOTT IND MULT DEP 2; Berman MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114572; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Berto R, 2014, BEHAV SCI, V4, P394, DOI 10.3390/bs4040394; James P., 2016, ENV HLTH PERSPECT; Kaplan R, 1989, EXPERIENCE NATURE PS; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Lin YH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00906; Mitchell R, 2011, J EPIDEMIOL COMMUN H, V65, P853, DOI 10.1136/jech.2010.119172; Pasini M, 2014, PROCD SOC BEHV, V159, P293, DOI 10.1016/j.sbspro.2014.12.375; Roe J, 2011, HEALTH PLACE, V17, P103, DOI 10.1016/j.healthplace.2010.09.003; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]	14	20	20	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169357	10.1371/journal.pone.0169357	http://dx.doi.org/10.1371/journal.pone.0169357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2TP	28052110	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500053
J	Qiu, YL; Zhang, YY; Hu, N; Dong, F				Qiu, Yaling; Zhang, Yangyang; Hu, Nan; Dong, Fan			A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell differentiation; cell surface receptor; leukemia; neutrophil	SEVERE CONGENITAL NEUTROPENIA; DISTINCT CYTOPLASMIC REGIONS; UNFOLDED PROTEIN RESPONSE; PLURIPOTENT STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PREMATURE APOPTOSIS; MUTATIONS; ACTIVATION; GENE; MICE	Mutations in ELANE encoding neutrophil elastase (NE) have been identified in the majority of patients with severe congenital neutropenia (SCN). The NE mutants have been shown to activate unfolded protein response and induce premature apoptosis in myeloid cells. Patients with SCN are predisposed to acute myeloid leukemia (AML), and progression from SCN to AML is accompanied by mutations in CSF3R encoding the granulocyte colony-stimulating factor receptor (G-CSFR) in approximate to 80% of patients. The mutations result in the expression of C-terminally truncated G-CSFRs that promote strong cell proliferation and survival. It is unknown why the CSF3R mutations, which are rare in de novo AML, are so prevalent in SCN/AML. We show here that a G-CSFR mutant, d715, derived from an SCN patient inhibited G-CSF-induced expression of NE in a dominant negative manner. Furthermore, G-CSFR d715 suppressed unfolded protein response and apoptosis induced by an SCN-derived NE mutant, which was associated with sustained activation of AKT and STAT5, and augmented expression of BCL-XL. Thus, the truncated G-CSFRs associated with SCN/AML may protect myeloid precursor cells from apoptosis induced by the NE mutants. We propose that acquisition of CSF3R mutations may represent a mechanism by which myeloid precursor cells carrying the ELANE mutations evade the proapoptotic activity of the NE mutants in SCN patients.	[Qiu, Yaling; Zhang, Yangyang; Hu, Nan; Dong, Fan] Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Dong, F (corresponding author), Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA.	fan.dong@utoledo.edu	zhang, yangyang/GZG-7467-2022		National Institutes of Health [R15HL112183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant R15HL112183 (to F. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aprikyan AAG, 2003, EXP HEMATOL, V31, P372, DOI 10.1016/S0301-472X(03)00048-1; Beel K, 2009, HAEMATOL-HEMATOL J, V94, P1449, DOI 10.3324/haematol.2009.009001; Bellanne-Chantelot C, 2004, BLOOD, V103, P4119, DOI 10.1182/blood-2003-10-3518; Carapeti M, 1997, LEUKEMIA, V11, P1005, DOI 10.1038/sj.leu.2400697; Cassinat B, 2004, LEUKEMIA, V18, P1553, DOI 10.1038/sj.leu.2403431; Debierre-Grockiego F, 2004, APOPTOSIS, V9, P717, DOI 10.1023/B:APPT.0000045785.65546.a2; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dong F, 1997, LEUKEMIA, V11, P120, DOI 10.1038/sj.leu.2400537; Dong F, 1998, J IMMUNOL, V161, P6503; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Gits J, 2006, LEUKEMIA, V20, P2111, DOI 10.1038/sj.leu.2404448; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Grenda DS, 2002, BLOOD, V100, P3221, DOI 10.1182/blood-2002-05-1372; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Hu N, 2015, J BIOL CHEM, V290, P24561, DOI 10.1074/jbc.M115.668871; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Klimiankou M, 2016, BLOOD, V127, P2638, DOI 10.1182/blood-2015-12-685784; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Lavallee VP, 2016, BLOOD, V127, P3054, DOI 10.1182/blood-2016-03-705053; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Liu H, 2006, J IMMUNOL, V176, P2407, DOI 10.4049/jimmunol.176.4.2407; Massullo P, 2005, BLOOD, V105, P3397, DOI 10.1182/blood-2004-07-2618; Maxson JE, 2016, BLOOD, V127, P3094, DOI 10.1182/blood-2016-04-709899; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Sano H, 2015, BRIT J HAEMATOL, V170, P391, DOI 10.1111/bjh.13439; Sehgal Pravin B, 2013, JAKSTAT, V2, pe24860, DOI 10.4161/jkst.24860; Tidow N, 1997, BLOOD, V89, P2369, DOI 10.1182/blood.V89.7.2369; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Xia J, 2009, BRIT J HAEMATOL, V147, P535, DOI 10.1111/j.1365-2141.2009.07888.x; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; Zhuang DZ, 2006, J BIOL CHEM, V281, P10745, DOI 10.1074/jbc.M510924200; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032	50	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3496	3505		10.1074/jbc.M116.755157	http://dx.doi.org/10.1074/jbc.M116.755157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073911	hybrid, Green Published			2022-12-26	WOS:000395538800037
J	Tuz, K; Li, C; Fang, X; Raba, DA; Liang, PD; Minh, DDL; Juarez, O				Tuz, Karina; Li, Chen; Fang, Xuan; Raba, Daniel A.; Liang, Pingdong; Minh, David D. L.; Juarez, Oscar			Identification of the Catalytic Ubiquinone-binding Site of Vibrio cholerae Sodium-dependent NADH Dehydrogenase A NOVEL UBIQUINONE-BINDING MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING NADH; PUMPING NADHQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; NADHUBIQUINONE OXIDOREDUCTASE; NADH/QUINONE OXIDOREDUCTASE; RHODOBACTER-SPHAEROIDES; PROSTHETIC GROUPS; REDOX PROPERTIES; SUBUNIT B	The sodium-dependent NADH dehydrogenase (Na+-NQR) is a key component of the respiratory chain of diverse prokaryotic species, including pathogenic bacteria. Na+-NQR uses the energy released by electron transfer between NADH and ubiquinone (UQ) to pump sodium, producing a gradient that sustains many essential homeostatic processes as well as virulence factor secretion and the elimination of drugs. The location of the UQ binding site has been controversial, with two main hypotheses that suggest that this site could be located in the cytosolic subunit A or in the membrane-bound subunit B. In this work, we performed alanine scanning mutagenesis of aromatic residues located in transmembrane helices II, IV, and V of subunit B, near glycine residues 140 and 141. These two critical glycine residues form part of the structures that regulate the site's accessibility. Our results indicate that the elimination of phenylalanine residue 211 or 213 abolishes the UQ-dependent activity, produces a leak of electrons to oxygen, and completely blocks the binding of UQ and the inhibitor HQNO. Molecular docking calculations predict that UQ interacts with phenylalanine 211 and pinpoints the location of the binding site in the interface of subunits B and D. The mutagenesis and structural analysis allow us to propose a novel UQ-binding motif, which is completely different compared with the sites of other respiratory photosynthetic complexes. These results are essential to understanding the electron transfer pathways and mechanism of Na+-NQR catalysis.	IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Li, Chen; Minh, David D. L.] IIT, Dept Chem, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Juarez, O (corresponding author), IIT, Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022; Minh, David/A-4655-2009	Fang, Xuan/0000-0001-6394-4015; Minh, David/0000-0002-4802-2618; Liang, Pingdong/0000-0002-8950-5755; Tuz, Karina/0000-0002-1669-4612; Juarez, Oscar/0000-0002-2915-8413	Illinois Institute of Technology start up funds; National Institutes of Health [R15GM114781]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114781] Funding Source: NIH RePORTER	Illinois Institute of Technology start up funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Illinois Institute of Technology start up funds (to O. J. and D. D. L. M.) and by National Institutes of Health Grant R15GM114781 (to D. D. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afri M, 2004, CHEM PHYS LIPIDS, V131, P123, DOI 10.1016/j.chemphyslip.2004.04.006; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; CROFTS A, 1992, BIOCHIM BIOPHYS ACTA, V1101, P162, DOI 10.1016/S0005-2728(05)80009-X; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hauss T, 2005, BBA-BIOENERGETICS, V1710, P57, DOI 10.1016/j.bbabio.2005.08.007; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; KLESS H, 1995, J MOL BIOL, V246, P120, DOI 10.1006/jmbi.1994.0071; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; Steuber J, 2015, BIOL CHEM, V396, P1015, DOI 10.1515/hsz-2015-0128; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3039	3048		10.1074/jbc.M116.770982	http://dx.doi.org/10.1074/jbc.M116.770982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053088	Green Published, hybrid			2022-12-26	WOS:000395535100042
J	Rahaman, KR; Hassan, QK				Rahaman, Khan Rubayet; Hassan, Quazi K.			Quantification of Local Warming Trend: A Remote Sensing-Based Approach	PLOS ONE			English	Article							SURFACE-TEMPERATURE; CLIMATE; PHENOLOGY; CANADA; REGION	Understanding the warming trends at local level is critical; and, the development of relevant adaptation and mitigation policies at those levels are quite challenging. Here, our overall goal was to generate local warming trend map at 1 km spatial resolution by using: (i) Moderate Resolution Imaging Spectroradiometer (MODIS)-based 8-day composite surface temperature data; (ii) weather station-based yearly average air temperature data; and (iii) air temperature normal (i.e., 30 year average) data over the Canadian province of Alberta during the period 1961-2010. Thus, we analysed the station-based air temperature data in generating relationships between air temperature normal and yearly average air temperature in order to facilitate the selection of year-specific MODIS-based surface temperature data. These MODIS data in conjunction with weather station-based air temperature normal data were then used to model local warming trends. We observed that almost 88% areas of the province experienced warming trends (i.e., up to 1.5 degrees C). The study concluded that remote sensing technology could be useful for delineating generic trends associated with local warming.	[Rahaman, Khan Rubayet; Hassan, Quazi K.] Univ Calgary, Dept Geomat Engn, 2500 Univ Dr NW, Calgary, AB, Canada	University of Calgary	Hassan, QK (corresponding author), Univ Calgary, Dept Geomat Engn, 2500 Univ Dr NW, Calgary, AB, Canada.	qhassan@ucalgary.ca		Hassan, Quazi K./0000-0002-7034-359X	Alberta Innovates Technology Future (AITF) Fellowship; University Research Grants Committee (URGC) of the University of Calgary; NSERC Discovery Grant	Alberta Innovates Technology Future (AITF) Fellowship; University Research Grants Committee (URGC) of the University of Calgary; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to acknowledge the following funding sources: (i) Alberta Innovates Technology Future (AITF) Fellowship to K. Rahaman, (ii) University Research Grants Committee (URGC) of the University of Calgary to Q. Hassan, and (iii) NSERC Discovery Grant to Q. Hassan.; The authors would like to acknowledge the following funding sources: (i) Alberta Innovates Technology Future (AITF) Fellowship to K. Rahaman, (ii) University Research Grants Committee (URGC) of the University of Calgary to Q. Hassan, and (iii) NSERC Discovery Grant to Q. Hassan. Additionally, the authors also acknowledge NASA and Environment Canada for providing MODIS and climate data respectively at free of cost.	Agarwal S, 2016, URBAN SUBURBAN REGIO; Akther MS, 2011, BOREAL ENVIRON RES, V16, P407; Beyer HL., 2015, GEOSPATIAL MODELING; Bourque CPA, 2008, FOREST CHRON, V84, P553, DOI 10.5558/tfc84553-4; Chiles P, 2012, GEOSTATISTICS MODELI; Chung U, 2004, CLIMATIC CHANGE, V66, P127, DOI 10.1023/B:CLIM.0000043136.58100.ce; Downing J, 2006, NATURAL REGIONS SUBR; Erdogan S, 2009, EARTH SURF PROC LAND, V34, P366, DOI 10.1002/esp.1731; Fritzsche J., 2013, TEMPERATURE TRENDS C; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hassan QK, 2007, SENSORS-BASEL, V7, P2028, DOI 10.3390/s7102028; Hassan QK, 2013, J PLANT ECOL, V6, P84, DOI 10.1093/jpe/rts010; Jarvis CH, 2001, J APPL METEOROL, V40, P1060, DOI 10.1175/1520-0450(2001)040<1060:ACASFI>2.0.CO;2; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Mahlstein I, 2012, GEOPHYS RES LET, V39, P1; Martellozzo F, 2015, REG ENVIRON CHANGE, V15, P881, DOI 10.1007/s10113-014-0658-0; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; Mears A, 2012, J GEOPHYS RES, V117, P19; Menne MJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013094; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Nalder IA, 1998, AGR FOREST METEOROL, V92, P211, DOI 10.1016/S0168-1923(98)00102-6; Osborn TJ, 2014, EARTH SYST SCI DATA, V6, P61, DOI 10.5194/essd-6-61-2014; Santer BD, 2008, INT J CLIMATOL, V28, P1703, DOI 10.1002/joc.1756; Santer BD, 2013, P NATL ACAD SCI USA, V110, P26, DOI 10.1073/pnas.1210514109; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Scott D, 2007, TOURISM MANAGE, V28, P570, DOI 10.1016/j.tourman.2006.04.020; Sekhon NS, 2014, SOC EARTH SCI SER, P3, DOI 10.1007/978-3-319-05906-8_1; Statistics Canada, 2016, PROV WIS DEM INF; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Vanderbei RJ, 2012, SIAM REV, V54, P597, DOI 10.1137/110827296; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Weng QH, 2009, ISPRS J PHOTOGRAMM, V64, P335, DOI 10.1016/j.isprsjprs.2009.03.007; WMO, 2013, 892 WMO; Yang J, 2013, NAT CLIM CHANGE, V3, P875, DOI [10.1038/nclimate1908, 10.1038/NCLIMATE1908]; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	36	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169423	10.1371/journal.pone.0169423	http://dx.doi.org/10.1371/journal.pone.0169423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072857	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200021
J	El-Araby, ME; Omar, AM; Khayat, MT; Assiri, HA; Al-Abd, AM				El-Araby, Moustafa E.; Omar, Abdelsattar M.; Khayat, Maan T.; Assiri, Hanan A.; Al-Abd, Ahmed M.			Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel	PLOS ONE			English	Article							CANCER DRUG-RESISTANCE; SOLID TUMORS; CURCUMIN; ABCB1; GENE; TRANSPORTERS; CHEMOTHERAPY; MODULATION; DISCOVERY; ANALOGS	P-glycoprotein (Pgp) is a membrane bound efflux pump spread in a variety of tumor cells and considered as a main component of multidrug resistance (MDR) to chemotherapies. In this work, three groups of compounds (imidazolone, oxazolone and vinyl dipeptide derivatives) were synthesized aiming to develop a molecular framework that effectively suppresses MDR. When tested for their influence on Pgp activity, four compounds coded Cur1-01, Cur1-12V, Curox-1 and Curox-3 significantly decreased remaining ATP concentration indicating Pgp substrate site blocking. On the other hand, Cur-3 and Cur-10 significantly increased remaining ATP concentration, which is indicative of Pgp ATPase inhibition. The cytotoxicity of synthesized compounds was examined against Pgp expressing/highly resistant colorectal cancer cell lines (LS-174T). Compounds Cur-1 and Cur-3 showed considerable cytotoxicity with IC50 values of 7.6 and 8.9 mu M, respectively. Equitoxic combination (at IC50 concentrations) of PTX and Cur-3 greatly diminished resistant cell clone from 45.7% to 2.5%, albeit with some drop in potency from IC50 of 7.9 nM to IC50 of 23.8 nM. On the other hand, combination of PTX and the non-cytotoxic Cur1-12V (10 mu M) significantly decreased the IC50 of PTX to 3.8 nM as well as the resistant fraction to 16.2%. The combination test was confirmed using the same protocol but on another resistant CRC cell line (HCT-116) as we obtained similar results. Both Cur-3 and Cur1-12V (10 mu M) significantly increased the cellular entrapment of Pgp probe (doxorubicin) elevating its intracellular concentration from 1.9 pmole/cell to 3.0 and 2.9 pmole/cell, respectively.	[El-Araby, Moustafa E.; Omar, Abdelsattar M.; Khayat, Maan T.] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut Chem, Jeddah, Saudi Arabia; [El-Araby, Moustafa E.] Helwan Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Cairo, Egypt; [Omar, Abdelsattar M.] Al Azhar Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt; [Assiri, Hanan A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Al-Abd, Ahmed M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia; [Al-Abd, Ahmed M.] Natl Res Ctr, Div Med, Dept Pharmacol, Cairo, Egypt	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); Al Azhar University; King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	El-Araby, ME (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut Chem, Jeddah, Saudi Arabia.; El-Araby, ME (corresponding author), Helwan Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Cairo, Egypt.	madaoud@kau.edu.sa	khayat, maan/P-6138-2015; El-Araby, Moustafa/J-6827-2012; Omar, Abdelsattar Mansour Ebeid/AAM-4319-2020; , Moustafa/ABD-1860-2020; Al-Abd, Ahmed/J-2826-2012; Omar, Abdelsattar/I-1427-2012	khayat, maan/0000-0002-9979-0481; El-Araby, Moustafa/0000-0002-7932-2226; , Moustafa/0000-0002-7932-2226; Al-Abd, Ahmed/0000-0001-7872-4867; Omar, Abdelsattar/0000-0002-9825-3465	Deanship of Scientific Research (DSR), at King Abdulaziz University, Jeddah, Saudi Arabia [G-416-166-36]; DSR	Deanship of Scientific Research (DSR), at King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This Project was funded by the Deanship of Scientific Research (DSR), at King Abdulaziz University, Jeddah, Saudi Arabia, under grant no. G-416-166-36. The authors, therefore, acknowledge with thanks DSR for technical and financial support, http//dsr.kau.edu.sa/Default.aspx?Site_ID=305&Lng=EN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah HM, 2015, J ADV RES, V6, P45, DOI 10.1016/j.jare.2014.11.008; Aboul-Enein AM, 2011, PLANT SIGNAL BEHAV, V6, P834, DOI 10.4161/psb.6.6.15166; Aggarwal BB, 2007, MOL TARGETS THERAPEU; Al-Abd AM, 2015, J CONTROL RELEASE, V219, P269, DOI 10.1016/j.jconrel.2015.08.055; Al-Abd AM, 2013, EUR J PHARMACOL, V718, P361, DOI 10.1016/j.ejphar.2013.08.009; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; BADR MZ, 1982, B CHEM SOC JPN, V55, P2267, DOI 10.1246/bcsj.55.2267; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chearwae W, 2004, BIOCHEM PHARMACOL, V68, P2043, DOI 10.1016/j.bcp.2004.07.009; Chen GK, 2002, GENE CHROMOSOME CANC, V34, P372, DOI 10.1002/gcc.10067; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Davis A J, 2000, Lancet Oncol, V1, P86, DOI 10.1016/S1470-2045(00)00019-X; Di Martino RMC, 2016, J MED CHEM, V59, P531, DOI 10.1021/acs.jmedchem.5b00894; El-Araby M, 2012, MOLECULES, V17, P12262, DOI 10.3390/molecules171012262; Farrell A, 2011, NAT MED, V17, P262, DOI 10.1038/nm0311-262; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jang SH, 2001, INVEST NEW DRUG, V19, P113, DOI 10.1023/A:1010662413174; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Karthikeyan S, 2015, ANTI-CANCER AGENT ME, V15, P605, DOI 10.2174/1871520615666150113103439; KASSAB NA, 1978, Z NATURFORSCH B, V33, P1145; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Khan KM, 2006, BIOORGAN MED CHEM, V14, P6027, DOI 10.1016/j.bmc.2006.05.014; Kim YK, 2007, BIOCHEM BIOPH RES CO, V355, P136, DOI 10.1016/j.bbrc.2007.01.117; Lee CY, 2012, TETRAHEDRON, V68, P5898, DOI 10.1016/j.tet.2012.04.102; Limtrakul P, 2007, ADV EXP MED BIOL, V595, P269; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Mahmoud AM, 2012, J ENZYM INHIB MED CH, V27, P673, DOI 10.3109/14756366.2011.607446; Mittra R, 2016, JUST DOES P GLYCOPRO, P153; MUKERJEE AK, 1993, INDIAN J CHEM B, V32, P973; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Nawwar MA, 2012, FITOTERAPIA, V83, P1256, DOI 10.1016/j.fitote.2012.06.007; NEYFAKH AA, 1988, EXP CELL RES, V174, P168, DOI 10.1016/0014-4827(88)90152-8; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P16; Sameen S, 2016, J THEOR BIOL, V389, P263, DOI 10.1016/j.jtbi.2015.10.019; Sikic BI, 1997, CANCER CHEMOTH PHARM, V40, pS13, DOI 10.1007/s002800051055; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sun XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22498; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Thomas Hilary, 2003, Cancer Control, V10, P159; UEDA K, 1987, J BIOL CHEM, V262, P505; Vyas A, 2013, CURR PHARM DESIGN, V19, P2047; Wang JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22146; WILSON WH, 1995, J CLIN ONCOL, V13, P1985, DOI 10.1200/JCO.1995.13.8.1985; Zhan AR, 1997, CANCER CHEMOTH PHARM, V40, P245, DOI 10.1007/s002800050654	53	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168938	10.1371/journal.pone.0168938	http://dx.doi.org/10.1371/journal.pone.0168938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068430	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900016
J	Stone, RP; Malecha, PW; Masuda, MM				Stone, Robert P.; Malecha, Patrick W.; Masuda, Michele M.			A Five-Year, In Situ Growth Study on Shallow-Water Populations of the Gorgonian Octocoral Calcigorgia spiculifera in the Gulf of Alaska	PLOS ONE			English	Article							DEEP-SEA; HABITAT; CORAL; AGE; ASSOCIATIONS; RATES	Gorgonian octocorals are the most abundant corals in Alaska where they provide important structural habitat for managed species of demersal fish and invertebrates. Fifty-nine gorgonian species have been reported from Alaska waters but little is known about their life history characteristics to help us gauge their ability to recover from seafloor disturbance. Colonies of the holaxonian Calcigorgia spiculifera were tagged beginning in 1999 at three sites in Chatham Strait, Southeast Alaska, using scuba and their growth measured annually for up to 5 years. Colonies were video recorded, and computer image analysis tools provided calibration of video images for measuring the length of several branches. Growth data indicate that C. spiculifera grows much slower (6.0 mm yr(-1)) than other gorgonians in Alaska for which there are data and that intraspecific growth is highly variable. We fit a Bayesian linear mixed-effects model that showed that average colony growth was significantly reduced with warmer temperature and presence of necrosis. The model further indicated that growth may slow among larger (older) colonies. Based on these results and previous studies, we propose that gorgonian growth rates are taxonomically constrained at the Suborder level and that holaxonians grow the slowest followed by scleraxonians and calcaxonians (2-3 times as fast). Findings of this study indicate that it would take approximately 60 years for C. spiculifera to grow to its maximum size and depending on the location and size of the parental standing stock, at least one and possibly 10 additional years for recruitment to occur. Our results further indicate that colonies that are injured, perhaps chronically in areas of frequent disturbance, grow at slower rates and if the current trend of ocean warming continues then we can expect these corals to grow more slowly, and the habitats they form will require more time to recover from disturbance.	[Stone, Robert P.; Malecha, Patrick W.; Masuda, Michele M.] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99801 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Stone, RP (corresponding author), NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99801 USA.	bob.stone@noaa.gov			Alaska Fisheries Science Center of NOAA Fisheries	Alaska Fisheries Science Center of NOAA Fisheries	We thank Ken Krieger, Linc Freese, Alex Wertheimer, Chuck O'Clair, Strydr Nutting, and Chris Lunsford for their assistance in the field, Jeff Regelin for performing the initial computer image analyses, Lou Barr for sharing his vast knowledge about the distribution of shallow water corals in Southeast Alaska, and Bruce Wing for help conceiving the original concept of this project. We thank Sandra Brooke (Florida State University Coastal and Marine Laboratory) for examining the reproductive biology of the coral specimens. We thank the captains and crew of the NOAA ship John N. Cobb for their assistance and support. This project was funded by the Alaska Fisheries Science Center of NOAA Fisheries. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the National Marine Fisheries Service, NOAA.	Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Andrews AH, 2009, MAR ECOL PROG SER, V397, P173, DOI 10.3354/meps08193; Beiring EA, 2000, MAR ECOL PROG SER, V196, P169, DOI 10.3354/meps196169; Benedetti MC, 2016, ESTUAR COAST SHELF S, V171, P106, DOI 10.1016/j.ecss.2015.12.026; Bramanti L, 2014, MAR BIOL, V161, P1015, DOI 10.1007/s00227-013-2383-5; BRAZEAU DA, 1992, BIOL BULL, V183, P269, DOI 10.2307/1542214; CARLSON PR, 1988, MAR GEOL, V85, P89, DOI 10.1016/0025-3227(88)90085-0; Fabricius K., 2001, SOFT CORALS SEA FANS; Fujioka JT, 2006, CAN J FISH AQUAT SCI, V63, P2330, DOI 10.1139/F06-120; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GRIGG RW, 1974, ECOLOGY, V55, P876, DOI 10.2307/1934424; Harbo RM, 1999, WHELKS WHALES COASTA; Harper David G. C., 1994, Ringing and Migration, V15, P84; Heifetz J, 2009, MAR ECOL PROG SER, V397, P295, DOI 10.3354/meps08304; Kass RE, 1998, AM STAT, V52, P93, DOI 10.2307/2685466; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Lacharite M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065394; Lamb A, 2005, MARINE LIFE PACIFIC; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKevett EM, 1974, GEOL SURV PROFESSION, V832, P1; Masuda MM, 2015, ICES J MAR SCI, V72, P2674, DOI 10.1093/icesjms/fsv163; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; OPTIMAS, 1999, OPTIMAS OPT 6 5 US G; Priori C, 2013, ESTUAR COAST SHELF S, V118, P43, DOI 10.1016/j.ecss.2012.12.011; Prouty NG, 2015, STATE DEEP SEA CORAL, P10; Sherwood OA, 2009, CAN J FISH AQUAT SCI, V66, P142, DOI 10.1139/F08-195; Simpson A, 2007, DEEP SEA CORAL DISTR, V304, P246; Sokal R.R., 2012, BIOMETRY PRINCIPLES; STONE R, 2001, P 1 INT S DEEP SEA C, P88; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Stone RP, 2014, ECOLOGY DEEP SEA COR, V16; Stone RP, 2014, ICES J MAR SCI; Stone RP, 2015, STATE DEEP SEA CORAL; Tsounis G, 2012, MAR ECOL PROG SER, V449, P161, DOI 10.3354/meps09521; VELIMIROV B, 1975, OECOLOGIA, V19, P259, DOI 10.1007/BF00345309; Waller RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090893; WEINBAUER MG, 1995, B MAR SCI, V56, P283; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; YOSHIOKA PM, 1991, MAR ECOL PROG SER, V69, P253, DOI 10.3354/meps069253	41	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169470	10.1371/journal.pone.0169470	http://dx.doi.org/10.1371/journal.pone.0169470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068374	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900037
J	Kim, DY; Han, KH; Jun, B; Kim, TH; Park, S; Ward, T; Webster, S; McEwan, P				Kim, Do Young; Han, Kwang-Hyub; Jun, Byungyool; Kim, Tae Hyun; Park, Sohee; Ward, Thomas; Webster, Samantha; McEwan, Phil			Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; VIRUS-INFECTION; UNITED-STATES; SOUTH-KOREA; GENERAL-POPULATION; JAPANESE PATIENTS; HCV INFECTION; GENOTYPE 1; IMPACT; COHORT	Background and Aims This study aims to investigate the cost-effectiveness of a one-time hepatitis C virus (HCV) screening and treatment program in South Korea where hepatitis B virus (HBV) prevails, in people aged 40-70, compared to current practice (no screening). Methods A published Markov model was used in conjunction with a screening and treatment decision tree to model patient cohorts, aged 40-49, 50-59 and 60-69 years, distributed across chronic hepatitis C (CHC) and compensated cirrhosis (CC) health states (82.5% and 17.5%, respectively). Based on a published seroepidemiology study, HCV prevalence was estimated at 0.60%, 0.80% and 1.53%, respectively. An estimated 71.7% of the population was screened. Post-diagnosis, 39.4% of patients were treated with a newly available all-oral direct-acting antiviral (DAA) regimen over 5 years. Published rates of sustained virologic response, disease management costs, transition rates and utilities were utilised. Results Screening resulted in the identification of 43,635 previously undiagnosed patients across all cohorts. One-time HCV screening and treatment was estimated to be cost-effective across all cohorts; predicted incremental cost-effectiveness ratios ranged from $5,714 to $8,889 per quality-adjusted life year gained. Incremental costs associated with screening, treatment and disease management ranged from $156.47 to $181.85 million USD; lifetime costs-offsets associated with the avoidance of end stage liver disease complications ranged from $51.47 to $57.48 million USD. Conclusions One-time HCV screening and treatment in South Korean people aged 40-70 is likely to be highly cost-effective compared to the current practice of no screening.	[Kim, Do Young; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Jun, Byungyool] Cha Univ, Coll Med, Dept Prevent Med, Pocheon Si, Kyung Gi Provin, South Korea; [Kim, Tae Hyun; Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Ward, Thomas; Webster, Samantha; McEwan, Phil] HEOR Ltd, Singleton Court Business Pk, Monmouth, Wales; [McEwan, Phil] Swansea Univ, Sch Human & Hlth Sci, Swansea, W Glam, Wales	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Swansea University	Han, KH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	gihankhys@yuhs.ac		Kim, Tae Hyun/0000-0003-1053-8958; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Sohee/0000-0001-8513-5163	Bristol-Myers Squibb Pharmaceuticals Ltd.	Bristol-Myers Squibb Pharmaceuticals Ltd.	This study was funded by Bristol-Myers Squibb Pharmaceuticals Ltd. The funder provided support in the form of salaries for authors DK, KH, BJ, TK, SP, TW, SW, and PM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; [Anonymous], 2012 NAT HLTH SCREEN; Bennett H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125846; Brook RA, 2011, AM J MANAG CARE, V17, P657; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; DiBonaventura Marco daCosta, 2011, J Med Econ, V14, P253, DOI 10.3111/13696998.2011.566294; Eckman MH, 2013, CLIN INFECT DIS, V56, P1382, DOI 10.1093/cid/cit069; El Khoury AC, 2012, J VIRAL HEPATITIS, V19, P153, DOI 10.1111/j.1365-2893.2011.01563.x; Hayashida Kenshi, 2002, J Epidemiol, V12, P22; Health Insurance Review and Assessment Service (HIRA), HIRA CLAIMS DAT; Imazeki F, 2005, LIVER INT, V25, P772, DOI 10.1111/j.1478-3231.2005.01062.x; International Monetary Fund, 2015, KOR GROSS DOM PROD C; Ishida H, 2012, INT SOC PHARMACOECON; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kao JH, 2015, J HEPATOL, V62, pS638, DOI 10.1016/S0168-8278(15)31012-6; KASL, 2014, CLIN MOL HEPATOL, V20, P89, DOI 10.3350/cmh.2014.20.2.89; Kim DD, 2015, GLOB PUBLIC HEALTH, V10, P296, DOI 10.1080/17441692.2014.984742; Kim DY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003896; Kim DY, 2013, LIVER INT, V33, P586, DOI 10.1111/liv.12108; Kim DY, 2015, CLIN EC OUTCOMES TRE; Korean Statistical Information Service (KOSIS), 2016, CONS PRIC IND; Lee CH, 2013, CLIN MOL HEPATOL, V19, P376, DOI 10.3350/cmh.2013.19.4.376; Lee SS, 2016, J MED VIROL, V88, P275, DOI 10.1002/jmv.24335; McEwan P, 2016, HEPATOL RES, V46, P423, DOI 10.1111/hepr.12570; McEwan P, 2016, EUR J GASTROEN HEPAT, V28, P173, DOI 10.1097/MEG.0000000000000510; McEwan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117334; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; McEwan Philip, 2014, Value Health Reg Issues, V3, P5, DOI 10.1016/j.vhri.2013.08.001; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McPhee F, APASL 2016; Ministry of Health and Welfare, 2005, NAT HLTH NUTR EX SUR; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Nakamura J, 2008, TOHOKU J EXP MED, V215, P33, DOI 10.1620/tjem.215.33; Okita K, 2007, COST EFFECTIVENESS H; Park YS, 1998, J MED MICROBIOL, V47, P643, DOI 10.1099/00222615-47-7-643; Selvapatt N, 2016, LIVER INT; Selvapatt N, 2015, J HEPATOL, V63, P797, DOI 10.1016/j.jhep.2015.05.015; Seong MH, 2013, J MED VIROL, V85, P1724, DOI 10.1002/jmv.23661; Shin HR, 2005, INTERVIROLOGY, V49, P18, DOI 10.1159/000087258; Shin HR, 2000, HEPATOL RES, V17, P185, DOI 10.1016/S1386-6346(99)00074-1; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Statistics Korea, S KOR POP SIZ 2014; Statistics Korea, S KOR LIF TABL; Su J, 2010, HEPATOLOGY, V52, P436, DOI 10.1002/hep.23726; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Ward T, 2016, PUBLIC HEALTH, V141, P42, DOI 10.1016/j.puhe.2016.08.002; Ward T, 2016, CLIN DRUG INVESTIG; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153	49	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167770	10.1371/journal.pone.0167770	http://dx.doi.org/10.1371/journal.pone.0167770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060834	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500015
J	Virk, RK; Gunalan, V; Lee, HK; Inoue, M; Chua, C; Tan, BH; Tambyah, PA				Virk, Ramandeep Kaur; Gunalan, Vithiagaran; Lee, Hong Kai; Inoue, Masafumi; Chua, Catherine; Tan, Boon-Huan; Tambyah, Paul Anantharajah			Molecular Evidence of Transmission of Influenza A/H1N1 2009 on a University Campus	PLOS ONE			English	Article							EPIDEMIOLOGIC DYNAMICS; VIRUS; H1N1; EVOLUTION	Background In the recent years, the data on the molecular epidemiology of influenza viruses have expanded enormously because of the availability of cutting-edge sequencing technologies. However, much of the information is from the temperate regions with few studies from tropical regions such as South-east Asia. Despite the fact that influenza has been known to transmit rapidly within semi-closed communities, such as military camps and educational institutions, data are limited from these communities. Objectives To determine the phylogeography of influenza viruses on a university campus, we examined the spatial distribution of influenza virus on the National University of Singapore (NUS) campus. Methods Consenting students from the NUS who sought medical attention at the UHC provided two nasopharyngeal swabs and demographic data. PCR was used for detection of influenza viruses. 34 full-genomes of pH1N1/09 viruses were successfully sequenced by Sanger method and concatenated using Geneious R7. Phylogenetic analysis was conducted using these 34 sequences and 1518 global sequences. Phylogeographic analysis was done using BaTS software and Association index and Fitch parsimony scores were determined. Results Integrating whole genome sequencing data with epidemiological data, we found strong evidence of influenza transmission on campus as isolates from students residing on-campus were highly similar to each other (AI, P value = 0.009; PS, P value = 0.04). There was also evidence of multiple introductions from the community. Conclusions Such data are useful in formulating pandemic preparedness plans which can use these communities as sentinel sites for detection and monitoring of emerging respiratory viral infections.	[Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Gunalan, Vithiagaran] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Lee, Hong Kai] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Inoue, Masafumi] Agcy Sci Technol & Res, Expt Therapeut Unit, Singapore, Singapore; [Chua, Catherine] Natl Univ Singapore, Univ Hlth Ctr, Singapore, Singapore; [Tan, Boon-Huan] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore	Virk, RK (corresponding author), Natl Univ Singapore, Dept Med, Singapore, Singapore.	drramandeepvirk@yahoo.com.sg	Tan, Boon Huan/ABB-8381-2021	Tan, Boon Huan/0000-0002-4976-7988; Gunalan, Vithiagaran/0000-0002-2020-9739	Infectious Diseases Research Fund; NUSMINDEF JPP grant; Ministry of Defence, Singapore; Biomedical Research Council, Singapore's Agency for Science, Technology, and Research (A*STAR)	Infectious Diseases Research Fund; NUSMINDEF JPP grant; Ministry of Defence, Singapore(Ministry of Defence, Singapore); Biomedical Research Council, Singapore's Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	The work at NUS was in part supported and funded by the Infectious Diseases Research Fund and NUSMINDEF JPP grant. The work at DSO National Laboratories was funded by the Ministry of Defence, Singapore. The work at the Institute of Molecular and Cell Biology (IMCB) was in part supported and funded by the Biomedical Research Council, which is part of Singapore's Agency for Science, Technology, and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Campbell DS, 1997, J OCCUP ENVIRON MED, V39, P408, DOI 10.1097/00043764-199705000-00006; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Graham M, 2009, PLOS ONE, V6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Holmes EC, 2011, J VIROL, V85, P6923, DOI 10.1128/JVI.00438-11; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kidd M, 2014, CURR OPIN PULM MED, V20, P242, DOI 10.1097/MCP.0000000000000049; Le MQ, 2013, EMERG INFECT DIS, V19, P1756, DOI 10.3201/eid1911.130349; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mitchell T, 2014, AM J HEALTH BEHAV, V38, P448, DOI [10.5993/AJHB.38.3.14, org/10.5993/AJHB.38.3.14]; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson M, 2009, PLOS CURRENTS INFLUE; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Okoror LE, 2011, INT J TROP MED PUBLI, V1, P1; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Poddar SK, 2002, J VIROL METHODS, V99, P63, DOI 10.1016/S0166-0934(01)00380-9; PONS VG, 1980, AM J EPIDEMIOL, V111, P23, DOI 10.1093/oxfordjournals.aje.a112871; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2009, PLOS CURRENTS, P1; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119485; Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168596	10.1371/journal.pone.0168596	http://dx.doi.org/10.1371/journal.pone.0168596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060851	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500036
J	Zhang, ZS; Li, LL; Chen, WL				Zhang, Zhong-Shuai; Li, Ling-Lu; Chen, Wen-Li			Ptilagrostis contracta (Stipeae, Poaceae), a New Species Endemic to Qinghai-Tibet Plateau	PLOS ONE			English	Article							FLORA	A new species, Ptilagrostis contracta, endemic to Qinghai-Tibet Plateau is described and illustrated. It is distinguished from other species in Ptilagrostis by having contracted panicles, 1-geniculate awns with hairy columns and scabrous bristles and evenly pubescent lemmas. Evidence from lemma epidermal pattern, cytology and molecular phylogenetic analyses based on the nuclear ITS sequence data confirm its systematic position in Ptilagrostis.	[Zhang, Zhong-Shuai; Li, Ling-Lu; Chen, Wen-Li] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Zhang, Zhong-Shuai; Li, Ling-Lu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, WL (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	chenwl@ibcas.ac.cn			National Natural Science Foundation of China [31070168, 31470300, 31110103911, 30990241]; Science and Technology Basic Work [2013FY112100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work	This work was funded by the National Natural Science Foundation of China (grant nos. 31070168, 31470300, 31110103911, and 30990241), http://www.nsfc.gov.cn/publish/portal1/; and Science and Technology Basic Work (grant no. 2013FY112100), http://most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; This study was supported in part by National Natural Science Foundation of China granted to DYH: (grant nos.: 31110103911), YFW: (grant nos.: 30990241) http://www.nsfc.gov.cn/publish/portal1/; Science and Technology Basic Work to DYH: (grant no.: 2013FY112100) http://most.gov.cn/. We acknowledge the curators of B, CAS, CDBI, GOET, HITBC, HNWP, K, KUN, PE for making the collections available for this study and the source (papers) of all the GenBank data we used in this article. Also we acknowledge two anonymous reviewers for comments that led to improvements of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Bao Y, 2003, ACTA BOT SIN, V45, P762; Barkworth M. E., 2007, FLORA N AM N MEXICO, V24, P109; Barkworth M.E., 1987, GRASS SYSTEMATICS EV, P251; BARKWORTH ME, 1983, SYST BOT, V8, P395, DOI 10.2307/2418359; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; FREITAG H, 1985, Notes from the Royal Botanic Garden Edinburgh, V42, P355; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamasha HR, 2012, PLANT SYST EVOL, V298, P351, DOI 10.1007/s00606-011-0549-5; Li MX, 1985, WUHAN BOT RES, V3, P297; Nobis M, 2015, ACTA BOT GALLICA, V162, P301, DOI 10.1080/12538078.2015.1090329; Nobis M, 2013, NORD J BOT, V31, P623, DOI 10.1111/j.1756-1051.2013.00115.x; Noltie H.J., 2000, FLORA BHUTAN INCLUDI, V3, P520, DOI DOI 10.1111/J.1756-1051.2001.TB00791.X; Peterson Paul M., 2005, SIDA Contributions to Botany, V21, P1355; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Romaschenko K, 2014, MOL PHYLOGENET EVOL, V70, P244, DOI 10.1016/j.ympev.2013.09.018; Romaschenko K, 2012, TAXON, V61, P18, DOI 10.1002/tax.611002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshevitz RYu, 1963, FLORA USSR, V2, P66; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tzvelev NN, 1983, GRASSES SOVIET UNI 2, P848; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu Z., 2006, FLORA CHINA, P188; Zhang ZS, 2016, PHYTOTAXA, V272, P94, DOI 10.11646/phytotaxa.272.1.7; Zhu C, 1982, PLANT CHROMOSOME CHR, P68	28	3	3	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0166603	10.1371/journal.pone.0166603	http://dx.doi.org/10.1371/journal.pone.0166603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060805	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500010
J	Chen, KJ; Chen, YP; Chao, AN; Wang, NK; Wu, WC; Lai, CC; Chen, TL				Chen, Kuan-Jen; Chen, Yen-Po; Chao, An-Ning; Wang, Nan-Kai; Wu, Wei-Chi; Lai, Chi-Chun; Chen, Tun-Lu			Prevention of Evisceration or Enucleation in Endogenous Bacterial Panophthalmitis with No Light Perception and Scleral Abscess	PLOS ONE			English	Article							PRIMARY IMPLANT PLACEMENT; SYMPATHETIC OPHTHALMIA; ANTIBACTERIAL ACTIVITY; ENDOPHTHALMITIS; VANCOMYCIN; CEFTAZIDIME	Panophthalmitis is the most extensive ocular involvement in endophthalmitis with inflammation in periocular tissues. Severe inflammation of the anterior and posterior segments is frequently accompanied by corneal opacity, scleral abscess, and perforation or rupture. Enucleation or evisceration was the only remaining viable treatment option when all options to salvage the eye had been exhausted. The purpose of this retrospective study is to examine the outcomes of patients with endogenous bacterial panophthalmitis, no light perception and scleral abscess who were treated with multiple intravitreal and periocular injections of antibiotics and dexamethasone. Evaluation included spreading of infection to contiguous or remote sites, following evisceration or enucleation, and sympathetic ophthalmia. Eighteen patients were diagnosed with EBP, with liver abscesses in eight patients, retroperitoneal infection in four, pneumonia in two, infective endocarditis in one, cellulitis in one, drug abuse in one, and mycotic pseudoaneurysm in one. Culture results were positive for Klebsiella pneumoniae in 12 patients, Streptococcus spp. in three, Pseudomonas aeruginosa in one, Escherichia coli in one, and Staphylococcus aureus in one. The average number of periocular injections was 2.2, and the average number of intravitreal injections was 5.8. No eye required evisceration or enucleation and developed the spreading of infection to contiguous or remote sites during the follow-up. No sympathetic ophthalmia was observed in the fellow eye of all patients. Prevention of evisceration or enucleation in patients with EBP, NLP and scleral abscess can be achieved by multiple intravitreal and periocular injections of antibiotics and dexamethasone.	[Chen, Kuan-Jen; Chen, Yen-Po; Chao, An-Ning; Wang, Nan-Kai; Wu, Wei-Chi; Lai, Chi-Chun; Chen, Tun-Lu] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Ophthalmol, Tayouan, Taiwan	Chang Gung Memorial Hospital	Chen, KJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Ophthalmol, Tayouan, Taiwan.	cgr999chiayi@yahoo.com.tw	Wang, Nan-Kai/AAO-6559-2020; Wang, Nan-Kai/D-6608-2011	Wang, Nan-Kai/0000-0002-6277-9879; Wang, Nan-Kai/0000-0002-6277-9879; Chen, Kuan-Jen/0000-0002-4994-8391; Lai, Chi-Chun/0000-0001-9547-7212; Chao, An-Ning/0000-0002-4761-9244				Abel AD, 2005, OPHTHAL PLAST RECONS, V21, P220, DOI 10.1097/01.IOP.0000159174.80985.E2; Androudi S, 2010, HIPPOKRATIA, V14, P131; Chen KJ, 2008, J CLIN MICROBIOL, V46, P2149, DOI 10.1128/JCM.00728-08; Chen KJ, 2013, OPHTHALMOLOGY, V120, pE48, DOI 10.1016/j.ophtha.2013.02.026; Chen KJ, 2011, AM J OPHTHALMOL, V151, P1105, DOI 10.1016/j.ajo.2011.03.015; Chen SD, 2014, OPEN OPHTHALMOL J, V8, P32, DOI 10.2174/1874364101408010032; CROXATTO JO, 1981, AM J OPHTHALMOL, V91, P342, DOI 10.1016/0002-9394(81)90287-7; Dresner SC, 2000, OPHTHALMOLOGY, V107, P1661, DOI 10.1016/S0161-6420(00)00262-1; Hui JI, 2010, CURR OPIN OPHTHALMOL, V21, P375, DOI 10.1097/ICU.0b013e32833b7a56; Jackson TL, 2014, SURV OPHTHALMOL, V59, P627, DOI 10.1016/j.survophthal.2014.06.002; Migliori Michael E, 2002, Curr Opin Ophthalmol, V13, P298, DOI 10.1097/00055735-200210000-00002; Ozgur OR, 2007, AM J OPHTHALMOL, V143, P902, DOI 10.1016/j.ajo.2006.11.029; Park I, 2013, J OCUL PHARMACOL TH, V29, P23, DOI 10.1089/jop.2012.0064; Raju B, 2008, RETINA-J RET VIT DIS, V28, P320, DOI 10.1097/IAE.0b013e318154ba07; Rathinam SR, 2006, AM J OPHTHALMOL, V141, P498, DOI 10.1016/j.ajo.2005.10.047; SCHEFFLER MM, 1951, AM J OPHTHALMOL, V34, P1427, DOI 10.1016/0002-9394(51)90484-9; SHORE JW, 1988, ARCH OPHTHALMOL-CHIC, V106, P1303, DOI 10.1001/archopht.1988.01060140463053; Tawfik HA, 2007, OPHTHALMOLOGY, V114, P1100, DOI 10.1016/j.ophtha.2006.09.027	18	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169603	10.1371/journal.pone.0169603	http://dx.doi.org/10.1371/journal.pone.0169603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056067	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100060
J	Ghanem, A; Dorner, J; Schulze-Hagen, L; Muller, A; Wilsing, M; Sinning, JM; Lutkens, J; Frerker, C; Kuck, KH; Graff, I; Schild, H; Werner, N; Grube, E; Nickenig, G				Ghanem, Alexander; Doerner, Jonas; Schulze-Hagen, Leonie; Mueller, Andreas; Wilsing, Marius; Sinning, Jan-Malte; Luetkens, Julian; Frerker, Christian; Kuck, Karl-Heinz; Graeff, Ingo; Schild, Hans; Werner, Nikos; Grube, Eberhard; Nickenig, Georg			Subacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long Term Follow-Up	PLOS ONE			English	Article							WHITE-MATTER; PROGNOSTIC VALUE; IMPAIRMENT; LESIONS; STROKE; SILENT; RISK; DEMENTIA; ATROPHY; HEALTH	Aims To date every post-procedural cerebrovascular embolic event (CVE) is dreaded for its potential to accelerate cognitive decline after transcatheter aortic valve implantation (TAVI). This study differentiates the impact of acute (procedural) and post-acute cerebrovascular embolic events (CVEs) on cognitive performance. Methods Magnetic resonance imaging (MRI) before, early and late after TAVI was performed to quantify embolic burden. Quantification of diffusion- and T1-weighted lesions, as well as white matter and total brain volumes, as well as cognitive function testing (MMSE) were assessed in 28 patients with a medium follow-up period of 34 months. Results Procedural diffusion-weighted lesions were observed in 17 patients (61%), but demonstrated locoregional remnants only in a minority of patients in long-term follow-up (6.5%). Acute CVEs did not impact the trajectory of late silent brain infarctions (SBI), white-matter hyperintensities, and cerebral atrophy. Functionally, early CVEs did not affect cognitive function. In contrast, patients with "new" SBIs after TAVI had a trend to cognitive deterioration in long-term follow-up ("new"SBI: MMSE-1.4 / no "new"SBI: MMSE +1.5, p = 0.067). Interestingly, only a fraction of these "new" SBIs evolved from procedural CVEs (22.2%). Conclusions Aquired SBIs after TAVI, but not DW-CVE per se are associated with functional impairment long-term after TAVI. In the context of subacute thrombosis seen in TAVI prostheses, these findings set the stage for tailored stroke prevention and comprehensive surrogate endpoint definitions in neuroprotective trials.	[Ghanem, Alexander; Frerker, Christian; Kuck, Karl-Heinz] Asklepios Klin St Georg, Dept Cardiol, Hamburg, Germany; [Ghanem, Alexander; Schulze-Hagen, Leonie; Wilsing, Marius; Sinning, Jan-Malte; Werner, Nikos; Grube, Eberhard; Nickenig, Georg] Univ Hosp Bonn, Dept Cardiol, Bonn, Germany; [Doerner, Jonas] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Doerner, Jonas; Mueller, Andreas; Luetkens, Julian; Schild, Hans] Univ Hosp Bonn, Dept Radiol, Bonn, Germany; [Graeff, Ingo] Univ Hosp Bonn, Emergency Dept, Bonn, Germany	Asklepios Klinik St. Georg; University of Bonn; University of Cologne; University of Bonn; University of Bonn	Ghanem, A (corresponding author), Asklepios Klin St Georg, Dept Cardiol, Hamburg, Germany.; Ghanem, A; Nickenig, G (corresponding author), Univ Hosp Bonn, Dept Cardiol, Bonn, Germany.	aghanem@web.de; georg.nickenig@ukb.uni-bann.de						Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Erten-Lyons D, 2013, JAMA NEUROL, V70, P616, DOI 10.1001/jamaneurol.2013.1957; Fink HA, 2015, ANN INTERN MED, V163, P107, DOI 10.7326/M14-2793; Ghanem A, 2013, CIRC-CARDIOVASC INTE, V6, P615, DOI 10.1161/CIRCINTERVENTIONS.112.000429; Ghanem A, 2013, EUROINTERVENTION, V8, P1296, DOI 10.4244/EIJV8I11A198; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kahlert P, 2012, CIRCULATION, V126, P1245, DOI 10.1161/CIRCULATIONAHA.112.092544; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Knecht S, 2008, EUR HEART J, V29, P2125, DOI 10.1093/eurheartj/ehn341; Knipp SC, 2005, EUR J CARDIO-THORAC, V28, P88, DOI 10.1016/j.ejcts.2005.02.043; Kruis RWJ, 2010, SEMIN CARDIOTHORAC V, V14, P111, DOI 10.1177/1089253210370903; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Nombela-Franco L, 2012, CIRCULATION, V126, P3041, DOI 10.1161/CIRCULATIONAHA.112.110981; Pache G, 2016, EUR HEART J, V37, P2263, DOI 10.1093/eurheartj/ehv526; Russo C, 2013, CIRCULATION, V128, P1105, DOI 10.1161/CIRCULATIONAHA.113.001984; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Windham BG, 2015, ANN INTERN MED, V163, P22, DOI 10.7326/M14-2057	22	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168852	10.1371/journal.pone.0168852	http://dx.doi.org/10.1371/journal.pone.0168852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056466	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100015
J	Huber, B; Schellenbacher, C; Shafti-Keramat, S; Jindra, C; Christensen, N; Kirnbauer, R				Huber, Bettina; Schellenbacher, Christina; Shafti-Keramat, Saeed; Jindra, Christoph; Christensen, Neil; Kirnbauer, Reinhard			Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; COMMON NEUTRALIZATION EPITOPE; NONMELANOMA SKIN-CANCER; MONOCLONAL-ANTIBODY; ACTINIC KERATOSES; L2; TYPE-16; L1; PROTECTION; VACCINATION	Common cutaneous human papillomavirus (HPV) types induce skin warts, whereas species beta HPV are implicated, together with UV-radiation, in the development of non-melanoma skin cancer (NMSC) in immunosuppressed patients. Licensed HPV vaccines contain virus like particles (VLP) self-assembled from L1 major capsid proteins that provide type restricted protection against mucosal HPV infections causing cervical and other ano-genital and oro-pharyngeal carcinomas and warts (condylomas), but do not target heterologous HPV. Experimental papillomavirus vaccines have been designed based on L2 minor capsid proteins that contain type-common neutralization epitopes, to broaden protection to heterologous mucosal and cutaneous HPV types. Repetitive display of the HPV16 L2 cross-neutralization epitope RG1 (amino acids (aa) 17-36) on the surface of HPV16 L1 VLP has greatly enhanced immunogenicity of the L2 peptide. To more directly target cutaneous HPV, L1 fusion proteins were designed that incorporate the RG1 homolog of beta HPV17, the beta HPV5 L2 peptide aa53-72, or the common cutaneous HPV4 RG1 homolog, inserted into DE surface loops of HPV1, 5,16 or 18 L1 VLP scaffolds. Baculovirus expressed chimeric proteins self-assembled into VLP and VLP-raised NZW rabbit immune sera were evaluated by ELISA and L1- and L2-based pseudovirion (PsV) neutralizing assays, including 12 novel beta PsV types. Chimeric VLP displaying the HPV17 RG1 epitope, but not the HPV5L2 aa53-72 epitope, induced cross-neutralizing humoral immune responses to beta HPV. In vivo cross-protection was evaluated by passive serum transfer in a murine PsV challenge model. Immune sera to HPV16L1-17RG1 VLP (cross-) protected against beta HPV5/20/24/38/96/16 (but not type 76), while antisera to HPV5L1-17RG1 VLP cross-protected against HPV2O/24/96 only, and sera to HPV1L1-4RG1 VLP cross-protected against HPV4 challenge. In conclusion, RG1-based VLP are promising next generation vaccine candidates to target cutaneous HPV infections.	[Huber, Bettina; Schellenbacher, Christina; Shafti-Keramat, Saeed; Jindra, Christoph; Kirnbauer, Reinhard] Med Univ Vienna, Dept Dermatol, Lab Viral Oncol, Vienna, Austria; [Christensen, Neil] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA; [Jindra, Christoph] Univ Vet Med, Equine Univ Clin, Res Grp Oncol, Vienna, Austria	Medical University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Veterinary Medicine Vienna	Kirnbauer, R (corresponding author), Med Univ Vienna, Dept Dermatol, Lab Viral Oncol, Vienna, Austria.	reinhard.kirnbauer@meduniwien.ac.at		Kirnbauer, Reinhard/0000-0002-5588-4179; Huber, Bettina/0000-0002-8086-7848; Shafti-Keramat, Saeed/0000-0002-4180-8853	Vienna Science and Technology Fund [LS11-006]	Vienna Science and Technology Fund	This research was supported by a grant to RK from the Vienna Science and Technology Fund (www.wwtf.at) (Life Science Call 2011) (LS11-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Bavinck JNB, 2001, J INVEST DERM SYMP P, V6, P207, DOI 10.1046/j.0022-202x.2001.00048.x; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Boxus M, 2016, J VIROL, V90, P6314, DOI 10.1128/JVI.00449-16; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2007, CURRENT PROTOCOLS CE, V26, P1, DOI DOI 10.1002/0471143030.CB2601S37; Cardoso JC, 2011, ACTA DERMATOVEN ALP, V20, P145; Carter JJ, 2003, J VIROL, V77, P11625, DOI 10.1128/JVI.77.21.11625-11632.2003; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; Denny L, 2013, VACCINE, V31, P5745, DOI 10.1016/j.vaccine.2013.09.032; Deschuyteneer M, 2010, HUM VACCINES, V6, P407, DOI 10.4161/hv.6.5.11023; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Florin L, 2006, J VIROL, V80, P6691, DOI 10.1128/JVI.00057-06; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Gaukroger JM, 1996, J GEN VIROL, V77, P1577, DOI 10.1099/0022-1317-77-7-1577; Gormley Rachel H, 2009, Curr HIV/AIDS Rep, V6, P130, DOI 10.1007/s11904-009-0018-8; Handisurya A, 2009, J GEN VIROL, V90, P136, DOI 10.1099/vir.0.006189-0; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Huber B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120152; JABLONSKA S, 1972, CANCER RES, V32, P583; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kalnin K, 2014, VACCINE, V32, P3540, DOI 10.1016/j.vaccine.2014.04.032; Kawana K, 1998, VIROLOGY, V245, P353, DOI 10.1006/viro.1998.9168; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kawana Y, 2001, J VIROL, V75, P2331, DOI 10.1128/JVI.75.5.2331-2336.2001; Kenyon E, 1998, J ACQ IMMUN DEF SYND, V17, P94, DOI 10.1097/00042560-199801010-00016; Kirnbauer R, 2016, J INVEST DERMATOL, V136, pS233, DOI 10.1016/j.jid.2016.06.446; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Kumar D, 2013, AM J TRANSPLANT, V13, P2411, DOI 10.1111/ajt.12329; Kwak K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097232; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Lee H, 2015, J VIROL, V89, P1428, DOI 10.1128/JVI.02898-14; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Levin MJ, 2010, JAIDS-J ACQ IMM DEF, V55, P197, DOI 10.1097/QAI.0b013e3181de8d26; Mackintosh LJ, 2009, BRIT J DERMATOL, V161, P56, DOI 10.1111/j.1365-2133.2009.09146.x; Mamoor S, 2012, VIROLOGY, V422, P413, DOI 10.1016/j.virol.2011.11.007; Martelli-Marzagao F, 2016, TRANSPL INFECT DIS, V18, P37, DOI 10.1111/tid.12479; MCLEAN CS, 1990, J CLIN PATHOL, V43, P488, DOI 10.1136/jcp.43.6.488; Mlakar B, 2014, J CLIN VIROL, V61, P237, DOI 10.1016/j.jcv.2014.07.009; NAKAI Y, 1986, INTERVIROLOGY, V25, P30, DOI 10.1159/000149652; Nieto K, 2012, HUM GENE THER, V23, P733, DOI 10.1089/hum.2011.202; Palefsky JM, 1997, CLIN DERMATOL, V15, P439, DOI 10.1016/S0738-081X(96)00155-1; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pfister H., 2003, JNCI-J NATL CANCER I, V31, P52, DOI DOI 10.1093/0XF0RDJ0UR-NALS.JNCIM0N0GRAPHS.A003483; Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Reusser NM, 2015, J CLIN MED, V4, P260, DOI 10.3390/jcm4020260; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 1997, J VIROL, V71, P6247, DOI 10.1128/JVI.71.8.6247-6252.1997; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2016, VIRUS RES; Schellenbacher C, 2013, J INVEST DERMATOL, V133, P2706, DOI 10.1038/jid.2013.253; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Scherer EM, 2016, EBIOMEDICINE, V10, P55, DOI 10.1016/j.ebiom.2016.06.042; Senger T, 2010, VACCINE, V28, P1583, DOI 10.1016/j.vaccine.2009.11.048; Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039; Struijk L, 2006, CANCER EPIDEM BIOMAR, V15, P529, DOI 10.1158/1055-9965.EPI-05-0747; Toft L, 2014, HUM VACC IMMUNOTHER, V10, P1147, DOI 10.4161/hv.27925; Tumban E, 2015, VACCINE, V33, P3346, DOI 10.1016/j.vaccine.2015.05.016; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Wang ZH, 1997, J GEN VIROL, V78, P2209, DOI 10.1099/0022-1317-78-9-2209; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Wu WH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0364-7; Yoon SW, 2012, VACCINE, V30, P3286, DOI 10.1016/j.vaccine.2012.03.009	77	28	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169533	10.1371/journal.pone.0169533	http://dx.doi.org/10.1371/journal.pone.0169533			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056100	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100051
J	Udomsinprasert, W; Kitkumthorn, N; Mutirangura, A; Chongsrisawat, V; Poovorawan, Y; Honsawek, S				Udomsinprasert, Wanvisa; Kitkumthorn, Nakarin; Mutirangura, Apiwat; Chongsrisawat, Voranush; Poovorawan, Yong; Honsawek, Sittisak			Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia	PLOS ONE			English	Article							SERUM AUTOTAXIN; DNA METHYLATION; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; CLEARANCE; SEVERITY; MARKER; CELLS	Objective Biliary atresia (BA) is a progressive fibroinflammatory liver disease. Autotaxin (ATX) has a profibrotic effect resulting from lysophosphatidic acid activity. The purpose of this study was to examine A TXexpression and ATXpromoter methylation in peripheral blood leukocytes and liver tissues from BA patients and controls and investigate their associations with outcome parameters in BA patients. Methods A total of 130 subjects (65 BA patients and 65 age-matched controls) were enrolled. DNA was extracted from circulating leukocytes and liver tissues of BA patients and from and age matched controls. ATXpromoter methylation status was determined by bisulfite pyrosequencing. ATX expression was analyzed using quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Results Decreased methylation of specific CpGs were observed at the ATX promoter in BA patients. Subsequent analysis revealed that BA patients with advanced stage had lower methylation levels of ATX promoter than those with early stage. ATXpromoter methylation levels were found to be associated with hepatic dysfunction in BA. In addition, ATX expression was significantly elevated and correlated with a decrease in ATX promoter methylation in BA patients compared to the controls. Furthermore, promoter hypomethylation and overexpression of ATX were inversely associated with jaundice status, hepatic dysfunction, and liver stiffness in BA patients. Conclusion Accordingly, it has been hypothesized that A TXpromoter methylation and A TXexpression in peripheral blood may serve as possible biomarkers reflecting the progression of liver fibrosis in postoperative BA. These findings suggest that the promoter hypomethylation and overexpression of ATX might play a contributory role in the pathogenesis of liver fibrosis in BA.	[Udomsinprasert, Wanvisa; Honsawek, Sittisak] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Biochem, Fac Med,Thai Red Cross Soc, Bangkok, Thailand; [Kitkumthorn, Nakarin] Mahidol Univ, Dept Oral & Biol, Fac Dent, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Fac Med, Bangkok, Thailand; [Chongsrisawat, Voranush; Poovorawan, Yong] Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand	Chulalongkorn University; Thai Red Cross Society; Mahidol University; Chulalongkorn University; Chulalongkorn University	Honsawek, S (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Dept Biochem, Fac Med,Thai Red Cross Soc, Bangkok, Thailand.	sittisak.h@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Udomsinprasert, Wanvisa/0000-0002-1132-7442	Thailand Research Fund [RSA5880019]; National Science and Technology Development Agency [RES5829130016]; National Research University Project, Office of Higher Education Commission [NRU59-056-AS]	Thailand Research Fund(Thailand Research Fund (TRF)); National Science and Technology Development Agency; National Research University Project, Office of Higher Education Commission	This research was funded by the Thailand Research Fund (RSA5880019), the National Science and Technology Development Agency (RES5829130016), and the National Research University Project, Office of Higher Education Commission (NRU59-056-AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Belinsky SA, 1995, TOXICOL LETT, V82-3, P335, DOI 10.1016/0378-4274(95)03486-2; Bian EB, 2013, CELL SIGNAL, V25, P355, DOI 10.1016/j.cellsig.2012.10.007; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; Cooper AB, 2007, J GASTROINTEST SURG, V11, P1628, DOI 10.1007/s11605-007-0322-9; Dong R, 2012, BIOCHEM BIOPH RES CO, V417, P986, DOI 10.1016/j.bbrc.2011.12.054; Dong R, 2011, PEDIATR RES, V70, P555, DOI 10.1203/PDR.0b013e318232a949; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983; Ikeda H, 2003, AM J PHYSIOL-GASTR L, V285, pG880, DOI 10.1152/ajpgi.00039.2003; Ikeda H, 2012, CLIN CHIM ACTA, V413, P1817, DOI 10.1016/j.cca.2012.07.014; Jansen S, 2009, CANCER LETT, V284, P216, DOI 10.1016/j.canlet.2009.04.029; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Kremer AE, 2016, J PEDIATR GASTR NUTR, V62, P530, DOI 10.1097/MPG.0000000000001044; Matthews RP, 2011, HEPATOLOGY, V53, P905, DOI 10.1002/hep.24106; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Petersen Claus, 2006, Clin Liver Dis, V10, P73, DOI 10.1016/j.cld.2005.10.001; Pleli T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103532; Rachakonda VP, 2015, OBESITY, V23, P965, DOI 10.1002/oby.20960; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Saito Y, 2002, P NATL ACAD SCI USA, V99, P10060, DOI 10.1073/pnas.152121799; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Superina R, 2011, ANN SURG, V254, P577, DOI 10.1097/SLA.0b013e3182300950; Tania M, 2010, BIOCHEM BIOPH RES CO, V401, P493, DOI 10.1016/j.bbrc.2010.09.114; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Udomsinprasert W, 2015, BIOMARKERS, V20, P89, DOI 10.3109/1354750X.2014.994564; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; [吴京 WU Jing], 2010, [建筑结构学报, Journal of Building Structures], V31, P31; Wunsch E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30847	33	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169306	10.1371/journal.pone.0169306	http://dx.doi.org/10.1371/journal.pone.0169306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052132	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500044
J	Ko, YF; Liau, JC; Lee, CS; Chiu, CY; Martel, J; Lin, CS; Tseng, SF; Ojcius, DM; Lu, CC; Lai, HC; Young, JD				Ko, Yun-Fei; Liau, Jian-Ching; Lee, Chien-Sheng; Chiu, Chen-Yaw; Martel, Jan; Lin, Chuan-Sheng; Tseng, Shun-Fu; Ojcius, David M.; Lu, Chia-Chen; Lai, Hsin-Chih; Young, John D.			Isolation, Culture and Characterization of Hirsutella sinensis Mycelium from Caterpillar Fungus Fruiting Body	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; CORDYCEPS-SINENSIS; CHEMICAL-COMPOSITION; SCIENTIFIC REDISCOVERY; QUALITY EVALUATION; NUTRITIONAL-VALUE; DNA; NUCLEOSIDES; PHYLOGENIES; ANAMORPH	The caterpillar fungus Ophiocordyceps sinensis (previously called Cordyceps sinensis) has been used for centuries in Asia as a tonic to improve health and longevity. Recent studies show that O. sinensis produces a wide range of biological effects on cells, laboratory animals and humans, including anti-fatigue, anti-infection, anti-inflammatory, antioxidant, and antitumor activities. In view of the rarity of O. sinensis fruiting bodies in nature, cultivation of its anamorph mycelium represents a useful alternative for large-scale production. However, O. sinensis fruiting bodies harvested in nature harbor several fungal contaminants, a phenomenon that led to the isolation and characterization of a large number of incorrect mycelium strains. We report here the isolation of a mycelium from a fruiting body of O. sinensis and we identify the isolate as O. sinensis' anamorph (also called Hirsutella sinensis) based on multi locus sequence typing of several fungal genes (ITS, nrSSU, nrLSU, RPB1, RPB2, MCM7, beta-tubulin, TEF-1 alpha, and ATP6). The main characteristics of the isolated mycelium, including its optimal growth at low temperature (16 degrees C) and its biochemical composition, are similar to that of O. sinensis fruiting bodies, indicating that the mycelium strain characterized here may be used as a substitute for the rare and expensive O. sinensis fruiting bodies found in nature.	[Ko, Yun-Fei; Liau, Jian-Ching; Lee, Chien-Sheng; Young, John D.] Chang Gung Biotechnol Corp, Taipei, Taiwan; [Ko, Yun-Fei; Chiu, Chen-Yaw; Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, New Taipei, Taiwan; [Ko, Yun-Fei; Martel, Jan; Lin, Chuan-Sheng; Tseng, Shun-Fu; Ojcius, David M.; Lu, Chia-Chen; Lai, Hsin-Chih; Young, John D.] Linkou Chang Gung Mem Hosp, Chang Gung Immunol Consortium, New Taipei, Taiwan; [Martel, Jan; Lin, Chuan-Sheng; Ojcius, David M.; Lai, Hsin-Chih; Young, John D.] Chang Gung Univ, Ctr Mol & Clin Immunol, Taoyuan, Taiwan; [Martel, Jan; Young, John D.] Chang Gung Univ, Lab Nanomat, Taoyuan, Taiwan; [Lin, Chuan-Sheng; Tseng, Shun-Fu; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan; [Lin, Chuan-Sheng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Chuan-Sheng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Ojcius, David M.] Univ Pacific, Arthur Dugoni Sch Dent, Dept Biomed Sci, San Francisco, CA USA; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei, Taiwan; [Lai, Hsin-Chih] Linkou Chang Gung Mem Hosp, Dept Lab Med, New Taipei, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ Sci & Technol, Coll Human Ecol, Grad Inst Hlth Ind & Technol, Taoyuan, Taiwan; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA	Ming Chi University of Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of the Pacific; Fu Jen Catholic University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Rockefeller University	Young, JD (corresponding author), Chang Gung Biotechnol Corp, Taipei, Taiwan.; Young, JD (corresponding author), Ming Chi Univ Technol, Biochem Engn Res Ctr, New Taipei, Taiwan.; Young, JD (corresponding author), Linkou Chang Gung Mem Hosp, Chang Gung Immunol Consortium, New Taipei, Taiwan.; Young, JD (corresponding author), Chang Gung Univ, Ctr Mol & Clin Immunol, Taoyuan, Taiwan.; Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Taoyuan, Taiwan.; Young, JD (corresponding author), Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA.	jdyoung@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020; Chiu, Chen-Yaw/CAA-0879-2022	Martel, Jan/0000-0003-0879-109X; Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	Primordia Institute of New Sciences and Medicine from the Ministry of Science and Technology of Taiwan [MOST103-2320-B-182-027-MY3]; Chang Gung Memorial Hospital [CMRPD190303, BMRPA04, QZRPD120]	Primordia Institute of New Sciences and Medicine from the Ministry of Science and Technology of Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by Primordia Institute of New Sciences and Medicine, grant MOST103-2320-B-182-027-MY3 from the Ministry of Science and Technology of Taiwan, and grants CMRPD190303, BMRPA04, and QZRPD120 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao T, 1997, Chinese Patent, Patent No. [CN1215754A, 1215754]; Barseghyan GS, 2011, INT J MED MUSHROOMS, V13, P565, DOI 10.1615/IntJMedMushr.v13.i6.90; Chen YQ, 2001, BIOCHEM SYST ECOL, V29, P597, DOI 10.1016/S0305-1978(00)00100-9; Chen YQ, 2004, FEMS MICROBIOL LETT, V230, P153, DOI 10.1016/S0378-1097(03)00889-9; Chioza A, 2013, ADV MICROBIOL, V3; Chioza A, 2014, J MYCOL, V2014; Choi GS, 2010, ALLERGY, V65, P1196, DOI 10.1111/j.1398-9995.2009.02300.x; Dai L, 1994, Chinese Patent, Patent No. [CN1095103A, 1095103]; Dong CH, 2011, J IND MICROBIOL BIOT, V38, P1027, DOI 10.1007/s10295-010-0877-4; Dong Caihong, 2015, Mycology-An International Journal On Fungal Biology, V6, P121, DOI 10.1080/21501203.2015.1043967; Dong CH, 2005, J APPL MICROBIOL, V99, P483, DOI 10.1111/j.1365-2672.2005.02640.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Hu X, 2013, CHINESE SCI BULL, V58, P2846, DOI 10.1007/s11434-013-5929-5; Huang TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15282; Huang TT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01374; Jia J, 2008, Chinese Patent, Patent No. [CN101407767A, 101407767]; Kalac P, 2013, J SCI FOOD AGR, V93, P209, DOI 10.1002/jsfa.5960; Leung PH, 2006, J APPL MICROBIOL, V101, P275, DOI 10.1111/j.1365-2672.2006.02930.x; Li G, 2010, Chinese Patent, Patent No. [CN101372672A, 101372672]; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Liu ZY, 2002, MYCOL RES, V106, P1100, DOI 10.1017/S0953756202006378; Lu CC, 2016, INNATE IMMUN-LONDON, V22, P522, DOI 10.1177/1753425916661402; Ng TB, 2005, J PHARM PHARMACOL, V57, P1509, DOI 10.1211/jpp.57.12.0001; Ni LQ, 2014, AM J BIOMED SCI, V6, P82; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shang HS, 2014, IN VIVO, V28, P811; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Steinkraus D. C., 1994, American Entomologist, V40, P235; Stone R, 2008, SCIENCE, V322, P1182, DOI 10.1126/science.322.5905.1182; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang XM, 2014, FOOD CHEM, V151, P279, DOI 10.1016/j.foodchem.2013.11.062; Wu LY, 2015, IN VIVO, V29, P263; Wu TN, 1996, SCI TOTAL ENVIRON, V182, P193, DOI 10.1016/0048-9697(96)05054-1; Xia F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33437; Yu L, 2006, J SEP SCI, V29, P953, DOI 10.1002/jssc.200600007; Yu Y, 1997, Chinese Patent, Patent No. [CN1036531C, 1036531]; Yue K, 2013, J PHARM PHARMACOL, V65, P474, DOI 10.1111/j.2042-7158.2012.01601.x; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhang YongJie, 2012, Mycology - An International Journal on Fungal Biology, V3, P2; Zhou XW, 2009, J PHARM PHARMACOL, V61, P279, DOI [10.1211/jpp/61.03.0002, 10.1211/jpp.61.03.0002]; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429; Zuo HL, 2013, ANAL METHODS-UK, V5, P5450, DOI 10.1039/c3ay40622a	49	11	12	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168734	10.1371/journal.pone.0168734	http://dx.doi.org/10.1371/journal.pone.0168734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046129	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300048
J	Campana, WM; Mantuano, E; Azmoon, P; Henry, K; Banki, MA; Kim, JH; Pizzo, DP; Gonias, SL				Campana, Wendy M.; Mantuano, Elisabetta; Azmoon, Pardis; Henry, Kenneth; Banki, Michael A.; Kim, John H.; Pizzo, Donald P.; Gonias, Steven L.			Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells	FASEB JOURNAL			English	Article						NMDA receptor; AMPA receptor; kainate receptor; peripheral nerve injury; migration	NMDA RECEPTOR; PLASMINOGEN-ACTIVATOR; INDUCED NOCICEPTION; REGULATED KINASE; STRIATAL NEURONS; NEUROPATHIC PAIN; GENE KNOCKDOWN; PROTEIN; SUBUNIT; PROLIFERATION	In the peripheralnervous system, Schwann cells (SCs) demonstrate surveillance activity, detecting injury and undergoing trans-differentiation to support repair. SC receptors that detect peripheral nervous system injury remain incompletely understood. We used RT-PCR to profile ionotropic glutamate receptor expression in cultured SCs. We identified subunits required for assembly of N-methyl-D-aspartic acid (NMDA) receptors (NMDA-Rs), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, and kainate receptors. Treatment of SCs with 40-100 mM glutamate or with 0.5- 1.0 mu M NMDA robustly activated Akt and ERK1/2. The response was transient and bimodal; glutamate concentrations that exceeded 250 mM failed to activate cell signaling. Phosphoprotein profiling identified diverse phosphorylated proteins in glutamate-treated SCs in addition to ERK1/2 and Akt, including p70 S6-kinase, glycogen synthase kinase-3, ribosomal S6 kinase, c-Jun, and cAMP response element binding protein. Activation of SC signaling by glutamate was blocked by EGTA and dizocilpine and by silencing expression of the NMDA-R NR1 subunit. Phosphoinositide 3-kinase/PI3K functioned as an essential upstream activator of Akt and ERK1/2 in glutamate-treated SCs. When glutamate or NMDA was injected directly into crush-injured rat sciatic nerves, ERK1/2 phosphorylation was observed in myelinated and nonmyelinating SCs. Glutamate promoted SC migration by a pathway that required PI3K and ERK1/2. These results identified ionotropic glutamate receptors and NMDA-Rs, specifically, as potentially important cell signaling receptors in SCs.-Campana, W. M., Mantuano, E., Azmoon, P., Henry, K., Banki, M. A., Kim, J. H., Pizzo, D. P., Gonias, S. L. Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells. FASEB J. 31, 1744-1755 (2017). www. fasebj.org	[Campana, Wendy M.; Henry, Kenneth; Kim, John H.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Mantuano, Elisabetta; Azmoon, Pardis; Banki, Michael A.; Pizzo, Donald P.; Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Mantuano, Elisabetta] Sapienza Univ Rome, Dept Expt Med, Rome, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; Sapienza University Rome	Campana, WM; Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@ucsd.edu; sgonias@ucsd.edu		Azmoon, Pardis/0000-0002-1512-5581; Banki, Michael/0000-0002-8910-4695; Mantuano, Elisabetta/0000-0001-5728-9261	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL60551]; FIRB from the Italian Ministry of Education, Universities, and Research [RBFR13RBK9]; NIH National Institute of Neurological Disorders and Stroke [P30-NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS097590] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIRB from the Italian Ministry of Education, Universities, and Research; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL60551 (to S.L.G.), and by FIRB 2013 (RBFR13RBK9) from the Italian Ministry of Education, Universities, and Research (to E.M.). The authors thank Katie Fichter [Department of Anesthesiology, University of California, San Diego (UCSD) School of Medicine] for technical assistance. IF microscopy was performed using the UCSD School of Medicine Light Microscopy Core Facility, sponsored by the NIH National Institute of Neurological Disorders and Stroke Grant P30-NS047101.	Akassoglou K, 2002, BIOL CHEM, V383, P37, DOI 10.1515/BC.2002.004; Allgaier C, 1999, BRIT J PHARMACOL, V126, P121, DOI 10.1038/sj.bjp.0702284; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; BOTTENSTEIN JE, 1980, EXP CELL RES, V129, P361, DOI 10.1016/0014-4827(80)90504-2; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008; Christensen PC, 2016, MUSCLE NERVE, V54, P451, DOI 10.1002/mus.25078; Crossthwaite AJ, 2004, J NEUROCHEM, V88, P1127, DOI 10.1046/j.1471-4159.2004.02257.x; EVANS PD, 1991, J EXP BIOL, V157, P593; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fink T, 1999, CAN J PHYSIOL PHARM, V77, P204, DOI 10.1139/cjpp-77-3-204; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Lau JCM, 2013, MOL VIS, V19, P1538; Lee MM, 1999, J NEUROSCI RES, V55, P702, DOI 10.1002/(SICI)1097-4547(19990315)55:6<702::AID-JNR5>3.3.CO;2-E; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIEBERMAN EM, 1989, GLIA, V2, P94, DOI 10.1002/glia.440020205; Liu GJ, 2003, NEUROREPORT, V14, P2079, DOI 10.1097/00001756-200311140-00014; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meinhardt MW, 2013, J NEUROSCI, V33, P2794, DOI 10.1523/JNEUROSCI.4062-12.2013; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2016, EXP NEUROL, V276, P41, DOI 10.1016/j.expneurol.2015.10.006; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Rajan I, 1998, J NEUROSCI, V18, P7836; Robinson DM, 2006, DRUGS, V66, P1515, DOI 10.2165/00003495-200666110-00015; Saitoh F, 2016, SCI REP-UK, V6, DOI 10.1038/srep29856; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sun LX, 1998, FEBS LETT, V441, P392, DOI 10.1016/S0014-5793(98)01590-7; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; Tan PH, 2010, ANESTHESIOLOGY, V112, P1482, DOI 10.1097/ALN.0b013e3181d69494; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Xu JD, 2008, J BIOL CHEM, V283, P17503, DOI 10.1074/jbc.M800917200; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x; Yu H, 2015, J VET MED SCI, V77, P427, DOI 10.1292/jvms.14-0555; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	57	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1744	1755		10.1096/fj.201601121R	http://dx.doi.org/10.1096/fj.201601121R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073836	Green Published			2022-12-26	WOS:000398504300038
J	Kim, HS; Nickoloff, JA; Wu, YH; Williamson, EA; Sidhu, GS; Reinert, BL; Jaiswal, AS; Srinivasan, G; Patel, B; Kong, K; Burma, S; Lee, SH; Hromas, RA				Kim, Hyun-Suk; Nickoloff, Jac A.; Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Burma, Sandeep; Lee, Suk-Hee; Hromas, Robert A.			Endonuclease EEPD1 Is a Gatekeeper for Repair of Stressed Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA END RESECTION; HOMOLOGOUS RECOMBINATION; GENOME INSTABILITY; RESTART; NUCLEASES; ROLES; EXO1; MECHANISM; PATHWAYS	Replication is not as continuous as once thought, with DNA damage frequently stalling replication forks. Aberrant repair of stressed replication forks can result in cell death or genome instability and resulting transformation to malignancy. Stressed replication forks are most commonly repaired via homologous recombination (HR), which begins with 5 ' end resection, mediated by exonuclease complexes, one of which contains Exo1. However, Exo1 requires free 5 ' -DNA ends upon which to act, and these are not commonly present in non-reversed stalled replication forks. To generate a free 5 ' end, stalled replication forks must therefore be cleaved. Although several candidate endonucleases have been implicated in cleavage of stalled replication forks to permit end resection, the identity of such an endonuclease remains elusive. Here we show that the 5 ' -endonuclease EEPD1 cleaves replication forks at the junction between the lagging parental strand and the unreplicated DNA parental double strands. This cleavage creates the structure that Exo1 requires for 5 ' end resection and HR initiation. We observed that EEPD1 and Exo1 interact constitutively, and Exo1 repairs stalled replication forks poorly without EEPD1. Thus, EEPD1 performs a gatekeeper function for replication fork repair by mediating the fork cleavage that permits initiation of HR-mediated repair and restart of stressed forks.	[Kim, Hyun-Suk; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Hromas, Robert A.] Univ Florida Hlth, Dept Med, Gainesville, FL 32610 USA; [Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Hromas, Robert A.] Univ Florida Hlth, Ctr Canc, Gainesville, FL 32610 USA; [Burma, Sandeep] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Indiana University System; Indiana University Bloomington; Colorado State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lee, SH (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Hromas, RA (corresponding author), Univ Florida Hlth, Dept Med, Gainesville, FL 32610 USA.; Hromas, RA (corresponding author), Univ Florida Hlth, Ctr Canc, Gainesville, FL 32610 USA.	slee@iupui.edu; robert.hromas@medicine.ufl.edu			National Institutes of Health Grants [R01 GM109645, CA139429, CA205224, R01 CA152367, R01 GM084020, RO1CA149461, RO1CA197796, R21CA202403]; National Aeronautics and Space Administration Grant [NNX16AD78G]; Leukemia and Lymphoma Society Grants [6253-13, 8995-14]; Florida BankheadColey program; NATIONAL CANCER INSTITUTE [R01CA151367, R01CA139429, R01CA149461, R01CA197796, R01CA205224, R21CA202403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020, R01GM109645] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration Grant; Leukemia and Lymphoma Society Grants(Leukemia and Lymphoma Society); Florida BankheadColey program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM109645, CA139429, and CA205224 (to R. H.); R01 CA152367 (to S. H. L.); R01 GM084020 (to J. A. N., E. A. W., and R. H.); and RO1CA149461, RO1CA197796, and R21CA202403 and the National Aeronautics and Space Administration Grant NNX16AD78G (to S. B.); and the Leukemia and Lymphoma Society Grants 6253-13 and 8995-14 and the Florida BankheadColey program (to R. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Costes A, 2013, BIOMOLECULES, V3, P39, DOI 10.3390/biom3010039; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Keijzers G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150058; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rass U, 2013, CHROMOSOMA, V122, P499, DOI 10.1007/s00412-013-0431-z; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Syeda AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016550; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Wray J, 2013, BLOOD, V121, P4359, DOI 10.1182/blood-2012-10-460527; Wu YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005675; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	43	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2795	2804		10.1074/jbc.M116.758235	http://dx.doi.org/10.1074/jbc.M116.758235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049724	hybrid, Green Published			2022-12-26	WOS:000395535100020
J	Ticha, A; Stanchev, S; Skerle, J; Began, J; Ingr, M; Svehlova, K; Polovinkin, L; Ruzicka, M; Bednarova, L; Hadravova, R; Polachova, E; Rampirova, P; Brezinova, J; Kasicka, V; Majer, P; Strisovsky, K				Ticha, Anezka; Stanchev, Stancho; Skerle, Jan; Began, Jakub; Ingr, Marek; Svehlova, Katerina; Polovinkin, Lucie; Ruzicka, Martin; Bednarova, Lucie; Hadravova, Romana; Polachova, Edita; Rampirova, Petra; Brezinova, Jana; Kasicka, Vaclav; Majer, Pavel; Strisovsky, Kvido			Sensitive Versatile Fluorogenic Transmembrane Peptide Substrates for Rhomboid Intramembrane Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MEMBRANE; PROTEOLYSIS; SELECTIVITY; DETERGENTS; ACTIVATION	Rhomboid proteases are increasingly being explored as potential drug targets, but their potent and specific inhibitors are not available, and strategies for inhibitor development are hampered by the lack of widely usable and easily modifiable in vitro activity assays. Here we address this bottleneck and report on the development of new fluorogenic transmembrane peptide substrates, which are cleaved by several unrelated rhomboid proteases, can be used both in detergent micelles and in liposomes, and contain red-shifted fluorophores that are suitable for high-throughput screening of compound libraries. We show that nearly the entire transmembrane domain of the substrate is important for efficient cleavage, implying that it extensively interacts with the enzyme. Importantly, we demonstrate that in the detergent micelle system, commonly used for the enzymatic analyses of intramembrane proteolysis, the cleavage rate strongly depends on detergent concentration, because the reaction proceeds only in the micelles. Furthermore, we show that the catalytic efficiency and selectivity toward a rhomboid substrate can be dramatically improved by targeted modification of the sequence of its P5 to P1 region. The fluorogenic substrates that we describe and their sequence variants should find wide use in the detection of activity and development of inhibitors of rhomboid proteases.	[Ticha, Anezka; Stanchev, Stancho; Skerle, Jan; Began, Jakub; Svehlova, Katerina; Polovinkin, Lucie; Ruzicka, Martin; Bednarova, Lucie; Hadravova, Romana; Polachova, Edita; Rampirova, Petra; Brezinova, Jana; Kasicka, Vaclav; Majer, Pavel; Strisovsky, Kvido] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo 2, Prague, Czech Republic; [Skerle, Jan; Ingr, Marek; Polovinkin, Lucie; Ruzicka, Martin] Charles Univ Prague, Dept Biochem, Fac Sci, Hlavova 2030-8, Prague 12843, Czech Republic; [Began, Jakub] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Vinicna 5, CR-12844 Prague, Czech Republic; [Ticha, Anezka] Charles Univ Prague, Fac Med 1, Katerinska 32, Prague 12108, Czech Republic; [Ingr, Marek] Tomas Bata Univ Zlin, Dept Phys & Mat Engn, Fac Technol, Nam TG Masaryka 5555, Zlin 76001, Czech Republic; [Polovinkin, Lucie] Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Charles University Prague; Tomas Bata University Zlin; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Strisovsky, K (corresponding author), Inst Organ Chem & Biochem, Flemingovo 2, Prague 16610, Czech Republic.	kvido.strisovsky@uochb.cas.cz	Strisovsky, Kvido/H-6284-2014; Brezinova, Jana/G-5594-2014; Majer, Pavel/G-1141-2019; Poláchová, Edita/AAH-2532-2020; Ingr, Marek/E-2478-2015; Skerle, Jan/G-5904-2014; Bednarova, Lucie/E-7622-2012; Tichá, Anežka/H-1657-2014; Růžička, Martin/G-5695-2014; Polovinkin, Lucie/AAB-9056-2019; Began, Jakub/G-6290-2014	Strisovsky, Kvido/0000-0003-3677-0907; Brezinova, Jana/0000-0002-2076-9891; Poláchová, Edita/0000-0002-4740-1114; Ingr, Marek/0000-0001-6741-9955; Skerle, Jan/0000-0002-7838-8418; Tichá, Anežka/0000-0002-2517-2488; Růžička, Martin/0000-0002-0245-487X; Svehlova, Katerina/0000-0002-5687-9574; Stanchev, Stancho/0000-0002-4880-0539; Began, Jakub/0000-0003-3934-3767	EMBO Installation Grant [2329]; Ministry of Education, Youth and Sports of the Czech Republic Projects [LK11206, LO1302]; National Subvention for Development of Research Organizations [RVO: 61388963]; Marie Curie Career Integration Grant [304154]	EMBO Installation Grant; Ministry of Education, Youth and Sports of the Czech Republic Projects(Ministry of Education, Youth & Sports - Czech Republic); National Subvention for Development of Research Organizations; Marie Curie Career Integration Grant	This work was supported by EMBO Installation Grant 2329, Ministry of Education, Youth and Sports of the Czech Republic Projects LK11206 and LO1302, Marie Curie Career Integration Grant Project 304154 (to K. S.), and National Subvention for Development of Research Organizations RVO: 61388963 to the Institute of Organic Chemistry and Biochemistry. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1983, BIOCHEM J, V213, P561; Chan EYL, 2013, BBA-BIOMEMBRANES, V1828, P2916, DOI 10.1016/j.bbamem.2013.05.012; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Etheridge SL, 2013, CELL TISSUE RES, V351, P301, DOI 10.1007/s00441-012-1542-1; Fenyo David, 2007, J Vis Exp, P192, DOI 10.3791/192; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haedke U, 2013, CURR OPIN CHEM BIOL, V17, P102, DOI 10.1016/j.cbpa.2012.11.024; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INTERNATIONAL UNION OF BIOCHEMISTRY NOMENCLATURE COMMITTEE., 1979, European Journal of Biochemistry, V97, P319, DOI 10.1111/j.1432-1033.1979.tb13116.x; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MONGAY C, 1974, ANN CHIM-ROME, V64, P409; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; PARRY G, 1976, FEBS LETT, V67, P123, DOI 10.1016/0014-5793(76)80348-1; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rath A, 2013, METHODS MOL BIOL, V1063, P197, DOI 10.1007/978-1-62703-583-5_11; Riestra AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005294; SCHEEL G, 1982, EUR J BIOCHEM, V127, P245, DOI 10.1111/j.1432-1033.1982.tb06862.x; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Solinova V, 2004, J CHROMATOGR B, V808, P75, DOI 10.1016/j.jchromb.2004.01.062; Song W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9022; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strisovsky K, 2016, FEBS J, V283, P1837, DOI 10.1111/febs.13638; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Wolf EV, 2015, ACS CHEM BIOL, V10, P2325, DOI 10.1021/acschembio.5b00514; Wolf EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072307; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	37	16	16	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2703	2713		10.1074/jbc.M116.762849	http://dx.doi.org/10.1074/jbc.M116.762849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28069810	Green Published, hybrid			2022-12-26	WOS:000395535100013
J	Gambara, G; Salanova, M; Ciciliot, S; Furlan, S; Gutsmann, M; Schiffl, G; Ungethuem, U; Volpe, P; Gunga, HC; Blottner, D				Gambara, Guido; Salanova, Michele; Ciciliot, Stefano; Furlan, Sandra; Gutsmann, Martina; Schiffl, Gudrun; Ungethuem, Ute; Volpe, Pompeo; Gunga, Hanns-Christian; Blottner, Dieter			Gene Expression Profiling in Slow-Type Calf Soleus Muscle of 30 Days Space-Flown Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; PGC-1 COACTIVATORS; MICROGRAVITY; SPACEFLIGHT; ATROPHY; ACCUMULATION; SUSPENSION; PHENOTYPE; REGROWTH; PATHWAYS	Microgravity exposure as well as chronic disuse are two main causes of skeletal muscle atrophy in animals and humans. The antigravity calf soleus is a reference postural muscle to investigate the mechanism of disuse-induced maladaptation and plasticity of human and rodent (rats or mice) skeletal musculature. Here, we report microgravity-induced global gene expression changes in space-flown mouse skeletal muscle and the identification of yet unknown disuse susceptible transcripts found in soleus (a mainly slow phenotype) but not in extensor digitorum longus (a mainly fast phenotype dorsiflexor as functional counterpart to soleus). Adult C57BI/N6 male mice (n = 5) flew aboard a biosatellite for 30 days on orbit (BION-M1 mission, 2013), a sex and age-matched cohort were housed in standard vivarium cages (n = 5), or in a replicate flight habitat as ground control (n = 5). Next to disuse atrophy signs (reduced size and myofiber phenotype I to II type shift) as much as 680 differentially expressed genes were found in the space-flown soleus, and only 72 in extensor digitorum longus (only 24 genes in common) compared to ground controls. Altered expression of gene transcripts matched key biological processes (contractile machinery, calcium homeostasis, muscle development, cell metabolism, inflammatory and oxidative stress response). Some transcripts (Fzd9, Casq2, Kcnma1, Ppara, Myf6) were further validated by quantitative real-time PCR (qRT-PCR). Besides previous reports on other leg muscle types we put forth for the first time a complete set of microgravity susceptible gene transcripts in soleus of mice as promising new biomarkers or targets for optimization of physical countermeasures and rehabilitation protocols to overcome disuse atrophy conditions in different clinical settings, rehabilitation and spaceflight.	[Gambara, Guido; Salanova, Michele; Gutsmann, Martina; Schiffl, Gudrun; Blottner, Dieter] Charite, Ctr Space Med Berlin, Neuromuscular Grp, Berlin, Germany; [Gambara, Guido; Salanova, Michele; Gutsmann, Martina; Schiffl, Gudrun; Blottner, Dieter] Charite, Vegetat Anat, Berlin, Germany; [Ciciliot, Stefano] Venetian Inst Mol Med, Padua, Italy; [Ciciliot, Stefano] Univ Padua, Dept Med DIMED, Padua, Italy; [Furlan, Sandra; Volpe, Pompeo] CNR, Inst Neurosci, Padua, Italy; [Ungethuem, Ute] Charite, Lab Funct Genom, Berlin, Germany; [Gunga, Hanns-Christian] Charite, Ctr Space Med, Dept Physiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Veneto Institute Molecular Medicine; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blottner, D (corresponding author), Charite, Ctr Space Med Berlin, Neuromuscular Grp, Berlin, Germany.; Blottner, D (corresponding author), Charite, Vegetat Anat, Berlin, Germany.	dieter.blottner@charite.de	Ciciliot, Stefano/L-3887-2019	Ciciliot, Stefano/0000-0002-5833-6581; Blottner, Dieter/0000-0003-0355-3340	Department of Economics and Technology of the German Government (BMWi) through the German AeroSpace Board, Deutsches Zentrum fur Luft- und Raumfahrt (DLR), e.V. Bonn, Germany [50WB821, 1121]	Department of Economics and Technology of the German Government (BMWi) through the German AeroSpace Board, Deutsches Zentrum fur Luft- und Raumfahrt (DLR), e.V. Bonn, Germany	This work was supported from grants of the Department of Economics and Technology of the German Government (BMWi) through the German AeroSpace Board, Deutsches Zentrum fur Luft- und Raumfahrt (DLR), e.V. Bonn, Germany (grant # 50WB821 and 1121 to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V2016, DOI [10.1007/s00360-008-0330-4, DOI 10.1007/S00360-008-0330-4]; Aviles EC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00110; Baldwin KM, 1996, MED SCI SPORT EXER, V28, P983, DOI 10.1097/00005768-199608000-00008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blottner D, 2009, J COMP PHYSIOL B, V179, P519, DOI 10.1007/s00360-008-0330-4; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Chopard A, 2000, J Gravit Physiol, V7, pS47; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Dinardo MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040235; Eisele PS, 2014, SEMIN IMMUNOPATHOL, V36, P27, DOI 10.1007/s00281-013-0406-4; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; LEBLANC A, 1985, J APPL PHYSIOL, V58, P1669, DOI 10.1152/jappl.1985.58.5.1669; LeBlanc A, 1997, INT J SPORTS MED, V18, pS283, DOI 10.1055/s-2007-972726; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Machida S, 2005, ACTA PHYSIOL SCAND, V183, P171, DOI 10.1111/j.1365-201X.2004.01395.x; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Moretti I, 2016, NATURE COMMUNICATION; Morris RT, 2004, J APPL PHYSIOL, V96, P398, DOI 10.1152/japplphysiol.00454.2003; MUSACCHIA XJ, 1990, J APPL PHYSIOL, V69, P2248, DOI 10.1152/jappl.1990.69.6.2248; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Ohira Y, 2002, ADV SPACE RES, V30, P777, DOI 10.1016/S0273-1177(02)00395-2; Ohira Y, 1985, J APPL PHYSL, V73; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Riley DA, 1998, ADV SPACE RES, V21, P1073, DOI 10.1016/S0273-1177(98)00029-5; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; SACCHETTO R, 1993, J MUSCLE RES CELL M, V14, P646, DOI 10.1007/BF00141561; Salanova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17027; Salanova M, 2011, FASEB J, V25, P4312, DOI 10.1096/fj.11-186049; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Staron RS, 1998, HISTOCHEM CELL BIOL, V110, P73, DOI 10.1007/s004180050267; Sugiura T, 2005, AM J PHYSIOL-REG I, V288, pR1273, DOI 10.1152/ajpregu.00688.2004; Tamhane AC, 2000, STAT DATA ANAL ELEME, P473; Taylor Wayne E, 2002, J Gravit Physiol, V9, P61; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Tricarico D, 2005, NEUROBIOL DIS, V20, P296, DOI 10.1016/j.nbd.2005.03.011; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Ulanova A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104735; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Weis J, 2000, DEV DYNAM, V218, P438, DOI 10.1002/1097-0177(200007)218:3<438::AID-DVDY1001>3.0.CO;2-6; White JR, 2015, EXP GERONTOL, V64, P17, DOI 10.1016/j.exger.2015.02.007; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; ZHOU MY, 1995, J APPL PHYSIOL, V78, P1740, DOI 10.1152/jappl.1995.78.5.1740; Zhou Z, 2001, J MUSCLE RES CELL M, V22, P311, DOI 10.1023/A:1013133616449	57	42	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169314	10.1371/journal.pone.0169314	http://dx.doi.org/10.1371/journal.pone.0169314			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076365	Green Published, Green Submitted, gold			2022-12-26	WOS:000391857100031
J	Zeng, QC; Lal, R; Chen, YN; An, SS				Zeng, Quanchao; Lal, Rattan; Chen, Yanan; An, Shaoshan			Soil, Leaf and Root Ecological Stoichiometry of Caragana korshinskii on the Loess Plateau of China in Relation to Plantation Age	PLOS ONE			English	Article							HORQIN SANDY LAND; BIOLOGICAL STOICHIOMETRY; VEGETATION SUCCESSION; LEYMUS-CHINENSIS; ORGANIC-MATTER; GREEN PROGRAM; NITROGEN; CARBON; PHOSPHORUS; INDICATORS	Caragana korshinskii, a leguminous shrub, a common specie, is widely planted to prevent soil erosion on the Loess Plateau. The objective of this study was to determine how the plantation ages affected soil, leaf and root nutrients and ecological stoichiometry. The chronosequence ages of C. korshinskii plantations selected for this study were 10, 20 and 30 years. Soil organic carbon (SOC) and soil total nitrogen (STN) of C. korshinskii plantations significantly increased with increase in the chronosequence age. However, soil total phosphorous (STP) was not affected by the chronosequence age. The soil C: N ratio decreased and the soil C: P and N: P ratios increased with increasing plantation age. The leaf and root concentrations of C, N, and P increased and the ratios C: N, C: P, and N: P decreased with age increase. Leaf N: P ratios were >20, indicating that P was the main factor limiting the growth of C. korshinskii. This study also demonstrated that the regeneration of natural grassland (NG) effectively preserved and enhanced soil nutrient contents. Compared with NG, shrub lands (C. korshinskii) had much lower soil nutrient concentrations, especially for long (>20 years) chronosequence age. Thus, the regeneration of natural grassland is an ecologically beneficial practice for the recovery of degraded soils in this area.	[Zeng, Quanchao; Chen, Yanan; An, Shaoshan] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Lal, Rattan] Ohio State Univ, Carbon Management & Sequestrat Ctr, Columbus, OH USA; [An, Shaoshan] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yang Iing, Shaanxi, Peoples R China	Northwest A&F University - China; University System of Ohio; Ohio State University; Northwest A&F University - China	An, SS (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China.; An, SS (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yang Iing, Shaanxi, Peoples R China.	shan@ms.iswc.ac.cn	Lal, Rattan/D-2505-2013	quanchao, zeng/0000-0003-1272-0227	National Natural Science Foundation of China [41671280, 41171226]; non-profit Industry Research Project of Chinese Ministry of Water Resources [201501045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); non-profit Industry Research Project of Chinese Ministry of Water Resources	This study was supported by the National Natural Science Foundation of China (41671280, 41171226) and the non-profit Industry Research Project of Chinese Ministry of Water Resources (201501045).	An SS, 2008, PEDOSPHERE, V18, P809, DOI 10.1016/S1002-0160(08)60077-6; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Cao CY, 2008, APPL SOIL ECOL, V40, P78, DOI 10.1016/j.apsoil.2008.03.008; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Cheng J, 2012, CLEAN-SOIL AIR WATER, V40, P127, DOI 10.1002/clen.201000438; Cheng M, 2015, J ARID LAND, V7, P216, DOI 10.1007/s40333-014-0043-3; Cheng M, 2015, CATENA, V124, P77, DOI 10.1016/j.catena.2014.09.006; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Feng X, 2013, SCI REPORTS, V3; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Li YF, 2016, ECOL ENG, V90, P387, DOI 10.1016/j.ecoleng.2016.01.079; Liu JB, 2014, POL J ENVIRON STUD, V23, P385; Mage SM, 2013, ECOSYSTEMS, V16, P284, DOI 10.1007/s10021-012-9612-5; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pan FJ, 2015, TREES-STRUCT FUNCT, V29, P883, DOI 10.1007/s00468-015-1170-y; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Ren HY, 2015, PLANT SOIL, V389, P211, DOI 10.1007/s11104-014-2349-5; Rong QQ, 2015, ECOL ENG, V76, P57, DOI 10.1016/j.ecoleng.2014.03.002; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Tessema ZK, 2011, J ARID ENVIRON, V75, P662, DOI 10.1016/j.jaridenv.2011.02.004; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; THOMAS RL, 1967, AGRON J, V59, P240, DOI 10.2134/agronj1967.00021962005900030010x; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Wang D, 2015, CLEAN-SOIL AIR WATER, V43, P1052, DOI 10.1002/clen.201300971; [王绍强 WANG ShaoQiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P3937; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wolf B, 2012, PLANT SOIL, V350, P297, DOI 10.1007/s11104-011-0908-6; Xue ZJ, 2013, ECOL ENG, V60, P204, DOI 10.1016/j.ecoleng.2013.07.045; Yu Y, 2001, ACTA ECOLOGICA SINIC, V22, P433; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zeng QC, 2016, CATENA, V147, P481, DOI 10.1016/j.catena.2016.07.047; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou H, 2012, SOIL TILL RES, V124, P17, DOI 10.1016/j.still.2012.04.006	44	35	39	15	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168890	10.1371/journal.pone.0168890	http://dx.doi.org/10.1371/journal.pone.0168890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076357	Green Submitted, Green Published, gold			2022-12-26	WOS:000391857100019
J	Koo, HJ; Sung, YS; Shim, WH; Xu, H; Choi, CM; Kim, HR; Lee, JB; Kim, MY				Koo, Hyun Jung; Sung, Yu Sub; Shim, Woo Hyun; Xu, Hai; Choi, Chang-Min; Kim, Hyeong Ryul; Lee, Jung Bok; Kim, Mi Young			Quantitative Computed Tomography Features for Predicting Tumor Recurrence in Patients with Surgically Resected Adenocarcinoma of the Lung	PLOS ONE			English	Article							TEXTURE ANALYSIS; PROGNOSTIC VALUE; 7TH EDITION; CT TEXTURE; CANCER; SURVIVAL; CLASSIFICATION; STAGE; HETEROGENEITY; ASSOCIATION	Purpose The purpose of this study was to determine if preoperative quantitative computed tomography (CT) features including texture and histogram analysis measurements are associated with tumor recurrence in patients with surgically resected adenocarcinoma of the lung. Methods The study included 194 patients with surgically resected lung adenocarcinoma who underwent preoperative CT between January 2013 and December 2013. Quantitative CT feature analysis of the lung adenocarcinomas were performed using in-house software based on plug-in package for ImageJ. Ten quantitative features demonstrating the tumor size, attenuation, shape and texture were extracted. The CT parameters obtained from 1-mm and 5mm data were compared using intraclass correlation coefficients. Univariate and multivariable logistic regression methods were used to investigate the association between tumor recurrence and preoperative CT findings. Results The 1-mm and 5-mm data were highly correlated in terms of diameter, perimeter, area, mean attenuation and entropy. Circularity and aspect ratio were moderately correlated. However, skewness and kurtosis were poorly correlated. Multivariable logistic regression analysis revealed that area (odds ratio [OR], 1.002 for each 1-mm 2 increase; P = 0.003) and mean attenuation (OR, 1.005 for each 1.0-Hounsfield unit increase; P = 0.022) were independently associated with recurrence. The receiver operating curves using these two independent predictive factors showed high diagnostic performance in predicting recurrence (C-index = 0.81, respectively). Conclusion Tumor area and mean attenuation are independently associated with recurrence in patients with surgically resected adenocarcinoma of the lung.	[Koo, Hyun Jung; Sung, Yu Sub; Shim, Woo Hyun; Xu, Hai; Kim, Mi Young] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Koo, Hyun Jung; Sung, Yu Sub; Shim, Woo Hyun; Xu, Hai; Kim, Mi Young] Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Xu, Hai] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Choi, Chang-Min] Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Choi, Chang-Min] Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hyeong Ryul] Asan Med Ctr, Thorac & Cardiovasc Surg, Seoul, South Korea; [Lee, Jung Bok] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Epidemiol & Biostat, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Nanjing Medical University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, MY (corresponding author), Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, MY (corresponding author), Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	mimowdr@amc.seoul.kr		Koo, Hyun Jung/0000-0001-5640-3835; Kim, Mi Young/0000-0003-0691-5546	Korean Association for the Study of Lung Cancer	Korean Association for the Study of Lung Cancer	Our study was funded by research grant from Korean Association for the Study of Lung Cancer in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Depeursinge A, 2015, MED PHYS, V42, P2054, DOI 10.1118/1.4916088; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2011, INVEST RADIOL, V46, P160, DOI 10.1097/RLI.0b013e3181f8e8a2; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Gierada DS, 2008, RADIOLOGY, V246, P265, DOI 10.1148/radiol.2461062097; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Iwano S, 2014, CANCER IMAGING, V14, DOI 10.1186/1470-7330-14-3; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Koo HJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002513; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Wilshire CL, 2015, ANN THORAC SURG; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Zhang HW, 2013, RADIOLOGY, V269, P801, DOI 10.1148/radiol.13130110	27	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0167955	10.1371/journal.pone.0167955	http://dx.doi.org/10.1371/journal.pone.0167955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068363	Green Submitted, gold, Green Published			2022-12-26	WOS:000391843900006
J	Pdnn, S; Noordeen, F; Kurukulasuriya, H; Alar, RT; Fernando, L				Pdnn, Sirisena; Noordeen, Faseeha; Kurukulasuriya, Harithra; Alar, Thanuja Romesh; Fernando, LakKumar			Effect of Climatic Factors and Population Density on the Distribution of Dengue in Sri Lanka: A GIS Based Evaluation for Prediction of Outbreaks	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; HEMORRHAGIC-FEVER; VECTOR; TEMPERATURE; VARIABILITY; SURVIVAL; RATES	Dengue is one of the major hurdles to the public health in Sri Lanka, causing high morbidity and mortality. The present study focuses on the use of geographical information systems (GIS) to map and evaluate the spatial and temporal distribution of dengue in Sri Lanka from 2009 to 2014 and to elucidate the association of climatic factors with dengue incidence. Epidemiological, population and meteorological data were collected from the Epidemiology Unit, Department of Census and Statistics and the Department of Meteorology of Sri Lanka. Data were analyzed using SPSS (Version 20, 2011) and R studio (2012) and the maps were generated using Arc GIS 10.2. The dengue incidence showed a significant positive correlation with rainfall (p< 0.0001). No positive correlation was observed between dengue incidence and temperature (p = 0.107) or humidity (p = 0.084). Rainfall prior to 2 and 5 months and a rise in the temperature prior to 9 months positively correlated with dengue incidence as based on the auto-correlation values. A rise in humidity prior to 1 month had a mild positive correlation with dengue incidence. However, a rise in humidity prior to 9 months had a significant negative correlation with dengue incidence based on the auto-correlation values. Remote sensing and GIS technologies give near real time utility of climatic data together with the past dengue incidence for the prediction of dengue outbreaks. In that regard, GIS will be applicable in outbreak predictions including prompt identification of locations with dengue incidence and forecasting future risks and thus direct control measures to minimize major outbreaks.	[Pdnn, Sirisena; Noordeen, Faseeha] Univ Peradeniya, Fac Med, Dept Microbiol, Peradeniya, Sri Lanka; [Kurukulasuriya, Harithra] Univ Peradeniya, Dept Earth Sci, Postgrad Inst Sci, Peradeniya, Sri Lanka; [Alar, Thanuja Romesh] Univ Peradeniya, Fac Sci, Dept Math, Peradeniya, Sri Lanka; [Fernando, LakKumar] Gen Hosp, Ctr Management Dengue & Dengue Haemorrhag Fever, Negombo, Sri Lanka	University of Peradeniya; University of Peradeniya; University of Peradeniya	Noordeen, F (corresponding author), Univ Peradeniya, Fac Med, Dept Microbiol, Peradeniya, Sri Lanka.	faseehan@pdn.ac.lk			National Research Council of Sri Lanka [11-129]	National Research Council of Sri Lanka	This work was funded by the National Research Council of Sri Lanka-Grant No: 11-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SR, 1980, SOC SCI MED-MED GEOG, V14, P307, DOI 10.1016/0160-8002(80)90043-X; Amarakoon AMD, 2004, W INDIAN MED J S2, V53, P60; [Anonymous], 2014, NEARLY 95 PERCENT PO; Chakravarti A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-32; Christophers SR., 1960, AEDES AEGYPTI YELLOW; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Goto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063717; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Kalra N, 1976, J COMMUNI DIS INDIA, p261 ; Kalra N. L., 1997, Dengue Bulletin, V21, P84; Kolivras KN, 2010, CLIM RES, V42, P1, DOI 10.3354/cr00861; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Munasinghe A, 2013, INT J COMPUTER SCI E, V1, p2320 ; Murugananthan K, 2014, INT J INFECT DIS, V27, P32, DOI 10.1016/j.ijid.2014.04.014; Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x; Napier M, 2003, APPL GIS MODELING DE; Pathirana S., 2009, Journal of Rural and Tropical Public Health, V8, P8; Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279; Rose JB, 2000, J AM WATER WORKS ASS, V92, P77; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Scott T, 2010, CURR TOP MICROBIOL, p338 ; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227; Sirisena P., 2016, SL J INFECT DIS, V6, P2, DOI [10.4038/sljid.v6i1.8107, DOI 10.4038/SLJID.V6I1.8107]; Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012; Thammapalo S, 2005, SE ASIAN J TROP MED, p462 ; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Ward M A, 1993, J R Army Med Corps, V139, P109; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WHO, 2019, DENG SEV DENG; World Health Organization, 2009, WHOHTMNTDDEN2009; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; YU HL, 2010, STOCH ENV RES RISK A, V25, P485, DOI DOI 10.1007/S00477-010-0417-9	35	31	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0166806	10.1371/journal.pone.0166806	http://dx.doi.org/10.1371/journal.pone.0166806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068339	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900003
J	Majerus, SJA; Fletter, PC; Ferry, EK; Zhu, H; Gustafson, KJ; Damaser, MS				Majerus, Steve J. A.; Fletter, Paul C.; Ferry, Elizabeth K.; Zhu, Hui; Gustafson, Kenneth J.; Damaser, Margot S.			Suburothelial Bladder Contraction Detection with Implanted Pressure Sensor	PLOS ONE			English	Article							SPINAL-CORD-INJURY; INCREASE CYSTOMETRIC CAPACITY; SYSTEM; NERVE; NEUROMODULATION; STIMULATION; SPHINCTER; ROOTS; CAT	Aims Managing bladder pressure in patients with neurogenic bladders is needed to improve rehabilitation options, avoid upper tract damage, incontinence, and their associated co-morbidities and mortality. Current methods of determining bladder contractions are not amenable to chronic or ambulatory settings. In this study we evaluated detection of bladder contractions using a novel piezoelectric catheter-free pressure sensor placed in a suburothelial bladder location in animals. Methods Wired prototypes of the pressure monitor were implanted into 2 nonsurvival (feline and canine) and one 13-day survival (canine) animal. Vesical pressures were obtained from the device in both suburothelial and intraluminal locations and simultaneously from a pressure sensing catheter in the bladder. Intravesical pressure was monitored in the survival animal over 10 days from the suburothelial location and necropsy was performed to assess migration and erosion. Results In the nonsurvival animals, the average correlation between device and reference catheter data was high during both electrically stimulated bladder contractions and manual compressions (r = 0.93 +/- 0.03, r = 0.89 +/- 0.03). Measured pressures correlated strongly (r = 0.98 +/- 0.02) when the device was placed in the bladder lumen. The survival animal initially recorded physiologic data, but later this deteriorated. However, endstage intraluminal device recordings correlated (r = 0.85 +/- 0.13) with the pressure catheter. Significant erosion of the implant through the detrusor was found. Conclusions This study confirms correlation between suburothelial pressure readings and intravesical bladder pressures. Due to device erosion during ambulatory studies, a wireless implant is recommended for clinical rehabilitation applications.	[Majerus, Steve J. A.; Fletter, Paul C.; Zhu, Hui; Damaser, Margot S.] Louis Stokes Vet Affairs Med Ctr, Adv Pltafform Technol Ctr, Cleveland, OH 44106 USA; [Majerus, Steve J. A.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH USA; [Majerus, Steve J. A.; Fletter, Paul C.; Damaser, Margot S.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Ferry, Elizabeth K.; Zhu, Hui] Louis Stokes Vet Affairs Med Ctr, Div Urol, Cleveland, OH 44106 USA; [Ferry, Elizabeth K.; Gustafson, Kenneth J.] Univ Hosp, Case Med Ctr, Inst Urol, Cleveland, OH USA; [Zhu, Hui; Damaser, Margot S.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA; [Gustafson, Kenneth J.; Damaser, Margot S.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA; [Gustafson, Kenneth J.] Louis Stokes Vet Affairs Med Ctr, Funct Elect Stimulat Ctr, Cleveland, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University Hospitals of Cleveland; Cleveland Clinic Foundation; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Damaser, MS (corresponding author), Louis Stokes Vet Affairs Med Ctr, Adv Pltafform Technol Ctr, Cleveland, OH 44106 USA.; Damaser, MS (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.; Damaser, MS (corresponding author), Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA.; Damaser, MS (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA.	damasem@ccf.org	Majerus, Steve/V-4378-2019	Majerus, Steve/0000-0002-5057-0189	Rehabilitation Research & Development Service of the Veterans Affairs Office of Research and Development, Case Western Reserve University [1I01RX000443-01A2]; Cleveland Clinic; Veterans Affairs [IK1RX001968] Funding Source: NIH RePORTER	Rehabilitation Research & Development Service of the Veterans Affairs Office of Research and Development, Case Western Reserve University; Cleveland Clinic; Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by 1I01RX000443-01A2 from the Rehabilitation Research & Development Service of the Veterans Affairs Office of Research and Development, Case Western Reserve University, and the Cleveland Clinic.	Anderson K, 2008, J SPINAL CORD MED, V31, P133, DOI 10.1080/10790268.2008.11760704; [Anonymous], 2013, J Spinal Cord Med, V36, P394, DOI 10.1179/1079026813Z.000000000196; Axisa F, 2009, IEEE ENG MED BIO, P4864, DOI 10.1109/IEMBS.2009.5332451; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Chow EY, 2010, IEEE T BIOMED CIRC S, V4, P340, DOI 10.1109/TBCAS.2010.2081364; Cleven NJ, 2012, IEEE T BIO-MED ENG, V59, P3124, DOI 10.1109/TBME.2012.2216262; Coosemans J, 2005, SENSOR ACTUAT A-PHYS, V123-24, P155, DOI 10.1016/j.sna.2005.03.040; Dalmose AL, 2003, NEUROUROL URODYNAM, V22, P130, DOI 10.1002/nau.10031; Fjorback MV, 2003, NEUROMODULATION, V6, P158, DOI 10.1046/j.1525-1403.2003.03024.x; Hansen J, 2005, J UROLOGY, V173, P2035, DOI 10.1097/01.ju.0000158160.11083.1b; Hansen J, 2007, IEEE T BIO-MED ENG, V54, P1212, DOI 10.1109/TBME.2007.890739; Horvath EE, 2010, NEUROUROL URODYNAM, V29, P401, DOI 10.1002/nau.20766; Jezernik S, 2001, NEUROUROL URODYNAM, V20, P215, DOI 10.1002/1520-6777(2001)20:2<215::AID-NAU23>3.3.CO;2-S; Karam R, 2016, IEEE T BIO-MED ENG, V63, P721, DOI 10.1109/TBME.2015.2469604; Kirkham APS, 2002, SPINAL CORD, V40, P272, DOI 10.1038/sj.sc.3101278; Kirkham APS, 2001, SPINAL CORD, V39, P420, DOI 10.1038/sj.sc.3101177; Kurstjens GAM, 2005, J UROLOGY, V174, P1482, DOI 10.1097/01.ju.0000173005.70269.9c; Lee DS, 2011, KAOHSIUNG J MED SCI, V27, P132, DOI 10.1016/j.kjms.2010.12.006; Majerus SJA, 2012, ACM J EMERG TECH COM, V8, DOI 10.1145/2180878.2180883; Majerus SJA, 2011, IEEE T BIO-MED ENG, V58, P763, DOI 10.1109/TBME.2010.2085002; Martens FMJ, 2010, NEUROUROL URODYNAM, V29, P395, DOI 10.1002/nau.20770; Melgaard J, 2011, IEEE T NEUR SYS REH, V19, P700, DOI 10.1109/TNSRE.2011.2171368; Opisso E, 2008, J UROLOGY, V180, P1403, DOI 10.1016/j.juro.2008.06.023; Schulman JH, 2008, P IEEE, V96, P1226, DOI 10.1109/JPROC.2008.922588; Valdastri P, 2004, IEEE T INF TECHNOL B, V8, P271, DOI 10.1109/TITB.2004.834389; Wang CC, 2008, IEEE T BIOMED CIRC S, V2, P44, DOI 10.1109/TBCAS.2008.921601; Wenzel BJ, 2006, J UROLOGY, V175, P1559, DOI 10.1016/S0022-5347(05)00657-9; Wenzel BJ, 2006, NEUROUROL URODYNAM, V25, P140, DOI 10.1002/nau.20204; Widerstrom-Noga EG, 1999, ARCH PHYS MED REHAB, V80, P580, DOI 10.1016/S0003-9993(99)90203-4	29	21	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168375	10.1371/journal.pone.0168375	http://dx.doi.org/10.1371/journal.pone.0168375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060842	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500029
J	Meggi, B; Bollinger, T; Mabunda, N; Vubil, A; Tobaiwa, O; Quevedo, JI; Loquiha, O; Vojnov, L; Peter, TF; Jani, IV				Meggi, Bindiya; Bollinger, Timothy; Mabunda, Nedio; Vubil, Adolfo; Tobaiwa, Ocean; Quevedo, Jorge I.; Loquiha, Osvaldo; Vojnov, Lara; Peter, Trevor F.; Jani, Ilesh V.			Point-Of-Care p24 Infant Testing for HIV May Increase Patient Identification despite Low Sensitivity	PLOS ONE			English	Article							DIAGNOSIS; ANTIGEN; INFECTION; ASSAY	The long delay in returning test results during early infant diagnosis of HIV (EID) often causes loss-to-follow-up prior to antiretroviral treatment (ART) initiation in resource-limited settings. A point-of-care (POC) test may help overcome these challenges. We evaluated the performance of the LYNX p24 Antigen POC test in Mozambique. 879 HIV-exposed infants under 18 months of age were enrolled consecutively at three primary healthcare clinics (PHC). Lancet heel-drawn blood was tested on-site by nurses using a prototype POC test for HIV Gag p24 antigen detection. Results of POC testing were compared to laboratory-based nucleic acid testing on dried blood spots. A comparison of the effect of sensitivity and timely test results return on successful diagnosis by POC and laboratory-based platforms was also calculated. The sensitivity and specificity of the LYNX p24 Ag test were 71.9%; (95% confidence interval [CI]: 58.5-83.0%) and 99.6% (95% CI: 98.9-99.9%), respectively. The predictive value of positive and negative tests were 93.2% (95% CI: 81.3-98.6%) and 97.9% (95% CI: 96.8-98.8%), respectively. Overall agreement was high (Cohen Kappa = 0.80; 95% CI: 0.71-0.89). Despite its lower sensitivity, the POC test had the potential to provide test results to up to 81% more patients compared to the laboratory-based test. This prototype POC p24 assay was feasible for use in PHCs but demonstrated low sensitivity for HIV detection. POC EID technologies that perform below standard recommendations may still be valuable diagnostic tools in settings with inefficient EID networks.	[Meggi, Bindiya; Mabunda, Nedio; Vubil, Adolfo; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Bollinger, Timothy; Tobaiwa, Ocean; Quevedo, Jorge I.; Vojnov, Lara; Peter, Trevor F.] Clinton Hlth Access Initiat, Maputo, Mozambique; [Loquiha, Osvaldo] Univ Eduardo Mondlane, Dept Math & Informat, Maputo, Mozambique	Eduardo Mondlane University	Meggi, B (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	bindiyameggi@gmail.com		Jani, Ilesh/0000-0002-6880-6655; Vojnov, Lara/0000-0003-0488-1012	UNITAID; Government of Flanders	UNITAID; Government of Flanders	This study was funded by UNITAID and the Government of Flanders. All the funding or sources of support received during this specific study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Carmona S, 2016, AIDS 2016; [CHAI Unitaid UNICEF], 2013, INN SAV LIV PROJ ACC; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; George E, 2007, J CLIN MICROBIOL, V45, P3416, DOI 10.1128/JCM.01314-07; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Ly TD, 2004, J VIROL METHODS, V122, P185, DOI 10.1016/j.jviromet.2004.08.018; SCHUPBACH J, 1994, J INFECT DIS, V170, P318, DOI 10.1093/infdis/170.2.318; Stevens W, 2008, Open AIDS J, V2, P17, DOI 10.2174/1874613600802010017; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, 2014, UND FAST TRACK ACC A; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2013, 2013 CONS GUID US S; World Health Organization, 2010, REC DIAGN HIV INF IN; Zijenah LS, 2005, JAIDS-J ACQ IMM DEF, V39, P391, DOI 10.1097/01.qai.0000158401.59047.84	16	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169497	10.1371/journal.pone.0169497	http://dx.doi.org/10.1371/journal.pone.0169497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060886	gold, Green Published			2022-12-26	WOS:000391641500102
J	Yamamoto, T; Asahina, M; Yamanaka, Y; Uchiyama, T; Hirano, S; Fuse, M; Koga, Y; Sakakibara, R; Kuwabara, S				Yamamoto, Tatsuya; Asahina, Masato; Yamanaka, Yoshitaka; Uchiyama, Tomoyuki; Hirano, Shigeki; Fuse, Miki; Koga, Yasuko; Sakakibara, Ryuji; Kuwabara, Satoshi			The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson's Disease	PLOS ONE			English	Article							URINARY DYSFUNCTION; DIAGNOSIS; EMG	Objective To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for distinguishing multiple system atrophy (MSA) from Parkinson's disease (PD). Methods We retrospectively reviewed 241 case records; both urodynamic study and sphincter EMG were performed in patients with MSA (n = 147) and PD (n = 94). Results There was a statistically significant difference (p < 0.01) in the mean PVR during the free-flow study (113.1 +/- 7.5 mL in MSA and 40.4 +/- 3.8 mL in PD), mean PVR during PFS (230.1 +/- 12.6 mL in MSA and 71.7 +/- 6.6 mL in PD), and mean duration of MUP for sphincter EMG (9.3 +/- 0.1 ms in MSA and 7.7 +/- 0.1 ms in PD). The area under the curve used for differentiating MSA from PD was 0.79 and 0.73 for PVR during PFS and the free-flow study, respectively. There was a mean duration of 0.69 ms for the sphincter EMG. Conclusions The present results suggested that PVR was more appropriate than sphincter EMG for differentiating MSA from PD.	[Yamamoto, Tatsuya; Asahina, Masato; Yamanaka, Yoshitaka; Uchiyama, Tomoyuki; Hirano, Shigeki; Sakakibara, Ryuji; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Univ, Dept Neurol, Continence Ctr, Mibu, Tochigi, Japan; [Fuse, Miki] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan; [Koga, Yasuko] Chiba Univ, Dept Mol Diag, Grad Sch Med, Chiba, Japan; [Sakakibara, Ryuji] Toho Univ, Sakura Med Ctr, Div Neurol, Dept Internal Med, Sakura, Japan	Chiba University; Dokkyo Medical University; Chiba University; Chiba University; Toho University	Yamamoto, T (corresponding author), Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan.	tatsuya-yamamoto@mbc.nifty.com	Sakakibara, Ryuji/AAE-3829-2019	Sakakibara, Ryuji/0000-0002-5803-169X; Asahina, Masato/0000-0002-4177-2379; Kuwabara, Satoshi/0000-0002-4716-8578; Yamamoto, Tatsuya/0000-0003-4297-6354				Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Giladi N, 2000, MUSCLE NERVE, V23, P731, DOI 10.1002/(SICI)1097-4598(200005)23:5<731::AID-MUS10>3.0.CO;2-#; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hajian Tilaki KO, 2011, J APP STAT, V38, P2009; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ito T, 2006, MOVEMENT DISORD, V21, P816, DOI 10.1002/mds.20815; Jellinger KA, 2014, MOVEMENT DISORD, V29, P1720, DOI 10.1002/mds.26052; Palace J, 1997, MUSCLE NERVE, V20, P1396; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Podnar S, 2004, MUSCLE NERVE, V29, P151, DOI 10.1002/mus.10478; Sakakibara R, 2015, NEUROUROL U IN PRESS; Sakakibara R, 2009, CLIN AUTON RES, V19, P20, DOI 10.1007/s10286-008-0489-5; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075; Vodusek DB, 2005, J NEURAL TRANSM, V112, P1657, DOI 10.1007/s00702-005-0377-2; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Winge K, 2010, ACTA NEUROL SCAND, V121, P198, DOI 10.1111/j.1600-0404.2009.01169.x; Yamamoto T, 2005, J NEUROL NEUROSUR PS, V76, P1645, DOI 10.1136/jnnp.2004.061036; Yamamoto T, 2011, NEUROUROL URODYNAM, V30, P102, DOI 10.1002/nau.20948; Yamamoto T, 2014, NEUROUROL URODYNAM, V33, P516, DOI 10.1002/nau.22441; Yamamoto T, 2012, NEUROUROL URODYNAM, V31, P1128, DOI 10.1002/nau.22208	24	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169405	10.1371/journal.pone.0169405	http://dx.doi.org/10.1371/journal.pone.0169405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060892	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500088
J	Frost, RLA; Monaghan, P				Frost, Rebecca L. A.; Monaghan, Padraic			Sleep-Driven Computations in Speech Processing	PLOS ONE			English	Article							SLOW-WAVE SLEEP; ALGEBRAIC-LIKE COMPUTATIONS; MEMORY CONSOLIDATION; NONADJACENT DEPENDENCIES; OFFLINE CONSOLIDATION; LANGUAGE-ACQUISITION; LOW ACETYLCHOLINE; VERBAL MEMORY; INFANTS; INTERFERENCE	Acquiring language requires segmenting speech into individual words, and abstracting over those words to discover grammatical structure. However, these tasks can be conflicting on the one hand requiring memorisation of precise sequences that occur in speech, and on the other requiring a flexible reconstruction of these sequences to determine the grammar. Here, we examine whether speech segmentation and generalisation of grammar can occur simultaneously-with the conflicting requirements for these tasks being over-come by sleep-related consolidation. After exposure to an artificial language comprising words containing non-adjacent dependencies, participants underwent periods of consolidation involving either sleep or wake. Participants who slept before testing demonstrated a sustained boost to word learning and a short-term improvement to grammatical generalisation of the non-adjacencies, with improvements after sleep outweighing gains seen after an equal period of wake. Thus, we propose that sleep may facilitate processing for these conflicting tasks in language acquisition, but with enhanced benefits for speech segmentation.	[Frost, Rebecca L. A.; Monaghan, Padraic] Univ Lancaster, Dept Psychol, Lancaster, England	Lancaster University	Frost, RLA (corresponding author), Univ Lancaster, Dept Psychol, Lancaster, England.	r.frost1@lancaster.ac.uk	Monaghan, Padraic/E-6812-2010	Monaghan, Padraic/0000-0003-3965-2682; Frost, Rebecca/0000-0002-5556-4466	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council [ES/L008955/1]; ESRC [ES/L008955/1] Funding Source: UKRI	International Centre for Language and Communicative Development (LuCiD); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the International Centre for Language and Communicative Development (LuCiD). The support of the Economic and Social Research Council [ES/L008955/1] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger SE, 2012, NEUROBIOL LEARN MEM, V98, P188, DOI 10.1016/j.nlm.2012.06.003; Altmann GTM, 2002, P NATL ACAD SCI USA, V99, P15250, DOI 10.1073/pnas.262659399; Ambridge B., 2011, CHILD LANGUAGE ACQUI; Ambridge B, 2013, COGNITIVE SCI, V37, P508, DOI 10.1111/cogs.12018; Batterink LJ, 2014, NEUROPSYCHOLOGIA, V65, P169, DOI 10.1016/j.neuropsychologia.2014.10.024; Black, 1990, FESTIVAL SPEECH SYNT; Brown H, 2012, J EXP CHILD PSYCHOL, V112, P56, DOI 10.1016/j.jecp.2011.11.010; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Christiansen M. H., 2016, BEHAV BRAIN SCI, V39; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Dumay N, 2005, BEHAV BRAIN SCI, V28, P69, DOI 10.1017/S0140525X05270024; Dumay N, 2007, PSYCHOL SCI, V18, P35, DOI 10.1111/j.1467-9280.2007.01845.x; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; Endress AD, 2007, COGNITION, V105, P247, DOI 10.1016/j.cognition.2006.09.010; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Frost RLA, 2016, COGNITION, V147, P70, DOI 10.1016/j.cognition.2015.11.010; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Gaskell MG, 2014, PSYCHOL SCI, V25, P1457, DOI 10.1177/0956797614535937; Gerken L, 2006, COGNITION, V98, pB67, DOI 10.1016/j.cognition.2005.03.003; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Lany J, 2007, COGNITIVE SCI, V31, P481, DOI 10.1080/15326900701326584; Lau HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027139; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mirkovic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152489; Morgan K., 2007, NHS SLEEP DIARY CLIN; Mueller JL, 2008, J COGNITIVE NEUROSCI, V20, P892, DOI 10.1162/jocn.2008.20511; Nieuwenhuis ILC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065046; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 2006, J EXP PSYCHOL GEN, V135, P322, DOI 10.1037/0096-3445.135.2.322; Perruchet P, 2004, J EXP PSYCHOL GEN, V133, P573, DOI 10.1037/0096-3445.133.4.573; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sheth BR, 2012, SLEEP, V35, P985, DOI 10.5665/sleep.1966; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Tamminen J, 2012, COGNITION, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Tomasello M., 2003, CONSTRUCTING LANGUAG; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; van den Bos E, 2012, J MEM LANG, V67, P507, DOI 10.1016/j.jml.2012.07.008; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Williams SE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00184	49	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169538	10.1371/journal.pone.0169538	http://dx.doi.org/10.1371/journal.pone.0169538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AE	28056104	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100052
J	Gahlot, S; Nasreen, N; Johnson, JA; Sahn, SA; Mohammed, KA				Gahlot, Satindra; Nasreen, Najmunnisa; Johnson, Judith A.; Sahn, Steven A.; Mohammed, Kamal A.			Heme Oxygenase-1 Deficiency Diminishes Methicillin-Resistant Staphylococcus aureus Clearance Due to Reduced TLR9 Expression in Pleural Mesothelial Cells	PLOS ONE			English	Article							CARBON-MONOXIDE; HOST-DEFENSE; MITOCHONDRIAL BIOGENESIS; HUMAN BETA-DEFENSIN-3; BACTERIAL INDUCTION; DENDRITIC CELLS; NASAL CARRIAGE; PNEUMONIA; SEPSIS; ACTIVATION	Methicillin Resistant Staphylococcus aureus (MRSA) cause pneumonia and empyema thoraces. TLR9 activation provides protection against bacterial infections and Heme oxygenase-1 (HO-1) is known to enhance host innate immunity against bacterial infections. However, it is still unclear whether HO-1 regulates TLR-9 expression in the pleura and modulates the host innate defenses during MRSA empyema. In order to determine if HO-1 regulates host innate immune functions via modulating TLR expression, in MRSA empyema, HO-1(+/+) and HO-1(-/-) mouse pleural mesothelial cells (PMCs) were infected with MRSA (1:10, MOI) in the presence or absence of Cobalt Protoporphyrin (CoPP) and Zinc Protoporphyrin (ZnPP) or CORM-2 (a Carbon monoxide donor) and the expression of mTLR9 and mBD14 was assessed by RT-PCR. In vivo, HO-1(+/+) and HO-1(-/-) mice were inoculated with MRSA (5x10(6) CFU) intra-pleurally and host bacterial load was measured by CFU, and TLR9 expression in the pleura was determined by histochemical-immunostaining. We noticed MRSA inducing differential expression of TLR9 in HO-1(+/+) and HO-1(-/-) PMCs. In MRSA infected HO-1(+/+) PMCs, TLR1, TLR4, and TLR9 expression was several fold higher than MRSA infected HO-1(-/-) PMCs. Particularly TLR9 expression was very low in MRSA infected HO-1(-/-) PMCs both in vivo and in vitro. Bacterial clearance was significantly higher in HO-1(+/+) PMCs than compared to HO-1(-/-) PMCs in vitro, and blocking TLR9 activation diminished MRSA clearance significantly. In addition, HO-1(-/-) mice were unable to clear the MRSA bacterial load in vivo. MRSA induced TLR9 and mBD14 expression was significantly high in HO-1(+/+) PMCs and it was dependent on HO-1 activity. Our findings suggest that HO-1 by modulating TLR9 expression in PMCs promotes pleural innate immunity in MRSA empyema.	[Gahlot, Satindra; Nasreen, Najmunnisa; Mohammed, Kamal A.] North Florida South Georgia Vet Hlth Syst, Malcom Randall Vet Affairs Med Ctr, Gainesville, FL 32608 USA; [Gahlot, Satindra; Nasreen, Najmunnisa; Mohammed, Kamal A.] Univ Florida, Dept Med, Div Pulm & Crit Care Med, Gainesville, FL 32611 USA; [Johnson, Judith A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Sahn, Steven A.] Med Univ South Carolina, Div Pulm & Crit Care Med, Charleston, SC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical University of South Carolina	Mohammed, KA (corresponding author), North Florida South Georgia Vet Hlth Syst, Malcom Randall Vet Affairs Med Ctr, Gainesville, FL 32608 USA.; Mohammed, KA (corresponding author), Univ Florida, Dept Med, Div Pulm & Crit Care Med, Gainesville, FL 32611 USA.	mkamal@medicin.ufl.edu			Veterans Affairs Merit grant; UF-Gatorade grant	Veterans Affairs Merit grant(US Department of Veterans Affairs); UF-Gatorade grant	This work was supported by the Veterans Affairs Merit grant and by the UF-Gatorade grant to K.A. Mohammed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Veterans Affairs Merit grant, and UF-Gatorade grant to KA Mohammed. This work was supported with resources and the use of facilities at the North Florida/South Georgia Veterans Health System, Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida, United States of America.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Antony VB, 2003, EUR RESPIR J, V21, P539, DOI 10.1183/09031936.03.00403902; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Christopher ME, 2008, INT J MOL SCI, V9, P1561, DOI 10.3390/ijms9091561; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Esposito S, 2013, EUR J CLIN MICROBIOL, V32, P877, DOI 10.1007/s10096-013-1821-0; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Iho S, 2015, HUM VACC IMMUNOTHER, V11, P755, DOI 10.1080/21645515.2014.1004033; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161, DOI 10.1097/01.qco.0000216627.13445.e2; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Mohammed KA, 1999, AM J RESP CRIT CARE, V159, P1653, DOI 10.1164/ajrccm.159.5.9810011; Mohammed KA, 2001, AM J PHYSIOL-LUNG C, V281, pL119, DOI 10.1152/ajplung.2001.281.1.L119; Mohammed KA, 2000, J INFECT DIS, V181, P1693, DOI 10.1086/315422; Mohammed KA, 2007, LUNG, V185, P355, DOI 10.1007/s00408-007-9046-6; Morse D, 2012, AM J RESP CRIT CARE, V185, P800, DOI 10.1164/rccm.201202-0224ED; Nakahira K, 2015, AM J PHYSIOL-LUNG C, V309, pL1387, DOI 10.1152/ajplung.00311.2015; Nasreen N, 2000, AM J PHYSIOL-LUNG C, V278, pL591, DOI 10.1152/ajplung.2000.278.3.L591; Nasreen N, 1999, J INFECT DIS, V180, P1616, DOI 10.1086/315057; Nasreen N, 2006, CANCER-AM CANCER SOC, V107, P2425, DOI 10.1002/cncr.22254; Nurjadi D, 2013, J INFECT DIS, V207, P666, DOI 10.1093/infdis/jis735; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Otterbein LE, 2005, CELL MOL BIOL, V51, P433, DOI 10.1170/T647; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parker D, 2012, J IMMUNOL, V189, P4040, DOI 10.4049/jimmunol.1201055; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; de Oca EPM, 2013, INNATE IMMUN-LONDON, V19, P227, DOI 10.1177/1753425912460708; Prasad R, 2014, PAEDIATR INT CHILD H, V34, P125, DOI 10.1179/2046905513Y.0000000085; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Sjolinder H, 2008, INFECT IMMUN, V76, P5421, DOI 10.1128/IAI.00615-08; Slebos DJ, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-7; Tachibana M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025046; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Yasuda H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035824; Zanger P, 2011, INFECT IMMUN, V79, P2658, DOI 10.1128/IAI.00101-11	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169245	10.1371/journal.pone.0169245	http://dx.doi.org/10.1371/journal.pone.0169245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052108	gold, Green Submitted, Green Published			2022-12-26	WOS:000391621500040
J	Stevens, AJ; Kennedy, MA				Stevens, Aaron J.; Kennedy, Martin A.			Structural Analysis of G-Quadruplex Formation at the Human MEST Promoter	PLOS ONE			English	Article							HUMAN PEG1/MEST; DNA TRIPLEX; METHYLATION; GENE; EXPRESSION; SEQUENCES; SINGLE; REGION	The promoter region of the imprinted gene MEST contains several motifs capable of forming G-quadruplex (G4) structures, which appear to contribute to consistent allelic dropout during polymerase chain reaction (PCR) analysis of this region. Here, we extend our previous analysis of MEST G4 structures by applying fluorescent footprinting techniques to assess non B-DNA structure and topology in dsDNA from the full MEST promoter region, under conditions that mimic PCR. We demonstrate that the buffer used for PCR provides an extremely favourable milieu for G4 formation, and that cytosine methylation helps maintain G4 structures during PCR. Additionally, we demonstrate G4 formation at motifs not previously identified through bioinformatic analysis of the MEST promoter, and provide nucleotide level resolution for topological reconstruction of these structures. These observations increase our understanding of the mechanisms through which methylation and G4 contribute towards allelic drop-out during PCR.	[Stevens, Aaron J.; Kennedy, Martin A.] Univ Otago, Sch Med, Dept Pathol, Christchurch, New Zealand	University of Otago	Stevens, AJ (corresponding author), Univ Otago, Sch Med, Dept Pathol, Christchurch, New Zealand.	aaron.stevens@otago.ac.nz	Kennedy, Martin A/A-4942-2008; Stevens, Aaron J./Y-2145-2019; Kennedy, Martin/O-4540-2019	Kennedy, Martin A/0000-0002-6445-8526; Stevens, Aaron J./0000-0001-9148-8045; Kennedy, Martin/0000-0002-6445-8526	Marsden Fund Council from New Zealand Government funding [11-U00-175 BMS]; Carney Centre for Pharmacogenomics, University of Otago; University of Otago Graduate Research Committee	Marsden Fund Council from New Zealand Government funding(Royal Society of New ZealandMarsden Fund (NZ)); Carney Centre for Pharmacogenomics, University of Otago; University of Otago Graduate Research Committee	This research was supported by the Marsden Fund (11-U00-175 BMS) Council from New Zealand Government funding, administered by the Royal Society of New Zealand, and by the Carney Centre for Pharmacogenomics, University of Otago.; We acknowledge the support of the University of Otago Graduate Research Committee by providing a Postgraduate Publishing Bursary (Doctoral) to AJS. We thank Grant Pearce of the Biomolecular Interaction Centre, from the University of Canterbury for access to the circular dichroism spectrometer. We also thank Allison Miller and Andrew Bagshaw for constructive advice.	Asensio JL, 1998, BIOCHEMISTRY-US, V37, P15188, DOI 10.1021/bi980057m; BATES PJ, 1995, NUCLEIC ACIDS RES, V23, P3627, DOI 10.1093/nar/23.18.3627; BAUMANN U, 1986, EUR J BIOCHEM, V161, P409, DOI 10.1111/j.1432-1033.1986.tb10460.x; Biffi G, 2013, NATURE CHEM; Biffi G, 2012, J AM CHEM SOC; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; Fletcher TM, 1998, BIOCHEMISTRY-US, V37, P5536, DOI 10.1021/bi972681p; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Leitner D, 2000, BIOCHEMISTRY-US, V39, P5886, DOI 10.1021/bi992630n; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; RADHAKRISHNAN I, 1994, BIOCHEMISTRY-US, V33, P11405, DOI 10.1021/bi00204a001; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; SAMADASHWILY GM, 1993, EMBO J, V12, P4975, DOI 10.1002/j.1460-2075.1993.tb06191.x; Saunders CJ, 2010, GENET TEST MOL BIOMA, V14, P241, DOI 10.1089/gtmb.2009.0178; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Stevens AJ, 2016, BIOCHEMISTRY-US, V55, P3714, DOI 10.1021/acs.biochem.6b00327; Stevens AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113955; Sundquist WI, 1989, TELOMERIC DNA DIMERI, DOI [10.1038/342825a0, DOI 10.1038/342825A0]; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; Weitzmann MN, 1996, J BIOL CHEM, V271, P20958, DOI 10.1074/jbc.271.34.20958; Wenzel JJ, 2009, CLIN CHEM, V55, P1361, DOI 10.1373/clinchem.2008.118661	34	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169433	10.1371/journal.pone.0169433	http://dx.doi.org/10.1371/journal.pone.0169433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052120	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500060
J	Roberts, R; Mayberry, LK; Browning, KS; Rakotondrafara, AM				Roberts, Robyn; Mayberry, Laura K.; Browning, Karen S.; Rakotondrafara, Aurelie M.			The Triticum Mosaic Virus 5 ' Leader Binds to Both eIF4G and elFiso4G for Translation	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS INITIATION; TOBACCO ETCH VIRUS; MESSENGER-RNAS; PLANT-VIRUSES; WHEAT-GERM; EIF(ISO)4F; COMPLEXES; SUBUNIT; ELEMENT	We recently identified a remarkably strong (739 nt-long) IRES-like element in the 5' untranslated region (UTR) of Triticum mosaic virus (TriMV, Potyviridae). Here, we define the components of the cap-binding translation initiation complex that are required for TriMV translation. Using bio-layer interferometry and affinity capture of the native translation apparatus, we reveal that the viral translation element has a ten-fold greater affinity for the large subunit eIF4G/elFiso4G than to the cap binding protein eIF4E/elFiso4E. This data supports a translation mechanism that is largely dependent on eIF4G and its isoform. The binding of both scaffold isoforms requires an eight base-pair-long hairpin structure located 270 nucleotides upstream of the translation initiation site, which we have previously shown to be crucial for IRES activity. Despite a weak binding affinity to the mRNA, elFiso4G alone or in combination with elFiso4E supports TriMV translation in a cap-binding factor-depleted wheat germ extract. Notably, TriMV 5' UTR-mediated translation is dependent upon eIF4A helicase activity, as the addition of the eIF4A inhibitor hippuristanol inhibits 5' UTR-mediated translation. This inhibition is reversible with the addition of recombinant wheat eIF4A. These results and previous observations demonstrate a key role of eIF4G and eIF4A in this unique mechanism of cap-independent-translation. This work provides new insights into the lesser studied translation mechanisms of plant virus-mediated internal translation initiation.	[Roberts, Robyn; Browning, Karen S.] Univ Wisconsin, Dept Plant Pathol, Madison, WI USA; [Mayberry, Laura K.; Rakotondrafara, Aurelie M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Austin	Rakotondrafara, AM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	rakatondrafa@wisc.edu		Roberts, Robyn/0000-0003-0017-0619	Hatch Formula Act Fund; National Science Foundation	Hatch Formula Act Fund; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Hatch Formula Act Fund and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; Lozano G, 2015, CURR OPIN VIROL, V12, P113, DOI 10.1016/j.coviro.2015.04.008; Martinez-Salas E, 2015, VIRUS RES, V206, P62, DOI 10.1016/j.virusres.2015.01.012; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; Roberts R, 2015, J VIROL, V89, P12427, DOI 10.1128/JVI.02099-15; Seifers DL, 2008, PLANT DIS, V92, P808, DOI 10.1094/PDIS-92-5-0808; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tatineni S, 2009, PHYTOPATHOLOGY, V99, P943, DOI 10.1094/PHYTO-99-8-0943; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Wang ZH, 2009, J BIOL CHEM, V284, P14189, DOI 10.1074/jbc.M808841200; Zhang JC, 2015, VIRUS RES, V206, P74, DOI 10.1016/j.virusres.2015.02.005	26	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169602	10.1371/journal.pone.0169602	http://dx.doi.org/10.1371/journal.pone.0169602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046134	Green Submitted, gold, Green Published			2022-12-26	WOS:000391612300208
J	Papaioannou, G; Petit, ET; Liu, ES; Baccarini, M; Pritchard, C; Demay, MB				Papaioannou, Garyfallia; Petit, Elizabeth T.; Liu, Eva S.; Baccarini, Manuela; Pritchard, Catrin; Demay, Marie B.			Raf Kinases Are Essential for Phosphate Induction of ERK1/2 Phosphorylation in Hypertrophic Chondrocytes and Normal Endochondral Bone Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; caspase; chondrocyte; growth plate; Raf kinase; phosphate; rickets	B-RAF; GROWTH-PLATE; PROTEIN-KINASE; CONSTITUTIVE ACTIVATION; CELL-PROLIFERATION; TRANSGENIC MICE; A-RAF; APOPTOSIS; DIFFERENTIATION; EXPRESSION	Hypophosphatemia causes rickets by impairing hypertrophic chondrocyte apoptosis. Phosphate induction of MEK1/2-ERK1/2 phosphorylation in hypertrophic chondrocytes is required for phosphate-mediated apoptosis and growth plate maturation. MEK1/2 can be activated by numerous molecules including Raf isoforms. A- and B-Raf ablation in chondrocytes does not alter skeletal development, whereas ablation of C-Raf decreases hypertrophic chondrocyte apoptosis and impairs vascularization of the growth plate. However, ablation of C-Raf does not impair phosphate-induced ERK1/2 phosphorylation in vitro, but leads to rickets by decreasing VEGF protein stability. To determine whether Raf isoforms are required for phosphate-induced hypertrophic chondrocyte apoptosis, mice lacking all three Raf isoforms in chondrocytes were generated. Raf deletion caused neonatal death and a significant expansion of the hypertrophic chondrocyte layer of the growth plate, accompanied by decreased cleaved caspase-9. This was associated with decreased phospho-ERK1/2 immunoreactivity in the hypertrophic chondrocyte layer and impaired vascular invasion. These data further demonstrated that Raf kinases are required for phosphate-induced ERK1/2 phosphorylation in cultured hypertrophic chondrocytes and perform essential, but partially redundant roles in growth plate maturation.	[Papaioannou, Garyfallia; Petit, Elizabeth T.; Liu, Eva S.; Demay, Marie B.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Papaioannou, Garyfallia; Liu, Eva S.; Demay, Marie B.] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Eva S.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Baccarini, Manuela] Univ Vienna, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Max F Perutz Labs, Doktor Bohr Gasse 9, A-1030 Vienna, Austria; [Pritchard, Catrin] Univ Leicester, Dept Mol & Cell Biol, Univ Rd, Leicester LE1 7RH, Leics, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Leicester	Demay, MB (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.; Demay, MB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	demay@helix.mgh.harvard.edu	; Baccarini, Manuela/B-6481-2014	Pritchard, Catrin/0000-0003-1859-4487; Baccarini, Manuela/0000-0002-3033-391X	National Institutes of Health [P30 AR061313, R01 AR061376]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR067854, P30AR066261, R01AR061376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974, T32DK007529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P30 AR061313 and R01 AR061376 (to M. B. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Carlevaro MF, 2000, J CELL SCI, V113, P59; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen ZJ, 2015, J BONE MINER RES, V30, P765, DOI 10.1002/jbmr.2409; Donohue MM, 2002, ENDOCRINOLOGY, V143, P3691, DOI 10.1210/en.2002-220454; Emons JAM, 2006, PEDIATR RES, V60, P288, DOI 10.1203/01.pdr.0000232790.53527.c6; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; KANEKO Y, 1994, CALCIFIED TISSUE INT, V54, P426, DOI 10.1007/BF00305531; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Kern F, 2013, ONCOGENE, V32, P2483, DOI 10.1038/onc.2012.254; Ko FC, 2016, J BONE MINER RES, V31, P2204, DOI 10.1002/jbmr.2891; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Liu ES, 2016, DEVELOPMENT, V143, P348, DOI 10.1242/dev.127142; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Papaioannou G, 2013, P NATL ACAD SCI USA, V110, pE3291, DOI 10.1073/pnas.1302797110; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Sebastian A, 2011, J ORTHOP RES, V29, P375, DOI 10.1002/jor.21262; Spirli C, 2012, HEPATOLOGY, V56, P2363, DOI 10.1002/hep.25872; Thiel G, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-8; Urosevic J, 2011, P NATL ACAD SCI USA, V108, P5015, DOI 10.1073/pnas.1016933108; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vakana E., 2016, ONCOTARGET, DOI 10.18632/oncotarget.14002; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	42	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3164	3171		10.1074/jbc.M116.763342	http://dx.doi.org/10.1074/jbc.M116.763342			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073913	hybrid, Green Published			2022-12-26	WOS:000395538800010
J	Tomino, A; Tsuda, M; Aoki, R; Kajita, Y; Hashiba, M; Terajima, T; Kano, H; Takeyama, N				Tomino, Atsutoshi; Tsuda, Masanobu; Aoki, Ruri; Kajita, Yuka; Hashiba, Masamitsu; Terajima, Tsuguaki; Kano, Hideki; Takeyama, Naoshi			Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; IMMUNE DYSFUNCTIONS; DR EXPRESSION; HLA-DR; SEPSIS; IMMUNOSUPPRESSION; INFECTION; IMMUNOTHERAPY; LIGANDS; TIME	Sepsis causes impairment of innate and adaptive immunity by multiple mechanisms, including depletion of immune effector cells and T cell exhaustion. Although lymphocyte dysfunction is associated with increased mortality and potential reactivation of latent viral infection in patients with septic shock, the relation between viral reactivation and lymphocyte dysfunction is obscure. The objectives of this study were 1) to determine the relation of lymphocyte dysfunction to viral reactivation and mortality, and 2) to evaluate recovery of lymphocyte function during septic shock, including T cell receptor (TCR) diversity and the expression of programmed death 1 (PD-1). In 18 patients with septic shock and latent cytomegalovirus (CMV) infection, serial blood samples were obtained on days 1, 3, and 7 after the onset of shock, and immune cell subsets and receptor expression were characterized by flow cytometry. TCR diversity of peripheral blood mononuclear cells was analyzed by Multi-N-plex PCR, and CMV DNA was quantified using a real-time PCR kit. A decrease of TCR diversity and monocyte HLA-DR expression were observed in the early stage of septic shock, while CD4+ T cells displayed an increase of PD-1 expression. Significant lymphopenia persisted for at least 7 days following the onset of septic shock. Normalization of TCR diversity and PD-1 expression was observed by day 7, except in patients who died. CMV reactivation was detected in 3 of the 18 patients during the first week of their ICU stay and all 3 patients died. These changes are consistent with the early stage of immune cell exhaustion and indicate the importance of normal lymphocyte function for recovery from septic shock. Ongoing lymphocyte dysfunction is associated with CMV reactivation and dissemination, as well as with unfavorable outcomes.	[Tomino, Atsutoshi; Tsuda, Masanobu; Aoki, Ruri; Kajita, Yuka; Hashiba, Masamitsu; Terajima, Tsuguaki; Kano, Hideki; Takeyama, Naoshi] Aichi Med Univ, Dept Emergency & Crit Care Med, Aichi, Japan	Aichi Medical University	Takeyama, N (corresponding author), Aichi Med Univ, Dept Emergency & Crit Care Med, Aichi, Japan.	takeyama@aichi-med-u.ac.jp						Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Condotta SA, 2013, J IMMUNOL, V190, P1991, DOI 10.4049/jimmunol.1202379; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim OY, 2010, CRIT CARE, V14, DOI 10.1186/cc8959; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Mansfield S, 2015, MED MICROBIOL IMMUN, V204, P431, DOI 10.1007/s00430-015-0407-0; Martinic MM, 2008, TRENDS IMMUNOL, V29, P116, DOI 10.1016/j.it.2007.12.002; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1370-x; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Spec A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1182-z; Takeyama N, 2007, ANN HEMATOL, V86, P787, DOI 10.1007/s00277-007-0332-4; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6; Venet F, 2013, CRIT CARE MED, V41, P111, DOI 10.1097/CCM.0b013e3182657948; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walton AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098819; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	39	23	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169653	10.1371/journal.pone.0169653	http://dx.doi.org/10.1371/journal.pone.0169653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072859	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200036
J	Kusakari, Y; Urashima, T; Shimura, D; Amemiya, E; Miyasaka, G; Yokota, S; Fujimoto, Y; Akaike, T; Inoue, T; Minamisawa, S				Kusakari, Yoichiro; Urashima, Takashi; Shimura, Daisuke; Amemiya, Erika; Miyasaka, Genki; Yokota, Shunsuke; Fujimoto, Yoshitaka; Akaike, Toru; Inoue, Takahiro; Minamisawa, Susumu			Impairment of Excitation-Contraction Coupling in Right Ventricular Hypertrophied Muscle with Fibrosis Induced by Pulmonary Artery Banding	PLOS ONE			English	Article							MYOCARDIAL FIBROSIS; HEART-FAILURE; PHOSPHORYLATION; ACTIVATION; STIFFNESS; MYOCYTES; RATS; CA2+	Interstitial myocardial fibrosis is one of the factors responsible for dysfunction of the heart. However, how interstitial fibrosis affects cardiac function and excitation-contraction coupling (E-C coupling) has not yet been clarified. We developed an animal model of right ventricular (RV) hypertrophy with fibrosis by pulmonary artery (PA) banding in rats. Two, four, and six weeks after the PA-banding operation, the tension and intracellular Ca2+ concentration of RV papillary muscles were simultaneously measured (n = 33). The PA-banding rats were clearly divided into two groups by the presence or absence of apparent interstitial fibrosis in the papillary muscles: F+ or F- group, respectively. The papillary muscle diameter and size of myocytes were almost identical between F+ and F-, although the RV free wall weight was heavier in F+ than in F-. F+ papillary muscles exhibited higher stiffness, lower active tension, and lower Ca2+ responsiveness compared with Sham and F- papillary muscles. In addition, we found that the time to peak Ca2+ had the highest correlation coefficient to percent of fibrosis among other parameters, such as RV weight and active tension of papillary muscles. The phosphorylation level of troponin I in F+ was significantly higher than that in Sham and F-, which supports the idea of lower Ca2+ responsiveness in F+. We also found that connexin 43 in F+ was sparse and disorganized in the intercalated disk area where interstitial fibrosis strongly developed. In the present study, the RV papillary muscles obtained from the PA-banding rats enabled us to directly investigate the relationship between fibrosis and cardiac dysfunction, the impairment of E-C coupling in particular. Our results suggest that interstitial fibrosis worsens cardiac function due to 1) the decrease in Ca2+ responsiveness and 2) the asynchronous activation of each cardiac myocyte in the fibrotic preparation due to sparse cell-to-cell communication.	[Kusakari, Yoichiro; Shimura, Daisuke; Amemiya, Erika; Miyasaka, Genki; Yokota, Shunsuke; Fujimoto, Yoshitaka; Akaike, Toru; Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Sch Med, Tokyo, Japan; [Urashima, Takashi] Jikei Univ, Dept Pediat, Sch Med, Tokyo, Japan; [Inoue, Takahiro] Jikei Univ, Dept Cardiac Surg, Sch Med, Tokyo, Japan	Jikei University; Jikei University; Jikei University	Kusakari, Y (corresponding author), Jikei Univ, Dept Cell Physiol, Sch Med, Tokyo, Japan.	kusakari@jikei.ac.jp	Shimura, Daisuke/ABB-8456-2021; Shimura, Daisuke/ABA-3516-2021	Shimura, Daisuke/0000-0002-9954-2162; Minamisawa, Susumu/0000-0003-4728-2116	Ministry of Education, Culture, Sports, Science and Technology of Japan [25136719, 15K08190, 26670096]; Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT-Supported Program for the Strategic Research Foundation at Private Universities;  [25-5481]; Grants-in-Aid for Scientific Research [17H01529] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan https.//kaken.nii.ac.jp/d/r/ 80338889.en.html. (25136719 and 15K08190 to YK, 26670096 to SM). The Vehicle Racing Commemorative Foundation (Y.K., S.M.). The Jikei University Graduate Research Fund (S.M.). The MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S.M.). Grant-in-Aid for JSPS Fellows Number 25-5481 (D.S.).	Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3301, DOI 10.1152/ajpheart.00259.2007; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fauconnier J, 2003, CARDIOVASC RES, V57, P670, DOI 10.1016/S0008-6363(02)00731-9; Fujimoto Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148666; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Herrmann S, 2011, J AM COLL CARDIOL, V58, P402, DOI 10.1016/j.jacc.2011.02.059; Hirakawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119360; Hirano S, 2006, J PHYSIOL SCI, V56, P297, DOI 10.2170/physiolsci.RP007306; Kajiwara H, 2000, BIOCHEM BIOPH RES CO, V272, P104, DOI 10.1006/bbrc.2000.2741; Kirchhefer U, 2014, J BIOL CHEM, V289, P33862, DOI 10.1074/jbc.M114.598938; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P16604, DOI 10.1073/pnas.1415933111; KURIHARA S, 1985, J PHYSIOL-LONDON, V361, P361, DOI 10.1113/jphysiol.1985.sp015650; KURIHARA S, 1994, JPN J PHYSIOL, V44, P591, DOI 10.2170/jjphysiol.44.591; Kusakari Y, 2006, J PHYSIOL SCI, V56, P219, DOI 10.2170/physiolsci.RP003706; Kusakari Y, 2013, J PHYSIOL SCI, V63, pS176; Mamidi R, 2012, ARCH BIOCHEM BIOPHYS, V525, P1, DOI 10.1016/j.abb.2012.05.024; Rain S, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002636; Rain S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000716; Rain S, 2013, CIRCULATION, V128, P2016, DOI 10.1161/CIRCULATIONAHA.113.001873; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Sakurai T, 2013, EXPT CELL RES; Sasano C, 2007, CIRC J, V71, P382, DOI 10.1253/circj.71.382; Shimura D, 2016, AM J PHYSIOL-HEART C, V310, pH92, DOI 10.1152/ajpheart.00411.2015; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Szymanska G, 1999, PFLUG ARCH EUR J PHY, V439, P1, DOI 10.1007/s004240051121; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Turner I, 2005, J CARDIOVASC ELECTR, V16, P151, DOI 10.1046/j.1540-8167.2005.30490.x; Uzzaman M, 2000, CIRC RES, V86, P871, DOI 10.1161/01.RES.86.8.871; WEBER KT, 1989, J MOL CELL CARDIOL, V21, P121, DOI 10.1016/0022-2828(89)90778-5; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026; Yamamoto K, 2002, CARDIOVASC RES, V55, P76, DOI 10.1016/S0008-6363(02)00341-3; Yoshida M, 2011, CARDIOVASC RES, V92, P95, DOI 10.1093/cvr/cvr182	34	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169564	10.1371/journal.pone.0169564	http://dx.doi.org/10.1371/journal.pone.0169564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068381	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900046
J	Leggatt, RA; Sundstrom, LF; Woodward, K; Devlin, RH				Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Woodward, Krista; Devlin, Robert H.			Growth-Enhanced Transgenic Coho Salmon (Oncorhynchus kisutch) Strains Have Varied Success in Simulated Streams: Implications for Risk Assessment	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMMON CARP; ENVIRONMENT INTERACTIONS; ATLANTIC SALMON; HORMONE TRANSGENESIS; FOOD; DOMINANCE; ABILITY; CONSEQUENCES; POPULATIONS	Growth hormone (GH) transgenic fish have accelerated growth and could improve production efficiency in aquaculture. However, concern exists regarding potential environmental risks of GH transgenic fish should they escape rearing facilities. While environmental effects have been examined in some GH transgenic models, there is a lack of information on whether effects differ among different constructs or strains of transgenic fish. We compared growth and survival of wild-type coho salmon (Oncorhynchus kisutch) fry, a fast-growing GH transgenic strain containing a metallothionein promoter (T-MT), and three lines/strains containing a reportedly weaker histone-3 promoter (T-H3) in hatchery conditions and semi-natural stream tanks with varying levels of natural food and predators. Rank order of genotype size and survival differed with varying environmental conditions, both within and among experiments. Despite accelerated growth in hatchery conditions, T-MT fry gained little or no growth enhancement in stream conditions, had enhanced survival when food was limiting, and inconsistent survival under other conditions. Rank growth was inconsistent in T-H3 strains, with one strain having highest, and two strains having the lowest growth in stream conditions, although all T-H3 strains had consistently poor survival. These studies demonstrate the importance of determining risk estimates for each unique transgenic model independent of other models.	[Leggatt, Rosalind A.; Sundstrom, L. Fredrik; Woodward, Krista; Devlin, Robert H.] Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, Ctr Aquat Biotechnol Regulatory Res, W Vancouver, BC, Canada; [Sundstrom, L. Fredrik] Uppsala Univ, Biol Educ Ctr, Uppsala, Sweden	Fisheries & Oceans Canada; Uppsala University	Leggatt, RA (corresponding author), Fisheries & Oceans Canada, Ctr Aquaculture & Environm Res, Ctr Aquat Biotechnol Regulatory Res, W Vancouver, BC, Canada.	rosalind.leggatt@gmail.com	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289	Canadian Regulatory System for Biotechnology; Marie Curie Outgoing International Fellowship from the European Community's Sixth Framework Programme [MOIF-CT-2005-8141]; Adlerbert Research Foundation	Canadian Regulatory System for Biotechnology; Marie Curie Outgoing International Fellowship from the European Community's Sixth Framework Programme; Adlerbert Research Foundation	Funding for this project was provided by the Canadian Regulatory System for Biotechnology (https://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7BBCF51B-1) to RHD. LFS was funded as a Marie Curie Outgoing International Fellowship (http://ec.europa.eu/research/mariecurieactions/) under contract MOIF-CT-2005-8141 from the European Community's Sixth Framework Programme (https://ec.europa.eu/research/fp6/pdf/fp6-in-brief_en.pdf). The present work does not necessarily reflect the Community's views and in no way anticipates its future policy in this area. The Adlerbert Research Foundation contributed financially to LFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, LME4 LINEAR MIXED EF; Chan Woon-Khiong, 1993, Molecular Marine Biology and Biotechnology, V2, P308; Crossin GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120173; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Devlin RH, 2007, ENV RISK ASSESS GENE, V3, P151, DOI 10.1079/9781845932961.0151; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1995, CAN J FISH AQUAT SCI, V52, P1376, DOI 10.1139/f95-133; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 1997, TRANSGENIC ANIMALS G, P105; Devlin RH, 2015, BIOSCIENCE, V65, P685, DOI 10.1093/biosci/biv068; Devlin RH, 2010, AQUACULTURE, V304, P66, DOI 10.1016/j.aquaculture.2010.03.023; DFO, 2013, 2013023 DFO CAN SCI; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Duan M, 2009, J FISH BIOL, V75, P1459, DOI 10.1111/j.1095-8649.2009.02393.x; Dunham RA, 2002, MAR BIOTECHNOL, V4, P604, DOI 10.1007/s10126-002-0034-9; FDA, 2015, SUPP APPR NEW AN DRU; Fox J., 2019, R COMPANION APPL REG, V.; Leggatt RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148687; Leggatt RA, 2012, AQUACULTURE, V356, P193, DOI 10.1016/j.aquaculture.2012.05.016; Lian H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065506; Moreau DTR, 2011, J FISH BIOL, V78, P726, DOI 10.1111/j.1095-8649.2010.02888.x; Moreau DTR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095853; Pitkanen TI, 1999, GENET ANAL-BIOMOL E, V15, P91, DOI 10.1016/S1050-3862(99)00011-X; R Core Team, 2013, R LANG ENV STAT COMP; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Reinhardt UG, 1999, CAN J FISH AQUAT SCI, V56, P1206, DOI 10.1139/cjfas-56-7-1206; Sloman KA, 2002, J FISH BIOL, V61, P1, DOI 10.1111/j.1095-8649.2002.tb01733.x; Sundstrom LF, 2016, ECOL APPL, V26, P67, DOI 10.1890/15-0252; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2014, J APPL ECOL, V51, P82, DOI 10.1111/1365-2664.12185; Sundstrom LF, 2011, EVOL ECOL, V25, P447, DOI 10.1007/s10682-010-9406-1; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2003, ETHOLOGY, V109, P701, DOI 10.1046/j.1439-0310.2003.00908.x; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Sundt-Hansen L, 2012, FUNCT ECOL, V26, P904, DOI 10.1111/j.1365-2435.2012.01999.x; Zhong CR, 2012, AQUACULTURE, V356, P404, DOI 10.1016/j.aquaculture.2012.04.019	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169991	10.1371/journal.pone.0169991	http://dx.doi.org/10.1371/journal.pone.0169991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068416	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900082
J	Dalmasso, G; Zapata, PAM; Brady, NR; Hamacher-Brady, A				Dalmasso, Giovanni; Zapata, Paula Andrea Marin; Brady, Nathan Ryan; Hamacher-Brady, Anne			Agent-Based Modeling of Mitochondria Links Sub-Cellular Dynamics to Cellular Homeostasis and Heterogeneity	PLOS ONE			English	Article							HELA-CELLS; AUTOPHAGOSOMAL DEGRADATION; MEMBRANE PERMEABILIZATION; PROTECTS MITOCHONDRIA; QUALITY-CONTROL; FUSION; FISSION; MITOPHAGY; MOVEMENT; TRANSPORT	Mitochondria are semi-autonomous organelles that supply energy for cellular biochemistry through oxidative phosphorylation. Within a cell, hundreds of mobile mitochondria undergo fusion and fission events to form a dynamic network. These morphological and mobility dynamics are essential for maintaining mitochondrial functional homeostasis, and alterations both impact and reflect cellular stress states. Mitochondrial homeostasis is further dependent on production (biogenesis) and the removal of damaged mitochondria by selective autophagy (mitophagy). While mitochondrial function, dynamics, biogenesis and mitophagy are highly-integrated processes, it is not fully understood how systemic control in the cell is established to maintain homeostasis, or respond to bioenergetic demands. Here we used agent-based modeling (ABM) to integrate molecular and imaging knowledge sets, and simulate population dynamics of mitochondria and their response to environmental energy demand. Using high-dimensional parameter searches we integrated experimentally-measured rates of mitochondrial biogenesis and mitophagy, and using sensitivity analysis we identified parameter influences on population homeostasis. By studying the dynamics of cellular subpopulations with distinct mitochondrial masses, our approach uncovered system properties of mitochondrial populations: (1) mitochondrial fusion and fission activities rapidly establish mitochondrial sub-population homeostasis, and total cellular levels of mitochondria alter fusion and fission activities and subpopulation distributions; (2) restricting the directionality of mitochondrial mobility does not alter morphology subpopulation distributions, but increases network transmission dynamics; and (3) maintaining mitochondrial mass homeostasis and responding to bioenergetic stress requires the integration of mitochondrial dynamics with the cellular bioenergetic state. Finally, (4) our model suggests sources of, and stress conditions amplifying, cell-to-cell variability of mitochondrial morphology and energetic stress states. Overall, our modeling approach integrates biochemical and imaging knowledge, and presents a novel open-modeling approach to investigate how spatial and temporal mitochondrial dynamics contribute to functional homeostasis, and how subcellular organelle heterogeneity contributes to the emergence of cell heterogeneity.	[Dalmasso, Giovanni; Zapata, Paula Andrea Marin; Hamacher-Brady, Anne] Heidelberg Univ, German Canc Res Ctr DKFZ, Lysosomal Syst Biol, Heidelberg, Germany; [Dalmasso, Giovanni; Zapata, Paula Andrea Marin; Brady, Nathan Ryan; Hamacher-Brady, Anne] Heidelberg Univ, BioQuant, Heidelberg, Germany; [Brady, Nathan Ryan] Heidelberg Univ, German Canc Res Ctr DKFZ, Syst Biol Cell Death Mech, Heidelberg, Germany; [Brady, Nathan Ryan; Hamacher-Brady, Anne] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hamacher-Brady, A (corresponding author), Heidelberg Univ, German Canc Res Ctr DKFZ, Lysosomal Syst Biol, Heidelberg, Germany.; Brady, NR; Hamacher-Brady, A (corresponding author), Heidelberg Univ, BioQuant, Heidelberg, Germany.; Brady, NR (corresponding author), Heidelberg Univ, German Canc Res Ctr DKFZ, Syst Biol Cell Death Mech, Heidelberg, Germany.; Brady, NR; Hamacher-Brady, A (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	nbrady7@jhu.edu; abrady9@jhu.edu	Hamacher-Brady, Anne/G-4268-2013; Dalmasso, Giovanni/A-7488-2013	Dalmasso, Giovanni/0000-0002-8586-6027; Brady, Nathan/0000-0002-1901-5996; Hamacher-Brady, Anne/0000-0001-5042-1338; Marin Zapata, Paula Andrea/0000-0002-8195-6228	German Cancer Research Center (DKFZ), through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; Federal Ministry of Education and Research (BMBF), Germany [0316191]	German Cancer Research Center (DKFZ), through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Cancer Research Center (DKFZ), through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association (NRB); and the e:Bio grant #0316191 (LysoSys) of the Federal Ministry of Education and Research (BMBF), Germany (AH-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden K, EASING PARAMETER SEN; Alden K, 2015, PACKAGE SPARTAN; Alden K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002916; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Axelrod R, 2006, HDB COMPUTATIONAL EC, V2, P1647, DOI DOI 10.1016/S1574-0021(05)02044-7; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birkedal R, 2006, AM J PHYSIOL-CELL PH, V291, pC1148, DOI 10.1152/ajpcell.00236.2006; Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Borlin CS, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0056-8; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; de Marchi S, 2014, ANNU REV POLIT SCI, V17, P1, DOI 10.1146/annurev-polisci-080812-191558; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Frechin M, 2015, NATURE; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Helbing D., 2011, DO AGENT BASED SIMUL; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jiang HD, 2010, P NATL ACAD SCI USA, V107, P11234, DOI 10.1073/pnas.1000156107; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kiryu-Seo S, 2010, J NEUROSCI, V30, P6658, DOI 10.1523/JNEUROSCI.5265-09.2010; Kuhn C, 2015, FRONT PHYSIOL, P6; KUMEI Y, 1989, J CELL SCI, V93, P221; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Macal CM, 2009, WINT SIM C; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Malpass K, 2013, NAT REV NEUROL, V9, P179, DOI [10.1038/nrneurol.2012.35, 10.1038/nrneurol.2013.55, 10.1038/nrneurol.2013.158, 10.1038/nrneurol.2013.119, 10.1038/nrneurol.2013.138, 10.1038/nrneurol.2013.77, 10.1038/nrneurol.2013.64, 10.1038/nrneurol.2013.35, 10.1038/nrneurol.2012.245]; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; MORRIS RL, 1993, J CELL SCI, V104, P917; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Narayanareddy BRJ, 2014, TRAFFIC, V15, P762, DOI 10.1111/tra.12171; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108; Patil H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120183; POLITOPOULOS I, 2007, REV ANAL AGENT BASED; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Rambold AS, 2011, AUTOPHAGY, V7, P1568, DOI 10.4161/auto.7.12.17992; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Saltelli A., GLOBAL SENSITIVITY A; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA292, DOI 10.1289/ehp.118-a292; SCHNAPP BJ, 1986, ANN NY ACAD SCI, V466, P909, DOI 10.1111/j.1749-6632.1986.tb38476.x; Scrucca L., 2012, J STAT SOFTWARE, V53; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Stonedahl F., 2011, GENETIC ALGORITHMS E; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tam ZY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004183; Tam ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076230; Team RC, 2015, R LANG ENV STAT COMP; Thiele JC, 2014, J STAT SOFTW, V58, P1; Thiele JC, 2012, METHODS ECOL EVOL, V3, P480, DOI 10.1111/j.2041-210X.2011.00180.x; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang X, 2011, MOL ONCOL, V5, P399, DOI 10.1016/j.molonc.2011.07.008; Watanabe W, 2007, OPT EXPRESS, V15, P2490, DOI 10.1364/OE.15.002490; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wikstrom JD, 2009, J BIOCH CELL BIOL; Wilensky U., 1999, NETLOGO; Wu M, 2013, INT J NANOMED, V8, P4033, DOI 10.2147/IJN.S52132; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhu YP, 2013, INT C DIGIT MANUF, P24, DOI 10.1109/ICDMA.2013.7	89	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168198	10.1371/journal.pone.0168198	http://dx.doi.org/10.1371/journal.pone.0168198			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060865	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500024
J	Ginige, MP; Garbin, S; Wylie, J; Krishna, KCB				Ginige, Maneesha P.; Garbin, Scott; Wylie, Jason; Krishna, K. C. Bal			Effectiveness of Devices to Monitor Biofouling and Metals Deposition on Plumbing Materials Exposed to a Full-Scale Drinking Water Distribution System	PLOS ONE			English	Article							MODIFIED ROBBINS DEVICE; BIOFILM FORMATION; STAINLESS-STEEL; COMMUNITY STRUCTURE; PIPE MATERIALS; BACTERIAL COMMUNITIES; NAEGLERIA-FOWLERI; IRON; DISINFECTANT; CORROSION	A Modified Robbins Device (MRD) was installed in a full-scale water distribution system to investigate biofouling and metal depositions on concrete, high-density polyethylene (HDPE) and stainless steel surfaces. Bulk water monitoring and a KIWA monitor (with glass media) were used to offline monitor biofilm development on pipe wall surfaces. Results indicated that adenosine triphosphate (ATP) and metal concentrations on coupons increased with time. However, bacterial diversities decreased. There was a positive correlation between increase of ATP and metal deposition on pipe surfaces of stainless steel and HDPE and no correlation was observed on concrete and glass surfaces. The shared bacterial diversity between bulk water and MRD was less than 20% and the diversity shared between the MRD and KIWA monitor was only 10%. The bacterial diversity on biofilm of plumbing material of MRD however, did not show a significant difference suggesting a lack of influence from plumbing material during early stage of biofilm development.	[Ginige, Maneesha P.; Wylie, Jason] CSIRO Land & Water, Wembley, WA, Australia; [Garbin, Scott] Water Corp Western Australia, Leederville, WA, Australia; [Krishna, K. C. Bal] Univ Western Sydney, Sch Comp Engn & Math, Penrith, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University	Ginige, MP (corresponding author), CSIRO Land & Water, Wembley, WA, Australia.	maneesha.ginige@csiro.au	Ginige, Maneesha P./A-4828-2012; Wylie, Jason/B-9891-2017		CSIRO Water for a Healthy Country Flagship; Water Corporation, Western Australia; Water Corporation	CSIRO Water for a Healthy Country Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Water Corporation, Western Australia; Water Corporation	The authors acknowledge the funding received from CSIRO Water for a Healthy Country Flagship and Water Corporation, Western Australia. Authors MPG and JW were affiliated to CSIRO and received support in the form of salaries from both CSIRO Water for a Healthy Country Flagship and Water Corporation. Author SG who was affiliated with Water Corporation received support in the form of salaries from Water Corporation. KCBK, who was affiliated to Curtin University did not receive support in the form of salaries from both CSIRO Water for a Healthy Country Flagship and Water Corporation. Since some authors were affiliated to the funding bodies, both funding bodies are considered to have made varying contributions to the study design, data collection and analysis, decision to publish and preparation of the manuscript. Specific contributions of funding bodies can be articulated by referring to the author contributions section.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Corti A, 2010, POLYM DEGRAD STABIL, V95, P1106, DOI 10.1016/j.polymdegradstab.2010.02.018; Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eboigbodin KE, 2008, J AM WATER WORKS ASS, V100, P131; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Fujita M, 2014, WATER RESOUR MANAG, V28, P1645, DOI 10.1007/s11269-014-0571-9; Ginige MP, 2011, BIOFOULING, V27, P151, DOI 10.1080/08927014.2010.547576; Gomes IB, 2014, WATER RES, V62, P63, DOI 10.1016/j.watres.2014.05.039; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hill VR, 2005, APPL ENVIRON MICROB, V71, P6878, DOI 10.1128/AEM.71.11.6878-6884.2005; Hong HC, 2010, J ENVIRON SCI-CHINA, V22, P663, DOI 10.1016/S1001-0742(09)60160-1; Kalmbach S, 1997, FEMS MICROBIOL ECOL, V22, P265, DOI 10.1016/S0168-6496(96)00098-0; Kerr CJ, 2000, BIOFOULING, V14, P267, DOI 10.1080/08927010009378419; Kielemoes J, 2000, ENVIRON TECHNOL, V21, P831, DOI 10.1080/09593330.2000.9618970; Krishna KCB, 2013, WATER SCI TECH-W SUP, V13, P1090, DOI 10.2166/ws.2013.093; LECHEVALLIER MW, 1991, APPL ENVIRON MICROB, V57, P857, DOI 10.1128/AEM.57.3.857-862.1991; LECHEVALLIER MW, 1990, J AM WATER WORKS ASS, V82, P87; LeChevallier MW, 1999, ROY SOC CH, P220; Lehtola MJ, 2005, WATER RES, V39, P1962, DOI 10.1016/j.watres.2005.03.009; Lehtola MJ, 2004, WATER RES, V38, P3769, DOI 10.1016/j.watres.2004.06.024; Liu G, 2014, ENVIRON SCI TECHNOL, V48, P5467, DOI 10.1021/es5009467; LUND V, 1995, WATER RES, V29, P1013, DOI 10.1016/0043-1354(94)00280-K; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; MCCOY WF, 1982, DEV IND MICROBIOL, V23, P551; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller HC, 2015, ENVIRON SCI TECHNOL, V49, P11125, DOI 10.1021/acs.est.5b02947; MIZUTANI T, 1978, J NON-CRYST SOLIDS, V30, P23, DOI 10.1016/0022-3093(78)90052-2; Momba MNB, 2004, WATER SA, V30, P175; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; Niquette P, 2000, WATER RES, V34, P1952, DOI 10.1016/S0043-1354(99)00307-3; PEDERSEN K, 1990, WATER RES, V24, P239, DOI 10.1016/0043-1354(90)90109-J; Percival S. L, 1999, BIOFILMS GOOD BAD UG, P155; Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5; Prince R, 2001, WORLD WAT ENV RES C, P1; Puzon GJ, 2009, ENVIRON SCI TECHNOL, V43, P6691, DOI 10.1021/es900432m; Roeder RS, 2010, INT J HYG ENVIR HEAL, V213, P183, DOI 10.1016/j.ijheh.2010.04.007; Rubulis J, 2007, WATER SCI TECHNOL, V55, P211, DOI 10.2166/wst.2007.261; SCHULTZ CL, 1995, J IND MICROBIOL, V15, P243, DOI 10.1007/BF01569831; Schwartz T, 1998, WATER RES, V32, P2787, DOI 10.1016/S0043-1354(98)00026-8; SERVAIS P, 1987, WATER RES, V21, P445, DOI 10.1016/0043-1354(87)90192-8; Silvestry-Rodriguez N, 2008, APPL ENVIRON MICROB, V74, P1639, DOI 10.1128/AEM.02237-07; Slaats P. G. G., 2004, PROCESSES INVOLVED G; Srinivasan S, 2008, WATER RES, V42, P3393, DOI 10.1016/j.watres.2008.04.025; Teng F, 2008, CORROS SCI, V50, P2816, DOI 10.1016/j.corsci.2008.07.008; Tokajian ST, 2005, CAN J MICROBIOL, V51, P325, DOI 10.1139/W05-007; Tsai YP, 2008, ENVIRON ENG SCI, V25, P929, DOI 10.1089/ees.2007.0025; van der Kooij D, 2005, WATER RES, V39, P2789, DOI 10.1016/j.watres.2005.04.075; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; VANDERKOOIJ D, 1995, WATER RES, V29, P1655, DOI 10.1016/0043-1354(94)00333-3; Wang HB, 2012, WATER RES, V46, P1070, DOI 10.1016/j.watres.2011.12.001; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Wang Y, 2013, J ENVIRON MANAGE, V124, P165, DOI 10.1016/j.jenvman.2013.02.018; Wingender J, 2004, WATER SCI TECHNOL, V49, P277, DOI 10.2166/wst.2004.0861; Zacheus OM, 2000, WATER RES, V34, P63, DOI 10.1016/S0043-1354(99)00113-X; Zhang Y, 2008, ENVIRON SCI TECHNOL, V42, P4280, DOI 10.1021/es702483d	61	18	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169140	10.1371/journal.pone.0169140	http://dx.doi.org/10.1371/journal.pone.0169140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060947	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500058
J	Grasman, J; Callender, HL; Mensink, M				Grasman, Johan; Callender, Hannah L.; Mensink, Marco			Proportional Insulin Infusion in Closed-Loop Control of Blood Glucose	PLOS ONE			English	Article							RESISTANCE; DELIVERY; GLUCAGON; RELEASE; SYSTEM	A differential equation model is formulated that describes the dynamics of glucose concentration in blood circulation. The model accounts for the intake of food, expenditure of calories and the control of glucose levels by insulin and glucagon. These and other hormones affect the blood glucose level in various ways. In this study only main effects are taken into consideration. Moreover, by making a quasi-steady state approximation the model is reduced to a single nonlinear differential equation of which parameters are fit to data from healthy subjects. Feedback provided by insulin plays a key role in the control of the blood glucose level. Reduced beta-cell function and insulin resistance may hamper this process. With the present model it is shown how by closed-loop control these defects, in an organic way, can be compensated with continuous infusion of exogenous insulin.	[Grasman, Johan] Univ Wageningen & Res Ctr, Biometris, Wageningen, Netherlands; [Callender, Hannah L.] Univ Portland, Dept Math, Portland, OR 97203 USA; [Mensink, Marco] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands	Wageningen University & Research; University of Portland; Wageningen University & Research	Grasman, J (corresponding author), Univ Wageningen & Res Ctr, Biometris, Wageningen, Netherlands.	johan.grasman@wur.nl		Mensink, Marco/0000-0002-9725-5709				Al Helal Z, 2015, J IND MANAG OPTIM, V11, P1149, DOI 10.3934/jimo.2015.11.1149; ALFORD FP, 1976, J CLIN ENDOCR METAB, V42, P830, DOI 10.1210/jcem-42-5-830; Allam F, 2013, J INTELL FUZZY SYST, V25, P403, DOI 10.3233/IFS-120648; Bequette BW, 2012, ANNU REV CONTROL, V36, P255, DOI 10.1016/j.arcontrol.2012.09.007; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BOLIE VW, 1961, J APPL PHYSIOL, V16, P783, DOI 10.1152/jappl.1961.16.5.783; Chee F, 2007, LECT NOTES CONTR INF, V368, P1, DOI 10.1007/978-3-540-74031-5; de Graaf AA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000554; Edelstein-Keshet L, 2005, CLASSICS APPL MATH, V46; Forlenza GP, 2015, DIABETES TECHNOL THE, V17, P304, DOI 10.1089/dia.2015.0055; Freckmann Guido, 2007, J Diabetes Sci Technol, V1, P695; Hall JE, 2011, GUYTON HALL MED PHYS; Hovorka R, 2013, DIABETES TECHNOL THE, V15, P4, DOI 10.1089/dia.2012.0185; Jazwinski Andrew H., 2007, STOCHASTIC PROCESSES; Katok A., 1995, INTRO MODERN THEORY; Litwack G., 2009, INSULIN AND IGFS; Liu WJ, 2008, J THEOR BIOL, V252, P608, DOI 10.1016/j.jtbi.2008.02.021; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medical Advisory Secretariat, 2009, CONT SUBC INS INF PU; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Shah VN, 2014, DIABETES TECHNOL THE, V16, P477, DOI 10.1089/dia.2014.0193; Southern J, 2008, PROG BIOPHYS MOL BIO, V96, P60, DOI 10.1016/j.pbiomolbio.2007.07.019; Sprague Jennifer E, 2011, Pediatr Endocrinol Rev, V9, P463; Steil GM, 2004, ADV DRUG DELIVER REV, V56, P125, DOI 10.1016/j.addr.2003.08.011; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wong JMW, 2007, J NUTR, V137, p2539S, DOI 10.1093/jn/137.11.2539S; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169135	10.1371/journal.pone.0169135	http://dx.doi.org/10.1371/journal.pone.0169135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060898	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500057
J	Yokobayashi, K; Kawachi, I; Kondo, K; Kondo, N; Nagamine, Y; Tani, Y; Shirai, K; Tazuma, S				Yokobayashi, Kenichi; Kawachi, Ichiro; Kondo, Katsunori; Kondo, Naoki; Nagamine, Yuiko; Tani, Yukako; Shirai, Kokoro; Tazuma, Susumu		JAGES Grp	Association between Social Relationship and Glycemic Control among Older Japanese: JAGES Cross-Sectional Study	PLOS ONE			English	Article							SELF-CARE BEHAVIORS; SUPPORT; IMPACT; ADULTS; HEALTH	Aim The present study examined whether social support, informal socializing and social participation are associated with glycemic control in older people. Methods Data for this population-based cross-sectional study was obtained from the Japan Gerontological Evaluation Study (JAGES) 2010 linked to the annual health check-up data in Japan. We analyzed 9,554 individuals aged >= 65 years without the certification of needed long-term care. Multivariate logistic regression models were used to assess the effect of social support, informal socializing and social participations on glycemic control. The outcome measure was HbA1c >= 8.4%. Results 1.3% of the participants had a level of HbA1c over 8.4%. Better glycemic control was significantly associated with meeting with friends one to four times per month (odds ratio [OR] 0.51, 95% confidence interval [CI] 0.30-0.89, compared to meeting with friends a few times per year or less) and participation in sports groups (OR 0.50, 95% CI 0.26-0.97) even after adjusting for other variables. Meeting with friends more than twice per week, receiving social support, and being married were not associated with better control of diabetes. Conclusions Meeting with friends occasionally is associated with better glycemic control among older people.	[Yokobayashi, Kenichi; Kawachi, Ichiro; Shirai, Kokoro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Yokobayashi, Kenichi; Tazuma, Susumu] Hiroshima Univ Med Sci, Dept Gen Internal Med, Hiroshima, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori; Nagamine, Yuiko] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan; [Kondo, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Gerontol & Evaluat Study, Ctr Gerontol & Social Sci, Obu City, Aichi, Japan; [Kondo, Naoki] Univ Tokyo, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Nagamine, Yuiko] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tani, Yukako] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan; [Tani, Yukako] Japan Soc Promot Sci, Tokyo, Japan; [Shirai, Kokoro] Univ Ryukyus, Dept Human Sci, Sch Law & Letters, Nishihara, Okinawa 90301, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Hiroshima University; Chiba University; Chiba University; National Center for Geriatrics & Gerontology; University of Tokyo; University of London; University College London; Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; University of the Ryukyus	Yokobayashi, K (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.; Yokobayashi, K (corresponding author), Hiroshima Univ Med Sci, Dept Gen Internal Med, Hiroshima, Japan.	yokobayashiken@gmail.com	Kondo, Katsunori/AAI-6373-2020; Fujino, Yoshihisa/F-3054-2010; Aida, Jun/S-9371-2019; Kondo, Naoki/ABC-5865-2020; Kondo, Naoki/K-3898-2012; Tsuboya, Toru/M-3847-2016	Fujino, Yoshihisa/0000-0002-9126-206X; Aida, Jun/0000-0002-8405-9872; Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; Tsuboya, Toru/0000-0001-7741-0751; Hanazato, Masamichi/0000-0002-0317-7616; Misawa, Jimpei/0000-0003-3987-8251; Nagamine, Yuiko/0000-0003-1901-6697; Ashida, Toyo/0000-0002-0334-121X	Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health from the Ministry of Health, Labour and Welfare, Japan [H22-Choju-Shitei-008, H24-Junkanki(Syosyu)-Ippan-007, H24-Chikpkibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Choju-Ippan-003, H26-Irryo-Shitei-003(Fukkou), H26-Choju-Ippan-006]; Japan Society for the Promotion of Science [22330172, 22390400, 23243070, 23590786, 23790710, 24390469, 24530698, 24683018, 25253052, 25870573, 25870881]; National Center for Geriatrics and Gerontology, Japan [24-17, 24-23, J09KF00804]; Japan Agency for Medical Research and Development	Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health from the Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center for Geriatrics and Gerontology, Japan; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study used data from the Japan Gerontological Evaluation Study (JAGES), conducted by the Center for Well-being and Society, Nihon Fukushi University as one of their research projects, which was supported by Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H22-Choju-Shitei-008, H24-Junkanki(Syosyu)-Ippan-007, H24-Chikpkibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Choju-Ippan-003, H26-Irryo-Shitei-003(Fukkou),H26-Choju-Ippan-006) from the Ministry of Health, Labour and Welfare, Japan; Grant-in-Aid for Scientific Research (KAKENHI) (22330172, 22390400, 23243070, 23590786, 23790710, 24390469, 24530698, 24683018, 25253052, 25870573, 25870881) from the Japan Society for the Promotion of Science; a grant from National Center for Geriatrics and Gerontology, Japan (24-17, 24-23, J09KF00804); and Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig A, 2010, J HEALTH SERV RES PO, V15, P223, DOI 10.1258/jhsrp.2010.009128; Chlebowy DO, 2006, DIABETES EDUCATOR, V32, P777, DOI 10.1177/0145721706291760; Choi SE, 2009, DIABETES EDUCATOR, V35, P978, DOI 10.1177/0145721709349220; De Vogli R, 2007, ARCH INTERN MED, V167, P1951, DOI 10.1001/archinte.167.18.1951; DECASTRO JM, 1994, PHYSIOL BEHAV, V56, P445, DOI 10.1016/0031-9384(94)90286-0; Fortmann AL, 2015, J BEHAV MED, V38, P153, DOI 10.1007/s10865-014-9587-0; Frosch DL, 2011, ARCH INTERN MED, V171, P2011, DOI 10.1001/archinternmed.2011.497; HAMMOND GS, 1992, DIABETES CARE, V15, P469, DOI 10.2337/diacare.15.4.469; Hilding A, 2015, DIABETES RES CLIN PR, V107, P166, DOI 10.1016/j.diabres.2014.09.057; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Ikeda A, 2011, J EPIDEMIOL COMMUN H, V65, P71, DOI 10.1136/jech.2009.090613; Ingram M, 2007, DIABETES EDUCATOR, V33, p172S, DOI 10.1177/0145721707304170; International Diabetes Federation, 2020, IDF DIABETES ATLAS; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Keyvanara Mahmoud, 2012, Med Arh, V66, P24; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; Ministry of Health, 2011, NAT HLTH NUTR SURV N; Ministry of Health; Labour and Welfare, DAT SPEC MED CHECK; Ministry of Health; Labour and Welfare, SPEC MED CHECK REP 2, P22; Ministry of Health Labour and Welfare Japan, BAS DIR COMPR IMPL N; Mitsuhashi Y, 2006, JPN J PUBLIC HLTH, V53, P92; Okura T, 2009, J AM GERIATR SOC, V57, P1816, DOI 10.1111/j.1532-5415.2009.02431.x; Saito M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111169; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0; Sukkarieh-Haraty O, 2015, HOLIST NURS PRACT, V29, P37, DOI 10.1097/HNP.0000000000000060; Tabuchi T, 2016, J EPIDEMIOL, V26, P14, DOI 10.2188/jea.JE20140183; Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; World Health Organization. WHO, 2015, 10 FACTS DIAB; Yazawa A, 2016, HYPERTENS RES, P1	32	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169904	10.1371/journal.pone.0169904	http://dx.doi.org/10.1371/journal.pone.0169904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060887	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500144
J	Xu, X; Huang, XF; Visser, RGF; Trindade, LM				Xu, Xuan; Huang, Xing-Feng; Visser, Richard G. F.; Trindade, Luisa M.			Engineering Potato Starch with a Higher Phosphate Content	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; WATER-DIKINASE ACTIVITY; ARABIDOPSIS LEAVES; BRANCHING ENZYME; BINDING DOMAIN; AMYLOSE-FREE; GRANULE; GENE; EXPRESSION; SYNTHASE	Phosphate esters are responsible for valuable and unique functionalities of starch for industrial applications. Also in the cell phosphate esters play a role in starch metabolism, which so far has not been well characterized in storage starch. Laforin, a human enzyme composed of a carbohydrate-binding module and a dual-specificity phosphatase domain, is involved in the dephosphorylation of glycogen. To modify phosphate content and better understand starch (de)phosphorylation in storage starch, laforin was engineered and introduced into potato (cultivar Kardal). Interestingly, expression of an (engineered) laforin in potato resulted in significantly higher phosphate content of starch, and this result was confirmed in amylose-free potato genetic background (amt). Modified starches exhibited altered granule morphology and size compared to the control. About 20-30% of the transgenic lines of each series showed red-staining granules upon incubation with iodine, and contained higher phosphate content than the blue-stained starch granules. Moreover, low amylose content and altered gelatinization properties were observed in these red-stained starches. Principle component and correlation analysis disclosed a complex correlation between starch composition and starch physico-chemical properties. Ultimately, the expression level of endogenous genes involved in starch metabolism was analysed, revealing a compensatory response to the decrease of phosphate content in potato starch. This study provides a new perspective for engineering starch phosphate content in planta by making use of the compensatory mechanism in the plant itself.	[Xu, Xuan; Huang, Xing-Feng; Visser, Richard G. F.; Trindade, Luisa M.] Wageningen Univ & Res, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Xu, Xuan] Huazhong Agr Univ, Natl Ctr Vegetable Improvement Cent China, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China; [Huang, Xing-Feng] Colorado State Univ, Dept Chem & Biol Engn, 1370 Campus Delivery, Ft Collins, CO 80523 USA	Wageningen University & Research; Huazhong Agricultural University; Colorado State University	Trindade, LM (corresponding author), Wageningen Univ & Res, Wageningen UR Plant Breeding, Wageningen, Netherlands.	luisa.trindade@wur.nl	Visser, Richard GF/B-3423-2012; Xu, Xuan/AAK-5677-2020; Trindade, Luisa M/F-8824-2010; Huang, Xingfeng/H-3980-2018	Visser, Richard GF/0000-0002-0213-4016; Xu, Xuan/0000-0003-1410-0873; 				Abel GJW, 1996, PLANT J, V10, P981, DOI 10.1046/j.1365-313X.1996.10060981.x; [Anonymous], PHOSPHORYLATION STAR; Av?rous L, 2014, STARCH POLYM GENETIC, P79; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Bay-Smidt AM, 1994, STARCH STAERKE GERMA; Blennow A, 2000, INT J BIOL MACROMOL, V27, P211, DOI 10.1016/S0141-8130(00)00121-5; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; BRISSON N, 1989, PLANT CELL, V1, P559, DOI 10.1105/tpc.1.5.559; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Comparot-Moss S, 2010, PLANT PHYSIOL, V152, P685, DOI 10.1104/pp.109.148981; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; EDWARDS A, 1995, PLANT J, V8, P283, DOI 10.1046/j.1365-313X.1995.08020283.x; Ellis RP, 1998, J SCI FOOD AGR, V77, P289, DOI 10.1002/(SICI)1097-0010(199807)77:3<289::AID-JSFA38>3.3.CO;2-4; Ferreira SJ, 2011, TRANSCRIPTOME BASED; Firouzabadi FN, 2007, TRANSGENIC RES, V16, P645, DOI 10.1007/s11248-006-9053-z; Frohberg C, 2011, Patent, Patent No. [CA2558747A1, 2558747]; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HIZUKURI S, 1970, BIOCHIM BIOPHYS ACTA, V212, P179, DOI 10.1016/0005-2744(70)90193-2; HOVENKAMPHERMELINK JHM, 1988, POTATO RES, V31, P241, DOI 10.1007/BF02365532; Huang XF, 2014, PLANTA, V240, P409, DOI 10.1007/s00425-014-2095-1; Huang XF, 2013, PLANT BIOTECHNOL J, V11, P470, DOI 10.1111/pbi.12033; Ji Q, 2004, PLANT BIOTECHNOL J, V2, P251, DOI 10.1111/j.1467-7652.2004.00069.x; Jobling SA, 1999, PLANT J, V18, P163, DOI 10.1046/j.1365-313X.1999.00441.x; Karim AA, 2007, J FOOD SCI, V72, pC132, DOI 10.1111/j.1750-3841.2006.00251.x; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kok-Jacon GA, 2005, PLANT BIOTECHNOL J, V3, P341, DOI 10.1111/j.1467-7652.2005.00128.x; Kortstee AJ, 1997, MODIFICATION POTATO; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kozlov SS, 2007, INT J BIOL MACROMOL, V40, P449, DOI 10.1016/j.ijbiomac.2006.11.001; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafora G, 1911, B GOV HOSP INSANE, V3, P111; Lanahan Michael B, 2005, INVENTORSMODIFIED ST; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd JR, 1999, BIOCHEM J, V338, P515, DOI 10.1042/0264-6021:3380515; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Mahlow S, 2014, NEW PHYTOL, V203, P495, DOI 10.1111/nph.12801; MANNERS DJ, 1989, CARBOHYD POLYM, V11, P87, DOI 10.1016/0144-8617(89)90018-0; Minassian BA, 1999, ANN NEUROL, V45, P262, DOI 10.1002/1531-8249(199902)45:2<262::AID-ANA20>3.0.CO;2-9; MORRISON WR, 1964, ANAL BIOCHEM, V7, P218, DOI 10.1016/0003-2697(64)90231-3; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Noda T, 2004, FOOD CHEM, V86, P119, DOI 10.1016/j.foodchem.2003.09.035; Ral JP, 2012, PLANT BIOTECHNOL J, V10, P871, DOI 10.1111/j.1467-7652.2012.00711.x; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Safford R, 1998, CARBOHYD POLYM, V35, P155, DOI 10.1016/S0144-8617(97)00249-X; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Santelia D, 2011, CURR OPIN BIOTECH, V22, P271, DOI 10.1016/j.copbio.2010.11.014; Schewe G, 2002, INVENTORSMONOCOTYLED; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Singh N., 2005, PROG FOOD BIOPOLYM R, V1, P43; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; TABATA S, 1975, STARKE, V27, P333, DOI 10.1002/star.19750271003; Vikso-Nielsen A, 2001, BIOMACROMOLECULES, V2, P836, DOI 10.1021/bm0155165; Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590; Visser RGF, 1997, STARCH-STARKE, V49, P438, DOI 10.1002/star.19970491103; VISSER RGF, 1991, PLANT MOL BIOL, V17, P691, DOI 10.1007/BF00037054; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang HL, 2013, FEBS LETT, V587, P749, DOI 10.1016/j.febslet.2013.01.066	65	13	14	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169610	10.1371/journal.pone.0169610	http://dx.doi.org/10.1371/journal.pone.0169610			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056069	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100062
J	Zhu, HX; Zhang, Y; Chen, JF; Qiu, JD; Huang, KT; Wu, MD; Xia, CL				Zhu, Huixia; Zhang, Ye; Chen, Jianfeng; Qiu, Jiangdong; Huang, Keting; Wu, Mindan; Xia, Chunlin			IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; DIFFUSE GLIOMAS; MUTANT IDH1; GLIOBLASTOMA; DIFFERENTIATION; PROLIFERATION; METABOLOME; DECREASES; PHENOTYPE; SURVIVAL	Aim of study Mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene were recently discovered in vast majority of World Health Organization (WHO) grade II/III gliomas. This study is to understand the effects of IDH1 R132H mutation in gliomagenesis and to develop new strategies to treat glioma with IDH1 R132H mutation. Materials and methods Over expression of IDH1 R132H in U87MG cells was done by transfecting cells with IDH1 R132H plasmid. MTT assay, scratch repair assay and western blot were performed to study effects of IDH1 R132H mutation on cell proliferation, migration, regulating AKT-mTOR signaling pathway and cell death respectively. NADP+/NADPH and GSH quantification assays were performed to evaluate effects of IDH1 R132H mutation on the production of antioxidant NADPH and GSH. Results We found that over expression of IDH1 R132H mutation decreased cell proliferation consistent with previous reports; however, it increased cell migration and enhanced AKT-mTOR signaling pathway activation. Mutations in isocitrate dehydrogenase (IDH) 1 also change the function of the enzymes and cause them to produce 2-hydroxyglutarate and not produce NADPH. We tested the level of NADPH and GSH and demonstrated that IDH1 R132H mutant stable cells had significantly low NADPH and GSH level compared to control or IDH1 wild type stable cells. The reduced antioxidants (NADPH and GSH) sensitized U87MG cells with IDH R132H mutant to 5-FU treatment. Conclusion Our study highlights the important role of IHD1 R132H mutant in up-regulating AKT-mTOR signaling pathway and enhancing cell migration. Furthermore, we demonstrate that IDH1 R132H mutation affects cellular redox status and sensitizes gliomas cells with IDH1 R132H mutation to 5FU treatment.	[Zhu, Huixia; Zhang, Ye; Xia, Chunlin] Soochow Univ, Suzhou, Jiangsu, Peoples R China; [Zhu, Huixia; Qiu, Jiangdong; Huang, Keting; Wu, Mindan] Nantong Univ, Coll Med, Nantong, Jiangsu, Peoples R China; [Chen, Jianfeng] Chinese Med Hosp, Wuxi, Jiangsu, Peoples R China	Soochow University - China; Nantong University	Xia, CL (corresponding author), Soochow Univ, Suzhou, Jiangsu, Peoples R China.	xiachunlin080@163.com	Chen, Jianfeng/GLR-5748-2022		Nantong University Natural Science Fund	Nantong University Natural Science Fund	HZ was supported by Nantong University Natural Science Fund. The funder had important role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130596; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Grille SJ, 2003, CANCER RES, V63, P2172; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; HOFMANN KH, 1980, Z ALLG MIKROBIOL, V20, P399, DOI 10.1002/jobm.3630200606; Jin GL, 2012, ONCOTARGET, V3, P774; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Leibetseder A, 2013, NEURO-ONCOLOGY, V15, P112, DOI 10.1093/neuonc/nos283; Liu Q, 2015, ACTA NEUROPATHOL, V130, P587, DOI 10.1007/s00401-015-1470-8; Liu Y, 2012, J NEURO-ONCOL, V109, P253, DOI 10.1007/s11060-012-0914-4; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Nie QM, 2015, MOL MED REP, V12, P6695, DOI 10.3892/mmr.2015.4241; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Olar A, 2015, ACTA NEUROPATHOL, V129, P585, DOI 10.1007/s00401-015-1398-z; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Reyes-Botero G, 2014, J NEURO-ONCOL, V116, P405, DOI 10.1007/s11060-013-1312-2; Sabit H, 2014, BRAIN TUMOR PATHOL, V31, P242, DOI 10.1007/s10014-013-0172-y; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; 于宝华, 2005, [中华病理学杂志, Chinese Journal of Pathology], V34, P674	31	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169038	10.1371/journal.pone.0169038	http://dx.doi.org/10.1371/journal.pone.0169038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052098	Green Submitted, gold, Green Published			2022-12-26	WOS:000391621500029
J	Gombedza, F; Kondeti, V; Al-Azzam, N; Koppes, S; Duah, E; Patil, P; Hexter, M; Phillips, D; Thodeti, CK; Paruchuri, S				Gombedza, Farai; Kondeti, Vinay; Al-Azzam, Nosayba; Koppes, Stephanie; Duah, Ernest; Patil, Prachi; Hexter, Madison; Phillips, Daniel; Thodeti, Charles K.; Paruchuri, Sailaja			Mechanosensitive transient receptor potential vanilloid 4 regulates Dermatophagoides farinae-induced airway remodeling via 2 distinct pathways modulating matrix synthesis and degradation	FASEB JOURNAL			English	Article						TGF-beta 1; myofibroblasts; PI3K; PAI-1; fibronectin	INTESTINAL EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; TRPV4 CHANNELS; BRONCHIAL-ASTHMA; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; LUNG INJURY; ACTIVATION; MYOFIBROBLAST; DIFFERENTIATION	Contributions of mechanical signals to airway remodeling during asthma are poorly understood. Transient receptor potential vanilloid 4 (TRPV4), a mechanosensitive ion channel, has been implicated in cardiac and pulmonary fibrosis; however, its role in asthma remains elusive. Employing a Dermatophagoides farinae-induced asthma model, we report here that TRPV4-knockout mice were protected from D. farinae-induced airway remodeling. Furthermore, lung fibroblasts that were isolated from TRPV4-knockout mice showed diminished differentiation potential compared with wild-type mice. Fibroblasts from asthmatic lung exhibited increased TRPV4 activity and enhanced differentiation potential compared with normal human lung fibroblasts. Of interest, TGF-beta 1 treatment enhanced TRPV4 activation in a PI3K-dependent manner in normal human lung fibroblasts in vitro Mechanistically, TRPV4 modulated matrix remodeling in the lung via 2 distinct but dependent pathways: one enhances matrix deposition by fibrotic gene activation, whereas the other slows down matrix degradation by increased plasminogen activator inhibitor 1. Of importance, both pathways are regulated by Rho/myocardin-related transcription factor-A and contribute to fibroblast differentiation and matrix remodeling in the lung. Thus, our results support a unique role for TRPV4 in D. farinae-induced airway remodeling and warrant further studies in humans for it to be used as a novel therapeutic target in the treatment of asthma.-Gombedza, F., Kondeti, V., Al-Azzam, N., Koppes, S., Duah, E., Patil, P., Hexter, M., Phillips, D., Thodeti, C. K., Paruchuri, S. Mechanosensitive transient receptor potential vanilloid 4 regulates Dermatophagoides farinae-induced airway remodeling via 2 distinct pathways modulating matrix synthesis and degradation.	[Gombedza, Farai; Kondeti, Vinay; Al-Azzam, Nosayba; Koppes, Stephanie; Duah, Ernest; Patil, Prachi; Hexter, Madison; Phillips, Daniel; Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED)	Paruchuri, S (corresponding author), Dept Chem, KNCL 406,190 E Buchtel Common, Akron, OH 44325 USA.	sp97@uakron.edu	Duah, Ernest/I-5985-2019; Gombedza, Farai/AAO-9776-2020	Duah, Ernest/0000-0002-5125-0830; Gombedza, Farai/0000-0002-1977-6242	James Foght Assistant Professorship (University of Akron); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant [R01HL119705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119705] Funding Source: NIH RePORTER	James Foght Assistant Professorship (University of Akron); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a James Foght Assistant Professorship (University of Akron; to S.P.), and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant (R01HL119705 to C.K.T.).	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chaudhuri R, 2014, EUR RESPIR J, V44, P895, DOI 10.1183/09031936.00047014; Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Conte E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024663; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Habibovic A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88811; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Liedtke W., 2007, V179, P473; Liedtke W, 2007, EXP PHYSIOL, V92, P507, DOI 10.1113/expphysiol.2006.035642; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Naumov DE, 2016, DOKL BIOCHEM BIOPHYS, V469, P260, DOI 10.1134/S1607672916040074; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B., 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramirez AM, 2006, AM J TRANSPLANT, V6, P2080, DOI 10.1111/j.1600-6143.2006.01430.x; ROCHE WR, 1989, LANCET, V1, P520; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Stumm CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095959; Sullivan MN, 2012, MOL PHARMACOL, V82, P464, DOI 10.1124/mol.112.078584; Sun QZ, 2016, CELL SIGNAL, V28, P307, DOI 10.1016/j.cellsig.2016.01.004; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tang MLK, 2006, PHARMACOL THERAPEUT, V112, P474, DOI 10.1016/j.pharmthera.2006.05.001; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Turato G, 2008, AM J RESP CRIT CARE, V178, P476, DOI 10.1164/rccm.200712-1818OC; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wilson JW, 1997, CLIN EXP ALLERGY, V27, P363; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	59	23	24	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1556	1570		10.1096/fj.201601045R	http://dx.doi.org/10.1096/fj.201601045R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073835	Green Published			2022-12-26	WOS:000398504300023
J	Kim, HJ; Kwon, S; Nam, SH; Jung, JW; Kang, M; Ryu, J; Kim, JE; Cheong, JG; Cho, CY; Kim, S; Song, DG; Kim, YN; Kim, TY; Jung, MK; Lee, KM; Pack, CG; Lee, JW				Kim, Hye-Jin; Kwon, Sojung; Nam, Seo Hee; Jung, Jae Woo; Kang, Minkyung; Ryu, Jihye; Kim, Ji Eon; Cheong, Jin-Gyu; Cho, Chang Yun; Kim, Somi; Song, Dae-Geun; Kim, Yong-Nyun; Kim, Tai Young; Jung, Min-Kyo; Lee, Kyung-Min; Pack, Chan-Gi; Lee, Jung Weon			Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2-and 3-dimensional environments	FASEB JOURNAL			English	Article						3D cell culture; FCCS; migration; protein interaction affinity; membrane proteins	TUMOR MICROENVIRONMENT; TETRASPANIN PROTEINS; INTEGRIN ALPHA-2; TM4SF5; PALMITOYLATION; MODULATION; EXPRESSION; CANCER; CELLS	Membrane proteins sense extracellular cues and transduce intracellular signaling to coordinate directionality and speed during cellular migration. They are often localized to specific regions, as with lipid rafts or tetraspanin-enriched microdomains; however, the dynamic interactions of tetraspanins with diverse receptors within tetraspanin-enriched microdomains on cellular surfaces remain largely unexplored. Here, we investigated effects of tetraspan(in) TM4SF5 (transmembrane 4 L6 family member 5)-enriched microdomains (T5ERMs) on the directionality of cell migration. Physical association of TM4SF5 with epidermal growth factor receptor (EGFR) and integrin alpha 5 was visualized by live fluorescence cross-correlation spectroscopy and higher-resolution microscopy at the leading edge of migratory cells, presumably forming TM4SF5-enriched microdomains. Whereas TM4SF5 and EGFR colocalized at themigrating leading region more than at the rear, TM4SF5 and integrin a5 colocalized evenly throughout cells. Cholesterol depletion and disruption in TM4SF5 post-translational modifications, including N-glycosylation and palmitoylation, altered TM4SF5 interactions and cellular localization, which led to less cellular migration speed and directionality in 2-or 3-dimensional conditions. TM4SF5 controlled directional cell migration and invasion, and importantly, these TM4SF5 functions were dependent on cholesterol, TM4SF5 post-translational modifications, and EGFR and integrin alpha 5 activity. Altogether, we showed that TM4SF5 dynamically interacted with EGFR and integrin a5 in migratory cells to control directionality and invasion.-Kim, H.-J., Kwon, S., Nam, S. H., Jung, J. W., Kang, M., Ryu, J., Kim, J. E., Cheong, J.-G., Cho, C. Y., Kim, S., Song, D.-G., Kim, Y.-N., Kim, T. Y., Jung, M.-K., Lee, K.-M., Pack, C.-G., Lee, J. W. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2-and 3-dimensional environments. FASEB J. 31, 1461-1481 (2017). www.fasebj.org	[Kim, Hye-Jin; Kwon, Sojung; Kang, Minkyung; Ryu, Jihye; Kim, Ji Eon; Cheong, Jin-Gyu; Cho, Chang Yun; Kim, Somi; Song, Dae-Geun; Kim, Tai Young; Lee, Kyung-Min; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Nam, Seo Hee; Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Kim, Yong-Nyun] Natl Canc Ctr, Gyeonggi Do, South Korea; [Jung, Min-Kyo; Pack, Chan-Gi] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Jung, Min-Kyo; Pack, Chan-Gi] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; University of Ulsan; Asan Medical Center	Lee, JW (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/F-9149-2012; Lee, Jung Weon/AAC-1146-2020	Lee, Jung Weon/0000-0003-2722-8200; KIM, TAI YOUNG/0000-0001-8086-2476; Jung, Jae Woo/0000-0001-7178-7400; Cheong, Jin-gyu/0000-0002-6190-0411	National Research Foundation (NRF) of Korea for Basic Science Research Program [NRF-2014R1A1A2058183, NRF-2016R1C1B2013275]; Tumor Microenvironment Global Core Research Center [20110030001]; Medicinal Bioconvergence Research Center [NRF-2013M3A6A4044019]; Bio and Medical Technology Development Program [NRF-2016M3A9A8915731]	National Research Foundation (NRF) of Korea for Basic Science Research Program; Tumor Microenvironment Global Core Research Center; Medicinal Bioconvergence Research Center; Bio and Medical Technology Development Program	FCCS study and Airyscan imaging was performed at the Confocal Microscope Core at Asan Institute for Life Sciences of Asan Medical Center. This work was supported by the National Research Foundation (NRF) of Korea for Basic Science Research Program [NRF-2014R1A1A2058183 (to C.-G.P.) and NRF-2016R1C1B2013275 (to K.-M.L.)], the Tumor Microenvironment Global Core Research Center (20110030001), the Medicinal Bioconvergence Research Center (NRF-2013M3A6A4044019), and the Bio and Medical Technology Development Program (NRF-2016M3A9A8915731; to J.W.L.).	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Choi YJ, 2014, BIOCHEM J, V462, P89, DOI 10.1042/BJ20140177; Detchokul S, 2014, BRIT J PHARMACOL, V171, P5462, DOI 10.1111/bph.12260; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102817; Lee D, 2015, HEPATOLOGY, V61, P1978, DOI 10.1002/hep.27721; Lee SA, 2011, FRONT BIOSCI-LANDMRK, V16, P1752, DOI 10.2741/3818; Lee SA, 2009, CARCINOGENESIS, V30, P1872, DOI 10.1093/carcin/bgp234; Lee SY, 2006, EXP CELL RES, V312, P2983, DOI 10.1016/j.yexcr.2006.06.001; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Muller-Pillasch F, 1998, GENE, V208, P25, DOI 10.1016/S0378-1119(97)00633-1; Nam SH, 2015, ONCOTARGET, V6, P21655, DOI 10.18632/oncotarget.4130; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275	23	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1461	1481		10.1096/fj.201600944RR	http://dx.doi.org/10.1096/fj.201600944RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073834				2022-12-26	WOS:000398504300016
J	Junka, A; Szymczyk, P; Ziolkowski, G; Karuga-Kuzniewska, E; Smutnicka, D; Bil-Lula, I; Bartoszewicz, M; Mahabady, S; Sedghizadeh, PP				Junka, Adam; Szymczyk, Patrycja; Ziolkowski, Grzegorz; Karuga-Kuzniewska, Ewa; Smutnicka, Danuta; Bil-Lula, Iwona; Bartoszewicz, Marzenna; Mahabady, Susan; Sedghizadeh, Parish Paymon			Bad to the Bone: On In Vitro and Ex Vivo Microbial Biofilm Ability to Directly Destroy Colonized Bone Surfaces without Participation of Host Immunity or Osteoclastogenesis	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; OSTEOMYELITIS; VIRULENCE; PATHOGENESIS; INFECTIONS; MECHANISMS	Bone infections are a significant public health burden associated with morbidity and mortality in patients. Microbial biofilm pathogens are the causative agents in chronic osteomyelitis. Research on the pathogenesis of osteomyelitis has focused on indirect bone destruction by host immune cells and cytokines secondary to microbial insult. Direct bone resorption by biofilm pathogens has not yet been seriously considered. In this study, common osteomyelitis pathogens (Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Streptococcus mutans) were grown as biofilms in multiple in vitro and ex vivo experiments to analyze quantitative and qualitative aspects of bone destruction during infection. Pathogens were grown as single or mixed species biofilms on the following substrates: hydroxyapatite, rat jawbone, or polystyrene wells, and in various media. Biofilm growth was evaluated by scanning electron microscopy and pH levels were monitored over time. Histomorphologic and quantitative effects of biofilms on tested substrates were analyzed by microcomputed tomography and quantitative cultures. All tested biofilms demonstrated significant damage to bone. Scanning electron microscopy indicated that all strains formed mature biofilms within 7 days on all substrate surfaces regardless of media. Experimental conditions impacted pH levels, although this had no impact on biofilm growth or bone destruction. Presence of biofilm led to bone dissolution with a decrease of total volume by 20.17 +/- 2.93% upon microcomputed tomography analysis, which was statistically significant as compared to controls (p < 0.05, ANOVA). Quantitative cultures indicated that media and substrate did not impact biofilm formation (Kruskall-Wallis test, post-hoc Dunne's test; p < 0.05). Overall, these results indicate that biofilms associated with osteomyelitis have the ability to directly resorb bone. These findings should lead to a more complete understanding of the etiopathogenesis of osteomyelitis, where direct bone resorption by biofilm is considered in addition to the well-known osteoclastic and host cell destruction of bone.	[Junka, Adam; Smutnicka, Danuta; Bartoszewicz, Marzenna] Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland; [Szymczyk, Patrycja; Ziolkowski, Grzegorz] Wroclaw Univ Technol, Fac Mech Engn, CAMT, FPC, Wroclaw, Poland; [Karuga-Kuzniewska, Ewa] Univ Wroclaw, Div Infect Dis Anim & Vet Adm, Wroclaw, Poland; [Bil-Lula, Iwona] Wroclaw Med Univ, Dept Clin Chem, Wroclaw, Poland; [Mahabady, Susan; Sedghizadeh, Parish Paymon] Univ Southern Calif, Ostrow Sch Dent, Ctr Biofilms & Craniofacial Mol Biol, Los Angeles, CA USA	Wroclaw Medical University; Wroclaw University of Science & Technology; University of Wroclaw; Wroclaw Medical University; University of Southern California	Mahabady, S (corresponding author), Univ Southern Calif, Ostrow Sch Dent, Ctr Biofilms & Craniofacial Mol Biol, Los Angeles, CA USA.	mahabady@use.edu	Bil-Lula, Iwona/ABA-2361-2021; Sedghizadeh, Parish/AAI-8453-2020	Bil-Lula, Iwona/0000-0002-2769-0166; Sedghizadeh, Parish/0000-0003-4190-0497; Szymczyk-Ziolkowska, Patrycja/0000-0001-7742-7182; Junka, Adam/0000-0002-7559-8903; BARTOSZEWICZ, MARZENNA/0000-0002-6542-2525; Ziolkowski, Grzegorz/0000-0002-9031-1528	National Institute on Minority Health and Health Disparities, National Institutes of Health [L32MD003617]; Ostrow School of Dentistry, University of Southern California; National Institutes of Health, National Institute on Minority Health and Health Disparities [L32MD003617]; University of Southern California, Ostrow School of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021982] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities, National Institutes of Health; Ostrow School of Dentistry, University of Southern California; National Institutes of Health, National Institute on Minority Health and Health Disparities; University of Southern California, Ostrow School of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was made possible by grant number L32MD003617 from the National Institute on Minority Health and Health Disparities, National Institutes of Health, in addition to a seed grant from the Ostrow School of Dentistry, University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Casey Chen at the University of Southern California for his help with the intellectual content of this work. We would also like to thank the National Institutes of Health, National Institute on Minority Health and Health Disparities for a grant to author PPS (L32MD003617), and also the University of Southern California, Ostrow School of Dentistry for a seed grant to author PPS.	Assis S, 2015, MICROSC MICROANAL, V21, P805, DOI 10.1017/S1431927615000768; Beck-Broichsitter BE, 2015, CURR OPIN INFECT DIS, V28, P240, DOI 10.1097/QCO.0000000000000155; Boody BS, 2015, J SPINAL DISORD TECH, V28, pE316, DOI 10.1097/BSD.0000000000000294; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Burne RA, 2001, METHOD ENZYMOL, V337, P403, DOI 10.1016/S0076-6879(01)37029-5; Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; Dang HY, 2016, MICROBIOL MOL BIOL R, V80, P91, DOI 10.1128/MMBR.00037-15; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Junka AF, 2015, J ORAL MAXIL SURG, V73, P451, DOI 10.1016/j.joms.2014.09.019; Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; Maffulli N, 2016, SURGEON; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Paterson JS, 2016, J BIOTECHNOL, V219, P90, DOI 10.1016/j.jbiotec.2015.12.033; Rumpler M, 2013, CALCIFIED TISSUE INT, V93, P526, DOI 10.1007/s00223-013-9786-7; Sanders J, 2013, ORTHOPEDICS, V36, P368, DOI 10.3928/01477447-20130426-07; Sedghizadeh PP, 2009, J AM DENT ASSOC, V140, P1259, DOI 10.14219/jada.archive.2009.0049; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917	25	34	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169565	10.1371/journal.pone.0169565	http://dx.doi.org/10.1371/journal.pone.0169565			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076372	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100042
J	Messinger, DS; Mattson, WI; Todd, JT; Gangi, DN; Myers, ND; Bahrick, LE				Messinger, Daniel S.; Mattson, Whitney I.; Todd, James Torrence; Gangi, Devon N.; Myers, Nicholas D.; Bahrick, Lorraine E.			Temporal Dependency and the Structure of Early Looking	PLOS ONE			English	Article							INFANT VISUAL HABITUATION; CHOICE-REACTION-TIMES; INDIVIDUAL-DIFFERENCES; HUMAN COGNITION; EYE-TRACKING; 1/F NOISE; 1ST YEAR; ATTENTION; MEMORY; PREFERENCES	Although looking time is used to assess infant perceptual and cognitive processing, little is known about the temporal structure of infant looking. To shed light on this temporal structure, 127 three-month-olds were assessed in an infant-controlled habituation procedure and presented with a pre-recorded display of a woman addressing the infant using infant directed speech. Previous individual look durations positively predicted subsequent look durations over a six look window, suggesting a temporal dependency between successive infant looks. The previous look duration continued to predict the subsequent look duration after accounting for habituation-linked declines in look duration, and when looks were separated by an inter-trial interval in which no stimulus was displayed. Individual differences in temporal dependency, the strength of associations between consecutive look durations, are distinct from individual differences in mean infant look duration. Nevertheless, infants with stronger temporal dependency had briefer mean look durations, a potential index of stimulus processing. Temporal dependency was evident not only between individual infant looks but between the durations of successive habituation trials (total looking within a trial). Finally, temporal dependency was evident in associations between the last look at the habituation stimulus and the first look at a novel test stimulus. Thus temporal dependency was evident across multiple timescales (individual looks and trials comprised of multiple individual looks) and persisted across conditions including brief periods of no stimulus presentation and changes from a familiar to novel stimulus. Associations between consecutive look durations over multiple timescales and stimuli suggest a temporal structure of infant attention that has been largely ignored in previous work on infant looking.	[Messinger, Daniel S.; Mattson, Whitney I.; Gangi, Devon N.] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Messinger, Daniel S.] Univ Miami, Dept Pediat, Coral Gables, FL 33124 USA; [Messinger, Daniel S.] Univ Miami, Dept Mus Engn, Coral Gables, FL 33124 USA; [Messinger, Daniel S.] Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; [Todd, James Torrence; Bahrick, Lorraine E.] Florida Int Univ, Dept Psychol, Miami, FL 33199 USA; [Myers, Nicholas D.] Univ Miami, Dept Educ & Psychol Studies, Coral Gables, FL 33124 USA; [Mattson, Whitney I.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Gangi, Devon N.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA	University of Miami; University of Miami; University of Miami; University of Miami; State University System of Florida; Florida International University; University of Miami; University of Michigan System; University of Michigan; University of California System; University of California Davis	Messinger, DS (corresponding author), Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA.; Messinger, DS (corresponding author), Univ Miami, Dept Pediat, Coral Gables, FL 33124 USA.; Messinger, DS (corresponding author), Univ Miami, Dept Mus Engn, Coral Gables, FL 33124 USA.; Messinger, DS (corresponding author), Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA.	dmessinger@miami.edu		Myers, Nicholas/0000-0001-9069-9940; Gangi, Devon/0000-0003-2885-4641	National Institutes of Health [MH62226, HD064943, HD053776, HD057284]; National Science Foundation [BCS-1323927, 1052736]; University of Miami, Department of Psychology/Fred C. and Helen Donn Flipse Research Support Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007109, R01HD057284, R01HD053776, K02HD064943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH073124, R01MH062226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Miami, Department of Psychology/Fred C. and Helen Donn Flipse Research Support Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health (https://www.nih.gov/ MH62226, HD064943, HD053776, HD057284), the National Science Foundation (http://www.nsf.gov/ BCS-1323927 & 1052736), and by the University of Miami, Department of Psychology/Fred C. and Helen Donn Flipse Research Support Fund.	Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Bahrick L. E., 2007, SOC RES CHILD DEV BO; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Bahrick LE, 2003, INFANT DISCRIMINATIO; Bahrick LE, 2016, ENHANCED ATTENTION S, P1705; Bahrick LE, 2008, AUDIOVISUAL TEMPORAL; Bahrick LE, 2013, DEV PSYCHOL, V49, P1919, DOI 10.1037/a0031238; Beebe B, 2007, DEV PSYCHOL, V43, P1360, DOI 10.1037/0012-1649.43.6.1360; BERTENTHAL BI, 1983, INFANT BEHAV DEV, V6, P331, DOI 10.1016/S0163-6383(83)80041-1; BORNSTEIN MH, 1988, PSYCHOL RES-PSYCH FO, V50, P130, DOI 10.1007/BF00309213; Chow SM, 2010, EMOTION, V10, P101, DOI 10.1037/a0017824; Civan A, 2005, INFANCY, V7, P111, DOI 10.1207/s15327078in0702_1; COHEN LB, 1969, J EXP CHILD PSYCHOL, V7, P419, DOI 10.1016/0022-0965(69)90004-6; COLOMBO J, 1991, CHILD DEV, V62, P1247, DOI 10.2307/1130804; Colombo J, 2001, ANNU REV PSYCHOL, V52, P337, DOI 10.1146/annurev.psych.52.1.337; COLOMBO J, 1987, CHILD DEV, V58, P474, DOI 10.2307/1130524; Colombo J, 2010, INFANCY, V15, P107, DOI 10.1111/j.1532-7078.2009.00012.x; Colombo J, 2009, NEUROBIOL LEARN MEM, V92, P225, DOI 10.1016/j.nlm.2008.06.002; Cuevas K, 2014, CHILD DEV, V85, P397, DOI 10.1111/cdev.12126; DELOACHE JS, 1976, CHILD DEV, V47, P145; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; FANTZ RL, 1963, SCIENCE, V140, P296, DOI 10.1126/science.140.3564.296; Feldman R, 2003, INFANT MENT HEALTH J, V24, P1, DOI 10.1002/imhj.10041; Fisher-Thompson D, 2014, INFANCY, V19, P227, DOI 10.1111/infa.12051; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gill SV, 2009, DEVELOPMENTAL SCI, V12, P888, DOI 10.1111/j.1467-7687.2009.00828.x; Gilmore RO, 2002, INFANT BEHAV DEV, V25, P399, DOI 10.1016/S0163-6383(02)00142-X; GREEN DM, 1984, ACTA PSYCHOL, V55, P231, DOI 10.1016/0001-6918(84)90043-X; HOROWITZ FD, 1972, DEV PSYCHOL, V7, P88, DOI 10.1037/h0032695; Jankowski JJ, 1997, J EXP CHILD PSYCHOL, V65, P127, DOI 10.1006/jecp.1996.2363; Johnson SP, 2003, P NATL ACAD SCI USA, V100, P10568, DOI 10.1073/pnas.1630655100; Kaldy Z, 2006, DEVELOPMENTAL SCI, V9, P482, DOI 10.1111/j.1467-7687.2006.00515.x; Kavsek M, 2012, DEV PSYCHOBIOL, V13, P21081; Kello CT, 2008, COGNITIVE SCI, V32, P1217, DOI 10.1080/03640210801944898; Kovack-Lesh KA, 2013, DEV PSYCHOL; Kovack-Lesh KA, 2014, DEV PSYCHOL, V50, P402, DOI 10.1037/a0033195; LAMING D, 1979, ACTA PSYCHOL, V43, P381, DOI 10.1016/0001-6918(79)90032-5; Messinger DS, 2012, INFANCY, V17, P233, DOI 10.1111/j.1532-7078.2011.00074.x; Oakes LM, 2010, J COGN DEV, V11, P255, DOI 10.1080/15248371003699977; Papageorgiou KA, 2014, PSYCHOL SCI; Perez-Edgar K, 2010, DEV PSYCHOL, V46, P1723, DOI 10.1037/a0021064; Perone S, 2014, DEV PSYCHOL, V50, P837, DOI 10.1037/a0034137; Perone S, 2013, COGNITIVE SCI, V37, P1, DOI 10.1111/cogs.12010; Posner MI, 2012, DEV PSYCHOL, V48, P827, DOI 10.1037/a0025530; Raudenbush SW, 2004, HLM 6 WINDOWS; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reynolds GD, 2012, INFANCY; Richards JE, 2000, CHILD DEV, V71, P602, DOI 10.1111/1467-8624.00170; Robertson SS, 2004, DEVELOPMENTAL SCI, V7, P194, DOI 10.1111/j.1467-7687.2004.00338.x; Rose SA, 2002, DEV PSYCHOL, V38, P895, DOI 10.1037//0012-1649.38.6.895; Rose SA, 2012, PSYCHOL SCI, V23, P1345, DOI 10.1177/0956797612444902; Schoner G, 2006, PSYCHOL REV, V113, P273, DOI 10.1037/0033-295X.113.2.273; Sheese BE, 2008, INFANT BEHAV DEV, V31, P501, DOI 10.1016/j.infbeh.2008.02.001; Sirois S, 2004, J COGNITIVE NEUROSCI, V16, P1352, DOI 10.1162/0898929042304778; Sirois S, 2002, TRENDS COGN SCI, V6, P293, DOI 10.1016/S1364-6613(02)01926-5; Smith LB, 2003, TRENDS COGN SCI, V7, P343, DOI 10.1016/S1364-6613(03)00156-6; Spencer JP, 2011, CHILD DEV PERSPECT, V5, P260, DOI 10.1111/j.1750-8606.2011.00194.x; Spencer JR, 2001, CHILD DEV, V72, P1327, DOI 10.1111/1467-8624.00351; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Yale ME, 1999, DEV PSYCHOL, V35, P505, DOI 10.1037/0012-1649.35.2.505	62	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169458	10.1371/journal.pone.0169458	http://dx.doi.org/10.1371/journal.pone.0169458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH6BJ	28076362	Green Published, gold			2022-12-26	WOS:000391857100038
J	Colins, A; Gerdtzen, ZP; Nunez, MT; Salgado, JC				Colins, Andrea; Gerdtzen, Ziomara P.; Nunez, Marco T.; Cristian Salgado, J.			Mathematical Modeling of Intestinal Iron Absorption Using Genetic Programming	PLOS ONE			English	Article							METAL-ION TRANSPORTER; TRANSFERRIN RECEPTOR; CELL MONOLAYERS; MUCOSAL BLOCK; HOMEOSTASIS; EXPRESSION; FERRITIN; DCYTB; DMT1; RAT	Iron is a trace metal, key for the development of living organisms. Its absorption process is complex and highly regulated at the transcriptional, translational and systemic levels. Recently, the internalization of the DMT1 transporter has been proposed as an additional regulatory mechanism at the intestinal level, associated to the mucosal block phenomenon. The short-term effect of iron exposure in apical uptake and initial absorption rates was studied in Caco-2 cells at different apical iron concentrations, using both an experimental approach and a mathematical modeling framework. This is the first report of short-term studies for this system. A non-linear behavior in the apical uptake dynamics was observed, which does not follow the classic saturation dynamics of traditional biochemical models. We propose a method for developing mathematical models for complex systems, based on a genetic programming algorithm. The algorithm is aimed at obtaining models with a high predictive capacity, and considers an additional parameter fitting stage and an additional Jackknife stage for estimating the generalization error. We developed a model for the iron uptake system with a higher predictive capacity than classic biochemical models. This was observed both with the apical uptake dataset used for generating the model and with an independent initial rates dataset used to test the predictive capacity of the model. The model obtained is a function of time and the initial apical iron concentration, with a linear component that captures the global tendency of the system, and a non-linear component that can be associated to the movement of DMT1 transporters. The model presented in this paper allows the detailed analysis, interpretation of experimental data, and identification of key relevant components for this complex biological process. This general method holds great potential for application to the elucidation of biological mechanisms and their key components in other complex systems.	[Colins, Andrea; Cristian Salgado, J.] Univ Chile, Dept Chem Engn & Biotechnol, Lab Proc Modeling & Distributed Comp, Santiago, Chile; [Gerdtzen, Ziomara P.; Cristian Salgado, J.] Univ Chile, Ctr Biotechnol & Bioengn, Dept Chem Engn & Biotechnol, Santiago, Chile; [Nunez, Marco T.] Univ Chile, Fac Sci, Dept Biol, Iron & Biol Aging Lab, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Salgado, JC (corresponding author), Univ Chile, Dept Chem Engn & Biotechnol, Lab Proc Modeling & Distributed Comp, Santiago, Chile.	jsalgado@ing.uchile.cl	Salgado, J. Cristian/N-1275-2013; Gerdtzen, Ziomara/H-2711-2013	Salgado, J. Cristian/0000-0002-5507-8695; Gerdtzen, Ziomara/0000-0002-7486-8537; Colins Rodriguez, Andrea/0000-0003-3584-2251	FONDECYT [1130317]; PIA CONICYT [FB0001]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PIA CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by FONDECYT Grant 1130317 and PIA CONICYT grant FB0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, ENCY RES DESIGN; ALVAREZHERNANDEZ X, 1991, BIOCHIM BIOPHYS ACTA, V1070, P205, DOI 10.1016/0005-2736(91)90165-5; Anderson D, 2004, MODEL SELECTION MULT, V2nd; [Anonymous], 2011, DRUG DESIGN STRATEGI; [Anonymous], 1998, MATLAB USERS GUIDE; ANTONINI E, 1965, PHYSIOL REV, V45, P123, DOI 10.1152/physrev.1965.45.1.123; Artursson P, 1997, PHARMACEUT RES, V14, P1655, DOI 10.1023/A:1012155124489; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Aytek A, 2008, J HYDROL, V351, P288, DOI 10.1016/j.jhydrol.2007.12.005; Baglivo JA, 2005, MATH LAB MATH STAT E; Banzhaf W., 1998, GENETIC PROGRAMMING; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; Salgado JC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-147; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Frazer DM, 2003, GUT, V52, P340, DOI 10.1136/gut.52.3.340; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Harvey RA, 2011, BIOCHEMISTRY-US, V5th; Haupt S.E., 2008, ARTIF INTELL; Hinton G. E., 1987, Complex Systems, V1, P495; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kolachala VL, 2007, WORLD J GASTROENTERO, V13, P1042, DOI 10.3748/wjg.v13.i7.1042; Koza JR, 1992, GENETIC PROGRAMMING; Lane DJR, 2015, NUTRIENTS, V7, P2274, DOI 10.3390/nu7042274; Liang RP, 2012, COMPUT BIOL MED, V42, P180, DOI 10.1016/j.compbiomed.2011.11.006; Linder MC, 2006, BIOL RES, V39, P143, DOI 10.4067/S0716-97602006000100016; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Maher RA, 2013, INTELLIGENT CONTROL, V9, P94, DOI [DOI 10.4236/ICA.2013.41013, 10.4236/ica.2013.41013]; McCallum H, 2008, POPULATION PARAMETER, V3; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moraglio A, 2012, 15 EUR C EUROGP 2012; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Natoli M, 2011, J CELL PHYSIOL, V226, P1531, DOI 10.1002/jcp.22487; Nunez MT, 2010, BIOFACTORS, V36, P88, DOI 10.1002/biof.84; Nunez MT, 2010, AM J PHYSIOL-CELL PH, V298, pC477, DOI 10.1152/ajpcell.00168.2009; ONEILCUTTING MA, 1987, ARCH INTERN MED, V147, P489, DOI 10.1001/archinte.147.3.489; Poli R., 2008, FIELD GUIDE GENETIC; Rehm H, 2006, PROTEIN BIOCH PROTEO; Riolo R, 2007, GENETIC PROGRAMMING, DOI [10.1007/978-0-387-49650-4, DOI 10.1007/978-0-387-49650-4]; Silva S., 2015, GPLAB A GENETIC PROG; Smart O, 2007, ENG APPL ARTIF INTEL, V20, P1070, DOI 10.1016/j.engappai.2007.02.002; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; STEWART WB, 1950, J EXP MED, V92, P375, DOI 10.1084/jem.92.4.375; Topchy A, 2001, P GEN EV COMP C GECC; Urbanowicz RJ, 2008, P 10 ANN C GEN EV CO, P339; World Health Organization, 2007, WHO ASS IR STAT POP; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Yeh KY, 2000, AM J PHYSIOL-GASTR L, V279, pG1070, DOI 10.1152/ajpgi.2000.279.5.G1070; Zhang Yongqiang, 2009, J SOFTWARE ENG APPL, V2, P354, DOI DOI 10.4236/JSEA.2009.25047; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587	56	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169601	10.1371/journal.pone.0169601	http://dx.doi.org/10.1371/journal.pone.0169601			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072870	gold, Green Published, Green Submitted			2022-12-26	WOS:000391844200032
J	Hampshire, T; Menys, A; Jaffer, A; Bhatnagar, G; Punwani, S; Atkinson, D; Halligan, S; Hawkes, DJ; Taylor, SA				Hampshire, Thomas; Menys, Alex; Jaffer, Asif; Bhatnagar, Gauraang; Punwani, Shonit; Atkinson, David; Halligan, Steve; Hawkes, David J.; Taylor, Stuart A.			A Probabilistic Method for Estimation of Bowel Wall Thickness in MR Colonography	PLOS ONE			English	Article							CROHNS-DISEASE; SEGMENTATION	MRI has recently been applied as a tool to quantitatively evaluate the response to therapy in patients with Crohn's disease, and is the preferred choice for repeated imaging. Bowel wall thickness on MRI is an important biomarker of underlying inflammatory activity, being abnormally increased in the acute phase and reducing in response to successful therapy; however, a poor level of interobserver agreement of measured thickness is reported and therefore a system for accurate, robust and reproducible measurements is desirable. We propose a novel method for estimating bowel wall-thickness to improve the poor interobserver agreement of the manual procedure. We show that the variability of wall thickness measurement between the algorithm and observer measurements (0.25mm +/- 0.81mm) has differences which are similar to observer variability (0.16mm +/- 0.64mm).	[Hampshire, Thomas; Hawkes, David J.] UCL, CMIC, Gower St, London WC1E 6BT, England; [Menys, Alex; Jaffer, Asif; Bhatnagar, Gauraang; Punwani, Shonit; Atkinson, David; Halligan, Steve; Taylor, Stuart A.] UCL, Ctr Med Imaging, 250 Euston Rd, London NW1 2PG, England	University of London; University College London; University of London; University College London	Hampshire, T (corresponding author), UCL, CMIC, Gower St, London WC1E 6BT, England.	thomas.hampshire.09@ucl.ac.uk	Atkinson, David/C-2270-2008; Halligan, Steve/C-5875-2009	Atkinson, David/0000-0003-1124-6666; Halligan, Steve/0000-0003-0632-5108; Taylor, Stuart/0000-0002-6765-8806	MRC Industrial Collaborative Student (DTA) program [G0900207-1/1]; Cancer Research UK [16463] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10338, CL-2007-18-015, NF-SI-0513-10019] Funding Source: researchfish	MRC Industrial Collaborative Student (DTA) program; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This thesis was funded by the MRC Industrial Collaborative Student (DTA) program (G0900207-1/1).	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; ADALSTEINSSON D, 1995, J COMPUT PHYS, V118, P269, DOI 10.1006/jcph.1995.1098; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bergman N., 1999, RECURSIVE BAYESIAN E; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; GANDER W, 1994, BIT, V34, P558, DOI 10.1007/BF01934268; Horsthuis K, 2009, EUR RADIOL, V19, P1450, DOI 10.1007/s00330-008-1287-0; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Li Z., 2011, ACCOUNTING RES, P44; Mahapatra Dwarikanath, 2012, Abdominal Imaging. Computational and Clinical Applications. Proceedings of the 4th International Workshop. Held in Conjunction with MICCAI 2012, P97, DOI 10.1007/978-3-642-33612-6_11; Mahapatra D, 2014, IEEE 11 INT S BIOM I; Mahapatra D, 2013, IEEE T MED IMAGING, V32, P2332, DOI 10.1109/TMI.2013.2282124; Mahapatra D, 2013, J DIGIT IMAGING, V26, P920, DOI 10.1007/s10278-013-9576-9; Nordin N., 2012, 1 WSEAS INT C BIOM H, P324; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panes J, 2013, J CROHNS COLITIS, V7, P556, DOI 10.1016/j.crohns.2013.02.020; Punwani S, 2009, RADIOLOGY, V252, P712, DOI 10.1148/radiol.2523082167; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Shim H, 2006, COMPUT METH PROG BIO, V84, P135, DOI 10.1016/j.cmpb.2006.09.001; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Taylor SA, 2009, RADIOLOGY, V251, P369, DOI 10.1148/radiol.2512081292; Tielbeek JAW, 2013, INFLAMM BOWEL DIS, V19, P1943, DOI 10.1097/MIB.0b013e3182905536; Tielbeek JAW, 2012, ABDOM IMAGING, V37, P967, DOI 10.1007/s00261-011-9822-x; Vos FM, 2012, IEEE ENG MED BIO, P3974, DOI 10.1109/EMBC.2012.6346837; Wang WP, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1330511.1330513; Wang WP, 1997, COMPUT AIDED DESIGN, V29, P379, DOI 10.1016/S0010-4485(96)00077-2; Weiss Y, 2001, IEEE T INFORM THEORY, V47, P736, DOI 10.1109/18.910585; Yang CJ, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P464; Ziech MLW, 2011, EUR J RADIOL, V80, pE299, DOI 10.1016/j.ejrad.2010.12.075	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0168317	10.1371/journal.pone.0168317	http://dx.doi.org/10.1371/journal.pone.0168317			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072831	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200002
J	Zhang, Q; Sun, XF; Xiao, XH; Zheng, J; Li, M; Yu, M; Ping, F; Wang, ZX; Qi, CJ; Wang, T; Wang, XJ				Zhang, Qian; Sun, Xiaofang; Xiao, Xinhua; Zheng, Jia; Li, Ming; Yu, Miao; Ping, Fan; Wang, Zhixin; Qi, Cuijuan; Wang, Tong; Wang, Xiaojing			Dietary Chromium Restriction of Pregnant Mice Changes the Methylation Status of Hepatic Genes Involved with Insulin Signaling in Adult Male Offspring	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; GLUCOSE-TOLERANCE; DNA METHYLATION; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PRENATAL EXPOSURE; MATERNAL DIET; RESISTANCE; RATS; SUPPLEMENTATION	Maternal undernutrition is linked with an elevated risk of diabetes mellitus in offspring regardless of the postnatal dietary status. This is also found in maternal micro-nutrition deficiency, especial chromium which is a key glucose regulator. We investigated whether maternal chromium restriction contributes to the development of diabetes in offspring by affecting DNA methylation status in liver tissue. After being mated with control males, female weanling 8-week-old C57BL mice were fed a control diet (CON, 1.19 mg chromium/kg diet) or a low chromium diet (LC, 0.14 mg chromium/kg diet) during pregnancy and lactation. After weaning, some offspring were shifted to the other diet (CON-LC, or LC-CON), while others remained on the same diet (CON-CON, or LC-LC) for 29 weeks. Fasting blood glucose, serum insulin, and oral glucose tolerance test was performed to evaluate the glucose metabolism condition. Methylation differences in liver from the LC-CON group and CON-CON groups were studied by using a DNA methylation array. Bisulfite sequencing was carried out to validate the results of the methylation array. Maternal chromium limitation diet increased the body weight, blood glucose, and serum insulin levels. Even when switched to the control diet after weaning, the offspring also showed impaired glucose tolerance and insulin resistance. DNA methylation profiling of the offspring livers revealed 935 differentially methylated genes in livers of the maternal chromium restriction diet group. Pathway analysis identified the insulin signaling pathway was the main process affected by hypermethylated genes. Bisulfite sequencing confirmed that some genes in insulin signaling pathway were hypermethylated in livers of the LC-CON and LC-LC group. Accordingly, the expression of genes in insulin signaling pathway was downregulated. There findings suggest that maternal chromium restriction diet results in glucose intolerance in male offspring through alterations in DNA methylation which is associated with the insulin signaling pathway in the mice livers.	[Zhang, Qian; Xiao, Xinhua; Zheng, Jia; Li, Ming; Yu, Miao; Ping, Fan; Wang, Zhixin; Qi, Cuijuan; Wang, Tong; Wang, Xiaojing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol,Dept Endocrinol, Translat Med Ctr,Minist Hlth,Peking Union Med Col, Beijing, Peoples R China; [Sun, Xiaofang] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Qingdao University	Xiao, XH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol,Dept Endocrinol, Translat Med Ctr,Minist Hlth,Peking Union Med Col, Beijing, Peoples R China.	xiaoxh2014@vip.163.com	Li, Ming/I-1323-2018; wang, zhixin/GZH-2500-2022	Li, Ming/0000-0002-8427-605X; 	National Key Research and Development Program of China [2016YFA0101002]; National Natural Science Foundation of China [81170736, 81570715]; National Natural Science Foundation for Young Scholars of China [81300649]; China Scholarship Council foundation [201308110443]; PUMC Youth Fund [33320140022]; Fundamental Research Funds for the Central Universities; Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Scholarship Council foundation(China Scholarship Council); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry	This study was funded by National Key Research and Development Program of China (2016YFA0101002), National Natural Science Foundation of China (No. 81170736, 81570715), National Natural Science Foundation for Young Scholars of China (No. 81300649), China Scholarship Council foundation (201308110443), PUMC Youth Fund (33320140022), Fundamental Research Funds for the Central Universities, and the Scientific Activities Foundation for Selected Returned Overseas Professionals of Human Resources and Social Security Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; ANDERSON RA, 1985, AM J CLIN NUTR, V41, P1177, DOI 10.1093/ajcn/41.6.1177; Anderson RA, 2000, DIABETES METAB, V26, P22; Bringhenti I, 2011, J NUTR BIOCHEM, V22, P1009, DOI 10.1016/j.jnutbio.2010.08.013; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FREUND H, 1979, JAMA-J AM MED ASSOC, V241, P496, DOI 10.1001/jama.241.5.496; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JEEJEEBHOY KN, 1977, AM J CLIN NUTR, V30, P531; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; JORHEM L, 1993, J AOAC INT, V76, P798; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kumar KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112991; Lailerd N, 2004, METABOLISM, V53, P101, DOI 10.1016/j.metabol.2003.07.014; LEFAVI RG, 1992, INT J SPORT NUTR, V2, P111, DOI 10.1123/ijsn.2.2.111; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; McLean M, 2006, DIABETIC MED, V23, P1213, DOI 10.1111/j.1464-5491.2006.01979.x; MERTZ W, 1959, AM J PHYSIOL, V196, P614, DOI 10.1152/ajplegacy.1959.196.3.614; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; OFFENBACHER EG, 1980, DIABETES, V29, P919, DOI 10.2337/diabetes.29.11.919; Padmavathi IJN, 2011, J MOL ENDOCRINOL, V47, P261, DOI 10.1530/JME-11-0010; Padmavathi IJN, 2010, DIABETES, V59, P98, DOI 10.2337/db09-0779; Petropoulos S, 2015, ENDOCRINOLOGY, V156, P2222, DOI 10.1210/en.2014-1643; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Seghieri G, 2002, DIABETES CARE, V25, P1761, DOI 10.2337/diacare.25.10.1761; Smith T, 2014, ENDOCRINE, V46, P70, DOI 10.1007/s12020-013-0034-8; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Suksomboon N, 2014, J CLIN PHARM THER, V39, P292, DOI 10.1111/jcpt.12147; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Ye J, 2012, PEDIATR RES, V72, P550, DOI 10.1038/pr.2012.123; Yokomizo H, 2014, AM J PHYSIOL-ENDOC M, V306, pE1163, DOI 10.1152/ajpendo.00688.2013; Zhang Q., 2016, NUTRIENTS, V8; Zheng J, 2015, J DIABETES INVEST, V6, P269, DOI 10.1111/jdi.12303	45	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169889	10.1371/journal.pone.0169889	http://dx.doi.org/10.1371/journal.pone.0169889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072825	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200055
J	Zhou, Y; Wang, GC; Zhang, J; Li, H				Zhou, Yan; Wang, Guochang; Zhang, Jun; Li, Han			A Hypothesis Testing Based Method for Normalization and Differential Expression Analysis of RNA-Seq Data	PLOS ONE			English	Article							FALSE DISCOVERY RATE; BIOCONDUCTOR	Next-generation sequencing technologies have made RNA sequencing (RNA-seq) a popular choice for measuring gene expression level. To reduce the noise of gene expression measures and compare them between several conditions or samples, normalization is an essential step to adjust for varying sample sequencing depths and other unwanted technical effects. In this paper, we develop a novel global scaling normalization method by employing the available knowledge of housekeeping genes. We formulate the problem from the hypothesis testing perspective and find an optimal scaling factor that minimizes the deviation between the empirical and the nominal type I error. Applying our approach to various simulation studies and real examples, we demonstrate that it is more accurate and robust than the state-of-the-art alternatives in detecting differentially expression genes.	[Zhou, Yan; Zhang, Jun] Shenzhen Univ, Inst Stat Sci, Coll Math & Stat, Shenzhen, Peoples R China; [Wang, Guochang] Jinan Univ, Coll Econ, Guangzhou, Guangdong, Peoples R China; [Li, Han] Shenzhen Univ, Coll Econ, Shenzhen, Peoples R China	Shenzhen University; Jinan University; Shenzhen University	Li, H (corresponding author), Shenzhen Univ, Coll Econ, Shenzhen, Peoples R China.	hli@szu.edu.cn	Zhang, Jun/W-9681-2019	Zhang, Jun/0000-0003-4332-5182	Tianyuan Fund for Mathematics [11526143, 11626160]; Doctor Start Fund of Guangdong Province [2016A030310062 (85118-000043)]; Natural Science Foundation of SZU [83600008303]; National Science Foundation of China [11501248, 11601094]	Tianyuan Fund for Mathematics(National Natural Science Foundation of China (NSFC)); Doctor Start Fund of Guangdong Province; Natural Science Foundation of SZU; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Tianyuan Fund for Mathematics (No. 11526143), the Doctor Start Fund of Guangdong Province (No. 2016A030310062 (85118-000043)) and the Natural Science Foundation of SZU (No. 83600008303) to Yan Zhou. This work was also supported by the National Science Foundation of China (Nos. 11501248 and 11601094) to Guochang Wang and by the Tianyuan Fund for Mathematics (No. 11626160) to Han Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Bullard JH, 2009, WORKING PAPER SERIES, P247; Chen CM, 2014, METHODS, V67, P354, DOI 10.1016/j.ymeth.2014.01.019; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Zhou Y, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-15	21	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169594	10.1371/journal.pone.0169594	http://dx.doi.org/10.1371/journal.pone.0169594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072846	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200029
J	Matchett, EL; Fleskes, JP				Matchett, Elliott L.; Fleskes, Joseph P.			Projected Impacts of Climate, Urbanization, Water Management, and Wetland Restoration on Waterbird Habitat in California's Central Valley	PLOS ONE			English	Article							SACRAMENTO-VALLEY; UNITED-STATES; TULARE BASIN; RICE FIELDS; LAND-USE; MODEL; RESOURCES; PINTAILS; PATTERNS; DROUGHT	The Central Valley of California is one of the most important regions for wintering waterbirds in North America despite extensive anthropogenic landscape modification and decline of historical wetlands there. Like many other mediterranean-climate ecosystems across the globe, the Central Valley has been subject to a burgeoning human population and expansion and intensification of agricultural and urban development that have impacted wildlife habitats. Future effects of urban development, changes in water supply management, and precipitation and air temperature related to global climate change on area of waterbird habitat in the Central Valley are uncertain, yet potentially substantial. Therefore, we modeled area of waterbird habitats for 17 climate, urbanization, water supply management, and wetland restoration scenarios for years 2006-2099 using a water resources and scenario modeling framework. Planned wetland restoration largely compensated for adverse effects of climate, urbanization, and water supply management changes on habitat areas through 2065, but fell short thereafter for all except one scenario. Projected habitat reductions due to climate models were more frequent and greater than under the recent historical climate and their magnitude increased through time. After 2065, area of waterbird habitat in all scenarios that included severe warmer, drier climate was projected to be >15% less than in the "existing" landscape most years. The greatest reduction in waterbird habitat occurred in scenarios that combined warmer, drier climate and plausible water supply management options affecting priority and delivery of water available for waterbird habitats. This scenario modeling addresses the complexity and uncertainties in the Central Valley landscape, use and management of related water supplies, and climate to inform waterbird habitat conservation and other resource management planning. Results indicate that increased wetland restoration and additional conservation and climate change adaptation strategies may be warranted to maintain habitat adequate to support waterbirds in the Central Valley.	[Matchett, Elliott L.; Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA 95620 USA	United States Department of the Interior; United States Geological Survey	Matchett, EL (corresponding author), US Geol Survey, Western Ecol Res Ctr, Dixon, CA 95620 USA.	ematchett@usgs.gov			California Landscape Conservation Cooperative, Central Valley Joint Venture, U.S. Fish and Wildlife Service [80250-A-H100]; Delta Waterfowl Foundation [2671]; California Department of Fish and Wildlife; U.S. Geological Survey-Western Ecological Research Center	California Landscape Conservation Cooperative, Central Valley Joint Venture, U.S. Fish and Wildlife Service; Delta Waterfowl Foundation; California Department of Fish and Wildlife; U.S. Geological Survey-Western Ecological Research Center(United States Geological Survey)	The California Landscape Conservation Cooperative, Central Valley Joint Venture, U.S. Fish and Wildlife Service (URLs: http://californialcc.org/, http://www.centralvalleyjointrenture.org/, http://fws.gov/; grant number 80250-A-H100; funding acquired by JPF), Delta Waterfowl Foundation (URL: littp://www.deltawaterfowl.org/; grant number 2671; funding acquired by JPF), California Department of Fish and Wildlife (URL: https://www.wildlife.ca.gov/), and U.S. Geological Survey-Western Ecological Research Center (URL: https://www.werc.usgs.gov/) provided funding or in-kind support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STAT WETL PROT STAT; Barbour, 2007, HEALDSB RES SEM MEG; Bird JA, 2000, J APPL ECOL, V37, P728, DOI 10.1046/j.1365-2664.2000.00539.x; Brown M, 2013, THESIS; Buler JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041571; Byrd KB, 2015, LANDSCAPE ECOL, V30, P729, DOI 10.1007/s10980-015-0159-7; California Department of Water Resources, 2016, CAL STAT WAT PROJ CE; California Department of Water Resources, 2015, CENTR VALL PROJ ST 1; California Department of Water Resources, 2016, LAND US SURV DAT; California Department of Water Resources, 2009, CAL WAT PLAN UPD; California Department of Water Resources U.S. Bureau of Reclamation, 2015, BAY DELT CONS PLAN C; California Department of Water Resources U.S. Bureau of Reclamation, 2013, BAY DELT CONS PLAR P; Casazza M, 2016, 7 N AM DUCK S 2016 F; Cayan D, 2012, USITC PUBL; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cayan DR, 2009, CALIFORNIA ENERGY CO; Central Valley Joint Venture, 2009, TECHNICAL REPORT; Central Valley Joint Venture, 2000, CENTR VALL WETL WAT; Central Valley Joint Venture, 2006, CENTR VALL JOINT VEN; CONROY MJ, 1989, J WILDLIFE MANAGE, V53, P99, DOI 10.2307/3801314; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Elphick CS, 2010, WATERBIRDS, V33, P181, DOI 10.1675/063.033.s114; Fleskes JP, 2016, J WILDLIFE MANAGE, V80, P679, DOI 10.1002/jwmg.1053; Fleskes JP, 2013, J FISH WILDL MANAG, V4, P351, DOI 10.3996/022013-JFWM-012; Fleskes JP, 2012, WETLAND HABITATS OF NORTH AMERICA: ECOLOGY AND CONSERVATION CONCERNS, P357; Fleskes JP, 2012, J FISH WILDL MANAG, V3, P266, DOI 10.3996/022012-JFWM-014; Fleskes JP, 2005, CALIF FISH GAME, V91, P207; Fleskes JP, 2003, WILDLIFE SOC B, V31, P793; GILMER DS, 1982, T N AM WILDL NAT RES, V47, P441; Gleick PH, 1999, J AM WATER RESOUR AS, V35, P1429, DOI 10.1111/j.1752-1688.1999.tb04227.x; Great Valley Center, 2005, STAT GREAT CENTR VAL; Hanak E., 2011, MANAGING CALIFORNIAS; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hickey C, 2003, SO PACIFIC SHOREBIRD; Howitt R.E., 2015, AGR RESOUR EC UPDATE; Jongsomjit D, 2013, LANDSCAPE ECOL, V28, P187, DOI 10.1007/s10980-012-9825-1; Joyce B, 2010, INTEGRATED SCENARIO; Joyce BA, 2011, CLIMATIC CHANGE, V109, P299, DOI 10.1007/s10584-011-0335-y; Matchett EL, 2015, 20151017 US GEOL SUR; McCabe GJ, 2010, CLIMATIC CHANGE, V99, P141, DOI 10.1007/s10584-009-9675-2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller MR, 2010, WETLANDS, V30, P939, DOI 10.1007/s13157-010-0090-2; MILLER MR, 1986, J WILDLIFE MANAGE, V50, P189, DOI 10.2307/3801895; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Naylor L. W., 2002, THESIS; Osnas EE, 2016, J WILDLIFE MANAGE, V80, P1227, DOI 10.1002/jwmg.21124; Pernollet CA, 2015, AGR ECOSYST ENVIRON, V214, P118, DOI 10.1016/j.agee.2015.08.018; Petrie M, 2016, J FISH WILD IN PRESS; Probstl-Haider U, 2016, ENVIRON MANAGE, V58, P446, DOI 10.1007/s00267-016-0720-4; Program G.C.R., 2009, LAND US SCEN NAT SCA; Radeloff VC, 2012, ECOL APPL, V22, P1036, DOI 10.1890/11-0306.1; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; RAVELING DG, 1989, J WILDLIFE MANAGE, V53, P1088, DOI 10.2307/3809615; Reclamation, 2013, DOWNSCALED CMIP3 CMI; Reiter ME, 2015, J AM WATER RESOUR AS, V51, P1722, DOI 10.1111/1752-1688.12353; Rogers P, 2016, BAY AREA NEWS G 0310; Rundel PW, 2013, LANDSCAPE DISTURBANC, P3; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Singh K. A., 2015, THESIS; State of California California Natural Resources Agency California Department of Water Resources, 2015, CAL GROUNDW UPD 2013; State Water Resources Control Board, 2016, EL WAT RIGHTS INF MA; State Water Resources Control Board, 2000, REV WAT RIGHT DEC 16; Stouffer RJ, 2006, J CLIMATE, V19, P723, DOI 10.1175/JCLI3632.1; Szeptycki LF, 2015, WHIT HOUS NDRP DROUG; U.S. Bureau of Reclamation, 2015, CENTR VALL PROJ CVP; U.S. Department of Agriculture National Agriculture Statistics Service, 2015, CAL CROP STAT; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Welch A. H., 2006, SAN FRANCISCO ESTUAR, V4, P1, DOI DOI 10.1021/ES702859E; Yarris GS, 2016, 7 N AM DUCK S 2016 F; Yates D, 2005, WATER INT, V30, P501, DOI 10.1080/02508060508691894; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; Yates D, 2009, J WATER RES PLAN MAN, V135, P303, DOI 10.1061/(ASCE)0733-9496(2009)135:5(303); Young CA, 2009, J AM WATER RESOUR AS, V45, P1409, DOI 10.1111/j.1752-1688.2009.00375.x; Zollitsch B, 2015, WD8354260010 US ENV	76	17	18	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169780	10.1371/journal.pone.0169780	http://dx.doi.org/10.1371/journal.pone.0169780			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068411	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900068
J	Huang, WY; Huang, CC; Chang, CC; Kor, CT; Chen, TY; Wu, HM				Huang, Wan-Yu; Huang, Chih-Cheng; Chang, Chia-Chu; Kor, Chew-Teng; Chen, Ting-Yu; Wu, Hung-Ming			Associations of Self-Reported Sleep Quality with Circulating Interferon Gamma-Inducible Protein 10, Interleukin 6, and High-Sensitivity C-Reactive Protein in Healthy Menopausal Women	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; POOR SLEEP; DURATION; INFLAMMATION; BIOMARKERS; CYTOKINES; MARKERS; RISK	Introduction Sleep disturbance is very common in menopausal women and poor sleep quality has been linked to systemic inflammation. However, the impact of poor sleep quality on health outcomes of menopausal women remains unclear. This study evaluated the relationships between sleep quality and inflammation in menopausal women. Participants and design This cross-sectional study enrolled 281 healthy women aged 45 to 60 years. The Pittsburgh Sleep Quality Index (PSQI) was used to measure quality of sleep. Multiplex assays were used to measure the levels of 9 cytokines in morning fasting plasma samples. Other variables measured in this study included clinical characteristics and high-sensitivity C-reactive protein (hs-CRP). Setting The study was performed at a medical center. Results The 281 participants comprised 79 (28%) perimenopausal women and 202 (72%) postmenopausal women. Global PSQI scores were positively correlated with plasma hs-CRP levels (P = 0.012) and were marginally associated with interferon gamma-inducible protein-10 (IP10), interleukin 6 (IL6), and macrophage inflammatory protein-1beta (MIP-1 beta) levels. After adjusting for age, body mass index, menopause duration, and follicle stimulating hormone, multiple linear regression analysis revealed that high PSQI scores and sleep efficiency < 65% were associated with elevated plasma levels of hs-CRP, IP10, and IL6. In addition, sleep duration < 5 hours was associated with high hs-CRP levels. Conclusion Our data show that poor sleep quality and low sleep efficiency are associated with elevated levels of circulating inflammatory factors IP10, IL6 and hs-CRP and that short sleep duration is associated with high levels of hs-CRP in menopausal women. These findings provide novel evidence that poor sleep quality is linked to low-grade systemic inflammation in menopausal women.	[Huang, Wan-Yu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Huang, Chih-Cheng] Changhua Christian Hosp, Dept Obstet Gynecol, Changhua, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Nephrol, Changhua, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Internal Med Res Ctr, Div Stat, Changhua, Taiwan; [Chen, Ting-Yu; Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wu, Hung-Ming] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Cheng Kung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Wu, HM (corresponding author), Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan.; Wu, HM (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.; Wu, HM (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	18288@cch.org.tw	Chen, Ting-Yu/AAD-8375-2021		Ministry of Science and Technology, Taiwan [MOST 105-2314-6-371-004]; Changhua Christian Hospital Research Foundation, Changhua City, Taiwan [100-CCH-IRP-50, 105-CCH-PRJ-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital Research Foundation, Changhua City, Taiwan	The study was funded by grant MOST 105-2314-6-371-004 from Ministry of Science and Technology, Taiwan, and by grants 100-CCH-IRP-50, and 105-CCH-PRJ-006 from Changhua Christian Hospital Research Foundation, Changhua City, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by grant MOST 105-2314-B-371-004 from Ministry of Science and Technology, Taiwan, and by grants 100-CCH-IRP-50, and 105-CCH-PRJ-006 from Changhua Christian Hospital Research Foundation, Changhua City, Taiwan. The authors thank all individuals for participating in this study. We also thank J Yu-Jun Chang, PhD. from Epidemiology and Biostatistics Center, Changhua Christian Hospital for her valuable help in data analysis.	Ahmadi Z, 2013, INFLAMMATION, V36, P364, DOI 10.1007/s10753-012-9555-1; Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Ameratunga D, 2012, INTERN MED J, V42, P742, DOI 10.1111/j.1445-5994.2012.02723.x; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Blumel JE, 2012, MATURITAS, V72, P359, DOI 10.1016/j.maturitas.2012.05.011; Born J, 1997, J IMMUNOL, V158, P4454; Branstetter SA, 2016, NICOTINE TOB RES, V18, P2252, DOI 10.1093/ntr/ntw179; Buysse D J, 1989, Psychiatry Res, V28, P193; Chang CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10096; Clancy KBH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064807; de Jager W, 2006, METHODS, V38, P294, DOI 10.1016/j.ymeth.2005.11.008; DINGES DF, 1995, ADV NEUROIMMUNOL, V5, P97, DOI 10.1016/0960-5428(95)00002-J; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Dowd JB, 2011, ANN EPIDEMIOL, V21, P799, DOI 10.1016/j.annepidem.2011.07.004; Freeman EW, 2015, MENOPAUSE, V22, P719, DOI 10.1097/GME.0000000000000392; Friedman EM, 2011, ANN NY ACAD SCI, V1231, P23, DOI 10.1111/j.1749-6632.2011.06040.x; Grandner MA, 2013, NAT SCI SLEEP, V5, P93, DOI 10.2147/NSS.S31063; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Hong S, 2005, BRAIN BEHAV IMMUN, V19, P165, DOI 10.1016/j.bbi.2004.07.008; Jackowska M, 2013, PSYCHONEUROENDOCRINO, V38, P1484, DOI 10.1016/j.psyneuen.2012.12.015; Jain SK, 2012, METAB SYNDR RELAT D, V10, P331, DOI 10.1089/met.2012.0045; Kapsimalls F, 2008, SLEEP MED, V9, P603, DOI 10.1016/j.sleep.2007.08.019; Kass AS, 2010, SCAND J RHEUMATOL, V39, P109, DOI 10.3109/03009740903270607; Kravitz HM, 2008, SLEEP, V31, P979; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Liu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092607; Liu Y, 2013, SLEEP, V36, P1421, DOI 10.5665/sleep.3028; Lou PA, 2015, DIABETES RES CLIN PR, V107, P69, DOI 10.1016/j.diabres.2014.09.060; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; Matthews KA, 2007, PSYCHOSOM MED, V69, P124, DOI 10.1097/01.psy.0000256574.30389.1b; Miller MA, 2009, SLEEP, V32, P857; Mills PJ, 2007, SLEEP, V30, P729, DOI 10.1093/sleep/30.6.729; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Perez-Lopez FR, 2009, FERTIL STERIL, V92, P1171, DOI 10.1016/j.fertnstert.2009.06.032; Polo-Kantola P, 2011, MATURITAS, V68, P224, DOI 10.1016/j.maturitas.2010.12.009; Prather AA, 2014, BRAIN BEHAV IMMUN, V35, P155, DOI 10.1016/j.bbi.2013.09.010; Prinz PN, 2000, CHRONOBIOL INT, V17, P391, DOI 10.1081/CBI-100101053; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Roberts WL, 2001, CLIN CHEM, V47, P418; Simpson N, 2007, NUTR REV, V65, pS244, DOI [10.1111/j.1753-4887.2007.tb00371.x, 10.1301/nr.2007.dec.S244-S252]; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; Tzeng JI, 2012, INT J NURS STUD, V49, P102, DOI 10.1016/j.ijnurstu.2011.08.004; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Xu XL, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/7404957; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	54	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169216	10.1371/journal.pone.0169216	http://dx.doi.org/10.1371/journal.pone.0169216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060925	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500068
J	Straube, B; van Kemenade, BM; Arikan, BE; Fiehler, K; Leube, DT; Harris, LR; Kircher, T				Straube, Benjamin; van Kemenade, Bianca M.; Arikan, B. Ezgi; Fiehler, Katja; Leube, Dirk T.; Harris, Laurence R.; Kircher, Tilo			Predicting the Multisensory Consequences of One's Own Action: BOLD Suppression in Auditory and Visual Cortices	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; TEMPORAL BINDING WINDOW; SENSORY ATTENUATION; SPEECH PRODUCTION; FALSE MEMORIES; NEURAL BASIS; SELF-AGENCY; CEREBELLUM; PERCEPTION; CORTEX	Predictive mechanisms are essential to successfully interact with the environment and to compensate for delays in the transmission of neural signals. However, whether and how we predict multisensory action outcomes remains largely unknown. Here we investigated the existence of multisensory predictive mechanisms in a context where actions have outcomes in different modalities. During fMRI data acquisition auditory, visual and auditory-visual stimuli were presented in active and passive conditions. In the active condition, a self-initiated button press elicited the stimuli with variable short delays (0-417ms) between action and outcome, and participants had to detect the presence of a delay for auditory or visual outcome (task modality). In the passive condition, stimuli appeared automatically, and participants had to detect the number of stimulus modalities (unimodal/bimodal). For action consequences compared to identical but unpredictable control stimuli we observed suppression of the blood oxygen level depended (BOLD) response in a broad network including bilateral auditory and visual cortices. This effect was independent of task modality or stimulus modality and strongest for trials where no delay was detected (undetected<detected). In bimodal vs. unimodal conditions we found activation differences in the left cerebellum for detected vs. undetected trials and an increased cerebellar-sensory cortex connectivity. Thus, action-related predictive mechanisms lead to BOLD suppression in multiple sensory brain regions. These findings support the hypothesis of multisensory predictive mechanisms, which are probably conducted in the left cerebellum.	[Straube, Benjamin; van Kemenade, Bianca M.; Arikan, B. Ezgi; Leube, Dirk T.; Kircher, Tilo] Philipps Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Fiehler, Katja] Justus Liebig Univ, Dept Expt Psychol, Giessen, Germany; [Leube, Dirk T.] AWO Ctr Psychiat Halle, Clin Psychiat & Psychotherapy, Halle, Germany; [Harris, Laurence R.] York Univ, Ctr Vis Res, N York, ON M3J 1P3, Canada; [Harris, Laurence R.] York Univ, Dept Psychol, N York, ON M3J 1P3, Canada	Philipps University Marburg; Justus Liebig University Giessen; York University - Canada; York University - Canada	Straube, B (corresponding author), Philipps Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany.	straubeb@med.uni-marburg.de	Kircher, Tilo/AAT-6480-2020; Straube, Benjamin/K-3126-2012; Harris, Laurence/AAT-9549-2021; Straube, Benjamin/M-6500-2019; Straube, Benjamin/ABR-2656-2022	Kircher, Tilo/0000-0002-2514-2625; Straube, Benjamin/0000-0002-9837-0944; Harris, Laurence/0000-0002-7154-8757; Straube, Benjamin/0000-0002-9837-0944; van Kemenade, Bianca/0000-0002-8631-9893	Deutsche Forschungsgemeinschaft [SFB/TRR 135 INST 162/445-1, IRTG 1901, STR-1146/8-1]; Natural Sciences and Engineering Research Council (NSERC)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/, grant numbers: SFB/TRR 135 INST 162/445-1, IRTG 1901 to BEA and STR-1146/8-1 to BS) and the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) of Canada to LRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Bass P, 2008, INT J PSYCHOPHYSIOL, V70, P137, DOI 10.1016/j.ijpsycho.2008.06.005; Baumann O, 2007, CEREB CORTEX, V17, P1433, DOI 10.1093/cercor/bhl055; Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blos J, 2012, NEUROIMAGE, V63, P882, DOI 10.1016/j.neuroimage.2012.07.028; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Cardoso-Leite P, 2010, PSYCHOL SCI, V21, P1740, DOI 10.1177/0956797610389187; Cerminara NL, 2009, J PHYSIOL-LONDON, V587, P429, DOI 10.1113/jphysiol.2008.163337; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Desantis A, 2014, EXP BRAIN RES, V232, P3317, DOI 10.1007/s00221-014-4001-2; Ding K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/612086; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Farrer C, 2013, CONSCIOUS COGN, V22, P1431, DOI 10.1016/j.concog.2013.09.010; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Ford JM, 2005, INT J PSYCHOPHYSIOL, V57, P143, DOI 10.1016/j.ijpsycho.2005.03.002; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gentsch A, 2011, J COGNITIVE NEUROSCI, V23, P3817, DOI 10.1162/jocn_a_00012; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Hoover AEN, 2012, EXP BRAIN RES, V222, P389, DOI 10.1007/s00221-012-3224-3; Hughes G, 2013, EUR J NEUROSCI, V37, P1152, DOI 10.1111/ejn.12120; Hughes G, 2013, PSYCHOL BULL, V139, P133, DOI 10.1037/a0028566; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Jackson SR, 2011, Q J EXP PSYCHOL, V64, P839, DOI 10.1080/17470218.2010.529580; Kauramaki J, 2010, J NEUROSCI, V30, P1314, DOI 10.1523/JNEUROSCI.1950-09.2010; Kawabe T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0991; KEELE SW, 1990, ANN NY ACAD SCI, V608, P179, DOI 10.1111/j.1749-6632.1990.tb48897.x; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kircher TTJ, 2003, CONSCIOUS COGN, V12, P656, DOI 10.1016/S1053-8100(03)00071-0; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Kurayama T, 2012, INT J PSYCHOPHYSIOL, V84, P26, DOI 10.1016/j.ijpsycho.2012.01.004; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Leube DT, 2010, COGN NEUROSCI-UK, V1, P111, DOI 10.1080/17588921003646156; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Leube DT, 2003, CONSCIOUS COGN, V12, P597, DOI 10.1016/S1053-8100(03)00079-5; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; Matsuzawa Masako, 2005, Magn Reson Med Sci, V4, P115, DOI 10.2463/mrms.4.115; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkinson A, 2011, COGN NEUROSCI-UK, V2, P47, DOI 10.1080/17588928.2010.525627; Pynn LK, 2013, VISION RES, V76, P124, DOI 10.1016/j.visres.2012.10.019; Roussel C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00115; Roussel C, 2013, NEUROPSYCHOLOGIA, V51, P922, DOI 10.1016/j.neuropsychologia.2013.02.005; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Sato A, 2008, CONSCIOUS COGN, V17, P1219, DOI 10.1016/j.concog.2008.01.003; SCHAFER EWP, 1973, SCIENCE, V181, P175, DOI 10.1126/science.181.4095.175; Shergill SS, 2013, NEUROIMAGE, V70, P356, DOI 10.1016/j.neuroimage.2012.12.043; Shimada S, 2010, EXP BRAIN RES, V201, P359, DOI 10.1007/s00221-009-2028-6; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Straube B, 2011, J COGNITIVE NEUROSCI, V23, P306, DOI 10.1162/jocn.2010.21505; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Kemenade BM, 2016, ATTEN PERCEPT PSYCHO; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	75	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169131	10.1371/journal.pone.0169131	http://dx.doi.org/10.1371/journal.pone.0169131			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060861	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500056
J	Tusnio, A; Taciak, M; Barszcz, M; Swiech, E; Bachanek, I; Skomial, J				Tusnio, Anna; Taciak, Marcin; Barszcz, Marcin; Swiech, Ewa; Bachanek, Ilona; Skomial, Jacek			Effect of Replacing Soybean Meal by Raw or Extruded Pea Seeds on Growth Performance and Selected Physiological Parameters of the Ileum and Distal Colon of Pigs	PLOS ONE			English	Article							TRYPSIN-INHIBITOR ACTIVITY; AMINO-ACID DIGESTIBILITY; CHAIN FATTY-ACIDS; PISUM-SATIVUM; IN-VITRO; ILEAL DIGESTIBILITY; PROCESSING METHODS; DIETARY FIBER; FABA BEANS; ANTINUTRITIONAL FACTORS	The use of pea seeds is limited due to the content of antinutritional factors that may affect gut physiology. Heat treatment such as extrusion may reduce heat-labile antinutritional factors and improve the nutritional value of pea seeds. This study determined the effect of partial replacement of soybean meal in pig diets by raw or extruded pea seeds on growth performance, nitrogen balance and physiology of the ileum and distal colon. The experiment was carried out in 18 castrated male piglets of initial body weight of 11 kg, divided into three groups. The animals were fed cereal-based diets with soybean meal (C), which was partly replaced by raw (PR) or extruded pea (PE) seeds. Nitrogen balance was measured at about 15 kg body weight. After 26 days of feeding, tissue samples were taken from the ileum and distal colon for histological measurements, and colonic digesta samples for analyses of microbial activity indices. The animals fed the PE diet had a significantly greater average daily gain than those fed the C diet and better apparent protein digestibility than those on the PR diet. Pigs fed the PR diet had a significantly greater butyric acid concentration and lower pH in the colon than pigs fed PE and C diets. There was no significant effect of the diet on other indices of microbial activity or morphological parameters. In conclusion, feeding a diet with extruded pea seeds improved growth performance of pigs, did not affect intestinal morphology and had a negligible effect on microbial activity in the distal colon.	[Tusnio, Anna; Taciak, Marcin; Barszcz, Marcin; Swiech, Ewa; Bachanek, Ilona; Skomial, Jacek] Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland	Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences	Tusnio, A (corresponding author), Polish Acad Sci, Dept Monogastr Nutr, Kielanowski Inst Anim Physiol & Nutr, Jablonna, Poland.	a.tusnio@ifzz.pl	Taciak, Marcin/H-3751-2017; Tuśnio, Anna/AAI-1430-2019; Barszcz, Marcin/AAL-4761-2021	Taciak, Marcin/0000-0002-8963-9745; Barszcz, Marcin/0000-0002-3428-9805; Skomial, Jacek/0000-0002-9026-0812; Tusnio, Anna/0000-0001-7480-3592; Swiech, Ewa/0000-0002-8752-1161	Ministry of Agriculture and Rural Development of Poland [149/2011]	Ministry of Agriculture and Rural Development of Poland	This work was supported by the Ministry of Agriculture and Rural Development of Poland 'Improvement of native plant protein feeds, their production, trade turnover and utilization in animal feed mixtures' No149/2011 Task 4.3 and 4.4 to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by funds from the programme 'Improvement of native plant protein feeds, their production, trade turnover and utilization in animal feed mixtures' of the Ministry of Agriculture and Rural Development of Poland. The authors thank MSc Eng. L. Staskiewicz and MSc Eng. P. Zakrzewski for technical assistance.	Abd El-Hady EA, 2003, LEBENSM-WISS TECHNOL, V36, P285, DOI 10.1016/S0023-6438(02)00217-7; ADAMS CA, 1975, PLANT PHYSIOL, V55, P1, DOI 10.1104/pp.55.1.1; ALLISON C, 1989, APPL ENVIRON MICROB, V55, P2894, DOI 10.1128/AEM.55.11.2894-2898.1989; ALMEIDA NG, 1991, J AGR FOOD CHEM, V39, P1627, DOI 10.1021/jf00009a018; Alonso R, 1998, FOOD CHEM, V63, P505, DOI 10.1016/S0308-8146(98)00037-5; Alonso R, 2000, FOOD CHEM, V68, P159, DOI 10.1016/S0308-8146(99)00169-7; Alonso R, 2000, J AGR FOOD CHEM, V48, P2286, DOI 10.1021/jf000095o; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; [Anonymous], NUTR REQUIREMENTS NU; AOAC, 2000, OFF METH AN AOAC; Barszcz M, 2011, J ANIM FEED SCI, V20, P613, DOI 10.22358/jafs/66219/2011; Barszcz M, 2016, ARCH ANIM NUTR, V70, P278, DOI 10.1080/1745039X.2016.1184368; Bau HM, 1997, J SCI FOOD AGR, V73, P1, DOI 10.1002/(SICI)1097-0010(199701)73:1&lt;1::AID-JSFA694&gt;3.0.CO;2-B; BISHNOI S, 1994, J FOOD SCI TECH MYS, V31, P73; BOISEN S, 1995, ANIM FEED SCI TECH, V51, P29, DOI 10.1016/0377-8401(94)00686-4; Boisen S, 1996, ACTA AGR SCAND A-AN, V46, P165, DOI 10.1080/09064709609415867; Carre B., 1989, Recent advances of research in antinutritional factors in legume seeds. Proceedings of the First International Workshop on "Antinutritional Factors (ANF) in Legume Seeds", November 23-25, 1988, Wageningen, Netherlands., P103; CHERRINGTON CA, 1991, J APPL BACTERIOL, V70, P161, DOI 10.1111/j.1365-2672.1991.tb04442.x; Collins CL, 2006, J SCI FOOD AGR, V86, P1894, DOI 10.1002/jsfa.2551; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; Cummings JH, 1986, CANC SURVEYS, V6, P601; DELZENNE NM, 1994, FOOD SCI TECHNOL-LEB, V27, P1, DOI 10.1006/fstl.1994.1001; Desrouilleres K, 2015, J FUNCT FOODS, V17, P816, DOI 10.1016/j.jff.2015.06.035; Diaz D, 2006, ITAL J ANIM SCI, V5, P43; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; FRIAS J, 1995, J AGR FOOD CHEM, V43, P2231, DOI 10.1021/jf00056a049; GATEL F, 1994, ANIM FEED SCI TECH, V45, P317, DOI 10.1016/0377-8401(94)90036-1; GATEL F, 1990, LIVEST PROD SCI, V26, P155, DOI 10.1016/0301-6226(90)90077-J; Gdala Jolanta, 1992, Journal of Animal and Feed Sciences, V1, P71; Grosjean F, 1999, ANIM SCI, V69, P591, DOI 10.1017/S1357729800051444; GUJSKA E, 1991, J FOOD SCI, V56, P443, DOI 10.1111/j.1365-2621.1991.tb05299.x; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hidaka H., 1986, Bifidobacteria and Microflora, V5, P37; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Huisman J., 2001, Recent developments in pig nutrition 3, P261; Huisman J., 1991, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V61, P901; Jansman A. J. M., 1993, Nutrition Research Reviews, V6, P209, DOI 10.1079/NRR19930013; Jerumianis J., 1979, BRAUWISSENSCHAFT, V25, P313; Jezierny D, 2010, ANIM FEED SCI TECH, V157, P111, DOI 10.1016/j.anifeedsci.2010.03.001; Jha R, 2012, ANIMAL, V6, P603, DOI 10.1017/S1751731111001844; JONDREVILLE C, 1992, J ANIM PHYSIOL AN N, V68, P113, DOI 10.1111/j.1439-0396.1992.tb00651.x; KAKADE ML, 1974, CEREAL CHEM, V51, P376; Kaufmann P, 1997, APPL ENVIRON MICROB, V63, P1268, DOI 10.1128/AEM.63.4.1268-1273.1997; Konieczka P, 2014, J ANIM FEED SCI, V23, P244, DOI 10.22358/jafs/65687/2014; Lalles JP, 1998, EAAP PUBLIC, P219; LETERME P, 1989, RECENT ADVANCES OF RESEARCH IN ANTINUTRITIONAL FACTORS IN LEGUME SEEDS, P121; LI DF, 1990, J ANIM SCI, V68, P1790; Mallillin AC, 2008, BRIT J NUTR, V100, P485, DOI 10.1017/S000711450891151X; Mekbungwan A, 2007, ANIM SCI J, V78, P342, DOI 10.1111/j.1740-0929.2007.00446.x; Molist F, 2009, ANIM FEED SCI TECH, V149, P346, DOI 10.1016/j.anifeedsci.2008.06.015; MUL AJ, 1994, REC ADV AN, P57; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; O'Neill HVM, 2012, ANIM FEED SCI TECH, V175, P158, DOI 10.1016/j.anifeedsci.2012.05.004; Oberreuther-Moschner DL, 2005, TOXICOL LETT, V159, P212, DOI 10.1016/j.toxlet.2005.05.008; ORTIZ LT, 1994, BRIT POULTRY SCI, V35, P743, DOI 10.1080/00071669408417739; Pacheco WJ, 2014, POULTRY SCI, V93, P2245, DOI 10.3382/ps.2014-03986; Palander S, 2006, ANIM FEED SCI TECH, V127, P89, DOI 10.1016/j.anifeedsci.2005.07.003; Partanen K, 2003, AGR FOOD SCI FINLAND, V12, P35, DOI 10.23986/afsci.5742; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; RADEMACHER M, 1999, STANDARDIZED ILEAL D; Rist VTS, 2013, ANIMAL, V7, P1067, DOI 10.1017/S1751731113000062; Salgado P, 2002, LIVEST PROD SCI, V74, P191, DOI 10.1016/S0301-6226(01)00297-4; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Shim SB, 2007, ASIAN AUSTRAL J ANIM, V20, P1444, DOI 10.5713/ajas.2007.1444; Smulikowska S, 2001, J ANIM FEED SCI, V10, P511; Stein HH, 2004, J ANIM SCI, V82, P2568; Taciak M, 2015, J ANIM FEED SCI, V24, P235, DOI 10.22358/jafs/65629/2015; Tako E, 2008, BRIT J NUTR, V99, P472, DOI 10.1017/S0007114507825128; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tosh SM, 2010, FOOD RES INT, V43, P450, DOI 10.1016/j.foodres.2009.09.005; Tsen HY, 1998, J APPL MICROBIOL, V85, P554, DOI 10.1046/j.1365-2672.1998.853535.x; VALDEBOUZE P, 1980, CAN J PLANT SCI, V60, P695, DOI 10.4141/cjps80-097; VANLEEUWEN P, 1993, EAAP PUBLIC, P335; Voragen AGJ, 1995, REC ADV AN, P93; WALKER AF, 1982, P NUTR SOC, V41, P41, DOI 10.1079/PNS19820006; Wang N, 1997, FOOD CHEM, V58, P59, DOI 10.1016/S0308-8146(96)00212-9; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002; Zraly Z, 2007, VET MED-CZECH, V52, P29, DOI 10.17221/2008-VETMED	80	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169467	10.1371/journal.pone.0169467	http://dx.doi.org/10.1371/journal.pone.0169467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060879	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500098
J	Westerlind, E; Persson, HC; Sunnerhagen, KS				Westerlind, Emma; Persson, Hanna C.; Sunnerhagen, Katharina S.			Return to Work after a Stroke in Working Age Persons; A Six-Year Follow Up	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SICK LEAVE; HEALTH; SCALE; DISABILITY; BEHAVIOR; PEOPLE; EQ-5D; CARE	Objectives Stroke is one of the most common and resource intensive diseases for society. Stroke in the working age population is increasing in different parts of the world. An incomplete return to work (RTW) after sick leave post stroke entails negative consequences for the affected person and an economical burden for society. The aim of this study was to explore the RTW rate and factors associated with RTW in a six-year follow up post stroke. Methods Data from 174 persons 63 years or younger, with first ever stroke in 2009-2010 in Gothenburg were analyzed. Baseline characteristics were collected through medical records and the Swedish Health Insurance Office provided information on sick leave up to 6 years post stroke. Time-to-event was presented and cox regression as well as logistic regression were used to analyze risk factors for no-RTW. Results The RTW rate was 74.7%, at the end of follow up. Participants continued to RTW until just over 3 years post stroke. Dependency at discharge (in the modified Rankin Scale) and sick leave prior to the stroke were significant risk factors for no-RTW after 1 year with odds ratio 4.595 and 3.585, respectively. The same factors were significant in time-to-event within six years post stroke with hazard ratio 2.651 and 1.929, respectively. Conclusions RTW after a stroke is incomplete, however RTW is possible over a longer period of time than previously thought. More severe disability at discharge from hospital and sick leave prior to the stroke were shown to be risk factors for no-RTW. This knowledge can contribute to more individualized vocational rehabilitation.	[Westerlind, Emma; Persson, Hanna C.; Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden	University of Gothenburg	Westerlind, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden.	westerlind.emma@gmail.com	Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Westerlind, Emma/AAN-7227-2021	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; 	Swedish Heart and Lung Foundation; Swedish Brain Foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation	This study was funded in part by the Swedish Heart and Lung Foundation and the Swedish Brain Foundation.	Altman D.G., 1991, PRACTICAL STATISTIC; Anema JR, 2009, J OCCUP REHABIL, V19, P419, DOI 10.1007/s10926-009-9202-3; Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P604, DOI 10.1136/jnnp-2012-303525; Bonner B, 2016, EUR J NEUROL, V23, P548, DOI 10.1111/ene.12887; Burstrom K, 2014, QUAL LIFE RES, V23, P431, DOI 10.1007/s11136-013-0496-4; Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295; Chang WH, 2016, J REHABIL MED; Cioncoloni D, 2012, NEUROREHABILITATION, V30, P315, DOI 10.3233/NRE-2012-0761; Clayton S, 2012, EUR J PUBLIC HEALTH, V22, P434, DOI 10.1093/eurpub/ckr101; Cumming TB, 2010, CEREBROVASC DIS, V30, P7, DOI 10.1159/000313438; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Endo M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009682; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Ghatnekar O, 2014, INT J TECHNOL ASSESS, V30, P203, DOI 10.1017/S0266462314000075; Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795; Hannerz H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000180; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Larsen LP, 2016, J REHABIL MED, V48, P339, DOI 10.2340/16501977-2061; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Maruthappu M, 2015, INT J STROKE, V10, P364, DOI 10.1111/ijs.12408; Medin J, 2007, BRAIN INJURY, V21, P457, DOI 10.1080/02699050701317643; Mishra NK, 2010, STROKE, V41, P2612, DOI 10.1161/STROKEAHA.110.589317; Nielsen MBD, 2015, EUR J PUBLIC HEALTH, V25, P96, DOI 10.1093/eurpub/cku016; Persson HC, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-162; Peters GO, 2013, DISABIL REHABIL, V35, P455, DOI 10.3109/09638288.2012.697251; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Riks-Stroke (the Swedish Stroke Register), 2015, ETT EFT STROK; Roding J, 2010, J REHABIL MED, V42, P155, DOI 10.2340/16501977-0497; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Stam M, 2013, WORK, V46, P207, DOI 10.3233/WOR-131747; Tanaka H, 2011, ARCH PHYS MED REHAB, V92, P743, DOI 10.1016/j.apmr.2010.12.009; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Vikholmen K, 2015, ACTA NEUROL SCAND, V132, P329, DOI 10.1111/ane.12404; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358; Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	42	55	55	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169759	10.1371/journal.pone.0169759	http://dx.doi.org/10.1371/journal.pone.0169759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28061507	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500135
J	Moccia, M; Palladino, R; Lanzillo, R; Carotenuto, A; Russo, CV; Triassi, M; Morra, VB				Moccia, Marcello; Palladino, Raffaele; Lanzillo, Roberta; Carotenuto, Antonio; Russo, Cinzia Valeria; Triassi, Maria; Morra, Vincenzo Brescia			Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; MS PATIENTS; IFN-BETA; IMPAIRMENT; PREDICTORS; GUIDELINES; EXPERIENCE; DIAGNOSIS; BURDEN; DRUGS	Background Disease modifying treatments (DMTs) are the main responsible for direct medical costs in multiple sclerosis (MS). The current investigation aims at evaluating possible associations between healthcare costs for treating relapsing remitting MS (RRMS) and disease evolution. Methods The present cohort study retrospectively included 544 newly diagnosed RRMS patients, prospectively followed up for 10.1+/-3.3 years. Costs for DMT administration and management were calculated for each year of observation. Following clinical endpoints were recorded: time to first relapse, 1-point EDSS progression, reaching of EDSS 4.0, reaching of EDSS 6.0, and conversion to secondary progressive MS (SP). Covariates for statistical analyses were age, gender, disease duration and EDSS at diagnosis. Results At time varying Cox regression models, 10% increase in annual healthcare costs was associated with 1.1% reduction in 1-point EDSS progression (HR = 0.897; p = 0.018), with 0.7% reduction in reaching EDSS 6.0 (HR = 0.925; p = 0.030), and with 1.0% reduction in SP conversion (HR = 0.902; p = 0.006). Conclusion Higher healthcare costs for treating MS have been associated with a milder disease evolution after 10 years, with possible reduction of long-term non-medical direct and indirect costs.	[Moccia, Marcello; Lanzillo, Roberta; Carotenuto, Antonio; Russo, Cinzia Valeria; Morra, Vincenzo Brescia] Univ Naples Federico II, Multiple Sclerosis Clin Care & Res Ctr, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy; [Palladino, Raffaele] Imperial Coll, Dept Primary Care & Publ Hlth, London, England; [Palladino, Raffaele; Triassi, Maria] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy	University of Naples Federico II; Imperial College London; University of Naples Federico II	Moccia, M (corresponding author), Univ Naples Federico II, Multiple Sclerosis Clin Care & Res Ctr, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy.	moccia.marcello@gmail.com	Palladino, Raffaele/AAG-6823-2020; Moccia, Marcello/N-6987-2015; Russo, Cinzia Valeria/AAA-8341-2021; Carotenuto, Antonio/AAE-1249-2020; Lanzillo, Roberta/AFA-8874-2022	Palladino, Raffaele/0000-0002-3437-812X; Moccia, Marcello/0000-0003-2613-3090; Russo, Cinzia Valeria/0000-0003-0345-8319; Carotenuto, Antonio/0000-0002-1574-9693; Lanzillo, Roberta/0000-0001-6388-8180	Federico II University of Naples, Italy	Federico II University of Naples, Italy	The authors received salary from the Federico II University of Naples, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenzia Italiana del Farmaco, 2016, BANC DAT FARM AIFA; Berto P, 2011, NEUROL SCI, V32, P1035, DOI 10.1007/s10072-011-0578-4; Birnbaum HG, 2009, CURR MED RES OPIN, V25, P869, DOI [10.1185/03007990902743869, 10.1185/03007990902743869 ]; Brown MG, 2015, NEUROLOGY, V84, pE181, DOI 10.1212/WNL.0000000000001676; Coppola G, 2006, EUR J NEUROL, V13, P1014, DOI 10.1111/j.1468-1331.2006.01422.x; Ernstsson O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159129; European Medicines Agency, 2016, EUR PUBL ASS REP NAT; Filippi M, 2013, NEUROL SCI, V34, P2085, DOI 10.1007/s10072-013-1485-7; Fogarty E, 2014, APPL HEALTH ECON HEA, V12, P635, DOI 10.1007/s40258-014-0128-3; Hartung DM, 2015, NEUROLOGY, V84, P2185, DOI 10.1212/WNL.0000000000001608; Hawton AJ, 2015, EUR J HEAL EC; Jokubaitis VG, 2016, ANN NEUROL, V80, P89, DOI 10.1002/ana.24682; Kalincik T, 2015, BRAIN, V138, DOI 10.1093/brain/awv258; Kappos L, 2015, J NEUROL NEUROSUR PS, V86, P1202, DOI 10.1136/jnnp-2014-310024; Karampampa Korinna, 2013, J Med Econ, V16, P939, DOI 10.3111/13696998.2013.807267; Kavaliunas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145435; Ke X, 2016, CURR MED RES OPIN; Kister I, 2016, J NEUROL NEUROSURG P; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Manouchehrinia A, 2012, CURR NEUROL NEUROSCI, V12, P592, DOI 10.1007/s11910-012-0291-6; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moccia M, 2016, ACTA NEUROL SCAND; Moccia M, 2016, MULT SCLER RELAT DIS, V10, P90, DOI 10.1016/j.msard.2016.09.011; Moccia M, 2016, MULT SCLER J, V22, P659, DOI 10.1177/1352458515599075; Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000; O'Connelln K, 2014, MULT SCLER RELAT DIS, V3, P678, DOI 10.1016/j.msard.2014.09.002; Palmer AJ, 2013, MULT SCLER J, V19, P1640, DOI 10.1177/1352458513488230; Paolicelli D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159214; Plantone D, 2016, CNS DRUGS; Raimundo K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-131; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sormani MP, 2013, NAT REV NEUROL, V9, P504, DOI 10.1038/nrneurol.2013.146; Spelman T, 2016, NEUROL-CLIN PRACT, V6, P102, DOI 10.1212/CPJ.0000000000000227; Stawowczyk E, 2015, EXPERT REV PHARM OUT, V15, P759, DOI 10.1586/14737167.2015.1067141; Trojano M, 2009, ANN NEUROL, V66, P513, DOI 10.1002/ana.21757; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; van Walraven C, 2008, NEUROEPIDEMIOLOGY, V30, P138, DOI 10.1159/000126908	38	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169489	10.1371/journal.pone.0169489	http://dx.doi.org/10.1371/journal.pone.0169489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056103	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100047
J	Schwarzer, M; Srutkova, D; Hermanova, P; Leulier, F; Kozakova, H; Schabussova, I				Schwarzer, Martin; Srutkova, Dagmar; Hermanova, Petra; Leulier, Francois; Kozakova, Hana; Schabussova, Irma			Diet Matters: Endotoxin in the Diet Impacts the Level of Allergic Sensitization in Germ-Free Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; BET V 1; COMMENSAL BACTERIA; AIRWAY INFLAMMATION; MICROBIAL COLONIZATION; NEONATAL COLONIZATION; PROTECTIVE PROPERTIES; HYGIENE HYPOTHESIS; GUT MICROBIOTA; EARLY-LIFE	Germ-free animals have been used to define the vital role of commensal bacteria on the maturation of the host immune system. However, the role of bacterial residues in diet in this setting is poorly understood. Here we investigated the effect of bacterial contamination in sterile diet on the level of allergic sensitization in germ-free mice. Sterile grain-based diets ST1 and R03 were tested for the level of bacterial contamination. ST1 contained higher amount of bacterial DNA, approximately ten times more endotoxin, and induced higher, TLR4-dependent, cytokine production in dendritic cells compared to R03. In a germ-free mouse model of sensitization to the major birch pollen allergen Bet v 1, feeding on ST1 for at least two generations was associated with decreased production of allergen-specific IgE and IgG1 antibodies in sera in comparison to R03. Furthermore, reduced levels of allergen-specific and ConA-induced cytokines IL-4, IL-5 and IL-13 accompanied by increased levels of IFN-gamma were detected in splenocytes cultures of these mice. Our results show that contamination of experimental diet with bacterial residues, such as endotoxin, significantly affects the development of allergic sensitization in germ-free mice. Therefore, careful selection of sterile food is critical for the outcomes of germ-free or gnotobiotic experimental models of immune-deviated diseases.	[Schwarzer, Martin; Srutkova, Dagmar; Hermanova, Petra; Kozakova, Hana] Czech Acad Sci, Inst Microbiol, Lab Gnotobiol, Vvi, Novy Hradek, Czech Republic; [Schwarzer, Martin; Leulier, Francois] Iniversite Claude Bernard Lyon 1, CNRS UMR 5242, Ecole Normale Super Lyon, IGFL, Lyon, France; [Schabussova, Irma] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Medical University of Vienna	Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	irma.schabussova@meduniwien.ac.at	Šrůtková, Dagmar/H-8511-2014; Kozakova, Hana/I-1153-2014; Schwarzer, Martin/P-9871-2017; Hermanová, Petra/K-6260-2017	Šrůtková, Dagmar/0000-0003-0054-5396; Kozakova, Hana/0000-0001-7352-5922; Schwarzer, Martin/0000-0002-1401-6578; Hermanová, Petra/0000-0003-0751-076X; Schabussova, Irma/0000-0002-2109-2640	Czech Science Foundation [303/09/0449, 16-06326S]; DK MCCA of the Austrian Science Fund [SFB F46]; OeAD-GmbH [CZ 15/2015]; Ministry of Education, Youth and Sports of the Czech Republic [7AMB12AT020, 7AMB15AT025];  [CZ.3.22/2.1.00/13.03892]	Czech Science Foundation(Grant Agency of the Czech Republic); DK MCCA of the Austrian Science Fund; OeAD-GmbH; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); 	This work was supported by grants 303/09/0449 and 16-06326S of the Czech Science Foundation (HK); SFB F46 and DK MCCA of the Austrian Science Fund (IS); OeAD-GmbH CZ 15/2015 (HK and IS); 7AMB12AT020 and 7AMB15AT025 of the Ministry of Education, Youth and Sports of the Czech Republic (HK); grant CZ.3.22/2.1.00/13.03892 (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens B, 2011, INT ARCH ALLERGY IMM, V156, P196, DOI 10.1159/000322352; Bilenki L, 2010, J IMMUNOL, V184, P7288, DOI 10.4049/jimmunol.0902829; Blumer N, 2005, CLIN EXP ALLERGY, V35, P397, DOI 10.1111/j.1365-2222.2005.02184.x; Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; Cunha FQ, 2003, J IMMUNOL, V171, P1001; Debarry J, 2010, ALLERGY, V65, P690, DOI 10.1111/j.1398-9995.2009.02253.x; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Gavett BSH, 1995, INTERLEUKIN 12 INHIB, V182, P1527; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gerhold K, 2002, J ALLERGY CLIN IMMUN, V110, P110, DOI 10.1067/mai.2002.125831; Gerhold K, 2006, J ALLERGY CLIN IMMUN, V118, P666, DOI 10.1016/j.jaci.2006.05.022; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Hazebrouck S, 2009, INT ARCH ALLERGY IMM, V148, P65, DOI 10.1159/000151507; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kozakova H, 2016, CELL MOL IMMUNOL, V13, P251, DOI 10.1038/cmi.2015.09; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Lau S, 2012, J ALLERGY CLIN IMMUN, V129, P1040, DOI 10.1016/j.jaci.2012.02.005; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Prefontaine D, 2010, CLIN EXP ALLERGY, V40, P1648, DOI 10.1111/j.1365-2222.2010.03570.x; Reliene R, 2006, DNA REPAIR, V5, P651, DOI 10.1016/j.dnarep.2006.02.001; Repa A, 2008, IMMUNOL LETT, V117, P50, DOI 10.1016/j.imlet.2007.11.025; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Rodriguez B, 2011, FEMS MICROBIOL ECOL, V76, P133, DOI 10.1111/j.1574-6941.2010.01035.x; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Schwarzer M, 2013, VACCINE, V31, P5405, DOI 10.1016/j.vaccine.2013.09.014; Simpson A, 2010, CLIN EXP ALLERGY, V40, P209, DOI 10.1111/j.1365-2222.2009.03391.x; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; Srutkova D, 2011, J MICROBIOL METH, V87, P10, DOI 10.1016/j.mimet.2011.06.014; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stiemsma LT, 2015, IMMUNOTARGETS THER, V4, P143, DOI 10.2147/ITT.S61528; Takakuwa T, 1996, EUR J IMMUNOL, V26, P2686, DOI 10.1002/eji.1830261121; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Trujillo C, 2003, INT J MED MICROBIOL, V293, P123, DOI 10.1078/1438-4221-00257; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; YOUNGNER JS, 1972, INFECT IMMUN, V6, P646, DOI 10.1128/IAI.6.4.646-647.1972; Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x	52	16	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0167786	10.1371/journal.pone.0167786	http://dx.doi.org/10.1371/journal.pone.0167786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052076	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500012
J	Schneider, A; Matkovich, SJ; Victoria, B; Spinel, L; Bartke, A; Golusinski, P; Masternak, MM				Schneider, Augusto; Matkovich, Scot J.; Victoria, Berta; Spinel, Lina; Bartke, Andrzej; Golusinski, Pawel; Masternak, Michel M.			Changes of Ovarian microRNA Profile in Long-Living Ames Dwarf Mice during Aging	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; DIFFERENTIAL EXPRESSION ANALYSIS; PRIMORDIAL FOLLICLE POOL; MURAL GRANULOSA-CELLS; GENE-EXPRESSION; CALORIC RESTRICTION; MOUSE OVARY; CANCER; GROWTH; PROMOTES	The Ames dwarf (df/df) mice have extended longevity and can preserve the ovarian reserve longer than Normal (N) mice. Based on this, the aim of our study was to evaluate the ovarian microRNA (miRNA) profile in young and aged df/df and N mice. Ovarian tissue was collected at 5-6 months and at 21-22 months of age for miRNA sequencing. We detected a total of 404 miRNAs in the ovarian samples, from which the abundance of 22 and 33 miRNAs changed with age in N and df/df mice, respectively. Of these, only three miRNAs were commonly regulated with age between N and df/df mice, indicating a very divergent miRNA profile between genotypes. We also detected that 46 miRNAs were regulated between N and df/df mice, of which 23 were regulated exclusively in young mice, 12 exclusively in old mice and 12 commonly regulated at young and old ages. Many genes likely to be targeted by these miRNAs are involved in the FoxO, mTOR, PI3k/Akt and insulin signaling pathways. These results suggest that the aging process has a differential impact on the ovarian miRNA profile in df/df mice, and suggest that these miRNAs can be central players in the maintenance of a younger ovarian phenotype.	[Schneider, Augusto] Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil; [Schneider, Augusto; Victoria, Berta; Spinel, Lina; Golusinski, Pawel; Masternak, Michel M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Bartke, Andrzej] Southern Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA; [Bartke, Andrzej] Southern Illinois Univ, Sch Med, Dept Physiol, Springfield, IL USA; [Golusinski, Pawel] Poznan Univ Med Sci, Dept Biol & Environm Studies, Poznan, Poland; [Golusinski, Pawel; Masternak, Michel M.] Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland	Universidade Federal de Pelotas; State University System of Florida; University of Central Florida; Washington University (WUSTL); Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii	Schneider, A (corresponding author), Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil.; Schneider, A; Masternak, MM (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Masternak, MM (corresponding author), Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland.	augusto.schneider@ufpel.edu.br; michal.masternak@ucf.edu	Bartke, Andzej/D-6640-2017; Matkovich, Scot J/AFP-0908-2022; Schneider, Augusto/B-5011-2014; Matkovich, Scot J/B-9077-2009	Bartke, Andzej/0000-0002-2569-557X; Matkovich, Scot J/0000-0002-7398-6857; Schneider, Augusto/0000-0002-3410-2860; Matkovich, Scot J/0000-0002-7398-6857; Golusinski, Pawel/0000-0002-3937-5315	Washington University Department of Medicine internal funds; Universidade Federal de Pelotas internal funds; National Institute on Aging of the National Institutes of Health [R01AG032290, P01AG031736]	Washington University Department of Medicine internal funds; Universidade Federal de Pelotas internal funds; National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Washington University Department of Medicine internal funds; Universidade Federal de Pelotas internal funds to AS; and National Institute on Aging of the National Institutes of Health (grants number R01AG032290, P01AG031736).	Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bartke A, 2001, EXP GERONTOL, V36, P21, DOI 10.1016/S0531-5565(00)00205-9; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Chandrashekar V, 1996, BIOL REPROD, V54, P1002, DOI 10.1095/biolreprod54.5.1002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Diez-Fraile A, 2014, HUM FERTIL, V17, P90, DOI 10.3109/14647273.2014.897006; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Hanoux V, 2007, CELL DEATH DIFFER, V14, P671, DOI 10.1038/sj.cdd.4402052; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; Huang CJ, 2014, INT J MED SCI, V11, P824, DOI 10.7150/ijms.8358; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karakaya C, 2015, FERTIL STERIL, V103, P1469, DOI 10.1016/j.fertnstert.2015.02.035; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Kim JY, 2014, AGING-US, V6, P524, DOI 10.18632/aging.100677; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuang HX, 2014, GYNECOL ENDOCRINOL, V30, P57, DOI 10.3109/09513590.2013.850659; Laszczynska M, 2008, HISTOL HISTOPATHOL, V23, P219, DOI 10.14670/HH-23.219; Li L, 2011, GEN COMP ENDOCR, V174, P232, DOI 10.1016/j.ygcen.2011.09.005; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Moreno JM, 2015, FERTIL STERIL, V104, P1037, DOI 10.1016/j.fertnstert.2015.07.001; Masternak MM, 2004, J GERONTOL A-BIOL, V59, P784; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mehta A, 2015, IMMUNITY, V42, P1021, DOI 10.1016/j.immuni.2015.05.017; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Petera J, 2013, REP PRACT ONCOL RADI, V18, P1, DOI 10.1016/j.rpor.2012.11.001; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Saccon TD, 2015, ANIM REPROD, V12, P1; Saccon TD, 2016, MOL CELLULAR ENDOCRI; Schneider A, 2017, MOL CELL ENDOCRINOL, V439, P328, DOI 10.1016/j.mce.2016.09.019; Schneider A, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0120-4; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Slot KA, 2006, REPRODUCTION, V131, P525, DOI 10.1530/rep.1.00946; Smith ER, 2008, LANCET ONCOL, V9, P1108, DOI 10.1016/S1470-2045(08)70281-X; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; te Velde ER, 1998, MOL CELL ENDOCRINOL, V145, P67, DOI 10.1016/S0303-7207(98)00171-3; Tung KH, 2005, AM J EPIDEMIOL, V161, P321, DOI 10.1093/aje/kwi046; Victoria B, 2015, AGING CELL; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yang SH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107730; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077853; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	68	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169213	10.1371/journal.pone.0169213	http://dx.doi.org/10.1371/journal.pone.0169213			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046124	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300145
J	Mason, AR; Elia, LP; Finkbeiner, S				Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven			The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; neurobiology; neurodegeneration; neurodegenerative disease; neurological disease; Ripk1; frontotemporal dementia; progranulin	FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; CELL-DEATH; INFLAMMATION; DEMENTIA; MUTATIONS; NEUROINFLAMMATION; POLYMORPHISM; NECROPTOSIS	Progranulin (PGRN), a secreted growth factor, is a key regulator of inflammation and is genetically linked to two common and devastating neurodegenerative diseases. Haploinsufficiency mutations in GRN, the gene encoding PGRN, cause frontotemporal dementia (FTD), and a GRN SNP confers significantly increased risk for Alzheimer's disease (AD). Because cellular and animal data indicate that increasing PGRN can reverse phenotypes of both FTD and AD, modulating PGRN level has been proposed as a therapeutic strategy for both diseases. However, little is known about the regulation of PGRN levels. In this study, we performed an siRNA-based screen of the kinome to identify genetic regulators of PGRN levels in a rodent cell-based model system. We found that knocking down receptor-interacting serine/threonine protein kinase 1 (Ripk1) increased both intracellular and extracellular PGRN protein levels by increasing the translation rate of PGRN without affecting mRNA levels. We observed this effect in Neuro2a cells, wild-type primary mouse neurons, and Grn-haploinsufficient primary neurons from an FTD mouse model. We found that the effect of RIPK1 on PGRN is independent of the kinase activity of RIPK1 and occurs through a novel signaling pathway. These data suggest that targeting RIPK1 may be a therapeutic strategy in both AD and FTD.	[Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA; [Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA 94158 USA; [Mason, Amanda R.] Univ Calif San Francisco, Dev & Stem Cell Biol Grad Program, San Francisco, CA 94158 USA; [Mason, Amanda R.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu			National Institutes of Health [3R01 NS039074, R21 NS093236]; California Institute for Regenerative Medicine (CIRM) [TG2-01153, RB4-06079, T32 HD007470, T32 GM007618]; Consortium for Frontotemporal Dementia Research; Taube/Koret Center for Neurodegenerative Disease Research; Hellman Foundation Program in Alzheimer's Disease Research; J. David Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093236, R01NS039074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Consortium for Frontotemporal Dementia Research; Taube/Koret Center for Neurodegenerative Disease Research; Hellman Foundation Program in Alzheimer's Disease Research; J. David Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants 3R01 NS039074, R21 NS093236; California Institute for Regenerative Medicine (CIRM) Grants TG2-01153, RB4-06079, T32 HD007470, and T32 GM007618; the Consortium for Frontotemporal Dementia Research; the Taube/Koret Center for Neurodegenerative Disease Research; the Hellman Foundation Program in Alzheimer's Disease Research; and the J. David Gladstone Institutes. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Capell A, 2014, J BIOL CHEM, V289, P25879, DOI 10.1074/jbc.M114.560128; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2011, J MOL NEUROSCI, V45, P549, DOI 10.1007/s12031-011-9553-z; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Demorrow Sharon, 2013, Transl Gastrointest Cancer, V2, P145; Elia L., 2014, OMICS APPL NEUROSCIE, P114; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Ionis Pharmaceuticals, 2016, BIOG ION PHARM REP N; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kalai M, 2007, CELL DEATH DIFFER, V14, P1050, DOI 10.1038/sj.cdd.4402110; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Moriwaki K, 2014, CYTOKINE GROWTH F R, V25, P167, DOI 10.1016/j.cytogfr.2013.12.013; Nguyen AD, 2013, J BIOL CHEM, V288, P8627, DOI 10.1074/jbc.M112.441949; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Serrero G, 2003, HUM PATHOL, V34, P1148, DOI 10.1016/S0046-8177(03)00425-8; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10	42	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3262	3272		10.1074/jbc.M116.752006	http://dx.doi.org/10.1074/jbc.M116.752006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069809	Green Published, hybrid			2022-12-26	WOS:000395538800018
J	Naito-Matsui, Y; Davies, LRL; Takematsu, H; Chou, HH; Tangvoranuntakul, P; Carlin, AF; Verhagen, A; Heyser, CJ; Yoo, SW; Choudhury, B; Paton, JC; Paton, AW; Varki, NM; Schnaar, RL; Varki, A				Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Heyser, Charles J.; Yoo, Seung-Wan; Choudhury, Biswa; Paton, James C.; Paton, Adrienne W.; Varki, Nissi M.; Schnaar, Ronald L.; Varki, Ajit			Physiological Exploration of the Long Term Evolutionary Selection against Expression of N-Glycolylneuraminic Acid in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CELL-ADHESION MOLECULE; LACKING COMPLEX GANGLIOSIDES; POLYSIALIC ACID; NERVOUS-SYSTEM; ACETYLNEURAMINIC ACID; RECOGNITION MEMORY; PERIRHINAL CORTEX; TRANSGENIC MICE; SIALIC ACIDS	All vertebrate cell surfaces display a dense glycan layer often terminated with sialic acids, which have multiple functions due to their location and diverse modifications. The major sialic acids in most mammalian tissues are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), the latter being derived from Neu5Ac via addition of one oxygen atom at the sugar nucleotide level by CMP-Neu5Ac hydroxylase (Cmah). Contrasting with other organs that express various ratios of Neu5Ac and Neu5Gc depending on the variable expression of Cmah, Neu5Gc expression in the brain is extremely low in all vertebrates studied to date, suggesting that neural expression is detrimental to animals. However, physiological exploration of the reasons for this long term evolutionary selection has been lacking. To explore the consequences of forced expression of Neu5Gc in the brain, we have established brain-specific Cmah transgenic mice. Such Neu5Gc overexpression in the brain resulted in abnormal locomotor activity, impaired object recognition memory, and abnormal axon myelination. Brain-specific Cmah transgenic mice were also lethally sensitive to a Neu5Gc-preferring bacterial toxin, even though Neu5Gc was overexpressed only in the brain and other organs maintained endogenous Neu5Gc expression, as in wild-type mice. Therefore, the unusually strict evolutionary suppression of Neu5Gc expression in the vertebrate brain may be explained by evasion of negative effects on neural functions and by selection against pathogens.	[Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Heyser, Charles J.] Univ Calif San Diego, Neurosci Behav Testing Core, La Jolla, CA 92093 USA; [Choudhury, Biswa; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Varki, Nissi M.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Takematsu, Hiromu] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Yoo, Seung-Wan] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Neurosci, Baltimore, MD 21205 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Naito-Matsui, Yuko] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyoto University; Johns Hopkins University; Johns Hopkins University; University of Adelaide; Kobe Pharmaceutical University	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Cheng, Pam/AAY-8063-2021; Carlin, Aaron/AAK-3806-2021	Takematsu, Hiromu/0000-0003-1689-9500	National Institutes of Health [R01GM32373, R37NS037096]; Mathers Foundation of New York; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation of New York; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01GM32373 (to A. Varki) and R37NS037096 (to R.S.), the Mathers Foundation of New York (to A. Varki), and by a fellowship from the Japan Society for the Promotion of Science (to Y.N.-M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; BRINSTER RL, 1982, NATURE, V296, P39, DOI 10.1038/296039a0; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Davies LRL, 2015, TOP CURR CHEM, V366, P31, DOI 10.1007/128_2013_419; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; SVENNERHOLM L, 1956, NATURE, V177, P524, DOI 10.1038/177524b0; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; TETTAMANTI G, 1965, NATURE, V206, P192, DOI 10.1038/206192a0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wan HM, 1999, J NEUROSCI, V19, P1142; Willems AP, 2016, BBA-GEN SUBJECTS, V1860, P1640, DOI 10.1016/j.bbagen.2015.12.017; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	60	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2557	2570		10.1074/jbc.M116.768531	http://dx.doi.org/10.1074/jbc.M116.768531			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049733	Green Published, hybrid			2022-12-26	WOS:000395535100001
J	Sunami, Y; Araki, M; Kan, S; Ito, A; Hironaka, Y; Imai, M; Morishita, S; Ohsaka, A; Komatsu, N				Sunami, Yoshitaka; Araki, Marito; Kan, Shin; Ito, Akihiro; Hironaka, Yumi; Imai, Misa; Morishita, Soji; Ohsaka, Akimichi; Komatsu, Norio			Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; PML-RAR-ALPHA; GENE-EXPRESSION; NONHISTONE PROTEINS; TYROSINE KINASES; PROSTATE-CANCER; DOWN-REGULATION; HL-60 CELLS; ACETYLATION	Differentiation therapy with all-trans-retinoic acid (ATRA) improves the treatment outcome of acute promyelocytic leukemia (APL); however, the molecular mechanism by which ATRA induces granulocytic differentiation remains unclear. We previously reported that the inhibition of the NAD-dependent histone deacetylase (HDAC) SIRT2 induces granulocytic differentiation in leukemia cells, suggesting the involvement of protein acetylation in ATRA- induced leukemia cell differentiation. Herein, we show that p300/CREB- binding proteinassociated factor (PCAF), a histone acetyltransferase (HAT), is a prerequisite for ATRA- induced granulocytic differentiation in leukemia cells. We found that PCAF expression was markedly increased in leukemia cell lines (NB4 and HL-60) and primary APL cells during ATRA- induced granulocytic differentiation. Consistent with these results, the expression of PCAF was markedly up- regulated in the bone marrow cells of APL patients who received ATRA- containing chemotherapy. The knockdown of PCAF inhibited ATRA- induced granulocytic differentiation in leukemia cell lines and primary APL cells. Conversely, the overexpression of PCAF induced the expression of the granulocytic differentiation marker CD11b at the mRNA level. Acetylome analysis identified the acetylated proteins after ATRA treatment, and we found that histone H3, a known PCAF acetylation substrate, was preferentially acetylated by the ATRA treatment. Furthermore, we have demonstrated that PCAF is required for the acetylation of histone H3 on the promoter of ATRA target genes, such as CCL2 and FGR, and for the expression of these genes in ATRA- treated leukemia cells. These results strongly support our hypothesis that PCAF is induced and activated by ATRA, and the subsequent acetylation of PCAF substrates promotes granulocytic differentiation in leukemia cells. Targeting PCAF and its downstream acetylation targets could serve as a novel therapeutic strategy to overcome all subtypes of AML.	[Sunami, Yoshitaka; Kan, Shin; Hironaka, Yumi; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Araki, Marito; Morishita, Soji; Ohsaka, Akimichi] Juntendo Univ, Sch Med, Dept Transfus Med & Stem Cell Regulat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Kan, Shin; Imai, Misa] Juntendo Univ, Sch Med, Leading Ctr Dev & Res Canc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Ito, Akihiro] RIKEN, Chem Genet Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	Juntendo University; Juntendo University; Juntendo University; RIKEN	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	Japan Society for the Promotion of Science (JSPS) KAKENHI [26893264, 25118725]; Juntendo University Young investigator joint project award [2608]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Juntendo University Young investigator joint project award; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 26893264 and 25118725; the Juntendo University Young investigator joint project award 2014 (Grant 2608); and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, and the MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project. The authors declare that they have no conflicts of interest with the contents of this article.	Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441; Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BURN TC, 1994, BLOOD, V84, P2776; Cang SD, 2009, INT J ONCOL, V35, P1417, DOI 10.3892/ijo_00000459; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Bellis F, 2014, CANCER RES, V74, P2328, DOI 10.1158/0008-5472.CAN-13-2568; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gocek Elzbieta, 2011, Cancers (Basel), V3, P2402, DOI 10.3390/cancers3022402; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jing YK, 2004, LEUKEMIA LYMPHOMA, V45, P639, DOI 10.1080/10428190310001609933; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kumar P, 2014, MOL PHARMACOL, V85, P946, DOI 10.1124/mol.114.092221; LANOTTE M, 1991, BLOOD, V77, P1080; Lee KH, 2002, BIOCHEM BIOPH RES CO, V296, P1125, DOI 10.1016/S0006-291X(02)02043-0; Lee SM, 2007, J PHARMACOL EXP THER, V322, P1084, DOI 10.1124/jpet.107.124461; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Miller WH, 2002, ONCOGENE, V21, P3496, DOI 10.1038/sj/onc/1205328; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Mori J, 1999, JPN J CANCER RES, V90, P660, DOI 10.1111/j.1349-7006.1999.tb00798.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Muraoka M, 1996, ONCOGENE, V12, P1565; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; Sakuma T, 2006, INT J ONCOL, V29, P117; Schaible AM, 2013, BIOCHEM PHARMACOL, V86, P476, DOI 10.1016/j.bcp.2013.04.015; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Su R, 2015, ONCOGENE, V34, P3226, DOI 10.1038/onc.2014.274; Sun WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P80, DOI 10.1093/abbs/gmr113; Sunami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057633; Waxman S, 2000, LEUKEMIA, V14, P491, DOI 10.1038/sj.leu.2401714; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; WILLMAN CL, 1991, BLOOD, V77, P726; Xiao LY, 2010, ACTA HAEMATOL-BASEL, V123, P71, DOI 10.1159/000264628; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976	64	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2815	2829		10.1074/jbc.M116.745398	http://dx.doi.org/10.1074/jbc.M116.745398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053092	Green Published, hybrid			2022-12-26	WOS:000395535100022
J	Priyamvada, H; Akila, M; Singh, RK; Ravikrishna, R; Verma, RS; Philip, L; Marathe, RR; Sahu, LK; Sudheer, KP; Gunthe, SS				Priyamvada, Hema; Akila, M.; Singh, Raj Kamal; Ravikrishna, R.; Verma, R. S.; Philip, Ligy; Marathe, R. R.; Sahu, L. K.; Sudheer, K. P.; Gunthe, S. S.			Terrestrial Macrofungal Diversity from the Tropical Dry Evergreen Biome of Southern India and Its Potential Role in Aerobiology	PLOS ONE			English	Article							BIOLOGICAL AEROSOL-PARTICLES; FUNGAL SPORES; RAIN-FOREST; DISPERSAL; MUSHROOMS; EVOLUTION; URBAN; MODEL; AIR; UV	Macrofungi have long been investigated for various scientific purposes including their food and medicinal characteristics. Their role in aerobiology as a fraction of the primary biological aerosol particles (PBAPs), however, has been poorly studied. In this study, we present a source of macrofungi with two different but interdependent objectives: (i) to characterize the macrofungi from a tropical dry evergreen biome in southern India using advanced molecular techniques to enrich the database from this region, and (ii) to assess whether identified species of macrofungi are a potential source of atmospheric PBAPs. From the DNA analysis, we report the diversity of the terrestrial macrofungi from a tropical dry evergreen biome robustly supported by the statistical analyses for diversity conclusions. A total of 113 macro fungal species belonging to 54 genera and 23 families were recorded, with Basidiomycota and Ascomycota constituting 96% and 4% of the species, respectively. The highest species richness was found in the family Agaricaceae (25.3%) followed by Polyporaceae (15.3%) and Marasmiaceae (10.8%). The difference in the distribution of commonly observed macrofungal families over this location was compared with other locations in India (Karnataka, Kerala, Maharashtra, and West Bengal) using two statistical tests. The distributions of the terrestrial macrofungi were distinctly different in each ecosystem. We further attempted to demonstrate the potential role of terrestrial macrofungi as a source of PBAPs in ambient air. In our opinion, the findings from this ecosystem of India will enhance our understanding of the distribution, diversity, ecology, and biological prospects of terrestrial macrofungi as well as their potential to contribute to airborne fungal aerosols.	[Priyamvada, Hema; Akila, M.; Singh, Raj Kamal; Philip, Ligy; Sudheer, K. P.; Gunthe, S. S.] Indian Inst Technol, EWRE Div, Dept Civil Engn, Madras, Tamil Nadu, India; [Ravikrishna, R.] Indian Inst Technol, Dept Chem Engn, Madras, Tamil Nadu, India; [Verma, R. S.] Indian Inst Technol, Dept Biotechnol, Madras, Tamil Nadu, India; [Marathe, R. R.] Indian Inst Technol, Dept Management Studies, Madras, Tamil Nadu, India; [Sahu, L. K.] Phys Res Lab, Ahmadabad, Gujarat, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Department of Space (DoS), Government of India; Physical Research Laboratory - India	Priyamvada, H; Gunthe, SS (corresponding author), Indian Inst Technol, EWRE Div, Dept Civil Engn, Madras, Tamil Nadu, India.	hema8689@gmail.com; s.gunthe@iitm.ac.in	Priyamvada, Hema/I-5232-2019; Muthuramalingam, Akila/G-4590-2011; Singh, Raj Kamal/B-3511-2015; KP, Sudheer/C-7123-2013	Singh, Raj Kamal/0000-0002-5569-3989; Raghunathan, Ravikrishna/0000-0003-3580-2516; Verma, Rama/0000-0001-7287-7803; Philip, Ligy/0000-0001-8838-2135; Priyamvada R, Hema/0000-0002-1064-3611; KP, Sudheer/0000-0002-0947-1197	Max Planck Partner Group at IIT Madras; Department of Science and Technology, Ministry of Science and Technology [CIE/12-13/204/DSTX/SACI]	Max Planck Partner Group at IIT Madras; Department of Science and Technology, Ministry of Science and Technology	Authors acknowledge the financial support from the Max Planck Partner Group at IIT Madras, and from the Department of Science and Technology, Ministry of Science and Technology (no. CIE/12-13/204/DSTX/SACI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew E. E., 2013, Journal of Ecology and the Natural Environment, V5, P318; Ansari TU, 2015, ATMOS ENVIRON, V122, P552, DOI 10.1016/j.atmosenv.2015.10.020; Arnolds, 1992, ANAL CLASSIFICATION, V19, P7; AYLOR DE, 1980, ANN NY ACAD SCI, V353, P116; Berch R, 1997, STANDARDIZED INVENTO; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Care Earth, 2006, RAP ASS BIOD CAMP IN; Despres VR, 2007, BIOGEOSCIENCES, V4, P1127, DOI 10.5194/bg-4-1127-2007; Despres V. R., 2012, TELLUS B, V64, P15598, DOI DOI 10.3402/TELLUSB.V64I0.15598; Dressaire E, 2016, P NATL ACAD SCI USA, V113, P2833, DOI 10.1073/pnas.1509612113; Dutta A.K., 2012, INDIAN J APPL PURE B, V27, P53; Dutta Arun Kumar, 2013, Biodiversity (Ottawa), V14, P196, DOI [10.1080/14888386.2013.848824, 10.1080/14888386.2013.805660]; Elbert W., 2006, ATMOS CHEM PHYS DISC, V6, P11317; Farook VA, 2013, MYCOSPHERE, V4, P97, DOI 10.5943/mycosphere/4/1/6; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gates GM, 2011, FUNGAL ECOL, V4, P56, DOI 10.1016/j.funeco.2010.07.005; Haga DI, 2014, ATMOS CHEM PHYS, V14, P8611, DOI 10.5194/acp-14-8611-2014; Hasan S., 2012, INT J APPL RES STUD, V1, P1; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbett DS, 1997, P NATL ACAD SCI USA, V94, P12002, DOI 10.1073/pnas.94.22.12002; Hrudayanath Thatoi, 2014, African Journal of Biotechnology, V13, P523; Huffman JA, 2012, ATMOS CHEM PHYS, V12, P11997, DOI 10.5194/acp-12-11997-2012; Huffman JA, 2009, ATMOS CHEM PHYS, V9, P7161, DOI 10.5194/acp-9-7161-2009; Ingold C. T., 1999, Mycologist, V13, P113, DOI 10.1016/S0269-915X(99)80040-8; Kavitha T., 2013, J AGR ENV SCI, V13, P982; Kolet M., 2013, NAT C BIOD STAT CHAL, P184; Lakhanpal T.N., 2014, P 8 INT C MUSHROOM B, P7; Liang LL, 2013, J AEROSOL SCI, V66, P179, DOI 10.1016/j.jaerosci.2013.08.013; Lodge D.J., 2004, COLLECTING DESCRIBIN, P128; Manoharachary C, 2005, CURR SCI INDIA, V89, P58; Mohanan C., 2014, Journal of Threatened Taxa, V6, P5636; Morris CE., 2008, BIOGEOSCI DISCUSS, V5, P191, DOI [10.5194/bgd-5-191-2008, DOI 10.5194/BGD-5-191-2008]; Mueller GM, 2004, RECOMMENDED PROTOCOL, P169; Nilima Wahegaonkar, 2011, Annals of Biological Research, V2, P198; Norros V., 2013, THESIS; Norros V, 2012, OIKOS, V121, P961, DOI 10.1111/j.1600-0706.2012.20052.x; Osmundson T. W., 2013, PLOS ONE, V8, P1; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Raja HA, 2017, FOOD CHEM, V214, P383, DOI 10.1016/j.foodchem.2016.07.052; Rajaratnam S, 2012, EUROPEAN J EXPT BIOL, V2, P369; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; Schumacher CJ, 2013, ATMOS CHEM PHYS, V13, P11987, DOI 10.5194/acp-13-11987-2013; Senthilarasu G., 2014, CURR RES ENV APPL MY, V4, P58, DOI DOI 10.5943/CREAM/4/1/5; Sesartic A, 2011, BIOGEOSCIENCES, V8, P1181, DOI 10.5194/bg-8-1181-2011; Spijkerboer HP, 2002, ECOL MODEL, V155, P1, DOI 10.1016/S0304-3800(01)00475-6; Swapna S., 2008, Journal of Mycology and Plant Pathology, V38, P21; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Valsan AE, 2016, ATMOS CHEM PHYS, V16, P9805, DOI 10.5194/acp-16-9805-2016; Valsan AE, 2015, ATMOS ENVIRON, V122, P321, DOI 10.1016/j.atmosenv.2015.09.071; van Dijk H, 2003, AMBIO, V32, P19, DOI 10.1639/0044-7447(2003)032[0019:KAUOEM]2.0.CO;2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yafetto L, 2008, PLOS ONE, V3, P1; Zhu C, 2015, ATMOS CHEM PHYS, V1, P1689; Zucconi L, 2002, POLAR BIOL, V25, P500, DOI 10.1007/s00300-002-0371-1	56	12	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169333	10.1371/journal.pone.0169333	http://dx.doi.org/10.1371/journal.pone.0169333			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072853	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200014
J	Little, P; Kvist, O; Grankvist, R; Jonsson, S; Damberg, P; Soderman, M; Arnberg, F; Holmin, S				Little, Philip; Kvist, Ola; Grankvist, Rikard; Jonsson, Stefan; Damberg, Peter; Soderman, Michael; Arnberg, Fabian; Holmin, Staffan			Preserved Collateral Blood Flow in the Endovascular M2CAO Model Allows for Clinically Relevant Profiling of Injury Progression in Acute Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ARTERY OCCLUSION; RAT-BRAIN; DEFUSE 2; DIFFUSION; REPERFUSION; EVOLUTION; PERFUSION; MRI; TRANSIENT	Interventional treatment regimens have increased the demand for accurate understanding of the progression of injury in acute ischemic stroke. However, conventional animal models severely inhibit collateral blood flow and mimic the malignant infarction profile not suitable for treatment. The aim of this study was to provide a clinically relevant profile of the emergence and course of ischemic injury in cases suitable for acute intervention, and was achieved by employing a M2 occlusion model (M2CAO) that more accurately simulates middle cerebral artery (MCA) occlusion in humans. Twenty-five Sprague-Dawley rats were subjected to Short (90 min), Intermediate (180 min) or Extended (600 min) transient M2CAO and examined longitudinally with interleaved diffusion-, T2- and arterial spin labeling perfusion-weighted magnetic resonance imaging before and after reperfusion. We identified a rapid emergence of cytotoxic edema within tissue regions undergoing infarction, progressing in several distinct phases in the form of subsequent moderation and then reversal at 230 min (p < 0.0001). We identified also the early emergence of vasogenic edema, which increased consistently before and after reperfusion (p < 0.0001). The perfusion of the penumbra correlated more strongly to the perfusion of adjacent tissue regions than did the perfusion of regions undergoing infarction (p = 0.0088). This was interpreted as an effect of preserved collateral blood flow during M2CAO. Accordingly, we observed only limited recruitment of penumbra regions to the infarction core. However, a gradual increase in infarction size was still occurring as late as 10 hours after M2CAO. Our results indicate that patients suffering MCA branch occlusion stand to benefit from interventional therapy for an extended time period after the emergence of ischemic injury.	[Little, Philip; Grankvist, Rikard; Damberg, Peter; Soderman, Michael; Arnberg, Fabian; Holmin, Staffan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Little, Philip; Kvist, Ola; Grankvist, Rikard; Soderman, Michael; Arnberg, Fabian; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Kvist, Ola] Capio St Gorans Hosp, Dept Radiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden; [Damberg, Peter] Karolinska Univ Hosp Solna, Karolinska Expt Res & Imaging Ctr KERIC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Saint Goran's Hospital; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital	Little, P; Holmin, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Little, P; Holmin, S (corresponding author), Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden.	philip.little@ki.se; staffan.holmin@ki.se		Grankvist, Rikard/0000-0003-3409-6154; Kvist, Ola/0000-0002-8730-5901; Holmin, Staffan/0000-0002-1628-1615	Swedish Society of Medicine; Soderbergska Stiftelsen; Uppdrag Besegra Stroke (Swedish Heart-Lung Foundation); Uppdrag Besegra Stroke (Karolinska Institutet); Uppdrag Besegra Stroke (Friends of Karolinska Institutet US); Uppdrag Besegra Stroke (Swedish order of St John); Ahlen-stiftelsen; Thurings stiftelse; Tore Nilsons stiftelse	Swedish Society of Medicine; Soderbergska Stiftelsen; Uppdrag Besegra Stroke (Swedish Heart-Lung Foundation); Uppdrag Besegra Stroke (Karolinska Institutet); Uppdrag Besegra Stroke (Friends of Karolinska Institutet US); Uppdrag Besegra Stroke (Swedish order of St John); Ahlen-stiftelsen; Thurings stiftelse; Tore Nilsons stiftelse	The study was funded and supported by the Swedish Society of Medicine, Soderbergska Stiftelsen, Uppdrag Besegra Stroke (supported by the Swedish Heart-Lung Foundation, Karolinska Institutet, Friends of Karolinska Institutet US and the Swedish order of St John), Ahlen-stiftelsen, Thurings stiftelse, Tore Nilsons stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded and supported by the Swedish Society of Medicine, Soderbergska Stiftelsen, Uppdrag Besegra Stroke (supported by the Swedish Heart-Lung Foundation, Karolinska Institutet, Friends of Karolinska Institutet US and the Swedish order of St John), Ahlen-stiftelsen, Thurings stiftelse, Tore Nilsons stiftelse. Experiments were performed at the Karolinska Experimental Research and Imaging Centre.	Abe O, 2003, EUR J RADIOL, V46, P67, DOI 10.1016/S0720-048X(02)00329-7; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Arnberg F, 2015, STROKE, V46, P835, DOI 10.1161/STROKEAHA.114.008407; Arnberg F, 2012, STROKE, V43, P2437, DOI 10.1161/STROKEAHA.112.655126; Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Bang OY, 2011, STROKE, V42, P2235, DOI 10.1161/STROKEAHA.110.604603; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; Beaulieu C, 1999, ANN NEUROL, V46, P568, DOI 10.1002/1531-8249(199910)46:4<568::AID-ANA4>3.0.CO;2-R; Carmichael S Thomas, 2005, NeuroRx, V2, P396; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; JIANG Q, 1993, J NEUROL SCI, V120, P123, DOI 10.1016/0022-510X(93)90262-W; Kanemitsu H, 2002, J CEREBR BLOOD F MET, V22, P1196, DOI 10.1097/01.wcb.0000037992.07114.95; KNIGHT RA, 1994, STROKE, V25, P1252, DOI 10.1161/01.STR.25.6.1252; KNIGHT RA, 1994, STROKE, V25, P500; Koizumi G, 1986, JPN J STROKE, V8, P8; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Menon BK, 2011, AM J NEURORADIOL, V32, P1640, DOI 10.3174/ajnr.A2564; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Morita Yoko, 1997, Keio Journal of Medicine, V46, P120; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Nagakane Y, 2011, STROKE, V42, P59, DOI 10.1161/STROKEAHA.110.580464; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Olivot JM, 2014, STROKE, V45, P1018, DOI 10.1161/STROKEAHA.113.003857; Prosser J, 2005, STROKE, V36, P1700, DOI 10.1161/01.STR.0000173407.40773.17; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Scalzo F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00008; Thomalla GJ, 2003, STROKE, V34, P1892, DOI 10.1161/01.STR.0000081985.44625.B6; Wheeler HM, 2015, INT J STROKE, V10, P723, DOI 10.1111/ijs.12436; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	38	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169541	10.1371/journal.pone.0169541	http://dx.doi.org/10.1371/journal.pone.0169541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068417	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900044
J	Mo, S; Phillips, E; Krawitz, BD; Garg, R; Salim, S; Geyman, LS; Efstathiadis, E; Carroll, J; Rosen, RB; Chui, TYP				Mo, Shelley; Phillips, Erika; Krawitz, Brian D.; Garg, Reena; Salim, Sarwat; Geyman, Lawrence S.; Efstathiadis, Eleni; Carroll, Joseph; Rosen, Richard B.; Chui, Toco Y. P.			Visualization of Radial Peripapillary Capillaries Using Optical Coherence Tomography Angiography: The Effect of Image Averaging	PLOS ONE			English	Article							HUMAN RETINAL MICROVASCULATURE; NERVE-FIBER LAYER; SPECKLE-VARIANCE; AMPLITUDE-DECORRELATION; QUANTITATIVE ASSESSMENT; MOTION CORRECTION; REGISTRATION	Objectives To assess the effect of image registration and averaging on the visualization and quantification of the radial peripapillary capillary (RPC) network on optical coherence tomography angiography (OCTA). Methods Twenty-two healthy controls were imaged with a commercial OCTA system (AngioVue, Optovue, Inc.). Ten 10x10 degrees scans of the optic disc were obtained, and the most superficial layer (50-mu m slab extending from the inner limiting membrane) was extracted for analysis. Rigid registration was achieved using ImageJ, and averaging of each 2 to 10 frames was performed in five similar to 2x2 degrees regions of interest (ROI) located 1 degrees from the optic disc margin. The ROI were automatically skeletonized. Signal-to-noise ratio (SNR), number of endpoints and mean capillary length from the skeleton, capillary density, and mean intercapillary distance (ICD) were measured for the reference and each averaged ROI. Repeated measures analysis of variance was used to assess statistical significance. Three patients with primary open angle glaucoma were also imaged to compare RPC density to controls. Results Qualitatively, vessels appeared smoother and closer to histologic descriptions with increasing number of averaged frames. Quantitatively, number of endpoints decreased by 51%, and SNR, mean capillary length, capillary density, and ICD increased by 44%, 91%, 11%, and 4.5% from single frame to 10-frame averaged, respectively. The 10-frame averaged images from the glaucomatous eyes revealed decreased density correlating to visual field defects and retinal nerve fiber layer thinning. Conclusions OCTA image registration and averaging is a viable and accessible method to enhance the visualization of RPCs, with significant improvements in image quality and RPC quantitative parameters. With this technique, we will be able to non-invasively and reliably study RPC involvement in diseases such as glaucoma.	[Mo, Shelley; Krawitz, Brian D.; Garg, Reena; Geyman, Lawrence S.; Rosen, Richard B.; Chui, Toco Y. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Mo, Shelley; Krawitz, Brian D.; Garg, Reena; Geyman, Lawrence S.; Efstathiadis, Eleni; Rosen, Richard B.; Chui, Toco Y. P.] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, New York, NY 10003 USA; [Phillips, Erika; Salim, Sarwat; Carroll, Joseph] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Efstathiadis, Eleni] William E Macaulay Honors Coll, New York, NY USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chui, TYP (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.; Chui, TYP (corresponding author), New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, New York, NY 10003 USA.	ychui@nyee.edu		Chui, Toco YP/0000-0003-2060-3848	Marrus Family Foundation; Bendheim-Lowenstein Family Foundation; Wise Family Foundation; New York Eye and Ear Chairman's Research Fund; Violett Fund; Milbank Foundation; Eye Institute of the National Institutes of Health [P30EY001931, R01EY024969]	Marrus Family Foundation; Bendheim-Lowenstein Family Foundation; Wise Family Foundation; New York Eye and Ear Chairman's Research Fund; Violett Fund; Milbank Foundation; Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Marrus Family Foundation (RBR), Bendheim-Lowenstein Family Foundation (RBR), Wise Family Foundation (RBR), New York Eye and Ear Chairman's Research Fund (RBR), Violett Fund (RBR), and Milbank Foundation (RBR). Research reported in this publication was supported by the Eye Institute of the National Institutes of Health under award numbers P30EY001931 (JC) and R01EY024969 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; ALTERMAN M, 1968, BRIT J OPHTHALMOL, V52, P26, DOI 10.1136/bjo.52.1.26; An L, 2008, OPT EXPRESS, P16; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bonini MA, 2015, RETINA-J RET VIT DIS, V35, P2339, DOI 10.1097/IAE.0000000000000850; Chan G, 2015, MICROVASC RES, V100, P32, DOI 10.1016/j.mvr.2015.04.006; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; Chui TY, 2014, BIOMED OPT EXPRESS, P5; Chui TY, 2013, INVEST OPHTH VIS SCI, P54; Fingler J, 2009, OPT EXPRESS, V17, P22190, DOI 10.1364/OE.17.022190; Gorczynska I, 2016, BIOMED OPT EXPRESS, V7, P911, DOI 10.1364/BOE.7.000911; Hendargo HC, 2013, BIOMED OPT EXPRESS, V4, P803, DOI 10.1364/BOE.4.000803; HENKIND P, 1967, BRIT J OPHTHALMOL, V51, P115, DOI 10.1136/bjo.51.2.115; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kim DY, 2011, BIOMED OPT EXPRESS, P2; KORNZWEIG AL, 1968, ARCH OPHTHALMOL-CHIC, V80, P696; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lozzi A, 2015, BIOMED OPT EXPRESS, V6, P2435, DOI 10.1364/BOE.6.002435; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Makita S, 2016, BIOMED OPT EXPRESS, V7, P1525, DOI 10.1364/BOE.7.001525; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Mo S, 2016, INVEST OPHTH VIS SCI, V57, pOCT130, DOI 10.1167/iovs.15-18932; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Pinhas A, 2013, BIOMED OPT EXPRESS, V4, P1305, DOI 10.1364/BOE.4.001305; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Sander B, 2005, BRIT J OPHTHALMOL, V89, P207, DOI 10.1136/bjo.2004.045989; Scoles D, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-9; Scripsema NK, 2016, INVEST OPHTH VIS SCI, V57, DOI [10.1167/iovs.15-18945, DOI 10.1167/]; Shirasawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110550; SNODDERLY DM, 1992, J NEUROSCI, V12, P1169; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P66, DOI 10.1001/jamaophthalmol.2014.3950; Tan PEZ, 2014, INVEST OPHTH VIS SCI, V55, P8439, DOI 10.1167/iovs.14-15056; Tan PEZ, 2015, INVEST OPHTH VIS SCI, V56, P3989, DOI 10.1167/iovs.14-15879; Tan PEZ, 2012, INVEST OPHTH VIS SCI, V53, P5728, DOI 10.1167/iovs.12-10017; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Yu PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135151; Yu PK, 2014, EXP EYE RES, V129, P83, DOI 10.1016/j.exer.2014.10.020; Zang PX, 2016, BIOMED OPT EXPRESS, V7, P2823, DOI 10.1364/BOE.7.002823; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901	44	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169385	10.1371/journal.pone.0169385	http://dx.doi.org/10.1371/journal.pone.0169385			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068370	Green Submitted, Green Published, gold			2022-12-26	WOS:000391843900030
J	Peters, C; Dulon, M; Kleinmuller, O; Nienhaus, A; Schablon, A				Peters, Claudia; Dulon, Madeleine; Kleinmueller, Olaf; Nienhaus, Albert; Schablon, Anja			MRSA Prevalence and Risk Factors among Health Personnel and Residents in Nursing Homes in Hamburg, Germany - A Cross-Sectional Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LONG-TERM-CARE; HOSPITAL GERIATRIC UNIT; MOLECULAR EPIDEMIOLOGY; NASAL COLONIZATION; BACTERIA; STAFF; FACILITIES; INFECTION; PERSISTENCE	Introduction The increase of multidrug-resistant organisms in hospitals causes problems in nursing homes. Staff in geriatric nursing homes are at greater risk of MRSA colonisation. The aim of the study was to describe the occupational exposure to MRSA among health personnel in geriatric nursing. Methods A point prevalence survey was conducted among health personnel and residents of geriatric nursing homes within the greater Hamburg district. Nasal swabs and, where relevant, wound swabs were collected for the screening survey. Risk factors for MRSA colonisation were identified by means of a questionnaire and using the files held on the residents. Where tests on nursing staff were positive, a control swab was taken; when the results were confirmed positive, decolonisation was performed. The responsible general practitioners were notified of positive MRSA findings among residents. A molecular biological examination of the MRSA samples was performed. Results A total of 19 institutions participated in the study. Nasal swabs were taken from 759 nursing staff and 422 residents. Prevalence of MRSA was 1.6% among staff and 5.5% among residents. MRSA colonisation among health personnel indicated a correlation with male gender (OR 4.5, 95% CI 1.4-14.1). Among the residents, chronic skin diseases (OR 3.2, 95% CI 1.0-10.3) and indwelling devices (OR 3.2, 95% CI 1.2-8.1) were identified as risk factors. No link between MRSA in residents and in health personnel could be established. Conclusion The number of MRSA colonisations among nursing staff and residents of geriatric nursing homes in Hamburg was rather low at 1.6% and 5.5% respectively and equates to the results of other surveys in non-outbreak scenarios.	[Peters, Claudia; Kleinmueller, Olaf; Nienhaus, Albert; Schablon, Anja] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, CVcare, Hamburg, Germany; [Dulon, Madeleine; Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Healthca, Dept Occupat Hlth Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Peters, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, CVcare, Hamburg, Germany.	c.peters@uke.de			Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services, Germany; German Ministry of Health [IIA5-2512FSB103]	Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services, Germany; German Ministry of Health	This study was funded by the Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services, Germany, unrestricted fund (URL: https://www.bgw-online.de), and a grant of the German Ministry of Health, grant number IIA5-2512FSB103 (URL: http://www.bmg.bund.de/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2010, J HOSP INFECT, V76, P97, DOI 10.1016/j.jhin.2010.04.027; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Andersen PS, 2013, EUR J CLIN MICROBIOL, V32, P1321, DOI 10.1007/s10096-013-1882-0; Andersson H, 2012, SCAND J INFECT DIS, V44, P641, DOI 10.3109/00365548.2012.671956; Baldwin NS, 2009, J AM GERIATR SOC, V57, P620, DOI 10.1111/j.1532-5415.2009.02181.x; Becker J, 2013, INT J MED MICROBIOL, V303, P31; Conrad A, 2011, KLINIKARZT, V40, P126; Dulon M, 2015, ZBL ARBEITSMED, V65, P210; Dulon M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-363; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; ECDC, 2013, ANT RES SURV EUR; Garcia-Garcia JA, 2011, ENFERM INFEC MICR CL, V29, P405, DOI 10.1016/j.eimc.2010.12.010; Geffers C, 2011, DTSCH ARZTEBL INT, V108, P87, DOI 10.3238/arztebl.2011.0087; Gibson KE, 2014, INFECT CONT HOSP EP, V35, P1458, DOI 10.1086/678599; Greenland K, 2011, J AM GERIATR SOC, V59, P768, DOI 10.1111/j.1532-5415.2011.03325.x; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Haamann F, 2011, ARBEITSMED SOZIALMED, V46, P585; Haamann F, 2011, INT ARCH OCC ENV HEA, V84, P259, DOI 10.1007/s00420-010-0610-7; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hawkins G, 2011, J HOSP INFECT, V77, P285, DOI 10.1016/j.jhin.2010.09.038; Heudorf U, 2014, BUNDESGESUNDHEITSBLA, V57, P414, DOI 10.1007/s00103-013-1927-7; Heudorf U, 2001, GESUNDHEITSWESEN, V63, P447, DOI 10.1055/s-2001-15924; Hogardt M, 2015, EURO SURVEILL, V20; Hubner NO, 2009, GESUNDHEITSWESEN, V71, P771, DOI 10.1055/s-0029-1241891; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Infektionspravention in Heimen-Empfehlung der Kommission fur Krankenhaushygiene und Infektionspravention beim Robert-Koch-Institut (RKI), 2005, BUNDESGESUNDHEITSBLA, V48, P1061, DOI [10.1007/s00103-005-1126-2, DOI 10.1007/S00103-005-1126-2]; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Koch AM, 2009, J HOSP INFECT, V71, P269, DOI 10.1016/j.jhin.2008.10.032; Koeck R., 2016, New Microbes and New Infections, V9, P24, DOI 10.1016/j.nmni.2015.11.004; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO), 2014, BUNDESGESUNDHEITSBLA, V57, P695, DOI [10.1007/s00103-014-1980-x, DOI 10.1007/s00103-014-1980-x, DOI 10.1007/S00103-014-1980-X]; Linder R, 2011, GMS HYG INFECT CONTR, V6, DOI 10.3205/dgkh000182; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; March A, 2014, SCAND J INFECT DIS, V46, P114, DOI 10.3109/00365548.2013.859392; Meyer E, 2014, DTSCH ARZTEBL INT, V111, P331, DOI 10.3238/arztebl.2014.0331; Mody L, 2007, J AM GERIATR SOC, V55, P1921, DOI 10.1111/j.1532-5415.2007.01468.x; Monaco M, 2009, J HOSP INFECT, V73, P182, DOI 10.1016/j.jhin.2009.06.026; Mossong J, 2013, EPIDEMIOL INFECT, V141, P1199, DOI 10.1017/S0950268812001999; Neuhaus B, 2002, BUNDESGESUNDHEITSBLA, V45, P894; Nillius D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153030; Oberdorfer H, 2015, GESUNDHEITSWESEN, V77, P854, DOI 10.1055/s-0034-1387709; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; Pfister G, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P506, DOI 10.1007/s00103-006-1278-8; Pflegestatistik, 2013, PFLEG 2013 PFLEG RAH; Ruscher C, 2014, INT J MED MICROBIOL, V304, P1123, DOI 10.1016/j.ijmm.2014.08.006; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Skramm I, 2011, APMIS, V119, P522, DOI 10.1111/j.1600-0463.2011.02758.x; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Woltering R, 2008, DEUT MED WOCHENSCHR, V133, P999, DOI 10.1055/s-2008-1075683	49	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169425	10.1371/journal.pone.0169425	http://dx.doi.org/10.1371/journal.pone.0169425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068356	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900032
J	Villalpando, DM; Navarro, R; del Campo, L; Largo, C; Munoz, D; Tabernero, M; Baeza, R; Otero, C; Garcia, HS; Ferrer, M				Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Largo, Carlota; Munoz, David; Tabernero, Maria; Baeza, Ramiro; Otero, Cristina; Garcia, Hugo S.; Ferrer, Mercedes			Docosahexaenoic Acid Supplemented Diet Influences the Orchidectomy-Induced Vascular Dysfunction in Rat Mesenteric Arteries	PLOS ONE			English	Article							ACETYLCHOLINE-INDUCED RELAXATION; NITRIC-OXIDE RELEASE; EICOSAPENTAENOIC ACID; FISH-OIL; SMOOTH-MUSCLE; SEX-HORMONES; SUPEROXIDE; INCREASES; ENDOTHELIUM; REACTIVITY	Over the past few decades, the cardiovascular benefits of a high dietary intake of long-chain polyunsaturated fatty acids (PUFAs), like docosahexaenoic acid (DHA), have been extensively studied. However, many of the molecular mechanisms and effects exerted by PUFAs have yet to be well explained. The lack of sex hormones alters vascular tone, and we have described that a DHA-supplemented diet to orchidectomized rats improve vascular function of the aorta. Based on these data and since the mesenteric artery importantly controls the systemic vascular resistance, the objective of this study was to analyze the effect of a DHA-supplemented diet on the mesenteric vascular function from orchidectomized rats. For this purpose mesenteric artery segments obtained from control, orchidectomized or orchidectomized plus DHA-supplemented diet were utilized to analyze: (1) the release of prostanoids, (2) formation of NO and ROS, (3) the vasodilator response to acetylcholine (ACh), as well as the involvement of prostanoids and NO in this response, and (4) the vasoconstrictor response to electrical field stimulation (EFS), analyzing also the effect of exogenous noradrenaline (NA), and the NO donor, sodium nitroprusside (SNP). The results demonstrate beneficial effects of DHA on the vascular function in orchidectomized rats, which include a decrease in the prostanoids release and superoxide formation that were previously augmented by orchidectomy. Additionally, there was an increase in endothelial NO formation and the response to ACh, in which NO involvement and the participation of vasodilator prostanoids were increased. DHA also reversed the decrease in EFS-induced response caused by orchidectomy. All of these findings suggest beneficial effects of DHA on vascular function by reversing the neurogenic response and the endothelial dysfunction caused by orchidectomy.	[Villalpando, Diva M.; Navarro, Rocio; del Campo, Lara; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Villalpando, Diva M.; del Campo, Lara; Ferrer, Mercedes] Hosp Univ La Paz IdiPAZ, Inst Invest, Area Cardiovasc, Madrid, Spain; [Largo, Carlota; Tabernero, Maria] Hosp Univ La Paz IdiPAZ, Inst Invest, Cirugia Expt, Madrid, Spain; [Munoz, David] Univ Autonoma Madrid, Fac Med, Gabinete Vet, Madrid, Spain; [Baeza, Ramiro; Otero, Cristina] CSIC, Inst Catalisis & Petroleoquim, Madrid, Spain; [Garcia, Hugo S.] Inst Tecnol Veracruz, Veracruz, Mexico	Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Ferrer, M (corresponding author), Hosp Univ La Paz IdiPAZ, Inst Invest, Area Cardiovasc, Madrid, Spain.	mercedes.ferrer@uam.es	Villalpando, Diva/AAG-6337-2020; Parra, Mercedes Ferrer/AAE-1746-2020; Navarro, Rocío/N-5505-2016; Ferrer, Mercedes/E-3556-2018; del Campo, Lara/A-8317-2015	Parra, Mercedes Ferrer/0000-0002-4670-7146; Navarro, Rocío/0000-0002-0083-7711; del Campo, Lara/0000-0002-0394-116X; Largo, Carlota/0000-0003-3306-7925	Fondo de Investigaciones Sanitarias [PI1100406]; Comunidad de Madrid [S2013/ABI-2783]; Fondo Europeo de Desarrollo Regional; Centro de Estudios America Latina (Grupo Santander-UAM)	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission); Centro de Estudios America Latina (Grupo Santander-UAM)	Supported by grants (to MF) from the Fondo de Investigaciones Sanitarias (PI1100406), Comunidad de Madrid (S2013/ABI-2783, "INSPIRA1-CM"), Fondo Europeo de Desarrollo Regional, and Centro de Estudios America Latina (Grupo Santander-UAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; Boeckxstaens GE, 1997, COMP BIOCHEM PHYS A, V118, P925, DOI 10.1016/S0300-9629(97)00022-4; Burban M, 2016, SHOCK, V46, P549, DOI 10.1097/SHK.0000000000000624; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Carter JR, 2012, AM J PHYSIOL-HEART C, V303, pH450, DOI 10.1152/ajpheart.00353.2012; Casos K, 2010, FREE RADICAL RES, V44, P821, DOI 10.3109/10715762.2010.485992; Chen DC, 1999, EUR J PHARMACOL, V372, P247, DOI 10.1016/S0014-2999(99)00226-5; Cignarella A, 2000, N-S ARCH PHARMACOL, V361, P166, DOI 10.1007/s002109900173; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; Engler MM, 2003, EXP BIOL MED, V228, P299, DOI 10.1177/153537020322800309; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515, DOI 10.1111/j.1476-5381.1988.tb10306.x; Ferrer M, 1999, CLIN SCI, V97, P625, DOI 10.1042/CS19990102; Gortan Cappellari G, 2013, J NUTR BIOCHEM, V24, P371, DOI 10.1016/j.jnutbio.2012.07.012; Hashimoto M, 1999, J NUTR, V129, P70, DOI 10.1093/jn/129.1.70; Jones RD, 2004, EUR J ENDOCRINOL, V151, P29, DOI 10.1530/eje.0.1510029; Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; LI YJ, 1992, EUR J PHARMACOL, V210, P23, DOI 10.1016/0014-2999(92)90647-M; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lopez Farre A., 2006, REV ESPANOLA CARDIOL, V6, P31, DOI DOI 10.1016/S1131-3587(06)74824-5; Marin J, 2000, CLIN SCI, V99, P277, DOI 10.1042/CS20000009; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Matsumoto T, 2009, J PHARMACOL EXP THER, V329, P324, DOI 10.1124/jpet.108.148718; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Munzel T, 1997, HERZ, V22, P158, DOI 10.1007/bf03044353; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Nishimura M, 2000, CLIN EXP PHARMACOL P, V27, P618, DOI 10.1046/j.1440-1681.2000.03311.x; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Otsuka K, 2005, BIOL PHARM BULL, V28, P1298, DOI 10.1248/bpb.28.1298; Pettit LK, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-16; Rossary A, 2007, BIOCHEM J, V406, P77, DOI 10.1042/BJ20061009; Sagredo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073474; Sato Kyosuke, 2013, J Smooth Muscle Res, V49, P63; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Siddiqui A, 1997, DEV BRAIN RES, V98, P247, DOI 10.1016/S0165-3806(96)00171-X; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Zarrouk A, 2015, STEROIDS, V99, P238, DOI 10.1016/j.steroids.2015.01.018	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168841	10.1371/journal.pone.0168841	http://dx.doi.org/10.1371/journal.pone.0168841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068359	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900014
J	Johns, LE; Ferguson, KK; McElrath, TF; Mukherjee, B; Seely, EW; Meeker, JD				Johns, Lauren E.; Ferguson, Kelly K.; McElrath, Thomas F.; Mukherjee, Bhramar; Seely, Ellen W.; Meeker, John D.			Longitudinal Profiles of Thyroid Hormone Parameters in Pregnancy and Associations with Preterm Birth	PLOS ONE			English	Article							POPULATION-BASED COHORT; SUBCLINICAL HYPOTHYROIDISM; INFLAMMATORY CYTOKINES; FUNCTION TESTS; 1ST TRIMESTER; DELIVERY; RISK; OUTCOMES; DYSFUNCTION; GESTATION	Introduction Overt thyroid disease in pregnancy is associated with numerous maternal and neonatal complications including preterm birth. Less is known about the contribution of trimester-specific subclinical alterations in individual thyroid hormones, especially in late gestation, on the risk of preterm birth. Herein, we examined the associations between subclinical changes in maternal thyroid hormone concentrations (TSH, total T3, free and total T4), measured at multiple time points in pregnancy, and the odds of preterm birth in pregnant women without clinical thyroid disease. Participants and Methods Data were obtained from pregnant women participating in a nested case-control study of preterm birth within on ongoing birth cohort study at Brigham and Women's Hospital in Boston, MA (N = 439; 116 cases and 323 controls). We measured thyroid hormones in plasma collected at up to four time points in pregnancy (median = 10, 18, 26, and 35 weeks). We used multivariate logistic regression models stratified by study visit of sample collection to examine associations. To reveal potential biological pathways, we also explored these relationships by obstetric presentation of preterm birth (e.g., spontaneous preterm delivery) that have been previously hypothesized to share common underlying mechanisms. Results In samples collected at median 10 and 26 weeks of gestation, we found inverse associations between FT4 and the odds of overall preterm birth (odds ratio [OR] = 0.57, 95% confidence interval (CI) = 0.33, 1.00; and OR = 0.53, 95% CI = 0.34, 0.84, respectively). Positive associations were detected for total T3 at these same time points (OR = 2.52, 95% CI = 1.20, 5.31; and OR = 3.40, 95% CI = 1.56, 7.40, respectively). These effect estimates were stronger for spontaneous preterm birth. Conclusions Our results suggest that subclinical alterations in individual maternal thyroid hormones may influence the risk of preterm birth, and the strength of these associations vary by gestational age.	[Johns, Lauren E.; Ferguson, Kelly K.; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Ferguson, Kelly K.] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [McElrath, Thomas F.] Harvard Med Sch, Brigham & Womens Hosp, Div Maternal & Fetal Med, Boston, MA USA; [Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Seely, Ellen W.] Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Meeker, JD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	meekerj@umich.edu	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250; Meeker, John/0000-0001-8357-5085	Abbott Diagnostics; National Institute of Environmental Health Sciences, National Institutes of Health [R01ES018872, P42ES017198, P01E5022844, P30ES017885, T32ES007062]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, T32ES007062, ZIAES103321] Funding Source: NIH RePORTER	Abbott Diagnostics(Abbott Laboratories); National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Subject recruitment and sample collection was originally funded by Abbott Diagnostics. Funding was also provided by the National Institute of Environmental Health Sciences, National Institutes of Health (grants R01ES018872, P42ES017198, P01E5022844, P30ES017885, and T32ES007062). Funding support for KKF was provided by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Aggarawal N, 2014, GYNECOL OBSTET INVES, V77, P94, DOI 10.1159/000357615; Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; Ashoor G, 2011, OBSTET GYNECOL, V117, P293, DOI 10.1097/AOG.0b013e318205152c; Barber KJ, 2005, J CLIN ENDOCR METAB, V90, P1655, DOI 10.1210/jc.2004-0785; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Chan SY, 2009, NAT CLIN PRACT ENDOC, V5, P45, DOI 10.1038/ncpendmet1026; Chen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109364; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Dittrich R, 2011, J REPROD IMMUNOL, V90, P58, DOI 10.1016/j.jri.2011.02.009; Ferguson KK, 2014, AM J REPROD IMMUNOL, V72, P326, DOI 10.1111/aji.12265; Ferguson KK, 2014, ENVIRON INT, V70, P118, DOI 10.1016/j.envint.2014.05.016; Ferguson KK, 2014, JAMA PEDIATR, V168, P61, DOI 10.1001/jamapediatrics.2013.3699; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Goldenberg RL, 2007, AM J CLIN NUTR, V85, p584S, DOI 10.1093/ajcn/85.2.584S; Gupta G, 2015, J CLIN DIAGN RES, V9, pBC04, DOI 10.7860/JCDR/2015/14640.6806; Hennessey JV, 2016, THYROID DIS PREGNANC; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; Kilby MD, 2005, PLACENTA, V26, P105, DOI 10.1016/j.placenta.2004.08.004; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Korevaar TI, 2016, J CLIN ENDOCR METAB, DOI DOI 10.1210/JC.2016-2942; Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P4382, DOI 10.1210/jc.2013-2855; Koulouri O, 2013, BEST PRACT RES CL EN, V27, P745, DOI 10.1016/j.beem.2013.10.003; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Laurberg P, 2016, J CLIN ENDOCR METAB, V101, P2484, DOI 10.1210/jc.2016-1387; Lazarus J, 2014, EUR THYROID J, V3, P76, DOI 10.1159/000362597; Leon G, 2015, PAEDIATR PERINAT EP, V29, P113, DOI 10.1111/ppe.12172; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; Li AM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.045; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Marchiori RC, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0032-3; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; McElrath TF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.010; Medici M, 2015, CLIN CHEM, V61, P704, DOI 10.1373/clinchem.2014.236646; MILLAR LK, 1994, OBSTET GYNECOL, V84, P946; Nazarpour S, 2015, INT J REPROD BIOMED, V13, P387; Negro R, 2011, ENDOCR PRACT, V17, P422, DOI 10.4158/EP10309.RA; NELSON JC, 1994, J CLIN ENDOCR METAB, V79, P76, DOI 10.1210/jc.79.1.76; Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352; Ong GSY, 2014, J CLIN ENDOCR METAB, V99, pE2668, DOI 10.1210/jc.2014-1918; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Rotondi M, 2002, J ENDOCRINOL INVEST, V25, P442, DOI 10.1007/BF03344035; Sahu MT, 2010, ARCH GYNECOL OBSTET, V281, P215, DOI 10.1007/s00404-009-1105-1; Saki F, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.19378; Schempf AH, 2007, PAEDIATR PERINAT EP, V21, P34, DOI 10.1111/j.1365-3016.2007.00785.x; Schneuer FJ, 2012, J CLIN ENDOCR METAB, V97, P3115, DOI 10.1210/jc.2012-1193; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Solanki A., 2013, INDIAN J ENDOCRINOL, V17, pS167, DOI [DOI 10.4103/2230-8210.119560, 10.4103/2230-8210.119560]; Stagnaro-Green A, 2005, THYROID, V15, P351, DOI 10.1089/thy.2005.15.351; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Volpe R, 1997, CRIT REV CL LAB SCI, V34, P405, DOI 10.3109/10408369709006421; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; YOSHIMURA M, 1995, THYROID, V5, P425, DOI 10.1089/thy.1995.5.425	61	16	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169542	10.1371/journal.pone.0169542	http://dx.doi.org/10.1371/journal.pone.0169542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060899	Green Published, gold			2022-12-26	WOS:000391641500107
J	Morgan, RG; Venturelli, M; Gross, C; Tarperi, C; Schena, F; Reggiani, C; Naro, F; Pedrinolla, A; Monaco, L; Richardson, RS; Donato, AJ				Morgan, R. Garrett; Venturelli, Massimo; Gross, Cole; Tarperi, Cantor; Schena, Federico; Reggiani, Carlo; Naro, Fabio; Pedrinolla, Anna; Monaco, Lucia; Richardson, Russell S.; Donato, Anthony J.			Age-Associated ALU Element Instability in White Blood Cells Is Linked to Lower Survival in Elderly Adults: A Preliminary Cohort Study	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; CANCER; HYPOMETHYLATION; RECOMBINATION; HYPERTENSION; TELOMERES; SEQUENCES; DELETION; REPEATS; BREAST	Background ALU element instability could contribute to gene function variance in aging, and may partly explain variation in human lifespan. Objective To assess the role of ALU element instability in human aging and the potential efficacy of ALU element content as a marker of biological aging and survival. Design Preliminary cohort study. Methods We measured two high frequency ALU element subfamilies, ALU-J and ALU-Sx, by a single qPCR assay and compared ALU-J/Sx content in white blood cell (WBCs) and skeletal muscle cell (SMCs) biopsies from twenty-three elderly adults with sixteen healthy sex-balanced young adults; all-cause survival rates of elderly adults predicted by ALU-J/Sx content in both tissues; and cardiovascular disease (CVD)- and cancer-specific survival rates of elderly adults predicted by ALU-J/Sx content in both tissues, as planned subgroup analyses. Results We found greater ALU-J/Sx content variance in WBCs from elderly adults than young adults (P < 0.001) with no difference in SMCs (P = 0.94). Elderly adults with low WBC ALU-J/Sx content had worse four-year all-cause and CVD-associated survival than those with high ALU-J/Sx content (both P = 0.03 and hazard ratios (HR) >= 3.40), while WBC ALU-J/Sx content had no influence on cancer-associated survival (P = 0.42 and HR = 0.74). SMC ALU-J/Sx content had no influence on all-cause, CVD-or cancer -associated survival (all P >= 0.26; HR <= 2.07). Conclusions These initial findings demonstrate that ALU element instability occurs with advanced age in WBCs, but not SMCs, and imparts greater risk of all-cause mortality that is likely driven by an increased risk for CVD and not cancer.	[Morgan, R. Garrett; Venturelli, Massimo; Gross, Cole; Richardson, Russell S.; Donato, Anthony J.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Morgan, R. Garrett; Richardson, Russell S.; Donato, Anthony J.] George E Wahlen Dept Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Venturelli, Massimo; Tarperi, Cantor; Schena, Federico] Univ Verona, Dept Neurol & Movement Sci, Verona, Italy; [Venturelli, Massimo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Naro, Fabio] Sapienza Univ, DAHFMO Unit Histol & Med Embryol, Rome, Italy; [Pedrinolla, Anna] Univ Verona, Dept Med, Verona, Italy; [Monaco, Lucia] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy; [Richardson, Russell S.; Donato, Anthony J.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; University of Verona; University of Milan; University of Padua; Sapienza University Rome; University of Verona; Sapienza University Rome; Utah System of Higher Education; University of Utah	Donato, AJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Donato, AJ (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.; Donato, AJ (corresponding author), Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.	tony.donato@utah.edu	Venturelli, Massimo/AAQ-4613-2020; Pedrinolla, Anna/ABC-7811-2020	Venturelli, Massimo/0000-0002-2469-8787; Schena, Federico/0000-0002-2052-5117; Pedrinolla, Anna/0000-0001-8888-619X	National Institutes of Health [AG040297, AG045339, P01 HL091830]; U.S. Department of Veterans Affairs [E6910-R, E1697-R, E1433-P, E9275-L]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health (https://projectreporter.nih.gov/reporter.cfm)[AG040297, AG045339, P01 HL091830]; and the U.S. Department of Veterans Affairs (www.va.gov)[E6910-R, E1697-R, E1433-P, E9275-L]. Financial sponsors played no role in the design, execution, analysis and interpretation of data, or writing of this study.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bondurand N, 2012, EUR J HUM GENET, V20, P990, DOI 10.1038/ejhg.2012.29; BURNET FM, 1962, AUSTRALAS ANN MED, V11, P79, DOI 10.1111/imj.1962.11.2.79; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen J, 2013, J MOL NEUROSCI, V50, P368, DOI 10.1007/s12031-013-0014-8; Choi BO, 2011, NEUROGENETICS, V12, P51, DOI 10.1007/s10048-010-0272-3; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/00131640121971374; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Jintaridth P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070386; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kataoka M, 2013, GENET MED, V15, P941, DOI 10.1038/gim.2013.41; Kim YH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-180; Kimura M, 2007, AM J PHYSIOL-REG I, V293, pR2210, DOI 10.1152/ajpregu.00615.2007; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P253, DOI 10.1007/s10654-011-9563-8; Martin GM, 2009, AGING CELL, V8, P761, DOI 10.1111/j.1474-9726.2009.00515.x; Morgan RG, 2014, J HYPERTENS, V32, P1293, DOI 10.1097/HJH.0000000000000157; Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013; Mustafina O. E., 2013, Frontiers in Genetics, V4, P96, DOI 10.3389/fgene.2013.00096; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oler AJ, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-11; Peixoto A, 2013, J HUM GENET, V58, P78, DOI 10.1038/jhg.2012.137; Rohlfs EM, 2000, GENE CHROMOSOME CANC, V28, P300, DOI 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Steenstrup T, 2013, EUR J EPIDEMIOL, V28, P181, DOI 10.1007/s10654-013-9780-4; Venturelli M, 2014, CLIN SCI, V127, P415, DOI 10.1042/CS20140051; Vijg J, 2014, CURR OPIN GENET DEV, V26, P141, DOI 10.1016/j.gde.2014.04.002; Wildschutte JH, 2015, NUCLEIC ACIDS RES, V43, P10292, DOI 10.1093/nar/gkv1089; Yang C, 2016, BREAST CANCER RES TR, V160, P447, DOI 10.1007/s10549-016-4021-7	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169628	10.1371/journal.pone.0169628	http://dx.doi.org/10.1371/journal.pone.0169628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060910	Green Published, gold			2022-12-26	WOS:000391641500119
J	Teng, Y; Bi, DH; Xie, GG; Jin, Y; Huang, Y; Lin, BH; An, XP; Feng, D; Tong, YG				Teng, Yue; Bi, Dehua; Xie, Guigang; Jin, Yuan; Huang, Yong; Lin, Baihan; An, Xiaoping; Feng, Dan; Tong, Yigang			Dynamic Forecasting of Zika Epidemics Using Google Trends	PLOS ONE			English	Article							VIRUS; STATES	We developed a dynamic forecasting model for Zika virus (ZIKV), based on real-time online search data from Google Trends (GTs). It was designed to provide Zika virus disease (ZVD) surveillance and detection for Health Departments, and predictive numbers of infection cases, which would allow them sufficient time to implement interventions. In this study, we found a strong correlation between Zika-related GTs and the cumulative numbers of reported cases (confirmed, suspected and total cases; p<0.001). Then, we used the correlation data from Zika-related online search in GTs and ZIKV epidemics between 12 February and 20 October 2016 to construct an autoregressive integrated moving average (ARIMA) model (0, 1, 3) for the dynamic estimation of ZIKV outbreaks. The forecasting results indicated that the predicted data by ARIMA model, which used the online search data as the external regressor to enhance the forecasting model and assist the historical epidemic data in improving the quality of the predictions, are quite similar to the actual data during ZIKV epidemic early November 2016. Integer-valued autoregression provides a useful base predictive model for ZVD cases. This is enhanced by the incorporation of GTs data, confirming the prognostic utility of search query based surveillance. This accessible and flexible dynamic forecast model could be used in the monitoring of ZVD to provide advanced warning of future ZIKV outbreaks.	[Teng, Yue; Huang, Yong; An, Xiaoping; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Teng, Yue; Bi, Dehua; Xie, Guigang; Jin, Yuan; Huang, Yong; An, Xiaoping; Tong, Yigang] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Bi, Dehua] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON, Canada; [Jin, Yuan] Beijing Inst Biotechnol, Beijing, Peoples R China; [Lin, Baihan] Univ Washington, Dept Psychol Phys & Comp Sci & Engn, Inst Prot Design, Computat Neurosci Program, Seattle, WA 98195 USA; [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; University of Waterloo; University of Washington; University of Washington Seattle; Chinese People's Liberation Army General Hospital	Teng, Y; Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.; Teng, Y; Tong, YG (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Feng, D (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Hosp Management, Div Standard Operat Management, Beijing, Peoples R China.	tong.yigang@gmail.com; danfeng@sklpb.org; yueteng@sklpb.org	Lin, Baihan/GXF-5198-2022	Lin, Baihan/0000-0002-7979-5509; Tong, Yigang/0000-0002-8503-8045	State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1408, SKLPBS1451]	State Key Laboratory of Pathogen and Biosecurity Program	This work was supported by grants from the State Key Laboratory of Pathogen and Biosecurity Program (No. SKLPBS1408 and No. SKLPBS1451).; We thank Drs. Wuchun Cao in State Key Laboratory of Pathogen and Biosecurity for discussions and our colleagues in the Beijing Institute of Microbiology and Epidemiology for help in technical assistance. This work was supported by grants from the State Key Laboratory of Pathogen and Biosecurity Program (No. SKLPBS1408 and No. SKLPBS1451).	Akhtar S, 2009, WORLD J GASTROENTERO, V15, P1607, DOI 10.3748/wjg.15.1607; Bakker KM, 2016, P NATL ACAD SCI USA, V113, P6689, DOI 10.1073/pnas.1523941113; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Hayden EC, 2016, NATURE, V531, P19, DOI 10.1038/531019a; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7; Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904; Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814; Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530; Mlakar J., 2009, NEW ENGL J MED, V374, P951; Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415; Stock J. H., 2011, INTRO ECONOMETRICS, V3rd; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110; Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112	26	92	95	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0165085	10.1371/journal.pone.0165085	http://dx.doi.org/10.1371/journal.pone.0165085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060809	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500007
J	Yamaguchi, S; Hayase, S; Aoki, N; Takehara, A; Ishigohoka, J; Matsushima, T; Wada, K; Homma, KJ				Yamaguchi, Shinji; Hayase, Shin; Aoki, Naoya; Takehara, Akihiko; Ishigohoka, Jun; Matsushima, Toshiya; Wada, Kazuhiro; Homma, Koichi J.			Sex Differences in Brain Thyroid Hormone Levels during Early Post-Hatching Development in Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							MOLECULAR-BASIS; GROWTH-FACTOR; THYROXINE; AVAILABILITY; EXPRESSION	Thyroid hormones are closely linked to the hatching process in precocial birds. Previously, we showed that thyroid hormones in brain had a strong impact on filial imprinting, an early learning behavior in newly hatched chicks; brain 3,5,3'-triiodothyronine (T-3) peaks around hatching and imprinting training induces additional T3 release, thus, extending the sensitive period for imprinting and enabling subsequent other learning. On the other hand, blood thyroid hormone levels have been reported to increase gradually after hatching in altricial species, but it remains unknown how the brain thyroid hormone levels change during post-hatching development of altricial birds. Here, we determined the changes in serum and brain thyroid hormone levels of a passerine songbird species, the zebra finch using radioimmunoassay. In the serum, we found a gradual increase in thyroid hormone levels during post-hatching development, as well as differences between male and female finches. In the brain, there was clear surge in the hormone levels during development in males and females coinciding with the time of fledging, but the onset of the surge of thyroxine (T-4) in males preceded that of females, whereas the onset of the surge of T-3 in males succeeded that of females. These findings provide a basis for understanding the functions of thyroid hormones during early development and learning in altricial birds.	[Yamaguchi, Shinji; Aoki, Naoya; Takehara, Akihiko; Homma, Koichi J.] Teikyo Univ, Fac Pharmaceut Sci, Dept Life & Hlth Sci, Itabashi Ku, Tokyo, Japan; [Hayase, Shin; Ishigohoka, Jun; Matsushima, Toshiya; Wada, Kazuhiro] Hokkaido Univ, Fac Sci, Dept Biol, Sapporo, Hokkaido 060, Japan	Teikyo University; Hokkaido University	Homma, KJ (corresponding author), Teikyo Univ, Fac Pharmaceut Sci, Dept Life & Hlth Sci, Itabashi Ku, Tokyo, Japan.	hommakj@pharm.teikyo-u.ac.jp		Wada, Kazuhiro/0000-0001-8137-9144; Ishigohoka, Jun/0000-0002-5713-9391	Ministry of Education, Culture, Sports, Science and Technology [26115522, 15H01449]; Japan Society for the Promotion of Science [24790089, 24590096, 15K07945, 25291071, 25290063, 26440182]; Naito Foundation; Japan Foundation of Applied Enzymology; NOVARTIS Foundation (Japan) for the Promotion of Science [13-113]; Uehara Memorial Foundation; Sagawa Foundation for Promotion of Cancer Research; Sumitomo Foundation [130063]; Takeda Science Foundation; Research Foundation for Pharmaceutical Sciences; Pharmaceutical Society of Japan Award for Young Scientists; Grants-in-Aid for Scientific Research [17H05932, 14J01737] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation); Sagawa Foundation for Promotion of Cancer Research; Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Research Foundation for Pharmaceutical Sciences; Pharmaceutical Society of Japan Award for Young Scientists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas "Memory dynamism" (26115522) from the Ministry of Education, Culture, Sports, Science and Technology (K.J.H.), http://memory-dynamism.jp/english/index.html; The Grant-in-Aid for Scientific Research on Innovative Areas "Adaptive Circuit Shift (15H01449) from the Ministry of Education, Culture, Sports, Science and Technology (K.J.H), http:/www.fmu.ac.jp/acs/en/,and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/) (N.A., 24790089; S.Y., 24590096, 15K07945; T.M., 25291071; K.W., 25290063; K.J.H., 26440182). Additional support was received from: 1. The Naito Foundation (K.J.H.); 2. The Japan Foundation of Applied Enzymology (K.J.H.); 3. NOVARTIS Foundation (Japan) for the Promotion of Science, 13-113 (K.J.H.); 4. The Uehara Memorial Foundation (K.J.H., S.Y.); 5. The Sagawa Foundation for Promotion of Cancer Research (S.Y.); 6. Grant for Basic Science Research Projects from the Sumitomo Foundation, 130063 (S.Y.); 7. Takeda Science Foundation (S.Y.); and 8. The Research Foundation for Pharmaceutical Sciences (S.Y.).; This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (N.A., 24790089; S.Y., 24590096, 15K07945; T.M.,25291071; K.W., 25290063; K.J.H., 26440182); the Grant-in-Aid for Scientific Research on Innovative Areas "Memory dynamism" (26115522) and "Adaptive circuit shift" (15H01449) from the Ministry of Education, Culture, Sports, Science and Technology (K.J.H.); the Naito Foundation (K.J.H.); the Japan Foundation of Applied Enzymology (K.J.H.); NOVARTIS Foundation (Japan) for the Promotion of Science (K.J.H.);the Uehara Memorial Foundation (K.J.H., S.Y.); the Sagawa Foundation for Promotion of Cancer Research (S.Y.); Sumitomo Foundation (S.Y.); Takeda Science Foundation (S.Y.); and the Pharmaceutical Society of Japan Award for Young Scientists (S.Y.).	Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; CHOPRA IJ, 1973, J CLIN ENDOCR METAB, V36, P311, DOI 10.1210/jcem-36-2-311; CHOPRA IJ, 1971, J CLIN ENDOCR METAB, V33, P865, DOI 10.1210/jcem-33-5-865; Darras VM, 2009, GEN COMP ENDOCR, V163, P58, DOI 10.1016/j.ygcen.2008.11.014; De Groef Bert, 2013, Front Endocrinol (Lausanne), V4, P63, DOI 10.3389/fendo.2013.00063; DeLong GR, 1989, OBSERVATIONS NEUROLO; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Iijima R, 2008, J BIOL CHEM, V283, P2255, DOI 10.1074/jbc.M709279200; Koibuchi N, 2009, CEREBELLUM, V8, P89, DOI 10.1007/s12311-008-0089-x; Konig S, 2002, CELL MOL NEUROBIOL, V22, P517, DOI 10.1023/A:1021828218454; LORENZ KONRAD Z., 1937, AUK, V54, P245; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; Mori C, 2015, J NEUROSCI, V35, P878, DOI 10.1523/JNEUROSCI.1804-14.2015; Olson JM, 1999, GEN COMP ENDOCR, V116, P204, DOI 10.1006/gcen.1999.7363; Patel J, 2011, J ENDOCRINOL, V209, P1, DOI 10.1530/JOE-10-0444; Raymaekers SR, 2016, GEN COMP ENDOCRINOLO; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Schew WA, 1996, GEN COMP ENDOCR, V101, P304, DOI 10.1006/gcen.1996.0033; Silverin B, 1996, GEN COMP ENDOCR, V103, P138, DOI 10.1006/gcen.1996.0104; Smith JW, 2002, NEUROSCI BIOBEHAV R, V26, P45, DOI 10.1016/S0149-7634(01)00037-9; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; TAGAWA M, 1987, GEN COMP ENDOCR, V68, P129, DOI 10.1016/0016-6480(87)90068-2; Thompson CK, 2016, J NEUROSCI, V36, P10356, DOI 10.1523/JNEUROSCI.4147-15.2016; Tobler M, 2009, J EXP BIOL, V212, P89, DOI 10.1242/jeb.020826; Van Herck SLJ, 2015, GEN COMP ENDOCR, V214, P30, DOI 10.1016/j.ygcen.2015.02.021; Van Herck SLJ, 2013, GEN COMP ENDOCR, V190, P96, DOI 10.1016/j.ygcen.2013.05.003; Yamaguchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2088; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x	31	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169643	10.1371/journal.pone.0169643	http://dx.doi.org/10.1371/journal.pone.0169643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060907	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500122
J	Hamilton, SL; Logan, CA; Fennie, HW; Sogard, SM; Barry, JP; Makukhov, AD; Tobosa, LR; Boyer, K; Lovera, CF; Bernardi, G				Hamilton, Scott L.; Logan, Cheryl A.; Fennie, Hamilton W.; Sogard, Susan M.; Barry, James P.; Makukhov, April D.; Tobosa, Lauren R.; Boyer, Kirsten; Lovera, Christopher F.; Bernardi, Giacomo			Species-Specific Responses of Juvenile Rockfish to Elevated pCO(2): From Behavior to Genomics	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; OCEAN ACIDIFICATION; CLIMATE-CHANGE; GENE-EXPRESSION; FISH; ACCLIMATION; IMPACTS; CARBON; LARVAE; PERFORMANCE	In the California Current ecosystem, global climate change is predicted to trigger large-scale changes in ocean chemistry within this century. Ocean acidification which occurs when increased levels of atmospheric CO2 dissolve into the ocean is one of the biggest potential threats to marine life. In a coastal upwelling system, we compared the effects of chronic exposure to low pH (elevated pCO(2)) at four treatment levels (i.e., pCO(2) = ambient [500], moderate [750], high [1900], and extreme [2800 mu atm]) on behavior, physiology, and patterns of gene expression in white muscle tissue of juvenile rockfish (genus Sebastes), integrating responses from the transcriptome to the whole organism level. Experiments were conducted simultaneously on two closely related species that both inhabit kelp forests, yet differ in early life history traits, to compare qhigh-CO2 tolerance among species. Our findings indicate that these congeners express different sensitivities to elevated CO2 levels. Copper rockfish (S. caurinus) exhibited changes in behavioral lateralization, reduced critical swimming speed, depressed aerobic scope, changes in metabolic enzyme activity, and increases in the expression of transcription factors and regulatory genes at high pCO(2) exposure. Blue rockfish (S. mystinus), in contrast, showed no significant changes in behavior, swimming physiology, or aerobic capacity, but did exhibit significant changes in the expression of muscle structural genes as a function of pCO(2), indicating acclimatization potential. The capacity of long-lived, late to mature, commercially important fish to acclimatize and adapt to changing ocean chemistry over the next 50-100 years is likely dependent on species-specific physiological tolerances.	[Hamilton, Scott L.; Fennie, Hamilton W.] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Logan, Cheryl A.; Makukhov, April D.; Tobosa, Lauren R.; Boyer, Kirsten] Calif State Univ Monterey Bay, Seaside, CA USA; [Sogard, Susan M.] Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA; [Barry, James P.; Lovera, Christopher F.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Moss Landing Marine Laboratories; California State University System; California State University Monterey Bay; National Oceanic Atmospheric Admin (NOAA) - USA; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz	Hamilton, SL (corresponding author), Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA.	shamilton@mlml.calstate.edu	Bernardi, Giacomo/F-6346-2011; Logan, Cheryl/AAU-3609-2021	Bernardi, Giacomo/0000-0002-8249-4678; Logan, Cheryl/0000-0001-7639-4956	NOAA [NA100AR4170060]; California Sea Grant [R/CC-07]; National Science Foundation [EF-1416919, EF-1416895]; San Jose State University; CSU Council for Ocean Affairs, Science, and Technology (COAST); CSU Program for Education and Research in Biotechnology (CSUPERB); Faculty Incentive Grant from CSU Monterey Bay; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; Emerging Frontiers [1416919] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant; National Science Foundation(National Science Foundation (NSF)); San Jose State University; CSU Council for Ocean Affairs, Science, and Technology (COAST); CSU Program for Education and Research in Biotechnology (CSUPERB); Faculty Incentive Grant from CSU Monterey Bay; NIH S10 Instrumentation Grants; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NOAA (NA100AR4170060) and California Sea Grant (R/CC-07), the National Science Foundation (EF-1416919 to S.L.H. and EF-1416895 to C.A.L.), San Jose State University, the CSU Council for Ocean Affairs, Science, and Technology (COAST), CSU Program for Education and Research in Biotechnology (CSUPERB), and a Faculty Incentive Grant to C.A.L. from CSU Monterey Bay. Support for laboratory experiments was provided by the Monterey Bay Aquarium Research Institute. We used the Vincent J. Coates Genomics Sequencing Laboratory at U.C. Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bignami S, 2013, GLOBAL CHANGE BIOL, V19, P996, DOI 10.1111/gcb.12133; Brett JR, 1958, INVESTIGATION FISH P; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Collins GM, 2013, CONSERV PHYSIOL, V1, DOI [10.1093/conphys/cot023, 10.1093/conphys/cot029]; Couturier CS, 2013, COMP BIOCHEM PHYS A, V166, P482, DOI 10.1016/j.cbpa.2013.07.025; DePasquale E, 2015, MAR ECOL PROG SER, V523, P145, DOI 10.3354/meps11142; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Esbaugh AJ, 2012, J COMP PHYSIOL B, V182, P921, DOI 10.1007/s00360-012-0668-5; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frieder C. A., 2012, BIOGEOSCI DISCUSS, V9, P4; Friederich GE, 2002, PROG OCEANOGR, V54, P185, DOI 10.1016/S0079-6611(02)00049-6; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gattuso, 2010, GUIDE BEST PRACTICES, P263; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamilton TJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2509; Heuer RM, 2014, AM J PHYSL REG; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Huth TJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2454-3; Jutfelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065825; Kashef NS, 2014, MAR ECOL PROG SER, V500, P231, DOI 10.3354/meps10669; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lefevre S, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow009; LENARZ WH, 1991, CAL COOP OCEAN FISH, V32, P41; Lewis E., 1998, ORNLCDIAC105 US DEP; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love M. S., 2002, ROCKFISHES NE PACIFI; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Michaelidis B, 2007, MAR BIOL, V150, P1417, DOI 10.1007/s00227-006-0436-8; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Plaut I, 2011, COMP BIOCH PHYS A, V131, P41; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabine Christopher L., 2004, SCIENCE, V305, P371; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Vagner M, 2008, MAR BIOL, V155, P183, DOI 10.1007/s00227-008-1016-x; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982	52	38	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169670	10.1371/journal.pone.0169670	http://dx.doi.org/10.1371/journal.pone.0169670			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056071	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100068
J	Villanueva-Garcia, C; Gordillo-Chavez, EJ; Lopez-Escamilla, E; Rendon-Franco, E; Munoz-Garcia, CI; Gama, L; Martinez-Flores, WA; Gonzalez-Rodriguez, N; Romero-Valdovinos, M; Diaz-Lopez, H; Galian, J; Villalobos, G; Maravilla, P; Martinez-Hernandez, F				Villanueva-Garcia, Claudia; Jose Gordillo-Chavez, Elias; Lopez-Escamilla, Eduardo; Rendon-Franco, Emilio; Irais Munoz-Garcia, Claudia; Gama, Lilia; Arony Martinez-Flores, Williams; Gonzalez-Rodriguez, Nayeli; Romero-Valdovinos, Mirza; Diaz-Lopez, Hilda; Galian, Jose; Villalobos, Guiehdani; Maravilla, Pablo; Martinez-Hernandez, Fernando			Clarifying the Cryptic Host Specificity of Blastocystis spp. Isolates from Alouatta palliata and A. pigra Howler Monkeys	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR CHARACTERIZATION; GEOGRAPHICAL-DISTRIBUTION; DIVERSITY; INFECTION; SUBTYPES; PCR; METAPOPULATION; AEQUATORIALIS; PARASITES	Although the presence of cryptic host specificity has been documented in Blastocystis, differences in infection rates and high genetic polymorphism within and between populations of some subtypes (ST) have impeded the clarification of the generalist or specialist specificity of this parasite. We assessed the genetic variability and host specificity of Blastocystis spp. in wild howler monkeys from two rainforest areas in the southeastern region of Mexico. Fecal samples of 225 Alouatta palliata (59) and A. pigra (166) monkeys, belonging to 16 sylvatic sites, were analyzed for infection with Blastocystis ST using a region of the small subunit rDNA (SSUrDNA) gene as a marker. Phylogenetic and genetic diversity analyses were performed according to the geographic areas where the monkeys were found. Blastocystis ST2 was the most abundant (91.9%), followed by ST1 and ST8 with 4.6% and 3.5%, respectively; no association between Blastocystis ST and Alouatta species was observed. SSUrDNA sequences in GenBank from human and non-human primates (NHP) were used as ST references and included in population analyses. The haplotype network trees exhibited different distributions: ST1 showed a generalist profile since several haplotypes from different animals were homogeneously distributed with few mutational changes. For ST2, a major dispersion center grouped the Mexican samples, and high mutational differences were observed between NHP. Furthermore, nucleotide and haplotype diversity values, as well as migration and genetic differentiation indexes, showed contrasting values for ST1 and ST2. These data suggest that ST1 populations are only minimally differentiated, while ST2 populations in humans are highly differentiated from those of NHP. The host generalist and specialist specificities exhibited by ST1 and ST2 Blastocystis populations indicate distinct adaptation processes. Because ST1 exhibits a generalist profile, this haplotype can be considered a metapopulation; in contrast, ST2 exists as a set of local populations with preferences for either humans or NHP.	[Villanueva-Garcia, Claudia; Galian, Jose] Univ Murcia, Fac Vet, Dept Zool & Antropol Fis, Murcia, Spain; [Villanueva-Garcia, Claudia; Jose Gordillo-Chavez, Elias; Gama, Lilia; Diaz-Lopez, Hilda] Univ Juarez Autonoma Tabasco, Ctr Invest Conservac & Aprovechamiento Recursos T, Dept Ecol Paisaje & Cambio Global, Villahermosa, Tabasco, Mexico; [Lopez-Escamilla, Eduardo; Arony Martinez-Flores, Williams; Romero-Valdovinos, Mirza; Maravilla, Pablo; Martinez-Hernandez, Fernando] Hosp Gen Dr Manuel Gea Gonzalez, Secretaria Salud, Mexico City, DF, Mexico; [Rendon-Franco, Emilio; Irais Munoz-Garcia, Claudia] Univ Autonoma Metropolitana, Unidad Xochimilco, Dept Prod Agr & Anim, Mexico City, DF, Mexico; [Gonzalez-Rodriguez, Nayeli] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Villalobos, Guiehdani] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico	University of Murcia; Universidad Juarez Autonoma de Tabasco; Universidad Autonoma Metropolitana - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Maravilla, P; Martinez-Hernandez, F (corresponding author), Hosp Gen Dr Manuel Gea Gonzalez, Secretaria Salud, Mexico City, DF, Mexico.	maravillap@yahoo.com; fherxyz@yahoo.com	Martinez, Arony/AAA-3855-2021; Gordillo-Chávez, Elías J/AAN-4948-2020	Martinez, Arony/0000-0002-9240-8905; Gordillo-Chávez, Elías J/0000-0003-3011-9590; Gonzalez-Rodriguez, Nayeli/0000-0001-7636-6998; Diaz Lopez, Hilda Maria/0000-0002-7754-9072; Munoz-Garcia, Claudia I./0000-0002-6679-016X; Maravilla, Pablo/0000-0003-2534-9447; VILLANUEVA, CLAUDIA/0000-0001-5026-2947; Gama, Lilia/0000-0002-5417-9697	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [182089, 168619]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was sponsored by Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant numbers 182089 and 168619.	Abe N, 2004, VET PARASITOL, V120, P235, DOI 10.1016/j.vetpar.2004.01.003; Alfellani MA, 2013, PARASITOLOGY, V140, P966, DOI 10.1017/S0031182013000255; Amato Katherine R., 2010, Neotropical Primates, V17, P59; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chambouvet A, 2015, P NATL ACAD SCI USA, V112, pE4743, DOI 10.1073/pnas.1500163112; Cortes-Ortiz L, 2010, CONSERV GENET RESOUR, V2, P21, DOI 10.1007/s12686-009-9124-6; Crockett CM, 1998, INT J PRIMATOL, V19, P549, DOI 10.1023/A:1020316607284; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gama L., 2013, DIV AC CIENC BIOL; GLANDER KE, 1978, FOLIA PRIMATOL, V29, P206, DOI 10.1159/000155840; Gonzalez-Hernandez M, 2014, INT J PRIMATOL, V35, P445, DOI 10.1007/s10764-014-9751-y; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Helenbrook WD, 2015, PARASITOL RES, V114, P2517, DOI 10.1007/s00436-015-4451-x; Helenbrook WD, 2015, J PARASITOL, V101, P341, DOI 10.1645/13-356.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INEGI, 2010, RED HIDR 30 GRIJ US; Kankare M, 2005, ANN ENTOMOL SOC AM, V98, P382, DOI 10.1603/0013-8746(2005)098[0382:GDAHCS]2.0.CO;2; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Maddison W.P., MESQUITE MODULAR SYS; Maddison WP, 2016, CHROMASEQ MESQUITE P; Moe KT, 1996, PARASITOL RES, V82, P439, DOI 10.1007/s004360050142; Oropeza- Hernandez P, 2011, PROGRAMA ACCION CONS; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roulin AC, 2015, EVOLUTION, V69, P2747, DOI 10.1111/evo.12770; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sallis ESV, 2003, J VET DIAGN INVEST, V15, P574, DOI 10.1177/104063870301500611; Sanchez-Aguillon F, 2013, J INFECT DEV COUNTR, V7, P763, DOI 10.3855/jidc.3512; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Scanlan PD, 2015, APPL ENVIRON MICROB, V81, P4071, DOI 10.1128/AEM.00520-15; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Scanlan PD, 2013, TRENDS PARASITOL, V29, P523, DOI 10.1016/j.pt.2013.08.006; Serio-Silva JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P267; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2016, PARASITOL INT S, P30154; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KS, 2008, CLIN MICROBIOL REV, V21, P639, DOI [10.1128/CMR.00022-08, DOI 10.1128/CMR.00022-08]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomasini N, 2004, PLOS ONE, V9; Vargas-Sanchez GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124006; Villalobos G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0461-2; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Westram AM, 2011, INFECT GENET EVOL, V11, P1083, DOI 10.1016/j.meegid.2011.03.024; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yoshikawa H, 2004, MICROBIOL-SGM, V150, P1147, DOI 10.1099/mic.0.26899-0; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169637	10.1371/journal.pone.0169637	http://dx.doi.org/10.1371/journal.pone.0169637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056072	Green Submitted, gold, Green Published			2022-12-26	WOS:000391639100065
J	Xie, GC; Li, W; Li, RD; Wu, K; Zhao, ED; Zhang, Y; Zhang, P; Shia, L; Wang, D; Yin, YP; Deng, R; Tao, KX				Xie, Gengchen; Li, Wei; Li, Ruidong; Wu, Ke; Zhao, Ende; Zhang, Yu; Zhang, Peng; Shia, Liang; Wang, Di; Yin, Yuping; Deng, Rui; Tao, Kaixiong			Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer Cells	PLOS ONE			English	Article							PROGRAMMED DEATH-1 LIGAND-1; CLINICAL-SIGNIFICANCE; EPITHELIAL-CELLS; CARCINOMA PATIENTS; PROGNOSTIC-FACTORS; COLORECTAL-CANCER; OVER-EXPRESSION; MIR-570 BINDING; UP-REGULATION; IN-VITRO	The most common cause of gastric cancer is infection with helicobacter pylori (HP), but the associated molecular mechanism is not well understood. In the present study, we found a marked increase in the expression of B7-H1, a member of the B7 co-stimulatory family of molecules that bind to programmed death-1 (PD-1) and play a critical immunoregulatory role in the cell-mediated immune response, in HP-positive gastric cancer tissue. Infection of cultured gastric cancer cells with HP promoted B7-H1 expression and inhibited miR-152 and miR-200b expression. We further demonstrated that these two miRNAs targeted B7-H1 mRNA and suppressed B7-H1 expression in gastric cancer cells. Finally, B7-H1 expression was found to correlate with miR-152 and miR-200b levels in gastric tumor tissues from human patients. Our findings suggest a novel mechanism by which HP infection promotes gastric cancer and also suggest potential targets, i.e., miR-152 and miR-200b, for the prevention and treatment of gastric cancer.	[Xie, Gengchen; Li, Wei; Li, Ruidong; Wu, Ke; Zhao, Ende; Zhang, Peng; Wang, Di; Yin, Yuping; Deng, Rui; Tao, Kaixiong] Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Yu] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Shia, Liang] Huazhong Univ Sci & Technol, Dept Clin Lab, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tao, KX (corresponding author), Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	kaixiongtao@hust.edu.cn	Zhao, Ende/B-9851-2013	Zhao, Ende/0000-0002-1355-6919	National Natural Science Foundation of China [81172294, 81572413, 81402357]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/): No. 81172294, KT, Role in conceptualization, investigation, resources, writing review & editing, visualization, supervision, project administration and funding acquisition; No. 81572413, KT, Role in conceptualization, investigation, resources, writing review & editing, visualization, supervision, project administration and funding acquisition; No. 81402357, EZ, Role in methodology and software.	Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Chen J, 2012, CANCER IMMUNOL IMMUN, V61, P101, DOI 10.1007/s00262-011-1094-3; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen XL, 2003, WORLD J GASTROENTERO, V9, P1370, DOI 10.3748/wjg.v9.i6.1370; Das S, 2006, J IMMUNOL, V176, P3000, DOI 10.4049/jimmunol.176.5.3000; Ding HL, 2005, CLIN IMMUNOL, V115, P184, DOI 10.1016/j.clim.2005.01.005; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Ferrone S, 2007, SURG ONCOL CLIN N AM, V16, P755, DOI 10.1016/j.soc.2007.08.004; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee S.-K., 2007, IEEE INT S ELECTROMA, V1, P1, DOI DOI 10.1002/MED.20079; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Wei, 2011, Chin J Cancer, V30, P540, DOI 10.5732/cjc.011.10197; Lina TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121841; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Parsonnet J, 1997, CANCER RES, V57, P3620; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shimada M, 2008, EUR J GASTROEN HEPAT, V20, P1144, DOI 10.1097/MEG.0b013e32830edb15; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang WP, 2013, HUM GENET, V132, P641, DOI 10.1007/s00439-013-1275-6; Wang WP, 2012, HUM MUTAT, V33, P480, DOI 10.1002/humu.22014; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Wu YY, 2010, CLIN EXP IMMUNOL, V161, P551, DOI 10.1111/j.1365-2249.2010.04217.x; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhu C, 2013, PROSTATE, V73, P1082, DOI 10.1002/pros.22656; Zhu JJ, 2014, HUM IMMUNOL, V75, P348, DOI 10.1016/j.humimm.2014.01.006	42	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168822	10.1371/journal.pone.0168822	http://dx.doi.org/10.1371/journal.pone.0168822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056089	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100013
J	Agarwal, E; Robb, CM; Smith, LM; Brattain, MG; Wang, J; Black, JD; Chowdhury, S				Agarwal, E.; Robb, C. M.; Smith, L. M.; Brattain, M. G.; Wang, J.; Black, J. D.; Chowdhury, S.			Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis	ONCOGENE			English	Article							HUMAN COLON-CARCINOMA; GROWTH-FACTOR-BETA; BREAST-CANCER; TUMOR-SUPPRESSOR; CELL-MIGRATION; UP-REGULATION; KINASE-B; ACTIN POLYMERIZATION; BLADDER-CANCER; MIM	Survival signaling is critical for the metastatic program of cancer cells. The current study investigated the role of Akt survival proteins in colorectal cancer (CRC) metastasis and explored potential mechanisms of Akt-mediated metastasis regulation. Using an orthotopic implantation model in mice, which uniquely recapitulates the entire multistep process of CRC metastasis, combined with an inducible system of short hairpin RNA-mediated Akt isoform knockdown in human CRC cells, our studies confirm a role of Akt2 in CRC cell dissemination to distant organs in vivo. Akt2 deficiency profoundly inhibited the development of liver lesions in mice, whereas Akt1 had no effect under the experimental conditions used in the study. Array analysis of human metastatic genes identified the scaffolding protein metastasis suppressor 1 (MTSS1) as a novel Akt2-regulated gene. Inducible loss of Akt2 in CRC cells robustly upregulated MTSS1 at the messenger RNA and protein level, and the accumulated protein was functionally active as shown by its ability to engage an MTSS1-Src-cortactin inhibitory axis. MTSS1 expression led to a marked reduction in levels of functional cortacin (pcortactin Y421), an actin nucleation-promoting factor that has a crucial role in cancer cell invasion and metastasis. MTSS1 was also shown to mediate suppressive effects of Akt2 deficiency on CRC cell viability, survival, migration and actin polymerization in vitro. The relevance of these findings to human CRC is supported by analysis of The Cancer Genome Atlas (TCGA) and NCBI GEO data sets, which demonstrated inverse changes in expression of Akt2 and MTSS1 during CRC progression. Taken together, the data identify MTSS1 as a new Akt2-regulated gene, and point to suppression of MTSS1 as a key step in the metastasis-promoting effects of Akt2 in CRC cells.	[Agarwal, E.; Robb, C. M.; Brattain, M. G.; Wang, J.; Black, J. D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Agarwal, E.; Brattain, M. G.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Smith, L. M.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Chowdhury, S.] Boston Univ, Med Ctr, Dept Med, Sect Gastroenterol, EBRC Room 525,650 Albany St, Boston, MA 02118 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Boston University	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.; Chowdhury, S (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Gastroenterol, EBRC Room 525,650 Albany St, Boston, MA 02118 USA.	jennifer.black@unmc.edu; sanjib@bu.edu		Agarwal, Ekta/0000-0002-5992-3358	NIH R01 [CA038173, CA054807, DK60632]; UNMC Cancer Center [CA036727]; NATIONAL CANCER INSTITUTE [R01CA054807, R21CA191894, R37CA038173, R01CA038173, P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNMC Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 grants CA038173 and CA054807 to MGB, by DK60632 to JDB and by UNMC Cancer Center Support Grant CA036727. We thank Katie Bailey for assistance with animal surgeries; Dr Adrian Black for critical reading of the manuscript and many helpful discussions, as well as analysis of Oncomine data; Drs Babu Guda and Xiao Peng (Bioinformatics and Systems Biology Core, UNMC) for help with The Cancer Genome Atlas database, and the Confocal Imaging and Histology Cores at UNMC for assistance with tissue processing and microscopy.	Agarwal E, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-145; Agarwal E, 2013, CELL SIGNAL, V25, P1711, DOI 10.1016/j.cellsig.2013.03.025; Arboleda MJ, 2003, CANCER RES, V63, P196; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chau NM, 2004, BREAST CANCER RES, V6, P55, DOI 10.1186/bcr739; Chaudhary F, 2014, BIOCHEM J, V465, P89; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Du P, 2013, J EXP THER ONCOL, V10, P91; Du P, 2011, ANTICANCER RES, V31, P3205; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fan H, 2012, ONCOGENE, V31, P2298, DOI 10.1038/onc.2011.411; Furbert-Harris PM, 2003, CELL MOL BIOL, V49, P1009; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jin KT, 2012, ONCOL LETT, V3, P11, DOI 10.3892/ol.2011.432; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Li J, 2016, TUMOR BIOL, V37, P8765, DOI 10.1007/s13277-015-4396-9; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Loberg RD, 2005, INT J ONCOL, V26, P1699; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049067; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Mertz KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4465; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; National Cancer Institute, 2010, SEER STAT FACT SHEET; Navenot JM, 2009, MOL PHARMACOL, V75, P1074, DOI 10.1124/mol.108.054270; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schemionek M, 2016, LEUKEMIA, V30, P823, DOI 10.1038/leu.2015.329; Schemionek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125783; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Wang DZ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/471020; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; Wang Y, 2007, CANCER INVEST, V25, P79, DOI 10.1080/07357900701205457; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Williams B, 2014, MELANOMA RES, V24, P404, DOI 10.1097/CMR.0000000000000077; WOLMARK N, 1983, CANCER, V51, P1315, DOI 10.1002/1097-0142(19830401)51:7<1315::AID-CNCR2820510723>3.0.CO;2-0; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Wu WY, 2014, MOL CELL BIOCHEM, V388, P249, DOI 10.1007/s11010-013-1916-z; Xie F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-95; Xu M, 2012, CELL MOL LIFE SCI, V69, P3601, DOI 10.1007/s00018-012-1129-8; Ye SC, 1999, CANCER RES, V59, P4725; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhou L, 2016, PATHOL ONCOL RES, V22, P7, DOI 10.1007/s12253-015-9963-2; Zhou WW, 2012, ACTA BIOCH BIOPH SIN, V44, P838, DOI 10.1093/abbs/gms071	73	30	31	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3104	3118		10.1038/onc.2016.460	http://dx.doi.org/10.1038/onc.2016.460			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	28068324	Green Accepted			2022-12-26	WOS:000402617900004
J	Fujishima, Y; Maeda, N; Matsuda, K; Masuda, S; Mori, T; Fukuda, S; Sekimoto, R; Yamaoka, M; Obata, Y; Kita, S; Nishizawa, H; Funahashi, T; Ranscht, B; Shimomura, I				Fujishima, Yuya; Maeda, Norikazu; Matsuda, Keisuke; Masuda, Shigeki; Mori, Takuya; Fukuda, Shiro; Sekimoto, Ryohei; Yamaoka, Masaya; Obata, Yoshinari; Kita, Shunbun; Nishizawa, Hitoshi; Funahashi, Tohru; Ranscht, Barbara; Shimomura, Iichiro			Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis	FASEB JOURNAL			English	Article							ADIPOSE-SPECIFIC PROTEIN; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULE; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; EXPRESSION; PLASMA; ACTIVATION; GROWTH; CDH13	Adiponectin, an adipocyte-derived protein abundant in the circulation, is thought to be protective against atherosclerosis. However, it is not fully understood how the association of adiponectin with vascular cells and its antiatherogenic effect are connected. In this study, T-cadherin was essential for accumulation of adiponectin in the neointima and atherosclerotic plaque lesions, and the adiponectin-T-cadherin association protected against vascular injury. In the apolipoprotein E-knockout (ApoE-KO) mice, adiponectin and T-cadherin colocalized on endothelial cells and synthetic smooth muscle cells in the aortic intima. Notably, aortic adiponectin protein disappeared in T-cadherin/ApoE double-knockout (Tcad/ApoE-DKO) mice with significant elevation of blood adiponectin concentration. Furthermore, in Tcad/ApoE-DKO mice, carotid artery ligation resulted in a significant increase of neointimal thickness compared with ApoE-KO mice. Finally, on a high-cholesterol diet, Tcad/ApoE-DKO mice increased atherosclerotic plaque formation, despite a 5-fold increase in plasma adiponectin level compared with that in ApoE-KO mice. In vitro, knockdown of T-cadherin from human aortic smooth muscle cells (HASMCs) with synthetic phenotype significantly reduced adiponectin accumulation on HASMCs and negated the inhibitory effect of adiponectin on proinflammatory change. Collective evidence showed that adiponectin accumulates in the vasculature via T-cadherin, and the adiponectin-T-cadherin association plays a protective role against neointimal and atherosclerotic plaque formations.-Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., Nishizawa, H., Funahashi, T., Ranscht, B., Shimomura, I. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis.	[Fujishima, Yuya; Maeda, Norikazu; Matsuda, Keisuke; Masuda, Shigeki; Mori, Takuya; Fukuda, Shiro; Sekimoto, Ryohei; Yamaoka, Masaya; Obata, Yoshinari; Kita, Shunbun; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan; [Maeda, Norikazu; Kita, Shunbun; Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Osaka, Japan; [Ranscht, Barbara] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	Osaka University; Osaka University; Sanford Burnham Prebys Medical Discovery Institute	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp		Fukuda, Shiro/0000-0002-0065-662X	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K09801]; JSPS KAKENHI [JP15H04853, JP26293221]; Takeda Science Foundation; Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd; Kowa Life Science Foundation; MSD Life Science Foundation; Suzuken Memorial Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd(Novo Nordisk); Kowa Life Science Foundation; MSD Life Science Foundation; Suzuken Memorial Foundation	The authors thank the Center of Medical Research and Education (Osaka University) for exceptional technical support; Futoshi Nakagami (Osaka University) for providing an excellent procedure for carotid artery ligation; and all members of the IIIrd Laboratory (Adiposcience Laboratory; Osaka University) for helpful discussions during the project. This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP16K09801 (to N.M.), JSPS KAKENHI Grant JP15H04853 (to I.S.), JSPS KAKENHI Grant JP26293221 (to T.F.), Takeda Science Foundation (to N.M.), Japan Foundation for Applied Enzymology (to Y.F.), Junior Scientist Development Grant supported by Novo Nordisk Pharma Ltd. (to Y.F.), Kowa Life Science Foundation (to Y.F.), MSD Life Science Foundation (to Y.F.), and Suzuken Memorial Foundation (to Y.F.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Cattaruzza M, 2002, J BIOL CHEM, V277, P6582, DOI 10.1074/jbc.M108283200; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Mori T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04895; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076199; Mukai Y, 2006, J CLIN INVEST, V116, P334, DOI 10.1172/JCI26223; Nakagami F, 2010, ATHEROSCLEROSIS, V211, P41, DOI 10.1016/j.atherosclerosis.2010.01.016; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova MP, 1998, FEBS LETT, V429, P207, DOI 10.1016/S0014-5793(98)00598-5; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Raines E.W., 2000, ANN NY ACAD SCI, V902, P51; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; Wang YJ, 2014, CIRC RES, V114, P792, DOI 10.1161/CIRCRESAHA.114.302439; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	57	60	67	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1571	1583		10.1096/fj.201601064R	http://dx.doi.org/10.1096/fj.201601064R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28062540				2022-12-26	WOS:000398504300024
J	Tessmer, MH; Anderson, DM; Buchaklian, A; Frank, DW; Feix, JB				Tessmer, Maxx H.; Anderson, David M.; Buchaklian, Adam; Frank, Dara W.; Feix, Jimmy B.			Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A(2) (PLA(2)) Enzyme, ExoU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); phospholipase; protein structure; Pseudomonas aeruginosa (P; aeruginosa); ubiquitin	AERUGINOSA CYTOTOXIN EXOU; III PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; EXOENZYME S; C2 DOMAIN; SPIN; DYNAMICS; IDENTIFICATION	The ExoU type III secretion enzyme is a potent phospholipase A(2) secreted by the Gram-negative opportunistic pathogen, Pseudomonas aeruginosa. Activation of phospholipase activity is induced by protein-protein interactions with ubiquitin in the cytosol of a targeted eukaryotic cell, leading to destruction of host cell membranes. Previous work in our laboratory suggested that conformational changes within a C-terminal domain of the toxin might be involved in the activation mechanism. In this study, we use site-directed spin-labeling electron paramagnetic resonance spectroscopy to investigate conformational changes in a C-terminal four-helical bundle region of ExoU as it interacts with lipid substrates and ubiquitin, and to examine the localization of this domain with respect to the lipid bilayer. In the absence of ubiquitin or substrate liposomes, the overall structure of the C-terminal domain is in good agreement with crystallographic models derived from ExoU in complex with its chaperone, SpcU. Significant conformational changes are observed throughout the domain in the presence of ubiquitin and liposomes combined that are not observed with either liposomes or ubiquitin alone. In the presence of ubiquitin, two interhelical loops of the C-terminal four-helix bundle appear to penetrate the membrane bilayer, stabilizing ExoU-membrane association. Thus, ubiquitin and the substrate lipid bilayer act synergistically to induce a conformational rearrangement in the C-terminal domain of ExoU.	[Tessmer, Maxx H.; Anderson, David M.; Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Tessmer, Maxx H.; Anderson, David M.; Frank, Dara W.; Feix, Jimmy B.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Buchaklian, Adam; Feix, Jimmy B.] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Feix, Jimmy B.] Med Coll Wisconsin, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Anderson, David M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Vanderbilt University	Feix, JB (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Feix, JB (corresponding author), Med Coll Wisconsin, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jfeix@mcw.edu			National Institutes of Health [GM114234, AI104922]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM114234 (to J. B. F.) and AI104922 (to D. W. F). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Anderson DM, 2015, J BACTERIOL, V197, P529, DOI 10.1128/JB.02402-14; Anderson DM, 2013, J BIOL CHEM, V288, P26741, DOI 10.1074/jbc.M113.478529; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Benson MA, 2011, BIOPHYS J, V100, P1335, DOI 10.1016/j.bpj.2011.01.056; Benson MA, 2010, CLIN CHIM ACTA, V411, P190, DOI 10.1016/j.cca.2009.10.025; Bucher D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003156; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Ellena JF, 2004, BIOPHYS J, V87, P3221, DOI 10.1529/biophysj.104.046748; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Klug CS, 1997, BIOCHEMISTRY-US, V36, P13027, DOI 10.1021/bi971232m; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rabin SDP, 2006, INFECT IMMUN, V74, P2552, DOI 10.1128/IAI.74.5.2552-2561.2006; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato H, 2005, J BACTERIOL, V187, P1192, DOI 10.1128/JB.187.3.1192-1195.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tamura M, 2004, BIOCHEM BIOPH RES CO, V316, P323, DOI 10.1016/j.bbrc.2004.02.050; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Victor KG, 2001, BIOPHYS J, V81, P2241, DOI 10.1016/S0006-3495(01)75871-7; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200	51	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3411	3419		10.1074/jbc.M116.760074	http://dx.doi.org/10.1074/jbc.M116.760074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069812	Green Published, hybrid			2022-12-26	WOS:000395538800030
J	Chitty, JL; Tatzenko, TL; Williams, SJ; Koh, YQAE; Corfield, EC; Butler, MS; Robertson, AAB; Cooper, MA; Kappler, U; Kobe, B; Fraser, JA				Chitty, Jessica L.; Tatzenko, Tayla L.; Williams, Simon J.; Koh, Y. Q. Andre E.; Corfield, Elizabeth C.; Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.			GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; XANTHOSINE 5-PHOSPHATE; CEREBROSPINAL-FLUID; BIOSYNTHESIS; SYNTHETASE; PURINE; AIDS; PHARMACOLOGY; INHIBITORS; HIV	Over the last four decades the HIV pandemic and advances in medical treatments that also cause immunosuppression have produced an ever-growing cohort of individuals susceptible to opportunistic pathogens. Of these, AIDS patients are particularly vulnerable to infection by the encapsulated yeast Cryptococcus neoformans. Most commonly found in the environment in purine-rich bird guano, C. neoformans experiences a drastic change in nutrient availability during host infection, ultimately disseminating to colonize the purine-poor central nervous system. Investigating the consequences of this challenge, we have characterized C. neoformans GMP synthase, the second enzyme in the guanylate branch of de novo purine biosynthesis. We show that in the absence of GMP synthase, C. neoformans becomes a guanine auxotroph, the production of key virulence factors is compromised, and the ability to infect nematodes and mice is abolished. Activity assays performed using recombinant protein unveiled differences in substrate binding between the C. neoformans and human enzymes, with structural insights into these kinetic differences acquired via homology modeling. Collectively, these data highlight the potential of GMP synthase to be exploited in the development of new therapeutic agents for the treatment of disseminated, life-threatening fungal infections.	[Chitty, Jessica L.; Tatzenko, Tayla L.; Williams, Simon J.; Koh, Y. Q. Andre E.; Corfield, Elizabeth C.; Cooper, Matthew A.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Chitty, Jessica L.; Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.; Fraser, James A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Kappler, Ulrike] Univ Queensland, Ctr Met Biol, St Lucia, Qld 4072, Australia; [Williams, Simon J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia	University of Queensland; University of Queensland; University of Queensland; Australian National University	Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.	jafraser@uq.edu.au	Robertson, Avril/A-4043-2012; Corfield, Elizabeth C/M-7086-2017; Cooper, Matthew A./C-7988-2009; Fraser, James A/B-4918-2012; Butler, Mark S./D-9973-2011; Chitty, Jessica/U-6619-2019; Williams, Simon/F-7447-2011; Kappler, Ulrike/A-9483-2013; Kobe, Bostjan/D-1292-2009	Robertson, Avril/0000-0002-9652-8357; Corfield, Elizabeth C/0000-0002-0119-157X; Cooper, Matthew A./0000-0003-3147-3460; Fraser, James A/0000-0001-5724-5285; Butler, Mark S./0000-0001-6689-4236; Chitty, Jessica/0000-0003-1776-1618; Williams, Simon/0000-0003-4781-6261; Kappler, Ulrike/0000-0002-2642-1319; Kobe, Bostjan/0000-0001-9413-9166; Tatzenko, Tayla/0000-0002-3525-4356	National Health and Medical Research Council [APP1049716]; Queensland Medical Research Scholarship; National Health and Medical Research Council Principle Research Fellowships [1003325, 1110971]; National Health and Medical Research Council Principle Research Fellowship [GNT1059354]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Medical Research Scholarship; National Health and Medical Research Council Principle Research Fellowships; National Health and Medical Research Council Principle Research Fellowship	This work was supported by National Health and Medical Research Council Grant APP1049716 (to J. A. F. and M. S. B.), a Queensland Medical Research Scholarship (to J. C.), National Health and Medical Research Council Principle Research Fellowships 1003325 and 1110971 (to B. K.), and National Health and Medical Research Council Principle Research Fellowship GNT1059354 (to M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JL, 2006, PROTEIN J, V25, P483, DOI 10.1007/s10930-006-9032-5; ABRAMS R, 1955, ARCH BIOCHEM BIOPHYS, V56, P184, DOI 10.1016/0003-9861(55)90347-7; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; [Anonymous], 1982, Morbidity and Mortality Weekly Report, V31, P507; Ballut L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9930; Bhat JY, 2008, BIOCHEM J, V409, P263, DOI 10.1042/BJ20070996; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Blundell RD, 2016, ACS INFECT DIS, V2, P651, DOI 10.1021/acsinfecdis.6b00121; BRENNER S, 1974, GENETICS, V77, P71; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P507; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P465; Cervantes-Madrid D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690492; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; COGGIN JH, 1965, J BACTERIOL, V89, P1348, DOI 10.1128/JB.89.5.1348-1353.1965; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; DUJARDIN G, 1994, GENE, V139, P127, DOI 10.1016/0378-1119(94)90535-5; EELLS JT, 1983, NEUROCHEM RES, V8, P1451; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; ELION GB, 1985, ADV ENZYME REGUL, V24, P323, DOI 10.1016/0065-2571(85)90084-6; Franco TMA, 2012, ARCH BIOCHEM BIOPHYS, V517, P1, DOI 10.1016/j.abb.2011.11.013; Franklin MC, 2015, PROTEINS, V83, P2124, DOI 10.1002/prot.24841; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; FUKUYAMA TT, 1966, J BIOL CHEM, V241, P4745; GARDNER WJE, 1979, CAN J MICROBIOL, V25, P380, DOI 10.1139/m79-059; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HITCHINGS GH, 1948, FED PROC, V7, P160; HYMES KB, 1981, LANCET, V2, P598; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jiang LH, 2010, FEMS YEAST RES, V10, P199, DOI 10.1111/j.1567-1364.2009.00600.x; Jongwutiwes U, 2008, JPN J INFECT DIS, V61, P111; Kuracka L, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/759808; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; LEE BH, 1974, BIOCHEM BIOPH RES CO, V60, P918, DOI 10.1016/0006-291X(74)90402-1; Li M, 2012, BRAZ J INFECT DIS, V16, P175, DOI 10.1016/S1413-8670(12)70301-X; Maruoka S, 2010, J MOL BIOL, V395, P417, DOI 10.1016/j.jmb.2009.10.053; MARX JL, 1984, SCIENCE, V224, P475, DOI 10.1126/science.6324344; Mendelsohn LG, 1996, INVEST NEW DRUG, V14, P287, DOI 10.1007/BF00194532; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; NAKAMURA J, 1995, J BIOL CHEM, V270, P7347, DOI 10.1074/jbc.270.13.7347; Oliver JC, 2014, ARCH BIOCHEM BIOPHYS, V545, P22, DOI 10.1016/j.abb.2014.01.004; Oliver JC, 2013, BIOCHEMISTRY-US, V52, P5225, DOI 10.1021/bi3017075; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; RAHMAN A, 1985, INVEST NEW DRUG, V3, P369; RIESENBERG DE, 1985, JAMA-J AM MED ASSOC, V254, P2521, DOI 10.1001/jama.254.18.2521; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts B D, 1994, J Insur Med, V26, P13; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; RODRIGUEZNUNEZ A, 1993, ACTA PAEDIATR, V82, P849, DOI 10.1111/j.1651-2227.1993.tb12577.x; SAKAMOTO N, 1972, J BIOL CHEM, V247, P5880; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SKIPPER HE, 1954, CANCER RES, V14, P294; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; SWEENEY MJ, 1972, CANCER RES, V32, P1803; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; VONDERSAAL W, 1985, BIOCHEMISTRY-US, V24, P5343, DOI 10.1021/bi00341a011; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Welin M, 2013, J MOL BIOL, V425, P4323, DOI 10.1016/j.jmb.2013.06.032; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; World Health Organization, 2016, GLOB HLTH OBS GHO DA; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; YARCHOAN R, 1986, LANCET, V1, P575; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	73	14	14	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3049	3059		10.1074/jbc.M116.767533	http://dx.doi.org/10.1074/jbc.M116.767533			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062578	hybrid, Green Published			2022-12-26	WOS:000395535100043
J	Chaudhry, WN; Concepcion-Acevedo, J; Park, T; Andleeb, S; Bull, JJ; Levin, BR				Chaudhry, Waqes Nasir; Concepcion-Acevedo, Jeniffer; Park, Taehyun; Andleeb, Saadia; Bull, James J.; Levin, Bruce R.			Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms	PLOS ONE			English	Article							DNA GYRASE; BACTERIAL BIOFILMS; RESISTANCE; DENSITY; ECOLOGY	In contrast to planktonic cells, bacteria imbedded biofilms are notoriously refractory to treatment by antibiotics or bacteriophage (phage) used alone. Given that the mechanisms of killing differ profoundly between drugs and phages, an obvious question is whether killing is improved by combining antibiotic and phage therapy. However, this question has only recently begun to be explored. Here, in vitro biofilm populations of Pseudomonas aeruginosa PA14 were treated singly and with combinations of two phages and bactericidal antibiotics of five classes. By themselves, phages and drugs commonly had only modest effects in killing the bacteria. However some phage-drug combinations reduced bacterial densities to well below that of the best single treatment; in some cases, bacterial densities were reduced even below the level expected if both agents killed independently of each other (synergy). Furthermore, there was a profound order effect in some cases: treatment with phages before drugs achieved maximum killing. Combined treatment was particularly effective in killing in Pseudomonas biofilms grown on layers of cultured epithelial cells. Phages were also capable of limiting the extent to which minority populations of bacteria resistant to the treating antibiotic ascend. The potential of combined antibiotic and phage treatment of biofilm infections is discussed as a realistic way to evaluate and establish the use of bacteriophage for the treatment of humans.	[Chaudhry, Waqes Nasir; Andleeb, Saadia] Natl Univ Sci & Technol, Islamabad, Pakistan; [Chaudhry, Waqes Nasir; Concepcion-Acevedo, Jeniffer; Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Park, Taehyun] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Bull, James J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	National University of Sciences & Technology - Pakistan; Emory University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Levin, BR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	blevin@emory.edu		Levin, Bruce R./0000-0003-3600-2780	National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, College of Science at the Georgia Insitute of Technology	National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, College of Science at the Georgia Insitute of Technology	National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, College of Science at the Georgia Insitute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, DOI 10.2217/FMB.10.125]; Abedon ST, 2015, PHARMACEUTICALS-BASE, V8, P525, DOI 10.3390/ph8030525; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; ALONSO JC, 1981, J VIROL, V39, P855, DOI 10.1128/JVI.39.3.855-860.1981; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Baeder DY, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0294; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Bu┬deker, 1992, ARCH COMPLEX ENV STU, V4, P65; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; Chaudhry WN, 2016, EXP THER MED, V11, P1031, DOI 10.3892/etm.2016.2996; Clarke T, 2003, NATURE, V425, P225, DOI 10.1038/425225a; CLINICAL and Laboratory Standards Institute (CLSI), 2013, METH DIL ANT SUSC TE; CONSTANTINOU A, 1986, J VIROL, V57, P875, DOI 10.1128/JVI.57.3.875-882.1986; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Danis-Wlodarczyk K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28115; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Escobar-Paramo P, 2012, EVOL APPL, V5, P583, DOI 10.1111/j.1752-4571.2012.00248.x; Essoh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130548; EUCAST, 2013, EUR COM ANT SUSC TES; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Giamarellou H, 2002, J ANTIMICROB CHEMOTH, V49, P229, DOI 10.1093/jac/49.2.229; Gonzalez MR, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00111-15; Gupta SK, 2011, INDIAN J PHARMACOL, V43, P371, DOI 10.4103/0253-7613.83103; HAAS CE, 1990, ANTIMICROB AGENTS CH, V34, P1637, DOI 10.1128/AAC.34.9.1637; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAMATAKE RK, 1981, P NATL ACAD SCI-BIOL, V78, P1532, DOI 10.1073/pnas.78.3.1532; Hancock REW, 2007, NAT REV DRUG DISCOV, V6, P28, DOI 10.1038/nrd2223; Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9; Harper DR, 2014, ANTIBIOTICS-BASEL, V3, P270, DOI 10.3390/antibiotics3030270; Kirby AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051017; Knezevic P, 2013, RES MICROBIOL, V164, P55, DOI 10.1016/j.resmic.2012.08.008; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; McGann P, 2016, ANTIMICROBIAL AGENTS; Migiyama Y, 2015, JAPANESE J INFECT DI; Payne RJH, 2001, J THEOR BIOL, V208, P37, DOI 10.1006/jtbi.2000.2198; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Torres-Barcelo C, 2016, TRENDS MICROBIOL, V24, P249, DOI 10.1016/j.tim.2015.12.011; Torres-Barcelo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106628; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001	46	170	176	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0168615	10.1371/journal.pone.0168615	http://dx.doi.org/10.1371/journal.pone.0168615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076361	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100015
J	Cuttone, A; Baekgaard, P; Sekara, V; Jonsson, H; Larsen, JE; Lehmann, S				Cuttone, Andrea; Baekgaard, Per; Sekara, Vedran; Jonsson, Hakan; Larsen, Jakob Eg; Lehmann, Sune			SensibleSleep: A Bayesian Model for Learning Sleep Patterns from Smartphone Events	PLOS ONE			English	Article								We propose a Bayesian model for extracting sleep patterns from smartphone events. Our method is able to identify individuals' daily sleep periods and their evolution over time, and provides an estimation of the probability of sleep and wake transitions. The model is fitted to more than 400 participants from two different datasets, and we verify the results against ground truth from dedicated armband sleep trackers. We show that the model is able to produce reliable sleep estimates with an accuracy of 0.89, both at the individual and at the collective level. Moreover the Bayesian model is able to quantify uncertainty and encode prior knowledge about sleep patterns. Compared with existing smartphone-based systems, our method requires only screen on/off events, and is therefore much less intrusive in terms of privacy and more battery-efficient.	[Cuttone, Andrea; Baekgaard, Per; Sekara, Vedran; Larsen, Jakob Eg; Lehmann, Sune] Tech Univ Denmark, DTU Compute, Lyngby, Denmark; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Sekara, Vedran; Jonsson, Hakan] Sony Mobile, Nya Vattentornet, Lund, Sweden	Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Cuttone, A (corresponding author), Tech Univ Denmark, DTU Compute, Lyngby, Denmark.	ancu@dtu.dk		Larsen, Jakob Eg/0000-0002-7461-9901; Sekara, Vedran/0000-0003-4490-3757; Lehmann, Sune/0000-0001-6099-2345; Baekgaard, Per/0000-0002-6720-1128	High Resolution Networks project (The Villum Foundation); Social Fabric (University of Copenhagen); Innovation Fund Denmark through the project Eye Tracking for Mobile Devices; Sony Mobile; Villum Fonden [00007192] Funding Source: researchfish	High Resolution Networks project (The Villum Foundation); Social Fabric (University of Copenhagen); Innovation Fund Denmark through the project Eye Tracking for Mobile Devices; Sony Mobile; Villum Fonden(Villum Fonden)	AC is funded in part by the High Resolution Networks project (The Villum Foundation), as well as Social Fabric (University of Copenhagen). PB is supported in part by the Innovation Fund Denmark through the project Eye Tracking for Mobile Devices. Sony Mobile provided support in the form of salaries for authors VS and HJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdullah S, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P673, DOI 10.1145/2632048.2632100; [Anonymous], 2014, TECMARK SURVEY FINDS; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; BankOfAmerica, 2015, TRENDS CONS MOB REP; Berg A, 2004, J BUS ECON STAT, V22, P107, DOI 10.1198/073500103288619430; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Chen ZY, 2013, INT CONF PER COMP, P145, DOI 10.4108/icst.pervasivehealth.2013.252148; Choe EK, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3053; Fonnesbeck CJ, 2015, PYMC VERSION 3; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gu WX, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P649, DOI 10.1145/2632048.2632084; Hao T., 2013, P C EMB NETW SENS SY, P1, DOI DOI 10.1145/2517351.2517359; Hossain HMS, 2015, IEEE INT CONF MOB DA, P44, DOI 10.1109/MDM.2015.42; Kasthuri Jayarajah, 2015, ADJ P 2015 ACM INT J, P753, DOI DOI 10.1145/2800835.2804393; Newport F., 2015, MOST US SMARTPHONE O; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Orzech KM, 2016, COMPUT HUM BEHAV, V55, P43, DOI 10.1016/j.chb.2015.08.049; Patil A, 2010, J STAT SOFTW, V35, P1; RICHTER CP, 1960, P NATL ACAD SCI USA, V46, P1506, DOI 10.1073/pnas.46.11.1506; Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273; Sekara V., 2015, ARXIV150604704; Yanzhi Ren, 2015, 2015 IEEE Conference on Computer Communications (INFOCOM). Proceedings, P1194, DOI 10.1109/INFOCOM.2015.7218494; Zhang M, 2015, ED INFORM TECHNOLOGI, P1; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816	26	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169901	10.1371/journal.pone.0169901	http://dx.doi.org/10.1371/journal.pone.0169901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076375	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100065
J	Perrigault, M; Tran, D				Perrigault, Mickael; Tran, Damien			Identification of the Molecular Clockwork of the Oyster Crassostrea gigas	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; CIRCADIAN CLOCK; CRYPTOCHROME/PHOTOLYASE FAMILY; TRANSCRIPTION REGULATION; ACTIVITY RHYTHMS; DNA PHOTOLYASE; CLASSIC RACE; E-BOXES; TIMELESS; PERIOD	Molecular clock system constitutes the origin of biological rhythms that allow organisms to anticipate cyclic environmental changes and adapt their behavior and physiology. Components of the molecular clock are largely conserved across a broad range of species but appreciable diversity in clock structure and function is also present especially in invertebrates. The present work aimed at identify and characterize molecular clockwork components in relationship with the monitoring of valve activity behavior in the oyster Crassostrea gigas. Results provided the characterization of most of canonical clock gene including clock, bmal/cycle, period, timeless, vertebrate-type cry, rev-erb, ror as well as other members of the cryptochrome/photolyase family (plant-like cry, 6-4 photolyase). Analyses of transcriptional variations of clock candidates in oysters exposed to light / dark regime and to constant darkness led to the generation of a putative and original clockwork model in C. gigas, intermediate of described systems in vertebrates and insects. This study is the first characterization of a mollusk clockwork. It constitutes essential bases to understand interactions of the different components of the molecular clock in C. gigas as well as the global mechanisms associated to the generation and the synchronization of biological rhythms in oysters.	[Perrigault, Mickael; Tran, Damien] Univ Bordeaux, EPOC, UMR 5805, Arcachon, France; [Perrigault, Mickael; Tran, Damien] CNRS, EPOC, UMR 5805, Arcachon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Perrigault, M (corresponding author), Univ Bordeaux, EPOC, UMR 5805, Arcachon, France.; Perrigault, M (corresponding author), CNRS, EPOC, UMR 5805, Arcachon, France.	mickael.perrigault@u-bordeaux.fr	Tran, Damien/AAU-8147-2020; Perrigault, Mickael/P-2887-2017	Perrigault, Mickael/0000-0002-7271-100X	project ACCUTOX ANR [ANR-13-CESA-0019]; project OSQUAR, Region Aquitaine	project ACCUTOX ANR(French National Research Agency (ANR)); project OSQUAR, Region Aquitaine	This work was funded through the projects ACCUTOX ANR (ANR-13-CESA-0019) and OSQUAR, Region Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bozek K, 2007, GENOME INFORM SER, V18, P65; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chang DC, 2003, J BIOL CHEM, V278, P38149, DOI 10.1074/jbc.M306937200; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Connor KM, 2011, P NATL ACAD SCI USA, V108, P16110, DOI 10.1073/pnas.1111076108; Constance CM, 2002, J BIOL RHYTHM, V17, P413, DOI 10.1177/074873002237136; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ellis I, 2011, INVERTEBR BIOL, V130, P236, DOI 10.1111/j.1744-7410.2011.00235.x; Emerson KJ, 2008, EVOLUTION, V62, P979, DOI 10.1111/j.1558-5646.2008.00324.x; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Ernest Naylor, 2010, CHRONOBIOLOGY OF MAR; Gouthiere L, 2005, PATHOL BIOL, V53, P285, DOI 10.1016/j.patbio.2004.12.025; Gouthiere L, 2005, BIOL RHYTHM RES, V36, P177, DOI 10.1080/09291010400026298; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Iwai S, 2006, J INSECT PHYSIOL, V52, P625, DOI 10.1016/j.jinsphys.2006.03.001; Kaneko M, 2006, P NATL ACAD SCI USA, V103, P14614, DOI 10.1073/pnas.0606563103; Kim WS, 2003, MAR BIOL, V142, P305, DOI 10.1007/s00227-002-0952-0; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mat AM, 2016, CHRONOBIOL INT, V33, P949, DOI 10.1080/07420528.2016.1181645; Mat AM, 2014, MAR BIOL, V161, P89, DOI 10.1007/s00227-013-2317-2; Mat AM, 2012, CHRONOBIOL INT, V29, P857, DOI 10.3109/07420528.2012.699126; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oliveri P, 2014, MAR GENOM, V14, P23, DOI 10.1016/j.margen.2014.02.001; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Tauber E, 2004, J BIOL RHYTHM, V19, P445, DOI 10.1177/0748730404268775; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Tran D, 2003, ENVIRON TOXICOL CHEM, V22, P914, DOI [10.1897/1551-5028(2003)022&lt;0914:EOPALO&gt;2.0.CO;2, 10.1002/etc.5620220432]; Tran D, 2015, AQUAT TOXICOL, V158, P41, DOI 10.1016/j.aquatox.2014.10.023; Tran D, 2011, CHRONOBIOL INT, V28, P307, DOI 10.3109/07420528.2011.565897; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zantke J, 2013, CELL REP, V5, P99, DOI 10.1016/j.celrep.2013.08.031; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang L, 2013, CURR BIOL, V23, P1863, DOI 10.1016/j.cub.2013.08.038; Zhao X, 2016, CIRCADIAN AMPLITUDE; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030; Zuther P, 2009, CHRONOS FIT 1 06	57	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169790	10.1371/journal.pone.0169790	http://dx.doi.org/10.1371/journal.pone.0169790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072861	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200048
J	Bartkowska, K; Swiatek, I; Aniszewska, A; Jurewicz, E; Turlejski, K; Filipek, A; Djavadian, RL				Bartkowska, Katarzyna; Swiatek, Izabela; Aniszewska, Agata; Jurewicz, Ewelina; Turlejski, Kris; Filipek, Anna; Djavadian, Rouzanna L.			Stress-Dependent Changes in the CacyBP/SIP Interacting Protein S100A6 in the Mouse Brain	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; AMYOTROPHIC-LATERAL-SCLEROSIS; CALCIUM-BINDING PROTEIN; ALZHEIMERS-DISEASE; HEAD ACCELERATION; RAT HYPOTHALAMUS; ARCUATE NUCLEUS; NERVOUS-SYSTEM; GLIAL-CELLS; SPINAL-CORD	The CacyBP/SIP target S100A6 is widely present in the nervous system, and its up-regulation is associated with certain neurodegenerative diseases. Here, we examined the involvement of S100A6 protein in stress responses in mice. Using Western blotting, we observed a marked change in brainstem structures, whereby stressed mice showed approximately one-third the protein level produced in the control group. A decreased level of S100A6 protein in stressed animals was also detected in the olfactory bulb and the cerebellum and stress-related structures such as the hippocampus and the hypothalamus. Additionally, using immunohistochemistry, high levels of S100A6 expression were observed in astrocytes localized in the border zones of all brain ventricles, tanycytes of the ventro-lateral walls of the hypothalamus, including the arcuate nucleus (ARH) and low levels of this protein were in neurons of the olfactory bulb, the hippocampus, the thalamus, the cerebral cortex, the brainstem and the cerebellum. Although S100A6-expressing cells in all these brain structures did not change their phenotype in response to stress, the intensity of immunofluorescent labeling in all studied structures was lower in stressed mice than in control animals. For example, in the ARH, where extremely strong immunostaining was observed, the number of immunolabeled fibers was decreased by approximately half in the stressed group compared with the controls. Although these results are descriptive and do not give clue about functional role of S100A6 in stress, they indicate that the level of S100A6 decreases in several brain structures in response to chronic mild stress, suggesting that this protein may modify stress responses.	[Bartkowska, Katarzyna; Aniszewska, Agata; Jurewicz, Ewelina; Filipek, Anna; Djavadian, Rouzanna L.] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Swiatek, Izabela; Turlejski, Kris] Cardinal Stefan Wyszynski Univ, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Cardinal Stefan Wyszynski University in Warsaw	Filipek, A; Djavadian, RL (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland.	a.filipek@nencki.nencki.gov.pl; r.djavadian@nencki.gov.pl	Jurewicz, Ewelina/ABG-6633-2021	Filipek, Anna/0000-0001-9484-9555; Krzysztof, Turlejski/0000-0001-6708-7815; Djavadian, Ruzanna/0000-0002-0416-0234; Jurewicz, Ewelina/0000-0003-2739-0662; Bartkowska, Katarzyna/0000-0002-4276-3204	National Science Centre Poland [2011/03/B/NZ1/00595]; Nencki Institute of Experimental Biology Polish Academy of Sciences	National Science Centre Poland(National Science Centre, Poland); Nencki Institute of Experimental Biology Polish Academy of Sciences	This work was supported by grant 2011/03/B/NZ1/00595 from the National Science Centre Poland to AF and by statutory funds from Nencki Institute of Experimental Biology Polish Academy of Sciences.	Baver SB, 2014, J NEUROSCI, V34, P5486, DOI 10.1523/JNEUROSCI.4861-12.2014; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Crane JW, 2005, STRESS, V8, P199, DOI 10.1080/10253890500333817; Crow JP, 1997, J NEUROCHEM, V69, P1936; CUNNINGHAM ET, 1990, J COMP NEUROL, V292, P651, DOI 10.1002/cne.902920413; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; FILIPEK A, 1993, NEUROREPORT, V4, P383, DOI 10.1097/00001756-199304000-00010; GAILLET S, 1991, EXP BRAIN RES, V87, P173; Gao W, 2013, NEUROSCI LETT, V533, P50, DOI 10.1016/j.neulet.2012.11.020; Henry BA, 2005, J NEUROENDOCRINOL, V17, P135, DOI 10.1111/j.1365-2826.2005.01274.x; HOSOYA Y, 1990, EXP BRAIN RES, V82, P513; Hoyaux D, 2002, J NEUROPATH EXP NEUR, V61, P736, DOI 10.1093/jnen/61.8.736; Hoyaux D, 2000, BBA-MOL CELL RES, V1498, P264, DOI 10.1016/S0167-4889(00)00101-4; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lee TS, 2007, MOL MED, V13, P1, DOI 10.2119/2006-00079.Lee; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Noorafshan A, 2014, ACTA NEUROBIOL EXP, V74, P44; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Pacak K, 1995, ANN NY ACAD SCI, V771, P115, DOI 10.1111/j.1749-6632.1995.tb44675.x; PALKOVITS M, 1980, BRAIN RES, V191, P161, DOI 10.1016/0006-8993(80)90320-0; Radley JJ, 2015, J COMP NEUROL, V523, P2769, DOI 10.1002/cne.23815; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022333; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Tiu SC, 2000, DEV BRAIN RES, V119, P159, DOI 10.1016/S0165-3806(99)00151-0; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; Wasik U, 2013, NEUROBIOL AGING, V34, P1380, DOI 10.1016/j.neurobiolaging.2012.11.007; Yamada J, 2012, NEUROSCIENCE, V226, P119, DOI 10.1016/j.neuroscience.2012.08.068; Yamashita N, 1999, J COMP NEUROL, V404, P235	34	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169760	10.1371/journal.pone.0169760	http://dx.doi.org/10.1371/journal.pone.0169760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068373	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900065
J	Costa, SSF; Wegmann, D; Ripperger, JA				Costa, Sara S. Fonseca; Wegmann, Daniel; Ripperger, Jurgen A.			Normalisation against Circadian and Age-Related Disturbances Enables Robust Detection of Gene Expression Changes in Liver of Aged Mice	PLOS ONE			English	Article							CASEIN KINASE 1; MESSENGER-RNA; FEEDBACK LOOP; AGING RAT; CLOCK; GENOME; BRAIN; MOUSE; TRANSCRIPTION; OSCILLATOR	The expression of some genes is affected by age. To detect such age-related changes, their expression levels are related to constant marker genes. However, transcriptional noise increasing with advancing age renders difficult the identification of real age-related changes because it may affect the marker genes as well. Here, we report a selection procedure for genes appropriate to normalise the mouse liver transcriptome under various conditions including age. These genes were chosen from an initial set of 16 candidate genes defined based on a RNA-sequencing experiment and published literature. A subset of genes was selected based on rigorous statistical assessment of their variability using both RNA-sequencing and Nanostring hybridization experiments. The robustness of these marker genes was then verified by the analysis of 130 publicly available data sets using the mouse liver transcriptome. Altogether, a set of three genes, Atp5h, Gsk3 beta, and Sirt2 fulfilled our strict selection criteria in all assessments, while four more genes, Nono, Tprkb, Tspo, and Ttr passed all but one assessment and were included into the final set of marker genes to enhance robustness of normalisation against outliers. Using the geometric mean of expression of the genes to normalise Nanostring hybridization experiments we reliably identified age-related increases in the expression of Casein kinase 1 delta and 1 epsilon, and Sfpq, while the expression of the glucose transporter Glut2 decreased. The age-related changes were verified by real-time PCR and Western blot analysis. As conclusion, proper normalisation enhances the robustness of quantitative methods addressing age-related changes of a transcriptome.	[Costa, Sara S. Fonseca; Wegmann, Daniel; Ripperger, Jurgen A.] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Wegmann, Daniel] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland	University of Fribourg; Swiss Institute of Bioinformatics; University of Lausanne	Wegmann, D; Ripperger, JA (corresponding author), Univ Fribourg, Dept Biol, Fribourg, Switzerland.; Wegmann, D (corresponding author), Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland.	daniel.wegmann@unifr.ch; juergenalexandereduard.ripperger@unifr.ch	; Wegmann, Daniel/K-2199-2012	Fonseca Costa, Sara/0000-0001-7794-7997; Wegmann, Daniel/0000-0003-2866-6739	Canton of Fribourg; Swiss National Science Foundation (SNSF) [31003A_152792]; SystemsX, the Swiss Initiative of Systems Biology [51PHP0_J57318]	Canton of Fribourg; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SystemsX, the Swiss Initiative of Systems Biology	This work was supported by the Canton of Fribourg, The Swiss National Science Foundation (SNSF) to JAR (31003A_152792), and SystemsX, the Swiss Initiative of Systems Biology to DW (51PHP0_J57318). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Christoph Leuenberger for discussion about the statistical methods used in the manuscript, Ka Yi Hui and Steven Brown for comments on the manuscript and Keith Harshman, Corinne Peter and Leonore Wigger for their expert help on the Nanostring hybridization experiment, and Steven Brown for the gift of specific antibodies. This work was supported by the Canton of Fribourg, the Swiss National Science Foundation (SNSF), and SystemsX, the Swiss Initiative for Systems Biology.	Aitchison J., HONORARY SENIOR RES; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; CARTER DB, 1975, J GERONTOL, V30, P28, DOI 10.1093/geronj/30.1.28; Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20; Costa SSF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00043; De J, 2009, BIOINFORMATICS, V25, DOI [10.1093/bioinformatics/btp073, DOI 10.1093/BIOINFORMATICS/BTP073]; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; GARTNER K, 1992, J EXP ANIM SCI, V35, P125; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Kowalska E, 2012, MOL CELL BIOL, V32, P4585, DOI 10.1128/MCB.00334-12; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Oklejewicz M, 2002, J BIOL RHYTHM, V17, P210, DOI 10.1177/07430402017003004; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; Partridge L, 1999, TRENDS ECOL EVOL, V14, P438, DOI 10.1016/S0169-5347(99)01646-8; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Simon A, 2015, BIOINFORMATICS, V31, DOI [10.1093/bioinformatics/btu638, DOI 10.1093/BIOINFORMATICS/BTU638]; SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Wang Q, 2013, PATTERN RECOGN LETT, V34, P34, DOI 10.1016/j.patrec.2012.06.002; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169615	10.1371/journal.pone.0169615	http://dx.doi.org/10.1371/journal.pone.0169615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068403	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900050
J	Li, Y; Wang, JH; Lin, F; Yang, YF; Chen, SS				Li, Yan; Wang, Jinghui; Lin, Feng; Yang, Yinfeng; Chen, Su-Shing			A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; SIGNALING PATHWAY; PROGESTERONE-RECEPTOR; ANDROGEN RECEPTOR; RHIZOMA-CURCUMAE; DRUG DISCOVERY; ESTROGEN; EXPRESSION; COMPLEMENTARY; COMPONENTS	Breast cancer is the most common carcinoma in women. Comprehensive therapy on breast cancer including surgical operation, chemotherapy, radiotherapy, endocrinotherapy, etc. could help, but still has serious side effect and resistance against anticancer drugs. Complementary and alternative medicine (CAM) may avoid these problems, in which traditional Chinese medicine (TCM) has been highlighted. In this section, to analyze the mechanism through which TCM act on breast cancer, we have built a virtual model consisting of the construction of database, oral bioavailability prediction, drug-likeness evaluation, target prediction, network construction. The 20 commonly employed herbs for the treatment of breast cancer were used as a database to carry out research. As a result, 150 ingredient compounds were screened out as active molecules for the herbs, with 33 target proteins predicted. Our analysis indicates that these herbs 1) takes a 'Jun-Chen-Zuo-Shi" as rule of prescription, 2) which function mainly through perturbing three pathways involving the epidermal growth factor receptor, estrogen receptor, and inflammatory pathways, to 3) display the breast cancer-related anti-estrogen, anti-inflammatory, regulation of cell metabolism and proliferation activities. To sum it up, by providing a novel in silico strategy for investigation of the botanical drugs, this work may be of some help for understanding the action mechanisms of herbal medicines and for discovery of new drugs from plants.	[Li, Yan; Wang, Jinghui; Chen, Su-Shing] Univ Florida, Dept Comp Informat Sci & Engn, Syst Biol Lab, Gainesville, FL 32611 USA; [Li, Yan; Wang, Jinghui; Lin, Feng; Yang, Yinfeng] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn MOE, Dalian, Liaoning, Peoples R China	State University System of Florida; University of Florida; Dalian University of Technology	Li, Y; Chen, SS (corresponding author), Univ Florida, Dept Comp Informat Sci & Engn, Syst Biol Lab, Gainesville, FL 32611 USA.; Li, Y (corresponding author), Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn MOE, Dalian, Liaoning, Peoples R China.	yanli@dlut.edu.cn; suchen@ufl.edu	Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022		Key Program of National Natural Science Foundation of China [81530100]; Oasis Scholar Fund of Shihezi University	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oasis Scholar Fund of Shihezi University	This work was supported by Key Program of National Natural Science Foundation of China (Grant No. 81530100) and the Oasis Scholar Fund of Shihezi University.; We are grateful for the Key Program of National Natural Science Foundation of China (Grant No. 81530100) and the Oasis Scholar Fund of Shihezi University.	Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Cao J, 2008, BIOMED CHROMATOGR, V22, P164, DOI 10.1002/bmc.911; Chen YF, 2012, PHARMACOL BIOCHEM BE, V102, P585, DOI 10.1016/j.pbb.2012.07.005; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Chiorean M, 2013, ACTA MED MARISIENSIS, V59, P231; Cohen I, 2002, SEMIN ONCOL; Cos S, 2006, CANCER DETECT PREV, V30, P118, DOI 10.1016/j.cdp.2006.03.002; Cui XJ, 2003, MOL ENDOCRINOL, V17, P575, DOI 10.1210/me.2002-0318; Cui Y, 2004, BREAST CANCER RES TR, V85, P263, DOI 10.1023/B:BREA.0000025422.26148.8d; De Gregori M, 2015, MINERVA ANESTESIOL, V81, P894; Dong HY, 2008, NAT PROD RES, V22, P1418, DOI 10.1080/14786410801931629; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Erhardt RAA, 2006, DRUG DISCOV TODAY, V11, P315, DOI 10.1016/j.drudis.2006.02.011; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Fryer RM, 2002, EXP NEPHROL, V10, P64; Gao JL, 2009, ONCOL REP, V22, P1077, DOI 10.3892/or_00000539; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Gu GW, 2012, J CELL PHYSIOL, V227, P3363, DOI 10.1002/jcp.24035; Handral HK, 2013, ASIAN J PHARM CLIN R, V6; Harris RE, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-27; He Y, 2012, J ETHNOPHARMACOL, V143, P851, DOI 10.1016/j.jep.2012.08.010; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Jia LB, 2012, CHIN J INTEGR MED, V18, P325, DOI 10.1007/s11655-011-0950-5; Jiang H, 2011, MOLECULES, V16, P3146, DOI 10.3390/molecules16043146; Kirkpatrick K, 2002, CURR MED RES OPIN, V18, P237, DOI 10.1185/030079902125000633; Kundu N, 2002, CANCER RES, V62, P2343; Lee HZ, 2011, AM J CHINESE MED, V39, P201, DOI 10.1142/S0192415X11008750; Lengacher Cecile A, 2002, Oncol Nurs Forum, V29, P1445, DOI 10.1188/02.ONF.1445-1452; Li J, 2002, WORLD J GASTROENTERO, V8, P493, DOI 10.3748/wjg.v8.i3.493; Li P, 2014, J ETHNOPHARMACOL, V151, P93, DOI 10.1016/j.jep.2013.07.001; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Liang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098717; Lin CC, 2011, IN VIVO, V25, P633; Lin JM, 2013, INT J ONCOL, V42, P651, DOI 10.3892/ijo.2012.1753; Lin TX, 2009, DTSCH Z AKUPUNKT, V52, P27, DOI 10.1016/J.DZA.2009.05.008; Liu H, 2013, J ETHNOPHARMACOL, V146, P773, DOI 10.1016/j.jep.2013.02.004; LIU L, 2005, HEILONGJIANG MED J, V18, P59; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Lu JJ, 2012, J ETHNOPHARMACOL, V143, P406, DOI 10.1016/j.jep.2012.07.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miquel J, 2002, ARCH GERONTOL GERIAT, V34, P37, DOI 10.1016/S0167-4943(01)00194-7; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; Nmeth K, 2003, EUR J NUTR, V1; Park CH, 2005, FEBS LETT, V579, P2965, DOI 10.1016/j.febslet.2005.04.013; Patel BB, 2009, NUTR CANCER, V61, P842, DOI 10.1080/01635580903285106; Peng W, 2011, MED CHEM RES, V20, P146, DOI 10.1007/s00044-010-9311-8; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Redeker N S, 2000, Sch Inq Nurs Pract, V14, P275; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Sessler DI, 2008, CONTEMP CLIN TRIALS, V29, P517, DOI 10.1016/j.cct.2008.01.002; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tang BH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00875; Tao W, 2013, J APPL MATH, P1, DOI [10.1155/2013/285967, DOI 10.1155/2013/285967, DOI 10.1016/J.JEP.2012.09.051]; Wang AM, 2016, PHARM BIOL, V54, P146, DOI 10.3109/13880209.2015.1024330; Wang JC, 2013, ENVIRON SCI POLLUT R, V20, P1441, DOI 10.1007/s11356-012-1048-0; Wang KT, 2010, J PHARM PHARMACOL, V62, P381, DOI 10.1211/jpp.62.03.0014; Wang XJ, 2005, INT J CANCER, V116, P799, DOI 10.1002/ijc.20880; Wei YJ, 2007, BIOMED CHROMATOGR, V21, P797, DOI 10.1002/bmc.775; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yates JS, 2005, SUPPORT CARE CANCER, V13, P806, DOI 10.1007/s00520-004-0770-7; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang AH, 2011, FITOTERAPIA, V82, P1160, DOI 10.1016/j.fitote.2011.07.014; Zhang F, 2011, MOL MED REP, V4, P1189, DOI 10.3892/mmr.2011.537; Zhou W, 2014, J ETHNOPHARMACOL, V151, P66, DOI 10.1016/j.jep.2013.11.007	76	14	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169363	10.1371/journal.pone.0169363	http://dx.doi.org/10.1371/journal.pone.0169363			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068355	Green Submitted, gold, Green Published			2022-12-26	WOS:000391843900028
J	Mwansa-Kambafwile, J; Maitshotlo, B; Black, A				Mwansa-Kambafwile, Judith; Maitshotlo, Boitumelo; Black, Andrew			Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation	PLOS ONE			English	Article							XPERT(R) MTB/RIF; PRIMARY-CARE; IMPACT; SETTINGS; AFRICA; TRIAL; TB	Background The impact of new diagnostics on pre-treatment loss to follow up (Pre-treatment LTFU) has not been widely investigated. The reported rate of pre-treatment LTFU is however lower in studies where Xpert MTB/Rif (Xpert) has been used onsite as opposed to centrally. The use of the Xpert at point of care (POC) could have a role in reducing the pre-treatment LTFU rate among TB patients. We aimed to determine the pre-treatment LTFU rate and the time to treatment initiation as well as to describe associated factors in patients diagnosed with TB using POC Xpert or smear microscopy. Method Xpert machines were installed at 7 primary healthcare facilities in inner-city Johannesburg. POC Xpert TB testing was the primary diagnostic method for all patients although there were some patients who were tested using only laboratory-based smear microscopy (during power outages or machine operator off-sick). Data on patients' demographics, TB diagnostic test (Xpert or smear microscopy), test result, and time to treatment initiation were collected. Associations and predictors of pre-treatment LTFU and time to treatment initiation were explored. Findings A total of 1981 people with presumptive TB were tested (1743 using Xpert and 238 using smear). A bacteriological diagnosis of TB was made in 271 patients (90% Xpert; 10% smear). The median time to treatment initiation in the smear group was 9 days (IQR: 4-20) while those tested using Xpert had a median time of 0 days (IQR: 0-0). Pre-treatment LTFU was 22.5% with no difference between diagnostic groups (p = 0.8). Conclusion The Pre-treatment LTFU rate of 22.5% found in this study is much higher than the 5% target of the South African National TB Control Program. POC Xpert resulted in a significantly greater proportion of bacteriologically proven TB patients being started on treatment within 30 days of presentation. No risk factors associated with pre-treatment LTFU were identified.	[Mwansa-Kambafwile, Judith; Maitshotlo, Boitumelo; Black, Andrew] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Mwansa-Kambafwile, Judith; Black, Andrew] Univ Witwatersrand, Dept Clin Med, Johannesburg, South Africa	University of Witwatersrand	Mwansa-Kambafwile, J (corresponding author), Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.; Mwansa-Kambafwile, J (corresponding author), Univ Witwatersrand, Dept Clin Med, Johannesburg, South Africa.	judy.mwansa@gmail.com			United States Agency for International Development; President's Emergency Plan for AIDS Relief [674-A-00-08-00005-00]	United States Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by United States Agency for International Development and the President's Emergency Plan for AIDS Relief (674-A-00-08-00005-00).	Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Hanrahan CF, 2015, INT J TUBERC LUNG D, V19, P811, DOI 10.5588/ijtld.15.0013; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Long R, 2003, INFECT CONT HOSP EP, V24, P831, DOI 10.1086/502145; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; NDoH (National Department of Health), 2014, NAT TUB MAN GUID; Schwartzman K, 2000, CAN MED ASSOC J, V163, P157; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Van den Handel T, 2015, INT J TUBERC LUNG D, V19, P392, DOI 10.5588/ijtld.14.0653; World Health Organisation, 2015, GLOB TB REP; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; Yimer SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-19	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0168659	10.1371/journal.pone.0168659	http://dx.doi.org/10.1371/journal.pone.0168659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068347	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900011
J	Chang, CF; Liao, KC; Chen, CH				Chang, Chi-Fen; Liao, Kang-Chun; Chen, Chung-Hwan			2-Phenylnaphthalene Derivatives Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Mediators by Downregulating of MAPK/NF-kappa B Pathways in RAW 264.7 Macrophage Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; RAW264.7 CELLS; TNF-ALPHA; LPS; EXPRESSION; MECHANISMS; ACID; SUPPRESSION; NAPHTHALENE; CYTOKINES	The anti-inflammatory pharmacological effect of eight 2-phenylnaphthalenes (PNAP-1-PNAP-8) on lipopolysaccharide (LPS)-induced RAW 264.7 (a mouse cell line) was investigated. Among them, 6,7-dihydroxy-2-(4'-hydroxyphenyl)naphthalene (PNAP-6) and 2-(4'-aminophenyl)-6,7-dimethoxynaphthalene (PNAP-8) exhibited the best anti-inflammatory activity in this study. PNAP-6 and PNAP-8 not only significantly decreased the expression of inducible nitric oxide synthase and cyclooxygenase-II, but also inhibited the production of nitric oxide, interleukin-6, and tumor necrosis factor-alpha in LPS stimulated cells. Moreover, PNAP-6 and PNAP-8 inhibited nuclear factor (NF)-kappa B activation by decreasing the degradation of I kappa B and nuclear translocation of NF-kappa B subunit (p65). In addition, PNAP-6 and PNAP-8 also attenuated the phosphorylation of ERK, p38, and JNK. These results suggest that PNAP-6 and PNAP-8 exert anti-inflammatory activities by down regulating NF-kappa B activation and the mitogen-activated protein kinase signaling pathway in LPS-stimulated Raw 264.7 cells. This is the first study demonstrating that PNAPs can inhibit LPS-induced pro-inflammatory mediators in macrophages cells.	[Chang, Chi-Fen] China Med Univ, Sch Med, Dept Anat, Taichung, Taiwan; [Liao, Kang-Chun] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Dept Orthoped, Coll Med, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chang, CF (corresponding author), China Med Univ, Sch Med, Dept Anat, Taichung, Taiwan.	cfchang@mail.cmu.edu.tw	Chen, Chung-Hwan/D-4036-2009	Chen, Chung-Hwan/0000-0001-8941-4792	China Medical University	China Medical University(China Medical University)	The authors would like to thank the China Medical University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; Arendt BK, 2002, LEUKEMIA, V16, P2142, DOI 10.1038/sj.leu.2402714; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang CF, 2012, INFLAMM RES, V61, P151, DOI 10.1007/s00011-011-0399-1; Chang CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141184; Cho EY, 2011, INT IMMUNOPHARMACOL, V11, P412, DOI 10.1016/j.intimp.2010.12.008; Cho YC, 2015, J ETHNOPHARMACOL, V162, P140, DOI 10.1016/j.jep.2014.12.056; Choi WS, 2012, CELL IMMUNOL, V280, P164, DOI 10.1016/j.cellimm.2012.12.007; Chopra P, 2008, EXPERT OPIN INV DRUG, V17, P1411, DOI 10.1517/13543784.17.10.1411 ; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Dyer KD, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-48; Fan GW, 2013, INFLAMMATION, V36, P1584, DOI 10.1007/s10753-013-9703-2; Han S, 2013, IMMUNOPHARM IMMUNOT, V35, P34, DOI 10.3109/08923973.2012.736522; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Ho FM, 2004, BRIT J PHARMACOL, V141, P1037, DOI 10.1038/sj.bjp.0705700; Honda KL, 2015, PROSTAG LEUKOTR ESS, V97, P27, DOI 10.1016/j.plefa.2015.03.002; Hsu CL, 2013, FOOD FUNCT, V4, P1216, DOI 10.1039/c3fo60041f; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Intayoung P, 2016, BIOL PHARM BULL, V39, P54, DOI 10.1248/bpb.b15-00479; Jeong YH, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1142-9; Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101; Jin SE, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1197-7; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Klintman D, 2005, ANN SURG, V242, P830, DOI 10.1097/01.sla.0000189132.86878.f7; Lee KH, 2002, EUR J MED CHEM, V37, P333, DOI 10.1016/S0223-5234(02)01354-5; Moldoveanu B, 2009, J INFLAMM RES, V2, P1; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Pan Min-Hsiung, 2011, J Tradit Complement Med, V1, P8; Peng XX, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0045-x; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Yuan F, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-84; Yuan JW, 2014, BIOORG MED CHEM LETT, V24, P2324, DOI 10.1016/j.bmcl.2014.03.072; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044107	39	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168945	10.1371/journal.pone.0168945	http://dx.doi.org/10.1371/journal.pone.0168945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060845	Green Submitted, gold, Green Published			2022-12-26	WOS:000391641500046
J	Cian, A; El Safadi, D; Osman, M; Moriniere, R; Gantois, N; Benamrouz-Vanneste, S; Delgado-Viscogliosi, P; Guyot, K; Li, LL; Monchy, S; Noel, C; Poirier, P; Nourrisson, C; Wawrzyniak, I; Delbac, F; Bosc, S; Chabe, M; Petit, T; Certad, G; Viscogliosi, E				Cian, Amandine; El Safadi, Dima; Osman, Marwan; Moriniere, Romain; Gantois, Nausicaa; Benamrouz-Vanneste, Sadia; Delgado-Viscogliosi, Pilar; Guyot, Karine; Li, Luen-Luen; Monchy, Sebastien; Noel, Christophe; Poirier, Philippe; Nourrisson, Celine; Wawrzyniak, Ivan; Delbac, Frederic; Bosc, Stephanie; Chabe, Magali; Petit, Thierry; Certad, Gabriela; Viscogliosi, Eric			Molecular Epidemiology of Blastocystis sp in Various Animal Groups from Two French Zoos and Evaluation of Potential Zoonotic Risk	PLOS ONE			English	Article							GENETIC DIVERSITY; INTESTINAL PARASITES; SUBTYPE DISTRIBUTION; NONHUMAN-PRIMATES; HUMANS; PREVALENCE; HOMINIS; IDENTIFICATION; CHIMPANZEES; INFECTION	Blastocystis sp. is a common intestinal parasite infecting humans and a wide range of animals worldwide. It exhibits an extensive genetic diversity and 17 subtypes (STs) have thus far been identified in mammalian and avian hosts. Since several STs are common to humans and animals, it was proposed that a proportion of human infections may result from zoonotic transmission. However, the contribution of each animal source to human infection remains to be clarified. Therefore, the aim of this study was to expand our knowledge of the epidemiology and host specificity of this parasite by performing the largest epidemiological survey ever conducted in animal groups in terms of numbers of species screened. A total of 307 stool samples from 161 mammalian and non-mammalian species in two French zoos were screened by real-time PCR for the presence of Blastocystis sp. Overall, 32.2% of the animal samples and 37.9% of the species tested were shown to be infected with the parasite. A total of 111 animal Blastocystis sp. isolates were subtyped, and 11 of the 17 mammalian and avian STs as well as additional STs previously identified in reptiles and insects were found with a varying prevalence according to animal groups. These data were combined with those obtained from previous surveys to evaluate the potential risk of zoonotic transmission of Blastocystis sp. through the comparison of ST distribution between human and animal hosts. This suggests that non-human primates, artiodactyls and birds may serve as reservoirs for human infection, especially in animal handlers. In contrast, other mammals such as carnivores, and non-mammalian groups including reptiles and insects, do not seem to represent significant sources of Blastocystis sp. infection in humans. In further studies, more intensive sampling and screening of potential new animal hosts will reinforce these statements and expand our understanding of the circulation of Blastocystis sp. in animal and human populations.	[Cian, Amandine; El Safadi, Dima; Osman, Marwan; Gantois, Nausicaa; Benamrouz-Vanneste, Sadia; Delgado-Viscogliosi, Pilar; Guyot, Karine; Chabe, Magali; Certad, Gabriela; Viscogliosi, Eric] Univ Lille, CHU Lille, CNRS, CIIL,Inserm,Inst Pasteur Lille,U1019,UMR 8204, Lille, France; [El Safadi, Dima; Osman, Marwan] Univ Libanaise, Fac Sante Publ, Ecole Doctorale Sci & Technol, LMSE, Tripoli, Lebanon; [Moriniere, Romain; Bosc, Stephanie] Parc Zool Lille, Lille, France; [Benamrouz-Vanneste, Sadia] Univ Catholic Lille, Fac Libre Sci & Technol Lille, Lab Ecol & Biodivers, Lille, France; [Li, Luen-Luen; Monchy, Sebastien] Univ Littoral Cote dOpale, CNRS, Lab Oceanol & Geosci, UMR 8187, Wimereux, France; [Noel, Christophe] Geneius Labs Ltd, INEX Business Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Poirier, Philippe; Nourrisson, Celine; Wawrzyniak, Ivan; Delbac, Frederic] Univ Blaise Pascal, Clermont Univ, Univ Auvergne, CNRS UMR 6023,Lab Microorganismes Genome & Enviro, Clermont Ferrand, France; [Petit, Thierry] Parc Zool Palmyre, Les Mathes, France; [Certad, Gabriela] Univ Catholic Lille, Grp Hop, Fac Med & Maieut, Inst Catholique Lille,Dept Rech Med, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Lebanese University; Universite Catholique de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite Catholique de Lille	Viscogliosi, E (corresponding author), Univ Lille, CHU Lille, CNRS, CIIL,Inserm,Inst Pasteur Lille,U1019,UMR 8204, Lille, France.	eric.viscogliosi@pasteur-lille.fr	Osman, Marwan/AAD-3784-2021; Safadi, Dima El/C-1022-2014; B, S/HGC-3038-2022; Nourrisson, Céline/AAC-1527-2019; Chabe, Magali/H-6045-2017	Osman, Marwan/0000-0002-6235-2760; Safadi, Dima El/0000-0001-6852-3682; B, S/0000-0003-1791-4389; Nourrisson, Céline/0000-0002-4003-805X; MONCHY, Sebastien/0000-0001-5808-4700; Poirier, Philippe/0000-0001-9173-2634; Chabe, Magali/0000-0002-6732-6772; wawrzyniak, ivan/0000-0002-5362-6117	Programme Orientations Strategiques from the University of Lille; Fonds Hospitalier d'Aide a l'Emergence from the CHRU of Lille; Centre National de la Recherche Scientifique; Institut Pasteur of Lille; Conseil National de la Recherche Scientifique; AZM & Saade Association; University of Lille	Programme Orientations Strategiques from the University of Lille; Fonds Hospitalier d'Aide a l'Emergence from the CHRU of Lille; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur of Lille; Conseil National de la Recherche Scientifique; AZM & Saade Association; University of Lille	This work was supported by grants from the Programme Orientations Strategiques from the University of Lille 2, the Fonds Hospitalier d'Aide a l'Emergence from the CHRU of Lille, the Centre National de la Recherche Scientifique and the Institut Pasteur of Lille. DES and MO were supported by PhD fellowships from the Conseil National de la Recherche Scientifique and the AZM & Saade Association and AC by a PhD fellowship from the University of Lille 2 and the Institut Pasteur of Lille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Geneius Laboratories Ltd. and the zoos of La Palmyre and Lille provided support in the form of salaries for authors (C. Noel, RM, SB, TP), but did not have any additional role in the study design, data collection and analysis, or decision to publish.	Abe N, 2002, VET PARASITOL, V106, P203, DOI 10.1016/S0304-4017(02)00050-X; Ajjampur SSR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160458; Ajjampur SSR, 2016, PARASITOL INT; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Alfellani MA, 2013, PARASITOLOGY, V140, P966, DOI 10.1017/S0031182013000255; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Andersen LO, 2016, J CLIN MICROBIOL, V54, P524, DOI 10.1128/JCM.02520-15; Audebert C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25255; Badparva E, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.14810; Bart A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-389; Belleza MLB, 2016, PARASITOL INT, V65, P291, DOI 10.1016/j.parint.2016.02.009; Bergamo do Bomfim T.C., 2013, J PARASITOL VECTOR B, V5, P20, DOI [10.5897/JPVB12.014, DOI 10.5897/JPVB12.014]; BOREHAM PFL, 1993, ADV PARASIT, V32, P1, DOI 10.1016/S0065-308X(08)60206-7; Chandrasekaran H, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0469-7; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; El Safadi D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1776-8; El Safadi D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-164; Eroglu F, 2010, PARASITOL RES, V107, P841, DOI 10.1007/s00436-010-1937-4; Fayer R, 2014, PARASITOL RES, V113, P1465, DOI 10.1007/s00436-014-3787-y; Fayer R, 2012, PARASITOL RES, V111, P1349, DOI 10.1007/s00436-012-2971-1; Gordo FP, 2002, VET PARASITOL, V107, P137; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Hamad I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06417; Helenbrook WD, 2015, PARASITOL RES, V114, P2517, DOI 10.1007/s00436-015-4451-x; Iguchi A, 2007, PARASITOL INT, V56, P107, DOI 10.1016/j.parint.2006.12.004; Kalousova B, 2014, INT J PRIMATOL, V35, P463, DOI 10.1007/s10764-014-9753-9; Konig G, 1997, ZBL BAKT-INT J MED M, V286, P435; Kostka M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-341; La Sala LF, 2015, REV ARGENT MICROBIOL, V47, P17, DOI 10.1016/j.ram.2014.12.006; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Lee MG, 1999, PARASITOL RES, V85, P109, DOI 10.1007/s004360050518; Leelayoova Saovanee, 2009, J Med Assoc Thai, V92 Suppl 1, pS53; Lepczynska M, 2016, INT J DERMATOL, V55, P259, DOI 10.1111/ijd.13064; Lim YAL, 2008, VET PARASITOL, V157, P154, DOI 10.1016/j.vetpar.2008.07.015; Nagel R, 2012, INTERN MED J, V42, P1187, DOI 10.1111/j.1445-5994.2011.02626.x; Navarro C, 2008, VET PARASITOL, V153, P347, DOI 10.1016/j.vetpar.2008.02.003; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Osman M, 2015, VET PARASITOL, V214, P167, DOI 10.1016/j.vetpar.2015.09.015; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Pérez-Cordón Gregorio, 2007, Rev. peru biol., V14, P301; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Roberts T, 2013, VET PARASITOL, V196, P85, DOI 10.1016/j.vetpar.2013.01.011; Ruaux CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107496; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Singh M, 1996, PARASITOL RES, V82, P165, DOI 10.1007/s004360050088; Spanakos G, 2011, J HELL VET MED SOC, V62, P216; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, PARASITOL INT; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; STENZEL DJ, 1994, PARASITOL RES, V80, P131, DOI 10.1007/BF00933780; Suresh K, 1997, PARASITOL RES, V83, P523, DOI 10.1007/s004360050292; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan TC, 2013, PARASITOL RES, V112, P85, DOI 10.1007/s00436-012-3107-3; TEOW WL, 1992, PARASITOL RES, V78, P453, DOI 10.1007/BF00931705; Valencakova A., 2014, Folia Veterinaria, V58, P175; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wang WQ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-215; Wu ZN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002885; YAMADA M, 1987, PARASITOL RES, V73, P527, DOI 10.1007/BF00535328; Yoshikawa H, 2004, TRENDS PARASITOL, V20, P251, DOI 10.1016/j.pt.2004.03.010; Yoshikawa H, 2016, PARASITOL INT; Yoshikawa H, 2012, PARASITOLOGY RES MON, P37; Yoshikawa H, 2007, J EUKARYOT MICROBIOL, V54, P33, DOI 10.1111/j.1550-7408.2006.00141.x; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; ZAMAN V, 1993, PARASITOL RES, V79, P73, DOI 10.1007/BF00931221; Zanzani SA, 2016, PARASITOL RES, V115, P307, DOI 10.1007/s00436-015-4748-9	75	103	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169659	10.1371/journal.pone.0169659	http://dx.doi.org/10.1371/journal.pone.0169659			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060901	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500123
J	Jenness, SM; Sharma, A; Goodreau, SM; Rosenberg, ES; Weiss, KM; Hoover, KW; Smith, DK; Sullivan, P				Jenness, Samuel M.; Sharma, Akshay; Goodreau, Steven M.; Rosenberg, Eli S.; Weiss, Kevin M.; Hoover, Karen W.; Smith, Dawn K.; Sullivan, Patrick			Individual HIV Risk versus Population Impact of Risk Compensation after HIV Preexposure Prophylaxis Initiation among Men Who Have Sex with Men	PLOS ONE			English	Article							UNITED-STATES; WHITE MEN; PREVENTION; ATLANTA; DISPARITIES; INFECTIONS; CHALLENGES; RESISTANCE; CONTINUUM; COHORT	Objectives Risk compensation (RC) could reduce or offset the biological prevention benefits of HIV pre-exposure prophylaxis (PrEP) among those at substantial risk of infection, including men who have sex with men (MSM). We investigated the potential extent and causal mechanisms through which RC could impact HIV transmission at the population and individual levels. Methods Using a stochastic network-based mathematical model of HIV transmission dynamics among MSM in the United States, we simulated RC as a reduction in the probability of condom use after initiating PrEP, with heterogeneity by PrEP adherence profiles and partnership type in which RC occurred. Outcomes were changes to population-level HIV incidence and individual-level acquisition risk. Results When RC was limited to MSM highly/moderately adherent to PrEP, 100% RC (full replacement of condoms) resulted in a 2% relative decline in incidence compared to no RC, but an 8% relative increase in infection risk for MSM on PrEP. This resulted from confounding by indication: RC increased the number of MSM indicated for PrEP as a function of more condomless anal intercourse among men otherwise not indicated for PrEP; this led to an increased PrEP uptake and subsequent decline in incidence. Conclusions RC is unlikely to decrease the prevention impact of PrEP, and in some cases RC may be counterintuitively beneficial at the population level. This depended on PrEP uptake scaling with behavioral indications. Due to the increased acquisition risk associated with RC, however, clinicians should continue to support PrEP as a supplement rather than replacement of condoms.	[Jenness, Samuel M.; Sharma, Akshay; Rosenberg, Eli S.; Weiss, Kevin M.; Sullivan, Patrick] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Hoover, Karen W.; Smith, Dawn K.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Sullivan, Patrick] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; Emory University	Jenness, SM (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	samuel.m.jenness@emory.edu	Weiss, Kevin/AAI-8250-2020; Goodreau, Steven/P-2366-2017	Weiss, Kevin/0000-0001-9669-8236; Sharma, Akshay/0000-0001-7864-5464; Sullivan, Patrick Sean/0000-0002-7728-0587; Jenness, Samuel/0000-0001-8840-105X	Centers for Disease Control [U38 PS004646]; National Institutes of Health [R21 HD075662]; Center for AIDS Research at Emory [P30 AI050409]; University of Washington [P30 AI027757]	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at Emory; University of Washington(University of Washington)	This work was supported by Centers for Disease Control [grant: U38 PS004646], the National Institutes of Health [R21 HD075662], the Center for AIDS Research at Emory [grant: P30 AI050409] and the University of Washington [grant: P30 AI027757]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Cambiano V, 2016, CURR OPIN HIV AIDS, V11, P56, DOI 10.1097/COH.0000000000000217; Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; de Wit JBF, 2015, SEX TRANSM INFECT, V91, pA68, DOI 10.1136/sextrans-2015-052270.183; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Food and Drug Administration, 2012, BACKGR PACK NDA S30; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hernandez-Romieu AC, 2015, SEX TRANSM DIS, V42, P505, DOI 10.1097/OLQ.0000000000000332; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jenness S, 2015, NAT HIV PREV C; Jenness SM, 2016, J INFECT DIS, V214, P1800, DOI 10.1093/infdis/jiw223; Kelley CF, 2015, CLIN INFECT DIS, V61, P1590, DOI 10.1093/cid/civ664; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Paz-Bailey G, 2016, AIDS, V30, P1985, DOI 10.1097/QAD.0000000000001139; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Punyacharoensin N, 2016, LANCET HIV, V3, pE94, DOI 10.1016/S2352-3018(15)00056-9; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Scott HM, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0089-8; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	35	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169484	10.1371/journal.pone.0169484	http://dx.doi.org/10.1371/journal.pone.0169484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060881	gold, Green Published			2022-12-26	WOS:000391641500100
J	Xiao, CF; Robertson, RM				Xiao, Chengfeng; Robertson, R. Meldrum			White - cGMP Interaction Promotes Fast Locomotor Recovery from Anoxia in Adult Drosophila	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASES; MESSENGER-RNA LEVELS; EYE COLOR MUTANTS; CYCLIC-GMP; MALPIGHIAN TUBULES; COURTSHIP BEHAVIOR; CIRCADIAN CLOCK; GENE; MELANOGASTER; LIGHT	Increasing evidence indicates that the white (w) gene in Drosophila possesses extra-retinal functions in addition to its classical role in eye pigmentation. We have previously shown that w(+) promotes fast and consistent locomotor recovery from anoxia, but how w(+) modulates locomotor recovery is largely unknown. Here we show that in the absence of w(+), several PDE mutants, especially cyclic guanosine monophosphate (cGMP)-specific PDE mutants, display wildtype-like fast locomotor recovery from anoxia, and that during the night time, locomotor recovery was light-sensitive in white-eyed mutant w1118, and light-insensitive in PDE mutants under w1118 background. Data indicate the involvement of cGMP in the modulation of recovery timing and presumably, light-evoked cGMP fluctuation is associated with light sensitivity of locomotor recovery. This was further supported by the observations that w-RNAi-induced delay of locomotor recovery was completely eliminated by upregulation of cGMP through multiple approaches, including PDE mutation, simultaneous overexpression of an atypical soluble guanylyl cyclase Gyc88E, or sildenafil feeding. Lastly, prolonged sildenafil feeding promoted fast locomotor recovery from anoxia in w1118. Taken together, these data suggest that a White-cGMP interaction modulates the timing of locomotor recovery from anoxia.	[Xiao, Chengfeng; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON, Canada	Queens University - Canada	Xiao, CF (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	xiao.c@queensu.ca	Robertson, Robert M/B-2482-2009; Xiao, Chengfeng/B-1432-2014	Robertson, Robert M/0000-0002-2666-7861; Xiao, Chengfeng/0000-0002-2301-1365	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 40930-09]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by RGPIN 40930-09 (RMR), Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; COBBS WH, 1985, NATURE, V317, P64, DOI 10.1038/317064a0; COBBS WH, 1985, NATURE, V313, P585, DOI 10.1038/313585a0; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Day JP, 2005, BIOCHEM J, V388, P333, DOI 10.1042/BJ20050057; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Evans JM, 2008, J EXP BIOL, V211, P890, DOI 10.1242/jeb.014837; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Garfinkel Mark D, 2004, Methods Mol Biol, V287, P151; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hardie RC, 2015, CURR OPIN NEUROBIOL, V34, P37, DOI 10.1016/j.conb.2015.01.008; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; Hing ALY, 1996, J NEUROBIOL, V30, P454; HOWELLS AJ, 1977, BIOCHEM GENET, V15, P1049, DOI 10.1007/BF00484496; HURWITZ RL, 1985, J BIOL CHEM, V260, P568; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Kroll JR, 2015, GENETICS, V201, P1087, DOI 10.1534/genetics.115.177600; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Morton DB, 2010, GENETICS, V186, P159, DOI 10.1534/genetics.110.118018; Morton DB, 2004, J BIOL CHEM, V279, P50651, DOI 10.1074/jbc.C400461200; Morton DB, 2002, ADV INSECT PHYSIOL, V29, P1, DOI 10.1016/S0065-2806(02)29001-3; NOLTE DJ, 1954, J GENET, V52, P111, DOI 10.1007/BF02981493; NOLTE DJ, 1950, J GENET, V50, P79, DOI 10.1007/BF02986797; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; OWEN WG, 1987, ANNU REV PHYSIOL, V49, P743, DOI 10.1146/annurev.ph.49.030187.003523; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; PIRROTTA V, 1984, EMBO J, V3, P563, DOI 10.1002/j.1460-2075.1984.tb01847.x; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shekhar S, 2010, THESIS; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SULLIVAN DT, 1980, BIOCHEM GENET, V18, P1109, DOI 10.1007/BF00484342; SULLIVAN DT, 1979, BIOCHEM GENET, V17, P565, DOI 10.1007/BF00498891; SULLIVAN DT, 1975, BIOCHEM GENET, V13, P603, DOI 10.1007/BF00484918; Vermehren-Schmaedick A, 2010, GENETICS, V186, P183, DOI 10.1534/genetics.110.118166; Xiao CF, 2016, GENETICS, V203, P787, DOI 10.1534/genetics.115.185066; Xiao CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135825; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	58	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168361	10.1371/journal.pone.0168361	http://dx.doi.org/10.1371/journal.pone.0168361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060942	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500028
J	Zhu, ZW; Tran, H; Mathahs, MM; Moninger, TO; Schmidt, WN				Zhu, Zhaowen; Tran, Huy; Mathahs, M. Meleah; Moninger, Thomas O.; Schmidt, Warren N.			HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RNA HELICASE; CORE PROTEIN; SUBCELLULAR-LOCALIZATION; HEME OXYGENASE-1; NS3 PROTEIN; BINDING; REPLICATION; DOMAIN; EXPRESSION	Introduction Telomerase repairs the telomeric ends of chromosomes and is active in nearly all malignant cells. Hepatitis C virus (HCV) is known to be oncogenic and potential interactions with the telomerase system require further study. We determined the effects of HCV infection on human telomerase reverse transcriptase (TERT) expression and enzyme activity in primary human hepatocytes and continuous cell lines. Results Primary human hepatocytes and Huh-7.5 hepatoma cells showed early de novo TERT protein expression 2-4 days after infection and these events coincided with increased TERT promoter activation, TERT mRNA, and telomerase activity. Immunoprecipitation studies demonstrated that NS3-4A protease-helicase, in contrast to core or NS5A, specifically bound to the C-terminal region of TERT through interactions between helicase domain 2 and protease sequences. Increased telomerase activity was noted when NS3-4A was transfected into cells, when added to reconstituted mixtures of TERT and telomerase RNA, and when incubated with high molecular weight telomerase `holoenzyme' complexes. The NS3-4A catalytic effect on telomerase was inhibited with primuline or danoprevir, agents that are known to inhibit NS3 helicase and protease activities respectively. In HCV infected cells, NS3-4A could be specifically recovered with telomerase holoenzyme complexes in contrast to NS5A or core protein. HCV infection also activated the effector caspase 7 which is known to target TERT. Activation coincided with the appearance of lower molecular weight car boxy-terminal fragment(s) of TERT, chiefly sized at 45 kD, which could be inhibited with pancaspase or caspase 7 inhibitors. Conclusions HCV infection induces TERT expression and stimulates telomerase activity in addition to triggering Caspase activity that leads to increased TERT degradation. These activities suggest multiple points whereby the virus can influence neoplasia. The NS3-4A protease-helicase can directly bind to TERT, increase telomerase activity, and thus potentially influence telomere repair and host cell neoplastic behavior.	[Zhu, Zhaowen; Mathahs, M. Meleah; Schmidt, Warren N.] Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; [Zhu, Zhaowen; Mathahs, M. Meleah; Schmidt, Warren N.] Vet Affairs Med Ctr, Res Serv, Iowa City, IA 52242 USA; [Zhu, Zhaowen; Tran, Huy; Schmidt, Warren N.] Univ Iowa Iowa City, Dept Internal Med, Roy G & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa Iowa City, Cent Microscopy Res Facil, Roy G & Lucille A Carver Coll Med, Iowa City, IA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Schmidt, WN (corresponding author), Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA.; Schmidt, WN (corresponding author), Vet Affairs Med Ctr, Res Serv, Iowa City, IA 52242 USA.; Schmidt, WN (corresponding author), Univ Iowa Iowa City, Dept Internal Med, Roy G & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	warren-schmidt@uiowa.edu		Assouline Dayan, Yehudith/0000-0002-2851-6629; Tran, Huy/0000-0001-5383-3143; schmidt, Warren/0000-0003-2893-6014	Veterans Affairs, Merit Review [2101BX000159-05]; Doriann Foundation for Hepatitis Research, University of Iowa; Veterans Affairs [I01BX000159] Funding Source: NIH RePORTER	Veterans Affairs, Merit Review(US Department of Veterans Affairs); Doriann Foundation for Hepatitis Research, University of Iowa; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs, Merit Review, 2101BX000159-05; and Doriann Foundation for Hepatitis Research, University of Iowa.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Abdalla MY, 2004, J INFECT DIS, V190, P1109, DOI 10.1086/423488; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Basu A, 2002, VIROLOGY, V298, P53, DOI 10.1006/viro.2002.1460; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Blackburn EH, 2011, COLD SPRING HARBOR P, V3; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brunori M, 2005, J MOL MED, V83, P244, DOI 10.1007/s00109-004-0616-2; Chatel-Chaix L, 2011, J VIROL, V85, P11022, DOI 10.1128/JVI.00719-11; Chiodi I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00133; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Errington W, 1999, J MED VIROL, V59, P456, DOI 10.1002/(SICI)1096-9071(199912)59:4<456::AID-JMV6>3.0.CO;2-0; Fassio E, 2010, ANN HEPATOL, V9, pS119, DOI 10.1016/S1665-2681(19)31736-3; Feng DY, 2002, CHINESE MED J-PEKING, V115, P597; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Fuller-Pace FV, 2013, RNA BIOL, V10, P121, DOI 10.4161/rna.23312; Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Iwai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020718; Kotoula V, 2002, LIVER, V22, P57, DOI 10.1046/j.0106-9543.2001.01594.x; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lee JH, 2014, HISTOCHEM CELL BIOL, V141, P137, DOI 10.1007/s00418-013-1166-x; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Ray RB, 2001, FEMS MICROBIOL LETT, V202, P149, DOI 10.1111/j.1574-6968.2001.tb10796.x; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Schmidt WN, 2014, CLIN GASTROENTEROL H, V12, P728, DOI 10.1016/j.cgh.2013.06.024; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Soares J, 2011, BIOCHEMISTRY-US, V50, P9046, DOI 10.1021/bi2010398; Steimer L, 2012, RNA BIOL, V9, P751, DOI 10.4161/rna.20090; TAHARA H, 1995, CANCER RES, V55, P2734; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Ulaner GA, 1998, CANCER RES, V58, P4168; Vaughan R, 2012, VIRUS RES, V169, P80, DOI 10.1016/j.virusres.2012.07.007; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Yoo HH, 2011, AGING CELL, V10, P557, DOI 10.1111/j.1474-9726.2011.00696.x; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491; Zhu ZW, 2013, J INFECT DIS, V208, P1653, DOI 10.1093/infdis/jit338; Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921; Zhu ZW, 2010, J MED VIROL, V82, P239, DOI 10.1002/jmv.21644	68	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0166853	10.1371/journal.pone.0166853	http://dx.doi.org/10.1371/journal.pone.0166853			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056029	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100001
J	Ben Yehuda, A; Risheq, M; Novoplansky, O; Bersuker, K; Kopito, RR; Goldberg, M; Brandeis, M				Ben Yehuda, Adi; Risheq, Marwa; Novoplansky, Ofra; Bersuker, Kirill; Kopito, Ron R.; Goldberg, Michel; Brandeis, Michael			Ubiquitin Accumulation on Disease Associated Protein Aggregates Is Correlated with Nuclear Ubiquitin Depletion, Histone De-Ubiquitination and Impaired DNA Damage Response	PLOS ONE			English	Article							INCLUSION-BODY FORMATION; DOUBLE-STRAND BREAKS; HUNTINGTONS-DISEASE; GENE-EXPRESSION; DEPENDENT MONOUBIQUITYLATION; NEUROLOGICAL PHENOTYPE; MUTANT HUNTINGTIN; PROTEASOME SYSTEM; REPAIR PROTEINS; NEURONAL DEATH	Deposition of ubiquitin conjugates on inclusion bodies composed of protein aggregates is a definitive cytopathological hallmark of neurodegenerative diseases. We show that accumulation of ubiquitin on polyQ IB, associated with Huntington's disease, is correlated with extensive depletion of nuclear ubiquitin and histone de-ubiquitination. Histone ubiquitination plays major roles in chromatin regulation and DNA repair. Accordingly, we observe that cells expressing IB fail to respond to radiomimetic DNA damage, to induce gamma-H2AX phosphorylation and to recruit 53BP1 to damaged foci. Interestingly ubiquitin depletion, histone de-ubiquitination and impaired DNA damage response are not restricted to PolyQ aggregates and are associated with artificial aggregating luciferase mutants. The longevity of brain neurons depends on their capacity to respond to and repair extensive ongoing DNA damage. Impaired DNA damage response, even modest one, could thus lead to premature neuron aging and mortality.	[Ben Yehuda, Adi; Risheq, Marwa; Novoplansky, Ofra; Goldberg, Michel; Brandeis, Michael] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem Safra Campus, Jerusalem, Israel; [Bersuker, Kirill; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA USA	Hebrew University of Jerusalem; Stanford University	Brandeis, M (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem Safra Campus, Jerusalem, Israel.	michael.brandies@mail.huji.ac.il	Novoplansky, Ofra/GRO-2474-2022	Novoplansky, Ofra/0000-0002-1239-7856; Goldberg, Michal/0000-0001-9397-2383	Zalman Cohen intermural grant from the Hebrew University of Jerusalem; Israeli Ministry of Health; Israeli Science Foundation (ISF) [1759/14]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Zalman Cohen intermural grant from the Hebrew University of Jerusalem; Israeli Ministry of Health; Israeli Science Foundation (ISF)(Israel Science Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded by a Zalman Cohen intermural grant from the Hebrew University of Jerusalem, by a grant from the Israeli Ministry of Health and by a grant from the Israeli Science Foundation (ISF 1759/14).; We would like to thank Mark Hipp, F. Ulrich Hartl and Rajat Gupta for plasmids and many fruitful discussions. To William Breuer for help with the FACS analysis. Naomi Book for help with confocal microscopy and to Tommer Ravid, Yuval Reiss, Drora Zenwirth, Moshe Oren and Efrat Shema for helpful comments. This project was funded by a Zalman Cohen intermural grant from the Hebrew University of Jerusalem, by a grant from the Israeli Ministry of Health and by a grant from the Israeli Science Foundation (ISF 1759/14).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bersuker K, 2016, J CELL BIOL, V213, P229, DOI 10.1083/jcb.201511024; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Ferlazzo ML, 2014, MOL NEUROBIOL, V49, P1200, DOI 10.1007/s12035-013-8591-7; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Frappier L, 2011, CURR OPIN GENET DEV, V21, P207, DOI 10.1016/j.gde.2011.02.005; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Li J, 2011, ACTA BIOCH BIOPHYS S; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Salomons FA, 2009, MOL CELL BIOL, V29, P1774, DOI 10.1128/MCB.01485-08; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shiloh Y, 2011, FEBS LETT, V585, P2795, DOI 10.1016/j.febslet.2011.07.034; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Yan QS, 2009, MOL CELL, V36, P110, DOI 10.1016/j.molcel.2009.08.019; Zhu QZ, 2009, DNA REPAIR, V8, P262, DOI 10.1016/j.dnarep.2008.11.007	56	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169054	10.1371/journal.pone.0169054	http://dx.doi.org/10.1371/journal.pone.0169054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052107	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500030
J	Kabeya, N; Sanz-Jorquera, A; Carboni, S; Davie, A; Oboh, A; Monroig, O				Kabeya, Naoki; Sanz-Jorquera, Alicia; Carboni, Stefano; Davie, Andrew; Oboh, Angela; Monroig, Oscar			Biosynthesis of Polyunsaturated Fatty Acids in Sea Urchins: Molecular and Functional Characterisation of Three Fatty Acyl Desaturases from Paracentrotus lividus (Lamark 1816)	PLOS ONE			English	Article							OCTOPUS-VULGARIS CUVIER; DIETARY LIPIDS; ECHINOIDEA; PROFILES; CLONING; GONADS; GROWTH; PUFA; ECHINODERMATA; METABOLISM	Sea urchins are broadly recognised as a delicacy and their quality as food for humans is highly influenced by their diet. Lipids in general and the long-chain polyunsaturated fatty acids (LC-PUFA) in particular, are essential nutrients that determine not only the nutritional value of sea urchins but also guarantee normal growth and reproduction in captivity. The contribution of endogenous production (biosynthesis) of LC-PUFA in sea urchins remained unknown. Using Paracentrotus lividus as our model species, we aimed to characterise both molecularly and functionally the repertoire of fatty acyl desaturases (Fads), key enzymes in the biosynthesis of LC-PUFA, in sea urchins. Three Fads, namely FadsA, FadsC1 and FadsC2, were characterised. The phylogenetic analyses suggested that the repertoire of Fads within the Echinodermata phylum varies among classes. On one hand, orthologues of the P. lividus FadsA were found in other echinoderm classes including starfishes, brittle stars and sea cucumbers, thus suggesting that this desaturase is virtually present in all echinoderms. Contrarily, the FadsC appears to be sea urchin-specific desaturase. Finally, a further desaturase termed as FadsB exists in starfishes, brittle stars and sea cucumbers, but appears to be missing in sea urchins. The functional characterisation of the P. lividus Fads confirmed that the FadsA was a.5 desaturase with activity towards saturated and polyunsaturated fatty acids (FA). Moreover, our experiments confirmed that FadsA plays a role in the biosynthesis of non-methylene interrupted FA, a group of compounds typically found in marine invertebrates. On the other hand, both FadsC desaturases from P. lividus showed.8 activity. The present results demonstrate that P. lividus possesses desaturases that account for all the desaturation reactions required to biosynthesis the physiological essential eicosapentaenoic and arachidonic acids through the so-called "Delta 8 pathway".	[Kabeya, Naoki; Sanz-Jorquera, Alicia; Carboni, Stefano; Davie, Andrew; Oboh, Angela; Monroig, Oscar] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland	University of Stirling	Monroig, O (corresponding author), Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland.	oscar.monroig@stir.ac.uk	Davie, Andrew/A-2247-2009; Kabeya, Naoki/A-2113-2015; Monroig, Oscar/K-9117-2014; Kabeya, Naoki/Q-5573-2016	Davie, Andrew/0000-0002-9524-618X; Kabeya, Naoki/0000-0002-2055-6554; Monroig, Oscar/0000-0001-8712-0440; Kabeya, Naoki/0000-0002-2055-6554; Carboni, Stefano/0000-0002-1302-1068	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; FP7 Project ENRICH [222492]; Grants-in-Aid for Scientific Research [16J06812] Funding Source: KAKEN	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; FP7 Project ENRICH; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. This investigation also received support from the FP7 Project ENRICH (Ref: 222492).	Agatsuma Y., 2010, Bulletin of the Aquaculture Association of Canada, V108, P4; Awada M, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-23; Barnathan G, 2009, BIOCHIMIE, V91, P671, DOI 10.1016/j.biochi.2009.03.020; Boudouresque CF, 2001, EDIBLE SEA URCHINS B, P243; Carboni S, 2015, AQUAC RES, V46, P969, DOI 10.1111/are.12256; Carboni S, 2013, COMP BIOCHEM PHYS A, V164, P376, DOI 10.1016/j.cbpa.2012.11.010; Castell JD, 2004, AQUACULTURE, V242, P417, DOI 10.1016/j.aquaculture.2003.11.003; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; CELLARIO C, 1990, AQUACULTURE, V84, P173, DOI 10.1016/0044-8486(90)90347-P; Cook EJ, 2009, J SHELLFISH RES, V28, P553, DOI 10.2983/035.028.0318; Cook EJ, 2000, J EXP MAR BIOL ECOL, V255, P261, DOI 10.1016/S0022-0981(00)00301-4; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Fernandez C, 2000, MAR ECOL PROG SER, V204, P131, DOI 10.3354/meps204131; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca-Madrigal J, 2014, J LIPID RES, V55, P1408, DOI 10.1194/jlr.M049791; Furesi R, 2014, INT J FOOD SYST DYN, P303; Gonzalez-Duran E, 2008, AQUACULTURE, V276, P120, DOI 10.1016/j.aquaculture.2008.01.010; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; Hui JHL, 2012, MOL BIOL EVOL, V29, P157, DOI 10.1093/molbev/msr175; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kelly JR, 2008, MAR ECOL PROG SER, V373, P1, DOI 10.3354/meps07746; Kelly M. S., 2010, Bulletin of the Aquaculture Association of Canada, V108, P23; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li MZ, 2013, AQUACULTURE, V416, P48, DOI 10.1016/j.aquaculture.2013.08.030; Lin H, 2007, AQUACULTURE, V264, P247, DOI 10.1016/j.aquaculture.2006.12.021; Liu HL, 2014, J AGR FOOD CHEM, V62, P12384, DOI 10.1021/jf504648f; Liu HL, 2014, MOL BIOL REP, V41, P7437, DOI 10.1007/s11033-014-3633-4; Liu HL, 2013, AQUACULTURE, V416, P146, DOI 10.1016/j.aquaculture.2013.09.015; Liyana-Pathirana C, 2002, J FOOD LIPIDS, V9, P105, DOI 10.1111/j.1745-4522.2002.tb00213.x; LOZANO J, 1995, MAR ECOL PROG SER, V122, P179, DOI 10.3354/meps122179; Meesapyodsuk D, 2012, LIPIDS, V47, P227, DOI 10.1007/s11745-011-3617-2; Monroig O, 2016, AQUACULTURE, V450, P38, DOI 10.1016/j.aquaculture.2015.07.003; Monroig O, 2013, MAR DRUGS, V11, P3998, DOI 10.3390/md11103998; Monroig O, 2012, AQUACULTURE, V360, P45, DOI 10.1016/j.aquaculture.2012.07.016; Monroig O, 2012, MAR BIOTECHNOL, V14, P411, DOI 10.1007/s10126-011-9423-2; Montes R, 2013, EUR J CLIN NUTR, V67, P658, DOI 10.1038/ejcn.2013.68; Muhlhausler BS, 2013, CURR OPIN ENDOCRINOL, V20, P56, DOI 10.1097/MED.0b013e32835c1ba7; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargent John R., 2002, P181; Sartori D, 2015, AQUACULT INT, V23, P111, DOI 10.1007/s10499-014-9802-6; Sartori D, 2015, AQUAC NUTR; Sartori D, 2016, AQUACULTURE, V451, P39, DOI 10.1016/j.aquaculture.2015.08.037; Sergiev PV, 2016, AGING-US, V8, P260, DOI 10.18632/aging.100889; Siliani S, 2016, MAR ENVIRON RES, V113, P124, DOI 10.1016/j.marenvres.2015.12.001; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sprague M, 2015, FOOD CHEM, V185, P413, DOI 10.1016/j.foodchem.2015.03.150; Surm JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136301; TAKAGI T, 1986, LIPIDS, V21, P558, DOI 10.1007/BF02534052; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267	52	35	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169374	10.1371/journal.pone.0169374	http://dx.doi.org/10.1371/journal.pone.0169374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052125	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500055
J	Lam, RS; Topfer, FM; Wood, PG; Busskamp, V; Bamberg, E				Lam, Rebecca S.; Toepfer, Felix M.; Wood, Phillip G.; Busskamp, Volker; Bamberg, Ernst			Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; MINIATURE SYNAPTIC EVENTS; HIPPOCAMPAL-NEURONS; MOTOR-NEURONS; AMPA RECEPTOR; ASTROGLIAL CELLS; OPTICAL CONTROL; VISUAL FUNCTION; PATCH-CLAMP; IN-VITRO	Differentiated neurons can be rapidly acquired, within days, by inducing stem cells to express neurogenic transcription factors. We developed a protocol to maintain long-term cultures of human neurons, called iNGNs, which are obtained by inducing Neurogenin-1 and Neurogenin-2 expression in induced pluripotent stem cells. We followed the functional development of iNGNs over months and they showed many hallmark properties for neuronal maturation, including robust electrical and synaptic activity. Using iNGNs expressing a variant of channelrhodopsin- 2, called CatCh, we could control iNGN activity with blue light stimulation. In combination with optogenetic tools, iNGNs offer opportunities for studies that require precise spatial and temporal resolution. iNGNs developed spontaneous network activity, and these networks had excitatory glutamatergic synapses, which we characterized with single-cell synaptic recordings. AMPA glutamatergic receptor activity was especially dominant in postsynaptic recordings, whereas NMDA glutamatergic receptor activity was absent from postsynaptic recordings but present in extrasynaptic recordings. Our results on long-term cultures of iNGNs could help in future studies elucidating mechanisms of human synaptogenesis and neurotransmission, along with the ability to scale-up the size of the cultures.	[Lam, Rebecca S.; Toepfer, Felix M.; Wood, Phillip G.; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Busskamp, Volker] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Max Planck Society; Technische Universitat Dresden	Lam, RS; Bamberg, E (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	Rebecca.Lam@biophys.mpg.de; Ernst.Bamberg@biophys.mpg.de	Lam, Rebecca S/H-6439-2013; Busskamp, Volker/E-6339-2015	Lam, Rebecca S/0000-0002-9574-5712; Busskamp, Volker/0000-0001-7517-8944	Volkswagen Foundation Freigeist Fellowship [A110720]; European Research Council [678071]; Deutsche Forschungsgemeinschaft [SFB 807]; Max Planck Society	Volkswagen Foundation Freigeist Fellowship; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a Volkswagen Foundation Freigeist Fellowship A110720 (VB), a European Research Council Starting Grant 678071 - ProNeurons (VB), the Deutsche Forschungsgemeinschaft SFB 807, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Belinsky GS, 2014, STEM CELL RES, V12, P101, DOI 10.1016/j.scr.2013.09.014; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Burbulla LF, 2016, ADV HEALTHC MAT; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Grignaschi G, 2004, EUR J NEUROSCI, V20, P2833, DOI 10.1111/j.1460-9568.2004.03712.x; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herman AM, 2014, ELIFE, V3, DOI 10.7554/eLife.01481; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kupper J, 1998, J PHYSIOL-LONDON, V507, P1, DOI 10.1111/j.1469-7793.1998.001bu.x; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Longart M, 2007, BRAIN RES BULL, V73, P210, DOI 10.1016/j.brainresbull.2007.02.014; Marrs GS, 2012, J PHYSIOL-LONDON, V590, P2391, DOI 10.1113/jphysiol.2011.226886; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Pre D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103418; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Reese AL, 2015, ELIFE, V4, DOI 10.7554/eLife.09262; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Riday TT, 2012, NEUROPHARMACOLOGY, V62, P1858, DOI 10.1016/j.neuropharm.2011.12.011; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Su CTE, 2015, JOVE-J VIS EXP, DOI 10.3791/52408; Sugimoto Y, 2009, CELL BIOL INT, V33, P174, DOI 10.1016/j.cellbi.2008.10.010; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Thoma EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038651; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Whitcomb DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10934; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xu Q, 2005, DEVELOPMENT, V132, P4987, DOI 10.1242/dev.02090; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhang ZW, 2004, J NEUROPHYSIOL, V91, P1171, DOI 10.1152/jn.00855.2003	63	43	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169506	10.1371/journal.pone.0169506	http://dx.doi.org/10.1371/journal.pone.0169506			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052116	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500065
J	Lathia, N; Sandstrom, GM; Mascolo, C; Rentfrow, PJ				Lathia, Neal; Sandstrom, Gillian M.; Mascolo, Cecilia; Rentfrow, Peter J.			Happier People Live More Active Lives: Using Smartphones to Link Happiness and Physical Activity	PLOS ONE			English	Article							ACTIVITY THERMOGENESIS; MOMENTARY ASSESSMENT; LIFE; SATISFACTION; PERSONALITY; ADULTS; TIME	Physical activity, both exercise and non-exercise, has far-reaching benefits to physical health. Although exercise has also been linked to psychological health (e.g., happiness), little research has examined physical activity more broadly, taking into account non-exercise activity as well as exercise. We examined the relationship between physical activity (measured broadly) and happiness using a smartphone application. This app has collected self-reports of happiness and physical activity from over ten thousand participants, while passively gathering information about physical activity from the accelerometers on users' phones. The findings reveal that individuals who are more physically active are happier. Further, individuals are happier in the moments when they are more physically active. These results emerged when assessing activity subjectively, via self-report, or objectively, via participants' smartphone accelerometers. Overall, this research suggests that not only exercise but also non-exercise physical activity is related to happiness. This research further demonstrates how smartphones can be used to collect large-scale data to examine psychological, behavioral, and health-related phenomena as they naturally occur in everyday life.	[Lathia, Neal; Mascolo, Cecilia] Univ Cambridge, Comp Lab, Cambridge, England; [Sandstrom, Gillian M.; Rentfrow, Peter J.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Cambridge; University of Cambridge	Rentfrow, PJ (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	pjr39@cam.ac.uk	Rentfrow, Peter Jason/ABB-9257-2021	Rentfrow, Peter Jason/0000-0002-9068-2118; Mascolo, Cecilia/0000-0001-9614-4380; Sandstrom, Gillian/0000-0002-0549-9600	UK Engineering and Physical Sciences Research Council; EPSRC [EP/I032673/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032673/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the UK Engineering and Physical Sciences Research Council's project "UBhave: ubiquitous and social computing for positive behaviour change" (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/I032673/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SMARTPH OS MARK SHAR, V3, P16; Arthur D, 2007, S DISCR ALG SOC IND; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Catalino LI, 2011, EMOTION, V11, P938, DOI 10.1037/a0024889; Dey A, 2011, ACM INT JOINT C PERV; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Elavsky S, 2005, ANN BEHAV MED, V30, P138, DOI 10.1207/s15324796abm3002_6; Gosling SD, 2015, ANNU REV PSYCHOL, V66, P877, DOI 10.1146/annurev-psych-010814-015321; Hansen CJ, 2001, HEALTH PSYCHOL, V20, P267, DOI 10.1037//0278-6133.20.4.267; Hemminki S, 2013, ACM INT C EMB NETW S; Jokela M, 2015, P NATL ACAD SCI USA, V112, P725, DOI 10.1073/pnas.1415800112; Kanning M, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00602; Kanning M, 2010, J SPORT EXERCISE PSY, V32, P253, DOI 10.1123/jsep.32.2.253; Kanning MK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00187; Kauer SD, 2012, J MED INTERNET RES, V14, P15, DOI 10.2196/jmir.1858; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Lathia N, 2013, ACM INT JOINT C PERV; Lathia N., 2013, P ACM C PERV UB COMP, P911, DOI DOI 10.1145/2494091.2497345; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Major MJ, 2016, J SPORT SCI, V34, P2160, DOI 10.1080/02640414.2016.1189086; Mehl MR., 2012, HDB RES METHODS STUD; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; PAVOT W, 1990, PERS INDIV DIFFER, V11, P1299, DOI 10.1016/0191-8869(90)90157-M; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUUSKANEN JM, 1995, AGE AGEING, V24, P292, DOI 10.1093/ageing/24.4.292; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Watson D., 1994, PANAS X MANUAL POSIT, DOI [DOI 10.17077/48VTM4T2, 10.17077/48vt-m4t2]; Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Wrzus C, 2015, EUR J PERSONALITY, V29, P250, DOI 10.1002/per.1986	38	80	79	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0160589	10.1371/journal.pone.0160589	http://dx.doi.org/10.1371/journal.pone.0160589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH2TP	28052069	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000391621500001
J	Zhang, N; Ye, XM; Wu, YZ; Huang, ZL; Gu, XY; Cai, QR; Shen, XG; Jiang, HX; Ding, HZ				Zhang, Nan; Ye, Xiaomei; Wu, Yuzhi; Huang, Zilong; Gu, Xiaoyan; Cai, Qinren; Shen, Xiangguang; Jiang, Hongxia; Ding, Huanzhong			Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; IN-VITRO; STAPHYLOCOCCUS-AUREUS; PREVENTION CONCENTRATION; BROILER-CHICKENS; STREPTOCOCCUS-PNEUMONIAE; RESISTANT MUTANTS; INFECTED CHICKENS; ESCHERICHIA-COLI; PHARMACOKINETICS	Mycoplasma gallisepticum is a common etiological cause of a chronic respiratory disease in chickens; its increasing antimicrobial resistance compromises the use of tetracyclines, macrolides and quinolones in the farm environment. Mutant selection window (MSW) determination was used to investigate the propensity for future resistance induction by danofloxacin, doxycycline, tilmicosin, tylvalosin and valnemulin. Killing of M. gallisepticum strain S6 by these antimicrobials was also studied by incubating M. gallisepticum into medium containing the compounds at the minimal concentration that inhibits colony formation by 99% (MIC99) and the mutant prevention concentration (MPC). Based on the morphology and colony numbers of M. gallisepticum on agar plates, the four kinds of sera in the order of the applicability for culturing M. gallisepticum were swine serum > horse serum > bovine serum > mixed serum. The MPC/MIC99 values for each agent were as follows: danofloxacin > tilmicosin > tylvalosin > doxycycline > valnemulin. MPC generated more rapid and greater magnitude killing than MIC99 against M. gallisepticum. Under exposure of 10(5)-10(9) CFU/mL at MPC drug levels, valnemulin had the slowest rate of reduction in viable organisms and danofloxacin had the highest rate of reduction.	[Zhang, Nan; Ye, Xiaomei; Wu, Yuzhi; Huang, Zilong; Gu, Xiaoyan; Shen, Xiangguang; Jiang, Hongxia; Ding, Huanzhong] South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China; [Cai, Qinren] Tech Ctr Zhuhai Entry Exit Inspect & Quarantine B, Zhuhai, Peoples R China	South China Agricultural University	Ding, HZ (corresponding author), South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China.	hzding@scau.edu.cn			National Key Research and Development Program of China [2016YFD0501300/2016YFD0501310]; 973 program [2013CB127200/2013CB127203]	National Key Research and Development Program of China; 973 program(National Basic Research Program of China)	This study is supported financially by National Key Research and Development Program of China (2016YFD0501300/2016YFD0501310) and 973 program (2013CB127200/2013CB127203).	Abu-Basha EA, 2007, VET RES COMMUN, V31, P477, DOI 10.1007/s11259-006-3543-6; Almeida D, 2007, ANTIMICROB AGENTS CH, V51, P4261, DOI 10.1128/AAC.01123-07; Blondeau JM, 2015, INT J ANTIMICROB AG, V45, P594, DOI 10.1016/j.ijantimicag.2014.12.034; Blondeau JM, 2012, VET MICROBIOL, V160, P85, DOI 10.1016/j.vetmic.2012.05.006; BRADBURY JM, 1994, AVIAN PATHOL, V23, P105, DOI 10.1080/03079459408418978; Cerda RO, 2010, J VET PHARMACOL THER, V33, P202, DOI 10.1111/j.1365-2885.2009.01103.x; Cui JC, 2006, J INFECT DIS, V194, P1601, DOI 10.1086/508752; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Dong YZ, 2000, ANTIMICROB AGENTS CH, V44, P2581, DOI 10.1128/AAC.44.9.2581-2584.2000; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; Firsov AA, 2013, ANTIMICROB AGENTS CH, V57, P4956, DOI 10.1128/AAC.00578-13; GREENBERGOFRATH N, 1993, APPL ENVIRON MICROB, V59, P547, DOI 10.1128/AEM.59.2.547-551.1993; HANNAN PCT, 1989, RES VET SCI, V46, P202, DOI 10.1016/S0034-5288(18)31146-9; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; HOLLANDERS B, 1986, COMP BIOCHEM PHYS B, V84, P83, DOI 10.1016/0305-0491(86)90275-0; Homma T, 2007, ANTIMICROB AGENTS CH, V51, P3810, DOI 10.1128/AAC.01372-06; Jordan FTW, 1996, AVIAN DIS, V40, P326, DOI 10.2307/1592228; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Laczay P, 2001, ACTA VET HUNG, V49, P31, DOI 10.1556/AVet.49.2001.1.5; Li BB, 2010, FEMS MICROBIOL LETT, V308, P144, DOI 10.1111/j.1574-6968.2010.02003.x; Linde HJ, 2004, J ANTIMICROB CHEMOTH, V53, P252, DOI 10.1093/jac/dkh036; Lu T, 2003, J ANTIMICROB CHEMOTH, V52, P1025, DOI 10.1093/jac/dkg480; LYNCH MJ, 1994, J AGR FOOD CHEM, V42, P289, DOI 10.1021/jf00038a012; Mei Q, 2015, EUR J CLIN MICROBIOL, V34, P737, DOI 10.1007/s10096-014-2285-6; Mitchell JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044158; Ni W, 2014, EUR J CLIN MICROBIOL, V33, P385, DOI 10.1007/s10096-013-1968-8; OKA H, 1989, J AGR FOOD CHEM, V37, P226, DOI 10.1021/jf00085a052; PETERSON SM, 1993, MAR POLLUT BULL, V26, P96, DOI 10.1016/0025-326X(93)90098-5; Quinn B, 2007, J ANTIMICROB CHEMOTH, V60, P1380, DOI 10.1093/jac/dkm375; RAZIN S, 1970, J BACTERIOL, V102, P306, DOI 10.1128/JB.102.2.306-310.1970; Reinhardt AK, 2002, ANTIMICROB AGENTS CH, V46, P590, DOI 10.1128/AAC.46.2.590-593.2002; ROBERTS MC, 1985, ANTIMICROB AGENTS CH, V28, P141, DOI 10.1128/AAC.28.1.141; TANNER AC, 1992, AVIAN DIS, V36, P714, DOI 10.2307/1591770; Wang R, 2011, J VET PHARMACOL THER, V34, P247, DOI 10.1111/j.1365-2885.2010.01215.x; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Wu CM, 2005, FEMS MICROBIOL LETT, V247, P199, DOI 10.1016/j.femsle.2005.05.012; Xiao X, 2015, VET J, V204, P54, DOI 10.1016/j.tvjl.2015.01.020; Zeng Z, 2011, J VET PHARMACOL THER, V34, P101, DOI 10.1111/j.1365-2885.2010.01223.x; Zhang BX, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0297-1; Zhang N, 2016, FRONTIERS MICROBIOLO, V7; Zhao XL, 2003, ANTIMICROB AGENTS CH, V47, P1023, DOI 10.1128/AAC.47.3.1023-1027.2003	43	21	22	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169134	10.1371/journal.pone.0169134	http://dx.doi.org/10.1371/journal.pone.0169134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052123	gold, Green Submitted, Green Published			2022-12-26	WOS:000391621500035
J	Hatami, A; Monjazeb, S; Milton, S; Glabe, CG				Hatami, Asa; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles G.			Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; Alzheimer disease; amyloid- (A); monoclonal antibody; peptide conformation	SMOOTH-MUSCLE-CELLS; A-BETA; MONOCLONAL-ANTIBODIES; PROTOFIBRIL FORMATION; PRESENILIN MUTATIONS; CEREBRAL-HEMORRHAGE; THIOFLAVIN-T; TOTTORI D7N; ENGLISH H6R; ANGIOPATHY	Most cases of Alzheimer's disease (AD) are sporadic, but a small percentage of AD cases, called familial AD (FAD), are associated with mutations in presenilin 1, presenilin 2, or the amyloid precursor protein. Amyloid precursor protein mutations falling within the amyloid- (A) sequence lead to a wide range of disease phenotypes. There is increasing evidence that distinct amyloid structures distinguished by amyloid conformation-dependent monoclonal antibodies have similarly distinct roles in pathology. It is possible that this phenotypic diversity of FAD associated with mutations within the A sequence is due to differences in the conformations adopted by mutant A peptides, but the effects of FAD mutations on aggregation kinetics and conformational and morphological changes of the A peptide are poorly defined. To gain more insight into this possibility, we therefore investigated the effects of 11 FAD mutations on the aggregation kinetics of A, as well as its ability to form distinct conformations recognized by a panel of amyloid conformation-specific monoclonal antibodies. We found that most FAD mutations increased the rate of aggregation of A. The FAD mutations also led to the adoption of alternative amyloid conformations distinguished by monoclonal antibodies and resulted in the formation of distinct aggregate morphologies as determined by transmission electron microscopy. In addition, several of the mutant peptides displayed a large reduction in thioflavin T fluorescence, despite forming abundant fibrils indicating that thioflavin T is a probe of conformational polymorphisms rather than a reliable indicator of fibrillization. Taken together, these results indicate that FAD mutations falling within the A sequence lead to dramatic changes in aggregation kinetics and influence the ability of A to form immunologically and morphologically distinct amyloid structures.	[Hatami, Asa; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Hatami, Asa] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Dept Biochem, Fac Sci, Jeddah 23218, Saudi Arabia; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Expt Biochem Unit, Jeddah 23218, Saudi Arabia	University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; King Abdulaziz University; King Abdulaziz University	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu			National Institutes of Health [AG033069, AG00538]; Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING [R01AG033069, P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG033069 and AG00538 and a grant from the Cure Alzheimer's fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Chatani E, 2005, BBA-PROTEINS PROTEOM, V1753, P64, DOI 10.1016/j.bbapap.2005.08.002; Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Di Fede G, 2013, FRONT BIOSCI-LANDMRK, V18, P1202, DOI 10.2741/4173; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Duboisset J, 2013, J PHYS CHEM B, V117, P784, DOI 10.1021/jp309528f; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elkins MR, 2016, J AM CHEM SOC, V138, P9840, DOI 10.1021/jacs.6b03715; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Handoko M, 2013, JAMA NEUROL, V70, P594, DOI 10.1001/jamaneurol.2013.48; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hernandez-Guillamon M, 2010, J BIOL CHEM, V285, P27144, DOI 10.1074/jbc.M110.135228; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kalimo H, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-60; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kutoku Y, 2015, INTERNAL MED, V54, P205, DOI 10.2169/internalmedicine.54.3021; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LUYENDIJK W, 1988, J NEUROL SCI, V85, P267, DOI 10.1016/0022-510X(88)90186-4; Maia LF, 2007, J NEUROL SCI, V257, P23, DOI 10.1016/j.jns.2007.01.054; Masuda Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2170, DOI 10.1271/bbb.80250; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; McLean D, 2013, ACS CHEM NEUROSCI, V4, P613, DOI 10.1021/cn300226q; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Nussbaum JM, 2013, PRION, V7, P14, DOI 10.4161/pri.22118; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Ovchinnikova OY, 2011, J MOL BIOL, V408, P780, DOI 10.1016/j.jmb.2011.02.049; Pasalar P, 2002, NEUROLOGY, V58, P1574, DOI 10.1212/WNL.58.10.1574; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Pezzini A, 2009, CURR MED CHEM, V16, P2498, DOI 10.2174/092986709788682047; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; Shimada H, 2011, DEMENT GERIATR COGN, V32, P45, DOI 10.1159/000330017; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; Van Nostrand WE, 2002, ANN NY ACAD SCI, V977, P258; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534; Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	64	79	80	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3172	3185		10.1074/jbc.M116.755264	http://dx.doi.org/10.1074/jbc.M116.755264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049728	Green Published, hybrid			2022-12-26	WOS:000395538800011
J	Ketkar, A; Voehler, M; Mukiza, T; Eoff, RL				Ketkar, Amit; Voehler, Markus; Mukiza, Tresor; Eoff, Robert L.			Residues in the RecQ C-terminal Domain of the Human Werner Syndrome Helicase Are Involved in Unwinding G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; enzyme mechanism; G-quadruplex; Werner syndrome helicase	SYNDROME PROTEIN; STRAND SEPARATION; GENE-EXPRESSION; S-PHASE; REPLICATION; FANCJ; CELLS; WRN; RECOGNITION; STABILITY	The structural and biophysical properties typically associated with G-quadruplex (G4) structures render them a significant block for DNA replication, which must be overcome for cell division to occur. The Werner syndrome protein (WRN) is a RecQ family helicase that has been implicated in the efficient processing of G4 DNA structures. The aim of this study was to identify the residues of WRN involved in the binding and ATPase-driven unwinding of G4 DNA. Using a c-Myc G4 DNA model sequence and recombinant WRN, we have determined that the RecQ-C-terminal (RQC) domain of WRN imparts a 2-fold preference for binding to G4 DNA relative to non-G4 DNA substrates. NMR studies identified residues involved specifically in interactions with G4 DNA. Three of the amino acids in the WRN RQC domain that exhibited the largest G4-specific changes in NMR signal were then mutated alone or in combination. Mutating individual residues implicated in G4 binding had a modest effect on WRN binding to DNA, decreasing the preference for G4 substrates by approximate to 25%. Mutating two G4-interacting residues (T1024G and T1086G) abrogated preferential binding of WRN to G4 DNA. Very modest decreases in G4 DNA-stimulated ATPase activity were observed for the mutant enzymes. Most strikingly, G4 unwinding by WRN was inhibited approximate to 50% for all three point mutants and >90% for the WRN double mutant (T1024G/T1086G) relative to normal B-form dsDNA substrates. Our work has helped to identify residues in the WRN RQC domain that are involved specifically in the interaction with G4 DNA.	[Ketkar, Amit; Mukiza, Tresor; Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	University of Arkansas System; University of Arkansas Medical Sciences; Vanderbilt University	Eoff, RL (corresponding author), Univ Arkansas Med Sci, Biomed Res Ctr 1, Rm B421E,4301 W Markham St, Little Rock, AR 72205 USA.	rleoff@uams.edu	Ketkar, Amit/H-8022-2019; Mukiza, Tresor/AAS-3093-2021	Mukiza, Tresor/0000-0002-4785-9432; ketkar, amit/0000-0002-6536-7415	National Institutes of Health from USPHS [GM084460, CA183895]; University of Arkansas for Medical Sciences Translational Research Institute CTSA [UL1TR000039]; NATIONAL CANCER INSTITUTE [R01CA183895] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM084460, R00GM084460] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; University of Arkansas for Medical Sciences Translational Research Institute CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM084460 and CA183895 from USPHS (to R. L. E.) and by University of Arkansas for Medical Sciences Translational Research Institute CTSA Grant Award UL1TR000039. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dai JX, 2011, J AM CHEM SOC, V133, P17673, DOI 10.1021/ja205646q; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Hu JS, 2005, P NATL ACAD SCI USA, V102, P18379, DOI 10.1073/pnas.0509380102; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lee JW, 2005, J BIOL CHEM, V280, P39627, DOI 10.1074/jbc.M506112200; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 2000, CANCER RES, V60, P2492; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Wu CG, 2013, ADV EXP MED BIOL, V973, P1, DOI 10.1007/978-1-4614-5037-5_1	36	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3154	3163		10.1074/jbc.M116.767699	http://dx.doi.org/10.1074/jbc.M116.767699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069813	hybrid, Green Published			2022-12-26	WOS:000395538800009
J	Meng, FL; Cang, XH; Peng, YY; Li, RH; Zhang, ZY; Li, FS; Fan, QQ; Guan, AS; Fischel-Ghosian, N; Zhao, XL; Guan, MX				Meng, Feilong; Cang, Xiaohui; Peng, Yanyan; Li, Ronghua; Zhang, Zhengyue; Li, Fushan; Fan, Qingqing; Guan, Anna S.; Fischel-Ghosian, Nathan; Zhao, Xiaoli; Guan, Min-Xin			Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; NONSYNDROMIC DEAFNESS; OXIDATIVE STRESS; C1494T MUTATION; GENE; AMINOACYLATION; EXPRESSION; TRANSLATION; SYNTHETASE; DISEASES	Nuclear modifier gene(s) was proposed to modulate the phenotypic expression of mitochondrial DNA mutation(s). Our previous investigations revealed that a nuclear modifier allele (A10S) in TRMU(methylaminomethyl-2-thiouridylate-methyltransferase) related to tRNA modification interacts with 12S rRNA 1555A3 -> G mutation to cause deafness. The A10S mutation resided at a highly conserved residue of the N-terminal sequence. It was hypothesized that the A10S mutation altered the structure and function of TRMU, thereby causing mitochondrial dysfunction. Using molecular dynamics simulations, we showed that the A10S mutation introduced the Ser(10) dynamic electrostatic interaction with the Lys(106) residue of helix 4 within the catalytic domain of TRMU. The Western blotting analysis displayed the reduced levels of TRMU in mutant cells carrying the A10S mutation. The thermal shift assay revealed the T-m value of mutant TRMU protein, lower than that of the wild-type counterpart. The A10S mutation caused marked decreases in 2-thiouridine modification of U34 of tRNALys, tRNAGlu and tRNAGln. However, the A10S mutation mildly increased the aminoacylated efficiency of tRNAs. The altered 2-thiouridine modification worsened the impairment of mitochondrial translation associated with the m. 1555A -> Gmutation. The defective translation resulted in the reduced activities of mitochondrial respiration chains. The respiratory deficiency caused the reduction of mitochondrial ATP production and elevated the production of reactive oxidative species. As a result, mutated TRMU worsened mitochondrial dysfunctions associated with m. 1555A3 -> G mutation, exceeding the threshold for expressing a deafness phenotype. Our findings provided new insights into the pathophysiology of maternally inherited deafness that was manifested by interaction between mtDNA mutation and nuclear modifier gene.	[Meng, Feilong; Cang, Xiaohui; Guan, Min-Xin] Zhejiang Univ, Sch Med, Zhejiang Childrens Hosp, Div Med Genet & Gen, Hangzhou 310058, Zhejiang, Peoples R China; [Meng, Feilong; Cang, Xiaohui; Peng, Yanyan; Zhang, Zhengyue; Li, Fushan; Fan, Qingqing; Zhao, Xiaoli; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Peng, Yanyan] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Li, Ronghua] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30307 USA; [Guan, Anna S.; Fischel-Ghosian, Nathan] UCLA Sch Med, Ahmanson Dept Pediat, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA; [Guan, Min-Xin] Zhejiang Univ, Joining Inst Genet & Genom Med, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Univ Toronto, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Cincinnati Children's Hospital Medical Center; Emory University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Zhejiang University; University of Toronto	Zhao, XL (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.	zhaoxiaoli@zju.edu.cn; gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736	National Natural Science Foundation of China [81330024, 31400709]; National Basic Research Priorities Program of China [2014CB541704, 2012CB967902]; NIDCD National Institutes of Health [RO1DC05230, RO1DC07696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007696, R01DC005230] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program of China(National Basic Research Program of China); NIDCD National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Natural Science Foundation of China Grant 81330024, National Basic Research Priorities Program of China Grant 2014CB541704, NIDCD National Institutes of Health Grants RO1DC05230 and RO1DC07696 (to M.-X.G.), National Natural Science Foundation of China Grant 31400709 (to X.C.), and National Basic Research Priorities Program of China Grant 2012CB967902 (to X.Z.). The MD simulations were carried out at National Supercomputer Center in Tianjin, China. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belostotsky R, 2012, RNA BIOL, V9, P33, DOI 10.4161/rna.9.1.18009; Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054; Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; KING MP, 1993, J BIOL CHEM, V268, P10228; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; Sathiamoorthy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047259; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Yan QF, 2006, BIOCHEM BIOPH RES CO, V342, P1130, DOI 10.1016/j.bbrc.2006.02.078; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Yan QF, 2004, BBA-GENE STRUCT EXPR, V1676, P119, DOI 10.1016/j.bbaexp.2003.11.010; Yu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114650; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001	73	36	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2881	2892		10.1074/jbc.M116.749374	http://dx.doi.org/10.1074/jbc.M116.749374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049726	Green Published, hybrid			2022-12-26	WOS:000395535100028
J	Wheaton, K; Sarkari, F; Johns, BS; Davarinejad, H; Egorova, O; Kaustov, L; Raught, B; Saridakis, V; Sheng, Y				Wheaton, Keith; Sarkari, Feroz; Johns, Beena Stanly; Davarinejad, Hossein; Egorova, Olga; Kaustov, Lilia; Raught, Brian; Saridakis, Vivian; Sheng, Yi			UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP PROTEINS; CELL-CYCLE PROGRESSION; INK4A TUMOR-SUPPRESSOR; EMBRYONIC STEM-CELLS; HISTONE H2A; LIGASE COMPLEX; X-INACTIVATION; CANCER; RING1B; LOCUS	UbE2E1/ UbcH6 is an E2 ubiquitin- conjugating enzyme that is regulated by USP7. We identified UbE2E1 as a novel component of Polycomb repressive complex 1 (PRC1), the E3 ligase complex responsible for histone H2A ubiquitination and gene silencing. We demonstrate that UbE2E1 is critical for the monoubiquitination of H2A at residue Lys- 119 ( uH2AK119) through its association with the PRC1 complex. UbE2E1 interacts with PRC1 subunits including Ring1A and Ring1B. Overexpression of UbE2E1 results in increased levels of uH2AK119, whereas overexpression of catalytically inactive UbE2E1_ C131A or UbE2E1 knockdown results in decreased levels of uH2AK119. The down- regulation of H2A ubiquitination by loss of function of UbE2E1 is correlated with alleviated p16(INK4a) promoter repression and induced growth inhibition in HCT116 cells. These results are specific to UbE2E1 as knockdown of UbE2D E2s does not show any effect on uH2AK119. We extended the UbE2E1 regulation of uH2AK119 to USP7 and showed that USP7 is also a key regulator for monoubiquitination at H2A Lys-119 as both knockdown and deletion of USP7 results in decreased levels of uH2AK119. This study reveals that UbE2E1 is an in vivo E2 for the PRC1 ligase complex and thus plays an important role in the regulation of H2A Lys- 119 monoubiquitination.	[Wheaton, Keith; Sarkari, Feroz; Johns, Beena Stanly; Davarinejad, Hossein; Egorova, Olga; Saridakis, Vivian; Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J1P3, Canada; [Kaustov, Lilia; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Sheng, Y (corresponding author), York Univ, Dept Biol, Toronto, ON M3J1P3, Canada.	yisheng@yorku.ca	Wheaton, Keith/AAF-1561-2021	Davarinejad, Hossein/0000-0002-6049-1492; Kaustov, Lilia/0000-0002-8474-559X	Canadian Institute of Health Research [106583]; York University startup funds; Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program [12939]; Ontario Research Fund Research Infrastructure Program (ORF-RI)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); York University startup funds; Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program; Ontario Research Fund Research Infrastructure Program (ORF-RI)	This work was support by Canadian Institute of Health Research operating Grant 106583 (to V.S. and Y.S.) and York University startup funds (to V.S. and Y.S.). Infrastructure was funded by the Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program Grant 12939 and the Ontario Research Fund Research Infrastructure Program (ORF-RI) (to V.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Benitz S, 2016, ONCOTARGET, V7, P11424, DOI 10.18632/oncotarget.6717; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Gehrke SG, 2003, BLOOD, V101, P3288, DOI 10.1182/blood-2002-07-2192; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lecona E, 2015, MOL CELL BIOL, V35, P1157, DOI 10.1128/MCB.01197-14; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Sahtoe DD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10292; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	47	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2893	2902		10.1074/jbc.M116.749564	http://dx.doi.org/10.1074/jbc.M116.749564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073915	hybrid, Green Published			2022-12-26	WOS:000395535100029
J	Igawa, M; Hata, H; Kato, M				Igawa, Momoko; Hata, Hiroki; Kato, Makoto			Reciprocal Symbiont Sharing in the Lodging Mutualism between Walking Corals and Sipunculans	PLOS ONE			English	Article							MODEL	Solitary scleractinian corals of the genera Heterocyathus and Heteropsammia inhabit soft marine bottoms without attaching to hard substrata. The corallums of these genera contain a coiled cavity inhabited by a sipunculan that roams the seafloor, carrying the host coral with it. The coral serves as a sturdy shelter that protects the sipunculan from possible predators. At the same time, the sipunculan maintains the coral in an upright position on the soft bottom. This coral-sipunculan association is unique because two phylogenetically distant coral genera have developed convergent associations with sipunculans. We investigate the process of convergent evolution of two coral species, Hc. aequicostatus and Hp. cochlea, in Okinawa, Japan, with their symbiotic sipunculans, using phylogenetic and morphological analyses. Phylogenetic analyses clarified that the symbiotic sipunculans comprise two distinct clades, surprisingly both of which are associated with both coral species. The bodily habitus of the sipunculan differed between coral species and fit the morphologies of the coiled cavities of their respective host corals. Our results suggest that the two coral species share two sipunculan clades and that sipunculan morphology is plastic and determined by the internal structure of their host corals.	[Igawa, Momoko; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Hata, Hiroki] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime, Japan	Kyoto University; Ehime University	Igawa, M (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan.	momoko.igawa.43e@gmail.com		Hata, Hiroki/0000-0001-9438-0646	Ministry of Education, Culture, Sports, Science and Technology [22247003, 15H02420]; Grants-in-Aid for Scientific Research [15H02420, 15H05230] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/) of the Ministry of Education, Culture, Sports, Science and Technology given to MK (grant numbers 22247003, 15H02420). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvier E. L., 1895, ANN SCI NAT ZOOL, V20, P1; Bouvier EL, 1894, ANN MAG NAT HIST SER, V14, P312; Cutler E. B, 1994, SIPUNCULA THEIR SYST; CUTLER EB, 1989, P BIOL SOC WASH, V102, P826; Diesing K.M., 1851, SYSTEMA HELMINTHUM; Ferrero-Vicente LM, 2013, J EXP MAR BIOL ECOL, V446, P345, DOI 10.1016/j.jembe.2013.06.011; GILL GA, 1977, LETHAIA, V10, P119, DOI 10.1111/j.1502-3931.1977.tb00601.x; GOREAU TF, 1968, NATURE, V217, P421, DOI 10.1038/217421a0; HICKSON SJ, 1924, INTRO STUDY RECENT C; HOEKSEMA B W, 1991, Zoologische Mededelingen (Leiden), V65, P221; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kawauchi GY, 2012, ZOOL SCR, V41, P186, DOI 10.1111/j.1463-6409.2011.00507.x; Macdonald JD, 1862, NAT HIST REV LOND, V1862, P78; Rambaut A., 2014, TRACER V1 6; RICE M E, 1976, Micronesica, V12, P119; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saiz Salinas J.I., 1986, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V8, P551; Schindewolf OH, 1958, AKAD WISS LIT AMN, V1958, P259; Stolarski J, 2001, ACTA PALAEONTOL POL, V46, P309; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Wells J.W., 1956, TREATISE INVERTEBR F, P328; Yonge C.M., 1975, P305	23	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169825	10.1371/journal.pone.0169825	http://dx.doi.org/10.1371/journal.pone.0169825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072881	Green Submitted, Green Published, gold			2022-12-26	WOS:000391844200051
J	Serrano, M; Elguezabal, N; Sevilla, IA; Geijo, MV; Molina, E; Arrazuria, R; Urkitza, A; Jones, GJ; Vordermeier, M; Garrido, JM; Juste, RA				Serrano, Miriam; Elguezabal, Natalia; Sevilla, Iker A.; Geijo, Maria V.; Molina, Elena; Arrazuria, Rakel; Urkitza, Alfonso; Jones, Gareth J.; Vordermeier, Martin; Garrido, Joseba M.; Juste, Ramon A.			Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; INFLAMMATORY-BOWEL-DISEASE; MYCOBACTERIUM-BOVIS BCG; SKIN-TEST; DIFFERENTIAL-DIAGNOSIS; INFECTED CATTLE; DAIRY-CATTLE; PROTECTION; ANTIGENS; ESAT-6	Paratuberculosis vaccination in cattle has been restricted due to its possible interference with the official diagnostic methods used in tuberculosis eradication programs. To overcome this drawback, new possibilities to detect Mycobacterium bovis infected cattle in paratuberculosis vaccinated animals were studied under experimental conditions. Three groups of 5 calves each were included in the experiment: one paratuberculosis vaccinated group, one paratuberculosis vaccinated and M. bovis infected group and one M. bovis infected group. The performance of the IFN-gamma release assay (IGRA) and the skin test using conventional avian and bovine tuberculins (A- and B-PPD) but also other more specific antigens (ESAT-6/CFP10 and Rv3615c) was studied under official and new diagnostic criteria. Regarding the IGRA of vaccinated groups, when A- and B-PPD were used the sensitivity reached 100% at the first post-challenge sampling, dropping down to 40-80% in subsequent samplings. The sensitivity for the specific antigens was 80-100% and the specificity was also improved. After adapting the diagnostic criteria for the conventional antigens in the skin test, the ability to differentiate between M. bovis infected and non-infected animals included in paratuberculosis vaccinated groups was enhanced. Taking for positive a relative skin thickness increase of at least 100%, the single intradermal test specificity and sensitivity yielded 100%. The comparative intradermal test was equally accurate considering a BPPD relative skin increase of at least 100% and greater than or equal to that produced by APPD. Using the specific antigens as a proteic cocktail, the specificity and sensitivity reached 100% considering the new relative and absolute cut-offs in all experimental groups (0>30% and Delta mm >= 2, respectively). Results suggest that the interference caused by paratuberculosis vaccination in cattle could be completely overcome by applying new approaches to the official tuberculosis diagnostic tests.	[Serrano, Miriam; Elguezabal, Natalia; Sevilla, Iker A.; Geijo, Maria V.; Molina, Elena; Arrazuria, Rakel; Garrido, Joseba M.; Juste, Ramon A.] NEIKER Tecnalia, Basque Inst Agr Res & Dev, Dept Anim Hlth, Derio, Bizkaia, Spain; [Jones, Gareth J.; Vordermeier, Martin] APHA, Dept Bacteriol, TB Immunol & Vaccinol, Surrey, England; [Juste, Ramon A.] SERIDA, Agrifood Res & Dev Reg Serv, Villaviciosa, Asturias, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Garrido, JM (corresponding author), NEIKER Tecnalia, Basque Inst Agr Res & Dev, Dept Anim Hlth, Derio, Bizkaia, Spain.	jgarrido@neiker.eus	Arrazuria, Rakel/O-9982-2016; Elguezabal, Natalia/ABF-8199-2021; Geijo, Maria V./K-6717-2014; Vordermeier, H Martin/C-6936-2011; Sevilla, Iker A/O-6060-2014; Geijo, Maria V./ABC-5808-2021; Serrano, Miriam/ABI-1266-2020; MOLINA, ELENA/L-1001-2014	Arrazuria, Rakel/0000-0002-0757-3915; Geijo, Maria V./0000-0002-3120-1038; Sevilla, Iker A/0000-0003-3968-3390; Geijo, Maria V./0000-0002-3120-1038; Elguezabal, Natalia/0000-0002-8765-5477; MOLINA, ELENA/0000-0001-9630-740X; Joseba M., Garrido/0000-0002-7559-0653; Serrano Azpeitia, Miriam/0000-0002-9579-1911	Departamento de Medio Ambiente, Planificacion del Territorio, Agricultura y Pesca (DMAPTAP) from the Basque Government [OFS2008001]; Departamento de Educacion y Universidades of the Basque Government [PRE_2015_2_0080]	Departamento de Medio Ambiente, Planificacion del Territorio, Agricultura y Pesca (DMAPTAP) from the Basque Government; Departamento de Educacion y Universidades of the Basque Government	This study was supported with funds from the Departamento de Medio Ambiente, Planificacion del Territorio, Agricultura y Pesca (DMAPTAP) from the Basque Government (OFS2008001). MS acknowledges support from the Departamento de Educacion y Universidades of the Basque Government (PRE_2015_2_0080). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aagaard C, 2010, PREV VET MED, V96, P161, DOI 10.1016/j.prevetmed.2010.06.007; Aagaard C, 2006, J CLIN MICROBIOL, V44, P4326, DOI 10.1128/JCM.01184-06; Alonso-Hearn M, 2012, J DAIRY SCI, V95, P618, DOI 10.3168/jds.2009-2860; Alvarez J, 2009, VET MICROBIOL, V135, P389, DOI 10.1016/j.vetmic.2008.09.060; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; BUDDLE BM, 1995, VACCINE, V13, P1123, DOI 10.1016/0264-410X(94)00055-R; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Carta T, 2013, RES VET SCI, V94, P191, DOI 10.1016/j.rvsc.2012.11.002; Casal C, 2012, PREV VET MED, V105, P149, DOI 10.1016/j.prevetmed.2012.02.007; CHIODINI RJ, 1984, ANTIMICROB AGENTS CH, V26, P930, DOI 10.1128/AAC.26.6.930; Elguezabal N, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-6; Flores-Villalva S, 2012, CLIN VACCINE IMMUNOL, V19, P797, DOI 10.1128/CVI.05668-11; Food E Authority S Centre E, 2015, TRENDS SOURC ZOON ZO, P13; Garrido JM, 2013, PLOS ONE, V8, P2; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hasonova L, 2006, VET MED-CZECH, V51, P193, DOI 10.17221/5539-VETMED; Hope JC, 2005, CLIN EXP IMMUNOL, V141, P432, DOI 10.1111/j.1365-2249.2005.02882.x; Howard CJ, 2002, CLIN EXP IMMUNOL, V130, P190, DOI 10.1046/j.1365-2249.2002.01987.x; Juste RA, 2011, VET CLIN N AM-FOOD A, V27, P127, DOI 10.1016/j.cvfa.2010.10.020; Juste Ramon A, 2009, BMC Res Notes, V2, P233, DOI 10.1186/1756-0500-2-233; Juste RA, 2009, INT J INFECT DIS, V13, P247, DOI 10.1016/j.ijid.2008.06.034; Mendoza M, 2015, TRANSBOUNDARY EMERGI; Meng C, 2015, VET IMMUNOL IMMUNOP, V168, P111, DOI 10.1016/j.vetimm.2015.09.001; Ministerio de agricultura alimentaciony medio ambiente, 2014, PROGR NAC ERR TUB BO; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Naser S A, 2004, CULTURE MYCOBACTERIU, V28, P1039; de Val BP, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-191; Rodwell TC, 2010, INT J INFECT DIS, V14, pE129, DOI 10.1016/j.ijid.2009.11.037; Seva J, 2014, VET MICROBIOL, V171, P139, DOI 10.1016/j.vetmic.2014.03.035; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Vordermeier M, 2011, VET MICROBIOL, V151, P8, DOI 10.1016/j.vetmic.2011.02.020; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Whelan AO, 2010, J CLIN MICROBIOL, V48, P3176, DOI 10.1128/JCM.00420-10	34	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169735	10.1371/journal.pone.0169735	http://dx.doi.org/10.1371/journal.pone.0169735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072845	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200041
J	Song, Y; Kim, HD; Lee, MK; Hong, IH; Won, CK; Bai, HW; Lee, SS; Lee, S; Chung, BY; Cho, JH				Song, Yuno; Kim, Hong-Duck; Lee, Min-Kwon; Hong, Il-Hwa; Won, Chung-Kil; Bai, Hyoung-Woo; Lee, Seung Sik; Lee, SungBeom; Chung, Byung Yeoup; Cho, Jae-Hyeon			Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model	PLOS ONE			English	Article							CORN-EARWORM LEPIDOPTERA; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; DISEASE; BETA; RISK; SILK; ANTIOXIDANT; ACTIVATION; INHIBITION	Alzheimer's disease (AD) is a slow, progressive neurodegenerative disease and the most common type of dementia in the elderly. The etiology of AD and its underlying mechanism are still not clear. In a previous study, we found that an ethyl acetate extract of Centipedegrass (CG) (i.e., EA-CG) contained 4 types of Maysin derivatives, including Luteolin, Isoorientin, Rhamnosylisoorientin, and Derhamnosylmaysin, and showed protective effects against Amyloid beta (A beta) by inhibiting oligomeric A beta in cellular and in vitro models. Here, we examined the preventative effects of EA-CG treatment on the A beta burden in the Tg (MoHu APPswe PS1dE9) AD mouse model. We have investigated the EA-CG efficacy as novel anti-AD likely preventing amyloid plaques using immunofluorescence staining to visually analyze A beta 40/42 and fibril formation with Thioflavin-S or 6E10 which are the profile of immunoreactivity against epitope A beta 1-16 or neuritic plaque, the quantitation of humoral immune response against A beta, and the inflammatory cytokine responses (Th1 and Th2) using ELISA and QRT-PCR. To minimize the toxicity of the extracted CG, we addressed the liver toxicity in response to the CG extract treatment in Tg mice using relevant markers, such as aspartate aminotransferase (AST)/alanine aminotransferase (ALT) measurements in serum. The EA-CG extract significantly reduced the A beta burden, the concentration of soluble A beta 40/42 protein, and fibril formation in the hippocampus and cortex of the Tg mice treated with EA-CG (50 mg/kg BW/day) for 6 months compared with the Tg mice treated with a normal diet. Additionally, the profile of anti-inflammatory cytokines revealed that the levels of Th2 (interleukin-4 (IL-4) and interleukin-10 (IL-10)) cytokines are more significantly increased than Th1 (interferon-gamma (IFN-gamma), interleukin-2(IL-2)) in the sera. These results suggest that the EA-CG fraction induces IL-4/IL-10-dependent anti-inflammatory cytokines (Th2) rather than pro-inflammatory cytokines (Th1), which are driven by IL-2/IFN-gamma. With regard to the immune response, EA-CG induced an immunoglobulin IgG and IgM response against the EA-CG treatment in the Tg mice. Furthermore, EA-CG significantly ameliorated the level of soluble A beta 42 and A beta 40. Similarly, we observed that the fibril formation was also decreased by EA-CG treatment in the hippocampus and cortex after quantitative analysis with Thioflavin-S staining in the Tg brain tissues. Taken together, our findings suggested that Maysin and its derivative flavonoid compounds in the EA-CG fraction might be beneficial therapeutic treatments or alternative preventative measures to adjuvant for boosting humoral and cellular include immune response and anti-inflammation which may lead to amyloid plaque accumulation in Alzheimer's patients' brains.	[Song, Yuno; Lee, Min-Kwon; Hong, Il-Hwa; Won, Chung-Kil; Cho, Jae-Hyeon] Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Jinju, South Korea; [Kim, Hong-Duck] New York Med Coll, Dept Environm Hlth Sci, Valhalla, NY 10595 USA; [Bai, Hyoung-Woo; Lee, Seung Sik; Lee, SungBeom; Chung, Byung Yeoup] Korea Atom Energy Inst, Adv Radiat Technol Inst, Jeongeup, South Korea	Gyeongsang National University; New York Medical College; Korea Atomic Energy Research Institute (KAERI)	Cho, JH (corresponding author), Korea Atom Energy Inst, Adv Radiat Technol Inst, Jeongeup, South Korea.	bychung@kaeri.re.kr; jaehcho@gnu.ac.kr			Nuclear R & D Program of the Ministry of Science and Technology; Ministry of Education, National Research Foundation, Korea [2013066165]	Nuclear R & D Program of the Ministry of Science and Technology; Ministry of Education, National Research Foundation, Korea	This project was supported in part by the Nuclear R & D Program of the Ministry of Science and Technology and by the Ministry of Education, National Research Foundation, Korea (No. 2013066165).	Barnes LL, 2015, J INFECT DIS, V211, P230, DOI 10.1093/infdis/jiu437; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Caldeira GL, 2013, J ALZHEIMERS DIS, V34, P115, DOI 10.3233/JAD-121444; Cecchi C, 2002, FREE RADICAL BIO MED, V33, P1372, DOI 10.1016/S0891-5849(02)01049-3; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Choi JS, 2014, ARCH PHARM RES, V37, P1354, DOI 10.1007/s12272-014-0351-3; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cornejo A, 2011, J ALZHEIMERS DIS, V27, P143, DOI 10.3233/JAD-2011-110623; Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526; Eckert A, 2001, J NEUROSCI RES, V64, P183, DOI 10.1002/jnr.1064; Farsi DA, 2008, PHYTOTHER RES, V22, P108, DOI 10.1002/ptr.2275; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Giovagnoli AR, 2006, DEMENT GERIATR COGN, V22, P238, DOI 10.1159/000094972; Godbolt AK, 2004, NEUROLOGY, V63, P1702, DOI 10.1212/01.WNL.0000143060.98164.1A; Goldman JS, 2002, INT J GERIATR PSYCH, V17, P649, DOI 10.1002/gps.657; Grossi C, 2014, NEURODEGENER DIS, V13, P131, DOI 10.1159/000355461; Guo BZ, 2001, J ECON ENTOMOL, V94, P564, DOI 10.1603/0022-0493-94.2.564; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hamidpour Rafie, 2014, J Tradit Complement Med, V4, P140, DOI 10.4103/2225-4110.136540; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; Holtzman JL, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00059; KARLINSKY H, 1992, AM J MED GENET, V44, P591, DOI 10.1002/ajmg.1320440512; Kim HD, 2007, IMMUNOL LETT, V112, P30, DOI 10.1016/j.imlet.2007.06.006; Kim HD, 2007, J GENE MED, V9, P88, DOI 10.1002/jgm.993; Kountouras J, 2010, COGN BEHAV NEUROL, V23, P199, DOI 10.1097/WNN.0b013e3181df3034; LaFontaine MA, 2002, NEUROCHEM RES, V27, P417, DOI 10.1023/A:1015560116208; Lee J, 2014, BMB REP, V47, P382, DOI 10.5483/BMBRep.2014.47.7.191; Lee Jung-Eun, 2013, Exp Neurobiol, V22, P84, DOI 10.5607/en.2013.22.2.84; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009; Longpre F, 2006, FREE RADICAL BIO MED, V41, P1781, DOI 10.1016/j.freeradbiomed.2006.08.015; Luck T, 2015, NEUROPSYCHOLOGY, V29, P382, DOI 10.1037/neu0000147; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Mattson MP, 1997, BRAIN RES, V771, P147, DOI 10.1016/S0006-8993(97)00824-X; Myhrer T, 1998, NEUROSCI BIOBEHAV R, V23, P131, DOI 10.1016/S0149-7634(98)00039-6; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Panza F, 2016, EXPERT OPIN EMERG DR, V6, P1; Panza F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3245935; Pasinetti GM, 1996, NEUROBIOL AGING, V17, P707, DOI 10.1016/0197-4580(96)00113-3; Piscopo P, 2006, NEUROSCI LETT, V398, P124, DOI 10.1016/j.neulet.2005.12.063; Rector BG, 2002, J ECON ENTOMOL, V95, P1303, DOI 10.1603/0022-0493-95.6.1303; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PVB, 2010, NEUROCHEM INT, V56, P780, DOI 10.1016/j.neuint.2010.02.017; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Song Y, 2015, PHARM BIOL, P8, DOI DOI 10.1016/1MARP0LBUL.2015.01.015; St George-Hyslop PH, 2000, ANN NY ACAD SCI, V924, P1; Wang J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00042; WISEMAN BR, 1990, J CHEM ECOL, V16, P2677, DOI 10.1007/BF00988078; Yegambaram M, 2015, CURR ALZHEIMER RES, V12, P116, DOI 10.2174/1567205012666150204121719; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017	55	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169509	10.1371/journal.pone.0169509	http://dx.doi.org/10.1371/journal.pone.0169509			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072821	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200023
J	Ivamoto, ST; Reis, O; Domingues, DS; dos Santos, TB; de Oliveira, FF; Pot, D; Leroy, T; Vieira, LGE; Carazzolle, MF; Pereira, GAG; Pereira, LFP				Ivamoto, Suzana Tiemi; Reis Junior, Osvaldo; Domingues, Douglas Silva; dos Santos, Tiago Benedito; de Oliveira, Fernanda Freitas; Pot, David; Leroy, Thierry; Esteves Vieira, Luiz Gonzaga; Carazzolle, Marcelo Falsarella; Guimaraes Pereira, Goncalo Amarante; Protasio Pereira, Luiz Filipe			Transcriptome Analysis of Leaves, Flowers and Fruits Perisperm of Coffea arabica L. Reveals the Differential Expression of Genes Involved in Raffinose Biosynthesis	PLOS ONE			English	Article							CANDIDATE GENES; PLANT MIRNAS; SMALL RNAS; GENOME; GALACTINOL; EVOLUTION; IDENTIFICATION; GENOTYPES; ELEMENTS; PROJECT	Coffea arabica L. is an important crop in several developing countries. Despite its economic importance, minimal transcriptome data are available for fruit tissues, especially during fruit development where several compounds related to coffee quality are produced. To understand the molecular aspects related to coffee fruit and grain development, we report a large-scale transcriptome analysis of leaf, flower and perisperm fruit tissue development. Illumina sequencing yielded 41,881,572 high-quality filtered reads. De novo assembly generated 65,364 unigenes with an average length of 1,264 bp. A total of 24,548 unigenes were annotated as protein coding genes, including 12,560 full-length sequences. In the annotation process, we identified nine candidate genes related to the biosynthesis of raffinose family oligossacarides (RFOs). These sugars confer osmoprotection and are accumulated during initial fruit development. Four genes from this pathway had their transcriptional pattern validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Furthermore, we identified similar to 24,000 putative target sites for microRNAs (miRNAs) and 134 putative transcriptionally active transposable elements (TE) sequences in our dataset. This C. arabica transcriptomic atlas provides an important step for identifying candidate genes related to several coffee metabolic pathways, especially those related to fruit chemical composition and therefore beverage quality. Our results are the starting point for enhancing our knowledge about the coffee genes that are transcribed during the flowering and initial fruit development stages.	[Ivamoto, Suzana Tiemi] Univ Estadual Londrina, Ctr Ciencias Biol, Programa Posgrad Genet & Biol Mol, Londrina, Brazil; [Ivamoto, Suzana Tiemi; dos Santos, Tiago Benedito; de Oliveira, Fernanda Freitas; Protasio Pereira, Luiz Filipe] Inst Agron Parana IAPAR, Lab Biotecnol Vegetal, Londrina, Brazil; [Reis Junior, Osvaldo; Carazzolle, Marcelo Falsarella; Guimaraes Pereira, Goncalo Amarante] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Genom & Expressao, Campinas, SP, Brazil; [Domingues, Douglas Silva] Univ Estadual Paulista UNESP, Inst Biociencias Rio Claro, Dept Bot, Rio Claro, Brazil; [Pot, David; Leroy, Thierry] UMR AGAP, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Esteves Vieira, Luiz Gonzaga] Univ Oeste Paulista UNOESTE, Programa Pos Grad Agron, Presidente Prudente, Brazil; [Protasio Pereira, Luiz Filipe] Embrapa Cafe, Empresa Brasileira Pesquisa Agr, Brasilia, DF, Brazil	Universidade Estadual de Londrina; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; CIRAD; Universite de Montpellier; Universidade do Oeste Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pereira, LFP (corresponding author), Inst Agron Parana IAPAR, Lab Biotecnol Vegetal, Londrina, Brazil.; Pereira, LFP (corresponding author), Embrapa Cafe, Empresa Brasileira Pesquisa Agr, Brasilia, DF, Brazil.	filipe.pereira@embrapa.br	Domingues, Douglas S/C-7372-2012; UNICAMP, CCES -/J-7787-2015; Vieira, Luiz Gonzaga Esteves/AAJ-5826-2020; Dos Santos, Tiago Benedito/AAC-3192-2019; Ivamoto, Suzana T/B-6808-2017; de Oliveira, Fernanda Freitas/HHS-7333-2022; Carazzolle, Marcelo Falsarella/C-6503-2012; Vieira, Luiz G E/D-2025-2013; Pereira, Luiz Filipe P/G-1606-2012; Pot, David/AAA-3983-2021; Pereira, Gonçalo A. G./B-7944-2012	Domingues, Douglas S/0000-0002-1290-0853; Ivamoto, Suzana T/0000-0001-7078-5809; de Oliveira, Fernanda Freitas/0000-0002-1586-0885; Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Pereira, Luiz Filipe P/0000-0002-2075-9941; Pereira, Luiz Filipe Protasio/0000-0002-4872-6607; Santos, Tiago/0000-0001-5698-7105	Brazilian Coffee Research Consortium, National Institute for Coffee Science and Technology (INCT-Cafe); Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Technological and Scientific Development (CNPq); Brazilian Innovation Agency (FINEP); Center for Computational Engineering and Sciences at Unicamp/SP-Brazil; CAPES; Fundacao Araucaria (FA); CNPq	Brazilian Coffee Research Consortium, National Institute for Coffee Science and Technology (INCT-Cafe); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Innovation Agency (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Center for Computational Engineering and Sciences at Unicamp/SP-Brazil; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We would like to acknowledge the support of the Brazilian Coffee Research Consortium, National Institute for Coffee Science and Technology (INCT-Cafe), Coordination for the Improvement of Higher Education Personnel (CAPES), National Council of Technological and Scientific Development (CNPq), Brazilian Innovation Agency (FINEP) and the Center for Computational Engineering and Sciences at Unicamp/SP-Brazil. STI, TBS and FFO acknowledge CAPES and Fundacao Araucaria (FA) for graduation fellowships. GAGP, DSD, LGEV and LFPP acknowledge CNPq for their research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of the Brazilian Coffee Research Consortium, National Institute for Coffee Science and Technology (INCT-Cafe), Coordination for the Improvement of Higher Education Personnel (CAPES), National Council of Technological and Scientific Development (CNPq), Brazilian Innovation Agency (FINEP) and the Center for Computational Engineering and Sciences at Unicamp/SP-Brazil. STI, TBS and FFO acknowledge CAPES and Fundacao Araucaria (FA) for graduation fellowships. GAGP, DSD, LGEV and LFPP acknowledge CNPq for their research fellowship.	Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bento dos Santos T, 2011, PLANT PHYSIOL BIOCH, V49, P441, DOI 10.1016/j.plaphy.2011.01.023; Bertrand B, 2015, PLANT CELL PHYSIOL, V56, P2035, DOI 10.1093/pcp/pcv117; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Budak H, 2015, FUNCT INTEGR GENOMIC, V15, P523, DOI 10.1007/s10142-015-0451-2; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66; Cenci A, 2012, PLANT MOL BIOL, V78, P135, DOI 10.1007/s11103-011-9852-3; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cotta MG, 2014, PLANT MOL BIOL, V85, P11, DOI 10.1007/s11103-013-0166-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; Davis AP, 2001, BOT J LINN SOC, V167, P357; de Carvalho K, 2014, MOL GENET GENOMICS, V289, P951, DOI 10.1007/s00438-014-0864-y; de Carvalho K, 2013, MOL BIOTECHNOL, V53, P315, DOI 10.1007/s12033-012-9529-4; De Castro Renato D., 2006, Braz. J. Plant Physiol., V18, P175, DOI 10.1590/S1677-04202006000100013; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Dereeper A, 2015, NUCLEIC ACIDS RES, V43, pD1028, DOI 10.1093/nar/gku1108; Dos Santos TB, 2015, GENET MOL BIOL, V38, P182, DOI 10.1590/S1415-475738220140171; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Vieira Luiz Gonzaga Esteves, 2006, Braz. J. Plant Physiol., V18, P95, DOI 10.1590/S1677-04202006000100008; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gangola MP, 2016, PHYTOCHEMISTRY, V125, P88, DOI 10.1016/j.phytochem.2016.02.009; Geromel C, 2006, J EXP BOT, V57, P3243, DOI 10.1093/jxb/erl084; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; ICO. International Coffee Organization, BOT ASP; Joet T, 2014, J EXP BOT, V65, P323, DOI 10.1093/jxb/ert380; Joet T, 2009, NEW PHYTOL, V182, P146, DOI 10.1111/j.1469-8137.2008.02742.x; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin CW, 2005, THEOR APPL GENET, V112, P114, DOI 10.1007/s00122-005-0112-2; Liu Y, 2014, MAR GENOM, V15, P1, DOI 10.1016/j.margen.2014.04.005; Lopes FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078931; Lopes FR, 2008, MOL GENET GENOMICS, V279, P385, DOI 10.1007/s00438-008-0319-4; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marcon HS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0550-1; Mondego JMC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-30; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Morea EGO, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0716-5; Peters S, 2009, PLANT CELL ENVIRON, V32, P1099, DOI 10.1111/j.1365-3040.2009.01991.x; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen S, 2000, Methods Mol Biol, V132, P365; Santos FC, 2015, CHROMOSOME RES, V23, P571, DOI 10.1007/s10577-015-9492-6; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Silva FA., 2009, 7 WORLD C COMP AGR 2; Sun C, 2015, GENOME BIOL EVOL, V7, P3085, DOI 10.1093/gbe/evv206; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Vidal RO, 2010, PLANT PHYSIOL, V154, P1053, DOI 10.1104/pp.110.162438; Vidigal DD, 2016, PLANT SCI, V246, P112, DOI 10.1016/j.plantsci.2016.02.015; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Yuyama PM, 2016, MOL GENET GENOMICS, V291, P323, DOI 10.1007/s00438-015-1111-x; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, P266, DOI 10.1038/nrm3983	64	20	20	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169595	10.1371/journal.pone.0169595	http://dx.doi.org/10.1371/journal.pone.0169595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068432	Green Published, gold			2022-12-26	WOS:000391843900048
J	Ottosson, M; Jakobsson, A; Johansson, F				Ottosson, Maximilian; Jakobsson, Albin; Johansson, Fredrik			Accelerated Wound Closure - Differently Organized Nanofibers Affect Cell Migration and Hence the Closure of Artificial Wounds in a Cell Based In Vitro Model	PLOS ONE			English	Article							ELECTROSPUN NANOFIBERS; POLYMERIC NANOFIBERS; EPITHELIAL-CELLS; TISSUE; ALIGNMENT; FIBROBLASTS; TOPOGRAPHY; SCAFFOLDS; PCL; ORIENTATION	Nanofiber meshes holds great promise in wound healing applications by mimicking the topography of extracellular matrix, hence providing guidance for crucial cells involved in the regenerative processes. Here we explored the influence of nanofiber alignment on fibroblast behavior in a novel in vitro wound model. The model included electrospun poly-epsilon-caprolactone scaffolds with different nanofiber orientation. Fibroblasts were cultured to confluency for 24h before custom-made inserts were removed, creating cell-free zones serving as artificial wounds. Cell migration into these wounds was evaluated at 0-,48- and 96h. Cell morphological analysis was performed using nuclei- and cytoskeleton stainings. Cell viability was assessed using a biochemical assay. This study demonstrates a novel in vitro wound assay, for exploring of the impact of nanofibers on wound healing. Additionally we show that it's possible to affect the process of wound closure in a spatial manner using nanotopographies, resulting in faster closure on aligned fiber substrates.	[Ottosson, Maximilian; Jakobsson, Albin; Johansson, Fredrik] Lund Univ, Dept Biol, Biointerface Grp, Unit Funct Zool, Lund, Sweden	Lund University	Johansson, F (corresponding author), Lund Univ, Dept Biol, Biointerface Grp, Unit Funct Zool, Lund, Sweden.	per_fredrik.johansson@biol.lu.se			NanoLund; Crafoord foundation; Royal Physiographic Society in Lund	NanoLund; Crafoord foundation; Royal Physiographic Society in Lund	The study was funded by grants from NanoLund, Crafoord foundation and Royal Physiographic Society in Lund. For the entire duration of the study all authors were employed by Lund University and none of the funding organizations played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KD, 2008, J MATER SCI-MATER M, V19, P1601, DOI 10.1007/s10856-008-3377-6; Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109; Baecker V., 2012, IMAGEJ US DEV C 2012; Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]; Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gomes SR, 2015, MAT SCI ENG C-MATER, V46, P348, DOI 10.1016/j.msec.2014.10.051; Hu MS, 2014, ANN BIOMED ENG, V42, P1494, DOI 10.1007/s10439-014-1010-z; Johnson J, 2009, J BIOMAT SCI-POLYM E, V20, P467, DOI 10.1163/156856209X416485; Klinkhammer K, 2010, J MATER SCI-MATER M, V21, P2637, DOI 10.1007/s10856-010-4112-7; Kunugi S, 2012, POLYM NANOMEDICINE, Vxi; Liu Y, 2009, EXP CELL RES, V315, P2544, DOI 10.1016/j.yexcr.2009.05.013; Liu Y, 2009, J BIOMED MATER RES A, V90A, P1092, DOI 10.1002/jbm.a.32165; Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; McKee CT, 2011, BIOPHYS J, V101, P2139, DOI 10.1016/j.bpj.2011.09.042; Mudge EJ, 2015, INT WOUND J, V12, P4, DOI 10.1111/iwj.12230; Nelson MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-825; Pelipenko J, 2015, EUR J PHARM SCI, V66, P29, DOI 10.1016/j.ejps.2014.09.022; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Qin SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119094; Raghunathan VK, 2013, J BIOMED MATER RES A, V101, P1069, DOI 10.1002/jbm.a.34417; Saha S, 2012, LANGMUIR, V28, P2028, DOI 10.1021/la203846w; Shang SH, 2010, EUR CELLS MATER, V19, P180, DOI 10.22203/eCM.v019a18; Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604; Stalder AF, 2006, COLLOID SURFACE A, V286, P92, DOI 10.1016/j.colsurfa.2006.03.008; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wu SC, 2010, J VASC SURG, V52, p59S, DOI 10.1016/j.jvs.2010.06.009; Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u	34	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169419	10.1371/journal.pone.0169419	http://dx.doi.org/10.1371/journal.pone.0169419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060880	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500089
J	Palisson, A; Courcou, A; Durand, B				Palisson, Aurore; Courcou, Aurelie; Durand, Benoit			Analysis of the Spatial Organization of Pastures as a Contact Network, Implications for Potential Disease Spread and Biosecurity in Livestock, France, 2010	PLOS ONE			English	Article							CATTLE MOVEMENTS; BLUETONGUE VIRUS; TRADE PATTERNS; EPIDEMIC; INTERNET; HERD	The use of pastures is part of common herd management practices for livestock animals, but contagion between animals located on neighbouring pastures is one of the major modes of infectious disease transmission between herds. At the population level, this transmission is strongly constrained by the spatial organization of pastures. The aim of this study was to answer two questions: (i) is the spatial configuration of pastures favourable to the spread of infectious diseases in France? (ii) would biosecurity measures allow decreasing this vulnerability? Based on GIS data, the spatial organization of pastures was represented using networks. Nodes were the 3,159,787 pastures reported in 2010 by the French breeders to claim the Common Agricultural Policy subsidies. Links connected pastures when the distance between them was below a predefined threshold. Premises networks were obtained by aggregating into a single node all the pastures under the same ownership. Although the pastures network was very fragmented when the distance threshold was short (1.5 meters, relevant for a directly-transmitted disease), it was not the case when the distance threshold was larger (500 m, relevant for a vector-borne disease: 97% of the nodes in the largest connected component). The premises network was highly connected as the largest connected component always included more than 83% of the nodes, whatever the distance threshold. Percolation analyses were performed to model the population-level efficacy of biosecurity measures. Percolation thresholds varied according to the modelled biosecurity measures and to the distance threshold. They were globally high (e.g. >17% of nodes had to be removed, mimicking the confinement of animals inside farm buildings, to obtain the disappearance of the large connected component). The network of pastures thus appeared vulnerable to the spread of diseases in France. Only a large acceptance of biosecurity measures by breeders would allow reducing this structural risk.	[Palisson, Aurore] Univ Paris Sud, Orsay, France; [Palisson, Aurore; Courcou, Aurelie; Durand, Benoit] Univ Paris Est, Hlth Anim Lab, Epidemiol Unit, Anses, Maisons Alfort, France	UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Durand, B (corresponding author), Univ Paris Est, Hlth Anim Lab, Epidemiol Unit, Anses, Maisons Alfort, France.	benoit.durand@anses.fr	Durand, Benoit/GSE-2511-2022	Durand, Benoit/0000-0003-0669-1394	Paris Sud University; French Ministry of Agriculture; Anses, the French Agency for Food Safety	Paris Sud University; French Ministry of Agriculture; Anses, the French Agency for Food Safety	This work was supported by the Paris Sud University, the French Ministry of Agriculture and the Anses, the French Agency for Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Buttner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074292; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Csardi G, 2006, INTER J; Dube C, 2011, PREV VET MED, V99, P102, DOI 10.1016/j.prevetmed.2011.01.013; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; Elbers ARW, 2013, EMER INFECT DIS, V19; Faburay B, 2016, VIROLOGY, V489, P128, DOI 10.1016/j.virol.2015.12.003; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Kiss IZ, 2006, J R SOC INTERFACE, V3, P55, DOI 10.1098/rsif.2005.0079; Kluiters G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0657-0; Lentz HHK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118701; Lentz HHK, 2016, PLOS ONE, V11; Leskovec J, 2016, ACM T INTEL SYST TEC, P8; Lindberg ALE, 1999, VET MICROBIOL, V64, P197, DOI 10.1016/S0378-1135(98)00270-3; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Munroe FA, 1999, PREV VET MED, V41, P119, DOI 10.1016/S0167-5877(99)00051-3; Mweu MM, 2013, PREV VET MED, V110, P379, DOI 10.1016/j.prevetmed.2013.02.015; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Nusinovici S, 2015, EFFECT WIND COXIELLA; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Palisson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152578; Pebesma E.J., 2005, R NEWS, V5; Pioz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085444; R Core Team, 2021, R LANGUAGE ENV STAT; Rautureau S, 2010, TRANSBOUND EMERG DIS; Saegerman C, 2012, ITAL J PUBLIC HLTH, V9; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Sahimi M, 1994, APPL PERCOLATION THE; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; Valle PS, 1999, PREV VET MED, V40, P165, DOI 10.1016/S0167-5877(99)00030-6; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	48	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169881	10.1371/journal.pone.0169881	http://dx.doi.org/10.1371/journal.pone.0169881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060913	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500143
J	Liu, X; Rahman, T; Yang, F; Song, C; Yong, TW; Liu, J; Zhang, CY; Yang, WY				Liu, Xin; Rahman, Tanzeelur; Yang, Feng; Song, Chun; Yong, Taiwen; Liu, Jiang; Zhang, Cuiying; Yang, Wenyu			PAR Interception and Utilization in Different Maize and Soybean Intercropping Patterns	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; USE EFFICIENCY; LIGHT INTERCEPTION; SIMULATION-MODEL; SYSTEMS; PRODUCTIVITY; CANOPY; YIELD; SOILS	The crop intercepted photosynthetically active radiation (PAR) and radiation use efficiency (RUE) vary markedly in different intercropping systems. The HHLA (horizontally homogeneous leaf area) and ERCRT (extended row crop radiation transmission) models have been established to calculate the intercepted PAR for intercrops. However, there is still a lack of study on the intercepted PAR and RUE under different intercropping configurations using different models. To evaluate the intercepted PAR and RUE in maize and soybean under different intercropping systems, we tested different strip intercropping configurations (SI 1, S12, and S13 based on ERCRT model) and a row intercropping configurations (RI based on HHLA model) in comparison to monoculture. Our results showed that the intercepted PAR and RUE of intercropping systems were all higher than those of monoculture. The soybean intercepted PAR in strip intercropping was 1.35 times greater than that in row intercropping. In row intercropping (RI), the lack of soybean intercepted PAR resulted in a significant reduction of soybean dry matter. Therefore, it is not the recommended configuration for soybean. In strip intercropping patterns, with the distance between maize strip increased by 0.2 m, the intercepted PAR of soybean increased by 20%. The S12 (maize row spacing at 0.4 m and the distance between maize strip at 1.6 m) was the recommended configuration to achieve the highest value of intercepted PAR and RUE among tested strip intercropping configurations. The method of dry matter estimation using intercepted PAR and RUE is useful in simulated experiments. The simulated value was verified in comparison with experimental data, which confirmed the credibility of the simulation model. Moreover, it also provides help in the development of functional-structural plant model (FSPM).	[Liu, Xin; Rahman, Tanzeelur; Yang, Feng; Yong, Taiwen; Liu, Jiang; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Yang, Feng; Song, Chun; Yong, Taiwen; Liu, Jiang; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China; [Yang, Feng; Song, Chun; Yong, Taiwen; Liu, Jiang; Yang, Wenyu] Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Peoples R China; [Song, Chun] Sichuan Agr Univ, Inst Ecol & Environm Sci, Chengdu, Peoples R China; [Zhang, Cuiying] Meteorol Bur, Heze, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.; Yang, WY (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China.; Yang, WY (corresponding author), Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Peoples R China.	mssiyangwy@sicau.edu.cn	Song, Chun/B-8298-2019	Song, Chun/0000-0001-9927-2599	National Key Research and Development Program of China [2016YFD0300209, 2016YFD0300602]; National Natural Science Foundation [31571615]; Program on Industrial Technology System of National Soybean [CARS-04-PS19]	National Key Research and Development Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program on Industrial Technology System of National Soybean	The research was supported by the National Key Research and Development Program of China (grant numbers 2016YFD0300209, 2016YFD0300602), the National Natural Science Foundation (grant number 31571615), and Program on Industrial Technology System of National Soybean (grant number CARS-04-PS19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Bouman BAM, 1996, AGR SYST, V52, P171, DOI 10.1016/0308-521X(96)00011-X; Daroub SH, 2003, AGR SYST, V76, P1157, DOI 10.1016/S0308-521X(02)00082-3; Echarte L, 2011, FIELD CROP RES, V121, P423, DOI 10.1016/j.fcr.2011.01.011; Gao Y, 2010, AGRON J, V102, P1149, DOI 10.2134/agronj2009.0409; Goudriaan J., 1977, CROP MICROMETEOROLOG; HARRIS D, 1987, FIELD CROP RES, V17, P259, DOI 10.1016/0378-4290(87)90039-6; KEATING BA, 1993, FIELD CROP RES, V34, P273, DOI 10.1016/0378-4290(93)90118-7; KINIRY JR, 1989, FIELD CROP RES, V20, P51, DOI 10.1016/0378-4290(89)90023-3; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lizaso JI, 2011, AGRON J, V103, P766, DOI 10.2134/agronj2010.0423; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; Oseni T. O., 2010, Journal of Agricultural Science (Toronto), V2, P229; Pronk AA, 2003, NJAS-WAGEN J LIFE SC, V51, P279, DOI 10.1016/S1573-5214(03)80020-9; Rodriguez-Navarro D.N., 2011, AGRON SUSTAIN DEV, V31, P173, DOI DOI 10.1051/agro/2010023; SIVAKUMAR MVK, 1984, AGR FOREST METEOROL, V31, P131, DOI 10.1016/0168-1923(84)90015-7; Tsubo M, 2002, AGR FOREST METEOROL, V110, P203, DOI 10.1016/S0168-1923(01)00287-8; Tsubo M, 2001, FIELD CROP RES, V71, P17, DOI 10.1016/S0378-4290(01)00142-3; Undie U. L., 2012, Journal of Agricultural Science (Toronto), V4, P37; Wang ZK, 2015, AGR FOREST METEOROL, V204, P58, DOI 10.1016/j.agrformet.2015.02.004; WILES LJ, 1991, AGR SYST, V35, P37, DOI 10.1016/0308-521X(91)90145-Z; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014	23	69	76	10	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169218	10.1371/journal.pone.0169218	http://dx.doi.org/10.1371/journal.pone.0169218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056056	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100025
J	Moraes, MMT; Galvao, MC; Cabral, D; Coelho, CP; Queiroz-Hazarbassanov, N; Martins, MFM; Bondan, EF; Bernardi, MM; Kirsten, TB				Moraes, Marcia M. T.; Galvao, Marcella C.; Cabral, Danilo; Coelho, Cideli P.; Queiroz-Hazarbassanov, Nicolle; Martins, Maria F. M.; Bondan, Eduardo F.; Bernardi, Maria M.; Kirsten, Thiago Berti			Propentofylline Prevents Sickness Behavior and Depressive-Like Behavior Induced by Lipopolysaccharide in Rats via Neuroinflammatory Pathway	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; NEUROTROPHIC FACTOR; DOUBLE-BLIND; MAJOR DEPRESSION; TNF-ALPHA; BRAIN; MICE; INFLAMMATION; ASTROCYTES; DISORDERS	Recent studies have demonstrated the intimate relationship between depression and immune disturbances. Aware of the efficacy limits of existing antidepressant drugs and the potential anti-inflammatory properties of propentofylline, we sought to evaluate the use of propentofylline as a depression treatment. We used a rat model of depression induced by repetitive lipopolysaccharide (LPS) administrations. We have studied sickness behavior, by assessing daily body weight, open field behavior, and TNF-alpha plasmatic levels. Anxiety-like behavior (light-dark test), depressive-like behavior (forced swim test), plasmatic levels of the brain-derived neurotrophic factor (BDNF, depression biomarker), and central glial fibrillary acidic protein (GFAP) expression (an astrocyte biomarker) were also evaluated. LPS induced body weight loss, open field behavior impairments (decreased locomotion and rearing, and increased immobility), and increased TNF-alpha levels in rats, compared with control group. Thus, LPS induced sickness behavior. LPS also increased the immobility and reduced climbing in the forced swim test, when compared with the control group, i.e., LPS induced depressive-like behavior in rats. Propentofylline prevented sickness behavior after four days of consecutive treatment, as well as prevented the depressive-like behavior after five days of consecutive treatments. Propentofylline also prevented the increase in GFAP expression induced by LPS. Neither LPS nor propentofylline has influenced the anxiety and BDNF levels of rats. In conclusion, repetitive LPS administrations induced sickness behavior and depressive-like behavior in rats. Propentofylline prevented both sickness behavior and depressive-like behavior via neuroinflammatory pathway. The present findings may contribute to a better understanding and treatment of depression and associated diseases.	[Moraes, Marcia M. T.; Cabral, Danilo; Martins, Maria F. M.; Bondan, Eduardo F.; Bernardi, Maria M.; Kirsten, Thiago Berti] Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil; [Galvao, Marcella C.; Queiroz-Hazarbassanov, Nicolle; Kirsten, Thiago Berti] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Coelho, Cideli P.] Univ Santo Amaro, Grad Program Anim Med & Welf, Sao Paulo, Brazil	Universidade Paulista; Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Kirsten, TB (corresponding author), Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil.; Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	thik@outlook.com	Bernardi, M. M./H-8418-2012; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; Bondan, Eduardo F./D-5417-2016; Kirsten, Thiago Berti/AAS-2166-2021; Bernardi, Maria/T-6813-2019	Bernardi, M. M./0000-0002-6860-9416; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Bondan, Eduardo F./0000-0002-3887-0023; Kirsten, Thiago Berti/0000-0002-4032-4355; Martins, Maria de Fatima/0000-0002-3970-0659; Coelho, Cideli/0000-0002-0492-1822	Sao Paulo Research Foundation (FAPESP) [2014/25113-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio) [1029/2014]; Paulista University (UNIP) [7-02-1001/2016]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio); Paulista University (UNIP)	This research was supported by the Sao Paulo Research Foundation (FAPESP grant 2014/25113-5) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio 1029/2014), and Paulista University (UNIP grant no. 7-02-1001/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589; Bay-Richter C, 2011, BEHAV BRAIN RES, V222, P193, DOI 10.1016/j.bbr.2011.03.060; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bondan EF, 2014, MICROSC RES TECHNIQ, V77, P23, DOI 10.1002/jemt.22308; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Carroll LJ, 2003, J CLIN EPIDEMIOL, V56, P651, DOI 10.1016/S0895-4356(03)00118-5; Clark D C, 1990, Crisis, V11, P104; Colman I, 2010, CAN J PSYCHIAT, V55, P622, DOI 10.1177/070674371005501002; Connor TJ, 2002, NEUROIMMUNOMODULAT, V10, P367, DOI 10.1159/000071478; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; de Paiva VN, 2010, BEHAV BRAIN RES, V215, P146, DOI 10.1016/j.bbr.2010.07.015; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Drzyzga LR, 2009, BRAIN RES BULL, V79, P248, DOI 10.1016/j.brainresbull.2009.03.009; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Garcia-Caceres C, 2013, ENDOCRIN METAB CLIN, V42, P57, DOI 10.1016/j.ecl.2012.11.003; Gough B, 2014, NEUROCHEM INT, V76, P109, DOI 10.1016/j.neuint.2014.07.003; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Jenkins E, 2012, DEPRESS RES TREAT, V2012, DOI DOI 10.1016/J.BIOPSYCH.2009.09.033; Joaquim A., 2015, REPROD FERTIL DEV; Jung S, 1997, J AUTOIMMUN, V10, P519, DOI 10.1006/jaut.1997.0159; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kirsten TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120263; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Levine JB, 1999, GLIA, V28, P215; Li NX, 2011, INT J NEUROPSYCHOPH, V14, P1091, DOI 10.1017/S1461145710001082; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; LONNQVIST JK, 1995, PSYCHIAT CLIN NEUROS, V49, pS111, DOI 10.1111/j.1440-1819.1995.tb01912.x; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; [NCR National Research Council. Committee for the Update of the Guide for the Care and Use of Laboratory Animals], 2011, GUIDE CARE USE LAB A; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Patti CL, 2005, PHARMACOL BIOCHEM BE, V81, P923, DOI 10.1016/j.pbb.2005.07.004; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Raedler TJ, 2011, CURR OPIN PSYCHIATR, V24, P519, DOI 10.1097/YCO.0b013e32834b9db6; Ribeiro DE, 2013, PHARMACOL BIOCHEM BE, V103, P535, DOI 10.1016/j.pbb.2012.09.022; Ridet JL, 1996, CELL TISSUE RES, V283, P39; SHIMIZU K, 1993, NEUROSCI LETT, V158, P9, DOI 10.1016/0304-3940(93)90599-G; Smialowska M, 2013, PHARMACOL REP, V65, P1572; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Soncini R, 2012, NEUROSCI LETT, V516, P114, DOI 10.1016/j.neulet.2012.03.070; Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	59	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169446	10.1371/journal.pone.0169446	http://dx.doi.org/10.1371/journal.pone.0169446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056040	gold, Green Submitted, Green Published			2022-12-26	WOS:000391639100042
J	Xu, TW; Xu, SX; Hu, LY; Zhao, N; Liu, Z; Ma, L; Liu, HJ; Zhao, XQ				Xu, Tianwei; Xu, Shixiao; Hu, Linyong; Zhao, Na; Liu, Zhe; Ma, Li; Liu, Hongjin; Zhao, Xinquan			Effect of Dietary Types on Feed Intakes, Growth Performance and Economic Benefit in Tibetan sheep and Yaks on the Qinghai-Tibet Plateau during Cold Season	PLOS ONE			English	Article							CRUDE PROTEIN-LEVEL; CARCASS CHARACTERISTICS; HIGH-ALTITUDE; DAIRY-COWS; CHINA; SILAGE; SUPPLEMENTATION; DIGESTIBILITY; ADAPTATION; GRASSLAND	Pastoralists on the Tibetan alpine rangeland suffered great economic loss in cold season, due to serious live-weight loss of domestic livestock under traditional grazing management. This study aimed to evaluate the effect of dietary types (crude protein levels) on feed intakes, growth performance and economic returns of local Tibetan sheep and yaks during cold season. Twenty-four yearling Tibetan sheep (25.29 +/- 3.95 kg LW) and twenty two-year old yaks (100.62 +/- 4.55 kg LW) with familiar body conditions were randomly assigned to four groups, fed oats hay (OH), oats silage (OS), total mixed ration (TMR) and traditionally grazed on the local cool-season pasture (TG), respectively, over a 135-day experiment. Daily dry matter intake was determined; all animals were weighed at the beginning and every 15 days of the 135-day experiment. Then, the total live-weight gain, average daily live-weight gain, gain rate, feed efficiency and net economic benefit were calculated. Results indicated that feed and nutrient intakes (DMI, DMI/kg LW, DMI/kg LW0.75 and CPI) of TMR, OH and OS were higher than TG (P< 0.05). Grazing animals suffered serious live weight loss, while TMR, OS and OH significantly (P < 0.05) improved total live-weight gain and gain rate in both Tibetan sheep and yaks during the entire experiment. TMR worked better in animal performance and feed efficiency, obtained the highest breeding profit in both Tibetan sheep and yaks among four treatments (P < 0.05). When expressed on net economic benefit, TMR shared the highest net economic benefit in Tibetan sheep, OH shared the highest net economic benefit in yaks, but, no significant difference of net economic benefit in yaks fed TMR and OH diets was determined (P> 0.05). Results indicated that TMR was a reasonable diet in promoting feed intakes, animal performance, feed efficiency and economic returns in domestic livestock, which should be considered by local herdsmen to increase their breeding profit during cold season.	[Xu, Tianwei; Xu, Shixiao; Hu, Linyong; Zhao, Na; Liu, Zhe; Ma, Li; Liu, Hongjin; Zhao, Xinquan] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Peoples R China; [Xu, Tianwei; Liu, Zhe; Ma, Li; Liu, Hongjin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Tianwei; Xu, Shixiao; Hu, Linyong; Zhao, Na; Ma, Li; Liu, Hongjin; Zhao, Xinquan] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Xu, SX; Zhao, XQ (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Peoples R China.; Xu, SX; Zhao, XQ (corresponding author), Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China.	sxxu@nwipb.cas.cn; xqzhao@nwipb.cas.cn	Liu, Hongjin/GRE-8828-2022		"Strategic Leading Science & Technology Program" of the Chinese Academy of Sciences [XDA05070200]; National Key Technology Support Program [2012BAD13B01, 2014BAC05B00]; "Science and Technology Service Network Initiative" of the Chinese Academy of Sciences [KFJ-SW-STS-177]; "Key Technology Support Program" of Qinghai Province [2014-NS-118, 2014-NS-112, 2015-SF-A4-2]	"Strategic Leading Science & Technology Program" of the Chinese Academy of Sciences; National Key Technology Support Program(National Key Technology R&D Program); "Science and Technology Service Network Initiative" of the Chinese Academy of Sciences; "Key Technology Support Program" of Qinghai Province	This work was supported by "Strategic Leading Science & Technology Program" of the Chinese Academy of Sciences (XDA05070200), "National Key Technology Support Program" (2012BAD13B01, 2014BAC05B00), "Science and Technology Service Network Initiative" of the Chinese Academy of Sciences (KFJ-SW-STS-177) and "Key Technology Support Program" of Qinghai Province (2014-NS-118, 2014-NS-112, 2015-SF-A4-2). All funding was received by Shixiao Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Atti N, 2004, SMALL RUMINANT RES, V54, P89, DOI 10.1016/j.smallrumres.2003.09.010; Cantalapiedra-Hijar G, 2009, J ANIM SCI, V87, P622, DOI 10.2527/jas.2008-1142; Chen GJ, 2015, J ANIM SCI, V28, P1736; Chen XB, 1997, ACTA ZOONUTRIMENTA S, V9, P57; Ding GengZhi, 2013, Chinese Journal of Animal Nutrition, V25, P248; Dong QM, 2006, LIVEST SCI, V101, P199, DOI 10.1016/j.livprodsci.2005.11.009; Dong SK, 2003, CAN J ANIM SCI, V83, P141, DOI 10.4141/A01-097; DURMOWICZ AG, 1993, J APPL PHYSIOL, V74, P2276, DOI 10.1152/jappl.1993.74.5.2276; [方精云 Fang Jingyun], 2015, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V30, P848; Feng JH, 2002, ECOL DOMESTIC ANIM, V23, P34; Groff EB, 2005, J DAIRY SCI, V88, P3619, DOI 10.3168/jds.S0022-0302(05)73047-2; Hajji H, 2015, ANIM PROD SCI; [郝力壮 Hao Lizhuang], 2013, [吉林农业科学, Journal of Jilin Agricultural Sciences], V38, P56; [黄建辉 Huang Jianhui], 2016, [科学通报, Chinese Science Bulletin], V61, P213; Karlsson L, 2011, LIVEST SCI, V138, P125, DOI 10.1016/j.livsci.2010.12.010; Li RL, 2012, CHINA HERBIVORES, P324; [刘兴元 Liu Xingyuan], 2012, [生态学报, Acta Ecologica Sinica], V32, P7688; Long RJ, 2008, RANGELAND J, V30, P241, DOI 10.1071/RJ08012; Long RJ, 2005, LIVEST PROD SCI, V93, P197, DOI 10.1016/j.livprodsci.2004.08.016; Long RJ, 1999, ANIM FEED SCI TECH, V80, P101, DOI 10.1016/S0377-8401(99)00057-7; Long RJ, 1999, PREV VET MED, V38, P195, DOI 10.1016/S0167-5877(98)00125-1; Michael R., 1995, ADV DAIRY TECH, V251, P257; Ministry of Environmental Protection of China, 2002, GB38382002, P1; Mulligan FJ, 2002, LIVEST PROD SCI, V77, P311, DOI 10.1016/S0301-6226(02)00030-1; Negesse T, 2001, SMALL RUMINANT RES, V39, P243, DOI 10.1016/S0921-4488(00)00193-0; Phengvichith V, 2007, TROP ANIM HEALTH PRO, V39, P59, DOI 10.1007/s11250-006-4443-z; Phillips CJC, 2001, J DAIRY SCI, V84, P1979, DOI 10.3168/jds.S0022-0302(01)74641-3; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; REDDY KJ, 1985, INDIAN J ANIM SCI, V55, P819; Shi QingHe, 1999, Acta Zoonutrimenta Sinica, V11, P51; Si BW, 2014, CHIN ANIM HUSBANDRY, V41, P131; Sun Y, 2015, RANGELAND J, V37, P181, DOI 10.1071/RJ14062; Tian LiHua, 2016, Journal of Southwest University for Nationalities - Natural Science Edition, V42, P119; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang CT, 2009, LAND DEGRAD DEV, V20, P187, DOI 10.1002/ldr.879; Wen L, 2013, CHINA PLOS ONE, V8, DOI [DOI 10.1371/JOURNAL.PONE.0058432, 10.1371/journal.pone.0058432]; Wen YL., 1993, J SW NATION COLL, V19, P236; Xin GS, 2011, LIVEST SCI, V136, P102, DOI 10.1016/j.livsci.2010.08.007; Xue B, 2005, J ANIM SCI, V83, P1908; Yan JP, 2016, P 2015 INT C SUST DE, P471; Yu G, 2005, INT GEOSCI REMOTE SE, P2961; Zaman MS, 2002, ANIM FEED SCI TECH, V99, P1, DOI 10.1016/S0377-8401(02)00148-7; Zhang B, 2010, FEED REV, V7, P21; Zhang JK, 2004, ANIM HUSBANDRY FEED, V25, P1; Zhang WJ, 2008, CHIN J ANIM SCI, V44, P58; [张宪洲 Zhang Xianzhou], 2015, [科学通报, Chinese Science Bulletin], V60, P3048; [赵亮 Zhao Liang], 2014, [第四纪研究, Quaternary Sciences], V34, P795; Zhao XQ, 1999, AMBIO, V28, P642; Zhao XQ, 2002, RESOUR SCI, V22, P50; Zhao XQ, 2011, ECORESTORING DEGRAD, P366; Zhao Z, 2005, CHINA HERBIVORES, V25, P14	52	33	43	12	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169187	10.1371/journal.pone.0169187	http://dx.doi.org/10.1371/journal.pone.0169187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056054	Green Submitted, Green Published, gold			2022-12-26	WOS:000391639100024
J	Tang, TT; Rendon, DA; Zawaski, JA; Afshar, SF; Kaffes, CK; Sabek, OM; Gaber, MW				Tang, Tien T.; Rendon, David A.; Zawaski, Janice A.; Afshar, Solmaz F.; Kaffes, Caterina K.; Sabek, Omaima M.; Gaber, M. Waleed			Imaging Radiation-Induced Gastrointestinal, Bone Marrow Injury and Recovery Kinetics Using F-18-FDG PET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INFLAMMATORY-BOWEL-DISEASE; TOTAL-BODY IRRADIATION; CROHNS-DISEASE; FDG-PET; NONINVASIVE ASSESSMENT; IONIZING-RADIATION; INTESTINAL-MUCOSA; MODEL; CANCER	Positron emission tomography using F-18-Fluro-deoxy-glucose (F-18-FDG) is a useful tool to detect regions of inflammation in patients. We utilized this imaging technique to investigate the kinetics of gastrointestinal recovery after radiation exposure and the role of bone marrow in the recovery process. Male Sprague-Dawley rats were either sham irradiated, irradiated with their upper half body shielded (UHBS) at a dose of 7.5 Gy, or whole body irradiated (WBI) with 4 or 7.5 Gy. Animals were imaged using F-18-FDG PET/CT at 5, 10 and 35 days post-radiation exposure. The gastrointestinal tract and bone marrow were analyzed for (18)FFDG uptake. Tissue was collected at all-time points for histological analysis. Following 7.5 Gy irradiation, there was a significant increase in inflammation in the gastrointestinal tract as indicated by the significantly higher F-18-FDG uptake compared to sham. UHBS animals had a significantly higher activity compared to 7.5 Gy WBI at 5 days post-exposure. Animals that received 4 Gy WBI did not show any significant increase in uptake compared to sham. Analysis of the bone marrow showed a significant decrease of uptake in the 7.5 Gy animals 5 days post-irradiation, albeit not observed in the 4 Gy group. Interestingly, as the metabolic activity of the gastrointestinal tract returned to sham levels in UHBS animals it was accompanied by an increase in metabolic activity in the bone marrow. At 35 days post-exposure both gastrointestinal tract and bone marrow F-18-FDG uptake returned to sham levels. (18)FFDG imaging is a tool that can be used to study the inflammatory response of the gastrointestinal tract and changes in bone marrow metabolism caused by radiation exposure. The recovery of the gastrointestinal tract coincides with an increase in bone marrow metabolism in partially shielded animals. These findings further demonstrate the relationship between the gastrointestinal syndrome and bone marrow recovery, and that this interaction can be studied using non-invasive imaging modalities.	[Tang, Tien T.; Gaber, M. Waleed] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Rendon, David A.; Zawaski, Janice A.; Kaffes, Caterina K.; Gaber, M. Waleed] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Afshar, Solmaz F.; Sabek, Omaima M.] Houston Methodist Hosp, Dept Surg, Res Inst, Houston, TX USA	Rice University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Gaber, MW (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Gaber, MW (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	gaber@bcm.edu		sabek, omaima/0000-0003-0919-0093; gaber, Mostafa/0000-0002-6192-0367; Tang, Tien/0000-0002-4242-6822; Zawaski, Janice/0000-0002-1355-6863	 [HDTRA 1-10-1-0026]		This work was supported by HDTRA 1-10-1-0026 (http://www.dtra.mil/Research/BasicandAppliedScienceDepartment/ResearchFundingOpportunities.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Brewer S, 2008, GASTROENTEROLOGY, V135, P744, DOI 10.1053/j.gastro.2008.06.040; CARSTEN AL, 1964, RADIAT RES, V22, P136, DOI 10.2307/3571704; CASARETT ALISON P., 1968; Cook GJR, 1999, EUR J NUCL MED, V26, P1363, DOI 10.1007/s002590050597; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Elicin O, 2014, INT J RADIAT ONCOL, V90, P1099, DOI 10.1016/j.ijrobp.2014.08.017; Gao CX, 2015, MBIO, V6, DOI 10.1128/mBio.01358-15; Garg S, 2010, RADIAT RES, V173, P469, DOI 10.1667/RR1742.1; GMUR J, 1983, BLOOD, V61, P746; HARVEY RF, 1980, LANCET, V1, P514; Higashi T, 2000, J NUCL MED, V41, P2026; Jones JW, 2015, HEALTH PHYS, V109, P440, DOI 10.1097/HP.0000000000000347; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kesner AL, 2008, J APPL CLIN MED PHYS, V9, P147, DOI 10.1120/jacmp.v9i3.2747; Knebel AR, 2011, DISASTER MED PUBLIC, V5, pS20, DOI 10.1001/dmp.2011.25; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; KUBOTA R, 1992, J NUCL MED, V33, P1972; Leide-Svegborn S, 2010, RADIAT PROT DOSIM, V139, P208, DOI 10.1093/rpd/ncq026; Loffler M, 2006, ANN NY ACAD SCI, V1072, P379, DOI 10.1196/annals.1326.014; Louis E, 2007, J NUCL MED, V48, P1053, DOI 10.2967/jnumed.107.040436; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Meisner RS, 2007, INFLAMM BOWEL DIS, V13, P993, DOI 10.1002/ibd.20134; Neurath MF, 2002, AM J GASTROENTEROL, V97, P1978; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Rendon DA, 2016, J NUCL MED, V57, P266, DOI 10.2967/jnumed.115.158121; Richter KK, 1997, ASS GRANULOCYTE TRAN, V5, P275, DOI [10.1002/(SICI)1520-6823(1997)5:6<275::AID-3.0.CO;2-V, DOI 10.1002/(SICI)1520-6823(1997)5:275::AID-3.0.CO;2-V]; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024072; SATO F, 1973, Journal of Radiation Research, V14, P115, DOI 10.1269/jrr.14.115; Satyamitra MM, 2016, RADIAT RES, V186, P99, DOI 10.1667/RR14436.1; SCARANTINO CW, 1984, RADIOTHER ONCOL, V2, P215, DOI 10.1016/S0167-8140(84)80062-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; van Kouwen MCA, 2006, NUCL MED BIOL, V33, P245, DOI 10.1016/j.nucmedbio.2005.11.003; van Waarde A, 2004, J NUCL MED, V45, P695; VIGNEULLE RM, 1989, RADIAT RES, V119, P313, DOI 10.2307/3577622; WAHL RL, 1994, RADIOLOGY, V191, P371, DOI 10.1148/radiology.191.2.8153308; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weisdorf D, 2006, BIOL BLOOD MARROW TR, V12, P672, DOI 10.1016/j.bbmt.2006.02.006; WITHERS HR, 1968, RADIOLOGY, V91, P998, DOI 10.1148/91.5.998	44	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169082	10.1371/journal.pone.0169082	http://dx.doi.org/10.1371/journal.pone.0169082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052129	gold, Green Published, Green Submitted			2022-12-26	WOS:000391621500032
J	Tsuchida, Y; Sumitomo, S; Ishigaki, K; Suzuki, A; Kochi, Y; Tsuchiya, H; Ota, M; Komal, T; Inoue, M; Morita, K; Okamura, T; Yamamoto, K; Fujio, K				Tsuchida, Yumi; Sumitomo, Shuji; Ishigaki, Kazuyoshi; Suzuki, Akari; Kochi, Yuta; Tsuchiya, Haruka; Ota, Mineto; Komal, Toshihiko; Inoue, Mariko; Morita, Kaoru; Okamura, Tomohisa; Yamamoto, Kazuhiko; Fujio, Keishi			TGF-beta 3 Inhibits Antibody Production by Human B Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; TGF-BETA; TARGETED DISRUPTION; MOUSE DEVELOPMENT; GENE-EXPRESSION; GERMINAL CENTER; IGA PRODUCTION; PLASMA-CELLS; IN-VIVO	TGF-beta is a pleotropic cytokine involved in various biological processes. Of the three isoforms of TGF-beta, TGF-beta 1 has long been recognized as an important inhibitory cytokine in the immune system and has been reported to inhibit B cell function in both mice and humans. Recently, it has been suggested that TGF-beta 3 may play an important role in the regulation of immune system in mice. Murine CD4(+)CD25(-)LAG3(+) regulatory T cells suppress B cell function through the production of TGF-beta 3, and it has been reported that TGF-beta 3 is therapeutic in a mouse model of systemic lupus erythematosus. The effect of TGF-beta 3 on human B cells has not been reported, and we herein examined the effect of TGF-beta 3 on human B cells. TGF-beta 3 suppressed B cell survival, proliferation, differentiation into plasmablasts, and antibody secretion. Although the suppression of human B cells by TGF-beta 1 has long been recognized, the precise mechanism for the suppression of B cell function by TGF-beta 1 remains elusive; therefore, we examined the effect of TGF-beta 1 and beta 3 on pathways important in B cell activation and differentiation. TGF-beta 1 and TGF-beta 3 inhibited some of the key molecules of the cell cycle, as well as transcription factors important in B cell differentiation into antibody secreting cells such as IRF4, Blimp-1, and XBP1. TGF-beta 1 and beta 3 also inhibited B cell receptor signaling. Our results suggest that TGF-beta 3 modifying therapy might be therapeutic in autoimmune diseases with B cell dysregulation in humans.	[Tsuchida, Yumi; Sumitomo, Shuji; Ishigaki, Kazuyoshi; Tsuchiya, Haruka; Ota, Mineto; Komal, Toshihiko; Inoue, Mariko; Morita, Kaoru; Okamura, Tomohisa; Yamamoto, Kazuhiko; Fujio, Keishi] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Ishigaki, Kazuyoshi; Suzuki, Akari; Kochi, Yuta] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Okamura, Tomohisa] Univ Tokyo, Max Planck Univ Tokyo Ctr Integrat Inflammol, Tokyo, Japan	University of Tokyo; RIKEN; University of Tokyo	Fujio, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan.	kfujio-tky@umin.ac.jp	Ishigaki, Kazuyoshi/ABF-6926-2021; Ota, Mineto/AAX-1503-2021; Kochi, Yuta/P-4487-2018; Suzuki, Akari/N-5389-2015; Sumitomo, Shuji/N-5570-2019	Ota, Mineto/0000-0003-4552-8573; Sumitomo, Shuji/0000-0003-4980-2664; Komai, Toshihiko/0000-0001-5890-3606; Inoue, Mariko/0000-0002-2482-7753	Ministry of Education, Culture, Sports, Science and Technology, KAKENHI from Japan Society for the Promotion of Science [23229007, 15K19566]; Grants-in-Aid for Scientific Research [15K19566] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, KAKENHI from Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, KAKENHI Grant-in-Aid for Scientific Research (S) (23229007) (received by KY and KF) and KAKENHI Grant-in-Aid for Young Scientists (B) (15K19566) (received by SS) from Japan Society for the Promotion of Science [https://www.jsps.go.jp/english/e-grants/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Bakhshayesh M, 2012, CL LYMPH MYELOM LEUK, V12, P138, DOI 10.1016/j.clml.2011.12.001; Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Bouchard C, 1997, J IMMUNOL, V159, P4155; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Caron G, 2015, CELL REP, V13, P1059, DOI 10.1016/j.celrep.2015.09.051; Cerutti A, 1998, J IMMUNOL, V160, P2145; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Chen G, 2012, J BIOL CHEM, V287, P23184, DOI 10.1074/jbc.M112.351411; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; DANG H, 1995, J IMMUNOL, V155, P3205; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Fleischer SJ, 2014, ARTHRITIS RHEUMATOL, V66, P3424, DOI 10.1002/art.38854; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Hall BE, 2013, J BIOL CHEM, V288, P32074, DOI 10.1074/jbc.M113.480764; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; KEHRL JH, 1989, J IMMUNOL, V143, P1868; KEHRL JH, 1991, J IMMUNOL, V146, P4016; Klein J, 2006, J IMMUNOL, V176, P2389, DOI 10.4049/jimmunol.176.4.2389; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lawrie CH, 2009, LEUKEMIA, V23, P581, DOI 10.1038/leu.2008.223; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Okamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7329; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; PELTON RW, 1990, DEVELOPMENT, V110, P609; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmid CA, 2015, J EXP MED, V212, P775, DOI 10.1084/jem.20141957; SHAH M, 1995, J CELL SCI, V108, P985; Shah S, 2008, EUR J IMMUNOL, V38, P2488, DOI 10.1002/eji.200838201; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Spender LC, 2013, J BIOL CHEM, V288, P5198, DOI 10.1074/jbc.M112.410274; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; VANVLASSELAER P, 1992, J IMMUNOL, V148, P2062; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	53	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169646	10.1371/journal.pone.0169646	http://dx.doi.org/10.1371/journal.pone.0169646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052118	gold, Green Submitted, Green Published			2022-12-26	WOS:000391621500070
J	Gao, MM; Liu, YP; Ma, X; Shuai, Q; Gai, JY; Li, Y				Gao, Mengmeng; Liu, Yaping; Ma, Xiao; Shuai, Qin; Gai, Junyi; Li, Yan			Evaluation of Reference Genes for Normalization of Gene Expression Using Quantitative RT-PCR under Aluminum, Cadmium, and Heat Stresses in Soybean	PLOS ONE			English	Article							HOUSEKEEPING GENES; GLYCINE-MAX; AGRICULTURAL SOILS; IDENTIFICATION; ZN; PB; CD; ACCUMULATION; ADAPTATION; VALIDATION	Quantitative reverse transcription polymerase chain reaction (qRT-PCR) is widely used to analyze the relative gene expression level, however, the accuracy of qRT-PCR is greatly affected by the stability of reference genes, which is tissue-and environment-dependent. Therefore, choosing the most stable reference gene in a specific tissue and environment is critical to interpret gene expression patterns. Aluminum (Al), cadmium (Cd), and heat stresses are three important abiotic factors limiting soybean (Glycine max) production in southern China. To identify the suitable reference genes for normalizing the expression levels of target genes by qRT-PCR in soybean response to Al, Cd and heat stresses, we studied the expression stability of ten commonly used housekeeping genes in soybean roots and leaves under these three abiotic stresses, using five approaches, BestKeeper, Delta Ct, geNorm, NormFinder and RefFinder. We found TUA4 is the most stable reference gene in soybean root tips under Al stress. Under Cd stress, Fbox and UKN2 are the most stable reference genes in roots and leaves, respectively, while 60S is the most suitable reference gene when analyzing both roots and leaves together. For heat stress, TUA4 and UKN2 are the most stable housekeeping genes in roots and leaves, respectively, and UKN2 is the best reference gene for analysis of roots and leaves together. To validate the reference genes, we quantified the relative expression levels of six target genes that were involved in soybean response to Al, Cd or heat stresses, respectively. The expression patterns of these target genes differed between using the most and least stable reference genes, suggesting the selection of a suitable reference gene is critical for gene expression studies.	[Gao, Mengmeng; Liu, Yaping; Ma, Xiao; Shuai, Qin; Gai, Junyi; Li, Yan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Ctr Soybean Improvement, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, Y (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Natl Ctr Soybean Improvement, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China.	yanli1@njau.edu.cn	Li, Yan/AAF-5886-2019	Li, Yan/0000-0002-1627-7763	National Natural Science Foundation of China [31371645]; Fundamental Research Funds for the Central Universities; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT13073]; Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (31371645) to YL (Li), the Fundamental Research Funds for the Central Universities to YL (Li), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT13073) to YL (Li), and the Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province to YL (Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fang XL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2730-2; Finger-Teixeira A, 2010, ECOTOX ENVIRON SAFE, V73, P1959, DOI 10.1016/j.ecoenv.2010.08.021; Ge LQ, 2015, ENVIRON SCI POLLUT R, V22, P15835, DOI 10.1007/s11356-015-4760-8; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; Hossain Z, 2012, AMINO ACIDS, V43, P2393, DOI 10.1007/s00726-012-1319-6; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Salazar MJ, 2012, J HAZARD MATER, V233, P244, DOI 10.1016/j.jhazmat.2012.07.026; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kochian LV, 2015, ANNU REV PLANT BIOL, V66, P571, DOI 10.1146/annurev-arplant-043014-114822; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Liang CY, 2013, PLANT PHYSIOL, V161, P1347, DOI 10.1104/pp.112.208934; Liu JG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2559-8; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CA, 2010, J HAZARD MATER, V182, P743, DOI 10.1016/j.jhazmat.2010.06.097; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Maejima Y, 2007, CHEMOSPHERE, V67, P748, DOI 10.1016/j.chemosphere.2006.10.038; MAFFJ, 2002, SURVEY CADMIUM CONTA; Marfa V, 2014, PLANT CELL ENVIRON, V37, P1672, DOI [10.1111/pce.12280, DOI 10.1111/PCE.12280]; Nawrot T, 2010, J BONE MINER RES, V25, P1441, DOI 10.1002/jbmr.22; Noriega GO, 2007, BIOMETALS, V20, P841, DOI 10.1007/s10534-006-9077-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Siebers MH, 2015, GLOBAL CHANGE BIOL, V21, P3114, DOI 10.1111/gcb.12935; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xue ZC, 2014, ENVIRON SCI POLLUT R, V21, P4656, DOI 10.1007/s11356-013-2433-z; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zhao L, 2013, PLANT MOL BIOL, V82, P279, DOI 10.1007/s11103-013-0062-z; Zhao YY, 2014, B ENVIRON CONTAM TOX, V92, P427, DOI 10.1007/s00128-014-1218-5; Zhu BG, 2006, J PLANT RES, V119, P247, DOI 10.1007/s10265-006-0267-1	43	31	34	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0168965	10.1371/journal.pone.0168965	http://dx.doi.org/10.1371/journal.pone.0168965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046130	Green Published, Green Submitted, gold			2022-12-26	WOS:000391612300080
J	Makarewicz, O; Lucas, M; Brandt, C; Herrmann, L; Albersmeier, A; Ruckert, C; Blom, J; Goesmann, A; van der Linden, M; Kalinowski, J; Pletz, MW				Makarewicz, Oliwia; Lucas, Marie; Brandt, Christian; Herrmann, Leonie; Albersmeier, Andreas; Rueckert, Christian; Blom, Jochen; Goesmann, Alexander; van der Linden, Mark; Kalinowski, Joern; Pletz, Mathias W.			Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15B	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; FLUOROQUINOLONE RESISTANCE; ANTIMICROBIAL RESISTANCE; UNITED-STATES; GENETIC-STRUCTURE; TOPOISOMERASE-IV; DNA GYRASE; EFFLUX	Streptococcus pneumoniae is a major pathogen that causes different invasive pneumococcal diseases (IPD). The pneumococcal polysaccharide capsule is a main virulence factor. More than 94 capsule types have been described, but only a limited number of capsule types accounted for the majority of IPD cases before the introduction of pneumococcal vaccines. After the introduction of the conjugated pneumococcal vaccine PCV7, which covered the seven most frequent serotypes in IPD in the USA, an increase in IPD caused by non vaccine serotypes was observed, and serotype 19A, which belongs to sequence type (ST) 199, was among the most prevalent STs. After the introduction of the extended vaccine PCV13, which includes serotype 19A, serogroup 15B/C increased in IPD. Therefore, whole genome sequences of 39 isolates of ST199 from Germany (collected between 1998 and 2011) with serotype 19A (n = 24) and serogroup 15B/C (n = 15) were obtained using an Illumina platform and were analysed to identify capsular switches within ST199. Two 19A to 15B/C serotype switch events were identified. Both events occurred before the introduction of PCV7, which indicates that a capsular switch from 19A to 15B among ST199 isolates is not unusual and is not directly linked to the vaccination. The observed serotype replacement appears to be the result of a vacant niche due to the displacement of vaccine serotypes that is now successfully occupied by ST199 clones.	[Makarewicz, Oliwia; Lucas, Marie; Brandt, Christian; Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany; [Herrmann, Leonie; Albersmeier, Andreas; Rueckert, Christian; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechol, Bielefeld, Germany; [Blom, Jochen; Goesmann, Alexander] Justus Liebig Univ Giessen, Inst Bioinformat & Syst Biol, Giessen, Germany; [van der Linden, Mark] Univ Hosp RWTH Aachen, German Natl Reference Ctr Streptococci, Aachen, Germany; [Rueckert, Christian] MIT, Dept Biol, Cambridge, MA USA	Friedrich Schiller University of Jena; University of Bielefeld; Justus Liebig University Giessen; RWTH Aachen University; RWTH Aachen University Hospital; Massachusetts Institute of Technology (MIT)	Makarewicz, O (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany.	oliwia.makarwicz@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019; van der Linden, Mark/B-9305-2009	Pletz, Mathias Wilhelm/0000-0001-8157-2753; van der Linden, Mark/0000-0002-6574-4313; Brandt, Christian/0000-0002-7199-3957; Ruckert-Reed, Christian/0000-0002-9722-4435; Goesmann, Alexander/0000-0002-7086-2568; Makarewicz, Oliwia/0000-0002-4404-1862	Federal Ministry of Education and Research [01KI1204, 01KI1501, 13GW0096D]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was funded by the Federal Ministry of Education and Research, grant numbers 01KI1204 (MWP), 01KI1501 (MWP) and 13GW0096D (OM) (https://www.bmbf.de/en/index.html).	Ambrose KD, 2005, ANTIMICROB AGENTS CH, V49, P4203, DOI 10.1128/AAC.49.10.4203-4209.2005; BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; Baylay AJ, 2015, ANTIMICROB AGENTS CH, V59, P3098, DOI 10.1128/AAC.04858-14; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brenwald NP, 2003, CLIN MICROBIOL INFEC, V9, P140, DOI 10.1046/j.1469-0691.2003.00482.x; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Conklin LM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-015-1312-2; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Del Grosso M, 2013, J MED MICROBIOL, V62, P1220, DOI 10.1099/jmm.0.061242-0; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Di Guilmi AM, 2003, J BACTERIOL, V185, P1650, DOI 10.1128/JB.185.5.1650-1658.2003; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Ferroni A, 2001, J MED MICROBIOL, V50, P828, DOI 10.1099/0022-1317-50-9-828; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; Gardete S, 2004, J BACTERIOL, V186, P1705, DOI 10.1128/JB.186.6.1705-1713.2004; Gill MJ, 1999, ANTIMICROB AGENTS CH, V43, P187, DOI 10.1128/AAC.43.1.187; Granger D, 2006, J ANTIMICROB CHEMOTH, V57, P61, DOI 10.1093/jac/dki401; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Imohl Matthias, 2010, Int J Microbiol, V2010, P874189, DOI 10.1155/2010/874189; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones ME, 2003, CLIN MICROBIOL INFEC, V9, P590, DOI 10.1046/j.1469-0691.2003.00573.x; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leal J, 2012, PEDIATR INFECT DIS J, V31, pE169, DOI 10.1097/INF.0b013e3182624a40; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Liyanapathirana V, 2015, DIAGN MICR INFEC DIS, V81, P66, DOI 10.1016/j.diagmicrobio.2014.09.028; Marrer E, 2006, ANTIMICROB AGENTS CH, V50, P685, DOI 10.1128/AAC.50.2.685-693.2006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; MUNOZ R, 1992, MOL MICROBIOL, V6, P2461; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pestova E, 1999, ANTIMICROB AGENTS CH, V43, P2000, DOI 10.1128/AAC.43.8.2000; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pletz MW, 2014, EUR RESPIR MONOGR, P266, DOI 10.1183/1025448x.10004913; Pletz MWR, 2006, ANTIMICROB AGENTS CH, V50, P1561, DOI 10.1128/AAC.50.4.1561-1563.2006; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Putnam SD, 2000, CLIN MICROBIOL INFEC, V6, P2, DOI 10.1046/j.1469-0691.2000.00001.x; Ramdani-Bouguessa N., 2015, New Microbes and New Infections, V6, P42, DOI 10.1016/j.nmni.2015.02.008; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Smith AM, 2005, ANTIMICROB AGENTS CH, V49, P4622, DOI 10.1128/AAC.49.11.4622-4627.2005; Smith AM, 2003, ANTIMICROB AGENTS CH, V47, P387, DOI 10.1128/AAC.47.1.387-389.2003; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; Thomas JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018649; Todorova K, 2015, MOL MICROBIOLOGY; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van der Linden M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0941-9; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	69	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2017	12	1							e0169370	10.1371/journal.pone.0169370	http://dx.doi.org/10.1371/journal.pone.0169370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2QJ	28046133	Green Published, gold, Green Submitted			2022-12-26	WOS:000391612300176
J	Porter, EG; Dykhuizen, EC				Porter, Elizabeth G.; Dykhuizen, Emily C.			Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; RECOGNITION; MUTATIONS; COMPLEX; H3	The architecture of chromatin is governed, in part, by ATP-dependent chromatin remodelers. These multiprotein complexes contain targeting domains that recognize post-translational marks on histones. One such targeting domain is the bromodomain (BD), which recognizes acetyl-lysines and recruits proteins to sites of acetylation across the genome. Polybromo1 (PBRM1), a subunit of the Polybromo-associated BRG1- or hBRM-associated factors (PBAF) chromatin remodeler, contains six tandem BDs and is frequently mutated in clear cell renal cell carcinoma (ccRCC). Mutations in the PBRM1 gene often lead to the loss of protein expression; however, missense mutations in PBRM1 have been identified and tend to cluster in the BDs, particularly BD2 and BD4, suggesting that individual BDs are critical for PBRM1 function. To study the role of these six BDs, we inactivated each of the six BDs of PBRM1 and re-expressed these mutants in Caki2 cells (ccRCC cells with the loss of function mutation in PBRM1). Four of the six BDs abrogated PBRM1 tumor suppressor function, gene regulation, and chromatin affinity with the degree of importance correlating strongly to the rate of missense mutations in patients. Furthermore, we identified BD2 as the most critical for PBRM1 and confirmed BD2-mediated association to histone H3 peptides acetylated at lysine 14 (H3K14Ac), validating the importance of this specific acetylation mark for PBRM1 binding. From these data, we conclude that four of the BDs act together to target PBRM1 to sites on chromatin; when a single BD is mutated, PBRM1 no longer controls gene expression properly, leading to increased cell proliferation.	[Porter, Elizabeth G.; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, HANS105,201 S Univ St, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dykhuizen, EC (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, HANS105,201 S Univ St, W Lafayette, IN 47907 USA.	edykhui@purdue.edu		dykhuizen, emily/0000-0003-3072-1469	National Institutes of Health [P30 CA023168]; NATIONAL CANCER INSTITUTE [U01CA207532, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sanger sequencing data were acquired by the Purdue Genomics Facility supported by National Institutes of Health Grant P30 CA023168. We thank Laura Deemer for assistance with cloning and mutagenesis, and Brian Smith from Medical College of Wisconsin for helpful discussion.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Charlop-Powers Z, 2010, CELL RES, V20, P529, DOI 10.1038/cr.2010.43; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Myrianthopoulos V, 2016, J MED CHEM, V59, P8787, DOI 10.1021/acs.jmedchem.6b00355; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Sanchez OF, 2015, TALANTA, V140, P212, DOI 10.1016/j.talanta.2015.03.046; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	31	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2601	2610		10.1074/jbc.M116.746875	http://dx.doi.org/10.1074/jbc.M116.746875			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053089	hybrid, Green Published			2022-12-26	WOS:000395535100004
J	Zhao, JF; Li, BW; Huang, XC; Morelli, X; Shi, N				Zhao, Jianfeng; Li, Bowen; Huang, Xiaochen; Morelli, Xavier; Shi, Ning			Structural Basis for the Interaction between Golgi Reassembly-stacking Protein GRASP55 and Golgin45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL SECRETION; COMPLEX; GROWTH; LOCALIZATION; EXPRESSION; GM130; JEM-1; ER	Golgin45 is required for normal Golgi structure and the transportation of protein from the ER. It forms a specific complex with GRASP55 in vivo. Little is known regarding the molecular details of this interaction and its structural role in stacking of the Golgi complex. Here, we present the crystal structure of the GRASP domains of GRASP55 in complex with the Golgin45 C-terminal peptide, determined at 1.33 a resolutn. Similar to the structure of GRASP65 bound to GM130 reported recently, this structure reveals more than one interacting site and involves both PDZ1 and PDZ2 domains of the GRASP simultaneously. The C-terminal peptides of Golgin45 and GM130 present a conserved PDZ domain binding motif sequence and recognize the canonical PDZ-peptide binding groove of the PDZ1 domains of GRASP55 and GRASP65. A main difference in this recognition process resides in a structural rearrangement of GRASP65-GM130 that does not occur for the GRASP55-Golgin45 complex. The binding site at the cleft between the PDZ1 and PDZ2 domains of GRASP65 is dominated by hydrophobic interactions with GM130 that are not observed in the GRASP55-Golgin45 complex. In addition, a unique zinc finger structure is revealed in the GRASP55-Golgin45 complex crystal structure. Mutagenesis experiments support these structural observations and demonstrate that two of these sites are required to form a stable complex. Finally, a novel Golgi stacking model is proposed according to these structural findings.	[Zhao, Jianfeng; Li, Bowen; Huang, Xiaochen; Shi, Ning] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Morelli, Xavier] Aix Marseille Univ, CRCM, INSERM, CNRS,Inst Paoli Calmettes, F-13009 Marseille, France	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Shi, N (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, 155 Yangqiao Rd W, Fuzhou 350002, Peoples R China.	shining@fjirsm.ac.cn	morelli, xavier/A-9218-2016	morelli, xavier/0000-0001-8101-7901	National Natural Science Foundation of China [31370738]; Hundred Talents Program of the Chinese Academy of Sciences; Agence Nationale de la Recherche [NR-15-CE18-0023]; Campus France [26203WD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Agence Nationale de la Recherche(French National Research Agency (ANR)); Campus France	This work was supported by National Natural Science Foundation of China Grant 31370738 and Hundred Talents Program of the Chinese Academy of Sciences and Campus France (Partenariats Hubert Curien CAI YUANPEI 2013 International program between France and China) Project 26203WD. This work was also supported by the Agence Nationale de la Recherche Grant NR-15-CE18-0023. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Ekkapongpisit M, 2007, J MED VIROL, V79, P552, DOI 10.1002/jmv.20806; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng YB, 2013, J BIOL CHEM, V288, P28418, DOI 10.1074/jbc.M113.478024; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; He P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040435; Hu F, 2015, J BIOL CHEM, V290, P26373, DOI 10.1074/jbc.M115.657940; Huang RY, 2015, BIOCHEM BIOPH RES CO, V467, P602, DOI 10.1016/j.bbrc.2015.08.119; Kim J, 2016, TRAFFIC, V17, P733, DOI 10.1111/tra.12403; Koldehoff M, 2008, INT J HEMATOL, V87, P39, DOI 10.1007/s12185-007-0013-z; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Lee I, 2014, P NATL ACAD SCI USA, V111, P1849, DOI 10.1073/pnas.1323895111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Pacaud R, 2014, BIOCHIMIE, V104, P36, DOI 10.1016/j.biochi.2014.05.005; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Rabouille C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00001; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Stein MF, 2015, BIOCHEM BIOPH RES CO, V459, P42, DOI 10.1016/j.bbrc.2015.02.057; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Tang DM, 2012, BIOL OPEN, V1, P1204, DOI 10.1242/bio.20122659; Tong JH, 1999, LEUKEMIA, V13, P1982, DOI 10.1038/sj.leu.2401560; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang XY, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00084; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	38	23	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2956	2965		10.1074/jbc.M116.765990	http://dx.doi.org/10.1074/jbc.M116.765990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049725	hybrid, Green Published			2022-12-26	WOS:000395535100035
J	Gonzalez-Costa, JJ; Reigosa, MJ; Matias, JM; Fernandez-Covelo, E				Jose Gonzalez-Costa, Juan; Joaquin Reigosa, Manuel; Maria Matias, Jose; Fernandez-Covelo, Emma			Analysis of the Importance of Oxides and Clays in Cd, Cr, Cu, Ni, Pb and Zn Adsorption and Retention with Regression Trees	PLOS ONE			English	Article							HEAVY-METALS; SIMULTANEOUS SORPTION; ACID SOILS; REMEDIATION; DESORPTION; ACCUMULATION; CADMIUM; COPPER; ZINC; LEAD	This study determines the influence of the different soil components and of the cation-exchange capacity on the adsorption and retention of different heavy metals: cadmium, chromium, copper, nickel, lead and zinc. In order to do so, regression models were created through decision trees and the importance of soil components was assessed. Used variables were: humified organic matter, specific cation-exchange capacity, percentages of sand and silt, proportions of Mn, Fe and Al oxides and hematite, and the proportion of quartz, plagioclase and mica, and the proportions of the different clays: kaolinite, vermiculite, gibbsite and chlorite. The most important components in the obtained models were vermiculite and gibbsite, especially for the adsorption of cadmium and zinc, while clays were less relevant. Oxides are less important than clays, especially for the adsorption of chromium and lead and the retention of chromium, copper and lead.	[Jose Gonzalez-Costa, Juan; Joaquin Reigosa, Manuel; Fernandez-Covelo, Emma] Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain; [Maria Matias, Jose] Univ Vigo, Dept Stat & Operat Res, Vigo, Spain	Universidade de Vigo; Universidade de Vigo	Reigosa, MJ (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Vigo, Spain.	mreigosa@uvigo.es	Reigosa, Manuel J/K-3551-2013; Roger, Manuel Joaquín Reigosa/O-4438-2019; Matías, José María/O-2704-2013	Reigosa, Manuel J/0000-0003-0527-1849; Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Matías, José María/0000-0003-3751-5043	Spanish Ministry of Education and Science [MTM2008-03010 Xunta de Galicia GRC 2015/12, MTM2008-03010]	Spanish Ministry of Education and Science(Spanish Government)	Support was provided by the Spanish Ministry of Education and Science under Grant No. MTM2008-03010 Xunta de Galicia GRC 2015/12.; We would like to thank the other members of the soil quality team, and especially its director, Maria Luisa Andrade, for the usefulness of their insights on the approaches regarding this issue at the meetings which preceded this study. J.M. Matias' research is funded by the Spanish Ministry of Education and Science under Grant No. MTM2008-03010.	Adeleye AS, 2016, CHEM ENG J, V286, P640, DOI 10.1016/j.cej.2015.10.105; Aguilar J, 2007, WATER AIR SOIL POLL, V180, P109, DOI 10.1007/s11270-006-9254-3; Ahmad-Ansuri ML, 2006, J EXP BIOL, P73; [Anonymous], 1999, WORLD REF BAS SOIL R; Arazi T, 1999, PLANT J, P161; Auso EA, 2007, J HAZARD MATER, P191; Becherucci ME, 2014, THALASSAS, V30, P9; Bi XY, 2007, SCI TOTAL ENVIRON, V387, P257, DOI 10.1016/j.scitotenv.2007.07.059; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bloomfield C, 1981, TRANSLOCATION METALS; Boonfueng T, 2005, J COLLOID INTERF SCI, V281, P80, DOI 10.1016/j.jcis.2004.08.048; Cervantes C, 2006, Rev Latinoam Microbiol, V48, P203; Chaturvedi PK, 2008, J HAZARD MATER, P698; Connell Does W, 1997, BASIC CONCEPTS ENV C; Covelo EF, 2008, J HAZARD MATER, V159, P342, DOI 10.1016/j.jhazmat.2008.02.025; Covelo EF, 2008, GEODERMA, V147, P75, DOI 10.1016/j.geoderma.2008.08.001; Covelo EF, 2007, J HAZARD MATER, V147, P852, DOI 10.1016/j.jhazmat.2007.01.123; Covelo EF, 2007, J HAZARD MATER, V147, P862, DOI 10.1016/j.jhazmat.2007.01.108; Covelo EF, 2007, J HAZARD MATER, V140, P308, DOI 10.1016/j.jhazmat.2006.09.018; Covelo EF, 2004, J COLLOID INTERF SCI, V280, P1, DOI 10.1016/j.jcis.2004.07.024; Covelo EF, 2005, THESIS; Dilks RT, 2016, CHEMOSPHERE, V146, P385, DOI 10.1016/j.chemosphere.2015.12.062; Dong DM, 2007, MICROCHEM J, V85, P270, DOI 10.1016/j.microc.2006.06.015; Eren E, 2008, J HAZARD MATER, V159, P235, DOI 10.1016/j.jhazmat.2008.02.035; Espino-Saldana AF, 2002, THESIS; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Fontes MPF, 2000, COMMUN SOIL SCI PLAN, V31, P2939, DOI 10.1080/00103620009370640; Gascova OL, 2008, PHYS CHEM EARTH, P1050; Gought LP, 1979, BULLETIN, V1466; Guitian F., 1976, TECNICAS ANALISIS SU; Hastie E T, 1990, GEN ADITIVE MODELS; HASTIE T, 2001, DATA MINING INFERENC; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jasso-Chavez R, 2003, EUROPEAN J BIOCH, P4942; Kesavan K, 2013, THALASSAS, V29, P15; Kesavan K, 2010, THALASSAS, V26, P35; Le Countre DT, 2001, THESIS; Lindsai WL, 1995, HEAVY METALS SOILS; Marmiroli M, 2005, ENVIRON POLLUT, V134, P217, DOI 10.1016/j.envpol.2004.08.004; McKenzie RM, 1971, GEODERMA, P29; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Mendoza-Cozati D, 2006, J THEOR BIOL, P919; Mohapatra M, 2007, J HAZARD MATER, V148, P553, DOI 10.1016/j.jhazmat.2007.03.008; Navarro M, 1997, COMP BIOCH PHYSL, P265; Navarro-Avino JP, 2007, ECOSISTEMAS, V16, P10; Nelly S, 2007, J HAZARD MATER, P226; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Park M, 2007, APPL CLAY SCI, V37, P143, DOI 10.1016/j.clay.2006.12.006; Pereira WG, 2002, J PLANT PHYSL, P513; Shang Shihh S, 2015, SOIL SEDIMENT CONTAM, V14, P559; Singh A, 2015, INT J ENVIRON SCI TE, V12, P353, DOI 10.1007/s13762-014-0542-y; Sipos P, 2008, CHEMOSPHERE, V73, P461, DOI 10.1016/j.chemosphere.2008.06.046; Susplugas S, 2002, J PLANT PHYSL, P503; Tejada M, 2007, J EXPT CHEM, V66, P226; The R Project, 2011, PACK RPART; Therneau TM, 2011, INTRO RECURSIVE SPLI; Turek M, 2005, SOIL SEDIMENT CONTAM, V14, P143, DOI 10.1080/15320380590911797; Vanthuyne M., 2007, Land Contamination & Reclamation, V15, P15, DOI 10.2462/09670513.844; Vega FA, 2010, J HAZARD MATER, V174, P522, DOI 10.1016/j.jhazmat.2009.09.083; Vega FA, 2009, J HAZARD MATER, V167, P615, DOI 10.1016/j.jhazmat.2009.01.016; Vega FA, 2010, J HAZARD MATER, P1; Wang X, 2008, CHEMOSPHERE, V72, P1260, DOI 10.1016/j.chemosphere.2008.05.001; Yadav R, 2010, ECOTOXICOLOGY, V19, P1574, DOI 10.1007/s10646-010-0543-7; Yuhua W, 2008, MINER ENG, P913; Zeng C, 2008, ENVIRON POLLUT, P470	65	18	18	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0168523	10.1371/journal.pone.0168523	http://dx.doi.org/10.1371/journal.pone.0168523			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072849	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200004
J	Agarwal, P; Gammon, EA; Sajib, AM; Sandey, M; Smith, BF				Agarwal, Payal; Gammon, Elizabeth A.; Sajib, Abdul Mohin; Sandey, Maninder; Smith, Bruce F.			Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin	PLOS ONE			English	Article							GENE-THERAPY; HEMATOPOIETIC-CELLS; VECTOR; EXPRESSION; DELIVERY; CANCER; REPLICATION; INFECTION; RECEPTOR	Adenoviruses are the most widely used vectors in cancer gene therapy. Adenoviruses vectors are well characterized and are easily manipulated. Adenovirus serotype 5 (Ad5) is the most commonly used human serotype. Ad5 internalization into host cells is a combined effect of binding of Ad5 fiber knob with the coxsackie virus and adenovirus receptor (CAR) and binding of RGD motifs in viral penton to cell surface integrins (av beta 3, av beta 5). Ad5's wide range of host-cell transduction and lack of integration into the host genome have made it an excellent choice for cancer therapeutics. However, Ad5 has limited ability to transduce cells of hematopoietic origin. It has been previously reported that low or no expression of CAR is a potential obstacle to Ad5 infection in hematopoietic origin cells. In addition, we have previously reported that low levels of cell surface integrins (av beta 3, av beta 5) may inhibit Ad5 infection in canine lymphoma cell lines. In the current report we have examined the ability of an Ad5 vector to infect human (HEK293) and canine non-cancerous (NCF and PBMC), canine non-hematopoietic origin cancer (CMT28, CML7, and CML10), and canine hematopoietic origin cancer (DH82, 17-71, OSW, MPT-1, and BR) cells. In addition, we have quantified CAR, av beta 3 and av beta 5 integrin transcript expression in these cells by using quantitative reverse transcriptase PCR (q-RT-PCR). Low levels of integrins were present in MPT1, 17-71, OSW, and PBMC cells in comparison to CMT28, DH82, and BR cells. CAR mRNA levels were comparatively higher in MPT1, 17-71, OSW, and PBMC cells. This report confirms and expands the finding that low or absent expression of cell surface integrins may be the primary reason for the inability of Ad5-based vectors to transduce cells of lymphocytic origin and some myeloid cells but this is not true for all hematopoietic origin cells. For efficient use of Ad5-based therapeutic vectors in cancers of lymphocytic origin, it is important to address the defects in cell surface integrins.	[Agarwal, Payal; Gammon, Elizabeth A.; Sajib, Abdul Mohin; Sandey, Maninder; Smith, Bruce F.] Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA; [Sandey, Maninder; Smith, Bruce F.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Smith, BF (corresponding author), Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA.; Smith, BF (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	smithbf@auburn.edu	Sajib, Abdul Mohin/AAO-1031-2021	Sajib, Abdul Mohin/0000-0001-5655-3147; Agarwal, Payal/0000-0002-1688-2680				Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Fowles JS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0942-8; Grellier E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-105; Hamed HA, 2013, CANCER BIOL THER, V14, P1039, DOI 10.4161/cbt.26110; Hemmi S, 1998, HUM GENE THER, V9, P2363, DOI 10.1089/hum.1998.9.16-2363; Huang S, 1996, J VIROL, V70, P4502, DOI 10.1128/JVI.70.7.4502-4508.1996; Ji N, 2015, ONCOTARGET; Kang S, 2014, BIOCHEM BIOPH RES CO, V453, P480, DOI 10.1016/j.bbrc.2014.09.107; Kibbe MR, 2000, ARCH SURG-CHICAGO, V135, P191, DOI 10.1001/archsurg.135.2.191; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Marini FC, 2000, CANCER GENE THER, V7, P816, DOI 10.1038/sj.cgt.7700174; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; North American Association of Central Cancer Registeries, 2015, CANC N AM 2008 2012, VTwo; O'Neill AM, 2011, CANCER BIOL THER, V11, P651, DOI 10.4161/cbt.11.7.14690; Program PCO, 2015, CAN LYMPH; Rogozhin VN, 2011, ACTA NATURAE, V3, P100, DOI 10.32607/20758251-2011-3-3-100-106; Seo HK, 2014, ONCOTARGET, V5, P5615, DOI 10.18632/oncotarget.2151; Stewart B, 2014, WORLD CANC REPORT 20; Tookman LA, 2015, MOL CANC RES; Vijayalingam S, 2009, VIROLOGY, V392, P62, DOI 10.1016/j.virol.2009.06.048; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xie H, 2014, BMB REP, V47, P104, DOI 10.5483/BMBRep.2014.47.2.090; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169532	10.1371/journal.pone.0169532	http://dx.doi.org/10.1371/journal.pone.0169532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068367	Green Published, gold, Green Submitted			2022-12-26	WOS:000391843900043
J	Lee, LH; Hwang, JI; Cheng, YC; Wu, CY; Lee, SW; Yang, SS; Yeh, HZ; Chang, CS; Lee, TY				Lee, Lu-Hung; Hwang, Jen-I; Cheng, Yu-Chi; Wu, Chun-Ying; Lee, Shou-Wu; Yang, Sheng-Shun; Yeh, Hong-Zen; Chang, Chi-Sen; Lee, Teng-Yu			Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RADIO-FREQUENCY ABLATION; SURGICAL RESECTION; ETHANOL INJECTION; CT; ULTRASONOGRAPHY; FEASIBILITY; SONOGRAPHY; MANAGEMENT; IMPROVES	Objectives To compare the efficacy and safety of ultrasound (US) and computed tomography (CT) in the guidance of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Materials and Methods We retrospectively analyzed consecutive treatment-naive patients who received curative RFA for HCC from January 2008 to July 2013. Patients were divided into the US group or the CT group according to their RFA guidance instruments. Patients who were only suitable for US-or CT-guided RFA were excluded. Cumulative incidences of and hazard ratios for HCC recurrence were analyzed after adjusting for competing mortality risk. Results We recruited a total of 101 patients in the US group and 51 patients in the CT group. The baseline demographic characteristics were not significantly different in both groups. Initial response rates were similar between the two groups (US vs. CT: 89.1% vs. 92.2%, p = 0.54), and complete tumor ablation was finally achieved for all patients. However, more ablations per session were performed in US group (median 2.0 [1.0-3.0] vs. 1.0 [1.0-2.0]; p<0.01). The 1-, 2- and 3-year local tumor recurrence rates (US vs. CT: 13.0%, 20.9%, and 29.2% vs. 11.2%, 29.8% and 29.8%, respectively) and overall mortality rates (US vs. CT: 5.2%, 9.6% and 16.5% vs. 0%, 3.1% and 23.8%, respectively) were not significantly different. In multivariate analysis, tumor characteristics and underlying liver function, but not US or CT guidance, were independent prognostic factors. The complication rates were similar between the two groups (US vs. CT: 10.9% vs. 9.8%; p = 0.71), and there was no procedure-related mortality. Conclusions With comparable major outcomes, either US or CT can be used in the guidance of RFA in experience hands.	[Lee, Lu-Hung; Wu, Chun-Ying; Lee, Shou-Wu; Yang, Sheng-Shun; Yeh, Hong-Zen; Chang, Chi-Sen; Lee, Teng-Yu] Taichung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taichung, Taiwan; [Hwang, Jen-I; Cheng, Yu-Chi] Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan; [Hwang, Jen-I; Wu, Chun-Ying] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Lee, Shou-Wu; Lee, Teng-Yu] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Yang, Sheng-Shun] Cent Taiwan Univ Sci & Technol, Dept Nursing, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University; Chung Shan Medical University; Central Taiwan University Science & Technology	Lee, TY (corresponding author), Taichung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taichung, Taiwan.; Lee, TY (corresponding author), Chung Shan Med Univ, Dept Med, Taichung, Taiwan.	gihepatology@gmail.com	Wu, Chun-Ying/AAX-5077-2021; Lee, Teng-Yu/H-4312-2019	Wu, Chun-Ying/0000-0001-5053-1801; Yang, Sheng-Shun/0000-0001-5800-1901	Ministry of Science and Technology [104-2314-B-075A-001]; Taichung Veterans General Hospital, Taiwan [104DHA0500198]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taichung Veterans General Hospital, Taiwan	This work was supported in part by the Ministry of Science and Technology (104-2314-B-075A-001) and Taichung Veterans General Hospital (104DHA0500198), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, RADIOLOGY, V273, P241, DOI 10.1148/radiol.14132958; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cha CH, 2000, AM J ROENTGENOL, V175, P705, DOI 10.2214/ajr.175.3.1750705; Chan ACY, 2008, ANN SURG, V247, P666, DOI 10.1097/SLA.0b013e31816a747a; Chen MH, 2007, J ULTRAS MED, V26, P1055, DOI 10.7863/jum.2007.26.8.1055; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Clasen S, 2014, EUR J RADIOL, V83, P111, DOI 10.1016/j.ejrad.2013.09.018; Clasen S, 2011, J VASC INTERV RADIOL, V22, P762, DOI 10.1016/j.jvir.2011.03.006; Crocetti L, 2008, INVEST RADIOL, V43, P33, DOI 10.1097/RLI.0b013e31815597dc; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Kang TW, 2013, CLIN RADIOL, V68, pE641, DOI 10.1016/j.crad.2013.07.008; Kim JE, 2011, EUR J RADIOL, V79, pE80, DOI 10.1016/j.ejrad.2011.03.090; Kim YJ, 2013, ABDOM IMAGING, V38, P98, DOI 10.1007/s00261-012-9883-5; Kitada T, 2008, HEPATOL RES, V38, P565, DOI 10.1111/j.1872-034X.2007.00308.x; Kliewer MA, 1999, AM J ROENTGENOL, V173, P1199, DOI 10.2214/ajr.173.5.10541088; Kondo Y, 2008, BRIT J SURG, V95, P996, DOI 10.1002/bjs.6058; Laspas F, 2009, J GASTROINTEST LIVER, V18, P323; Lee MW, 2011, J ULTRAS MED, V30, P607, DOI 10.7863/jum.2011.30.5.607; Lee TY, 2015, RADIOLOGY, V276, P294, DOI 10.1148/radiol.15141864; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maruyama H, 2009, LIVER INT, V29, P708, DOI 10.1111/j.1478-3231.2008.01875.x; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park BJ, 2009, J VASC INTERV RADIOL, V20, P490, DOI 10.1016/j.jvir.2009.01.004; Park Y, 2010, EUR J RADIOL, V75, P391, DOI 10.1016/j.ejrad.2009.04.054; Sheafor DH, 1998, RADIOLOGY, V207, P705, DOI 10.1148/radiology.207.3.9609893; Sheafor DH, 2000, AM J ROENTGENOL, V174, P939, DOI 10.2214/ajr.174.4.1740939; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uehara T, 2007, J GASTROENTEROL, V42, P306, DOI 10.1007/s00535-006-1949-0; Wu J, 2015, PATHOL ONCOL RES, V21, P637, DOI 10.1007/s12253-014-9868-5	38	24	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169655	10.1371/journal.pone.0169655	http://dx.doi.org/10.1371/journal.pone.0169655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068369	Green Published, Green Submitted, gold			2022-12-26	WOS:000391843900054
J	Beisser, D; Kaschani, F; Graupner, N; Grossmann, L; Jensen, M; Ninck, S; Schulz, F; Rahmann, S; Boenigk, J; Kaiser, M				Beisser, Daniela; Kaschani, Farnusch; Graupner, Nadine; Grossmann, Lars; Jensen, Manfred; Ninck, Sabrina; Schulz, Florian; Rahmann, Sven; Boenigk, Jens; Kaiser, Markus			Quantitative Proteomics Reveals Ecophysiological Effects of Light and Silver Stress on the Mixotrophic Protist Poterioochromonas malhamensis	PLOS ONE			English	Article							BACTERIVOROUS FLAGELLATE; ENGINEERED NANOPARTICLES; TOXICITY; TRANSCRIPTOME; CHRYSOPHYCEAE; METABOLISM; GENES; ACCUMULATION; RESPONSES; EXPOSURE	Aquatic environments are heavily impacted by human activities including climate warming and the introduction of xenobiotics. Due to the application of silver nanoparticles as bactericidal agent the introduction of silver into the environment strongly has increased during the past years. Silver ions affect the primary metabolism of algae, in particular photosynthesis. Mixotrophic algae are an interesting test case as they do not exclusively rely on photosynthesis which may attenuate the harmful effect of silver. In order to study the effect of silver ions on mixotrophs, cultures of the chrysophyte Poterioochromonas malhamensis were treated in a replicate design in light and darkness with silver nitrate at a sub-lethal concentration. At five time points samples were taken for the identification and quantitation of proteins by mass spectrometry. In our analysis, relative quantitative protein mass spectrometry has shown to be a useful tool for functional analyses in conjunction with transcriptome reference sequences. A total of 3,952 proteins in 63 samples were identified and quantified, mapping to 4,829 transcripts of the sequenced and assembled transcriptome. Among them, 720 and 104 proteins performing various cellular functions were differentially expressed after eight days in light versus darkness and after three days of silver treatment, respectively. Specifically pathways of the energy and primary carbon metabolism were differentially affected by light and the utilization of expensive reactions hints to an energy surplus of P. malhamensis under light conditions. The excess energy is not invested in growth, but in the synthesis of storage metabolites. The effects of silver were less explicit, observable especially in the dark treatments where the light effect could not mask coinciding but weaker effects of silver. Photosynthesis, particularly the light harvesting complexes, and several sulphur containing enzymes were affected presumably due to a direct interference with the silver ions, mainly affecting energy supply.	[Beisser, Daniela; Rahmann, Sven] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Genome Informat, Hufelandstr 55, D-45147 Essen, Germany; [Beisser, Daniela; Graupner, Nadine; Grossmann, Lars; Jensen, Manfred; Boenigk, Jens] Univ Duisburg Essen, Fac Biol, Biodivers, Univ Str 5, D-45141 Essen, Germany; [Ninck, Sabrina; Schulz, Florian; Kaiser, Markus] Univ Duisburg Essen, Chem Biol, Ctr Med Biotechnol ZMB, Fac Biol, Univ Str 2, D-45117 Essen, Germany; [Kaschani, Farnusch; Graupner, Nadine; Grossmann, Lars; Jensen, Manfred; Boenigk, Jens] Univ Duisburg Essen, Ctr Water & Environm Res ZWU, Univ Str 2, D-45117 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Beisser, D (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Genome Informat, Hufelandstr 55, D-45147 Essen, Germany.; Beisser, D (corresponding author), Univ Duisburg Essen, Fac Biol, Biodivers, Univ Str 5, D-45141 Essen, Germany.	daniela.beisser@uni-due.de	Beisser, Daniela/AAR-8642-2020	Beisser, Daniela/0000-0002-0679-6631; Kaschani, Farnusch/0000-0001-6572-3232; Ninck, Sabrina/0000-0003-0921-7110	Deutsche Forschungsgemeinschaft [SPP 1704, RA 1898/1-1, BO 3245/14-1]; Mercator Research Center Ruhr [INST 20876/127-1 FUGG, Pr-2013-0036]; ERC [258413]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mercator Research Center Ruhr; ERC(European Research Council (ERC)European Commission)	This work was financially supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/): D.B., S.R., J.B., Priority Programme DynaTrait (SPP 1704), grant numbers RA 1898/1-1 and BO 3245/14-1; M.K., grant number INST 20876/127-1 FUGG, Mercator Research Center Ruhr (http://www.mercur-research.de/en/): N.G., Pr-2013-0036 and an ERC starting grant (https://erc.europa.eu/): M.K., grant number 258413.	ALBRIGHT LJ, 1972, WATER RES, V6, P1589, DOI 10.1016/0043-1354(72)90083-8; Bai YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14582; Batley GE, 2013, ACCOUNTS CHEM RES, V46, P854, DOI 10.1021/ar2003368; BEATTIE A, 1961, BIOCHEM J, V79, P531, DOI 10.1042/bj0790531; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Boenigk J, 2000, J EUKARYOT MICROBIOL, V47, P350, DOI 10.1111/j.1550-7408.2000.tb00060.x; Boenigk J, 2002, AQUAT MICROB ECOL, V27, P195, DOI 10.3354/ame027195; Boenigk J, 2005, AQUAT TOXICOL, V71, P249, DOI 10.1016/j.aquatox.2004.11.009; Boenigk J, 2006, AQUAT MICROB ECOL, V44, P71, DOI 10.3354/ame044071; Boenigk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095340; CARON DA, 1990, LIMNOL OCEANOGR, V35, P433, DOI 10.4319/lo.1990.35.2.0433; Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dewez D, 2012, TOXICOL ENVIRON CHEM, V94, P1536, DOI 10.1080/02772248.2012.712124; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Forster B, 2006, PROTEOMICS, V6, P4309, DOI 10.1002/pmic.200500907; Gaedke Ursula, 1998, Advances in Limnology, V53, P119; Guazzaroni ME, 2013, ENVIRON MICROBIOL, V15, P1088, DOI 10.1111/1462-2920.12021; Guo HY, 2016, SCI TOTAL ENVIRON, V554, P246, DOI 10.1016/j.scitotenv.2016.02.084; Hahn MW, 1998, APPL ENVIRON MICROB, V64, P1910; Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003; Hastie T, 2016, IMPUTE IMPUTATION MI; He RF, 2012, AM J BOT, V99, P232, DOI 10.3732/ajb.1100429; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; HUTNER SH, 1953, ANN NY ACAD SCI, V56, P852, DOI 10.1111/j.1749-6632.1953.tb30263.x; Institute WW, 2009, NAN CONS PROD INV; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; JONES RI, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P87; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kopriva Stanislav, 2008, V27, P31; Kurian D, 2006, PROTEOMICS, V6, P1483, DOI 10.1002/pmic.200500413; Kurian D, 2006, PROTEOMICS, V6, P3614, DOI 10.1002/pmic.200600033; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Lee SW, 2016, SCI TOTAL ENVIRON, V553, P565, DOI 10.1016/j.scitotenv.2016.02.064; Leonardo T, 2016, ENVIRON SCI TECHNOL, V50, P359, DOI 10.1021/acs.est.5b03306; Li TT, 2015, BIORESOURCE TECHNOL, V180, P250, DOI 10.1016/j.biortech.2015.01.005; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liu ZF, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw106; Ma X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-168; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Nishida K, 2014, F1000RESEARCH; Oksanen J, 2022, R PACKAGE VERSION; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Pfandl K, 2004, J EUKARYOT MICROBIOL, V51, P626, DOI 10.1111/j.1550-7408.2004.tb00596.x; Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111; PRINGSHEIM EG, 1952, Q J MICROSC SCI, V93, P71; R Core Team, 2013, R LANG ENV STAT COMP; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI [10.1897/1551-5028(1999)018&lt;0089:BATOSC&gt;2.3.CO;2, 10.1002/etc.5620180112]; RAVEN JA, 1995, CHRYSOPHYTE ALGAE, P95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rottberger J, 2013, AQUATIC MICROBIAL EC; SANDERS JG, 1990, SCI TOTAL ENVIRON, V97-8, P761, DOI 10.1016/0048-9697(90)90273-W; SANDERS RW, 1990, MICROBIAL ECOL, V19, P97, DOI 10.1007/BF02015056; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Stoecker DK, 1998, EUR J PROTISTOL, V34, P281, DOI 10.1016/S0932-4739(98)80055-2; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang JX, 2008, CHEMOSPHERE, V73, P1121, DOI 10.1016/j.chemosphere.2008.07.040; Wang S, 2016, NANOTOXICOLOGY, P1; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; Watson SB, 2010, NOVA HEDWIGIA, P213, DOI 10.1127/1438-9134/2010/0136-0213; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Wilson SL, 2012, FEMS MICROBIOL ECOL, V82, P405, DOI 10.1111/j.1574-6941.2012.01404.x; Xie J, 2015, ENVIRON SCI TECHNOL, V49, P11182, DOI 10.1021/acs.est.5b03272; Yergeau E, 2010, APPL ENVIRON MICROB, V76, P5432, DOI 10.1128/AEM.00873-10; Zhang XM, 2001, J PHYCOL, V37, P738, DOI 10.1046/j.1529-8817.2001.00127.x	78	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0168183	10.1371/journal.pone.0168183	http://dx.doi.org/10.1371/journal.pone.0168183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056027	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100003
J	Hong, F; Rachidi, SM; Lundgren, D; Han, D; Huang, X; Zhao, HY; Kimura, Y; Hirano, H; Ohara, O; Udono, H; Meng, SD; Liu, B; Li, ZH				Hong, Feng; Rachidi, Saleh Mohammad; Lundgren, Debbie; Han, David; Huang, Xiu; Zhao, Hongyu; Kimura, Yayoi; Hirano, Hisashi; Ohara, Osamu; Udono, Heichiiro; Meng, Songdong; Liu, Bei; Li, Zihai			Mapping the Interactome of a Major Mammalian Endoplasmic Reticulum Heat Shock Protein 90	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CELL-SURFACE EXPRESSION; LEUCINE-RICH REPEAT; LARGE GENE LISTS; ANTIGEN PRESENTATION; EMBRYONIC-DEVELOPMENT; MOLECULAR CHAPERONE; CROSS-PRESENTATION; MASS-SPECTROMETRY; MASTER CHAPERONE	Up to 10% of cytosolic proteins are dependent on the mammalian heat shock protein 90 (HSP90) for folding. However, the interactors of its endoplasmic reticulum (ER) paralogue (gp96, Grp94 and HSP90b1) has not been systematically identified. By combining genetic and biochemical approaches, we have comprehensively mapped the interactome of gp96 in macrophages and B cells. A total of 511 proteins were reduced in gp96 knockdown cells, compared to levels observed in wild type cells. By immunoprecipitation, we found that 201 proteins associated with gp96. Gene Ontology analysis indicated that these proteins are involved in metabolism, transport, translation, protein folding, development, localization, response to stress and cellular component biogenesis. While known gp96 clients such as integrins, Toll-like receptors (TLRs) and Wnt co-receptor LRP6, were confirmed, cell surface HSP receptor CD91, TLR4 pathway protein CD180, WDR1, GANAB and CAPZB were identified as potentially novel substrates of gp96. Taken together, our study establishes gp96 as a critical chaperone to integrate innate immunity, Wnt signaling and organ development.	[Hong, Feng; Rachidi, Saleh Mohammad; Liu, Bei; Li, Zihai] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Lundgren, Debbie; Han, David] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA; [Huang, Xiu; Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Kimura, Yayoi; Hirano, Hisashi] RIKEN Res Ctr Allergy & Immunol, Lab Immunogenom, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan; [Udono, Heichiiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Immunol, Okayama, Japan; [Meng, Songdong] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Medical University of South Carolina; University of Connecticut; Yale University; RIKEN; Yokohama City University; Kazusa DNA Research Institute; Okayama University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, B; Li, ZH (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	liube@musc.edu; zihai@musc.edu	Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571	NIH [CA186866, CA188419, AI070603, AI077283, CA193939, RO1 AI070603, RO1 AI077283, RO1 GM059507]; Hollings Cancer Center's American Cancer Society Institutional Research Grant [ACS-IRG-97-219-14]; NATIONAL CANCER INSTITUTE [R01CA193939, P30CA138313, P01CA186866, R01CA188419] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077283, R01AI070603, U01AI125859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center's American Cancer Society Institutional Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by multiple NIH grants: CA186866, CA188419, AI070603 and AI077283 (to Z.L.), CA193939 (to B.L.), RO1 AI070603 (Z.L.), RO1 AI077283 (Z.L.) and RO1 GM059507 (H.Z.), and the Hollings Cancer Center's American Cancer Society Institutional Research Grant (ACS-IRG-97-219-14) (to F.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berwin B, 2002, J IMMUNOL, V168, P4282, DOI 10.4049/jimmunol.168.9.4282; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BORNSTEIN P, 1995, P NATL ACAD SCI USA, V92, P4547, DOI 10.1073/pnas.92.10.4547; Bruneau N, 1998, J CELL SCI, V111, P2665; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hanninen A, 2000, IMMUNOL REV, V173, P109, DOI 10.1034/j.1600-065X.2000.917303.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang SI, 2006, MOL CELL PROTEOMICS, V5, P1131, DOI 10.1074/mcp.M500162-MCP200; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8; Li Z, 1994, Behring Inst Mitt, P37; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu B, 2013, P NATL ACAD SCI USA, DOI [10.1093/nar/gkn923, DOI 10.1093/NAR/GKN923]; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046633; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MAKI RG, 1990, P NATL ACAD SCI USA, V87, P5658, DOI 10.1073/pnas.87.15.5658; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Marino S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000519; Melendez K, 2006, CELL STRESS CHAPERON, V11, P334, DOI 10.1379/CSC-187.1; Metelli A, 2016, CANC RES; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Nganga A, 2000, BIOCHEM J, V352, P865, DOI 10.1042/0264-6021:3520865; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pulford K, 1999, IMMUNOLOGY, V96, P262; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Robert J, 1999, J IMMUNOL, V163, P4133; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; Speicher K D, 2000, J Biomol Tech, V11, P74; SRIVASTAVA PK, 1984, INT J CANCER, V33, P417, DOI 10.1002/ijc.2910330321; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang Q, 2005, CANCER DETECT PREV, V29, P544, DOI 10.1016/j.cdp.2005.09.010; Wang XP, 2005, WORLD J GASTROENTERO, V11, P1056, DOI 10.3748/wjg.v11.i7.1056; Wang XP, 2005, WORLD J GASTROENTERO, V11, P429; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang Jin-liang, 2003, ELECTROCHEMICAL ED R, V10, P72, DOI DOI 10.1074/JBC.M207976200; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	72	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169260	10.1371/journal.pone.0169260	http://dx.doi.org/10.1371/journal.pone.0169260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056051	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100029
J	Bolt, SL; Boyland, NK; Mlynski, DT; James, R; Croft, DP				Bolt, Sarah L.; Boyland, Natasha K.; Mlynski, David T.; James, Richard; Croft, Darren P.			Pair Housing of Dairy Calves and Age at Pairing: Effects on Weaning Stress, Health, Production and Social Networks	PLOS ONE			English	Article							GROUP-SIZE; MILK ALLOWANCE; PLAY-BEHAVIOR; GROWTH-RATE; PERFORMANCE; RESPONSES; SYSTEMS; CATTLE; INCREASES; CONTACT	The early social environment can influence the health and behaviour of animals, with effects lasting into adulthood. In Europe, around 60% of dairy calves are reared individually during their first eight weeks of life, while others may be housed in pairs or small groups. This study assessed the effects of varying degrees of social contact on weaning stress, health and production during pen rearing, and on the social networks that calves later formed when grouped. Forty female Holstein-Friesian calves were allocated to one of three treatments: individually housed (I, n = 8), pair-housed from day five (P5, n = 8 pairs), and pair-housed from day 28 (P28, n = 8 pairs). From day 48, calves were weaned by gradual reduction of milk over three days, and vocalisations were recorded as a measure of stress for three days before, during and after weaning. Health and production (growth rate and concentrate intakes) were not affected by treatment during the weaning period or over the whole study. Vocalisations were highest post-weaning, and were significantly higher in I calves than pair-reared calves. Furthermore, P28 calves vocalised significantly more than P5 calves. The social network of calves was measured for one month after all calves were grouped in a barn, using association data from spatial proximity loggers. We tested for week-week stability, social differentiation and assortment in the calf network. Additionally, we tested for treatment differences in: coefficient of variation (CV) in association strength, percentage of time spent with ex-penmate (P5 and P28 calves only) and weighted degree centrality (the sum of the strength of an individual's associations). The network was relatively stable from weeks one to four and was significantly differentiated, with individuals assorting based on prior familiarity. P5 calves had significantly higher CV in association strength than I calves in week one (indicating more heterogeneous social associations) but there were no significant treatment differences in week four. The mean percentage of time that individuals spent with their ex-penmate after regrouping decreased from weeks 1-4, though treatment did not affect this. There were also no significant differences in weighted degree centrality between calves in each rearing treatment. These results suggest that early pair-rearing can allow calves the stress buffering benefits of social support (and that this is more effective when calves are paired earlier) without compromising health or production, and sheds light on the early development of social behaviour in cattle.	[Bolt, Sarah L.; Boyland, Natasha K.; Croft, Darren P.] Univ Exeter, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England; [Bolt, Sarah L.] Agr & Hort Dev Board, Kenilworth, Warwick, England; [Boyland, Natasha K.] Compass World Farming, Godalming, Surrey, England; [Mlynski, David T.; James, Richard] Univ Bath, Ctr Networks & Collect Behav, Dept Phys, Bath, Avon, England	University of Exeter; Agriculture & Horticulture Development Board (AHDB); University of Bath	Boyland, NK (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England.; Boyland, NK (corresponding author), Compass World Farming, Godalming, Surrey, England.	Natasha.boyland@gmail.com	Croft, Darren P/B-5503-2009; James, Richard/E-5061-2013	Croft, Darren P/0000-0001-6869-5097; 	Agriculture and Horticulture Development Board (AHDB) - Dairy; Agriculture and Horticulture Development Board (AHDB)- Dairy; BBSRC [BB/K002562/1, BB/K003070/1, BB/K002376/1, BB/K001302/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K002376/1, BB/K001302/1, BB/K002562/1, BB/K003070/1] Funding Source: researchfish	Agriculture and Horticulture Development Board (AHDB) - Dairy; Agriculture and Horticulture Development Board (AHDB)- Dairy; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by 1. Agriculture and Horticulture Development Board - Dairy (http://dairy.ahdb.org.uk/) Grant holder - DPC, Department for Environment, Food and Rural Affairs (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs) Grant holder - DPC, University of Exeter (http://www.exeter.ac.uk/) Grant holder - DPC 2. The Agriculture and Horticulture Development Board (AHDB)- Dairy, had some influence on the study and preparation of the manuscript; SB is employed by AHDB.	Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; ARAVE CW, 1985, J DAIRY SCI, V68, P923, DOI 10.3168/jds.S0022-0302(85)80910-3; Bates D., MATRIX SPARSE DENSE; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bernal-Rigoli JC, 2012, J ANIM SCI, V90, P2818, DOI 10.2527/jas.2011-4722; Boe KE, 2003, APPL ANIM BEHAV SCI, V80, P175, DOI 10.1016/S0168-1591(02)00217-4; Boogert NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0561; Borgatti S. P., 1999, UCINET 6 0 VERSION 1; Bouissou M.-F., 1976, Biology of Behaviour, V1, P17; BOUISSOU MF, 1978, BEHAVIOUR, V64, P148, DOI 10.1163/156853978X00486; Boyland NK, 2013, BEHAV ECOL SOCIOBIOL, V67, P1877, DOI 10.1007/s00265-013-1622-6; Boyland NK, 2016, APPL ANIM BEHAV SCI, V174, P1, DOI 10.1016/j.applanim.2015.11.016; Braun K, 2000, NEUROSCIENCE, V95, P309; Brent LJN, 2014, ANN NY ACAD SCI, V1316, P1, DOI 10.1111/nyas.12315; BROOM DM, 1978, ANIM BEHAV, V26, P1255, DOI 10.1016/0003-3472(78)90116-1; Budzynska M, 2008, APPL ANIM BEHAV SCI, V112, P33, DOI 10.1016/j.applanim.2007.08.004; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Chua B, 2002, J DAIRY SCI, V85, P360, DOI 10.3168/jds.S0022-0302(02)74082-4; Cobb CJ, 2014, J DAIRY SCI, V97, P3099, DOI 10.3168/jds.2013-7823; Costa JHC, 2015, J DAIRY SCI, V98, P6381, DOI 10.3168/jds.2015-9395; Costa JHC, 2014, J DAIRY SCI, V97, P7804, DOI 10.3168/jds.2014-8392; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Drewe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039068; Duve LR, 2012, J DAIRY SCI, V95, P6571, DOI 10.3168/jds.2011-5170; Faerevik G, 2007, APPL ANIM BEHAV SCI, V108, P215, DOI 10.1016/j.applanim.2007.01.010; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.10.012; Gaillard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090205; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Gygax L, 2010, ETHOLOGY, V116, P10, DOI 10.1111/j.1439-0310.2009.01708.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hanninen L, 2003, ACTA AGR SCAND A-AN, V53, P21, DOI 10.1080/09064700300511; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Holm L, 2002, APPL ANIM BEHAV SCI, V79, P175, DOI 10.1016/S0168-1591(02)00137-5; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; James D., CHRON CHRONOLOGICAL; Jasper J, 2008, APPL ANIM BEHAV SCI, V110, P136, DOI 10.1016/j.applanim.2007.03.017; Jensen MB, 2015, J DAIRY SCI, V98, P2568, DOI 10.3168/jds.2014-8272; Jensen MB, 1997, APPL ANIM BEHAV SCI, V54, P109, DOI 10.1016/S0168-1591(96)01183-5; Jensen MB, 1998, APPL ANIM BEHAV SCI, V56, P97, DOI 10.1016/S0168-1591(97)00106-8; Kanitz E, 2004, BRAIN BEHAV IMMUN, V18, P35, DOI 10.1016/S0889-1591(03)00085-0; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Koene Paul, 2014, Animals, V4, P93, DOI 10.3390/ani4010093; Krause J, 2002, LIVING GROUPS; Kung L, 1997, J DAIRY SCI, V80, P2529, DOI 10.3168/jds.S0022-0302(97)76206-4; MAATJE K, 1993, VET REC, V133, P266, DOI 10.1136/vr.133.11.266; Marce C, 2010, ANIMAL, V4, P1588, DOI 10.1017/S1751731110000650; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; Meagher RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132828; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Napolitano F, 2008, APPL ANIM BEHAV SCI, V110, P58, DOI 10.1016/j.applanim.2007.03.020; Newberry RC, 2008, APPL ANIM BEHAV SCI, V110, P3, DOI 10.1016/j.applanim.2007.03.021; Novak MA, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P153, DOI 10.1079/9780851990040.0153; Oksanen J., **DATA OBJECT**; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; PRICE EO, 1990, APPL ANIM BEHAV SCI, V27, P263, DOI 10.1016/0168-1591(90)90061-H; Priestley SM, 2006, J NUTR, V136, p2078S, DOI 10.1093/jn/136.7.2078S; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Raussi S, 2010, BEHAV PROCESS, V84, P726, DOI 10.1016/j.beproc.2010.05.005; REINHARDT V, 1981, J AGR SCI, V96, P309, DOI 10.1017/S0021859600066089; REINHARDT V, 1981, BEHAVIOUR, V77, P121, DOI 10.1163/156853981X00194; SACHSER N, 1993, PHYSIOL BEHAV, V53, P539, DOI 10.1016/0031-9384(93)90151-5; SATO S, 1987, BEHAV PROCESS, V15, P333, DOI 10.1016/0376-6357(87)90017-9; Schleyer T., 1998, UNTERSUCHUNGEN EINFL; Snijders TAB, 2011, ANNU REV SOCIOL, V37, P131, DOI 10.1146/annurev.soc.012809.102709; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svensson C, 2006, PREV VET MED, V73, P43, DOI 10.1016/j.prevetmed.2005.08.021; Svensson C, 2003, PREV VET MED, V58, P179, DOI 10.1016/S0167-5877(03)00046-1; Tapki I, 2007, ACTA AGR SCAND A-AN, V57, P55, DOI 10.1080/09064700701464405; Team RC, 2014, R LANG ENV STAT COMP; Thomas TJ, 2001, APPL ANIM BEHAV SCI, V74, P165, DOI 10.1016/S0168-1591(01)00164-2; Tuchscherer M, 2006, HORM BEHAV, V50, P753, DOI 10.1016/j.yhbeh.2006.06.026; VEISSIER I, 1994, APPL ANIM BEHAV SCI, V41, P199, DOI 10.1016/0168-1591(94)90023-X; VEISSIER I, 1989, APPL ANIM BEHAV SCI, V24, P43, DOI 10.1016/0168-1591(89)90124-X; Veissier I, 1998, APPL ANIM BEHAV SCI, V57, P233, DOI 10.1016/S0168-1591(98)00099-9; Vieira AD, 2012, J DAIRY SCI, V95, P5149, DOI 10.3168/jds.2011-5073; Vieira AD, 2010, J DAIRY SCI, V93, P3079, DOI 10.3168/jds.2009-2516; VITALE AF, 1986, APPL ANIM BEHAV SCI, V16, P217, DOI 10.1016/0168-1591(86)90115-2; WARNICK VD, 1977, J DAIRY SCI, V60, P947, DOI 10.3168/jds.S0022-0302(77)83968-4; Watts JM, 2000, APPL ANIM BEHAV SCI, V67, P15, DOI 10.1016/S0168-1591(99)00108-2; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001	85	30	32	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0166926	10.1371/journal.pone.0166926	http://dx.doi.org/10.1371/journal.pone.0166926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052122	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500007
J	Hven, L; Frost, P; Bonde, JPE				Hven, Lisbeth; Frost, Poul; Bonde, Jens Peter Ellekilde			Evaluation of Pressure Pain Threshold as a Measure of Perceived Stress and High Job Strain	PLOS ONE			English	Article							REPETITIVE WORK; MUSCULOSKELETAL PAIN; TEMPORAL SUMMATION; SENSITIVITY; ASSOCIATION; SYMPTOMS; CORTISOL; MARKER	Objective To investigate whether pressure pain threshold ( PPT), determined by pressure algometry, can be used as an objective measure of perceived stress and job strain. Methods We used cross-sectional base line data collected during 1994 to 1995 within the Project on Research and Intervention in Monotonous work (PRIM), which included 3123 employees from a variety of Danish companies. Questionnaire data included 18 items on stress symptoms, 23 items from the Karasek scale on job strain, and information on discomfort in specified anatomical regions was also collected. Clinical examinations included pressure pain algometry measurements of PPT on the trapezius and supraspinatus muscles and the tibia. Associations of stress symptoms and job strain with PPT of each site was analyzed for men and women separately with adjustment for age body mass index, and discomfort in the anatomical region closest to the point of pressure algometry using multivariable linear regression. Results We found significant inverse associations between perceived stress and PPT in both genders in models adjusting for age and body mass index: the higher level of perceived stress, the lower the threshold. For job strain, associations were weaker and only present in men. In men all associations were attenuated when adjusting for reported discomfort in regions close to the site of pressure algometry. The distributions of PPT among stressed and non-stressed persons were strongly overlapping. Conclusions Despite significant associations between perceived stress and PPT, the discriminative capability of PPT to distinguish individuals with and without stress is low. PPT measured by pressure algometry seems not applicable as a diagnostic tool of a state of mental stress.	[Hven, Lisbeth; Bonde, Jens Peter Ellekilde] Bispebjerg Frederiksberg Univ Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Frost, Poul] Aarhus Univ Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Aarhus, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Aarhus University	Bonde, JPE (corresponding author), Bispebjerg Frederiksberg Univ Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	jpb@bbh.regionh.dk		Bonde, Jens Peter Ellekilde/0000-0002-8181-3673				Alderling M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-288; Arendt-Nielsen L, 2011, J MAN MANIP THER, V19, P186, DOI 10.1179/106698111X13129729551903; Ballegaard S, 2009, SCAND J CLIN LAB INV, V69, P713, DOI 10.1080/00365510903042734; Ballegaard S, 2014, SCAND J CLIN LAB INV, V74, P116, DOI 10.3109/00365513.2013.862847; Ballegaard S, 2012, SCAND J CLIN LAB INV, V72, P459, DOI 10.3109/00365513.2012.695023; Bonde JP, 2005, OCCUP ENVIRON MED, V62, P41, DOI 10.1136/oem.2003.011296; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Crettaz B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069460; Fallentin N, 2001, SCAND J WORK ENV HEA, V27, P21, DOI 10.5271/sjweh.583; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lautenbacher S, 2005, PAIN, V115, P410, DOI 10.1016/j.pain.2005.03.025; PRADALIER A, 1981, PHYSIOL BEHAV, V27, P961, DOI 10.1016/0031-9384(81)90354-1; Rugulies R, 2006, AM J EPIDEMIOL, V163, P877, DOI 10.1093/aje/kwj119; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; SELYE H, 1973, AM SCI, V61, P692; SETTERLIND S, 1995, STRESS MEDICINE, V11, P85, DOI 10.1002/smi.2460110116; Staud R, 2003, PAIN, V102, P87, DOI 10.1016/s0304-3959(02)00344-5; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Theorell T, 2006, REPORT EUROPEAN HEAR; Thomsen JF, 2007, OCCUP ENVIRON MED, V64, P527, DOI 10.1136/oem.2005.021170; Uddin Z, 2016, PAIN MED, V17, P1694, DOI 10.1093/pm/pnv105; Uddin Zakir, 2014, Open Orthop J, V8, P302, DOI 10.2174/1874325001408010302; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0167257	10.1371/journal.pone.0167257	http://dx.doi.org/10.1371/journal.pone.0167257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052089	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500008
J	Otani, Y; Yonezawa, A; Tsuda, M; Imai, S; Ikemi, Y; Nakagawa, S; Omura, T; Nakagawa, T; Yano, I; Matsubara, K				Otani, Yuki; Yonezawa, Atushi; Tsuda, Masahiro; Imai, Satoshi; Ikemi, Yasuaki; Nakagawa, Shunsaku; Omura, Tomohiro; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo			Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats	PLOS ONE			English	Article							MASS-SPECTROMETRY; CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODIES; SERUM CLEARANCE; IGG ANTIBODIES; IN-VITRO; LC; IMMUNOGLOBULIN; GLYCOSYLATION; BINDING	Therapeutic monoclonal antibodies (mAbs) have heterogeneities in their structures. Multiple studies have reported that the variety of post-translational modifications could affect the pharmacokinetic profiles or pharmacological potencies of therapeutic mAbs. Taking into the account that the structural modification of mAbs would affect the efficacy, it is worth investigating the structural alteration of therapeutic mAbs in the blood and the relationship between their structures and pharmacological effects. Herein, we have developed the method to isolate rituximab from plasma in which endogenous IgGs interfere the detection of rituximab, and successfully developed the analytical method with a liquid chromatograph time-of-flight mass spectrometer to detect the structure of rituximab in plasma with errors less than 30 parts per millions. Eight types of carbohydrate chains in rituximab were detected by this method. Interestingly, time-dependent changes in carbohydrate chains such as AAF (G2F) and GnGn (G0) were observed in rats, although the amino acids were stable. Additionally, these structural changes were observed via incubation in plasma as in the rat experiment, suggesting that a certain type of enzyme in plasma caused the alterations of the carbohydrate chains. The present analytical methods could clarify the actual pharmacokinetics of therapeutic mAbs, and help to evaluate the interindividual variations in pharmacokinetics and efficacy.	[Otani, Yuki; Yonezawa, Atushi; Tsuda, Masahiro; Imai, Satoshi; Ikemi, Yasuaki; Nakagawa, Shunsaku; Omura, Tomohiro; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto, Japan; [Yonezawa, Atushi; Tsuda, Masahiro; Yano, Ikuko] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Yano, Ikuko] Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan	Kyoto University; Kyoto University; Kobe University	Yonezawa, A (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto, Japan.; Yonezawa, A (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan.	ayone@kuhp.kyoto-u.ac.jp	Tomohiro, Omura/AAR-8420-2021; Yonezawa, Atsushi/AAS-8423-2020	Yonezawa, Atsushi/0000-0002-8057-6768; Imai, Satoshi/0000-0003-4737-8695; Nakagawa, Shunsaku/0000-0002-1285-122X; Nakagawa, Takayuki/0000-0003-1890-0843	Japan Agency for Medical Research and development, AMED; Ministry of Education, Science, Culture and Sports of Japan; Grants-in-Aid for Scientific Research [16K18938, 16K18939] Funding Source: KAKEN	Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development, AMED, and a grand-in-aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture and Sports of Japan.	Adamczyk M, 2000, J IMMUNOL METHODS, V237, P95, DOI 10.1016/S0022-1759(00)00135-6; Alessandri L, 2012, MABS-AUSTIN, V4, P509, DOI 10.4161/mabs.20450; Chen XY, 2009, GLYCOBIOLOGY, V19, P240, DOI 10.1093/glycob/cwn120; Chu KO, 2012, MOL PHARMACEUT, V9, P3422, DOI 10.1021/mp3005403; Chung S, 2012, MABS-AUSTIN, V4, P326, DOI 10.4161/mabs.19941; Cragg MS, 2004, BLOOD, V104, P2540, DOI 10.1182/blood-2004-05-1733; Dick LW, 2008, BIOTECHNOL BIOENG, V100, P1132, DOI 10.1002/bit.21855; Gasdaska JR, 2012, MOL IMMUNOL, V50, P134, DOI 10.1016/j.molimm.2012.01.001; GMEINER B, 1987, CANCER RES, V47, P2311; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Golay J, 2013, MABS-AUSTIN, V5, P826, DOI 10.4161/mabs.26008; Hampson G, 2010, J IMMUNOL METHODS, V360, P30, DOI 10.1016/j.jim.2010.05.009; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Li C, 2013, MABS-AUSTIN, V5, P565, DOI 10.4161/mabs.24814; Li H, 2013, AAPS J, V15, P337, DOI 10.1208/s12248-012-9435-5; Liu HC, 2014, MABS-AUSTIN, V6, P1145, DOI 10.4161/mabs.29883; Liu YD, 2016, BIOLOGICALS, V44, P163, DOI 10.1016/j.biologicals.2016.02.003; LOMBARDO A, 1980, CLIN CHIM ACTA, V108, P337, DOI 10.1016/0009-8981(80)90339-3; Lunemann JD, 2015, NAT REV NEUROL, V11, P80, DOI 10.1038/nrneurol.2014.253; Saba JA, 2002, ANAL BIOCHEM, V305, P16, DOI 10.1006/abio.2002.5651; Saitoh E, 2003, INT J ONCOL, V23, P303; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sinha S, 2008, J AM SOC MASS SPECTR, V19, P1643, DOI 10.1016/j.jasms.2008.07.004; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Yan XM, 2015, BIOMED PHARMACOTHER, V70, P299, DOI 10.1016/j.biopha.2014.12.048; Zauner G, 2013, MOL CELL PROTEOMICS, V12, P856, DOI 10.1074/mcp.R112.026005; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169588	10.1371/journal.pone.0169588	http://dx.doi.org/10.1371/journal.pone.0169588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052138	Green Submitted, Green Published, gold			2022-12-26	WOS:000391621500069
J	Okuno, T; Koutsogiannaki, S; Ohba, M; Chamberlain, M; Bu, WM; Lin, FY; Eckenhoff, RG; Yokomizo, T; Yuki, K				Okuno, Toshiaki; Koutsogiannaki, Sophia; Ohba, Mai; Chamberlain, Matthew; Bu, Weiming; Lin, Fu-Yan; Eckenhoff, Roderic G.; Yokomizo, Takehiko; Yuki, Koichi			Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B-4 production	FASEB JOURNAL			English	Article						anesthesia; lipid mediator; inhibitor	NEUTROPHIL RESPIRATORY BURST; SUPPRESSES PROSTAGLANDIN E-2; MURINE DENDRITIC CELLS; ARACHIDONIC-ACID; INHIBITORS; CHEMOTAXIS; ISOFLURANE; QUANTITATION; INFUSION; RECEPTOR	Propofol is an intravenous anesthetic that produces its anesthetic effect, largely via the GABA(A) receptor in the CNS, and also reduces the N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced neutrophil respiratory burst. Because fMLP-stimulated neutrophils produce leukotriene (LT)B-4, we examined the effect of propofol on LTB4 production in vivo and in vitro Cecal ligation and puncture surgery was performed in mice, with or without exposure to propofol. Propofol attenuated the production of 5-lipoxygenase (5-LOX)-related arachidonic acid (AA) derivatives in the peritoneal fluid. Also, in the in vitro experiments on fMLP-stimulated neutrophils and 5-LOX-transfected human embryonic kidney cells, propofol attenuated the production of 5-LOX-related AA derivatives. Based on these results, we hypothesized that propofol would directly affect 5-LOX function. Using meta-azi-propofol (AziPm), we photolabeled stable 5-LOX protein, which had been used to solve the X-ray crystallographic structure of 5-LOX, and examined the binding site(s) of propofol on 5-LOX. Two propofol binding pockets were identified near the active site of 5-LOX. Alanine scanning mutagenesis was performed for the residues of 5-LOX in the vicinity of propofol, and we evaluated the functional role of these pockets in LTB4 production. We demonstrated that these pockets were functionally important for 5-LOX activity. These two pockets can be used to explore a novel 5-LOX inhibitor in the future.-Okuno, T., Koutsogiannaki, S., Ohba, M., Chamberlain, M., Bu, W., Lin, F.-Y., Eckenhoff, R. G., Yokomizo T., Yuki, K. Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B-4 production.	[Okuno, Toshiaki; Ohba, Mai; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Koutsogiannaki, Sophia; Chamberlain, Matthew; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Cardiac Anesthesia, Boston, MA USA; [Lin, Fu-Yan] Boston Childrens Hosp, Immune Dis Inst, Boston, MA USA; [Koutsogiannaki, Sophia; Yuki, Koichi] Harvard Med Sch, Dept Anesthesia, Boston, MA USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	Juntendo University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553; Eckenhoff, Roderic/0000-0002-5581-746X; Koutsogiannaki, Sophia/0000-0003-3555-1681	U.S. National Institutes of Health, Institute of General Medical Sciences [GM101345, GM118277, P01GM055876]; Children's Hospital Medical Center (CHMC) Anesthesia Foundation; Foundation of Strategic Research Projects in Private Universities - Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1311011]; MEXT/Japan Society for the Promotion of Science (JSPS) [15H05901, 15H05904, 15H04708, 16K08596, 15KK0320]; Takeda Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277, P01GM055876, K08GM101345] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	U.S. National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Hospital Medical Center (CHMC) Anesthesia Foundation; Foundation of Strategic Research Projects in Private Universities - Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported, in part, by U.S. National Institutes of Health, Institute of General Medical Sciences Grants GM101345 and GM118277 (to K.Y.) and P01GM055876 (to R.G.E); Children's Hospital Medical Center (CHMC) Anesthesia Foundation (to K.Y.); Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to T.Y.); MEXT/Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) 15H05901, 15H05904, and 15H04708 (to T.Y.) and 16K08596 and 15KK0320) (to T.O.); and the Takeda Science Foundation (to T.Y. and T.O.). The authors declare no conflicts of interest.	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; ALBANESE J, 1990, ANESTHESIOLOGY, V73, P214, DOI 10.1097/00000542-199008000-00004; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Frohlich D, 1996, EUR J ANAESTH, V13, P582, DOI 10.1046/j.1365-2346.1996.d01-405.x; GEPTS E, 1987, ANESTH ANALG, V66, P1256; Gerstmeier J, 2016, FASEB J, V30, P1892, DOI 10.1096/fj.201500210R; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Heine J, 2000, BRIT J ANAESTH, V85, P424, DOI 10.1093/bja/85.3.424; Inada T, 2015, J IMMUNOTOXICOL, V12, P261, DOI 10.3109/1547691X.2014.938874; Inada T, 2013, J IMMUNOTOXICOL, V10, P262, DOI 10.3109/1547691X.2012.712066; Inada T, 2011, J IMMUNOTOXICOL, V8, P359, DOI 10.3109/1547691X.2011.620036; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Landa P, 2013, NAT PROD COMMUN, V8, P105; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; Mitra S, 2015, BIOCHEMISTRY-US, V54, P6333, DOI 10.1021/acs.biochem.5b00930; Murphy PG, 1996, EUR J ANAESTH, V13, P471, DOI 10.1046/j.1365-2346.1996.00003.x; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; OHISHI N, 1990, J BIOL CHEM, V265, P7520; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; PERKINS RS, 1995, BIOCHEM J, V310, P795, DOI 10.1042/bj3100795; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; SERHAN CN, 1995, AM J RESP CELL MOL, V12, P251, DOI 10.1165/ajrcmb.12.3.7873189; SHORT TG, 1994, BRIT J ANAESTH, V72, P302, DOI 10.1093/bja/72.3.302; Steinhilber D, 2014, BASIC CLIN PHARMACOL, V114, P70, DOI 10.1111/bcpt.12114; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Wu YR, 2012, J MED CHEM, V55, P2597, DOI 10.1021/jm201497k; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403; Yuki K, 2013, ANESTH ANALG, V117, P803, DOI 10.1213/ANE.0b013e3182a00ae0	38	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1584	1594		10.1096/fj.201601095R	http://dx.doi.org/10.1096/fj.201601095R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069825	Green Published			2022-12-26	WOS:000398504300025
J	Li, L; Zhang, QJ; Yang, HQ; Zou, QJ; Lai, CD; Jiang, F; Zhao, P; Luo, ZW; Yang, JY; Chen, Q; Wang, Y; Newsome, PN; Frampton, J; Maxwell, PH; Li, WJ; Chen, SH; Wang, DY; Siu, TS; Tam, S; Tse, HF; Qin, BM; Bao, XC; Esteban, MA; Lai, LX				Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Yang, Jiayin; Chen, Qian; Wang, Yan; Newsome, Philip N.; Frampton, Jon; Maxwell, Patrick H.; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Siu, Tak-Shing; Tam, Sidney; Tse, Hung-Fat; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue			Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; LARGE-ANIMAL-MODEL; LIVER REPOPULATION; CARBOCYANINE DYE; RAT BLASTOCYSTS; PIGS; MICROINJECTION; GENERATION; HEPATOCYTES	From the (a)CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, and Guangzhou Medical University, Guangzhou 511436, China, (b)CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, (c)Laboratory of RNA, Chromatin, and Human Disease, CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, (d)Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China, (e)Hong Kong-Guangdong Stem Cell and Regenerative Medicine Research Centre, The University of Hong Kong and Guangzhou Institutes of Biomedicine and Health, Hong Kong SAR, China, (f)Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China, (g)State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Research Center for Liver Fibrosis, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital and (h)Biomedical Research Center, Southern Medical University, Guangzhou 510515, China, (i)Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, (j)National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit and Centre for Liver Research, and (k)Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom, (l)Cambridge Institute for Medical Research, Wellcome Trust/Medical Research Council (MRC) Building, Cambridge CB2 0XY, United Kingdom, mDepartment of Clinical Biochemistry Unit, Queen Mary Hospital, Hong Kong SAR, China, (n)Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, Guangdong, China, and (o)Laboratory of Metabolism and Cell Fate, CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, Guangdong, China	[Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Bao, Xichen; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Lab RNA Chromatin & Human Dis, Guangzhou 510530, Guangdong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat; Esteban, Miguel A.] Univ Hong Kong, Hong Kong Guangdong Stem Cell & Regenerat Med Re, Hong Kong, Hong Kong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat; Esteban, Miguel A.] Guangzhou Inst Biomed & Hlth, Hong Kong, Hong Kong, Peoples R China; [Chen, Qian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Yan] Nanfang Hosp, Dept Infect Dis,State Key Lab Organ Failure Res, Guangdong Prov Res Ctr Liver Fibrosis, Guangdong Prov Key Lab Viral Hepatitis Res, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Yan] Nanfang Hosp, Hepatol Unit, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Yan] Southern Med Univ, Biomed Res Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Newsome, Philip N.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Birmingham Liver Biomed Res Unit, Natl Inst Hlth Res NIHR, Birmingham B15 2TT, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Maxwell, Patrick H.] Wellcome Trust Med Res Council MRC Bldg, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Siu, Tak-Shing; Tam, Sidney] Queen Mary Hosp, Dept Clin Biochem Unit, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong Shenzhen Hosp, Dept Med, Shenzhen 518053, Guangdong, Peoples R China; [Qin, Baoming] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Lab Metab & Cell Fate, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Cambridge; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Esteban, MA; Lai, LX (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.; Esteban, MA; Lai, LX (corresponding author), Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China.	miguel@gibh.ac.cn; lai_liangxue@gibh.ac.cn	Newsome, Philip N/D-4495-2018; Yang, Huaqiang/AAU-6402-2021; Tse, Hung-Fat/C-4426-2009; Maxwell, Patrick H/C-5557-2008	Newsome, Philip N/0000-0001-6085-3652; Tse, Hung-Fat/0000-0002-9578-7808; Maxwell, Patrick H/0000-0002-0338-2679; Tse, Hung Fat/0000-0003-4665-7887; Yang, Huaqiang/0000-0002-4287-0026	National Key Research and Development Program of China [2016YFA0100102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020106]; National Natural Science Foundation of China (NSFC) [31401275]; Guangdong Province Science and Technology Program [2013B050800010, 2013B060300017, 2014030304010, 2014B030301058, 2014A030312001, 2015B020229002, 2016B030229007]; Guangzhou Science and Technology Cooperation Program [2012J5100040, 201508030027]; Key Deployment Project of the Chinese Academy of Sciences [KSZDEW-Z-005-003-002]; Pearl River Science and Technology Nova Program of Guangzhou [201610010107]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015294]; Wellcome Trust Senior Investigator Award [096956/Z/11/Z]; NSFC and Hong Kong Research Grants Council Joint Research Fund [81261160506, N-HKU 730/12]; Medical Research Council [MR/K008781/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10122] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish; MRC [MR/K008781/1] Funding Source: UKRI	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Program; Guangzhou Science and Technology Cooperation Program; Key Deployment Project of the Chinese Academy of Sciences; Pearl River Science and Technology Nova Program of Guangzhou; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Wellcome Trust Senior Investigator Award(Wellcome Trust); NSFC and Hong Kong Research Grants Council Joint Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Key Research and Development Program of China Grant 2016YFA0100102; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01020106; National Natural Science Foundation of China (NSFC) Grant 31401275; Guangdong Province Science and Technology Program Grants 2013B050800010, 2013B060300017, 2014030304010, 2014B030301058, 2014A030312001, 2015B020229002, and 2016B030229007; Guangzhou Science and Technology Cooperation Program Grants 2012J5100040 and 201508030027; Key Deployment Project of the Chinese Academy of Sciences Grant KSZDEW-Z-005-003-002; Pearl River Science and Technology Nova Program of Guangzhou Grant 201610010107; Youth Innovation Promotion Association of the Chinese Academy of Sciences Grant 2015294; Wellcome Trust Senior Investigator Award 096956/Z/11/Z (to P. H. M.); and NSFC and Hong Kong Research Grants Council Joint Research Fund Grants 81261160506 and N-HKU 730/12. The authors declare that they have no conflicts of interest with the contents of this article.	Ashorn Merja, 2006, Paediatr Drugs, V8, P47, DOI 10.2165/00148581-200608010-00004; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bosze Z, 2006, WORLD RABBIT SCI, V14, P1; BREM G, 1985, ZUCHTHYGIENE, V20, P251; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Elgilani F, 2017, AM J PATHOL, V187, P33, DOI 10.1016/j.ajpath.2016.09.013; Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gissen P, 2003, J INHERIT METAB DIS, V26, P13, DOI 10.1023/A:1024011110116; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Grompe M, 2001, SEMIN LIVER DIS, V21, P563, DOI 10.1055/s-2001-19035; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hickey RD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3838; Hickey RD, 2014, STEM CELL RES, V13, P144, DOI 10.1016/j.scr.2014.05.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; Kuijk EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22154; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Macsai MS, 2001, AM J OPHTHALMOL, V132, P522, DOI 10.1016/S0002-9394(01)01160-6; Nakamura K, 2007, J NUTR, V137, p1556S, DOI 10.1093/jn/137.6.1556S; REESE JA, 1981, IN VITRO CELL DEV B, V17, P935; RUSSO P, 1990, AM J HUM GENET, V47, P317; Schauwvlieghe PP, 2013, CORNEA, V32, P91, DOI 10.1097/ICO.0b013e318243e474; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Trautwein C, 1998, J CLIN INVEST, V101, P1960, DOI 10.1172/JCI504; Vogel A, 2004, HEPATOLOGY, V39, P433, DOI 10.1002/hep.20077; Wang Yu, 2014, Cell Regen, V3, P3, DOI 10.1186/2045-9769-3-3; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yan Quanmei, 2014, Cell Regen, V3, P12, DOI 10.1186/2045-9769-3-12; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024; Zhang LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31460; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Zou QJ, 2015, J MOL CELL BIOL, V7, P580, DOI 10.1093/jmcb/mjv061	47	13	14	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4755	4763		10.1074/jbc.M116.764787	http://dx.doi.org/10.1074/jbc.M116.764787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28053091	Green Published, hybrid			2022-12-26	WOS:000397585100031
J	Du, KY; Murakami, S; Sun, YM; Kilpatrick, CL; Luscher, B				Du, Keyong; Murakami, Shoko; Sun, Yingmin; Kilpatrick, Casey L.; Luscher, Bernhard			DHHC7 Palmitoylates Glucose Transporter 4 (Glut4) and Regulates Glut4 Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAIN; SERTOLI-CELL GENE; PROTEIN PALMITOYLATION; GLUCOSE-TRANSPORTER; GABA(A) RECEPTORS; INSULIN; IDENTIFICATION; PHOSPHORYLATION; TRAFFICKING; ASSOCIATION	Insulin-dependent translocation of glucose transporter 4 (Glut4) to the plasma membrane plays a key role in the dynamic regulation of glucose homeostasis. Werecently showed that this process is critically dependent on palmitoylation of Glut4 at Cys-223. To gain further insights into the regulation of Glut4 palmitoylation, we set out to identify the palmitoyl acyltransferase (PAT) involved. Here we report that among 23 mammalian DHHC proteins, DHHC7 is the major Glut4 PAT, based on evidence that ectopic expression of DHHC7 increased Glut4 palmitoylation, whereas DHHC7 knockdown in 3T3-L1 adipocytes andDHHC7KOin adipose tissue and muscle decreased Glut4 palmitoylation. Moreover, inactivation of DHHC7 suppressed insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes and primary adipocytes. Finally, DHHC7 KO mice developed hyperglycemia and glucose intolerance, thereby confirming that DHHC7 represents the principal PAT for Glut4 and that this mechanism is essential for insulin- regulated glucose homeostasis.	[Du, Keyong; Sun, Yingmin] Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA; [Murakami, Shoko; Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA	Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906	National Institutes of Health [DK084319, MH062391, MH083911]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH062391, RC1MH089111, R01MH083911, R01MH062391, R01MH099851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants DK084319 (NIDDK; to K.D.) and MH062391 and MH083911 (to B.L.). This work was also supported by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2015, ADIPOCYTE, V4, P286, DOI 10.1080/21623945.2015.1048051; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, BIOCHEM SOC T, V38, P522, DOI 10.1042/BST0380522; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Hornemann T, 2015, J INHERIT METAB DIS, V38, P179, DOI 10.1007/s10545-014-9753-0; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kilpatrick CL, 2016, J BIOL CHEM, V291, P27371, DOI 10.1074/jbc.M116.732768; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lampson MA, 2000, J CELL SCI, V113, P4065; Lievens PMJ, 2016, MOL CELL BIOL, V36, P2208, DOI 10.1128/MCB.00144-16; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin BR, 2013, BIOCHEM SOC T, V41, P43, DOI 10.1042/BST20120271; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2012, J BIOL CHEM, V287, P34337, DOI 10.1074/jbc.M112.379297; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Omata W, 1997, BIOCHEM BIOPH RES CO, V241, P401, DOI 10.1006/bbrc.1997.7810; POULIOT JF, 1995, BBA-BIOMEMBRANES, V1234, P191, DOI 10.1016/0005-2736(94)00272-Q; Ren WY, 2015, BIOCHEM BIOPH RES CO, V460, P709, DOI 10.1016/j.bbrc.2015.03.094; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Ren WY, 2013, J BIOL CHEM, V288, P10902, DOI 10.1074/jbc.M112.369371; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Ross SA, 1997, BIOCHEM BIOPH RES CO, V239, P247, DOI 10.1006/bbrc.1997.7459; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	55	33	33	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2979	2991		10.1074/jbc.M116.747139	http://dx.doi.org/10.1074/jbc.M116.747139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057756	hybrid, Green Published			2022-12-26	WOS:000395535100037
J	Shen, ZN; Li, YR; Gasparski, AN; Abeliovich, H; Greenberg, ML				Shen, Zheni; Li, Yiran; Gasparski, Alexander N.; Abeliovich, Hagai; Greenberg, Miriam L.			Cardiolipin Regulates Mitophagy through the Protein Kinase C Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; SUPPRESSES TEMPERATURE SENSITIVITY; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; STATIONARY-PHASE; UP-REGULATION; YEAST; MITOCHONDRIAL; PHOSPHORYLATION; COMPLEX	Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is important for cardiovascular health, and perturbation of CL metabolism is implicated in cardiovascular disease. Although the role of CL in mitochondrial function, biogenesis, and genome stability has been studied, recent findings indicate that it is essential for functions apart from mitochondrial bioenergetics. In this study, we report that mitophagy is perturbed in CL-deficient yeast cells. Mutants of autophagy/ mitophagy genes ATG8, ATG18, and ATG32 synthetically interact with CL synthase mutant crd1 Delta. CL-deficient cells exhibited decreased GFP-tagged mitochondrial proteins inside the vacuole and decreased free GFP, consistent with decreased mitophagy. Both PKC and high osmolarity glycerol (HOG) MAPK pathways were shown previously to be required for mitophagy. Activation of both MAPKs was defective in CL-deficient cells. Deletion of HOG pathway genes SHO1, SSK1, STE50, and HOG1 exacerbated crd1 Delta growth. 1 M sorbitol and 0.2 M NaCl, which induce the HOG pathway, rescued growth of the mutant. Activation of the MAPK Slt2p was defective in crd1 Delta cells, and up-regulation of the PKC pathway by expression of the PKC1(R398P) gene, which encodes constitutively activated Pkc1p, rescued crd1 Delta growth and mitophagy defects. These findings indicate that loss of CL impairs MAPK pathway activation, and decreased activation of thePKCpathway leads to defective mitophagy.	[Shen, Zheni; Li, Yiran; Gasparski, Alexander N.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA; [Abeliovich, Hagai] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	Wayne State University; Hebrew University of Jerusalem	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mgreenberg@wayne.edu	Gasparski, Alexander/K-7918-2019	Gasparski, Alexander/0000-0002-6012-4887	National Institutes of Health [R01 HL117880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL117880. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bessa C, 2013, FEMS YEAST RES, V13, P700, DOI 10.1111/1567-1364.12069; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gaspard GJ, 2015, J BIOL CHEM, V290, P9284, DOI 10.1074/jbc.M115.641878; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Hage-Sleiman R, 2016, IMMUNOL RES, V64, P869, DOI 10.1007/s12026-016-8787-9; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984; Huwiler A, 1996, P NATL ACAD SCI USA, V93, P6959, DOI 10.1073/pnas.93.14.6959; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kofinger J, 2015, STRUCTURE, V23, P809, DOI 10.1016/j.str.2015.02.012; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Sakoh-Nakatogawa M, 2015, FEBS LETT, V589, P744, DOI 10.1016/j.febslet.2015.02.003; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shen ZN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891707; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	55	48	49	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2916	2923		10.1074/jbc.M116.753574	http://dx.doi.org/10.1074/jbc.M116.753574			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062576	Green Published, hybrid			2022-12-26	WOS:000395535100031
J	Dou, S; Gadonna-Widehem, P; Rome, V; Hamoudi, D; Rhazi, L; Lakhal, L; Larcher, T; Bahi-Jaber, N; Pinon-Quintana, A; Guyonvarch, A; Huerou-Luron, ILE; Abdennebi-Najar, L				Dou, Samir; Gadonna-Widehem, Pascale; Rome, Veronique; Hamoudi, Dounia; Rhazi, Larbi; Lakhal, Lyes; Larcher, Thibaut; Bahi-Jaber, Narges; Pinon-Quintana, Arturo; Guyonvarch, Alain; Huerou-Luron, Isabelle L. E.; Abdennebi-Najar, Latifa			Characterisation of Early-Life Fecal Microbiota in Susceptible and Healthy Pigs to Post-Weaning Diarrhoea	PLOS ONE			English	Article							STRAND CONFORMATION POLYMORPHISM; GUT MICROBIOTA; ENVIRONMENTAL-TEMPERATURE; DIVERSITY; COMMUNITIES; STABILITY; BACTERIA; COLIBACILLOSIS; TRANSMISSION; IMMUNITY	Early-life microbial exposure is of particular importance to growth, immune system development and long-lasting health. Hence, early microbiota composition is a promising predictive biomarker for health and disease but still remains poorly characterized in regards to susceptibility to diarrhoea. In the present study, we aimed to assess if gut bacterial community diversity and composition during the suckling period were associated with differences in susceptibility of pigs to post-weaning diarrhoea. Twenty piglets from 5 sows (4 piglets / litter) were weaned in poor housing conditions to challenge their susceptibility to post-weaning diarrhoea. Two weeks after weaning, 13 pigs exhibited liquid faeces during 2 or 3 days and were defined as diarrhoeic (D) pigs. The other 7 pigs did not have diarrhea during the whole post-weaning experimental periodand were defined as healthy (H) pigs. Using a molecular characterisation of fecal microbiota with CE-SSCP fingerprint, Next Generation Sequencing and qPCR, we show that D and H pigs were mainly discriminated as early as postnatal day (PND) 7, i.e. 4 weeks before post-weaning diarrhoea occurence. At PND 7 H pigs displayed a lower evenness and a higher abundance of Prevotellaceae, Lachnospiraceae, Ruminocacaceae and Lactobacillaceae compared to D pigs. The sPLS regression method indicates that these bacterial families were strongly correlated to a higher Bacteroidetes abundance observed in PND 30 H pigs one week before diarrhoea. These results emphasize the potential of early microbiota diversity and composition as being an indicator of susceptibility to post-weaning diarrhoea. Furthermore, they support the health promoting strategies of pig herds through gut microbiota engineering.	[Dou, Samir; Gadonna-Widehem, Pascale; Hamoudi, Dounia; Rhazi, Larbi; Bahi-Jaber, Narges; Abdennebi-Najar, Latifa] Inst Polytech LaSalle Beauvais, UP EGEAL 2012 10 101, Rue Pierre Waguet, Beauvais, France; [Rome, Veronique; Huerou-Luron, Isabelle L. E.] INRA, ADNC UR1341, Domaine Prise, St Gilles, France; [Lakhal, Lyes] Inst Polytech LaSalle Beauvais, Direct Rech, Rue Pierre Waguet, Beauvais, France; [Larcher, Thibaut] INRA, UMR APEX 703, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Nantes, France; [Pinon-Quintana, Arturo; Guyonvarch, Alain] INVIVO NSA, Direct Sci Tech & Innovat, Dept Innovat & Prospect, Talhouet St Nolff, France	UniLaSalle; INRAE; UniLaSalle; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Abdennebi-Najar, L (corresponding author), Inst Polytech LaSalle Beauvais, UP EGEAL 2012 10 101, Rue Pierre Waguet, Beauvais, France.; Huerou-Luron, ILE (corresponding author), INRA, ADNC UR1341, Domaine Prise, St Gilles, France.	Isabelle.Luron@rennes.inra.fr; latifanajar60@gmail.com	Abdennebi-Najar, Latifa/AAG-3231-2021; Rhazi, Larbi/AAX-6192-2020; Larcher, Thibaut/X-8500-2019	Rhazi, Larbi/0000-0001-6489-3109; Luron, Isabelle/0000-0002-1769-5246; Abdennebi-Najar, latifa/0000-0003-3070-2639	INVIVO-NSA; LaSalle Beauvais; INRA Institute	INVIVO-NSA; LaSalle Beauvais; INRA Institute	The study was funded by INVIVO-NSA, LaSalle Beauvais and INRA Institute and no additional external funding was received for this study. The funders had no role in the preparation of the manuscript and decision to publish.	Allen-Vercoe E, 2014, IMMUNOL LETT, V162, P54, DOI 10.1016/j.imlet.2014.05.014; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Buddington RK, 2010, NEONATOLOGY, V97, P250, DOI 10.1159/000253756; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen Minjie, 2009, Weishengwu Xuebao, V49, P1555; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Devillers N, 2007, ANIMAL, V1, P1033, DOI 10.1017/S175173110700016X; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Ettreiki C, 2012, WORLD J GASTROENTERO, V18, P2619, DOI 10.3748/wjg.v18.i21.2619; Guerra-Ordaz AA, 2014, APPL ENVIRON MICROB, V80, P4879, DOI 10.1128/AEM.00770-14; Hillenmeyer ME, 2015, P NATL ACAD SCI USA, V112, P13952, DOI 10.1073/pnas.1511688112; Isolauri E, 2015, BENEF MICROBES, V6, P167, DOI 10.3920/BM2014.0114; Jakobsson HE, 2013, GUT; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jurgens MH, 1997, J ANIM SCI, V75, P593; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski J, 2012, CURR PROTOC MICROBIO, V1; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; LEDIVIDICH J, 1980, BRIT J NUTR, V44, P313, DOI 10.1079/BJN19800046; LEDIVIDICH J, 1981, LIVEST PROD SCI, V8, P75, DOI 10.1016/0301-6226(81)90032-4; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Madec F, 2000, VET MICROBIOL, V72, P295, DOI 10.1016/S0378-1135(99)00202-3; Magurran AE, 2013, MEASURING BIOL DIVER; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Michelland RJ, 2009, MOL ECOL RESOUR, V9, P1359, DOI 10.1111/j.1755-0998.2009.02609.x; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Pajarillo EAB, 2014, J GEN APPL MICROBIOL, V60, P140, DOI 10.2323/jgam.60.140; Passlack N, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0351-7; Pissavin C, 2012, POULTRY SCI, V91, P2294, DOI 10.3382/ps.2011-01911; Pouillart PR, 2010, INFLAMM BOWEL DIS, V16, P783, DOI 10.1002/ibd.21130; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044573; Royce LA, 2013, APPL MICROBIOL BIOT, V97, P8317, DOI 10.1007/s00253-013-5113-5; Ryu H, 2013, APPL ENVIRON MICROB, V79, P196, DOI 10.1128/AEM.02802-12; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Singh P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0109-2; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Werner JJ, 2014, APPL ENVIRON MICROB, V80, P3375, DOI 10.1128/AEM.00166-14; Xie T, 1997, J CLIN PATHOL-MOL PA, V50, P276, DOI 10.1136/mp.50.5.276; Zhang HS, 2015, ISME J, V9, P770, DOI 10.1038/ismej.2014.165	58	118	127	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169851	10.1371/journal.pone.0169851	http://dx.doi.org/10.1371/journal.pone.0169851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072880	Green Published, gold, Green Submitted			2022-12-26	WOS:000391844200052
J	Li, L; Zhang, HL; Zhang, M; Zhao, MX; Feng, LJ; Luo, X; Gao, ZT; Huang, Y; Ardayfio, O; Zhang, JH; Lin, Y; Fan, H; Mi, Y; Li, GB; Liu, L; Feng, LY; Luo, FJ; Teng, L; Qi, W; Ottl, J; Lingel, A; Bussiere, DE; Yu, ZT; Atadja, P; Lu, C; Li, E; Gu, J; Zhao, KH				Li, Ling; Zhang, Hailong; Zhang, Man; Zhao, Mengxi; Feng, Lijian; Luo, Xiao; Gao, Zhenting; Huang, Ying; Ardayfio, Ophelia; Zhang, Ji-Hu; Lin, Ying; Fan, Hong; Mi, Yuan; Li, Guobin; Liu, Lei; Feng, Leying; Luo, Fangjun; Teng, Lin; Qi, Wei; Ottl, Johannes; Lingel, Andreas; Bussiere, Dirksen E.; Yu, Zhengtian; Atadja, Peter; Lu, Chris; Li, En; Gu, Justin; Zhao, Kehao			Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED	PLOS ONE			English	Article							HISTONE H3; PROTEIN EED; SELECTIVE-INHIBITION; STRUCTURAL BASIS; A687V EZH2; MUTATION; POTENT; IDENTIFICATION; REFINEMENT; ASSAY	Polycomb repressive complex 2 (PRC2), a histone H3 lysine 27 methyltransferase, plays a key role in gene regulation and is a known epigenetics drug target for cancer therapy. The WD40 domain-containing protein EED is the regulatory subunit of PRC2. It binds to the trimethylated lysine 27 of the histone H3 (H3K27me3), and through which stimulates the activity of PRC2 allosterically. Recently, we disclosed a novel PRC2 inhibitor EED226 which binds to the K27me3-pocket on EED and showed strong antitumor activity in xenograft mice model. Here, we further report the identification and validation of four other EED binders along with EED162, the parental compound of EED226. The crystal structures for all these five compounds in complex with EED revealed a common deep pocket induced by the binding of this diverse set of compounds. This pocket was created after significant conformational rearrangement of the aromatic cage residues (Y365, Y148 and F97) in the H3K27me3 binding pocket of EED, the width of which was delineated by the side chains of these rearranged residues. In addition, all five compounds interact with the Arg367 at the bottom of the pocket. Each compound also displays unique features in its interaction with EED, suggesting the dynamics of the H3K27me3 pocket in accommodating the binding of different compounds. Our results provide structural insights for rational design of novel EED binder for the inhibition of PRC2 complex activity.	[Li, Ling; Zhang, Hailong; Zhang, Man; Zhao, Mengxi; Feng, Lijian; Luo, Xiao; Gao, Zhenting; Huang, Ying; Lin, Ying; Fan, Hong; Mi, Yuan; Li, Guobin; Liu, Lei; Feng, Leying; Luo, Fangjun; Teng, Lin; Qi, Wei; Yu, Zhengtian; Atadja, Peter; Lu, Chris; Li, En; Gu, Justin; Zhao, Kehao] China Novartis Inst BioMed Res, Shanghai, Peoples R China; [Ardayfio, Ophelia; Zhang, Ji-Hu] Novartis Inst BioMed Res, Cambridge, MA USA; [Ottl, Johannes] Novartis Inst BioMed Res, Basel, Switzerland; [Lingel, Andreas; Bussiere, Dirksen E.] Novartis Inst BioMed Res, Emeryville, CA USA	Novartis; Novartis; Novartis; Novartis	Gu, J; Zhao, KH (corresponding author), China Novartis Inst BioMed Res, Shanghai, Peoples R China.	Justin.gu@novartis.com; Kehao.zhao@novartis.com	Lingel, Andreas/AAP-5078-2021	Zhao, Kehao/0000-0003-2485-058X	Novartis Institutes for Biomedical Research (NIBR)	Novartis Institutes for Biomedical Research (NIBR)	This research was funded by Novartis Institutes for Biomedical Research (NIBR). The funder provided support in the form of salaries for authors L.Li, H.Z., M.Zhang., M.Zhao., Li.F., X.L., Z. G., Y.H., O.A., JH.Z., Y.L., H.F., Y.M., G.L., L.Liu., Le.F., F.L., L.T., W.Q., J.O., A.L., D.E. B., Z.Y., P.A., C.L., E.L., J.G., and K.Z., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Huang Y, 2016, J MED CHEM UNPUB; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kroeze LI, 2012, BLOOD, V119, P1318, DOI 10.1182/blood-2011-07-365213; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2013, ANAL BIOCHEM, V443, P214, DOI 10.1016/j.ab.2013.08.029; Lingel A, 2016, J MED CHEM; Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musselman CA, 2014, BBA-GENE REGUL MECH, V1839, P686, DOI 10.1016/j.bbagrm.2014.04.001; Obier N, 2015, STEM CELL REV REP, V11, P50, DOI 10.1007/s12015-014-9550-z; Ott HM, 2014, MOL CANCER THER, V13, P3062, DOI 10.1158/1535-7163.MCT-13-0876; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi W, 2016, NATURE CHEM IN PRESS; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Quinn AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp899; Santiago C, 2011, J COMPUT AID MOL DES, V25, P1171, DOI 10.1007/s10822-011-9505-2; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208	40	32	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169855	10.1371/journal.pone.0169855	http://dx.doi.org/10.1371/journal.pone.0169855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072869	gold, Green Submitted, Green Published			2022-12-26	WOS:000391844200053
J	Givaty-Rapp, Y; Yadav, NS; Khan, A; Grafi, G				Givaty-Rapp, Yemima; Yadav, Narendra Singh; Khan, Asif; Grafi, Gideon			S1-Type Endonuclease 2 in Dedifferentiating Arabidopsis Protoplasts: Translocation to the Nucleus in Senescing Protoplasts Is Associated with De-Glycosylation	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CHROMATIN DECONDENSATION; BFN1 NUCLEASE; PLANT-CELLS; DNA; SENESCENCE; DEGRADATION; RETENTION; THALIANA; SIGNALS	Cell dedifferentiation characterizes the transition of leaf cells to protoplasts and is accompanied by global chromatin decondensation. Here we show that in Arabidopsis, chromo-centric chromatin undergoes prompt and gradual decondensation upon protoplasting. We hypothesized that prompt chromatin decondensation is unlikely to be driven solely by epigenetic means and other factors might be involved. We investigated the possibility that S1-type endonucleases are involved in prompt chromatin decondensation via their capability to target and cleave unpaired regions within superhelical DNA, leading to chromatin relaxation. We showed that the expression and activity of the S1-type endonuclease 2 (ENDO2) is upregulated in dedifferentiating protoplasts concomitantly with chromatin decondensation. Mutation of the ENDO2 gene did not block or delay chromocentric chromatin decondensation upon protoplasting. Further study showed that ENDO2 subcellular localization is essentially cytoplasmic (endoplasmic reticulum-associated) in healthy cells, but often localized to the nucleus and in senescing/ dying cells it was associated with fragmented nuclei. Using in gel nuclease assays we identified two ENDO2 variants, designated N1 (cytoplasmic variant) and N2 (cytoplasmic and nuclear variant), and based on their capability to bind concanavalin A (ConA), they appear to be glycosylated and de-glycosylated (or decorated with ConA non-binding sugars), respectively. Our data showed that the genome is responding promptly to acute stress (protoplasting) by acquiring decondensation state, which is not dependent on ENDO2 activity. ENDO2 undergoes de-glycosylation and translocation to the nucleus where it is involved in early stages of cell death probably by introducing double strand DNA breaks into superhelical DNA leading to local chromatin relaxation and fragmentation of nuclei.	[Givaty-Rapp, Yemima; Yadav, Narendra Singh; Khan, Asif; Grafi, Gideon] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Desert Res Inst, Midreshet Ben Gurion, Israel	Ben Gurion University	Grafi, G (corresponding author), Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Desert Res Inst, Midreshet Ben Gurion, Israel.	ggrafi@bgu.ac.il	Yadav, Narendra Singh/C-3330-2013	Yadav, Narendra Singh/0000-0003-0122-173X	Israel Science Foundation [175/12]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (https://www.isf.org.il/#/) grant no. 175/12 (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 1998, FEBS LETT, V429, P134, DOI 10.1016/S0014-5793(98)00563-8; Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; BEARD P, 1973, J VIROL, V12, P1303, DOI 10.1128/JVI.12.6.1303-1313.1973; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BLANK T, 1992, EXP CELL RES, V202, P224, DOI 10.1016/0014-4827(92)90069-K; Damri M, 2009, REJUV RES, V12, P435, DOI 10.1089/rej.2009.0887; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Doherty R, 2015, J BIOMOL SCREEN, V20, P829, DOI 10.1177/1087057115581581; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Farage-Barhom S, 2011, MOL PLANT, V4, P1062, DOI 10.1093/mp/ssr045; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Grafi G, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00053; Granot G, 2015, BBA-GENE REGUL MECH, V1849, P239, DOI 10.1016/j.bbagrm.2014.12.003; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ito J, 2002, PLANT CELL, V14, P3201, DOI 10.1105/tpc.006411; JAMET E, 1990, CELL DIFFER DEV, V29, P37, DOI 10.1016/0922-3371(90)90022-O; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Lesniewicz K, 2013, PLANT CELL PHYSIOL, V54, P1064, DOI 10.1093/pcp/pct061; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Maniatis T., 1982, MOL CLONING; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Sakamoto W, 2014, J EXP BOT, V65, P3835, DOI 10.1093/jxb/eru091; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu ZH, 2016, BIOCHEM BIOPH RES CO, V473, P953, DOI 10.1016/j.bbrc.2016.03.160; Zemach A, 2005, PLANT CELL, V17, P1549, DOI 10.1105/tpc.105.031567; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200	37	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0170067	10.1371/journal.pone.0170067	http://dx.doi.org/10.1371/journal.pone.0170067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068427	gold, Green Published, Green Submitted			2022-12-26	WOS:000391843900084
J	Li, XL; Xu, KW; Zhang, YY; Sun, CJ; He, Y				Li, Xiaoli; Xu, Kaiwen; Zhang, Yuying; Sun, Chanjun; He, Yong			Optical Determination of Lead Chrome Green in Green Tea by Fourier Transform Infrared (FT-IR) Transmission Spectroscopy	PLOS ONE			English	Article							SUCCESSIVE PROJECTIONS ALGORITHM; REFLECTANCE SPECTROSCOPY; VARIABLE SELECTION; PHTHALOCYANINE; REGRESSION; SPECTRA; QUALITY; L.	The potential of Fourier transform infrared (FT-IR) transmission spectroscopy for determination of lead chrome green in green tea was investigated based on chemometric methods. Firstly, the qualitative analysis of lead chrome green in tea was performed based on partial least squares discriminant analysis (PLS-DA), and the correct rate of classification was 100%. And then, a hybrid method of interval partial least squares (iPLS) regression and successive projections algorithm (SPA) was proposed to select characteristic wavenumbers for the quantitative analysis of lead chrome green in green tea, and 19 wavenumbers were obtained finally. Among these wavenumbers, 1384 (C = C), 1456, 1438, 1419(C = N), and 1506 (CNH) cm(-1) were the characteristic wavenumbers of lead chrome green. Then, these 19 wavenumbers were used to build determination models. The best model was achieved by least squares support vector machine (LS-SVM) algorithm with high coefficient of determination and low root-mean square error of prediction set (R-p(2) = 0.864 and RMSEP = 0.291). All these results indicated the feasibility of IR spectra for detecting lead chrome green in green tea.	[Li, Xiaoli; Xu, Kaiwen; Zhang, Yuying; Sun, Chanjun; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.	yhe@zju.edu.cn	Li, Xiaoli/GYQ-7384-2022; He, Yong/E-3218-2010	He, Yong/0000-0001-6752-1757; Li, Xiaoli/0000-0001-9689-9054	National Natural Science Foundation of China [31471417]; Zhejiang Province Public Welfare Technology Application Research Project [2014C32091]; Zhejiang Province Public Technology Research Program [2015C02008]; Special Funding Projects for Basic Scientific Research Projects in Universities [2015QNA6005]; Scientific Research Project of Zhejiang Provincial Department of Education [Y201225966]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Public Welfare Technology Application Research Project; Zhejiang Province Public Technology Research Program; Special Funding Projects for Basic Scientific Research Projects in Universities; Scientific Research Project of Zhejiang Provincial Department of Education	This research was funded by the National Natural Science Foundation of China (Project No: 31471417), Zhejiang Province Public Welfare Technology Application Research Project (Project No: 2014C32091), Zhejiang Province Public Technology Research Program (Project No: 2015C02008), Special Funding Projects for Basic Scientific Research Projects in Universities (Project No: 2015QNA6005), and Scientific Research Project of Zhejiang Provincial Department of Education (Project No: Y201225966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the National Natural Science Foundation of China (Project No:31471417), Zhejiang Province Public Welfare Technology Application Research Project (Project No:2014C32091), Zhejiang Province Public Technology Research Program (Project No:2015C02008), Special Funding Projects for Basic Scientific Research Projects in Universities (Project No:2015QNA6005). Scientific Research Project of Zhejiang Provincial Department of Education (Project No: Y201225966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatise OI, 2010, BIOL TRACE ELEM RES, V136, P127, DOI 10.1007/s12011-010-8608-2; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Chen JB, 2016, J MOL STRUCT, V1115, P55, DOI 10.1016/j.molstruc.2016.02.079; Chen L. Y., 2008, TROP AGR ENG, V32, P38; Chen R, 2015, ANAL LETT, V48, P1502, DOI 10.1080/00032719.2014.984190; Chen X, 2009, ANAL CHIM ACTA, V638, P16, DOI 10.1016/j.aca.2009.02.002; Chi QH, 2014, CONTROL ENG PRACT, V22, P181, DOI 10.1016/j.conengprac.2013.02.010; Dai WL, 2015, J STAT PLAN INFER, V163, P1, DOI 10.1016/j.jspi.2015.02.010; Ji GL, 2015, CHEMOMETR INTELL LAB, V144, P56, DOI 10.1016/j.chemolab.2015.03.008; Jiang HY, 2015, FOOD CHEM, V183, P30, DOI 10.1016/j.foodchem.2015.03.024; Larkin PJ, 2011, IR RAMAN PRINCIPLES; Lee MS, 2014, FOOD CHEM, V158, P351, DOI 10.1016/j.foodchem.2014.02.127; Li X., 2015, SCI REP, V5, P1, DOI DOI 10.1038/SREP16774; Li XL, 2015, COMPUT ELECTRON AGR, V112, P28, DOI 10.1016/j.compag.2015.01.005; Li XL, 2013, COMPUT ELECTRON AGR, V98, P46, DOI 10.1016/j.compag.2013.07.014; Liu F, 2008, ANAL CHIM ACTA, V615, P10, DOI 10.1016/j.aca.2008.03.030; Liu F, 2009, FOOD CHEM, V115, P1430, DOI 10.1016/j.foodchem.2009.01.073; Liu SD, 2016, OCCUPATION HLTH, V32, P172; Miliani C, 2007, APPL SPECTROSC, V61, P293, DOI 10.1366/000370207780220840; Shen WZ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/375827; Staniford MC, 2015, RSC ADV, V5, P3974, DOI 10.1039/c4ra11139g; Suykens JAK, 2001, NEURAL NETWORKS, V14, P23, DOI 10.1016/S0893-6080(00)00077-0; Suzuki A, 2016, APPL SURF SCI, V380, P127, DOI 10.1016/j.apsusc.2016.02.026; Tarantilis PA, 1998, SPECTROCHIM ACTA A, V54, P651, DOI 10.1016/S1386-1425(98)00024-9; tih S K, 2014, PLANTA MED, V80, P1023, DOI [10.1055/s-0034-1382904, DOI 10.1055/S-0034-1382904]; Wang X, 2015, ANAL METHODS-UK, V7, P787, DOI [10.1039/C4AY02106A, 10.1039/c4ay02106a]; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu D, 2013, TRENDS FOOD SCI TECH, V29, P5, DOI 10.1016/j.tifs.2012.08.004; Wu H, 2013, J ANSHAN NORMAL U, V2, P41; Xia D., 2015, DISCRETE DYN NAT SOC, V2015, P18; Xiong CW, 2015, FOOD CHEM, V176, P130, DOI 10.1016/j.foodchem.2014.12.057; Xiong ZJ, 2015, FOOD CHEM, V179, P175, DOI 10.1016/j.foodchem.2015.01.116; Yang BJ, 2014, FOOD CHEM TOXICOL, V65, P227, DOI 10.1016/j.fct.2013.12.047; Yavuz A, 2011, J APPL POLYM SCI, V122, P1293, DOI 10.1002/app.33657; Yun YH, 2013, SPECTROCHIM ACTA A, V111, P31, DOI 10.1016/j.saa.2013.03.083; Zou Y, 2014, EUR FOOD RES TECHNOL, V239, P357, DOI 10.1007/s00217-014-2219-7	36	7	9	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2017	12	1							e0169430	10.1371/journal.pone.0169430	http://dx.doi.org/10.1371/journal.pone.0169430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WO	28068348	gold, Green Submitted, Green Published			2022-12-26	WOS:000391843900033
J	Gholami, M; Pakdaman, A; Montazeri, A; Virtanen, JI				Gholami, Mahdia; Pakdaman, Afsaneh; Montazeri, Ali; Virtanen, Jorma I.			Evaluation of the Impact of a Mass Media Campaign on Periodontal Knowledge among Iranian Adults: A Three-Month Follow-Up	PLOS ONE			English	Article							ORAL-HEALTH PROMOTION; RANDOMIZED-TRIALS; BEHAVIOR; TELEVISION	Objectives This study aimed to evaluate the impact of a national media campaign to promote oral health and periodontal knowledge among adults after a three-month follow-up. Methods We conducted a population-based study of adults aged 18 to 50 years using a stratified multi-stage sampling method in Tehran, Iran in 2011. The campaign included an animation clip about periodontal health and disease telecast on national TV for ten consecutive days. We used an instrument to assess the effect of the campaign at baseline, immediately after the campaign and after a three-month follow-up. A total of 543 participants responded at baseline and immediately after the intervention, and 294 were interviewed at the three-month follow-up assessment (response rate: 54.1%). We assessed each participant's periodontal knowledge score, calculated as a sum of correct answers, and the change in their score following the campaign. We then used a five-item questionnaire to evaluate the participants' opinion of the success of the campaign. We used descriptive statistics and generalised estimating equations (GEE) analysis to conduct the statistical analysis. Results The mean score for knowledge improvement from baseline to immediate post-intervention evaluation was higher among those who saw the campaign (0.61) than among those who did not (0.29); the corresponding figures from immediate evaluation to three-month followup were -0.17 and 0.15, respectively. Adjusting for baseline values, the GEE analysis demonstrated that improvement in the mean score of post-campaign knowledge associated significantly with age, education and seeing the campaign. Significant interaction between the time since seeing the campaign and whether the participant saw it (p < 0.001) revealed that the mean difference in the knowledge score between the groups who did and did not see the campaign was 0.4 at the immediate evaluation and -0.04 at the three-month follow-up. The participants received the campaign well in terms of being appealing (91.4%), worth bearing in mind (83.4%) and containing valuable information (80.3%). Conclusions Our findings indicate that a population-based media campaign promoting oral health and periodontal knowledge among adults had a positive short-term impact, although the effect seemed to plateau after three months.	[Gholami, Mahdia; Pakdaman, Afsaneh] Univ Tehran Med Sci, Sch Dent, Dept Community Oral Hlth, Tehran, Iran; [Montazeri, Ali] ACECR, Hlth Metr Res Ctr, Iranian Inst Hlth Sci Res, Mental Hlth Res Grp, Tehran, Iran; [Virtanen, Jorma I.] Univ Oulu, Res Unit Oral Hlth Sci, Oulu, Finland; [Virtanen, Jorma I.] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland	Tehran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); University of Oulu; University of Oulu	Pakdaman, A (corresponding author), Univ Tehran Med Sci, Sch Dent, Dept Community Oral Hlth, Tehran, Iran.	pakdaman@sina.tums.ac.ir	Virtanen, Jorma/AAP-1160-2021; Montazeri, Ali/C-9276-2009; Gholami, Mahdia/N-2833-2018	Virtanen, Jorma/0000-0001-6574-9942; Montazeri, Ali/0000-0002-5198-9539; PAKDAMAN, AFSANEH/0000-0003-2964-059X; Gholami, Mahdia/0000-0001-7734-3712	Tehran University of Medical Science and Health Services [90-01-69-12892]	Tehran University of Medical Science and Health Services(Tehran University of Medical Sciences)	This study was supported by Tehran University of Medical Science and Health Services grant no. 90-01-69-12892.	Croxson L J, 1993, Int Dent J, V43, P167; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Donyavi T, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-9; Dutta MJ, 2007, HEALTH COMMUN, V21, P1, DOI 10.1080/10410230701283256; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Friel S, 2002, HEALTH PROMOT INT, V17, P119, DOI 10.1093/heapro/17.2.119; Gholami M, 2014, E MEDITERR HEALTH J, V20, P196, DOI 10.26719/2014.20.3.196; Gholami M, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-31; Jawad M, 2016, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0252-6; Kay EJ, 1996, COMMUNITY DENT ORAL, V24, P231, DOI 10.1111/j.1600-0528.1996.tb00850.x; Liu YY, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-18; Mahdavian M, ASIAN J AGR EXTENSIO, V6; Martensson C, 2004, SWED DENT J, V28, P165; Martensson C, 2006, Int J Dent Hyg, V4, P8; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Montazeri Ali, 2008, BMC Res Notes, V1, P50, DOI 10.1186/1756-0500-1-50; Randolph W, 2004, ANNU REV PUBL HEALTH, V25, P419, DOI 10.1146/annurev.publhealth.25.101802.123046; RISE J, 1988, COMMUNITY DENT ORAL, V16, P1, DOI 10.1111/j.1600-0528.1988.tb00543.x; Saito H, 2002, INT DENT J, V52, P197, DOI 10.1002/j.1875-595X.2002.tb00924.x; Saleh A, 2012, ASIAN PAC J CANCER P, V13, P1217, DOI 10.7314/APJCP.2012.13.4.1217; SCHOU L, 1987, COMMUNITY DENT ORAL, V15, P14, DOI 10.1111/j.1600-0528.1987.tb00473.x; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Sorrell JT, 2009, J DENT EDUC, V73, P1293; Tones K, 1994, HLTH PROMOTION EFFEC; Tones K, 1994, HLTH ED EFFECTIVENES; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Yevlahova D, 2009, AUST DENT J, V54, P190, DOI 10.1111/j.1834-7819.2009.01118.x; Yu FSK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144492	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169668	10.1371/journal.pone.0169668	http://dx.doi.org/10.1371/journal.pone.0169668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060959	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500126
J	Jacques, MF; Orme, P; Smith, J; Morse, CI				Jacques, Matthew F.; Orme, Paul; Smith, Jonathon; Morse, Christopher I.			Resting Energy Expenditure in Adults with Becker's Muscular Dystrophy	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; X-RAY ABSORPTIOMETRY; PHYSICAL-ACTIVITY ASSESSMENT; BODY-COMPOSITION; PULMONARY-FUNCTION; DUCHENNE; SIZE; FAT; CHILDREN; BOYS	Purpose The purpose of this study was: 1) To compare Resting energy expenditure (REE) in adult males with Becker's Muscular Dystrophy (BeMD, n = 21, 39 +/- 12 years) and healthy controls (CTRL, n = 12, 37 +/- 12 years) 2) Determine whether other physiological parameters correlate with REE in BeMD, and 3) Compare current prediction methods of REE with measured REE. Methods REE was calculated via indirect calorimetry using continuous, expired gas analysis following an overnight fast. Fat free mass (FFM) and fat mass were measured by bioelectrical impedance. B-mode ultrasound measured Tibialis Anterior (TA) and Gastrocnemius Medialis (GM) anatomical cross sectional area (ACSA). The Bone Specific Physical Activity Questionnaire measured physical activity. Results No difference in REE was found between CTRL and BeMD groups (1913 +/- 203 & 1786 +/- 324 Kcal respectively). Other physiological comparisons showed increased fat mass (+54%), decreased TA ACSA (-42%), increased GM ACSA (+25%) as well as reduced respiratory function (FVC -28%; FEV1-27%) in BeMD adults compared to controls. REE estimated from prediction equations (Schofield's) in Muscular Dystrophy were different from measured REE (P<0.05, bias = -728kcal), while the Mifflin equation was no different from measured REE (r(2) = 0.58, Bias = -8kcal). Within the present BeMD, REE predicted from FFM (REE = FFM x 34.57-270; r(2) = 0.85) and body mass (REE = BM x 15.65 + 421.5; r(2) = 0.66), were not different from measured REE (bias equals 0 and 0.2kcals, respectively) Conclusions Despite no differences in REE between CTRL and BeMD adults, increased fat masses highlights the requirement for explicit nutritional guidelines, as well as maintenance of physical activity levels, where possible. Prediction equations are frequently used in clinical settings, however these have been shown to be less accurate in BeMD; therefore, the equations proposed here should be used where possible.	[Jacques, Matthew F.; Morse, Christopher I.] Manchester Metropolitan Univ, Hlth Exercise & Act Living HEAL Res Ctr, Cheshire Campus, Crewe, England; [Orme, Paul; Smith, Jonathon] Neuromuscular Ctr, Winsford, Cheshire, England	Manchester Metropolitan University	Jacques, MF (corresponding author), Manchester Metropolitan Univ, Hlth Exercise & Act Living HEAL Res Ctr, Cheshire Campus, Crewe, England.	M.Jacques@stu.mmu.ac.uk	Morse, Christopher/AAE-7913-2022	Morse, Christopher/0000-0002-5261-2637; Jacques, Matthew/0000-0002-1058-1107				[Anonymous], 1984, HUM NUTR CLIN NUTR; ASTRUP A, 1992, J CLIN ENDOCR METAB, V74, P279, DOI 10.1210/jc.74.2.279; Bonifati MD, 2000, MUSCLE NERVE, V23, P1344, DOI 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.3.CO;2-6; Bosy-Westphal A, 2003, J NUTR, V133, P2356, DOI 10.1093/jn/133.7.2356; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Elliott SA, 2012, EUR J PAEDIATR NEURO, V16, P631, DOI 10.1016/j.ejpn.2012.02.011; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Fonseca JA, 2005, CHEST, V128, P1258, DOI 10.1378/chest.128.3.1258; GARBY L, 1994, EUR J CLIN NUTR, V48, P376; GOLDSTEIN M, 1989, JPEN-PARENTER ENTER, V13, P603, DOI 10.1177/0148607189013006603; Gonzalez-Bermejo J, 2005, EUR RESPIR J, V25, P682, DOI 10.1183/09031936.05.00031304; Hachisuka KJ, 1997, ARCH PHYS MED REHAB, V78, P13, DOI 10.1016/S0003-9993(97)90003-4; HAPKE EJ, 1972, CHEST, V61, P41, DOI 10.1378/chest.61.1.41; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huml RA., 2015, MUSCULAR DYSTROPHY C; Igawa S, 2002, CLIN EXP PHARMACOL P, V29, pS13, DOI [10.1046/j.1440-1681.29.s4.7.x, 10.1046/j.1440-1681.29.s4.6.x]; ISBELL TR, 1991, JPEN-PARENTER ENTER, V15, P165, DOI 10.1177/0148607191015002165; Jeronimo G, 2016, NUTRITION, V32, P391, DOI 10.1016/j.nut.2015.09.004; JONES DA, 1983, J NEUROL SCI, V60, P307, DOI 10.1016/0022-510X(83)90071-0; KOENIG M, 1989, AM J HUM GENET, V45, P498; Marra M, 2015, J PEDIATR-US, V166, P1390, DOI 10.1016/j.jpeds.2015.03.013; MCANENA OJ, 1986, JPEN-PARENTER ENTER, V10, P555, DOI 10.1177/0148607186010006555; McCabe MP, 2013, EATING DISORDERS ENC, V34, P90; McDonald CM, 2005, AM J PHYS MED REHAB, V84, P483, DOI 10.1097/01.phm.0000166880.91117.04; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P802, DOI 10.1016/j.apmr.2004.10.012; McDonald CM, 1995, AM J PHYS MED REHABI, V74, pS104; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Miles JM, 2006, ENERGY EXPENDITURE H; Mok E, 2010, CLIN NUTR, V29, P633, DOI 10.1016/j.clnu.2010.03.011; Morse CI, 2016, J MUSCULOSKEL NEURON, V16, P339; Morse CI, 2015, J MUSCULOSKEL NEURON, V15, P154; Okasora K, 1999, PEDIATR INT, V41, P121, DOI 10.1046/j.1442-200X.1999.4121048.x; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Reeves SL, 1996, EUR J CLIN NUTR, V50, P398; Shimizu-Fujiwara M, 2012, BRAIN DEV-JPN, V34, P206, DOI 10.1016/j.braindev.2011.05.005; Sun G, 2005, AM J CLIN NUTR, V81, P74; Tamura T, 2002, CLIN EXP PHARMACOL P, V29, pS2, DOI [10.1046/j.1440-1681.29.s4.3.x, 10.1046/j.1440-1681.29.s4.2.x]; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Weeks BK, 2016, EUR J SPORT SCI, P1; World Health O, 2005, HUM EN REQ NS; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169848	10.1371/journal.pone.0169848	http://dx.doi.org/10.1371/journal.pone.0169848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060911	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000391641500141
J	Pan, XL; Sang, SM; Fei, GQ; Jin, LR; Liu, HM; Wang, ZL; Wang, H; Zhong, CJ				Pan, Xiaoli; Sang, Shaoming; Fei, Guoqiang; Jin, Lirong; Liu, Huimin; Wang, Zhiliang; Wang, Hui; Zhong, Chunjiu			Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease	PLOS ONE			English	Article							METABOLIZING ENZYMES; COGNITIVE FUNCTION; HYPOMETABOLISM; PREDICTION; PHOSPHATES; DECLINE; BRAIN	Background Thiamine metabolites and activities of thiamine-dependent enzymes are impaired in Alzheimer's disease (AD). Objective To clarify the mechanism for the reduction of thiamine diphosphate (TDP), an active form of thiamine and critical coenzyme of glucose metabolism, in AD. Methods Forty-five AD patients clinically diagnosed and 38 age-and gender-matched control subjects without dementia were voluntarily recruited. The contents of blood TDP, thiamine monophosphate (TMP), and thiamine, as well as the activities of thiamine diphosphatase (TDPase), thiamine monophosphatase (TMPase), and thiamine pyrophosphokinase (TPK), were assayed by high performance liquid chromatography. Results Blood TDP contents of AD patients were significantly lower than those in control subjects (79.03 +/- 23.24 vs. 127.60 +/- 22.65 nmol/L, P < 0.0001). Activities of TDPase and TMPase were significantly enhanced in AD patients than those in control subjects (TDPase: 1.24 +/- 0.08 vs. 1.00 +/- 0.04, P < 0.05; TMPase: 1.22 +/- 0.04 vs. 1.00 +/- 0.06, P < 0.01). TPK activity remained unchanged in AD as compared with that in control (0.93 +/- 0.04 vs. 1.00 +/- 0.04, P > 0.05). Blood TDP levels correlated negatively with TDPase activities (r = -0.2576, P = 0.0187) and positively with TPK activities (r = 0.2426, P = 0.0271) in all participants. Conclusion Enhanced TDPase and TMPase activities may contribute to the reduction of TDP level in AD patients. The results imply that an imbalance of phosphorylation-dephosphorylation related to thiamine and glucose metabolism may be a potential target for AD prevention and therapy.	[Pan, Xiaoli; Sang, Shaoming; Fei, Guoqiang; Jin, Lirong; Zhong, Chunjiu] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai, Peoples R China; [Pan, Xiaoli; Sang, Shaoming; Fei, Guoqiang; Jin, Lirong; Zhong, Chunjiu] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China; [Pan, Xiaoli; Sang, Shaoming; Liu, Huimin; Zhong, Chunjiu] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Pan, Xiaoli; Sang, Shaoming; Liu, Huimin; Zhong, Chunjiu] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China; [Wang, Zhiliang; Wang, Hui] Reg Hlth Serv Ctr Xujiahui, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhong, CJ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai, Peoples R China.; Zhong, CJ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China.; Zhong, CJ (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China.; Zhong, CJ (corresponding author), Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China.	zhongcj@163.com			973 project [2011CBA00400]; National Natural Science Foundation of China [81071019, 91332201, 81600930]; Natural Science Foundation of Shanghai [13JC1401500]; fund for Medical emerging cutting-edge technology in Shanghai [SHDC12012114]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); fund for Medical emerging cutting-edge technology in Shanghai	This study is supported by 973 project (grant no. 2011CBA00400), the National Natural Science Foundation of China (grant nos. 81071019, 91332201, 81600930), the Natural Science Foundation of Shanghai (13JC1401500) and fund for Medical emerging cutting-edge technology in Shanghai (SHDC12012114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bettendorff L, 1996, J NEUROCHEM, V66, P250; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Fellgiebel A, 2007, PSYCHIAT RES-NEUROIM, V155, P167, DOI 10.1016/j.pscychresns.2006.12.002; Gibson GE, 2016, ANN NY ACAD SCI, V1367, P21, DOI 10.1111/nyas.13031; Gibson GE, 2008, ANN NY ACAD SCI, V1147, P221, DOI 10.1196/annals.1427.038; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Gold M, 1998, METAB BRAIN DIS, V13, P43, DOI 10.1023/A:1020678912330; Kellett KAB, 2011, INT J MOL EPIDEMIOL, V2, P114; Koh F, 2015, NUTRIENTS, V7, P2415, DOI 10.3390/nu7042415; LAFORENZA U, 1988, J NEUROCHEM, V51, P730, DOI 10.1111/j.1471-4159.1988.tb01805.x; Li H, 2016, J ALZHEIMERS DIS; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Lu JW, 2015, NEUROSCI BULL, V31, P676, DOI 10.1007/s12264-015-1563-3; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meador K, 1993, J Geriatr Psychiatry Neurol, V6, P222; Mimori Y, 1996, METAB BRAIN DIS, V11, P89, DOI 10.1007/BF02080934; Mosconi L, 2006, J NUCL MED, V47, P1778; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; NOLAN KA, 1991, ARCH NEUROL-CHICAGO, V48, P81, DOI 10.1001/archneur.1991.00530130093025; Pan X, 2016, ASVIDE, V3, P162, DOI DOI 10.1016/J.EBI0M.2015.11.039; Pan XL, 2010, BRAIN, V133, P1342, DOI 10.1093/brain/awq069; RAO VLR, 1995, ALCOHOL CLIN EXP RES, V19, P523; RAO VLR, 1993, BRAIN RES, V631, P334, DOI 10.1016/0006-8993(93)91554-6; SHEU KFR, 1988, ARCH NEUROL-CHICAGO, V45, P841, DOI 10.1001/archneur.1988.00520320027010; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Vardy ERLC, 2012, NEURODEGENER DIS, V9, P31, DOI 10.1159/000329722; Zhao RB, 2001, BBA-GENE STRUCT EXPR, V1517, P320, DOI 10.1016/S0167-4781(00)00264-5	31	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167273	10.1371/journal.pone.0167273	http://dx.doi.org/10.1371/journal.pone.0167273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060825	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500012
J	Zupa, R; Rodriguez, C; Mylonas, CC; Rosenfeld, H; Fakriadis, I; Papadaki, M; Perez, JA; Pousis, C; Basilone, G; Corriero, A				Zupa, Rosa; Rodriguez, Covadonga; Mylonas, Constantinos C.; Rosenfeld, Hanna; Fakriadis, Ioannis; Papadaki, Maria; Perez, Jose A.; Pousis, Chrysovalentinos; Basilone, Gualtiero; Corriero, Aldo			Comparative Study of Reproductive Development in Wild and Captive-Reared Greater Amberjack Seriola dumerili (Risso, 1810)	PLOS ONE			English	Article							ATLANTIC BLUEFIN TUNA; POLYUNSATURATED FATTY-ACIDS; BASS DICENTRARCHUS-LABRAX; FINAL OOCYTE MATURATION; GERM-CELL PROLIFERATION; HORMONE AGONIST GNRHA; CARP CYPRINUS-CARPIO; SEA BASS; BROODSTOCK DIETS; EGG QUALITY	The greater amberjack Seriola dumerili is a large teleost fish with rapid growth and excellent flesh quality, whose domestication represents an ambitious challenge for aquaculture. The occurrence of reproductive dysfunctions in greater amberjack reared in captivity was investigated by comparing reproductive development of wild and captive-reared individuals. Wild and captive-reared breeders were sampled in the Mediterranean Sea during three different phases of the reproductive cycle: early gametogenesis (EARLY, late April-early May), advanced gametogenesis (ADVANCED, late May-early June) and spawning (SPAWNING, late June-July). Fish reproductive state was evaluated using the gonado-somatic index (GSI), histological analysis of the gonads and determination of sex steroid levels in the plasma, and correlated with leptin expression in the liver and gonad biochemical composition. The GSI and sex steroid levels were lower in captive-reared than in wild fish. During the ADVANCED period, when the wild greater amberjack breeders were already in spawning condition, ovaries of captive-reared breeders showed extensive atresia of late vitellogenic oocytes and spermatogenic activity ceased in the testes of half of the examined males. During the SPAWNING period, all captive-reared fish had regressed gonads, while wild breeders still displayed reproductive activity. Liver leptin expression and gonad proximate composition of wild and captive greater amberjack were similar. However, the gonads of captive-reared fish showed different total polar lipid contents, as well as specific lipid classes and fatty acid profiles with respect to wild individuals. This study underlines the need for an improvement in rearing technology for this species, which should include minimum handling during the reproductive season and the formulation of a specific diet to overcome the observed gonadal decrements of phospholipids, DHA (22:6n-3) and ARA (20:4n-6), compared to wild breeders.	[Zupa, Rosa; Pousis, Chrysovalentinos; Corriero, Aldo] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Vet Clin & Anim Prod, Valenzano, Bari, Italy; [Rodriguez, Covadonga; Perez, Jose A.] Univ La Laguna, Fac Ciencias, Dept Biol Anim Edafol & Geol, San Cristobal la Laguna, Tenerife, Spain; [Mylonas, Constantinos C.; Fakriadis, Ioannis; Papadaki, Maria] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece; [Rosenfeld, Hanna] Israel Oceanog & Limnol Res, Natl Ctr Mariculture, Elat, Israel; [Basilone, Gualtiero] CNR, Inst Marine Coastal Environm, Capo Granitola, TP, Italy	Universita degli Studi di Bari Aldo Moro; Universidad de la Laguna; Hellenic Centre for Marine Research; Israel Oceanographic & Limnological Research Institute; Consiglio Nazionale delle Ricerche (CNR)	Corriero, A (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Vet Clin & Anim Prod, Valenzano, Bari, Italy.	aldo.corriero@uniba.it	Papadaki, Maria/AAP-4864-2020; Zupa, Rosa/ABF-3050-2021; Basilone, Gualtiero/D-2896-2017; Fakriadis, Ioannis/AAV-1558-2020; Corriero, Aldo/AAH-1542-2021; Pérez Pérez, José Antonio/L-4293-2014; González, Covadonga Rodríguez/L-5173-2014; Zupa, Rosa/ABE-9966-2021	Papadaki, Maria/0000-0002-7878-8868; Zupa, Rosa/0000-0001-5516-1299; Basilone, Gualtiero/0000-0002-5732-5055; Fakriadis, Ioannis/0000-0001-7180-3642; Corriero, Aldo/0000-0001-7068-9438; Pérez Pérez, José Antonio/0000-0002-5662-7246; González, Covadonga Rodríguez/0000-0002-2805-0048; Pousis, Chrysovalentinos/0000-0003-4355-2393; Mylonas, Constantinos/0000-0003-1805-4392	European Union's Seventh Framework Programme for research, technological development and demonstration [KBBE-2013-07, 603121]	European Union's Seventh Framework Programme for research, technological development and demonstration	Funding provided by the European Union's Seventh Framework Programme for research, technological development and demonstration, KBBE-2013-07 single stage: Exploring the biological and socio-economic potential of new/emerging candidate fish species for the expansion of the European aquaculture industry (DIVERSIFY) (Grant Agreement: 603121). Project Coordinator: Dr. Constantinos C Mylonas.	Almansa E, 1999, AQUACULTURE, V170, P323, DOI 10.1016/S0044-8486(98)00415-3; [Anonymous], 2016, IUCN RED LIST THREAT; Antonopoulou E, 2011, GEN COMP ENDOCR, V172, P234, DOI 10.1016/j.ygcen.2011.03.008; AOAC, 2012, OFF METH AN ASS AOAC; Asturiano JF, 2001, AQUACULTURE, V194, P173, DOI 10.1016/S0044-8486(00)00515-9; Asturiano JF, 1999, 6 INT S REPR PHYSL F; Basilone G, 2006, FISH OCEANOGR, V15, P271, DOI 10.1111/j.1365-2419.2005.00391.x; Bauchot ML, 1987, FICHES FAO IDENTIFIC; BELL JG, 1994, BBA-LIPID LIPID MET, V1211, P335, DOI 10.1016/0005-2760(94)90158-9; Bell MV, 1996, AQUACULTURE, V144, P189, DOI 10.1016/S0044-8486(96)01311-7; BROMAGE N, 1992, AQUACULTURE, V100, P141, DOI 10.1016/0044-8486(92)90355-O; Bruce M, 1999, AQUACULTURE, V177, P85, DOI 10.1016/S0044-8486(99)00071-X; Carragher J.F., 1991, P253; Cejas JR, 2004, COMP BIOCHEM PHYS B, V138, P91, DOI 10.1016/j.cbpc.2004.03.003; Cervigon F., 1993, PECES MARINOS VENEZU, V2; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Christie W.W., 2003, LIPID ANAL; COM. Communication from the Commission to the European Parliament the Council the European Economic and Social Committee and the Committee of the Regions, 2013, COMM COMM EUR PARL C, P1; Corriero A, 2007, AQUACULTURE, V272, P675, DOI 10.1016/j.aquaculture.2007.08.030; Corriero A, 2007, J FISH BIOL, V70, P83, DOI 10.1111/j.1095-8649.2006.01257.x; Corriero A, 2009, ANIM REPROD SCI, V116, P346, DOI 10.1016/j.anireprosci.2009.02.013; CUISSET B, 1994, COMP BIOCHEM PHYS C, V108, P229, DOI 10.1016/1367-8280(94)90035-3; Diaz MV, 1997, P 6 C NAT AC, P389; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Failler P., 2015, 9724 FAO 1; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Fernandez-Palacios H, 2015, AQUAC RES, V46, P1748, DOI 10.1111/are.12330; FERNANDEZPALACIOS H, 1995, AQUACULTURE, V132, P325, DOI 10.1016/0044-8486(94)00345-O; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia A., 2001, MONOGRAFIAS I CANARI, V4, P561; Garcia-Lopez A, 2006, AQUACULTURE, V254, P583, DOI 10.1016/j.aquaculture.2005.10.007; GarciaHernandez MP, 1997, GEN COMP ENDOCR, V106, P389, DOI 10.1006/gcen.1997.6887; Grau A, 1996, SCI MAR, V60, P391; Haddy JA, 1999, J FISH BIOL, V55, P1304, DOI 10.1111/j.1095-8649.1999.tb02077.x; Henrotte E, 2011, LIPIDS, V46, P179, DOI 10.1007/s11745-010-3512-2; Huising MO, 2006, ENDOCRINOLOGY, V147, P5786, DOI 10.1210/en.2006-0824; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Jerez S, 2006, AQUACULTURE, V252, P199, DOI 10.1016/j.aquaculture.2005.06.031; Jover M, 1999, AQUACULTURE, V179, P25, DOI 10.1016/S0044-8486(99)00149-0; KIME DE, 1982, GEN COMP ENDOCR, V48, P222, DOI 10.1016/0016-6480(82)90020-X; Kozul V, 2001, SCI MAR, V65, P215, DOI 10.3989/scimar.2001.65n3215; Kozul V, 2001, J APPL ICHTHYOL, V17, P134, DOI 10.1046/j.1439-0426.2001.00301.x; Labbe A C, 1993, FISH NUTR PRACT C, P49; Lazzari A., 2000, Cahiers Options Mediterraneennes, V47, P241; Lazzari A., 1988, J AQUATIC PRODUCTS, V2, P133; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li K, 2015, AQUACULTURE, V446, P310, DOI 10.1016/j.aquaculture.2015.05.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandich A, 2004, MAR BIOL, V144, P127, DOI 10.1007/s00227-003-1185-6; Manganaro A, 1992, 23 CONG SIBM RAV IT, P246; MARINO G, 1995, J APPL ICHTHYOL, V11, P9, DOI 10.1111/j.1439-0426.1995.tb00002.x; Marino G., 1995, Cahiers Options Mediterraneennes, V16, P115; Mercure F, 1996, GEN COMP ENDOCR, V102, P130, DOI 10.1006/gcen.1996.0054; Micale V, 1999, AQUAC RES, V30, P349, DOI 10.1046/j.1365-2109.1999.00336.x; Micale Valeria, 1998, Animal Biology, V7, P125; Mustonen AM, 2002, J EXP ZOOL, V293, P119, DOI 10.1002/jez.10142; Mylonas CC, 1998, J WORLD AQUACULT SOC, V29, P379, DOI 10.1111/j.1749-7345.1998.tb00662.x; Mylonas CC, 2004, AQUACULTURE, V237, P141, DOI 10.1016/j.aquaculture.2004.04.015; Mylonas CC, 2001, REV FISH BIOL FISHER, V10, P463; Mylonas CC, 1998, GEN COMP ENDOCR, V110, P276, DOI 10.1006/gcen.1998.7073; Mylonas CC, 1997, J FISH BIOL, V50, P34, DOI 10.1006/jfbi.1996.0275; Mylonas CC, 1997, J FISH BIOL, V51, P234, DOI 10.1006/jfbi.1997.0433; Mylonas CC, 2007, REV FISH SCI, V15, P183, DOI 10.1080/10641260701484572; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nakada M., 2008, FAO Fisheries Technical Paper, P199; Nakada M., 2000, ENCY AQUACULTURE, P1007; Nash JP, 2000, FISH PHYSIOL BIOCHEM, V22, P355, DOI 10.1023/A:1007850014021; Navas JM, 1997, J FISH BIOL, V51, P760, DOI 10.1006/jfbi.1997.0484; Norberg B., 2002, COMP BIOCH PHYSL, V132, P567; Nyuji M, 2016, GEN COMP ENDOCR, V225, P224, DOI 10.1016/j.ygcen.2015.10.008; O'Neill B, 2015, AQUACULTURE, V448, P169, DOI 10.1016/j.aquaculture.2015.05.034; OLSEN RE, 1989, J EXP MAR BIOL ECOL, V129, P189, DOI 10.1016/0022-0981(89)90056-7; Olsen Y, 2014, AQUACULTURE, V428, P203, DOI 10.1016/j.aquaculture.2014.03.002; Ouchi K., 1989, Bulletin of Nansei National Fisheries Research Institute, P1; Ouchi K, 1985, B NATL RES I AQUACUL, V7, P13; Pankhurst NW, 2000, MAR FRESHW BEHAV PHY, V33, P141, DOI 10.1080/10236240009387087; Pastor E., 2000, Cahiers Options Mediterraneennes, V47, P371; Patino R, 2003, BIOL REPROD, V68, P516, DOI 10.1095/biolreprod.102.009662; Paxton JR, 1989, ZOOLOGICAL CATALOGUE, V7; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perez MJ, 2007, COMP BIOCHEM PHYS B, V146, P187, DOI 10.1016/j.cbpb.2006.10.097; Pinillos ML, 2003, AQUAC RES, V34, P1181, DOI 10.1046/j.1365-2109.2003.00926.x; Poortenaar CW, 2001, AQUACULTURE, V201, P271, DOI 10.1016/S0044-8486(01)00549-X; Quemener L, 2002, AQUAT LIVING RESOUR, V15, P293, DOI 10.1016/S0990-7440(02)01187-7; Rahman MA, 2001, J FISH BIOL, V58, P462, DOI 10.1111/j.1095-8649.2001.tb02265.x; RINCHARD J, 1993, GEN COMP ENDOCR, V92, P168, DOI 10.1006/gcen.1993.1153; Rodriguez C, 2004, COMP BIOCHEM PHYS B, V139, P619, DOI 10.1016/j.cbpc.2004.07.013; Rodriguez C, 1998, AQUACULTURE, V169, P9, DOI 10.1016/S0044-8486(98)00328-7; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Rodriguez-Barreto D, 2012, AQUACULTURE, V360, P1, DOI 10.1016/j.aquaculture.2012.07.013; Rodriguez-Barreto D, 2015, AQUAC RES IN PRESS; Rodriguez-Barreto D, 2014, EUR J LIPID SCI TECH, V116, P584, DOI 10.1002/ejlt.201300462; Rosenbaum M, 1998, TRENDS ENDOCRIN MET, V9, P117, DOI 10.1016/S1043-2760(98)00028-9; Rosenfeld H, 2012, GEN COMP ENDOCR, V175, P55, DOI 10.1016/j.ygcen.2011.09.013; Rozen S, 2000, Methods Mol Biol, V132, P365; Sargent John R., 2002, P181; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Scott AP, 2013, J FISH BIOL, V83, P233, DOI 10.1111/jfb.12150; Scott AP, 2010, J FISH BIOL, V76, P183, DOI 10.1111/j.1095-8649.2009.02483.x; SCOTT AP, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P645; Segvic-Bubic T, 2016, FISH RES, V179, P271, DOI 10.1016/j.fishres.2016.03.018; Sley A, 2014, CAH BIOL MAR, V55, P421; Smith CL, 1997, NATL AUDUBON SOC FIE; Sorbera LA, 1998, ANN NY ACAD SCI, V839, P535, DOI 10.1111/j.1749-6632.1998.tb10863.x; Sorbera LA, 2001, BIOL REPROD, V64, P382, DOI 10.1095/biolreprod64.1.382; Stacey N.E., 2005, FISH PHYSIOL, P359; STECF. Scientific Technical and Economic Committee for Fisheries, 2014, 27033 STECF EUR EN; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tesch F-W., 2003, EEL; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tucker John W. Jr., 1994, Journal of the World Aquaculture Society, V25, P345, DOI 10.1111/j.1749-7345.1994.tb00218.x; Vazirzadeh A, 2014, J ANIM PHYSIOL AN N, V98, P1060, DOI 10.1111/jpn.12171; Verakunpiriya V, 1996, FISHERIES SCI, V62, P610, DOI 10.2331/fishsci.62.610; Vermeirssen ELM, 1998, GEN COMP ENDOCR, V112, P163, DOI 10.1006/gcen.1998.7132; Vermeirssen ELM, 1996, GEN COMP ENDOCR, V101, P180, DOI 10.1006/gcen.1996.0020; WADE MG, 1994, BIOL REPROD, V51, P131, DOI 10.1095/biolreprod51.1.131; WADE MG, 1993, GEN COMP ENDOCR, V90, P109, DOI 10.1006/gcen.1993.1065; Watanabe T, 2003, AQUACULTURE, V227, P35, DOI 10.1016/S0044-8486(03)00494-0; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1; Zupa R, 2013, J APPL ICHTHYOL, V29, P71, DOI 10.1111/j.1439-0426.2012.02045.x	125	44	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169645	10.1371/journal.pone.0169645	http://dx.doi.org/10.1371/journal.pone.0169645			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056063	Green Published, Green Submitted, gold			2022-12-26	WOS:000391639100066
J	Hoshino, T; Inagaki, F				Hoshino, Tatsuhiko; Inagaki, Fumio			Application of Stochastic Labeling with Random-Sequence Barcodes for Simultaneous Quantification and Sequencing of Environmental 16S rRNA Genes	PLOS ONE			English	Article							TIME PCR ASSAYS; DIGITAL PCR; MICROBIAL DIVERSITY; CLONE LIBRARIES; RARE BIOSPHERE; CYCLE NUMBER; DEEP-SEA; AMPLIFICATION; PRIMERS; GENERATION	Next-generation sequencing (NGS) is a powerful tool for analyzing environmental DNA and provides the comprehensive molecular view of microbial communities. For obtaining the copy number of particular sequences in the NGS library, however, additional quantitative analysis as quantitative PCR (qPCR) or digital PCR (dPCR) is required. Furthermore, number of sequences in a sequence library does not always reflect the original copy number of a target gene because of biases caused by PCR amplification, making it difficult to convert the proportion of particular sequences in the NGS library to the copy number using the mass of input DNA. To address this issue, we applied stochastic labeling approach with random-tag sequences and developed a NGS-based quantification protocol, which enables simultaneous sequencing and quantification of the targeted DNA. This quantitative sequencing (qSeq) is initiated from single-primer extension (SPE) using a primer with random tag adjacent to the 5' end of target-specific sequence. During SPE, each DNA molecule is stochastically labeled with the random tag. Subsequently, first-round PCR is conducted, specifically targeting the SPE product, followed by second-round PCR to index for NGS. The number of random tags is only determined during the SPE step and is therefore not affected by the two rounds of PCR that may introduce amplification biases. In the case of 16S rRNA genes, after NGS sequencing and taxonomic classification, the absolute number of target phylotypes 16S rRNA gene can be estimated by Poisson statistics by counting random tags incorporated at the end of sequence. To test the feasibility of this approach, the 16S rRNA gene of Sulfolobus tokodaii was subjected to qSeq, which resulted in accurate quantification of 5.0 x 10(3) to 5.0 x 10(4) copies of the 16S rRNA gene. Furthermore, qSeq was applied to mock microbial communities and environmental samples, and the results were comparable to those obtained using digital PCR and relative abundance based on a standard sequence library. We demonstrated that the qSeq protocol proposed here is advantageous for providing less-biased absolute copy numbers of each target DNA with NGS sequencing at one time. By this new experiment scheme in microbial ecology, microbial community compositions can be explored in more quantitative manner, thus expanding our knowledge of microbial ecosystems in natural environments.	[Hoshino, Tatsuhiko; Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan; [Hoshino, Tatsuhiko; Inagaki, Fumio] JAMSTEC, Res & Dev Ctr Submarine Resources, Geobiotechnol Grp, Nankoku, Kochi, Japan; [Inagaki, Fumio] JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokohama, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Hoshino, T (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan.; Hoshino, T (corresponding author), JAMSTEC, Res & Dev Ctr Submarine Resources, Geobiotechnol Grp, Nankoku, Kochi, Japan.	hoshinot@jamstec.go.jp	Inagaki, Fumio/AAI-1156-2019	Inagaki, Fumio/0000-0003-2887-6525	Japan Society for the Promotion of Science (JSPS) [26251041, 15K14907]; Grants-in-Aid for Scientific Research [26251041] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grand-in-Aid for Science Research (no. 26251041 to FI, no. 15K14907 to TH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the technical assistance of S. Hashimoto, Y. Hamada, and T. Terada. The authors are also acknowledge M. Tanaka and M. Murayama for the assistance in sampling. This work is supported by the Japan Society for the Promotion of Science (JSPS) Grand-in-Aid for Science Research (no. 26251041 to FI, no. 15K14907 to TH).	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ballantyne KN, 2008, GENOMICS, V91, P301, DOI 10.1016/j.ygeno.2007.10.016; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Ben-Dov E, 2012, ENV MICROBIOL REP, V4, P183, DOI 10.1111/j.1758-2229.2011.00318.x; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Brankatschk R, 2012, APPL ENVIRON MICROB, V78, P4481, DOI 10.1128/AEM.07878-11; Callbeck CM, 2013, J MICROBIOL METH, V93, P148, DOI 10.1016/j.mimet.2013.03.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Coyne KJ, 2005, LIMNOL OCEANOGR-METH, V3, P381, DOI 10.4319/lom.2005.3.381; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fratczak A, 2009, BIOCHEMISTRY-US, V48, P514, DOI 10.1021/bi8021069; Fu GK, 2011, P NATL ACAD SCI USA, V108, P9026, DOI 10.1073/pnas.1017621108; Gonzalez LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029176; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; Hoshino T, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01554; Hoshino T, 2012, SYST APPL MICROBIOL, V35, P390, DOI 10.1016/j.syapm.2012.06.006; Inagaki F, 2015, SCIENCE, V349, P420, DOI 10.1126/science.aaa6882; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Takai K, 1999, GENETICS, V152, P1285; Towe S, 2010, J MICROBIOL METH, V82, P338, DOI 10.1016/j.mimet.2010.07.005; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	46	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169431	10.1371/journal.pone.0169431	http://dx.doi.org/10.1371/journal.pone.0169431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052139	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500059
J	Konigsbrugge, O; Posch, F; Antlanger, M; Kovarik, J; Klauser-Braun, R; Kletzmayr, J; Schmaldienst, S; Auinger, M; Zuntner, G; Lorenz, M; Grilz, E; Stampfel, G; Steiner, S; Pabinger, I; Saemann, M; Ay, C				Koenigsbruegge, Oliver; Posch, Florian; Antlanger, Marlies; Kovarik, Josef; Klauser-Braun, Renate; Kletzmayr, Josef; Schmaldienst, Sabine; Auinger, Martin; Zuntner, Guenther; Lorenz, Matthias; Grilz, Ella; Stampfel, Gerald; Steiner, Stefan; Pabinger, Ingrid; Saeemann, Marcus; Ay, Cihan			Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolismin Patients on HemoDIalysis (VIVALDI)	PLOS ONE			English	Article							WARFARIN INITIATION; ISCHEMIC-STROKE; RISK-FACTORS; MORTALITY; MORBIDITY; OUTCOMES; DISEASE; COHORT; DEATH	Background Atrial fibrillation (AF) adds significant risk of stroke and thromboembolism in patients on hemodialysis (HD). The aim of this study was to investigate the prevalence of AF in a population-based cohort of HD patients and practice patterns of antithrombotic therapy for stroke prevention in AF. Methods The Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemodialysis (VIVALDI), an ongoing prospective observational cohort study, investigates the prevalence of AF and the risk of thromboembolic events in HD patients in Vienna, Austria. We analyzed cross-sectional data of 626 patients (63.4% men, median age 66 years, approx. 73% of HD patients in Vienna), who provided informed consent. A structured interview with each patient was performed, recent and archived ECGs were viewed and medical histories were verified with electronic records. Results The overall prevalence of AF was 26.5% (166 patients, 71.1% men, median age 72 years) of which 57.8% had paroxysmal AF, 3.0% persistent AF, 32.5% permanent AF, and 6.6% of patients had newly diagnosed AF. The median CHA(2)DS(2)-VASc Score was 4 [25th-75th percentile 3-5]. In multivariable analysis, AF was independently associated with age (odds ratio: 1.05 per year increase, 95% confidence interval: 1.03-1.07), male sex (1.7, 1.1-2.6), history of venous thromboembolism (2.0, 1.1-3.6), congestive heart failure (1.7, 1.1-2.5), history of or active cancer (1.5, 1.0-2.4) and time on HD (1.08 per year on HD, 1.03-1.13). Antithrombotic treatment was applied in 84.4% of AF patients (anticoagulant agents in 29.5%, antiplatelet agents in 33.7%, and both in 21.1%). In AF patients, vitamin-K-antagonists were used more often than low-molecular-weight heparins (30.1% and 19.9%). Conclusions The prevalence of AF is high amongst HD patients and is associated with age, sex, and distinct comorbidities. Practice patterns of antithrombotic treatment indicate a lack of consensus for stroke prevention in HD patients with AF.	[Koenigsbruegge, Oliver; Posch, Florian; Grilz, Ella; Stampfel, Gerald; Steiner, Stefan; Pabinger, Ingrid; Ay, Cihan] Med Univ Vienna, Dept Med 1, Clin Div Hematol & Hemostaseol, Vienna, Austria; [Posch, Florian] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Antlanger, Marlies; Saeemann, Marcus] Med Univ Vienna, Clin Div Nephrol, Dept Med 3, Vienna, Austria; [Kovarik, Josef] Wilhelminenspital Stadt Wien, Dept Med 6, Vienna, Austria; [Klauser-Braun, Renate; Kletzmayr, Josef] Donauspital, Dept Med 3, Vienna, Austria; [Schmaldienst, Sabine] Kaiser Franz Josef Spital, Dept Med 1, Vienna, Austria; [Auinger, Martin] Hietzing Hosp, Dept Med 3, Vienna, Austria; [Zuntner, Guenther] Rudolfstiftung Hosp, Dept Med 1, Vienna, Austria; [Lorenz, Matthias] Vienna Dialysis Ctr, Vienna, Austria; [Ay, Cihan] Univ North Carolina Chapel Hill, McAllister Heart Inst, Dept Med, Thrombosis & Hemostasis Program, Chapel Hill, NC USA	Medical University of Vienna; Medical University of Graz; Medical University of Vienna; Wilhelminenspital; Donauspital; Kaiser-Franz-Josef Hospital; Hietzing Hospital; Rudolfstiftung Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ay, C (corresponding author), Med Univ Vienna, Dept Med 1, Clin Div Hematol & Hemostaseol, Vienna, Austria.; Ay, C (corresponding author), Univ North Carolina Chapel Hill, McAllister Heart Inst, Dept Med, Thrombosis & Hemostasis Program, Chapel Hill, NC USA.	cihan.ay@meduniwen.ac.at		Konigsbrugge, Oliver/0000-0002-6183-3685; Ay, Cihan/0000-0003-2607-9717; Posch, Florian/0000-0002-0448-6314	Osterreichische Nationalbank Jubilaumsfond (Austrian Nationbank Anniversary fund) [16433]; Osterreichische Gesellschaft fur Innere Medizin (Austrian Society for Internal Medicine) Joseph-Skoda-Prize	Osterreichische Nationalbank Jubilaumsfond (Austrian Nationbank Anniversary fund); Osterreichische Gesellschaft fur Innere Medizin (Austrian Society for Internal Medicine) Joseph-Skoda-Prize	Support was provided by Osterreichische Nationalbank Jubilaumsfond (Austrian Nationbank Anniversary fund) grant number 16433 awarded to IP [https://www.oenb.at/Ueber-Uns/Forschungsfoerderung/Jubilaeumsfonds.html] and Osterreichische Gesellschaft fur Innere Medizin (Austrian Society for Internal Medicine) Joseph-Skoda-Prize 2014 awarded to CA [http://www.oegim.at/aktuell/preise/josef-skoda-projektfoerderungspreis.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar I, 2006, INT J CARDIOL, V106, P47, DOI 10.1016/j.ijcard.2004.12.048; Buiten MS, 2014, HEART, V100, P685, DOI 10.1136/heartjnl-2013-305417; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Chao TF, 2014, HEART RHYTHM, V11, P1752, DOI [10.1016/j.hrthm.20l4.06.021, 10.1016/j.hrthm.2014.06.021]; Friberg L, 2015, EUR HEART J, V36, P297, DOI 10.1093/eurheartj/ehu139; Gage BF, 2015, VALIDATION CLIN CLAS, V285, P2864; Genovesi S, 2005, AM J KIDNEY DIS, V46, P897, DOI 10.1053/j.ajkd.2005.07.044; Genovesi S, 2008, AM J KIDNEY DIS, V51, P255, DOI 10.1053/j.ajkd.2007.10.034; Genovesi S, 2015, NEPHROL DIAL TRANSPL, V30, P491, DOI 10.1093/ndt/gfu334; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart RG, 1999, ANN INTERN MED, V131, P688, DOI 10.7326/0003-4819-131-9-199911020-00010; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Knoll F, 2012, NEPHROL DIAL TRANSPL, V27, P332, DOI 10.1093/ndt/gfr341; Kramar R, 2015, JAHRESBERICHT 2013; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Molnar AO, 2016, J AM SOC NEPHROL, V27, P2825, DOI 10.1681/ASN.2015050535; Nagge J, 2002, ARCH INTERN MED, V162, P2605, DOI 10.1001/archinte.162.22.2605; Ohsawa M, 2016, J EPIDEMIOL, V26, P272, DOI 10.2188/jea.JE20150077; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Shah M, 2014, CIRCULATION, V129, P1196, DOI 10.1161/CIRCULATIONAHA.113.004777; Shen JI, 2015, AM J KIDNEY DIS, V66, P677, DOI 10.1053/j.ajkd.2015.05.019; Shih CJ, 2016, CIRCULATION, V133, P265, DOI 10.1161/CIRCULATIONAHA.115.018294; Stel VS, 2005, NEPHROL DIAL TRANSPL, V20, P2803, DOI 10.1093/ndt/gfi099; Vazquez E, 2009, KIDNEY INT, V76, P324, DOI 10.1038/ki.2009.185; Wang HH, 2014, AM J KIDNEY DIS, V63, P604, DOI 10.1053/j.ajkd.2013.10.013; Wetmore JB, 2013, J AM SOC NEPHROL, V24, P2053, DOI 10.1681/ASN.2012111077; Wetmore JB, 2011, AM J KIDNEY DIS, V58, P73, DOI 10.1053/j.ajkd.2011.02.387; Wiesholzer M, 2001, AM J NEPHROL, V21, P35, DOI 10.1159/000046216; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154627	39	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169400	10.1371/journal.pone.0169400	http://dx.doi.org/10.1371/journal.pone.0169400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052124	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500058
J	Pawlowski, MN; Crow, SE; Meki, MN; Kiniry, JR; Taylor, AD; Ogoshi, R; Youkhana, A; Nakahata, M				Pawlowski, Meghan N.; Crow, Susan E.; Meki, Manyowa N.; Kiniry, James R.; Taylor, Andrew D.; Ogoshi, Richard; Youkhana, Adel; Nakahata, Mae			Field-Based Estimates of Global Warming Potential in Bioenergy Systems of Hawaii: Crop Choice and Deficit Irrigation	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; GREENHOUSE-GAS EMISSIONS; ETHANOL-PRODUCTION; PERENNIAL GRASSES; ENERGY CROPS; CARBON FLUX; SUGARCANE; CO2; ACCUMULATION; N2O	Replacing fossil fuel with biofuel is environmentally viable from a climate change perspective only if the net greenhouse gas (GHG) footprint of the system is reduced. The effects of replacing annual arable crops with perennial bioenergy feedstocks on net GHG production and soil carbon (C) stock are critical to the system-level balance. Here, we compared GHG flux, crop yield, root biomass, and soil C stock under two potential tropical, perennial grass biofuel feedstocks: conventional sugarcane and ratoon-harvested, zero-tillage napiergrass. Evaluations were conducted at two irrigation levels, 100% of plantation application and at a 50% deficit. Peaks and troughs of GHG emission followed agronomic events such as ratoon harvest of napiergrass and fertilization. Yet, net GHG flux was dominated by carbon dioxide (CO2), as methane was oxidized and nitrous oxide (N2O) emission was very low even following fertilization. High N2O fluxes that frequently negate other greenhouse gas benefits that come from replacing fossil fuels with agronomic forms of bioenergy were mitigated by efficient water and fertilizer management, including direct injection of fertilizer into buried irrigation lines. From soil intensively cultivated for a century in sugarcane, soil C stock and root biomass increased rapidly following cultivation in grasses selected for robust root systems and drought tolerance. The net soil C increase over the two-year crop cycle was three-fold greater than the annualized soil surface CO2 flux. Deficit irrigation reduced yield, but increased soil C accumulation as proportionately more photosynthetic resources were allocated belowground. In the first two years of cultivation napiergrass did not increase net greenhouse warming potential (GWP) compared to sugarcane, and has the advantage of multiple ratoon harvests per year and less negative effects of deficit irrigation to yield.	[Pawlowski, Meghan N.; Crow, Susan E.] Univ Hawaii Manoa, Dept Natl Resources & Environm Management, Honolulu, HI 96822 USA; [Meki, Manyowa N.] Texas A&M Agri Life Blackland Res & Extens Ctr, Temple, TX USA; [Kiniry, James R.] ARS, USDA, Grassland Soil & Water Res Lab, Temple, TX USA; [Taylor, Andrew D.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Ogoshi, Richard; Youkhana, Adel] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Nakahata, Mae] Hawaiian Commercial & Sugar, Puunene, HI USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Crow, SE (corresponding author), Univ Hawaii Manoa, Dept Natl Resources & Environm Management, Honolulu, HI 96822 USA.	crows@havvaii.edu	Taylor, Andrew D/I-5040-2012	Crow, Susan/0000-0001-8735-1580	Department of Energy [DE-FG36-08GO88037]; Office of Naval Research [N00014-12-1-0496, N00014-16-1-2221]; United States Department of Agriculture-Agricultural Research Service [003232-00001]; USDA National Institute of Food and Agriculture, Hatch project [HAW01130-H]; Hawaiian Commercial and Sugar (HCS)	Department of Energy(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA National Institute of Food and Agriculture, Hatch project; Hawaiian Commercial and Sugar (HCS)	This work was supported by the Department of Energy http://science.energy.gov/programs/ [award number DE-FG36-08GO88037], the Office of Naval Research http://www.onr.navy.mil/en.aspx [grants N00014-12-1-0496 and N00014-16-1-2221], and the United States Department of Agriculture-Agricultural Research Service, http://www.ars.usda.gov/main/main.htm [award number 003232-00001]. This work was further supported by the USDA National Institute of Food and Agriculture, Hatch project https://nifa.usda.gov/program/capacity-grants (project HAW01130-H), managed by the College of Tropical Agriculture and Human Resources. The commercial affiliation, Hawaiian Commercial and Sugar (HC&S), provided support in the form of salary for author MN. Further resources were provided by HC&S in terms of 1) field site access within the commercial plantation to meet the identified objectives of the study and 2) cost sharing to meet the 20% requirement of a federal funding source through use of space and infrastructure within the HC&S headquarters and processing facility for office, laboratory (sample processing), and storage needs for the project duration. As the representative for the direct stakeholder for the overarching project, MN provided input on the needs of HC&S operations moving forward from sugarcane cultivation to diversified farming (including alternative grasses for biofuel feedstock) and agreed to the final field location and fundamental experimental treatments, but did not have any additional role in the specific study design, data collection and analysis, decision to publish, or preparation of the manuscript. In her capacity as primary stakeholder, MN also assisted with funding acquisition by developing budgets to cover the costs of the HC&S field crew for plot installation and maintenance and field equipment repair or construction on site as needed. The specific role of this author is articulated in the 'author contributions' section. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos B, 2005, SOIL SCI SOC AM J, V69, P387, DOI 10.2136/sssaj2005.0387; Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; [Anonymous], 2001, STATE FOOD INWORLD; Arneth A, 2010, BIOGEOSCIENCES, V7, P121, DOI 10.5194/bg-7-121-2010; BALLCOELHO B, 1992, PLANT SOIL, V142, P297, DOI 10.1007/BF00010975; Carr MKV, 2012, EXP AGR, V48, P176, DOI 10.1017/S0014479711000901; Case SDC, 2014, GCB BIOENERGY, V6, P76, DOI 10.1111/gcbb.12052; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; de Graaff MA, 2014, SOIL BIOL BIOCHEM, V69, P147, DOI 10.1016/j.soilbio.2013.10.047; de Morais RF, 2012, PLANT SOIL, V356, P23, DOI 10.1007/s11104-011-0944-2; Denmead OT, 2010, AGR FOREST METEOROL, V150, P748, DOI 10.1016/j.agrformet.2009.06.018; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Dou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115598; Drewer J, 2012, GCB BIOENERGY, V4, P408, DOI 10.1111/j.1757-1707.2011.01136.x; Evensen CI, 1997, AGRON J, V89, P638, DOI 10.2134/agronj1997.00021962008900040016x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Galdos MV, 2010, GCB BIOENERGY, V2, P37, DOI 10.1111/j.1757-1707.2010.01037.x; Gauder M, 2012, GCB BIOENERGY, V4, P289, DOI 10.1111/j.1757-1707.2011.01135.x; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Grantz DA, 2009, CROP SCI, V49, P643, DOI 10.2135/cropsci2008.04.0210; Hillier J, 2009, GCB BIOENERGY, V1, P267, DOI 10.1111/j.1757-1707.2009.01021.x; Intergovernmental Panel on Climate Change, 2014, CLIM CHANG 2013 PHYS; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; Kinoshita CM., 1995, PRODUCTION BIOMASS E; Kinoshita CM, 1999, XXE81709 U HAW; Knoll JE, 2012, BIOENERG RES, V5, P206, DOI 10.1007/s12155-011-9122-x; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; La Scala N, 2006, SOIL TILL RES, V91, P244, DOI 10.1016/j.still.2005.11.012; Litton CM, 2008, FUNCT ECOL, V22, P941, DOI 10.1111/j.1365-2435.2008.01479.x; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Mathew R. P., 2012, Applied and Environmental Soil Science, V2012, P548620; Matson PA, 1996, J GEOPHYS RES-ATMOS, V101, P18533, DOI 10.1029/96JD01536; Meki MN, 2014, CO2 SEQUESTRATION AND VALORIZATION, P251, DOI 10.5772/57177; Mosier Arvin, 2004, Environment Development and Sustainability, V6, P11, DOI 10.1023/B:ENVI.0000003627.43162.ae; NULLET D, 1990, GEODERMA, V47, P171, DOI 10.1016/0016-7061(90)90054-D; Oates LG, 2016, GCB BIOENERGY, V8, P539, DOI 10.1111/gcbb.12268; Otto R., 2016, BIOENERG RES, P1; Richter DD, 2015, NEW PHYTOL, V206, P900, DOI 10.1111/nph.13338; Richter GM, 2015, AGR ECOSYST ENVIRON, V200, P169, DOI 10.1016/j.agee.2014.11.011; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Salimon CI, 2004, GLOBAL CHANGE BIOL, V10, P833, DOI 10.1111/j.1529-8817.2003.00776.x; Samson R, 2005, CRIT REV PLANT SCI, V24, P461, DOI 10.1080/07352680500316508; Sartori F, 2006, CRIT REV PLANT SCI, V25, P441, DOI 10.1080/07352680600961021; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith DM, 2005, FIELD CROP RES, V92, P169, DOI 10.1016/j.fcr.2005.01.017; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Smith KE, 2010, SOIL SCI, V175, P349, DOI 10.1097/SS.0b013e3181e93d3c; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sumiyoshi Y, 2016, GCB BIOENERGY; Tiemann LK, 2015, GCB BIOENERGY, V7, P161, DOI 10.1111/gcbb.12126; Torn MS, 2015, SOIL-GERMANY, V1, P575, DOI 10.5194/soil-1-575-2015; Valencia-Gica RB, 2010, SOIL SCI, V175, P500, DOI 10.1097/SS.0b013e3181f79669; Venterea R.T., 2010, FLUX, V2010, P1; Walter A, 2011, ENERG POLICY, V39, P5703, DOI 10.1016/j.enpol.2010.07.043; Walter K, 2015, BIOMASS BIOENERG, V81, P556, DOI 10.1016/j.biombioe.2015.08.011; Weier KL, 1998, AUST J AGR RES, V49, P1, DOI 10.1071/A97026; Wendt JW, 2013, EUR J SOIL SCI, V64, P58, DOI 10.1111/ejss.12002; West TO, 2002, ENVIRON POLLUT, V116, P439, DOI 10.1016/S0269-7491(01)00221-4; WOODARD KR, 1993, CROP SCI, V33, P818, DOI 10.2135/cropsci1993.0011183X003300040039x	64	8	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0168510	10.1371/journal.pone.0168510	http://dx.doi.org/10.1371/journal.pone.0168510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052075	Green Published, gold, Green Submitted			2022-12-26	WOS:000391621500018
J	Ren, ST; Zhang, XM; Sun, PF; Sun, LJ; Guo, X; Tian, T; Zhang, J; Guo, QY; Li, X; Guo, LJ; Che, J; Wang, B; Zhang, H				Ren, Shu-Ting; Zhang, Xue-Mei; Sun, Peng-Fei; Sun, Li-Juan; Guo, Xue; Tian, Tian; Zhang, Jian; Guo, Qi-Yuan; Li, Xue; Guo, Li-Jun; Che, Jin; Wang, Bing; Zhang, Hui			Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59	PLOS ONE			English	Article							T-CELL RESPONSES; MUCOSAL IMMUNITY; CROSS-PROTECTION; UNITED-STATES; VIRUS; INFECTION; MICE; ADULTS; IGA; PERSPECTIVE	Intranasal vaccination is more potent than parenteral injection for the prevention of influenza. However, because the poor efficiency of antigen uptake across the nasal mucosa is a key issue, immunostimulatory adjuvants are essential for intranasal vaccines. The immunomodulator mannatide or polyactin (PA) has been used for the clinical treatment of impaired immunity in China, but its adjuvant effect on an inactivated trivalent influenza vaccine (ITIV) via intranasal vaccination is unclear. To explore the adjuvant effect of PA, an inactivated trivalent influenza virus with or without PA or MF59 was instilled intranasally once a week in BALB/c mice. Humoral immunity was assessed by both the ELISA and hemagglutination inhibition (HI) methods using antigen-specific antibodies. Splenic lymphocyte proliferation and the IFN-gamma level were measured to evaluate cell-mediated immunity. The post-vaccination serum HI antibody geometric mean titers (GMTs) for the H1N1 and H3N2 strains, antigen-specific serum IgG and IgA GMTs, mucosal SIgA GMT, splenic lymphocyte proliferation, and IFN-gamma were significantly increased in the high-dose PA-adjuvanted vaccine group. The seroconversion rate and the mucosal response for the H3N2 strain were significantly elevated after high-dose PA administration. These adjuvant effects of high-dose PA for the influenza vaccine were comparable with those of the MF59 adjuvant, and abnormal signs or pathological changes were not found in the evaluated organs. In conclusion, PA is a novel mucosal adjuvant for intranasal vaccination with the ITIV that has safe and effective mucosal adjuvanticity in mice and successfully induces both serum and mucosal antibody responses and a cell-mediated response.	[Ren, Shu-Ting; Sun, Peng-Fei; Tian, Tian; Zhang, Jian; Wang, Bing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Peoples R China; [Zhang, Xue-Mei; Guo, Xue; Guo, Qi-Yuan; Li, Xue] Changchun Inst Biol Prod Co Ltd, 6 Vaccine Workshop, Changchun, Peoples R China; [Sun, Peng-Fei] Xian City Ctr Hosp, Dept Pathol, Xian, Peoples R China; [Sun, Li-Juan] Capital Bio Technol, Sci Res Management Ctr, Reagent R&D Dept, Beijing, Peoples R China; [Guo, Li-Jun] Changchun Inst Biol Prod Co Ltd, Changchun, Peoples R China; [Che, Jin; Wang, Bing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Therapeut Vaccines Engn Ctr Shaanxi Prov, Xian, Peoples R China; [Zhang, Hui] Xian Med Univ, Hlth Sci Ctr, Dept Pharm, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Medical University	Ren, ST; Wang, B (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Peoples R China.; Wang, B (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Therapeut Vaccines Engn Ctr Shaanxi Prov, Xian, Peoples R China.; Zhang, H (corresponding author), Xian Med Univ, Hlth Sci Ctr, Dept Pharm, Xian, Peoples R China.	rst@mail.xjtu.edu.cn; wangbing@mail.xjtu.edu.cn; zhanghuilinda@mail.xjtu.edu.cn			National Science and Technology Major Project of China [2013ZX10004003004]; Changchun Institute of Biological Products Co., Ltd.; Chinese Government	National Science and Technology Major Project of China; Changchun Institute of Biological Products Co., Ltd.; Chinese Government	As a cooperative institution, Changchun Institute of Biological Products Co., Ltd. also performed with the National Science and Technology Major Project (No.2013ZX10004003004) of China with us. Changchun Institute of Biological Products Co., Ltd. provided the support in the form of salaries for authors XMZ, LJS, XG, QYG, XL and LJG. During the course of the study, LJS was affiliated by Changchun Institute of Biological Products Co., Ltd., but now affiliated by Capital Bio Technology. Capital Bio Technology did not provided the support in the form of salaries for author LJS. The specific roles of these authors are articulated in the 'author contributions' section. The funding organization for this work is Chinese Government not Changchun Institute of Biological Products Co., Ltd.. Capital Bio Technology did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder for this study only provided financial support in the form of research materials in this work, but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainai A, 2013, HUM VACC IMMUNOTHER, V9, P1962, DOI 10.4161/hv.25458; Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Barchfeld GL, 1999, VACCINE, V17, P695, DOI 10.1016/S0264-410X(98)00252-7; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bin Seo Y, 2014, CLIN VACCINE IMMUNOL, V21, P989, DOI 10.1128/CVI.00615-13; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Deng JH, 2014, INT J PHARMACEUT, V468, P187, DOI 10.1016/j.ijpharm.2014.04.003; Eglia A, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13940; [冯素玲 Feng Suling], 2013, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V34, P604; Greenbaum E, 2004, VACCINE, V22, P2566, DOI 10.1016/j.vaccine.2003.12.018; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Ji XP, 2006, SICHUAN MED J, V27, P799; [荆晶 Jing Jing], 2013, [基础医学与临床, Basic & Clinical Medicine], V33, P1435; Jodar L, 2001, VACCINE, V19, P1594, DOI 10.1016/S0264-410X(00)00358-3; Kim ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137608; Knudsen NPH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19570; Lee BJ, 2014, CLIN EXP VACCINE RES, V3, P194, DOI 10.7774/cevr.2014.3.2.194; Liu R, 2006, BMC J, V29, P230; Mbawuike IN, 1996, CELL IMMUNOL, V173, P64, DOI 10.1006/cimm.1996.0252; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Myc A, 2003, VACCINE, V21, P3801, DOI 10.1016/S0264-410X(03)00381-5; Nafziger AN, 2014, J CLIN PHARMACOL, V54, P719, DOI 10.1002/jcph.299; Nagatomo D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/471468; Otani N, 2016, CELL IMMUNOL; Rose MA, 2014, HUM VACC IMMUNOTHER, V10, P2115, DOI 10.4161/hv.29609; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Su QJ, 2014, INT J STD AIDS, V25, P24, DOI 10.1177/0956462413496771; Tamura S, 2010, VACCINE, V28, P6393, DOI 10.1016/j.vaccine.2010.05.019; Tamura S, 2010, JPN J INFECT DIS, V63, P8; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Taylor SF, 1997, J IMMUNOL, V159, P3453; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Woof JM, 2004, IMMUNOLOGY, V113, P175, DOI 10.1111/j.1365-2567.2004.01958.x; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Zeng X Y, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P204; Zhang J, 2009, CHINA MED HERALD, V6, P72	42	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2017	12	1							e0169501	10.1371/journal.pone.0169501	http://dx.doi.org/10.1371/journal.pone.0169501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH2TP	28052136	Green Published, Green Submitted, gold			2022-12-26	WOS:000391621500064
J	Fechter, K; Dorronsoro, A; Jakobsson, E; Ferrin, I; Lang, V; Sepulveda, P; Pennington, DJ; Trigueros, C				Fechter, Karoline; Dorronsoro, Akaitz; Jakobsson, Emma; Ferrin, Izaskun; Lang, Valerie; Sepulveda, Pilar; Pennington, Daniel J.; Trigueros, Cesar			IFN gamma Regulates Activated V delta 2+T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells	PLOS ONE			English	Article							DELTA T-CELLS; STROMAL CELLS; INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; LYMPHOCYTE-PROLIFERATION; CYTOKINE ANALYSIS; ENCEPHALOMYELITIS; CYTOTOXICITY; INHIBITION; RESPONSES	gamma delta T cells play a role in a wide range of diseases such as autoimmunity and cancer. The majority of circulating human gamma delta T lymphocytes express a V gamma 9V delta 2+ (V delta 2+) T cell receptor (TCR) and following activation release pro-inflammatory cytokines. In this study, we show that IFN gamma, produced by V delta 2+ cells, activates mesenchymal stem cell (MSC)-mediated immunosupression, which in turn exerts a negative feedback mechanism on gamma delta T cell function ranging from cytokine production to proliferation. Importantly, this modulatory effect is limited to a short period of time (<24 hours) post-T cell activation, after which MSCs can no longer exert their immunoregulatory capacity. Using genetically modified MSCs with the IFNy receptor 1 constitutively silenced, we demonstrate that IFN gamma is essential to this process. Activated gamma delta T cells induce expression of several factors by MSCs that participate in the depletion of amino acids. In particular, we show that indolamine 2,3-dioxygenase (IDO), an enzyme involved in L-tryptophan degradation, is responsible for MSC -mediated immunosuppression of V delta 2+ T cells. Thus, our data demonstrate that gamma delta T cell responses can be immuno-modulated by different signals derived from MSC.	[Fechter, Karoline; Dorronsoro, Akaitz; Jakobsson, Emma; Ferrin, Izaskun; Lang, Valerie; Trigueros, Cesar] Fdn Inbiomed, Fdn Stem Cell Res, Mesenchymal Stem Cell Lab, San Sebastian, Spain; [Sepulveda, Pilar] Fdn Invest Hosp Univ La Fe, Valencia, Spain; [Pennington, Daniel J.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med, London, England	University of London; Queen Mary University London	Trigueros, C (corresponding author), Fdn Inbiomed, Fdn Stem Cell Res, Mesenchymal Stem Cell Lab, San Sebastian, Spain.	ctrigueros@inbiomed.org	Sepúlveda, Pilar/GWN-0626-2022; Sepulveda, Pilar/AAA-6636-2022; Dorronsoro, Akaitz/O-8905-2017	Sepulveda, Pilar/0000-0001-6071-7431; Dorronsoro, Akaitz/0000-0001-6141-8484; Pennington, Daniel/0000-0001-7889-9923; Fechter, Karoline/0000-0002-6894-2438	"Obra Social KUTXA", Ministerio de Economia y Competitividad [FIS PI12/01982]; Basque Country Government; Diputacion Foral de Guipuzcoa	"Obra Social KUTXA", Ministerio de Economia y Competitividad; Basque Country Government(Basque Government); Diputacion Foral de Guipuzcoa	This work was supported by the "Obra Social KUTXA", Ministerio de Economia y Competitividad (FIS PI12/01982), the Basque Country Government and the Diputacion Foral de Guipuzcoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Antunes MA, 2014, J CELLULAR BIOCH; Battistini L, 1997, J IMMUNOL, V159, P3723; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carcamo-Orive I, 2008, EXP CELL RES, V314, P1777, DOI 10.1016/j.yexcr.2008.01.020; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chien YH, 2014, ANN REV IMMUNOLOGY; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dorronsoro A, 2013, BONE MARROW RES, DOI 10.1155/2013/203643; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; FOLLOWS GA, 1992, INFECT IMMUN, V60, P1229, DOI 10.1128/IAI.60.3.1229-1231.1992; Garcia VE, 1997, J IMMUNOL, V159, P1328; Gong GM, 2009, BLOOD, V113, P837, DOI 10.1182/blood-2008-06-162792; GOODIER MR, 1995, PARASITE IMMUNOL, V17, P413, DOI 10.1111/j.1365-3024.1995.tb00909.x; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hu CY, 2012, CELL MOL IMMUNOL, V9, P245, DOI 10.1038/cmi.2011.50; Hwu P, 2000, J IMMUNOL, V164, P1521; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Krampera M, 2011, LEUKEMIA, V25, P565, DOI 10.1038/leu.2011.8; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Liu XH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/317801; Mabuchi T, 2012, J DERMATOL SCI, V65, P4, DOI 10.1016/j.jdermsci.2011.11.007; Martinet L, 2010, BIOCHEM PHARMACOL, V80, P838, DOI 10.1016/j.bcp.2010.05.002; Martinet L, 2009, EUR J IMMUNOL, V39, P752, DOI 10.1002/eji.200838812; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Petrini I, 2009, EUR J CLIN INVEST, V39, P813, DOI 10.1111/j.1365-2362.2009.02171.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prigione I, 2009, STEM CELLS, V27, P693, DOI 10.1634/stemcells.2008-0687; Rajan AJ, 1996, J IMMUNOL, V157, P941; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035	56	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0169362	10.1371/journal.pone.0169362	http://dx.doi.org/10.1371/journal.pone.0169362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076364	gold, Green Published, Green Submitted			2022-12-26	WOS:000391857100034
J	McDowall, P; Lynch, HJ				McDowall, Philip; Lynch, Heather J.			Ultra-Fine Scale Spatially-Integrated Mapping of Habitat and Occupancy Using Structure-From-Motion	PLOS ONE			English	Article							ECOLOGY; LIDAR	Organisms respond to and often simultaneously modify their environment. While these interactions are apparent at the landscape extent, the driving mechanisms often occur at very fine spatial scales. Structure-from-Motion (SfM), a computer vision technique, allows the simultaneous mapping of organisms and fine scale habitat, and will greatly improve our understanding of habitat suitability, ecophysiology, and the bi-directional relationship between geomorphology and habitat use. SfM can be used to create high-resolution (centimeter-scale) three-dimensional (3D) habitat models at low cost. These models can capture the abiotic conditions formed by terrain and simultaneously record the position of individual organisms within that terrain. While coloniality is common in seabird species, we have a poor understanding of the extent to which dense breeding aggregations are driven by fine scale active aggregation or limited suitable habitat. We demonstrate the use of SfM for fine scale habitat suitability by reconstructing the locations of nests in a gentoo penguin colony and fitting models that explicitly account for conspecific attraction. The resulting digital elevation models (DEMs) are used as covariates in an inhomogeneous hybrid point process model. We find that gentoo penguin nest site selection is a function of the topography of the landscape, but that nests are far more aggregated than would be expected based on terrain alone, suggesting a strong role of behavioral aggregation in driving coloniality in this species. This integrated mapping of organisms and fine scale habitat will greatly improve our understanding of fine-scale habitat suitability, ecophysiology, and the complex bi-directional relationship between geomorphology and habitat use.	[McDowall, Philip; Lynch, Heather J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	McDowall, P (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	Philip.McDowall@stonybrook.edu	McDowall, Phil/AAK-8612-2021	McDowall, Philip/0000-0002-3683-3202	US National Science Foundation Office of Polar Programs [NSF/OPP-1255058]; Institute of Advanced Computational Science at Stony Brook University	US National Science Foundation Office of Polar Programs(National Science Foundation (NSF)); Institute of Advanced Computational Science at Stony Brook University	This work was funded by the US National Science Foundation Office of Polar Programs (Award No. NSF/OPP-1255058) and the Institute of Advanced Computational Science at Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agisoft LLC, 2016, PHOTOSCAN; [Anonymous], 2007, SIFTGPU GPU IMPLEMEN; Baddeley A. J., 2005, J STAT SOFTWARE, V12; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Changchang Wu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3057, DOI 10.1109/CVPR.2011.5995552; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dandois JP, 2010, REMOTE SENS-BASEL, V2, P1157, DOI 10.3390/rs2041157; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Fargallo JA, 2001, BEHAV ECOL SOCIOBIOL, V50, P141, DOI 10.1007/s002650100341; Fonstad MA, 2013, EARTH SURF PROC LAND, V38, P421, DOI 10.1002/esp.3366; Garabedian JE, 2014, REMOTE SENS ENVIRON, V145, P68, DOI 10.1016/j.rse.2014.01.022; Green S, 2014, J ARCHAEOL SCI, V46, P173, DOI 10.1016/j.jas.2014.02.030; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; JOHN EA, 1990, HOLARCTIC ECOL, V13, P187; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kersten T.P., 2012, LNCS, P1, DOI [10.1007/978-3-642-34234-9_1, DOI 10.1007/978-3-642-34234-9_, DOI 10.1007/978-3-642-34234-9_1]; Lavy A, 2015, METHODS ECOL EVOL, V6, P521, DOI 10.1111/2041-210X.12331; Lawson CR, 2014, ECOGRAPHY, V37, P732, DOI 10.1111/ecog.00535; Lookingbill TR, 2005, CAN J FOREST RES, V35, P1744, DOI 10.1139/X05-109; McClure CJW, 2012, CONDOR, V114, P482, DOI 10.1525/cond.2012.110139; Opedal OH, 2015, PLANT ECOL DIVERS, V8, P305, DOI 10.1080/17550874.2014.987330; Pickard J, 2002, AUST J BOT, V50, P409, DOI 10.1071/BT01053; Portugal SJ, 2014, J EXP BIOL, V217, P3326, DOI 10.1242/jeb.103291; Questad EJ, 2014, ECOL APPL, V24, P385, DOI 10.1890/13-0775.1; RAND AS, 1964, ECOLOGY, V45, P745, DOI 10.2307/1934922; Seabra R, 2011, J EXP MAR BIOL ECOL, V400, P200, DOI 10.1016/j.jembe.2011.02.010; Stone-house Bernard, 1975, BIOL PENGUINS; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Tattoni C, 2012, ECOL MODEL, V245, P103, DOI 10.1016/j.ecolmodel.2012.03.020; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Wu CC, 2013, 2013 INTERNATIONAL CONFERENCE ON 3D VISION (3DV 2013), P127, DOI 10.1109/3DV.2013.25; Zahawi RA, 2015, BIOL CONSERV, V186, P287, DOI 10.1016/j.biocon.2015.03.031	35	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2017	12	1							e0166773	10.1371/journal.pone.0166773	http://dx.doi.org/10.1371/journal.pone.0166773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH6BJ	28076351	Green Published, gold, Green Submitted			2022-12-26	WOS:000391857100003
J	Agullo, L; Romero-Silva, MJ; Domenech, M; Seeger, M				Agullo, Loreine; Jose Romero-Silva, Maria; Domenech, Mirian; Seeger, Michael			p-Cymene Promotes Its Catabolism through the p-Cymene and the p-Cumate Pathways, Activates a Stress Response and Reduces the Biofilm Formation in Burkholderia xenovorans LB400	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA F1; LONG-TERM SURVIVAL; ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; MYCOBACTERIUM-SMEGMATIS; AROMATIC-COMPOUNDS; OXIDATIVE STRESS; GENOMIC ANALYSIS; STRAIN LB400; CEPACIA H111	p-Cymene is an aromatic terpene that is present in diverse plant species. The aims of this study were to study the p-cymene metabolism in the model aromatic-degrading bacterium Burkholderia xenovorans LB400, and its response to p-cymene. The catabolic p-cymene (cym) and p-cumate (cmt) genes are clustered on the LB400 major chromosome. B. xenovorans LB400 was able to grow on p-cymene as well as on p-cumate as a sole carbon and energy sources. LB400 growth attained higher cell concentration at stationary phase on p-cumate than on p-cymene. The transcription of the key cymAb and cmtAb genes, and p-cumate dioxygenase activity were observed in LB400 cells grown on p-cymene and on p-cumate, but not in glucose-grown cells. Diverse changes on LB400 proteome were observed in p-cymene-grown cells compared to glucose-grown cells. An increase of the molecular chaperones DnaK, GroEL and ClpB, the organic hydroperoxide resistance protein Ohr, the alkyl hydroperoxide reductase AhpC and the copper oxidase CopA during growth on p-cymene strongly suggests that the exposure to p-cymene constitutes a stress condition for strain LB400. Diverse proteins of the energy metabolism such as enolase, pyruvate kinase, aconitase AcnA, succinyl-CoA synthetase beta subunit and ATP synthase beta subunit were induced by p-cymene. Electron microscopy showed that p-cymenegrown cells exhibited fuzzy outer and inner membranes and an increased periplasm. p-Cymene induced diverse membrane and transport proteins including the p-cymene transporter CymD. Biofilm formation was reduced during growth in p-cymene in strain LB400 compared to glucose-grown cells that may be associated with a decrease of diguanylate cyclase protein levels. Overall, these results indicate active p-cymene and p-cumate catabolic pathways in B. xenovorans LB400. In addition, this study showed that p-cymene activated a stress response in strain LB400 and reduced its biofilm formation.	[Agullo, Loreine; Jose Romero-Silva, Maria; Seeger, Michael] Univ Tecn Federico Santa, Dept Chem, Mol Microbiol & Environm Biotechnol Lab, Valparaiso, Chile; [Agullo, Loreine; Jose Romero-Silva, Maria; Seeger, Michael] Univ Tecn Federico Santa, Ctr Biotecnol, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile; [Domenech, Mirian] CSIC, Ctr Invest Biol, Dept Microbiol Mol & Biol Infecc, Madrid, Spain	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Seeger, M (corresponding author), Univ Tecn Federico Santa, Dept Chem, Mol Microbiol & Environm Biotechnol Lab, Valparaiso, Chile.	michael.seeger@usm.cl	Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022; Domenech, Mirian/G-2561-2018	Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686; Domenech, Mirian/0000-0002-0942-8180	FONDECYT [1110992, 1151174]; USM [131342, 131562]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); USM	MS acknowledges support from FONDECYT (1110992 and 1151174) (hap://www.fondecyt.cl) and USM (131342 and 131562) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Bae HW, 2007, FEMS MICROBIOL LETT, V266, P54, DOI 10.1111/j.1574-6968.2006.00497.x; Bebien M, 2002, J BACTERIOL, V184, P1556, DOI 10.1128/JB.184.6.1556-1564.2002; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Camara B, 2004, ENVIRON MICROBIOL, V6, P842, DOI 10.1111/j.1462-2920.2004.00630.x; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chavez F. P., 2011, CURR ENZYM INHIB, V7, P163, DOI DOI 10.2174/; Chavez FP, 2004, APPL ENVIRON MICROB, V70, P3064, DOI 10.1128/AEM.70.5.3064-3072.2004; Chirino B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075746; Choi EN, 2003, MICROBIOL-SGM, V149, P795, DOI 10.1099/mic.0.26046-0; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; DEFRANK JJ, 1977, J BACTERIOL, V129, P1356, DOI 10.1128/JB.129.3.1356-1364.1977; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; Duche O, 2002, APPL ENVIRON MICROB, V68, P1491, DOI 10.1128/AEM.68.4.1491-1498.2002; Eaton RW, 1996, J BACTERIOL, V178, P1351, DOI 10.1128/jb.178.5.1351-1362.1996; Eaton RW, 1997, J BACTERIOL, V179, P3171, DOI 10.1128/jb.179.10.3171-3180.1997; Fazli M, 2014, ENVIRON MICROBIOL, V16, P1961, DOI 10.1111/1462-2920.12448; Fuentes S, 2014, APPL MICROBIOL BIOT, V98, P4781, DOI 10.1007/s00253-014-5684-9; Gildemeister E, 1960, DIE ATHERISCHEN O LE, V4; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Jimenez J. I., 2010, HDB HYDROCARBON LIPI, P1297, DOI DOI 10.1007/978-3-540-77587-4_91; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Vargas-Straube MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151273; Keane A, 2007, NATO SCI S SS IV EAR, V76, P105; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; Lee K, 2006, J MICROBIOL, V44, P192; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Ohta Y, 2001, MICROBIOL-SGM, V147, P31, DOI 10.1099/00221287-147-1-31; Patrauchan MA, 2011, ARCH MICROBIOL, V193, P641, DOI 10.1007/s00203-011-0705-x; Phoenix P, 2003, ENVIRON MICROBIOL, V5, P1309, DOI 10.1111/j.1462-2920.2003.00426.x; Ponce BL, 2011, ENZYME MICROB TECH, V49, P509, DOI 10.1016/j.enzmictec.2011.04.021; Puskas LG, 2000, DNA SEQUENCE, V11, P9, DOI 10.3109/10425170009033965; Radke M., 1987, ADV PETROLEUM GEOCHE, V2, P204; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; SEEGER M, 1992, GEOMICROBIOL J, V10, P227, DOI 10.1080/01490459209377923; Sharma IM, 2014, MICROBIOL-SGM, V160, P2304, DOI 10.1099/mic.0.080200-0; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004	54	15	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169544	10.1371/journal.pone.0169544	http://dx.doi.org/10.1371/journal.pone.0169544			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072820	gold, Green Published			2022-12-26	WOS:000391844200026
J	Bachman, PM; Ahmad, A; Ahrens, JE; Akbar, W; Baum, JA; Brown, S; Clark, TL; Fridley, JM; Gowda, A; Greenplate, JT; Jensen, PD; Mueller, GM; Odegaard, ML; Tan, JG; Uffman, JP; Levine, SL				Bachman, Pamela M.; Ahmad, Aqeel; Ahrens, Jeffrey E.; Akbar, Waseem; Baum, James A.; Brown, Scott; Clark, Thomas L.; Fridley, Jennifer M.; Gowda, Anilkumar; Greenplate, John T.; Jensen, Peter D.; Mueller, Geoffrey M.; Odegaard, Matthew L.; Tan, Jianguo; Uffman, Joshua P.; Levine, Steven L.			Characterization of the Activity Spectrum of MON 88702 and the Plant-Incorporated Protectant Cry51Aa2.834_16	PLOS ONE			English	Article							THURINGIENSIS DELTA-ENDOTOXINS; GENETICALLY-ENGINEERED CROPS; HESPERUS HEMIPTERA-MIRIDAE; BACILLUS-THURINGIENSIS; LYGUS-LINEOLARIS; HOST PLANTS; INSECTICIDAL ACTIVITY; NONTARGET ORGANISMS; TRANSGENIC CROPS; CRYSTAL PROTEINS	The spectrum of insecticidal activity of Cry51Aa2.834_16 protein targeting hemipteran and thysanopteran insect pests in cotton was characterized by selecting and screening multiple pest and non-pest species, based on representation of ecological functional groups, taxonomic relatedness (e.g. relationship to species where activity was observed), and availability for effective testing. Seven invertebrate orders, comprising 12 families and 17 representative species were screened for susceptibility to Cry51Aa2.834_16 protein and/or the ability of the protein to protect against feeding damage in laboratory, controlled environments (e.g. greenhouse/growth chamber), and/or field studies when present in cotton plants. The screening results presented for Cry51Aa2.834_16 demonstrate selective and limited activity within three insect orders. Other than Onus insidiosus, no activity was observed for Cry51Aa2.834_16 against several groups of arthropods that perform key ecological roles in some agricultural ecosystems (e.g. pollinators, decomposers, and natural enemies).	[Bachman, Pamela M.; Ahmad, Aqeel; Fridley, Jennifer M.; Jensen, Peter D.; Mueller, Geoffrey M.; Odegaard, Matthew L.; Tan, Jianguo; Uffman, Joshua P.; Levine, Steven L.] Monsanto Co, St Louis, MO 63146 USA; [Ahrens, Jeffrey E.; Akbar, Waseem; Baum, James A.; Brown, Scott; Clark, Thomas L.; Gowda, Anilkumar; Greenplate, John T.] Monsanto Co, Chesterfield, MO USA	Monsanto; Monsanto	Bachman, PM; Ahmad, A (corresponding author), Monsanto Co, St Louis, MO 63146 USA.	pamela.m.bachman@monsanto.com; aqeel.ahmad@monsanto.com			Monsanto Company	Monsanto Company	All authors on this manuscript are employed by the Monsanto Company. This manuscript has been reviewed in accordance with the peer- and administrative-review policies of the authors' organization. Time spent by other authors on the testing, assessment and preparation of the manuscript was supported by their employer. The employer provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asiimwe P, 2014, ENVIRON ENTOMOL, V43, P263, DOI 10.1603/EN12328; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Bauer PJ, 2004, AGRON J, V96, P369, DOI 10.2134/agronj2004.0369; Baum JA, 2012, J ECON ENTOMOL, V105, P616, DOI 10.1603/EC11207; Berge Jean Baptiste, 2010, GM Crops, V1, P214, DOI 10.4161/gmcr.1.4.13421; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Carpenter J, 2002, COMP ENV IMPACTS BIO; Carstens Keri, 2014, GM Crops Food, V5, P11, DOI 10.4161/gmcr.26560; CHELLEMI DO, 1994, ENVIRON ENTOMOL, V23, P337, DOI 10.1093/ee/23.2.337; Chougule NP, 2012, TOXINS, V4, P405, DOI 10.3390/toxins4060405; CLEVELAND TC, 1982, ENVIRON ENTOMOL, V11, P1049, DOI 10.1093/ee/11.5.1049; Cook D, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10024; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Ellsworth P. C, 2001, COST EFFECTIVE LYGUS; EPA, 2010, BAC THUR CRY3BB1 PRO; EPA, 2012, BAC THUR ECRY3 1AB I; EPA, 2010, BAC THUR CRY3AB1 CRY; Ervin D., 2010, IMPACT GENETICALLY E; Esquivel JF, 2007, ENVIRON ENTOMOL, V36, P725, DOI 10.1603/0046-225X(2007)36[725:HPOTTP]2.0.CO;2; Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330; Gowda A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12213; GraphPad PRISM&REG;, 2013, PRISM 6 WIND VERS 6; Grimaldi David, 2005, pi; James C., 2014, GLOBAL STATUS COMMER; Jerga A., 2016, ARCH BIOCH BIOPHYS; Kelker MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112555; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Li H., 2015, SCI REP, V5; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; Luttrell R.G., 2014, Midsouth Entomologist, V7, P89; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Moar WJ, 2016, J INVERTEBR PATHOL; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; OECD Guidelines for the Testing of Chemicals, 2009, OECD GUID TEST CHEM; OECD (Organization for Economic Co-operation and Development), 2007, CONS DOC SAF INF TRA; Organisation for Economic Co-operation and Development, 1984, OECD GUID TEST CHEM; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Porcar M, 2009, APPL ENVIRON MICROB, V75, P4897, DOI 10.1128/AEM.00686-09; Raybould A, 2011, TRANSGENIC RES, V20, P599, DOI 10.1007/s11248-010-9442-1; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2009, J APPL ENTOMOL, V133, P571, DOI 10.1111/j.1439-0418.2009.01423.x; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Rukarwa RJ, 2014, 3 BIOTECH, V4, P217, DOI 10.1007/s13205-013-0153-1; SAS, 2012, SAS SOFTW REL 9 4 TS; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Snodgrass GL, 2006, ENVIRON ENTOMOL, V35, P1417, DOI 10.1603/0046-225X(2006)35[1417:SOTPBH]2.0.CO;2; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Tan JG, 2016, ENVIRON TOXICOL CHEM, V35, P287, DOI 10.1002/etc.3075; Tan JG, 2011, ENVIRON ENTOMOL, V40, P1613, DOI 10.1603/EN11060; Torres JB, 2008, TRANSGENIC RES, V17, P345, DOI 10.1007/s11248-007-9109-8; van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Wach M, 2016, TRANSGENIC RES, V25, P499, DOI 10.1007/s11248-016-9945-5; WALTERS FS, 1995, ENTOMOL EXP APPL, V77, P211, DOI 10.1007/BF02383036; Waterhouse D. F., 1989, ACIAR MONOGR SER, Vi-vii, P1; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WIDNER WR, 1989, J BACTERIOL, V171, P965, DOI 10.1128/jb.171.2.965-974.1989; Williams M, 2014, 2014 BELTW COTT C JA; Wilson L, 2006, P 13 AUSTR COT RES C; Xu CC, 2015, BIOCHEM BIOPH RES CO, V462, P184, DOI 10.1016/j.bbrc.2015.04.068; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747; Zhu YC, 2015, PEST MANAG SCI, V71, P40, DOI 10.1002/ps.3761	64	33	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169409	10.1371/journal.pone.0169409	http://dx.doi.org/10.1371/journal.pone.0169409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072875	Green Published, Green Submitted, gold			2022-12-26	WOS:000391844200018
J	Ohtsuka, H; Iguchi, T; Hayashi, M; Kaneda, M; Iida, K; Shimonaka, M; Hara, T; Arai, M; Koike, Y; Yamamoto, N; Kasahara, K				Ohtsuka, Hiroko; Iguchi, Tomohiro; Hayashi, Moyuru; Kaneda, Mizuho; Iida, Kazuko; Shimonaka, Motoyuki; Hara, Takahiko; Arai, Morio; Koike, Yuichi; Yamamoto, Naomasa; Kasahara, Kohji			SDF-1 alpha/CXCR4 Signaling in Lipid Rafts Induces Platelet Aggregation via PI3 Kinase-Dependent Akt Phosphorylation	PLOS ONE			English	Article							RECEPTOR GLYCOPROTEIN-VI; CD34(+) PROGENITOR CELLS; CEREBELLAR GROWTH CONES; FACTOR-I; MEMBRANE RAFTS; TYROSINE KINASE; ACTIVATION; ASSOCIATION; CXCR4; LYN	Stromal cell-derived factor-1 alpha (SDF-1 alpha)-induced platelet aggregation is mediated through its G protein-coupled receptor CXCR4 and phosphatidylinositol 3 kinase (P13K). Here, we demonstrate that SDF-1 alpha induces phosphorylation of Akt at Thr308 and Ser473 in human platelets. SDF-1 alpha-induced platelet aggregation and Akt phosphorylation are inhibited by pretreatment with the CXCR4 antagonist AMD3100 or the P13K inhibitor LY294002. SDF-1 alpha also induces the phosphorylation of PDK1 at Ser241 (an upstream activator of Akt), GSK3 beta at Ser9 (a downstream substrate of Akt), and myosin light chain at Ser19 (a downstream element of the Akt signaling pathway). SDF-1 alpha-induced platelet aggregation is inhibited by pretreatment with the Akt inhibitor MK-2206 in a dose-dependent manner. Furthermore, SDF-1 alpha-induced platelet aggregation and Akt phosphorylation are inhibited by pretreatment with the raft-disrupting agent methyl-beta-cyclodextrin. Sucrose density gradient analysis shows that 35% of CXCR4, 93% of the heterotrimeric G proteins G alpha i-1, 91% of G alpha i-2, 50% of G beta and 4.0% of PI3K beta, and 4.5% of Akt2 are localized in the detergent-resistant membrane raft fraction. These findings suggest that SDF-1 alpha/CXCR4 signaling in lipid rafts induces platelet aggregation via P13K-dependent Akt phosphorylation.	[Ohtsuka, Hiroko; Iguchi, Tomohiro; Hayashi, Moyuru; Kaneda, Mizuho; Iida, Kazuko; Kasahara, Kohji] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Tokyo, Japan; [Ohtsuka, Hiroko; Shimonaka, Motoyuki] Tokyo Univ Sci, Dept Chem, Tokyo, Japan; [Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Tokyo, Japan; [Arai, Morio] Baxalta Japan Ltd, Tokyo, Japan; [Koike, Yuichi] Ohu Univ, Sch Pharmaceut Sci, Dept Drug Metab & Clin Pharmacokinet, Fukushima, Japan; [Yamamoto, Naomasa] Ohu Univ, Sch Pharmaceut Sci, Dept Biochem, Fukushima, Japan; [Hayashi, Moyuru] Tohoku Med & Pharmaceut Univ, Fac Med, Dept Physiol, Aoba Ku, Sendai, Miyagi, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo University of Science; Tokyo Metropolitan Institute of Medical Science; Tohoku Medical & Pharmaceutical University	Kasahara, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Tokyo, Japan.	kasahara-kj@igakuken.or.jp			JSPS KAKENHI [26440071]; Baxalta Japan, Ltd	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Baxalta Japan, Ltd	This work was supported by JSPS KAKENHI Grant Number 26440071 (to K.K.) for Scientific Research (C). Baxalta Japan, Ltd provided support in the form of salaries for authors [MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section." Please note that one or more authors is affiliated to "Baxalta Japan Ltd."	Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Badolia R, 2015, BLOOD, V125, P175, DOI 10.1182/blood-2014-05-576306; Bodin S, 2003, BBA-BIOMEMBRANES, V1610, P247, DOI 10.1016/S0005-2736(03)00022-1; Bodin S, 2003, THROMB HAEMOSTASIS, V89, P318, DOI 10.1055/s-0037-1613449; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; Chatterjee M, 2014, FASEB J, V28, P2864, DOI 10.1096/fj.14-249730; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Dangelmaier C, 2014, THROMB HAEMOSTASIS, V111, P508, DOI 10.1160/TH13-06-0484; Dorahy DJ, 1998, BIOCHEM J, V333, P373, DOI 10.1042/bj3330373; Ezumi Y, 2002, BLOOD, V99, P3250, DOI 10.1182/blood.V99.9.3250; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Geisler T, 2012, EUR J RADIOL, V81, pE486, DOI 10.1016/j.ejrad.2011.06.019; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Jorbenadze R, 2014, PLATELETS, V25, P409, DOI 10.3109/09537104.2013.829913; Kasahara K, 1999, BIOPHYS CHEM, V82, P121, DOI 10.1016/S0301-4622(99)00111-8; Kasahara K, 2002, NEUROCHEM RES, V27, P823, DOI 10.1023/A:1020265225916; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; Kasahara K, 2013, BLOOD, V122, P3340, DOI 10.1182/blood-2013-04-491290; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kowalska MA, 1999, BRIT J HAEMATOL, V104, P220, DOI 10.1046/j.1365-2141.1999.01169.x; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li X, 2004, GASTROENTEROLOGY, V126, P122, DOI 10.1053/j.gastro.2003.10.061; Lin ML, 2014, MOL CARCINOGEN, V53, P360, DOI 10.1002/mc.21984; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Miki T, 2013, GLYCOCONJUGATE J, V30, P819, DOI 10.1007/s10719-013-9487-5; Moscardo A, 2014, FEBS LETT, V588, P3154, DOI 10.1016/j.febslet.2014.06.057; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Sekino-Suzuki N, 2013, J NEUROCHEM, V124, P514, DOI 10.1111/jnc.12040; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Signorello MG, 2014, BIOCHIMIE, V105, P182, DOI 10.1016/j.biochi.2014.07.014; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stellos K, 2012, J THROMB HAEMOST, V10, P49, DOI 10.1111/j.1538-7836.2011.04547.x; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Walsh TG, 2015, CELL SIGNAL, V27, P37, DOI 10.1016/j.cellsig.2014.09.021; Woulfe DS, 2010, EXPERT REV HEMATOL, V3, P81, DOI 10.1586/EHM.09.75; Wurster T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097405; Wurster T, 2013, INT J CARDIOL, V164, P111, DOI 10.1016/j.ijcard.2011.06.082; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; Yuyama K, 2007, J BIOL CHEM, V282, P26392, DOI 10.1074/jbc.M705046200; Yuyama K, 2011, J NEUROCHEM, V116, P845, DOI 10.1111/j.1471-4159.2010.07071.x; Zhang Y, 2012, J THROMB HAEMOST, V10, P411, DOI 10.1111/j.1538-7836.2011.04607.x	53	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2017	12	1							e0169609	10.1371/journal.pone.0169609	http://dx.doi.org/10.1371/journal.pone.0169609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH5WR	28072855	Green Submitted, gold, Green Published			2022-12-26	WOS:000391844200033
J	Danielson, KM; Rubio, R; Abderazzaq, F; Das, S; Wang, YYE				Danielson, Kirsty M.; Rubio, Renee; Abderazzaq, Fieda; Das, Saumya; Wang, Yaoyu E.			High Throughput Sequencing of Extracellular RNA from Human Plasma	PLOS ONE			English	Article							MICRORNA EXPRESSION PATTERNS; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; CELL-GROWTH; MIRNA; IDENTIFICATION; SIGNATURES; TARGET; PROFILES; PROTEIN	The presence and relative stability of extracellular RNAs (exRNAs) in biofluids has led to an emerging recognition of their promise as 'liquid biopsies' for diseases. Most prior studies on discovery of exRNAs as disease-specific biomarkers have focused on microRNAs (miRNAs) using technologies such as qRT-PCR and microarrays. The recent application of next-generation sequencing to discovery of exRNA biomarkers has revealed the presence of potential novel miRNAs as well as other RNA species such as tRNAs, snoRNAs, piRNAs and lncRNAs in biofluids. At the same time, the use of RNA sequencing for biofluids poses unique challenges, including low amounts of input RNAs, the presence of exRNAs in different compartments with varying degrees of vulnerability to isolation techniques, and the high abundance of specific RNA species (thereby limiting the sensitivity of detection of less abundant species). Moreover, discovery in human diseases often relies on archival biospecimens of varying age and limiting amounts of samples. In this study, we have tested RNA isolation methods to optimize profiling exRNAs by RNA sequencing in individuals without any known diseases. Our findings are consistent with other recent studies that detect microRNAs and ribosomal RNAs as the major exRNA species in plasma. Similar to other recent studies, we found that the landscape of biofluid microRNA transcriptome is dominated by several abundant microRNAs that appear to comprise conserved extracellular miRNAs. There is reasonable correlation of sets of conserved miRNAs across biological replicates, and even across other data sets obtained at different investigative sites. Conversely, the detection of less abundant miRNAs is far more dependent on the exact methodology of RNA isolation and profiling. This study highlights the challenges in detecting and quantifying less abundant plasma miRNAs in health and disease using RNA sequencing platforms.	[Danielson, Kirsty M.; Das, Saumya] Massachusetts Gen Hosp, Cardiovasc Inst, Boston, MA 02114 USA; [Rubio, Renee; Abderazzaq, Fieda; Wang, Yaoyu E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Ctr Canc Computat Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Das, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Inst, Boston, MA 02114 USA.; Wang, YYE (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Ctr Canc Computat Biol, Boston, MA 02115 USA.	sdas@mgh.harvard.edu; yewang@jimmy.harvard.edu	Das, Saumya/R-7644-2019	Das, Saumya/0000-0002-4521-4606; Danielson, Kirsty/0000-0002-1667-2528	National Institutes of Health [UH2TR000901]; Dana-Farber Strategic Plan Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000901, UH3TR000901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Strategic Plan Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	KMD and SD are supported by National Institutes of Health UH2TR000901; RR, FA, and YEW are supported by Dana-Farber Strategic Plan Initiative.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balaj L, 2011, NATURE COMMUNICATION, V2, P9; Baran-Gale J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00352; Barturen G., 2014, METHODS NEXT GENERAT; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen Z, 2013, J CLIN INVEST, V123, P1057, DOI 10.1172/JCI65344; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Egyhazi S, 2004, CLIN CHEM, V50, P975, DOI 10.1373/clinchem.2003.027102; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gandhi R, 2015, MULT SCLER J, V21, P1095, DOI 10.1177/1352458515578771; Garmire LX, 2013, RNA, V19, P735, DOI 10.1261/rna.039271.113; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Li X, 2015, BIOTECHNIQUES, V59, P13, DOI 10.2144/000114306; Ling SK, 2013, J MOL CELL CARDIOL, V65, P127, DOI 10.1016/j.yjmcc.2013.10.003; Liu D, 2014, CANCER EPIDEMIOL, V38, P85, DOI 10.1016/j.canep.2013.12.005; Long JY, 2013, J BIOL CHEM, V288, P36202, DOI 10.1074/jbc.M113.498634; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Mi SL, 2007, BLOOD, V110, p75A; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nassirpour R, 2013, PLOS ONE, V8; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Roberts BS, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv724; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sanders K, 2015, MULT SCLER J, V21, pNP4; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sheng YR, 2014, BIOCHEM CELL BIOL, V92, P152, DOI 10.1139/bcb-2013-0128; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tian Y, 2012, INT J ONCOL, V40, P1105, DOI 10.3892/ijo.2011.1306; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L., 2014, PLOS ONE, V9; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yang WH, 2013, BIOCHEM BIOPH RES CO, V433, P24, DOI 10.1016/j.bbrc.2013.02.076; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	83	46	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0164644	10.1371/journal.pone.0164644	http://dx.doi.org/10.1371/journal.pone.0164644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060806	Green Submitted, Green Published, gold			2022-12-26	WOS:000391641500004
J	Han, ZP; Kautto, L; Nevalainen, H				Han, Zhiping; Kautto, Liisa; Nevalainen, Helena			Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS PROTEASES; PSEUDALLESCHERIA-BOYDII; CYSTIC-FIBROSIS; SERINE-PROTEASE; EXTRACELLULAR PROTEASES; MOLECULAR PHYLOGENY; PROTEOMIC ANALYSIS; PROTEINS; IDENTIFICATION; APIOSPERMUM	Scedosporium aurantiacum is an opportunistic filamentous fungus increasingly isolated from the sputum of cystic fibrosis patients, and is especially prevalent in Australia. At the moment, very little is known about the infection mechanism of this fungus. Secreted proteases have been shown to contribute to fungal virulence in several studies with other fungi. Here we have compared the profiles of proteases secreted by a clinical isolate Scedosporium aurantiacum (WM 06.482) and an environmental strain (WM 10.136) grown on a synthetic cystic fibrosis sputum medium supplemented with casein or mucin. Protease activity was assessed using class-specific substrates and inhibitors. Subtilisin-like and trypsin-like serine protease activity was detected in all cultures. The greatest difference in the secretion of proteases between the two strains occurred in mucin-supplemented medium, where the activities of the elastase-like, trypsin-like and aspartic proteases were, overall, 2.5-75 fold higher in the clinical strain compared to the environmental strain. Proteases secreted by the two strains in the mucin-supplemented medium were further analyzed by mass spectrometry. Six homologs of fungal proteases were identified from the clinical strain and five from the environmental strain. Of these, three were common for both strains including a subtilisin peptidase, a putative leucine aminopeptidase and a PA-SaNapH-like protease. Trypsin-like protease was identified by mass spectrometry only in the clinical isolate even though tryp-sin-like activity was present in all cultures. In contrast, high elastase-like activity was measured in the culture supernatant of the clinical strain but could not be identified by mass spectrometry searching against other fungi in the NCBI database. Future availability of an annotated genome will help finalise identification of the S. aurantiacum proteases.	[Han, Zhiping; Kautto, Liisa; Nevalainen, Helena] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Han, Zhiping; Kautto, Liisa; Nevalainen, Helena] Macquarie Univ, Biomol Frontiers Res Ctr, Sydney, NSW, Australia	Macquarie University; Macquarie University	Han, ZP (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.; Han, ZP (corresponding author), Macquarie Univ, Biomol Frontiers Res Ctr, Sydney, NSW, Australia.	zhiping.han@students.mq.edu.au		Han, Zhiping/0000-0001-5665-4618; Nevalainen, Helena/0000-0003-0083-4630; Kautto, Liisa/0000-0002-4724-8818				Alastruey-Izquierdo A, 2007, ANTIMICROB AGENTS CH, V51, P748, DOI 10.1128/AAC.01177-06; Alvarez E, 2010, J CLIN MICROBIOL, V48, P4410, DOI 10.1128/JCM.01646-10; Amini A, 2016, UTILITY BROMELAIN AC, P43; Banerjee B, 2002, J IMMUNOL, V169, P5137, DOI 10.4049/jimmunol.169.9.5137; Barata RA, 2002, J BIOSCI BIOENG, V94, P304, DOI 10.1016/S1389-1723(02)80168-2; Belmessikh A, 2013, J TAIWAN INST CHEM E, V44, P377, DOI 10.1016/j.jtice.2012.12.011; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Birinci A, 2014, MIKROBIYOL BUL, V48, P491; Blyth CC, 2010, MED MYCOL, V48, pS37, DOI 10.3109/13693786.2010.500627; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capilla J, 2003, ANTIMICROB AGENTS CH, V47, P1948, DOI 10.1128/AAC.47.6.1948-1951.2003; Coelho DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8409183; Cremer G, 1996, J MYCOL MED, V6, P165; da Silva BA, 2006, CURR MICROBIOL, V53, P18, DOI 10.1007/s00284-005-0156-1; da Silva BA, 2012, J PROTEOME RES, V11, P172, DOI 10.1021/pr200875x; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; De Bernardis F, 2001, MED MYCOL, V39, P303, DOI 10.1080/mmy.39.4.303.313; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Dienes D, 2007, ENZYME MICROB TECH, V40, P1087, DOI 10.1016/j.enzmictec.2006.08.013; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; Dubovenko AG, 2010, FUNGAL BIOL-UK, V114, P151, DOI 10.1016/j.funbio.2009.11.004; Dunaevskii YE, 2008, RUSS J BIOORG CHEM+, V34, P286, DOI 10.1134/S1068162008030059; Farnell E, 2012, FUNGAL BIOL-UK, V116, P1003, DOI 10.1016/j.funbio.2012.07.004; Fragner D, 2009, ELECTROPHORESIS, V30, P2431, DOI 10.1002/elps.200800770; FROSCO M, 1992, INFECT IMMUN, V60, P728, DOI 10.1128/IAI.60.3.728-734.1992; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Gilgado F, 2009, MED MYCOL, V47, P371, DOI 10.1080/13693780802256539; GOLDBERG GI, 1990, ANN NY ACAD SCI, V580, P375, DOI 10.1111/j.1749-6632.1990.tb17945.x; Grinyer J, 2004, CURR GENET, V45, P170, DOI 10.1007/s00294-003-0475-3; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Harun A, 2010, MED MYCOL, V48, pS45, DOI 10.3109/13693786.2010.517224; Heath CH, 2009, CLIN MICROBIOL INFEC, V15, P689, DOI 10.1111/j.1469-0691.2009.02802.x; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; HOUDRET N, 1986, BIOCHIM BIOPHYS ACTA, V880, P54, DOI 10.1016/0304-4165(86)90119-4; Huang HL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-178; Iadarola P, 1998, EXP LUNG RES, V24, P233, DOI 10.3109/01902149809041532; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Kaur J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122354; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kleinschmidt-DeMasters BK, 2002, HUM PATHOL, V33, P116, DOI 10.1053/hupa.2002.30186; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; KOJIMA K, 1979, ANAL BIOCHEM, V100, P43, DOI 10.1016/0003-2697(79)90106-4; KOLATTUKUDY PE, 1993, INFECT IMMUN, V61, P2357, DOI 10.1128/IAI.61.6.2357-2368.1993; KOTHARY MH, 1984, INFECT IMMUN, V43, P320, DOI 10.1128/IAI.43.1.320-325.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larcher G, 1996, BIOCHEM J, V315, P119, DOI 10.1042/bj3150119; Manalil NS, 2010, FUNGAL BIOL-UK, V114, P637, DOI 10.1016/j.funbio.2010.05.005; McShane D, 2003, EUR RESPIR J, V21, P37, DOI 10.1183/09031936.03.00027603; Mirzaei M, 2014, J PROTEOME RES, V13, P517, DOI 10.1021/pr400696u; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; MUMFORD RA, 1980, J BIOL CHEM, V255, P2227; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Novillo C, 1997, INSECT BIOCHEM MOLEC, V27, P247, DOI 10.1016/S0965-1748(96)00092-6; Obayashi Y, 2005, LIMNOL OCEANOGR, V50, P722, DOI 10.4319/lo.2005.50.2.0722; Ortoneda M, 2002, J MED MICROBIOL, V51, P924, DOI 10.1099/0022-1317-51-11-924; Ottesen M., 1970, METHOD ENZYMOL, P199, DOI [10.1016/0076-6879(70)19014-8, DOI 10.1016/0076-6879(70)19014-8]; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pereira M, 2009, MYCOPATHOLOGIA, V167, P25, DOI 10.1007/s11046-008-9147-7; Peretti A, 2015, GENOME ANNOUNC, V3, P1, DOI [10.1128/genomeA.01476-14, DOI 10.1128/GEN0MEA.01476-14]; Peterson R, 2011, MYCOL PROG, V10, P207, DOI 10.1007/s11557-010-0690-5; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Powers JC, 2000, J APPL TOXICOL, V21, pS177; RAUSCHER M, 1995, EXP MYCOL, V19, P26, DOI 10.1006/emyc.1995.1004; ROBINSON BWS, 1990, J ALLERGY CLIN IMMUN, V86, P726, DOI 10.1016/S0091-6749(05)80176-9; STEPANOV VM, 1977, BIOCHEM BIOPH RES CO, V77, P298, DOI 10.1016/S0006-291X(77)80196-4; TAKEUCHI M, 1988, AGR BIOL CHEM TOKYO, V52, P1279; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Zhou ZM, 2002, J BIOL CHEM, V277, P1892, DOI 10.1074/jbc.M109096200	74	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169403	10.1371/journal.pone.0169403	http://dx.doi.org/10.1371/journal.pone.0169403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060882	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500087
J	Huang, MW; Chen, CW; Lin, WC; Ke, SW; Tsai, CF				Huang, Min-Wei; Chen, Chih-Wen; Lin, Wei-Chao; Ke, Shih-Wen; Tsai, Chih-Fong			SVM and SVM Ensembles in Breast Cancer Prediction	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; CLASSIFICATION	Breast cancer is an all too common disease in women, making how to effectively predict it an active research problem. A number of statistical and machine learning techniques have been employed to develop various breast cancer prediction models. Among them, support vector machines (SVM) have been shown to outperform many related techniques. To construct the SVM classifier, it is first necessary to decide the kernel function, and different kernel functions can result in different prediction performance. However, there have been very few studies focused on examining the prediction performances of SVM based on different kernel functions. Moreover, it is unknown whether SVM classifier ensembles which have been proposed to improve the performance of single classifiers can outperform single SVM classifiers in terms of breast cancer prediction. Therefore, the aim of this paper is to fully assess the prediction performance of SVM and SVM ensembles over small and large scale breast cancer datasets. The classification accuracy, ROC, F-measure, and computational times of training SVM and SVM ensembles are compared. The experimental results show that linear kernel based SVM ensembles based on the bagging method and RBF kernel based SVM ensembles with the boosting method can be the better choices for a small scale dataset, where feature selection should be performed in the data pre-processing stage. For a large scale dataset, RBF kernel based SVM ensembles based on boosting perform better than the other classifiers.	[Huang, Min-Wei] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Chen, Chih-Wen] Kaohsiung Municipal Chinese Med Hosp, Dept Pharm, Kaohsiung, Taiwan; [Chen, Chih-Wen] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Lin, Wei-Chao] Asia Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Ke, Shih-Wen] Chung Yuan Christian Univ, Dept Informat & Comp Engn, Taoyuan, Taiwan; [Tsai, Chih-Fong] Natl Cent Univ, Dept Informat Management, Taoyuan, Taiwan	Taichung Veterans General Hospital; Kaohsiung Medical University; Asia University Taiwan; Chung Yuan Christian University; National Central University	Chen, CW (corresponding author), Kaohsiung Municipal Chinese Med Hosp, Dept Pharm, Kaohsiung, Taiwan.; Chen, CW (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan.	chenchihwen@yahoo.com.tw						Abdelaal M. M. A., 2010, INT MULT COMP SCI IN, P11; Ali A., 2009, INT C INT SCI INF TE, P1259; Aruna S., 2011, CCSEA CS IT, V2, P37, DOI DOI 10.5121/CSIT.2011.1205; Baten A., 2006, BMC BIOINFORM S5, V7, P1; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buck T. A. E., 2006, SVM KERNELS OPTIMIZA; Byun H, 2003, INT J PATTERN RECOGN, V17, P459, DOI 10.1142/S0218001403002460; Cruz JA, 2006, CANCER INFORM, V2, P59; Das SR, 2012, PROCEDIA ENGINEER, V38, P1340, DOI 10.1016/j.proeng.2012.06.165; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Frosyniotis D, 2003, PATTERN ANAL APPL, V6, P32, DOI 10.1007/s10044-002-0174-6; Gayathri BM., 2013, INT J PARALLEL DISTR, V4, P105, DOI [10.5121/ijdps.2013.4309, DOI 10.5121/IJDPS.2013.4309]; HAPPEL BLM, 1994, NEURAL NETWORKS, V7, P985, DOI 10.1016/S0893-6080(05)80155-8; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Huang CL, 2008, EXPERT SYST APPL, V34, P578, DOI 10.1016/j.eswa.2006.09.041; Joshi J., 2014, INT J ENG RES GEN SC, V2, P315; Kharya S., 2012, INT J COMPUTSCIENGIN, V2, P55, DOI DOI 10.5121/IJCSEIT.2012.2206; Kim HC, 2003, PATTERN RECOGN, V36, P2757, DOI 10.1016/S0031-3203(03)00175-4; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Lavanya D., 2012, INT J INFORM TECHNOL, V2, P17, DOI DOI 10.5121/IJITCS.2012.2103; LG A., 2013, J HLTH MED INFORM, V4, P2, DOI [10.4172/2157-7420.1000124, DOI 10.4172/2157, DOI 10.4172/2157-7420.1000124]; Li R, 2010, ADV MAT RES, V108-111, P95, DOI [10.4028/www.scientific.net/AMR.108-111.95, 10.1109/GCIS.2010.278]; Mezghani DBA., 2010, INT J HYBRID INF TEC, V3, P23; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Powers D. M, 2011, ARXIV201016061; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Salama GI, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING & SYSTEMS (ICCES'2012), P180, DOI 10.1109/ICCES.2012.6408508; Sant A., 2013, INT J ADVCOMPUT RES, V3, P256; Saunders C., 2009, BREAST CANC; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Senturk Z.K., 2014, BREAST CANC DIAGNOSI, V4, P35, DOI [10.5121/cseij.2014.4104, DOI 10.5121/CSEIJ.2014.4104]; Shajahaan SS., 2013, INT J EMERGING TECHN, V3, P362; Vapnik V., 1998, STAT LEARNING THEORY; Wozniak M, 2014, INFORM FUSION, V16, P3, DOI 10.1016/j.inffus.2013.04.006; Yekkehkhany B., 2014, INT C GEOSP INF RES, P281; You H, 2010, INT J INTERACT MULTI, V1, P6, DOI 10.9781/ijimai.2010.131	39	134	138	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0161501	10.1371/journal.pone.0161501	http://dx.doi.org/10.1371/journal.pone.0161501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060807	Green Published, gold, Green Submitted			2022-12-26	WOS:000391641500001
J	Mieusset, R; Walschaerts, M; Isus, F; Almont, T; Daudin, M; Hamdi, SM				Mieusset, Roger; Walschaerts, Marie; Isus, Francois; Almont, Thierry; Daudin, Myriam; Hamdi, Safouane M.			Diagnosis of Partial Retrograde Ejaculation in Non-Azoospermic Infertile Men with Low Semen Volume	PLOS ONE			English	Article							MALE REPRODUCTIVE-TRACT; SPINAL-CORD-INJURY; SEXUAL DYSFUNCTION; DUCT OBSTRUCTION; DISORDERS; URINE; SPERM; ANEJACULATION; MANAGEMENT; UPDATE	In non-azoospermic patients with low semen volume (LSV), looking for partial retrograde ejaculation (PRE) by searching sperm in the postejaculatory urine (PEU) is required. The use of a retro-ejaculatory index (R-ratio) was suggested to define PRE, but none of the studies indicated a specific threshold above which PRE must be considered. Our objective was to propose a threshold value for the R-ratio as indicative of PRE in patients with LSV selected to be devoid of any known causes or risk factors for retrograde ejaculation or LSV. Among our data base (2000-2009) including 632 patients with PEU, 245 male patients from infertile couples who had had a first semen analysis with LSV (< 2mL) and a second semen analysis associated with PEU, were selected on the previous criteria. A prospective control group was randomly constituted (2007-2008) of 162 first consulting male patients from infertile couples, with a normal semen volume (>= 2mL) on a first semen analysis and who accepted to collect PEU with their usual second semen analysis, selected on the previous criteria. To define an R-ratio threshold indicative of PRE, we used a ROC curve analysis and a regression tree based on a classification and regression tree (CART) algorithm. Of the 245 LSV patients, 146 still presented low semen volume (< 2 mL) on the second semen analysis. From the use of the CART algorithm, two low (1.5% and 2.8%) and two high R-values (7.1% and 8.3%) were defined, according to the lower reference limit for semen volume of 2.0 mL (WHO 1999) or 1.5 mL (WHO 2010) respectively. As only one or no patient with normal semen volume was observed above the two high R-values, we suggest an R-value higher than the range of [7.1-8.3]% as indicative of PRE until confirmation by a prospective multicenter study.	[Mieusset, Roger; Walschaerts, Marie; Isus, Francois; Almont, Thierry; Daudin, Myriam; Hamdi, Safouane M.] Univ Toulouse III Paul Sabatier, Grp Rech Fertil Humaine, Human Fertil Res Grp, Toulouse, France; [Isus, Francois] CHU Toulouse, Hop Paule Viguier, Androl Med Reprod, Toulouse, France; [Daudin, Myriam] CHU Toulouse, Hop Paule Viguier, Explorat Biol Med Reprod, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse	Hamdi, SM (corresponding author), Univ Toulouse III Paul Sabatier, Grp Rech Fertil Humaine, Human Fertil Res Grp, Toulouse, France.	safouane.hamdi@univ-tlse3.fr	HAMDI, Safouane/AAC-4205-2019	DAUDIN, Myriam/0000-0003-3700-5596; ISUS, Francois/0000-0002-9467-0085; Walschaerts, Marie/0000-0002-9114-1663; Almont, Thierry/0000-0002-2536-2636; Mieusset, Roger/0000-0001-9057-630X; /0000-0002-2434-3441				Alwaal A, 2015, FERTIL STERIL, V104, P1051, DOI 10.1016/j.fertnstert.2015.08.033; Ariagno JI, 2005, ARCH ANDROLOGY, V51, P431, DOI 10.1080/014850190953294; Barazani Y, 2012, ASIAN J ANDROL, V14, P525, DOI 10.1038/aja.2012.29; Brackett NL, 1998, J UROLOGY, V159, P1931, DOI 10.1016/S0022-5347(01)63200-2; Breiman L., 1984, CLASSIFICATION REGRE; Chehensse C, 2013, HUM REPROD UPDATE, V19, P507, DOI 10.1093/humupd/dmt029; Clement P, 2015, BASIC CLIN PHARM TOX; Colpi GM, 1997, HUM REPROD, V12, P2186, DOI 10.1093/humrep/12.10.2186; CRICH JP, 1978, FERTIL STERIL, V30, P572; Dohle GR, 2003, ANDROLOGIA, V35, P321, DOI 10.1046/j.1439-0272.2003.00577.x; Dohle GR, 2003, UROL RES, V31, P22, DOI 10.1007/s00240-003-0295-4; Eisenberg ML, 2008, J UROLOGY, V180, P255, DOI 10.1016/j.juro.2008.03.019; El-Assmy A, 2012, INT UROL NEPHROL, V44, P1623, DOI 10.1007/s11255-012-0253-6; Engelbertz F, 2010, FORENSIC SCI INT, V194, P15, DOI 10.1016/j.forsciint.2009.10.002; Fedder J, 2013, ANDROLOGY-US, V1, P602, DOI 10.1111/j.2047-2927.2013.00083.x; Fode M, 2012, ASIAN J ANDROL, V14, P61, DOI 10.1038/aja.2011.70; GOLUBOFF ET, 1995, UROLOGY, V45, P925, DOI 10.1016/S0090-4295(99)80109-5; Gudeman SR, 2015, J UROLOGY, V193, P1318, DOI 10.1016/j.juro.2014.10.048; Jefferys A, 2012, FERTIL STERIL, V97, P306, DOI 10.1016/j.fertnstert.2011.11.019; Jungwirth A, EAU WORKING GROUP MA; Kamischke A, 2002, INT J ANDROL, V25, P333, DOI 10.1046/j.1365-2605.2002.00379.x; Kamischke A, 1999, HUM REPROD UPDATE, V5, P448, DOI 10.1093/humupd/5.5.448; Lotti F, 2013, ANDROLOGY-US, V1, P764, DOI 10.1111/j.2047-2927.2013.00114.x; Lotti F, 2012, HUM REPROD, V27, P974, DOI 10.1093/humrep/des032; Marconi M, 2009, INT BRAZ J UROL, V35, P299, DOI 10.1590/S1677-55382009000300006; Mehta A, 2012, J ANDROL, V33, P917, DOI 10.2164/jandrol.111.015974; MIEUSSET R, 1995, HUM REPROD, V10, P613, DOI 10.1093/oxfordjournals.humrep.a135998; Previnaire JG, 2016, SPINAL CORD; Rigot JM, 2013, PROG UROL, V23, P657, DOI 10.1016/j.purol.2013.01.011; Sigman M, 2008, UROLOGY, V71, P110, DOI 10.1016/j.urology.2007.09.032; Soler JM, 2007, J UROLOGY, V178, P2082, DOI 10.1016/j.juro.2007.07.047; Soler JM, 2011, EUR J PHYS REHAB MED, V47, P677; TEMPLETON A, 1982, BRIT J OBSTET GYNAEC, V89, P1064, DOI 10.1111/j.1471-0528.1982.tb04668.x; Tomita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136844; WEISSENBERG R, 1984, INT J ANDROL, V7, P142, DOI 10.1111/j.1365-2605.1984.tb00769.x; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0168742	10.1371/journal.pone.0168742	http://dx.doi.org/10.1371/journal.pone.0168742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060836	Green Published, Green Submitted, gold			2022-12-26	WOS:000391641500038
J	Sharma, SK; Vashishtha, R; Chauhan, LS; Sreenivas, V; Seth, D				Sharma, Surendra K.; Vashishtha, Richa; Chauhan, L. S.; Sreenivas, V.; Seth, Divya			Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting	PLOS ONE			English	Article							SKIN-TEST; COUNTRIES; ASSAYS	Background There are currently two tests for diagnosing latent tuberculosis infection (LTBI); TST and IGRA. However, it is still unclear that which one of these tests performs better in high TB-burden settings. Methods 1511 household contacts of pulmonary TB patients were enrolled to compare the performance of TST and IGRA for LTBI. At baseline all participant underwent testing for IGRA [QuantiFERON-TB (R) Gold In-tube (QFT-GIT) assay] and TST [2 tuberculin unit (TU), purified protein derivative (PPD), RT23, Staten Serum Institute (SSI), Copenhagen, Denmark]. All the household contacts were followed-up for two years for incident TB cases. Results Active TB was diagnosed in 76 household contacts at an incidence rate of 2.14 per 1000 person-years. Both, TST [Hazard Ratio (HR): 1.14, 95% confidence interval (CI): 0.72-1.79, p = 0.57], as well as QFT-GIT assay (HR: 1.66, 95% CI: 0.97-2.84, p = 0.06) results at baseline were not significantly associated with subsequent development of active TB among household contacts of pulmonary TB patients. Conclusion Neither TST nor IGRA predicted subsequent development of active TB among household contacts of pulmonary TB patients during follow-up. However, keeping in view the cost, and other logistics, TST remains the most preferred method for LTBI diagnosis in resource-limited, high TB-burden settings.	[Sharma, Surendra K.; Vashishtha, Richa] All India Inst Med Sci, Dept Internal Med, New Delhi, India; [Chauhan, L. S.] Natl Ctr Dis Control NCDC2, New Delhi, India; [Sreenivas, V.; Seth, Divya] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, SK (corresponding author), All India Inst Med Sci, Dept Internal Med, New Delhi, India.	sksharma.aiims@gmail.com			Central TB Division (CTD), Ministry of Health & Family Welfare, Government of India [NI-1041]; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR7730/Med/14/1080/2006]; Ministry of Science and Technology, Government of India [SB/S2/JCB-04/2013]	Central TB Division (CTD), Ministry of Health & Family Welfare, Government of India; Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India)	This work was supported by grant from Central TB Division (CTD), (NI-1041), Ministry of Health & Family Welfare, Government of India and Department of Biotechnology (DBT), (No.BT/PR7730/Med/14/1080/2006) Ministry of Science and Technology, Government of India. Surendra K. Sharma was supported by J.C. Bose National Fellowship (SB/S2/JCB-04/2013) from the Ministry of Science and Technology, Government of India.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Chan-Yeung M, 2007, J AM GERIATR SOC, V55, P1592, DOI 10.1111/j.1532-5415.2007.01316.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Hill PC, 2006, CLIN INFECT DIS, V40, P273; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Karmakar S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/239021; Kruczak K, 2014, SCAND J INFECT DIS, V46, P649, DOI 10.3109/00365548.2014.927955; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; MALIK SK, 1974, INDIAN J CHEST DIS, V16, P94; Malson JL, 2001, TOB CONTROL, V10, P181, DOI 10.1136/tc.10.2.181; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; National Tuberculosis Association of USA, 1961, DIAGN STAND CLASS TB; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Revised National Tuberculosis Control Programme (RNTCP), 2010, TRAIN MOD MED PRACT, P1; Sharma S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-165; Sharma SK, 2005, LANCET INFECT DIS, V5, P415, DOI 10.1016/S1473-3099(05)70163-8; Sharma SK, 2012, CHEST, V142, P761, DOI 10.1378/chest.12-0142; Song SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100267; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2014, WHOHTMTB201501	26	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169539	10.1371/journal.pone.0169539	http://dx.doi.org/10.1371/journal.pone.0169539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060926	gold, Green Published, Green Submitted			2022-12-26	WOS:000391641500106
J	Titova, E; Salvesen, O; Bentsen, SB; Sunde, S; Steinshamn, S; Henriksen, AH				Titova, Elena; Salvesen, Oyvind; Bentsen, Signe Berit; Sunde, Synnove; Steinshamn, Sigurd; Henriksen, Anne Hildur			Does an Integrated Care Intervention for COPD Patients Have Long-Term Effects on Quality of Life and Patient Activation? A Prospective, Open, Controlled Single-Center Intervention Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SELF-MANAGEMENT; HOSPITAL ANXIETY; DEPRESSION SCALE; HEALTH; VALIDATION; EXACERBATIONS	Background Implementation of the COPD-Home integrated disease management (IDM) intervention at discharge after hospitalizations for acute exacerbations of COPD (AECOPD) led to reduced hospital utilization during the following 24 months compared to the year prior to study start. Aims To analyze the impact of the COPD-Home IDM intervention on health related quality of life, symptoms of anxiety and depression, and the degree of patient activation during 24 months of follow-up and to assess the association between these outcomes. Methods A single center, prospective, open, controlled clinical study. Changes in The St. George Respiratory Questionnaire (SGRQ), the Hospital anxiety (HADS-A) and depression (HADS-D) and the patient activation measure (PAM) scores were compared between the patients in the integrated care group (ICG) and the usual care group (UCG) 6, 12 and 24 months after enrolment. Results The questionnaire response rate was 80-96%. There were no statistically significant differences in the change of the SGRQ scores between the groups during follow up. After 12 months of follow-up there was a trend towards a reduction in the mean HADS-A score in the ICG compared to the UCG. The HADS-D scores remained stable in the ICG compared with an increasing trend in the UCG. Clinically significant difference in the PAM score was achieved only in the ICG, 6.7 (CI95% 0.7 to 7.5) compared to 3.6 (CI95%-1.4 to 8.6) in the UCG. In a logistic regression model a higher HADS-D score and current smoking significantly increased the odds for a low PAM score. Conclusion The COPD-Home IDM intervention did not result in any statistically significant changes in mean SGRQ, HADS-A, HADS-D or PAM scores during the 24 months of follow-up.	[Titova, Elena; Steinshamn, Sigurd; Henriksen, Anne Hildur] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Titova, Elena; Sunde, Synnove; Steinshamn, Sigurd; Henriksen, Anne Hildur] Univ Trondheim Hosp, Dept Thorac & Occupat Med, Trondheim, Norway; [Salvesen, Oyvind] Norwegian Univ Sci & Technol, Fac Med, Trondheim, Norway; [Bentsen, Signe Berit] Univ Stavanger, Dept Hlth Educ, Stavanger, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Universitetet i Stavanger	Titova, E (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Titova, E (corresponding author), Univ Trondheim Hosp, Dept Thorac & Occupat Med, Trondheim, Norway.	elena.titova@ntnu.no			Research Council of Norway	Research Council of Norway(Research Council of Norway)	Our research was supported by the Research Council of Norway. The Research Council of Norway had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, GLOB STRAT DIAGN MAN; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bos-Touwen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126400; Bourbeau J, 2013, CHRON RESP DIS, V10, P99, DOI 10.1177/1479972312473844; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Chavannes Niels H, 2009, Prim Care Respir J, V18, P171, DOI 10.3132/pcrj.2009.00003; Dixon A, 2009, PATIENT, V2, P257, DOI 10.2165/11313790-000000000-00000; Esteban C, 2009, RESP MED, V103, P1201, DOI 10.1016/j.rmed.2009.02.002; Fowles JB, 2009, PATIENT EDUC COUNS, V77, P116, DOI 10.1016/j.pec.2009.02.018; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Hernandez Carme, 2015, Int J Integr Care, V15, pe006; Hernandez C, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.22; Hibbard JH, 2013, HEALTH AFFAIR, V32, P216, DOI 10.1377/hlthaff.2012.1064; Jakovljevic M, 2014, EUR NEUROPSYCHOPHARM, V24, P333, DOI 10.1016/j.euroneuro.2013.11.014; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kinney RL, 2015, PATIENT EDUC COUNS, V98, P545, DOI 10.1016/j.pec.2015.02.005; Kruis AL, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5392; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Miravitlles M, 2004, THORAX, V59, P387, DOI 10.1136/thx.2003.008730; Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21, DOI 10.1097/00004479-200701000-00005; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Nici Linda, 2012, Proc Am Thorac Soc, V9, P9, DOI 10.1513/pats.201201-014ST; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rademakers J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-577; Rice K, 2014, CLIN CHEST MED, V35, P337, DOI 10.1016/j.ccm.2014.02.004; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Schuz N, 2015, COPD; Skolasky Richard L, 2008, Spine (Phila Pa 1976), V33, pE784, DOI 10.1097/BRS.0b013e31818027f1; SNAITH RP, 1987, BRIT J PSYCHIAT, V150, P387, DOI 10.1192/bjp.150.3.387; Stepleman L, 2010, DISABIL REHABIL, V32, P1558, DOI 10.3109/09638280903567885; Sunde S, 2013, SCANDINAVIAN J CARIN; Titova E, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0170-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0167887	10.1371/journal.pone.0167887	http://dx.doi.org/10.1371/journal.pone.0167887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EH3AX	28060921	gold, Green Published			2022-12-26	WOS:000391641500017
J	Yan, WQ; Xu, GH; Li, M; Xie, J; Han, C; Zhang, S; Luo, A; Chen, C				Yan, Wenqiang; Xu, Guanghua; Li, Min; Xie, Jun; Han, Chengcheng; Zhang, Sicong; Luo, Ailing; Chen, Chaoyang			Steady-State Motion Visual Evoked Potential (SSMVEP) Based on Equal Luminance Colored Enhancement	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SPECTRAL SENSITIVITIES; CONES; CORTEX	Steady-state visual evoked potential (SSVEP) is one of the typical stimulation paradigms of brain-computer interface (BCI). It has become a research approach to improve the performance of human-computer interaction, because of its advantages including multiple objectives, less recording electrodes for electroencephalogram (EEG) signals, and strong anti-interference capacity. Traditional SSVEP using light flicker stimulation may cause visual fatigue with a consequent reduction of recognition accuracy. To avoid the negative impacts on the brain response caused by prolonged strong visual stimulation for SSVEP, steadystate motion visual evoked potential (SSMVEP) stimulation method was used in this study by an equal-luminance colored ring-shaped checkerboard paradigm. The movement patterns of the checkerboard included contraction and expansion, which produced less discomfort to subjects. Feature recognition algorithms based on power spectrum density (PSD) peak was used to identify the peak frequency on PSD in response to visual stimuli. Results demonstrated that the equal-luminance red-green stimulating paradigm within the low frequency spectrum (lower than 15 Hz) produced higher power of SSMVEP and recognition accuracy than black-white stimulating paradigm. PSD-based SSMVEP recognition accuracy was 88.15 +/- 6.56%. There was no statistical difference between canonical correlation analysis (CCA) (86.57 +/- 5.37%) and PSD on recognition accuracy. This study demonstrated that equal-luminance colored ring-shaped checkerboard visual stimulation evoked SSMVEP with better SNR on low frequency spectrum of power density and improved the interactive performance of BCI.	[Yan, Wenqiang; Xu, Guanghua; Li, Min; Xie, Jun; Han, Chengcheng; Zhang, Sicong; Luo, Ailing] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China; [Xu, Guanghua; Luo, Ailing] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China; [Chen, Chaoyang] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Wayne State University	Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China.; Xu, GH (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China.	ghxu@mail.xjtu.edu.cn	Li, Min/W-2652-2017; Chen, Chaoyang/H-3605-2012	Li, Min/0000-0002-2959-9147; Chen, Chaoyang/0000-0003-0838-2245	National Natural Science Foundation of China [91420301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (91420301). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Alkan Ahmet, 2006, J Med Syst, V30, P413, DOI 10.1007/s10916-005-9001-0; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Delon-Martin C, 2006, NEUROIMAGE, V31, P1567, DOI 10.1016/j.neuroimage.2006.02.013; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; MCCANN JJ, 1976, VISION RES, V16, P445, DOI 10.1016/0042-6989(76)90020-1; Miner LA, 1998, ARCH PHYS MED REHAB, V79, P1029, DOI 10.1016/S0003-9993(98)90165-4; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Peters BO, 1998, NEURAL NETWORKS, V11, P1429, DOI 10.1016/S0893-6080(98)00060-4; Snowden RJ, 2004, CURR BIOL, V14, pR828, DOI 10.1016/j.cub.2004.09.033; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 1994, CLIN NEUROPHYSIOL, V90, P444; Xie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04953; Xie J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039707; Yin EW, 2015, IEEE T NEUR SYS REH, V23, P693, DOI 10.1109/TNSRE.2015.2403270; Yin EW, 2015, IEEE T BIO-MED ENG, V62, P1447, DOI 10.1109/TBME.2014.2320948	23	26	28	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2017	12	1							e0169642	10.1371/journal.pone.0169642	http://dx.doi.org/10.1371/journal.pone.0169642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AX	28060906	gold, Green Submitted, Green Published			2022-12-26	WOS:000391641500121
J	Aromseree, S; Middeldorp, JM; Pientong, C; van Eijndhoven, M; Ramayanti, O; Lougheed, SM; Pegtel, DM; Steenbergen, RDM; Ekalaksananan, T				Aromseree, Sirinart; Middeldorp, Jaap M.; Pientong, Chamsai; van Eijndhoven, Monique; Ramayanti, Octavio; Lougheed, Sinead M.; Pegtel, D. Michiel; Steenbergen, Renske D. M.; Ekalaksananan, Tipaya			High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS; RIG-I; VIRAL MIRNAS; EXOSOMES; CELLS; ENDOCYTOSIS; MODULATION; PATHWAY; VITRO	Different types of cells infected with Epstein-Barr virus (EBV) can release exosomes containing viral components that functionally affect neighboring cells. Previously, we found that EBV was localized mostly in infiltrating lymphocytes within the stromal layer of cervical lesions. In this study, we aimed to determine effects of exosome-transferred EBV-encoded RNAs (EBERs) on keratinocytes expressing human papillomavirus (HPV) 16 E6/E7 (Donorl-HPV16 HFKs). Lipid transfection of in vitro-transcribed EBER1 molecules (ivt EBER1) into Donorl-HPV16 HFKs caused strong induction of interferon (IFN)-related genes and interleukin 6 (IL-6). To gain insights into the physiological situation, monocyte-derived dendritic cells (moDCs), low passage Donorl-HPV16 HFKs and primary keratinocytes were used as recipient cells for internalization of exosomes from wild-type EBV (wt EBV) or B95-8 EBV-infected lymphoblastoid cell lines (LCLs). qRT-PCR was used to determine the expression of EBER1, HPV16 E6/E7, IFN-related genes and IL-6 in recipient cells. The secretion of inflammatory cytokines was investigated using cytometric bead array. Wt EBV-modified exosomes induced both IFN-related genes and IL-6 upon uptake into moDCs, while exosomes from B95-8 EBV LCLs induced only IL-6 in moDCs. Internalization of EBV modified exosomes was demonstrated in Donorl-HPV16 HFKs, yielding only EBER1 but not EBER2. However, EBER1 transferred by exosomes did not induce IFN-related genes or IL-6 expression and inflammatory cytokine secretion in Donorl-HPV16 HFKs and primary keratinocytes. EBER1 copy numbers in exosomes from wt EBV-infected LCLs were 10-fold higher than in exosomes from B95-8 LCLs (equal cell equivalent), whereas ivt EBER1 was used at approximately 100-fold higher concentration than in exosomes. These results demonstrated that the induction of IFN-related genes and IL-6 by EBER1 depends on quantity of EBER1 and type of recipient cells. High levels of EBER1 in cervical cells or infiltrating dendritic cells may play a role in the inflammation-to-oncogenesis transition of HPV-associated cervical cancer through modulation of innate immune signals.	[Aromseree, Sirinart; Pientong, Chamsai; Ekalaksananan, Tipaya] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Aromseree, Sirinart; Pientong, Chamsai; Ekalaksananan, Tipaya] Khon Kaen Univ, HPV & EBV, Khon Kaen, Thailand; [Aromseree, Sirinart; Pientong, Chamsai; Ekalaksananan, Tipaya] Khon Kaen Univ, Carcinogenesis Res Grp, Khon Kaen, Thailand; [Middeldorp, Jaap M.; van Eijndhoven, Monique; Ramayanti, Octavio; Pegtel, D. Michiel; Steenbergen, Renske D. M.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pathol, Med Ctr, Amsterdam, Netherlands; [Lougheed, Sinead M.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Med Ctr, Amsterdam, Netherlands	Khon Kaen University; Khon Kaen University; Khon Kaen University; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Ekalaksananan, T (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Ekalaksananan, T (corresponding author), Khon Kaen Univ, HPV & EBV, Khon Kaen, Thailand.; Ekalaksananan, T (corresponding author), Khon Kaen Univ, Carcinogenesis Res Grp, Khon Kaen, Thailand.	tipeka@kku.ac.th	Pegtel, Dirk Michiel/ABD-5481-2021	Pegtel, Dirk Michiel/0000-0002-7357-4406; Steenbergen, Renske/0000-0002-2327-9839; Middeldorp, Jaap Michiel/0000-0002-0765-4125	Thailand Research Fund; Khon Kaen University through the Royal Golden Jubilee Ph.D. Program [PHD/0193/2552]; National Research Council of Thailand [PK/2556-88]	Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University through the Royal Golden Jubilee Ph.D. Program; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the Thailand Research Fund and Khon Kaen University through the Royal Golden Jubilee Ph.D. Program (grant no. PHD/0193/2552) (http://rgj.trf.or.th/main/home/) and by the National Research Council of Thailand (grant no. PK/2556-88) (http://en.nrct.go.th/en/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; Aromseree S, 2015, J CLIN VIROL, V73, P70, DOI 10.1016/j.jcv.2015.10.015; Canitano A, 2013, CANCER LETT, V337, P193, DOI 10.1016/j.canlet.2013.05.012; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; CLARKE PA, 1992, J GEN VIROL, V73, P3169, DOI 10.1099/0022-1317-73-12-3169; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; de Martel C, 2009, CRIT REV ONCOL HEMAT, V70, P183, DOI 10.1016/j.critrevonc.2008.07.021; Duan YM, 2015, CANCER LETT, V361, P67, DOI 10.1016/j.canlet.2015.02.037; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandes JV, 2015, ONCOL LETT, V9, P1015, DOI 10.3892/ol.2015.2884; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; Hesselink AT, 2014, J CLIN MICROBIOL, V52, P890, DOI 10.1128/JCM.03195-13; Iwakiri D, 2014, CANCERS, V6, P1615, DOI 10.3390/cancers6031615; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nanbo A, 2005, J VIROL, V79, P12280, DOI 10.1128/JVI.79.19.12280-12285.2005; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Okano M, 2012, AM J MED SCI, V343, P483, DOI 10.1097/MAJ.0b013e318236e02d; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schutze DM, 2014, J VIROL, V88, P1714, DOI 10.1128/JVI.02859-13; Steenbergen RDM, 1996, ONCOGENE, V13, P1249; Takada K, 2001, SEMIN CANCER BIOL, V11, P461, DOI 10.1006/scbi.2001.0413; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Tummers B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7537; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005	39	9	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169290	10.1371/journal.pone.0169290	http://dx.doi.org/10.1371/journal.pone.0169290			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056059	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100032
J	Moriya, N; Shibasaki, S; Karasaki, M; Iwasaki, T				Moriya, Nozomu; Shibasaki, Seiji; Karasaki, Miki; Iwasaki, Tsuyoshi			The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; FIBROBLAST-LIKE SYNOVIOCYTES; GROWTH-FACTOR; TYROSINE KINASE; TH17 CELLS; SEF; INTERLEUKIN-17; ACTIVATION; MECHANISMS; LIPOPOLYSACCHARIDE	Objective Rheumatoid arthritis (RA) is an autoimmune inflammatory disease affecting joints. Elevated plasma levels of microRNA-223-3p (miR-223-3p) in patients with RA are implicated in the pathogenesis of the disease. This study aimed to analyze the functional role of miR-223-3p in the pathogenesis of RA by overexpressing miR-223-3p in synovial cell lines. Methods Arthritis was induced in the RA model of SKG mice by injection of B-glucan. The histopathologic features of joints were examined using hematoxylin and eosin and immunohistochemical staining. Plasma levels of miRNA were determined by panel real-time PCR analysis. Target genes of the differentially expressed miRNAs in SKG mice were analyzed using miRNA target prediction algorithms. The dual-luciferase reporter system was used to evaluate the relationship between miR-223-3p and IL-17 receptor D (IL-17RD). The activity of miR-223-3p was analyzed by transfection of plasmid vectors overexpressing miR-223-3p into IL-17RD-expressing NIH3T3 and MH7A cell lines. 116 and II17rd mRNA expression was analyzed by quantitative real-time PCR. IL-17RD protein expression was analyzed by western blot analysis. Results We identified 17 upregulated miRNAs (fold change > 2.0) in plasma of SKG mice injected with B-glucan relative to untreated SKG mice. II17rd was identified as the candidate target gene of miR-223-3p using five miRNA target prediction algorithms. The transfection of plasmid vectors overexpressing miR-223-3p into NIH3T3 and MH7A cells resulted in the down regulation of Il1 7rdexpression and upregulation of 116 expression. Expression of miR-223-3p and 116 m RNA in MH7A cells was upregulated; however, that of II17rd m RNA was down regulated following TNF-alpha stimulation. IL-17RD expression in synovial tissues from SKG mice and RA patients was inversely correlated with the severity of arthritis. Conclusion This study is the first to demonstrate that miR-223-3p downregulates IL-17RD in both mouse and human cells; miR-223-3p may contribute to the pathogenesis of RA by downregulating the expression of IL-17RD and upregulating that of IL-6 in synovial cells.	[Moriya, Nozomu] Hyogo Univ Hlth Sci, Sch Pharm, Dept Biopharmaceut, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo, Japan; [Shibasaki, Seiji; Karasaki, Miki] Hyogo Univ Hlth Sci, Gen Educ Ctr, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo, Japan; [Iwasaki, Tsuyoshi] Hyogo Coll Med, Dept Internal Med, Div Rheumatol, 1-1Mukogawa Cho, Nishinomiya, Hyogo, Japan; [Iwasaki, Tsuyoshi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharmacotherapy, 1-3-6 Minatojima, Kobe, Hyogo, Japan; [Moriya, Nozomu] Japanese Poison Informat Ctr, 1-1-1 Amakubo, Tsukuba, Ibaraki, Japan	Hyogo College of Medicine	Iwasaki, T (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Rheumatol, 1-1Mukogawa Cho, Nishinomiya, Hyogo, Japan.; Iwasaki, T (corresponding author), Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharmacotherapy, 1-3-6 Minatojima, Kobe, Hyogo, Japan.	tsuyo-i@huhs.ac.jp						Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Azizi G, 2013, INT J RHEUM DIS, V16, P243, DOI 10.1111/1756-185X.12132; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Fuchs Y, 2012, DEV CELL, V23, P611, DOI 10.1016/j.devcel.2012.07.013; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li N, 2013, INT J CLIN EXP PATHO, V6, P1375; Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mellett M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7669; Miyazawa K, 1998, J BIOCHEM-TOKYO, V124, P1153, DOI 10.1093/oxfordjournals.jbchem.a022233; Moriya N, 2012, BIOL PHARM BULL, V35, P473, DOI 10.1248/bpb.35.473; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Niimoto T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-209; Preger E, 2004, P NATL ACAD SCI USA, V101, P1229, DOI 10.1073/pnas.0307952100; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shibuya H, 2013, MOD RHEUMATOL, V23, P674, DOI 10.1007/s10165-012-0710-1; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Truchetet ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/295132; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Tsunemi S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4252; Tsunemi S, 2010, CLIN IMMUNOL, V136, P197, DOI 10.1016/j.clim.2010.03.428; Xiong SQ, 2003, J BIOL CHEM, V278, P50273, DOI 10.1074/jbc.M306936200; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Zheng H, 2013, INT J MOL SCI, V14, P8179, DOI 10.3390/ijms14048179; Ziv I, 2006, J BIOL CHEM, V281, P39225, DOI 10.1074/jbc.M607327200	49	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169702	10.1371/journal.pone.0169702	http://dx.doi.org/10.1371/journal.pone.0169702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056105	Green Published, gold, Green Submitted			2022-12-26	WOS:000391639100070
J	Raask, T; Maestu, J; Latt, E; Jurimae, J; Jurimae, T; Vainik, U; Konstabel, K				Raeaesk, Triin; Maeestu, Jarek; Laett, Evelin; Juerimaee, Jaak; Juerimaee, Toivo; Vainik, Uku; Konstabel, Kenn			Comparison of IPAQ-SF and Two Other Physical Activity Questionnaires with Accelerometer in Adolescent Boys	PLOS ONE			English	Article							EUROPEAN ADOLESCENTS; PUBERTAL BOYS; SHORT-FORM; VALIDITY; CHILDREN; RELIABILITY; FITNESS; YOUTH; AGREEMENT	Self-report measures of physical activity (PA) are easy to use and popular but their reliability is often questioned. Therefore, the general aim of the present study was to investigate the association of PA questionnaires with accelerometer derived PA, in a sample of adolescent boys. In total, 191 pubertal boys (mean age 14.0 years) completed three self-report questionnaires and wore an accelerometer (ActiGraph GT1M) for 7 consecutive days. The PA questionnaires were: International Physical Activity Questionnaire-Short Form (IPAQ-SF), Tartu Physical Activity Questionnaire (TPAQ), and the Inactivity subscale from Domain Specific Impulsivity (DSO scale. All three questionnaires were significantly correlated with accelerometer derived MVPA: the correlations were 0.31 for the IPAQ-SF MVPA, 0.34 for the TPAQ MVPA and-0.29 for the DSI Inactivity scale. Nevertheless, none of the questionnaires can be used as a reliable individual-level estimate of MVPA in male adolescents. The boys underreported their MVPA in IPAQ-SF as compared to accelerometer-derived MVPA (respective averages 43 and 56 minutes); underreporting was more marked in active boys with average daily MVPA at least 60 minutes, and was not significant in less active boys. Conversely, MVPA index from TPAQ overestimated the MVPA in less active boys but underestimated it in more active boys. The sedentary time reported in IPAQ-SF was an underestimate as compared to accelerometer-derived sedentary time (averages 519 and 545 minutes, respectively).	[Raeaesk, Triin; Maeestu, Jarek; Laett, Evelin; Juerimaee, Jaak; Juerimaee, Toivo] Univ Tartu, Fac Med, Inst Sport Sci & Physiotherapy, Tartu, Estonia; [Vainik, Uku; Konstabel, Kenn] Univ Tartu, Dept Psychol, Tartu, Estonia; [Konstabel, Kenn] Natl Inst Hlth Dev, Tallinn, Estonia	University of Tartu; University of Tartu; National Institute for Health Development - Estonia	Raask, T (corresponding author), Univ Tartu, Fac Med, Inst Sport Sci & Physiotherapy, Tartu, Estonia.; Konstabel, K (corresponding author), Univ Tartu, Dept Psychol, Tartu, Estonia.; Konstabel, K (corresponding author), Natl Inst Hlth Dev, Tallinn, Estonia.	triin.raask@ut.ee; kenn.konstabel@tai.ee	Mäestu, Evelin/B-7826-2019; , jarek/AAG-5620-2021; Vainik, Uku/H-8888-2019	Mäestu, Evelin/0000-0002-2939-9890; Vainik, Uku/0000-0002-9375-9520; Jurimae, Jaak/0000-0003-4819-5241; Maestu, Jarek/0000-0002-6931-3932	Estonian Research Council [IUT 20-58]; Estonian Ministry of Education and Science [SF0180048s09]	Estonian Research Council; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	The research was supported by institutional grant number IUT 20-58 from the Estonian Research Council and institutional grant no. SF0180048s09 from the Estonian Ministry of Education and Science (https://hm.ee/en). The funders had no role in study design, data collection and analysis, decistion to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Armstrong N, 2006, SPORTS MED, V36, P1067, DOI 10.2165/00007256-200636120-00005; Benitez-Porres J, 2013, J SPORT SCI, V31, P1741, DOI 10.1080/02640414.2013.803594; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boon RM, 2010, BRIT J SPORT MED, V44, P741, DOI 10.1136/bjsm.2008.052167; Carstensen B., 2013, METHCOMP FUNCTIONS A; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Ellery CVL, 2014, INT J OBESITY, V38, P1, DOI 10.1038/ijo.2013.125; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gwynn JD, 2010, AUST NZ J PUBL HEAL, V34, pS57, DOI 10.1111/j.1753-6405.2010.00555.x; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Harro J, 2009, BIOL PSYCHOL, V81, P9, DOI 10.1016/j.biopsycho.2009.01.001; Hong TK, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-93; Kim Y, 2011, PUBLIC HEALTH NUTR, V16, P440; Konstabel K, 2014, INT J OBESITY, V38, pS135, DOI 10.1038/ijo.2014.144; Lachat CK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-37; Latt E, 2013, J PUBLIC HEALTH-HEID, V21, P231, DOI 10.1007/s10389-012-0549-0; Latt E, 2015, SCAND J PUBLIC HEALT, V43, P276, DOI 10.1177/1403494815569867; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Machado-Rodrigues AM, 2011, J SPORT SCI, V29, P1503, DOI 10.1080/02640414.2011.593185; Martinez-Gomez D, 2009, NUTR HOSP, V24, P226; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; Martinez-Gomez D, 2010, AM J HUM BIOL, V22, P750, DOI 10.1002/ajhb.21076; Nilsson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-322; Ottevaere C, 2011, J SCI MED SPORT, V14, P317, DOI 10.1016/j.jsams.2011.02.008; Raask T, 2015, J SPORT SCI, V16, P1; Raask T, 2015, PERCEPT MOTOR SKILL, V121, P245, DOI 10.2466/10.03.PMS.121c13x7; Rangul V, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-47; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Tsukayama E, 2012, EUR J PERSONALITY, V26, P318, DOI 10.1002/per.841; Utsal L, 2012, HORM RES PAEDIAT, V78, P31, DOI 10.1159/000339831; Wang C, 2013, RES Q EXERCISE SPORT, V84, pS80, DOI 10.1080/02701367.2013.850991; Wedderkopp N, 2003, PEDIATR EXERC SCI, V15, P419, DOI 10.1123/pes.15.4.419; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	36	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2017	12	1							e0169527	10.1371/journal.pone.0169527	http://dx.doi.org/10.1371/journal.pone.0169527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH3AE	28056080	gold, Green Published, Green Submitted			2022-12-26	WOS:000391639100049
